0001193125-15-079092.txt : 20150306 0001193125-15-079092.hdr.sgml : 20150306 20150305174047 ACCESSION NUMBER: 0001193125-15-079092 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150306 DATE AS OF CHANGE: 20150305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIVERSAL HEALTH REALTY INCOME TRUST CENTRAL INDEX KEY: 0000798783 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 236858580 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09321 FILM NUMBER: 15678550 BUSINESS ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH RD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 610-265-0688 MAIL ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH ROAD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 10-K 1 d834449d10k.htm UNIVERSAL HEALTH REALTY INCOME TRUST--FORM 10-K Universal Health Realty Income Trust--Form 10-K
Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

x    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2014

 

OR

 

¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to                     

 

Commission File No. 1-9321

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

(Exact name of registrant as specified in its charter)

 

Maryland   23-6858580

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

Universal Corporate Center

367 South Gulph Road

P.O. Box 61558

King of Prussia, Pennsylvania

 

19406-0958

(Zip Code)

(Address of principal executive offices)  

 

Registrant’s telephone number, including area code: (610) 265-0688

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class

Shares of beneficial interest, $.01 par value

 

Name of each exchange on which registered

New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes  ¨    No  x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 

Yes  ¨    No  x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  x    No  ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes  x    No  ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  ¨    Accelerated filer  x    Non-accelerated filer  ¨   Smaller reporting company  ¨
      (Do not check if a smaller

reporting company)

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes  ¨    No  x

 

Aggregate market value of voting shares and non-voting shares held by non-affiliates as of June 30, 2014: $555,012,765 (For the purpose of this calculation only, all members of the Board of Trustees are deemed to be affiliates). Number of shares of beneficial interest outstanding of registrant as of January 31, 2015: 13,301,298

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant’s definitive proxy statement for our 2015 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange Commission within 120 days after December 31, 2014 (incorporated by reference under Part III).

 

 

 


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

2014 FORM 10-K ANNUAL REPORT

TABLE OF CONTENTS

 

PART I   

Item 1

 

Business

     1   

Item 1A

 

Risk Factors

     9   

Item 1B

 

Unresolved Staff Comments

     19   

Item 2

 

Properties

     20   

Item 3

 

Legal Proceedings

     26   

Item 4

 

Mine Safety Disclosures

     26   
PART II   

Item 5

 

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

     26   

Item 6

 

Selected Financial Data

     28   

Item 7

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     31   

Item 7A

 

Quantitative and Qualitative Disclosures About Market Risk

     51   

Item 8

 

Financial Statements and Supplementary Data

     52   

Item 9

 

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

     52   

Item 9A

 

Controls and Procedures

     52   

Item 9B

 

Other Information

     55   
PART III   

Item 10

 

Directors, Executive Officers and Corporate Governance

     55   

Item 11

 

Executive Compensation

     55   

Item 12

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

     55   

Item 13

 

Certain Relationships and Related Transactions, and Director Independence

     55   

Item 14

 

Principal Accountant Fees and Services

     55   
PART IV   

Item 15

 

Exhibits and Financial Statement Schedules

     56   

SIGNATURES

     58   

Index to Financial Statements and Schedule

     59   

Exhibit Index

     94   

Exhibit 10.2—Advisory Agreement renewal

  

Exhibit 21—Subsidiaries of Registrant

  

Exhibit 23.1—Consent of KPMG LLP

  

Exhibit 31.1—Section 302 Certification of the Chief Executive Officer

  

Exhibit 31.2—Section 302 Certification of the Chief Financial Officer

  

Exhibit 32.1—Section 906 Certification of the Chief Executive Officer

  

Exhibit 32.2—Section 906 Certification of the Chief Financial Officer

  


Table of Contents

This Annual Report on Form 10-K is for the year ended December 31, 2014. This Annual Report modifies and supersedes documents filed prior to this Annual Report. Information that we file with the Securities and Exchange Commission (the “SEC”) in the future will automatically update and supersede information contained in this Annual Report. In this Annual Report, “we,” “us,” “our” and the “Trust” refer to Universal Health Realty Income Trust and its subsidiaries.

 

As disclosed in this Annual Report, including in Part I, Item 1.-Relationship with Universal Health Services, Inc. (“UHS”), a wholly-owned subsidiary of UHS (UHS of Delaware, Inc.) serves as our Advisor pursuant to the terms of an annually renewable Advisory Agreement dated December 24, 1986. Our officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc. In addition, three of our hospital facilities are leased to subsidiaries of UHS and thirteen medical office buildings, including certain properties owned by limited liability companies in which we either hold 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. Any reference to “UHS” or “UHS facilities” in this report is referring to Universal Health Services, Inc.’s subsidiaries, including UHS of Delaware, Inc.

 

In this Annual Report, the term “revenues” does not include the revenues of the unconsolidated limited liability companies (“LLCs”) in which we have various non-controlling equity interests ranging from 33% to 95%. We currently account for our share of the income/loss from these investments by the equity method (see Note 8 to the Consolidated Financial Statements included herein).


Table of Contents

PART I

 

ITEM 1. Business

 

General

 

We are a real estate investment trust (“REIT”) which commenced operations in 1986. We invest in health care and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings (“MOBs”). As of February 28, 2015 we have sixty-one real estate investments or commitments located in eighteen states in the United States consisting of: (i) six hospital facilities including three acute care, one rehabilitation and two sub-acute; (ii) forty-eight MOBs; (iii) three free-standing emergency departments, and; (iv) four preschool and childcare centers.

 

Available Information

 

We have our principal executive offices at Universal Corporate Center, 367 South Gulph Road, King of Prussia, PA 19406. Our telephone number is (610) 265-0688. Our website is located at http://www.uhrit.com. Copies of the annual, quarterly and current reports we file with the SEC, and any amendments to those reports, are available free of charge on our website. Additionally, we have adopted governance guidelines, a Code of Business Conduct and Ethics applicable to all of our officers and directors, a Code of Ethics for Senior Officers and charters for each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board of Trustees. These documents are also available free of charge on our website. Copies of such reports and charters are available in print to any shareholder who makes a request. Such requests should be made to our Secretary at our King of Prussia, PA corporate headquarters. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K relating to amendments to or waivers of any provision of our Code of Ethics for Senior Officers by promptly posting this information on our website. The information posted on our website is not incorporated into this Annual Report.

 

In accordance with Section 303A.12(a) of The New York Stock Exchange Listed Company Manual, we submitted our CEO’s Certification to the New York Stock Exchange in 2014. Additionally, contained in Exhibits 31.1 and 31.2 of this Annual Report are our CEO’s and CFO’s certifications regarding the quality of our public disclosure under Section 302 of the Sarbanes-Oxley Act of 2002.

 

Overview of Facilities

 

As of February 28, 2015, we have investments in sixty-one facilities, located in eighteen states and consisting of the following:

 

Facility Name

  Location   Type of Facility   Ownership   Guarantor

Southwest Healthcare System, Inland Valley Campus(A)

  Wildomar, CA   Acute Care   100%   Universal Health Services, Inc.

McAllen Medical Center(A)

  McAllen, TX   Acute Care   100%   Universal Health Services, Inc.

Wellington Regional Medical Center(A)

  W. Palm Beach, FL   Acute Care   100%   Universal Health Services, Inc.

Kindred Hospital Chicago Central(B)

  Chicago, IL   Sub-Acute Care   100%   Kindred Healthcare, Inc.

Vibra Hospital of Corpus Christi(B)

  Corpus Christi, TX   Sub-Acute Care   100%   Kindred Healthcare, Inc.

HealthSouth Deaconess Rehabilitation Hospital(F)

  Evansville, IN   Rehabilitation   100%   HealthSouth Corporation

Family Doctor’s Medical Office Bldg.(B)

  Shreveport, LA   MOB   100%   Christus Health Northern Louisiana

Kelsey-Seybold Clinic at Kings Crossing(B)

  Kingwood, TX   MOB   100%   Kelsey-Seybold
Medical Group, PLLC

Professional Bldgs. at Kings Crossing Building A(B)

  Kingwood, TX   MOB   100%  

Building B(B)

  Kingwood, TX   MOB   100%  

Chesterbrook Academy(B)

  Audubon, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

 

1


Table of Contents

Facility Name

  Location   Type of Facility   Ownership   Guarantor

Chesterbrook Academy(B)

  New Britain, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Chesterbrook Academy(B)

  Newtown, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Chesterbrook Academy(B)

  Uwchlan, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Southern Crescent Center I(B)

  Riverdale, GA   MOB   100%  

Southern Crescent Center, II(D)

  Riverdale, GA   MOB   100%  

Suburban Medical Plaza II(C)

  Louisville, KY   MOB   33%  

Desert Valley Medical Center(E)

  Phoenix, AZ   MOB   100%  

Cypresswood Professional Center(B) 8101

  Spring, TX   MOB   100%  

8111

  Spring, TX   MOB   100%  

Desert Springs Medical Plaza(D)

  Las Vegas, NV   MOB   100%  

701 South Tonopah Bldg.(A)

  Las Vegas, NV   MOB   100%  

Santa Fe Professional Plaza(E)

  Scottsdale, AZ   MOB   100%  

Sheffield Medical Building(B)

  Atlanta, GA   MOB   100%  

Summerlin Hospital MOB I(D)

  Las Vegas, NV   MOB   100%  

Summerlin Hospital MOB II(D)

  Las Vegas, NV   MOB   100%  

Medical Center of Western Connecticut(B)

  Danbury, CT   MOB   100%  

Mid Coast Hospital MOB(C)

  Brunswick, ME   MOB   74%  

Rosenberg Children’s Medical Plaza(E)

  Phoenix, AZ   MOB   100%  

Gold Shadow(D)

       

700 Shadow Lane MOB

  Las Vegas, NV   MOB   100%  

2010 & 2020 Goldring MOBs

  Las Vegas, NV   MOB   100%  

St. Mary’s Professional Office Building(C)

  Reno, NV   MOB   75%  

Apache Junction Medical Plaza(E)

  Apache Junction, AZ   MOB   100%  

Spring Valley Medical Office Building(E)

  Las Vegas, NV   MOB   100%  

Spring Valley Hospital Medical Office Building II(D)

  Las Vegas, NV   MOB   100%  

Sierra San Antonio Medical Plaza(E)

  Fontana, CA   MOB   100%  

Phoenix Children’s East Valley Care Center(E)

  Phoenix, AZ   MOB   100%  

Centennial Hills Medical Office Building(D)

  Las Vegas, NV   MOB   100%  

Palmdale Medical Plaza(D)

  Palmdale, CA   MOB   100%  

Summerlin Hospital Medical Office Building III(D)

  Las Vegas, NV   MOB   100%  

Vista Medical Terrace(D)

  Sparks, NV   MOB   100%  

The Sparks Medical Building(D)

  Sparks, NV   MOB   100%  

Auburn Medical Office Building II(E)

  Auburn, WA   MOB   100%  

Texoma Medical Plaza(G)

  Denison, TX   MOB   95%  

BRB Medical Office Building(E)

  Kingwood, TX   MOB   100%  

North Valley Medical Plaza(E)

  Phoenix, AZ   MOB   100%  

Lake Pointe Medical Arts Building(E)

  Rowlett, TX   MOB   100%  

Forney Medical Plaza(E)

  Forney, TX   MOB   100%  

Tuscan Professional Building(E)

  Irving, TX   MOB   100%  

Emory at Dunwoody Building(E)

  Atlanta, GA   MOB   100%  

PeaceHealth Medical Clinic(E)(H)

  Bellingham, WA   MOB   100%  

Forney Medical Plaza II(J)

  Forney, TX   MOB   95%  

Northwest Texas Professional Office Tower(E)

  Amarillo, TX   MOB   100%  

5004 Poole Road MOB(A)

  Denison, TX   MOB   100%  

Ward Eagle Office Village(E)

  Farmington Hills, MI   MOB   100%  

The Children’s Clinic at Springdale(E)

  Springdale, AR   MOB   100%  

The Northwest Medical Center at Sugar Creek(E)

  Bentonville, AR   MOB   100%  

Hanover Emergency Center (E)(K)

  Mechanicsville, VA   Free-standing
Emergency
  100%  

Weslaco Free-standing Emergency Department(L)

  Weslaco, TX   Free-standing
Emergency
  100%  

Mission Free-standing Emergency Department(L)

  Mission, TX   Free-standing
Emergency
  100%  

Haas Medical Office Park (E)(I)

  Ottumwa, IA   MOB   100%   Regional Hospital Partners

 

(A) Real estate assets owned by us and leased to subsidiaries of Universal Health Services, Inc. (“UHS”).
(B) Real estate assets owned by us and leased to an unaffiliated third-party or parties.
(C) Real estate assets owned by a limited liability company (“LLC”) in which we have a noncontrolling ownership interest as indicated above and include tenants who are unaffiliated third-parties.
(D) Real estate assets owned by us or an LLC in which we hold 100% ownership interests and include tenants who are subsidiaries of UHS.

 

2


Table of Contents
(E) Real estate assets owned by us or an LLC in which we hold 100% ownership interests and include tenants who are unaffiliated third-parties.
(F) The lessee on the HealthSouth Deaconess Rehabilitation Hospital (“Deaconess”) is HealthSouth/Deaconess L.L.C., a joint venture between HealthSouth Properties Corporation and Deaconess Hospital, Inc. The lease with Deaconess is scheduled to expire on May 31, 2019.
(G) Real estate assets owned by an LLC in which we have a noncontrolling ownership interest as indicated above. Tenants of this MOB include subsidiaries of UHS.
(H) This MOB was acquired during the first quarter of 2012. In connection with the third-party loan agreement on this property, we are required to maintain separate financial records for the related entities.
(I) This MOB was acquired during the first quarter of 2015.
(J) Real estate assets owned by a limited partnership (“LP”) in which we have a noncontrolling ownership interest as indicated above and include tenants who are unaffiliated third-parties.
(K) This free-standing emergency department was acquired during the third quarter of 2014 and has a 10-year initial term lease agreement with HCA Health Services of Virginia, Inc.
(L) This free-standing emergency department was acquired during the first quarter of 2015 and has a 10-year initial term lease agreement with a subsidiary of UHS.

 

Other Information

 

Included in our portfolio at December 31, 2014 are six hospital facilities with an aggregate investment of $130.4 million, (excluding the Bridgeway which was sold on December 31, 2014, as discussed below). The leases with respect to the seven hospital facilities, including the Bridgeway, comprised approximately 33% of our consolidated revenues in 2014 and approximately 36% of our consolidated revenues in each of 2013 and 2012.

 

As of January 1, 2015, the leases on our six hospital facilities have fixed terms with an average of 2.8 years remaining and include renewal options ranging from one to five, five-year terms. The remaining lease terms for each hospital facility, which vary by hospital, are included herein in Item 2. Properties.

 

We believe a facility’s earnings before interest, taxes, depreciation, amortization and lease rental expense (“EBITDAR”) and a facility’s EBITDAR divided by the sum of minimum rent plus additional rent payable to us (“Coverage Ratio”), which are non-GAAP financial measures, are helpful to us and our investors as a measure of the operating performance of a hospital facility. EBITDAR, which is used as an indicator of a facility’s estimated cash flow generated from operations (before rent expense, capital additions and debt service), is used by us in evaluating a facility’s financial viability and its ability to pay rent. For the hospital facilities owned by us at the end of each respective year (including Bridgeway which was sold on December 31, 2014, as discussed herein), the combined weighted average Coverage Ratio was approximately 8.0 (ranging from 2.7 to 18.3) during 2014, 6.3 (ranging from 2.5 to 18.5) during 2013 and 5.9 (ranging from 2.1 to 14.4) during 2012. The Coverage Ratio for individual facilities varies. See “Relationship with Universal Health Services, Inc.” below for Coverage Ratio information related to the hospital facilities leased to subsidiaries of UHS.

 

Pursuant to the terms of the leases for our hospital facilities, free-standing emergency departments and the preschool and childcare centers, each lessee, including subsidiaries of UHS, is responsible for building operations, maintenance, renovations and property insurance. We, or the LLCs in which we have invested, are responsible for the building operations, maintenance and renovations of the MOBs, however, a portion, or in some cases all, of the expenses associated with the MOBs are passed on directly to the tenants. Cash reserves have been established to fund required building maintenance and renovations at the multi-tenant MOBs. Lessees are required to maintain all risk, replacement cost and commercial property insurance policies on the leased properties and we, or the LLC in which we have invested, are also named insureds on these policies. In addition, we, UHS or the LLCs in which we have invested, maintain property insurance on all properties. For additional information on the terms of our leases, see “Relationship with Universal Health Services, Inc.”

 

See our consolidated financial statements and accompanying notes to the consolidated financial statements included in this Annual Report for our total assets, liabilities, debt, revenues, income and other operating information.

 

3


Table of Contents

Relationship with Universal Health Services, Inc. (“UHS”)

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. The hospital leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each hospital leased to subsidiaries of UHS are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 36% of our total revenue for the five years ended December 31, 2014 (approximately 28% for the year ended December 31, 2014 and approximately 30% for each of the years ended December 31, 2013 and 2012). The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests. As a result of these transactions, we own 100% of each of these LLCs and began accounting for each on a consolidated basis effective on the date of purchase of the minority ownership interests. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2014 (approximately 22% for each of the years ended December 31, 2014 and 2013 and 21% for the year ended December 31, 2012). In addition, including the two free-standing emergency departments (“FEDs”) acquired by us from subsidiaries of UHS during the first quarter of 2015 (as discussed below), fifteen MOBs/FEDs, that are either wholly or jointly-owned, include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the three leased hospital properties listed below at their appraised fair market value.

 

During the third quarter of 2014, a wholly-owned subsidiary of UHS provided notification to us that, upon expiration of The Bridgeway’s lease term which occurred in December, 2014, it intended to exercise its option to purchase the real property of the facility. Upon expiration of the lease, the wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility and on December 31, 2014, The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, was sold to UHS. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain appraisals of the property to determine its fair market value. Based upon the independent property appraisals obtained by each party, the sales price of The Bridgeway was $17.3 million. A gain on divestiture of approximately $13.0 million is included in our results of operations for the twelve-month period ended December 31, 2014. During each of the last three years, our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with The Bridgeway’s lease.

 

During the first quarter of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened FEDs located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions,

 

4


Table of Contents

ten-year lease agreements with six, 5-year renewal terms have been executed with UHS for each FED. The first four, 5-year renewal terms (covering years 2025 through 2044) include 2% annual lease rate increases, computed on accumulative and compounded basis, and the last two, 5-year renewal terms (covering the years 2045 through 2054) will be at the then fair market value lease rates. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually. These two leases are cross defaulted with one another.

 

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of Lease Term      Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000        December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

 

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor.

 

The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. Our advisory fee was 0.70% during each of 2014 and 2013, and 0.65% during 2012, of our average invested real estate assets, as derived from our consolidated balance sheet. In December of 2014, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2015 pursuant to the same terms as the Advisory Agreement in place during 2014 and 2013.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each

 

5


Table of Contents

year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2014, 2013 or 2012 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.5 million during 2014, $2.4 million during 2013 and $2.1 million during 2012 and were based upon average invested real estate assets of $363 million, $338 million and $326 million during 2014, 2013 and 2012, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2014 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2014 and 2013, UHS owned 5.9% and 6.1%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the Securities and Exchange Commission (“SEC”) and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 28% of our consolidated revenues for the year ended December 31, 2014 and 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

 

Taxation

 

We believe we have operated in such a manner as to qualify for taxation as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, and we intend to continue to operate in such a manner. If we qualify for taxation as a REIT, we will generally not be subject to federal corporate income taxes on our net income that is currently distributed to shareholders. This treatment substantially eliminates the “double taxation”, i.e., at the corporate and shareholder levels, that usually results from investment in the stock of a corporation.

 

Please see the heading “If we fail to maintain our REIT status, we will become subject to federal income tax on our taxable income at regular corporate rates” under “Risk Factors” for more information.

 

Competition

 

We compete for the acquisition, leasing and financing of health care related facilities. Our competitors include, but are not limited to, other REITs, banks and other companies, including UHS. Some of these competitors are larger and may have a lower cost of capital than we do. These developments could result in fewer investment opportunities for us and lower spreads over the cost of our capital, which would hurt our growth.

 

In most geographical areas in which our facilities operate, there are other facilities that provide services comparable to those offered by our facilities. In addition, some competing facilities are owned by tax-supported governmental agencies or by nonprofit corporations and may be supported by endowments and charitable contributions and exempt from property, sales and income taxes. Such exemptions and support are not available to certain operators of our facilities, including UHS. In some markets, certain competing facilities may have greater financial resources, be better equipped and offer a broader range of services than those available at our

 

6


Table of Contents

facilities. Certain hospitals that are located in the areas served by our facilities are specialty hospitals that provide medical, surgical and behavioral health services that may not be provided by the operators of our hospitals. The increase in outpatient treatment and diagnostic facilities, outpatient surgical centers and freestanding ambulatory surgical centers also increases competition for us.

 

In addition, the number and quality of the physicians on a hospital’s staff are important factors in determining a hospital’s success and competitive advantage. Typically, physicians are responsible for making hospital admission decisions and for directing the course of patient treatment. The operators of our facilities also compete with other health care providers in recruiting and retaining qualified hospital management, nurses and other medical personnel. From time-to-time, the operators of our acute care hospitals may experience the effects of a shortage of skilled nursing staff nationwide, which has caused and may continue to cause an increase in salaries, wages and benefits expense in excess of the inflation rate. Our operators may experience difficulties attracting and retaining qualified physicians, nurses and medical support personnel. We anticipate that our operators, including UHS, will continue to encounter increased competition in the future that could lead to a decline in patient volumes and harm their businesses, which in turn, could harm our business.

 

A large portion of our non-hospital properties consist of MOBs which are located either close to or on the campuses of hospital facilities. These properties are either directly or indirectly affected by the factors discussed above as well as general real estate factors such as the supply and demand of office space and market rental rates. To improve our competitive position, we anticipate that we will continue investing in additional healthcare related facilities and leasing the facilities to qualified operators, perhaps including subsidiaries of UHS.

 

Regulation and Other Factors

 

During 2014, 2013 and 2012, 25%, 28% and 28%, respectively, of our revenues were earned pursuant to leases with operators of acute care services hospitals, all of which are subsidiaries of UHS. A significant portion of the revenue earned by the operators of our acute care hospitals is derived from federal and state healthcare programs, including Medicare and Medicaid (excluding managed Medicare and Medicaid programs).

 

Our hospital facilities derive a significant portion of their revenue from third-party payors, including the Medicare and Medicaid programs. Changes in these government programs in recent years have resulted in limitations on reimbursement and, in some cases, reduced levels of reimbursement for healthcare services. Payments from federal and state government programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially increase or decrease program payments, as well as affect the cost of providing service to patients and the timing of payments to facilities. Neither we nor the operators of our hospital facilities are able to predict the effect of recent and future policy changes on our respective results of operations. In addition, the uncertainty and fiscal pressures placed upon federal and state governments as a result of, among other things, the funding requirements and other provisions of the Patient Protection and Affordable Care Act, may affect the availability of taxpayer funds for Medicare and Medicaid programs. If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on the business, financial position and results of operations of the operators of our hospital facilities, and in turn, ours.

 

In addition, the healthcare industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things: hospital billing practices and prices for services; relationships with physicians and other referral sources; adequacy of medical care and quality of medical equipment and services; ownership of facilities; qualifications of medical and support personnel; confidentiality, maintenance, privacy and security issues associated with health-related information and patient medical records; the screening, stabilization and transfer of patients who have emergency medical conditions; certification, licensure and accreditation of our facilities; operating policies and procedures, and; construction or expansion of facilities and services.

 

7


Table of Contents

These laws and regulations are extremely complex, and, in many cases, the operators of our facilities do not have the benefit of regulatory or judicial interpretation. In the future, it is possible that different interpretations or enforcement of these laws and regulations could subject the current or past practices of our operators to allegations of impropriety or illegality or could require them to make changes in their facilities, equipment, personnel, services, capital expenditure programs and operating expenses. Although UHS and the other operators of our hospital facilities believe that their policies, procedures and practices comply with governmental regulations, no assurance can be given that they will not be subjected to additional governmental inquiries or actions, or that they would not be faced with sanctions, fines or penalties if so subjected. Even if they were to ultimately prevail, a significant governmental inquiry or action under one of the above laws, regulations or rules could have a material adverse effect upon them, and in turn, us.

 

Each of our hospital facilities is deemed certified, meaning that they are accredited, properly licensed under the relevant state laws and regulations and certified under the Medicare program. The effect of maintaining certified facilities is to allow such facilities to participate in the Medicare and Medicaid programs. The operators of our hospital facilities believe that the facilities are in material compliance with applicable federal, state, local and other relevant regulations and standards. However, should any of our hospital facilities lose their deemed certified status and thereby lose certification under the Medicare or Medicaid programs, such facilities would be unable to receive reimbursement from either of those programs and their business, and in turn, ours, could be materially adversely affected.

 

The various factors and government regulation related to the healthcare industry, such as those outlined above, affects us because:

 

(i) The financial ability of lessees to make rent payments to us may be affected by governmental regulations such as licensure, certification for participation in government programs, and government reimbursement, and;

 

(ii) Our bonus rents on the three acute care hospitals operated by subsidiaries of UHS are based on our lessees’ net revenues which in turn are affected by the amount of reimbursement such lessees receive from the government.

 

A significant portion of the revenue earned by the operators of our acute care hospitals is derived from federal and state healthcare programs, including Medicare and Medicaid. Under the statutory framework of the Medicare and Medicaid programs, many of the general acute care operations are subject to administrative rulings, interpretations and discretion that may affect payments made under either or both of such programs as well as by other third party payors. The federal government makes payments to participating hospitals under its Medicare program based on various formulas. For inpatient services, the operators of our acute care hospitals are subject to an inpatient prospective payment system (“IPPS”). Under IPPS, hospitals are paid a predetermined fixed payment amount for each hospital discharge. The fixed payment amount is based upon each patient’s Medicare severity diagnosis related group (“MS-DRG”). Every MS-DRG is assigned a payment rate based upon the estimated intensity of hospital resources necessary to treat the average patient with that particular diagnosis. These rates are based upon historical national average costs and do not consider the actual costs incurred by a hospital in providing care. The MS-DRG rates are adjusted annually based on geographic region and are weighted based upon a statistically normal distribution of severity.

 

For outpatient services, acute care hospitals are paid under an outpatient prospective payment system (“PPS”) according to ambulatory procedure codes. The outpatient PPS rate is a geographic adjusted national payment amount that includes the Medicare payment and the beneficiary co-payment. Special payments under the outpatient PPS may be made for certain new technology items and services through transitional pass-through payments and special reimbursement rates.

 

Three of our acute care hospital facilities operated by subsidiaries of UHS and two sub-acute care hospital facilities operated by an unaffiliated third-party are located in Texas, Florida, California and Illinois. The

 

8


Table of Contents

majority of these states have reported significant budget deficits that have resulted in reductions of Medicaid funding during the last few years and which could adversely affect future levels of Medicaid reimbursement received by certain operators of our facilities, including the operators of our hospital facilities. We can provide no assurance that reductions to Medicaid revenues earned by operators of certain of our facilities, particularly our hospital operators in the above-mentioned states, will not have a material adverse effect on the future operating results of those operators which, in turn, could have a material adverse effect on us.

 

Executive Officers of the Registrant

 

Name

  

Age

  

Position

Alan B. Miller

   77   

Chairman of the Board, Chief Executive Officer and President

Charles F. Boyle

   55   

Vice President and Chief Financial Officer

Cheryl K. Ramagano

   52   

Vice President, Treasurer and Secretary

Timothy J. Fowler

   59   

Vice President, Acquisition and Development

 

Mr. Alan B. Miller has been our Chairman of the Board and Chief Executive Officer since our inception in 1986 and was appointed President in February, 2003. He had previously served as our President until 1990. Mr. Miller has been Chairman of the Board and Chief Executive Officer of UHS since its inception in 1978. He previously held the title of President of UHS as well, until 2009 when Marc D. Miller was elected as President of UHS. He is the father of Marc D. Miller, who was elected to our Board of Trustees in December, 2008 and also serves as President and a member of the Board of Directors of UHS.

 

Mr. Charles F. Boyle was appointed Chief Financial Officer in February, 2003 and had served as our Vice President and Controller since 1991. Mr. Boyle has held various positions at UHS since 1983 and currently serves as its Vice President and Controller. He was appointed Controller of UHS in 2003 and had served as its Assistant Vice President-Corporate Accounting since 1994.

 

Ms. Cheryl K. Ramagano was appointed Secretary in February, 2003 and has served as our Vice President and Treasurer since 1992. Ms. Ramagano has held various positions at UHS since 1983 and currently serves as its Vice President and Treasurer. She was appointed Treasurer of UHS in 2003 and had served as its Assistant Treasurer since 1994.

 

Mr. Timothy J. Fowler was elected as our Vice President of Acquisition and Development upon the commencement of his employment with UHS in 1993.

 

ITEM 1A. Risk Factors

 

We are subject to numerous known and unknown risks, many of which are described below and elsewhere in this Annual Report. Any of the events described below could have a material adverse effect on our business, financial condition and results of operations. Additional risks and uncertainties that we are not aware of, or that we currently deem to be immaterial, could also impact our business and results of operations.

 

The revenues and results of operations of the tenants of our hospital facilities, including UHS, and our medical office buildings, are significantly affected by payments received from the government and other third party payors.

 

The operators of our hospital facilities and tenants of our medical office buildings derive a significant portion of their revenue from third party payors, including the Medicare and Medicaid programs. Changes in these government programs in recent years have resulted in limitations on reimbursement and, in some cases, reduced levels of reimbursement for health care services. Payments from federal and state government programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially

 

9


Table of Contents

increase or decrease program payments, as well as affect the cost of providing service to patients and the timing of payments to facilities. Our tenants are unable to predict the effect of recent and future policy changes on their operations.

 

Three of our acute care hospital facilities operated by subsidiaries of UHS and two sub-acute care hospital facilities operated by an unaffiliated third-party are located in Texas, Florida, California and Illinois. The majority of these states have reported significant budget deficits that have resulted in reductions of Medicaid funding during the last few years and which could adversely affect future levels of Medicaid reimbursement received by certain operators of our facilities, including the operators of our hospital facilities. We can provide no assurance that reductions to Medicaid revenues earned by operators of certain of our facilities, particularly our hospital operators in the above-mentioned states, will not have a material adverse effect on the future operating results of those operators which, in turn, could have a material adverse effect on us. In addition, the uncertainty and fiscal pressures placed upon federal and state governments as a result of, among other things, the funding requirements and other provisions of the Patient Protection and Affordable Care Act, may affect the availability of taxpayer funds for Medicare and Medicaid programs. If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on the business, financial position and results of operations of the operators of our hospital facilities, and in turn, ours.

 

In addition to changes in government reimbursement programs, the ability of our hospital operators to negotiate favorable contracts with private payors, including managed care providers, significantly affects the revenues and operating results of those facilities. Private payors, including managed care providers, increasingly are demanding that hospitals accept lower rates of payment. Our hospital operators expect continued third party efforts to aggressively manage reimbursement levels and cost controls. Reductions in reimbursement amounts received from third party payors could have a material adverse effect on the financial position and results of operations of our hospital operators.

 

Reductions or changes in Medicare funding could have a material adverse effect on the future operating results of the operators of our facilities, including UHS, which could, in turn, materially reduce our revenues and net income.

 

On January 3, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012 (the “2012 Act”). The 2012 Act postponed for two months sequestration cuts mandated under the Budget Control Act of 2011. The postponed sequestration cuts include a 2% annual reduction over ten years in Medicare spending to providers. Medicaid is exempt from sequestration. In order to offset the cost of the legislation, the 2012 Act reduces payments to other providers totaling almost $26 billion over ten years. Approximately half of those funds will come from reductions in Medicare reimbursement to hospitals. Although the Bipartisan Budget Act of 2013 has reduced certain sequestration-related budgetary cuts, spending reductions related to the Medicare program remain in place. On December 26, 2013, President Obama signed into law H.J. Res. 59, the Bipartisan Budget Act of 2013, which includes the Pathway for SGR Reform Act of 2013 (“the Act”). In addition, on February 15, 2014, Public Law 113-082 was enacted. The Act and subsequent federal legislation achieves new savings by extending sequestration for mandatory programs – including Medicare – for another three years, through 2024.

 

The 2012 Act includes a document and coding (“DCI”) adjustment and a reduction in Medicaid disproportionate share hospital (“DSH”) payments. Expected to save $10.5 billion over 10 years, the DCI adjustment decreases projected Medicare hospital payments for inpatient and overnight care through a downward adjustment in annual base payment increases. These reductions are meant to recoup what Medicare authorities consider to be “overpayments” to hospitals that occurred as a result of the transition to Medicare Severity Diagnosis Related Groups. The reduction in Medicaid DSH payments is expected to save $4.2 billion over 10 years. This provision extends the changes regarding DSH payments established by the Legislation and determines future allotments off of the rebased level. We cannot predict the effect this enactment will have on operators (including UHS), and, thus, our business.

 

10


Table of Contents

The uncertainties of health care reform could materially affect the business and future results of operations of the operators of our facilities, including UHS, which could, in turn, materially reduce our revenues and net income.

 

In March, 2010, the Health Care and Education Reconciliation Act of 2010 and the Patient Protection and Affordable Care Act were enacted into law and created significant changes to health insurance coverage for U.S. citizens as well as material revisions to the federal Medicare and state Medicaid programs. The two combined primary goals of these acts are to provide for increased access to coverage for healthcare and to reduce healthcare-related expenses. Medicare, Medicaid and other health care industry changes are scheduled to be implemented at various times during this decade. We cannot predict the effect, if any, these enactments will have on operators (including UHS) and, thus, our business.

 

There have been several attempts in Congress to repeal or modify various provisions of the Patient Protection and Affordable Care Act (the “PPACA”). We cannot predict whether or not any of these proposed changes to the PPACA will become law and therefore can provide no assurance that changes to the PPACA, as currently implemented, will not have a material adverse effect on the future operating results of the tenants/operators of our properties and, thus, our business.

 

In addition, a case currently pending before The Supreme Court of the United States, King vs. Burwell, challenges the federal government’s ability to subsidize premiums paid by certain eligible individuals that obtain health insurance policies through federally facilitated exchanges. A number of our properties are located in states that utilize federally facilitated exchanges. The Supreme Court of the United States’ decision in this case could result in an increased number of uninsured patients in the states that utilize federally facilitated exchanges which would have an adverse impact on the future operating results of the tenants/operators of our facilities located in these states and, thus, our business.

 

Increased competition in the health care industry has resulted in lower revenues and higher costs for our operators, including UHS, and may affect our revenues, property values and lease renewal terms.

 

The health care industry is highly competitive and competition among hospitals and other health care providers for patients and physicians has intensified in recent years. In most geographical areas in which our facilities are operated, there are other facilities that provide services comparable to those offered by our facilities. In addition, some competing facilities are owned by tax-supported governmental agencies or by nonprofit corporations and may be supported by endowments and charitable contributions and exempt from property, sales and income taxes. Such exemptions and support are not available to certain operators of our facilities, including UHS.

 

In some markets, certain competing facilities may have greater financial resources, be better equipped and offer a broader range of services than those available at our facilities. Certain hospitals that are located in the areas served by our facilities are specialty hospitals that provide medical, surgical and behavioral health services that may not be provided by the operators of our hospitals. The increase in outpatient treatment and diagnostic facilities, outpatient surgical centers and freestanding ambulatory surgical centers also increases competition for our operators.

 

In addition, the operators of our facilities face competition from other health care providers, including physician owned facilities and other competing facilities, including certain facilities operated by UHS but the real property of which is not owned by us. Such competition is experienced in markets including, but not limited to, McAllen, Texas, the site of our McAllen Medical Center, a 430-bed acute care hospital, and Riverside County, California, the site of our Southwest Healthcare System-Inland Valley Campus, a 132-bed acute care hospital.

 

In addition, the number and quality of the physicians on a hospital’s staff are important factors in determining a hospital’s competitive advantage. Typically, physicians are responsible for making hospital

 

11


Table of Contents

admission decisions and for directing the course of patient treatment. Since the operators of our facilities also compete with other health care providers, they may experience difficulties in recruiting and retaining qualified hospital management, nurses and other medical personnel.

 

We anticipate that our operators, including UHS, will continue to encounter increased competition in the future that could lead to a decline in patient volumes and harm their businesses, which in turn, could harm our business.

 

Operators that fail to comply with governmental reimbursement programs such as Medicare or Medicaid, licensing and certification requirements, fraud and abuse regulations or new legislative developments may be unable to meet their obligations to us.

 

Our operators, including UHS and its subsidiaries, are subject to numerous federal, state and local laws and regulations that are subject to frequent and substantial changes (sometimes applied retroactively) resulting from legislation, adoption of rules and regulations, and administrative and judicial interpretations of existing law. The ultimate timing or effect of these changes cannot be predicted. Government regulation may have a dramatic effect on our operators’ costs of doing business and the amount of reimbursement received by both government and other third-party payors. The failure of any of our operators to comply with these laws, requirements and regulations could adversely affect their ability to meet their obligations to us. These regulations include, among other items: hospital billing practices and prices for service; relationships with physicians and other referral sources; adequacy of medical care; quality of medical equipment and services; qualifications of medical and support personnel; the implementation of, and continued compliance with, electronic health records’ regulations; confidentiality, maintenance and security issues associated with health-related information and patient medical records; the screening, stabilization and transfer of patients who have emergency medical conditions; certification, licensure and accreditation of our facilities; operating policies and procedures, and; construction or expansion of facilities and services.

 

If our operators fail to comply with applicable laws and regulations, they could be subjected to liabilities, including criminal penalties, civil penalties (including the loss of their licenses to operate one or more facilities), and exclusion of one or more facilities from participation in the Medicare, Medicaid and other federal and state health care programs. The imposition of such penalties could jeopardize that operator’s ability to make lease or mortgage payments to us or to continue operating its facility. In addition, our bonus rents are based on net revenues of the UHS hospital facilities, which in turn are affected by the amount of reimbursement that such lessees receive from the government.

 

Although UHS and the other operators of our acute care facilities believe that their policies, procedures and practices comply with governmental regulations, no assurance can be given that they will not be subjected to governmental inquiries or actions, or that they would not be faced with sanctions, fines or penalties if so subjected. Because many of these laws and regulations are relatively new, in many cases, our operators don’t have the benefit of regulatory or judicial interpretation. In the future, it is possible that different interpretations or enforcement of these laws and regulations could subject their current or past practices to allegations of impropriety or illegality or could require them to make changes in the facilities, equipment, personnel, services, capital expenditure programs and operating expenses. Even if they were to ultimately prevail, a significant governmental inquiry or action under one of the above laws, regulations or rules could have a material adverse effect upon them, and in turn, us.

 

A worsening of the economic and employment conditions in the United States could materially affect our business and future results of operations of the operators of our facilities which could, in turn, materially reduce our revenues and net income.

 

Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Our operators’ patient volumes, revenues and financial results depend significantly on the universe of patients with health

 

12


Table of Contents

insurance, which to a large extent is dependent on the employment status of individuals in certain markets. A worsening of economic conditions may result in a higher unemployment rate which will likely increase the number of individuals without health insurance. As a result, the operators of our facilities may experience a decrease in patient volumes. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the UHS hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties.

 

The deterioration of credit and capital markets may adversely affect our access to sources of funding and we cannot be certain of the availability and terms of capital to fund the growth of our business when needed.

 

To retain our status as a REIT, we are required to distribute 90% of our taxable income to shareholders and, therefore, we generally cannot use income from operations to fund our growth. Accordingly, our growth strategy depends, in part, upon our ability to raise additional capital at reasonable costs to fund new investments. We believe we will be able to raise additional debt and equity capital at reasonable costs to refinance our debts (including third-party debt held by various LLCs in which we own non-controlling equity interests) at or prior to their maturities and to invest at yields which exceed our cost of capital. We can provide no assurance that financing will be available to us on satisfactory terms when needed, which could harm our business. Given these uncertainties, our growth strategy is not assured and may fail.

 

To fund all or a portion of our future financing needs, we rely on borrowings from various sources including fixed rate, long-term debt as well as borrowings pursuant to our revolving credit agreement. If any of the lenders were unable to fulfill their future commitments, our liquidity could be impacted, which could have a material unfavorable impact on our results of operations and financial condition.

 

In addition, the degree to which we are, or in the future may become, leveraged, our ability to obtain financing could be adversely impacted and could make us more vulnerable to competitive pressures. Our ability to meet existing and future debt obligations depends upon our future performance and our ability to secure additional financing on satisfactory terms, each of which is subject to financial, business and other factors that are beyond our control. Any failure by us to meet our financial obligations would harm our business.

 

In the event we need to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time. Our inability to obtain financing on terms acceptable to us could have a material unfavorable impact on our results of operations, financial condition and liquidity.

 

A substantial portion of our revenues are dependent upon one operator. If UHS experiences financial difficulties, or otherwise fails to make payments to us, or elects not to renew the leases on our three acute care hospitals, our revenues could be materially reduced.

 

For the year ended December 31, 2014, UHS accounted for 35% of our consolidated revenues. In addition, as of December 31, 2014, subsidiaries of UHS leased three of the six hospital facilities owned by us with terms expiring in 2016 (The Bridgeway was sold on December 31, 2014). We cannot assure you that UHS will renew the leases at existing lease rates or fair market value lease rates, or continue to satisfy its obligations to us. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases. The failure or inability of UHS to satisfy its obligations to us, or should UHS elect not to renew the leases on our three acute care hospitals, our revenues and net income could be materially reduced, which could in turn reduce the amount of dividends we pay and cause our stock price to decline.

 

13


Table of Contents

Our relationship with UHS may create conflicts of interest.

 

In addition to being dependent upon UHS for a substantial portion of our revenues and leases, since 1986, UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, has served as our Advisor. Pursuant to our Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. Further, all of our officers are employees of the Advisor. As of December 31, 2014 we had no salaried employees although our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time compensation awards in the form of restricted stock and/or cash bonuses. We believe that the quality and depth of the management and advisory services provided to us by our Advisor and UHS could not be replicated by contracting with unrelated third parties or by being self-advised without considerable cost increases. We believe that these relationships have been beneficial to us in the past, but we cannot guarantee that they will not become detrimental to us in the future.

 

All transactions with UHS must be approved by a majority of our Independent Trustees. We believe that our current leases and business dealings with UHS have been entered into on commercially reasonable terms. However, because of our historical and continuing relationship with UHS and its subsidiaries, in the future, our business dealings may not be on the same or as favorable terms as we might achieve with a third party with whom we do not have such a relationship. Disputes may arise between us and UHS that we are unable to resolve or the resolution of these disputes may not be as favorable to us as a resolution we might achieve with a third party.

 

We hold significant, non-controlling equity ownership interests in various LLCs.

 

For the year ended December 31, 2014, 22% of our consolidated and unconsolidated revenues were generated by LLCs in which we hold, or held, a majority, non-controlling equity ownership interest. As of December 31, 2014, we hold non-controlling equity ownership interests, ranging from 33% to 95%, in five LLCs/LPs.

 

Our level of investment and lack of control exposes us to potential losses of our investments and revenues. Although our ownership arrangements have been beneficial to us in the past, we cannot guarantee that they will continue to be beneficial in the future.

 

Pursuant to the operating and/or partnership agreements of most of the five LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member.

 

In addition to the above-mentioned rights of the third-party members, from time to time, we have had discussions with third-party members about purchasing or selling the interests to each other or a third party. If we were to sell our interests, we may not be able to redeploy the proceeds into assets at the same or greater return as we currently receive. During any such time that we were not able to do so, our ability to increase or maintain our dividend at current levels could be adversely affected which could cause our stock price to decline.

 

14


Table of Contents

The bankruptcy, default, insolvency or financial deterioration of our tenants could significantly delay our ability to collect unpaid rents or require us to find new operators.

 

Our financial position and our ability to make distributions to our shareholders may be adversely affected by financial difficulties experienced by any of our major tenants, including bankruptcy, insolvency or a general downturn in the business. We are exposed to the risk that our operators may not be able to meet their obligations, which may result in their bankruptcy or insolvency. Although our leases and loans provide us the right to terminate an investment, evict an operator, demand immediate repayment and other remedies, the bankruptcy laws afford certain rights to a party that has filed for bankruptcy or reorganization. An operator in bankruptcy may be able to restrict our ability to collect unpaid rents or interest during the bankruptcy proceeding.

 

Required regulatory approvals can delay or prohibit transfers of our healthcare facilities.

 

Transfers of healthcare facilities to successor tenants or operators may be subject to regulatory approvals or ratifications, including, but not limited to, change of ownership approvals under certificate of need laws and Medicare and Medicaid provider arrangements that are not required for transfers of other types of commercial operations and other types of real estate. The replacement of any tenant or operator could be delayed by the regulatory approval process of any federal, state or local government agency necessary for the transfer of the facility or the replacement of the operator licensed to manage the facility. If we are unable to find a suitable replacement tenant or operator upon favorable terms, or at all, we may take possession of a facility, which might expose us to successor liability or require us to indemnify subsequent operators to whom we might transfer the operating rights and licenses, all of which may materially adversely affect our business, results of operations, and financial condition.

 

Real estate ownership creates risks and liabilities that may result in unanticipated losses or expenses.

 

Our business is subject to risks associated with real estate acquisitions and ownership, including:

 

   

general liability, property and casualty losses, some of which may be uninsured;

 

   

the illiquid nature of real estate and the real estate market that impairs our ability to purchase or sell our assets rapidly to respond to changing economic conditions;

 

   

real estate market factors, such as the supply and demand of office space and market rental rates, changes in interest rates as well as an increase in the development of medical office condominiums in certain markets;

 

   

costs that may be incurred relating to maintenance and repair, and the need to make expenditures due to changes in governmental regulations, including the Americans with Disabilities Act;

 

   

environmental hazards at our properties for which we may be liable, including those created by prior owners or occupants, existing tenants, mortgagors or other persons, and;

 

   

defaults and bankruptcies by our tenants.

 

In addition to the foregoing risks, we cannot predict whether the leases on our properties, including the leases on the properties leased to subsidiaries of UHS, which have options to purchase the respective leased facilities at the end of the lease or renewal terms at the appraised fair market value, will be renewed at their current rates at the end of the lease terms in 2016. If the leases are not renewed, we may be required to find other operators for these facilities and/or enter into leases with less favorable terms. The exercise of purchase options for our facilities may result in a less favorable rate of return for us than the rental revenue currently earned on such facilities. Further, the purchase options and rights of first refusal granted to the respective lessees to purchase or lease the respective leased facilities, after the expiration of the lease term, may adversely affect our ability to sell or lease a facility, and may present a potential conflict of interest between us and UHS since the price and terms offered by a third-party are likely to be dependent, in part, upon the financial performance of the facility during the final years of the lease term.

 

15


Table of Contents

Significant potential liabilities and rising insurance costs and availability may have an adverse effect on the operations of our operators, which may negatively impact their ability to meet their obligations to us.

 

As is typical in the healthcare industry, in the ordinary course of business, our operators, including UHS, are subject to medical malpractice lawsuits, product liability lawsuits, class action lawsuits and other legal actions. Some of these actions may involve large claims, as well as significant defense costs. If their ultimate liability for professional and general liability claims could change materially from current estimates, if such policy limitations should be partially or fully exhausted in the future, or payments of claims exceed estimates or are not covered by insurance, it could have a material adverse effect on the operations of our operators and, in turn, us.

 

Property insurance rates, particularly for earthquake insurance in California, have also continued to increase. We own two MOBs in California that could not obtain earthquake insurance at rates which are economically beneficial in relation to the risks covered. Our tenants and operators, including UHS, may be unable to fulfill their insurance, indemnification and other obligations to us under their leases and mortgages and thereby potentially expose us to those risks. In addition, our tenants and operators may be unable to pay their lease or mortgage payments, which could potentially decrease our revenues and increase our collection and litigation costs. Moreover, to the extent we are required to foreclose on the affected facilities, our revenues from those facilities could be reduced or eliminated for an extended period of time. In addition, we may in some circumstances be named as a defendant in litigation involving the actions of our operators. Although we have no involvement in the activities of our operators and our standard leases generally require our operators to carry insurance to cover us in certain cases, a significant judgment against us in such litigation could exceed our and our operators’ insurance coverage, which would require us to make payments to cover the judgment.

 

If we fail to maintain our REIT status, we will become subject to federal income tax on our taxable income at regular corporate rates.

 

In order to qualify as a REIT, we must comply with certain highly technical and complex Internal Revenue Code provisions. Although we believe we have been qualified as a REIT since our inception, there can be no assurance that we have been so qualified or will remain qualified in the future. Failure to qualify as a REIT may subject us to income tax liabilities, including federal income tax at regular corporate rates. The additional income tax incurred may significantly reduce the cash flow available for distribution to shareholders and for debt service. In addition, if disqualified, we might be barred from qualification as a REIT for four years following disqualification. Also, if disqualified, we will not be allowed a deduction for distributions to stockholders in computing our taxable income and we could be subject to increased state and local income taxes.

 

Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.

 

Even if we remain qualified for taxation as a REIT, we may be subject to certain federal, state and local taxes on our income and assets, including taxes on any undistributed income, tax on income from some activities conducted as a result of a foreclosure, and state or local income, property and transfer taxes. Any of these taxes would decrease cash available for the payment of our debt obligations.

 

Dividends paid by REITs generally do not qualify for reduced tax rates.

 

In general, dividends (qualified) paid by a U.S. corporation to individual U.S. shareholders are subject to Federal income tax at a maximum rate of 20% (subject to certain additional taxes for certain taxpayers). In contrast, since we are a REIT, our distributions to individual U.S. shareholders are not eligible for the reduced rates which apply to distributions from regular corporations, and thus may be subject to Federal income tax at a rate as high as 39.6% (subject to certain additional taxes for certain taxpayers).

 

16


Table of Contents

Should we be unable to comply with the strict income distribution requirements applicable to REITs utilizing only cash generated by operating activities, we would be required to generate cash from other sources which could adversely affect our financial condition.

 

To obtain the favorable tax treatment associated with qualifying as a REIT, in general, we are required each year to distribute to our shareholders at least 90% of our net taxable income. In addition, we are subject to a tax on any undistributed portion of our income at regular corporate rates and might also be subject to a 4% excise tax on this undistributed income. To meet the distribution requirements necessary to achieve the tax benefits associated with qualifying as a REIT, we could be required to: (i) seek borrowed funds even if conditions are not favorable for borrowing; (ii) issue equity which could have a dilutive effect on the future dividends and share value of our existing shareholders, and/or; (iii) divest assets that we might have otherwise decided to retain. Securing funds through these other non-operating means could adversely affect our financial condition and future results of operations.

 

Complying with REIT requirements may cause us to forego otherwise attractive opportunities.

 

To qualify as a REIT for federal income tax purposes, we continually must satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our stock. We may be unable to pursue investments that would be otherwise advantageous to us in order to satisfy the source-of-income, asset-diversification or distribution requirements for qualifying as a REIT. Thus, compliance with the REIT requirements may hinder our ability to make certain attractive investments.

 

The market value of our common stock could be substantially affected by various factors.

 

Many factors, certain of which are outside of our control, could have an adverse effect on the share price of our common stock. These factors include certain of the risks discussed herein, our financial condition, performance and prospects, the market for similar securities issued by REITs, demographic changes, operating results of our operators and other hospital companies, changes in our financial estimates or recommendations of securities analysts, speculation in the press or investment community, the possible effects of war, terrorist and other hostilities, adverse weather conditions, the level of seasonal illnesses, changes in general conditions in the economy, financial markets or overall interest rate environment, or other developments affecting the health care industry.

 

Ownership limitations and anti-takeover provisions in our declaration of trust and bylaws and under Maryland law and in our leases with UHS may delay, defer or prevent a change in control or other transactions that could provide shareholders with a take-over premium. We are subject to significant anti-takeover provisions.

 

In order to protect us against the risk of losing our REIT status for federal income tax purposes, our declaration of trust permits our Trustees to redeem shares acquired or held in excess of 9.8% of the issued and outstanding shares of our voting stock and, which in the opinion of the Trustees, would jeopardize our REIT status. In addition, any acquisition of our common or preferred shares that would result in our disqualification as a REIT is null and void. The right of redemption may have the effect of delaying, deferring or preventing a change in control of our company and could adversely affect our shareholders’ ability to realize a premium over the market price for the shares of our common stock.

 

Our declaration of trust authorizes our Board of Trustees to issue additional shares of common and preferred stock and to establish the preferences, rights and other terms of any series of preferred stock that we issue. Although our Board of Trustees has no intention to do so at the present time, it could establish a series of preferred stock that could delay, defer or prevent a transaction or a change in control that might involve the payment of a premium over the market price for our common stock or otherwise be in the best interests of our shareholders.

 

17


Table of Contents

The Master Lease Documents by and among us and certain subsidiaries of UHS, which governs the three acute care hospital properties and the freestanding emergency departments leased to subsidiaries of UHS, includes a change of control provision. The change of control provision grants UHS the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the leased hospital properties at their appraised fair market values. The exercise of this purchase option may result in a less favorable rate of return earned on the sales proceeds received than the rental revenue currently earned on such facilities.

 

These provisions could discourage unsolicited acquisition proposals or make it more difficult for a third-party to gain control of us, which could adversely affect the market price of our securities and prevent shareholders from receiving a take-over premium.

 

We depend heavily on key management personnel and the departure of one or more of our key executives or a significant portion of our operators’ local hospital management personnel could harm our business.

 

The expertise and efforts of our senior executives and key members of our operators’ local hospital management personnel are critical to the success of our business. The loss of the services of one or more of our senior executives or of a significant portion of our operators’ local hospital management personnel could significantly undermine our management expertise and our operators’ ability to provide efficient, quality health care services at our facilities, which could harm their business, and in turn, harm our business.

 

Increasing investor interest in our sector and consolidation at the operator or REIT level could increase competition and reduce our profitability.

 

Our business is highly competitive and we expect that it may become more competitive in the future. We compete for the acquisition, leasing and financing of health care related facilities. Our competitors include, but are not limited to, other REITs, banks and other companies, including UHS, some of which are larger and may have a lower cost of capital than we do. These developments could result in fewer investment opportunities for us and lower spreads over our cost of our capital, which would hurt our growth. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our business goals and could improve the bargaining power of property owners seeking to sell, thereby impeding our investment, acquisition and development activities. If we cannot capitalize on our development pipeline, identify and purchase a sufficient quantity of healthcare facilities at favorable prices or if we are unable to finance acquisitions on commercially favorable terms, our business, results of operations and financial condition may be materially adversely affected.

 

We may be required to incur substantial renovation costs to make certain of our healthcare properties suitable for other operators and tenants.

 

Healthcare facilities are typically highly customized and may not be easily adapted to non-healthcare-related uses. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure, are costly and at times tenant-specific. A new or replacement operator or tenant may require different features in a property, depending on that operator’s or tenant’s particular operations. If a current operator or tenant is unable to pay rent and vacates a property, we may incur substantial expenditures to modify a property before we are able to secure another operator or tenant. Also, if the property needs to be renovated to accommodate multiple operators or tenants, we may incur substantial expenditures before we are able to re-lease the space. These expenditures or renovations may materially adversely affect our business, results of operations and financial condition.

 

We are subject to significant corporate regulation as a public company and failure to comply with all applicable regulations could subject us to liability or negatively affect our stock price.

 

As a publicly traded company, we are subject to a significant body of regulation, including the Sarbanes-Oxley Act of 2002. While we have developed and instituted a corporate compliance program based on what we believe are the current best practices in corporate governance and continue to update this program in response to

 

18


Table of Contents

newly implemented or changing regulatory requirements, we cannot provide assurance that we are or will be in compliance with all potentially applicable corporate regulations. For example, we cannot provide assurance that in the future our management will not find a material weakness in connection with its annual review of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We also cannot provide assurance that we could correct any such weakness to allow our management to assess the effectiveness of our internal control over financial reporting as of the end of our fiscal year in time to enable our independent registered public accounting firm to state that we have maintained effective internal control over financial reporting as of the end of our fiscal year. If we fail to comply with any of these regulations, we could be subject to a range of regulatory actions, fines or other sanctions or litigation. If we must disclose any material weakness in our internal control over financial reporting, our stock price could decline.

 

Different interpretations of accounting principles could have a material adverse effect on our results of operations or financial condition.

 

Generally accepted accounting principles are complex, continually evolving and may be subject to varied interpretation by us, our independent registered public accounting firm and the SEC. Such varied interpretations could result from differing views related to specific facts and circumstances. Differences in interpretation of generally accepted accounting principles could have a material adverse effect on our financial position or results of operations.

 

Item 1B. Unresolved Staff Comments

 

None.

 

19


Table of Contents
ITEM 2. Properties

 

The following table shows our investments in hospital facilities leased to UHS and other non-related parties and also provides information related to various properties in which we have significant investments, some of which are accounted for by the equity method. The capacity in terms of beds (for the hospital facilities) and the five-year occupancy levels are based on information provided by the lessees.

 

    Type of
facility
  Number
of
available
beds @
12/31/14
          Lease Term     % of RSF
under
lease with
guaranteed
escalators
    Range of
guaranteed
escalation
 

Hospital Facility Name and
Location

      Average Occupancy(1)     Minimum
rent(5)
    End of
initial
or
renewed
term
    Renewal
term
(years)
     
      2014     2013     2012     2011     2010            

Southwest Healthcare System:

Inland Valley Campus(2)(7)

Wildomar, California

  Acute Care     132        59     58     62     70     78   $ 2,648,000        2016        15        0      

McAllen Medical Center(3)(7)

McAllen, Texas

  Acute Care     430        44     43     43     45     47     5,485,000        2016        15        0      

Wellington Regional Medical Center(7)

West Palm Beach, Florida

  Acute Care     153        59     58     69     73     70     3,030,000        2016        15        0      

HealthSouth Deaconess Rehab. Hospital(8)

Evansville, Indiana

  Rehabilitation     85        80     79     79     75     71     714,000        2019        5        0      

Vibra Hospital of Corpus Christi

Corpus Christi, Texas

  Sub-Acute Care     74        58     58     53     54     64     742,000        2019        25        100     3

Kindred Hospital Chicago Central(9)

Chicago, Illinois

  Sub-Acute Care     84        54     51     51     46     40     1,474,000        2016        5        0      

 

    Type
of
facility
                                  Lease Term              

Facility Name and Location

    Average Occupancy(1)     Minimum
rent(5)
    End of
initial
or
renewed
term
    Renewal
term
(years)
    % of RSF
under
lease with
guaranteed
escalators
    Range of
guaranteed
escalation
 
    2014     2013     2012     2011     2010            

Spring Valley MOB I(4)
Las Vegas, Nevada

    MOB        60     64     68     75     93   $ 544,000        2015-2018        Various        69     2 %-3% 

Spring Valley MOB II(4)
Las Vegas, Nevada

    MOB        77     76     76     67     53     1,087,000        2016-2020        Various        25     1 %-3% 

Summerlin Hospital MOB I(4)
Las Vegas, Nevada

    MOB        66     77     81     90     91     778,000        2015-2020        Various        43     2 %-3% 

Summerlin Hospital MOB II(4)
Las Vegas, Nevada

    MOB        78     74     82     83     97     1,263,000        2015-2021        Various        52     2 %-3% 

Summerlin Hospital MOB III(4)
Las Vegas, Nevada

    MOB        90     81     71     64     63     1,920,000        2015-2024        Various        45     2 %-3% 

St. Mary’s Professional Office Building(11)
Reno, Nevada

    MOB        100     98     99     100     99     4,448,000        2015-2025        Various        28     2 %-3% 

Rosenberg Children’s Medical Plaza
Phoenix, Arizona

    MOB        99     99     100     100     100     1,989,000        2015-2019        Various        56     2 %-4% 

Phoenix Children’s East Valley Care Center Phoenix, Arizona

    MOB        100     100     100     100     100     936,000        2032        20        0     —     

Gold Shadow—700 Shadow(4)
Las Vegas, Nevada

    MOB        97     84     82     78     86     811,000        2015-2020        Various        38     2

Gold Shadow—2010 & 2020 Goldring MOBs(4) Las Vegas, Nevada

    MOB        64     92     95     95     91     889,000        2015-2021        Various        46     2 %-3% 

Centennial Hills MOB(4)
Las Vegas, Nevada

    MOB        71     62     62     63     58     1,459,000        2015-2024        Various        44     2 %-3% 

Suburban Medical Plaza II(11)
Louisville, Kentucky

    MOB        98     100     100     100     98     2,500,000        2015-2025        Various        21     3

Lake Pointe Medical Arts Building(6) Rowlett, Texas

    MOB        100     97     96     95     —          1,555,000        2017-2023        Various        24     3 %-4% 

Tuscan Medical Properties(6)
Las Colinas, Texas

    MOB        91     99     98     100     —          903,000        2015-2022        Various        100     2 %-3% 

PeaceHealth Medical Clinic(10)
Bellingham, Washington

    MOB        100     100     100     —          —          2,563,000        2021        20        100     1

 

20


Table of Contents

 

(1) Average occupancy rate for the hospital facilities is based on the average number of available beds occupied during each of the five years ended December 31, 2014. Average available beds is the number of beds which are actually in service at any given time for immediate patient use with the necessary equipment and staff available for patient care. A hospital may have appropriate licenses for more beds than are in service for a number of reasons, including lack of demand, incomplete construction and anticipation of future needs. The average occupancy rate of a hospital is affected by a number of factors, including the number of physicians using the hospital, changes in the number of beds, the composition and size of the population of the community in which the hospital is located, general and local economic conditions, variations in local medical and surgical practices and the degree of outpatient use of the hospital services. Average occupancy rate for the multi-tenant medical office buildings is based on the occupied square footage of each building, including any applicable master leases.
(2) In July, 2002, the operations of Inland Valley Regional Medical Center (“Inland Valley”) were merged with the operations of Rancho Springs Medical Center (“Rancho Springs”), an acute care hospital located in California and also operated by UHS, the real estate assets of which are not owned by us. Inland Valley, our lessee, was merged into Universal Health Services of Rancho Springs, Inc. The merged entity is now doing business as Southwest Healthcare System (“Southwest Healthcare”). As a result of merging the operations of the two facilities, the revenues of Southwest Healthcare include the revenues of both Inland Valley and Rancho Springs. Although we do not own the real estate assets of the Rancho Springs facility, Southwest Healthcare became the lessee on the lease relating to the real estate assets of the Inland Valley facility. Since the bonus rent calculation for the Inland Valley campus is based on net revenues and the financial results of the two facilities are no longer separable, the lease was amended during 2002 to exclude from the bonus rent calculation the estimated net revenues generated at the Rancho Springs campus (as calculated pursuant to a percentage based allocation determined at the time of the merger). The average occupancy rates shown for this facility for all years were based on the combined number of beds occupied at the Inland Valley and Rancho Springs campuses.
(3) During the first quarter of 2001, UHS purchased the assets and operations of the 60-bed McAllen Heart Hospital located in McAllen, Texas. Upon the acquisition by UHS, the Heart Hospital began operating under the same license as an integrated department of McAllen Medical Center. As a result of combining the operations of the two facilities, the revenues of McAllen Medical Center include revenues generated by the Heart Hospital, the real property of which is not owned by us. Accordingly, since the bonus rent calculation for McAllen Medical Center is based on the combined net revenues of the two facilities, the McAllen Medical Center lease was amended during 2001 to exclude from the bonus rent calculation, the estimated net revenues generated at the Heart Hospital (as calculated pursuant to a percentage based allocation determined at the time of the merger). In addition, during 2000, UHS purchased the South Texas Behavioral Health Center, a behavioral health care facility located in McAllen, Texas. In 2006, a newly constructed replacement facility for the South Texas Behavioral Health Center was completed and opened. The license for this facility, the real property of which is not owned by us, was also merged with the license for McAllen Medical Center. There was no amendment to the McAllen Medical Center lease related to the operations of the South Texas Behavioral Health Center and its revenues are excluded from the bonus rent calculation. In 2015, the newly constructed Weslaco and Mission Free Standing Emergency Departments (“FEDs”) were completed and opened. The license for these facilities is part of the license of McAllen Medical Center. The real property of these two FEDs was purchased by us and leased back to McAllen Medical Center. There was no amendment to the McAllen Medical Center lease related to the operations of the FEDs and their revenues will be excluded from the bonus rent calculation. No assurance can be given as to the effect, if any, the consolidation of the facilities as mentioned above, had on the underlying value of McAllen Medical Center. Base rental commitments and the guarantee by UHS under the original lease continue for the remainder of the lease terms. The average occupancy rates are based upon the combined occupancy and combined number of beds at McAllen Medical Center and McAllen Heart Hospital.
(4) The real estate assets of this facility are owned by us (either directly or through an LLC in which we hold 100% of the ownership interest) and include tenants who are subsidiaries of UHS.
(5) Minimum rent amounts contain impact of straight-line rent adjustments, if applicable.
(6) These properties were acquired in 2011.
(7) See Note 2 to the consolidated financial statements-Relationship with UHS and Related Party Transactions, regarding UHS’s purchase option, right of first refusal and change of control purchase option related to these properties.
(8) The lessee of this facility has a purchase option which is exercisable, subject to certain terms and conditions, at the expiration of each lease term. If exercised, the purchase option stipulates that the purchase price be the fair market value of the facility, subject to stipulated minimum and maximum prices. As currently being utilized, we believe the estimated current fair market value of the property is between the stipulated minimum and maximum prices. The lessee also has a first refusal to purchase right which, if applicable and subject to certain terms and conditions, grants the lessee the option to purchase the property at the same terms and conditions as an accepted third-party offer.

 

21


Table of Contents
(9) The lessee of this facility has a purchase option which is exercisable, subject to certain terms and conditions, at the expiration of each lease term. If exercised, the purchase option stipulates that the purchase price be the fair market value of the facility, subject to a stipulated minimum price. We believe the estimated current fair market value of the property exceeds the stipulated minimum price. The lessee also has a first refusal to purchase right which, if applicable and subject to certain terms and conditions, grants the lessee the option to purchase the property at the same terms and conditions as an accepted third-party offer.
(10) This MOB was acquired in January, 2012.
(11) The real estate assets of these facilities are owned by LLCs in which we hold non-controlling ownership interests (75% applicable to St. Mary’s Professional Office Building and 33% applicable to Suburban Medical Plaza II).

 

Leasing Trends at Our Significant Medical Office Buildings

 

During 2014, we had a total of 80 new or renewed leases related to the medical office buildings indicated above, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 11% of the aggregate rentable square feet of these properties (6% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occupancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $22 per square foot during 2014. The weighted-average leasing commissions on the new and renewed leases commencing during 2014 was approximately 2% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2014 was approximately 2% of the future aggregate base rental revenue over the lease terms. Rent abatements were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2014, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 1%.

 

Set forth is information detailing the rentable square feet (“RSF”) associated with each of our investments as of December 31, 2014 and the percentage of RSF on which leases expire during the next five years and thereafter. For the MOBs that have scheduled lease expirations during 2015 of 20% or greater (of RSF), we have included information regarding estimated market rates relative to lease rates on the expiring leases.

 

                  Percentage of RSF with lease expirations  
     Total
RSF
     Available
for Lease
Jan. 1,
2015
    2015     2016     2017     2018     2019     2020
and
Later
 

Hospital Investements

               

McAllen Medical Center

     422,276         0     0     100     0     0     0     0

Wellington Regional Medical Center

     196,489         0     0     100     0     0     0     0

Southwest Healthcare System—Inland Valley Campus

     164,377         0     0     100     0     0     0     0

Kindred Hospital Chicago Central

     115,554         0     0     100     0     0     0     0

HealthSouth Deaconess Rehab. Hospital

     77,440         0     0     0     0     0     100     0

Vibra Hospital of Corpus Christi

     69,700         0     0     0     0     0     100     0
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Sub-total Hospitals

     1,045,836         0     0     86     0     0     14     0
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other Investements

               

Medical Office Buildings:

               

Saint Mary’s Professional Office Building

     190,754         0     5     1     8     0     2     84

Goldshadow—2010—2020 Goldring MOB’s(a)

     74,774         32     21     5     21     2     0     19

Goldshadow—700 Shadow Lane MOB(a)

     42,060         3     45     6     11     0     12     23

Texoma Medical Plaza

     115,284         4     10     0     2     6     2     76

Suburban Medical Plaza II

     103,011         4     2     9     1     6     2     76

Desert Springs Medical Plaza

     102,579         44     13     2     0     6     8     27

Peace Health Medical Clinic

     98,886         0     0     0     0     0     0     100

Centennial Hills Medical Office Building

     96,573         26     7     6     2     13     5     41

Summerlin Hospital Medical Office Building II(a)

     92,313         23     20     7     14     9     16     11

Summerlin Hospital Medical Office Building I(a)

     89,636         38     23     23     4     4     2     6

The Sparks Medical Building

     35,127         8     9     13     4     6     3     57

Vista Medical Terrace

     50,921         50     9     1     10     9     7     14

North Valley Medical Plaza

     80,379         59     14     5     4     10     3     5

Summerlin Hospital Medical Office Building III

     77,713         0     2     13     0     6     44     35

 

22


Table of Contents
                  Percentage of RSF with lease expirations  
     Total
RSF
     Available
for Lease
Jan. 1,
2015
    2015     2016     2017     2018     2019     2020
and
Later
 

Mid Coast Hospital MOB

     74,629         0     0     77     0     7     0     16

Sheffield Medical Building

     73,446         58     3     5     8     0     4     22

North West Texas Professional Office Tower

     72,351         0     3     46     3     0     0     48

Rosenberg Children’s Medical Plaza

     66,231         1     3     17     0     74     5     0

Sierra San Antonio Medical Plaza

     59,160         32     4     6     9     7     3     39

Palmdale Medical Plaza

     58,150         47     0     0     5     9     0     39

Spring Valley Medical Office Building

     57,828         40     19     11     21     9     0     0

Spring Valley Medical Office Building II

     57,432         17     0     13     0     39     14     17

Southern Crescent Center II

     53,680         35     0     11     0     0     15     39

Desert Valley Medical Center

     53,625         21     14     15     9     11     0     30

Tuscan Professional Building

     52,868         12     17     8     0     12     0     51

Lake Pointe Medical Arts Building

     50,974         0     0     0     33     23     14     30

Forney Medical Plaza

     50,947         9     0     0     0     80     0     11

Southern Crescent Center I

     41,897         46     0     0     6     21     27     0

Auburn Medical Office Building

     41,311         10     0     0     9     0     0     81

BRB Medical Office Building

     40,733         0     17     4     0     9     3     67

Cypresswood Professiona Center—8101(b)

     10,200         0     100     0     0     0     0     0

Cypresswood Professional Center—8111

     29,882         5     7     0     11     0     16     61

Medical Center of Western Connecticut

     36,141         0     0     4     24     5     67     0

Phoenix Children’s East Valley Care Center

     30,960         0     0     0     0     0     0     100

Forney Medical Plaza II

     30,507         67     0     0     0     5     0     28

Apache Junction Medical Plaza

     26,901         31     9     4     22     0     0     34

Santa Fe Professional Plaza

     24,883         28     0     27     11     11     0     23

Professional Bldg at King’s Crossing—Bldg A (d)

     11,528         100     0     0     0     0     0     0

Professional Bldg at King’s Crossing—Bldg B(c)

     12,790         0     36     41     11     0     12     0

The Children’s Clinic at Springdale

     9,761         0     0     0     0     0     0     100

Northwest Medical Center at Sugar Creek

     13,696         0     0     0     0     0     0     100

Kelsey-Seybold Clinic at King’s Crossing

     20,470         0     0     0     0     0     0     100

Emory at Dunwoody Building

     20,366         0     0     0     0     0     0     100

Ward Eagle Office Village

     16,282         0     0     0     0     0     0     100

Family Doctor’s MOB

     12,050         0     0     100     0     0     0     0

701 South Tonopah Building

     10,747         0     0     0     0     0     0     100

5004 Pool Road MOB

     4,400         0     0     0     0     0     0     100

Preschool and Childcare Centers:

               

Chesterbrook Academy—Audubon

     8,300         0     0     0     0     0     0     100

Chesterbrook Academy—Uwchlan

     8,163         0     0     0     0     0     0     100

Chesterbrook Academy—Newtown

     8,100         0     0     100     0     0     0     0

Chesterbrook Academy—New Britain

     7,998         0     0     100     0     0     0     0

Free-Standing Emergency Departments:

               

Hanover Freestanding Emergency Center

     22,000         0     0     0     0     0     0     100
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Sub-total Other Investments

     2,531,397         19     8     10     6     9     6     42
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

     3,577,233         13     6     32     4     7     8     30
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) The estimated market rates related to the 2015 expiring RSF are greater than the lease rates on the expiring leases by an average of approximately 3%.
(b) The estimated market rates related to the 2015 expiring RSF are less than the lease rates on the expiring leases by an average of approximately 5%.
(c) The estimated market rates related to the 2015 expiring RSF are less than the lease rates on the expiring leases by an average of approximately 11%.
(d) A new lease was executed on this building subsequent to January 1, 2015 for 100% of the available space on January 1, 2015.

 

On a combined basis, based upon the aggregate revenues and square footage for the hospital facilities owned as of December 31, 2014 (including The Bridgeway which was sold on December 31, 2014) and 2013, the average effective annual rental per square foot was $17.47 and $17.22, respectively. On a combined basis, based upon the aggregate consolidated and unconsolidated revenues and the estimated average occupied square footage for our MOBs and childcare centers owned as of December 31, 2014 and 2013, the average effective annual rental per square foot was $27.22 and $27.47, respectively. On a combined basis, based upon the aggregate consolidated and unconsolidated revenues and estimated average occupied square footage for all of our properties owned as of December 31, 2014 and 2013, the average effective annual rental per square foot was $23.83 and $23.82, respectively. The estimated average occupied square footage for 2014 was calculated by averaging the unavailable rentable square footage on January 1, 2014 and January 1, 2015. The estimated average occupied square footage for 2013 was calculated by averaging the unavailable rentable square footage on January 1, 2013 and January 1, 2014.

 

23


Table of Contents

During 2014, one of the UHS-related hospitals (McAllen Medical Center) generated revenues that comprised more than 10% of our consolidated revenues. None of the properties had book values greater than 10% of our consolidated assets as of December 31, 2014. Including 100% of the revenues generated at the properties owned by our unconsolidated LLCs, none of our unconsolidated LLCs had revenues greater than 10% of the combined consolidated and unconsolidated revenues during 2014. Including 100% of the book values of the properties owned by our unconsolidated LLCs, none of the properties had book values greater than 10% of the consolidated and unconsolidated assets.

 

The following table sets forth the average effective annual rental per square foot for 2014, based upon average occupied square feet for McAllen Medical Center:

 

Property

   2014
Average
Occupied
Square
Feet
     2014
Revenues
     2014
Average
Effective
Rental
Per Square
Foot
 

McAllen Medical Center

     422,276       $ 7,121,000       $ 16.86   

 

The following table sets forth lease expirations for each of the next ten years for properties owned or invested in as of December 31, 2014.

 

     Expiring
Square
Feet
     Number
of
Tenants
     Annual Rentals of
Expiring
Leases(1)
     Percentage
of
Annual
Rentals(2)
 

Hospital properties

           

2015

     0         0       $ 0         0

2016

     898,696         4       $ 12,414,000         17

2017

     0         0       $ 0         0

2018

     0         0       $ 0         0

2019

     147,140         2       $ 1,491,000         2

2020

     0         0       $ 0         0

2021

     0         0       $ 0         0

2022

     0         0       $ 0         0

2023

     0         0       $ 0         0

2024

     0         0       $ 0         0

Thereafter

     0         0       $ 0         0
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-hospital facilities

     1,045,836         6       $ 13,905,000         19
  

 

 

    

 

 

    

 

 

    

 

 

 

Other consolidated properties

           

2015

     176,967         68       $ 4,764,000         7

2016

     188,920         54       $ 4,864,000         7

2017

     126,827         45       $ 3,219,000         4

2018

     220,209         56       $ 7,855,000         11

2019

     137,163         34       $ 3,981,000         6

2020

     166,357         38       $ 5,026,000         7

2021

     200,366         23       $ 5,612,000         8

2022

     124,565         13       $ 2,994,000         4

2023

     91,357         18       $ 2,671,000         4

2024

     42,544         4       $ 1,209,000         1

Thereafter

     86,506         9       $ 2,253,000         3
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-other consolidated properties

     1,561,781         362       $ 44,448,000         62
  

 

 

    

 

 

    

 

 

    

 

 

 

 

24


Table of Contents
     Expiring
Square
Feet
     Number
of
Tenants
     Annual Rentals of
Expiring
Leases(1)
     Percentage
of
Annual
Rentals(2)
 

Other unconsolidated properties

(MOBs)

           

2015

     84,344         7       $ 2,221,000         3

2016

     11,976         9       $ 330,000         0

2017

     19,146         6       $ 558,000         1

2018

     19,434         6       $ 560,000         1

2019

     7,333         3       $ 208,000         0

2020

     135,931         11       $ 3,906,000         5

2021

     16,915         5       $ 459,000         1

2022

     27,802         6       $ 755,000         1

2023

     24,808         6       $ 815,000         1

2024

     47,394         8       $ 1,397,000         2

Thereafter

     94,948         8       $ 2,716,000         4
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-other unconsolidated properties

     490,031         75       $ 13,925,000         19
  

 

 

    

 

 

    

 

 

    

 

 

 

Total all properties at December 31, 2014

     3,097,648         443       $ 72,278,000         100
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) The annual rentals of expiring leases reflected above were calculated based upon each property’s 2014 average rental rate per occupied square foot applied to each property’s scheduled lease expirations (on a square foot basis). These amounts include the data related to the unconsolidated LLCs in which we hold various non-controlling ownership interests at December 31, 2014 and exclude the bonus rentals earned on the UHS hospital facilities.
(2) The percentages of annual rentals reflected above were calculated based upon the annual rentals of expiring leases (as reflected above) divided by the total annual rentals of expiring leases (as reflected above).

 

25


Table of Contents
ITEM 3. Legal Proceedings

 

None

 

ITEM 4. Mine Safety Disclosures

 

Not applicable

 

PART II

 

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Our shares of beneficial interest are listed on the New York Stock Exchange. The high and low closing sales prices for our shares of beneficial interest for each quarter in the years ended December 31, 2014 and 2013 are summarized below:

 

     2014      2013  
     High
Price
     Low
Price
     High
Price
     Low
Price
 

First Quarter

   $ 44.21       $ 40.03       $ 58.03       $ 51.82   

Second Quarter

   $ 44.55       $ 41.73       $ 58.85       $ 41.47   

Third Quarter

   $ 44.74       $ 41.26       $ 46.53       $ 38.52   

Fourth Quarter

   $ 49.13       $ 41.47       $ 45.60       $ 40.06   

 

Holders

 

As of January 31, 2015, there were approximately 380 shareholders of record of our shares of beneficial interest.

 

Dividends

 

It is our intention to declare quarterly dividends to the holders of our shares of beneficial interest so as to comply with applicable sections of the Internal Revenue Code governing REITs. Our revolving credit facility limits our ability to increase dividends in excess of 95% of cash available for distribution, as defined in our revolving credit agreement, unless additional distributions are required to be made so as to comply with applicable sections of the Internal Revenue Code and related regulations governing REITs. In each of the past two years, dividends per share were declared as follows:

 

     2014      2013  

First Quarter

   $ .625       $ .620   

Second Quarter

     .630         .625   

Third Quarter

     .630         .625   

Fourth Quarter

     .635         .625   
  

 

 

    

 

 

 
   $ 2.520       $ 2.495   
  

 

 

    

 

 

 

 

26


Table of Contents

Stock Price Performance Graph

 

The following graph compares our performance with that of the S&P 500 and a group of peer companies, where performance has been weighted based on market capitalization. Companies in our peer group are as follows: HCP, Inc., Nationwide Health Properties, Inc. (included until July, 2011 when it was acquired by Ventas, Inc.), Omega Healthcare Investors, Inc., Health Care REIT, Inc., Healthcare Realty Trust, Inc., LTC Properties, Inc., and National Health Investors, Inc.

 

The total cumulative return on investment (change in the year-end stock price plus reinvested dividends) for each of the periods for us, the peer group and the S&P 500 composite is based on the stock price or composite index at the end of fiscal 2009.

 

LOGO

 

     Base
Period
Dec 09
     INDEXED RETURNS
Years Ending
 

Company Name / Index

      Dec 10      Dec 11      Dec 12      Dec 13      Dec 14  

Universal Health Realty Income Trust

   $ 100       $ 122.24       $ 139.02       $ 190.69       $ 159.53       $ 202.90   

S&P 500 Index

   $ 100       $ 115.06       $ 117.49       $ 136.30       $ 180.44       $ 205.14   

Peer Group

   $ 100       $ 119.16       $ 137.75       $ 163.34       $ 149.74       $ 205.10   

 

27


Table of Contents
ITEM 6. Selected Financial Data

 

The following table contains our selected financial data for, or at the end of, each of the five years ended December 31, 2014. You should read this table in conjunction with our consolidated financial statements and related notes contained elsewhere in this Annual Report and Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

     (000s, except per share amounts)  
     2014     2013     2012     2011     2010  

Operating Results:

          

Total revenues(1)

   $ 59,786      $ 54,280      $ 53,950      $ 29,494      $ 28,878   

Net income(2)

   $ 51,551      $ 13,169      $ 19,477      $ 73,794      $ 16,310   

Balance Sheet Data:

          

Real estate investments, net of accumulated depreciation(1)(3)

   $ 380,109      $ 297,748      $ 314,386      $ 288,633      $ 125,257   

Investments in LLCs, net(1)(4)

     8,605        39,201        28,636        33,057        80,442   

Intangible assets, net of accumulated amortization(3)

     23,123        20,782        26,293        28,081        1,080   

Total assets(1)(3)

     428,866        373,145        383,038        370,929        216,135   

Total indebtedness, including debt premium(1)(3)(5)

     213,155        199,987        197,936        174,836        67,563   

Other Data:

          

Funds from operations(6)

   $ 35,937      $ 34,955      $ 34,280      $ 32,468      $ 32,582   

Cash provided by (used in):

          

Operating activities

     32,796        31,294        30,783        21,372        23,049   

Investing activities

     (4,038     (13,373     (8,565     (7,454     (15,202

Financing activities

     (29,815     (17,491     (30,819     (7,426     (7,798

Per Share Data:

          

Basic earnings per share:

          

Total basic earnings per share(2)

   $ 3.99      $ 1.04      $ 1.54      $ 5.84      $ 1.33   

Diluted earnings per share:

          

Total diluted earnings per share(2)

   $ 3.99      $ 1.04      $ 1.54      $ 5.83      $ 1.33   

Dividends per share

   $ 2.520      $ 2.495      $ 2.460      $ 2.425      $ 2.415   

Other Information (in thousands)

          

Weighted average number of shares outstanding—basic

     12,927        12,689        12,661        12,644        12,259   

Weighted average number of shares and share equivalents outstanding—diluted

     12,934        12,701        12,669        12,649        12,262   

 

(1) As discussed in Note 1 “Summary of Significant Accounting Policies—Investments in Limited Liability Companies”, our consolidated financial statements include the consolidated accounts of our consolidated investments and those investments that meet the criteria of a variable interest entity. Please see Note 1 for further discussions.
(2)

Net income and earnings per share during 2014 includes: (i) a $25.4 million gain recorded in connection with our purchase of third-party minority ownership interests in eight LLCs (January and August, 2014, as discussed below) in which we formerly held non-controlling majority ownership interests (we own 100% of each of these entities since the effective dates); (ii) a $13.0 million gain on the divestiture of real property (the Bridgeway), and; (iii) $427,000 of transaction costs related to the 2014 acquisition and divestiture activity previously mentioned. Net income and earnings per share during 2013 includes approximately $200,000 of transaction costs related to the acquisition of three MOBs during 2013 and the first quarter of 2014. Net income and earnings per share during 2012 includes an $8.5 million gain on the divestitures of properties owned by two unconsolidated LLCs in which we formerly held non-controlling majority ownership interests, and $680,000 of transaction costs related to the acquisition of a medical clinic and

 

28


Table of Contents
 

medical office building in 2012. Net income and earnings per share data during 2011 includes: (i) a $28.6 million gain recorded in connection with our purchase of third-party minority ownership interests in various LLCs in which we formerly held non-controlling majority ownership interests (we own 100% of each of these entities since that time); (ii) a $35.8 million gain on the divestitures of properties owned by unconsolidated LLCs in which we formerly held non-controlling majority ownership interests; (iii) $518,000 of transaction costs related to the acquisition of four MOBs during 2011 and the first quarter of 2012, and; (iv) a $5.4 million charge for a provision for asset impairment recorded on a certain MOB.

(3) Amounts include: (i) the fair value of the real property (as of 2014) of the eight previously unconsolidated LLCs, which we began consolidating during the first and third quarters of 2014, subsequent to our purchase of the third-party minority ownership interests on January 1, 2014 and August 1, 2014 (we owned 100% of each of these entities at December 31, 2014), and; (ii) the fair values of the real property (as of 2011) of various previously unconsolidated LLCs, which we began consolidating during the fourth quarter of 2011 subsequent to our purchase of the third-party minority ownership interests (we owned 100% of each of these entities at December 31, 2011).
(4) Investments in LLCs at December 31, 2014, 2013, 2012 and 2011 reflect the consolidation of various LLCs, as mentioned in notes 2 and 3 above, as well as the divestiture of property owned by various unconsolidated LLCs during 2012 and 2011. Additionally, at December 31, 2013, Investments in LLCs reflects the deconsolidation of Palmdale Medical Properties. This LLC was deemed to be a variable interest entity during the term of the master lease and was consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC is no longer be deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method. Effective January 1, 2014, Investments in LLCs reflects the consolidation of Palmdale Medical Properties, since we purchased the third-party minority ownership interests in Palmdale and began accounting for this LLC on a consolidated basis as of that date.
(5) Excludes third-party debt that is non-recourse to us, incurred by unconsolidated LLCs in which we hold various non-controlling equity interests as follows: $52.7 million as of December 31, 2014, $80.1 million as of December 31, 2013, $77.5 million as of December 31, 2012, $101.8 million as of December 31, 2011 and $271.7 million as of December 31, 2010 (See Note 8 to the consolidated financial statements).
(6) Our funds from operations (“FFO”) during 2014, 2013, 2012 and 2011 are net of reductions for transaction costs of $427,000, $203,000, $680,000 and $518,000, respectively.

 

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, and adjusted funds from operations (“AFFO”) and AFFO per diluted share, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. We compute FFO, as reflected below, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. AFFO was also computed for 2014, 2013, 2012, 2011 and 2010, as reflected below, since we believe it is helpful to our investors since it adjusts for the transaction costs related to acquisitions. FFO/AFFO do not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO/AFFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders.

 

29


Table of Contents

A reconciliation of our reported net income to FFO and AFFO for each of the last five years is shown below:

 

     (000s)  
     2014     2013      2012     2011     2010  

Net income

   $ 51,551      $ 13,169       $ 19,477      $ 73,794      $ 16,310   

Depreciation and amortization expense on real property/intangibles:

         

Consolidated investments

     20,548        18,496         20,030        7,173        6,156   

Unconsolidated affiliates

     2,290        3,290         3,293        10,558        10,116   

Provision for asset impairment

     —         —          —         5,354        —    

Less gains:

         

Gains on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, net

     (25,409 )     —          —         (28,576     —    

Gain on divestiture of real property

     (13,043     —          —         —         —    

Gains on divestiture of properties owned by unconsolidated LLCs, net

     —         —          (8,520     (35,835     —    
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Funds From Operations

     35,937        34,955         34,280        32,468        32,582   

Transaction costs

     427        203         680        518        —    
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Funds From Operations

   $ 36,364      $ 35,158       $ 34,960      $ 32,986      $ 32,582   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

30


Table of Contents
ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

We are a real estate investment trust (“REIT”) that commenced operations in 1986. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings (“MOBs”). As of February 28, 2015, we have sixty-one real estate investments or commitments in eighteen states consisting of:

 

   

six hospital facilities including three acute care, one rehabilitation and two sub-acute;

 

   

three free-standing emergency departments;

 

   

forty-eight medical office buildings (“MOBs”), including five owned by unconsolidated LLCs, and;

 

   

four preschool and childcare centers.

 

Forward Looking Statements

 

This report contains “forward-looking statements” that reflect our current estimates, expectations and projections about our future results, performance, prospects and opportunities. Forward-looking statements include, among other things, the information concerning our possible future results of operations, business and growth strategies, financing plans, expectations that regulatory developments or other matters will not have a material adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical facts. Words such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “appears,” “projects” and similar expressions, as well as statements in future tense, identify forward-looking statements.

 

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Such factors include, among other things, the following:

 

   

a substantial portion of our revenues are dependent upon one operator, Universal Health Services, Inc. (“UHS”). We cannot assure you that subsidiaries of UHS will renew the leases on our three acute care hospitals at existing lease rates or fair market value lease rates. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues and results of operations could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases;

 

   

a number of legislative initiatives have recently been passed into law that may result in major changes in the health care delivery system on a national or state level to the operators of our facilities, including UHS. No assurances can be given that the implementation of these new laws will not have a material adverse effect on the business, financial condition or results of operations of our operators;

 

   

a subsidiary of UHS is our Advisor and our officers are all employees of a wholly-owned subsidiary of UHS, which may create the potential for conflicts of interest;

 

   

lost revenues resulting from the exercise of purchase options, lease expirations and renewals, loan repayments and other restructuring;

 

31


Table of Contents
   

our ability to continue to obtain capital on acceptable terms, including borrowed funds, to fund future growth of our business. Our $150 million revolving credit agreement is scheduled to expire on July 24, 2015. We are in the process of renegotiating our Credit Agreement and, although we can provide no assurance we will do so, we expect to complete the replacement credit facility by March 31, 2015;

 

   

the outcome of known and unknown litigation, government investigations, and liabilities and other claims asserted against us or the operators of our facilities;

 

   

failure of the operators of our hospital facilities to comply with governmental regulations related to the Medicare and Medicaid licensing and certification requirements could have a material adverse impact on our future revenues and the underlying value of the property;

 

   

the potential unfavorable impact on our business of deterioration in national, regional and local economic and business conditions, including a worsening of credit and/or capital market conditions, which may adversely affect, our ability to obtain capital which may be required to fund the future growth of our business and refinance existing debt with near term maturities;

 

   

a deterioration in general economic conditions which could result in increases in the number of people unemployed and/or insured and likely increase the number of individuals without health insurance; as a result, the operators of our facilities may experience decreases in patient volumes which could result in decreased occupancy rates at our medical office buildings;

 

   

a worsening of the economic and employment conditions in the United States could materially affect the business of our operators, including UHS, which may unfavorably impact our future bonus rentals (on the UHS hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties;

 

   

real estate market factors, including without limitation, the supply and demand of office space and market rental rates, changes in interest rates as well as an increase in the development of medical office condominiums in certain markets;

 

   

government regulations, including changes in the reimbursement levels under the Medicare and Medicaid program resulting from, among other things, the various health care reform initiatives being implemented;

 

   

there have been several attempts in Congress to repeal or modify various provisions of the Patient Protection and Affordable Care Act (the “PPACA”). We cannot predict whether or not any of these proposed changes to the PPACA will become law and therefore can provide no assurance that changes to the PPACA, as currently implemented, will not have a material adverse effect on the future operating results of the tenants/operators of our properties and, thus, our business. In addition, a case currently pending before The Supreme Court of the United States, King vs. Burwell, challenges the federal government’s ability to subsidize premiums paid by certain eligible individuals that obtain health insurance policies through federally facilitated exchanges. A number of our properties are located in states that utilize federally facilitated exchanges. The Supreme Court of the United States’ decision in this case could result in an increased number of uninsured patients in the states that utilize federally facilitated exchanges which would have an adverse impact on the future operating results of the tenants/operators of our facilities located in these states and, thus, our business;

 

   

the issues facing the health care industry that affect the operators of our facilities, including UHS, such as: changes in, or the ability to comply with, existing laws and government regulations; unfavorable changes in the levels and terms of reimbursement by third party payors or government programs, including Medicare (including, but not limited to, the potential unfavorable impact of future reductions to Medicare reimbursements resulting from the Budget Control Act of 2011, as discussed below) and Medicaid (most states have reported significant budget deficits that have, in the past, resulted in the reduction of Medicaid funding to the operators of our facilities, including UHS); demographic changes; the ability to enter into managed care provider agreements on acceptable terms; an increase in uninsured and self-pay patients which unfavorably impacts the collectability of patient accounts;

 

32


Table of Contents
 

decreasing in-patient admission trends; technological and pharmaceutical improvements that may increase the cost of providing, or reduce the demand for, health care, and; the ability to attract and retain qualified medical personnel, including physicians;

 

   

in August, 2011, the Budget Control Act of 2011 (the “2011 Act”) was enacted into law. The 2011 Act imposed annual spending limits for most federal agencies and programs aimed at reducing budget deficits by $917 billion between 2012 and 2021, according to a report released by the Congressional Budget Office. The 2011 Act provides for new spending on program integrity initiatives intended to reduce fraud and abuse under the Medicare program. Among its other provisions, the law established a bipartisan Congressional committee, known as the Joint Select Committee on Deficit Reduction (the “Joint Committee”), which was tasked with making recommendations aimed at reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The Joint Committee was unable to reach an agreement by the November 23, 2011 deadline and, as a result, across-the-board cuts to discretionary, national defense and Medicare spending were implemented on March 1, 2013 resulting in Medicare payment reductions of up to 2% per fiscal year with a uniform percentage reduction across all Medicare programs. We cannot predict whether Congress will restructure the implemented Medicare payment reductions or what federal other deficit reduction initiatives may be proposed by Congress. We also cannot predict the effect this enactment will have on operators (including UHS), and, thus, our business;

 

   

in March, 2010, the Health Care and Education Reconciliation Act of 2010 and the Patient Protection and Affordable Care Act were enacted into law and created significant changes to health insurance coverage for U.S. citizens as well as material revisions to the federal Medicare and state Medicaid programs. The two combined primary goals of these acts are to provide for increased access to coverage for healthcare and to reduce healthcare-related expenses. Medicare, Medicaid and other health care industry changes are scheduled to be implemented at various times during this decade. We cannot predict the effect, if any, these enactments will have on operators (including UHS) and, thus, our business;

 

   

two of our MOBs, which are located in California, could not obtain earthquake insurance at rates which are economically beneficial in relation to the risks covered;

 

   

competition for our operators from other REITs;

 

   

the operators of our facilities face competition from other health care providers, including physician owned facilities and other competing facilities, including certain facilities operated by UHS but the real property of which is not owned by us. Such competition is experienced in markets including, but not limited to, McAllen, Texas, the site of our McAllen Medical Center, a 430-bed acute care hospital, and Riverside County, California, the site of our Southwest Healthcare System-Inland Valley Campus, a 132-bed acute care hospital;

 

   

changes in, or inadvertent violations of, tax laws and regulations and other factors than can affect REITs and our status as a REIT;

 

   

should we be unable to comply with the strict income distribution requirements applicable to REITs, utilizing only cash generated by operating activities, we would be required to generate cash from other sources which could adversely affect our financial condition;

 

   

our majority ownership interests in five LLCs in which we hold non-controlling equity interests. In addition, pursuant to the operating and/or partnership agreements of most of the five LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90

 

33


Table of Contents
 

days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member;

 

   

fluctuations in the value of our common stock, and;

 

   

other factors referenced herein or in our other filings with the Securities and Exchange Commission.

 

Given these uncertainties, risks and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Our actual results and financial condition, including the operating results of our lessees and the facilities leased to subsidiaries of UHS, could differ materially from those expressed in, or implied by, the forward-looking statements.

 

Forward-looking statements speak only as of the date the statements are made. We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes.

 

A summary of our critical accounting policies is outlined in Note 1 to the consolidated financial statements. We consider our critical accounting policies to be those that require us to make significant judgments and estimates when we prepare our financial statements, including the following:

 

Revenue Recognition:    Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments:    On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Depreciation is computed using the straight-line method over the useful lives of the buildings and capital improvements. The value of intangible assets is amortized over the remaining lease term.

 

34


Table of Contents

Asset Impairment:    Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

Investments in Limited Liability Companies (“LLCs”):    Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

35


Table of Contents

Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July 1, 2013 through December 31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January 1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.

 

Effective August 1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January 1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August 1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014, as discussed below. Each of the property’s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.

 

Federal Income Taxes:    No provision has been made for federal income tax purposes since we qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax is expected to be due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for investment losses.

 

Relationship with UHS and Related Party Transactions:    UHS is our principal tenant and through UHS of Delaware, Inc., a wholly owned subsidiary of UHS, serves as our advisor (the “Advisor”) under an Advisory Agreement dated December 24, 1986 between the Advisor and us (the “Advisory Agreement”). Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2014 we had no salaried employees, our officers do receive stock-based compensation.

 

Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. Our advisory fee was 0.70% during each of 2014 and 2013, and 0.65% during 2012, of our

 

36


Table of Contents

average invested real estate assets, as derived from our consolidated balance sheet. In December of 2014, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2015 pursuant to the same terms as the Advisory Agreement in place during 2014 and 2013.

 

The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 28% for the year ended December 31, 2014 and 30% for each of the years ended December 31, 2013 and 2012. The decrease during 2014, as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at the effective dates). Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for 22% of the combined consolidated and unconsolidated revenues for each of the years ended December 31, 2014 and 2013 and 21% of the combined consolidated and unconsolidated revenues for the year ended December 31, 2012. The hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another. In addition, including the two free-standing emergency departments (“FEDs”) acquired by us from subsidiaries of UHS during the first quarter of 2015, fifteen MOBs/FEDs, that are either wholly or jointly-owned, include tenants which are subsidiaries of UHS.

 

For additional disclosure related to our relationship with UHS, please refer to Note 2 to the consolidated financial statements—Relationship with UHS and Related Party Transactions.

 

Recent Accounting Pronouncements:    For a summary of recent accounting pronouncements, please see Note 1 to the Consolidated Financial Statements as included in this Annual Report on Form 10-K for the year ended December 31, 2014.

 

Results of Operations

 

Year ended December 31, 2014 as compared to the year ended December 31, 2013:

 

Effective August 1, 2014, we purchased the minority ownership interests, ranging from 5% to 15%, held by third-party members in six LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, we now own 100% of each of these six LLCs and our Consolidated Statement of Income for the year ended December 31, 2014 includes the revenues and expenses associated with each of these properties for the five-month period ended December 31, 2014. Prior to August 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method, as discussed above.

 

Effective January 1, 2014, we purchased the 5% minority ownership interests held by third-party members in Palmdale Medical Properties (“Palmdale”) and Sparks Medical Properties, two LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and our Consolidated Statement of Income for the year ended December 31, 2014 includes the revenues and expenses associated with each of these properties. Prior to January 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method. Prior to our purchase of the minority ownership interest in Palmdale, and as a result of a master lease agreement with a wholly-owned subsidiary of UHS which expired on July 1, 2013, Palmdale was previously included in our financial statements on a consolidated basis during the period of January 1, 2013 through June 30, 2013, and on an unconsolidated basis during the period of July 1, 2013 through December 31, 2013.

 

The table below provides supplemental financial information related to each of the above-mentioned entities for the year ended December 31, 2013 and also presents 2013 on an “As Adjusted” financial statement presentation basis similar to the presentation applied for each entity for the year ended December 31, 2014. Other than the increased depreciation and amortization expense resulting from the amortization of the intangible assets recorded in connection with these transactions, there was no material impact to our net income as a result of the consolidation of these LLCs.

 

37


Table of Contents

Year Ended December 31, 2014 as compared to the Year Ended December 31, 2013:

 

     As reported in
Consolidated
Statements
of Income for
the Year
Ended
December 31,
2014
    As reported in
Consolidated
Statements
of Income for
the Year
Ended
December 31,
2013
    Year Ended
December 31,
2013
Statements
of Income
Adjustments
(a.)
    “As
Adjusted”
Year
Ended
December 31,
2013
    “As
Adjusted”
Variance
 

Revenues

   $ 59,786      $ 54,280      $ 4,184      $ 58,464      $ 1,322   

Expenses:

          

Depreciation and amortization

     20,885        18,753        1,044        19,797        (1,088 )

Advisory fees to UHS

     2,545        2,369        0        2,369        (176 )

Other operating expenses

     16,882        14,409        2,083        16,492        (390 )

Transaction costs

     427        203        0        203        (224 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     40,739        35,734        3,127        38,861        (1,878 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gains

     19,047        18,546        1,057        19,603        (556 )

Equity in income of unconsolidated LLCs

     2,428        2,095        (207 )     1,888        540   

Gains on fair value recognition resulting from purchase of minority interests in majority-owned LLCs

     25,409        0        0        0        25,409   

Gain on divestiture of real property

     13,043        0        0        0        13,043   

Interest expense, net

     (8,376 )     (7,472 )     (850 )     (8,322 )     (54 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 51,551      $ 13,169      $ 0      $ 13,169      $ 38,382   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a.) Adjustments include: (i) revenue and expense impact for the five months ended December 31, 2013, for the six LLCs that we began consolidating effective August 1, 2014, as mentioned above, and; (ii) revenue and expense impact for the six months ended December 31, 2013 for Palmdale Medical Properties that we began consolidating effective January 1, 2014 (this LLC was accounted for on a consolidated basis for the first six months of 2013), and; (iii) revenue and expense impact for the year ended December 31, 2013 for Sparks Medical Properties that we began consolidating effective January 1, 2014.

 

During 2014, net income increased $38.4 million to $51.6 million as compared to $13.2 million during 2013. The increase was primarily attributable to the following, as computed utilizing the “As Adjusted” Variance column indicated on the table above:

 

   

an increase of $25.4 million from the aggregate gain recorded during 2014 on the fair value recognition resulting from purchase of minority interests in majority-owned LLCs, as discussed above;

 

   

an increase of $13.0 million from the gain recorded during 2014 on the divestiture of real property (The Bridgeway);

 

   

an increase of $347,000 in bonus rental earned on the hospital facilities leased to wholly-owned subsidiaries of UHS;

 

   

a decrease of approximately $1.1 million (As Adjusted) attributable to a net increase in depreciation and amortization expense, resulting primarily from the fair value recognition recorded in connection with our acquisition of minority ownership interests in eight LLCs in January and August, 2014;

 

   

a decrease of $224,000 resulting from the increase in transaction costs, and;

 

   

other combined net increase of approximately $895,000, including net income generated at properties acquired during 2014 and 2013.

 

38


Table of Contents

Total revenues increased by $1.3 million (As Adjusted) during 2014 as compared to 2013 primarily due to: (i) the revenues generated at MOBs acquired during 2014 and 2013; (ii) an increase in bonus rental revenue, as mentioned above, and; (iii) other combined net changes at existing properties.

 

Included in our other operating expenses are expenses related to the consolidated medical office buildings, which totaled $15.5 million and $14.8 million (“As Adjusted”) for 2014 and 2013, respectively. A large portion of the expenses associated with our consolidated medical office buildings is passed on directly to the tenants either directly as tenant reimbursements of common area maintenance expenses or included in base rental amounts. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred and are included as tenant reimbursement revenue in our consolidated statements of income.

 

During 2014, we had a total of 80 new or renewed leases related to the medical office buildings, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 11% of the aggregate rentable square feet of these properties (6% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occutopancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $22 per square foot during 2014. The weighted-average leasing commissions on the new and renewed leases commencing during 2014 was approximately 2% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2014 was approximately 2% of the future aggregate base rental revenue over the lease terms. Rent abatements were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2014, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 1%.

 

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, and adjusted funds from operations (“AFFO”) and AFFO per diluted share, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. We compute FFO, as reflected below, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. AFFO was also computed for the years ended 2014 and 2013, as reflected below, since we believe it is helpful to our investors since it adjusts for the effect of the transaction costs related to acquisitions. FFO/AFFO do not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO/AFFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders.

 

39


Table of Contents

Below is a reconciliation of our reported net income to FFO and AFFO for 2014 and 2013 (in thousands):

 

     2014     2013  

Net income

   $ 51,551      $ 13,169   

Depreciation and amortization expense on real property/intangibles of consolidated investments

     20,548        18,496   

Depreciation and amortization expense on real property/intangibles of unconsolidated affiliates

     2,290        3,290   

Gains on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     (25,409 )     —     

Gain on divestiture of real property

     (13,043 )     —     
  

 

 

   

 

 

 

Funds From Operations

     35,937        34,955   

Transaction costs

     427        203   
  

 

 

   

 

 

 

Adjusted Funds From Operations

   $ 36,364      $ 35,158   
  

 

 

   

 

 

 

 

Our FFO increased $1.0 million to $35.9 million during 2014 as compared to $35.0 million during 2013. The increase was primarily due to: (i) a favorable change of $38.4 million in net income, as discussed above; (ii) minus the $38.5 million of combined gains, as discussed above, plus; (iii) the favorable effect of the adding back increased depreciation expense incurred by us and our unconsolidated affiliates amounting to approximately $1.1 million. Our AFFO, which excludes transactions costs incurred during each year, were $36.4 million during 2014 as compared to $35.2 million during 2013.

 

40


Table of Contents

Year ended December 31, 2013 as compared to the year ended December 31, 2012:

 

Our Consolidated Statement of Income for the year ended December 31, 2012, includes the revenue and expenses associated with Palmdale Medical Properties, an LLC in which we held a 95% non-controlling equity interest as of December 31, 2013 (we now hold 100% of the ownership in this LLC effective as of January 1, 2014). As previously discussed, effective July 1, 2013, the master lease agreement between Palmdale Medical Properties and Palmdale Regional Medical Center, a wholly-owned subsidiary of UHS, expired. Therefore, effective on July 1, 2013, this LLC was no longer considered a variable interest entity and we began accounting for this LLC on an unconsolidated basis pursuant to the equity method. Prior to the expiration of the master lease, this LLC was accounted for on a consolidated basis, through June 30, 2013. The table below reflects the “As Adjusted” Statement of Income for the twelve months ended December 31, 2012, reflecting the revenue and expense impact of the deconsolidation of this LLC as if it had been deconsolidated effective July 1, 2012, since our Consolidated Statement of Income for the first six months of 2013 includes the revenue and expenses associated with Palmdale Medical Properties. There was no material impact to our net income as a result of the deconsolidation of this LLC.

 

    Year Ended December 31, 2013     Year Ended December 31, 2012        
    As reported
in
Consolidated
Statements
of Income
    As reported
in
Consolidated
Statements
of Income
    July 1 –
December 31,
2012
Statements
of Income
for
Palmdale
Medical
Properties
    “As
Adjusted”
    “As
Adjusted”
Variance
 

Revenues

  $ 54,280      $ 53,950      $ 657      $ 53,293      $ 987   

Expenses:

         

Depreciation and amortization

    18,753        20,216        172        20,044        1,291   

Advisory fees to UHS

    2,369        2,119        —          2,119        (250

Other operating expenses

    14,409        14,575        266        14,309        (100

Transaction costs

    203        680        —          680        477   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    35,734        37,590        438        37,152        1,418   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gains, net

    18,546        16,360        219        16,141        2,405   

Equity in income of unconsolidated LLCs

    2,095        2,365        (13     2,378        (283

Gains on divestiture of properties owned by unconsolidated LLCs

    —          8,520        —          8,520        (8,520

Interest expense, net

    (7,472     (7,768     (206     (7,562     90   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 13,169      $ 19,477      $ —       $ 19,477      ($ 6,308
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

During 2013, net income decreased $6.3 million to $13.2 million as compared to $19.5 million during 2012. The decrease was primarily attributable to the following, as computed utilizing the “As Adjusted” Variance column indicated on the table above:

 

   

an unfavorable change of $8.5 million resulting from the aggregate net gains recorded during 2012 on divestiture of properties owned by two unconsolidated LLCs in which we formerly held noncontrolling majority ownership interests, as discussed below and herein (see Note 3 to the Consolidated Financial Statements);

 

41


Table of Contents
   

a favorable change of $1.3 million (As Adjusted) resulting from a decrease in depreciation and amortization expense, resulting primarily from a $1.7 million decrease in amortization expense recorded on intangible assets, partially offset by an increase in depreciation expense resulting from MOBs acquired during 2013 and the fourth quarter of 2012;

 

   

a favorable change of $477,000 resulting from a decrease in transaction costs;

 

   

a favorable change of $90,000 (As Adjusted) in interest expense due primarily to a decrease in the average effective borrowing rate pursuant to the terms of our $150 million revolving credit agreement, partially offset by an increase in our average outstanding borrowings (as discussed below in Credit facilities and mortgage debt), and;

 

   

other combined net favorable changes of $354,000 including the aggregate net operating income (before depreciation and amortization and interest expense) generated at three MOBs acquired during 2013 and the fourth quarter of 2012, partially offset by the net operating losses incurred at a newly constructed MOB that opened in April, 2013 (property is owned by an unconsolidated LLC in which we hold a noncontrolling majority ownership interest).

 

Total revenues increased approximately $1.0 million (As Adjusted) during 2013, as compared to 2012, due primarily from increases resulting from MOBs acquired during 2013 and the fourth quarter of 2012, partially offset by other combined revenue decreases experienced at certain properties.

 

Included in our other operating expenses are expenses related to the consolidated medical office buildings, which totaled $12.9 million and $12.6 million (As Adjusted basis), for 2013 and 2012, respectively. The increase in other operating expenses during 2013, as compared to 2012, is primarily attributable to expenses related to the MOBs acquired during 2013 and the fourth quarter of 2012. A large portion of the expenses associated with our consolidated medical office buildings is passed on to the tenants either directly as tenant reimbursements of common area maintenance expenses or included in base rental amounts. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred and are included in tenant reimbursements and other revenue in our consolidated statements of income.

 

During 2013, we had a total of 106 new or renewed leases related to the medical office buildings indicated above, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 13% of the aggregate rentable square feet of these properties (8% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occupancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $17 per square foot during 2013. The weighted-average leasing commissions on the new and renewed leases commencing during 2013 was approximately 3% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2013 was approximately 2% of the future aggregate base rental revenue over the lease terms. Rent abatements were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2013, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 6%.

 

42


Table of Contents

Below is a reconciliation of our reported net income to FFO and AFFO for 2013 and 2012 (in thousands):

 

     2013      2012  

Net income

   $ 13,169       $ 19,477   

Depreciation and amortization expense on real property/intangibles of consolidated investments

     18,496         20,030   

Depreciation and amortization expense on real property/intangibles of unconsolidated affiliates

     3,290         3,293   

Gains (net of related transaction costs) on divestiture of properties owned by unconsolidated LLCs

     —           (8,520
  

 

 

    

 

 

 

Funds From Operations

     34,955         34,280   

Transaction costs

     203         680   
  

 

 

    

 

 

 

Adjusted Funds From Operations

   $ 35,158       $ 34,960   
  

 

 

    

 

 

 

 

Our FFO increased $675,000 to $35.0 million during 2013 as compared to $34.3 million during 2012. The increase was primarily due to: (i) an unfavorable change of $6.3 million resulting from the decrease in net income, as discussed above; (ii) an unfavorable change of $1.5 million in the add-back of depreciation and amortization expense on real property/intangibles, and; (iii) a favorable change of $8.5 million in gains recorded on divestiture of properties owned by an unconsolidated LLCs. Our AFFO, which excludes transactions costs incurred during each year, were $35.2 million during 2013 as compared to $35.0 million during 2012.

 

Effects of Inflation

 

Inflation has not had a material impact on our results of operations over the last three years. However, since the healthcare industry is very labor intensive and salaries and benefits are subject to inflationary pressures, as are supply and other costs, we and the operators of our hospital facilities cannot predict the impact that future economic conditions may have on our/their ability to contain future expense increases. Depending on general economic and labor market conditions, the operators of our hospital facilities may experience unfavorable labor market conditions, including a shortage of nurses which may cause an increase in salaries, wages and benefits expense in excess of the inflation rate. Their ability to pass on increased costs associated with providing healthcare to Medicare and Medicaid patients is limited due to various federal, state and local laws which have been enacted that, in certain cases, limit their ability to increase prices. Therefore, there can be no assurance that these factors will not have a material adverse effect on the future results of operations of the operators of our facilities which may affect their ability to make lease payments to us.

 

Most of our leases contain provisions designed to mitigate the adverse impact of inflation. Our hospital leases require all building operating expenses, including maintenance, real estate taxes and other costs, to be paid by the lessee. In addition, certain of the hospital leases contain bonus rental provisions, which require the lessee to pay additional rent to us based on increases in the revenues of the facility over a base year amount. In addition, most of our MOB leases require the tenant to pay an allocable share of operating expenses, including common area maintenance costs, insurance and real estate taxes. These provisions may reduce our exposure to increases in operating costs resulting from inflation. To the extent that some leases do not contain such provisions, our future operating results may be adversely impacted by the effects of inflation.

 

43


Table of Contents

Liquidity and Capital Resources

 

Year ended December 31, 2014 as compared to December 31, 2013:

 

Net cash provided by operating activities

 

Net cash provided by operating activities was $32.8 million during 2014 as compared to $31.3 million during 2013. The $1.5 million increase was attributable to:

 

   

a favorable change of $2.2 million due to an increase in net income plus the adjustments to reconcile net income to net cash provided by operating activities (depreciation and amortization, amortization on debt premium, restricted stock-based compensation, gain on divestiture of real property and gains on purchases of minority interests in majority owned LLCs), as discussed above in Results of Operations;

 

   

an unfavorable change of $1.0 million in accrued expenses and other liabilities resulting primarily from the timing of accrued expenses and other liabilities disbursements;

 

   

an unfavorable change of $319,000 in tenant reserves, escrows, deposits and prepaid rents resulting primarily from a decrease in prepaid rents, and;

 

   

other combined net favorable changes of $646,000, including a favorable change in rent receivable of approximately $200,000.

 

Net cash used in investing activities

 

Net cash used in investing activities was $4.0 million during 2014 as compared to $13.4 million during 2013.

 

2014:

 

During 2014, we used $4.0 million of net cash in investing activities as follows:

 

   

spent $1.3 million to fund equity investments in unconsolidated LLCs;

 

   

spent $2.9 million on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

spent $15.6 million to acquire the real estate assets of three medical office buildings;

 

   

spent $4.7 million (plus a net note payable of $2.3 million to the previous third-party minority interest member, which was satisfied during January, 2015) to acquire the minority interests in eight majority-owned LLCs in two separate transactions effective August 1, 2014 and January 1, 2014, as previously discussed;

 

   

spent $100,000 consisting of a deposit on real estate assets related to the acquisition of a medical office buildings that we purchased during the first quarter of 2015;

 

   

received $17.3 million of cash proceeds in connection with the sale of The Bridgeway, as discussed above;

 

   

received $2.3 million of cash distribution proceeds in connection with refinancing of third-party debt by the LLC that owns the Texoma Medical Plaza in which we have a 95% non-controlling equity interest, and;

 

   

received $1.0 million of cash in excess of income related to our unconsolidated LLCs ($3.4 million of cash distributions received less $2.4 million of equity in income of unconsolidated LLCs);

 

44


Table of Contents

2013:

 

During 2013, we used $13.4 million of net cash in investing activities as follows:

 

   

spent $3.0 million to fund equity investments in unconsolidated LLCs;

 

   

spent $4.6 million in advances in the form of member loans to unconsolidated LLCs;

 

   

spent $3.4 million on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

spent $4.7 million to acquire the real estate assets of two medical office buildings;

 

   

spent $150,000 consisting of a deposit on real estate assets related to the acquisition of two medical office buildings that we purchased during the first quarter of 2014;

 

   

received $2.3 million of cash in excess of income related to our unconsolidated LLCs ($4.4 million of cash distributions received less $2.1 million of equity in income of unconsolidated LLCs), and;

 

   

received $114,000 in repayments of advances previously made to an unconsolidated LLC.

 

Net cash used in financing activities

 

Net cash used in financing activities was $29.8 million during 2014 as compared to $17.5 million during 2013.

 

The $29.8 million of net cash used in financing activities during 2014 consisted of: (i) generated $19.3 million of net cash from the issuance of shares of beneficial interest, $19.0 million of which related to our at-the-market equity issuance program (as discussed below) and approximately $250,000 of which was primarily related to our dividend reinvestment program; (ii) paid $32.7 million of dividends; (iii) paid $12.3 million on mortgage and other notes payable that are non-recourse to us (including the pay-off of the $9.1 million outstanding mortgage balance on the Summerlin Hospital Medical Office Building I utilizing borrowed funds under our revolving credit facility); (iv) paid $4.0 million net repayments on our revolving line of credit, and; (v) paid $94,000 as partial settlement of accrued dividend equivalent rights.

 

The $17.5 million of net cash used in financing activities during 2013 consisted of: (i) generated $12.0 million of additional net borrowings on our revolving line of credit; (ii) generated $11.2 million of proceeds related to a new mortgage note payable (refinance) that is non-recourse to us; (iii) generated $5.8 million of net cash from the issuance of shares of beneficial interest, $5.5 million of which related to our at-the-market equity issuance program (as discussed below) and approximately $250,000 of which was related to our dividend reinvestment program; (iv) paid $31.8 million of dividends; (v) paid $14.4 million on mortgage and other notes payable that are non-recourse to us (including the pay-off of a mortgage note payable that was refinanced during the first quarter of 2013, resulting in the above-mentioned $11.2 million of mortgage proceeds to us); (vi) paid $101,000 as partial settlement of accrued dividend equivalent rights, and; (vii) paid $95,000 of financing costs on mortgage and other notes payable.

 

During the fourth quarter of 2013, we commenced an at-the-market (“ATM”) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $50 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (“Merrill Lynch”), as sales agent and/or principal.

 

Since inception of this program, we have issued 580,900 shares at an average price of $45.97 per share, which generated approximately $25.6 million of net cash proceeds or receivables (net of approximately $1.1 million, consisting of compensation of $667,000 to Merrill Lynch, as well as $391,000 of other various fees and expenses), as follows:

 

   

2014:    We issued 426,187 shares at an average price of $47.51 per share which generated approximately $19.5 million of net cash proceeds or receivables (net of approximately $700,000, consisting of compensation of $506,000 to Merrill Lynch, as well as $195,000 of other various fees and expenses), and;

 

45


Table of Contents
   

2013:    We issued 154,713 shares at an average price of $41.71 per share which generated approximately $6.1 million of net cash proceeds or receivables (net of $357,000, consisting of compensation of $161,000 to Merrill Lynch, as well as $196,000 of other various fees and expenses).

 

In connection with this ATM program, our consolidated balance sheet includes approximately $1.1 million at December 31, 2014, and $600,000 at December 31, 2013, of net proceeds due to us in connection with shares issued in late December 2014 and 2013. The net cash proceeds related to these shares was received by us in early January 2015, and early January, 2014, respectively. The net proceeds receivable were non-cash items, as presented on the Consolidated Statements of Cash Flows at December 31, 2014 and 2013.

 

Year ended December 31, 2013 as compared to December 31, 2012:

 

Net cash provided by operating activities

 

Net cash provided by operating activities was $31.3 million during 2013 as compared to $30.8 million during 2012. The $511,000 increase was attributable to:

 

   

a favorable change of $1.1 million due to an increase in net income plus the adjustments to reconcile net income to net cash provided by operating activities (depreciation and amortization, amortization on debt premium, restricted stock-based compensation and net gains on divestiture of properties owned by unconsolidated LLCs), as discussed above in Results of Operations;

 

   

a favorable change of $116,000 in rent receivable;

 

   

an unfavorable change of $191,000 in tenant reserves, escrows, deposits and prepaid rents, and;

 

   

other combined net unfavorable changes of $526,000, resulting primarily from an increase in leasing commissions paid during 2013, as compared to 2012.

 

Net cash used in investing activities

 

Net cash used in investing activities was $13.4 million during 2013 as compared to $8.6 million during 2012. The factors contributing to the $13.4 million of net cash used in investing activities during 2013 are detailed above.

 

2012:

 

During 2012, we used $8.6 million of net cash in investing activities as follows:

 

   

spent $3.0 million to fund equity investments in unconsolidated LLCs;

 

   

spent $8.0 million to fund an advance in the form of a member loan to an unconsolidated LLC that owned the Centinela Medical Building Complex to extinguish its third-party debt (this entity divested its property during the fourth quarter of 2012 and the member loan was repaid to us in full);

 

   

spent $4.0 million on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

spent $16.9 million (net of certain acquired liabilities, third-part debt and prepaid deposits) to acquire the real estate assets of two medical office buildings;

 

   

spent $711,000 on payments made in settlement of assumed liabilities related to the acquired properties;

 

   

received $8.6 million in repayments of advances previously provided to unconsolidated LLCs as follows:

 

   

$8.0 million from the LLC that owned the Centinela Medical Building in which we had a 90% non-controlling equity interest (this property was divested during the fourth quarter of 2012), and;

 

   

$600,000 from various other LLCs in which we own non-controlling equity interests.

 

46


Table of Contents
   

received $3.2 million of cash in excess of income related to our unconsolidated LLCs ($5.6 million of cash distributions received less $2.4 million of equity in income of unconsolidated LLCs);

 

   

received $12.2 million, net, of cash in connection with our share of the proceeds received from the divestiture of property owned by two unconsolidated LLCs, and;

 

   

received $100,000 of refunded real estate deposits.

 

Net cash used in financing activities

 

Net cash used in financing activities was $17.5 million during 2013 as compared to $30.8 million during 2012. The factors contributing to the $17.5 million of net cash used in financing activities during 2013 are detailed above.

 

The $30.8 million of net cash used in financing activities during 2012 consisted of: (i) generated $4.6 million from additional net borrowings on our revolving line of credit; (ii) generated $14.0 million of proceeds related to two mortgage notes payable that are non-recourse to us; (iii) generated $350,000 of net cash from the issuance of shares of beneficial interest; (iv) paid $31.2 million of dividends; (v) paid $18.1 million on mortgage and other notes payable that are non-recourse to us (including the pay-offs of two mortgage notes payable that were refinanced during the second and fourth quarters of 2012, resulting in the $14.0 million of proceeds, as mentioned above, as well as a $600,000 mortgage principal pay-down); (vi) paid $384,000 of financing costs on mortgage and other notes payable, and; (vii) paid $106,000 as partial settlement of accrued dividend equivalent rights.

 

Additional cash flow and dividends paid information for 2014, 2013 and 2012:

 

As indicated on our consolidated statements of cash flows, we generated net cash provided by operating activities of $32.8 million during 2014, $31.3 million during 2013 and $30.8 million during 2012. As also indicated on our statements of cash flows, noncash expenses such as depreciation and amortization expense, amortization on debt premium, restricted stock-based compensation expense and provision for asset impairment, as well as the gains recorded during 2014 and 2012, are the primary differences between our net income and net cash provided by operating activities for each year. In addition, as reflected in the cash flows from investing activities section, we received $1.0 million during 2014, $2.3 million during 2013 and $3.2 million during 2012, of cash distributions in excess of income from various unconsolidated LLCs which represents our share of the net cash flow distributions from these entities. These cash distributions in excess of income represent operating cash flows net of capital expenditures and debt repayments made by the LLCs.

 

We generated $33.8 million during 2014, $33.6 million during 2013 and $34.0 million during 2012 related to the operating activities of our properties recorded on a consolidated and an unconsolidated basis. We paid dividends of $32.7 million during 2014, $31.8 million during 2013 and $31.2 million during 2012. During 2014, the $33.8 million of net cash generated related to the operating activities of our properties exceeded the $32.7 million of dividends paid by approximately $1.1 million. During 2013, the $33.6 million of net cash generated related to the operating activities of our properties exceeded the $31.8 million of dividends paid by approximately $1.9 million. During 2012, the $34.0 million of net cash generated related to the operating activities of our properties exceeded the $31.2 million of dividends paid by approximately $2.8 million.

 

As indicated in the cash flows from investing activities and cash flows from financing activities sections of the statements of cash flows, there were various other sources and uses of cash during each of the last three years. Therefore, the funding source for our dividend payments is not wholly dependent on the operating cash flow generated by our properties in any given period. Rather, our dividends, as well as our capital reinvestments into our existing properties, acquisitions of real property and other investments are funded based upon the aggregate net cash inflows or outflows from all sources and uses of cash from the properties we own either in whole or through LLCs, as outlined above.

 

47


Table of Contents

In determining and monitoring our dividend level on a quarterly basis, our management and Board of Trustees consider many factors in determining the amount of dividends to be paid each period. These considerations primarily include: (i) the minimum required amount of dividends to be paid in order to maintain our REIT status; (ii) the current and projected operating results of our properties, including those jointly-owned in LLCs, and; (iii) our future capital commitments and debt repayments, including those of our jointly-owned LLCs. Based upon the information discussed above, as well as consideration of projections and forecasts of our future operating cash flows, management and the Board of Trustees have determined that our operating cash flows have been sufficient to fund our dividend payments. Future dividend levels will be determined based upon the factors outlined above with consideration given to our projected future results of operations.

 

Included in the various sources of cash were: (i) funds generated from the repayments of advances made from us to LLCs ($114,000 in 2013 and $8.6 million in 2012); (ii) cash distributions of refinancing proceeds from LLCs of $2.3 million in 2014; (iii) $17.3 million in 2014 of funds generated from the divestiture of real property; (iv) net borrowings on our revolving credit agreement ($12.0 million during 2013 and $4.6 million during 2012); and; (v) issuance of shares of beneficial interest ($19.3 million during 2014, $5.8 million during 2013 and $350,000 during 2012). In addition, during 2012, funds were generated from the divestiture of property owned by unconsolidated LLCs, our share of which was $12.2 million.

 

In addition to the dividends paid, the following were also included in the various uses of cash: (i) investments in LLCs ($1.3 million during 2014 and $3.0 million during each of 2013 and 2012); (ii) advances made to LLCs/third-party partners ($4.6 million during 2013 and $8.0 million during 2012); (iii) additions to real estate investments and acquisitions of real property ($2.9 million in 2014, $3.4 million in 2013 and $4.0 million in 2012); (iv) acquisitions of medical office buildings ($15.6 million in 2014, $4.7 million in 2013 and $16.9 million in 2012); (v) acquisition of minority interests in majority-owned LLCs ($4.7 million in 2014); (vi) net repayments on our revolving credit agreement ($4.0 million during 2014); (vii) net repayments of mortgage, construction, third-party partners and other loans payable of consolidated MOBs and LLCs, net of financing costs ($12.3 million during 2014, $3.3 million during 2013 and $4.5 million during 2012); (viii) partial settlement of dividend equivalent rights (approximately $100,000 during each of 2014, 2013 and 2012); (ix) deposits on real estate assets ($100,000 during 2014 and $150,000 during 2013), and; (x) payments of assumed liabilities on acquired properties ($711,000 in 2012).

 

We expect to finance all capital expenditures and acquisitions and pay dividends utilizing internally generated and additional funds. Additional funds may be obtained through: (i) the issuance of equity pursuant to our at-the-market (“ATM”) equity issuance program (which has $23.3 million of gross proceeds remaining for issuance as of December 31, 2014); (ii) borrowings under our $150 million revolving credit facility (which has $54.0 million of available borrowing capacity, net of outstanding borrowings and letters of credit, as of December 31, 2014); (iii) borrowings under or refinancing of existing third-party debt pursuant to mortgage loan agreements entered into by our LLCs, and/or; (iv) the issuance of other long-term debt.

 

We believe that our operating cash flows, cash and cash equivalents, available borrowing capacity under our revolving credit facility and equity issuance capacity pursuant to the terms of the ATM program, and access to the capital markets provide us with sufficient capital resources to fund our operating, investing and financing requirements for the next twelve months, including providing sufficient capital to allow us to make distributions necessary to enable us to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986. In the event we need to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time. Our inability to obtain financing on terms acceptable to us could have a material unfavorable impact on our results of operations, financial condition and liquidity.

 

Credit facilities and mortgage debt

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. We are in the process of renegotiating our Credit Agreement and, although

 

48


Table of Contents

we can provide no assurance we will do so, we expect to complete a replacement credit facility by March 31, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2014, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2014, we had $89.8 million of outstanding borrowings and $6.3 million of letters of credit outstanding against our Credit Agreement. We had $54.0 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2014. There are no compensating balance requirements. The average amounts outstanding under our Credit Agreement were $104.6 million in 2014, $86.3 million in 2013 and $75.4 million in 2012 with corresponding effective interest rates, including commitment fees, of 2.4% in 2014, 2.2% in 2013 and 2.4% in 2012. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $89.8 million at December 31, 2014.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2014. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2014
 

Tangible net worth

   $ 125,000      $ 181,458   

Debt to total capital

     < 55     30.0

Debt service coverage ratio

     >3.00x        25.4x   

Debt to cash flow ratio

     < 3.50x        1.29x   

 

We have sixteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2014, with a combined outstanding balance of $122.9 million (excluding net debt premium of $523,000 at December 31, 2014). The following table summarizes our outstanding mortgages at December 31, 2014 (amounts in thousands):

 

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date

Spring Valley Medical Office Building fixed rate mortgage loan (b.)

   $ 4,920         5.50   February, 2015

Desert Valley Medical Center floating rate mortgage loan (c.)

     3,861         3.41   October, 2015

Palmdale Medical Plaza fixed rate mortgage loan (c.)

     6,008         3.69   October, 2015

Summerlin Hospital Medical Office Building III floating rate mortgage loan

     11,025         3.41   December, 2016

Peace Health fixed rate mortgage loan

     21,248         5.64   April, 2017

Auburn Medical II floating rate mortgage loan

     7,183         2.90   April, 2017

Medical Center of Western Connecticut fixed rate mortgage loan

     4,785         6.00   June, 2017

 

49


Table of Contents

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

     11,729         5.50   October, 2017

Phoenix Children’s East Valley Care Center fixed rate mortgage loan

     6,485         5.88   December, 2017

Centennial Hills Medical Office Building floating rate mortgage loan

     10,642         3.41   January, 2018

Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan

     4,479         3.41   February, 2018

Rosenberg Children’s Medical Plaza fixed rate mortgage loan

     8,479         4.85   May, 2018

Vibra Hospital of Corpus Christi fixed rate mortgage loan

     2,902         6.50   July, 2019

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

     6,601         4.54   June, 2022

BRB Medical Office Building fixed rate mortgage loan

     6,673         4.27   December, 2022

Tuscan Professional Building fixed rate mortgage loan

     5,862         5.56   June, 2025
  

 

 

      

Total

   $ 122,882        
  

 

 

      

 

(a.) Amortized principal payments are made on a monthly basis.
(b.) This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility.
(c.) We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.

 

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $124.7 million as of December 31, 2014. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

 

Contractual Obligations:

 

The following table summarizes the schedule of maturities of our outstanding borrowing under our revolving credit facility (“Credit Agreement”), the outstanding mortgages applicable to our properties recorded on a consolidated basis and our other contractual obligations as of December 31, 2014 (amounts in thousands):

 

     Payments Due by Period (dollars in thousands)  

Debt and Contractual Obligation

   Total      Less than 1 Year      2-3 years      4-5 years      More than
5 years
 

Long-term non-recourse debt-fixed(a)(b)

   $ 85,692       $ 12,973       $ 45,421       $ 12,432       $ 14,866   

Long-term non-recourse debt-variable(a)(b)

     37,190         4,923         18,578         13,689         —     

Long-term debt-variable(c)

     89,750         89,750        —           —           —     

Estimated future interest payments on debt outstanding as of December 31, 2014(d)

     18,450         6,484         8,134         1,961         1,871   

Equity and debt financing commitments(e)

     2,639         2,639         —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total contractual obligations

   $ 233,721       $ 116,769       $ 72,133       $ 28,082       $ 16,737   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) The mortgages are secured by the real property of the buildings as well as property leases and rents. Property-specific debt is detailed above.
(b) Consists of non-recourse debt with a fair value of approximately $124.7 million as of December 31, 2014. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow. Excludes $52.7 million of combined third-party debt outstanding as of December 31, 2014, that is non-recourse to us, at the unconsolidated LLCs in which we hold various non-controlling ownership interests (see Note 8 to the consolidated financial statements).
(c)

Consists of $89.8 million of borrowings outstanding as of December 31, 2014 under the terms of our $150 million Credit Agreement which matures on July 24, 2015. The amount outstanding approximates fair value

 

50


Table of Contents
 

as of December 31, 2014. We are in the process of renegotiating our Credit Agreement, and although we can provide no assurance we will do so, we expect to complete a replacement credit facility by March 31, 2015.

(d) Assumes that all debt outstanding as of December 31, 2014, including borrowings under the Credit Agreement, and the sixteen loans, which are non-recourse to us, remain outstanding until the stated maturity date of the debt agreements at the same interest rates which were in effect as of December 31, 2014. We have the right to repay borrowings under the Credit Agreement at any time during the terms of the agreement, without penalty. Interest payments are expected to be paid utilizing cash flows from operating activities or borrowings under our revolving Credit Agreement.
(e) As of December 31, 2014, we have equity investment and debt financing commitments remaining in connection with our investments in various unconsolidated LLCs. As of December 31, 2014, we had outstanding letters of credit which secured the majority of these equity and debt financing commitments. The $54.0 million of available borrowing capacity as of December 31, 2014, pursuant to the terms of our Credit Agreement, is net of the standby letters of credit outstanding at that time. Our remaining financing commitments related to our investments in unconsolidated LLCs are as follows (in thousands):

 

     Amount  

Grayson Properties

   $ 406   

FTX MOB Phase II

     1,076   

Arlington Medical Properties

     1,157   
  

 

 

 

Total

   $ 2,639   
  

 

 

 

 

Off Balance Sheet Arrangements

 

As of December 31, 2014, we are party to certain off balance sheet arrangements consisting of standby letters of credit and equity and debt financing commitments as detailed on the above “Contractual Obligations” table. Our outstanding letters of credit at December 31, 2014 totaled $6.3 million consisting of: (i) $2.1 million related to Centennial Hills Medical Properties; (ii) $1.3 million related to Palmdale Medical Properties; (iii) $1.3 million related to Banburry Medical Properties; (iv) $1.1 million related to FTX MOB Phase II, and; (v) $478,000 related to Arlington Medical Properties.

 

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

 

Market Risks Associated with Financial Instruments

 

As of December 31, 2014, 2013, and 2012, we had no material outstanding interest rate swap agreements.

 

During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. During the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20 million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. From inception through December 31, 2014, no payments have been made to us by the counterparties pursuant to the terms of these caps which expire on January 13, 2017.

 

The sensitivity analysis related to our fixed and variable rate debt assumes current market rates with all other variables held constant. The fair value of our debt is approximately $214 million. The difference between actual amounts outstanding and fair value is approximately $1.8 million.

 

51


Table of Contents

The table below presents information about our financial instruments that are sensitive to changes in interest rates, including debt obligations as of December 31, 2014. For debt obligations, the table presents principal cash flows and related weighted average interest rates by contractual maturity dates.

 

     Maturity Date, Year Ending December 31  

(Dollars in thousands)

   2015     2016     2017     2018     2019     Thereafter     Total  

Long-term debt:

          

Fixed rate:

          

Debt(a)

   $ 12,973      $ 2,154      $ 43,267      $ 8,969      $ 3,463      $ 14,866      $ 85,692   

Average interest rates

     5.3     5.4     5.2     5.1     5.0     4.8     5.1

Variable rate:

          

Debt(b)

   $ 94,673      $ 11,446      $ 7,132      $ 13,689      $ —       $ —       $ 126,940   

Average interest rates

     2.6     3.3     3.5     3.4     —         —         3.2

Interest rate caps:

          

Notional amount

   $ —       $ —       $ 30,000      $ —       $ —       $ —       $ 30,000   

Interest rates

         1.5        

 

(a) Consists of non-recourse mortgage notes payable.
(b) Includes $37.2 million of non-recourse mortgage notes payable and of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.

 

As calculated based upon our variable rate debt outstanding as of December 31, 2014 that is subject to interest rate fluctuations, each 1% change in interest rates would impact our net income by approximately $1.7 million.

 

ITEM 8. Financial Statements and Supplementary Data

 

Our Consolidated Balance Sheets, Consolidated Statements of Income, Changes in Equity and Cash Flows, together with the report of KPMG LLP, an independent registered public accounting firm, are included elsewhere herein. Reference is made to the “Index to Financial Statements and Schedule.”

 

ITEM 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 

None.

 

ITEM 9A. Controls and Procedures

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

As of December 31, 2014, under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), we performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “1934 Act”). Based on this evaluation, the CEO and CFO have concluded that our disclosure controls and procedures are effective to ensure that material information is recorded, processed, summarized and reported by management on a timely basis in order to comply with our disclosure obligations under the Securities and Exchange Act of 1934 and the SEC rules thereunder.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting or in other factors during the fourth quarter of 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

52


Table of Contents

Management’s Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining an adequate system of internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control—Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Based on its assessment, management has concluded that we maintained effective internal control over financial reporting as of December 31, 2014, based on criteria in Internal Control—Integrated Framework (2013), issued by the COSO. The effectiveness of our internal control over financial reporting as of December 31, 2014 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.

 

53


Table of Contents

Report of Independent Registered Public Accounting Firm

 

The Shareholders and Board of Trustees

Universal Health Realty Income Trust:

 

We have audited Universal Health Realty Income Trust’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Universal Health Realty Income Trust’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, Universal Health Realty Income Trust maintained, in all material respects, effective internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Universal Health Realty Income Trust and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the financial statement schedule III, real estate and accumulated depreciation, and our report dated March 6, 2015 expressed an unqualified opinion on those consolidated financial statements and financial statement schedule III.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 6, 2015

 

54


Table of Contents
ITEM 9B. Other Information

 

None.

 

PART III

 

ITEM 10. Directors, Executive Officers and Corporate Governance

 

There is hereby incorporated by reference the information to appear under the captions “Proposal No. 1” (Election of Trustees), “Section 16(a) Beneficial Ownership Reporting Compliance” and “Corporate Governance” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2014. See also “Executive Officers of the Registrant” appearing in Item 1 hereof.

 

ITEM 11. Executive Compensation

 

There is hereby incorporated by reference information to appear under the caption “Executive Compensation” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2014.

 

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

There is hereby incorporated by reference the information to appear under the caption “Security Ownership of Certain Beneficial Owners and Management” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2014.

 

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

 

There is hereby incorporated by reference the information to appear under the captions “Certain Relationships and Related Transactions” and “Corporate Governance” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2014.

 

ITEM 14. Principal Accounting Fees and Services

 

There is hereby incorporated herein by reference the information to appear under the caption “Relationship with Independent Registered Public Accounting Firm” in our Proxy Statement, to be filed with the Securities and Exchange Commission within 120 days after December 31, 2014.

 

55


Table of Contents

PART IV

 

ITEM 15. Exhibits, Financial Statement Schedules

 

(a) Documents filed as part of this report:

 

  (1) Financial Statements: See “Index to Financial Statements and Schedule”

 

  (2) Financial Statement Schedules: See “Index to Financial Statements and Schedule”

 

  (3) Exhibits:

 

3.1 Declaration of Trust, dated as of August 1986, previously filed as Exhibit 4.1 to the Trust’s Registration Statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.2 Amendment to Declaration of Trust, dated as of June 15, 1993, previously filed as Exhibit 4.2 to the Trust’s Registration Statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.3 Amended and restated bylaws previously filed as Exhibit 4.3 to the Trust’s registration statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.4 Amendment to the bylaws, effective as of September 6, 2013, previously filed as Exhibit 3.2 to the Trust’s Current Report on Form 8-K dated September 6, 2013, is incorporated herein by reference.

 

10.1 Advisory Agreement, dated as of December 24, 1986, between UHS of Delaware, Inc. and the Trust, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated December 24, 1986, is incorporated herein by reference.

 

10.2 Agreement dated December 4, 2014, to renew Advisory Agreement dated as of December 24, 1986 between Universal Health Realty Income Trust and UHS of Delaware, Inc. is filed herewith.

 

10.3 Contract of Acquisition, dated as of August 1986, between the Trust and certain subsidiaries of Universal Health Services, Inc., previously filed as Exhibit 10.2 to Amendment No. 3 of the Registration Statement on Form S-11 and S-2 of Universal Health Services, Inc. and the Trust (File No. 33-7872), is incorporated herein by reference.

 

10.4 Form of Leases, including Form of Master Lease Document Leases, between certain subsidiaries of Universal Health Services, Inc. and the Trust, previously filed as Exhibit 10.3 to Amendment No. 3 of the Registration Statement on Form S-11 and Form S-2 of Universal Health Services, Inc. and the Trust (File No. 33-7872), is incorporated herein by reference.

 

10.5 Corporate Guaranty of Obligations of Subsidiaries Pursuant to Leases and Contract of Acquisition, dated December 1986, issued by Universal Health Services, Inc. in favor of the Trust, previously filed as Exhibit 10.5 to the Trust’s Current Report on Form 8-K dated December 24, 1986, is incorporated herein by reference.

 

10.6 Lease, dated December 22, 1993, between the Trust and THC-Chicago, Inc., as lessee, previously filed as Exhibit 10.14 to the Trust’s Annual Report on Form 10-K for the year ended December 31, 1993, is incorporated herein by reference.

 

10.7* Universal Health Realty Income Trust 1997 Incentive Plan, previously filed as Exhibit 10.1 to the Trust’s Form 10-Q for the quarter ended September 30, 1997, is incorporated herein by reference.

 

10.8 Credit Agreement, dated as of July 25, 2011, by and among the Trust, the financial institutions from time to time party thereto and Wells Fargo Bank, National Association, as Administrative Agent, Bank of America, N.A., as Syndication Agent and Fifth Third Bank, N.A., JPMorgan Chase Bank, N.A. and SunTrust Bank as Co-Documentation Agents, previously filed as Exhibit 10.1 to the Trust’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, is incorporated herein by reference.

 

56


Table of Contents

10.9 Dividend Reinvestment and Share Purchase Plan included in the Trust’s Registration Statement on Form S-3 (Registration No. 333-81763) filed on June 28, 1999, is incorporated herein by reference.

 

10.10 Asset Exchange and Substitution Agreement, dated as of April 24, 2006, by and among the Trust and Universal Health Services, Inc. and certain of its subsidiaries, previously filed as Exhibit 10.1 to the Trust’s Current Report on Form 8-K dated April 25, 2006, is incorporated herein by reference.

 

10.11 Amendment No. 1 to the Master Lease Document, between certain subsidiaries of Universal Health Services, Inc. and the Trust, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated April 25, 2006, is incorporated herein by reference.

 

10.12* Universal Health Realty Income Trust 2007 Restricted Stock Plan, previously filed as Exhibit 10.1 to the Trust’s Current Report on Form 8-K, dated April 27, 2007, is incorporated herein by reference.

 

10.13* Form of Restricted Stock Agreement, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated April 27, 2007, is incorporated herein by reference.

 

10.14 ATM Equity OfferingSM Sales Agreement, dated November 8, 2013, among the Trust, UHS of Delaware, Inc., and Merrill Lynch, Pierce, Fenner & Smith Incorporated, previously filed as Exhibit 1.1 to the Trust’s Current Report on Form 8-K dated November 8, 2013, is incorporated herein by reference.

 

11 Statement re computation of per share earnings is set forth on the Consolidated Statements of Income.

 

21 Subsidiaries of Registrant, filed herewith.

 

23.1 Consent of Independent Registered Public Accounting Firm, filed herewith.

 

31.1 Certification from the Trust’s Chief Executive Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, filed herewith.

 

31.2 Certification from the Trust’s Chief Financial Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, filed herewith.

 

32.1 Certification from the Trust’s Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.

 

32.2 Certification from the Trust’s Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.

 

101.INS XBRL Instance Document, filed herewith.

 

101.SCH XBRL Taxonomy Extension Schema Document, filed herewith.

 

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document, filed herewith.

 

101.DEF XBRL Taxonomy Extension Definition Linkbase Document, filed herewith.

 

101.LAB XBRL Taxonomy Extension Label Linkbase Document, filed herewith.

 

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document, filed herewith.

 

* Management contract or compensatory plan or arrangement.

 

Exhibits, other than those incorporated by reference, have been included in copies of this Annual Report filed with the Securities and Exchange Commission. Shareholders of the Trust will be provided with copies of those exhibits upon written request to the Trust.

 

57


Table of Contents

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

UNIVERSAL HEALTH REALTY INCOME TRUST
By:  

/S/    ALAN B. MILLER        

   

Alan B. Miller,

Chairman of the Board,

Chief Executive Officer and President

 

Date: March 6, 2015

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signatures

  

Title

 

Date

/S/    ALAN B. MILLER        

Alan B. Miller

  

Chairman of the Board, Chief

Executive Officer and President

(Principal Executive Officer)

  March 6, 2015

/S/    JAMES E. DALTON, JR.        

James E. Dalton, Jr.

   Trustee   March 6, 2015

/S/    MILES L. BERGER        

Miles L. Berger

   Trustee   March 6, 2015

/S/    ELLIOT J. SUSSMAN        

Elliot J. Sussman, M.D., M.B.A.

   Trustee   March 6, 2015

/S/    ROBERT F. MCCADDEN        

Robert F. McCadden

   Trustee   March 6, 2015

/S/    MARC D. MILLER        

Marc D. Miller

   Trustee   March 6, 2015

/S/    CHARLES F. BOYLE        

Charles F. Boyle

  

Vice President and Chief Financial Officer

(Principal Financial and Accounting

Officer)

  March 6, 2015

 

58


Table of Contents

INDEX TO FINANCIAL STATEMENTS AND SCHEDULE

 

     Page  

Consolidated Financial Statements:

  

Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements and Schedule

     60   

Consolidated Balance Sheets—December 31, 2014 and December 31, 2013

     61   

Consolidated Statements of Income—Years Ended December 31, 2014, 2013 and 2012

     62   

Consolidated Statements of Comprehensive Income

     63   

Consolidated Statements of Changes in Equity—Years Ended December 31, 2014, 2013 and 2012

     64   

Consolidated Statements of Cash Flows—Years Ended December 31, 2014, 2013 and 2012

     65   

Notes to the Consolidated Financial Statements

     67   

Schedule III—Real Estate and Accumulated Depreciation—December 31, 2014

     90   

Notes to Schedule III—December 31, 2014

     93   

 

59


Table of Contents

Report of Independent Registered Public Accounting Firm

 

The Shareholders and Board of Trustees

Universal Health Realty Income Trust:

 

We have audited the accompanying consolidated balance sheets of Universal Health Realty Income Trust and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2014. In connection with our audits of the consolidated financial statements, we also have audited financial statement schedule III, real estate and accumulated depreciation. These consolidated financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Universal Health Realty Income Trust and subsidiaries as of December 31, 2014 and 2013, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2014, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related financial statement schedule III, real estate and accumulated depreciation, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Universal Health Realty Income Trust’s internal control over financial reporting as of December 31, 2014, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 6, 2015 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 6, 2015

 

60


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED BALANCE SHEETS

(dollar amounts in thousands)

 

     December 31,
2014
    December 31,
2013
 

Assets:

    

Real Estate Investments:

    

Buildings and improvements

   $ 451,005      $ 368,295   

Accumulated depreciation

     (106,480     (97,921
  

 

 

   

 

 

 
     344,525        270,374   

Land

     35,584        27,374   
  

 

 

   

 

 

 

Net Real Estate Investments

     380,109        297,748   
  

 

 

   

 

 

 

Investments in and advances to limited liability companies (“LLCs”), net

     8,605        39,201   

Other Assets:

    

Cash and cash equivalents

     3,861        3,337   

Base and bonus rent receivable from UHS

     2,086        2,053   

Rent receivable—other

     4,219        3,310   

Intangible assets (net of accumulated amortization of $19.7 million and $13.7 million at December 31, 2014 and December 31, 2013, respectively)

     23,123        20,782   

Deferred charges, goodwill and other assets, net

     6,863        6,714   
  

 

 

   

 

 

 

Total Assets

   $ 428,866      $ 373,145   
  

 

 

   

 

 

 

Liabilities:

    

Line of credit borrowings

   $ 89,750      $ 93,700   

Mortgage and other notes payable, non-recourse to us (including net debt premium of $523,000 and $834,000 at December 31, 2014 and December 31, 2013, respectively)

     123,405        106,287   

Accrued interest

     545        491   

Accrued expenses and other liabilities

     8,522        5,156   

Tenant reserves, escrows, deposits and prepaid rents

     2,063        1,881   
  

 

 

   

 

 

 

Total Liabilities

     224,285        207,515   
  

 

 

   

 

 

 

Equity:

    

Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding

     —          —     

Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2014 - 13,301,204 2013 -12,858,643

     133        128   

Capital in excess of par value

     240,835        220,691   

Cumulative net income

     531,595        480,044   

Cumulative dividends

     (567,894     (535,176

Accumulated other comprehensive loss

     (88     (57
  

 

 

   

 

 

 

Total Equity

     204,581        165,630   
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 428,866      $ 373,145   
  

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

61


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF INCOME

(amounts in thousands, except per share amounts)

 

     Year ended December 31,  
     2014     2013     2012  

Revenues:

      

Base rental—UHS facilities

   $ 15,601      $ 14,773      $ 15,438   

Base rental—Non-related parties

     31,386        27,955        27,213   

Bonus rental—UHS facilities

     4,607        4,260        4,142   

Tenant reimbursements and other—Non-related parties

     7,490        6,812        6,674   

Tenant reimbursements and other—UHS facilities

     702        480        483   
  

 

 

   

 

 

   

 

 

 
     59,786        54,280        53,950   
  

 

 

   

 

 

   

 

 

 

Expenses:

      

Depreciation and amortization

     20,885        18,753        20,216   

Advisory fees to UHS

     2,545        2,369        2,119   

Other operating expenses

     16,882        14,409        14,575   

Transaction costs

     427        203        680   
  

 

 

   

 

 

   

 

 

 
     40,739        35,734        37,590   
  

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated limited liability companies (“LLCs”), interest expense and gains

     19,047        18,546        16,360   

Equity in income of unconsolidated LLCs

     2,428        2,095        2,365   

Gains on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     25,409        0        0   

Gain on divestiture of real property

     13,043        0        0   

Gains on divestitures of properties owned by unconsolidated LLCs

     0        0        8,520   

Interest expense, net

     (8,376     (7,472     (7,768
  

 

 

   

 

 

   

 

 

 

Net income

   $ 51,551      $ 13,169      $ 19,477   
  

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 3.99      $ 1.04      $ 1.54   
  

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 3.99      $ 1.04      $ 1.54   
  

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding—Basic

     12,927        12,689        12,661   

Weighted average number of share equivalents

     7        12        8   
  

 

 

   

 

 

   

 

 

 

Weighted average number of shares and equivalents outstanding—Diluted

     12,934        12,701        12,669   
  

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

62


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(dollar amounts in thousands)

 

     Year ended December 31,  
     2014     2013     2012  

Net Income

   $ 51,551      $ 13,169      $ 19,477   

Other comprehensive loss:

      

Unrealized losses on interest rate caps

     (115     (57     0   

Amortization of interest rate cap fees

     84        0        0   
  

 

 

   

 

 

   

 

 

 

Total other comprehensive loss:

     (31     (57     0   
  

 

 

   

 

 

   

 

 

 

Total comprehensive income

   $ 51,520      $ 13,112      $ 19,477   
  

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

63


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

     Common Shares      Capital in
excess of
par value
                 Accumulated  other
comprehensive loss
    UHT
Shareholders’
Equity
             
     Number
of Shares
     Amount        Cumulative
net income
     Cumulative
dividends
        Non-controlling
Interests
    Total
Equity
 

January 1, 2012

     12,667       $ 127       $ 213,566      $ 447,398       ($ 472,230     —        $ 188,861      $ 84      $ 188,945   

Shares of Beneficial Interest:

                     

Issued

     22         —           305        —           —          —          305        —          305   

Partial settlement of dividend equivalent rights

     —           —           (106     —           —          —          (106     —          (106

Restricted stock-based compensation expense

     —           —           329        —           —          —          329        —          329   

Dividends ($2.46/share)

     —           —           —          —           (31,195     —          (31,195     —          (31,195

Comprehensive income:

                     

Net income

     —           —           —          19,477         —          —          19,477        (10     19,467   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

January 1, 2013

     12,689         127         214,094        466,875         (503,425     —          177,671        74        177,745   

Shares of Beneficial Interest:

                     

Issued

     170         1         6,323        —           —          —          6,324        —          6,324   

Partial settlement of dividend equivalent rights

     —           —           (101     —           —          —          (101     —          (101

Restricted stock-based compensation expense

     —           —           375        —           —          —          375        —          375   

Dividends ($2.495/share)

     —           —           —          —           (31,751     —          (31,751     —          (31,751

Deconsolidation of LLC

     —           —           —          —           —          —          0        (74     (74

Comprehensive income:

                     

Net income

     —           —           —          13,169         —          —          13,169          13,169   

Unrealized loss on interest rate cap

     —           —           —          —           —          (57     (57       (57

Subtotal - comprehensive income

             13,169           (57     13,112        0        13,112   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

January 1, 2014

     12,859         128         220,691        480,044         (535,176     (57     165,630        0        165,630   

Shares of Beneficial Interest:

                     

Issued

     443         5         19,839        —           —          —          19,844        —          19,844   

Partial settlement of dividend equivalent rights

     —           —           (94     —           —          —          (94     —          (94

Restricted stock-based compensation expense

     —           —           399        —           —          —          399        —          399   

Dividends ($2.52/share)

     —           —           —          —           (32,718     —          (32,718     —          (32,718

Comprehensive income:

                     

Net income

     —           —           —          51,551         —          —          51,551          51,551   

Unrealized loss on interest rate cap

     —           —           —          —           —          (31     (31     —          (31
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal - comprehensive income

     —           —           —          51,551         —          (31     51,520        0        51,520   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

December 31, 2014

     13,302       $ 133       $ 240,835      $ 531,595       ($ 567,894   ($ 88   $ 204,581      $ 0      $ 204,581   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

64


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(amounts in thousands)

 

     Year ended December 31,  
     2014     2013     2012  

Cash flows from operating activities:

      

Net income

   $ 51,551      $ 13,169      $ 19,477   

Adjustments to reconcile net income to net cash provided by operating activities:

      

Depreciation and amortization

     20,975        18,843        20,216   

Amortization on debt premium

     (312     (433     (657

Restricted/stock-based compensation expense

     399        375        329   

Gain on divestiture of real property

     (13,043     0        0   

Gains on purchase of minority interests in majority-owned LLCs

     (25,409     0        0   

Gains on divestiture of properties owned by unconsolidated LLCs

     0        0        (8,520

Changes in assets and liabilities:

      

Rent receivable

     (555     (746     (862

Accrued expenses and other liabilities

     (509     523        278   

Tenant reserves, escrows, deposits and prepaid rents

     (303     16        207   

Accrued interest

     (62     (22     66   

Other, net

     64        (431     249   
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     32,796        31,294        30,783   
  

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

      

Investments in LLCs

     (1,337     (3,013     (2,973

Repayments of advances made to LLCs

     0        114        8,551   

Advances made to LLCs

     0        (4,580     (8,000

Cash distributions in excess of income from LLCs

     1,029        2,346        3,169   

Cash distribution of refinancing proceeds from LLCs

     2,280        0        0   

Additions to real estate investments, net

     (2,866     (3,415     (3,985

Deposits on real estate assets

     (100     (150     100   

Net cash paid for acquisition of medical office buildings

     (15,600     (4,675     (16,891

Payment of assumed liabilities on acquired properties

     0        0        (711

Cash paid to acquire minority interests in majority-owned LLCs

     (4,744     0        0   

Cash proceeds received from divestiture of property owned by unconsolidated LLCs, net

     0        0        12,175   

Cash proceeds received from divestiture of real property

     17,300        0        0   
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (4,038     (13,373     (8,565
  

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

      

Net borrowings on line of credit

     0        11,950        4,600   

Net repayments on line of credit

     (3,950     0        0   

Proceeds from mortgages and other notes payable

     0        11,150        14,000   

Repayments of mortgages and other notes payable

     (12,327     (14,401     (18,084

Financing costs paid on mortgage and other notes payable

     0        (95     (384

Dividends paid

     (32,718     (31,751     (31,195

Partial settlement of dividends equivalent rights

     (94     (101     (106

Issuance of shares of beneficial interest, net

     19,274        5,757        350   
  

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

     (29,815     (17,491     (30,819
  

 

 

   

 

 

   

 

 

 

(Decrease)/increase in cash and cash equivalents

     (1,057     430        (8,601

Increase/(decrease) in cash due to recording of LLCs on a consolidated/unconsolidated basis

     1,581        (141     0   

Cash and cash equivalents, beginning of period

     3,337        3,048        11,649   
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 3,861      $ 3,337      $ 3,048   
  

 

 

   

 

 

   

 

 

 

 

65


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF CASH FLOWS—(Continued)

(amounts in thousands)

 

     Year ended December 31,  
     2014     2013     2012  

Supplemental disclosures of cash flow information:

      

Interest paid

   $ 8,268      $ 7,517      $ 7,994   
  

 

 

   

 

 

   

 

 

 

Supplemental disclosures of non-cash transactions:

      

Debt assumed on acquisition of real estate

   $ 0      $ 0      $ 22,441   
  

 

 

   

 

 

   

 

 

 

Supplemental disclosures of non-cash transactions:

      

Consolidation of LLCs:

      

Net real estate investments

   $ 84,064      $ 0      $ 0   

Cash and cash equivalents

     1,581        0        0   

Intangible assets

     6,490        0        0   

Rent receivable - other

     388        0        0   

Deferred charges, goodwill and other assets, net

     100        0        0   

Investment in LLCs

     (28,616     0        0   

Mortgage and other notes payable, non-recourse to us

     (29,758     0        0   

Accrued interest

     (116     0        0   

Accrued expenses and other liabilities

     (1,245     0        0   

Tenant reserves, escrows, deposits and prepaid rents

     (485     0        0   

Note payable to previous third party member

     (2,250     0        0   

Gains on purchases of minority interests in majority-owned LLCs

     (25,409     0        0   
  

 

 

   

 

 

   

 

 

 

Cash paid for purchase of minority interests in majority-owned LLCs

   $ 4,744      $ 0      $ 0   
  

 

 

   

 

 

   

 

 

 

Deconsolidation of LLC:

      

Net real estate investments

   $ 0      $ 11,597      $ 0   

Cash and cash equivalents

     0        141        0   

Rent receivable - other

     0        207        0   

Deferred charges, goodwill and other assets, net

     0        135        0   

Mortgage and other notes payable, non-recourse to us

     0        (6,215     0   

Other liabilities

     0        (368     0   

Third-party equity interest

     0        (54     0   
  

 

 

   

 

 

   

 

 

 

Investment in LLC

   $ 0      $ 5,443      $ 0   
  

 

 

   

 

 

   

 

 

 

 

See accompanying notes to these consolidated financial statements.

 

66


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2014

 

(1)   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings. As of February 28, 2015, we have sixty-one real estate investments or commitments located in eighteen states consisting of:

 

   

six hospital facilities including three acute care, one rehabilitation and two sub-acute;

 

   

three free-standing emergency departments;

 

   

forty-eight medical office buildings, including five owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the three Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

 

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized

 

67


Table of Contents

when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2014, and will be amortized over the remaining lease terms (aggregate weighted average of 4.4 years at December 31, 2014) and is expected to result in estimated aggregate amortization expense of $5.6 million, $4.5 million, $3.9 million $2.5 million and $1.9 million for 2015, 2016, 2017, 2018 and 2019, respectively. Amortization expense on intangible values of in place leases was $6.1 million for the year ended December 31, 2014, $6.0 million for the year ended December 31, 2013 and $7.8 million for the year ended December 31, 2012. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $14.4 million for the year ended December 31, 2014, $12.5 million for the year ended December 31, 2013 and $12.2 million for the year ended December 31, 2012.

 

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

 

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the

 

68


Table of Contents

decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July 1, 2013 through December 31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January 1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.

 

Effective August 1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January 1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August 1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014, as discussed below. Each of the property’s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.

 

69


Table of Contents

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $469 million and $316 million, respectively, at December 31, 2014.

 

Stock-Based Compensation

 

We expense the grant-date fair value of restricted stock awards over the vesting period. We recognize the grant-date fair value of equity-based compensation and account for these transactions using the fair-value based method.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

 

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

70


Table of Contents

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $25.4 million net gain recorded during 2014 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2014 that impacted, or are expected to impact us.

 

In August 2014, FASB issued ASU No. 2014-15, “Preparation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, “Presentation of Financial Statements—Liquidation Basis of Accounting”. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.

 

In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. We adopted this updated guidance in 2014 and the adoption of this update did not have a material impact on our consolidated financial statements.

 

(2)   RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. The hospital leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each hospital leased to subsidiaries of UHS are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

71


Table of Contents

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 36% of our total revenue for the five years ended December 31, 2014 (approximately 28% for the year ended December 31, 2014 and approximately 30% for each of the years ended December 31, 2013 and 2012). The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests. As a result of these transactions, we own 100% of each of these LLCs and began accounting for each on a consolidated basis effective on the date of purchase of the minority ownership interests. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2014 (approximately 22% for each of the years ended December 31, 2014 and 2013 and 21% for the year ended December 31, 2012). In addition, including the two free-standing emergency departments (“FEDs”) acquired by us from subsidiaries of UHS during the first quarter of 2015 (as discussed below), fifteen MOBs/FEDs, that are either wholly or jointly-owned, include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the three leased hospital properties listed below at their appraised fair market value.

 

During the third quarter of 2014, a wholly-owned subsidiary of UHS provided notification to us that, upon expiration of The Bridgeway’s lease term which occurred in December, 2014, it intended to exercise its option to purchase the real property of the facility. Upon expiration of the lease, the wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility and on December 31, 2014, The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, was sold to UHS. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value. Based upon the property appraisals obtained by each party, the sales price of The Bridgeway was $17.3 million. A gain on divestiture of approximately $13.0 million is included in our results of operations for the twelve-month period ended December 31, 2014. During each of the last three years, our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with The Bridgeway’s lease.

 

During the first quarter of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened FEDs located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six, 5-year renewal terms have been executed with UHS for each FED. The first four, 5-year renewal terms (covering years 2025 through 2044) include 2% annual lease rate increases, computed on accumulative and compounded basis, and the last two, 5-year renewal terms (covering the years 2045 through 2054) will be at the then fair market value lease rates. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.

 

72


Table of Contents

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

 

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases.

 

As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC was no longer deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method from July 1, 2013 through December 31, 2013.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and began accounting for them on a consolidated basis.

 

We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by UHS of Texoma, Inc. (“Texoma Hospital”), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the

 

73


Table of Contents

“Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor.

 

The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. Our advisory fee was 0.70% during each of 2014 and 2013, and 0.65% during 2012, of our average invested real estate assets, as derived from our consolidated balance sheet. In December of 2014, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2015 pursuant to the same terms as the Advisory Agreement in place during 2014 and 2013.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2014, 2013 or 2012 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.5 million during 2014, $2.4 million during 2013 and $2.1 million during 2012 and were based upon average invested real estate assets of $363 million, $338 million and $326 million during 2014, 2013 and 2012, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2014 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2014 and 2013, UHS owned 5.9% and 6.1%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the Securities and Exchange Commission (“SEC”) and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 28% of our consolidated revenues for the year ended December 31, 2014 and 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

 

(3)   ACQUISITIONS AND DISPOSITIONS

 

2015:

 

Acquisitions:

 

In February, 2015, we purchased the Haas Medical Office Park, a single-tenant, two single story buildings having an aggregate of approximately 16,000 rentable square feet, located in Ottumwa, Iowa, for approximately $4.1 million.

 

74


Table of Contents

In January and February of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened free-standing emergency departments (“FEDs”) located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six 5-year renewal terms have been executed with UHS for each FED. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.

 

2014:

 

Acquisitions:

 

During 2014, we spent $15.6 million to acquire the following clinics and MOB:

 

   

spent $8.6 million to acquire the Hanover Emergency Center, a 22,000 rentable square feet, free-standing, full service emergency and imaging center, located in Mechanicsville, VA, in August, 2014. The single-tenant property is occupied pursuant to the terms of a 10-year lease with HCA Health Services of Virginia, Inc., and;

 

   

spent $7.2 million, including a $150,000 deposit made in 2013, to purchase the following in a single transaction in January, 2014:

 

   

The Children’s Clinic at Springdale – a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;

 

   

The Northwest Medical Center at Sugar Creek – a 13,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.

 

The aggregate purchase price for these clinics and MOB was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the clinics and MOB at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years at the time of acquisition (aggregate weighted average of 9.5 years at December 31, 2014) for the Hanover Emergency Center and approximately 9.7 years at the time of acquisition (aggregate weighted average of 8.7 years at December 31, 2014) for the Arkansas facilities.

 

Land

   $ 3,010   

Buildings and improvements

     10,664   

Intangible assets

     2,076   

Deposit paid in 2013

     (150 )
  

 

 

 

Net cash paid

   $ 15,600   
  

 

 

 

 

75


Table of Contents

Additionally, during 2014, we spent an aggregate of $7.0 million, including $4.7 million in cash plus an additional $2.3 million in the form of a note payable to the previous third-party member (which was fully repaid in January, 2015 and is reflected in “Accrued expenses and other liabilities” on our Consolidated Balance Sheet at December 31, 2014) to purchase the minority ownership interests held by third party members in eight LLCs (as noted in the table below) in which we previously held various non-controlling majority ownership interests ranging from 85% to 95%.

 

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC      Effective Date  

Palmdale Medical Properties

     95     Palmdale Medical Plaza         January 1, 2014   

Sparks Medical Properties…

     95     Vista Medical Terrace & Sparks MOB        January 1, 2014   

DVMC Properties

     90     Desert Valley Medical Center         August 1, 2014   

Santa Fe Scottsdale

     90     Santa Fe Professional Plaza         August 1, 2014   

PCH Medical Properties

     85     Rosenberg Children’s Medical Plaza         August 1, 2014   

Sierra Medical Properties

     95     Sierra San Antonio Medical Plaza         August 1, 2014   

PCH Southern Properties

     95     Phoenix Children’s East Valley Care Center         August 1, 2014   

3811 Bell Medical Properties

     95     North Valley Medical Plaza         August 1, 2014   

 

As a result of these minority ownership purchases, we now own 100% of each of these LLCs, which own medical office buildings, and began accounting for each on a consolidated basis at the effective date as noted in the table above. Pursuant to current accounting standards, at the effective date, we were required to record each property’s assets and liabilities at their fair values which resulted in the recording of a $25.4 million non-cash gain, which is included in our Consolidated Statement of Income for the twelve months ended December 31, 2014, representing the difference between the fair values and the equity method carrying value of each investment. The calculated fair value, categorized in level 3 of the fair value hierarchy and utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property. Each property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates. The capitalization rate and discount rate ranged from 7%-8.75% and 8%-9.75%, respectively.

 

The aggregate purchase price for these MOBs was allocated to net tangible property ($84.0 million), identified intangible assets ($6.5 million), and long term debt ($29.8 million). Substantially all of the intangible assets include the value of the in-place leases at these MOBs at the time of acquisition which will be amortized over the combined average remaining lease term of approximately 4.7 years at the time of acquisition (aggregate weighted average of 4.3 years at December 31, 2014) for the August, 2014 transactions and 5.3 years at the time of acquisition (aggregate weighted average of 5.5 years at December 31, 2014) for the January, 2014 transactions. Other than the increased depreciation and amortization expense resulting from the amortization of the intangible assets recorded in connection with these transactions, there was no material impact on our net income as a result of the consolidation of these LLCs.

 

Divestitures:

 

In December, 2014, upon expiration of The Bridgeway’s lease term, a wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility. The sale of The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, generated $17.3 million of sale proceeds. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value of $17.3 million. Our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with this lease. A $13.0 gain is included in our Consolidated Statement of Income for the twelve months ended December 31, 2014, representing the difference between the fair market value and the book value of this property.

 

76


Table of Contents

2013:

 

Acquisition:

 

In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.

 

In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.

 

The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which are being amortized over the then average remaining lease term of approximately 9.8 years (aggregate weighted average of 8.4 years at December 31, 2014).

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 

 

The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

New Construction:

 

The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

 

Divestitures:

 

There were no divestitures during 2013.

 

2012:

 

Acquisitions and New Construction:

 

In January and December, 2012, we purchased the:

 

   

PeaceHealth Medical Clinic, a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;

 

77


Table of Contents
   

Northwest Texas Professional Office Tower – a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.

 

The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 5.0 years at December 31, 2014).

 

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 

 

The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets

   Fair Value at
December 31, 2012
     Valuation Technique      Unobservable inputs      Range  

PeaceHealth Medical Clinic (a.)(b.)

   $ 30,400,000         Income Capitalization Approach         Capitalization Rate         7.50
           Discount Rate         8.50

Northwest Texas Professional Office Tower

   $ 9,600,000         Income Capitalization Approach         Capitalization Rate         8.60
           Discount Rate         9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.

 

For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.

 

Divestiture:

 

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing

 

78


Table of Contents

costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December 31, 2012.

 

In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December 31, 2012.

 

Assuming the 2012 acquisitions and divestitures occurred on January 1, 2012, our pro forma net revenues and net income for the year ended December 31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

 

As of December 31, 2014, our net intangible assets total $23.1 million (net of $19.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 4.4 years.

 

(4)   LEASES

 

All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility’s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.

 

Minimum future base rents from non-cancelable leases related to properties included in our financial statements on a consolidated basis, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2015

   $ 49,207   

2016

     46,051   

2017

     30,330   

2018

     25,799   

2019

     21,127   

Thereafter

     57,916   
  

 

 

 

Total minimum base rents

   $ 230,430   
  

 

 

 

 

Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property’s operating costs.

 

(5)   DEBT AND FINANCIAL INSTRUMENTS

 

Debt:

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. We are in the process of renegotiating our Credit Agreement and, although we can provide no assurance we will do so, we expect to complete a replacement credit facility by March 31,

 

79


Table of Contents

2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2014, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2014, we had $89.8 million of outstanding borrowings and $6.3 million of letters of credit outstanding against our revolving credit agreement. We had $54.0 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2014. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $104.6 million in 2014, $86.3 million in 2013 and $75.4 million in 2012 with corresponding effective interest rates, including commitment fees, of 2.4% in 2014, 2.2% in 2013 and 2.4% in 2012. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $89.8 million at December 31, 2014.

 

On February 10, 2015, we borrowed an additional $4.9 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Spring Valley Medical Office Building. The mortgage loan on this property matured on February 10, 2015.

 

On July 1, 2014, we borrowed an additional $9.1 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Summerlin Hospital Medical Office Building I. The mortgage loan on this property matured on July 1, 2014.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2014. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2014
 

Tangible net worth

   $ 125,000      $ 181,458   

Debt to total capital

     < 55     30.0

Debt service coverage ratio

     > 3.00x        25.4x   

Debt to cash flow ratio

     < 3.50x        1.29x   

 

80


Table of Contents

We have sixteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2014, with a combined outstanding balance of $122.9 million (excluding net debt premium of $523,000 at December 31, 2014). The following table summarizes our outstanding mortgages at December 31, 2014 (amounts in thousands):

 

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date

Spring Valley Medical Office Building fixed rate mortgage loan (b.)

   $ 4,920         5.50   February, 2015

Desert Valley Medical Center floating rate mortgage loan (c.)

     3,861         3.41   October, 2015

Palmdale Medical Plaza fixed rate mortgage loan (c.)

     6,008         3.69   October, 2015

Summerlin Hospital Medical Office Building III floating rate mortgage loan

     11,025         3.41   December, 2016

Peace Health fixed rate mortgage loan

     21,248         5.64   April, 2017

Auburn Medical II floating rate mortgage loan

     7,183         2.90   April, 2017

Medical Center of Western Connecticut fixed rate mortgage loan

     4,785         6.00   June, 2017

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

     11,729         5.50   October, 2017

Phoenix Children’s East Valley Care Center fixed rate mortgage loan

     6,485         5.88   December, 2017

Centennial Hills Medical Office Building floating rate mortgage loan

     10,642         3.41   January, 2018

Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan

     4,479         3.41   February, 2018

Rosenberg Children’s Medical Plaza fixed rate mortgage loan

     8,479         4.85   May, 2018

Vibra Hospital of Corpus Christi fixed rate mortgage loan

     2,902         6.50  

July, 2019

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

     6,601         4.54   June, 2022

BRB Medical Office Building fixed rate mortgage loan

     6,673         4.27   December, 2022

Tuscan Professional Building fixed rate mortgage loan

     5,862         5.56   June, 2025
  

 

 

      

Total

   $ 122,882        
  

 

 

      

 

(a.) Amortized principal payments are made on a monthly basis.
(b.) This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility.
(c.) We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.

 

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $124.7 million as of December 31, 2014. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

 

As of December 31, 2014, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2015(a)

   $ 107,646   

2016

     13,600   

2017

     50,399   

2018

     22,658   

2019

     3,463   

Later

     14,866   
  

 

 

 

Total

   $ 212,632   
  

 

 

 

 

81


Table of Contents

 

(a) Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.

 

Financial Instruments:

 

During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. During the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20 million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. From inception through December 31, 2014, no payments have been made to us by the counterparties pursuant to the terms of these caps which expire on January 13, 2017.

 

(6)   DIVIDENDS AND EQUITY ISSUANCE PROGRAM

 

Dividends:

 

During each of the last three years, dividends were declared and paid by us as follows:

 

   

2014:    $2.52 per share of which $1.478 per share was ordinary income and $1.042 per share was total capital gain (total capital gain amount includes Unrecaptured Section 1250 gain of $.305 per share).

 

   

2013:    $2.495 per share of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution.

 

   

2012:    $2.46 per share of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain includes Unrecaptured Section 1250 gain of $.281 per share).

 

Equity Issuance Program:

 

During the fourth quarter of 2013, we commenced an at-the-market (“ATM”) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $50 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (“Merrill Lynch”), as sales agent and/or principal.

 

Since inception of this program, we have issued 580,900 shares at an average price of $45.97 per share, which generated approximately $25.6 million of net cash proceeds or receivables (net of approximately$1.1 million, consisting of compensation of $667,000 to Merrill Lynch, as well as $391,000 of other various fees and expenses), as follows:

 

   

2014:    We issued 426,187 shares at an average price of $47.51 per share which generated approximately $19.5 million of net cash proceeds or receivables (net of approximately $701,000, consisting of compensation of $506,000 to Merrill Lynch, as well as $195,000 of other various fees and expenses), and;

 

   

2013:    We issued 154,713 shares at an average price of $41.71 per share which generated approximately $6.1 million of net cash proceeds or receivables (net of $357,000, consisting of compensation of $161,000 to Merrill Lynch, as well as $196,000 of other various fees and expenses).

 

In connection with this ATM program, our consolidated balance sheet includes approximately $1.1 million at December 31, 2014, and $600,000 at December 31, 2013, of net proceeds due to us in connection with shares issued in late December 2014 and 2013. The payment related to these shares was received by us in early January 2015, and early January, 2014, respectively. The net proceeds receivable were non-cash items, as presented on the Consolidated Statements of Cash Flows at December 31, 2014 and 2013.

 

82


Table of Contents
(7)   INCENTIVE PLANS

 

During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the “2007 Plan”). A total of 75,000 shares were authorized for issuance under this plan and a total of 57,825 shares, net of cancellations, have been issued pursuant to the terms of this plan, 39,245 of which have vested as of December 31, 2014. At December 31, 2014 there are 17,175 shares remaining for issuance under the terms of the 2007 Plan.

 

During 2014, there were 9,850 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.21 per share ($425,619 in the aggregate). These restricted shares are scheduled to vest in June of 2016 (the second anniversary of the date of grant).

 

During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).

 

During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares vested in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.

 

We expense the grant-date fair value restricted stock awards under the straight-line method over the stated vesting period of the award. In connection with these grants, we recorded compensation expense of approximately $399,000, $375,000 and $329,000 and during 2014, 2013 and 2012, respectively. The remaining expenses associated with these grants is approximately $381,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December 31, 2014.

 

Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the “1997 Plan”) provided for the granting of stock options and dividend equivalents rights (“DERs”) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25% per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. As of December 31, 2014, there were 36,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.94 per share and a remaining weighted average life of 1.6 years. The net expense recorded in connection with the DERs did not have a material impact on our consolidated financial statements during each of the years ended December 31, 2014, 2013 and 2012.

 

During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. DERs with respect to 36,000 shares, 40,000 shares

 

83


Table of Contents

and 43,000 shares were outstanding at December 31, 2014, 2013 and 2012, respectively. In December of 2014, 2013 and 2012, DERs which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $94,000, $106,000 and $116,000, respectively.

 

Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     (8,000      26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     (3,000      29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2014

     40,000       $ 35.65       $ 36.53/$30.06   

Exercised

     (4,000      33.07       $ 30.06/$34.07   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2014

     36,000       $ 35.94       $ 34.90/$36.53   
  

 

 

    

 

 

    

 

 

 

 

During 2014, there were 4,000 stock options exercised with a total in-the-money value of $44,160. During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930.

 

There were no unvested options as of December 31, 2014. The following table provides information about options outstanding and exercisable options at December 31, 2014:

 

     Options
Outstanding
and Exercisable
 

Number

     36,000   

Weighted average exercise price

   $ 35.94   

Aggregate intrinsic value

   $ 438,430   

Weighted average remaining contractual life

     1.6   

 

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2014 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$34.90 -$34.90

     13,000         34.90         0.7   

$36.53 -$36.53

     23,000         36.53         2.2   
  

 

 

    

 

 

    

 

 

 

Total

     36,000       $ 35.94         1.6   
  

 

 

    

 

 

    

 

 

 

 

84


Table of Contents
(8)   SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are or were the primary beneficiary. In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own MOBs. As of December 31, 2014, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. The majority of these LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans. These LLCs maintain property insurance on the properties.

 

Effective August 1, 2014, we purchased the minority ownership interests, ranging from 5% to 15%, held by third-party members in six LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and began to account for them on a consolidated basis effective August 1, 2014. Prior to August 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method.

 

Effective January 1, 2014, we purchased the 5% minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and account for them on a consolidated basis. Prior to January 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method. Previously, Palmdale Medical Properties (“Palmdale”) was included in our financial statements on a consolidated basis through June 30, 2013 as a result of a master lease arrangement with a wholly-owned subsidiary of UHS, which expired on July 1, 2013.

 

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC    Effective Date  

Palmdale Medical Properties

     95 %   Palmdale Medical Plaza      January 1, 2014   

Sparks Medical Properties

     95 %   Vista Medical Terrace & Sparks MOB      January 1, 2014   

DVMC Properties

     90 %   Desert Valley Medical Center      August 1, 2014   

Santa Fe Scottsdale

     90 %   Santa Fe Professional Plaza      August 1, 2014   

PCH Medical Properties

     85 %   Rosenberg Children’s Medical Plaza      August 1, 2014   

Sierra Medical Properties

     95 %   Sierra San Antonio Medical Plaza      August 1, 2014   

PCH Southern Properties

     95 %   Phoenix Children’s East Valley Care Center      August 1, 2014   

3811 Bell Medical Properties

     95 %   North Valley Medical Plaza      August 1, 2014   

 

85


Table of Contents

The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of December 31, 2014:

 

Name of LLC/LP

   Ownership     Property Owned by LLC

Suburban Properties

     33 %   Suburban Medical Plaza II

Brunswick Associates (a.)

     74 %   Mid Coast Hospital MOB

Arlington Medical Properties (b.)

     75 %   Saint Mary’s Professional
Office Building

Grayson Properties (c.)

     95 %   Texoma Medical Plaza

FTX MOB Phase II (d.)

     95 %   Forney Medical Plaza II

 

(a.) This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December 31, 2014.
(b.) We have funded $5.2 million in equity as of December 31, 2014 and are committed to invest an additional $1.1 million. This LLC has a third-party term loan of $23.3 million, which is non-recourse to us, outstanding as of December 31, 2014.
(c.) We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014
(d.) We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December 31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December 31, 2014.

 

Below are the combined statements of income for the LLCs accounted for under the equity method at December 31, 2014, 2013 and 2012. The data for the year ended December 31, 2014 includes the financial results for the six above-mentioned LLCs in which we purchased the minority ownership interests in August, 2014 for the period of January through July of 2014 (during which they were accounted for under the equity method). The data for the year ended December 31, 2012 includes the prorated amounts, through the date of their divestitures, for two LLCs that were divested during the year (Canyon Healthcare Properties, 95% ownership interest, divested in February, 2012 and 575 Hardy Investors, 90% ownership interest, divested in October, 2012).

 

     For the Year Ended December 31,  
     2014(b.)      2013(c.)      2012(c.) (d.)  
     (amounts in thousands)  

Revenues

   $ 17,292       $ 21,001       $ 21,448   

Operating expenses

     6,769         8,705         8,974   

Depreciation and amortization

     2,968         4,039         4,140   

Interest, net

     4,261         6,353         6,056   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 3,294       $ 1,904       $ 2,278   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures (a.)

   $ 2,428       $ 2,095       $ 2,365   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ —        $ 8,520   
  

 

 

    

 

 

    

 

 

 

 

(a.) Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.
(b.) As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014.

 

86


Table of Contents
(c.) As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
(d.) As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.

 

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2014 and 2013:

 

     December 31,  
     2014(a.)      2013(a.)(b.)  
     (amounts in thousands)  

Net property, including CIP

   $ 62,450       $ 119,547   

Other assets

     7,367         9,479   
  

 

 

    

 

 

 

Total assets

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Liabilities

   $ 3,348       $ 5,336   

Mortgage notes payable, non-recourse to us

     52,728         80,112   

Advances payable to us

     —           22,911   

Equity

     13,741         20,667   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 8,605       $ 39,201   
  

 

 

    

 

 

 

 

(a.) The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December 31, 2014.
(b.) As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. The amounts reflected for December 31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December 31, 2013.

 

87


Table of Contents

As of December 31, 2014, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2015

   $ 23,832   

2016

     530   

2017

     5,727   

2018

     445   

2019

     466   

2020 and After

     21,728   
  

 

 

 

Total

   $ 52,728   
  

 

 

 

 

Name of LLC

   Mortgage
Loan
Balance (a.)
     Maturity Date  

Arlington Medical Properties (b.)

     23,287         October, 2015   

FTX MOB Phase II (c.)

     5,548         August, 2017   

Grayson Properties (d.)

     14,893         September, 2021   

Brunswick Associates (e.)

     9,000         December, 2024   
  

 

 

    
   $ 52,728      
  

 

 

    

 

(a.) All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(b.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.
(c.) This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.
(d.) This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.
(e.) This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July 1, 2015 through December 31, 2024.

 

Pursuant to the operating and/or partnership agreements of most of the five LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member

 

(9)   SEGMENT REPORTING

 

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower

 

88


Table of Contents

performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

 

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

 

(10)   QUARTERLY RESULTS (unaudited)

 

     2014 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 14,288       $ 14,317       $ 15,258       $ 15,923       $ 59,786   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 3,458       $ 3,408       $ 3,048       $ 3,185       $ 13,099   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     316         —           25,093        —           25,409   

Gain on divestiture of real property

     —           —           —           13,043         13,043   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,774       $ 3,408       $ 28,141       $ 16,228       $ 51,551   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.

 

     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.

 

89


Table of Contents

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2014

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2014
    Date of
Completion of

Construction,
Acquisition
or Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments
to Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Inland Valley Regional Medical Center
Wildomar, California

    —        $ 2,050      $ 10,701     $ 14,596      $ 2,050      $ 25,297        $ 27,347      $ 11,175        2007        1986        43 Years   

McAllen Medical Center
McAllen, Texas

    —          4,720        31,442       10,189        6,281        40,070          46,351        24,385        1994        1986        42 Years   

Wellington Regional Medical Center
West Palm Beach, Florida

    —          1,190        14,652       17,370        1,663        31,549          33,212        16,258        2006        1986        42 Years   

HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana

    —          500        6,945       1,062        500        8,007          8,507        5,069        1993        1989        40 Years   

Kindred Hospital Chicago
Central Chicago, Illinois

    —          158        6,404       1,838        158        8,242          8,400        8,242        1993        1986        25 Years   

Family Doctor’s Medical Office Building
Shreveport, Louisiana

    —          54        1,526       494        54        2,020          2,074        902        1991        1995        45 Years   

Kelsey-Seybold Clinic at King’s Crossing

    —          439        1,618       870        439        2,488          2,927        1,091        1995        1995        45 Years   

Professional Buildings at King’s Crossing
Kingwood, Texas

    —          439        1,837       185        439        2,022        3        2,464        889        1995        1995        45 Years   

Chesterbrook Academy
Audubon, Pennsylvania

    —          307        996       —          307        996          1,303        413        1996        1996        45 Years   

Chesterbrook Academy
New Britain, Pennsylvania

    —          250        744       —          250        744          994        309        1991        1996        45 Years   

Chesterbrook Academy
Uwchlan, Pennsylvania

    —          180        815       —          180        815          995        338        1992        1996        45 Years   

Chesterbrook Academy
Newtown, Pennsylvania

    —          195        749       —          195        749          944        311        1992        1996        45 Years   

The Southern Crescent Center I (b.)

    —          1,130        5,092       (2,271     1,130        2,821          3,951        2,269        1994        1996        45 Years   

The Southern Crescent Center II (b.)
Riverdale, Georgia

    —          —          —         5,015        806        4,209          5,015        1,943        2000        1998        35 Years   

The Cypresswood Professional Center
Spring, Texas

    —          573        3,842       585        573        4,427        53        5,053        2,398        1997        1997        35 Years   

701 South Tonopah Building
Las Vegas, Nevada

    —          —          1,579       68        —          1,647          1,647        931        1999        1999        25 Years   

Sheffield Medical Building (c.)
Atlanta, Georgia

    —          1,760        9,766       (7,327     736        3,463        1        4,200        1,348        1999        1999        25 Years   

Medical Center of Western Connecticut
Danbury, Connecticut

    4,785        1,151        5,176       544        1,151        5,720          6,871        2,899        2000        2000        30 Years   

Vibra Hospital of Corpus Christi
Corpus Christi, Texas

    2,902        1,104        5,508       —          1,104        5,508          6,612        1,085        2008        2008        35 Years   

Apache Junction Medical Plaza (d.)
Apache Junction, AZ

    —          240        3,590       621        240        4,211        1        4,452        479        2004        2004        30 Years   

Auburn Medical Office Building II (d.)
Auburn, WA

    7,183        —          10,200       176        —          10,376          10,376        1,034        2009        2009        36 Years   

BRB Medical Office Building (d.)
Kingwood, Texas

    6,673        430        8,970       24        430        8,994        4        9,428        885        2010        2010        37 Years   

Centennial Hills Medical Office Building (d.)
Las Vegas, NV

    10,642        —          19,890       804        —          20,694        116        20,810        2,154        2006        2006        34 Years   

Desert Springs Medical Plaza (d.)
Las Vegas, NV

    —          1,200        9,560       443        1,200        10,003        144        11,347        1,212        1998        1998        30 Years   

700 Shadow Lane & Goldring MOBs (d.)
Las Vegas, NV

    6,601        400        11,300       1,141        400        12,441        155        12,996        1,430        2003        2003        30 Years   

Spring Valley Hospital MOB I (d.)
Las Vegas, NV

    4,920        —          9,500       338        —          9,838        36        9,874        1,029        2004        2004        35 Years   

 

90


Table of Contents

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2014 — (Continued)

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2014
    Date of
Completion of

Construction,
Acquisition
or Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments
to Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Spring Valley Hospital MOB II (d.)
Las Vegas, NV

    —          —          9,800       8        —          9,808        202        10,010        1,031        2006        2006        34 Years   

Summerlin Hospital MOB I (d.)
Las Vegas, NV

    —          460        15,440       512        460        15,952        43        16,455        1,889        1999        1999        30 Years   

Summerlin Hospital MOB II (d.)
Las Vegas, NV

    11,729        370        16,830       851        370        17,681        43        18,094        2,040        2000        2000        30 Years   

Summerlin Hospital MOB III (d.)
Las Vegas, NV

    11,025        —          14,900       1,459        —          16,359        32        16,391        1,581        2009        2009        36 Years   

Emory at Dunwoody Building
Dunwoody, GA

    —          782        3,455       —          782        3,455          4,237        395        2011        2011        35 Years   

Forney Medical Plaza Forney, TX

    —          910        11,960       31        910        11,991          12,901        1,621        2011        2011        35 Years   

Lake Pointe Medical Arts Building
Rowlett, TX

    —          1,100        9,000       31        1,100        9,031          10,131        1,077        2011        2011        35 Years   

Tuscan Professional Building
Irving, TX

    5,862        1,100        12,525       73        1,100        12,598          13,698        1,299        2011        2011        35 Years   

Peace Health Medical Clinic
Bellingham, WA

    21,248        1,900        24,910       —          1,900        24,910          26,810        2,554        2012        2012        35 Years   

Northwest Texas Professional Office Tower
Amarillo, TX

    —          —          7,180       —          —          7,180          7,180        485        2012        2012        35 Years   

Ward Eagle Office Village Farmington Hills, MI

    —          220        3,220       —          220        3,220          3,440        165        2013        2013        35 Years   

5004 Poole Road MOB Denison, TX

    —          96        529       —          96        529          625        28        2013        2013        35 Years   

Desert Valley Medical Center (f.)
Phoenix, AZ

    3,861        2,280        4,624       —          2,280        4,624        26        6,930        74        1996        1996        30 Years   

Hanover Emergency Center
Mechanicsville, VA

    —          1,300        6,224       —          1,300        6,224          7,524        72        2014        2014        35 Years   

North Valley Medical Plaza (f.)
Phoenix, AZ

    —          930        6,929       —          930        6,929          7,859        111        2010        2010        30 Years   

Northwest Medical Center at Sugar Creek
Bentonville, AR

    —          1,100        2,870       —          1,100        2,870          3,970        78        2014        2014        35 Years   

The Children’s Clinic at Springdale
Springdale, AR

    —          610        1,570       —          610        1,570          2,180        66        2014        2014        35 Years   

Rosenberg Children’s Medical Plaza (f.)
Phoenix, AZ

    8,479        0        23,302       —          0        23,302          23,302        327        2001        2001        35 Years   

Phoenix Children’s East Valley Care Center (f.) Phoenix, AZ

    6,485        1,050        10,900       —          1,050        10,900          11,950        152        2006        2006        35 Years   

Palmdale Medical Plaza (f.)
Palmdale, CA

    6,008        0        10,555       —          0        10,555        48        10,603        372        2008        2008        34 Years   

Santa Fe Professional Plaza (f.)
Scottsdale, AZ

    —          1,090        1,960       —          1,090        1,960        109        3,159        31        1999        1999        30 Years   

Sierra San Antonio Medical Plaza (f.) Fontana, CA

    —          0        11,538       —          0        11,538          11,538        184        2006        2006        30 Years   

Vista Medical Terrace & Sparks MOB (f.)
Sparks, NV

    4,479        0        9,276       —          0        9,276        176        9,452        370        2008        2008        30 Years   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

TOTALS

  $ 122,882      $ 33,768      $ 401,899     $ 49,730      $ 35,584      $ 449,813      $ 1,192      $ 486,589      $ 106,480         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

91


Table of Contents

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2014—(Continued)

(amounts in thousands)

 

 

a.. Costs capitalized/divested subsequent to acquisition.
b. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
c. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
d. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
e. Consists of outstanding balances as of December 31, 2014 on third-party debt that is non-recourse to us.
f. During 2014, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.

 

92


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO SCHEDULE III

DECEMBER 31, 2014

(amounts in thousands)

 

(1) RECONCILIATION OF REAL ESTATE PROPERTIES

 

The following table reconciles the Real Estate Properties from January 1, 2012 to December 31, 2014:

 

     2014     2013     2012  

Balance at January 1,

   $ 395,669      $ 401,474      $ 363,498   

Impact of deconsolidation of an LLC(a.)

     —          (13,185     —     

Impact of consolidation of eight LLCs(b.)

     84,064       —          —     

Property additions

     3,298        3,415        3,985   

Acquisitions

     13,674        4,065        33,991   

Disposals

     (10,116     (100     —     
  

 

 

   

 

 

   

 

 

 

Balance at December 31,

   $ 486,589      $ 395,669      $ 401,474   
  

 

 

   

 

 

   

 

 

 

 

(2) RECONCILIATION OF ACCUMULATED DEPRECIATION

 

The following table reconciles the Accumulated Depreciation from January 1, 2012 to December 31, 2014:

 

     2014     2013     2012  

Balance at January 1,

   $ 97,921      $ 87,088      $ 74,865   

Impact of deconsolidation of an LLC(a.)

     —          (1,588     —     

Disposals

     (5,859     —          —     

Current year depreciation expense

     14,413        12,464        12,223   

Other

     5       (43     —     
  

 

 

   

 

 

   

 

 

 

Balance at December 31,

   $ 106,480      $ 97,921      $ 87,088   
  

 

 

   

 

 

   

 

 

 

 

(a.) The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
(b.) During 2014, the Trust purchased the minority ownership interests held by third-party members in eight LLCs (January and August, 2014) in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.

 

93


Table of Contents

Exhibit Index

 

Exhibit No.

    

Exhibit

  10.2       Agreement dated December 4, 2014, to renew Advisory Agreement dated as of December 24, 1986 between Universal Health Realty Income Trust and UHS of Delaware, Inc.
  11       Statement re computation of per share earnings is set forth on the Consolidated Statements of Income.
  21       Subsidiaries of Registrant.
  23.1       Consent of Independent Registered Public Accounting Firm.
  31.1       Certification from the Trust’s Chief Executive Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934.
  31.2       Certification from the Trust’s Chief Financial Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934.
  32.1       Certification from the Trust’s Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2       Certification from the Trust’s Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
    101.INS       XBRL Instance Document
    101.SCH       XBRL Taxonomy Extension Schema Document
  101.CAL       XBRL Taxonomy Extension Calculation Linkbase Document
  101.DEF       XBRL Taxonomy Extension Definition Linkbase Document
  101.LAB       XBRL Taxonomy Extension Label Linkbase Document
  101.PRE       XBRL Taxonomy Extension Presentation Linkbase Document

 

 

94

EX-10.2 2 d834449dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

 

December 4, 2014

 

Steve Filton

Senior Vice President & CFO

UHS of Delaware, Inc.

367 South Gulph Road

King of Prussia, PA 19406

 

Dear Steve;

 

The Board of Trustees of Universal Health Realty Income Trust, at today’s meeting, authorized the renewal of the current Advisory Agreement between Universal Health Realty Income Trust and UHS of Delaware, Inc. (“Agreement”) upon the same terms and conditions.

 

This letter constitutes Universal Health Realty Income Trust’s offer to renew the Agreement, through December 31, 2015, upon the same terms and conditions. Please acknowledge UHS of Delaware’s acceptance of this offer by signing in the space provided below and returning one copy of this letter to me. Thank you.

 

Sincerely,

/s/ Cheryl K. Ramagano

Cheryl K. Ramagano

Vice President and Treasurer

 

Agreed and Accepted:
UHS OF DELAWARE, INC.
By:  

/s/ Steve Filton

Steve Filton

Senior Vice President and CFO

 

CC: Charles Boyle

EX-21 3 d834449dex21.htm EX-21 EX-21

Exhibit 21

 

Subsidiaries of Registrant

 

Jurisdiction

 

3811 Bell Medical Properties, LLC

   Delaware

5004 Pool Road Properties, LP

   Texas

73 Medical Building, LLC

   Connecticut

653 Town Center Investments, LLC

   Arizona

653 Town Center Phase II, LLC

   Arizona

ApaMed Properties, LLC

   Arizona

Arlington Medical Properties, LLC

   Arizona

Auburn Medical Properties II, LLC

   Delaware

Banburry Medical Properties, LLC

   Delaware

BRB/E Building One, LLC

   Texas

Brunswick Associates, LLC

   New York

Centennial Medical Properties, LLC

   Delaware

Cimarron Medical Properties, LLC

   Texas

Cobre Properties, LLC

   Delaware

Cypresswood Investments, L.P

   Georgia

Deerval Properties, LLC

   Arizona

DesMed, LLC

   Arizona

DTX Medical Properties, LLC

   Texas

DVMC Properties, LLC

   Arizona

Eagle Medical Properties, LLC

   Michigan

Forney Deerval, LLC

   Texas

Forney Willetta, LLC

   Texas

FTX Healthcare GP, LLC

   Texas

FTX MOB Phase II, LLC

   Texas

Gold Shadow Properties, LLC

   Arizona

Grayson Properties, LP

   Texas

Gulph Investments

   Maryland

Hanover Medical Properties, LLC

   Virginia

NSHE TX Bay City, LLC

   Texas

NSHE TX Cedar Park, LLC

   Texas

NWTX Healthcare Properties, LLC

   Texas

NWTX Medical Properties, LLC

   Texas

Oneida Medical Properties, LP

   Texas

Osage Medical Properties, LLC

   Arkansas

Ottumwa Medical Properties, LLC

   Iowa

Palmdale Medical Properties, LLC

   Delaware

Paseo Medical Properties II, LLC

   Arizona

PAX Medical Holdings, LLC

   Delaware

PCH Medical Properties, LLC

   Arizona

PCH Southern Properties, LLC

   Delaware

Riverdale Realty, LLC

   Georgia

Santa Fe Scottsdale, LLC

   Arizona

Saratoga Hospital Properties, LP

   Texas

Sheffield Properties, LLC

   Georgia

Shiloh Medical Properties, LLC

   Arkansas

Sierra Medical Properties, LLC

   Arizona

Sparks Medical Properties, LLC

   Delaware

Spring Valley Medical Properties, LLC

   Arizona

Spring Valley Medical Properties II, LLC

   Delaware

Suburban Properties, LLC

   Kentucky

Tuscan Medical Properties, LLC

   Delaware

UHT TRS, LLC

   Delaware

UHT/Ensemble Properties I, LLC

   Delaware

Willetta Medical Properties, LLC

   Arizona
EX-23.1 4 d834449dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Trustees

Universal Health Realty Income Trust:

 

We consent to the incorporation by reference in the registration statements (Nos. 333-143944 and 333-57815) on Form S-8 and in the registration statements (Nos. 333-81763 and 333-185092) on Form S-3 of Universal Health Realty Income Trust of our reports dated March 6, 2015, with respect to the consolidated balance sheets of Universal Health Realty Income Trust as of December 31, 2014 and 2013, and the related consolidated statements of income, comprehensive income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the related financial statement schedule III, real estate and accumulated depreciation, and the effectiveness of internal control over financial reporting as of December 31, 2014, which reports appear in the December 31, 2014 annual report on Form 10-K of Universal Health Realty Income Trust.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 6, 2015

EX-31.1 5 d834449dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

 

CERTIFICATION - Chief Executive Officer

 

I, Alan B. Miller, certify that:

 

1. I have reviewed this annual report on Form 10-K of Universal Health Realty Income Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 6, 2015

 

/s/ Alan B. Miller

President and Chief

Executive Officer

EX-31.2 6 d834449dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

 

CERTIFICATION - Chief Financial Officer

 

I, Charles F. Boyle, certify that:

 

1. I have reviewed this annual report on Form 10-K of Universal Health Realty Income Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 6, 2015

 

/s/ Charles F. Boyle

Vice President and

Chief Financial Officer

EX-32.1 7 d834449dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-K for the year ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan B. Miller, President and Chief Executive Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Alan B. Miller

President and Chief Executive Officer

March 6, 2015

 

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 8 d834449dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles F. Boyle, Vice President and Chief Financial Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Charles F. Boyle

Vice President and Chief Financial Officer

March 6, 2015

 

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 9 uht-20141231.xml XBRL INSTANCE DOCUMENT 99000 30400000 13700 9800 13301298 0.95 0.95 16000 4100000 13600 12800000 6 13600 6 1.00 0.15 0.15 0.05 0.05 1.00 6 0.90 0.90 4400 625000 16300 4100000 10000000 1 0.0150 20000000 2 0.0150 555012765 22000 33.89 51000 188945000 74865000 11649000 363498000 36.53 26.09 447398000 12667000 127000 84000 188861000 213566000 -472230000 35.22 0.024 43000 177745000 87088000 3048000 401474000 0.0065 9600000 30400000 36.53 29.44 466875000 12689000 127000 74000 177671000 214094000 -503425000 144000 23240000 1900000 6020000 16891000 40000000 799000 32090000 534000 799000 72000 9600000 12858643 12858643 95000000 35.65 0.01 0.022 5000000 0.01 40000 165630000 106287000 97921000 491000 5156000 5336000 129026000 128000 -57000 480044000 165630000 373145000 13700000 220691000 97921000 20667000 93700000 207515000 834000 3337000 27374000 270374000 129026000 535176000 39201000 2053000 297748000 373145000 39201000 20782000 368295000 395669000 6714000 119547000 22911000 50000000 9479000 0.0070 3310000 1881000 80112000 36.53 30.06 2 -57000 480044000 12859000 128000 0 165630000 220691000 -535176000 11000 316000 610000 4685000 4700000 21000 3749000 0.061 0.05 2 0.05 13301204 13301204 95000000 35.94 1.00 36000 35.94 18 0 0.01 0.024 5000000 61 0.01 36000 204581000 123405000 106480000 14866000 545000 2300000 8522000 57916000 50399000 29800000 89800000 6300000 3348000 69817000 133000 -88000 531595000 25799000 124700000 3463000 204581000 230430000 21127000 30330000 22658000 428866000 19700000 240835000 106480000 122882000 107646000 13741000 122882000 46051000 150000000 89750000 224285000 523000 49207000 13600000 212632000 54000000 3861000 2500000 1192000 35584000 344525000 84000000 69817000 449813000 401899000 6500000 7000000 567894000 8605000 23100000 33768000 35584000 1900000 438430 2086000 380109000 428866000 4500000 8605000 5600000 23123000 451005000 486589000 6863000 3900000 62450000 125000000 16 1.29 7367000 181458000 0.0070 4219000 2063000 0.300 52728000 0.95 25.40 0.0364 0.0150 36000 35.94 34.90 0.95 0.95 5 3.50 36.53 0.33 0.85 3.00 0.15 23000 36.53 13000 34.90 75000 17175 381000 36000 35.94 9000000 48 5 5 5500000 1400000 2500000 23300000 5200000 1100000 3 6 1 3 2 4 0.95 14900000 2600000 400000 14900000 2600000 400000 316000000 469000000 1.00 150000000 50000000 20000000 5485000 1621000 11991000 11960000 910000 910000 12901000 1212000 144000 10003000 9560000 1200000 1200000 11347000 5069000 8007000 6945000 500000 500000 8507000 11175000 25297000 10701000 2050000 2050000 27347000 3030000 1943000 4209000 806000 5015000 311000 749000 749000 195000 195000 944000 413000 996000 996000 307000 307000 1303000 165000 3220000 3220000 220000 220000 3440000 2648000 931000 1647000 1579000 1647000 28000 529000 529000 96000 96000 625000 2398000 53000 4427000 3842000 573000 573000 5053000 395000 3455000 3455000 782000 782000 4237000 1581000 11025000 32000 16359000 14900000 16391000 479000 1000 4211000 3590000 240000 240000 4452000 1031000 202000 9808000 9800000 10010000 1034000 7183000 10376000 10200000 10376000 309000 744000 744000 250000 250000 994000 1091000 2488000 1618000 439000 439000 2927000 74000 3861000 26000 4624000 4624000 2280000 2280000 6930000 72000 6224000 6224000 1300000 1300000 7524000 111000 6929000 6929000 930000 930000 7859000 78000 2870000 2870000 1100000 1100000 3970000 66000 1570000 1570000 610000 610000 2180000 327000 8479000 23302000 23302000 0 0 23302000 152000 6485000 10900000 10900000 1050000 1050000 11950000 372000 6008000 48000 10555000 10555000 0 0 10603000 31000 109000 1960000 1960000 1090000 1090000 3159000 184000 11538000 11538000 0 0 11538000 370000 4479000 176000 9276000 9276000 0 0 9452000 485000 7180000 7180000 7180000 1077000 9031000 9000000 1100000 1100000 10131000 1085000 2902000 5508000 5508000 1104000 1104000 6612000 24385000 40070000 31442000 4720000 6281000 46351000 889000 3000 2022000 1837000 439000 439000 2464000 2899000 4785000 5720000 5176000 1151000 1151000 6871000 902000 2020000 1526000 54000 54000 2074000 2154000 10642000 116000 20694000 19890000 20810000 2040000 11729000 43000 17681000 16830000 370000 370000 18094000 8242000 8242000 6404000 158000 158000 8400000 16258000 31549000 14652000 1190000 1663000 33212000 2269000 2821000 5092000 1130000 1130000 3951000 1348000 1000 3463000 9766000 1760000 736000 4200000 338000 815000 815000 180000 180000 995000 1430000 6601000 155000 12441000 11300000 400000 400000 12996000 1889000 43000 15952000 15440000 460000 460000 16455000 1029000 4920000 36000 9838000 9500000 9874000 1299000 5862000 12598000 12525000 1100000 1100000 13698000 885000 6673000 4000 8994000 8970000 430000 430000 9428000 2554000 21248000 24910000 24910000 1900000 1900000 26810000 -88000 531595000 13302000 133000 0 204581000 240835000 -567894000 0.95 0.90 0.95 0.95 3010000 2076000 15600000 10664000 150000 0.85 0.95 0.95 0.90 0.0650 2902000 0.0427 6673000 0.0564 21248000 0.0341 11025000 0.0341 3861000 0.0588 6485000 0.0485 8479000 0.0550 4920000 0.0341 4479000 0.0600 4785000 0.0550 11729000 0.0290 7183000 0.0556 5862000 0.0341 10642000 0.0369 6008000 0.0454 6601000 8 6 0.059 17300000 21728000 5727000 466000 445000 23832000 530000 52728000 0.95 0.90 0.95 0.74 9000000 0.95 0.95 0.75 23287000 0.85 0.95 0.95 0.33 0.90 5548000 0.05034 0.95 14893000 0.20 2015-02-10 4900000 2014-07-01 9100000 17300000 0.20 0.36 2 8100000 30000 P4Y3M18D P9Y9M18D 8600000 P10Y P10Y P9Y8M12D 7200000 P5Y6M 12200000 8000000 P5Y1M6D 17300000 5400000 1.04 29.44 12000 31294000 2.495 12701000 1.04 -3415000 3000 12689000 6324000 14401000 13185000 1900000 431000 375000 3013000 31751000 -57000 0 100000 0 13169000 86300000 0 46290 18546000 22000 0 13112000 150000 4580000 -57000 7517000 21001000 54280000 95000 0 14773000 13169000 4260000 4675000 2095000 1904000 13112000 18843000 31751000 7472000 6000000 430000 523000 0 11150000 1588000 3415000 12464000 12500000 18753000 -17491000 0 -433000 -13373000 74000 5757000 0 35734000 57000 2369000 114000 11950000 375000 14409000 106000 54280000 480000 16000 746000 6353000 4039000 0 40000 101000 101000 4065000 0 0 27955000 0 2346000 2.495 8705000 0.535 43000 6812000 1.960 203000 -141000 29.44 29.44 43.54 8730 380104 375000 2015-06 0 0 0 0 0 0 0 0 0 0 0 0 0 -207000 6215000 54000 141000 135000 11597000 5443000 368000 161000 196000 154713 357000 600000 6100000 41.71 -57000 57000 13169000 13169000 170000 1000 0 74000 6324000 375000 13169000 13112000 31751000 0 57000 101000 6323000 375000 101000 31751000 P9Y9M18D 150000 0.22 0.30 1100000 2400000 338000000 3.99 33.07 10-K UNIVERSAL HEALTH REALTY INCOME TRUST No UHT 7000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2014, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">530</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,727</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">445</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">466</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2020 and After</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Mortgage<br /> Loan<br /> Balance&#xA0;(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity&#xA0;Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties (b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,287</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,548</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August, 2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties (d.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,893</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">September,&#xA0;2021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates (e.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2024</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July&#xA0;1, 2015 through December&#xA0;31, 2024.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Federal Income Taxes</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $469 million and $316 million, respectively, at December&#xA0;31, 2014.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Real Estate Investments</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On the date of acquisition, the purchase price of a property is allocated to the property&#x2019;s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December&#xA0;31, 2014, and will be amortized over the remaining lease terms (aggregate weighted average of 4.4 years at December&#xA0;31, 2014) and is expected to result in estimated aggregate amortization expense of $5.6&#xA0;million, $4.5&#xA0;million, $3.9 million $2.5 million and $1.9 million for 2015, 2016, 2017, 2018 and 2019, respectively. Amortization expense on intangible values of in place leases was $6.1 million for the year ended December&#xA0;31, 2014, $6.0 million for the year ended December&#xA0;31, 2013 and $7.8 million for the year ended December&#xA0;31, 2012. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $14.4 million for the year ended December&#xA0;31, 2014, $12.5 million for the year ended December&#xA0;31, 2013 and $12.2 million for the year ended December&#xA0;31, 2012.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table provides information about options outstanding and exercisable options at December&#xA0;31, 2014:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="86%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options<br /> Outstanding<br /> and&#xA0;Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Number</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average exercise price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Aggregate intrinsic value</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">438,430</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average remaining contractual life</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(9)</b></font></td> <td width="1%" valign="top"><font size="1">&#xA0;</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>SEGMENT REPORTING</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.</font></p> </div> Accelerated Filer No 32796000 <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(2)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Leases:</i>&#xA0;&#xA0;&#xA0;&#xA0;We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. The hospital leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each hospital leased to subsidiaries of UHS are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 36% of our total revenue for the five years ended December&#xA0;31, 2014 (approximately 28% for the year ended December&#xA0;31, 2014 and approximately 30% for each of the years ended December&#xA0;31, 2013 and 2012). The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests. As a result of these transactions, we own 100% of each of these LLCs and began accounting for each on a consolidated basis effective on the date of purchase of the minority ownership interests. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December&#xA0;31, 2014 (approximately 22% for each of the years ended December&#xA0;31, 2014 and 2013 and 21% for the year ended December&#xA0;31, 2012). In addition, including the two free-standing emergency departments (&#x201C;FEDs&#x201D;) acquired by us from subsidiaries of UHS during the first quarter of 2015 (as discussed below), fifteen MOBs/FEDs, that are either wholly or jointly-owned, include tenants which are subsidiaries of UHS.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December&#xA0;24, 1986 (the &#x201C;Master Lease&#x201D;), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i)&#xA0;purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii)&#xA0;renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month&#x2019;s notice should a change of control of the Trust occur, to purchase any or all of the three leased hospital properties listed below at their appraised fair market value.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the third quarter of 2014, a wholly-owned subsidiary of UHS provided notification to us that, upon expiration of The Bridgeway&#x2019;s lease term which occurred in December, 2014, it intended to exercise its option to purchase the real property of the facility. Upon expiration of the lease, the wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility and on December&#xA0;31, 2014, The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, was sold to UHS. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value. Based upon the property appraisals obtained by each party, the sales price of The Bridgeway was $17.3 million. A gain on divestiture of approximately $13.0 million is included in our results of operations for the twelve-month period ended December&#xA0;31, 2014. During each of the last three years, our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with The Bridgeway&#x2019;s lease.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the first quarter of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened FEDs located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six, 5-year renewal terms have been executed with UHS for each FED. The first four, 5-year renewal terms (covering years 2025 through 2044) include 2% annual lease rate increases, computed on accumulative and compounded basis, and the last two, 5-year renewal terms (covering the years 2045 through 2054) will be at the then fair market value lease rates. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="52%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 50pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Type&#xA0;of&#xA0;Facility</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Annual<br /> Minimum<br /> Rent</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>End&#xA0;of<br /> Lease&#xA0;Term</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Renewal<br /> Term<br /> (years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute&#xA0;Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,485,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(a)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,030,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,648,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(b)&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired effective as of July&#xA0;1, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June&#xA0;30, 2013 since we were the primary beneficiary through that date. Effective July&#xA0;1, 2013, this LLC was no longer deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method from July&#xA0;1, 2013 through December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and began accounting for them on a consolidated basis.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We have funded $2.6 million in equity as of December&#xA0;31, 2014, and are committed to fund an additional $400,000, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by UHS of Texoma, Inc. (&#x201C;Texoma Hospital&#x201D;), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Advisory Agreement:&#xA0;&#xA0;&#xA0;&#xA0;</i>UHS of Delaware, Inc. (the &#x201C;Advisor&#x201D;), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the &#x201C;Advisory Agreement&#x201D;) dated December&#xA0;24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the &#x201C;Independent Trustees&#x201D;). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Advisory Agreement expires on December&#xA0;31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor&#x2019;s performance has been satisfactory. Our advisory fee was 0.70% during each of 2014 and 2013, and 0.65% during 2012, of our average invested real estate assets, as derived from our consolidated balance sheet. In December of 2014, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2015 pursuant to the same terms as the Advisory Agreement in place during 2014 and 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2014, 2013 or 2012 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.5 million during 2014, $2.4 million during 2013 and $2.1 million during 2012 and were based upon average invested real estate assets of $363 million, $338 million and $326 million during 2014, 2013 and 2012, respectively.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Officers and Employees:</i>&#xA0;&#xA0;&#xA0;&#xA0;Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December&#xA0;31, 2014 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time compensation awards in the form of restricted stock and/or cash bonuses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Share Ownership:</i>&#xA0;&#xA0;&#xA0;&#xA0;As of December&#xA0;31, 2014 and 2013, UHS owned 5.9% and 6.1%, respectively, of our outstanding shares of beneficial interest.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>SEC reporting requirements of UHS:</i>&#xA0;&#xA0;&#xA0;&#xA0;UHS is subject to the reporting requirements of the Securities and Exchange Commission (&#x201C;SEC&#x201D;) and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 28% of our consolidated revenues for the year ended December&#xA0;31, 2014 and 30% of our consolidated revenues for each of the years ended December&#xA0;31, 2013 and 2012, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC&#x2019;s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Revenue Recognition</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility&#x2019;s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility&#x2019;s current quarter&#x2019;s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.</font></p> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December&#xA0;31, 2014 were as follows:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="10" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Options Outstanding and<br /> Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:48pt"><font style="font-family:Times New Roman" size="1"><b>Exercise Price</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise<br /> Price&#xA0;Per<br /> Share</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life&#xA0;(in<br /> Years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">$34.90&#xA0;-$34.90</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">34.90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.7</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">$36.53&#xA0;-$36.53</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">23,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">36.53</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2.2</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">36,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">35.94</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.6</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Investments in Limited Liability Companies (&#x201C;LLCs</b>&#x201D;)</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB&#x2019;s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#xA0;divestiture of property; (ii)&#xA0;annual budget approval, and; (iii)&#xA0;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties was consolidated in our financial statements through June&#xA0;30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July&#xA0;1, 2013 through December&#xA0;31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January&#xA0;1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective August&#xA0;1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August&#xA0;1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014, as discussed below. Each of the property&#x2019;s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.</font></p> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="32%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="border-bottom:1px solid #000000;width:21pt" align="center"><font style="font-family:Times New Roman" size="1"><b>Assets</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fair Value at<br /> December&#xA0;31,&#xA0;2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Valuation Technique</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Unobservable inputs</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Range</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">PeaceHealth Medical Clinic (a.)(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">30,400,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Capitalization&#xA0;Rate</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Discount Rate</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Northwest Texas Professional Office Tower</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9,600,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Capitalization Rate</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8.60</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Discount&#xA0;Rate</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">The fair value of the land was estimated based upon the sales comparison approach.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div> 2014-12-31 The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests. <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash and Cash Equivalents</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.</font></p> </div> 2.520 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Prior to August&#xA0;1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership<br /> prior&#xA0;to<br /> minority<br /> interest<br /> purchase</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January&#xA0;1,&#xA0;2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Vista Medical Terrace &amp; Sparks MOB</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Professional Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix&#xA0;Children&#x2019;s&#xA0;East&#xA0;Valley&#xA0;Care&#xA0;Center</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">3811&#xA0;Bell&#xA0;Medical&#xA0;Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">North Valley Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of December&#xA0;31, 2014:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="66%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban&#xA0;Medical&#xA0;Plaza&#xA0;II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates (a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington&#xA0;Medical&#xA0;Properties&#xA0;(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Saint Mary&#x2019;s Professional<br /> Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Texoma&#xA0;Medical&#xA0;Plaza</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II (d.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Forney&#xA0;Medical&#xA0;Plaza&#xA0;II</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have funded $5.2 million in equity as of December&#xA0;31, 2014 and are committed to invest an additional $1.1&#xA0;million. This LLC has a third-party term loan of $23.3&#xA0;million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have funded $2.6 million in equity as of December&#xA0;31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December&#xA0;31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> </div> P5Y <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(10)</b></font></td> <td width="1%" valign="top"><font size="1">&#xA0;</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>QUARTERLY RESULTS (unaudited)</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,288</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,317</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,258</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,923</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">59,786</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income before gains</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,458</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,408</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,048</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,185</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,099</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">316</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,093</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,409</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Gain on divestiture of real property</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,043</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,043</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,774</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,408</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">28,141</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">16,228</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">51,551</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.29</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2.18</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3.99</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.29</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2.18</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3.99</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014.</font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,885</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,502</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,448</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,445</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">54,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,427</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,941</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,303</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,498</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,169</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes our outstanding mortgages at December&#xA0;31, 2014 (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="64%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br /> Balance<br /> (in&#xA0;thousands)&#xA0;(a)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Interest<br /> Rate</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity<br /> Date</b></font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical&#xA0;Office&#xA0;Building&#xA0;fixed&#xA0;rate mortgage&#xA0;loan&#xA0;(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,920</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">February, 2015</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center floating rate mortgage loan (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,861</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2015</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Plaza fixed rate mortgage loan (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,008</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October,&#xA0;2015</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,025</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Peace Health fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,248</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.64</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">April, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical II floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,183</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">April, 2017</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,785</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,729</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2017</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix Children&#x2019;s East Valley Care Center fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,485</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.88</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,642</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">January, 2018</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">February, 2018</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">May, 2018</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vibra Hospital of Corpus Christi fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,902</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">July, 2019</font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane and Goldring MOBs fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,601</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June, 2022</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,673</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2022</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tuscan Professional Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,862</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.56</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June,&#xA0;2025</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">122,882</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Amortized principal payments are made on a monthly basis.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was repaid in full on February&#xA0;10, 2015, utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="52%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="border-bottom:1px solid #000000;width:50pt" align="center"><font style="font-family:Times New Roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Type&#xA0;of&#xA0;Facility</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Annual<br /> Minimum<br /> Rent</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>End&#xA0;of<br /> Lease&#xA0;Term</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Renewal<br /> Term<br /> (years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute&#xA0;Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5,485,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December,&#xA0;2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(a)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,030,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December,&#xA0;2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,648,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December,&#xA0;2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(b)&#xA0;</font></td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(6)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>DIVIDENDS AND EQUITY ISSUANCE PROGRAM</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Dividends:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During each of the last three years, dividends were declared and paid by us as follows:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>2014:</u>&#xA0;&#xA0;&#xA0;&#xA0;$2.52 per share of which $1.478 per share was ordinary income and $1.042 per share was total capital gain (total capital gain amount includes Unrecaptured Section&#xA0;1250 gain of $.305 per share).</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>2013:</u>&#xA0;&#xA0;&#xA0;&#xA0;$2.495 per share of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>2012:</u>&#xA0;&#xA0;&#xA0;&#xA0;$2.46 per share of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain includes Unrecaptured Section&#xA0;1250 gain of $.281 per share).</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Equity Issuance Program:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2013, we commenced an at-the-market (&#x201C;ATM&#x201D;) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $50 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (&#x201C;Merrill Lynch&#x201D;), as sales agent and/or principal.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Since inception of this program, we have issued 580,900 shares at an average price of $45.97 per share, which generated approximately $25.6 million of net cash proceeds or receivables (net of approximately$1.1 million, consisting of compensation of $667,000 to Merrill Lynch, as well as $391,000 of other various fees and expenses), as follows:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>2014:</u>&#xA0;&#xA0;&#xA0;&#xA0;We issued 426,187 shares at an average price of $47.51 per share which generated approximately $19.5 million of net cash proceeds or receivables (net of approximately $701,000, consisting of compensation of $506,000 to Merrill Lynch, as well as $195,000 of other various fees and expenses), and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><u>2013:</u>&#xA0;&#xA0;&#xA0;&#xA0;We issued 154,713 shares at an average price of $41.71 per share which generated approximately $6.1 million of net cash proceeds or receivables (net of $357,000, consisting of compensation of $161,000 to Merrill Lynch, as well as $196,000 of other various fees and expenses).</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In connection with this ATM program, our consolidated balance sheet includes approximately $1.1 million at December&#xA0;31, 2014, and $600,000 at December&#xA0;31, 2013, of net proceeds due to us in connection with shares issued in late December 2014 and 2013. The payment related to these shares was received by us in early January 2015, and early January, 2014, respectively. The net proceeds receivable were non-cash items, as presented on the Consolidated Statements of Cash Flows at December&#xA0;31, 2014 and 2013.</font></p> </div> false --12-31 2014 12934000 3.99 <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(8)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are or were the primary beneficiary. In accordance with the Financial Accounting Standards Board&#x2019;s (&#x201C;FASB&#x201D;) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#xA0;divestiture of property; (ii)&#xA0;annual budget approval, and; (iii)&#xA0;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own MOBs. As of December&#xA0;31, 2014, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. The majority of these LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans. These LLCs maintain property insurance on the properties.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective August&#xA0;1, 2014, we purchased the minority ownership interests, ranging from 5% to 15%, held by third-party members in six LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and began to account for them on a consolidated basis effective August&#xA0;1, 2014. Prior to August&#xA0;1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the 5% minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and account for them on a consolidated basis. Prior to January&#xA0;1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method. Previously, Palmdale Medical Properties (&#x201C;Palmdale&#x201D;) was included in our financial statements on a consolidated basis through June&#xA0;30, 2013 as a result of a master lease arrangement with a wholly-owned subsidiary of UHS, which expired on July&#xA0;1, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership<br /> prior&#xA0;to<br /> minority<br /> interest<br /> purchase</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January&#xA0;1,&#xA0;2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Vista Medical Terrace &amp; Sparks MOB</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Professional Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix&#xA0;Children&#x2019;s&#xA0;East&#xA0;Valley&#xA0;Care&#xA0;Center</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">3811&#xA0;Bell&#xA0;Medical&#xA0;Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">North Valley Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of December&#xA0;31, 2014:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="66%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban&#xA0;Medical&#xA0;Plaza&#xA0;II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates (a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington&#xA0;Medical&#xA0;Properties&#xA0;(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="top"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="top" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="top" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Saint Mary&#x2019;s Professional<br /> Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Texoma&#xA0;Medical&#xA0;Plaza</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II (d.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Forney&#xA0;Medical&#xA0;Plaza&#xA0;II</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have funded $5.2 million in equity as of December&#xA0;31, 2014 and are committed to invest an additional $1.1&#xA0;million. This LLC has a third-party term loan of $23.3&#xA0;million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have funded $2.6 million in equity as of December&#xA0;31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December&#xA0;31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2014.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined statements of income for the LLCs accounted for under the equity method at December&#xA0;31, 2014, 2013 and 2012. The data for the year ended December&#xA0;31, 2014 includes the financial results for the six above-mentioned LLCs in which we purchased the minority ownership interests in August, 2014 for the period of January through July of 2014 (during which they were accounted for under the equity method). The data for the year ended December&#xA0;31, 2012 includes the prorated amounts, through the date of their divestitures, for two LLCs that were divested during the year (Canyon Healthcare Properties, 95% ownership interest, divested in February, 2012 and 575 Hardy Investors, 90% ownership interest, divested in October, 2012).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>For the Year Ended December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(c.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012(c.)&#xA0;(d.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,292</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,001</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,448</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,769</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,974</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,968</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,140</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,261</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,353</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net income before gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,294</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,904</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,278</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income before gains on divestitures (a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,428</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,095</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,365</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,520</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014. Prior to August&#xA0;1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December&#xA0;31, 2014, include the financial results of the six mentioned LLCs for seven months ended July&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January&#xA0;1, 2014. Prior to January&#xA0;1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December&#xA0;31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August&#xA0;1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December&#xA0;31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January&#xA0;1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July&#xA0;1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June&#xA0;30, 2013 and then on an unconsolidated basis for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December&#xA0;31, 2014 and 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="82%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(a.)(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">62,450</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">119,547</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,367</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69,817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,348</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,336</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,911</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,741</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,667</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69,817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,605</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,201</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014. The amounts reflected for December&#xA0;31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December&#xA0;31, 2013.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2014, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">530</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,727</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">445</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">466</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2020 and After</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Mortgage<br /> Loan<br /> Balance&#xA0;(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity&#xA0;Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties (b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,287</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,548</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August, 2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties (d.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,893</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">September,&#xA0;2021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates (e.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2024</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July&#xA0;1, 2015 through December&#xA0;31, 2024.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the operating and/or partnership agreements of most of the five LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (&#x201C;Offering Member&#x201D;) to the other member(s) (&#x201C;Non-Offering Member&#x201D;) in which it either agrees to: (i)&#xA0;sell the entire ownership interest of the Offering Member to the Non-Offering Member (&#x201C;Offer to Sell&#x201D;) at a price as determined by the Offering Member (&#x201C;Transfer Price&#x201D;), or; (ii)&#xA0;purchase the entire ownership interest of the Non-Offering Member (&#x201C;Offer to Purchase&#x201D;) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90 days to either: (i)&#xA0;purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii)&#xA0;sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Asset Impairment</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management&#x2019;s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.</font></p> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(3)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>ACQUISITIONS AND DISPOSITIONS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2015:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In February, 2015, we purchased the Haas Medical Office Park, a single-tenant, two single story buildings having an aggregate of approximately 16,000 rentable square feet, located in Ottumwa, Iowa, for approximately $4.1 million.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In January and February of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened free-standing emergency departments (&#x201C;FEDs&#x201D;) located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six 5-year renewal terms have been executed with UHS for each FED. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2014:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2014, we spent $15.6 million to acquire the following clinics and MOB:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">spent $8.6 million to acquire the Hanover Emergency Center, a 22,000 rentable square feet, free-standing, full service emergency and imaging center, located in Mechanicsville, VA, in August, 2014. The single-tenant property is occupied pursuant to the terms of a 10-year lease with HCA Health Services of Virginia, Inc., and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">spent $7.2 million, including a $150,000 deposit made in 2013, to purchase the following in a single transaction in January, 2014:</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%"><font size="1">&#xA0;</font></td> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Children&#x2019;s Clinic at Springdale &#x2013; a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="8%"><font size="1">&#xA0;</font></td> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Northwest Medical Center at Sugar Creek &#x2013; a 13,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price for these clinics and MOB was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the clinics and MOB at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years at the time of acquisition (aggregate weighted average of 9.5 years at December&#xA0;31, 2014) for the Hanover Emergency Center and approximately 9.7 years at the time of acquisition (aggregate weighted average of 8.7 years at December&#xA0;31, 2014) for the Arkansas facilities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,010</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,664</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,076</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Additionally, during 2014, we spent an aggregate of $7.0 million, including $4.7 million in cash plus an additional $2.3 million in the form of a note payable to the previous third-party member (which was fully repaid in January, 2015 and is reflected in &#x201C;Accrued expenses and other liabilities&#x201D; on our Consolidated Balance Sheet at December&#xA0;31, 2014) to purchase the minority ownership interests held by third party members in eight LLCs (as noted in the table below) in which we previously held various non-controlling majority ownership interests ranging from 85% to 95%.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px">&#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership<br /> prior to<br /> minority<br /> interest<br /> purchase</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Effective Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Plaza</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January&#xA0;1,&#xA0;2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties&#x2026;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Vista&#xA0;Medical&#xA0;Terrace&#xA0;&amp;&#xA0;Sparks&#xA0;MOB</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">January 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Professional Plaza</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix&#xA0;Children&#x2019;s&#xA0;East&#xA0;Valley&#xA0;Care&#xA0;Center</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">North Valley Medical Plaza</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">August 1, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As a result of these minority ownership purchases, we now own 100% of each of these LLCs, which own medical office buildings, and began accounting for each on a consolidated basis at the effective date as noted in the table above. Pursuant to current accounting standards, at the effective date, we were required to record each property&#x2019;s assets and liabilities at their fair values which resulted in the recording of a $25.4 million non-cash gain, which is included in our Consolidated Statement of Income for the twelve months ended December&#xA0;31, 2014, representing the difference between the fair values and the equity method carrying value of each investment. The calculated fair value, categorized in level&#xA0;3 of the fair value hierarchy and utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property. Each property&#x2019;s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates. The capitalization rate and discount rate ranged from 7%-8.75% and 8%-9.75%, respectively.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price for these MOBs was allocated to net tangible property ($84.0 million), identified intangible assets ($6.5 million), and long term debt ($29.8 million). Substantially all of the intangible assets include the value of the in-place leases at these MOBs at the time of acquisition which will be amortized over the combined average remaining lease term of approximately 4.7 years at the time of acquisition (aggregate weighted average of 4.3 years at December&#xA0;31, 2014) for the August, 2014 transactions and 5.3 years at the time of acquisition (aggregate weighted average of 5.5 years at December&#xA0;31, 2014) for the January, 2014 transactions. Other than the increased depreciation and amortization expense resulting from the amortization of the intangible assets recorded in connection with these transactions, there was no material impact on our net income as a result of the consolidation of these LLCs.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestitures:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In December, 2014, upon expiration of The Bridgeway&#x2019;s lease term, a wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility. The sale of The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, generated $17.3 million of sale proceeds. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value of $17.3 million. Our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with this lease. A $13.0 gain is included in our Consolidated Statement of Income for the twelve months ended December&#xA0;31, 2014, representing the difference between the fair market value and the book value of this property.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2013:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisition:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which are being amortized over the then average remaining lease term of approximately 9.8 years (aggregate weighted average of 8.4 years at December&#xA0;31, 2014).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">316</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">610</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,685</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property&#x2019;s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>New Construction:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestitures:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">There were no divestitures during 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2012:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions and New Construction:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In January and December, 2012, we purchased the:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">PeaceHealth Medical Clinic, a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Northwest Texas Professional Office Tower &#x2013; a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 5.0 years at December&#xA0;31, 2014).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,090</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">799</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(534</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt (including fair value adjustment of $799)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(23,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,891</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property&#x2019;s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="32%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 21pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Assets</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Fair Value at<br /> December&#xA0;31,&#xA0;2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Valuation Technique</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Unobservable inputs</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Range</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PeaceHealth Medical Clinic (a.)(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30,400,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalization&#xA0;Rate</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Discount Rate</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Northwest Texas Professional Office Tower</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,600,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalization Rate</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8.60</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">Discount&#xA0;Rate</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The fair value of the land was estimated based upon the sales comparison approach.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestiture:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In February, 2012, Canyon Healthcare Properties, a limited liability company (&#x201C;LLC&#x201D;) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members&#x2019; share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December&#xA0;31, 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members&#x2019; share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December&#xA0;31, 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assuming the 2012 acquisitions and divestitures occurred on January&#xA0;1, 2012, our pro forma net revenues and net income for the year ended December&#xA0;31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2014, our net intangible assets total $23.1 million (net of $19.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 4.4 years.</font></p> </div> -2866000 <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Minimum future base rents from non-cancelable leases related to properties included in our financial statements on a consolidated basis, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="80%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="87%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">49,207</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">46,051</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">30,330</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,799</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">21,127</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">57,916</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total minimum base rents</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">230,430</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2014, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="90%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">107,646</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">50,399</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,658</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,866</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212,632</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.</font></td> </tr> </table> </div> <div> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,288</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,317</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,258</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15,923</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">59,786</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income before gains</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,458</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,408</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,048</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,185</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,099</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">316</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,093</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,409</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Gain on divestiture of real property</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,043</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,043</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,774</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,408</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">28,141</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">16,228</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">51,551</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.29</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2.18</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3.99</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.29</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2.18</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3.99</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014.</font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,885</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,502</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,448</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,445</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">54,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,427</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,941</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,303</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,498</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,169</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.</font></td> </tr> </table> </div> P1Y7M6D <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(1)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Nature of Operations</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Universal Health Realty Income Trust and subsidiaries (the &#x201C;Trust&#x201D;) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings. As of February&#xA0;28, 2015, we have sixty-one real estate investments or commitments located in eighteen states consisting of:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">six hospital facilities including three acute care, one rehabilitation and two sub-acute;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">three free-standing emergency departments;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">forty-eight medical office buildings, including five owned by unconsolidated limited liability companies (&#x201C;LLCs&#x201D;), and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">four preschool and childcare centers.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the three Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management&#x2019;s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Revenue Recognition</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility&#x2019;s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility&#x2019;s current quarter&#x2019;s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Real Estate Investments</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On the date of acquisition, the purchase price of a property is allocated to the property&#x2019;s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December&#xA0;31, 2014, and will be amortized over the remaining lease terms (aggregate weighted average of 4.4 years at December&#xA0;31, 2014) and is expected to result in estimated aggregate amortization expense of $5.6&#xA0;million, $4.5&#xA0;million, $3.9 million $2.5 million and $1.9 million for 2015, 2016, 2017, 2018 and 2019, respectively. Amortization expense on intangible values of in place leases was $6.1 million for the year ended December&#xA0;31, 2014, $6.0 million for the year ended December&#xA0;31, 2013 and $7.8 million for the year ended December&#xA0;31, 2012. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $14.4 million for the year ended December&#xA0;31, 2014, $12.5 million for the year ended December&#xA0;31, 2013 and $12.2 million for the year ended December&#xA0;31, 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash and Cash Equivalents</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Asset Impairment</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management&#x2019;s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Investments in Limited Liability Companies (&#x201C;LLCs</b>&#x201D;)</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB&#x2019;s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#xA0;divestiture of property; (ii)&#xA0;annual budget approval, and; (iii)&#xA0;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties was consolidated in our financial statements through June&#xA0;30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July&#xA0;1, 2013 through December&#xA0;31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January&#xA0;1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective August&#xA0;1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August&#xA0;1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014, as discussed below. Each of the property&#x2019;s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Federal Income Taxes</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $469 million and $316 million, respectively, at December&#xA0;31, 2014.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Stock-Based Compensation</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value of restricted stock awards over the vesting period. We recognize the grant-date fair value of equity-based compensation and account for these transactions using the fair-value based method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Fair Value</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">See Note 3-Acquisitions and Dispositions, for disclosure related to the $25.4 million net gain recorded during 2014 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>New Accounting Standards</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Except as noted below, there were no new accounting pronouncements during 2014 that impacted, or are expected to impact us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In August 2014, FASB issued ASU No.&#xA0;2014-15, &#x201C;Preparation of Financial Statements&#x2014;Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern&#x201D; (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity&#x2019;s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity&#x2019;s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, &#x201C;Presentation of Financial Statements&#x2014;Liquidation Basis of Accounting&#x201D;. Even when an entity&#x2019;s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December&#xA0;15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity&#x2019;s operations and financial results. We adopted this updated guidance in 2014 and the adoption of this update did not have a material impact on our consolidated financial statements.</font></p> </div> 0000798783 <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(4)</b></font></td> <td width="1%" valign="top"><font size="1">&#xA0;</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>LEASES</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility&#x2019;s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Minimum future base rents from non-cancelable leases related to properties included in our financial statements on a consolidated basis, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="80%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="87%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">49,207</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">46,051</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">30,330</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">25,799</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">21,127</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">57,916</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total minimum base rents</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">230,430</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property&#x2019;s operating costs.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>New Accounting Standards</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Except as noted below, there were no new accounting pronouncements during 2014 that impacted, or are expected to impact us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In August 2014, FASB issued ASU No.&#xA0;2014-15, &#x201C;Preparation of Financial Statements&#x2014;Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity&#x2019;s Ability to Continue as a Going Concern&#x201D; (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity&#x2019;s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity&#x2019;s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, &#x201C;Presentation of Financial Statements&#x2014;Liquidation Basis of Accounting&#x201D;. Even when an entity&#x2019;s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity&#x2019;s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December&#xA0;15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity&#x2019;s operations and financial results. We adopted this updated guidance in 2014 and the adoption of this update did not have a material impact on our consolidated financial statements.</font></p> </div> <div> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>Schedule III</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>Universal Health Realty Income Trust</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>Real Estate and Accumulated Depreciation &#x2014; December&#xA0;31, 2014</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>(amounts in thousands)</b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="44%"></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom"></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" rowspan="2"> <p style="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:31pt"> <font style="font-family:Times New Roman" size="1"><b>Description</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Initial Cost</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="14" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Gross amount at<br /> which carried<br /> at end of period</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" rowspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Accumulated</b></font><br /> <font style="font-family:Times New Roman" size="1"><b>Depreciation</b></font><br /> <font style="font-family:Times New Roman" size="1"><b>as of Dec. 31,<br /> 2014</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" rowspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Date of<br /> Completion&#xA0;of</b></font><br /> <font style="font-family:Times New Roman" size="1"><b>Construction,</b></font><br /> <font style="font-family:Times New Roman" size="1"><b>Acquisition<br /> or Significant<br /> improvement</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" rowspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Date<br /> Acquired</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" rowspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Average</b></font><br /> <font style="font-family:Times New Roman" size="1"><b>Depreciable<br /> Life</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Encumbrance<br /> (e.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Land</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Building<br /> &amp;<br /> Improv.</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Adjustments<br /> to Basis (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Land</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Building &amp;<br /> Improvements</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>CIP</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Inland Valley Regional Medical Center<br /> <i>Wildomar, California</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,050</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,701</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">14,596</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,050</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">25,297</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">27,347</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,175</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2007</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">43&#xA0;Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">McAllen Medical Center<br /> <i>McAllen, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,720</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">31,442</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,189</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,281</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">40,070</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">46,351</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">24,385</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">42 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Wellington Regional Medical Center<br /> <i>West Palm Beach, Florida</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,190</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">14,652</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">17,370</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,663</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">31,549</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">33,212</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">16,258</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">42 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">HealthSouth Deaconess Rehabilitation Hospital <i>Evansville, Indiana</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">500</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,945</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,062</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">500</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,007</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,507</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,069</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1993</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1989</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">40 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Kindred Hospital Chicago<br /> <i>Central Chicago, Illinois</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">158</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,404</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,838</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">158</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,242</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,400</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,242</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1993</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">25 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Family Doctor&#x2019;s Medical Office Building<br /> <i>Shreveport, Louisiana</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,526</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">494</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,020</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,074</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">902</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1991</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Kelsey-Seybold Clinic at King&#x2019;s Crossing</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">439</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,618</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">870</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">439</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,488</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,927</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,091</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Professional Buildings at King&#x2019;s Crossing<br /> <i>Kingwood, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">439</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,837</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">185</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">439</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,022</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,464</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">889</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Chesterbrook Academy<br /> <i>Audubon, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">307</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">307</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,303</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">413</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Chesterbrook Academy<br /> <i>New Britain, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">250</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">744</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">250</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">744</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">309</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1991</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Chesterbrook Academy<br /> <i>Uwchlan, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">815</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">815</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">995</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">338</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1992</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Chesterbrook Academy<br /> <i>Newtown, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">195</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">749</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">195</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">749</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">944</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">311</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1992</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">The Southern Crescent Center I (b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,130</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,092</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">(2,271</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,130</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,821</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,951</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,269</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">45 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">The Southern Crescent Center II (b.)<br /> <i>Riverdale, Georgia</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">806</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,209</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,943</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1998</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">The Cypresswood Professional Center<br /> <i>Spring, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">573</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,842</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">585</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">573</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,427</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">53</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,053</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,398</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1997</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1997</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">701 South Tonopah Building<br /> <i>Las Vegas, Nevada</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,579</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">68</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,647</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,647</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">931</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">25 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Sheffield Medical Building (c.)<br /> <i>Atlanta, Georgia</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,760</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,766</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">(7,327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">736</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,463</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,200</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,348</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">25 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Medical Center of Western Connecticut<br /> <i>Danbury, Connecticut</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,785</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,151</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,176</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">544</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,151</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,720</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,871</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,899</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Vibra Hospital of Corpus Christi<br /> <i>Corpus Christi, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,902</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,104</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,508</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,104</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,508</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,612</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1085</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Apache Junction Medical Plaza (d.)<br /> <i>Apache Junction, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">240</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,590</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">621</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">240</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,211</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,452</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">479</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2004</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2004</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Auburn Medical Office Building II (d.)<br /> <i>Auburn, WA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,183</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,200</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">176</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,376</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,376</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,034</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">36 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">BRB Medical Office Building (d.)<br /> <i>Kingwood, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,673</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">430</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,970</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">430</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,428</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">885</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2010</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2010</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">37 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Centennial Hills Medical Office Building (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,642</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">19,890</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">804</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">20,694</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">116</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">20,810</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,154</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">34 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Desert Springs Medical Plaza (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,200</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,560</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">443</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,200</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,003</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">144</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,347</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,212</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1998</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1998</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">700 Shadow Lane&#xA0;&amp; Goldring MOBs (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,601</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">400</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,300</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,141</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">400</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">12,441</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">155</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">12,996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,430</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2003</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2003</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30&#xA0;Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Spring Valley Hospital MOB I (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,920</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,500</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">338</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,838</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">36</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,874</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,029</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2004</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2004</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Spring Valley Hospital MOB II (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,800</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,808</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">202</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,010</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,031</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">34&#xA0;Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Summerlin Hospital MOB I (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">460</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">15,440</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">512</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">460</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">15,952</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">43</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">16,455</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,889</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Summerlin Hospital MOB II (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,729</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">370</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">16,830</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">851</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">370</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">17,681</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">43</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">18,094</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,040</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Summerlin Hospital MOB III (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">14,900</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,459</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">16,359</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">32</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">16,391</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,581</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">36 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Emory at Dunwoody Building<br /> <i>Dunwoody, GA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">782</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,455</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">782</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,455</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,237</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">395</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Forney Medical Plaza <i>Forney, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">910</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,960</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">31</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">910</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,991</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">12,901</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,621</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Lake Pointe Medical Arts Building<br /> <i>Rowlett, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">31</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,031</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,131</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,077</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Tuscan Professional Building<br /> <i>Irving, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">5,862</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">12,525</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">73</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">12,598</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">13,698</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,299</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2011</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Peace Health Medical Clinic<br /> <i>Bellingham, WA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">21,248</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,900</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">24,910</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,900</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">24,910</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">26,810</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,554</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Northwest Texas Professional Office Tower<br /> <i>Amarillo, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">485</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Ward Eagle Office Village <i>Farmington Hills, MI</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">220</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,220</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">220</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,220</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,440</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">165</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">5004 Poole Road MOB <i>Denison, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">96</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">529</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">96</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">529</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">625</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">28</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Desert Valley Medical Center (f.)<br /> <i>Phoenix, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,861</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,624</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,624</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,930</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">74</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1996</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Hanover Emergency Center<br /> <i>Mechanicsville, VA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,300</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,224</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,300</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,224</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,524</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">72</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">North Valley Medical Plaza (f.)<br /> <i>Phoenix, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">930</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,929</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">930</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,929</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">7,859</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">111</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2010</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2010</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Northwest Medical Center at Sugar Creek<br /> <i>Bentonville, AR</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,870</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,870</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,970</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">78</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">The Children&#x2019;s Clinic at Springdale<br /> <i>Springdale, AR</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">610</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,570</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">610</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,570</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">66</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Rosenberg Children&#x2019;s Medical Plaza (f.)<br /> <i>Phoenix, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">8,479</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">23,302</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">23,302</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">23,302</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2001</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2001</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Phoenix Children&#x2019;s East Valley Care Center (f.) <i>Phoenix, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,485</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,050</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,900</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,050</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,900</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,950</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">152</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Palmdale Medical Plaza (f.)<br /> <i>Palmdale, CA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">6,008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,555</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,555</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">48</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">10,603</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">372</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;<br /> &#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">33.5<br /> Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;<br /> &#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Santa Fe Professional Plaza (f.)<br /> <i>Scottsdale, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,090</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,960</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,090</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,960</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">109</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">3,159</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">31</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1999</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Sierra San Antonio Medical Plaza (f.) <i>Fontana, CA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,538</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,538</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">11,538</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">184</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2006</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1">Vista Medical Terrace&#xA0;&amp; Sparks MOB (f.)<br /> <i>Sparks, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">4,479</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,276</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">0</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,276</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">176</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">9,452</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">370</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">2008</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">30 Years</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="margin-left:3.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="1"><b>TOTALS</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">122,882</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">33,768</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">401,899</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">49,730</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">35,584</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">449,813</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">1,192</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">486,589</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="1">106,480</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">a..</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">Costs capitalized/divested subsequent to acquisition.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">b.</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I &amp; Southern Crescent Center II.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">c.</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">d.</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">e.</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">Consists of outstanding balances as of December 31, 2014 on third-party debt that is non-recourse to us.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="1">f.</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="1">During 2014, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.</font></td> </tr> </table> <p style="font-size:1px;margin-top:12px;margin-bottom:0px"> &#xA0;</p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>UNIVERSAL HEALTH REALTY INCOME TRUST</b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>NOTES TO SCHEDULE III</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>DECEMBER 31, 2014</b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"> <font style="font-family:Times New Roman" size="2"><b>(amounts in thousands)</b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(1)</b></font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>RECONCILIATION OF REAL ESTATE PROPERTIES</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The following table reconciles the Real Estate Properties from January&#xA0;1, 2012 to December&#xA0;31, 2014:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Balance at January&#xA0;1,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">395,669</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">401,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">363,498</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Impact of deconsolidation of an LLC(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(13,185</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Impact of consolidation of eight LLCs(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">84,064</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Property additions</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,298</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,415</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,985</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Acquisitions</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,674</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">4,065</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">33,991</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Disposals</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(10,116</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(100</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Balance at December&#xA0;31,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">486,589</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">395,669</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">401,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(2)</b></font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>RECONCILIATION OF ACCUMULATED DEPRECIATION</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The following table reconciles the Accumulated Depreciation from January&#xA0;1, 2012 to December&#xA0;31, 2014:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2014</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Balance at January&#xA0;1,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">97,921</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">87,088</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">74,865</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Impact of deconsolidation of an LLC(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(1,588</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Disposals</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(5,859</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Current year depreciation expense</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">14,413</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">12,464</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">12,223</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">(43</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Balance at December&#xA0;31,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">106,480</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">97,921</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">87,088</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July&#xA0;1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">During 2014, the Trust purchased the minority ownership interests held by third-party members in eight LLCs (January and August, 2014) in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.</font></td> </tr> </table> </div> FY <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(7)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>INCENTIVE PLANS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the &#x201C;2007 Plan&#x201D;). A total of 75,000 shares were authorized for issuance under this plan and a total of 57,825 shares, net of cancellations, have been issued pursuant to the terms of this plan, 39,245 of which have vested as of December&#xA0;31, 2014. At December&#xA0;31, 2014 there are 17,175 shares remaining for issuance under the terms of the 2007 Plan.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2014, there were 9,850 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.21 per share ($425,619 in the aggregate). These restricted shares are scheduled to vest in June of 2016 (the second anniversary of the date of grant).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares vested in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value restricted stock awards under the straight-line method over the stated vesting period of the award. In connection with these grants, we recorded compensation expense of approximately $399,000, $375,000 and $329,000 and during 2014, 2013 and 2012, respectively. The remaining expenses associated with these grants is approximately $381,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December&#xA0;31, 2014.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the &#x201C;1997 Plan&#x201D;) provided for the granting of stock options and dividend equivalents rights (&#x201C;DERs&#x201D;) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25%&#xA0;per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. As of December&#xA0;31, 2014, there were 36,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.94 per share and a remaining weighted average life of 1.6 years. The net expense recorded in connection with the DERs did not have a material impact on our consolidated financial statements during each of the years ended December&#xA0;31, 2014, 2013 and 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. DERs with respect to 36,000 shares, 40,000 shares and 43,000 shares were outstanding at December&#xA0;31, 2014, 2013 and 2012, respectively. In December of 2014, 2013 and 2012, DERs which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $94,000, $106,000 and $116,000, respectively.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="57%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 71pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding Options</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br /> of&#xA0;Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise<br /> Weighted-<br /> Average&#xA0;Price</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Grant&#xA0;Price&#xA0;Range<br /> (High-Low)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2012</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(8,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26.76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">27.65/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$30.06</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.06/$34.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding options vested and exercisable as of December&#xA0;31, 2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34.90/$36.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2014, there were 4,000 stock options exercised with a total in-the-money value of $44,160. During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">There were no unvested options as of December&#xA0;31, 2014. The following table provides information about options outstanding and exercisable options at December&#xA0;31, 2014:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="86%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options<br /> Outstanding<br /> and&#xA0;Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Number</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average exercise price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Aggregate intrinsic value</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">438,430</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average remaining contractual life</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December&#xA0;31, 2014 were as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options Outstanding and<br /> Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 48pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise Price</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise<br /> Price&#xA0;Per<br /> Share</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life&#xA0;(in<br /> Years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$34.90&#xA0;-$34.90</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34.90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">0.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$36.53&#xA0;-$36.53</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.6</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 2015-01-05 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Fair Value</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">See Note 3-Acquisitions and Dispositions, for disclosure related to the $25.4 million net gain recorded during 2014 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.</font></p> </div> 1 <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Additionally, during 2014, we spent an aggregate of $7.0 million, including $4.7 million in cash plus an additional $2.3 million in the form of a note payable to the previous third-party member (which was fully repaid in January, 2015 and is reflected in &#x201C;Accrued expenses and other liabilities&#x201D; on our Consolidated Balance Sheet at December&#xA0;31, 2014) to purchase the minority ownership interests held by third party members in eight LLCs (as noted in the table below) in which we previously held various non-controlling majority ownership interests ranging from 85% to 95%.</font></p> <p style="margin-top:0px;margin-bottom:0px">&#xA0;</p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:59pt"><font style="font-family:Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Ownership<br /> prior to<br /> minority<br /> interest<br /> purchase</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Property Owned by LLC</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Effective Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Plaza</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">January&#xA0;1,&#xA0;2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Sparks Medical Properties&#x2026;</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Vista&#xA0;Medical&#xA0;Terrace&#xA0;&amp;&#xA0;Sparks&#xA0;MOB</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">January 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Desert Valley Medical Center</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Santa Fe Professional Plaza</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">85</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">Phoenix&#xA0;Children&#x2019;s&#xA0;East&#xA0;Valley&#xA0;Care&#xA0;Center</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">North Valley Medical Plaza</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">August 1, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="57%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 71pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding Options</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br /> of&#xA0;Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise<br /> Weighted-<br /> Average&#xA0;Price</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Grant&#xA0;Price&#xA0;Range<br /> (High-Low)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2012</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(8,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26.76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">27.65/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(3,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$30.06</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(4,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.06/$34.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding options vested and exercisable as of December&#xA0;31, 2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.94</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34.90/$36.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Stock-Based Compensation</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value of restricted stock awards over the vesting period. We recognize the grant-date fair value of equity-based compensation and account for these transactions using the fair-value based method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.</font></p> </div> 4000 Yes 12927000 19844000 12327000 834000 -64000 399000 1337000 32718000 -31000 25409000 10116000 3950000 51551000 104600000 13043000 44160 49730000 19047000 62000 0 51520000 25400000 100000 13099000 0 -115000 8268000 17292000 59786000 0 4744000 15601000 51551000 4607000 15600000 2428000 3294000 51520000 20975000 32718000 8376000 6100000 -1057000 -509000 -84000 0 3298000 14413000 14400000 20885000 -29815000 17300000 -312000 -4038000 19274000 0 5859000 40739000 31000 2545000 84064000 0 0 399000 16882000 94000 59786000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined statements of income for the LLCs accounted for under the equity method at December&#xA0;31, 2014, 2013 and 2012. The data for the year ended December&#xA0;31, 2014 includes the financial results for the six above-mentioned LLCs in which we purchased the minority ownership interests in August, 2014 for the period of January through July of 2014 (during which they were accounted for under the equity method). The data for the year ended December&#xA0;31, 2012 includes the prorated amounts, through the date of their divestitures, for two LLCs that were divested during the year (Canyon Healthcare Properties, 95% ownership interest, divested in February, 2012 and 575 Hardy Investors, 90% ownership interest, divested in October, 2012).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>For the Year Ended December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(c.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012(c.)&#xA0;(d.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,292</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,001</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,448</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,769</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,974</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,968</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,140</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,261</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,353</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net income before gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,294</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,904</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,278</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income before gains on divestitures (a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,428</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,095</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,365</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,520</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014. Prior to August&#xA0;1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December&#xA0;31, 2014, include the financial results of the six mentioned LLCs for seven months ended July&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January&#xA0;1, 2014. Prior to January&#xA0;1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December&#xA0;31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August&#xA0;1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December&#xA0;31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January&#xA0;1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July&#xA0;1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June&#xA0;30, 2013 and then on an unconsolidated basis for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.</font></td> </tr> </table> </div> 702000 -303000 555000 4261000 2968000 2280000 36000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,<br /> 2014</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">125,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">181,458</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt; 55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&gt;&#xA0;3.00x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25.4x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt;&#xA0;3.50x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.29x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Nature of Operations</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Universal Health Realty Income Trust and subsidiaries (the &#x201C;Trust&#x201D;) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings. As of February&#xA0;28, 2015, we have sixty-one real estate investments or commitments located in eighteen states consisting of:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">six hospital facilities including three acute care, one rehabilitation and two sub-acute;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">three free-standing emergency departments;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">forty-eight medical office buildings, including five owned by unconsolidated limited liability companies (&#x201C;LLCs&#x201D;), and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">four preschool and childcare centers.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the three Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management&#x2019;s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.</font></p> </div> 94000 94000 13674000 0 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December&#xA0;31, 2014 and 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="82%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2014(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(a.)(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">62,450</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">119,547</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,367</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69,817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,348</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,336</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">52,728</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,911</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,741</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,667</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">69,817</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,605</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,201</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December&#xA0;31, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January&#xA0;1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children&#x2019;s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children&#x2019;s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August&#xA0;1, 2014. The amounts reflected for December&#xA0;31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December&#xA0;31, 2013.</font></td> </tr> </table> </div> 0 31386000 0 1029000 2.52 6769000 0.04 1.042 -5000 7490000 1.478 427000 1581000 <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(5)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>DEBT AND FINANCIAL INSTRUMENTS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Debt:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In July, 2011, we entered into a $150 million revolving credit agreement (&#x201C;Credit Agreement&#x201D;) which is scheduled to expire on July&#xA0;24, 2015. We are in the process of renegotiating our Credit Agreement and, although we can provide no assurance we will do so, we expect to complete a replacement credit facility by March&#xA0;31, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines &#x201C;Base Rate&#x201D; as the greatest of: (a)&#xA0;the administrative agent&#x2019;s prime rate; (b)&#xA0;the federal funds effective rate plus 0.50%, and; (c)&#xA0;one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December&#xA0;31, 2014, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2014, we had $89.8 million of outstanding borrowings and $6.3 million of letters of credit outstanding against our revolving credit agreement. We had $54.0 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December&#xA0;31, 2014. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $104.6 million in 2014, $86.3 million in 2013 and $75.4 million in 2012 with corresponding effective interest rates, including commitment fees, of 2.4% in 2014, 2.2% in 2013 and 2.4% in 2012. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $89.8 million at December&#xA0;31, 2014.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On February&#xA0;10, 2015, we borrowed an additional $4.9 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Spring Valley Medical Office Building. The mortgage loan on this property matured on February&#xA0;10, 2015.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On July&#xA0;1, 2014, we borrowed an additional $9.1 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Summerlin Hospital Medical Office Building I. The mortgage loan on this property matured on July&#xA0;1, 2014.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December&#xA0;31, 2014. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,<br /> 2014</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">125,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">181,458</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt; 55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&gt;&#xA0;3.00x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25.4x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt;&#xA0;3.50x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.29x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We have sixteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December&#xA0;31, 2014, with a combined outstanding balance of $122.9 million (excluding net debt premium of $523,000 at December&#xA0;31, 2014). The following table summarizes our outstanding mortgages at December&#xA0;31, 2014 (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="64%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br /> Balance<br /> (in&#xA0;thousands)&#xA0;(a)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Interest<br /> Rate</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity<br /> Date</b></font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical&#xA0;Office&#xA0;Building&#xA0;fixed&#xA0;rate mortgage&#xA0;loan&#xA0;(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,920</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">February, 2015</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center floating rate mortgage loan (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,861</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2015</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Plaza fixed rate mortgage loan (c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,008</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.69</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October,&#xA0;2015</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,025</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Peace Health fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,248</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.64</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">April, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical II floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,183</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">April, 2017</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,785</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,729</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">October, 2017</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix Children&#x2019;s East Valley Care Center fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,485</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.88</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2017</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,642</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">January, 2018</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">February, 2018</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">May, 2018</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vibra Hospital of Corpus Christi fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,902</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2">July, 2019</font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane and Goldring MOBs fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,601</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June, 2022</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,673</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2022</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tuscan Professional Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,862</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.56</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">June,&#xA0;2025</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">122,882</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Amortized principal payments are made on a monthly basis.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">This loan was repaid in full on February&#xA0;10, 2015, utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $124.7 million as of December&#xA0;31, 2014. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2014, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="90%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">107,646</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">50,399</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,658</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,866</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">212,632</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>Financial Instruments:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. During the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20&#xA0;million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. From inception through December&#xA0;31, 2014, no payments have been made to us by the counterparties pursuant to the terms of these caps which expire on January&#xA0;13, 2017.</font></p> </div> P1Y7M6D 0.0975 0.0875 P15Y 0.55 30.06 P90D 0.0050 0.0150 0.0250 2031 P35Y P45Y P15Y P10Y 0.08 0.07 P3Y 0.90 34.07 P60D 0.0030 0.0075 0.0175 0.01 0.0050 2022 P3Y P25Y P13Y P3Y 36.53 P2Y2M12D 36.53 34.90 P8M12D 34.90 57825 P1Y 43.21 9850 425619 399000 39245 2016-06 0.25 P1Y7M6D P10Y -25409000 4744000 -2250000 388000 -29758000 -116000 -1581000 6490000 -100000 -485000 -84064000 28616000 -1245000 0 0 0 0 0 0 0 0 506000 195000 426187 701000 1100000 19500000 47.51 0.0035 Greatest of (a) the administrative agent's prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. 2015-07-24 One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50% 50000000 0.0100 0.0200 2016-12 Acute Care P15Y 2031 P5Y 3 P35Y 31000 2011 2011 P30Y 443000 1998 1998 P40Y 1062000 1989 1993 P43Y 14596000 1986 2007 2016-12 Acute Care P15Y P35Y 5015000 1998 2000 P45Y 1996 1992 P45Y 1996 1996 P35Y 2013 2013 2016-12 Acute Care P15Y P25Y 68000 1999 1999 P35Y 2013 2013 P35Y 585000 1997 1997 P35Y 2011 2011 P36Y 1459000 2009 2009 P30Y 621000 2004 2004 P34Y 8000 2006 2006 P36Y 176000 2009 2009 P45Y 1996 1991 P45Y 870000 1995 1995 2 2021 P5Y 1 P5Y P30Y 1996 1996 P35Y 2014 2014 P30Y 2010 2010 P35Y 2014 2014 P35Y 2014 2014 P35Y 2001 2001 P35Y 2006 2006 P33Y6M 2008 2008 P30Y 1999 1999 P30Y 2006 2006 P30Y 2008 2008 P35Y 2012 2012 P35Y 31000 2011 2011 P35Y 2008 2008 P42Y 10189000 1986 1994 P45Y 185000 1995 1995 P30Y 544000 2000 2000 P45Y 494000 1995 1991 P34Y 804000 2006 2006 P30Y 851000 2000 2000 P25Y 1838000 1986 1993 P42Y 17370000 1986 2006 P45Y -2271000 1996 1994 P25Y -7327000 1999 1999 P45Y 1996 1992 P30Y 1141000 2003 2003 P30Y 512000 1999 1999 P35Y 338000 2004 2004 P35Y 73000 2011 2011 P37Y 24000 2010 2010 P35Y 2012 2012 -31000 31000 51551000 51551000 443000 5000 0 19844000 399000 51551000 51520000 32718000 31000 94000 19839000 399000 94000 32718000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">316</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">610</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,685</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> P8Y4M24D 2014-01-01 Palmdale Medical Plaza 2014-08-01 Santa Fe Professional Plaza 2014-01-01 Vista Medical Terrace & Sparks MOB 2014-08-01 Sierra San Antonio Medical Plaza <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,090</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">799</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(534</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt (including fair value adjustment of $799)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(23,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,891</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> P5Y <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price for these clinics and MOB was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition as detailed in the table below.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,010</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,664</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,076</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15,600</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> P4Y8M12D P9Y6M P8Y8M12D 2014-08-01 Rosenberg Children's Medical Plaza 2014-08-01 Phoenix Children's East Valley Care Center 2014-08-01 North Valley Medical Plaza 2014-08-01 Desert Valley Medical Center P5Y3M18D 0.22 0.28 P4Y4M24D P4Y4M24D 0.305 2019-07 2022-12 2017-04 2016-12 2015-10 2017-12 2018-05 2015-02 2018-02 2017-06 2017-10 2017-04 2025-06 2018-01 2015-10 2022-06 P180D 15 P5Y P90D P180D 13000000 2014-12 1100000 2014-01-01 Palmdale Medical Plaza 2014-08-01 Santa Fe Professional Plaza 2014-01-01 Vista Medical Terrace & Sparks MOB P10Y Mid Coast Hospital MOB 2024-12 2014-08-01 Sierra San Antonio Medical Plaza Forney Medical Plaza II Saint Mary's Professional Office Building 2015-10 2014-08-01 Rosenberg Children's Medical Plaza 2014-08-01 Phoenix Children's East Valley Care Center 2014-08-01 North Valley Medical Plaza Suburban Medical Plaza II 2014-08-01 Desert Valley Medical Center 2017-08 P7Y Texoma Medical Plaza 2 P1Y 2021-09 2500000 --12-31 363000000 4600000 1.54 26.76 8000 30783000 0.92 2.460 12669000 1.54 -3985000 8000 12661000 305000 18084000 1500000 -249000 329000 2973000 31195000 0 0 0 19467000 75400000 0 148930 16360000 -66000 8520000 19477000 -100000 11600000 8000000 0 7994000 21448000 53950000 384000 0 15438000 19477000 4142000 16891000 2365000 2278000 55400000 20216000 31195000 7768000 7800000 -8601000 278000 0 14000000 3985000 12223000 12200000 20216000 -30819000 0 -657000 -8565000 350000 12175000 37590000 2119000 8551000 4600000 329000 14575000 116000 483000 207000 862000 6056000 4140000 0 43000 106000 106000 33991000 22441000 711000 27213000 8520000 3169000 2.46 8974000 1.166 6674000 1.294 680000 0 0.0950 0.0860 Income Capitalization Approach Capitalization Rate Northwest Texas Professional Office Tower 0.0850 0.0750 Income Capitalization Approach Capitalization Rate PeaceHealth Medical Clinic 27.65 26.09 39.05 10375 405144 329000 2014-06 1100000 7400000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19477000 22000 -10000 305000 329000 19477000 31195000 106000 305000 329000 106000 31195000 232000 2700000 680000 P7Y 0.21 0.30 0.281 1100000 2100000 326000000 667000 391000 580900 1100000 25600000 45.97 2 900000 P10Y P5Y 2044 2054 2025 2045 2 900000 12800000 P10Y P5Y 0.02 0.27 0.27 3427000 13885000 0.29 0.29 316000 3458000 3774000 14288000 2017-01-13 134500 0.23 0.23 2941000 13502000 0.26 0.26 3408000 3408000 14317000 0.26 0.26 3303000 13448000 2017-01-13 136000 2.18 2.18 25093000 3048000 28141000 15258000 0.27 0.27 3498000 13445000 1.24 1.24 13043000 3185000 16228000 15923000 0000798783 2014-10-01 2014-12-31 0000798783 2013-10-01 2013-12-31 0000798783 2014-07-01 2014-09-30 0000798783 us-gaap:InterestRateCapMember 2013-07-01 2013-09-30 0000798783 2013-07-01 2013-09-30 0000798783 2014-04-01 2014-06-30 0000798783 2013-04-01 2013-06-30 0000798783 us-gaap:InterestRateCapMember 2014-01-01 2014-03-31 0000798783 2014-01-01 2014-03-31 0000798783 2013-01-01 2013-03-31 0000798783 uht:OptionOneMemberuht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:OptionTwoMemberus-gaap:MinimumMemberuht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:OptionOneMemberus-gaap:MinimumMemberuht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:OptionTwoMemberus-gaap:MaximumMemberuht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:OptionOneMemberus-gaap:MaximumMemberuht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-03-06 0000798783 uht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-01-01 2015-02-28 0000798783 uht:AtMarketAtmProgramsMember 2013-10-01 2014-12-31 0000798783 us-gaap:OtherExpenseMemberuht:AtMarketAtmProgramsMember 2013-10-01 2014-12-31 0000798783 uht:MerrillLynchAndCoNtMtnMemberuht:AtMarketAtmProgramsMember 2013-10-01 2014-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2012-01-01 2012-12-31 0000798783 uht:BridgewayMember 2012-01-01 2012-12-31 0000798783 uht:CapitalGainMember 2012-01-01 2012-12-31 0000798783 uht:RevenueMemberuht:UniversalHealthServicesIncMember 2012-01-01 2012-12-31 0000798783 uht:CombinedMemberuht:UniversalHealthServicesIncMember 2012-01-01 2012-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2012-01-01 2012-12-31 0000798783 uht:MedicalOfficeBuildingsMember 2012-01-01 2012-12-31 0000798783 uht:CumulativeDividendsMember 2012-01-01 2012-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000798783 us-gaap:ParentMember 2012-01-01 2012-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2012-01-01 2012-12-31 0000798783 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000798783 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000798783 uht:DeconsolidationOfLimitedLiabilityCompaniesMember 2012-01-01 2012-12-31 0000798783 uht:ConsolidationOfLimitedLiabilityCompaniesMember 2012-01-01 2012-12-31 0000798783 uht:CanyonHealthcarePropertiesMemberuht:CanyonSpringsMedicalPlazaMember 2012-01-01 2012-12-31 0000798783 uht:FiveSeventyFiveHardyInvestorMemberuht:CentinelaMedicalBuildingComplexMember 2012-01-01 2012-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2012-01-01 2012-12-31 0000798783 us-gaap:MinimumMember 2012-01-01 2012-12-31 0000798783 us-gaap:MaximumMember 2012-01-01 2012-12-31 0000798783 uht:PeaceHealthMedicalClinicMemberus-gaap:FairValueInputsLevel3Member 2012-01-01 2012-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMemberus-gaap:FairValueInputsLevel3Member 2012-01-01 2012-12-31 0000798783 2012-01-01 2012-12-31 0000798783 2008-01-01 2008-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:GraysonPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:DvmcPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SuburbanPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ThirtyEightElevenBellMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchSouthernPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ArlingtonMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoLpMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SierraMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SparksMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SantaFeScottsdaleMember 2014-01-01 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PalmdaleMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:BridgewayMember 2014-01-01 2014-12-31 0000798783 uht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:PalmdaleMedicalPlazaFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:TuscanyProfessionalBuildingFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:AuburnMedicalTwoMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:LomaVistaMedicalIncMember 2014-01-01 2014-12-31 0000798783 uht:SpringValleyMedicalOfficeBuildingMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:RosenbergChildrensMedicalPlazaFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:PhoenixChildrensEastValleyCareCenterFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:DesertValleyMedicalCenterFloatingRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingThreeMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:PeaceHealthMedicalClinicFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:BrbMedicalOfficeBuildingMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:VibraHospitalOfCorpusChristiFixedRateMortgageLoanMember 2014-01-01 2014-12-31 0000798783 uht:CapitalGainMember 2014-01-01 2014-12-31 0000798783 uht:InPlaceLeasesMember 2014-01-01 2014-12-31 0000798783 uht:RevenueMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:CombinedMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:JanuaryTwoThousandFourteenMember 2014-01-01 2014-12-31 0000798783 uht:DvmcPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:ThirtyEightElevenBellMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:PchSouthernPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:PchMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:ChildrensClinicAndNorthwestMedicalCenterMember 2014-01-01 2014-12-31 0000798783 uht:HanoverEmergencyCenterMember 2014-01-01 2014-12-31 0000798783 uht:AugustTwentyFourteenMember 2014-01-01 2014-12-31 0000798783 uht:TwentyFourteenAcquisitionMember 2014-01-01 2014-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2014-01-01 2014-12-31 0000798783 uht:SierraMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:SparksMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:SantaFeScottsdaleMember 2014-01-01 2014-12-31 0000798783 uht:PalmdaleMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 uht:TwoThousandThirteenAcquisitionsMember 2014-01-01 2014-12-31 0000798783 uht:CumulativeDividendsMember 2014-01-01 2014-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000798783 us-gaap:ParentMember 2014-01-01 2014-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0000798783 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000798783 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000798783 uht:PeaceHealthMedicalClinicMember 2014-01-01 2014-12-31 0000798783 uht:BrbMedicalOfficeBuildingKingwoodTexasMember 2014-01-01 2014-12-31 0000798783 uht:TuscanMedicalPropertiesIrvingTxMember 2014-01-01 2014-12-31 0000798783 uht:SpringValleyHospitalMobLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:SummerlinHospitalMobLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:ChesterbrookAcademyUwchlanPennsylvaniaMember 2014-01-01 2014-12-31 0000798783 uht:SheffieldMedicalBuildingAtlantaGeorgiaMember 2014-01-01 2014-12-31 0000798783 uht:TheSouthernCrescentCenterMember 2014-01-01 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember 2014-01-01 2014-12-31 0000798783 uht:KindredHospitalChicagoCentralChicagoIllinoisMember 2014-01-01 2014-12-31 0000798783 uht:SummerlinHospitalMobIiLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember 2014-01-01 2014-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember 2014-01-01 2014-12-31 0000798783 uht:ProfessionalCenterAtKingCrossingKingwoodTexasMember 2014-01-01 2014-12-31 0000798783 uht:McallenMedicalCenterMcallenTexasMember 2014-01-01 2014-12-31 0000798783 uht:VibraHospitalOfCorpusChristiCorpusChristiTexasMember 2014-01-01 2014-12-31 0000798783 uht:LakePointeMedicalArtsRowlettTxMember 2014-01-01 2014-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2014-01-01 2014-12-31 0000798783 uht:VistaMedicalTerraceSparksMobSparksNvMember 2014-01-01 2014-12-31 0000798783 uht:SierraSanAntonioMedicalPlazaFontanaCaMember 2014-01-01 2014-12-31 0000798783 uht:SantaFeProfessionalPlazaScottsdaleAzMember 2014-01-01 2014-12-31 0000798783 uht:PalmdaleMedicalPlazaPalmdaleCaMember 2014-01-01 2014-12-31 0000798783 uht:PhoenixChildrenEastValleyCareCenterPhoenixAzMember 2014-01-01 2014-12-31 0000798783 uht:RosenbergChildrenMedicalPlazaPhoenixAzMember 2014-01-01 2014-12-31 0000798783 uht:TheChildrenClinicAtSpringdaleSpringdaleArMember 2014-01-01 2014-12-31 0000798783 uht:NorthwestMedicalCenterAtSugarCreekBentonvilleArMember 2014-01-01 2014-12-31 0000798783 uht:NorthValleyMedicalPlazaPhoenixAzMember 2014-01-01 2014-12-31 0000798783 uht:HanoverEmergencyCenterMechanicsvilleVaMember 2014-01-01 2014-12-31 0000798783 uht:DesertValleyMedicalCenterPhoenixAzMember 2014-01-01 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:KelseyseyboldClinicAtKingCrossingMember 2014-01-01 2014-12-31 0000798783 uht:ChesterbrookAcademyNewBritainPennsylvaniaMember 2014-01-01 2014-12-31 0000798783 uht:AuburnMedicalOfficeBuildingAuburnWaMember 2014-01-01 2014-12-31 0000798783 uht:SpringValleyHospitalMobIiLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:ApacheJunctionMedicalPlazaApacheJunctionAzMember 2014-01-01 2014-12-31 0000798783 uht:SummerlinHospitalMobIiiLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:EmoryAtDunwoodyDunwoodyGaMember 2014-01-01 2014-12-31 0000798783 uht:TheCypresswoodProfessionalCenterSpringTexasMember 2014-01-01 2014-12-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2014-01-01 2014-12-31 0000798783 uht:SevenZeroOneSouthTonopahLasVegasNevadaMember 2014-01-01 2014-12-31 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2014-01-01 2014-12-31 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2014-01-01 2014-12-31 0000798783 uht:ChesterbrookAcademyAudubonPennsylvaniaMember 2014-01-01 2014-12-31 0000798783 uht:ChesterbrookAcademyNewtownPennsylvaniaMember 2014-01-01 2014-12-31 0000798783 uht:TheSouthernCrescentCenterIiRiverdaleGeorgiaMember 2014-01-01 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterMember 2014-01-01 2014-12-31 0000798783 uht:InlandValleyRegionalMedicalCenterWildomarCaliforniaMember 2014-01-01 2014-12-31 0000798783 uht:HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember 2014-01-01 2014-12-31 0000798783 uht:DesertSpringsMedicalPlazaLasVegasNvMember 2014-01-01 2014-12-31 0000798783 uht:ForneyMedicalPlazaForneyTxMember 2014-01-01 2014-12-31 0000798783 uht:McAllenMedicalCenterMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:McAllenMedicalCenterMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:BaseRateMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2014-01-01 2014-12-31 0000798783 uht:AtMarketAtmProgramsMember 2014-01-01 2014-12-31 0000798783 us-gaap:OtherExpenseMemberuht:AtMarketAtmProgramsMember 2014-01-01 2014-12-31 0000798783 uht:MerrillLynchAndCoNtMtnMemberuht:AtMarketAtmProgramsMember 2014-01-01 2014-12-31 0000798783 uht:DeconsolidationOfLimitedLiabilityCompaniesMember 2014-01-01 2014-12-31 0000798783 uht:ConsolidationOfLimitedLiabilityCompaniesMember 2014-01-01 2014-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2014-01-01 2014-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2014-01-01 2014-12-31 0000798783 uht:RangeOneMember 2014-01-01 2014-12-31 0000798783 uht:RangeTwoMember 2014-01-01 2014-12-31 0000798783 us-gaap:MinimumMemberuht:ArlingtonMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:MinimumMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 us-gaap:BuildingMemberus-gaap:MinimumMember 2014-01-01 2014-12-31 0000798783 us-gaap:BuildingImprovementsMemberus-gaap:MinimumMember 2014-01-01 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberus-gaap:MinimumMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MinimumMemberuht:FederalFundsEffectiveRateMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MinimumMemberus-gaap:BaseRateMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MinimumMember 2014-01-01 2014-12-31 0000798783 us-gaap:MinimumMember 2014-01-01 2014-12-31 0000798783 us-gaap:MaximumMemberuht:ArlingtonMedicalPropertiesMember 2014-01-01 2014-12-31 0000798783 us-gaap:MaximumMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 us-gaap:BuildingMemberus-gaap:MaximumMember 2014-01-01 2014-12-31 0000798783 us-gaap:BuildingImprovementsMemberus-gaap:MaximumMember 2014-01-01 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberus-gaap:MaximumMemberuht:UniversalHealthServicesIncMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MaximumMemberus-gaap:BaseRateMember 2014-01-01 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MaximumMember 2014-01-01 2014-12-31 0000798783 us-gaap:MaximumMember 2014-01-01 2014-12-31 0000798783 uht:RangeThreeMember 2014-01-01 2014-12-31 0000798783 2014-01-01 2014-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMember 2013-01-01 2013-12-31 0000798783 uht:RevenueMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:CombinedMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:ChildrensClinicAndNorthwestMedicalCenterMember 2013-01-01 2013-12-31 0000798783 uht:TwoThousandThirteenAcquisitionsMember 2013-01-01 2013-12-31 0000798783 uht:CumulativeDividendsMember 2013-01-01 2013-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000798783 us-gaap:ParentMember 2013-01-01 2013-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-12-31 0000798783 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000798783 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000798783 uht:AtMarketAtmProgramsMember 2013-01-01 2013-12-31 0000798783 us-gaap:OtherExpenseMemberuht:AtMarketAtmProgramsMember 2013-01-01 2013-12-31 0000798783 uht:MerrillLynchAndCoNtMtnMemberuht:AtMarketAtmProgramsMember 2013-01-01 2013-12-31 0000798783 uht:DeconsolidationOfLimitedLiabilityCompaniesMember 2013-01-01 2013-12-31 0000798783 uht:ConsolidationOfLimitedLiabilityCompaniesMember 2013-01-01 2013-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2013-01-01 2013-12-31 0000798783 us-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 us-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 2013-01-01 2013-12-31 0000798783 2011-01-01 2011-12-31 0000798783 uht:BridgewayMember 2014-12-01 2014-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2012-12-01 2012-12-31 0000798783 uht:FiveSeventyFiveHardyInvestorMemberuht:CentinelaMedicalBuildingComplexMember 2012-10-01 2012-10-31 0000798783 uht:JanuaryTwoThousandFourteenMember 2014-01-01 2014-01-31 0000798783 uht:ChildrensClinicAndNorthwestMedicalCenterMember 2014-01-01 2014-01-31 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-01 2012-01-31 0000798783 uht:HanoverEmergencyCenterMember 2014-08-02 2014-08-31 0000798783 uht:AugustTwentyFourteenMember 2014-08-02 2014-08-31 0000798783 uht:ForneyMedicalPlazaMember 2013-04-01 2013-04-30 0000798783 uht:CanyonHealthcarePropertiesMemberuht:CanyonSpringsMedicalPlazaMember 2012-02-01 2012-02-29 0000798783 us-gaap:SubsequentEventMember 2015-02-01 2015-02-28 0000798783 uht:RevenueMemberuht:UniversalHealthServicesIncMember 2010-01-01 2014-12-31 0000798783 uht:CombinedMemberuht:UniversalHealthServicesIncMember 2010-01-01 2014-12-31 0000798783 uht:BridgewayMember 2014-12-31 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementAdditionalBorrowingToRepayOutstandingMortgageBalanceMember 2014-07-01 2014-07-01 0000798783 uht:NewRevolvingCreditFacilityAgreementAdditionalBorrowingToRepayOutstandingMortgageBalanceMemberus-gaap:SubsequentEventMember 2015-02-10 2015-02-10 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:GraysonPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:DvmcPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SuburbanPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ThirtyEightElevenBellMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchSouthernPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ArlingtonMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoLpMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SierraMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SparksMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SantaFeScottsdaleMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PalmdaleMedicalPropertiesMember 2014-12-31 0000798783 us-gaap:EquityMethodInvestmentsMember 2014-12-31 0000798783 uht:BridgewayMember 2014-12-31 0000798783 uht:UniversalHealthServicesIncMember 2014-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2014-12-31 0000798783 uht:SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember 2014-12-31 0000798783 uht:PalmdaleMedicalPlazaFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember 2014-12-31 0000798783 uht:TuscanyProfessionalBuildingFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:AuburnMedicalTwoMortgageLoanMember 2014-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember 2014-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:LomaVistaMedicalIncMember 2014-12-31 0000798783 uht:SpringValleyMedicalOfficeBuildingMortgageLoanMember 2014-12-31 0000798783 uht:RosenbergChildrensMedicalPlazaFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:PhoenixChildrensEastValleyCareCenterFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:DesertValleyMedicalCenterFloatingRateMortgageLoanMember 2014-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingThreeMortgageLoanMember 2014-12-31 0000798783 uht:PeaceHealthMedicalClinicFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:BrbMedicalOfficeBuildingMortgageLoanMember 2014-12-31 0000798783 uht:VibraHospitalOfCorpusChristiFixedRateMortgageLoanMember 2014-12-31 0000798783 uht:DvmcPropertiesMember 2014-12-31 0000798783 uht:ThirtyEightElevenBellMedicalPropertiesMember 2014-12-31 0000798783 uht:PchSouthernPropertiesMember 2014-12-31 0000798783 uht:PchMedicalPropertiesMember 2014-12-31 0000798783 uht:TwentyFourteenAcquisitionMember 2014-12-31 0000798783 uht:SierraMedicalPropertiesMember 2014-12-31 0000798783 uht:SparksMedicalPropertiesMember 2014-12-31 0000798783 uht:SantaFeScottsdaleMember 2014-12-31 0000798783 uht:PalmdaleMedicalPropertiesMember 2014-12-31 0000798783 uht:CumulativeDividendsMember 2014-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000798783 us-gaap:ParentMember 2014-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2014-12-31 0000798783 us-gaap:CommonStockMember 2014-12-31 0000798783 us-gaap:RetainedEarningsMember 2014-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000798783 uht:PeaceHealthMedicalClinicMember 2014-12-31 0000798783 uht:BrbMedicalOfficeBuildingKingwoodTexasMember 2014-12-31 0000798783 uht:TuscanMedicalPropertiesIrvingTxMember 2014-12-31 0000798783 uht:SpringValleyHospitalMobLasVegasNvMember 2014-12-31 0000798783 uht:SummerlinHospitalMobLasVegasNvMember 2014-12-31 0000798783 uht:SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember 2014-12-31 0000798783 uht:ChesterbrookAcademyUwchlanPennsylvaniaMember 2014-12-31 0000798783 uht:SheffieldMedicalBuildingAtlantaGeorgiaMember 2014-12-31 0000798783 uht:TheSouthernCrescentCenterMember 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember 2014-12-31 0000798783 uht:KindredHospitalChicagoCentralChicagoIllinoisMember 2014-12-31 0000798783 uht:SummerlinHospitalMobIiLasVegasNvMember 2014-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingLasVegasNvMember 2014-12-31 0000798783 uht:FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember 2014-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember 2014-12-31 0000798783 uht:ProfessionalCenterAtKingCrossingKingwoodTexasMember 2014-12-31 0000798783 uht:McallenMedicalCenterMcallenTexasMember 2014-12-31 0000798783 uht:VibraHospitalOfCorpusChristiCorpusChristiTexasMember 2014-12-31 0000798783 uht:LakePointeMedicalArtsRowlettTxMember 2014-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2014-12-31 0000798783 uht:VistaMedicalTerraceSparksMobSparksNvMember 2014-12-31 0000798783 uht:SierraSanAntonioMedicalPlazaFontanaCaMember 2014-12-31 0000798783 uht:SantaFeProfessionalPlazaScottsdaleAzMember 2014-12-31 0000798783 uht:PalmdaleMedicalPlazaPalmdaleCaMember 2014-12-31 0000798783 uht:PhoenixChildrenEastValleyCareCenterPhoenixAzMember 2014-12-31 0000798783 uht:RosenbergChildrenMedicalPlazaPhoenixAzMember 2014-12-31 0000798783 uht:TheChildrenClinicAtSpringdaleSpringdaleArMember 2014-12-31 0000798783 uht:NorthwestMedicalCenterAtSugarCreekBentonvilleArMember 2014-12-31 0000798783 uht:NorthValleyMedicalPlazaPhoenixAzMember 2014-12-31 0000798783 uht:HanoverEmergencyCenterMechanicsvilleVaMember 2014-12-31 0000798783 uht:DesertValleyMedicalCenterPhoenixAzMember 2014-12-31 0000798783 uht:KelseyseyboldClinicAtKingCrossingMember 2014-12-31 0000798783 uht:ChesterbrookAcademyNewBritainPennsylvaniaMember 2014-12-31 0000798783 uht:AuburnMedicalOfficeBuildingAuburnWaMember 2014-12-31 0000798783 uht:SpringValleyHospitalMobIiLasVegasNvMember 2014-12-31 0000798783 uht:ApacheJunctionMedicalPlazaApacheJunctionAzMember 2014-12-31 0000798783 uht:SummerlinHospitalMobIiiLasVegasNvMember 2014-12-31 0000798783 uht:EmoryAtDunwoodyDunwoodyGaMember 2014-12-31 0000798783 uht:TheCypresswoodProfessionalCenterSpringTexasMember 2014-12-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2014-12-31 0000798783 uht:SevenZeroOneSouthTonopahLasVegasNevadaMember 2014-12-31 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2014-12-31 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2014-12-31 0000798783 uht:ChesterbrookAcademyAudubonPennsylvaniaMember 2014-12-31 0000798783 uht:ChesterbrookAcademyNewtownPennsylvaniaMember 2014-12-31 0000798783 uht:TheSouthernCrescentCenterIiRiverdaleGeorgiaMember 2014-12-31 0000798783 uht:WellingtonRegionalMedicalCenterMember 2014-12-31 0000798783 uht:InlandValleyRegionalMedicalCenterWildomarCaliforniaMember 2014-12-31 0000798783 uht:HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember 2014-12-31 0000798783 uht:DesertSpringsMedicalPlazaLasVegasNvMember 2014-12-31 0000798783 uht:ForneyMedicalPlazaForneyTxMember 2014-12-31 0000798783 uht:McAllenMedicalCenterMember 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LineOfCreditMember 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LetterOfCreditMember 2014-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2014-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2014-12-31 0000798783 uht:GrossMember 2014-12-31 0000798783 uht:NetMember 2014-12-31 0000798783 uht:GraysonPropertiesMember 2014-12-31 0000798783 uht:TexomaMedicalPropertiesMember 2014-12-31 0000798783 uht:PreschoolAndChildcareCenterMember 2014-12-31 0000798783 uht:SubacuteCenterMemberuht:HospitalsMember 2014-12-31 0000798783 uht:AcuteCareCenterMemberuht:HospitalsMember 2014-12-31 0000798783 uht:RehabilitationCenterMemberuht:HospitalsMember 2014-12-31 0000798783 uht:HospitalsMember 2014-12-31 0000798783 uht:FreestandingEmergencyDepartmentsMember 2014-12-31 0000798783 uht:ArlingtonMedicalPropertiesMember 2014-12-31 0000798783 uht:FtxMobPhaseTwoLpMember 2014-12-31 0000798783 uht:MedicalOfficeBuildingsMemberus-gaap:LimitedLiabilityCompanyMember 2014-12-31 0000798783 uht:MedicalOfficeBuildingsMemberus-gaap:MajorityOwnedSubsidiaryUnconsolidatedMember 2014-12-31 0000798783 uht:MedicalOfficeBuildingsMember 2014-12-31 0000798783 uht:BrunswickAssociatesMember 2014-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2014-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2014-12-31 0000798783 uht:RangeOneMember 2014-12-31 0000798783 uht:RangeTwoMember 2014-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMemberus-gaap:MinimumMember 2014-12-31 0000798783 us-gaap:MinimumMember 2014-12-31 0000798783 us-gaap:MaximumMember 2014-12-31 0000798783 uht:RangeThreeMember 2014-12-31 0000798783 uht:PeriodOneMemberus-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2014-12-31 0000798783 uht:PeriodTwoMemberus-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2014-12-31 0000798783 2014-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:LimitedLiabilityCompanyMember 2014-01-01 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2014-01-01 0000798783 uht:UniversalHealthServicesIncMember 2013-12-31 0000798783 uht:TwoThousandThirteenAcquisitionsMember 2013-12-31 0000798783 uht:CumulativeDividendsMember 2013-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000798783 us-gaap:ParentMember 2013-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2013-12-31 0000798783 us-gaap:CommonStockMember 2013-12-31 0000798783 us-gaap:RetainedEarningsMember 2013-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:MinimumMember 2013-12-31 0000798783 us-gaap:MaximumMember 2013-12-31 0000798783 2013-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2012-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2012-12-31 0000798783 uht:CumulativeDividendsMember 2012-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000798783 us-gaap:ParentMember 2012-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2012-12-31 0000798783 us-gaap:CommonStockMember 2012-12-31 0000798783 us-gaap:RetainedEarningsMember 2012-12-31 0000798783 us-gaap:MinimumMember 2012-12-31 0000798783 us-gaap:MaximumMember 2012-12-31 0000798783 uht:PeaceHealthMedicalClinicMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0000798783 2012-12-31 0000798783 uht:CumulativeDividendsMember 2011-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000798783 us-gaap:ParentMember 2011-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2011-12-31 0000798783 us-gaap:CommonStockMember 2011-12-31 0000798783 us-gaap:RetainedEarningsMember 2011-12-31 0000798783 us-gaap:MinimumMember 2011-12-31 0000798783 us-gaap:MaximumMember 2011-12-31 0000798783 2011-12-31 0000798783 uht:HanoverEmergencyCenterMember 2014-08-31 0000798783 2014-06-30 0000798783 us-gaap:InterestRateCapMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2014-03-31 0000798783 us-gaap:InterestRateCapMember 2014-03-31 0000798783 us-gaap:InterestRateCapMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2013-09-30 0000798783 us-gaap:InterestRateCapMember 2013-09-30 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2013-08-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2013-06-30 0000798783 uht:FiveSeventyFiveHardyInvestorMember 2012-10-31 0000798783 uht:FiveSevenFiveHardyInvestorsMember 2012-10-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2014-08-01 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:LimitedLiabilityCompanyMember 2014-08-01 0000798783 us-gaap:MinimumMemberus-gaap:LimitedLiabilityCompanyMember 2014-08-01 0000798783 us-gaap:MinimumMember 2014-08-01 0000798783 us-gaap:MaximumMemberus-gaap:LimitedLiabilityCompanyMember 2014-08-01 0000798783 us-gaap:MaximumMember 2014-08-01 0000798783 2014-08-01 0000798783 uht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-03-06 0000798783 uht:FreestandingEmergencyDepartmentsMemberus-gaap:SubsequentEventMember 2015-02-28 0000798783 us-gaap:SubsequentEventMember 2015-02-28 0000798783 uht:ForneyMedicalPlazaMember 2013-04-30 0000798783 uht:CanyonHealthcarePropertiesMember 2012-02-29 0000798783 2015-01-31 0000798783 uht:ChildrensClinicMember 2014-01-31 0000798783 uht:NorthwestMedicalCenterMember 2014-01-31 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-31 utr:sqft iso4217:USD shares pure uht:Times uht:Property uht:Derivative iso4217:USD shares uht:State uht:MortgageLoan uht:Option uht:Building uht:Segment uht:RenewalOptions UHS has three 5-year renewal options at existing lease rates (through 2031). The fair value of the land was estimated based upon the sales comparison approach. Amortized principal payments are made on a monthly basis. As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014. The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December 31, 2014. As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. The amounts reflected for December 31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December 31, 2013. This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement. We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property. Costs capitalized/divested subsequent to acquisition. The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method. During 2014, the Trust purchased the minority ownership interests held by third-party members in eight LLCs (January and August, 2014) in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements. UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031). Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage. Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement. We have funded $5.2 million in equity as of December 31, 2014 and are committed to invest an additional $1.1 million. This LLC has a third-party term loan of $23.3 million, which is non-recourse to us, outstanding as of December 31, 2014. Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively. As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013. As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method. All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity. We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement. This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options. This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July 1, 2015 through December 31, 2024. We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building. Consists of outstanding balances as of December 31, 2014 on third-party debt that is non-recourse to us. During 2014, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned. We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility. This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility. This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December 31, 2014. We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014 We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December 31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December 31, 2014. EX-101.SCH 10 uht-20141231.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF INCOME link:calculationLink link:presentationLink link:definitionLink 106 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:calculationLink link:presentationLink link:definitionLink 107 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:calculationLink link:presentationLink link:definitionLink 108 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 109 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Relationship with UHS and Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Acquisitions and Dispositions link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Debt and Financial Instruments link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Dividends and Equity Issuance Program link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Incentive Plans link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Summarized Financial Information of Equity Affiliates link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Segment Reporting link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Quarterly Results link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Real Estate and Accumulated Depreciation link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Relationship with UHS and Related Party Transactions (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Acquisitions and Dispositions (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Debt and Financial Instruments (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Incentive Plans (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Summarized Financial Information of Equity Affiliates (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Quarterly Results (Tables) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Relationship with UHS and Related Party Transactions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Acquisitions and Dispositions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Purchased Minority Ownership Interest (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - QuantitativeInformationAboutSignificantUnobservableInputsTable (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Leases - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Schedule of minimum future base rents from non-cancelable leases (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Summary of Outstanding Mortgages, Excluding Net Debt Premium (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Incentive Plans - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalence (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Options Outstanding and Exercisable Options (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Summarized Financial Information of Equity Affiliates - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 153 - Disclosure - Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 154 - Disclosure - Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 155 - Disclosure - Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 156 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 157 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 158 - Disclosure - Segment Reporting - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 159 - Disclosure - Quarterly Results (Detail) link:calculationLink link:presentationLink link:definitionLink 160 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Detail) link:calculationLink link:presentationLink link:definitionLink 161 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 162 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 11 uht-20141231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 uht-20141231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 uht-20141231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 14 uht-20141231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 15 g834449g19f05.jpg GRAPHIC begin 644 g834449g19f05.jpg M_]C_X``02D9)1@`!`0(!>@%Z``#_X4ZP:'1T<#HO+VYS+F%D;V)E+F-O;2]X M87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&%P+S$N M,"]G+VEM9R\B"B`@("!X;6QN&%P+S$N,"]S5'EP92]297-O M=7)C945V96YT(R(*("`@('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E M+F-O;2]X87`O,2XP+W0O<&&UL;G,Z&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*("`@('AM M;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O'1E;G-I'1E;G-I&UP.D-R M96%T941A=&4](C(P,34M,#(M,C54,3(Z,C@Z,S&UP34TZ3W)I9VEN86Q$;V-U;65N M=$E$/2)U=6ED.D4Y,$$V,#DY14-%0D1#,3$Y0C-#.#4W1C(W0S,P1#!$(@H@ M("!X;7!44&3TB1F%L"UD969A=6QT(CXR-#PO&UP.E1H=6UB;F%I;',^"B`@("`\ M&UP1TEM9SIH96EG:'0](C$V,"(*("`@("`@>&UP1TEM9SIF M;W)M870](DI014'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O9DAX M.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!;T%%04%W15(F(WA!.T%! M25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'05%! M2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&0F=C M24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A15D5' M13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4 M:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q4S!6 M=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S8E&=:17DF(WA!.V]B M2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%9WAD M56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W`F(WA!.S`K4'IH2E-K=$U4 M53504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D71R<2MV+V%!07=$05%!0T5135)!1#A!.4PV8G!U;DA4 M6HR>%9%+V]Z5&8K5U-(+VM7=CE-5F0K:DY. M+S5:268X06M7=CE-5F0K:DY.+S5:268K4F$O,'A6,S9-,#,O;&MH+W=#4F$O M,'@F(WA!.U8S-DTP,R]L:V@O-49R+U1&6&9O>E1F*U=32"]!2D9R+U1&6&9O M>E1F*U=32"]K5W8Y359D*VI.3B\U6DEF.$%K5W8Y359D*VI.3B\F(WA!.S5: M268K4F$O,'A6,S9-,#,O;&MH+W=#4F$O,'A6,S9-,#,O;&MH+S5&%8S-DTP,R]L:V@F(WA!.R]W0U)A+S!X5C,V33`S+VQK:"\U1G(O5$989F]Z M5&8K5U-(+T%*1G(O5$989F]Z5&8K5U-(+VM7=CE-5F0K:DY.+S5:268X06M7 M=CDF(WA!.TU69"MJ3DXO-5I)9BM282\P>%8S-DTP,R]L:V@O=T-282\P>%8S M-DTP,R]L:V@O-49R+U1&6&9O>E1F*U=32"]!2D9R+U1&54YQ5VTF(WA!.S9C M3D]U:4Q71451>550<'(O2V9B1E54<&XO2$YT4#A!:D1(+T%-4D=+;VY&6%EQ M-T9867$W1EA9<3=&6%EQ."MV4'ET,5(W+T%&0SDF(WA!.S`O>DI0<#`Y.61' M-6%E0TEI8V]Z=2]P4WEI5F965TEU0D150E9#<7)+-C%5;%5N6#AP9GI&:75R M35(O;4AF4U%,038S,#AN$$F(WA!.S`S5EI(;VXU9"MA9%`Q94'$F(WA!.VQZ9'F9V67)G,$5S9DI14E5, M>%%Q:7%U6#AQ4$YA5W-D<$0U-79O3&5+849L:FA34T]L=D4X-W8F(WA!.T%# M='A6968Q9TM'5VY&15)A1VQC5E-U-2]*3'IX3V)38R]M4'%!,4-Z=#-T;W(S M,$A,,&QU1G5(8F4U,DQ-;U$P3S9+<6Y98G%Q*VXF(WA!.R]K;#5H,"]4-W$Q M79Y;C5R M2S5L.5=.:E9V=%)*>C5R5F-663=99FM04@Q M4S$P+U9D4#`S>FYE,E9P971B>39F1$9"2$1(6GHF(WA!.S(X:5-.2VMD<3%T M1GEC<"MW<61A;FMD.%9497@O3$AZ8D)E1S=N.#@V:%!).31B>&\V5$Q#05IO M2E!14TIR:#%724I&3D=&3E)35&4F(WA!.W!15E9E:31Q-T9867$W1EA9<3=& M6%EQ:'14+S0U=#,O04U96E`K26Y&6&%:+W=!8S(P+S1W>"\X4D=+;VY&6%EQ M-T9867$W1EA9<36-:,BM&,&EE,74T4V554TXV2DUJ3%)L-4UZ4U4T,55X:7!+=5-R,%1Y M.7(RG)&:SAE<%AS#$R,4)O5C,O04]-='8O,59X5C,V9710-68K4W1V+S%6 M>%8S-F5T4#5F*U-T=B\Q5GA6,S8F(WA!.V5T4#5F*U-T=B\Q5GA6,S9E=%`U M9BM3='8O,59X5C,V9710-68K4W1V+S%6>%8S-F5T4#5F*U-T=B\Q5GA6,S9E M=%`U9BM3='8O,58F(WA!.WA6,S9E=%`U9BM3='8O,59X5C,V9710-68K4W1V M+S%6>%8S-F5T4#5F*U-T=B\Q5GA6,S9E=%`U9BM3='8O,59X5C,V9710-68K M4W0F(WA!.W8O,59X5E9H,5%49VU',V553#ER9SA$57(T,&MX5E4K='HO.'-5 M,S-W+SA!5E1&6&97-2\K5TMB-S1F*W%M2W4K='HO05!,1DXY.%`F(WA!.R]6 M5$989E%1F9D0O,55X5C,Q=68O04I9 M<'9V:"\V<5EQ-S8S4"]W07-5,S-W+W=$5E1&6&8F(WA!.U6Y&5F9&6%EQ:'14+T%/3V(F(WA!.V0O.$%'1U0O04EI8U9D<&XO2$YT M4"M-368O15)I<4IX5C)+=7A606%N+W9B<%`X07I&3B\Q0WHT<7)A6B]W06,R M,"\T=W@O.%)'2V\F(WA!.T4V:#5I.5)W,FQO:UER-F)R3TI#-4@R5DMH531C M=C5Q;FHT67%K2&TV-B]-,EA4668X4#)+5VPV6EAJ8U)Z5S@O=T%%=')/:V-R M9E%9I7I295AD2W5G M,79!7-+,U)C*VTU14Q!=E)Q0FPT:FQI<4TF(WA!.S%J M>D(O=T$U1%%XE(V9%DV M6F%J56)71S-J5#9T3VXQ05-41V4F(WA!.S1C=F-E;W@T*VMR2T],35!S0D18 M1E548V%H+WIK3D0U:70W>3(P<3!U9$MU571L=71.;&YT4D9BE9155AM6"]N23E03D9U.3DU971)3D5U MD1/,'E+:U@R*U(T;6Q!1DQB2W`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`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`F(WA!.U5)*W-E84Y164-+,6MI9UE63G9: M&MM03E3-75R M=5-E-6%N47IC66TF(WA!.TUH2'90:7%)*V]E87!Q+U=B.45Q2V-,4&I#=$\Y M9E=I=5AR-VAX9U9#-FHU67-P;U5..4='16)R26MT>&9Z>55C5D%P-GEU;S8Y M04TF(WA!.TMO4EE03#EI:V1J63(P8C-%0TQ&-E=M,TYW6C9"449->E=Y2U9, M06HT-4-!935X5E5';"MA-VA697DU84YV5FIC6#`Q.4U2-$=.>$PF(WA!.T-P M.$1Z664R2W1Y955.56ML13EX9E!Q17=.5EA52&EN9U5G541,06QT1$=R939G M2$959$IA*V(U66UI;D]L6$5,07$X1%)4:%=8=TXF(WA!.UAK2%0O2D]"564MJ96Q$44EX8U4U4SEY M<5EQ:DU69&EQ1S%0+VIM,V8X07AH:R\T:6-69'!N+T%">F)4+VI$2"]X15EQ M:6,F(WA!.U9D:7)S5E%'<"\W,C94+WI&3B\Q0WHT<6HX5F1I<6AD,SEJ6G@K M<&58159T1V8R-6Y60CDW15EQ:VQX*UE0:RM+47A,<4M836=&470F(WA!.W-R M,T%0'I!.4]I M=T0Y6GAP6&9P6%=,<%`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`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`K:'1.879"87!D>DU55TEO6FY&=5E21%9L5C0O5%IM4G5F32]% M9T)64B]K%)G=7I%14$Q<'8X-DA& M6&Q/;"M14'ID=#4F(WA!.V)3-&PX,TUO:6AJ:FYS>D\Y,&I/3E-&>$DS<7EW M27I6=$MX9VQ!,6%+5'AX5FU8:TA1+TUE:F%,3EHV.69N56)O,U4P;'9-,#!T M>38F(WA!.S(W53E.2&QM5D=:=&E7;V]7<"M%0F%!2W-L>%8R2W!"-38P4HS=&5(1U)762MR2$A/>2]#1"LF(WA!.W=A M.41T:7)#3'8X04PS.#-N='19:'0O3W!8-BLR;TYA32]/F)4+VI$2"]W05)'2V]N M1EA9<3=&6%EQ-T9867$W1EA9<3%8F(WA!.S,V M5#`S+VQR:"\U1TPO6$989G!05&8X06QR:"\U1TPO049X5C,V5#`S+VQR:"\U M1TPO6$989G!05&8X06QR:"\U1TPO049X5C,V5#`F(WA!.S,O;')H+S5'3"]8 M1EAF<%!49CA!;')H+S5'3"]!1GA6,S94,#,O;')H+S5'3"]81EAF<%!49CA! M;')H+S5'3"]!1GA6,S94,#,O;'(F(WA!.V@O-4=,+UA&6&9P4%1F.$%L%8S-E0P,R]L%8S M-E0P,R]L%8S-E0P,R]L%8S-E0P,R]L&UP.E1H=6UB;F%I;',^"B`@(#QX M;7!-33I$97)I=F5D1G)O;0H@("`@&UP+FEI M9#HW1#E"1C-!14)"0D-%-#$Q0C,R.41&.#A%-S$R-S,S."(*("`@('-T4F5F M.F1O8W5M96YT240](GAM<"YD:60Z-T0Y0D8S045"0D)#130Q,4(S,CE$1C@X M13&UP34TZ2&ES=&]R>3X* M("`@(#QR9&8Z4V5Q/@H@("`@(#QR9&8Z;&D*("`@("`@&UP+FEI9#I$14-" M,$5",3@X,#A$13$Q03DX-#@S-$1$14,Q-35#02(*("`@("`@&UP34TZ2&ES=&]R>3X*("`@/'AM<%109SI-87A086=E4VEZ90H@("`@ M&UP1SIGP)?`P$1``(1`0,1`?_$`!X``0`"`P`#`0$````` M```````'"`4&"0,$"@$"_\0`4A````4$``$%"PD&`P4'!`,``P0%!@<``0(( M"1<85Y?7$1(3%!46=Y:VU=8A-SA66(:5F*8*&B(C,K<9,38D,SE!428T0E)Q M>($U0V%R1%-U_\0`%P$!`0$!``````````````````$"`__$`#<1`0$``0(# M!P(%`@8"`P$````!$0(A$C%106%QD:&QT0.!$R)2P?`R0C-BB0:'(F&&BV.1AAHS8@HHHK(;(@@H@C62L\ MQ!,\TR^6>>>5[Y9YY7OEEE>][WO>][T$FHS7]UT#D:B#HIC;U&: M_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U M&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC M;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#H MIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B M#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D M:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT M#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7] MUT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS M7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@ MHS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@< MC40=%,;>HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN M@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U&:_ MNN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC;U& M:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HIC; MU&:_NN@HS7]UT#D:B#HIC;U&:_NN@HS7]UT#D:B#HI MC;U&:_NN@HS7]UT#D:B#HIC;U&:_NN@K1N%$<4$]U!9&$?F8B+T M8,'V42:"3Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M5AW*^C;(_P!S_;QKT$GPC\S$1>C!@^RB302?0*!0*!0*!0*!0*!0*!0*!0*! M0*!0*"HN\>VJ)I/KHZIU4F/(R0#Y5)6)'DV1W0ELQBLXHL'@3 M))%!4EU7+BJJR8*G+)2,543X">IFBY=--EDS<>-O=)O:@&-]S]B(V,RQGQ%] M>61K!'T:Q$!-F.Q<=RFIRM`F:'99#1%J.7&MJ;'9K@0Y;0S!D@8(MY/25\N] M2ID:[:%S,`$BRL6Z9MPWBMN,8Q?'G=KZ,XE\6C0928#MD@>:U1O(+#>T;Q\\ MTIWP[.#2?S:67'/?.-L;QXXGXM>A,UR&QHJ8,R+@[ZD-X.2.&^CN:&9P88):3FH M&IF%B+G.LOB.6\A,R3,"*.H*11@NQ31G4?3<"9TFE#`JZ-DH"Z-4F<;3?:R[ M==KO]G]1'Q;N'S.3K2&A'.P`)T^XFD_'JVE5S1O+D=M%SH<6$CBI)MFV]9$8 M35:BXKQ\DIYQ7>#?35@RMH245-GSI`,L1/"%A=&J)FS&[Z>*P]H;G1C#8QW+[T(1[&DE-Q%=D:I"\](Y=SP4R M200>[/3%QN%/#XJ"LH)R7:YVPX-6VW/.-Y=YSG/GW7=@4GBOZU&'))[A67TW MT:`&'!D23$GO,TUIQ*2>KWE>5GI$:`0RBA3B!//&B[E=;6*I3"3FPIN-\N@^ MH6R$9B:F&$=251P7IOFSLQM,\\].['>D8WQ2=)2,5%I=.2DXRR,6(TQ@'*/;339U)2&:*K:D4R8MBY)&-E%8P:#331<3BXB3FAR0OQ229<332^W2["\/J"4ER@F MV9C.CM;=:"Y6(=62F#F:CH1T-R)0`*L?-)8:>@KAI.'!JWVY8SO.WEOG&_59 M,+;'7036H'<*\L-D#6H=@`R>'+!S(^20;,HP!@,`I"%#9(%AQ'+,-K*1U]N-"131 MJ?3MLEVSFYS+-N>-\6SIG;MQ%CMK=XE_7&!]>76W8FM*^P.U#[BB&X7ATNO+ M#"0E259.;YEQ#YN9S/5I)SH9S%:"4E+BJN*3C82382TMOCFTQ8,."R6>,9)@X<_TW.UMS,68 MYYWLY;S%J0)"XENED7"N,J\9=42RBU9W4]9%5'1HHF9V+0D\I,?`2B9C9&2& MI'JTH.-8'91HJI)9QOEU-$63QDNWDE5.N,;!)R'#JZ=G%SG+.,\^K1XKXNG# M\F=4`2(^G4TI&CD9OR6D\93BF9FRFJ[2BI+\M2B705=RQ\DI;A=\J%A?(,V@XC`F`@1=&JR\F/V,XI.OD2Z]N>7XR6`);>. M>EBGO?%,=F$Q^,@"28#*'&JG$G6(Z5=C#DFD&>47JVBMT)>*@/4MY2L,(U+@ M%#XA4LT6W%V_-PV\\7?O[FX9\3W3M*E9K00Z)*4$B6G"JQPSC:61C>5W`QD& M4I5:R>[F-$ZQ+B,Q3<8ITB.A(40##>:"BZ23A5/"EBX:;@?.%28I.&XSV<^< M[.>V<^BLD/<9*+YM(P^Y$5H*##;3[V%V5A-RD9$;4Z$GEY-U[8C]?@CCC9%3 M8-,%WDN+2&RK*BPS%(XW3[4L84&@9.'I)3+LXR6Z+,Y[)IO9C?$WN>OCY;K7 MJ'$XT62FHW'PH[`(I1INO7++;1%716G(EB6<`WB%Y41E`FJHYP^A`D%@@-XP MF&C6()CP1+INGG/W]9LY.:K\7F;=GUD0XG0[IVSV26_ MS7"BGBI:JN."1)8E&4VLRE=F:SQ7M'+Z>@MN9E=LMN,9:S,$&LZ64J..*FDY M)&0E->)&T$F`WVH*["RO@`DKC81U>._"24SB3 MZ9+$]$M:R,N&>50^\,8U+`&XYE)-9-Y6R;F+MSB$>4U)E%(R)RV7;^5CIN-# MCM`>9,S81&-HP*Z$*EX#AU8XL;<^SERSCGCOPC[B M'\TEQ+RS>[-WO=,U-ZOQ*]+D6=T;7$W,&8\DKKN8<>$C*2P),7(U"D64D,FY M8VCU1F=&9Q^(4I[OE!4"2HVFRHO8LJJ0!LI@&7L8-E01APZL9QMOVS.VUVSG MT;KKSO'K1MFM28VM7+I+^\4/A7B!;V/\`V\D75J0] M-->X\"@9(B%\3Z_"6WRTX"31C26\5\V1<;6)GM?FZ7=2HCI+86CJBCJ"HVBH M>0)<+-7P#&S'!-73IDEFJW.=68B6W%&Q9-D=IVH)+!U-8ZHM,^26!2<&K?&^+ MCG-[W;[_`&RLMK-M,8V$D_<2/!686;`.J\_%83)K!=?S6;O@N:C!B2)9RC%, MDE.P01+9O/)*LF!&EC#(-/P.^4+7-7+`"S'#WZ<^MG[.2$1<;Z7WL1U^D9W: MMPN0AG8'9XKK"C%V'MJ7=VQC=75*5W/$1%W*,!*$0-XVI(0*XUS*RH%$QVB' MPFL;+K8/A0LYFG.^G$NV<2YY_9T)5^+-I"779.9K=E!6=SWC9O3 M&L%T9&B^8!D.1E6!DHZJ2FTHE?0$>FF=*SG96!$6SE18U5G#5M<;7';.WEGMDO6OZUIXIFL&P\5,-_&5AP1JZW3JN5 MCL4--0QH^:ZFJ&RQ[,NM)2F,BM952B3J<:`BJ0X=73E<*4L1U*$>Y.",G*1V8TB[V9HZM?R.,X& MJ*KIQ-4N&2-C@"CE[#"Z=4WL[<=G/I>E\5TZ,E`H%`H%`H%`H%`H%`H%`H%` MH%!6';VZDD-U]<'/!^3W48P=&3@9,@QK)R4EEET['LH1FZTIZL9T^03 MA@H4721592`BBNCCFREU!&.J!8L=(',RQXL73>&YY]9UEVL\E&9%X=NY6W43 M;#L3=?P-))OBTRSAT\LYS=[F8QM-MLM$=7"@V"G1\N:>] MD-AXF4Y\<\K:5+G@XDB9U-"*D*+-/)./26&W22.Y)!=3G57I)"LK*0RBX51: M\GMS.YV`+R]&2*[)'< M:V^/)"HFQV3>`TEL8LWFLSCZ\(=0R+F%/X$O+AU_/Y_(UJUZRDH;4R,1D2,2Q/86`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`0>)FGN8PDL M\V4/.E-X@IETW(71/&EHP`DG(V*.3O#N1ZQX%P#E+9`8)H>?>8BZ^>W/@[?T MS'J@4AP6-FG+'"@P);VEAE6`0.&4Z.&C%>3#A1WML)'9>;QC!?9\DO45;DYR M#N1U>2X^S(N@@D8-M(S%,)OD@L!D543BH7\29S)?Z^.[R]ES)M.NW-O[[X/4 MY/S9EG30X=DV6ZFK&^UFL&RS#*/!K2HKOEL-Z`@&2"?@5I6Y6L8D8S#5C+95 MELLY$6+#3U45A?OFX%,P6+&05$DUR3'#STW3=^>>5Y9O/E;C&,)8A7A:2;&4 MB0$N+LUL-P,O77=S;':AH)Z7'[@2',O-;9]KR00,,ERGCCQ5DGR\UW%(A@R$ MN)B>53CR*G`E,TO`\-F07:J8XGE8\.K+;C`!(@'RZ"E)H")UQU[I/YOVM(T]X8$9:PZ]KD>*J##[PG155-C#H&PY*)6^EOHH6G- MU2"J$R=G&9#.O"^#>;#WP:1NV#BP#4$LF.3"P+)YFQ3`MU9N=\?EVSTD^%8E M#@I>6&_P[&^H320"(:I1'',#[+IQ-GF+IFU4111)T73FQV09`,+.8C72TR7( MP+K.5A\U881':G!O46IN4NS?@_(F M<$-K>Y:[O,&ENAA26J3:A2>OJ.3I'9+?6@YA*0V2:R>_=.,7,TS3SVQ.WEG>;8SCM7TXB.FN&]>OA"$,EYNMK,E,$-R M?95<^5.-^>%"Y=K=C3&P#)+:YL3'\E\XEEK<;P[M!JML!$Z,\&K**H^66Q]<"+&30]>FD&%+.$ M0,1AG@VFH*I9Q(,6&7BH+"Y?)=4ARA8P"HEFN28QO=-TVYYV]MVS>?*W#J)H M?JLH:3$<=#+Y`R_++MDMO[N;<:<#ME17$.IA-I*$-HFT.N.Y MR=LXZMGF[$!!MR-+#"!FB09`5X77GBEF0WP.AKK#>2;'!RRXX%Y$NGH!6V:" M,G!E$\L:_$N;SQ=/#C.TN),^A]DJ>RRW$RIE'#7RMHZS`KF< MI!=;#X8R/A+2:81Y>(%DHF15S2^HK+,S.BF%,LVA2N`:+F..9OY>>J:IORO; M.6\SX7O3[$W"G97%MCO=KNT61BIX53,@D4@^"WA"(+=$+ < M0S@-DIB8AY!Y"ZLRSKJXLY\?GFZ749*!0*!0*!0*!0*!0*!0*!0*!0*"L.Y7 MT;9'^Y_MXUZ"3X1^9B(O1@P?91)H)/H%`H%`H%`H%`H%`H%`H%`H%`H%`H%` MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%` MH%`H%`H%`H%`H%`H%`H%!6'- M>@D^$?F8B+T8,'V42:"3Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0* M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0* M!0*!0*!0*!05AW*^C;(_W/\`;QKT$GPC\S$1>C!@^RB302?0*!0*!0*#^<,\ M1,<<\,L<\,\;9X9X7MECGCE:U\U[VO:]KVOW*#^J!0*!0 M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"L.Y7T;9'^Y_MXUZ"3X1^9B(O1 M@P?91)H)/H%`H%`H.>O%+%=&>E,F([(FQOP"[G2X8H:R"^72\W7&R(J&%N5V M65.1F;DICE3;LCN\O)7E",`'JAA8G6^8=81T,R3MA01P#I99V`D^=M9D]=E/:?8@@IZW<#Z4=FX9=168WG%2ZY-OXXV-F:+C[Y7 ME)D/@`*9C+34XO9D:MDV\%)U$':VEX-XFT<%9?UO!.?\_GRN)-6))^;ZF+,9 M_+B7[<\]UF.Q/A"?YW>#]4=I'M+,N-[:EF<2GAQZXM*%4^4GHWV)G",SQ/"J MF_8[-00472C$6",LW>T@NU57%)I'7`$IH@:DB+"8"D#8V)B;228NC5JSB9S. M+MY[8DQGQ?7<_'>GQ\QWF_58N<-I3(:CB=ZF53\`1%`RGMI(.+)TN1P,CEB^ M9P8L2$#+8#F2X.0V6%A1PL+Y"8G&;[*FM[:*>G0@(;F1]#9R'2'$CIBZE#B2 MQJB`(,G*Y(!0(BB`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`?%QAB??/\[TQ4"@4"@4"@4%8=ROHVR/\`<_V\:]!)\(_,Q$7HP8/L MHDT$GT"@4"@4&GO^/6%*[-7X[E!E-61&"ZB7DUS,I[H"4Z6JX"%A@C.)1805 MLJ=2U$`,R``9"#-%1<0C(`!@/O!@0\\1G&\VJM"?P]M("$$(&LXFJ\$JL'-M M2*.!.CU;C%GJB%F[BI`-,S?1PL92,L3;[4"0=RZL\1;7<"F`*.7.'Q2PX@.1 M>+5G.;GKFY;<]M+M0I)2XN0W_K!`;Q1(2"`+P^C.*)F.J),9DBUB=@4QDIAI M$$)-Q(QNG)V5TA,`+IF8B>0%S*9"$BN00S=][OSWN_CU;"KZMZV+\THNQZY` ML0J\_-PD$G(4RJ,>M8Y)224+E12)7`B\1TS-<+B$B!@P0(F,#MC!$@8,$2@H M)4<8',9N,9N.F=O)[.S7T;M@_0A*_L&OT)SGC/=C&:XC30U5:KL(@ES)UKZ^ MH;B)ES=A+E3!I%CDJI%P3-@1`A;EQ12V`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`9N16<1@U)=*6W'TKMB(7X(O(^+F(JQ%M&TXJDO\` M?)\YD9>5FZDF@06VU"\[XWW6BHA04RV*XAVDNI3S2X\V M1V4C*'WPM-LJ\$ML.]6,%E( M=LK`Y7L:FG5JWDMB"B?%VTLE$Z5C[4V7F;M5L&ZQ!$R-H4CA6.`J3C6+%AS8 MRBXW$>1[I3(8+:3RQQPOEZ*>)G%";::?$2DEQN(5%;2P7@U3>S$ZW^;^#SJO M$^@?7$_E%G$&D&-M6IZ2@`SETXXJKQR-93:IH8R71Y0AQRFTBQQ0::N,2/)R MJW'`"2=[&="8KMY9+**8&WG:Z233=7],MGK/'^;^DD&&>*5P]=AY);D/PIMG M$+Y@?3'CX[%;KEO3=O2`X)-:Q`B@3%F\#X19'CY8<"(;4DU MK(3D+@YM[%S(SC`5":23@O/,_MMF^<:L8[,=O_6'DC+B[1*+R3T%N,-I-D6<%;B!)Z6G,15AAJJ4ON2Q1&0'C@Z"3_`$ARO7,1BX-M M5*$'$^@RQ!761=%[L9USMN.#GFXZ)%,*:VUKHI8ILEAL1N)LN&GFUE6V'A5MH$IH;D68O%LEC2XCCYEP;X7' MX>K;QDO/:ZN6=O;+>U/C,0PB23$T3K>OFS2"_)6:S9D`NT'(DPRV'PWX^?DI MN*+6"Z>3IQS0E2#(`CB';N;V/M:'FQ(SP9K#42*J\T%#5,3B(4'!<6YF)V[X MMQG&<8G/MLF6!FKC(1PRWCLA!38C"2&U-L90]MR\(I69/3F#@PW^\M58T7WT MO8*#';\K\N2`QE.R5@=:KG>+"82%)*&64AV6XQ>X4-"B:=IK,&S*_G)*T!G93?=Y*)[3NJ'T)FI+<6&\Z#!%SO` M"-$4)IET@4')R#KB*?537X>TW[+;?\A-M\)"G958,&Y2LX\6L4P>I M0H:;"HA*2L)].VXS,_??;/3:8[;AK:!Q4)UOL^VX).P,GOAO._B=;&Z4EG2Q MK)2..V(VA^#&;)Z(X%4-XRD0$5GN$:<"VXW:<3TP%"'CQJKH+>1!7WBW&ZZA MP3ASG'Y)JWZW59V3N\[T;YPW.*PI;;)>OK$FZ%WU&,PSI$\IRBSGV3;"(D0+ M*96('\7:+[)1KB))SWD=-%;("ZVLC%WXAHA1:'\JGD$^;3,D<12&O1PYQ>.VW(>G;=1=4UN'$^+X9D^&I^<4L;!"2'#T>/ M\^@IDFL24B#&:*N;G7[B&V2KCS,#X"T9X+P\6W+..W&<=,?;.>Y720N.. MUG%%DQ&(+BQVLB:HJ5-4URS5G\BP5A-4HOV!VH8<`*BFJ)$-S0YEUBOE)(KZ MT8$CN3#+&?;94#+955QI'$TP8("%GT^6;M>+EGG-.>V;^,S.>Z8X'XN*>YWX M[V9L/!D@0@DY;J;&ZF,"336OH_I*XN\:#Q:%*3FU;W,811XB0B%KZW75%33\I[/#[&K`Z-$ M"5#J\AR,M1_9U+P@.*FLLV0GFQ'0TD`R475]+*)P^(UAP7.,Z;SSORQO<[TW2UGJY4-Q)EQ0"IG!9Q#21"<%ZS&USS4CLDJSG'4TR&#$;*-QS@F2DK)I`^-)8V+; M/@2,J,0J3)?]KMIY M^P99;**!4^3*$NGALSO+OMMMGOFW+MCG?!O$GVM8<9[6;*[LF(2=\&:R[4/O M2\RR=4((D>)DR?9I9,R=>.&981*4E( MX4\CJS_OTV:NF6R:"4M;I+K7;T;I!0NG28?2#!UIGW8G\H^)A7)A)(8!Z[<%=680.! M@SPVV26;\6+OC\N<]G;C9"CHXSL:*=MOVW"T(RX_GKJ\S=E#^!\4U#6375WC MK5B:(O`@[&V0FFTM1@VO*H.9]$6Y28C`#?S=2UG)@"KB]Y'1U4LT?TYLDO#U MY:NWEB_:W';VXZ3:JS`O;!:UP5.#H9)^.G!+$6,M^JK.4!T@T(D&G,ADU3*Y M,=#7G*2$15'$QBK-ZXJP,JXH)Y-Q7BJ6N8J*42,V8MG/%<BIR`UVHW4^V*0S M&$T$E%:+42L<\$Y,NI*"TJJHMS]N43>F,AEHIP-01FBUTD^%B)B$>3$!*('` M\1<+ABXAF2I0(;#$0/++`2V.=K9X97QR[N-[VHCFN;X1NOIR8CLD9R?L:%'2 MILP#N*JZM`R(@XZX*6R`2R`Y\I%-MS)D9OW/$P[RP#O-M`.1@V28<(>)@1O7 M(V\GT:XKW9QPY[<=.G=RSWMPQX7&N6"5':/9+`NUR,$N< M6W"SU%,NVRJ.ZG&MJ^"<+@.5*$QQW\W^:YOGE#I#@OZOIK6EZ.BE(!EIJ@=(-DLF M@#WQL7CNW+,LN>^O1HY3Y@`L3<[M@IQ1.YG0EE2I!:53894MD"2:K)B8 M\=\\L==_"YB,P^"OJ_BZW6Y0E`O'>D_MZ_V\NW;[8BX;WTKB M1_1=JS$:VI/@)KZAR9K[*T7&$]820%A0,P4VS+#3'7'[K;0J*O1V?44QZ-Q_(;Z15TR>$.ADR`I9.L2 M+-=F)MB2S[6Y[++SWVL0W)?`^U=E-*"2'#+.T`01Z!0=>'PHA2"Q%APR0S"L MBNB5BBDYG*[XL.]W/BG=<8 MZ])VY6"_PSH/`?2'):0^)G0'N@;I/'>"4&W/3B;CG>H[RQ)-5,R5E8JHM=.P;YE+ MS0BQ$KF:#.DU(04,8$75;G_-9;]O_9(W#J@2447>9!,W^3UY M#+BH^3"CINQD@"QUF.US6*"+BA-=+/&LEP-T8BK5AS0>()7/`B&)JLX?\O+[ MW*,P.$UKN3EMTRB0?L]I24^W$>?+YB1$?;?08V=TCJK!`CQ8?RN81&2GR=@I MK"<5*KJHV4V2$^.3CO+%W&(R?'`0[8CCN,;=,X[,YQT^^,]Z*&AP/=66HUQF MD/)VQ;G3+Q?!4-D,EMR1.1%1X]UQG1M[`Q6C)H+1AEKIWC*<\FR7(KJV>(G5 MQV(RFM&'$HJ+J/8.F M3T8XE9P<\FN]F*D%!E-)7"H:("HM!'3U`IXE<<='Q'*EC9(QF&;!,YN<]MSZ MRR^ZO^?"XUC-D&*[]\TS_;C'M$?H_"&@XE%XL7K\[[ M>/P!!Y$[0L\'C,J:8=NM=M=58PM0X-!>"(R$-H(*JT#AC(,1QNMI/-RN1/#` M2W8L+B<#@5L7CN/4=&2&0B,M'9C=;=THJ)BD',1# MH9LEU6[=FTQOM)OB;^^6E*_!HU'76*U6"IJDP#IK&U:BG5!G*N+O;P#@;C1A M262TUQP_DT^7980.,I(3])$SN:N,3&:JDG`72%)FFB!H\":''UGA9 M?'O78UDUL;FK[#5&0@OJ3)*,K[L5GHX7I*ZVAJ[G55I7`(E,PBY)I-IELAKH M)`DFDRB2UV2SFRW2%L!S8:9DI*"D>.$MS<_/[YOG4&*/#?@-3AZ:X2,+,F8M M">MMC6Y[T,A.%`Q72LLFYD9TXBIK?.9-/,F19-GBQTU:1/_``K(+V(EV1Y:OQLHT9R$YM M:'(G..(72XT588;A6A%1OY)A5*')D7$1;R@1#`.F$2[B(IRX3+-=DY3;.+>> M_.<_^^]KI_A!:W."9GE-;W?\_2$N.AK3\STI'>SU::R`Q4391J+#'DDDW7Q: M/RTRKB:`U%Y31&,WI+D]_M:/B0P0;30TRQ)/\4''<28DQCKOCEG?'WDEO:OW M`D/I>OT,1I"*$ZGD]4"*VBD,=O..03:"?>!QO-\O8@@E5HZV6\U$4T(D)`1) M&*CE$`AF(03RN1SQH]6?YVN)W[3U_PCI;])\'_W#2J-_2_Q-/W_ M`.-=I-;?H[0)Z%HM]AD*C%YWQONFFB%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H M%!&#!_U7-WI/2?[,1%02?0*!0*!0*!05AW*^C;(_W/\`;QKT$GPC\S$1>C!@ M^RB302?0*!0*!01?,TT1?KW&[DEV9'>GL6.VG@GW6W$H@*!W$$=852*$BIQ% M+1R:BM+2TN+BFFHJ&A(B5HW3DT9D2*>DL*2`VV5=Z@P3<1(;35Y-P*-H2^3%+"I:&:L;*V&)PW&<;?SLYI9V:^C=L'Z$)7]@U^A.<\9 M[M,!^A6%_P"UW#^T]J%YWQONM%1"@BA^SS!L5JA1#E"9XHC=:/D,%4BD/V16 M@SU0ZF"&#!3!1*)[A6$XV8(9FBAHM@:/ MC+[CV+=<F\\*GEH[*ZYR`X M"+384_0H]W2IV,W36TT948KD<"A8F5&/'+D49&7CJB;L5)%C!PS[)!D8&05!8.C.]HR)@PVVU MWLC'V&W6NAN&;$LLYI)B)$9[]?RF<9#)=.3F+(:J0N3HS=.-,N=[V8]KG?OY M*RZ4<9N1]E9+U*:S^A""VZUMR3TU(K#PB79,U)(1^V&!K5HX>+>_EQSTXESTN;[LO"6-I,HE>*BH3(*JG1$:-(OM##T*OQQ(3;30#Z2C* M$@LX5YKJNEMA('`-#"FP3,T_EXM^WE)9MUN9C?NN.:LQ_CKE&@R#\S2+K4*B M0G(\3[,2EJ0X$"7"SA>6+M-^[=T%URW*?,I%]M&3,,.H$2S] MIXKHR?(S%:4F#RFQ5=/>D0HLR,!=;+^,L:/U$P66D%9S2E8F=9I,='6$D_@$ M*H@9@B49LQBRYEF9F8NULNV;TZJRQUQM]5Q(/AN1YUQ>TB]?DUB("HD.$_&@+H`5QB)LU<04#)(6;)XFBV9VGY;JF\S M<=VZ>DJQ5H.%R-BQ7%?R8[A4"15.?""FFS5DP5U-894; M8RL544PHJ&#B8H`EB66;7:].W[]/"I\HA0*!0*!0*!0*!0*!0*!0*#Y\OVGK M_A'2WZ3X/_N&E4=/I?XFG[_\:[2:V_1V@3T+1;[#(5&+SOC?=--$*!0*!0*! M0*!0*!0*!0*!0*!0*!0*!0*",&#_`*KF[TGI/]F(BH)/H%`H%`H%`H*P[E?1 MMD?[G^WC7H)/A'YF(B]&#!]E$F@D^@4"@4"@H3Q+(]-R=J4[VJ5@U^[!8>>, M5+QUE1'(V$6S,ADVO)+8<0DG0VYQ@,P!Y/BD1,"?[3;)@TF@NTZ@7;F9ZUE+ MQ4T:TW%YR<^GC+8A_/HX!M^Q6*Z,$=(1'F]5K"7UI>59'=4.N-AN$L@69"&Z6\ M6L0G;_W^W\Z)+OO=%F=]K9C']N=]IM-L]Z07)JMN>)++_@!S0@^74[)QXF.E M&\!S:ML$F[A!K?C^+&;$)V7S!QR#+9)5;SL9KGC1R-YI,?)`"45X):3143&Z M6:L8JF=.,RXQHU:<=N;G'OFY]WT;[-?1NV#]"$K^P:_1SG.>,]T$%F4Y<=.` M#64O2((!CK.$/=.S3(GL3$"M%F(ER6>8<8!J%BN6'\C+/`_@<\%>]\3>(_<& ML6W>[3G>ORO-1DH*U3+IEJ)L4Y"#RGW5[7Z:W23! MISJA`+(V>QS2,A10S`1>*V8U75>5GYN7GGJ`<..,IL482$W+G9N3=D3#E*ZO.):RC-HJ<%,=-'L%Z'Q"RF`R6PQG) M(;83G0E+D]^ M&N6EJO#Y/:!S2?,YR:YRVY64I3EF5`V"CQLE>)M.*D6'V(BMF/D=87"2.GMI MJHN!@;(9>4#*PMJ*H?&&+`C@$RIFW.)C$G*<^=SS[5.$C@KLE(@B2H,PGATC M$9(T+B/1,RX#N+BRAFH%G2`QGODC9'L6X6)!"MU6.9G"ZFI%P_$11Q[SXMV&3&F(YH3=NOL;/U#U:@M(EUA1^_'"0..E7=4LIY$!]R M9(F30)79:(XLEIGMLIX4)UKC(C$.'->V5(;B>L/(#X=B]#+?=A(#)=BAD.Q4%<`D9>=`1P4T\T5%<1];4$ M1962A=<`*JV:8=,'BY(EF"9U7BN>W;/?>OW7(HR4"@4"@4"@4"@4"@4"@4"@ M^?+]IZ_X1TM^D^#_`.X:51T^E_B:?O\`\:ZMZZ,9SBZ^02+A,LD%L!(;C`3` MN"EQ!D"!CFR4/+$$+(Q%0YBX85KVP#N..,-?'&UQ11,^^SN9MWNTYWK\IE\P MW5TUR;^%0UV243,Z3U^3S#=737)OX5#79)0S.D]?D\PW5TUR;^%0UV24,SI/ M7Y/,-U=-WL3 M[8_G>FB@4"@4"@4"@K#N5]&V1_N?[>->@D^$?F8B+T8,'V42:"3Z!0*!0*!0 M*!0*"$-FOHW;!^A"5_8-?HLYSQGNTP'Z%87_`+7X MYTWF`4+XYCCAX9";[3G41:;[2,_1$^4<[$<5KANF-I`;" MJ=;+^CITEA`"A@LNLYV)2JC&O&B)`4X"6+J>!(N7/`8475.&V=%GJ(X\MGB] MMI7E%#Q\9S`-W1MSF>'BQBYQC/3'JN*W>(+H\[2,LJC;VO@9 M83(*3AEF6U,G)39S3F,B%U,5#%7%<]D?Q*Y(GET'-!#620QM,&7;AHH)H13& M!*YDX=6WY;ORVN[T_P#$3T6LPVG)V6U\'!L)]+CA:[1;%[1;IV@628F@ M*-(2?^RVQ\T)#P=K1B2/UID-())CZ/[I8;ND)^ON0U]OM5FM@F>6DM$2139@ MVH.%P'0DA*(##8C9A"3.;;B3MWY])CM>FU.(7`P$:,E\;$C+&F;I>;H>3#+1 M/L_@GQ\^,WJP%Y-;;D2VS?(Z<0Y#1QE%;0!VN[&&JKR`ZTMPHIM*-9Q$J M3AN=M^W;?_U]\5O"1OII0I/,SYK#AY%EVQ`Q_*H<.KI=\8VN^>7GV=6?=>Y6J3$( MBJ;UV$B9J)A=E1O)!E2<+S1DA/*L"8%X=KQ>\C9T\9!*E6V^7`6,I#=5S`H9 M)0.@#!!B_P`O*]ABWE+>SE>)+ MJ<1<*18OFI(:CD5$R%358H";)&A4\\$7->(GB![$+(F>*#C"RSG,?]IDHA0* M!0*!0*!0*!0*!0*!0*!0*#Y\OVGK_A'2WZ3X/_N&E4=/I?XFG[_\:[2:V_1V M@3T+1;[#(5&+SOC?=--$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*",&#_`*KF M[TGI/]F(BH)/H%`H%`H%`H*P[E?1MD?[G^WC7H)/A'YF(B]&#!]E$F@D^@4" M@4"@4"@4"@A#9KZ-VP?H0E?V#7Z+.<\9[M,!^A6%_P"UW#^T]J%YWQONM%1" M@HEM#PTM+-S7PBR1LA$BJ_WDWFL69:0JDI>FY@`E&V3559;+I]TB-9(9Z(9$ MP4UQ4,9*!M.'4Q<3&)<4YF5+%`0#4U73M,>4OO*Y&;?<#N&VJ[-8W#I)I4W' MX29_'7"-3]D]V]E)\WHT99;84SX:F*$ M\1P$\<=FF27EGGIT\NSGF[7+IA`W"/X?VLLJMB;(3A!:9\F,WRM=N.$S.>PS MO`(>7$11;JI81O/>5W(V%"QE'5CY6UE-&.6+Y#XFBM@3@!`@L=(V67LS>?;>[MVN%KUPG'C' M![)F%#1,-,3DML`G$;RLJ&;JS+.LDFTFTN>4DDW6=W&TZFJ1IZC#:K6-W1*E MRNTX=E#6R1&!/*6]#47RK!#4L#8 MY$[XH$!AF.268NF\K9=N;OKFUZ8[#DAOM"7E&Z MDZF[YOK1IV/H(F,W"A!*+JR1;P!!+Q<:B6:IRWQG7[8Z/:MRE` MZWM+*\XNB.EN7=KYO+2VZT*'4IP)$6LPD@1\THW;J,WL74,(OK"P>3&I9>=K MD4`$\166E3,/`C;`C8Z=,:KG$G*3&_/G;^^%^J,E`H%`H%`H%`H%`H%`H%`H M%`H/GR_:>O\`A'2WZ3X/_N&E4=/I?XFG[_\`&NTFMOT=H$]"T6^PR%1B\[XW MW331"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@C!@_ZKF[TGI/]F(BH)/H%`H% M`H%`H*P[E?1MD?[G^WC7H)/A'YF(B]&#!]E$F@D^@4"@4"@4"@4"@A#9KZ-V MP?H0E?V#7Z+.<\9[M=0DA3<&H2,@HI/)065O6Y.2$DA@*6`S/*:E&(),@3P' M.#EB8.1DT,$#B*:,%RP=\[9CCA!6R$Q%YWQONYNS1^T&<-'7F5'S"RYDBKA3`/,P1NKMH@L()^X>(H=_&$M4.E<>$1TU2)U&2E\.T/POJ?I]=/R?O./ M"(Z:I$ZC)2^':'X7U/T^NGY/WG'A$=-4B=1DI?#M#\+ZGZ?73\G[SCPB.FJ1 M.HR4OAVA^%]3]/KI^3]YQX1'35(G49*7P[0_"^I^GUT_)^\X\(CIJD3J,E+X M=H?A?4_3ZZ?D_><>$1TU2)U&2E\.T/POJ?I]=/R?O./"(Z:I$ZC)2^':'X7U M/T^NGY/WG'A$=-4B=1DI?#M#\+ZGZ?73\G[SCPB.FJ1.HR4OAVA^%]3]/KI^ M3]YQX1'35(G49*7P[0_"^I^GUT_)^\X\(CIJD3J,E+X=H?A?4_3ZZ?D_><>$ M1TU2)U&2E\.T/POJ?I]=/R?O./"(Z:I$ZC)2^':'X7U/T^NGY/WG'A$=-4B= M1DI?#M#\+ZGZ?73\G[SCPB.FJ1.HR4OAVA^%]3]/KI^3]YQX1'35(G49*7P[ M0_"^I^GUT_)^\X\(CIJD3J,E+X=H?A?4_3ZZ?D_><>$1TU2)U&2E\.T/POJ? MI]=/R?O./"(Z:I$ZC)2^':'X7U/T^NGY/WG'A$=-4B=1DI?#M#\+ZGZ?73\G M[SCPB.FJ1.HR4OAVA^%]3]/KI^3]YQX1'35(G49*7P[0_"^I^GUT_)^\X\(C MIJD3J,E+X=H?A?4_3ZZ?D_><>$1TU2)U&2E\.T/POJ?I]=/RY$\N)B2L1<^FL1&3FP\""PL"YK"ZCDTX',`B`((&$(/C MF/E:P85LL[VMO3KELQ)GMG2SLK[#M;+VRUU@+*WRVRA6++VO\`];78 MR%>W^?RT<;SOC?=-5$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"+H_P`\,G9. M...>.6027-;(A?3$U8@5ZR!([D.%C4Q MI.R94SILBQ@A1"G2,GHF$C%R,[!817VEJ)HRX#;="* MG#IKAF;+;,=F-[N_6R3>D295) MLXMB)H_E1\14JM.(5M`C9R@OUU.,S&#^>C07'`0:3<.L@@A*`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`(`N`%A@$""%AB&$'CCAACCCC:UB/8H%`H%`H%`H%`H%`H%`H% M`H%`H%`H/7-FRA`J8.GC1^5[6MW:"CCVR'O>U[8`8H-Q1+VO8/#*]KVHU-.J_VWQQB>;C5Q+?VA'5:.X1F>#&JQ M=KR,L2_#LCL6.G$KQH;@81MJSY92P@-B0ABL9#A.Z5O'LF MP!R#?C&7'@:.MNRO'3C1FPVF*XE%UGL=KHU5&F;9"&^WT[DXJM(;S)HJVU"I M"/G++KF;R8`F@)HQT_$F<\/*8F^\WMSG%Z_;L6`E[A* MSA):86'3-O8^9[SD'3ES:$;)++:U03&ZRGOKDJ2`Y76UP8?C%$F`LE0P]F2T MW2KQP1/#K+\;BBDF_*OF\EF29,D&2:Y/[=IJFJ?FY7&^;C?.U['O#<&^R9*H M)%E3V`W-/5/8?7/:=XZ]&XPP6'RJ2KK0SF@TFJDHTQ^>Q`HD1Z\16"S7`^$D MW'2LNB'DL=4-FOHW;!^A"5_8-?HQ. M<\9[M0A&%X='A>(AQXGC088:,&"*,,*Q&L(***(U$G,0003-*OGF)GG>^6>> M5[Y997OEE>][WO0O.^-]TG\B,,=$48>H+4]TT0Y$88Z(HP]06I[IH'(C#'1% M&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#' M1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C M#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH' M(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[I MH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I M[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]0 M6I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP M]06I[IH'(C#'1%&'J"U/=-`Y$88Z(HP]06I[IH*63`L$#4G*\%:IZS:^R3*D M=(2!($QG9*0$IHQXS&PO!J1QG1\"MI#:45(Y*TP8(BF3:^11.4&W'*$`-!X-%CR"7&V;]NMZ_:>MVG;9-<"&=8-B8^`?[(B1@$_%5MPLYXM)>CQEE'; M'*$W,T'&GGDA0R3SZDBJ5@`5ANJRRWE%+5CHLQ_.Z:!R(PQT11AZ@M3 MW30.1&&.B*,/4%J>Z:!R(PQT11AZ@M3W30.1&&.B*,/4%J>Z:!R(PQT11AZ@ MM3W30.1&&.B*,/4%J>Z:!R(PQT11AZ@M3W30.1&&.B*,/4%J>Z:!R(PQT11A MZ@M3W30.1&&.B*,/4%J>Z:#\O"<+8VOEE$<7XXXVO?+*[":EK6M:W=O>][I/ M_P`EK4%.9AX:^?\NP1-"'$N+?$*V-Q,L<;FIIU7>2XZXV\^2#^>9KH]OX-;N'-LUL MMB9_EI3B;6FR?"T=*`V7\.&>,B;4800@")]L^Y8903+JV&&%["AA#X98WR'# MUNF??/IIS?./WS?W[DS_`$7P_.'_`*PIM_DLJ;$2'G.+OM;/^D3*.8"C-!:E MA`;?[XMC.F8>>7<\">OC>][#&B=MOA,3SMS_`/%KKLT"DXTWU-V[6[_-&+6" MG%\E!S%]:]8M9-7F>B%K7MWV!J4)A2)]?:(HQGBDNV=5ZZN6>O#GWM\%MM?N#1PS]<$`RBL_4B M*'F?5`,`E]X3:WB0 M0?>DNO7>=OA-IZ-[B71'35O23*3D3M9X;S4FC*+;O'P:JQD5>1XHQ3F!'SY` M`AINKI91;\-%17RY5][J!2+DMI%E5Y*QQTJ@1Q=$\?LPSQ7EG_OQZ]-^QT!H MA0*!0*!0*"L.Y7T;9'^Y_MXUZ"3X1^9B(O1@P?91)H)/H%`H%`H%`H%`H(0V M:^C=L'Z$)7]@U^BSG/&>[.09\R<.^BR/O9)(H7G?&^Z4Z(4"@4"@4"@4"@4" M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%$)JXC6M,1/,U$+?5G5L1L(!CE:VNFL M37-S1+A06V=\+V=J>W!;-B+B>%[=^.L2TZ6(C``6N.(?L';NW-33;W3K=I_W M]LHB\W^)IM1\KLY$@2(D))U?>S^UMD(&Z># M@`3/J#FAMS,\RZ5(/#"V0YUYAN,0^/?,RI>.&,\A;CCU=MSXXU3RN9/LP7-- MWMB/^;KKQ$G`_48G_-)1OO'#K.G).,?^8A>7(H'@>7"A>]NY8(^O*;[.`VPQ M\(&:$S%%S&=-YZ?OIMGI>*>6#G.\0B(?Y<^\/TK+R$2^50D71F<&M(0HP%_Z M3>,*3T5@M^`9X?)X=,;KA?QO#^/Q80Y;#'(48TWEJQW:I9ZS,]FP-;BN:0*: MX29\CRDJZQR"=$\7QC_;U@/K5YQ6.?);$F3.3,@--J.`82]\;`9M9RKQ8S?, M/$L8%RSQM<<&KIF==.-4],N@J&O(;G2B2\VUE*<*&I@XF4U90U$FK)2@7R[O M>CDE$@,8)FP;,"33,:DI%&FU9`C1545`P>C%(0,#&3H`(IP*Z*9'* MFQK%0;EG;GLG[R=_555S[F;'Z\3LHPA+D..G;5768E:TF,GF2:\.%OFD8=3> M+T:BJER2>EG8=QL=O)X_F\G&F^LJ[U:UC@F:P6!)*/D\44`N)9G,G/\`JO=V M8F?3HV'EQXHLE_RHWT:A+7X@+_,"JWPFWG<>QS9N(M)7\R8N(PEQ8F'OD46AIMK$P M6,*5`O\`UE"$E[#K6QSDOG>WRXJA)`03>&7]`>.-[XW&=,Y:<_ZKGTG#^[]Q MX3.J[GRL8GY>V/VW/=VW?9;/;,3'(C;RM>_=$#M%Z_/U7#B;6K6_7PCXM",#PS#)(`OE@)>-8V9C$M<# M'#^;F;,MU'313%\\;7S,CFQ1!!K]\(.)GE?+*Y+;>=M\;E5>5N*CJ!'BROLM MD.UQ;.2>V2Y@ROQEJHV#4W+C:!*8""'!GXZV\,%%46%2&`68BB=E60F23(`X MB#FAP@0ALPRS1JO=.NK;R[;]I7)QO\`:W*,.`,K39+"Y8Y#\3&VB33W_P!U]\>OCE]`L51! M%4&,I*CB&8Y9,5L)$P[Q+:#`;20U&^4ROAA@*/@F(Q0F6$.&?!XYG#PP8ATZ M-:XYL<8;+(2YRSG>[U(U`H(P8/\`JN;O2>D_V8B*@D^@4"@4"@4"@K#N5]&V M1_N?[>->@D^$?F8B+T8,'V42:"3Z!0*!0*!0*!0*"$-FOHW;!^A"5_8-?HLY MSQGNSD&?,G#OHLC[V22*%YWQONE.B%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H% M`H%`H%`H,(Y',VV:@JKI=[@1&JV$(F*H+;C-B67>#"D(/;DN*(P=[A6!+C=RC7#C^J\/=SU>79]\/5YEFS MVR7^V[X[6*^+-.?*9U7TP-.B"(9S*Y_P#HK^F.RACL5+I,R7M8-0#+N:)VP? MRR&Q$9&!<2X-R\4G],^^K>^7*>OBO="L!0EKBS"L>0-%+"B-EEEVB->< MKM:[,($U1VN%';2 M'ED94551)D2H8@XX>&0;#0*!0:\Z6DU'RAG6R]6PWG@VU(/P2BWW2BIK@0SX M7RV\&=258L;(&@^Y>]N\'+B8_+?Y/EH.?:YPG=,`U4ZYX99[WU&>IX?(R([= M.)3?NMN=Q\_]X(<9<?SHPV)37)K7)0!C&]\1B6#*G=%CY<43)?/$3 M`7R,54@,O!""`#C`8W%H<&KGC,ZS&J>.R3J46IKRVB_AN[B;[DD*BP5"#%%P0S.6(80HX+/Z MORSOY^7/T8GS%XH6QW\4V*V1'3A_Y8Y!7F^4&^EPZQ MU.X%L\K"LR&7V*0&$MF0=8@H89@(?EG9=5[]IY3>^<\'O(W">UF;[D:TH)KI MV#'V+:JR;62^U+FFUTO[8,]93:KF9JP@C.^0K.M%1VF-^^]ZT\1ZU(43OMTR6-),O2B]76TFXQ32W*S MJ2G`*FM9KK+B7TU*1RZ,W&V4*!YJSH5C9L88`T8&RS!PQ%##"[S(EO=CS_>W MHL?1%/9\WXU)UK6B[-DZ9$'*4%'^!$A1@DEF5IT<)C,/ORQ=%AJ,TUU2,;\; MO?`,`YFW04S'/.V1@^`#B(+@62WE/ORGG=E1I%W3W(`9I#N*+8I6;JO33.WIF_M+'.O%A2GO8)CBV><3Q(T<_G:XDS;4*SBT:X6J9>V5K%U-A M:TQ8GH,H;1)I.^!HL"&N)\@--5Q[V^ONBC".@9AC%0VUJI'0H3<>PJ?ECD6 M"6YR7954S8.(8^(:<+_+P,W7OG3F=;G.J^-^,.LB$A(;71TQNMI&2FZWT4F` MG(Z$A)Q-)1TE/*X6"+$$Q,(`ER1`F7#QQ#`*E0`@`<+6P#PQQM:U&&5H%`H% M!&#!_P!5S=Z3TG^S$14$GT"@4"@4"@4%8=ROHVR/]S_;QKT$GPC\S$1>C!@^ MRB302?0*!0*!0*!0*!00ALU]&[8/T(2O[!K]%G.>,]V<@SYDX=]%D?>R210O M.^-]TIT0H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!`,_[3Z[:L-LNZ]@Y M@9$6):@-XJAEG&K8><;K4._PPQ264SD_`Z[GNMB9B88@H;11%I7&OE:P1+.B MR6\I;X?NIESH-X-G/]ET^UAQ@B.3W\(6S&]:>MLX8V2S_ANJ1MJ:VSA27G-< M0N,">2#DM+\()H_>VOD340;Y!W-8TS^JYOZ=._GJY3[99MM\,B-G^LD)9P)530)VS3"$`M!6#OW<3$=ZL-(!.AA#L%;$&Q92=B(_WD'<#`09X M&1>^$N3BO*?E\.?GS_G1TE($"*62)IB82*)R:GE@"1!/(%P29(B3+!X@EBA, MH7P#`+%BX.&`0``(>`00>&.`>&..-K6,O;O>UK7O>_]Z" MG,O<0O1N!CF23*^UT%-5QXC>+X,NTB-]=D`P/W>]\`2CUM'%E['QKY_R[!$D M`P)<6^(5L;B9XXW+-.J\I?'&WGR0=_B9)SY_E:T::;S[)>-?P([E3($.0'&B MD)?Y,1K2%M>LP6G9IG?=W'-122*UAC\F6`(F%^_L7AZZM,^^?^/$XI[D;;M; M=C8MS:9;^R!$'#88NLS#&EPNG#[5-]W2`X=HI!:*@0UM4%53;J*S49/&@`BI MJ4U*[7;:Z]4<9QGXO#6E@;`?-/`.FF<.F:M,NJVX_IVQV]>?+/3*]6B'$.XC MFUVNS?F=FZUZ8[#I:>N.6-'@=CK<)VQRZ`7Y':ED@N$P>15[75W,2V+EP"(/ M9N8H,@'$90:;J;RF64"X1RQ<$SJTZ=-Q;JG;OIG+_=GTYKD7W5W`:_\`,DOA M2[-8DL/D%4(4FC4B90^[;^JY=+49LC1SCX6_JM?-``SSQ_H"N):X=&>&?KGW MFJ>TI_BAQVB_Q29JEQ$8D+8?]Z4G/I'-+R1B/<_JN:6X11I92+8X_+?O@3HV M.=L;W"N):U#AO9=-_P#*3WP\Y;C!\-NXX)5?VE:D3C;+6E^Y# M][X$-G3I&#E&SOE_EA8%'=!P6PG=_AN'EA83'+NXY8VRM>U$LLYRSQEB*Y?X MDNHD1NG.-2\C&IIFN^%_%(#UK;2[L',Q@:V5K8@*#,B\DX1&>'GW>^\IO\XT MD,(/^:85`0[VRN6:;=^4ZW:?;//[(IY1>)YL=_+C"&8KT*CD]\@;_P!F%(K/ M6PXZ:8_C`4$77^)7(0BYGJF`-K97!?^YKPE#?Z0$4SFI)@^T"Z06(C;2H9#N&?%9&M3.2VI M`3=*FL.]!_VUA+ZS8J&&7,+IO&V>68XK/Z?R^'/[WF]D?A.:O-8<=2UL79[T MJ63`PQD0;4N<'K&S0%'&$R'[IF%U@V[H$.A8F,\A_`&XL&"$$ROX7'.UL+8# MCO;C5XS-\_ZO5XN2CBI1!_%'&U&N^VB$%\@;9VJAH_"[_N7`_P!T"',NN!@5 MI#&QP_Y0AL_KL+W1,<1A+Y9""9V&=-YRZ?\`3O/*W/JU5?WSVR9RRRXAD_0= M=B>9YH<7)W"LA"SI%,CZD'G\,G'E6]GK):O48;![$,]I);Y7-B M34F)T*:V%(W=JH>2&(['^S$W&69>:$C'SZ0X22E$J0AJQ%>+MHT[V@^,4-3- M);4+C3C-MDZ8SJ[^DQWY^R-)\CU::K2PD+BL\34U'L?*P]RQ6`=7#9[5&-7& M;'N'@99"_A5]K]KX[--Z1GJ6'$[\5Q-37%+/$9ODE M6'P&"5$IT[*2!&N!O+`,4PC+@-O%\G\_8VYZM7%?TR__`&Y=WY">4YAXR[5`?'(SF2ZKRGY9TG[VYM\W1>UK6M:UK6M:UK6M:UNY:UK?):UK6 M^2UK6_RM1E^T"@4"@4"@C!@_ZKF[TGI/]F(BH)/H%`H%`H%`H*P[E?1MD?[G M^WC7H)/A'YF(B]&#!]E$F@D^@4"@4"@H+Q,5"6RFHKR(05*+=BB57,\8G:S6 M5%R442%%-X66Y.:I=?BF/Y4<(!Q-8\I2JU[+;$CI>N2-&RCI6T_(AXF=N`ID M36G&=YF;YQ,XVYXVVEWOSE?S8SC'9RLQCS33Q"Y#V<1U"/)50'7-JQK]!/#V;TY3R@P)O8T]9Y9 MR5CCA#,N60%!G&41^/>1C*'<)=\Q=F7%(N*19/)R6O.ZSX4[G'*A*R66Q;AXBG)_BMB\,DQ9ST M:M6>V69[>DQ-ISSY?2GLU]&[8/T(2O[!K]'.=\;[I/\ M_G7T(R?^+0QVNT0\_G7T(R?^+0QVNT#S^=?0C)_XM#':[0//YU]",G_BT,=K MM`\_G7T(R?\`BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_XM#':[0//YU]",G_B MT,=KM`\_G7T(R?\`BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_XM#':[0//YU]" M,G_BT,=KM`\_G7T(R?\`BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_XM#':[0// MYU]",G_BT,=KM`\_G7T(R?\`BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_XM#': M[0//YU]",G_BT,=KM`\_G7T(R?\`BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_X MM#':[04JE/BB0/&$B7A4NR9AEJ>KACWM!$`(S!G&4R(H..5[8NU`C61W"7C0 MH)EC;&ZW*"@RV^7QRL8.*IP.V[H2;W\$)D(]'7(!6#H5$42HF0H5DAFS&X4H>UK`K2< M:#Q'L7\L_P`]^\TSVU7T>=N-+07A[*QJ6)+9X;8F-2*=^O[)[=[`P"ZY^<^. M>`F(M[R?,<_C.0@4.VSRPQ;+(N@-K++O`$]OA=P,*Q,ZM4Q)<=-,V\IS^^[8 MV]QB==9$,F"4'0YN!L:9!#[\(U`6NS@D=H&[Y9=X'B#*:VS3_JLE\N?H_EP;9<3]Z&@B<(<+;S&1U`'Q@H_=J=J MH4;(B>!?*_>64(IAA7E=Q"G\P^X)Y.,.Y$\%GW`3!P&^60@0QI[=7VDN_P![ MCV:_R;<5>3OYLL[)J4))IO\`EG&CISKMKD042Y6_R9A%I4V5V"G0\(;$#O?" MZB1CMOB@B8^,%0@+Y8@@DSIG+3;_`*K^VG'N_?\`#:A!UWL-L*P][-O#?_,/ M9C:X@\6I?N_*-AR4-6?&/#&(!B_RC%<(YP*?YV#`#QRRQN..]F-/A)GSY^JX MT0Q'#FOQ/`A!6BZ5#A7$'P&6$9,K6=CB#!WMWN=S0[665R6V\[;XW*F([5L7/(06`Y#%$SOW]!Y@7LXRV-\"\%R2!A?+OKX`J,*A8WRO:UK MY7QPEO&U\KVM:W=O;N]RUK?Y6M0>;S^=?0C)_P"+0QVNT%:M@>()!&JY0D// M^2E&Y]6\'BWVJINR&%*076*+G<((LS(V0)85G^\S@HMKAADVJVE*[$17#_`+JF-3?4P[D4C_Y;%4.:I[E='M;'Y+=P8B-;.V-K"=_: MW9K_`,N,][-[PB>/RAI\U1EPX)G"O>W]-AU0FEQPYQ0[ M?Y7M@X`!,[?*(+EGW,Z'%/T3[75/WIY-XRK/_P!/2=KY,0'_`/1+&J2+':E? M&W_@\MQ=OX?3K"Y=RW?&?-*X5N[?O2%NY;NOY_-S.GIJGAJGM9^_P"9,DHTFEL$Q[!)SHLXV4UQ'&TBS=,NX@;0QT/%7(%FF9F-4VWNVKE-[V M=.^3LR@34$+B6$E6=-$4I=8L;/G7I_AG-G=RVVGH$O[0;.&)9"/.J,)D;C1G M!XM-E,[SFC(JD,G!WO-0FHJWE5@J;/;C31$QH$T%,?S^>OH:N';5BV7EIY28 MYS/._;'BZEP'IQ#,!NT25@==)QF/8(Z!X%8V6V&?D33%.RAC>V>.8":\W1+8 MH#$2,L,[A8M:,4AD-$$'$,(!!"QPQM1FZK9CE.DVGEV^-7;\_G7T(R?^+0QV MNT9//YU]",G_`(M#':[0//YU]",G_BT,=KM`\_G7T(R?^+0QVNT#S^=?0C)_ MXM#':[0//YU]",G_`(M#':[0//YU]",G_BT,=KM`\_G7T(R?^+0QVNT#S^=? M0C)_XM#':[08:(U0\KK,'\<`X8B&V(^0C977&E^ M"&[M[AVQ4LA[6QOX8$*_;(4B[175:(-:0>2I%;*B&(=,R<*L(I!ON!;D)8[\)2$NMH-0\,=Q2_&3)D48LU:IRMF636]&] M1W'/J+M"MP(P5">&^,@'$N014\QB<#56FDC(+3^\)F(XU9-PP#[W^+O\LK8][\O=[E%DMY2WP4,D;C6 M\*6+/&/.?>F"%&Y;OO"XQVX#TOY=W#N]]8+")DM[9&,K=R]K8E["Y7O\EK7O M\E&I]/7?[;]YCW5ASXCDD2=K:\^)GKM)D3O.`F@JKK$CW3]8-E$=RR\(`JW; MJ<3=;_(-QS/QA[5/UW#MD:&X<1&XOH1EIJZ:TEU%7GA)J6\8V+PXLTV66[V\ M\>N.&=MSV6]F+6#Q_BJ[L?[9-.N>S5H]/V[T:`VA)K*X<.OXH`W\O)+D&4#; MME/?"6$DV3_@5@B;"A-%.97,`#L8$(3$$4OY)C%GC9=5\L<,];WKUPEJ-O[' MK-+QW%2YP]>'E&V.6)L1KZO:_O2>GL8,WP[S(PKO^4%^'VBKN#/#*^1URKD2 M.50.'?"C&AE"PN6>1FW3G/YM7C9/:7REB8/\-$%]?S=E]U-Z-C?&_P")9;(\ MZBZ\QFI97[G?EO,+4Y"@T')+O>W=LGJRNM6M?N]\/G;O;8DXL6.^=576WQ()I ME()Q,N"]`9QDB9F3(4G1@_Q55R(,;ZNLMUQ=(KICQ8QYSK\2T4.0BHP[="6? M`1#&#_5DX!1NCK*3PR\,[=4DV[[OW3][&Q.%A"PH6>6&8`SIG+3 MGOU;_P#QFWG:LKK[HWJAJZ;.K<+0FTFX]E?O\G#*:Q@H/F9'2*,'8,P*ZIA? MAYRR8X\C%N^R$#5W2;`MD()X($/'/+&Y+JMYW/=V?:FKK@*%<@P5I0Q'+-5TYQV[7,EV^\K4M?.'S!^MLPK\\LQV;#O M&3W/'H$6+CCFS8Z89Q&.L?*9&DB,Y]J$9.PVQ9!)M1P)JV89[P3\,=[W]\OX;8WR^2BR6\I;X14-=XRO#<22YXPC;(DI-P(7SQ& MO!\;R].H%Q<;][8*RC$+`>B5A?//N88BF#X):U[VOF/AA_%1>#5TQXXGOA2F M1?VDS1EF&,DMO,#8)ZN`43P!!%-I$11.HF1LK]Z#X=`FV8HZ?)8$?+^$(3!F MF1<\KVQQ+Y7[[O34^EJ[I.V[WVEB*_\`'8V_E7_9=7^$K.;]L/\`("Y7,:F7 M-O$\\O\`=V-J;&UJ>R+P4BN&&/AP/#/&W@CN6-[YW'%].SUCWP/V M>5[R1>W.TXN/$,GT$7Y3J8AR$;82&-:_RB`%D9XK\SDD\GG?NVN6*X88XX99 M6#RPSOW]A^))RT:)WXS4UQO^S4\))AC!G5Z#WK+ZMAGX:ZK*DRR0>%',7OWP MA@ZF,Q>9+>/B"WOE<7`ZC&"^5\KY>!MEW+V)?JZ[VX\)/_;H-'7#/X?L0%[< ME^F6LC25@`<\"+EM"K"7',3&[R^(`_G&X$92C>"&5;XB9X_QW[N5\ MJ,W7JO/5?.N5!K]G-C4ZC*:"8W1V%R3EGSH,*O>QEJF&HGUMW.U<>ZD\S:WA M!6*V/(Z'3_`/+E)C']7+K. M5VMY/H=:R4HH+8;B&KN`^[%9&04A*5'2J@$BJFY5%.3RY,ZX%$JF@%4XL?63 M((JB<`3RQ]K6H*GR?OKI#"WC`$<'EPX-CW+]T`HGCC6[E_X/DO1J:=5Y:;?M5?O\6O4=P?R8 M:););*GLOE#+Z[:D;)24FBX?^$;!YEHS(1[XME?_`/E9N_`OA;N""BAA7MG< M<%[<3QU:9Z9SZ/WGM[8O2_?0SPM-FCA._P##@M["RCK=KJE99W_HSR2>4^3Y M##+96^6^>;`L:#M:]A2>&?>X9/Y_.9PSMU3[9O[8]3RSQ@GS_.(,;A[:YD#7 M^[!M+;,&PK7O<.Q9Q&"N>=K7$OWG=PN/R3MU7[3 M3^^KV.:7OP\_X)3XHKQ;R>9^4^CZPZM0-$5L<,OER+)[CEPMLHYR?@_Z0SH" MB`8SMC;//#'OKAV&=/9I\[;[<+\_PK(1'G/$[%S[_N]P0OYLV)B8=P,0MD%:V%AQV1+"&#@HX@E[$MS>G*>4PG M6B%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H(P8/^JYN])Z3_9B(J"3Z!0*!0*!0 M*"L.Y7T;9'^Y_MXUZ"3X1^9B(O1@P?91)H)/H%`H%`H%`H%`H(0V:^C=L'Z$ M)7]@U^BSG/&>[.09\R<.^BR/O9)(H7G?&^Z4Z(4"@4"@4$"RSM1K)`H8PLW[ M#PA$/@,+YB!25*C'91F]NYWV.`11Q+B>:,#"?)8$``$08;*^.`0>>>6.-RR6 M\I;X3+GM(_';X:[!+9#)4P.N5Q;87%PO$D12:Z$`0O;N]PWRBGFPAQ4"2O>U M_P#;C3[+E,,?YH@V`/\`,HU-&J]F/&R>G/T4I5/VCIDO4^92]:]4'O*(]A/% M21MPR:UU7,!YLIN0X>>..8A3/PMP2_AX_JU2 M?SMXN&>J#IYW\XOTNQDJ)B;`@^LS.>RXQV%=\X:]S0S"9$22WTVV&DI:K-,^ M2[KE*+,37$?><=\SM,\I++_N MD;GNL6GXNH:B-N-HWC7A<$&^>6M:I"F5T;0*VO[9=15L1H^I(2(LCM[Q8EG! M7CKNGG&N*\&<^WN094BGW3'?)FSLN-L3.W;R M5Q-Z3Z\2'WQW9;C2:-FS8W\)\L:G-[[!&Q\+_P">1E5W!WTE-BF!K6[ML^[# M!][YDL`;8EL9/'*S5?[?IZMKTQ_QTR^=M[TLL/2C@.1YX$PO\4R(592Q M[W(_>.-GM(];2IK*W3K8>+GISV6$V:,6RPMW+YWY9I)DH M'+O_`)>^"P"Q`[E[X8`XA]S"Q/\`^O35/#39[2+;1]Q&N"5#@5B41;#:31R` M&'X'`I%)5DMT+$+N=[X+`NR$,MAX/O?X>\PP[V]OD[GQ_C!<.W/\`[M/QY0[O^7DF%-@5?OO_`-?)<5&^^[O_`"[WN]W_`)4.#5T] M9\G^+WH3E\I>1Y;4/^GDG4'^,0F5_S_`/SW+4.&]=/^_1_^C_%# MCD7N>):F<2L_:_\`3D'P\MHB6&7_`.;9K#`3<>Y?_.U\KVMW/^=#@O73_OT_ M*`19;V[7^'_*V]2-LFX6TK-R%MB)P;4/KD!1@0*IO)$QOA1,: M>W5;_IT_-GL_?,'BY/W^6XMC=']>2&7\66$2Z[RU/#F#[O\`4`$YY3F*-FYE M?&W M--YOIYC(:][=]D/F+D-GGW<\\\L[WRN2VWG;?%8"B%`H%`H%`H%`H%`H%`H% M`H%`H%`H%`H%`H%`H%`H%!&#!_U7-WI/2?[,1%02?0*!0*!0*!05AW*^C;(_ MW/\`;QKT$GPC\S$1>C!@^RB302?0*!0*!0:/),EQ[#K&L\AY3 M=#T>2T0;S;0B-QP2@0ZDK*8Y-%2)4,8V9`!$&,[3>H M?96Y6K,B:_JFT[.G>-EK7Y`25%8*#&BI<5.Q'-%PQ2\-SC%ST>26=R-48&O'6,U;$0_%64MX@BQM@_ MGXWVMF\2@]B-\5%'P5SI7(5)PNIIN!A8$L$EE!5`D":-@BF@,!!);G$MQSQ. M7B]Q9VWU?;LY(FLZ]/\`$B1L"XRI4XAP\H/IOE9`4@U`F(HIH)=N"GL3]SRH MG`BJ24FYA8J*HG!Y'R!4R4M<:ABXSBXZXN/-Z6WST9S.ULG3-WNQLM7!4AB6 M2B9DY%Y+0\5$WBPER^14ADIFBMCAC&V>%[@E[B"6MGC>^/\`%;NC3SGC/=F= M8WRRGS!43FV4[VN[RI*,8Z`.F6NOI2^`3'%9Z0*&`;%2C9O`L,('_,P"&RP$ MRP_BMC>WRT-7.^-]TWJ*DG(Y$RIJY\DEII(+(Z^NR4H$N_\<04&1T-^NDK?#N]]@8:; M`'=#F!$O>U[8!B)..8E[7L'CE>U[4:FC5>6F^58GO8Q\B6Y7$#*$DXF["7[@.8K,BF,"U\,;?)EE8L^ MS?A;97PPRP[VV>9?PI/ZMM)B!I$K#?**%>/(>86U34$MW+^#S&(X`6SP MPM:Q>^'>AX":_ISEIGVTYOG;$S1/^S&/AO"@YN-:U/0QLL[#&%A3.;>34XL3 M-[WRN;%$9LQZ<-);,6SO?+/RPRQ"P]_DS+8!WR#N2_5S^J_[9[Z=3H3'/`); M#0,X&S^PS/0C>6=A#2O#.B>FK1=^>?R=W,K(\V1QLK)I,3Y.[X6SR'&SRMB( M.(.)ACE3^?S^5G\2]/M=6K'E+(NJE\*B++D"Z0^MH.(!)B"7P\%YM*NXDGQH MU1@?^8.;6UW,0JW@P;_+_**IA8/#OLK!8AVOW*,\7=I_VR^^6)=W!JT7/HEC M3`B1)9FBA(!Y[&F2Z&0E+"R*=_+;Q2)V&7[E_^MO`H&'<_P#BB9O6^;9BD,0\ M0[GB,41J3[W^GQ1BM*A-Y&E$XZD<:/$V92C)P;J^,KJ M>*FV@$$)OF2Q\T2S3;DQLP+EXK_WB9\\+MT0H%`H%`H%`H%`H%`H%`H%`H%` MH%`H%`H%`H%`H%`H%`H%`H%!&#!_U7-WI/2?[,1%02?0*!0*!0*!05AW*^C; M(_W/]O&O02?"/S,1%Z,&#[*)-!)]`H%`H%!SQXI+,3'WIT[T198,ZOU-*OR& MW*-?6HJ66)K8)AHRLT7.F2RRFD:0759^#1@K))!X*S'`;*Z<?+>7:^/)PHC^`7WM'P5=S4^5=6DJ47DA-U7=&I3]#U4.1;-)@D:[G7I+;QWQZ*FE*B\F>;> MSPSJ7F4HA"JMCS9!+6&G&V\F/J<5S9 M-N[KRNTZQ"J=KML>RWHI:INV&I?*DPW*<:BD$&C48.)`C6(VH)'IA\@'E>52[C?"4??<=(*TQT M=27A&3BFG5=][PLO3+M>I!"V'S4-BI0V%=9TP/\O?##&&QL*S!+"9]V_?Y`7`O_%> MV/>VOW*,_B:IRX9X:9\+$,#@A:'QKX#S]S_`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`H%`H%`H%!6'C!@^RB302?0*!0*!0*!0*!00ALU]&[8/T(2O[!K]%G.>,]V<@SYDX M=]%D?>R210O.^-]TIT0H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H% M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!&#!_U7-WI/2?[,1%02?0 M*!0*!0*!05AW*^C;(_W/]O&O02?"/S,1%Z,&#[*)-!)]`H%`H%`H./W]",2%-5BB++#G<[2\Y+>S-O=)MENBMQ6D],V/-Q?AK\Z#L"HFX#'T'=&RH+]; M&`"/M4_6HC.%+:!>+!"-G`HLM-5'*W&@N/RZZ2\37U4/Q1OGT\/QP0<&VS7T;M@_0A*_L&OT9G.>,]V<@SYDX=]%D?>R210O.^-]T MIT0H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%` MH%`H%`H%`H%`H%`H%`H%`H%!&#!_U7-WI/2?[,1%02?0*!0*!0*!05AW*^C; M(_W/]O&O02?"/S,1%Z,&#[*)-!)]`H%`H%`H.9'$[U5GG:N,F:UH>,P6[6\C MJJYG)4![$1XCNN/I9(K)5-*-Y:)O#,@9=L=/",SQ8\K(2@UC:>&N$EM;3%87 M//!*N$\.;6FR9YY[++BS]K*YXO3@Q['J&M3*U82I:U1?K36=9$?7"394F6`3 M2Y.$8$RLIN61AE6`9#*&C;R6FHVT]TW:\:QM([P+)+*';"*Z$]6P/GU(C@_G M\K7',YQ9OF27;[^.,W$W3)CPFI@3ILL@I$PQZ/IRH[^19Q'5Y.7D=VG]B3$Q MQFRVBCBQ]Y8#.!,908KN>##;CM57(9P*N$D!FHI`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`&\:]!)\(_,Q$7HP8/LHDT$GT"@4"@4"@4"@4$(;-?1NV#]"$K^P:_19 MSGC/=G(,^9.'?19'WLDD4+SOC?=*=$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!01@P?]5S=Z M3TG^S$14$GT"@4"@4"@4%8=ROHVR/]S_`&\:]!)\(_,Q$7HP8/LHDT$GT"@4 M"@4"@4"@4$(;-?1NV#]"$K^P:_19SGC/=G(,^9.'?19'WLDD4+SOC?=*=$*! M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*! M0*!0*!0*!0*!0*!0*!01@P?]5S=Z3TG^S$14$GT"@4"@4"@4%8=ROHVR/]S_ M`&\:]!)\(_,Q$7HP8/LHDT$GT"@4"@4"@4"@4$(;-?1NV#]"$K^P:_19SGC/ M=G(,^9.'?19'WLDD4+SOC?=*=$*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0* M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!01@P?]5S=Z3TG^ MS$14$GT"@4"@4"@4%8=ROHVR/]S_`&\:]!)\(_,Q$7HP8/LHDT$GT"@4"@4" M@4'S5\5/8C:"$MMVRZLMB):@K51C$(L%39#@1J1;-[2B=_*;9G5:?Q[<:`C` MX$T.=HN9"1VD<;1I&4$EFID?(+]7$L7S[)%5%..FB2SEFW.US,\OZ;RZYSW3 MJQ1/!,F<(E%GP%GBT0;XE[S/3KB^7\AC3C&-^#BXLWGG/AC&W+GVN_6S7T M;M@_0A*_L&OU6)SGC/=6"&=RV.1A^*"0D.[=CB$XU8I7,8EJ%L.=)C9EVNEA M9"E#A:/A"QLL)?"^8!DN((`.%?`4+/(//'*Y;-[RYWMGRDKGJL7H8W$_)QL; MV=T3%[O.?)SU6+T,;B?DXV-[.Z&+W><^3GJL7H8W$_)QL;V=T,7N\Y\G/58O M0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&QO9W0Q>[SGR<]5B]#&XGY.-C>SNAB] MWG/DYZK%Z&-Q/R<;&]G=#%[O.?)SU6+T,;B?DXV-[.Z&+W><^3GJL7H8W$_) MQL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY:^@<0"('3FO!-V,]LUD1K.`ZU M'%@GZ@[%&,D9R)Q<^3GJL7H8W$_)QL;V M=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&QO9W0Q>[SGR<]5B]# M&XGY.-C>SNAB]WG/DYZK%Z&-Q/R<;&]G=#%[O.?)SU6+T,;B?DXV-[.Z&+W> M<^3GJL7H8W$_)QL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY:^+Q`(A`=1!C MC1EMH&[U1OJ[K3F[GJ#L596.-M`441(65HN4O'GA!$]-4W(@D39BUN\!,JQ$ M+*]LA\.Z,7N\Y\M@YZK%Z&-Q/R<;&]G=#%[O.?)SU6+T,;B?DXV-[.Z&+W>< M^3GJL7H8W$_)QL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&Q MO9W0Q>[SGR<]5B]#&XGY.-C>SNAB]WG/DYZK%Z&-Q/R<;&]G=#%[O.?)SU6+ MT,;B?DXV-[.Z&+W><^3GJL7H8W$_)QL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O M=YSY:^YN(#$#-3BJLZHRVT0$TZX&HU"AU3U!V**ES#D?3H1V4ST4(02/+8YJ M#C=B^BM])+V_C-JBF3*AVN(-C:XQ>[SGRV#GJL7H8W$_)QL;V=T,7N\Y\G/5 M8O0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&QO9W0Q>[SGR<]5B]#&XGY.-C>SNA MB]WG/DYZK%Z&-Q/R<;&]G=#%[O.?)SU6+T,;B?DXV-[.Z&+W><^3GJL7H8W$ M_)QL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&QO9W0Q>[SGR M<]5B]#&XGY.-C>SNAB]WG/DYZK%Z&-Q/R<;&]G=#%[O.?+7VEQ`(A?C5;+X9 ML9;:.5H/-OHSK:KB2-0=BCB2OMMQ)Q970UI,-AQY<,TGJJ8<*GB1@.]\!RPX M0N%[XY6H739M<9G?/EL'/58O0QN)^3C8WL[H8O=YSY.>JQ>AC<3\G&QO9W0Q M>[SGR<]5B]#&XGY.-C>SNAB]WG/DYZK%Z&-Q/R<;&]G=#%[O.?)SU6+T,;B? MDXV-[.Z&+W><^3GJL7H8W$_)QL;V=T,7N\Y\G/58O0QN)^3C8WL[H8O=YSY. M>JQ>AC<3\G&QO9W0Q>[SGR<]5B]#&XGY.-C>SNAB]WG/DYZK%Z&-Q/R<;&]G M=#%[O.?+/:TS(U)C6=AU!M)CZ0C#=F1&1UQ!D:/GC&KI3#@\$PPJ%?&FV]D9 M$5\"YU..ECA,U8KD`8+BX"!B7M>W=%F,=^^USVV?LM-1"@4"@4"@4%8=ROHV MR/\`<_V\:]!)\(_,Q$7HP8/LHDT$GT"@4"@4"@4%`=CN&3I[M3+#?F288Y45 MAVD99*?<@M=JR\W6@ENXFT&M+C,;#J1VG(*2VCSO/*";DYD92.Y$L3# M4-F3+.6%E!/&IJLF,[>WA>Q=W*/B)B^9"M'F$ MI7:=F)>6,(>.[D MML[&PCO5K.5FN$`0T@.UOK+87"H0XQ44RCKR<92E,`,T7S#'+"#$C8X>`X&> M`P.65A`\\<\<;V,O9;Z$FM=!1&TC`Y%TANI":A)1?,84QF`FI)($@1!S'&RS M&'R"*EPL,AA<\Q1+XWS$RRSRO>X9>@4"@4"@4"@4"@4&D,N.VK'XST';!(8D M)(#W59$<]QCIHY8XZEH@DIJB=!L:%%L3!&*HB?CB2*^#*A9!YYA!8Y"B7N&[ MT"@4"@4"@4"@4"@T@S'C5-R0B2P.2&R>S?9#HCQ,4;'36)<)JO!>:#D720B= M86Q$88PKL9NC@G1`+FBV!8<`$7$$T/AF&[T"@4"@4"@4"@4"@TB0([:LGH:< MW'B2&/I24]XUD0D``=-D,PW5$DB->4V.=R')B@BB`ISS9R"H&20F6111+EA4 M\\$,3,C@YCEZ^NS=Z!0*!0*!0*!0*!0*#2(SCQJQ%&\?1.Q20R:R8P9#4CQG M)Q@Z:4C">U64@D&VWB0ZB>%'.GQBJ0F%`!3IP<8T:S#R',"B#"9YW%WWO.MW MH%`H%`H%`H%`H%!I#8CMJM!RR.[4(D,67)7C!@^RB302?0*!0*!0*!0*#DMQ--MMP=26^XI5A]LZT-Z`XJA5 MPR<^)+V,7%LT8E&4"JUX@T-7(C:;(?+8=21([U3BPYI&>2RB.ELG%960T$FF M#G@E+'$WHTS5<7BS;B2=G?>Z?RJINOBT[+%'X]9$2HBBAIZO0--VE$`SNR7X M6?(NQGG;M>W8W5G@KMA>3UU+9+>QA-7E9N-\=K+S(6SCS&1W`9NN-?PI,`N6 M:)B3>VS59C&/RY]\=>WST=/XS6R20BM/8-T0]$3JUMV(1^(P+K:P6*"_"$[I M:OH>WY.)M)CH)IG&3B+G@84977@D2,HQ9B MLL@AO>77T6#<;47'0WH_;H9U6,M%HK95U+HWBX*3B+X,?"Y9C/YLX[N=[O\` MMQCB_BI;D;`*\B2R(\XY8+#)"(S@N<)J M$8FE=&D=Q*!]!+I%\44RUE-6/^/I8X)+KF=],MGG-[Y\GDPXGVPN6QUCUV3" MN.GV7$[&X6.*9.-_39W?HP4"@4"@4"@P[A/*B8WUQ20T,5S+:A@J:F("FIHJL;#!(!GU`8(B3S,6,&Q,"X8F5@^<1X\7;= M+7,#9)L[&Q-K([)8B_5B*)Q+M2#%EYCH^OLR3C.[$@B/M9MDG(,[GRB.!VY' M9&3GN,N,17;.*VUV@ZC:*B^2%!"<5'3@TW&+<9LW[9);;)X;;]M6!5.(CNE' M,4<1UM.>%H+F;9_A^8MU=<2G&K@6[)`[=?ZZ]'D*89GDP\ MA.=AICMS57:(`'=`5T+`?(T`.'3;IQ;)JZ[W.<8[)WRMYV1X@NS<1:>:4;$L M6$HZ=@FP^6GX4P/A:JN0:PMG@$5:0 MH9)7<0[E")")*L33IEU66V8SCOQ+V]G)V9HP4"@4"@4"@4'&'9K>#=+7C:F, MFVJ1EKV6U[EC:*'M;8FC@\NK:]MA.K>?2:[39<0*BD^[8\?*)=:N*9L[+TE:V+CABZ M%52"][C6\*3JLS&>9=S=F9MKNH(SL.-\A++V&WIC5CEV[6_=*L&[N;Z["Z\;2N-E:\0HA;'Q'O MF[]4T9E.!\B&HQB6.6E>,Q71)\MNG-U-PW)PD=I3I+ESN^TZ9QVK*<-7;61-P(:DQWR41C4XLQ;L5*\#ITG0 MIBX@X5G5$C<5$P+R[%`3I4UY6":2L=5E!M9X7=@ M=IEI3Y-HW364CI1AD,HDSFB^F0^%QRRJMGSJ427T\=026M@CW#-)2PJKB.GY MFM,EYYMVDDYW//?%FW3MZ[.6CLXS6V2G'#MF^/H)B%G,K6#4#4K:G:Z-Y8"? MYF27*8V;/JQP5@0TMI"XW$AG8MUBH"BZ4IROILNT59-GDE)-MU,QL9-YF^"9 MDSFW5JTRSE^7&]\;T\/;%XAN)_2 MPI->4HQ9*"<*@%#*:BQTVC9!Y*@)E`<:UAC5N2W.P(**1CUDO%RD6FT3"BLN1'1E%?= M*R>547_L\RT(^J/-72D]3*+CA)(`K>0!L%E4(Y8EF,[W$[;C/\SR<2&?Q5=N M7RK)6N#12M4W?L,ZMXE[4QE[)M=&E%1U$:-W1)OOB:9;IVXM[B;XQ.O+..SM;2/Q8-HSN ML.HDS(>O$7Y*4H[BM+4;8]WBO51&9,<.DMM$=U\=_)\Q!#9%ZN.[P()!ARLQ M1/N+(@R_*Q0-QX.O-,&*J8FB9U;\M-U3;G^6:IO]]UA=L.(G)46;G:M:XPFT M6,Z(^=.R46:_[1R`ZRZZ=,LYUS6QWO(S$CN.?)"\BD;/Y/8#C/)N#I=&$:8.HR?P9/ELT->ZR;M8S<<=QRF;C-Z\/+;E.4SU\ MTPZ6UXL;3:13 MR\X72Z5EUR`]%8,XM/!P"ECPV)"P&80Y-6K.V,3.>=N_C=^6(Z,49*!0*!0* M!04YWNU$#WDUX7]=#\OO^&&Z[5M`/.Q=CH!!-*SD;R(9$/CLA7*N0@I)9UJK MY[!/$<*88*"EU@D0NCJ`1E)/J!,R73>&YQ+CK[[6?94M0X6;P,-*"4",'SWM38G\-V'&]#VAT(-%Q.]`9F@DL M,"7([R[])/JKU76*RGZS\P7N:$3P2][.<>0EMRKIA#)I=_+5\;)P)(AE6N2;P[CMIGOEAK!=&8_F3CMR(SF5UCPWBM[IER\=QC$SCAXM\\.8*$UU.!/!#DACZ0 M8"81P$8J(8+AX&`A`KYX7#BI%_!);S&U^FW5MU[>3A)4(S>WU85=0%5B0 M*W745E\R_FK)*#L`I2@VHU(R4_90;#I:A4R2/R,Z741/EQ_%%0J:`()6!$W? MJ7,U8TRSQQC&,8MLDQTD6FCGAUI;L:^R7`VL%0$P4$3< M,7&89!(!=\4+A7"!.&KI]P,\0KXDFJR\7;OZRS]UXZ,E`H%`H%`H%!RC5^&4 MZ!]XW=O.V]S)B:[U>1EF)1YGYQM`;S1D6+VAXEB)#[)4C)E:P*G@#7%^7AQ,?^6<];OBX[,S$?WKOPJ&-KY-\;265 MFN2'M&VO"KL4N:JP.OHS'(-:!E3:=;-K4N"E74B(1)Y/L#/%46T5FEW:I&;- M1"6U$IB(HF1<3N);KMF,26XS>O#R\._'.R$I<*UK2)KSMAKNC[`RY'2#N!M6 M\MHI,<34+-2ZW@(^;M81?B@J$H)9A/.1ZHBM!*P5"BF7-&5M-R/(JOF<2%`X M3&$UV73<2\,Q,\N=N?'?]UO-2M?G5K-%`,5.6;G'.))'5+>9JFOQU#T7`,=F MET1$2$J/6VTX18T?LXJVT<=+.J9#/)#S4L1EHV4S-Y$"J>6*F;=SW[V MU9VB%`H%`H%`H.;^^_#TOO4N0,L'-B)$AXI`+F6WP@-9M,R*Y"93E?*@73R: M&[GBR9<:+T:#A6&.5*G[,H950CN+=.KBFJIN)94R`.`FM.KASM+G;?/I99C* M#IEX0A&)W,UFFDQO")V9\WF>#+=69C$F M^;CMN,7 MIA0Q'X3BTAQ+#S"3]R).+//6.3D63-6)&385UK:I>$,BC/[?=2IYQDG$G"JPJK@14BZR#D$;!/&N/>[3\W.;[]^;;=KT2RF<,.*$C M5*"-4R;_`'\(B0IL(P=FS;^.XM\P\9&E-I3,;G9P*3JL&EED@`H]GTI*5SY9 M*(EO(Z,.73$H0/`B`)1..YMVWEGA,8]GH["\(O338:9H[GU8CXJU91:,_-6? M7@YF[C!@^RB302?0*! M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*! M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"L.Y7T;9'^Y_M MXUZ"3X1^9B(O1@P?91)H)/H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H% M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H% M`H%`H%`H%`H%!6'->@D^$?F8 MB+T8,'V42:"3Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0 M*!05AW*^C;(_W/\`;QKT$GPC\S$1>C!@^RB302?0*!0*!0*!0*!0*!0*!0*! M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*! M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*"L.Y7T;9'^Y_MXUZ"3X1^9B(O1@P?91 M)H)/H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H% M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`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`/?^!=:$.'_,`;80N/>BA!Y_P"8]WO />]R[N-[VN:TS-DO\V?_9 ` end XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt - Additional Information (Detail) (USD $)
12 Months Ended 3 Months Ended 0 Months Ended
Dec. 31, 2014
MortgageLoan
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2014
Derivative
Sep. 30, 2013
Derivative
Jul. 01, 2014
Feb. 10, 2015
Debt Instrument [Line Items]              
Outstanding borrowing $ 150,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity            
Outstanding borrowings under revolving credit agreement 89,750,000us-gaap_LineOfCredit 93,700,000us-gaap_LineOfCredit          
Outstanding borrowings under letter of credit 6,300,000us-gaap_LettersOfCreditOutstandingAmount            
Available borrowing capacity 54,000,000us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity            
Average amounts outstanding under our revolving credit agreement 104,600,000us-gaap_LineOfCreditFacilityAverageOutstandingAmount 86,300,000us-gaap_LineOfCreditFacilityAverageOutstandingAmount 75,400,000us-gaap_LineOfCreditFacilityAverageOutstandingAmount        
Effective interest rate 2.40%us-gaap_DebtInstrumentInterestRateEffectivePercentage 2.20%us-gaap_DebtInstrumentInterestRateEffectivePercentage 2.40%us-gaap_DebtInstrumentInterestRateEffectivePercentage        
Line of credit, fair value of borrowings outstanding 89,800,000us-gaap_LinesOfCreditFairValueDisclosure            
Mortgage loan maturity period Jan. 05, 2015            
Percentage of increase dividends in excess of cash available for distribution 95.00%uht_PercentageOfIncreaseDividendsInExcessOfCashAvailableForDistribution            
Balance of Non Recourse Mortgages 122,882,000us-gaap_NonRecourseDebt [1]            
Net debt premiums 523,000us-gaap_DebtInstrumentUnamortizedPremium 834,000us-gaap_DebtInstrumentUnamortizedPremium          
Number of non-recourse mortgages 16uht_NumberOfNonrecourseMortgages            
Mortgage loan fair value 124,700,000us-gaap_LongTermDebtFairValue            
Interest Rate Cap              
Debt Instrument [Line Items]              
Number of interest rate cap agreements       2us-gaap_DerivativeNumberOfInstrumentsHeld
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
1us-gaap_DerivativeNumberOfInstrumentsHeld
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
   
Notional amount       20,000,000invest_DerivativeNotionalAmount
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
10,000,000invest_DerivativeNotionalAmount
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
   
Premium paid       134,500uht_PremiumsPaidForDerivatives
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
136,000uht_PremiumsPaidForDerivatives
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
   
Expiration date of interest rate cap       Jan. 13, 2017 Jan. 13, 2017    
Interest Rate Cap | LIBOR              
Debt Instrument [Line Items]              
Derivative instruments, LIBOR rate       1.50%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
1.50%us-gaap_DerivativeBasisSpreadOnVariableRate
/ us-gaap_DerivativeInstrumentRiskAxis
= us-gaap_InterestRateCapMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
   
New Revolving Credit Facility Agreement, Additional Borrowing to Repay Outstanding Mortgage Balance              
Debt Instrument [Line Items]              
Revolving credit borrowing capacity additional amount           9,100,000us-gaap_ProceedsFromLinesOfCredit
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementAdditionalBorrowingToRepayOutstandingMortgageBalanceMember
 
Mortgage loan maturity period           Jul. 01, 2014  
New Revolving Credit Facility Agreement, Additional Borrowing to Repay Outstanding Mortgage Balance | Subsequent Event              
Debt Instrument [Line Items]              
Revolving credit borrowing capacity additional amount             4,900,000us-gaap_ProceedsFromLinesOfCredit
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementAdditionalBorrowingToRepayOutstandingMortgageBalanceMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Mortgage loan maturity period             Feb. 10, 2015
New Revolving Credit Facility Agreement              
Debt Instrument [Line Items]              
Unsecured revolving credit agreement terminated Jul. 24, 2015            
Outstanding borrowing 150,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
           
Revolving credit borrowing capacity additional amount 50,000,000us-gaap_ProceedsFromLinesOfCredit
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
           
Credit facility, Interest Rate Terms One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%            
Base rate description Greatest of (a) the administrative agent's prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%.            
Fee payable on unused portion of commitment 0.35%us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
           
New Revolving Credit Facility Agreement | Minimum              
Debt Instrument [Line Items]              
Fee payable on unused portion of commitment 0.30%us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
           
New Revolving Credit Facility Agreement | Maximum              
Debt Instrument [Line Items]              
Fee payable on unused portion of commitment 0.50%us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
           
New Revolving Credit Facility Agreement | LIBOR              
Debt Instrument [Line Items]              
Margin points added to the reference rate 2.00%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
           
New Revolving Credit Facility Agreement | LIBOR | Minimum              
Debt Instrument [Line Items]              
Margin points added to the reference rate 1.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
           
Margin points added to the base rate 1.00%uht_MarginOnBaseRate
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
           
New Revolving Credit Facility Agreement | LIBOR | Maximum              
Debt Instrument [Line Items]              
Margin points added to the reference rate 2.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_VariableRateAxis
= us-gaap_LondonInterbankOfferedRateLIBORMember
           
New Revolving Credit Facility Agreement | Base Rate              
Debt Instrument [Line Items]              
Margin points added to the reference rate 1.00%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
           
New Revolving Credit Facility Agreement | Base Rate | Minimum              
Debt Instrument [Line Items]              
Margin points added to the reference rate 0.75%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
           
New Revolving Credit Facility Agreement | Base Rate | Maximum              
Debt Instrument [Line Items]              
Margin points added to the reference rate 1.50%us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_VariableRateAxis
= us-gaap_BaseRateMember
           
New Revolving Credit Facility Agreement | Federal Funds Effective Rate | Minimum              
Debt Instrument [Line Items]              
Margin points added to the base rate 0.50%uht_MarginOnBaseRate
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_VariableRateAxis
= uht_FederalFundsEffectiveRateMember
           
New Revolving Credit Facility Agreement | Letters of Credit              
Debt Instrument [Line Items]              
Outstanding borrowing 50,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_ShortTermDebtTypeAxis
= us-gaap_LetterOfCreditMember
           
New Revolving Credit Facility Agreement | Swingline/Short-Term Loans              
Debt Instrument [Line Items]              
Outstanding borrowing $ 20,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
/ us-gaap_CreditFacilityAxis
= uht_NewRevolvingCreditFacilityAgreementMember
/ us-gaap_ShortTermDebtTypeAxis
= us-gaap_LineOfCreditMember
           
[1] Amortized principal payments are made on a monthly basis.
XML 17 R54.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]    
Net property, including CIP $ 62,450uht_EquityMethodInvestmentSummarizedFinancialInformationAssetsPropertyPlantAndEquipmentNet [1] $ 119,547uht_EquityMethodInvestmentSummarizedFinancialInformationAssetsPropertyPlantAndEquipmentNet [1],[2]
Other assets 7,367uht_EquityMethodInvestmentSummarizedFinancialInformationOtherAssets [1] 9,479uht_EquityMethodInvestmentSummarizedFinancialInformationOtherAssets [1],[2]
Total assets 69,817us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets [1] 129,026us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets [1],[2]
Liabilities 3,348us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities [1] 5,336us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilities [1],[2]
Mortgage notes payable, non-recourse to us 52,728uht_EquityMethodInvestmentSummarizedFinancialInformationMortgageNotesPayable [1] 80,112uht_EquityMethodInvestmentSummarizedFinancialInformationMortgageNotesPayable [1],[2]
Advances payable to us   22,911uht_EquityMethodInvestmentSummarizedFinancialInformationOtherLiabilities [1],[2]
Equity 13,741us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity [1] 20,667us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity [1],[2]
Total liabilities and equity 69,817us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity [1] 129,026us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity [1],[2]
Our share of equity and advances to LLCs $ 8,605us-gaap_EquityMethodInvestments [1] $ 39,201us-gaap_EquityMethodInvestments [1],[2]
[1] The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December 31, 2014.
[2] As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. The amounts reflected for December 31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December 31, 2013.
XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.1.9
Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options outstanding and Exercisable, shares 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Options outstanding and Exercisable, weighted average exercise price per share $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 1 year 7 months 6 days
Price Range 1  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of exercise prices, lower limit $ 34.90us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
/ us-gaap_RangeAxis
= uht_RangeOneMember
Range of exercise prices, upper limit $ 34.90us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
/ us-gaap_RangeAxis
= uht_RangeOneMember
Options outstanding and Exercisable, shares 13,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
/ us-gaap_RangeAxis
= uht_RangeOneMember
Options outstanding and Exercisable, weighted average exercise price per share $ 34.90us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
/ us-gaap_RangeAxis
= uht_RangeOneMember
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 8 months 12 days
Price Range 2  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of exercise prices, lower limit $ 36.53us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
/ us-gaap_RangeAxis
= uht_RangeTwoMember
Range of exercise prices, upper limit $ 36.53us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
/ us-gaap_RangeAxis
= uht_RangeTwoMember
Options outstanding and Exercisable, shares 23,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
/ us-gaap_RangeAxis
= uht_RangeTwoMember
Options outstanding and Exercisable, weighted average exercise price per share $ 36.53us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
/ us-gaap_RangeAxis
= uht_RangeTwoMember
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 2 years 2 months 12 days
Price Range 3  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options outstanding and Exercisable, shares 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
/ us-gaap_RangeAxis
= uht_RangeThreeMember
Options outstanding and Exercisable, weighted average exercise price per share $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
/ us-gaap_RangeAxis
= uht_RangeThreeMember
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 1 year 7 months 6 days
EXCEL 19 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0"2XK.50`(``"0E```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VLUNVD`4!>!]I;Z#Y6V% MA_FC:05DD;;+-E+3!YC:%VQASU@SDQ3>OF.3H"JB(%2DG@T([+GWX,6WXK+IRLKYSL3TT:]9;\J-61,3T^F,EK5ELGSAB*= M'.\)==.'=RE&SHYN&*[\?<'SN6_IT?BFHNS>^/C5="D&V[;LE_.;G\YMBM-# MCJ1TJU534N7*QRX]@2+TGDP5:J+8M<7X7G2FL2^Y3^P?;PYL?.-7#C+\OG'P MA3D$2`X)DD.!Y-`@.68@.=Z#Y+@!R?$!)`>?H@1!$96CD,I13.4HJ'(453D* MJQS%58X"*T>15:#(*E!D%2BR"A19!8JL`D56@2*K0)%5H,@J4&25*+)*%%DE MBJP215:)(JM$D56BR"I19)4HLDH4616*K`I%5H4BJT*15:'(JE!D52BR*A19 M%8JL"D56C2*K1I%5H\BJ4635*+)J%%DUBJP:15:-(JM&D76&(NOL?\D:4P>$ MV/CZ[Q'&,6=*""'N6@I7_N-P/_3X*6V,YR>]&D0^=C0H;ASK`!SV)@:09]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24 MFV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A M363X8<'%#U1?````__\#`%!+`P04``8`"````"$`;'?)KXD"``"W)```&@`( M`7AL+U]R96QS+W=OK9F=;]NU'B_UEY5#Z=C>?7KBP^;S:Z-GX?VQR'V^3_OJ'\-XV/J8LQET3!N M8V[4="O5YR?:+TIF5;\01]AQ!,4QEAS'6!3':G(:BEK); MPCB.'<>A.-[,&2?ET[Z@:NKRO]?H_>Q:@:7"[B/81L)&L&`$W\Q9*!/^+[4R MW?IGA!M4-\(V@D`C:+81-#2"85>R@:5LV%UN8)M;MA$L-()E&\%"([A9C3!U M]KI M;>0(]E;AG6(+RT%AL;L*-I6P_2#0#\+V@T`_:#:0-02RH9<.K!W#[G(#V]RR M@6PAD!U[+G5P+M7L44?#4<>RF6PAD]VL]GS+\1-.[7Y6*N?R#4V\G(3/E_7Y M)_R;L'<(AF'W-FQM86M!H!8T6PL::D&SM:"A%@R[=`RL'(DUX=O#LVO&P=ORLDFC#OOW4A5U_\?AT M"QW$Z16#PK#1!\DG;&L*M*:PK2G8FNR],M-FU<_^W6CU!P``__\#`%!+`P04 M``8`"````"$`S4![=WP%``"H$@``#P```'AL+W=O'SE^ING#ZGWI.1Z@PC:3:7CC?5E__&CN=7',5 M\3A5XL)Y$;GSY?+//SX?TNS'.DU_=$A`Y1?.3NO]>;>;ASN1\/Q3NA>*KFS2 M+.&:EMFVF^\SP:-\)X1.XJ[;ZXVZ"9?*J13.L]_12#<;&8I9&A:)4+H2R43, M-=G/=W*?.Y>?-S(6WZN(.GR_O^,)^7Z.G4[,%%K%<4WE&=\N5ZKCLRWS2I^"[%(7^[R2P[SX]2 M1>G!?)52^W):#;.8^:OY MC%WY-_[==,Z"Z_E\%8#$R`4-]P,:[)Z#S`!4RF2_ZR18D:';^=TJ8,NO;'$W M!14/5+Q6+W65Z?(65"CQIZP,/Z)R[8/*"$,JJ?C-D*;7/NW+:8_.P,W91]SX MN$U4N*>8QDV5H$@2GKVP=,,"N562JHHKS?PP3`NEP,CG" M5/8M5F=BKE1_%8LHOSPL2 M%0S]3-"_Q>N"ODZU^R38?(&(;R6O]@X(PX>].Q M&`W$UO15]B#V::;I#,!;L>S[%I=_%SS3(HM?Z.:<&F7-_0!_U8+Q05#BYW3* M:%$FD"@LDH*:.H4S$V@!8>Q;-+9#7:LPQ)$:NS64KW[4X$$SW_\"TC8R13_>#?**1,2U.@%9'*S91 MB[)?6$%.78O3=DCHWE,;'B.U[B^H?1L[[-Y7$T)L70O;^;/,3:VQA!(',#3`)-.B06V[3BW)B/_@@]36A!#_@86M'\=I6,YFYJ"Y+[)P1PV: MW637QL@1G"3`\LC-O]U`+#PJ)9 MK9%JPM#,6!3:DW@;LY2_3@L=2#142Y#5;U_KVH]H*J4)MCQ_CD.;POXPJ"7( MACKI@V_!LHK?;3&S- M^3*EYX0TEE%YN`15VD!G4M.Q@6[508`\;!ZT:`36/C'4A!!IST*Z,3*P^N9! M9![6/"T:AI;[:OBZ$L2?()E_BER7LX!.V1)UD&C/(OJH@]M5/I,\BRS$RO"0 M:%HT_#R63T"$C4\/IWPK:*HP#XMF]VD+T0]6JF<171'TWF2$77J"YX9G(7TC M$_/DR&XD7\O8M"`#-%=2Y#0V@Z$A(DV+1F#M.KCS0V21%@TA2@/-G'E566NI MZ)_`C%#EIJ5H"`,;6DRWZ]0,(=-#B^E?"%UQFF.IUP<[+/I)3<="VC\5&1T4 M-)7OJ2WZB7DNR=FLP,`0Z:&%=+L.!C;!&AM:3%M3<:W*P-"D9LABVAY>9D)S M26\F3C/'$&FF16//7QN68(O%@BJB,3:C#O;YH05SNPZF9H0TTZ)AZ$&$*6T1 M]773/LSQ@Z[`T`AAI@7I=,NHZ45&R..0WK"8/^4K"F\XJD;I[O$ET^5_```` M__\#`%!+`P04``8`"````"$`2\MUR(0(```0)@``&````'AL+W=O#TV&_=ATG7!_J MW7&)$6[.U\1H'Q]WFR9O-R^'YMACD'.SKWNX_NYY=^ITM,/FFG"'^OSEY?1I MTQY.$.)AM]_UWX>@R\5A<_/;T[$]UP][X/U-^/5&QQZ^6.$/N\VY[=K'?@7A MUGBA-N=DG:PATOWM=@<,9-H7Y^;Q;OE9W%2>OUS?WPX)^G?7O';&_XONN7VM MSKOM[[MC`]F&.LD*/+3M%PG];2M-X+RVO,NA`G^>%]OFL7[9]W^UK[\VNZ?G M'LH=`"-)[&;[/6^Z#604PJS<0$;:M'NX`/B[..SDTH",U-^&S]?=MG^^6WKA M*H@<3P!\\=!T?;F3(9>+S4O7MX?_$"14*`SBJB#PJ8,$JT@XB1=!D#<4( MG\K1=5:^&T3Q,/T;GK[RA,_W30D7-!"&SW=.&2I/^'S?E)%RA$\]9?(FRS46 M::AY7O?U_>VY?5W`1H(R=*=:;DMQ`]%TL3%/8_E_5'THNPSR64898D%A.UBR M7^\C[W;]%5;91D%2A$"3&"&"(C*-D$M*1LVYH>"&DALJP[`&AB--6$>_'ZBY?@NR7D M85QA4<0N'B'1L$)%$#I\">+X1"XG#G[$5W7!'4KB$/A>3*^@,AP(4V@>US.5 M8,:4S9,B)!R8>L*+61DS'#>8F@YNE`1L?17QY<$+WRVORL#3VA",S5IRL9ZN>-()THW M9M>7(@3I1G["AC,<-NB:^!`.09J]@N-+@@\CUO`J`T_H2O7'SI'+=*43H\MV M9(H0'\\4AUU]ID=UH\RU01Y!/L]=H48$$2@CS&(G9)D@%8K!BKA/'K%EF"C"Q MS(F+B*.`)::P7$KBXCJN8#V\,ETH8RD&KF>,TH$P9H12@1C%./#9>*;&3<+$ MPPM9VRXLCY+.(03SJ$P/2E?*A^OIHM@@=%EF4X$8I"O".&9;-E,`DR]Q\7V' M77YAN91T%C^P-)WI0AE+&7$]8Q0=A#$[)E.AAF7": M!*E>6!)$)!].7>#5. M,SSM7YJ#=VD]U]9Z"6^9"H-7]RGV^`.13`&F\N74)?(CU@(*RZ5D+E$X\1N6 M666Z4,:P?#^T^EWI2`LO');[5('PB4D@@H"UQ$P!:'%X&R!1A"84UY&(NR$R*:)2`1:E4E)D,,45Y?89L<2FX&DQ=!/TX0SA^(4-FD+D, MS029R1"-8F<(QVF"]T^,X+T"NJV(!4.:PVIJP6G/"O8?L[&07U6Y*-%PJV' M6>.HQI>C1>*MGJKG!CCE^R$9ZMHR5#A<3RB0KEO";R0R!3!+C7&U2\3[8F&Y ME&R6D#?,N-R'G+ M>X!W\A["<#G`FDJJ0)2W8*(AFU`C;]M4V*;2-E7$1'DSJ3><6,X'B-LB4`C6 M&E,/08PXTW79A)J(CX[:5-BHTC95Q$2)SRB^CQ1\1O_Q'W%2#T&,-SN_L@FE M2>:VJ;!-I6VJB(GRGA%Q'^%M2SI^(Y]ZB&&TV=F53:B)]NBH386-*FU314R4 MMA0DK*]]A#;J&MJQK&6.(,:;G6$9O'TB-0V@-,G<-A6VJ;1-\DV6*1;RQC=3 M\"V%0W-^:K)FO^\6F_9%OG4"9\W][6C&5V*@+\$[,<-K+=:(?%MF.)ZL$1=& M!@K6B`O&K@[0MG!>#'MNWU%SG!^"[7_?\```#__P,`4$L#!!0`!@`(```` M(0"\HRQOS@4``.@7```9````>&PO=V]R:W-H965T__K)X:]KG;BME[X"'?;=TMWU_N/.\KMS*NN@FS4'N M867=M'71P\=VXW6'5A:K85.]\P+?GWIU4>U=]'#77N.C6:^K4N9-^5++?8]. M6KDK>N#?;:M#=_16E]>XJXOV^>7PI6SJ`[AXJG95_V-PZCIU>?=MLV_:XFD' M<;^+J"B/OH M^JYWOQ@2]&\EWSKRN]-MF[??VFKU1[67D&VHDZK`4],\*^BWE3+!9L_:_3A4 MX,_66?I?59MM#N6.(2`5VM_J1RZZ$C(*;21`K3V6S`P+POU-7 MJC4@(\7[\/.M6O7;I1M.)_',#P7`G2?9]8^5'(V;13`)YK&(IY!C.D)V\Z(O[1=N\.=!R\/>[0Z$:6-R! MYV-:,(@Q41_E"1*DG#PH+TL7S@JDH(/BOMX+$48+[Q4J4FI0>@9D(K(C0J5? M^(A1(QBBB"LP9D(Z+*181Q5='E. MXS?8)Y]AKS99[(69X!1!FGT$"337,V-]&B1L/:?K(IHG9.`9$0@XD[<78-AE MQ<#&;JI1T=!%C&`V+A[G>$XM)D>E&Z1)?JX/`E7&G'-1:.8OU:C3E,@L2TXM M)B&E%M<30FVY(`("4900M^048Q)2`D$(73=M!4XM)D^E%H3GA4JBMC!^7#T%HI!?/)L'#)!I`.7WD6BI*^0-_%!8 M&#^NJ(//I8O\PB2(+'Y$GW#XZ"T#8S-_2AA(_JZL,\H)X\EE55#1$3-![C^Z MS@B@>206DZ<:_[?S1-%@/+FV"D1A/I-Y;`T6NCZ?D<&GDTO7A1^2.,T8E`3< M'@,*!XN!RZM`%-YAHG`2L/&?<4#,3F5N`,)DXD<)^7>JK1F24H7;0T(M,4/B M:4\%59PHB*>"!9T9B'#N"]\*RO#AQX(,(R.0@*G6S^?(@.9J%;.4IQH%HX%, MPYAI6G8>Q=0E/X\ZA6L&G1N%--)P+2@+'DD:0L40M)M%/R61P3B;CTQ$;:*0: MQ=J'#:]L1(VW'FHQR2J1(H?U0H^CI+%#RHY@&B#JE*O,LN348A*Z21S5(P:4 M%W)'CI/UU5>C*"%+#2G&)*3DAV1(J6$$VR]D"D7+S!2_7ZDSGK M,2%`E)Y"QI=`?7810'-(+":_3VE7<$Z[0NOL(NKC)P7MAO+$+8/%X*F^O=): M7W=%&W;Q83AEXI-J%*VY$%,F/MF(&HM.+4@6'U;QZ;"6[49FGAA'7[=PHNZA)="?P+@==/TQP_PA[WQC?[^?P```/__`P!0 M2P,$%``&``@````A`-G2[VBD!```X!$``!D```!X;"]W;W)K&ULG%A;;ZLX$'Y?:?\#XKV`(2$7)3DJ6-T]TAYIM=K+,R%.@@HX MPK1I__V.,0&/(9?3/K1AYO/D^V;&'MS5MX\BM]Y9)3)>KFWB>+;%RI3OLO*P MMO_Y^^5I;ENB3LI=DO.2K>U/)NQOFU]_69UY]2J.C-461"C%VC[6]6GINB(] MLB(1#C^Q$CQ[7A5)#8_5P16GBB6[9E&1N[[GA6Z19*6M(BRK1V+P_3Y+&>7I M6\'*6@6I6)[4P%\7&"$-LLS^K/)JAM%>GR^Z'D M5;+-0?<'F23I)7;S,`A?9&G%!=_7#H1S%=&AYH6[<"'29K7+0(%,NU6Q_=I^ M)DOJ$]O=K)H$_9NQL]`^6^+(S[]5V>Z/K&20;:B3K,"6\U<)_;Z3)ECL#E:_ M-!7XL[)V;)^\Y?5?_/P[RP['&LH]!452V'+W29E((:,0QO&G,E+*G]9I4 MT"B#/,LH:QO:'98+J,_[AI!PLG+?(:EI"XI&0!@17Q`R@S(NU0PN$.Y80RYT MUN-UN)"38$GN$C52!HC=L?4-(D-$X&$('4)FTPZ"R`:8K$SQY&KS7$C+15`* MC2-DM/^")CV1`DTZ9;%IH)H!<8)2ZPF\E/UV(N6BM0W"N[P!I[`3K3@I4-@T MP<2#'^R/D3\8^*GNGQ+=CP1``G]>@%PT$###!",%4@*>I`+LCY%_1`#RS_7U M2$#X%0%RT4#`'!.,%$@)"$*=0%.A6/>/5(@B/Q*(!,R^(D`N&@A8&`(4:-&T M4#!US+:/#;]O[%Z*_($S[^,C`7(ZCQQ]M_>`7&0*F!DM$BE0*R!P/*/%8MWO M+YR)<5)2Y`^=6;_'D(#%5P3(10,!Q*B``G456!@$8\-O5H@:?JU"2`"!2:.7 MX';J&S2F/@^,U$8M2#L3!Q:J6S`?.6^,EKA_5!,UI>Z9R>FD4Z/3\< M-+("]=\>$]-"=0OF(X>%QN>QMS.B1LR]+:]0.C'30MM((XF20T`C=F?+JY&A M)XJ0X9;7!TLPMFETP.BF08#0\?I6P&F5$^!Q]FI>&.P'6QY-E M`:ZS]W]J+C5H/)<@]^:6;U%:,[26JT<810"L!R7;-\;6[59IT`.ZYI9O45?/ MH[@%]'KD#5R>$EHKJPNUNF\6K#JPF.6YL%+^)B_+/KS@==;N(O_LR^N,88_@ M@M_0GK.#(ZB2MW0U4/-3\TM=\MKN%DW'X_P MGQ0&UTO/`?">\_KR`%_L=O^;V?P/``#__P,`4$L#!!0`!@`(````(0"4CJ$] MK@(``+4&```9````>&PO=V]R:W-H965TM%S=F9G MEJ*6%X^J0P_"6*G[$M,DQ4CT7%>R;TK\^]?-V3E&UK&^8IWN18F?A,47J\^? MEEMM[FTKA$/`T-L2M\X-"T(L;X5B-M&#Z.%-K8UB#FY-0^Q@!*M"D>K()$T+ MHICL<618F(]PZ+J67%QKOE&B=Y'$B(XYZ-^V8N=\,9URK`2C6 MLI/N*9!BI/CBMNFU8>L.?#_2G/$]=[AY0:\D-]KJVB5`1V*C+SW/R9P`TVI9 M27#@8T=&U"6^I(NK&2:K9W2-;*NW7XVLOLM>0-@P)C^`M=;W'GI; M^4=03%Y4WX0!_#"H$C7;=.ZGWGX3LFD=3'L*AKRO1?5T+2R'0($FF4P]$]<= M-`!'I*1?&1`(>PSGK:Q<6^*L2*:S-*,`1VMAW8WTE!CQC75:_8T@NJ.*)),= M"9QW)!,H>+^8Q$:"KVOFV&II]!;!6H%*.S"_\N@""/>&HOQH\2V'8,V37'J6 M$L,BA^8M3.5A1>FL6)('R)+O0%<1!,<#:$00:&?L"?HX[NGU=OSG(OYXM@:L?/(XV8(B2>%6F:CHV#GNMG(&W4C9A9T\^P\S]XP/#L5]J/-X&-_/W!?]+R!@['80,1`[.-0*"T. M7<;4X_81/S,E3".^B*ZSB.N-WQHH=#\^'7>MRTE8+>,+V#4&UH@[9AK96]2) M&DK39`;)F[COQ!NGA_`1K[6#_2)&PO=V]R:W-H965T M2;@ M)*B`D>TT[;_?8Q_"Q:8A[4NNWSG?=Z[8F[O7(G=>*!<9*R.7>('KT#)A:58> M(O?G?T]?EZXC9%RF<!INTDSB$"EW>%T'[GW9/T0 MSEQ_N]$)^I71L^A\=L21G?_B6?I/5E+(-M1)56#'V+."?DO53V#L6]9/N@(_ MN)/2?7S*Y;_L_#?-#D<)Y9Y!1"JP=?KV2$4"&04W'LI(6`X"X-4I,M4:D)'X M5;^?LU0>(W:R?A9,S8 M1R$ZKL=8QML-9V<'F@6H1!6KUB-K<*@"FH(4I&]"?"]"4*6<`?NC3A M,`TDK4MS"?TZG3*"JG6#((ME0X`2$#35K=0-;&HS3J`'KS,JH\B%J-JTD<7* M8$307*=^,@^"H/F_EUFH[,=#5D:F@&5+@"$C:(4"9MYJ.BQ@_AD!RL@20!H" M%(`@R$,G3?-)`^JE8=%7<3W_"FRQMRV%[`BR*ZX6_\!X76=41J,]AB";<=5G MO,ZDP%9L;=(P-@35I9UZ;>OUGRN" M^VADL&H43A:9O#M91*T=0X-:I"-IP&75UV#-EO8=N:-I^-1"([BL#`GF=-6H M_G@M9\/C1=0VZN1B)`>XNPP!\\9UW0J(LOM=/7Z[9+>M<6TU.F,U:H#4V&,C M$0XN,'/,"*+J*L.QH`7T!^U#VXL,KB]KT!`USCVPSVZ8--Q5_0I;CS""*)RT M\,JD&1ONQH(/KCKS*49ZN^[]&H3&LKM-@[:REIXY:C7*&+7V,-5KAM!8?=<; M4:,M`>;II4;971]"!3\^:MIJ=-1JU`#IP%8;;SEU(K:>;%;+U:C18U-H++0; MRSVXV,R6T[Z;Y?[^R4E=$#Z1?#R7]4=O:;4\%:$MX>"\@/]D^:Y M`D>_YM?F-G8?ZD-P\P=(1K+X4#?N`!>,^8O'Q1%[;F(KW]'P``__\#`%!+`P04``8` M"````"$`1`F(%5P(``!:*P``&0```'AL+W=O'L9_ M_Z4^K<:CLDI.^^20G]*'\8^T'/_R^/-/]^]Y\;5\3=-J9"*D^/IV_K3+CV<3XBD[9-6/ M.NAX=-QMOKR<\B)Y.AC=WX-YLFMBUV]8^&.V*_(R?ZXF)MS4#91K7D_74Q/I M\7Z?&07VMH^*]/EA_#G8Z/ER/'V\KV_0/UGZ7H+_1^5K_JZ+;/];=DK-W3;S M9&?@*<^_6M,O>XN,\Y1YJWH&_BA&^_0Y>3M4?^;OOZ;9RVMEIGMA%%EAF_T/ MD98[^2CFM8D2 M3H8*F;IIKK-&)%7R>%_D[R.S%,U$EN?$+NQ@8R(WZ>(FMTV@_\L?DS@VR&<; MY6%L]A"3&J5)^F^/0;!:WT^_F4S=>:.M,S)_.R-L$3<6-BUM7$&!I$!1H`&8 M&HVM4).+4.CE]=#HL<963S.0;0.ZL8=D[-QB%9`[(+C->D'BR$LV$?XLY6R, MTO9.KL(9MM'<)NI,T)TQZVOXG;'&Z,Y0$%,@*)`4*`>0GF!%]%RW08+,4H>" M;$Y'9B.]/N76R=B!>QH$P1P/8NN,YFU>Q!0("B0%B@(-`))AM@8HX_KPK?'# MV$PZ2`F26EMG,Z_7YS+`TN+F8I/R@@))@:)``X"4F(T/*ADV(=:)*(K(H+?. M)IA%;L\ADJY>%>YJ-Y>2`D6!!@#I,QLGU'=]IJPQUK5>T9ER-MW88@H$!9(" M18$&`(W>MGZD!/0O%^O4NUR<$9!!@:!`4J`HT``@&>N/R+!.>#)6$5WTS@:H MH$`XT*3A;+)>X$R4U$-1H`%`J@*S<<'9N9Y;M376$P3K;M^OJ^K66P%%C`A& M)".*$0T)EF'+\LU)%KABWK,I>RLHQ_EU1#`;R8AB1$."Y=CJ>KL<5Y/1)LVR M+7!&W=AC1@0CTA.0@C@#%7/1D&!QMM0"<3TIYPHS$C5?XD_?!LX(BJ)$,!O) MB&)$0X)5V+(*5`PK.H$KQF9P;1V]T`9X*R@'%''?NE(BF9=B1$."Y=C:"N3T M3(JKQ&A20EID[-="L_FY?F!.^JVXO=HV!(Q(1A0C&A*LR%;3X8I<[46*(C+F M;0`*=#T+,2."$Z"@]G9<4RSQNY#8ZT9'%[L4DNP8AD1#&B(<&"S.!N3[?0>N$. M;K4@SQ&VW@A.CW/KB&`VDA'%B(8$J['U^N;%$[HJW[//>:MN\#$C@A')B&)$ M0X+ED.Z@)]M<+>_)-EKPXY`2P8AD1+7$[I>D9NO_N8BUD59AX,9PH66(R*+9 MVB>F=CRD!(14B(948QH2+"<#W4/(>\>5GQ5T58A]FXPU:B-9#;* MDR9_9Q.^JD`4I,X^\*&IU_\0J/8BQ8H]H_-&G9;8DV:<9)T)YB`948QH2+"T MFQJ+B#<6X9+LPEMO!"4YMXX(9B,948QH2+`*6^#)WF`E7]\;(M<6]*PF;]4- M/F9$,"(948QH2+`Q1; M64V#`9^_K-D$-E;-]B\B2B0CBA$-"9;XH28CXDV&D%=1<>J[LCCUPB4??=T@A'!B&1$,:(A M02KF'VHH:J_>IQ/>JKN],2."$X4*^\E:G<[>\%*WKP)6Z-VG+%B&1$,:(AP0H_U&_,>;]A%)+) MV'HK.('.KR."V4A&%",:$BS'%G.P`PY<;*X%Z"E7]OLT?H+!B&!$,J(8T9!@ M.1]J)LPA0=[KLLFAG4/LW:ZM+NHCO4\WH8H1>V:QO6].G3N"Z`Z3'=/B)8W3 MPZ$<[?(W>[QP84YDM+0]^O@YLD=G"-^&F^TE'H>;^!(7X49RKV\3\```#__P,`4$L#!!0`!@`(````(0#]S%*/ M_P<``(@I```9````>&PO=V]R:W-H965TB8UC-+:Q@$QF_OU6=Q=070V&SLMD MW#[='*H.']CNQX_?SZ?%M[RJB_*R]<1R[2WRRZ[<%Y>7K??/WU\^W'N+NLDN M^^Q47O*M]R.OO8]//__T^%967^MCGC<+6.%2;[UCTUP?5JMZ=\S/6;TLK_D% MWCF4U3EKX&7ULJJO59[MU:3S:>6OU_'JG!473Z_P4,U9HSPI\E/6@/_Z6%SK=K7S;LYRYZSZ^GK]L"O/5UCBN3@5S0^UJ+[F4 M5?9\@O/^+L)LUZZM7EC+GXM=5=;EH5G"'O<%G($L^Z+* M#UOODWA(XSMO]?2H"O1OD;_5Y/^+^EB^_5(5^]^+2P[5AC[)#CR7Y5C@VT.X(SDB?VL/_Q.:]W4%%89NE' M0(#\._B7,AH0$6R[UO/AP,7^^:X]8)X&=VM`P'RQ7->-U\*N:2WV+W6 M37G^3XL$+J47"7`1^(N+^/T:]KR5]J!.Z7/69$^/5?FV@)S`4>IK)E,G'F`M M>2X!5$2OT)W=V,G!6&6@4W!)6BAH8[WQ9'BE6WN^)$ M(3M0HC5AYRTE`T8I0O/(;;]N.Y"3H*]&>T1HGFNB1<0"&3`L0.7GG[P4FRN^;X91`7CCQ9KE5$UD5JT$H8A&*`HCLZ\I MBN2?/FBC?AFB;S=5:(8"N/J5Q89?<:@B;:4C9KDD`YVS)30Y)Y"#*FI#SU,C MI@T)1&9C7M%);?\T>65*A56;&1!\$TS"[/4QDS+XI0,;84T$BM(IF MC(P8A_<'F#]]0:I9DW=(5!$;=,2TP5`^.V.^374[8RBZD;%.862LKZMI%D)" ML3#?K)PX=9_TM8AQC-_74<4R-F98(GHVQWP-=.-*\%G&$Q31WNII-C]\B5QR M]'D84[.F(Z9Q3FV0$;-K3C"7CV>\5>2FAA^3M(CDJH.29BJN,E`3AO;;5[VO M86UTQ&(3BFAN`K\/!!HBV#>KPR`_86B`[()Q._&U*%*?74)Q'[$,I2@8J`Z# M^(29`7+[['I)_);<[6?MG<+H)2 M,[18>471>%Y18',#,`92NO:DGY(-3?2P.?92CM1/PC92`I2:`R84@S MU;R`V+$2M>36&\\K"@:JX\378(BO_"LA%*ECZ:#0$3,HDGBD%//R&FA.3N05 M5=2&GC=0!">^!G/XBJ(^K_>L9RDJ!MPX`3:8`U@4T<"*M>@_2V.;Q@@;.!%6 MJ=GU;!$613<2JQ$\4!XGP@9#A.5?R:"(1H4PUTSLNP@;S"(LJJB-,<*&3H15 M:M81B[`HZA-K?9I!A=V2T`FQ2LW<6(A%$4ULX/>?=75@.Q%';.B$6*7FAMCE MFJ!H/+`H&*B.$V+#`<0&[*N`!$4D*73$"&PHH>>,6#5K\A$65=3&&&)#)\0J M->N('5CK$9;U+,5E!EK"$#OOOA/.02V*:'`!M8PX::>RDNN$VE!#\O;#`8IN M)'<,M:$3:I6:-2U@#\X)BFADQE`;O@NU:M9T<@E8D25DQ+B`(B?4*C4K@I5< M%-U`+2KLY$9.J%5JYL9"+8IH8@/[UQK]7#Q@R`FUD51S0^RR35`T'E@4#)AQ M0FTT@%K!GV911`)+1\RDO`NUD48F>+GUI2>JJ`T];Z`(3JB-YCS-HNA68/4R M`VX8:F]_VHGF(!9%-+"`6/YPT*DX8B,GQ"KU9&(U0=O$QB&[8:>XRD!YG!`; M:592WD38TZM\JG/<):*6,6LBR$^S:$P#5?Y^V9/87[/2I;@6R*P^ M,?#*I\H-1-O5K$UD8>=;B[A9=O=*XTYFF65B_6 M.:]>\C0_G>K%KGR56\?NX>OD;E1O:TOB&/:UQ3)*UCMW[8XW]@YLA?NDPL?& M$]@BIZXS/NX_I$/Z3W$`1P@&CQW".^K:YVO%$;RC-L"MNK=@']PU>\G_R*J7 MXE(O3OD!3G:]O(/V5'HGG7[1E%>U-^VY;&`'G/KO$78\YK!M:[T$\:$LF_:% M+&FWA_+I?P```/__`P!02P,$%``&``@````A`$%0`;IH!0``!14``!D```!X M;"]W;W)K&ULE%C;CN(X$'U?:?\AROLD<6X0!(PZ M.+T[TJRT6NWE.1T,1$T(2M*7^?LMIP*X*CT-\,#E^+A+:E#D6]+@_;A?W/WX]?IK;5=OEAG>_K@UK8/U1K?UW^^LO\K6Z> MVYU2G046#NW"WG7=<>:Z;;%35=XZ]5$=8&13-U7>P<]FZ[;'1N7K?E*U=WW/ MB]TJ+P\V6I@UM]BH-YNR4+(N7BIUZ-!(H_9Y!_ZWN_+8GJQ5Q2WFJKQY?CE^ M*>KJ"":>RGW9_>B-VE95S+YM#W63/^U!][L(\^)DN_\Q,E^515.W]:9SP)R+ MCHXU)V[B@J7E?%V"`AUVJU&;A?T@9ID?V.YRW@?HWU*]M<9WJ]W5;[\UY?I[ M>5`0;UAF"R.YK]V&?@S\9:JTW^LN_^JM]^5^5VUT&Z(U"D MAK2@(CD[_WG6[GN=@L[B)UHX@4"Z-:3 M:KO'4INTK>*E[>KJ/R2)P10:\09?M,=>5+&9@^10?5'..V,\"!I'21AZTE84- M#PW$HH4LORZ%$).Y^PJI*092^@&),E8GALZ#MBLYD"$`[^9"T[,9%U2=I4'8 M36D?I_RD0).U@M/2*0+F2OYYF=ZYU9@1>)0BQY1)1"G9F')9A\@)[I&CR5"K M-$X)73I%4GC6O.*`Y$!F`,0Y*.W;8ZW)"QN$&TGT6>A2)"5],?E.=`D*!I\. MATGD&2]!A4I&CNEPAL-]'(@H>!YN%Z7)(U',D11)*$HXX>12N:B*CB?,44F' M_21D0G!\+"2^1X@FCX2P\*=(.@GQ0C:^,L<])PI(>KR`^BU-MG!$'"7FBY(S M)(]%3NX1J1S,@,@Q:5/&&SC#:"]?;Y+Z4DC MMUD5I$@RW.:`Y$!F`,3)A#KYN7.:?'7/09+A'`K1W3!?K`:E`%BX_\;33U.45801P&N4,.3!,4:95P2)!->EV>+LF;)Y,$S]I M"&0-N6*K8^LC%!;SGB$'ABGJ9YU;'_%-#;KN0L"NY`?[)]7"SW1I;QO,78Y- M(T2.D,Q$:+AU/[L]W-C]()G&V4F,PFWTR"&Z')&"(YF)4!=U#[O=1>QX-(K^ MJ,J1A141>3KAO,I-AN@?7LJ0`AF73&0#@E;CF#P95)+N>(:D&S*B?UKP]L+P-?OJ\6Q@F2[BO`LB1YS,1*B+NNL8M7O;8P870N-C;L". M6>G`PG.-YP1>:/YI2-B>N!KHI@YM5=0O^D;)AS/D&3W?=CWXNF\P/!4SN.H`W#T/P"74,=^J/_)F M6QY::Z\V8-)S)M"B&KS&PA]=?>PO<9[J#JZ?^J\[N&Y4<'L"_[ML:U/7W>F' M7N!\@;G\'P``__\#`%!+`P04``8`"````"$`7^D^BVH"``#+!0``&0```'AL M+W=OWDVCD,LXCBR36G__8YMH*3LI>6!X'#FR_&9<6:W3ZI&C\)8J9L< MTR3%2#1<%[+9YOC']_7-&"/K6%.P6C9[)1H7(4;4S(%_6\G6GFB*OP6GF-GMVQNN50N(C:RE>PY0C!2?WF\;;=BF MAGT_T0'C)W987.&5Y$9;7;H$<"0:O=[SA$P(D.:S0L(.?.S(B#+'=W2Z'&`R MGX5\?DIQL!>_D:WTX9.1Q1?9"`@;VN0;L-%ZYZ7WA;\%Q>2J>AT:\-6@0I1L M7[MO^O!9R&WEH-L9;,CO:UH\KX3E$"A@DE[F25S78`"^D9)^,B`0]A2N!UFX M*L?]89*-TCX%.=H(Z];2(S'B>^NT^A5%](B*D-X1`M#>D?(7!]@?3& M&*_KI64+`X-DE!/?:91]&X<]-/+GT1=`NC"Y= M#LX/"%M91%$8P'!C>7&C8P$X[[?@BW(,R!<+Z8"^LA!%HY#C>#+*4OAT)`4A9\5O#0%C%N:@+C4VIT6_KR? M7\/SWP```/__`P!02P,$%``&``@````A`+I8I!YP`P``.`H``!D```!X;"]W M;W)K&ULE%9;;ZLX$'Y?:?\#XKT!`R%-E*0J5-US MI#W2:K5[SK,#3F(5,,).T_[[,^,AE$O5-B]Q\'PS_N;B&:_O7LK">1:-EJK: MN&SFNXZH,I7+ZK!Q___O\>;6=;3A5[?]\X_U635/^BB$<('OQU[)9>62A57S M%1MJOY>9>%#9J125(2.-*+@!_OHH:WVQ5F9?,5?RYNE4WV2JK,'$3A;2O%JC MKE-FJ^^'2C5\5X#?+RSBV<6V_9B8+V76**WV9@;F/"(Z]7GI+3VPM%WG$CS` ML#N-V&_<>[9*6>!ZV[4-T$\ISKKWW]%'=?ZKD?G?LA(0;<@39F"GU!-"O^>X M!1/O19N"?QLG%GI\*\Z\Z?Q/R<#20[CEXA(ZM\M<'H3.(*)B9!7.TE*D" M","O4THL#8@(?['K6>;FN''#>#9?^"$#N+,3VCQ*-.DZV4D;5?XB$&M-D9&@ M-0+K.T8^4`Q;15A;109_IPH>L;9!>."&;]>-.CM06P]NH\X]*EE50&M(V?.6,1:NO6>(<]:"$@+!->E`P1"17A"8'J#3<8(H7,\) ME8:<@N7PO(0@MS;RZ$?:VQ@0@$!<3P"5('@]?R$HT8@"@:(W"KV-`85H2H$M ML`(_20WJ;=S`)B7PV7QT/HD7E#-_$4?Q$)`2@$$)=&EC_J(##3@"F7Z8/JX9 M!/>(CY(6W(IR6W@!ASB:S@@N,?AS2U[1D)BXC#WP^6H?E*2 M3SDLKN&`X!Z'VZ&?"8F)0Q#$\Y$\)?F4`XZCWCW^.!<([G$8^9F0F#B$43RZ MV"F)IQ26UU!`,%)X*[-H[&M"F+8FHMMX5#,IR:=$L'J_'@R+'E*!UCU*2PNB MBQ.P(`XGS0P/W;COL!FUV(]3P]K>2O,!NU0RW4H'6X/[`*-RX#LV]`@N#XV$ M;L!]UD:LF5%0>FV`[DL+PJ5K%M%\5$TXO#$PL'1]GH8QS:%2-`>1BJ+03J9. M.&A#:`+=+CT"$G@$6/W1_CW#UX&-U4B2L.#R;O`Z$Z\EYIRTO6['TR#7V/-CD[E.L$%-P%TC0QW?>!)L`/!UVIQ+>`,/NM;38^T]D MFY*U'QQV78#^+NF=&_\]?F'W7]KR]%O94(@VY$EDQ[]H17-!3Y`YW\.,'!E[ MP:&?P13")+P3X"3\7S7-4X2S!'H:\[^:\KE+VQ^M=Z)%=JO$G^S^*RW/%P$S M+2`,&(WMZ3VE/(L_D>*2.]*.IGU3N"W=T+(=+U8S)?KU7@O\]X+_"HO MT5B40+Y6%[$T$]EAU[*[!_4*X/R:8?63+3A6X9$OHP/V7_&"0*&3)_2R]V&A M02@X).WU$.Z"5TA+WBMBJ8"K5A!;D2@%Y@"=IH8A`%J-#*DPD;^?246&8B13 M7F-I,$$B!^11,;,5Z:-BKA46*B1\/"J*H;R,$"VTURXBL53,]Y6CH@4@%7K5C9BD0I5-Q3PV"10?V/)T.Q3;:VYXVE0I(=OU>) MB5)H,L-@D2T_0H9BFVSCD$G%HF.:P]8QE$R7W$0^'Y*;&@:+:_41+A3;7,1= MFE(R[\"BD+A8T+38H=N31&2:R?T.OU$V".%TB[C6R]E:;]6KM!#K1B@%/^NT6BHV';7D\ MGFSB%I[;3(C4(%YQF$Q(-)E!D1:XOTV(L[X3+1Y(U7"PV*38IL>3RJ9ND3J3 MQT0U_B'8D;/.$ZT9`-6H!T`HF0\`HMHNQLNRVV+(;!:2:..LM=0<94<2 M>[H!^C]M4>X`%N!#US%VB1[0M>!!!LMAU2$O%@M`7BV'<$M">0*1W],U;<\T MH57%O9S=\$1!8*RVZB-2?W;1#^"P<L/9<-]RI:P-!PBN>"5AY7Y(U@ MU^YK_<@$'#.ZOQEJVY5:J:IZ>7;`@+6`D>UL=O^^8T_" M)6G335]"8,Z<,V?&#*O;E[IRGIE47#2)2[S`=5B3BHPW1>+^^/YP,W<=I6F3 MT4HT+'%?F7)OU^_?K?9"/JF2,>T`0Z,2M]2Z7?J^2DM64^6)EC40R86LJ89; M6?BJE8QF-JFN_#`(IGY->>,BPU*^A4/D.4_9O4AW-6LTDDA640WUJY*WZLA6 MIV^AJZE\VK4WJ:A;H-CRBNM72^HZ=;I\+!HAZ;8"WR]D0M,CM[TYHZ]Y*H42 MN?:`SL="SSTO_(4/3.M5QL&!:;LC69ZX=V2Y(8'KKU>V03\YVZO!?T>58O]1 M\NPS;QAT&^9D)K`5XLE`'S/S")+]L^P'.X&OTLE83G>5_B;VGQ@O2@WCCL&1 M,;;,7N^92J&C0..%L6%*104%P*]3N!A(1>.(])//TWBX\568/W5-/U2HJ]`Z<& M-%5+S1DD2V`VSB9_=0:63,Z=2;*I@%8PCNEA#!B/[M'_Z)DD&-O`#5CN#:$B M@B9GBI.QXF5G!IRXH6UK&)#XQ!6&9S8\683!K(N/F@HS'#;ULJ0!#R2G'27: MPO`4):=!W$]Z)#F]1M*`!Y*]"Y3$,$I&010%74DCR=DUD@8\D)QWE"B)890, MX]FB/TXC2;/3!R_,Y<8:\$"RIT1)#!\D"0G[+HPD%]=(&K"1[%^[:'ZJBQC4 M!:>D'_A(%U;J%5XM^D1YT<\-'1]`>'S#*)B<31:7,.ZHFLF"?6!5I9Q4[,R" M)7`(NZ>X_#>P_$/[RG4!V+TM+=@7*@O>**=B.:0&W@P.LL3MC3=:M':';(6& MK6O_EO"59;#C`@_`N1#Z>&.^#]UW>_T;``#__P,`4$L#!!0`!@`(````(0!A M[)%T1`X``)!3```9````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``TD:Y?EFT]1&1XUY:`)$-NI:09ZE[IFSGJQ6Y-)P/MSH]-E3*(9I>ZK#@0 M'$@.%`>:`\.!)2`)T&T!PP/TXGK[NE1R-IFQ&5$&41'6J/DD_+#!#YHV"8(# MR8'B0'-@.+`$)#&[#8O&[%?DJ3,#'P^N;P2QLVE&`TM`D@RW\5Z?#-\(DL&6TS*(0C(6TXZXJJ`@N>!` M3>EI.-^>/A]V*(F.^_010BGL\Z*S](2,@<2`X4!YH#PX$E M(`G9^0\:\K#*]XT@=+:+PJ)KN(.&Q$X;+3M+1%))$7.:S@[%N]4< M&`XL`4E^,K<,T`1]7!.U&C+#-J0RJMQ64"\+^RX,A8%M@PEU$5U]4\7RY=+3#'5461GZ5D M0K&2$E%%DT-,89UT!1H-Q`"QE*3)\0Z,)*=G9@2_EF9DSH(M_0T7MQW%33;W MOB+=#ZJH:`,529OEU._,:1L);100#<0`L92DJ?#^:W@J@EMCJ>!N,VL\77T[ M@*V?U>7=RQ46$`E$`=%`#!!+21JV-U_#PPY6C87--LLR"ZIF3LRZ+',51;0( MB`^LJUV"1@'10`P02TD:O?=APZ,/KHU%SSUF1KQ='48%1`"10!00#<0`L92D MH7I+-3S48,#<;9<-2DB:"N;^/E_>\R_7-V:9> M1A5-`'=T`C02B(HD+!)^S_0_Z:*O$TT6)$QCH&=+29H.-W.'3X'V")> M1A5-1VC7$@$:"41%$M?,Z#)"/TV"G\!ERH,]&HI25/AC=C@U2`/MLV= M`%D-YLR_E%'5!EX!$4`D$!5)8ZV+&7.>ND]@H$]+29H(9@][IDB7)YRS\RMS M;MLJ(`*(!**`:"`&B*4D#?4JL^<-LBO_GAT@JNB8AW8M$:"10!00#<0`L92D MH5YEYO).,\>=?E2U@55`!!`)1$727#>YC\'2^P9W<.-`7]_$P'$M)6FRF`7T MV^7,C6+/5.BR@@NV))4Y]W05$`%$`E%`-!`#Q%*2AGR5[\N#H^N;"N#[8KNV M8@00"40!T4`,$$M)&BKS?0/-4/!QZ8J_8%:DS+G;JX`((!*(`J*!F$C"]G<7 MS$"Z_UG:*,F!__!@^&Y7J_G&/^.[752U@UL!$4`D$`5$`S&1Q!TQ6^9L("QM MDD;.'*`?_87+QL=S>]KE!!?,I99113,`3A`T$H@"HH$8():2-&3ODP9;FVEP M53US.ZIHJ*%=2P1H)!`%1`,Q0"PE::C>EY%0A\WMJ6_%ZQOF=E2U`59`!!`) M1`'10`P0&TF8[;.[VOI?9GN:@ZL,W+3+P.'!&3H)&`=%`#!!+29J!JTS:--BOM*[ANP]1%2^B_^3+#U%$H^?>3H)&`=%` M#!!+21K]IWS;=)!OBZJ0A3]+`O=V(K9JTR*!*"`:B`%B*4F2,&/&S2]Q1>^E M2=T*-KAV%:UO5991Y99Z[O5!=5<[=-`)%`%!`-Q`"QE*1I^)2+FW6Z M..YCHXJE@=W2J"ZJ-@W>#`"*!*"`:B`%B*4ES\BD+..NR@`6_>(^J-L`* MB``B@2@@&H@!8BE)0_;NC)3!QSOB+'BY'A,05334T*XE`C02B`*B@1@@EI(T MU$]9/'_S!@T^5'Q0M14?*[UYZ:KXT(3FA!,9#]YJ%!`-Q`"QE*0Y81YPF.V= M!9>7K@(%NXXNHZH]^0J(`"*!*"`:B`%B*4E#9EZPI^*#5>NK>&[HJADG`H@$ MHH!H(`:(I20-E9F^@:/;9?YPC0^JIN+G-TVI?[#&<^,G9IQ((`J(!F*`6$K2 MG'S*"LZZK&#!;^)$%:UX,'Z@D4`4$`W$`+&4)"'/F?'[N.)K=>]G%5%%0@4B M@$@@"H@&8H!82M)0.\Q=_X7>O,O<%_U;5)%0@0@@$H@"HH$8():2--1/^;?%(/\654W%=RSI4=$F M10"10!00#<0`L92D*?!.[.I)O_"M^&W:@MUY+*.J#;`"(H!((`J(!F*`6$K2 MD+VS(B'W%'CP8>Y?\H@N*TT)TO^ M0<.">[(*B``B@2@@&H@!8BE)0V:^K2?4X+OZ*IZ[LVK!B0`B@2@@&H@!8BE) M0BVN\FNU&G9N?CT:54VE#[G=&IN02@*0TO[>"KTJT92SNHPM-BNO^;5E5PAR:`2"`*B`9B M@%A*TN"99^L9Y^C"PJ/;_(.VR@)0A4@@DH@4(HW((+()2N/K\%_^/S-?^9@R M]_@]7-#X3:4H\H\5N$R#&7\D5M6J+E\*0B01*40:D4'DGQWH3]Z=ESMBR$YX M%F!XGMM^>_RVK;:OKZ?1YO#=/^?/*1_O+S@^A+`HW%,("]\%>Z&ULE%;;;J,P$'U?:?\!^;V`N>2F)%6KJKLK[4JKU5Z>'3#! M*F!D.TW[]SNV"04G39,\!$B.SYDS,QZSO'VI*^^9"LEXLT+8#Y%'FXSGK-FN MT)_?CS#>DR7??Q$L_\X:"MF&.ND*;#A_TM!ON?X)%@='JQ]-!7X*+Z<%V57J M%]]_I6Q;*BAW"HZTL47^^D!E!AD%&C\R862\@@#@VZN9;@W("'DQUSW+5;E" M\<1/IV&,`>YMJ%2/3%,B+]M)Q>M_%H1U4#U)U)'`M2/!$S^)TNGL`I;`1F0, M/A!%UDO!]QYT#6C*EN@>Q`M@ULZ2=YU!-'K-G5YDE@):0CF>USB$8!Z'P+(NB'$4*+3R3V$H!>-0XCF/;V)\OX$I$>,`HC'`9P7UF"H M'_(&WF-7VH(2TU1#J\DU2AJ\0N!BH#1+>@O6I`5-;!&B-`S#'C#R"#4=)OF\ M1PT>*R>A6UZ+Z81G.$EGIX4GUPAKL"OL.K88',;&<^B_!38R/+U&5X-=W4GO MQV;:8@ZZ4>J_!382UD-_L*/.9UJ#76&WF2SF((S]0:./A.?7"&OP6'@63QW' M%G/J0TM!/]<89?-XI+=8C MY>+:&O0XQS`FW;;J4(=88O\MV%%U\553RJ#'VM$D^,VI?:@M^=@2[;T!Q%;UDBOH@7,VM"?@HBP MQ[Q]4+PUA\V&*SB>S6T)KV,4#D-H'N05G*O#@WZ1Z%_PUO\!``#__P,`4$L# M!!0`!@`(````(0`%E8"%C@D``)8W```9````>&PO=V]R:W-H965T'LGDH121ZD7;4.^AC@Y?/J04Z?ZG;^?3ZFO9M%5]V:_]C;=>E9=# M?:PNS_OU/W]__I"N5VU77([%J;Z4^_7WLEW_]/#C#_=O=?.E?2G+;L5[N+3[ M]4O77>^VV_;P4IZ+=E-?RPL_\E0WYZ+C/S;/V_;:E,41@LZG;>!Y\?9<5)>U M[.&NL>FC?GJJ#N6G^O!Z+B^=[*0I3T7'\V]?JFO;]W8^V'1W+IHOK]J^PZ=KE?GP]UOSY>Z*1Y/_+J_^:PX]'W##T;WY^K0U&W]U&UX=UN9 MJ'G-N^UNRWMZN#]6_`I$V5=-^;1??_3O\C1=;Q_NH4#_5N5;J_Q_U;[4;[\T MU?'WZE+R:O-Q$B/P6-=?A/2WHVCBP5LC^C.,P)_-ZE@^%:^G[J_Z[=>R>G[I M^'!'_(K$A=T=OW\JVP.O*.]F$T2BIT-]X@GPOU?G2EB#5Z3X!O^^5*'/Y:O'LNT^5Z++]>KPVG;U^3\I\K$KV4F`G?!_1SIY)S#$0/XO!OKI MA@51DL+IS^C+('H;"3-6%%T1T M\E'T`GWQ2V[Y8'Y]\+TTO=]^Y2-P0%$F17P"W42Z(N\58N!X?D.2O#XTR9"/ M^/A8]3F)(#VG8*>?+Y,2-:-`5^2]@F;$2Z5F]'XF0LS]H5ZX%])'3031-'?><`+P6R9%2K&4!BV%6$_A_7$2XMEQDB+EU$J#=NI$ M/[7U.(DX6@!CG*0HAG%BNX#4)Y>'M5':^4,-M33%@D8!8&,G$4?35,XAQTF* M?"^$1*--]/,':JA>HAGJ9DLMU]W"7$6KI);NA13^]0.@2 M@_F2O3/`0I6<"6$:WUPN!PR/B^H,X[J[#;V>JD#NHE0EJ_54C5'Z$NHD_5N1Y%SVI8I,D$@W9HXJK=[3&2]: M(<0VS9S.L9Y(ABK5HE.+A.^T2H!Z?H8HRP(Z46G1QVWI2N%;+16HDC,D]CRR M+OJI)200*\$2L$&@ M7@=^7W);KK$0HOO]6DX0W_<"RC3L1ILAOG>KIUXKLHB\O]P&5BL'JF[S8G[E MP!!S/0X$QI5BSN0GH3^S-$"?^[5J_%U(@)P/(GHO)6Y='#(RZ<\"PK0,NA0) MB1MWN)M26_3Q;WH<0TR/AT[\ M!K61']W:HVK&XX/*\#@!N*7'1T`>WFYMY-H<2I%J,J5%][@3R$,KD*-*/?T4 MR,.E((=`.D3&)@55TN,L2>D>!8];>MR)XZ$5QU'5>]S;>'0#@(H12SMA.[3" M-JJ(I>GJ-ZBHI=DB;$.4/I0L)#3*4*1X2FW1+,V5>OHI=$=+T0V!>AU& MT(TJ1+<7,P*J'`5V)H^6#RC#Y(I)'HR2G&Q14J3:;(GGD1')0S[O<(#G&C0S,4I)'5B1'%>ZY64+7 M63QN:7(GDD=6)$>5D\EEQR.U=")Y9$5R5!&3D]]EYH.*FCQ>1'*((O//]\C] M4H8JQ>1JBX;RV`GEH)XU.:K4TT^A/%Z*<@@DA3"??J-*FCPU38['[4P>.Y$< MU#1!@^2HZDW.-FFD_DYH[.$)AI@FCYU(#FHC/\+H#%7$Y/3F=U`9)E]$\GB4 MY'2_@BK595,DCYU(#NIYDQLDQ[B1@5E*\MB*Y*B2)@]V'AG#'(];FMR)Y+$5 MR5'5FYR_2JAYW!OYS2>&C-32B>2Q%.($)QN^@:5X?%%($],D#-& M.8XBU613'$^<.`[J>8\;',>XD7%9RO'$BN.HZCV>D%N7'(];>MR)XXD5QU%U M\WB0:!X?X3B&C-32B>.)%<=1I7O<)\_R\D%%/9XNXCA$Z=./,3*O,A0I'E=; M-(ZG3AP']:S'4:6>?HKCZ5*.0Z!>AQ&.HTJ^@QVE,<%4CL?M/)XZ<1S4-$&# MXZCJ/%%;?XKLF.8%]Y60]' M7(JT9%E$GW/PSYG$>V9J8>7G2?*#G'/9/)=Y>3JUJT/]*CX]$LOW.4P8*3]8QKQ[ZC@`R9R)$MC?B06@VP<2?B19/1(VG^5M1V"^%=1 MU^*Y_*-HGJM+NSJ53SQU;R/V+(W\KDK^T-57^!SGL>[X]U#PWQ?^_5O)OW7Q M-ES\5-==_X,8S+?^B[J'_P$``/__`P!02P,$%``&``@````A`&^!4:5$`P`` M'0P``!D```!X;"]W;W)K&ULG%9=;YLP%'V?M/^` M_%[`$)(2A52MJFZ3-FF:]O'L@`E6`2/;:=I_OVN;I`$2DC0/24C./>=^:^2$&N+.B4CTQ38F<=",5K_Y9$&ZI M+$G0DL!G2X(#-[B-<#0]S^+9C$R!CT21Y4+PK0-;`YJR(7H'\1R8=663DY5! M23KF7@>94$!+&,?+$@=^O/!>H(=I"WH8@H(]P@/U?0H@>YC"\:;NI#4X0?#^ M+HWCOK0%3+.B)ZE6OA M2VRK!=GN1M%8>S_D6_IIW%OS8QMVZ%QX=,A761>^R+M:5+O?HSVXRKWP$?O" M\6U_Q4[Y%_Z0@9FH\RMVRL+@M';-372)B1G*!-E'H_6P]P>7?3+:`YX]_S1D M37\0L6:U=$J:PU'`=V>P'\(>[^R%XHTYYZRX@F.9^5K`,9S"(&ULG%A;CZLX#'Y?:?\#XOT4`A2&JNW1 M0($]TJZT6NWEF:%IBZ:0"IC+^??K$&YQF.FT+Y.I8W^Q/SN)R?K[>W'67FE5 MYZSJY/ ME#8:()3U1C\US65E&'5VHD5:+]B%EC!S8%61-O"S.AKUI:+IOC4JSH9EFJY1 MI'FI"X15]14,=CCD&=VQ[*6@92-`*GI.&_"_/N67NDRX"8T.QCML,_%EI>WI(7\[-7^SM-YH?3PVD>PD1\>:-W$.8?4 MM>RE;ECQGU`BW*D!Q.I`8!Q!B&.Z'.,3.[NS@[&SL\QQ\4\,G8=<<9!'CM)B04IK*-;7+;&(M39>H<*R3BD02G!`C$JR M1MAK\!K@N#LLB+`@QH)D(C`@QB%0J"$^[BXD1R7YGR2+$D5<, MA)+3[EF>KQ`+=E@084&,!Q*'03Q^^%S)(;?;Z$#.4':>B^(0*IXH M7,_R<0;%/(%R&3"(ZXFF(0WT08T2P&YFJ* M85G>>"2U)9[,8'S(E7\/5]Q(Y@HZ$)3U0"AU^]"QD).AF);)LO"EMY-`3!\5 M;S0/@K1B"<3&.R"9!QES+VU%[C`NKB_=C*VA3-IR2^L/20@LDW3P?AJOWP\(AO/>;[++/>[M6&YH[\*(E44JZ)$$LDIY+W;Q'/>ACMP>=W:AHL6<-KK*'U*0(02'P9*"4'$AZ-6 MWX+N5%&DBF)5E$@B.6[>[*&XB7E'X*)IE$(RT1$5$*'$O9D$CGN]46L,?##L M19&J%:NB1!+)@?-&#@5^3\)%/RA'A.[+@'1-HZR%3OEPU.J#W*FB2!7%JBB1 M1'+6RMX/M2E3\2_@XUNP(!$^`>;(S!*7@A MNJ1'^D=:'?.RUL[T`"28"_YF48DW)O&C89?VL_N)-?`VU/Y[@K=`"H%[?_`P``__\#`%!+`P04``8`"````"$`!#&MG:`"```X!@`` M&0```'AL+W=OB=8%$B,:YD"_K65G3VR*OX=.,?.T[VZX5AU0[&0CW6M/BI'B MR\>JU8;M&LC[A4X9/W'WBRMZ);G15IGU]2'.SH&]E:'SX967R1K0"SH4R^`#NMGSSTL?`A.$RN3C_T M!?AF4"%*MF_<=WWX+&15.ZAV"@GYO);%:RXL!T.!)DI2S\1U`P+@%RGI.P,, M82_]_T$6KL[PY#9*9_&$`ASMA'4/TE-BQ/?6:?4[@.B1*I`D1Y(IJ#_N)U$R M3VEZ^W\6$A3U">;,L?7*Z`."IH$[;<=\"](E,/O,IJ`IZ!AR_5NJD*,GN??!0@('A0#5Z,5;]=AY,X M#_;B3JR;$`#N06UR(>0:,8G/(?DU9)8.D#.QDW.QWN()M."_1?M#@!MII)1. MAPMZ>S8!U#=^']A>!O)1X$P3E'ILX/LT^4,9AL0'WZ#*\PM-`33KFV`^F<;Q MA7';,8`N8/\2`9/L[PD4-#U'A"S"I(9&5L)48BN:QB*N]WX*$[A\B`X/Q'WB M.^`BOH&'HQ\S,FS`X':L$E^9J61K42-*H(RC&4R%":,?%DYW_?CLM(.1[3]K M>*$%]&T<`;C4VIT6<#$9WOSU'P```/__`P!02P,$%``&``@````A`/MBI6V4 M!@``IQL``!,```!X;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M M)[8;!W6*V+&;K4T;Q&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8 ME@HFVE[5_+S*UM4*WDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;` MU#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$& M%#(:3Y?0VJ']?DH]ATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!` MAA6-D9HG9()]B.(NCD:"8LT`;Q)__/QY.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5 MD1SBB!4-?A.KL$S(P5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM' M+E(H.BVC>1-S7D3N\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO= M?9<2Q]VG%X([-'!$6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JV MY?"N;+>];=C$RI)G]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77 MY44IABJM&Q+;:YO..UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29 M#`P<7""P68,$5Q]1%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H< M8BN'Q&J/C^WPNA[.CALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AF MBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[ M$R]E$;SP$E`[F8XL+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.O MA`W[4Y/99/G"FZU,,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/, M>E$*E%2CLTFQO@'!\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q M@,'].E1!GS&5<.-A*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8, M[F3\N>]I!HT"W>04\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QI MT]9)6RW;K"^XT\WYGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD* M0Y/L(&,<8[Z4%3]F\=%]6QET$1^R+&=BW/8>*-V@>WV<)NB!7I%H MKB3O)E?TNW=(O8:V)9(6;>Z=<1M;-F=^\R9'$G7S_4L4&I_]-`N2>&$.+P>F MX<=>L@KBIX7YUP?G8F8:6>[&*S=,8G]AOOJ9^?WMKW]UD^6OH?_QV?=S`TC$ MV<)\SO/-M65EWK,?N=EELO%C^&:=I)&;P\?TR^N,C(H"JW18'!E16X0 MFP6%Z\@3(1*YZ:?MYL)+HHV;!X]!&.2OE)9I1-[UNZ,DVSA?FJ#YD%-^\ M6RW,*],H1%XF*P#QN_]LD_R[WQ1_OOG#-]\,_O7M=__XT5_]\Z??[W_WT[>F M5;%!-,$&W30O!YUDX>N"LE5*<'NS3F(DR!S41+1U_2E.OL0.^0Z<`<0C/[N] MR7XV/KLA'!D2>%X2)JF1@Y5!/GHD=B._^,72#8/'-"`_6[M1$+X6AT?D`'6, M\G=1`&8B!ZV"PWGY/!(TE4PS`H.1:4R.8)DB$,DE![MEFXT`.&0X&1*W88"=B-E\.@-_9F%U- MSB;9V!D[4Z62,;ZX;S?"<.RH5"6'H?-F^O9LZE3/K$VZ,@V?*P)(P*G58@"A MVQ'?4X>\SN$G9RYH2BT&$[C\31@\Q46YS;8;F-%Y:;#)B>8.J?>DTE+9F-)# M$T"3H1^"R,^,#_X7X\@>ZHAD.$;E+ M0_W8,$&E55V]+"U@CJ/HGU@]6QQSZK6/T:O5$`VY#&(Q",-ZE3.VR3H`CMS> MP((K]]/8@0]&^?[A=0.K@!C6AL2CK>)WG%\_I>[K<$0C36Q`EH3!BJ!X6M*U M1SGW6U[=.\M[RABHDZ M\-]2F4[+>FBK`EG3,_*`]`H&E]/Y?#X;7LUFL[D]'MHV5?)CZ=%!O/)??-(^ M4*:F?0030#`?S^97(P`RL&>4U5D1C`'`=#*938;SD0W_T]IZ>@2J=3HQ=5L5 M(=!D581`DU7I9810@T614AT&35J>(,/-5N581`DU41`DU6 MI4U6A;$*'7'-L8H0:+(J0J#)JLHFGV4&AM,0FJV*$&BR*D)P;JM6RZKE_;U# M6V[[,[/V^3%=R<':\3%)5]!\JLZ1#Q/ZZQQ6B6GP]$S^YLD&_GU, M\AQ.OMW>K`+W*8G=$-Y:U8CJ;\=(.#T)9R(79OX<>)^`&=-5*?`6+$[%H?99 MF\SP[:D]F-J3T56QB%+$.O)7P3;:EZ[F?=!70(U$MWS!D0[CFDGI#DT'UB)6 M*,TG.(*:FEI:<`#X1.42@B-4R-B'Q>621U(#!;ER5F$)1T`4.C$4@#71I1YY4HYP+/!D"W1NX4 MSD.04Y!4I!L"P-$"`1EBJ*G^#C$&3148>X.F$HPA,#7XC#&!+<%42$T8`(^6 MJ&CF"4.F8IQ1#0B"K@R)O&&D*T5B#+IR9&.*D:X4B2#HRI#8$KI2),:@*T>#A(U]2=_/@O\!:M#CQ]+)N;_8"DJK!L>N-+,)63`U_ MZ*Z;A@QSY?KI@:6_(KB2TU4]MS._XQEL=YOK(5P0I+NC&P,)"]T8B+U+#,K= M4%&80I6L(`I[IVIWP6HB>,JF,QQF)A%LKG!`L23Y<+(9UU<1&,(%4J@BMS-7Z",SHM*E& MN8/*V$5Y[,HPU^J1I-&AS^8=YTN.*DTX'*J)MHPIX`:\P]H@9PZZ$-V5)RRX MQ;,O0NPLX]T.41="AY[3D<+'+3H&N46KF#/`A2F6X(*%!UL,J)194<'A<6?F M0()*D\%R:@-RL:"5A`26PQ-4=L8HJ"T<`O1Z/\G5)RK@1QFSXQHJ"87H%AT2 M4O^I/#9%[VAO<:QNH")^U;HVP/![>E(WRLK8@JXC1HRSS.HI7&LI`W!==4)( MV65MY27]MT&N'I#[NR_Y..QJ8 MLW:YL#HTN/6':T-W@)\]I[7!Y)1'$9SGJ>FM<=F:K'8SL8V:DR/A_KV(!EH3 MHHPOBSM/56HDJD-1N3$.M[-NTWG=NC MF''4R/*2B`X`T]U_00&A1GSI@#D>HAJEJ?'$8[V%HRXNN)84S-IR3U$B.?AH MG^-G0"'0^QJ51]U$)4?//>>.)%DI;9QQ[4XXEF>;6IGO:Y"UJ;!V9-#T3M:G MM50[O`/:ZN@K"NNNIV=AO&#H1WJU5KF]SN$9@F#]$2,F;0R9;*X$`M!4\2QO%%W- M!QU920U>P:REAIETO)P]JV%_XJ[CN.A(^R>>_5=I09Y]!(\L'+P6^/">.,1R>JK MG,AYCL=M$,+.RV260.[X];89;!M[5QPL;]'LHE5?HT2NZ,*T8*TH2PLH%+.4 M$5PO@6G!.0596L"^H#4&:1$MV)!0FA;T74I:\`[3@@MP9''!D)(6J_N)H.[M M0W:DNUD@.X+((K@PK<:.H#DDXQA$EJ75V!$,AVF!R+*T&CL"0D3+!B:RM!H[ M@A4P+7`W65JU'6TP'*(U$=3]U4$[LKY*;CT7P85I-79D?74LZ*N85F-'UE>) MR+*X&CL"5:0O&[Z0I=78DP#(V=F1U/Q'4_6Y&93U^).CQ!97&=O`. MZ8C,8T1T5%!IK,9Z^5C0RPLJC;U8_[8%_;N@TE@*Z"&);/A"7*+:1F-6N[:@ M=N_<595U68"Y/Z8)+6.6`KDPDD10'^"QWO# MD\,-T$NA(=:'R5WL,F3J62_96DR$#HPLTK/^17;!DR,#H@@R;5,G\283, MNWBSK2W$YE)2ND5(O`_B3_Z*]1Q6PZ03($+I@[_-4[?V/S:D1H**^4#V5ZYI ML"FB>.QAM1ET.?_\`-LI5THDDWL4.Z0Q(`+\+]L3FL1.1A&D\37(' M1#&L'R'=O,_@:1#PU]BFP<+\[_W==/[VWAE=S`9WLPM[[$\NYI.[MQ<3>WGW M]JTS'XP&R_^!RJ(PSJ[A611\,[V:74>"E29:L\TL/'@B2K->! MYUO9)H6DDCW[?AZ%UF@PF%MS*W+I7OQ`Y#H+X5=I*6P)_F-S;&&B#P5\NET_ MP(8379405D:V+/](F-S^'P``__\#`%!+`P04``8`"````"$`%#T8[46C``"; M,`(`%````'AL+W-H87)E9%-T&UL[)W;;AS)M:;O!YAW2`@R-@60 M%`^B6FVW>X.B*(O>$J4A*3<,8U\DJY)D=1>KZ,HJ4>PK/\3<##`#-.91^E'\ M)//]:T5D1AZJ2,F][P8V6E)E9F3$.O[K$)'?_?OGZW'VJ9B5H^GDCX^V-[<> M9<5D,!V.)I=_?/3Q[/7&BT=9.<\GPWP\G11_?'17E(_^_?O__M^^*\MYQK.3 M\H^/KN;SF]\_?5H.KHKKO-R98/I8C+_XZ/GNUM[C[+%9/3W17'@/VWO[GSSZ/OORM'WW\V_ M?S4=+*Z+R3QC(MGA9#Z:WV5'$W\#$\_6/IZ^RAX_^>[I_/OOGNH1?VQ[)WLW MG@U MS%[E\\[(U7VO1^4@'V=_+?)9]AI*ETM'#'>&@7OO??W7]M-GLUSBE)W>79]/ MQ^VK']^+AOY`%&:L>(CI.)S]A_%77L&!XO93.*64F89&<-L?RC& MXXV?)M/;279:Y"7*,LR.RG)1S-J#'T_;OX0AXEM/BIOI;&XDF^?S+CO^6G0X M%$;XRW2\F,SSV1TS'Z/42UYD%[,#9.)R.NLL?G\P*'B8JT,?9LDH!]/K:W3O M=#X=_+2>G5[ELZ+,WB_F9BZ8_9+'/BS.QZ-!]GH\S>?M6P[>'Y^^?WOT:O_L M\%7VV[X2HB^O%V(@Z+#"'@U$^QW2U[^M_<_9AAE6=S>_6L^-BOIZ=3>=Y1Y/> M0H+V<-R=]0_9D8UDG=EH8@O*AY_RR0"NSJ?9>'0]DD2,1_GY:"P#/)A>W^23 M$9?7'KU]>U`^>K*>38H.3]^+%]E^618]!#S(RRM[U4!_*?Z^&'W*QR)U>R$O MI'E"=?R:RGES\8U77N\_>WF-]GU:#R6!]+4'F_OIK_,,QQ, M<7W.ZJ.3L=O:O^ZN,T/)Z7STJ1C?=;S8J^*BP!P-LP$J=ED@Y9?3Z?"6%]MP MMJ0P\5X&F+`$!K27_C9P$RYVA-L\%@L=\.[1',+/9M-;"7M[D'<0YC*_=/[X M=";3.7)QD]^).\QJ.MF`"]/%#"XB3'!P;309C!?F&$3L87$^SU"+Z]'BVJB[ MM[.[OK6UY81]L?O,__%;T11UG"T@Z6@R+R!^1VCC]>(S8*9D*>*O+RTJ`"1K M$^*LF,A;,6`QPVBL9T4Y@&;\!96?EJ.YC\,R;_+1D/MZ!-VYE?"E_9)#E&1^ MU^'6AUD4D](M,9P[+R;%Q0A+,ZX6NIX]WMS:AC.S#$U;%'_(]D19HVYX,%_, MKZ:ST<_%\`]B7)&-Y,:&3H+EYOW77W[]I3W7X")\X.ZKOUWY[O[7_M[06K:1 M;>^N[VYMK^]L/=,ON]G&]L[ZB[T7Z\^?[7:FD=^,,)@R:\5G[!D.XJ(F0>=N M-]0HH\P9#V'H.NCCH+YI./HT&@+(.N*0VGR7'9G,67&%2>\;3L/./L=QZW M)]81#6-)_[TK/>D'7#6PN)B/P'U/EGO6EEE<7VH/VS/]&HL@):EM0'O$!XMW M)=E?/4)'#;YZ))?@KWY\NES96HJU=-&M^^Y=6NO^_@6T;EHUS13/G9X!Z]X= M'I^=9N]?1YB^)')KHCHI[FZMSH`=;>F^O(,R](U<>971]+N=IV+)V1AL/>-M] M0ZQ>6B3.$LQY&/QCQQV]2C"NS3>%3VT.[`\_C4HBD>RBP-6"#WJ0W'N#D4+! M(#"BR>B9VV,1;4[*'"P%*!M,RRZ2/-"/;CG#Y)>L[<@,/TZ4/$-AV!30BPMQ MAR`7LN".23D=CY!'@\8/@<@1= M3I;!?MY=]O/ZWYYU+OU)D\J@XT4^"G`!S#*87D[0`GX&YRS&Q@R#WS`HNUG, M!E>"ZE#G>C0!1AC-'&256LIU_J/]ND&D#,UZ%[#7.Q7-!%\+6AO-%W"$5Y!5 M&H,:/39JTZ&:?O*0>WY_0)&+3^+\KLW*WFGM0M#$)&?O9B\..E0.)O MSSN+Q9P0().-F5AHBV7W3?$JN#MOF=='8LZ^LO2Z81EMB>$/+=_>K\(E))LU-@M&RYF M,AE*\UG*;M=TCG_NK$N;"4,0A4HO@WZ+JE!,LF%*\"DGF\9?JZ#X.A]:,"-9 MT0OS&R3Q\XBD)U%<]CC$+*#>[UI65_('9QIZ[WY`Y2CA=2Y5D M&\Q(+&&$R+U\^;HJP1"K(R?:O*X-TB;Y1DP,"1=TT!0[NM2AC5(Y57FN67DU MNJD,E[G72N.+BPO/*+7$/%M#*VIYP2.OG6\^<4/"'\JP]5D2KPSCAWQ\34FKJ"W)ORJO)#F+^900 MF:D$9&1.`S4:D!C]?#-2!K!F*J_A#M-HUYS=%?JQ:K6WFK"[C&#+EEG3^=5LNKB\ M,C&$4QMF6S+0B8I,T<*0+@IU,9=I&#M9807->$JV.@.V5L=;_>T=U3%A(_DE MD*Z1EECPVD+(TW#_&/5@Q2B`GII;&MFDYK>84\>/=W$C,ENK81#7`%1\&3.< MUM^QC9(>J"&X8OII5TFE(CZMRXC`[=35E&6YZ``-;F;%)T$7K+_CW0AER.[A M->I+"<1;P>XBO$U* MT_#;"3&Z8M_OJI=Y]XX+_6$)#%NE?R+<Q3!=K0]#RDIO9?G`>(#W*1?\? M&:YP6$T`N)R=P5HHAI#(U4F(B!'EK[I,%GQ>9?OP[.5"!0.PJ,9M0L>NA4^@ MZP,-__RJ-GN&6A6^SX0VEPB6HU+LA67$*DMX,9(QDJB6#,`?P?"8$U+VW?Q> M;52#.4MA4QC3ANPG53#DF3S2!%\.D)A9Z8(RX\"(A-%+PSIYKL35BH1#32]D M9`!0LIM&@Y@CZ/"XD2=O9BAI(_APG9*I:Z;W.WFQCQ,9 M-!57+/V/Y6265>BIHGLVR&\Z.9W]5O&Q\X2ESMI>QPL&RTH/G;GY[##< M'G@5U=[L'__I\!1Z98?_X^,1#1E?DN(]5>WJB].[-O'.'+T]`3.; M,\\D`[X(W,I_RSS7UKY/Z=7$0^+7D$D\6X<_+_.Q*N49`!B`4C4.;;<'#/=5 M[1+WW6_T,"U[6=?RXBPZ##SR0AVEU9#6Z=22_8[VK#XH3TW`3XE^/K8)9MO9X9W-O MYZGEHYX(EGFZ1C\_^W:O^;MC2[OTO'FED]T_:.BDBW.'<$O8UQGL'O9U[D<6 MVN:((*I-@Y9-Z+4([6=.%^=S-8%0"'V(PBY9X&Y[V'L6N.S^MMP_^\)Q._=_ MF8%!?@%Y]]4SHZBM*V;ISZBN>NW^Z9OL]=OW/RSM1+)>EHLQ]7YO1ZEA@LH1 MGRQWU)&\_>&/)*<4"%CA0_Z9]!.!:9*^!![H7]8B@R-3M=GRD@][0<-SD$%? M462M]?CIE^IQE6R/Z0I9D"I9$=W50RL`U6C8(&Q+E>\/;OQ+,_<'5_3WX&HQ M*J'!1U`F:>3HL.5$$3K,"/U%;7$V=[\TT?\@1K6';$O/R$(H0X9;6-:%O M7IWG)3`@2,^_LFQX/2B*85"FOB%BI!,T!V.(K`A!.>ULT;U,HCCIW3A@+XLO MPW,N'.V5JG;C+%73CJ!^/B#)2SM/0)C+XMCV0!^<$5HH;Z*AN2&#!LDUL!(] MM:"W!S&Z6?N0Y?KM_J]7-!\M4MH%GM=;/:]?]V(.H;]FUDON+WA)(]IO+[UB MQ$+H`F7NTY'V0_;RQ"K7`K9"K_2FNM]-G"%!8A5';X9KOT3WJZDK*MI]]W^( M%#="RT*K?\ZS*`[7)VD#7?MU39W^XL=?5SIF!7(ZH9!KUA@'LD#O`=.(#E6- M?J-A>Y*K0269<$27%C0SM+VH4EC50#7Z8JC0'RZL6N@1N.PZRY)5,[T'Q,6P MM1@^;?456+VH/563:[DQFUQ-S')="?S11+5CO<+SLU_P-)G)W[&/'L\;@I5=F5@U/LG+#7J$M`:'#H]NT M^DKP)EI79+IEJLV^N+7O)8FI@DS\;P)C#BJF!D\!O]NO==/1Z[O:MT*Z9I]R M^X86:B$V,"UNWU:C!@EGSYS>?45#;_LEQQ@P>&P-P$IPW80DM/(Q,QP<(:>J MI&I#:#]:H;_(!!.OKP:3?4%8:&:/;;9WF<)$:V9O3\:@7HH5VS><:3T;OIZ0 MP8N&J7WKZ>+Z.M1V3D=TT9#V5OIOW\LO4M@/-!,-@+>=)S^^>[=_\E M_>GXZ/71P?[Q6;9_TR!Z61G M](\38/:L1`@]N9^=*,>O-#ZQ99&=S18Q^Q?K4T+@:TJX_?,?_]LN__,?_X>@ M'4;-:$.P])9EY]ZQ7#(CZG7N$_%LKJ$W,Q+G[LLED%=U@4%/7BVN*:&KHUI% M@E@6J)OQLH%OUJ&Z@7Y@,X8+!(KOYJ6UOU;JM7BRC$HBN4+A;<.? MJ0=>SS!MEP6UN`'V#OJL@XN*8B/N;\FP@UR?#.[4WHT\!\`Y4)>$O3H\9_YT M&4@D86_B_;HXGZD0_NLO.R^L267/DO=7=.RH.#:G1`@"Z2>CR*XT0"@MEJ06 M!^!@PTC>^4,1SJ!Q:8X&U.[>H6.=__F/_]L6(!5E(Z62'LB$V)3F"C5$1)*O MX](TU0:QQ4I5IRI*_Z'](A_F`23N/(G!ACZV4DR*M[:TBTJQFT(+OU#W];+6 MKY4;71!W^6Q).RGOR;!G*N2H;_"(@ZOI=&R<[\A#)PFMHM;%PO24)^FI,XD( MX;TB*SIZQBK,4XFZR#]-9Q0KD7;+B\-EH/B0`IO:6ERP42+D$FTG(@)83*]I M)^-/;RJ@?\5JRCZFOT]J%P&/Q7%2[;I'[*:8XO5Y>4$I;WK'*UGZ4V2.'9L3 M^?_A)NE4FZ/U`$S9-D-7$9M&KO,[!$%+TBLB*`)@<,<-X(ZK""K`=T[+UVPI M\U15OU4G4$CY#Q=D5/#NC*F95O4*6BQ"SY9^=@)2A93UT_!]8ARJI#;Y+G7M ML<":>N<1O0;9&J_72UQJ.Q;TU.T5-@,CNMGW9F^V$(%N<)74*%6PRTS?<_(] ME[`2*74F"R/J96$FWDM`SJNXA<5P_MI#!]VR4"?2^$YB#KH&<[)V_5ZMO0XM MV[5"W1;E)C4T^*R?"'#HZT0$L21=,KD0ZOF.(%8"*`/@T1-280-V1%+$($.! MJ54'75CZLD6)H>E:SGC[W-H<#?H&T6B\L:828DO%W_>Q<>>`WKBY4?=:2:5,:N;-/:+09"I*H2&=`A8\7)2;V9OI MK1ZR=@W<$PA`BDW!2Z@5:(N3,R6JJT&X5\)Y**0( M3R*01+-!=X.DQ0CT0"P3E!?-@@B)?L;J(-(?9F^$L0A@NDL.R8 MN7?YA"A77E)(83&QE@N'AMAL*GQPT`O;V`YR)!/JUT8*7<`OJZ'`@HX%N_2@ ML'H?::.!`K:6H"-U5C2UI2Q%.T/57X[=\EMI:DZ6=\WF=$V!7Z?L4)7^R?2: M/MG47,]\;5>W3__\;\(;Y$9T5;$#]2J`J28(+9)6:FD%N3: MUD?.P-+!)ES M*Q*X@/PW%^K7.RP]\4HQ@+%J"V^[]?>LLC+0J#R-F=KI!W%F(Y;&:Y@6X:0V M=2K?*O'1;DYL(N`8`^H66LNQ2@>[>FURQ`.C:S8+ZFEZV"3P82!<<]-62YUG M16,+1?J*6.:&J?!A`X^4>\)!DXO[#``N-&*AX,)9R`_SD8H+ZJMC5).C+BB, MB3GP").FHL_R;;P=X^%;1SH4E-EJ+$71)ZZ@-M@U(I7:7(P^:_W1"D$$*]V) M?16+F8'_VTT_>A!VEP:AW81?%L'C\P7P/2?!L"")IEE%OBI,[>:D3E/XPII; M(-Z]?VDTH'='=A3E#M*(X-:Y8<%#ZWSE5Q)`E_,KWF/\U]X"U<87I3T.;70" M@*SZAF7@0ENM*V7$,=K,/Y@O6+4$`((C*EI2&$LB*D&+)'/O:02:X69G0]\R M?H&@X=RJ))Y&(6?C'1'>"%H+*^-;BP1_-O9`-&=KHIDG%1X62:A0X**1682( MR(9-+\&RU926O9MXW";AJ5^NVUW($3?MS%:G=IE=XC8$]R$WD*#6'$S03=AS M;E/A#>89HE4K/H=(P)ED31P19FD.2?+$Q9@040:4K%+=+FD6V@QP-=QHLG$S MSM&)P'RS-VY@>N7`8J#8RF&.L<7VE(8L,I`@\D"P@98V*"F[X0FOC?ETP_]& M#WFUWZHC&\;RB!K-$B]NX$M-*,TW1_&#$MZ9;9]8NM<%H+&@A."A=3A]NVR< M297`.CH/Q\1>RSG92V([GY?/;2;J7KJ^65#6$-XU6NL'AJ'J`8L2W6Y,$0!N M+`]#=J8-%?4XW4`:0;$!ZAK?SYITT6RJ]!0=B#N;FT94KM2S"CQ=64JMD=XZ MVV"-P8QL"J.6.1;'61-6@+&`%(W'88`6,.R8RQ.9UT,O\]1YK$Y&X[VO0,W( M$M=$D%V\8F9)C@@YU2U1I@&>L&D<0^A`J"#PSG]E-/`QC7Y%'$$S.6?DPY)) MGF0Z(R`P_8&\>)MZ7Q7XH9/="Z97<+"HL7Q+M]!9@T$!&@:%DUC97]7?PCC( M&Z_G+YDE8XBV-"8`I4T=XCA2/*PDA"-R1!!'\^\N,#IS;E@UQ=`<8*F^7W^) M^P^8.),T]':.N*CV8):_,M.2FK#5]OVYN:F,>SS6NE'G/!7PF;]:N8-8GQ:601>EF])&_S^:^_A.,?V.3S M;',O_>?N9KWG1XTM^/CTH(CDJOP]K2ZD>_CO<_OO-_;?%T8A?ORVM4DHVW=J MM>8DLU7)H,5^)FHPO6F,4WJQEI`N*?>63YIGHO2LHNGMGZHF=V;?Z/ MO]E\\46/[6S20G6#__8#4J2-;@*9USVPH)*=FI&4"B\68_*W]!&(;5IH4W%I MM_/#`9+36]SIUZ.P8Y&2"I:G/9P4HQX.-ZPJGKFAG;V-9WM1%I%TO?@!`_;- MAAQ)/>[NQFX8EF9H8*B`0+T%U4I%=MQ$3<`HM.JK?+PM#8FR^%#.;Z<"_)"' M`NMY;N>+7K;3L?<'L?1F?U&7GM<,.Q:?%++9HV$1X#.@$=0WYD@QJIN>7?;0 MDVA^1O%=2-&`2<5<`BXV"MH6+Y,4937#!BI4Q%`BY@)K98%<4G+KS'I?Q\AD M1_CIT4QO:L=$YL60!IFQ>FJX'00E9K@3928SP.$Y`==^&A6WJ(+8H`R)O\"P MJ](*F7"I\H>$_G77RV`TX_@AV76=YC/"VRL_C$P&3T"V>F8I(TI)?R$O+!%>;L\^4O4P%R0GSP;\@( M=&)FZ4MMA3L1]+KSH]:HJ#@F[60ZR4H2B?B)=<3[#!):H@\0ZTM`7QJ43%(=,RD*S*"*49>\ M(E'(*%(%K*0@#3?-8$8W#8=T=!"O4=<&B"H([GGHN[6C!6WOF0OUK>5S`0X6 M%!EAZRDYR&%::$JJ)7%2R&XJ%?6#:"!M/R`2L_")?@DO#48WZ!1"Y!-TR1// MV8FC')%P-IA#(IF*(#Q1;C])=G8H2Y#"$Y@U/'RM\19MN0S$&XQDEBJ2VFG8 M)(<4WB"/I?C%10D9#7L//I/'F%?"NHH$7Z8%CK=UU$T%]J[)3JIH((%U+L?2O2JF6V*+*R=?HN6VO.@(K>UR69OX#!JB,F.>`D<*%:4K,I3GFC+;8^V2N M%V!H#*"UQ5GDR.X:BWP552.4QO/Q"!/L4IB'4+QI/ZNT9S'#B%\OR3`&U`N) MHG_"9$;+$$Q+I5K,G7=?(VP5!Y$,^U$D;2T6$KA&*&-%X$'FH];GQ"OT>R#/ M*58NP'6AQSXW.5MQM6$JVV_P)(W.R:IU,6&SH*!98]/J(,%MW[I/N,6[A6EE MIBE9418C.9"HCLR(T+)Z2R443T-;)#_I`A6^5CK*F-T0SM8RXDAZ3@2*!AXA MKXA/!R2ET/.5Z=3(5DG0SG&9WR&%`#-S05HIG%GZB_G9BU,[B0/XT6.9 M<)<5\"JCU=;PA`PJ5UBI#EUT-0TINGYF&0KYUSDTTX&N2>@NHK]=WH^1K86: MJ_.9I_7_#_RG_%G$X-#:K4=/O_]N,!U[''/-*;7;^F7VFKV-?LL9D6[)T8FW M'&:`M]'5BQP4K+R11M`/3VW0^?>J[5;O2@Z3?8_A%%NKXU[J`I$!.4>4"*6. MDS"[UK@[;#8T(R,;S$7;>(F$U(+HYAP`@J]+?S6@%@L45(,XB9&M4>8.60%_ MU=F%%6)!HB5(""V(!=46<)&(>=+]#A,6CH6;W?EV<_I/9D-+8GNFCGM?[Y^^ M-$PFT#@D2>I3NP1,VXUF&2U'6YTX88Y1J+32*W\&XUAEQ`5.'9EI7M[W8E!6 M)&FUO:7C2$;4*Q>JM9@K4IVN9Z)B$A@*;5AGD9^_(,!@\([9R6J*$G6_COTR0GQ@')4TMG^^Z7Z,Z5.C83:Z=D@6^\0*#$D&/EV$DPG_Z>XPZ? M_/K+DH[:/W!5E_,)1R&,>7QXB8.VXT003TN4V"VZI^YB!,O%?@];6'/VL6Q" M5RK`0ZY]=_=WXV]]+YRS9Y_7,1C&851L!*Z4461 M8'K-&202K60S&*!.$#)31L')R&"#`$4&3UE`07-4/>2EHH<*UZ?3,I%X?"/' M""QF]*5[@`;SE,,K'6=8^5T;JDH=:=N%.?7QF&GF!E4S66ZSO6),]%["&O"C MDBM4F7H3:.;'*<:E.J4@T426MK1I(TJEW2YI"K91!L^$H]>`2G*4=?0,,:W% M+KY04JA_R09MTKF5($C(FD8`R#XP"PAGF(;LQA*CJ;8V3:`R,[I_B>FDZY@[ ML4,BK]*LEHJ)F^FCR8A&N4,,(^E&M(>(U/S6>BO<9HI5$7S>:'<>$W,G8+&2 M:9Z]E`@,?(C!ZQ.RH'+F#QAA,SM4*<,DFJ*1=P@AKG1;7&R4@%ORK=)=55%8 MC)33VGEA155`E-+$<%HF3UOW1S(O]>U"HJJE2Z_JT+6^'E"K^TLS(:&W3X1. MK;-M55I3)P!-QV0L<')/G`J&LMI'RI*,X&"">$2%Y`V:W=WPH!IK:+"83BZ1 M8[5_Q3-^2MJ945SLG,6H8>V+")PQJ9%V1*\-(=)R-HPZ-0VL80_[H#Y!%;"5 M7H<8^I,]9[YQRUHCHJ>,-@OQ94,*+%[A0NA&3.+G_FQ'DO)/DIDF+$;+RGDD MI)(?#DH1VA[<:"'8)<>9./69.[]ZD!0<`#@(+TSN!'MEZ81X:`T>S'FM(-J. MQI8.57P(4-N"OZ"FJ)$[8E(2M'9WS-J'%8>U**G9P%FK;$OL4_DSG6P82#^_ M?U.":Q;9S98ICHWH-:",VT3$_1#?Y`:\K!:?DK+K[^$8UH0X.9! M)I6EWC7Y"7!%>LA`JY8.?7$A'7-GQ50QQKMDS@LZ\BTW%`NLFI)\\6TUI-#:L+9%''MG&B%M/GQ0C4JNW>=LOM-'EN6NR,FAZT3CYJO MC:O%([?,S(JU@B&4>S=]E4KO_4X*O;WW.P5@:LMU5/K;GJYFL/M=:&.U$\[8 M+O[%YZO9*(>_T0EK>(Z*N+U,_3KJ9FL05&)NU6_\TI-[A,M,V=+34JR/G.%H MR\;@6R*Z#7GBZ9/+W*60AZL#ME_`Q="W`-U]VK-:BI![/@WA.&%[:^MW$5TN M]]KA_<$R"6>IM\:4.TYEN3I)Q"OIE*/%0F-1O%2\1)\2O?5S42K],:I_C>;* MN2_EEN&Y'KU.YM$5-1C1,FT!U`0;)B2N[R28],>R";-(]OIB@W!(563CB>1F M,3Y;HU$P.]8.EEWSX)"SX602!*$:CD,9"7+B!#5/WQWUA$H='`D9*3`L4$(9 M0R%B]0,QEU#K%,%Z"\Z`X/91JTE>3(LAMVX9HX@:!3R8=E3,*'#WBBE^7P#9 M,XT:@FFF.ZY$#XLF>AM&+YK*YO?UW@Q(`,1V&KB3KFOFM] MQN=8NX?8]JYF)]X=NI`M"RN:7X0AH*KB-IKNM.H`J`RU(;L*XT<7%II)?7@C MN3^%6'5`Z9M10CKVE)0:KRNS%WO/M>07S[>?0^[(:0=(YN92I[`HO`#X M=]SL#_YNXGZE';6NO&(!^4-]=$4L8#S:EC`Z;FZTT9,TDC<9N/^V;$SR!&A0 M'5+/*N,8"@#`3H=G+_;LDF9(5@(0KZRN,_UF#&A7:@,VJ$DNXN-+0IIXCV1% M*D$\D,Q%*4_M,C?,6A'16$\65IZ_\XRAJ:&VJHN!#>G4.Y(E5<):'XW$?#1@ MKP5!M`E31#W!6C4?ME7A,!X*+"E`*92\0'1L0T>L&T%_7L`HL;D9FI!YH@:K MFB'\2MG+PVJ@'H[P[ZB20$Z=H4%J%!X%+%I/V7\6;2I%"[M;]68?BWU1"&NJ MGPW%#&2P]G03!^-*F815QDDJW#HT^-GS MNFU([WB\N_T\=E`TNX`0PKYL3V643#+1L/C',%GP3S_?,[2'@WV'!XD4 M:;88]K;=4MT:I/EN.$^0+);M3<,=RHC%<A=)%VMT)Z*_7J'G-DA&;OQ?@9/A#Y9`_Q*`M=&(DMP@FTC,!9W*((ZV:X(W'+.Q%??"0HK!\,$ M.#T$":Z2?O=,QRF%'PWWH974?L[3=%V)4Y2]I;6G[B^/W?^RX5JU,X>=:V3L M9_[=K-$$)XU3T-QDC@9C*&G?2S,]@!!O`3GC;-NXMR-+*F95JWIBO^NGVB?X M:PR!*VQ)&4L`LM!>I39G&S>M+2;=&2Z;V&YW2J:!ML'+7)#5;MF*B!A,V&!2 MEH(-^(Z:89I^PC+6N!PQ21F%[^J4N6ADI2GVWB&8?9-W_RSZUGFPBJD&9YIT MZFCHV9?,T-M\"/BL#RQ\)$&K;:!=7XBE!8U#V`M6@I+\2!G.(@G/>R5'W=C* MZP:48%%(=YKD!/5B'(A[3O1L@K-K>N#@'RY+>CP+7^\`2@R!QT9"\0'`Q>^M MF9LD>4WK3I(%#=(+VO9@YQH@#H*,Z*`R-BWN]F-A)X@0Q?VD`W5:E;?=]B"8 M(50L*[9NT;[TSDL9U*^LZS]7?M1:3N/BK-0CXBIDM+/[]4N)!4N.8?)N"Y<.$@3KRX"W.7$KFX9]PDA?QM-JX'2.8/N-X ML*7Q+;U*7W5B>"RDS10!D:.LFGFS`<[\'.!"4#&>72:?Q0PH(\[F&YIF8R_H M#1+KWZS0<*TT2`+JD\?#SB2?OKGBJJ$6D;5>@L!61M1U??36;`21D=0FE%E: MA)?P>[XDH3?J7'@?@Z^7X4`:.+J@\7+J*QLR.E0]K3([&_NU;7/E?T4I5P># MN?J*F/6DH.C8F!O>_'AG+^FD5BQ@L:8''2PQ!(\ZQ#(85KQ/;5=;BP\(V:X' MN4`*K>D7WD500U"1=OZD"7L9<@L0VFFB-`&T*OFC2<;L:/)MG@[]/L("9G@( MCE%S82=9&VU`"\!+=9K8/RR!:/>_03E3Y115^DY:4YU*E:)NL:Q^HIL"):+`C0B> M,)7AVEY&*3P3DP%K1C!C>%UXE*%P0D@Y=;%O.F'KE$MG"`B4&*CR$OY0[62D M@&$GI!*&BEG5!IJ&]]Y=A'5R_G48K"XI:?'"%IB=QOZ?=FQPZ!]ELYR%6!4* M32P%G&,Y5G(9VH[8X"&G48`OPM)3'3$(ZCVJZD9#]X0JM.:X3\-=Y$`UJVIFF'&9,^#G=7&J449@O5VSA>WT8V;<:X MYQME8770H$.O)!SB"CHJR>E5S_`A90FG!&%L(HJTQZ7XO@J?T#GI9_77C6@< M$>K4.>7W&X!%*%]6LS0U%4QG-+9=4,*I>F(@6%A`+T0=OFDD"$[E1D4C6QM+>N(42J M0+LTJD.KXNX2<7R;O.UE?%NMJ8@-M1`:2NY;.113M!ZY97U5J%IH;$)XANX! MI8/*<,?XD'W8V'[U>V$2;-/Y<(I*J*I$4"<3ELA'S#W".49,1+W!P)`L4;LC M;MJT1BYGRN--P2);XB(=^AIPC)/53F9JVDE`GKG4&4?4A.UMYQG0> M9@:KZJM`B68>>@4]M(#P0M*AJ8SSSL*VQWI3H5ZG1QN/N5M1K8+3&*J&*RVJ ML/8TE=9420WM-^;.I:T*8^:8?,OM6?HXM#.'_)Z93=9J1H@_+>UB1!&R8_H, MP@I[S3A>?FR&S\22[\_'5IU:T&N7E+V;S=7O$?;7_)S([XT)\;=\KO3H@TZ['@@(T1@_7P)L$ MA#:/*O0TY\>F_NGB1E>JWT.>!NJY[#.TJES68P)O^3W)DF`OK0(NKJOQT=:# M6<8AF$ISQ`5EO3E'10X0]=&%-!C(8CWA-,!5IZHHZ<<7&T-5UJHY,F6G7E>4`@)B3Y<&IPSE@?Z5;Q!YDPF"PA%<7M;C"X%I\\`2E)NF.Y5I;*.AD\.W^V='?.[V MS=&'[(>CLS>9QM@_?I79E<-7V8?]$SZ&<':R?WRZ?V"W-L>POOBW*@O'4RW_ MZWO=?^6;W?H?R7\Y7=5L$B$U;5514YGD$$<8U*P/?Y!XAK.3Y!CLVU56^E`A M*5(13T,W"[*&+5&+FL80GY-2R7D^^$E2[0I7=1NF8[K25<=86:^;-KP))=I> M/8N[`0J29"R1NN]NEZQ+DE:ER:4AZ3$J!BBV=S6=[;B#UZ0"=>0W]54D9?Z] M#=LWS8:\^C`NGVJ,^94BP8KHP!77$9MZT$?]:LD#3U);(TQSC>B$G9I7$Q>B M&VE9>;6(<[5Y^7NK]_$VW:+3?6T;JTRYW(Z:0,,<]-&T,(9/(%D99*F/T8FM M]Y[J"Z5=(V,X/#B/IT?P%H=EFH>,LQ>`K1SLGM$,C:P:@V&SFB=50"DPAQ?, MU?;UP/,IX'B3;-IN1DR92I#L220<04ATQM8>>KD@8$6,F#'"'B775JO:WP8& M/<><<=F&U0DV.;8(7QG<&,J:;!8Y8SZL\-P::JLH+C;.)@F0(,;02$*K]U;+ M("$7#@V*\):WFQ._@675AT9WGU=5GQE<<"F$`UG]W=\F=-S,R"^QA+W[YK@^`!=HAT1+AX3&`,=-TY6%P@ MD3&%X+=="XVE2P838$VGF0PM)TR7W94+\+$G+Z^.=/'^/,<%[QB^I MQ?8R.??P`37WE$N:L8G,T4>DVPZ;<+I@%]+6&NL!4# MTN_M;Y5,6JJ"H`DP21W:-%I%%X%UY>]DON,,1=<>\0XVV)2L=L8=1HU@<DPD' M+4W?9W"3A)5_22P>-`2]4=4]^R;I$*"JNUUE3'3J!A:I0ZU>\G6@>NL_6D02#%, M7G+[Q99/U7=E550.:P_D\(.K=%X4R<+L:HM4^J8Z\QZTZ0%S*I^ M3Q<]XX#8_'!*-V9?RU@@(+0/1]K5X#E.7:A"&28M>C-#'0_.A7,?9/&#!T=.8X^I59P"#&RLG?-"!&>%_@Q16P0< MI#_DB_I&YB6:HY^C'@Y'3JDH&H@45?,YM^OPF2"X?3JNBF>EC$YDB+2*9LUH M<_[]J[J*8+R/^%TD$7Z"BL&\+OTX<8@<+"JWP^RC1<$,R%('V*&:S[$@L)J5.#NNN9?70D';9F?6<^FZS M.(&6@&(E@GV$T,Z,8`WH$_HHEC;G*&X9\5VO[OE&O[[,65?]OR1L",'=$(O MX'JV/_M)B8P2O(EB@\^,DIC9YHY:$<%-1R!9H`@X6(93E^\AC`7GYT1)6..` M%&!9J.^GK4I!;A4@AW=5[.*!.N;^\F)Z81 MJE1=!(BU=QAYC8YW5FE'C\(U*_:#CC\5?5_9[DH)1Z:Y-B<1`T?]T8'@AL2B M/]S0HCZ*USZ:XUW/3'KE-^6,W7:DLT.\9+*&X*MUM=>?'#)'^.GG76J+.RD" M2(#=;93$&W3W>HT,0P><)8:K%TU:&!5U;Q@V8QK^$EFMEZ62$$D;R)?<#;N; MA?8Y&LSJC9)P]5!HV[.XH\D+@J:J]4-1Y$3B%NA:?ATJR M\(!6J3X61P<-^2"`?;ZUE94"PX6^WPJR9:1X)*)3639>_>^4(#H?B5>BC068 MX@+MV_1DM42-R=&7*#QPV/-5ILMT.,?-\B%;,OJ\GO5EM#SG:MO/L7;ZTD-( MA`B<"8Z8X+%>C^"=+Q?(VY+AUNS\&&%'3TSL;.WL259M]^[.UK-GV@GF/5;$ M1Z%JX7.VWADNPDA2I=[L5FTTX+,"USKQ5K!/Q%26B8*S@(`EI1P_20Y<.V[9 MXMJ[WGJ"NCE.DA/]ZDGN,TCJ9PQ5V)-0.%TD'=69ZPA\FBL))( M8UP"5V6FV[JU4Q^K6"^J'M?SC8BP)=/(O51?1G"(KE5!'$OY6C#C[_6I*G<& M%CF'A@V)??SMUM;Z%C+K#!G?=73SC&'5!ZMMGB0D9;KS$59=KZN.!W8^UJC4 M,#%>S#VG6\#4D$G&*@Q4DZ7S\9(WX4LOV3'5M#;<.;N[8<_O].+77UY[''#7 MOF/?CM]H__J.U##'C+=_/L$RM'\[G`SUAO;/;R6HO_YR!KYI7V(4`=_VSWVW MKID,=C[H^VZP/V8[2Q;WBQXPK^X7E?:EL;_^?OR M6LXI).T??^#;'"CS')=X0D6)&N=QK3$CS'PPF"W[&T8_6"7/7B6%2)(JLT/<:0'`V$A$BJMM?DT MC\3LA/.>"W3--8+*?0H@93>$O%5(B>9NUNWA]U<)S]>J#J.V;&*V/[)A& M*^BI#M-'S=QZIE^.L:,ID^\Y6#*&*,P3#'$%OM)6`,TA#SU9,80QQ%9.MZ@2 MS".B*Z-#-]/28ZP]<%X29?EJ')]6NT>#XPH-;.%SBCJ/0H15U6]1?4!$SHW` MJ%Z\800\6CA+1_2"858&!_KYAC^A.V`"`!$;()P`]RT0TJU(@`IS,;\;J`<4 M#'X4`E39$]U?K3C0MZW\^^F^93I#/I%#ZAZB,,Y_SJ/2$"_$(\C!RO'>="6DE/0DA^JL[)9)V MLX@N6R>4^.$S4?"U3"]Y-YE\:*':$^CYI@< M-G9TZ&1800`MCD=#TPLDD^E:M22$%!O4*IQXA;BM1:'D$S[R8>6$QK2K%4:, M4N5)=CL>.%EY3LRI#^OY"2RD5"!DM&">QS#AVK"4`&'^/22[%FL\_'DSA ML*2W,HFXHB?]E/H!G96MLERWGM$7JL:J:<84`JT1L3/H9(] M0O`$><78#(G!QA@T/$V28(@% M[4N6;-5&6UH=/,&\PY!;3_!4Z[',A7P(K/)5A8_AZ43/L,P8 MLGFQZ[Z$86#"8^)67J,4WF3(R`%I%@WS&2:.AZ_VH`=:0M= M_#@VH(@.H4:@%J7`RER-L-YXN40>34,K4VL#61>H=40^Q-U(/(93X@W!TNH` M4$>/5>.JHTLE4VH_H](>"V)9]5Y%3YZW;?=*(]S23^M1VQ]R%,=T=I?MQ^S1 M[V,?F<.>__J^M2!5KVC<8_DXU20F<:Q;#>@;;!ID[&@@2D;]CERSD73 M_M#&*VTQ)F8&ME$%P+XDR?=Z`VO)@:F6LI$GMQ/HXG!KJBI82B[LGT4(E\R& M!D$=4S@@^28X$$?'MMWP:KX3RB8?FQ9U_?_'WKDMQ95-X4R]+^<@:S#"J;K&JMV&21>. MR;T&R.(.YY:#SLSY"SQ+$_)4+X1U),\W4-)LPX/\9('JZ-K6"U4LE#QM`4R+ M>T37&J);M)2$22[?4@$^T:H2%[2XF1(&;'79\[J)L)/`<=ITNA9VR&WUW(-" MNI$S,3[S'\IE]CVB*@S<="1V1X2Y*'4XZ+_L9!-C39ZI&)"D[]9%IL&[$'9F M(8N``U:V*F%C+G/OV$J]-%R37E!H:;/(0W'[FPJ^LKR^\B1:%]'Y:6ELND/^ M,G'=9F7YV30]Q\>K""*O5T=KNF:81B`^[J*LVO6Z-C-UP469O2&4PUZRT.#3 M3CVI8774LO0>CPMW$CLQD1E(DC91GBMC7ZCL,WRL2)X[5-,1[@%HE68XC!<2 MN(,WP%M.0&%+B!?8$ZZ4N"@-*/IMA(5L=2IEN&.FE^D0KF[U8!6JG0],"K:> M#FT[YR^MG2'2B*!O(>X$40+E:'8N)FF!:K:G!'Z\\UX8F[*'O&36#"#I],,W MY/Q:H5S/0G+-`(V#QIM\%L,A7&S99PQ%5!U(=#_V%RFW)%;`U/B1;M>^RLF_ M`+:H)B85]D2SV4(O?F?3_F)',^<7'11'C#%8T:1,R/U2V7=)>6E*HFQZ$>Y3 MV*QM)N00"Q`SL@^-S:2RD&P[5SZM`DVDV7*V,R+@9@Z`62&BA-*H+V1O0(>` M888DN01W4BJ@UX:*4SG/=,#]3%`CB47/&NDS87X6L7!O,34H+F)1S&-A"&6KOMI^9BUWG3!RX8FY/H_C M_LR;.D`0'U76*D:1TQ&X/JP_1ORX?D$=M6%_47-M_Y;>97JBG]XXA`7.G(JN MFAEB0@5=$;([)N;IT:P;(5?I'=9!0=00>38M9;_@/I;[,I&@A`6M4H$`VAKR M='X<3Z5=A85D-1"(UD027&")UX'LEHU@(Q;M=/;&15X0J!33]=)\B8[_3C>= M.7:=[?'-6LR/B$),W-+6YLL\;"[_;-6^]!016$ZL%+A?BHDD%B;/4D(&P_F*QFMT%^)?Z!M"M!LMM1J\_6V55_ZQ,<]%IU^^/5^>5G8!+UV$#!$$Z`ZGY1;RWZ,9R-P]]3>DF9:>DI, M.-H+#HE]@]%GB-R8XS\(D>T7,#<9DK)U`O-V-L?]89_]PV$DFQ"MHE!@A%+# M>]2WM!0E>.#-`<1-HM/1,-.,.\NNW]]^83X$09M7E*(*NU2JF9&8OTLJ,Y$J M;&@9@8UVU*E'9KVD>X6M=GZ.Y3MO`;5>BG(GQ$O1!72P&&\J8Y?VA&E;]^4N MF=+/7#61LV@X%3:I"(GK;=2 MG#'4B?]X^,4??MS9W[$JV9&* M:%_N[+_;#1\T#Q=M?)JWOW\1,AWIU+_;_NOKL0\X:34E4I+IJN-0JML^W>(@!$3?#O M"@3?,$'RT05$,=[`B?\MDRGK'!T99-3E*\#UX%S*C$W_9KF"+SV4#D9Z2!:% M#Z_JPIC!VLF6P`JQ4\-YQ-:\$X?(3//PSHY<+R?CH*'[L-C&\%H_4+\+,T6K M/\'XNS@BN[0Q8-[%64Y+F;B^^/,9D?(R:"%"W1_ M@.`XK&)/G32!:\.U?2T&LOEV.9>`^U M`F6ZK[FS?WBQ54L/,8:?SJ[9J[)*=HBEF&#[ON:T`:CK>:ISQP>MN_/\4)Q- MZJ.&@Q@?/\=RK9'+9*N<&]'3O4T>B:RV].3KIX&1.4B::SX`*5Y\.#L_AJ.: M__6%X87DW3[&P,7IL5I?_/4O_\7ZFTL;1;KUY>4M#JB2NQ-?(\,-V>J65F+M MY;7E1(@$\V"901,3\\D^()7!$5':J[B*=YU%E,@/A)]UFY&NJY)+I[T M$X(3YK1+?79A!/)TX-7Q]GUR)GONLW5GZ6'WWJCN*@#K,%/5.#+7QLIJ.(LMBE^Q1CTB*^%BRY8_ M!B7?L[A$XMI&5RG8)"? MI(29Y!@3^Q2TH6A'%FGO\BZZ(SX0\)4B."K`+[,BPCRND.2CV(K$G#JR19"5 M?'GJ5"QC]?TYM.DT1Y;'UM'1]1W_BD$>>\Y#!85_%7,W^K-?E(ERS\-P[_T/ M5AO3U^[>_)2)@>FP<].WK&F#>8>8`0H@*`&#JWX\E(*[,)V6#]4,[(>XD`J;^= MDTQ7/_JD+4"(O_[Z)4C:KU_>*7.J_FDQ4<1]`+HW8L?TON&][='U/("JCGM*E]Q MH[TKAQ%FZ9G!P]\WZZP^G;9L]2'JTCF\YW4^GR``!YU6UU?[U@V4)U@6]VN\)$NBQX122]FY2T MJ3!@[,-2^*Y0W"`^/6:)T7KJ8[]BRS/2OGJ3-GU!J>55\%D--X-V05I14,24 M;"R5ZZ+EF);LWLU[BK4(.6E%C;-]RC1;@ M*9K,D-^O(\WV;P&210SAW]A8ZG(?=.U0Z^L]!0;=CEC)B%\V*F49=5I2*<_: M24E/)O%+Q9@KUF(Y.NO49LQ4`3(:9T@=H',C<6>FJ MR$W:6YZ<$T72,MW7YTD1AFJ>VQ0W#[CFM/I'^^FTE]?"F`(R?%/0.7;0#^]5 ME)A0DC4V%EI0)2'WIK2/(Q`,$S\\&)$%;-/8$6T(-`>J4E;NH*`;!M(KDRWH M2*DL2]^%-8)?PAK)*190!75$/=<0K.X4(K;=*/*\K/TU)+MC;T45CS\?1"<_FV92R M._Y6FW(-FR2M,==VNSLEXUAL!?77K)SQ^;L//E$WK&40BEL"(>:Y210KA+S;@&^,U4C`: MV^0E+AF8[^T=E-TXZG9RBJ9?[Z-[PT"#R.J^/@@IW!8+%N&C9,#\FD8LP>B7W@NQT%]%KB>^9@\SJ%+NJDV&]!1$"DACIFG8D"M'7 M]\#($VZPP4'#G`3UK7NRZ!B=S1+ST>@XAVD44?`V=;F4'9!^9^O!?(]*)(5:4OHY>?U3'[>T90=%1")7^ MA)!4XG%T#*,0OII9&KSZ`?S`MQ@:;U"RSTYG%R(P-M?Q:R/:HA(M7I7?-S_L MZ>54V."F$78]H<19)P-QU@8>L":56PZ>>+JRLC9Z=ZG8^-XER5&VW>*P+ZN* M+`XM.LQ5N55)EUN7][.S`*INC.(QL'JV.E48:QZ%`F1^';($"'2BS;ICJ4V;8"30->,=%!50XVT;VXCI\SAR)8N$?1$YB'3+U? M$W\PBUU.B<J_V*!OAD`0.LAC:4`3`QAT0TC,? MICOF>,0]6MD&Z:/S%,0&J7;9#2D1-GFG]M.\#B,@U1YIT5+R(RLTG/9J2P[9 M./,7Q^-ZK9Y6),+G.3#.S-44+S.OL2D9H7+V9T%6.#O?\(UVEM<)R(I*UCQ* MTR,6^I>SH/_]3.8:G]Y2*B.OD+490Z5N!+"PR[J1F>H=NY&]HN%#X0AV9KNS MDYBS1*X]$OJ/&>IA\%TU'15X<@LKFOHPQ>3[I/&`LS!)$2$Q;)O9-<.93,@- M3P\EUD+U,LX415(4;PE)K?(:!8M5^8-T(.PON]8JE@7+#S!?L"]0SRQ4Y=T+ M>!$^1X,5YGQHX'&(5!CLX`!18/!@Z5`/<6=)Q)(RZ!R=0J&.LZSA/ER2["K] M'X85A0_)[BFB?&VI4*%XN4%[+S9(-?'N!<:ZHNELET?V.MG:65F"L338]`ZG MWHEW3$I.:\^0D/JQN6E7>!,:T!49$>H31UAAR'%CL MG4,0Z]ZY@VPS9S4]!F)!_@]!;$I&H0GA/GR?J\+13"%[UJ)3._JLI-+_BV2- M_--T-FBWUYGE+/);JV5*,7!MZQZU;)H>!'4B(N9JD9ZV9^.U)J+:DVO1J%F+ MTTG/[^1C154*(P>R%D2^PY]P$\98RL+ZYF:KRZU.EE;7F@0..+<$'[5'F5T$ M1[SUJ?T5ZIKT?%JUGNM/W:.\-[&259TZW,!19$""1B^(:J!UK0M$./W>^KD]?/#U,R\U(`Y-=-3WY8,5DWK5[IM[UXXO_OJE[\T"0;VH MX6DR1F4%"#N,C4G*2PM6E*%3MJTG!EEBHVGT`?VE@FUH["GZ`37 M%GA:Q#=+\DD3XZ-4*6O3K`M0:(!`\`0W.QG"4!<'BM:'-?$U73R^/;AC50P3 M`3(XT1L;31"+FE%2C'-JH"OU^:2IDB1XSLVOOEJD`HK;HQ4B#3[6)(M!DQ7"EN>B69;(7%6*/ M`YA::*QYR7O4,<3(8R^8]RZ\$%]I]T@%812[E%(C$0">TN#""\V M&")3YLHO(8J![D/2N*]9Z)+?8.1ZMO>"#X!3NYYGE-96_!D11G4O.,^B2),B M.U3\UR(O"+I+&Q92UR)^3M>GI#)?'W\F)T=V/-U8A98@'GO*/HJ$="M/L/E) M__F;L0Y?.GT@SG/CN.=WU#'H/EX8QOZB*NC(IG0QRKW];%"P:]1US,"6-)&, M>_$V_@L;A346,GG%VQP]R_MZ$$:-5W.]Q^-1ZN^.3N.,\-&&_L?A$TJ/IP_I M@K)VY44(3E,%O-$]J=FQWBFPQ"(7U7[J]>?]3!]\SL#N4IZ65OLOULFPJ/2V4PM M2?P["G1\C!?=TA`WY.TFR&(8]F^5.P@3F45R:S$^TDCCUS8%H5;47F]O[6_O MUY]N8:2RF*!FD6YN!0]F=V9PBH[$1ZQFC,(PDX#2B0!N;ON@6AUNW/)8)KKQ MOHFI-H`RURA0,H>]TAV;&GI+,XPG]4KS=[%?D9;O%TPCCU'-GM^?_<)]Q:FF M4O8@%;4]$1K7SMQP6#M)JM'.PS-L575[L)5!]K-+ZL`ZLT\7;V@/]%;%$_1Z M-[F2#$:,= M]N\X?U60)\-6F7J:D'1M\ATPT5 M_:JPBMRP)Q09[M!A1\$-J]Q\UZC0!XHMV!RZFGP/+M62''EJ@,TX7S^WKZ3: M#MT(,&H2H19J()53EOD\0N]9X]JA$9NA6`GS=-&Z/_%(&!_)H!Z"#3<77R`L M+I?7;S-+R65`H(0X-?^C?0)ZCO;'_O'?\-:G;)$276M-T]V@SW#+ M(+-#-/S`C'AM]55JW;9C85`IM,VTCI?;SP]&ZOOP:N?MUML7.UNO1SMO]P_V M?GRS_?:@D6M:NZ&C'67UJ,D=7ENR@L\@AYS MA#NHS#5E6V8H9;KZ,#6\-9O493H:`/W#Z#T6FLN!X_2D5+*(MR[7C$^V,%VF MPT$@+>,=P#1R>.B*;'H$K"&!%0Y4[],EPU!B-U:DX!%V)4M8$U5BD!!30`>^ MLWK28QI5$%N2P+3T=PGG:`IS>HP)9E?Y"<.1P^0):_KY9D:==O+TL_D#$+F& M0N3,HL.%Z4H")F+0S7JSD0E!PQ$,$2-L00.55`S]XN83J"Y&^EMZW5W?4OX< M6C0'5M#LPW+H`S2D`A2IGY'I&\Q=*\SG1+1=ZEU`$T:N%K6*5R-)BGK*?*Y. MOT*:)1XC(A*:+--/*JQ&=IO*WFLMI-EU*/O%?(W>):X8:8)ZYNJ0_U.9:;0= MD?$&2II6KA'TION,7N\\W]VC7>6='1O]GNXQEL6$6PK-S/+P=4!CK&/+P@G*T^DWH?@PW/I3WMB'@]F[FFE`>R([?Z@G_0"E7J&.`D$QAMO M)#[_!\*13!LQRZH[*`Z2BUO3CQ#&B#7)"4:I:D20GGY_PB4@%'TX72X9TF-^ MEA5M$$`2]!TM'O&S-+NSA-V8,VQ9#TAXV\KR!.@`)OMM&BF#ED"?"(2#JSYW M%]2"H&NJ9)N/`D^$PL)T#0>*7P/(KTX3=EE+HP0,[`Y;\MZO+*X*5`!O0)SV9]ZP' MQ_[@P/;U!##LJ5X=V"4\2DWG%C:*<@J=M?3-'F;JTFNISLAESCS:,IGRQS.S M09VTACF]<6C;R+0H%-%&%6E2/-*PP?)A0,9[6AO7 ML`AQ(I2`S8N!>R\]:#JVZ@TZA0E2Q[J8I1&99ZEMBR,5]:R M.T!JJUO="QLE\/WCB9UQ8;WT*/@WJ]Y$NVM&9$J-K,\H&W7=E3/CR8F41!1\ M!8!H,_DD;P2_5/R7O[_X>M4AD M-`8K$CH%_N;N\+H$.>3"1%=E8'+1E>UC%,0?T8J0QU86I\(33$!CG#$XD$_> M*(K`IYSY@O8$>Q@"S6;AWGD(8G\CT!":/;E&01G%\14IN:J"SVCGL1#JG+T! MS@L8LA*S9,*>N[HH60#G2:HIWUA91V#CHB]^@9T@/I:LQ^0ODY7TB?OS;M#J MK.)]6+*1;:('\K-`C6DGL]`:CE=#KDBG0E]295Q\5OO*F=^!`ME&0CG*02!7M>86:[0C?>8%@<(/M':).@LUF@(S-J.4B/";O$QLQD2EQ8F^!R MK\7W;``66YIGIBS3]AG?IL&RD*.TT2N%_HX,"XT\W/-IFSCPT?_8TWASXYFQ MG.C8N#XYO=.]*3!/'SY^)4Y76F^Y`)?`TAUQF=)NL"V=V6W:MG!*ZC6"L^:I M.F;TLR&S/C3+_?#D7.V`^1$/0EH^H\XS[`38XAVT6M72UN`JWYZ8#P\%-<.,M&>&_3"1$*KN7>'P==?'L3.18FHZB?,"JZUM_JAWYS??C^: M3NN/[;>QSYA.;MW^#3[UH[\YO:7]!"5,*[_47ZF.O?DP;BO5$;N^6?]6&].R MTW;9\?+J9K/L'Z77@6H:`'%"`F:D>YA)P-R`AA;&JZO+:?3/J(B6ZS+%U1!H)Q_/<&GJZ2GI M938(MT_F!Q=QC?B.[9;1H].4&TF0D476P3'3N1[J.XR3;7L'X.[F>47UQ3[W M1COUQR3?R-]6''U;_>PP.K/WD@1P,JN/W_9\ZRK'[DQQQMO M8?'UBTO8KU^B"O+UB\4"OGZ!$K!;@BKR]8MT$79\V&:Q1"7$5:]F,Z1G7`^T M7AG1?=ZE;N=E9/6BLBT>M:\J8\T-0;^;G7]4MY:D/'A:OX,V$W!CY(5UHD^:B4HD MJ]3"BJ09?QQ"1BUS[*=`&Z^H'DAJUO_2V$0]%C(CZJTT:YO.] MY^DF&CRP6.S]A)703LRJ?<7!W8V"#0#$]E`WDMI\<$03ST*7Y#[M`>2LJ":(Q-AI1UV\C7W(`1$Y(_P8GE?T0 M1;I?$J:7.1,LAD0J?I%3\]-#(6(I*K&`=-="#]V9"X6Q MZRZJ4FC&JV5?1E['%B*>I_#)VC+4GD+,`8"B%Q[W)AP%@9JJZ8%E(K6_*IFUUN3I>8*O[ MM:30E%C!/CGZQ+Q>D!NW*=X"9<(:T^T:K\7W+_1AFJGE!5P00+R4$R);ZCAP MTPEBA0,6O_$KRQQ,YLQX8GWIET?%OOK&Q;HWKK,O=<0O?"KM'E.(S+!]WG97 M5[Y^B6E9]7ZOW/@RA*4[Q]H271EL3`R.(*,MBS4*GN')Q-L]H.'%GM=72N65 MMXGH$Y`%KHK"(X[URYYF:F.+E(E7:/I+&7/#.5)_I"$6+*WI[H1(B#O%/&J[ M9@4QN5W]G:M;'KU2;RSH],0*-?CWW(,(@VW3B2QG\YF\X@3L/G##ZI"U M#QML(GO+]T#`CUW`'LU57`2MT[!L[N_WMMXT/XIO M&B(?RZ(*,#V74FPATECHF?V%%LXX/B'33>2D;1L-`#5@EWE3]1H;Q@,(UL+G M_[AQ3QJTY6F7-S'APN]I8;R\MKYA"9G^C3006B"24X$;#612ZH_.QX,K:^42 M>K`3,_3L[,6>SP(#834J[T#H'R_PT\ZNW(G/$!OQ&72;5?BC=H_!03E04L(K&ZN/00$I%D_*Y=X!$(]#I-6-\9Y/WV8=/N[ M`:93T>_M[TIIADS'$1CS%P%`$K-R9JOSH0?>2#?Y`*=W+5>Y/UL';RS=)[0$ M.(N<#H52G&ZI2?1(;-:1#(FKY-(;2D3#J!6UK=,08_UI]2G(%4^M,NXL[>.P M'8XUNKN2O$(/R(J9%U9YGJ+(L%!9>!2E/$J5-UC/&/.CUY\OCCXLC=Z=G5P? M\>Y7)_A'T/3@&/LX]/EF!QZ29OOH^)U?"A`X;TEYLB)7R\[0KS7:+%E5C<38 M!P%D;T11QTYCA-`A"(A,K`FV7,.4,J1-34(0\X/2;NW0P>&=#[O&[+'UC"K1 MV!FLC,'UG0>+L`&(I;I%%WNH]GS];- M3!'U3I"MW_>>(*VS/< MW-KJLZ7QQOJ]-[>^/"V(/'#CP8LC7W\:02[F_>LN;K2POF)POO?6IBL^I6G^ MK8TWK;N6-O2`6TM-)_H$PC]>)N8K&T_7EM:9U'D?L9$\]H@K8QK@K[JQA.QH_C.FQ$&EH&46_4!R8A3>X9'=R&0DWHZ($>V(T5Y6%R8%*:46#!W.[FPR4' M:N4!@M$GR6$AD;AF+Y5L=+](+#F+$6R61CYB/82EI`9X&!_&[0HURU(1@/LL MMJYA-;Q+QL?*S\V^P*)4>8'W$:<1L"6:BL#3@7*2`.%J?`E>.D#S;1N2;9P4 MD^]&1JE%"F5@X??/#HM]I46[\02P7JAO]RN\(2986FLKG[\V1Q"-O$2E]@1J M+IJ>MLF*<>2VI5UW(%72'QMU`PO2P@P/@(FC3<1:MU7 MV1G1+8_N+%^>"/[E)W?1-#-,;?=V-6JJI+1;PSK->]?KFOF!>RK+5>FC60XV M"14L6%DGE2&-9-W7,%<[\VA1BZ`4V"."@A0"I4ZZ&0%XUYTI1NS0AE"O$4K;UZ!Y@)1C!QNHTX%G*LL-%3-$(:*L]9&DTV:0TR%,T.CA3'N(!<\&]TIJ+"B3'-D\"*C`H99H>R!]W%P[KXK2VS^>=8==X(_ M<`A\`6A.U&D0KMW$91PWS(JZ=<>-&KP)$4Q+8VLJ@A$8@[8&A\1G7.ALD^75 M4HPL+JS1I/+9>!/UT%Z3=%L/HL-HBC,&V`K:V0O)YG5W6D#Q"UT?T'KFN(J[ MF,HE#A0&9V(EA_.8#YR_VPZCF9$G4&:XPV/]D@WN&TOKDW]-N$]+,V]Q88*2 M38+GMX;[])O!G58(!=S)E)Q`704R_&L@_&1SN?2,T#1^;66Z1)NDQP`^\*8N MAJ\]$M)B\E)$7!(4@*3F'?X>V3)-2Z.DHDV2X7P:?&WI@;-SRQ%+=L[L$]7S MH>8!6I0V1!]N(NZ2E(F+L'<$^>6I"DD5]#"F0FD1F<"$Y1!34"FDFO+U5/:G M#SJZ5[2+RN9-#-;B1412;^\XDZT#DSK2D,'@ZV34TU/Y?1GU=':!(.(OT4OM M;R'?8\;;XH"FIU[KKQ[G$@(,_%CZT+$.&C`\H*9W=`8/:H9B.GZ0$R`-3XM++X+`&7/B M945=-DZ7*-39"2[(4JT2CBHP$(=U-FSD_.R]::CJLV$M&+/!&_EI8DM`KX^U4`>Y2V6E.8A77^TM_XR7:R!'&&!*@`E M0'B9@%M61Q$CKG-QF-![AWU&A.TP.(@AF">6F\TO\(:(5`-](DF5B1R7(0H- M.W.*-]PN'G6M*Z(;3@UI5*HJ-G$M46P,[:.F8AX%Y06%QWH8:,G9+Z/SV2?0 MT`I!#"0.]7Q0 MPDA4=S08X66%QS*SI'/Q&X,59^P(0+/":W$9F*Q8.L\O;*Y)YT+[&@<_MEY+ M:Q]SA5;J5>WCVC=;(%X!JT5=.B(W)^Z+3>6LA"B&^"V5)C[LF18:"N4CY%`H MS\P,,?ESAQ(5W0S:9!;O.Q?@(EQ-JDU]Z:"G:DI M<&L^HX0$R60S"Q/EA0R#@I*#IL(^B7+%'ISF%^H/N]S^;K=`J%W?50W6MW>: M,5M_>OF>&:'FMJF_V79]I,F@_V/PKSRM?[#E_A:FGDJAJ+_]O;PPX3MU>^QI MAKGX`PK:T]>7GYJFCZ$X8"FZV MN"%DK3]=75]^-AU8:F@_DWJ1N)_-Y;8I\:+QA?H7S'-;6^.U?;\8>FW3MSB\ MEK;F*\_J%RP::=:?VJ._79A0==QD8Y?(%VUC:Y+9JJ!UD M0)&J=6=]!-ETO*^ABW'=KRX3"L)8KHG,`TDJ(^4S+ECJ0.*;)1;$9WK-R2ID M#._JYU;=;,J MC2Z+L^/H5I:2M.CZI]P!J%JYGX=_;A9`\WSW&)92&.%9PQP<;]_7_3UQ#30U MTSULJ?"M$6M:G.9`FT&1X][>FZV#G=VWH]U7HY`>N?7JU<[KG:V#MI'?+HK3_;:=*UI*,%9Y M<&$)AM$G9D*'X+5UT(5EY?)CM'=I9'2T4NJ.1$XPPU0W;*:'K8L[59:G-.'A MF2M2\DV2F$6`.6,R1;^_HJN+4A>33GE-"!@-N\\!DS.KMWQVBW1(@KL^.)K^ M._BAK56,G$ROMO:?FY,)8S<\H/.39% MUK?R,YM?-/S.V017MGAW?$IEJD'GFT3/!"\$F\&Z"S7DN/,.ZMW+,/2YW%>`6XZ@R>2) MU':5^]_?@)=3R/@L?"G6P-+]88[SA`QUN]G5I"_-B(`.A`=Z3)D(X4:X0F&L M/H&R,$W)45$N@5WA&3!31)H=VGGQ$>3>`]XATDWP`BFZDSVC(=^QT:F<9]2V M+0R\8[9?R/30[KF"]W)LZN]TEB\NFXM@*ON"CB,5A]?[I$\3C_7$9V'+TX MFI7(S?,H\OI`@P$QG-2,GC%/R5RH"-_*QAJ7=)>PH7>X$"N!=""JR$W1+=,- M8G0*)QQA+2GG`[DL1E<*3[6=^,!__.>MM7#U-"K[")(GNO[IS=WL%T:N(4)X%13 MB5)4@R25*(9W[,4QZT_\1[Z`,]%Z?AST,V$C)"]Z#*;E2B>7K1<[)(A62U9I MQ4J+^)W@2Z%)VG<\@###T'<(43Y!AT=A_)TB#+';'BL!8I[*?6_1\ID%#E(A M,5(_PYN[*U$13,?\;N'LW`$+^GU%V-$1H7/[.NY3@TZ&@4D8B+7(&;:%+&OF@:;/H0LXJY,SM*"^#`=A M2*$2LA@L$R8CWQU".XQ][,T*'OM:*N6*`7VP6+[7*;VYH$"@N M!`O-'?@<%XAY7S/;?_L')!B4B1@O#^?T:(!Z64_!Y6# M4D%,^#0%M?N8.&`6ZHLM!.+V#BV68&8')D+'"Z@<7'5,;WD MQ*F*T`(_M^T+A8A"P3@Y>*E$`3EJI&"I$JHY!'CL887W,Q3G?V M5M,YNXS\UW+O.:A1-77OPPTNO`>*D>DC*>=C@0KN_EVPX*&77UQQ"^"_TQV# M59&R*)AH>G4X!U$MH.3^H.JI<.[!*SZP?X>#[^9?;SZ?A07V7U>_VJR,1[3`88\T*]? M4F.8X9<,:X8MMBFGCG-M74Y1#V.3PT>(C)1S.9W^>??VRLU-#[?GUW06M=4-P^<6EZBES?[OV$K;4`4^S/LMWIXON;[VS+P$\>H/%;X8ZYWI/ M?U;GAOP^)3R"3KW8JX/_*2M@]$Y9 M8R.:SRP>MU!Y90-VZZ7Z`'V@]H?@$%:+*+;40B'7C]X[`A18(#<04<#\U#PP MM5<95;+WK3DR)-*'\*>12G\,=I,:,2#C%Z;%'!<$?L#*H>4,K:5NN4$E+0%Q M[?8KWY4JFFH94NFVC)4'GI_Q')/TN\B._IX06"TJP.Z'@%OR#0@$SAH`:UZD M$&U#(:`!'Q5>.8&F8`MSZ;/3C#_O86S=>,VK&%W?@$W?%A&22>*JF.2?. MCL\P#)$S_)9?/@*\XZ)SZ#>`;DTU?4024:X/9[Q^4;7-$>FE=D8L;,P**VUQ M-1?\6DN_$5&9'R&@]1#^/@)0T[RE;P"GA@X15"C%9KD($V(G.@@Z*0+O=>7R MVLCQ)'PQ$=355@?E2;_7I).2(&!@8:F'?WR#LC8&TWPB!D:AJ!:BRB]"5#(Y M0X$)WZ9,$FMX\%0:#7P,+M%(SV@@W&\:"2%K#6FLH@$8E%1UI&P M?/A<(4OXMJ+8T>TH2-)2A7IXL: M*XVVZ(5S02O\V/,OK/.H/GD2N3(A1MM,;=#DYKA85#;3![;Z=X,N"1<]E=.A ML%6K;SP"D"W!R$R=+:!Y)O_@PYF6[:W?`^T\?RZ;C]E8;!+#%Z@3+_2/;P/3RDQLR$M(H]6$QQKN_'U6WM,V9*S7?]!/=Q M]/SD>PTDQ."DZ-V>S"&2>>>U'CD>ND;E$.R'R+94D[BLT&4K:'R1K70=82`4 METOYP7#X+=YVLR(\K6RR/V&E@$T8E_4:1T_IG;PC0V=3E M"\(>Y&?-/BOBJ@YK%T^5+)`#@/4OMSS4E'XC9\A=L_ZV96_4O_7-Q@G7LN7% M$MWRK9_MZ'*%<1Q"71AD[OZO?W<`ID79$CR:AH)6\VG8V\&']*SHI(C1N`,T M*2*&)\+J+IK,H3OG((TT^MMT@7F,1J`<%I5#3">SO);U/IKO)Q'S_U7A4R+_ M4730][3$RLP8A7,-AB!H2IWH0=A:ZLQ%3+U'?9Z#L2A#:EYX*\H2OPY$%S*P M!O"YC8Z`-4B#YEA$`%-/`Y@;1[3.PY%4U:Z%O<5^J1:.S3R&6'"56R+N'7U4 M+5T.NHB@$3W=LCEV)^I.J:9HV=\GTAO2XE`-3-Z.\.5!338 M;?U5Y,#UYZ]I6%Q_%G+NL>Q[!$F<)O#URTNTP_JG*3K1IXOUN1?:&$!//__" M-]5DZO=%)'H<$OOT^[20_M+7+[3!'M<;[X_2G+3QB(AIH3M9)6TBHH"660RP^"R6PAM*?2#.5(G`4TDU)3H!<%6;P'GKX M*.2X.3(:AL^8(2N=+:X?7&@H'].@@]'_U0@>+=),9-\4OG=3V>[M>&TVE1XE M1&MO1MC*'-;O680-Z4AW%Y;0!6/IVQ20)+>4*)8_)*B8=68%ZJQZ+KW3>XL% MTUS1GW-V2IX><4J>]KL!--`Q%1?4]+(G&8=\Y%_K#0(=JDWD;#D'4:Y`'2(J M76%>F)Y_>/?NE+'8W/M!@K^L`7(ZJ%*28FQY+Y[D0<+#];>V*10#IE"CU* M$VK*0OTF%-W1:_[VKI*V.:F/MUH?23(4:4IY\^'L*M^FR=:/EX2DS>(:BM.# M8O`)[X!FJ6L2>/J0'.L'I$,)'I!.[A=BC-K`H:^L^-)!RNAHYSR6F*HO+;=: M'.7C[#\A?K4X(2'6DD,(91.^`&AO;+W8^T"_\G4(/' M->C\?@*O9'7#=ID$(4%;34;M5J7`BWDTKOL(O^H%4??I>7<^@A[:YPUV`",% M!,&1:0_')R)%R_@,9<_U"Y0E7.7&_M>X."C\]6!(C-%6(ZGP7[G\,WC`[TED'EGX4"([(*3?A88$KZG,#E#ZBY8\NCQ#5 M46IW@1*(%*,1;V/Z]QH"/]K;?[>X= M[+S]??V`3&@PTPM+5%E!CHE"\2[W=!Y(23Q.B5/ZYX<3C=9F5J@(EUSH.Q*C M8?[7/PN[PQ@.6>V1S1U#6^@:F;J,ESH+M%1L"KY3G8B5,603@`08"3F]EYQ7 MLH]`0I/_-WYNG_>'3/SY!!TM9&A+>.M!LIA\#/!#=ZSC*./?)*XXEA&Z_C0V M=&.0#])PFSNOX%R2I*QE;'VM'YR@]!(S*!X)%( MJ0F:6-%=-V)`(U3UGHP?IHA0-\+.`L:2/F0\@<9`^G3_EB^!Y0U/[T"NV>4_&A0CH$AGEW;#S4F M0A="72QR!!*QZ$?(SN/T`<_$(0SOE7$)!G1T@B(L11C`\Q?,89645NU''9"( MM5J3`=_.]SHQ:AY*M!]09H%+9H-.&4E@CDKWVS,?E*(LT>@AFH%=&:H^^?B& M/?@G+RX_GAV9,B1DR:P))WT<_PF:I;OB:HS^5!B$XI*GX632C=UM@H6A7SCQ MVZ74K/4/=VAGS+[]/-KS3)#F@1^W]@ZV]U[_/_;.=#>.),GSKQ(H=,^H`%+% M2]?L3@$I'BJB=1`DI>J9QGQ(DBF24V0F-Y,I%0OS&/MEO\VSS)/M[V]^1(2[ M1V22Q5)C%P,TNEM)#S_-S>WXF]F_P)Z//KX]/JJ>H`3-B2H8G67QF+(1%QW: M>Y?3O*2@'SL=D8H$I'A,?T5PGF8_[D&#MQ=ITZ+%8P6%4H]7(X37&T:R571X M_]-AW@`)T-5I)7BK,^(Y9[#NBN/5'&\4);A+$3$N]D5;6"/=A9"@1F!3.JRS M/>N"GEI:)D9HQ"676Y]=7LW%)T!L*%%43WO3[`M(_F]LL(W1(E?$R]C;4)C3 M?UMIO1LG@25DKXE<-,5K&4\;MBH?EZBU\6@Y/A_Q83D-"/-AKT<9L)"I]R5+ M;%/QW(QNTDE+(=WL\5FBW[4=^S%&U)XU>$D2>.+$&/^*UVXTE^=1C[K/,4N@ MK5BC,6?MH/%;OU'<)8^F"<8T;5N0#"0^E#?+QH;[2_DGY@P#&XHD+-I7_-); MP[/5E"K:;F*-@HP7UV3F!\GR[$%X/K/C5T[H:M?0B?;L#)#SKU6VFE7L""VO MO(OTE/*.(U\8#`!UACU?)B-AVM^R\R`A]?\NV-W3[D`I83ZTQ`GIG_:5E91% M;V-@2/_V9DI8K?>68?])_^PTX,VA_]:HA!O*OC%]./&SJ9_ZMMH MB($N,?\\K4#:9%]R4/P]_7G;I3'EW/[K/TM_'1.O[$QQ68^#6@!/>X5RC^I( MPO2OC<#!]$_6)_'%Z>]AW86D(TKVD#;?I?[\-14V$2#3/P4P5_J[!9>D/^Y; MB&-V%08QJ53FZ>7NO3:IM^2;"&-7/8.Y&*!T(@57]_X8G>8L%'P])'VCU7D+ MH#6KUYIY8'Z^O#J;H`&OD/">="G$+EQF80];@.^%RLS6]NX4]\%HO%(1/C', M_DI=J>)7*KIK?`Q0':'!5)?!@$VZA?825::D^O7ZZI]F-\/3T3]_!S^1ICWZ M[L>?3`L_0E>Y@+B'<"WI[8>C"^?--YY31Z2X7NE-_SG@ORY_^/%_SGY37IE_ M_H[Z(M_QS],),]`+=8A`;DF+?/,? MK&<*#A%F.OM"I`:JA+0!XJ;C^+'"U>V/6VOEG?D+NHEBZ6,X#>5\3X?G61R5 MCG(J/N3^S%BR6DXNLR,@+W[Q"/;<`G8FI[>3J878!"K!&B1C1B#,]IG<_GA$ MH/X7LT6L5&\G4K?C$NNC2Z.R'4O]IFS@B;,#_6?6ZS MV!83Y1_IL`=-2&B8&]QVB4_5]]?)Y*R#2+?!?O%8GDPG$^*=3H=GH^N[=/3! M_&Q^HM";`\H@S>ZN..3\DHA`7J.C(;WW-_SX]?2"B]K?B-YN,2#T-SKFU;9K M8"6LN1^J.Q&*/!.[S3`?3QON6N92K\MYQA)3K<=M0':/WW@PO.JGW+2_B)U3GV4KU M?O1EF+(>^6JE^'J3];3XO[TA?F>I2=,#FBW(_ M=H3+U$`O==JDQD_9S+?*(WH,O;L0=]8DNE#,G M;IZ.[8\6/_>&YHLA\J7ZB?%YYMYY#9O1X^EU+X-:R5NU.GL"2"JGGS.Q1T?[E-Z:GX:CJV>PRZ7'O_*Z9T7G%)B M>3?".XR<&L3Z3\D=OOWQ/>Z6B\`.DV>P,"=K_E4Z4&CK!0%XR=$;H MEW0>5&OB7+UN,3A,_VQ"U07*W'1$L:W_,VM(UX[]2E1+/ZK_P@YE72X3R^>5)!%LS MQA<4O&ARAB?PKI"DJ^53H]4L(B(%>^`XG)57GM,!(O[_M.GO/Y!_MSK^4!UM_[2[\_'M;LF[ M<;B[_>']MB7K]2E\#W<';ZO=HV.R]U8'AQ\.=@$JY7E\CR'(.C%1R$?$W3^] MO.+T1*]-)PC6,OP("FMR/N(D1]O M9@MM>">RO^V0VW0"ZBC[PQ/J"5(1(YTF/Z^EOS6VJ[6Y:;N<"`;;VQ_??7P+ M#>Q0M>>`!F1SAD#2+Y<@@X:GB".&"WD?W.\BA"?K*\]>ODQG\^09I45?I;]N MSZF"@Q7R#G\!%-&8@>#OU"9//_@`]69>B2=;FVD[+;Z5QVRIW&4\ALXA"9'EY31O+=1H7!"U,/_P3J/=UJN6XTLN M;F5ICHF0EDPQJ5YJ5).;`7/AF?5.>#W0UGOKM.I/Z@0]V2&Y7/"6>*;A_\31 M$"GE`*@FR6S)L!;^7V:TWV^D56Z M!C!20\O;S5%R*>V:_87>#D`EW#E\,_Q<3:LGQP*+;WF32YM\W.LV:$Z.V=TX#'< MF"R"K/8A0MKW`Q(J'>OC>$+YN.D7@]6"&N/J(C0CX>.[NT%,9-L"GZK-Y:]_"TAP6 MWH:W8.9Z%MKY0`NB`;+VS:]SC_DQ9!X1B)%-"`"-W4S\RMVX4_/*N;7+_B-( MB0=HNM7KNGBU0B.WHI4%`!`;U47Q-**KK#2V4%*$DMC&7I[Q3I!:F.9P@=#$ M];SB09`F?RH1$K?2U_ILX.*8&'$V->A`8BP!!D.$(KNRFJD3EDZ462N[G(9? MZCN)WBUC8>T*G>AQ+V+VL7I#V43PE'_T+AH-/](^VAMWSXW<_-;`7T!E4CJ%_;= M@*"*F"#?URF,7E?-=9R>P\[HA!O#K=V+*7SV#=#C0/1=#+_QBAVZX%"\]\() MX?V'>1SJ:9E5;X!5(_KLF@@E1B67^#9&5K(%,4NX(H9-`+[5X!RVJ!'3Z7UH MZ*8A_I=G?O=7)2=0WX+0VAH.J-AS.;]..Q"=I8H2S%`6_=_@C)(0FOIO"'PU M1M(2VBV\#VSC4C'.@UBV:+LISH7#.W-3)D[%E8;,E(Q]-A%6R+N#&Z_GW0W/ MZFN7::0&'6FSW1_K5X+3.8D=07?NI#FTZM%J[Z1[^OU12KSE7@)-$+X0] M:I*2"+Y1XBBT21=>(AXS79U!.M^BR%:HFU3Y0DE<[U`@%L("\>.J6@G?9IWUF)FW1JA`9*9D$:,W4DYI(PK0#6*#D8"Q. MS0O-HCO!0R8]<"1(,!()884G%M)H\3(^'NDS0N2I,G4^^1CC&FQMC[H+A4D$ M.P18%G+>Y,-K7^Z]VS6+8]]]:HJ!9XX^-45@V$::8H0!)UJ]MQPZ!RZ'CNH6 M?&SKO1S5/S;GM,3I9_$EG427MQ2!?8BA/0.4G2]%5:3QZBW2W5:K00PMX-SK M^T&B%\FCWW,,1SO5GS*];!_@#)Y:J5LKF`/0MGBE;K&(?+V$AF/9G)3XC=#2 M'X,)+/V="_*T6O-6OO2/*/;=?URT[+^]5:34/GDJ9O^6=NQ*F4J#:?HCZNBW M[!6L/S!]6F9-Q/N.CTT]-S4I5W2@2XR?OSD&Y:U.RH"0Z!CIA%$34R4$)PK1 MH=*U:\4)D2#KW:']42=R>^8C=)I9'Q]CIADJ[3$ZS6R$C]%I9F)LV34[K(H' M%`1%IA("`PHL6)$N@U%`_.@&8T\NC>Z->(2P9A#@I1,OX&MHH=&QT)@\C491G*,S3 M4!\L)4X)ON=`2_\.@6%2+$XE?OC4"#[8)FP@0>?1T@)3];N>SG_A>02K7@QQ M3;,K9/RBW6693^C0O&9LAV(LA4)C<]7/4>9DO^7<<"0)5P64\QYA\'%:U6=/ M`_Y0Z:Z0*V[XJQ2S=,D][_P]FE;_$12_>WY4GE2PP&6[&?_`@(-3HOJ(!YAF MMJMFJS;@/IU=LR7%)U:'ZC-M](Z*@I(B):"#@;T:GDZJ/71#'@`KXU35X!PN M/09*DZVR7GSFUXF#KI_,0<&@+&9+#'";M)VV>/COV.YN[U9E-23N.5B1P=NV M995EQZ;/>YP_VNSL]`+W$J6`\EF3``8.RA02,W:R;.';CR\6ZJ"$%&\-Z M^7FNFK@@&,2P4&VXKTCN-P(QV\BZVA9/GRZ3.`(Y=/IG4J8X@@&*GVX[5$7E M(FK,'-"SGLW[=5*>"H#TXE3Z'$,BS0`T\716NXW2;7IP1_GZJ/KF^ M82_7V5K\_*IX,TE(@N^EE@B"E)!.5K86\`*\VDA69P$/M;XE$SXOM00R>Y)E MHD=VQZX/*;E<+8J\XK%&27)&NB`Y:#;ZL0E8Z9F1&20;+DYDJP>A=U(_9KK2 MHZ$@&C!;)^J9K?9,/!AGD^RXS-IDE\".T^]3\2OLJ$)%.X2M@:NO2R98P+1( MI)]'\M@T/M"@_">D=(B)59I"E'/$I+,ANVWL,_U;K<`14'7-JIPS<&+.L^SI MR")]CUP>'?1@#"=IWPWU.O2K0;)>.SA\/;7T\7?B*]+@G5F,I"=Z.A`M&2DB MO+O2M(O)VAMA399D]:[BFK(&W\K)QHFI.`ED["Q76@%/LQG2!"70F82LAOI; MN@D^E53Z,X*PNF70>!4:[K(K73&DZNAQE=-L-I2&XI)R68%>:^42+J;=K[]T M&:S2W_$]F+/7K\KH.#KI?O>H+"HJ<%&_$-DV7`16$R,C@7["ZA:90G!WWU9T MB"&+ARP+)"29+`HDXH[$$E(>^^OP+MWW@9G=[/ZZ>^XFC'B&Z)HV?FL,UNXC M$N;H;"[7Z(A76O26-H;9;JVN;Z0_O_%Z9\*UNAB6*Z56`-FD_6Y;86]95VJK MD*Z?4S#)4S@OO;G]7YD8:S!%#\_(8TF;+Y9MC/)!IG/K/%'M^PX^MJ^\4&5& MY1ED3#"IC*.7JAJ#HA-N.;$J%W;TZ;B>=:-N>H^0>#E,]<=RO*%=ACREJ0S>K3- MACHL6Q,'C1TFLDH/&+.8XAAM4XC).TY@83Z:WGOR3TF1*]:Y,2JG6G&Y"9A+.>ZJO_.@%X3-3+E%)1?K=9SUN"`O(\\\+\@S]&6" MJSZIGI@`EOGE'G?_#A`6,*Z0$9,DB/@":Z?@&$UP"O`\!*ZVE*!L5LT'JJ5< M2:8?!51FS1XSN@M+]VS7I=!^X+<=GS7%G1*O^]D%WRI&M2-%#;7;L+DAZ%]8 ME*0+Z35[Z-$=L5>96M2[*Y9%#_S/+UBEG$'J`=MSKTX"R?X')FV+,W[$I:;G MQQGTSFW18;QS/!'V\OAS;1B*')ITQX(L/)+WP1:YS5ZS&0G:27;E"J%OI<^L M6<-"N$OZ1V=P>V6FLDP%HG2EY="2Q2G[X^`&(ULHOIYV:\[WKC'-^;[,'_,Q MY=/W7VZF8Y*3HWM"KT.BX_[SZ>/=-1@DR,7>EH"(QH.6!23&5G#K/HM*1&J$$E2MA:T/9B[W-_!%A*1UZ"(`AB@2\_M M^39`F\N@W'3"/1TI_:ICTM)ITP\7*.;FF#7+5AYJ`N2&K5OVUF M8`ZC%9ED:QR$ETS2.15:RB&`%(]3/&T<:;%QNAS%Q/`SA:RBJDUK&4?3CO`3 M,$0\LK+M,O6+P)6:6`ZGD>DE#5IZ8U;I@/(3.LMOM.9%RJXMM)ZZTH]AA!;^ M87""](^IO7>QT3&5G[,>R7P'FH[+5SL.PY7,%%KMI(05(UW$EF':F\L3&[YW M%R=M6ELY,L=%N^\NU>!??F^DNN]UTF&.\5\NVDTT3X M"X!K+9I[X$M+V]3,9M#AS_AA7$2_5@=_FBD\$D]=\TV%1%GQHM2!^@?L%;F:YUM(OTMPVM-^5)>P3L7,C(C1Y2CL2#.6@$:6_3OM_M(WNM$5( MM6G1*]BGXEDH``?OS)"P/*=1#V/VVW36S:#*!BQZH%"-!KBX&8CI0B^/3?ZH M#25[&HV]G%MB505GDG_48BPWNZ;9'!M/CQG+W$I MU]A2J<;J>>N1=G:Q=)/V'6#4`Z("<'EPPSN.FRAM;8QR5BW4GSN^D^Q)L1XA M#_I6V#8TF`J2=IA8_2J9T[(')\1`:?7(3Q;`]MD%L($84JZ:&,`V%LZT#F"S M=X;PA=I65B1&OQT^*.Z='\)KCK/>-5H@V<)][$+NAW"'MP7OX0ZF_B]X_+YD M&D_3/E'0VZ^ZL?AFGR`;11$09$NI(_EZE]V,C#J93*>3KSSKV>$VW.RQT0SK M]!F:!.+,Y,IB_7#-**`ONK7NU8WR`3J]Q'63?CSX$KR:<09"40-D*$A-WJ^) M1C>WE!V$;:=#](TAOLOF`)1<_G-0Y0HC85K"E2_O'`Z10WR) M%HIY%BUURB4-,\QNMY1%&2:D?2@<,V\054_=;B6NL@ZE=JNZ=M8^C.3VHGYB MTCU#E7>'G([E3'=DE'9ZX%:)X>DRTYN1 MN%,G?S9RVE^V"M3`M_NO/QRF#70#4N$N9[I2N/UW3;7=/@ M:ZD#<$G[5\'M*=4H*\.X]+Y^ M&",043]448^@`%0!D')1OD*GIP^+1,$$2+8"4HV88(5#!%`XE$-B!G0ZTTO7 MG[X@DH6CW["ZGW2$]48@.!=IKHNV9$]KH2>K()KNDG4G9@KKZ*RT\0;+TZVX M+KSHR?![F\?P3!($Y&\O*]<8V0$Q6ZA0!`F:4R#RQ#4-$&-7G+9.ZF/#VBK6 MM$C"]<=G?'7Z/7$U))L1U+>Y:>M_SJ(^]\#C>,.S8G'F8TL*]_`R*;`C_B:CF1FE_,8F=R<8$O8A&J%\#0U8R M`&WQPR?N.%KG#O3,P(F3CS/X[]V]>&,>OA&QB\<@AU9GOW=Q(2QN#[D*)3\K$\V4OKJM2?JZ=!.AMA!G M2%ETE:XF;VZ2X&>2X.A^7N8%17R6CA67JD))D018-M"2X(+%CQI[5I(3T-!W M.Q-W+-R=9H\=`H>S]@<+2[#.)+;F9GWJ('86+>*MQS;=T.A3W"DP&`PGSU;7 M,A=M;[)J2MYP#CR]=FNBV%M2)JW[]2S=8-ELM/1RZ?7%ZMI6NE#W;1&8%!\,/GQ`3:D<* M=Y3<&2/5&;K'IC->=J:+[8+W62@C/$M7U*[5L=HNQ7&?TWVUNI;%>&^L;6RL MKA5.EY]S7`.MH>NL-?CIF=//E-2*^J5H0U(["2Z\DDB$H6(Z5R!T,%80?W9+ MMK??3-*T1\-I!M!#CVH>Q.!,`JO=*O#B&CP7+$UIMIV%G"9\*":^V\PX@ORM M,!W3M7HM*O>>4:<-MFQPS32K:&]Q!MB4AG:B-4"(0K^F?;+"6;8FG+,4Y+U> M;$'LLGP1M=`7N5:/WF=@)-L2)6TA`4W12"C:,%84*%/VK7Y(@^R[&F(2T,/H M8N8[NZ,DK(PM(+S1!*+?#3B>16SQ`J8[.T"&N!BM(H8*3_9D71AHZEA61EA<52V1J?,S6XGI[]T MC!9@-=![W'LW MSBW>]^O:\LD&!V@ZRR99I'_[.&9UPQL%Y0$_5-52YK:^\6S-$5$DS^ZCP9"/ MVB>CHUFD)1BZ'Q?#[MVO@/]F%C0#7*Q1PN+C=L^D4VDBM]L+!9C17H MF\\A3RN<3O@3%\=WGZEU?_S50GKI-%`N;QW$:/2;SCSOA7,_`1U."42KGNNM MS,7=@K+#7IH7=&'G*]4GEBPJ/#`*3#]`Q'U>$+?XN22%\?-6H76+L?K<.!F- M%QOQABC9'#O'K2,P2\;Z\[&E?C/A3GPQG7*YH_%$Z;\%(PL]V(NN&%7VU_\J M[IIVMV[0D.S75Z]>&$--_Q`8F)WPB!MM0=7L+S<\Q([J&14*G>M,*)1)H-/) MM5G[[&<7CBW+!5.SCCI&49WW:.%W+"1KV3"6M[C'BM];#9_1)T57LWUU&U&1 M3=8E'R@C:<+Z'R<=)#+'(E^KL9!5&=K.VB_X`/UJ?&XY/!1(W6P7A(T!`9-G MO4]8QFX:#T?@H.0%IJPM!??8R9.R&V*Y;N++D![BDI^[]#0=4]AUCRYE.E)F M9&RH]23ZE2U>UT,Z#=\4O%4F%MQKAKN]:WY3L]D5ZOHN.*16Z\Y9MEJ-W/`= MMJ!64_=.+2O_-"U-IB_5(E/(%+KP9D2\7)#D#_^XS)U^NQ*`3%ES;-[$)K-> M<7>4I(NU\.!T\2-3'!QK<6*LS'B>6@Y,-3G47>^]RH$S-6]PLK5=\M=2GV;W M:A1F:!>L6T)_6.^U0$-T0TS#*L9=/>%M_!?>ESQ)?G.O,KN5VT*>G/;$D2DP MT?)D72G%?\J:NC^:W^B=*WZT"%S8G&9F[MIP6,UJ(SQ$(,1*Z-EF)YOIM)V9 M^+XY9!?J3NDP.>PZDWMZ,G+)<5%&]6:]U"^$ML*"4X39Q^Z,6,>[],[54!I= MHFQ8@MJ(E9=OEI"PZA+OF11%[`$YNE_B%PU-,$GZ3)=,"J'2:000%&""[DH1 M:5]U)-@]/NII"I+08AP0%:0%?#3@4-N\5HL;[=\;9K?%WF*%EK2_(V1C*C9BU\3E MC`GM,Q`;1-@AQ2[Z*Z;S,MW-&()ON*2R-:5=IPDS2O#/O>._6C7.@PNAYBA) M>^6/5A'^/A0E[7>O@&DO[)39U2GZJ=U% MZ?D+-*!"&;"V?$.G\+F07#W$K&UE9MV?1TP`TXG+^J$"7)[5L_H#Z"VW\FW[^F^0/!$FI&AQUU(B^EL$'5AF]T^IB?I.K+/ MX^TN`6WP"W5F9M?!8&53AEZ]2^E.B'[;+Y<3B]LO5/URE<7N#W/OO]!HQ7^MDXDYE86B6D!FAT_;Q:_^.-WXY[T$#WM M?E<0GV5V@@%]H4X'13-AUU]DEYQ1\`WFPEG#H;,-*JS+*X`/:SXIJM:Q_;Z`>U&Y+B"*+C8*YNXW&NQ1@;F8Q8.]K1.),J%#LD"&7;(I3F_>*B$ZC;-:_OUU#*?#X. M)MQ.%RZZ_70TE)OTEG8V1#F]CZK2UT^J1Z1SP*T`+"C+X]_7Y6(%Q]ZL9]E3 M!KYD?77M53J%OK&6T>ILM.>ET4K)#5,TBY/UC)O'VV,Q-UM$=W"C4)"0\\QW M(.T(T1OVWL3EP-H-]FRMQ>3!+-_*FQ1AV9"=A.G/AH@"66>^A\VGS[?^;.H+ M*%J9$51YU(>1/N/&32?S\XLX(Z]&;>1JU#>_(AV/?WJJSO*6_GJ(JXWJ8/`4 MMDV*)CAV=G6)9FCC`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`/<=#Y$LGT_^C+,+Q0&&;PD(V@J M7/5`)=7@ECV^'79..WS@9PA;TRVV/?.A.%06JG:&8QQ#Q$QB%;+X''Y,&<1F MQR5L0^X=XYS*"+Y],26.X)(^F__L(-T!@>GL,+GW''(TS-LYJ)*_PHW_-9W> M0*ZMFA>F%YBWVK58J7X>I-^:L3#7L#:?EX73UX>OXT&DX^BJ]]S0S8[\/78\ M`'/@63_!"NML*6G_35KYE*YCT^>Z27_WQIYB?J\6]64]OEA;$];AC,@G)(91 MY62!-[`WYZQ5<>[>*;6CC"*C5FGT_8=_N>A3:A:/Y)VL7P8-V#_1\C?0S<,^ M6_#=+M%4=WH;=N9CT-D**SJ]X#$[#=+#IVR[+(U5D!##!G@39<],NK)?Z;R.YN?@ M(0E7'/TBI-88_[<77@99X@%[,]+\;];)C:Z/>V_<#7'_/^]B&6-KSTJ6M[)& MBVSI:'*KMKSL?#*\NG8SW\[V?M-+K20R M1(0S3#079:/?IMH/K(4AL;:#!G.JB]-L[IT+!';LI2 M@!'3O-SFM3I#_VRXE+P_"0YAA]LWG#P=2J-0;PYC.[^1\[S>LMJ1@S]<2,$]HMW=`+7`=W!2U)MUVZOW_=7TV+6X$]J$X08)X.8]H.'JKBX%]2PI&.:V$!W:^!AWFG/F9#TZK14D@ M`UEVA^%JZ=Z$\W48NOYJH0KTA^`]/_ON\)KNOS!2?B,=AFK#/LD=V%#Z(*7W MI?P)@OU!])W:@1_,*7&%=HWX2?=?,=G6`K8[@8QD8O/R^1;S`BH*-EZ42*>" M-@``[TY+9&M`1="3^MR34M1+-TZ]9!K$(;BCDA+UREV7-#VKQ:IC$XF MT<$D!OK#>N1%LR1,TO^[^)I()7B+!%HM&-T[T#7PG[Q'L@?#.3C+S&*HS^N9 M04HRYD8&J5!0<]B.QU4:+?Q'J&!QD.1#B:58#Q5Q<#+Q`>_$")E?SBB#EBZ\ MOS#&)WN51JXE4Y5`F$T#^3(E:T,26Q(#$HIW.:0,LB`G)D&N)1HRB>(AXKE@ M%D_.!0;@Y".`,L@"3"Q`+ZGKF]6B+OR.V)1UW&ES!#1=X4S@`F![I^D+07LVV#14P MBM77&AZ],`R^P`-Q1:DX7LB'AM/#W.H?````__\#`%!+`P04``8`"````"$` M%D0;5*<%``"/%@``&````'AL+W=OYEI M\.?C[US\'3B+;^_UWGGC75^US=(E,]]U>%.VZZK9+MU__GYZ2%RG'XIF7>S; MAB_=#]Z[WU:__K(XMMU+O^-\<,!"TR_=W3`%_VL/?`&5C9M5Q<# M_.RV7G_H>+$>-]5[C_I^Y-5%U;C2PKR[Q4:[V50E?VS+UYHW@S32\7TQ`/]^ M5QWZ3VMU>8NYNNA>7@\/95L?P,1SM:^&C]&HZ]3E_,>V:;OB>0]^OY.P*#]M MCS\FYNNJ[-J^W0PS,.=)HE.?4R_UP-)JL:[``Q%VI^.;I?N=S/.`NMYJ,0;H MWXH?>^-OI]^UQ]^Z:OU'U7"(-N1)9."Y;5\$],=:/(+-WF3WTYB!/SMGS3?% MZW[XJSW^SJOM;H!T,_!(.#9??SSROH2(@ID99<)2V>Z!`/SKU)4H#8A(\3[^ M?ZS6PV[I!M&,Q7Y``.X\\WYXJH1)URE?^Z&M_Y,@HDQ)(U09"8"]6J>[V#1N!70/ MZ7A;T63AO4$$2P7))`0N@(9@1#Y%!/X)X@&]$T?P_'Z.8I/%,3V9']W()"09 MHRS\RHT'B``$QB1P.3@"#$$T/`^(=;"$A/I@XP$Z.+SG8`%>NN##*>0!M0Z6 MD'A,6+28`M M8M:YF80H8HPE^EC)RURG\5E:HE<90G"9E@!;M"(K7A*B:"4^\:W;EYL`FL9Q MJ"4$Q2O%Q&Y+J-AD$8PM@A(B"2;1Y":8RT%*_3/E1D`L;X_;B+;$0;LM54EA M#'4PGZ#0$$N]+R=M1%M!L9*2*A`0 M[1@F9DF^B%QTO2%/M3^TM9](C(H1.Q3_4AM6=-,4]I$D23>K.1`1Q0$*M MTYC<7?I/I'I#;9V:NF%8D9,84S",)_CPNU2>3&4^M/S.%$:F+$ECINM:596I M\VD0^QJ`J7VA\S'4PY7D384^U)JDXF-*.91].-%Z@A!^1!-M`Y&D=ZG]B,:" M:S0Y24YAPO'-A]FYS=%RF&K1P;3NZ@-4OGDC-;/4*E,8E59&M13(K*)U\0ER M:JZ8F%!T0V9ODPHJ=N&XV665*8Q2,W\B%6B=),FYR-W5!^BT#S!M6"74[`.4 M@EAH(5"Q0P@_AO"=B9[5"RY?!2KE&XR?I()9:&XJQ_0:3]@6B@5.5/N64"8 M\06IRM]$P'>>;W1;'#FK(UPI_VDG8/:K-35U_H%%<9)."@]#`D;B,]HFQB3W M:]NXR](V6WP51A;60V)YD>-E(P,H>L%=/6%$8UJ1;M0RM0KS*;DA,T15IA8A M2,2B1LFK_P$``/__ M`P!02P,$%``&``@````A`&@!UKF(!0``LQ0``!D```!X;"]W;W)K&ULG%A;CZM&#'ZOU/^`>-_``.$2)3E:;NV13J6JZN69)9,$ M;0@1L)?S[VMC+C-#FI/T9=F8SQY_ML<>9OWELSQI[[QNBNJ\T=G"U#5^SJM= M<3YL]+_^3)]\76O:[+S+3M69;_3OO-&_;'_^:?U1U:_-D?-6`POG9J,?V_:R M,HPF/_(R:Q;5A9_AS;ZJRZR%G_7!:"XUSW:=4GDR+--TC3(KSCI96-7WV*CV M^R+G<96_E?S;*K'Y]NSSE57D!$R_%J6B_=T9U MK3L#[DSE9/MCN?LS,ET5>5TVU;Q=@SB!'YYP#(S#`TG:]*X`! MAEVK^7ZC/[-5R@+=V*Z[`/U=\(]&^%]KCM7'+W6Q^U:<.40;\H09>*FJ5X1^ MW:$(E(V9=MIEX/=:V_%]]G9J_Z@^?N7%X=A"NI?`"(FM=M]CWN0043"SL)9H M*:].X`#\U,7)#T>X5X=DK,O#37[*EB\O?T'1Z37@^MB28[0C#\\$EW5X3 MGGD7^5E M0T%?+\6!!BK)-*Q`=C$DB$C"DA'1@!A)#(*)MVW*.LD`&712$@"Y,5;>9ABSGC`EWP0P(YW>[";$2J(%8%B2I(!8'D-6P5T>O;:4'P M1H>0C,&`ZE+"'A+(ZXK/#I:NJV0N(L!$)Q8U'),YGA*`1-5(10W;M9W`'T,F ML8/]+++K-I6'/>\']8=Z,Z+VN`:EA4`3CT@5Q"1PNU`\,9OY4^ET)A(",-@/ M4T1-3UXG%O)TUC".TPQEZCX5,('0J(E6GC` M$IK\;5H(5FFYX&7J`!I57FI^%3$VW803+-$(A8\0@S! M*C&EZ$/"#%O'9$QA'A%`8#8(<.@],5/M[,/KL;,+`HD*UO3]2>K0,AGHB4I8 MPQY%=!S?7?K*5HEZA,!'TKG62).93BKI**U4)HGC^NY*9#3Q21#+Q` M/7=$/4#D2(9)Q?=,?^KCU"!G*JFTBH>Q'+>$S!`GM\#P[M[/:.0K9-7FWZ,F M+M%,$O>2H8B7`DOY\"S7V)@G`70Y^)1 MTC5&9_*SWV&#M4$A'15`(G/!:7T_%YKM(I=KG9%0=%QD<,[PE<8=,>&,T%>< MJ'.ET20SE;27T#)RHY$IXAR_GR)-?6A)0_!"-A-%^!\?-A0&PO=V]R:W-H965T,56*KB[PKY^W%S.,C*5=25O5\0(_ M":65492.@(T'HN>` MK5(/#GI7NBVX3,YNW_H"?->HY!7=M?:'VG_EHFXL5#L'0\[7HGR^X89!0H$F M2G/'Q%0+`N")I'"=`0FA3_Y_+TK;%#B;1OEEG"4`1UMN[*UPE!BQG;%*_@F@ MY$`52-(#20;J#^=IE,[R))_^GX4$1=[@#;5TM=1JCZ!I(*;IJ6O!9`',1V=! MQ^#U7U;!HR.Y=BR>"UP8*,_C*LF2V9(\0E+9`;0.(!B)%]`8L3DB7"U`WR`2 MK)^*?#OM1RT./-8R2Z;C0.MS#%0B&X,V;X"R9#Z`1@HA=:<*71HS:+/WE;I+ M@#M-2)I/A@`^M>L`\LWM-S8G&R,)D[&$]T,[<('!X4LMLC1^%3J`YKZ>>?1* M&,R;HPBGDRB?CWXO"0\:PVB%SI-R&B5[#1/O^)\,! M3%1/:WY/=2TZ@UI>P=4XNH01TF$FP\*JWM=_JRS,DG]MX-/)H5'C","54O:X M<)TV?(Q7?P$``/__`P!02P,$%``&``@````A`'B(V&ULG)U?L^/6D>3?-V*_@Z+?+5T2)"_I ML#PQ)('=B=B'C8W]\]QNM:T.2VI%=WL\\^TW#ZKJ($\6>`'B1;(310@_U@$R M`?(6__0O__'K+]_]^\O[_[ES__UO_SIGY^__/WKSQ\_?OL.>_CM MZX_O?O[V[?<__O##UP\_?_SU_=?O/__^\3=L^>OG+[^^_X;_^^5O/WS]_=N_^_+QKS^^^]?='X?32_?NAS__:7R'_N^GC__\ M2O_[NZ\_?_[G?_ORZ:?_\>FWCWB[T:C2@K]\_OSW4OIO/Q4)+_XAO7H86_`_ MOWSWT\>_OO_'+]_^U^=__O>/G_[V\S?T^PBD0O;'G_[S_O'K![REV,WW^V/9 MTX?/O^``\,_O?OU4U@;>DO?_,?[[GY]^^O;SC^^ZT_?'UY=NA_+O_O+QZ[?A M4]GEN^\^_./KM\^__C\KVOFN;"=[WPG^[3O9OWZ_/Q]WQU/9RQNO[/R5^+>_ M\O7[P_[X>A[_\V^\\.`O/-47[B[?GX_'P^G\.ON?_,'`Q_?Q_O[;^S__ZQGWAS?J*=?#O?P;! M_D\__#MZ]\&+KE:$]=B_M7OM<\GIL2X9<@K>XJT4-/-;3\_#E M15C_W)[]\5#_`V-#KE9T&-=_Z=!-A;L*O0H#"]P(CT\G:-KY74_ MOL/[4]?5Z?`JQVTUK[XT]^>S=LT*=E@B=2^[%]G+W8HF^EZ%@82#,]O8R M+,4M$%HMZ^%J1:>1J.M>3^>6^&;;IV.]J]"K,)#0'#RN"^L/OA2G@S^U!W>U M(COXP\ON?)'3[&8%=/0J]"H,)#1'_]H>_7B%6[.LRNL2B*R(JQ4YR.553^R; M;9=E);!W*YI@>Q4&$AJV$F3HZOWVLBK%+5"GB\I*?%$=CV.LX(6?%7*_)>'"[GW71U'"]>-RN@HU>A5V$@H3GZTM'U M[_Q8W1[_*9W07F3'O]M=]`KEV^GPD](G96"E)2C.N7KM[,QG^2*+#LA9[47> M@?/I>):5?O,*9K`=^Y*['$\G>4W?[O5E=WB553DT%=VI0^_KD;7,Q437,YOE M"K,<:7VZ24#*RU3L5-B*M>WY:2S M,Q-NV4YRY%>OFH[\EI1[4OJD#*RT!U_\\OF#-Y<%PN35.:KLR(OM_$_*/2E] M4@96VH,O?DD'__;5M]R6Y&M8.H6LRE;3_N4H';GY7J:.W)/2)V5@I44HIKD> MP2RV731']?:=5<4)\?HBB_OF!N*CCJ\%[E M.(?C17AO7E`NM--R?)'+Q-VK)N@^*0,K+6(Q44)<6&EFN\OS]K.?+PKYZE9\?NYW>N-Z\ M@!ELQY/2IYJ!E98!RX*7TCJ_VY=7:3M.M5AO*G"LSQ=477[=&]O^V44 M509^58LBUOWV:;V?M6Q)B5>O,H3=Y:Q7J[I]0K#],H(J`[^J11`#7T`P2\8[ M-%TI]R>)Z==]&'=3):'O5JLFD'A=*'VJ&5AI0<3,5RZK.5,_J:F71QA8?-,[ M?$O*/2E]4@96VH,O;DF7UY4';QZ+9E,WTA.?O3KQ+2GWI/1)&5AI#U[\>V$) MS9IV>L>MRBY*A]>]QJB];9\Z?*YVYJ9PK[=*Y>I$CG+IC:H/M MA1%4Z7TG4\W`2HM0_'$]@KFI(,CROW9690S[0W>62]K-"Z;CNR>E3\K`2LL@ MQKW.,KI9`Y>W^^I5D4$N:MUU>QCU/2E]4@966A2Q[K>OOMVL9I5@9!B M5-T^(:C)]ZEF8*5%$`-?0#!+;E=4BE%=&#?;^TGS8*V:0.)UH?2I9F"E!1$S M7[FLYDS]I!;2J6G?DG)/2I^4@97VX,7&5QZ\N>Y"C.K4FV])N2>E3\K`2GOP MXM\+2VC6M.6:<^VLRBY*>"2=K,&V\S5)E=[W,=4,K#0(AZ?\>:QN_1EWV+*^ MKU[E"(>3?BI]\X+I^.Y)Z9,RL-(RB$6OCE&'6;?6<\"K'.>U2V[M!0LQRJLF MZ#XI`RLM8O'.U?9W,*?EBU6*45[C5">]E-U\^W2X]Z3T21E8:0&>\N_#K']K MC/(J0^AVQX,8_,T+F,%V/"E]JAE8:1G$O]\^W0]SOJUGNQO&`Z MX'M2^J0,K+0(3_GV8C;095[4OJD#*PT!W\4&U]W\..K%K]_Y%73Z7M+RCTI?5(&5MJ# M%_]^>PD=9TU;+ZQ>92?R\4535-U'J..L5VN(\BHWB9>37+5NOGTA0WG5Q-PG M96"E)7S*OH_9OE.&\IJ'B\QV,1WMO;X@EEV?E(&5]OB?\N[CK'?KA$9-VI9F"E11#K7CA/YBQ;3H/KT8J[>A4N/_0I4UI6M2H.^YZ4/BGXVX+1O,;%V(*(BZ];5JZKIDS*P MTAZ\6/?"$IKU:[VLGJS*'\;J]SYO=?.T=N(%H?2I9F"E)7C*FD_9FF>>0GF5 M755/AQ=](N[;I[;=7$ MW"=E8*4E?,J\3]F\4W[RFH>+3(WZ7E\P+3*M&;BF/?ZGK/LT:]WRME^]RM/' M/GU@[-NG-_R>E#XI`RLM@ECWPID^9]GI1+D]$D96&D) MGG+LTYQCI_SD58^;H/Y\]U=,;>F3,K#2(+R*8Z_SBO%5R;DU/WF5GQ&7E)_J M]MJ-I/1)&5AI4<2SWUY/KW->K7=R5Z\*A/0Q7MT^(=A^J1NI9F"E11#G7D`P MY\4_R;%3?GH-?YZJSNE#C%HT<<3+0NE3SF3,K#2'KSX]\J#-Q_'H5`S4GQZM:II==R2M5 MM?Q%Z/CULW(3H4BWNC46RCTI?5(&5EJ`IXSY-1OS3'KR*L\;Q[T^"/?M4U?N M2>F3,K#2(H@WKTY/K[,VK>G)J^R:=$A?CO#-"^&I[B2ZUB=E8*4%?,JY7[-S MI_#D-<:4EUBR[5H_';[6#%S3'OY3MOTZ:]N:G;S*EMC^)7UAT+?S$E,C[U/- MP$J#9:OH M\B(/0VYUU+ZI`RLM`3%(>DY^3J?.)NOXI_D$^F+Y%X5N>,B)GBKVR>4 MY->I9F"E12D.2B@+R\G\5A#DW;Z>PY7]Z9FLMUO=/B'$*T+I4\W`2HL@KKV` M8#XL"/*`[WH.MYYZ=4X7IUH41WU/2I^4@966XRD#/\\9^&MJ11AX'.+-7\V5IX*9-[I.IX*^O]>S54V'>DO*/2E]4@96VH,7NUY8.;,> M+8O[>K8J]^A.'[O6S=&0>U+ZI`RLM`1/^?$Y^_%,9O(JSTRGG1C>S;=/;;DG MI4_*P$J+()Z\.C.=9^U9,Y-763_.^DCVYIL7,E/=272M3\K`2@-X>_Q/^?5EUJ]E#5V]RB/'X2S;;[Z=UEA2^J0, MK+0(Q2)7N]S%#+6U"#W/O<@)+GM9=S??S@2VVTGI4\W`2DM0''(]@?FI$,BU MZ'JQ*C_17U+4\.W3`=^3TB=E8*5%$)]>9Q676;^65'3UJIJ:I%NWNGTZ)<+A M0^E3S MO-CWRH,W&U](3Q>KFL[>6U+N2>F3,K#2'KP8]\(*FG5K.4^O%ZMZZ&RQ.1IR MKR\(I4_*P$I#L'MYRIJMO/7FF?P497Y=/7=J#5$PM>:>)0QD*0?'?_N)B2PD M"8F8].H4M7N9-6PYYFN4^>4I_8U1;%\(4E$VH8/3#F"2P$F2V#NQ?S M7+YNI30518\6W;0]UAC:9?N=CAD8*@&#),%XRLYW&(0X\U4["4WH$1LZ'D7) MW>`M"J;#!HF]9I)`HA)(2!(2,O3=RYRCZ[4LJB+DGO2C^RB8WGNT0QT<("H!A"0!> MKD69G2'G]`>XTW;JB.UY8@.(2@`A24`V^3H&[\V<*>DA6Y3YU>QRD=YAC:GU MHS4J@4@E$)$D1&+V2V>*^3=?NO`=Y;`H%5@($D8BEVN]W:?:]:>('DV7AU_-GI)^F+MKFZ?%E22`$)6 M/KX#`"%)0(I;/@%BYBH@\E$EFA`>7$`N>9A4W4X@\9*0`*(20$@2D&*83X"8 MOS)(3EMU*-JC?I!)Q\FA$C!4`@9)@E'L\@D,/#I:HQ*(5`(124)4?)*(EAS$;%5(4DRIL]$>DI`]!XE*(%$) M)"2U).,PL_4D/OM,2.1LP-#.\.#),O-#KJDJUM4]2YC5&?N**@SK)$EPBG$2 MSLJEYN/06BP=M08LLN7Q_6;?'4@$(^?:("Q"5 M`$*2@!3#?`+$_!7O"V?%%%/JG+0"\GJ0+(E513;M)WJ2`*)5`"%)0(IA/@%B M_LH@.:;4B6F/^D$F'1@J`4,E8)`D&,4NG\`P=V6,N9A2IZ<]Z@>9=("H!!"5 M`$*2@!2[?`+$W%5`-*;4$6J%XY*^_+:KV^D$(=N.$T0E<)`D',4DG^`P3Q6. ME%+J'+4"TNFX5YP@9,W1$)70$)4`0I*`%(\DD+768=;:`N644J>F%2"D%/EP M#D1DT4&D$HA4`A%)+=$XZ(R(%B["/A=-2%)*J>/3G$0N;IAA3>[L)$G"%&NM MPAAKDH2DF.43).:M0I)22AVB-EVL9U)*K9K.F20!A^Q\A`8.28*#(V.]LZ?B:`E*F&NN$I@4`D,)`F#./Q:!G-:_),-4@P0#&3(X]L) M!I7`H!(85`(#2<)0W/*)967FBK>$CUT>B^+8PX/'$R3/JZ_;:4'%2T("B$H` M(4E`BE\^`6+V*B!Y(84+%Y#S3D#1D=@>1XV.J`00E0!"DH`4OWP"Q.R507)* MJ=/4'O6#/#JN5RH!0R5@D"08Q2Z?P#!W98RYE%(GJSWJ!YET@*@$$)4`0I*` M%+M\`L3<54`TI=0A:X5CYG.%NIW6%=GVB`8.E4.G=M/%4N^4=2:L%$ ME"3\R`,9^0B)7WD@28B>\W:?FR8D*:74\6I.(A>WVZX6$`D9MOZG184V?;(!A"5`$*2@!2_?`+$ M[%5`Y$2^[NK$M0+RF@8#3ML)A(P[0%0""$D"4OSR"1"S5P;)*:5.77O4#_+H M6%@JH1\J`8,DP2AV^02&N2MCS*64.G7M43_(I`-$)8"H!!"2!*38Y1,@YJX" MHBFE#F`K')?\C*YNIW5%MAWK2B5PD-1RC&/3UG/XE#7A2"FE#F,K(-TN/7FH MVR>0).%7C\C`1S;\[!%)`B*>OC*E^-"U%BBGE#J;S4Z5G%)J`1&1:WMK4A6( MJ$J(<%!/+#&?O28D*:74$6U.(A$[84:C;']E._]3.^'7N;0+++S MD1V@*@&4)`$M/KH-U!Q80.5-GT0W<V=>N#Y80S148O\X;NTSS!G15[EG"":A58"!) M&$I*V,!@X0(K?DID,U^9YN%WP4"Q9)3`H!(85`(#2<)0_%\85IY>EAS:5AQ3 MGO$)>':U/+[D#\J\H%EP,W&&)^G%@J/L,DH`)4E`2P+8!FK9@4%SG*E3\LI5 MY/PB^17+SW;24,ZDF;J;N`=$.RFZ!"5)+>4XX6X3I<_&8\JY-.-EUL[#/G_Y MQ`N60+ULBB[X36**+@[*DH`6_]\&NBK-^)R]Q\O6"Q8Y*:?XLN41?L%)5<*) MAFSD+*_4OR[)?YGE@_@,='7F-.-C^P0TI9DZW<_3 MC#R\03LM@"R"4DX)4)4`2I*`%N>7=J[S%1_O)Z"R+*_XK>=Q>>,`:N//^B<6 MH+6J1=K8V739K?L/";14);0E(PCMFL5KT:)%U>_$`)42R-@+<*F$'WE7"5=4 MEH:*<4T<=\H!FQ/98*@!1"2`J`80D`2D.3\U8`K%`T"ZD]'MTNV;2 M8'=.4YJC8+J(@X2R1EP(5`()22W).,6/2-8_`O7Y?P*5`F8=$SAV)\\5\.WM M)4!SRWU7=Q--[+,T-))P2B!9Z)B/!F2X'"KK_,`'"Z]NCV,&!B4);U>2@$%5 M@H$C>F+A^5A`QIA+C5[FJ?&09AWM>+S@>-@@*4?2/AY)$DBH2DB*"=/"6VJ( M>3:3S,P5J#,$QXZ(*=TPCUZ.&1@J85VI!`R2!*-8[!,8YLB,@8;HLSH?(1CI M]IA!R-BC'RH!1"6`D"0@Q3V?`#&S%9!TI^]S!8UDWUU2WN'!@T%"/A[GB$H@ M(4E(BH<2R3,A,U: M19=C?(]B^_SF/>9G? M>Q_U.>9MQ_,(_01)4I^K0/+0X,/)8&$ MUZ,32W&L[B7.)6#:*Z=P"DR2I&'%4`ESX8KF,P>%3!!1SX> M#5,))"J!A"0A*8[Z!(D9L)!H`/#!A&^`D(\'B$H`40D@)`E(,=0G0,Q_!20% M@#J?L"RW2R>?#Z,C9.,!HA)`5`((20)2?)1`5EZ4?0)A"Y3]OPXJ=-<48A"1 MC0>12B!2"40D"5'Q4R):.EO,?H4D^7^=6OB0A&P\2%0"B4H@(4E(BI4^06+. M*R3)_^L(P\F+\@^A[&I57+/@.^3L(R%P5`(.28)37)5PUBXU,^,6ZYP;1)X] M'AT6ETI@4`D,*H&!I(8!3UNW,-C+%O]D/\HF5[AEZ9ZE/DM#(PF#^'_IPRK7 MW,]/1]0[LBCS"_+K21]01T'KFSJA!*!D_+;@L@10JA)0K!E=<"M!RRO3YPWR M0=@50P7',@.]O)ZD`-VS@D50*YOZCHZJ!%"2!+08KIQ9*T'-JK%G#J82!0!J M90;ZA]4#:*G*@&5)$$MEKP-UM(Q=&VV^0(2-O'(B1EC8!4"9`D"61Q^&V0 ME@T8,C\!V_N416LF/L?.UUO;S2(G)9'@5`F<)`EGL?YMG!8:A%/2(BY#5F:@ M^"MIN:=!0ZU@$=3*FNNM2@`E24!+/A#0Y8_(\`4#O$Q=)87F**OC..5M`*7M M9Y&24DRT4R50DM12EOTKY3I7&5^90#6R[;WL,:@7E']-]I2OMG4_D57[:=M7DRO^SKE<<+(D3NJ%FDI[WA;Z_Z)EJJ$%D>K;5VQ>'W` M8XMZUKN+/<^!'(_NEJ5[EM"Q[>QX! M&0P42$8)#"J!024PD"0,Q?V%8>7I9;F!6Y$>WV#1696[PFOZ,#$*VO6F(T'! M22DEUIM*X"1).(OY$^?;]^.(C.,Z8#A87KK'\#*W`OP]EWH[SXV,CE$,"1*5 M0$*2D!2'?X+$`H&02*1$GZS,2([X4D,BH6`1)"IA[:D$$I*$I'@XD:R_!?3A MCP*5;ACJC,B2NX[I;RKWOEW6GC@=UAYEC>B82N`D23B+A1/GTMHSQV>X?(O@ MPR+?6'F4&Z)?*J%?*H&#).$H)OT$AWDZ<\S=!/BP2%]YK^G'&O<\33)(*"Y$ M1U0""4DMR3C1<3V)#X`4DO8,N>Z]RD!.Y_1G1E$P!;Y[EOHL#8TD(!(:%I:6 M3X$4$%GP(#';-I+]^2(%MRAH2,CJO24\5*@'N3='-2"R*\H#?EB#@+H#&M4:>'CPJ@4GDB-P)2!K M']'!J1(X21+.8JG4JZ6KM#DPP\V%3Y\M:73X'8)\YI"31\=4`HE*("%)2(JE M/D%B#BPDDBUQQEB9D1R/+^F)"@^=#!(R]^B)2B`AJ24I-YM/D(SE[<.$',J\ MZ'%'O(!],TG]/DE#(PG'-JD=R1)("&['ZM`0I*0 MX*">Z4@I;SLR\U32)TH:R.FT$S^][7GD9(#8GJP^O28DD&@5 M2$@2DF*K3Y"8"PM)"F5UR.2T&//W\O:U*HX=..3R8Z^`HQ)P2!*FV6.?D,#QRM6Q]) MR:`YVM6YE0]6K6]O,/.JK7N)ZV:_3Q(@"XH_>!#(XM3;5JUY/$/./8SST9:V M:@_X,*A]R'7;>\$2)R4*/SMY:&8TDZJ$L_CW-DYS?N:<^4"^3K\LWDF2,!9GW\9HF8`99Y*O#\;T5AZ.$EK02MO-$B8%D,!4"9@D"69Q M_&V8EA4$4RX/5YR;?Z7K`$2JD2($D2R)(:!'*EF5C>$$Y9DNAEQ)*'G%:P MQ!F[H6:J!$Z2A'-S!O)AF\*94G:=RCN^&7E+",^,'Z/4M]EH9&$H:9F+.&P>($?.C-Y,US M.H.!@L@H@4$E,*@$!I*$`6_EMK/+IV]R*V:>AGJ5&<(K_D!2O=T+FN6&7["1 MVW*`E@/E_@%4)8"2)*#%]V7!K;N,^%Q.!H7SI>SM94:*G_S.'_=X18.:XQJ/ M`?4S*TD`?1ACQE&=GR'S+QH,]@L%=.UT4PJ`0&E]Q$F$?E)P&1TJF/\+2&GB^O MZJ*71'3?*QGRYCO,.KTS_$:^[)+7C(W:W0&LAQD^T2G[CFX`4E5 M`KDY`\U/&TUW&'7^YT-.BRU+:Y;"C9^:=<_$257"65+#ME-S+@+EO]&JXS\Y M0J1?;][/C1R=Z2IEG*!5"5TE26A+=A#:-4O7(D>[=/7G17!Z4C(9CPX7'I7N M6<)51JO`0)(PS*2<-0P6)[`0.,J)Z8&!4D9991`2I*0%N/?1FJ1@4GG MG@S[?%!'O9SUQA=KT';4H,Z<6I10`E0E@)(DH,7]MX%:;A#0%+[K^-#1_/(' MAKZ]P9Q+WW4_<7G$VJ7D$ATEJ04=AX!N`O7QH0(J8>6Z]S+K*/[\/2=3KVA0 M]:LHN?>QZDH9&$M#-<<9'AS+H3#*M`T9+0W<[N:N\[7W[$B7E%%^W=M6Q\KRI0SV=2KHIOG'&B\8HFS'&<;:'BNJ2];EH2S1(!MR];" M@W"F<.KC21T4/]JF]QI>L,1)427ZJ1+Z29)P%O,7SA7VZ#-)6\B<3NOH4DMM MZ3<<]EZP!$D))2!5`B1)`EG2@4"N\T^?6"J<*9W6P:8/.2V?+'%2B@E.EBBY3A4F1[6Z*EO!.T*H&6)*&=245KEFZ.1+N] MF@9LA3+*>'3`4NF>)9B&5H&!)&$H`4$ZMH;!<@7.ZC?3*0]!#09*)*,$!I7` MH!(82!*&S5'&!YRVJRY_8=C+/+/-?)CO!4OKC3)*K#>5P$E2RSE.-Y5>K;N* M^%Q4X10'O^Z]S#@OQSRPS`L6.+UJ2BU]['F2AD82SLU!QD>D"F>*IG62:KE: M'M+/H^Q]>X,Y%TWK?B*X`)2"R]AC@)(DH#A0/?E6-K2\LOW3H_Q@V">I/EZV M7M!PYES*`UE]V28)E'9$8X>%LGC_MF5KJ4':F0)X.\$5?UJ=_,`KED`II`2H M2@`E24!GHLS*=EIR8-"9`%['L(X!/`^3\.U+E)12@E(E4)(DE,7]M[73<@-3 MS@1PG]'JJQ;3K>3TO>V]8HF34DIPJ@1.DH2S^/XV3DL,PID"N(]NC=,S_V&@ M%RQQ4CX)3I7`29)PEFP@G"L2@(]K;2%S`*]37<TFS_/=>L`1)`28@50(D M20)9PH-`KCPU+78(9PK@==SK0T[;SQ(GA9S@5`F<)`GGYBCDLUZ%4ZZDB`B1 M3CCXY>\->]D2;>R,_%,ET)+4T';;IM#:RUKS1`#7+P-$V919;EFZ9ZG/TM!( MPC`3=I9/O\ZGO<*+W@K@4=8P4!P9EQ@85`*#2F`@21BP:C:=79W/94E8%*58!;SWX9IL4$P]4:C\XFOU>-G0&U' M2Z"44NQR&;N>6@Q0JA+0XO[;0"TW"*A$E6O7S)?=[0YYY=I^&LZ96XW8T82% ME4O1980'*4E"6OQ_&ZDE!R9-MQI='?KZ:-W:3AK,F75+(27:J1(@21+(F2BS MRN4['^;*D#@]]4XCRB*R'6;Z:1%D"92"2H"J!%"2!+0$@&W=M.C`H/E.HZLC M7\&O90P&G[FFOFYBCDHV#;DS-]$:6K M$V,YX:8[C2A;ZBIEG>BJ2J`E2;I:(L2&I6O)HT75RPR6+@64\>BP6%6Z9PD= MTRHPD"0,)1QL8+!,@;?FS3L-'A<;#)1&1@D,*H%!)3"0)`S%^X5AY=EEJ8%; M,7.GT0RA/5S2*-#."YKE-G>GP3-G8\%1;ADE@)(DH,7[MX%::F!0>)]8&]:< ME9DG7(XY@<^-IIVYC%!&"4Z5P$F2^9ED23*RY;6O69]+*FM5'X)V7 M>3!]T;/N%@5+G.4X^1D.VJD2VDF26K-R3T^;O8,U]+4USSLHAKZ8=Y.R]8XJ2,XF)7!2E7`6[Q?.FL M\Y&\+62.:W5RK\<8N7/&HK7HL01)`24@50(D20)9/%\@USG*NHG!79WK^Y#3 M4L<2)V63X%0)G"0)9\D%VS@M44@_4URK`W]Y;:>O#'=>MD1+*29H50(M24); M$@31+BU9"QPMHGZ'!FY"N60\*BQ2E>Y9PN5%JW#L),FQEU1`Q[YN/C(>N>!E MBZ,RHFRZ^(&!8LB(!0:5P*`2&$@2AF+YPK#RK+*PT+9"/QE#*R)3E+/JD+Y! M&]N7EEGL)>P-F"H!DZ06.M^\U$W* M)G%NJ@1(DJ2;Q?.W05I:8,B9C^^;\<*[TT$OQN"T_2QQ4C8)3I7`29)P%K?? MQFDY03A3[/:9OWZQ/:=Q7_C=ZO$D6^*D5!*<*H&3).$LR4`X5\3N=0.&\37O MD>'AC^!&P1)D[(8N02H!DB2!+-%!(-<%!!_FVS8S?WQ?9_Z64W-W2;]LAU]S M7M5,BCC13)7`29)PENRPC=-2AW#*-08)(<()Q^[\\?VJ`T5Q%YCZ_Y]G! M?GXE":2%Q].-D&Z.,C[,ETEA?NF;PG7F;[F.=&F$6^?;&]"XBQ"0RFU MC.3`)$DPB_MONHSX*%_!3#<:7N8=/9W33+[.*Y9`*:9$/U4"*$D"6NQ_&Z@% M!P%-#[[KQ-_2SW/Z'>?.MS>8TW:KIPE$U^2Z MT?`R`]V_Y(S[CDNO8"D*H%$,Q1RW8V&#P)NFYEO-.J\X(>=HC.VG66]S-QIY MN'"\=+I^@O1AE!DG\FXCM=3`I#"_E,!]Y*^C'BZZ+(%J.VI0'ARD%%Z"E"0A+0E@ M6TLM.PAI^O:)3_[UEIX0.=HK#5!M1PWJ3$LIJ@2H2EB[)+6@XP#?3:`^^I=! M9])I'1`\WFRD;Y_XY@7(NI/)`),TX`9\--,9`QP'\VZ#M/#`D#/IU`?_UF:F M6:V=5RQQ4E3Q9O),85^U+$DS<9S;5JU/]15.69/7SLL<])AOJ;Q@B;,<)W\B MU<>>^8+[<-)P-X[KE7ZNL,?Y,<-R6PC(B!:>VN1=N$7!$F3LAA:M2EBT)$DS M9W+,.O_T8;YM,W,ZK3-_'W):/EGBI!03BU8E<)(DG"5!2#-7'18K"K=LX33 M3ZO`0)(PE(`@'5O#8+D""_[-=,J#@8.!$LDH@4$E,*@$!I*$0:+,PK>`?(AO MN]3R$^$ZZ[><4J_G;'<4.`)$)8"H!!"2!*18.S5C"<22@("DQ.GC?>U"CP]> M4[9.\W_1$@H9(QQ(5`()22W).'QW/8G/ZF62_*RS#O1]T)"Z/2[2]RY)?9:& M1A*,8N)/8,PFC)07?1KOXX;PN%Y?6DD"B28,D)`D)'AOGR$IY8O?U&V&^Q[V MG=P#W#J>QQL@MN-R')&30T1N5T!N50$*2D!2_?(+$[+5=9/E/\.OHVVDM MSORE4ZV*MQR7,;+O:(Q*P"%)<(IU/H%C3MO@8(J3!A2>@CL>%4X3\NAHA4IH MA4HX=I+DV(M;TK&O/4W,9''V\7F?/J?G*;C!0/8<#"J!024PD"0,Q2>)8>G$ M,%MMWO^9CZSK9-MR8ES28/6N;J>%1(8]L@%$)8"0U(*,HVC7@_CD6@%)`<7+ M_$YT=\E?\TTC<.]=DOHL#8TD*&+MZ_^PV@?0"I5XW[6K) M2B!1"20D"4FQ3B)9:3(^!;8ERA^1UF&QCQ),+:`3ALP\5IE*("))B(JA$M'2 M*C/_%9)D^74B[$,2\O'HC4KHC4H@(4E(BJT^06(N+"3I05*=^3KE@YDL5JNH M,>3RT1B5@$.2X!1S)9RU2\T\N<'"R,ET'2#K'H\.1J,23$4EM$0E,)#4,!RV M#8JUERW^Z5*437>(MRS=L]1G:6@D81#_?_L$.?BTUN;]SYDLRB+*I`_WHF"" M`PF9MZVH+(&$JH0$!\4K:HFDE*=;>PUE!Y_::B3XE%(^/4=/;#\-B4KHB4H@ M(4E(BFG*N;'J\?%A?AZL9K(H\VDWZBRQ>2&31=E$#DRR^[&'P"1),(NC$N92 MP\R`\:[56YF4R0XR`G:F763CXQ%BX:D$#I7`09)P%#]]@L/LESEF0MFAF?%Z M>4E_%1T%T]L/$G+V.(54`@E)0B+^O]01LUTAD6OQP0>K^K7@93=#0O8=/5$) M/5$))"0)2?'1)WIBMBLDFLD./CHU4%[EQ,+%@.P[2%0"B4H@(4E(BH42R3JC M//C\TY8H9;(HLRO!_B4]'YL*JO5G"43D\R,WB$@2HF*H1+2TRLQ_A40SV:$. M0GV0R:8"(B%KC_-%)9"0U)*4*^03)&.Y6DYZ/G;P,EQOZH4N9[*I:L*I+PRI MSU5#(PG.E]4+,FQ8WUP*U:>)CZ) M%!Y5WVMMG!J^SR=3SKQ^=@ M,J\NZVAZ.U[D*@=.LG0_;9($3JH2SF*EZR\`/GL4;]MT4#.9T\O\XHR!*>U" M!!TY^'C8(%$)'5,))"0)2;'2)TC,>84D94X?5.HD^V/Z&N#A_[-VALN-'$<2 M?A6%'N"\(#'D4F$KX@B2X3_W$#H?)3M.]CIVUW&O[ZRIJI[LK`9[,''_I$1A M=CY43V=B`!1YE&FBD*MG4U0""DF"8EY**'8![0N=,6Y4J&35/)_;5%+;H!_E M+1NZXUXN:T\L&!TCRT],E8!)DF":T1+FQ'QBQ"BSU=#9#3T]C58>N7NV2R6L M/)7`09)P2"R8<;@;,\^]RIQ$\8K0AVIH9/G MY$X,0F=4^>YU=[H[EXTX*L3Y)3^@6>3IN2J"SR\:ME^FP.3JB:(24$@2%//2&U#<>AFEQK$8P/E!2\C`DT,E7$4J@8.DGL.^*WH#QUJN M=P+*'P;"GU3!4?_T8UP[HY9$!:^N(KWF<;:JMTX2%+'^R742`S*Y);A.-(Y% M59#@A\OEW1D/VHRF%`DDY.]K%4A($A*DRV2GT<2P2QR6C*;&L383,T*,W%L#$9EW$JD$(I5` M1)(0F:D2T6R5N0<+B9SH\[D-OKQ*0EZ>)"J!1"60D"0D9JTWD+@3"XF\'09) M&O;6ND$<:U5;'"L28-:\P-5DC*OMMF1EXE(:..JZ4])^%` MHE4@(4E(S#%O('&#%9+BBVTPY+9)#WRQ5>6Y8ZF1@>=24PDX)`F..2;A[%UJ M;K2,]?0DV^[SF<=`KB>'JX4<.CNB$CJB$A!($@1SS`,(;K1H](>^R",>DX$L M.AE4`H-*8"!)&,PQB6'BB\,QD?5=?)O^SG=OCM)[(NE0N+\R27T/ MWX8N7FL(F71BJ`0,E8!!4H^ATQPG*VLXQ;&^A8^RZPV)@NVMXNLD M(;G-WF.P(C=D\`X^J@($X:(/,I,EA0)(.3E:Q5`2!(0G-,-*ROF)@I( MR2EMO**MK=-#R2GM\>UB+Q)`[-S8Z`%"DH"82](ELM,\8D)B#U1S2AND&.XN MIHG6D$EG:U0"D4H@(DF(S"B):':UN*\*27'WBM;$E[_-%^[+O0O_:(7^7"N&?1")7"H!`Z2A,-\\@8. MMU7A*/WBC*-(K_HJ'L+YUDE#<9NDQ()`IL*S*390V1_!*.]KC!$)FO5XR`%$)("0) M",[IAG45$P`%I(\>S^;!]@T,E<)`D'.:,-RPK-U+A M*-&DC0`TD#OI%SC(CF._*A(XM`H<)`F'^2)Q[-QS8\Y?SU.321L'N/+@N]]] MYT!$MIQ$*H%()1"1)$1FC40T228Q[4](2C)I0P&ODI`C)XE*(%$))"0)B3GE M#21NK$(B+SDNEO3?S2X'R:15T2633TP)."H!AR3!,=,DG+U+S;VVP[K_5"RR M3/W#XB*7SI:H!`:5P$"2,)AA'F!PG\55^&%$*2/^P$`.G0PJ@4$E,)`D#.:5 MPK#O&Q\QP`)9]?)8"2U(.N MT_,.@<;.DE`)1W8E;6O MHS%X3T"E$\_G*'-0N&+YS#L*IJ"4"Z*C//HO.LJ2@.)$CRW=P33`FNNZ68## M?MJ_+\.-3_HC<_33R[I^JH1^DB289M?'%JX;/8[,&XT$"?33RS[HIQ=,^^EE M':A*`"5)0,W%CX&Z_S-H'=5Y;B/Z5M>697W)AZ>4E#5RU:H$2I*$TAS^&*5G M`Z8S8>G\L-SF]UD[ M'^LFY$>9MI,22F*J!$R2!-/2@6#N^(9$#.[K&=4<<6EF]C!&S.*HB]8+II1Y MG"VMM4.G!$JJ$DK+#T*YTU,\>0AH2=1M_M]54#_.%)2"3K93)8"2)*"'XU#, M_1/0$KC;>$#>D\LH^7.437$I[B2N2L`EJ<==9P%*7W>LWA@AV+'>ZT_#GL]E MTN"E2B]5>JW26R<)PR#O[&'P]`$W8G.4;00,&E+`H!(85`*#2F`@21CP4O+U M-7F;&I,`N]=_<*,PRMP*D*G+IS0\47!=/B"Q,^EOA10))%0E)&;OM*)F))X& MA$2V.73!R\+4[FKDY)&"2>+/X3A2JD!"54)B%GX#B3L^D]1,&7,"/^@(Y8;D M4`EK2R5PD"0<9M$W<+BC,\?H;F',"?R@(Y0,DD0ED*@$$I*$Q%SX!A(W;2'I M;SIA:7F5@SPN@Z5%WI\@*@%$)8"0)"!FM#>`N"\+2`E$;5[@&HC$8K%MD;LG MATK@4`D<)`F'^2AQ[+R)$T,!>YX:?MKL0./!.`+9FT%$-IY$*H%()1"1)$3B M_[/MRYU52.2EQQI+`[Y*D@49QK`1JP02E4!"4D^RS@*DWDQ(8G2@D)3XTB8, M;JXYN%_8JC:<(KWBSWQ@];#5O'62X)AW$L[.I19#`#NL^T_E+3#/"EQ7T@6_ MKY"S>ZD2&+0*#"0)`T[C"(,];3XBB@<%)H,_<[-`,*@$!I7`0)(PF%]*'_:] M$XCI?S@R!ZYRZ[8-";1K9?#V-1Z?)>-VF%R"X"2K7U\@<)(DG.:GQSC=B86S M1)IN.N'#4_WX,PJFH&3\*Q5`50(H20)J=GL,U(V:06OB:?,%K[73#S*EI%"0 ME"J!DB2A-"\^1NDNSI2C/!13!R,/C=KIQYF"4FA(4)4`2I*`FED?`W6;%U"- M2S&3,.+29_V!.O9-/\R4DT)%;OW"6--6F%=K"/=592/'X ME).B1G*J!$Z2A-,,7CAWO+N-.84]9(U8;9QA!)/R#C$*II040Y)2)5"2U%$N MH^&)NUS%GZF_TRL_S<^R]M-\!JQ0CJJ`6UI M(Q'99YT#_9QEVZEG\IR]P+!J-NLF!K$$@HB.2*4@DD)`F)6?P-))X(A$3# MV-+-5[S[7/[4>19T)!0VDD0ED)`D).;A-Y"XY3-)25M+/UZQ#A_*@HZ#LD1R MJ`0.DH3#//H&#K=TYACDJ:6;KCCL"$6#];2QME3"5:(22$@2$G/A&TC M.DF(Q/\GG8D1AWUG:KIIDQ`CQE42SEPH,/DX%L.I>52F!0"0PD M"8/Y)?5AMJS<7KO7?Y!4VJ1#NT`>M#]H!KET@J@$$)4`0I*`F&'>`.+^*B`E MJ,0LPXA<2W43'G:8)&3=JP02E4!"DI"88=Y`XO[*)#6HM%F&UQI")IT8*@%# M)6"0)!AFES=@N+LRQBBG]$,21PTAETX2E4"B$DA($A(SS!M(W%^%1'-*-R/Q MKDZ#6'C288*0<^?*4@D@)/4@MXU(7/:-2,PR]_4'N80NV\.;>=0!B;7JK9.$ M0UQ]Y\8;\PG[QI2;-$L;8WC-W5L!$9%O1V=*%8BH2HAP4CU'S&I]_R^N-R40D,*J$E*H&!)&$PTSS`X%Z+ ME^;#G,+3#==7&`SDTJL$!I7`H!(82!(<MAV'SC+@$)UP.W:C M_XROLWS)>CM(7FEH)R6!M>F@)$G::69[C-)M6BC%==!/+_-^WMV7/QV) MAGK%E-3+MN:!5"60DB2DYL;'2-W'F;0&NS85<=Q-/\24D1)#;I(J@9&DGM%N MSQYC7)^I;U/+;R67*/N@FU$Q(XTR[F:1WO*?6ZN$=)`\]FU#,2F1NXFKL]]E MGI>H^@C4,\04E*)&M)1G-<8%RI*`XD0/MM2>65HJ^RE(O!\=L11R6O+%&R3:"T0.8[J.@].`QI:1\ MDMU4"90D":5E`Z'?EY;F!6S$(I]WDR(ZKZ"AEE015":`D]:#KD,=#H#$>4D!+/HTR-WK\S>7R M8X$E*F:D4<:)IDAO>;!!HEGG.QXC]8C!I#6?QOC(Y*P-C8(I9LTS/)DR5BY+ MTE"]7%QY/&4NW2&BH'VS44$L!QQKJ^4%( M-:+&T,D`/3T-6NK'F;;4R[J5JQ)`29*66@HX!NKY04!+1&WS*"W4G!8QR,L2 MCT\Y*:UD0U4")TG":?XOG#L<,D91]I`UHK:)E9'<9*<"I<>/*26EE*14"90D M":4E!*'174,\H4E*),@JH$4)($U&+$,5`/(`):(FH; M>[E%HT%$C:HI+86>I%4)M"0)K42CR?NJ&'39(=[KY!KTDA+*>E98IBJ]5.FU M2CAW>J*"\]3!?:M#Z,I#\-,!LHCJP0&E<"@$AA(ZAG6<9;"L.^R MBD&8W(I!-(TJ=X.'3_I3C\L2!?TZ&T33J&,W*-);'FU@>^L@RV.@-<>,HFF; ME&G[1\FE\6B/67-I.TC>FWA=B@1*"CO23K1#E^3.=MHSRVT9V>V?EQBCF3%F MT?O':*@?:$KJ95T_50(I24)JOG^LGYX8<.1V_=5EG'J!(8 M21)&\_QCC)X6F'$42F/PYD?=]`--22F=A`WP4,]5`BE5":GY_C%23PQ,^J"+ M$LLVEEYZ>_,=FSAZS1NPT`-,-(7]$]<`,H+I@O.R[:7`Z`J`90D`37_/P;JR4%`2SJ-P:,!^O108G@4 M3$$IJ,1&PC--5PF@5"6@%@&.@7IX8-`:3F,JZ0?]]*-,,2FI)*9*P"1),"T` M',/TZ,"8HWP:\TH_Z*`8J&<'!GVH\;3--#4#Q-W^ M/MCA^O2C3#$IJ"2F2L`D23`M`AS#]/#`F(-\&F-/O9VPC,KIAYER4E1)3I7` M29)P6@(XQNG903B%`[Z1$6.-I_)+%[33'YYBYE'(WU4")DD]YCJY5#!W^'L, M/.T9:SIM48[SD99I+<\V"#%K`-)A7*?>\8H4P$M MZ;1-/+T*ZNEDULYV'`*E7+,N9("2).W$B1Y;M8/YJJ>[\E?&ES;SE--$_:UR ME$UQ[73YN\.OVS^0KP!PJ4IP+49(7_>L7D\?75/O3R4I\-C3]96_+$5ZJ1(8 M*-UDRT@2AD'@V M'+I6#+YPVF:6VO55$MN^\:A+.T@N+5!2;LE.D224YOW'*#TU"&5=<%X64>:$ M+U&HR<=0T^EU12EEQ0*I2N@G24)J]G^,U(,#D]9LVH:6CKOIAY@R4D1)1I7` M2)(PFO4?8_30P(RC8!H32S_JIA]H2DHA)4E5`BE)0FKN?XS48E9 MI1^!^G&FH!13$E0E@)+4@XY&H^[;AD;34>\T>SXO;3KJ:O/5]N+Q&6<[S+81 M%>EM^\=0)9SF_]+0'981LTS[;M;0UD:>&B1N*:#)1*5@D,*H%!)3"0)`QF M_]*'GE%7](5=X!HR]^F'Z]#3[6YZ&LN9%0=%DE@)(DH)8! MCH%Z>F!0.'VY=]JFK0[S3#S:8]:/]=M!8,E)& MR26K$AA)ZAG7.:N'&&-"*S..PFF476]F%,Q`HXR;6:2WA24!'429?9M0S&QE MT,%=TS;9U;IYJFLV'I]B4DJ)?K8CY_4*3*H23)SFL34;8UT9?Z M/=,HF'+:>?8W9'BN;&Q"+`FGN?ZQ=>MY03C%,YZ7F/[Z^*/U\[[.THC'IYR4 M3K*?*J&?)`FG)0/AW.'_,=*UAZP)O$U^-HDKDK`)4EP)1!-OE";XV%//^96A^O0W[E[__^?UOO]E7:K#USC`\472M*G\`9>DU8!S'G$*LG M#&[8J7RU_2&&N_:LBW[$2&7$ZO\`K6NP%@VLK`DKSD[7\"%6.T[?UR=]Z_40 M8V$%5?9?M-6/15@O`PVHI0ZHK`FJ!02Y7`^A>M#`/]2NP_+GW9[Q5W]\O[[[]]^^,N7 M?_T#)_N$(-;4'[Z^__JG'W&BIY_6%8)_OSYV9X^MVV9][-X>N[_^N7K[_][1_??OC]_5>\+)_^PSY9^NK6Y/_S_?]JU2C^]O_[N^]#__6P````#__P,`4$L#!!0` M!@`(````(0"9?#"RD`0``.<0```9````>&PO=V]R:W-H965T:=T#<'T.S&&/9/@I+9HYT1AJ-9KG&N&VC`&T!B9.W MGVH*8[J,E^0FA.JJG_JJ=R^^OQ>Y]L:K.A/E4F<34]=XF8I-5NZ6^C]_/W^; MZ5K=).4FR47)E_H'K_7OJU]_61Q%]5+O.6\T4"CKI;YOFL/<,.ITSXNDGH@# M+Z%E*ZHB:>"UVAGUH>+)I@TJD1#;+=9RB.1OA:\;%"D MXGG20/[U/CO4)[4B?42N2*J7U\.W5!0'D%AG>=9\M**Z5J3S'[M25,DZ!^YW MYB3I2;M]N9`OLK02M=@V$Y`S,-%+9M_P#5!:+389$,BR:Q7?+O4G-H^9JQNK M15N@?S-^K`?_:_5>''^KLLW/K.10;>@GV0-K(5ZDZX^--$&P<1']W/;`GY6V MX=OD-6_^$L??>;;;-]#=+A!)L/GF(^)U"A4%F8G5II&*'!*`OUJ1R:$!%4G> MV^Q.A%XCHC<"+2[ M0'AV@.);KS=K/WXATNDAX?NZ30-4"P[,+M-@9^/*+!A:LK7^4-,EJ48FC M!H,:2E(?$CE%V!S$9.$=>(X7'HHE8YYD4!L*WC6,EK<5LYB_,-Z@B]/.*4`G MF*&]DZ5ZA"&!04H3A\?D491",YD$5&6..6I0`G9QSDM0044,\,"A)PDBD M23)/3KH[I91Q2QW0^]YV/9>DB3Y>.V"FEN.2O@VQG4&W]2+,]%21:"C"F.\Z MQ"$>4?%9+Z+``M678&6<"FL[9'`'Z#-M83U[2K(,L?D.ZU##=SPR-N,1C6ND MTR^2RCB5U/6F?3';61N@#Y)._1FCJ-A^!W4HPBS?M,A7XA&5:[#>%V%E'(4E M,`'Z(*QM.S.U%B$VWV$=:KBV34E'-*Z1RO,/6;WOKWHRB&(2C@!]$-.U/(NT MA]A^AW,H,C,9(U,D'A&Y!NI?@CZT+,DXRDJF48`^@]63&B(T8#4LRV?GY:2= M`3&V*]6X!B*=:)<]1-(&$I0964&#S@DS9;;GD$S#SD$^;JRQBHQE3NGJ%8_) M7"666S89I(\1XUZO["DS`A0P=$+BL=6G<[A'/)0977_&=*XBRR,`0;X_+QD> M'%1>,F>"S@DWT=G4)'MLV+7?P\5/H8KM6R8I:SPF4Y9%IF;X=GM!!Y=FF+%I"+)[9X@,1.,GV7"8X.2K4G71'GY@H63,I%A$I[= MSDQ]Y,DD;XZ=&)B0"6^">!,I>+7C(<_S6DO%J[SEN7!JZJUX`PW8'([>$$_L M$=Q,Q^Q/S(8KJST2`?T%+>UR3[0"YIZNN4;?!-?,0[+C?R35+BMK+>=;2-"< M>,!4X4457QIQ:*\2:]'`!;/]=P\_*'"X,Y@3<-X*T9Q>9!GZGRA6_P,``/__ M`P!02P,$%``&``@````A`!Q-L]N/!@``[AP``!D```!X;"]W;W)K&ULG%G;CJ,X$'U?:?\!\3X)-I>$J-.C@5'OCK0CK59[>:8) M2="$$`%]^_LMNPS89:9#^J73<1V7CZN*4PZ^^_Q:G9SGHFG+^KQUV<)SG>*< MU[OR?-BZ__S]\&GM.FV7G7?9J3X76_>M:-W/][_^BRMI%?2G.8-G7395U\+4Y+-M+4V0[.:DZ+;GG1M@T MVMY;E<]Q5V7-CZ?+I[RN+N#BL3R5 MW9MTZCI5OOEV.-=-]GB"?;^R(,M[W_*+Y;XJ\Z9NZWVW`'=+)&KO.5[&2_!T M?[(@IL%#X6GO#X!`?CK5*4H#8A(]BH_7\I==]RZ?K0(5Y[/`.X\%FWW4`J7 MKI,_M5U=_8<@IERA$ZZ$DW<<[OEL\0 M_UR!$@3!XS."3$3:(T3:@-]`$J)#2?J0[^E,]9S$)),3C\WU$H3HC`CGM$=0 M1A"JVQF)25`E>@`8"P@G!`6R2D1L4VW`"$I@4V`K4:I7XB+F;5TNL\0]%I+U MT;S")'JK*(A,0(H`!O$?\^BM!I#!$=ZPI*S! M%.TR<`:'Z!8.`JQQ&+T)_W]7`BPQH'L,T$S$"943BL-T02NZZN<=57.%$JG@9HZ$06A=!J-*U%`7?RI MCC&TJW3X:SL;/Q-61I3U"@^BIZ0$$^EMZP92MT*?JM9@IAU&'$5NB`813RI< MTMO6Q6B$*T[LJ;)/).4F^61$/XDV)M%8<1*Q5`$F$D/$5)[SE,8.3')<:I0!F/&V'#L,!D3_9Z9Y5['-2)PO!J6P`,@1Y2> M96W$I$$$?"8-%/)KQ88HG88V8M(@`CX_?[V6&P&AIQZ.*-58PF"L(CQT*+N9 M.:[]ZC#)$IV?3[:7?(WL1+$A"C(V%ANW>B%'E$F9C1LW&9.>,#/+=F\`#2:Q M2SBB]"QK(R:-B6YP_0C'4<.O%1NB=!K:B$%#+/DAL9`3+:D?8XY/GT)AL;%@ M'1-`J@!FZKCVN]]D.]$.9NFPC\I^1=H4RJPVZP"H4`9E3?],PD+_B1:++;]_ M0O7%+!I;?Q1/%5M$:5E6\^2(26.B)2 M;:3/;J,^HO!-2.Q9[QN4W4@81Q:%W2!K*YO?R[^N;+[U>"#* MI.R-E6`R)HWC2I%A'X#?F'!J5A5E#:6^/F2N-J'\`="]\46D/]4'R/DG42#Q MTW3H`T$X'EVQ89'(M>`UILXUM-X[C2B+ZT1C8*): M;@TL2KY.0S^`J8PCR"!KOZCS!Q0E&TRTCP\$5KHA@J?U;^2J0(3K^"Q@$8PH MB^M$\_@(5[N5:.JOJ"*&4"4GZ3084!95R!H5R@A"?6,)P&6,U4-8?RW#JG8@^!\!8K>'H;O*_"+UU]D1<=CW4']TSRWR/< M*Q9P>^`M`+ROZZ[_(L(]W%3>_P\``/__`P!02P,$%``&``@````A`![I9R?O M`P``YPX``!D```!X;"]W;W)K&ULG%?1;J,X%'T? M:?\!\5[`0)(F2E*UV^WN2+/2:C0S^TS`2:P"1MAIVK^?>VU(P$!(FH<$R+GW MW'ML'^SEPWN66F^T%(SG*YLXGFW1/.8)RW/E[M[VQ(RRI,HY3E=V1]4 MV`_K/[XLC[Q\%7M*I049,YE(G*6D:2:A?[%DAZFQ9?$VZ M+"I?#\5=S+,"4FQ8RN2'2FI;6;SXNLMY&6U2Z/N=A%%62+W*SN8.I.9%Q"`6QLJ MY`O#E+85'X3DV?\:1*I4.HE?)8'?*@F9.J$_F=U?D<75%:D&GR,9K9=(/FC1^/TUP"PV"6S3Z09,& M6I[V,X5MIEKDRXUAT,J&;LYR^?[]B4`WJT%JZKXP M.(NHW1/?X5!2O-JG4/G&GH-3_^L.Z?,CC2ZW"!Z2RU MQ9FZ^Y^R,Q4UJGN%ZNKN&W9V67>%[GBG^4:M4$UGN9\,[%E\]*J;%[F*,NL( MS3U$A>IINL?.<#LZTKPV*O@^[Q2Z&Q=_R,[@Y-#J=(1,&Y3A+!VE:QL[E]3U M<'W>T-OQC)8[^B=-4V'%_(!G"0+O^=/3TSGG,5`GE=,?<,PHHAW]-RIW+!=6 M2K<0ZCDS<+92'U3TC>2%VNQON(0#AKK&ULE%1=;YLP%'V?M/]@^;T8"$E:%%(EB[I56J5I MVL>S8RY@!6-D.Z7]][O&+4W7:LI>`-O'Y]Q[[KVLKA]42^[!6*F[@B913`ET M0I>RJPOZ\\?-Q24EUO&NY*WNH*"/8.GU^N.'U:#-P38`CB!#9PO:.-?GC%G1 M@.(VTCUT>%)IH[C#I:F9[0WPN*BE@I\510><" MB8&6.XS?-K*WSVQ*G$.GN#D<^PNA58\4>]E*]SB24J)$?EMWVO!]BWD_)!D7 MS]SCX@V]DL)HJRL7(1T+@;[-^8I=,61:KTJ)&7C;B8&JH)LDW\XI6Z]&?WY) M&.S)-[&-'CX;67Z5':#96"9?@+W6!P^]+?T67F9O;M^,!?AF2`D5/[;NNQZ^ M@*P;A]6>8T(^K[Q\W($5:"C21.D8AM`M!H!/HJ3O##2$/XSO09:N*>AL$#[B2191%DZ7UZ>P<)"1&.".^[X M>F7T0+!I4-/VW+=@DB/S^QEA%!Z[\>""8E-CL!:K<+].TFR^8O?HG7@";0,( MGR^@"<%0=9)&N?.E/=A+>T=\+-NP<2J3OB\S^Q\9#WXE$S9.93#EQ?M*V6LE MWR4S[+5_>^HO(>[4KC1;3@(AV0#*QB8]M1"[YWP+/;B@Z-M+8=+L\B^E`,I" M<:>S4+FW6DL-[,QZ.D`QZ+G-=QQ4\O.DA8J MO!I'2]0U8;#"PNE^;,Z]=C@0XV>#_S_`TL<1@BNMW?/"C^[T1UW_`0``__\# M`%!+`P04``8`"````"$`(`Z%*F\(```N*0``&0```'AL+W=OS[#N>:@)-0`YC" M9#+S[T_+0MAZVT.4Y"(VC[M?6>IN>9$?_OU]V&=^^>=P%QP?LW;.RF;\XR;8 M[HZOC]GEHO5/)9L)+^OC=KT/COYC]H\?9O]]^N]_'CZ"\\_PS?#D'^G(2W`^K"_T\_R:#T]G?[V-G`[[O&-9I?QAO3MF MI4+U;*(1O+SL-GXCV+P?_.-%BIS]_?I"YQ^^[4ZA4CML3.0.Z_//]],_F^!P M(HGGW7YW^1.)9C.'3;7[>@S.Z^<]]?NW[:XW2COZP>0/N\TY"(.72X[D\O)$ M>9^]O)'[8YZ((8]<_9?'K,_[.K*+F3S3P_1`*UV_D>8V,^$;\%'^[S; M#G9'GT:;XB0B\!P$/X5I=RL0.>>9=RN*P.2]H^[';7MX>LX52KEBV M"C:99Y[]\-+:"7H+#_Z21?962(LY5A+97$8?RZXY#X>I`VZM#)5>V M+:]0ID;O^+E7/]J:-41R4?=H^Z6&2E<_VJJ&RCG;M4IB5.Z<8/GJ1]LOM4?# M%9TG;55[E9SK%,N5*`YW6O2NGK2]>GHF)VI3ILG`BY230?TD:/8M5VCG2[VS M58*('SL%'ABX]U'1X6HL+F5T5:FI^E!*W&?-O$R;-E$+EAY") MQ&@N#&F6__5D.Z[WD/]%4_/F:E231A2,FY&'-G5E(V9BH=Q`T$300M!&T$'0 M1=!#T$(EL?Q+FR4`.T0+!$L$J`/(7]%GL*-XM] M@=(W_=JH0BV\]%"77?T<:](D&6A'MZ@K"]6+A@)QQ[VBI3LUE8UR:BD0.\&9 MM)6%8T4B+V\ M(I316-DHIXD"L1-=%.$$I\I(>@C&"`8(A@A&".8()@BF"&8(U@@6")8)8`61KJK8&&TR^+N^I.)13@^9BE? MXDR!>JE)D[*\P!0]IW#+I.AB49?'Q;W;3<.VRKI10Q=QBA7]>--$I*6)N`4; M&FF;B'1T$:<"9](U$>EI(@77C:LK&I-^J@C,*0,4@3,9FHB,=)&B!?/)V$1D MHHM4*M"=J8G(+"E2],H5R*-YJ@B$<*&)N$X%9M1EJ@@,[$H:13./5B54#=^K M$N&H5TG)AD9KTJ84E4G!QB&LR\.?5(FF8;F0$$T3C9:FX5J@T3;1Z.@:6*Q= M$XV>-(JG_SZ"`8(A@A&",8()@BF"F00R+G;!\B!N?H MV8OEG$O&]^_WA! M0`HVE'W7I)&>DE!W,'T$`P1#!",$8P03!%,$,PG4B+D6)HL\?G_$%DI5C`<$ M;:F.J8ZN%-"-M12B1W"60D87=^&H9Y$'T:E)DUMUN)`B=7G\?H<;TBC.Q":" M%H(V@@Z"+H(>@CZ"`8(A@A&",8()@BF"F01_';*Y/'Y_R!9*50][=/.P5,=N M.:*`;JSE"#WW?2]'A*.>([8%25N3-M<[P)+CP#6E+H_?[W$C*>)4;!<>%YHF M(JVD2(%?W$PT.II&&9^CNR8:/4W#]6!`^JD:,)<,-(V"!94W--$8)34<#\=T M;*(Q26H47`?NR*8F&K.D1M$NXK/@/%4$6EHD16RZD,"`+5-%P&BEB7AN.6Y$ MJQ=ZU?B]>A&.>KV4'$CEFK3QY!-3SH'W(W5Y^)-R26HX.;MB)?_@)K]IHMA* M*M+""UP)VB8:'="H>-H?E$'71+('DG&\Y)-4J@8$?0`:T+6AB<8(-*`HP5&3HQ9';8XZ''4YZG'4YVC`T9"C$4=C MCB8<33F:<33G:,'1DJ.5AO1I4[RA3\;UNTN`\DU_\OTM>_=:$PO<(BLT*QO> M\=5C*Y4[#8Z:'+4X:G/4X:C+48^C/D<#CH8_NC`LEPFT>..KC)KXAH%G!ZAH-&56:%_+Y*?CEP M\,^O?MW?[\/,)G@7WT[1AR%/#S<*JU)\[-J.%5:=N:\Y51I;9GSCE.E MY6/.>TZ5EH@Y'SA56@3F?.14:9V7\XE3G48\?^LP?:UV6K_ZP_7Y=7<,,WO_ MA2)BY<278F?YO9O\<0E.T;+]T?WY_N[FU+-FFU20M1\:7]QJ7]>?7'I\5)U,]RSWEC M089*+NU]TQSFCB.S/2]3.1$'7L$O6U&7:0-?ZYTC#S5/-RJH+!S/=0.G3//* MUAGF]34YQ':;9_Q19,>25XU.4O,B;8!?[O.#;+.5V37IRK1^/A[N,E$>(,4Z M+_+F326UK3*;?]E5HD[7!_>;[;-[#<,Y@13FR^>7OD,H.* M0IJ)-\-,F2@``-ZM,L?6@(JDKTO;@POGFV:_M/U@,@M=GX'<6G/9/.68TK:R MHVQ$^;\6J1EU2?QS$OA[3C)]SS&,4NPZ-H=< M.!G51&NN0HUN1,4X@DHQ8JUAKJ]:()Q,(^,5_GE'^CMI(ZYH79S= M3456@29Z1)TM/HM:]OO)3+5O]Q8,V;N0:^`_V%A^[91,[P#@NMV-[8>DA/%9 MU#.J_HAQ]S/T;]*GE]U215VTR[.JCZ%W"S5B8J"9$PS<92\40V\!1C$&?LG: M?>(7%4LZ$=W&&%I\#^P"$*K-OAHQ195S:6M7C`+54,1HSI*10J&S7\\SMJ%0 MY\,'!8#NVPE`$\]).M6@0F0#N5"AX;;A!^1:,=.B/M'0X#K1`(AL$Q>`1C:' M@8NQUOBUC8$5&"X6^2-6H$-&5I#L#!?PAOO!B%.U9J_Q(NI4;`1/AXS@D=W@ M`M[9K?6CMWIF9(.AQ!@R[GMOQ,%O>+I6:>A]%YKW5'P6H2OUO)/T7O*NHGWE MC1AV"/?.[SYD#QVF^J\`R'=RZH.E9])M,'F)+7.Y[PHI!6)HYX MW@I@%^Y&N[/@@XHGXS&<$=6JTG$/SHYX/3+^P"((B$9^@<)#B#HQDIC8ZPZB M3O<3'`0/Z8[_F]:[O))6P;<`[DZPTK4^2NHOC3BHP]E:-'`$5!_W<.3G<&YQ M)R#>"M&T7[`\I_:?"*N?````__\#`%!+`P04``8`"````"$`JGF'TLX"``!' M"```&0```'AL+W=OO/YTWHOU9.N M&#,(&!J=X M8:7&<,BBX)3=2;H3K#&>1+&:&!B_KGBKCVR"CJ$31#WMVBLJ10L46UYS\^I( M,1)T]5`V4I%M#;Y?XBFA1V[7&-`+3I74LC`!T(5^H$//RW`9`M-FG7-P8&-' MBA49OHE7MW&,P\W:!?2'L[T^>T:ZDONOBN??><,@;9@G.P-;*9\L]"&WKZ!S M..A][V;@AT(Y*\BN-C_E_AOC965@NF?@R!I;Y:]W3%-(%&B"9&:9J*QA`'!% M@MNE`8F0%W??\]Q4&9[,@]DBFL0`1UNFS3VWE!C1G392_/4@YZ@C20XD<#^0 MQ/-@FLP6Z0B6T(_(&;PCAFS62NX1K!K0U"VQ:S!>`?/[CL"*Q=Y8<(9A5<-@ M-4S#\R:.DL4Z?(;LZ`%TZT%P/8$Z1`BJG33(C9>V8"MMP[5CN?4OSF62]V4F ME\A8,,S.^>"C).V(O;0'3=V2.3F\P_32 MA(4T/DT+[HLG\U-\WJ7'#%W.+Q&RX`_S]*"ATN(2)0ON6XJC2=1EY3UY4"_/ MV7_RM+5[],:PX+YX.GF[+SQFZ')YB9`%?YBG!PV58BA\XSTY=-_4.XD>4+U( MEZ<-TUNB4*(OT?>%Y'R'I.GDS80ZR@Q/73&:=1^]K*_GOMP)IDKVA=6U1E3N M;*V.H4_WMCM';A*WK;L/4,9;4K)'HDK>:%2S`KI&P0)VA_('@6\8V;IBNI4& M"KA[K.#`9E"JH@#`A93FV+!'3?<+L/D'``#__P,`4$L#!!0`!@`(````(0`5 MJ<'GJ@0``,46```9````>&PO=V]R:W-H965T:_Q#E_9`XYE(0<-1.U9DCS4BCT5R>0S`0-8E1'$K[[V?[0A+;"8EY MJ0I\V>[$2O/[^F6?>!RE92HN-CR:A[Y$BH?NT.&[\?_Y^^_;D>ZR*BWV< MT8)L_"_"_._;GW]:7VGYSDZ$5!Y4*-C&/U75>14$+#F1/&83>B8%?'*@91Y7 M\+(\!NQ9#':>'+"JMR3`UZ.*0)>:7))2=%)8N4)(LK6#\[ MI6=VJY8G8\KEUX&RP`J;=?[%';`V^Z5Y+#QG]'J91KYP78M&O1O M2JZL];_'3O3Z:YGN?T\+`MV&.?$)["A]Y^B//7\++@ZLJ]_$!/XLO3TYQ)>L M^HM>?R/I\53!N&>P([ZQU?[KE;`$.@IE)M&,5TIH!@N`OUZ>S18@1X-Z.L.HMY25]+[FPBN;_20B)1C!O MH-DYYNY!*RA\6Y.L4*^R;Y&P.E[DF5?9^&!4T&?0V8\M"M%\'7Q`.Q(%O4@( M_C90302PG'I-L([VFKK[)K>9%OM&6B;AGL(L-AT?IZ\3AJZDIE MR4Q%O]O[F;H(<1@FV^Y2B&;U#J22A&PE\$&[N&ASV-0VFRR9F=CQ%#W- MFG%K>^;QW/H&W=\SAPW=R-RS9.SA+EV$.#QH(PG92@@\T][3.!^)J_3-V492 MT*"3$$^+T6T5M"YM>TE!NIF:H6M#14X9)&A3OJDLO[,*&O03)",[[*,G8%L$C4W?H>K'DHG?HE+)T7U0AIZP2]&!8*NZ[D5-<"=J4;S8F9ZN@05M% M3G$E:$,:AX:M%-0Q::>XBD;%E:(ZQ!Z**_XH/AA7"AIA*R.NQMV(HS&QI:"V MO2"VFF^X%IN14VP)VABR%5L*&O:74VQ%';&%FPV^V(J<8DO0@[&E*-M? M_,&\?>\=-UMQE=Y;.[84-.PO[!1;@M:U[=A24-M7&/<\LF.GV!*T*6_&EH(& M;86=8DO0IK3YE*6@CDD[Q18>%5N*ZA![*+;PF-A2T`A;&;%U_S<1'A-7"FK; M"N*JYW:(G>)*T.9P+5_IOP;GT^:FI24E=HHK0>O2,]QDL(PK!76,VBFNL/RU M-_#TKBA;;/I07(FK]`W:<:6@85]-G>)*T+JV'5<*:OMJAGML!8>#6F+?M[6@ M37G35@JZQ95M*WF:*(_LR2\DRYB7T`L_*41P.%&_6Y]B/HM#S*#^``X1 MS_&1_!&7Q[1@7D8.<&DX6X+B8P*E:.`'X M0&EU>\$/.NL#Z.W_````__\#`%!+`P04``8`"````"$`"!$0*[L3``#79P`` M&0```'AL+W=OGXSN[[:OC[NOCZ]?O]X_:]_%K^MKZ_V MAX?7KP_/N]?MQ^N_M_OK?WSZS__X\&OW]OO^QW9[N"(-K_N/US\.AY^;V]O] MXX_MR\/^9O=S^TI7ONW>7AX.],^W[[?[GV_;AZ]]HY?GVV@V2VY?'IY>KZV& MS=LY.G;?OCT];K/=XQ\OV]>#5?*V?7XXT/CW/YY^[D7;R^,YZEX>WG[_X^=O MC[N7GZ3BR]/ST^'O7NGUUW=[>DZ=.'KT]T!\;L5V_;;Q^O/\\WW2JYOOWTH3?0OY^V MO_;>?U_M?^Q^E6]/7[NGURU9F_QD//!EM_O=B-9?#:+&M]"ZZ#WPWV]77[?? M'OYX/OS/[E>U??K^XT#N7M(=F1O;?/T[V^X?R:*DYB9:&DV/NV<:`/W_U1W?75U^V^T/Q9%1=7SW^L3_L7O[77IRS"MLXXL8+ M&K6]ODANEJO98DY]G:LD9B7T=T3)1._413]T^LL-YXN;.%JNUGWW$RT3;DE_ MN>7R9KUCOA;]S\?S-PSWQAU$M+6+T.0'XMQ"FZCY;-1\_&:+$]AO*?$_//3XB[Z M@#.G,F8J$M(DTR#7H-"@U*#2H-:@T:#5H/-`8"J:M@)3C<^9 M$D]&FD*2E$T$%`LM^GC[;:F"B:_&@U6S0=Y7NAB:!<.E"?*"X1KI?KCBCGLF M=T/O*9`,2`ZD`%("J8#40!H@+9#.)X$Q:)Z^P!A&.C2&)3%-Y)XWX\'P?:ZG M@Y#8,`.2`RF`E$`J(#60!D@+I/-)8!]:VBZPCY$.[O*491:"=+(IJ-O3C2>3\(#7$$)`=2 M`"F!5$!J(`V0%DCGD\!T9I_@+\;36DB0%TN(,D0YH@)1B:A"5"-J$+6(N@"%EC&E MG)]C)JRBY3NF)U/!J[!BI.)JI>+*20V!A2A'5"`J$56(:D0-HA91%Z#0CJ;. M\^UX(L)L64@%G=SSO2GNC/W\"`.4H52.J$!4(JH0U8@:1"VB+D"A94R9Z5OF M_1'&!:MO-(M4A*UUA`U28NUL#BA'5"`J$56(:D0-HA91%Z#0CJ8<]>UX(L*X M>O6-Y1>TMLB<`\H0Y8@*1"6B"E&-J$'4(NH"%%K&%**^9=Z_-)K3*SV)6:1" M[$Z'V"#E0@Q0SNI)ET@5B$I$%:(:48.H1=0%*#2D*6)]0YX(,:YY_1#SRV`. M,4#9'%".J$!4(JH0U8@:1"VB+D"A94R->H%E;$E+DZ+X^7X^5+FN6(]G,QU& M@Y0TS%Q#03FB`E&)J$)4(VH0M8BZ`(7&,C7L!<;BDMS M0JFU2Y!O0I9R*&.IA3MPS1$5J*M$5+F&YM`[FLV5=VHGX`SC#RDTS&55=815 M-2.S2_:"P1URVLE%I/R0P;BRVB.:=095T0KBBJ7N^E-8^C!HIB?Y@GM;4(8, MBG1OI1N2V*D2-#F`6J1X`.MYO%3U<'-B`*$+3*%\_I05V;K:G[(8+<@PP^W& M,Q47J33T':6-DHE0_YEF[[I?E9I/G&I M!+D>:]&UM)_KJ"6\DUI$,"DU,D7&)B8VX6H@L M4@&L=P#&`Z8A_1E,A0',0BZ<^>*XK1FE(MAMR#V9[%@IW(KHBSIV4)&CAM`LJ'3K>8>54.:%8ESFU MDQ+MC=,NJ$74,3(5SG#3\=PMA*$G3%5_?LJ:$D,%)B/RA`PJ%2F7Q1DC9615 M`.9.2G05J*M$5+F&_CVK@J1V4J*^05TMHHY1:-+(K?ZA2PC>I64TNWB>: M.D9;VJ+`TBSE6]HBVB?ZIE"E9L[JO=UD(3TZ726B"AO6B!ILV"+J&%$U2?X( M;:CW,VY%GEY3%KBS861*)9EIJ10M4P.J1,BKS47YO-_XT&>$X>%E(]?]SF&3U8IBMP_H!/DW'T>N MD`D=:&I_G03V$\L3#C0-U5QOD8F6P5QQ!',]-_3=K(V:+5C(J^P9T=WU7P!< M)RHR"A&@ID/W6G$IBJ=ZKT3(]5Z+O,#3N. MW(8^=!>-^WWN,@V5NRQ2^:;",#4[*6IHBLFC5LU$R(5W+L@F5S*;J4F^8($3 MR75&[Y5TY7JO1;E-KL5-XI;5/K4;$3B174/WSEV,PNQRTW;H+KV5.WMZQ$W= MPB*57>KP(&6IZ7VS"+GXSD6[S:[Y?!:I0"A$P@]P3"\>-QGI:+14V'TMRH^G M%]^]W_M(>@W=.W\QHC_#B*+5L=G0[`']V?#$'&C$55)9I))*Q7YJRJO32<5" M+JQS:6>3*II'L=)T8591[@5>.CNK3$/E+XO"K%JXBK&_K]04::;A5%AG(N1G%6NW6;6: MK]5B6'`;LP8,T8E)=4;O%?9>BW*;5-&-,R=[BT?G=S[BK:%WYRU&?DX=]Y;> M4I_M+=Q<+RP*LVNAEN)4I"BFCAHU$R$7WKD@K@=7:Y@";?=!>*.W>(Q3O5?2 ME>N]9D1;&%/?N`6%?372]8BOAKZ=KQB1RP9CQ(LC\U^L]_OG^JIO&&86(Y59 M*@%2:3B962+D999HE_5JY4T6O<4*D?"C&YPEFJ>ZKT3(=5^+3:8"&-]*'"VN_!XH-=EOJP8Q(G*@%2DIH([$R$7W+D@ MK@9C2"T6F$XMT3+5>R5"KO=:E,NZM5:K9B,"T]6@:/;V6H+"['+)&[K+[/C] MZN)L=_'I@7<`&_/I0;#76NAJD*6FURT14%JJP^UJZ/UH-BH#?^TAZ#=T/LZ'KS)\-73B$_GKOX4:,AQN,5'JI%3D5 MJ:D`ST3(!7@NB%>N>*44%RQP(KWLL">W>I5TY7JO1;ELMF!O+`(GTFOHWKF+ M49!>L:O.0G=1-+POO4Q#M7A9%"Y>^KY2<:"[EHSV-&O`>[F\'4:`5.Y-H9O5?2 ME>N]9B15(IP:RO43J3;T[E*-49AJQPH/LZE^UTIF&BIO6:12#0H/;DBC/)H1 M60:NG?N&F[5 MV2..7>Z&R44Q_CYWF8;*71:IY(+"@Z7HSX2[6,B%=VZ>XJ0.Z0/)?A.4K%36 M%BQP(KG.Z+V2KESOM2BW"UE\$R7^Q'CGK,LSH^TF&,N(\X;!..^SH_R MG-XK$7*]UXQXC:/]&?ANI/<1W_%]^:L:(\J_(;+CY;&2Q&R^_7ER^CPQMGMU M_^M^@ER4I@ZY$6C#92Q$VTF)NAQ1X52)5.G0<>V5$Y)V-:(&48NH"U`P;2W' M3B,N_H"VUQ)&/J-@#J/OEH8?P*4B1!KL+$(4%8,0?M(H4G9:FT?1>JW3 M@46"R43W5HJ>J2%5(N2E`Z(&42O(V]\*ZG6%SAD[>_"=\\_=3[+ZZ+>LR?#R MW:(EGD0(\D+>(6=E;9R,A6A++D&9(RJ<*I$J'3JNO7)"TJY&U"!J$74!"JUJ MMJSG3QA+WN%Z!P."G!521!FB'%&!J$14(:H1-8A:1%V`0LN8K:!OF7,/3Y9V M#^E/JH+\-*+W^.C\YX:^5+QTA\WA\,QF1P^/'RB?GO27IJ6:GQCY/2]6NL:2 MAKY4O'3S2C@^4][K\26+_J&($^.S&X/`?HS"GE6IEBY'I8[L*):FGO7'=V)0 M7/[Z@<_(?2TF[962:1W*$.6("D0EH@I1C:A!U"+J`A1ZCJP<6,8%_H6O45H: M32K2+`J_]+J$3!BD9.[+6)?W/=@<48&H1%0AJA$UB%I$78!".YK"[8((XSK/ MCS!&+IS2):`,48ZH0%0BJA#5B!I$+:(N0*%E+JM2EUBE,E)AI&KNU$FY,+*Z M@C`"5&##$E&%J$;4(&H1=0$*C)7HHG1ZHNK%PYP3Y(41H@Q1CJA`5"*J$-6( M&D0MHBY`H65T17C",ECY)19YWU`%D@')@10^"8=X67F58'G%*-@ZQ$N]-(L4 MS9O#K@#J51&B*600PJV#2/'68;9*O%,>^UD,BQS;.H06T&74"2=A\9181,<& MYHB&GDG4:5W5,1F/:H M54P/D<@REDL[Z]%%G*A:N&"!\QQJJBV_4#$%G[^S/NOYY<1H40N/1>&!GW9) M*@W)=V,NZ2,B$R'?V:R=TS=>)VIB*+C1L2\[AF;LVV\T_.N)V'"J>*@B`A MD:6'I6Q4T[<-$^][0[ST6)&SXGJE*R=MF/-.C'HU86`+\ESMD+M#;V*Q475;Q].)JY%P$>:5#*/PO$$_$)0Z*1=B7+NYR35'J0)1B:A" M5"-J$+6(S.\*F'NTYR#6D/9W`NSKU%^V;]^WZ?;Y>7_UN/O#_`8`'6%_^C!@ M^P,%]ZLE_4)!_UDE7$GDMPOTE>5Z8XZ&R$)PY8ZN]!&GKR2SC3D'&&FS,K^1 MT!M7MUDMZ,IBM$U,5_H]OVX3T:CI;0`C_40KNM)_3@5MZ'YL::ZO+".ZG[Y` MA"O4#QW`CO2SI'[H2''DRISNAUXO.':%[H=>KS=VA?Q#FZBQ*S0">E_:V!4: M`;T<;.P*W2F]'&OD"C49;4$-1N7)T:-^GI.?Z66G(SW,R<_T^LZQ*V1E.\$I M*],3J1OS""JVH>>E-^9)5+Q"CTUOS`.I>(5^C./S&+\W`QN1OZ=AC'--#+ZK:-#:OE4'NZ>;N1V\NI2OIZ)6,KIA'W'&\ M].0V71F[]8P,;YXCQC;T9/S&/$Z,5^@!^8UYJABOT%/QY,:Q$=##W71E;`3W M9(/[41ND="4=O4(O'MN8%V?A".C-8AOS_BR\0B\8VYC7:.$5>L_8QKQ%;.P* MC=JVN1T<1#^K\O/A^_:_'MZ^/[WNKYZWWVC*G?4?EKW9'V:Q_SCP9]Q?=@?Z M815:H.DG+N@'=+;TKJ.9>>GOM]WN(/^@KF^'G^3Y]'\"````__\#`%!+`P04 M``8`"````"$`-26/R8,%``!`%@``&0```'AL+W=OC4U/LM)&BJ)Y[U5U4NR3LRCXVO_.*__+YN>?5N^B?*E.G-<>>"BJM7^JZ\LR"*KTQ/.D M&H@++V#E(,H\J>&R/`;5I>3)OMF4GX-H.)P&>9(5OO2P+&_Q(0Z'+.6Q2%]S M7M3223Y#W!_A.$FU[^;"<9]G:2DJ<:@'X"Z01-V8%\$B`$^;U3Z#"%!VK^2'M?\8 M+EDT\8/-JA'H[XR_5];_7G42[[^4V?Y;5G!0&_*$&7@6X@5-O^X1@LV!L_NI MR<#OI;?GA^3U7/\AWG_EV?%40[HG$!$&MMQ_CWF5@J+@9B!II.(,!."OEV=8 M&J!(\M'\OF?[^K3V1]-!-)^$DRG8>\^\JI\R].E[Z6M5B_P?:14B*^,E4E[@ M5WF)!I/9&]9FQM>)QU(!1I!XZ1.-JM2O'M0 MI1!B=4FPYL,E.-9*2OI&VQ])"VJ@DT?TLO;A\0+1*JB'M\UX&JV"-\AAJFRV MKDU(+7;:`D5&MW$78!800``F"DC!_Q`%>L$H]/VW&FC#Z@2UTQ9Z2]P%F`40 MRI#]+N5H,H`4]!>Q5AJW0:[`ZQ6IE=&HR<3#M".S6AV;.&-C;SL=F6V$-U2A MS?LZ6S1NV&I]M@I9F)OO'"1V$&8CA`WH=3L;-*9L)#*>$37')O"F"G?&2`<1 M.PBS$4)P>@]!-*8$%6+)Y2"Q@S`;(6P@T-OE0F/*1B(1/(56\4TZ# M,!LA!'%"6^WH>G6A,26H$$LN!XD=A-D(8;.@;+`Y3D>#&23[.C'<1XDII)F) MLJH4`DH8+:/AG&H92Z/(/"Q,`F-@;':-I^T#3MB',%=O%[.QIJ0U9,GI0K$+ M,0)13MC!K02CI*,Y3NE/)`UEZX?&I\MJJR%+5`U=5U59M:Z80CJZSDPV:`S8 MTJT8KM<"MNI.,6C(UE59M5#L6C$"44[8PBU.-Y=JJ'I_*\960[:NRNH37:55 MZXHI5QU=VRJG,6"7MV+X1%IYH--TQX9BI,#Q:$#,0)1 M3MCD+4Y8DA-XBN]]M40WG;XD(3J'9L.NIL9*"QB'#L0(1/GC6+#X?U*.:HC8 MFMIS16GJ0''H0(Q`E!/V?XO3?]54#1^;K!HU9+;/G#=T8]5JZD`LM"'"/[IK M)#76-/4::OODSH5B%V($HIQZ1E(XA'Y\/>%8?9VZU)#5.#4$A6<&MCOFE56; M#J80VCAG[=<'C>"N@12Y`TE#MJKN0'*M&($HIYZ!-%_<,.@C=R!IR-;UIH&D M-MJZRGT=77_PJ1/=-9`:ZTZUN@-)6[52QR[$"$1UQ;'0Z0"S*7XWWME7\96K M6[\2PMHSQ3J>=3^'U$:P,CW`A?#X!]U+*QF!/,Z1IP\Y+X]\Q\_GRDO%*Q[5 M@.5F96!YCK0-%TOL)G"C[DHTA".FYI3(68E@I4FYLS*&E>:SUUF9Z`.K[DH( MWN0\=U;`&[PX]'`+P1O,ZKZ5*:Q,>U=FL-+,>N<^&PO=V]R:W-H965T9AY'S(PBR M01`-L.7VAW_\]?QT\>?V=?^X>_EX.1F-+R^V+_>[A\>7;Q\O__U[\MO-Y<7^ MT>]E^O/Q[N[_\QZ?__9\/OW:O?^R_;[>'"]+PLO]X^?UP^+&^NMK? M?]\^W^U'NQ_;%VKYNGM]OCO0/U^_7>U_O&[O'MI.ST]7T_%X>?5\]_AR:36L M7]^B8_?UZ^/]-MK=_WS>OARLDM?MT]V!YK___OACS]J>[]^B[OGN]8^?/WZ[ MWSW_(!5?'I\>#W^W2B\OGN_7^;>7W>O=ER>Z[K\F\[M[UMW^`]0_/]Z_[O:[ MKX<1J;NR$\5K7EVMKDC3IP\/CW0%QNP7K]NO'R\_3];-E#:Z#_/&Y_ M[;V?+_;?=[_2U\>'ZO%E2]:F=3(K\&6W^\.(Y@\&4>[ MGT^'?^U^9=O';]\/M-P+NB)S8>N'OZ/M_IXL2FI&TW8:][LGF@#]_^+YT;@& M6>3NK_;SU^/#X3O]-!\MKL>S"8E??-GN#\FC47EY3\6IV31,9&'SN^M%GS^`#'4EM>^GTR1VGH_ET M<7W37OM`SZ7K29^NYVITLUC,ESV)7='^UVB^X.=Y\^O.Y^75`,H\O;_[@S$7&R-DIXH]E!NZUW M;.?1;C%:/ALU'R]I'6E3[2E<_/EI?KWXNR+2=?HD_>5+KMNP71I.YTQ72/=3I<7[-:153?Z!D@$)`:2`$F! M9$!R(`60$D@%I`;2^"0P&$7QP&`F&$T7HRZXOSD<&46A+2V9TC;UG$$O=R?$ M2Q`!B8$D0%(@&9`<2`&D!%(!J8$T/@G,2_?UP+S#V\=(AS9TQ/-'(!&0&$@" M)`62`5\L=.J/-'(#&0!$@*)`.2 M`RF`E$`J(#60QB>!>4V9$-AWV"%;\="*C#R71!0ABA$EB%)$&:(<48&H1%0A MJA$U`0KM9Y)@?T,;_YS=F`K=U5IOOH%/;#Y-R1N[VJU#H8O>C)6+BA1WC!#% MB!)$*:(,48ZH0%0BJA#5B)H`A>8V:;)O[A/N:K/JP*0.^>X**#(9M(D6(A4C M2A"EB#)$.:("48FH0E0C:@(4VL_D\K[]WAU.3>&NXJE#RENAX+4=24J\%5`L MNE@J090BRA#EB`I$):(*48VH"5!H;9/U^]8^X:VN2/`#@%\WV`3)G%B$KADA MBA$EB%)$&:(<48&H1%0AJA$U`0KM9])ZWW[&6Q<4)L\]J;'E`6T+=J9;<[!* M5E2^JL\31(H[1HAB1`FB%%&&*$=4("H158AJ1$V`0EN;BL"W]0E?=06$;U*_ MIG"^"BB:`(H1)8A21!FB'%&!J$14(:H1-0$*[6=2?M]^[_556SH$OMI5$UXA M?S/364`G);X**)X`2A"EB#)$.:("48FH0E0C:@(4VMI4"[ZM3_BJ*RY\7_7K M#>>K@*()H!A1@BA%E"'*$16(2D05HAI1$Z#0?J8<.,-^MGH(7+(K*'R7G&N7 M[*3$)0'%E&2Y4,Q2":(4488H1U0@*A%5B&I$38`"DT[/JZ-:\;".8B0IYP91 MA"A&E"!*$66(U M4%L]8E5T>^F$YC?RD*"-L;%(=5M=M#-*!8DN/6`FJD1H?J-.$W.18NV%:&=4 M"A)=>L!*5(G0?*6JFUJD6'LCV@F%*ZBKL1-.CR77U"):01YNXQ"%*D812X6+ MHYX$Q"+%'1/4E2+*I*-GF1MUD):+%*LO4%>)J)*.GOJ52M5KD6+U3:`K-+PN MS$RR-EF,S#/_P_?'^S]N=P;T/@$VC\U:;_X\Q7K-H6`]L%YC*7FV&2-*6+TL M9(HHDXZ^==0142Y2;)T"=96(*NQ8(VJ"CJ&E=0EWPL6Q4C,G::92,TO3/6A? MZ>R7I7P7UULX8B'?[D[[JGT8NIB,Q\ITB>LTHQM\-[[6G++FH>$S%J*LLM,T MO581).?Q)NV,9K.1WDD%2PS-J.3!AF94L=#@C&H>C_9#-^_Y2MT!&I8Z,JO0 M*TP1Z-^ZWK?_7"GIW]$LFOOWJOD*[FBNH^]2>DFCJ1.2T!H[-//[S5?J)I>P M%.W[SERSN9I#RNI]77H.&0O)''+6OFC=@[X+=*W&+UC"'U]K+EGST/`5"Y$E MNBL!AZUY/%_5?*7N+@U+'9E5Z![DM(%[G`@:1EPETP[)3M],.R07H\T2.:%Y M^TT]E[/8?AY*1!5'TU30<>T9:L\1%:**M9>"CFNO4%6-J!%5I#VTNJEV_4UY MPNJN./9WGT4F$G3^,E^IG&PS=5)DUTX*%\()R0+&W,^&ZOFL)U3;3B="]1N& MSW@LDNWF")Z?.ZF9"]6+T51E)05+'`F*K8>5/-B002H6&IQ1S>.%H5JE8@U+ M'9E5Z!6F.O>]XGVAVM;X_A'"U*)3H=IU]%T*G<4)29B,G?8@5"_PWFX[SOR@ MU!.JWS"'S`U(!X2\:W.9@_ERX'0UFJM[9L$2_OCZZDK6/&2"BH5.A&IWO8&J MLAFI&LM,W@F3W:;-$3LB+RS&B1%3QLJ2"CFO/ M4%6.J!!5K+T4=%Q[A:IJ1(VHTJ&:(LY95C?BRNH6!:%Z,5;A:]..0[GW4&2* M6$@6,&;D0C5%:IU5.PESB5V`U4NJE2L@*EAB:4$K M%AH.U3Q>H&JLG+9AJ2.S"MWCO-.F&9XV,9*=OA%T?!]'3B@(U5:[AQ)1Q<$T M%71<>X;:`L_KGD[[L? MQ\XER1'X8-*$4NTM#LD2;UC*OT@=T2(G-)=OZ\2($E'%FRL5='QS9:@J1U2( M*M9>"CJNO4)5-:)&5,'6-2=`?NES(KHY)C;@RJ4/B?YL9H`A1C"A!E"+*$.6("D0E MH@I1C:@)4&@_4P"?L:5=Y>^=<2R**$,6($D0IH@Q1CJA`5"*J$-6(F@"% M]C.5^-M=DN[$>DL[Y'WS`4@$)`:2^"2$]X M%B:V+)AJ<"/U%I$+"0Y!GD)(Z50>'5GI=0SC&A=,B4_=X2 MZ&,[[DBF$2FX6J>=/CHA>,01\X#N8`2KKH0E:(T[/5X9$1K`9&J^`Y]8;IO8 M!9YJ4;# MV@HD`A(#28"D0#(@.9`"2`FD`E(#:7P2FNR\S'.!F29=.?+"9:S>W9:1 M;WLG)2AR4BI'5F?"L4B)I:TNZL@H1:D,48ZH0%0BJA#5B!J'^BQM,F_?TL,W M]85-U/V;ND.F8I#49**/][@CW=M%2F4YD1,R\5Z$)NI8)A8I-G+"2`ZX4T&> M+C5@QD+!@%.5&N8BQ0,6C&3`4M#Q`2L6&ARP%BD>L'&H;P7/JT<66(\X1"O( MPVU8RM\4MB.%'Y:*G92'$NR8(LJDHV>KJ2I"\X<4428=Q0SXVQ4BQ68H M4%>)J)*.HGXQ55NL%BE6WP2Z0BOKPNI$-,)R:F%18&4GY5O9HL#*@!*G*[`R MZ,J<%.GRS:"J^5RDV`P%JB\15=+15Z]R_EJD6'T3Z`JM;`JL,WS9U6/^;=2B MP,I.RK>R18&5`24+Z)@BRAQ25E9'!KE(L1D*U%4BJJ2C;V656]4BQ>J;0%=@ MY:4N]]Z5P[1:PBK0(=_X+.49WR$O%8D1)=@Q191AQQQ1@1U+1)5T]"VM]25LIJAX3,6DN%S5NZ^S2HO`0;JKLM'%2PX=P+.0=PK%V^Z[&:=_ZN_&#'%JM M0,J:A\X`,Q:2X7,>WIW^TIN`5=@L6&)H^)(U#PU?L9`,7[-R._QT1"^D]O]3 M-\J&Q8_,)?2'\VKQ)=;BC,1A-X*\`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`+<];F=3BHC=[60BU]LXYHUN9%(=@G(6WF?2'4 MNWQY?]Q=/V*]W(J8JF>_^K_>LR]A\']SL%7W8'^JLP ME%?37\2@OP*TI3]&,3;OH?^ZVQWX'V:`[N\*??JO`````/__`P!02P,$%``& M``@````A`&-)!98W'@``J*0``!D```!X;"]W;W)K&ULK)U=<]NXDH;OMVK_@\OW$XN2J`]7DE-C\9N4:FOK[.ZUQU$2U\16RO:< MF?GWVR"Z":!?"I)=!H-!L-H`&2XL=__/7TX^I?^Y?7Q\/SI^ODP^3Z M:O_\?_I^N_]Z_4_/O_G?WS\\_#R M^^OW_?[MBC0\OWZZ_O[V]O/VYN;UX?O^Z?[UP^'G_IE*OAY>GN[?Z)\OWVY> M?[[L[[_TE9Y^W$PGD\7-T_WC\[75?SR^_=TKO;YZ>KBMOST? M7NY_^T'7_5T#J;NQAN(UKV_6-Z3I\\+ M#^ER,DM(_.JW_>M;\6A47E\]_/'Z=GCZ/RN4L"JKA"1[)?27E23Q"@NN0'^Y MPOS#,IFL9TM2$6EHR?7H+]>;?EBEZ7RQ.E&1XKVWD/YR1?\R(RVNN2+]E18] M_T0J)M25?9/F?Z3-#]-5FJ0+X]I85>D4XT5I=7[>A293:9;^Y\)F9U*5_H>K MGNC'A,+&7J07/]&+O+'QUX=S=O]V__GCR^'/*YHDZ%)??]Z;*2>Y-6HED*V? MAM`^%MD4TD;+KT;-IVOJ9@K:5QJ/__JY0)@DE-B)AQHM1 MFVF0:U!H4&I0:5!KT&C0:M!IL-5@YX$;5^HB.C"-Q<(]V;*UUWQV0]M+X! MD@')@11`2B`5D!I(`Z0%T@'9`MGY)'`8=6G@,#,MI33&+IR6C)K0DY9,2947 M"GKH#$+2`1F0'$@!I`12`:F!-$!:(!V0+9"=3P+GTO(?.#<>C48Z]"$3+QJ! M9$!R(`60$D@%I`;2`&F!=$"V0'8^"1Q&>4_@L'=&HU$3>M(2%8TS-?4,0D,T M`LF!%$!*(!60&D@#I`72`=D"V?DD<*[9$_D92#P:C73H0R9>-`+)@.1`"B`E MD`I(#:0!T@+I@&R!['P2.(QRXL!A)AKM*GCA[&@4A;ZT1,7C7,7C(#3$(Y`< M2`&D!%(!J8$T0%H@'9`MD)U/`O>:C4/@WWA`]N*A%P5Y(8DH0Y0C*A"5B"I$ M-:(&48NH0[1%M`M0Z#^3"OL#VL3G;&7VP9,/,>7B"JL6*-4@U(MHBZH&#K+Y.(7.,NF[D%D610XBZ7<*I(E%BEGJ_RJL6*-4@U(MHBZH&#K+Y.&^LTPZDZ0?S,GWV_?'A]_O#@:, M'D&9LR0^'^5LW@\XBP(?^CD_!YQ%,_KCIL!$;1'S9)!R/@1=)4L%/H2*-4HU MJ+Y%U`450Q^:9-OWX8D;F0MO7IQ<.M#Z,9I5N>J]05;Z2BWYO03R*T&%:< M7+2GX_TDQ7[FD4(_B5Y[6\[<9J@$T;3M6:T\68M4S.I&A)S5+:/YM+=ZGBSF MZLY(QQ*SP/!C?:2W5_&Q9#9*)L_R)AY&9C\V7.ULJJ;EC4C%HC(3(1>5.2,9 M2^I2"RD.PA'[R%I-`UGFL\HUY5NM)L):I&)6-R+DK&X9S>WI_SQ9I ML5Y_'#'RUZ/9%-:CH:*GWD5[/T4T;")M!F0F;1G%QI'5?-YZ1$Z[I(^,N.HC MB\)QI)\>V)CBD[F="+F(S!G)>@3CR*H-PQ''T="X>+%R33GOSV9J)UB+5'P< ML79G=&>3W=&( MD(O(G)&L1]!'W#A%I5.+?30T[OJ($?T9*LYFD#,,%9V47D4;M+IE%!M'5O-Y MXXA"Y)(^,N)J'%E$RZ0X8&-V0F;0.)0ARA$5B$I$%:(:48.H1=0AVB+:!2B, M<;.3O2#&[<8WB'&+3*(W1$LZ5R-Z,QVDQ,L9HAQ1@:A$5"&J$36(6D0=HBVB M78!"EUZV;9_BMEV0.Q3:(,H0Y8@*1"6B"E&-J$'4(NH0;1'M`A3XSRPJ%X1D M+QX.:4;>`2Z0#$@.I`!2`JE\$EZ&WG&^ZP3,'%.H"8M12EG[,.#P3H%4C"XJ M+!0>DTU4QI0[*1F[A=,NJ$14,3*9D[/4NU,0^LOL0LZ?BCDLI#B^LQ"]W@Y=$$V0GCUNM0V= M9+8!%SC)[AK\Z7K&&PD_>M*YRC8V+&7N''A&:2>Q=B\E$>TVM5\JM844^P&! MJ;UK7(*K$N2G).G<93RADTP>?H&3C+B:0"Q*`SOG>H]J$A2JF,:=Q$*^DQ@M M^TA:NJOH,[U"U`8!`7F;2'G['T9F9?(ZS>U10R>1U9S+N>[FW$>&@X5 M-3MN6.K$4&'MOA=8^Y%=L#0>A"!&`>OUG30TY45!Z@ZK0B>93/<")]G$.)A/ M.%>FKG%!E^KTS]S,HO`Y,>FRD`N"G.OQI`NW&*3XQ*0[-"Y168D]P5#Q#B]# M)Y'4)4XRXFJH,+(OHIC#\XU9[0I?@P_P]Q8$/7I$&_T(DZX-&W&I-+TR*(ZUPFGL6])+\Z,WIVD]$)N M3_85PYX6%)KGYF![`CTF12\<1N&\^FDA.:%:*.Z^OIZSC;-*W;NZYA:T; MD4I3Y^+0.I-T^3.(<=YJW3^W=L(^4U/9Q\BW+TWUNDM'!WW%4,KY.+3OLHR) MCH[`*$;>;DRD',H0Y8@*1"6B"E&-J$'4(NH0;1'M`A3ZSR0KNG_?]UPBW;,' MWUH4'AZD;D7G@!RD9`+/6!=5%)0C*A"5B"I$-:(&48NH0[1%M`M0Z&Z3XOCN M/C&&;$;D+\AS1BXV-X@R1#FB`E&)J$)4(VH0M8@Z1%M$NP"%_C/9SP7^XV3) MR_KF%GE9+9`,2`ZD`%("J8#40!H@+9`.R!;(SB>ARV@>#5SVKH.*N=&B9G-& M+CG=B!3%Z+!Z>^M>/]PS%C()A1-*5=Z=.RF9`0I$):(*48VH0=0BZA!M$>T8 MT1:!3`U];[)`/US?YWO.)?TH9N3[?D">6UW.P;ZW0HL@HUZXW4,OE<\'*>?[ M0;N@DJ6B.Z/*J?*L6JC]0^VD1'OCM`MJ'?)TJ2OLG"I/:*%.B;9.2K3OG'9" M82_J!/?$I(U9[9R1WUT#\NQ4%Y-Q/;.=<4-EX?)<[BZKBJ3D8@I745")J$)4 M(VH0M8@Z1%M$.T8C0R7567KPWTX@UM,5R/+%3_ M;U@J.K-E(N2=^8AV^[S48KE0BUHA`I3PNN95ZZ4HCBVBE0BYUFM1;EM?+2=N M2]?/$XT(Q%IO17&L]4Z$7.M;4=K39`OKKYHF.YAVCW]$6 M!9/!2GEZ8^ZQ4%(3/[82(>_82A!']7JA@KI@@1,#_XS6*VG*M5X+LJW/)S,5 M9B)3[(V437^E;J<>N)?MQA=Z+UL)_U[OU=^5&*FWI&:IRK`;&1BK%8 MST3(Q7HNVOFYR*G.9PH1.!+K_7`L17&L]4J$7.NU*.=99J8/>!H1B+7>BN)8 MZYT(N=:WHIQ;G^CCFYT('&D]['\2NF2<&W&UZ#-R$;HQMW6,E+\RZ54W8R$Z MJ9,$*4=4.%4B53IT?`JO4%6-J'&J1'OKT''M':K:(MHY5:0]]#KU>>#U]XTZ MHT5UAD7!I)LN(`5CJ=C,DYF[;F9J]CMQ)`5C*3L9T<.`:H8O6,V)B?@,@ZJS M#*I%RAJ4K"?*H.8<@UK1$O-0)T)1#VU%RAHTG2[54K4[85`8./KT10?./P\_ M*2).G5RG>"HCR!_&+.5?'PYC/LWQS@E9%1V/RZ@J4'OIT/&!5J&J&E'C5$F# MK4/'M7>H:HMHYU3!,*;P@&$\7?1'\^>_@Y4:+6H86Z063W<`WR]?&ZE(@^=H M+IN)$'73(#0RC+E!NZ9,YU,5I`6K,7?`!S4Z%DII*V90)4)1@VIICPV:Z#N3 MC0C$#&JEK9A!G0A%#=I*>VS0;*%2F9T('#$H',8TI"!P_)?WSAS&1HV*'$;^ M,![0\:[+4BODC=D<4<&(%G89:*5#Q[57J*I&U#A5HKUUZ+CV#E5M$>V<*AC& MYO3&W^OH2?6L5RE3/D[RMT`6J=58#:T-5SRQ!^(3)O\@8V086RFCT8U2W`,/ MNL3/Y3DV5"P4+.5@0\U2<1L:ITML:!E%_=")$(7K<(5@PU:D[)I++^2H\]6= M:]ZI\::S8+":H]IH>)PW6'LUX6`5Y(;3QJ%1P_J)/V,A?[`B*IPJ<7'IT''M M%:JJ$35.E6AO'3JNO4-56T0[IXJTA[UQV0G4`D^@!+GT9(,H0Y0C*A"5B"I$ M-:(&48NH0[1%M`M0Z#]SH*`GN\6L?V\\?L:SL$<1_JU0090]#*,1GQ49DTJ\ M7]X([1L]D%BN3C\LLL!#"$&A?3J/&I.BW[P=?UAD8?:VVG_SR?H,^TQ--0$P M\NW#QT7Z)JFB+Y5ZA^&A_\Q62MM'9T1G/"^R,%65@8R"IO6!PT8J^E+)L<>0 M%V;#X!MX(NJ,N#**D7<#OE=*4@YEB')$!:(2486H1M0@:A%UB+:(=@$*.YB\ M?(G_C+CRGT7A,R%+=>MDLQBD9(+/$.6("D0EH@I1C:A!U"+J$&T1[0(4NM0D MOQ>$)"?47J:W8.3B;X,H0Y0C*A"5B"I$-:(&48NH0[1%M`M0Z#^34%[@/YM_ M!@N)1=XS(0M-,B`YD`)(":0"4@-I?!)6E3M?>M;?JM2A_<6+G^VM` M,7]9(9-@#BE+NM0W]+E!DG+^&K0+*L6LV/%"Y53Y#:I3R=I)B?;&:2<4!J'. MX>)+Z!(3-T&^]U@J=C$9USOQ.(23DHLI$)6(*D0UHH;16+3IY/&$8S!C7%H4 M;MGAZ6>1HB72!9'JTDR$HEO57*3L5G4QG7MO$O0CO&")8-NMIX%2U,0LJD0H M:E$M4GR"GJS3N7 M+1?M]KQO.5LH'Q0B0%83J;K^AD6.F12&,)D4A+#NJO/.X)9&CQ*O\,#E$A#3KM MI4/'M5>HJD;4.%40VM0[@;].+(1&7/G%HF!V39ET"?<"6>+8P.6. ML'9'3_,K:O%P'#!2XT`MQQNI&`N[ M3%2Y76[.R!S7NDZ"&S:NHB>ETLWR'!,J$?)2#5%NPWPZ7>N?C6U$XIPX7YE= MDI]KZ(GZK&ROUZ+ZP6Z_PJ!?N4/:/NHV7#$:=9D(N:C+!?%R-5OJWU M]*(F-N8J$7+-UX)L\]/)0F>;S8GFPZ"_;'NXPNVA(&?BQJ'C,9BQD)_O(2J< MJB'?<^BX]@I5U8@:ITHOBBN].WQ?;.*FL5>LGVE>J2>_-RP5WXF(4'1IRJ5! M.V87(_F>2!P9LW:.EL9BLU8E0E&+:FG/6I2,Y7LB#+V-5?KZ'J)`&G?;2H>/:*U15(VJ<*@AMZL*HO\Z;=HT6Y2Z+ MU+2KEN3-BJ5B\UXF0I0R#FL=IH$BQ>O_0C]#7[#`B8GX#(,J:2IJ4"U2UJ#9 M>@JO=)RP*`QL&D;1CCHSL(T:U5.,7.AM5@-R'H<4D(6"P+;U/%0X56[./D-[ MA=IK1$V@/?27V8OY^<2)!,Z(*[\P\F[WKP!EB')$!:(2486H1M0@:A%UB+:( M=@$*_6UWFWN%:,R'?#\,5[_6-2Z/(P^1MXO'6X098AR1`6B$E&%J$;4 M(&H1=8BVB'8!"OVG=P/QJ%O;'-^_,<@HO%>M?W5XXZ1D=LH0Y8@*1"6B"E&- MJ$'4(NH0;1'M`A2Z]++D?HW)O2#O7C6B#%&.J$!4(JH0U8@:1"VB#M$6T2Y` MH?_T)N!$2&*VO[;([>(W0#(@.9#")Z&).OD]82(FN6N+*&LS9VF4L:B'E3N MSITW:ZY#?X:%#*^=A=Q!2<[UZ&?3C&+XCG0AY>3[,;WA99K'>RD-^=K-AVY]S[K<-^=^H11!,CJL>CJ M;-J1NC\)!U!0.7*\9[FH7\GK:( M[RQ,Z7<"5`P5TOXY0Y?>Z;\HIJU\&-0#L$9N6(C( M64&>F!]^"^8L[9[SMNA6C_8/IV-!OP_,72:L1Z+-VY/39UEM38]1OP_:]!E1 M,KDL];'R^@(X'_*2QT'.,?J(+,B1N<#(7&#T'5E@]"%98/0E66#T*5E@]"U9 M8/0Q66#T-5E@]#E9GZEA9)*L\]?P9&*3,C]7$>;EDHC(F;:FDR)?:D2NU(@\ MJ1$Y4B/RHT;D1@^IJS:)T257S8F4E[HD$\O,C[0-`SM=Z01&Q,R7PIR8NNU% MSK'*PD?25FJ&)X<-8K)%)(^Q;2YPR64#.]XH>7'0YDFMU8D_>780DT;)M4,# M.$`ORPJ3"::%PLBWTB2M+"SGKI/<9IERF\HZR&V#F*@CMX$ZS_L!V_7L1Y/JX&:'K^\^]7^!Z^3R\[WIF M*NPA9Q6Q>-B+E!_VPFS8)_.5[E?ZO+O-UD^$O2B*F4`?@;>ZZ(<[9":BK\"S M?C_LT[7:8-&7X>-F*-__>[81_`GY("UB%NX'UY`@2-4@HE3$9HE(^:-!&K"W MJ]>3B9K/J4?L3N;8]I\G(M$=LX!ZQ.KR/G9&/<+Z@YIK-2BI1^)FJ!XQN?\E MHX'W"L%H\/,C;KL%2P,T5&GAVT27R6'CO>`OD1:I(?@9'3?*9< M9/)YWT7O2RCX._74D%S#7<*,?GU)V$98=*&B"+6;C!,_M3.(13:ZK.G4/,+M MG9A'6,J-&_(V,/*VSY2WS38BYNTSM]+R-?K`W7:+XOT6!;E[8,?#B-QMI;QM MH@)37)=<#(=3Y3KJ.)(7#=B83./%:D$SIAWJWO M!!DYA.LZ.7((,'((,'((,+I\8'3YP.CR@;4CK!MAVQ&V"YERI]ECZ$CD7UD_ MY5G>G@3!Q\P?07@S/)%OW?MBZ=IMLI2-)`8V)N;7W$Y9:"JJ9%Z^'.\W/8/G MMY,QL86W&BH+35K\3B_:C#J<,9GY-N+K[XGY'3ES>;[8PGL*1]EH\D=MX^DG M'A+^('EH(*>Q?LOXN82AJB^V\-[!#`WLOZJM#3SK%Q@2^8JW'XK"PL9AYS`N MYI(E9:-).WP;3T2@N3^O(U"8VTQO$F39",M'6#'"RA%6C;!ZA#4CK!UAW0C; MCK!=R)0[34+BN]-D'28F'_YX?3L\5?O';WT>F@R!E%CPB`8_-D>MM M4D1BLB:1ZX&1ZX&1ZX&1ZX&1ZX&1ZX&1ZX&1ZX&1ZX&1ZX&1ZWUF77_S^GV_ M?\ONW^X_?WS:OWS;;_8_?KQ>/1S^>";?TPO+'KYZV7_]='VW3F[-@Q?DGJ&" ME$RII!]TNH0.B&_[4^*16K0>41DMLJ`X]53;2SGI"ONC?B]9UIE2',MV1.E-J MQ^Y'H=LDC;2>F0T=[)NF[+6FH MI!TMZ:BD&RVYHY*[T9(-E6Q&2S(JR6G/B%>:T5*3CZXT66("=3Q.39B.1E5" M464MN!D<]_KYX\_[;_OM_'9VL5D]OE:E]4*XH*Q>VY[CVA:I4Y;1^KBV?WQ_ M>HAL2TA<9[AD-5G;;T38CYOW[U9GQI]%08BT@*$6:[N0LHD1$FE!*BP.M`A'RBBM.VTI.0K/K5175<+8O?L<"U8PD=;^YJBAMILRX-KEV:[SE1$,S# M:`&+W\B<=YEP[3)GH1,LW)FG5$\345NV=C'!$F]6G)TMF$RH2S18S;D7`UEO M7\M@#/V;GV"D(MDJEK4-KQ0X)6`&7C:A&Z[0"S0N[6)VTQAO'+'O(U27%&TR M`!#H-:+!YO\@6K$HT?URNQ[X4X5_H;"/Z%.2`3!2"!T=*KP^C;U[*AC\!ZX; M]G5!,^WNP_)"6/?OW!23F/@AZ<*DC=1"X^]7JX*UVMZ$78+["9(,D=': M,*[#M?4`^@O'3/'=,ZB(QKI:Q(;W+3[0F*_>=M.Z7]:^_+"^T>6Z/A'0.,-3MRCUVW7GA>6UQ)%7>CNB9 MU/"7/6VJO(.?S<%KSPW)=]RI.GFA[T^\*B]K5S`LFB$<=+\O"Y+0XJ4B=2=( M&G+*.XB_/9;G5K)5Q1"Z*F^>7\X/!:W.0/%4GLKNG9.Z3E4LOAYJVN1/)\C[ M+8CS0G+S'Q9]518-;>F^&P&=)P*U\0/^4Y-(J_W?:([W\UI2[;V5-H-J@$U/@B=)G9OIUQR!P]BSOC"OP9^/L MR#Y_.75_T5.1K/Q.)[,IL#R1-HN*QFEZQ0O;4>K?X51@%2")$02>"))-!F- MIWX4P#OO.4;H"$]T'`_RB]$/GN@73@Y>ME0R\.+`4H9'O.V<(*%L`EY1+%[07\2#\0CI$\,I:5"VL8I&FAZ5[7 MT6R\]%ZA40JTV=@V@6ZQE1:L*QAM8@*I"60*X$%&?5J@_/^0%F-A:U5TDGOID4+K3\\6F;,HY5EVB`R[U^^M9#$0E(+R51$BP]6F!H?:_1)-&*; MRB=[G1'IL0LDA%Y4:C_MR\1[>=L;R903"TDM)%,1+1U8JVHZ]YN#&>LA(Z*4 MVT(2"TDM)%,1+;ZI'A\K=S1C6_YGR\V(]-@%8I1[9I2[-^K+;2&IA60JHJ7# MCB?*-GF_W,Q8#QD1I=P6DEA(:B&9BFCQS3\3'S/6XQ/(=>5O32`Q@=0$,@70 M0@O@##&\=MQ:#PXAZ!TV6$(_,";+5AJ`>OT"'!N[6R*-H(2]43@U1E`JK>;\ M7?$\](UUG*%%!%GU/,K+]-39>!K<-H$89K"'RY[=(!2%,O7KYBMV%>D#Z^I6 M-#A&D7C2$Z>26(R">.*/C4IDT@(VU%O,>IYLA`W/4PP\+4\!724VJKYE@PUZ M-KPO,1I=!W8J_82>D1]%OKY19&@Q3$\V$(?GB>-3U5-`5SW-;2M`G_MZHI&J M)Q(+/@',P>ML*%.7;[3\T=-K0J-1PU5 M:(14H7OH7A6$42R^T=F'71I84(80/"RAV@''2K.(=IT04@Y?@46E-A0 M:D.9!FG]"+S"$#WE=>'Q)<9YWS`_DC;PYEW3HGLH>"^7RJ-.)"3/SH<"$^T0XNLOB: M/,+%)8$%XH]@]]E3VLD?\&JOOPI=_P<``/__`P!02P,$%``&``@````A`,%K M?8"O)```Z-\``!D```!X;"]W;W)K&ULK)U;D]NV MUJ;OIVK^@\OWVVY)+?6ADGP52Z3$DT[USO]S^__L_]X^O_^N5__H^?_G[X]N?C MQ_O[IU=JX>OCSZ\_/CW]=?OV[>/[C_=?[A[?//QU_U4EOS]\^W+WI/_]]L?; MQ[^^W=]].%7Z\OGM].)B\?;+W:>OK_L6;K^]I(V'WW__]/Y^]?#^GU_NOS[U MC7R[_WSWI/X_?OSTUZ-K[[;G__\ZQ_O'[[\I29^^_3YT]-_3HV^ M?O7E_6WUQ]>';W>_?=9]_WMR>??>M7WZ'S3_Y=/[;P^/#[\_O5%S;_N.\IYO MWMZ\54N__/3AD^[`#/NK;_>___SZU\GM<7(Y??WVEY].(_2_/]W__1C\^]7C MQX>_U]\^?6@_?;W7<$LH(\%O#P]_&M/J@T&J_!:URY,$^V^O/MS_?O?/ST_' MA[\W]Y_^^/@DO>>Z)7-GMQ_^L[I_?*\A53-OIG/3TON'S^J`_GSUY9/Q#0W) MW;]/?__]Z7$[G5]<3V;_Z[?[QJ?QDVGS]ZOT_'Y\>OOR?WFIB MV^I;F=I69NI^7SY;O)E?7[4C#&9RI. MY%2]QL:[K#QOKB87-[.K\SQ'F"^_I^!FXT>XD( M$^8?]BK7;V97L\G\^?\;.(< MQ_S#5CWGH&_[.#]-&ZN[I[M??OKV\/-2\]Z]?IC?3G][^2U/5>VOSCC:3V&+I+,R\9)I= MI:!(09F"=0HV*:A24*>@24&;@BX%VQ3L4K!/P2$%QP"\E3R#1HJ=_Q\:F6:, M1FYTWSD0B)8(XBQJN9L$1 MW376I^XZT=]9.![]29QDL';"K4`*D!)D#;(!J4!JD`:D M!>E`MB`[D#W(`>08DD@4/:='B&*L8U$L":(!9`52@)0@:Y`-2`52@S0@+4@' ML@79@>Q!#B#'D$0#KT7.B($WUO'`]V2F!6\PCUXF03`8#4$`4H"4(&N0#4@% M4H,T("U(![(%V8'L00X@QY!$6FBE-D(+8QUK84D0!"`KD`*D!%F#;$`JD!JD M`6E!.I`MR`YD#W(`.88D&GAY[XB!-];QP/=DJJ5B$`3S)`@&HR$(0`J0$F0- ML@&I0&J0!J0%Z4"V(#N0/<@!Y!B22`N3"8\0XV0>JV'1]+2CN@0C$6MA,L416O2)I6+0^?([LUFL47XF,_%6 MKN**J"`JB=9$&Z**J"9JB%JBCFA+M"/:$QV(CA&*Y3'YY`AY;/H9RA-FI#94 M@%9F_SX-%:"25FNB#5%%5!,U1"U11[0EVA'MB0Y$QPC%6IA\:D,%:&7>$Z6A`E32:DVT(:J(:J*&J"7JB+9$.Z(]T8'H M&*%8"Y-UAEJ<7JQ=:/'[S/*XSU:CF+'(KYZ6>J"?%%`$^&V`B^LXC%;6RNM; M9.O=^'K1+4S'I<JN"J"1:$VV(*J*:J"%JB3JB+=&.:$]T(#I&*-;"Y&/IY/0" M;^K3N,B;+`J]R:)GO*FW"KTI4V]V<3',:?$=F.5\>`?/Q(%=_?O+O9N&"4'_ MJ"-:$15$)=&::$-4$=5$#5%+U!%MB79$>Z(#T3%"L19I`F4>=2_P)B92YG"5 MF:Y";[+H&6_JK;R\A6LJK#>[\-L7\1V8A?X(;[)Y@;_G!I8.2,Y MV]#2--WL+IS5S>D\CIXF?G%R6D"4UL#\-3037"N^_71%?UZA&5?R%LVT!AZN M-DOG,EU#GIF5'<#/>IE[_.['(XF!XM,GT9[FYVX0_]G2HN M7<7SBMO60\5[-`OKS2Z@NK4*59]=>!UBV&6[9(\O&6+O%;+ MV8#\*`1^9S7NC2Y/GY8XH<+6"U#IF]*#/NZY1B'J^8]I:%I)YJP>17X\NTC< M;6E$4,5G_-@:/3-I6:O>M76R/$BI3@-3VHN]S+?3E7(Z+O_]\-?W?#M4FBOH MF46AT@,ZIW1O=.D7:X5M*D!EU'JLM%D2CO#1?@49YL"S'BG==LO%)=&*J"`J MB=9$&Z**J"9JB%JBCFA+M"/:$QV(CA&*M3"+O5"+'U[[S^RRT6ORSJ)D[9^^ M>O!63LP544%4$JV)-D0544W4$+5$'=&6:$>T)SH0'2,4*S=NO6E>E:83HT4^ MCI?.RJ,544%4$JV)-D0544W4$+5$'=&6:$>T)SH0'2,4::$G7!Q%YY^Z)_/X M(651L/8'68$4("7(&F0#4H'4(`U("]*!;$,2#]FXQ;B>+*G[6G2I=4>P-O-O M5OJUF:LH7Q^LL':Q1F::'(QF%WY;O5_.>"LW496^=8?61!M?,6A^DJSS*F_E MVJK95N.1;RN]G]8WY8UF$[]D/-U/YZW^=:%8+[.$#Q\4S[AXO^(/']KZ M$*Z14'JYRRTM"@[+K"R*I4C3OL);N;9*MK4FVK!B152S8D/4LF)'M(TJQD-J M%O8CAM0F$,$#]K)'T9!:*_\R9F6MDB'U&[/6N_N*LO)#BK;6MJU`L8UOWE6L MB&I6;(A:5NR(ME'%>$A-$C)B2&UB$PZI36-"+[56X9#V*!G29">@,%.3/#X: M4K2UME;1D*)BQ;9J5FR(6E;LB+91Q7A(3383#FF:?[PHM]9!1,S?/=*5G=\L MG54XTKV560?YJ7F29."%K2@KUU;)MM9$&U:LB&I6;(A:5NR(ME'%>*1-7A6. M]#-3K,W50N?M49SJ3M)4]]):A4^[]!&R397CNK\(KIC32N]7-WVSHCWX7.-1YW(5D3 M;)W5=[H0ZVNRUA'Z&O-DE=BC>#MJFNR)+B]M147.,'CIL*R<4;`=99$V)_+Z MVHMK;AJ:S>@[7-Q%XH:7JORE@K:FR2.I=E9^AFA<6^?NK75&_MXZB_0P-O=V M.5E<)J.V]1?S70I&+58RS9J?B52FQI<]BB-UFCQ`ELY*8SH,>="GTX-[Y8R\ M[Q86N4A-;K5TQ:'39I2T70PCU2)_JUP0=]4:M2R"YU%0]QF MM,W<<-!RI.U<_C=B!CZ9QS.P14G,5@<$\34.-:/W>WK3/R7>@L.A.WSUP^UE9W M,D9;8YYHVZ,D;I-%Q](4\N+'+/6\1MWY_H=4]&V]Y*CS^OK47^4I6_E!=D-DM73L[J?-P.%_1- MI0[0\FX[B\[%;>:&@Y9C;PN'D911EO;Z^!YRTM5KJVPB_KRD>$\YJF/M;,*KYC>2.-:#YM* MC5IGY.^VL^AK6A5 M$)5$:Z(-4454$S5$+5%'M"7:$>V)#D3'",5::&&`&)I=FR_V'!U&IJDDC'J4 MA%&RF%C.!RNW3%@1%40ET9IH0U01U40-44O4$6V)=D1[H@/1,4*Q=&;K8L0R MH]_I"-]?S2WR,;,D6A$51"71FFA#5!'51`U12]01;8EV1'NB`]$Q0K$6)F4? MH87=.PB7?#;IUU]^EV.&-'RP\J$"5,R!2J(UT8:H(JJ)&J*6J"/:$NV(]D0' MHF.$(GD6XW9)3N;Q3.90$"I$*Z*"J"1:$VV(*J*:J"%JB3JB+=&.:$]T(#I& M*-;"Y-]AJ)A5VX\]<18VE0_"R*+DB9-L`BV]U1!&1`512;0FVA!51#510]02 M=41;HAW1GNA`=(Q0+)U)@D/ISK\D6/0Y<_C$L2@\YDBT(BJ(2J(UT8:H(JJ) M&J*6J"/:$NV(]D0'HF.$8BU,TCI""YNNAZ'2([V]-2\9],V@UU?IRFPQF/@X M`2IH51*MB39$%5%-U!"U1!W1EFA'M"T)=H1[8D.1,<(Q5JDFP3/S%G<"UCTR)R5#%9FZ2:Z MM_*A,E1TJ*!52;0FVA!51#510]02=41;HAW1GNA`=(Q0+,^XO8`%]P(<"D.% M>P&T*HA*HC71AJ@BJHD:HI:H(]H2[8CV1`>B8X1B+=*]@&="A?G^8LCDPU!) M3I@LO96+BQ510502K8DV1!513=00M40=T99H1[0G.A`=(Q3+,R[?7S#?=R@, M%6P!K&A5$)5$:Z(-4454$S5$+5%'M"7:$>V)#D3'",5:F`Q[Q.JK3\BCE7"/ MXD0E/<*S7`Q6/E2`"EJ51&NB#5%%5!,U1"U11[0EVA'MB0Y$QPA%\ER-R_=/ MYG&^[U`0*D0KHH*H)%H3;8@JHIJH(6J).J(MT8YH3W0@.D8HUB*7[__0=S%< M,=VW*(FBY-WQTEL-4414$)5$:Z(-4454$S5$+5%'M"7:$>V)#D3'",7*C4OW MKYCN.Q1&D;7R:$6K@J@D6A-MB"JBFJ@A:HDZHBW1CFA/="`Z1BC6PJ3=+W_@ M7/59>OC`L#$;^+P5K90RZS]%AYZ:;Y''_RLLRB^-!'JI^G!C MO'O;N#\%4;C&^Q.ELZO+9%%>.@.IDFLXOM=Q2=L5DS:+(J7Y30S.ZKS4?>OZ M&A,WN1>VGM5UD7[6JG3E+]+5I#0C`J_/@*+`ZU&LZR6$M17/"VN-0F%MZ_TN M7GK@O+RRQ2^2-4TP?NAS,5?,.RR*U)Y=)J>`ELY*/@6^7XNKP;D^\G0[8WT(5/OS4"E M;TI64<^OTY7O#VEX:B5>$%L4>S&^<\)5/.O%SDB!.PC-R=E=T)Z!7^#LL#-X MB6M?YQ:AD[G_.I67?>7$J9ED7.RB-!#:684/'PAMC?3QU$%HHM(W!:''+B8X1B M+T)SH0'2,4RS-NT7_-1;]#/@B61"NB@J@D6A-MB"JBFJ@A:HDZHBW1CFA/ M="`Z1BC6PJSJ1X1*GP2$Z]/K'B5/E?2EIK=R<;$B*HA*HC71AJ@BJHD:HI:H M(]H2[8CV1`>B8X1B>=)$ZOR+M&MF3`Z%H6*M/%K1JB`JB=9$&Z**J"9JB%JB MCFA+M"/:$QV(CA&*M3#9TXA0L4E:^%3I4?Q4P`'FD(^+)=&*J"`JB=9$&Z** MJ"9JB%JBCFA+M"/:$QV(CA&*M4B3Y&>TL)EO$"HW/4J>*LE6X]);#:%"5!"5 M1&NB#5%%5!,U1"U11[0EVA'MB0Y$QPC%\HS+^&^8\3L4AHJU\FA%JX*H)%H3 M;8@JHIJH(6J).J(MT8YH3W0@.D8HUB+-^)\)%:;U-ST*3E\./\JN?Z0?;5YZ MV)#D3'",5:C,OO;YC?6Q2OQ.;I1]Z] ME8N+%5%!5!*MB39$%5%-U!"U1!W1EFA'M"J(MD0[HCW1@>@8H5B+V)#D3'",5:F"0[S._-NY?KF],'F)]9 ME/7I>;@K=F.1_U*+I4,*"_^R$K^2:*U\*E3DZLV"K_&*;F)R,2X-[NWC/-BQ M\+-5&;;*L"+#R@Q;9]@FPZH,JS.LR;`VP[H,VV;8+L/V&7;(L&/,$GG2S/C% M3C:Y8)8\L,#-!G;>SYQ9X&@.F9]T'3QT-O>G*Y);&9=%3LROC2:OO`86S%X9 M)D]#!R=/`Y&E@\C0P>5K( M$GG2Q/*'7R5/+IAT.I8L"Y*S,LO`S"T")&;?G*HZ)C'!)":8Q`23F&`2$TQB M@DE,,(D))C'!)":8Q`23F&`2$TQBABP12!TSR@$D> M,,D#)GG`)`^8Y`&3/&"2!TSR@$D>,,D#)GG`)`^8Y`E9(L^XA'1RP8S4L>!4 M+9'$Z6MZ*VF3(DD3H*2GXW(S_=)69M+N67P(SY]_.QVO4^1;J_!A@K-+@Y46 MML,CAR>X!C/[LT$W^-4@9Q&=R@LNEXR".A4M]KX#2F8_K]+/.AZMGTXB;9GI#,M@MRS%SCR3V/2S4F%\PU M'(N4YV';P4S=R_7+W71_@?"X[5"SUWEQD7Y_L^ZYK_5"G=,E_7,ZA9 MK#,.W3JS\U]].5A%0ML+].=NKX)?K#X-E&[9&KQ(YLG(]?_)/G%MRR*9>7JZPU4]^_74J\$JN9L!T3^$5XLEZ8M8:X0V8Q7MXROA%/RPQ M.363NKAI6M^3HP'U'HCCUT/5T%$SM]HW-M&S?F@L\_BV_;#/LLGB^B;9/]1@ MV&[IKZ&EX'K)\*A79X?G98>P)R:`T^>Z8Y'NUD[/GESG[`/-U@P/8KLK!$RW M.K2F_">Y,;-H"G5_SG'[15;LN);Y-;T<%TS1"*:)&4S=!5MGV";#J@RK,ZS) ML#;#N@S;9M@NP_89=LBP8\P2>,,D#)GG`)`^8Y`&3 M/&"2!TSRA"R1QZQZQ\C3KY)C>7J6!%3R[%%`#69!0(%),3`I!B;%P*08F!0# MDV)@4@Q,BH%),3`I!B;%P*08F!0#DV(ABQ6;CDP]3O;)ZL2Q,*#(5A.R(L/* M#%MGV";#J@RK,ZS)L#;#N@S;9M@NP_89=LBP8\P2>4;F1R9JTB>497[[:3D! MDCA]36\E;5(D:5(D95(D85(D75(D65(D55(D45(D35(D25(D15(D05(D/5(D M.0*4J&$2FA'3FU[&40V;%&F!-BQ+9POL0;FJBMS!+%A:V]6KM8I_MF_A7_Z< MS"2DO:;_)08I:?OF@U92#NS[%Y6Z0VO>:K9(-@*D^&#F)FA)/ES`,6D^,-]< M>J=R@Z$U;S5;)$F^7&,P0;PP7<$S.,3#?7'I1^:+9+$7SXTF+D+ MR(F&"X@E7I0FNC^6)TXS^:]E^JERUQ/%NK7S0BO8>Q;_".$B>1$DOQG,7'/R M&S0GOP&3EZ"N7`),+H&Z<@DP.0#J2FTPJ8VZ4AM,VJ*NA`23D&'=1$B3_HZ9 M#FSB[5_?OIM,>Q;OU2RP5^/,M#(^-QW8QK1`&ZPRF;UKK-^PG5U<7IC_XE_E MD-!]8]_;M#U-+9+>7O)<(\D9;/N:;8?.SA;))I+\XP7=D,>\H!OR M(71#/I3KQE4R&G*K%W1#CO:";LCUT`VYWM`-\^;@ZDTRGJKG$FNFO0;-TVM3LTEM%2XD4R;]2)&?JD=EK^6[SG2V>3F)M?)SJ)RD9_$.\%62D\A)K)FD^F[_Y20OZ(:G9<,NS*RYGK-FY:4*.8ZV> MF[^L63]_W2SRTU=O]-ST]8)^R>.&?@73EVW_N>GK!=V09[Z@&_),=$.>F>O& M5;("E&>^H!ORS!=T0YZ);L@SAV[TGIDLS#1]93IPQC/-#M`8SS3V:5;:,^^L MFKZL6>BLF>FKMXJFKQ1I^DJ1IJ\7-"]G2BMJ^DJ1IJ\4R4E>T+R[)2:S9,]/7"[HA)T$WY"1#-XR3W&2FKTP'SCB)V8<:XR1VW\I[A*8O MR_RQ)GD)F&8F,*V.P>058'(+,#D!F+P`3&X`)C\`D^I@FAK`)#&8HAY,\H%) M/C"%=@*TRK,BP,L/6&;;)L"K#Z@QK,JS-L"[#MAFVR[!]AATR[!BS1!Z3YX^1 MQ^X+A).0>:TK>)WD]%)L,`L""DR*@4DQ,"D&)L7`I!B8%`.38F!2#$R*@4DQ,"D&)L7` MI!B8%`M9HIA).LIL6*614\H,`44F.0!DSQ@D@=,\H!)'C#)`R9YP"0/ MF.0!DSQ@D@=,\H!)'C#)$[)$'I-YA?+X==C(7TJ=:%\9:99E\D0Z$\_P^Q9C.K:-G1LR36L-EF7NOTZ\D@UL`D)IC$ M!).88!(33&*"24PPB0DF,<$D)IC$!).88!(33&*"2QSL99)6\T2 M!)D7F&(-3/*`21XPR0,F><`D#YCD`9,\8)('3/*`21XPR0,F><`D#YCD"5DL MCX[EQK'VC#PG^R1CMRP)J&3W=#GQ9CZ@R(J,79EAZPS;9%B5876&-1G69EB7 M8=L,VV78/L,.&7:,6:*8V7((9\?G%+-;%.$4J$.Y""BRU81,\J"NY`&3/&"2 M!TSR@$D>,,D#)GG`)`^8Y`&3/&"2!TSR@$F>D"7RF)QYC#Q]CAVM+2Z'O#O8 MRKA.=IH54(-9$%!@4@Q,BH%),3`I!B;%P*08F!0#DV)@4@Q,BH%),3`I!B;% MP*18R'K%WCY^O+]_6MT]W?WRTY?[;W_<+^\_?WY\]?[AGU^U@62.Y0?\U;?[ MWW]^_4Z!>7N*3HWX4&?*9F;,M(N:+3-CICVH;-G,E,VR91>FGCX?GJMW8>KIX\;9,J.#/NN:*YN8 ML=;G`;)E9JQUW#I;9NY=9WTS93>ZG+[I*59,K42?T;2NY M$G5!W_V1*='7-9@[SJIVK5KZ1M!,K6NY@;Z,,E-RH^;TU8BY$LFL;^7+E4@L M?4=KD0CJA]BRY1<:43ULV"Y$HVH?G8J5Z+1T8\@ M94H6JJ-?ILZ5J(Y^)SE7HA'5K_3F2C2B^LW87(E&5#]7FBO1B.K',S,E<]69 M9^O,56>>KZ.QGF?'>JZQGF?'>JZQUH_<9WJPT%CK)]J+K?&?NT77R,X^9K/-S]51^H$.7N3M5 M#W1Z*EN(]_1>:1WNJ/ M7)E>/4]O]4>N3*^@I[=ZYYPKT_B?1,B5_3JY_37K!4;03-_?&;?)\%]GM[]^ M9]4C,7-:;B\GMUM]H2?'YYWIK_[(]5>OK*>W^B-7IF,'T]O3Z6VVJ;*9*^R)4N5++,E*Y44V97RZE)B M9=?)JTM)=9D;G=7EI4IRWK2ZG*ODY$UOAXGF\9>?_KK[X[Z[^_;'IZ^/KS[? M_Z[E_L7IN,*W3W^8O<;^?YX>_E(:\/K5;P]/3P]?3O_\>'_WX?Z;,=";@M\? M'I[<_\BUWO[]\.W/4TKQR_\5````__\#`%!+`P04``8`"````"$`R,S$T](- M``"K3P``&0```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`0$D%B2`)) M(1DDAQ20$E)UQ>I4&7:K4]7T-[E65PSM_/ON&5"U9'=X(Q/YZ.QDS,3)B4.0 M'B!`?$D!"2`2)(0DDA620'%)`2DC5%:M393JU.E4E]H6DXHE9K9JQ M>[L1)ZLOG*P^!!VR&N)#`D@(B2`Q)(&DD`R20PI(":FZ8@V`6M%9(W`\K>MP MNZOR-4] M'3?U&W)2_\I-_4.4'CJO;4LJ:O))`2DD1:28E)!24D;*206I)%46V8.BUD_= M07DC]=OE5C?U&^I>I(]`'LDG!:20%)%B4D)*21DI)Q6DDE199/>R6B&=T,O- M@DI.)9V2=^H^HF2\D][7;GH?HG1%SU34Y),"4DB*2#$I(:6DC)23"E))JBRR M.UZMHD[H^&;1975\2]V9'>2I^ZOV_.^3`E)(BD@Q*2&EI(R4DPI22:HLLGM9 MK9-.Z.5F667U6(0FB@]<46F=4VQH9]O,#%-F:#QI7.$J8G2K6>F=4VY(=.6>X2%:H>H+F]73_C"4V4WF+$MF)28BIVFW=6[*F)TLUG;"LG%:9BMWGG6K$T4;KY MRFK+&IZQNW16%[>CB_JNW/YQO?QVMU'0^RA"/5-HGK75K=@KZI:ZHZ:CS$>2 MIZ/,0R*?48&)ZAZW<]\Z-%'ZN".V%9,25DQ)&2OFI,)4[.ZJ<[U3FBB]JY75 MECU$[KK[^*6NNM1RUA@MJ4<(G3G0G4YU5'>F=&<(3P?)K&J:NG*G4QUUK*E` M!]E-N=.ICKJI'V!=3*\OSL^=S45MS$1R^;!3[I['NJ%C^Y3H()./J6Y5+NYN>WQE3@\[FTZ[9R#+ M(V130Q/YT^D0YU-IKBMV<\X=$T\'69_S5\[Q^3KJ6%.!#K*;0C:U^]X\#IV< M3R29D$UMC"P&#\?G[GFL-W=LGQ(=9#ZYTI8FW7H]V?2.7YY=CWDGI"5[EKIR/MWF.NK8.>3I('MJ M05ZU-U6.-17T-X6\:IMJ9BFY1KONR:LFYHU9ZAW[E)A]TA\?:4N3-V:I=^Q" MKEL_UBV%#NK.4FWC/YNE>K;]\[Q2=V+>?]4X;F[<=*\:-9G;8W.21_))`2DD M1:28E)!24D;*206I)%46V6>O3!U6+ZN+OW>=O:JB<[W74C=KQE?.A<]2M=EK9^*?CWNCS*EN[YRT9>W<&SNE MPIV=:LE<#L_'((_DDP)22(I(,2DAI:2,E),*4DFJ++)[6:W>W13XM;=AQJHI M9P0:4M=/AT_Z\;5S:3=O*TJ4GFT]DD\*2"$I(L6DA)22,E).*D@EJ;+('I33 MEO1C+NDU=5.?2WI&^:2`%)(B4DQ*2"DI(^6D@E22*HNL7E;7"7]3ZM=-V:G? MDI/Z9LU0K^OG)NJ0^B2?%)!"4D2*20DI)66DG%202E)ED3TH:G'=G8^.S_KJ M]E=]ZC,_[7KG0G7 M1"TYJ>\LB^UVNN=0Y1)?9!OVM)1`2DD1:28E)!24D;*206I)%46V8-RVBI7 MGK[AXQ9+VKF.,F>#1_))`2DD1:28E)!24D;*206I)%46V;WKW# M1>ZD=Y'KWE8U43JG/9)/"D@A*2+%I(24DC)23BI():FRR!Z3TQ:Y:F)Q+S2Q MHIWKJ&[F(\IG5$`*21$I)B6DE)21/>DS11A]0G^:2`%)(B4DQ*2"DI(^6D@E22*HOL03EMD3OE(E>3R?,YR2/Y MI(`4DB)23$I(*2DCY:2"5)(JB^Q>_ML6N5,NR2?%)!"4D2* M20DI)66DG%202E)ED=WQIRUDIUS(:NJF-Q>RC/))`2DD1:28E)!24D;*206I M)%46V;VL5HS=.V6_?@]'?JW&O:ILR4E]\Y"RG=FQ:O5,17TV^*2`%)(B4DQ* M2"DI(^6D@E22U*_[M*M\.<9F4)I?ZVE^8.1YM?VZFJ^>GG:#Y>:[^B6>BTMY MI>K`S<\$W4VG\CM!]2O=*+F0DOJG>U!RJ7];R"V97,_4,D-V""4W4E*?26[) M]%Q:JW]L""7J-XSJ)Y$H&4M)_0XU2B92,NG=`ZDCMWS[]DWJR&W*OA+I';E7 MUESPCZ5'Y/E-?'3E2 M^0Y.7XGTJ'Q)I*]$>E2^V-!3(E5Z:TB%WGCIS-Z^E*[L[4GIR-Y^'$D_RI=' MN4?RZOE,O2K+$GG??*;>)N\KN9&2ONW(&[8S]?XLZ\A+Z#+&?27RPU^?>[-< M#6-/2WSSS+%<--W:L;H<7GS?Z9>0F8-^0+`3+V+S!)YZW^FWNGO M*[F1DKY.D5>89^J=9=:1KP+,U*O+++F3DKO>DKF4S'M+Y-L4,_7.-EN3;U#, MU*O;+)&O39P,_K-]6WS8^M-?^SW[S*;0#YP;3-7GXDK?[GH_PHWDI^O4E^D&HX>-AL M]OI_U`8./[/WZ?\```#__P,`4$L#!!0`!@`(````(0`_6ME0)00``.L-```8 M````>&PO=V]R:W-H965T&ULE%?;CJ,X$'T?:?\!\=X!DY!T M4))1<]L=:5<:C?;R3,!)4`-&V.ET__V4[1BPZ&.EJ39VFCFVA9N MZ0EC9@%#0[?VB;$VNY?#L3+Q348'OG57@0W:NV`]R^0.7QQ.#E[)@IZT]7\[\E3M'`+?VF+*TY)2VE9\I(_5_ M$B04]23>E02>GY#<<)Q?'>%Y=41HMO#\U;/8_H;GXNH)S\>V!%5",#P?W')Y M]83G75LZ,M6BEE0?5/6 M'/KY\TY4*KB3KL);ZR&&$C(6X>F(2"%Z$^C_H01'DBN8X@KR,2H^SQ MF`3-T=+(:/(IB0%*-9+U8C5LHB4##N`X&;>KS<%PPXR#1\^ZPE!B%N*NXAT9 MF8;8-"2F(1T9M&"A1/<'R\%&N9"1I%!B%J)<3P@-#2.KI995D\7*P(_KDS^D M5,`3M:K@J3)P^-`IFB2X0.Z7Q,&&)&_@%4&$$B,E/2_TXD1J4448*X,>H92C MUA0X508=K,E9/2*'@TTYQH$))>9:H;FQ&JE5%6*L#)\72*TJ>*H,-Q3Q26MT MV]\^(!QL*C)NNU!B^BO"+&`DUX<#%(\=X#I`!F%B.J2:PZ^/_OH191P,%[T< M'/BY#B>6:&*))Y9D8DG'%JV7^"TY3CW_T"[@2#WZH>4T1E%F9&I*-9,NDG^.1_W%12XAXD=%RJ^Z%KYKWG90/5%$#866QATQ MH`:1O:,R)5,4GY.O]("2(N7<*Z>G&G=''.&JHE9.SGRF7<*]VUOEO!WR>9M_ M.TR[%\"8,+7'7@"CP-3^L@Z@L:9V*#1L(&9R'=?G"2"NFH#UA,&2+?T_PHPK#.7%G`#X0PM0+!.7T/]-V M/P$``/__`P!02P,$%``&``@````A`%.B^+ON"0``Z2\``!@```!X;"]W;W)K M'Z9__Y;/E='*^;([/FWU[;!ZFOYKS]+?'?_[C_J,] M?3N_- M.Z?#?AXL%LG\L-D=IRK"^C0F1OORLMLV1;O]?FB.%Q7DU.PW%QC_^6WW?C;1 M#MLQX0Z;T[?O[[-M>WB'$$^[_>[RJPLZG1RVZ_KUV)XV3WO(^R>+-EL3N_N# MA#_LMJ?VW+Y<[B#<7`V4YKR:K^80Z?'^>0<9R+)/3LW+P_1WMJ[#U73^>-\5 MZ*]=\W%V_C\YO[4?U6GW_,?NV$"U89[D##RU[3=)K9\E!,YSXLV[&?CW:?+< MO&R^[R__:3]$LWM]N\!TQY"13&S]_*MHSENH*(2Y"V(9:=ON80#P[^2PDZT! M%=G\[*X?N^?+V\,T3.[B=!$RH$^>FO.%[V3(Z63[_7QI#_]3)*9#J2"!#@)7 M'60UVC?4OG#5OBRZ8]$BN>'^D8X!5QTC2$$,0F+)`P@XG]CGY$"?Q.07EQ(A2#E!2/PH?H*Q\2D4I+$!A MQ!!GZ<>I*2?N*7,HNZT]M/+MM9=.N/:1/X1,<9;=.B`G+,=`@8$2`QP#%08$ M!FH'\/*$YDN2'*81R^@9-5:8XJ>J\Y7(5X<;R"'@6"]<:L#!.<$.Y MA"A*PU4_@=T#P!4AL@6N7`^V7"X3YD^)<`E+-%^U:YQ%:1"$"^ON51(6T?&5 ME&1422=NETBF.'TBN0(2_5`G2;I8]&/I?`KL4V*`8Z#"@,!`[0!>QK#&CL]8 MDF']=>53K@<:"7)%$>58\86 M:&'+C=D,L#"`S(?R2V,V?(Z!R@##`80QFP"U`W@5`>UQ>T6D$ZX(:H%,<72# M!&@GR8W5C*\P0#?!F%X:JZ%S#%0&&/07QFK\:P?PRL%`@^%Z1+"&?+UW=EZX M(*@',DU2"\(L9&R%2I9K1K^&%`0I"<()4FGD\SL)XE-_Y>-72.HLYQFZ4AFE MRORM`:F[C"E2GW=.D((@)4$X02J""(+4+N)G*G75^$R5"O,$%%[S,Z9(>IM? M10DJ1:X)?2D*@I0X2(J"<.)277,1UD6O)_[F5ELS/$!^C:2$&E\C);B\&H5( MXV5,D72-TC0E*E,SU-I"7A8*+T``K\TKM%J7'B-*Y"NEGS"WMS`K1N7YL#1- M4J1PA/61-4S1/6O/?Q8OPBCH;^K75&JR\355"LZO*5IN,^;(O&Y#SC6BJQPD MRQ55*,2K)`@G2$4009#:1?S?/,I:@S%%_>I858IXEF&*L0HE/21!.D(H@@B"U MB_B92W4V/G.EY?S,L1IEBJ3R3,(`/7RYMNL5PW_6"^R,@I?6V:P%G"`5CH$& M((A'[2)^>:14<\HS\M.0$GA^F=`H,F94H%[ET:.26[O)M+#(L$=I[<:#$Z2R MR'`,8>TF1NTB?FVD;KN]-DKM^;7I%U_U_L:,))2CA,^#?I/DUFP&65ADT*&T M9N/`"5)99#"$L&83HG81KS#!W]*MG=`RU-<,8_')`:NZ3]+6,#R0;?^%!LC/3I+X-G4LO`#PS359H18M/4:T7"PBI)&X M=XN!?O,4]<`8A1>`E--UG\5AS-+^.Y'?CC>I9/G;+FE'E%JF27VWY1K1%0^6 M\Q$,!Y1KB%<"3=([-?X^EENSR;2P2+?'8(?2FHT#)TAED<$0PII- MB-I%_,(@[3JR,$K#PK_]+]PA:H(L5"15F'"%6B"W9C/(PB(R*^)06K-QX`2I M+#(80EBS"5&[B%\8)'5E8:[_>A$.2-ZPWY74Z[$FJ6=K%@8I0YMOKAG][E(0 MI"0()TBED<_O)(A/_96/7Z&;5&^H]*F_LR!9FVE2GW=.D((@)4$X02J""(+4 M+N)G>I.<#0?D+'GMT20U,S&+R8<`3>A+41"DO!:$$Y?JFHL@+K6+^&6Y2;:& M0[(5:Z3$07"S<1ODDPJIB)\.0GC^:(2U-4(!_7+=)$U# MI3J]/0?_G)5IDCI6%2RB>(DZ+/<8+$2ZI_#,0;18XFVM]!AQR&+\VS/W&+,E M6MPKSSPT1N$Q2#E5'52*LSA)X>R8_<#JU_,YFN-V)([#":;/?GR?;]KL\I;R$ M0S8652>H!5O#,4#H3837<+)Z",_8.AO"<[;.A_""K>&H(HU?LC6<6*0X9VLX MN$CQBJWA_"+@Z.Y\F^>8$4%W?R/.Y)'=56?US:]^ZX MY5-[@2/6W7_?X$A]`Z>)X/3M=/+2MA?SA[R!/:3_^'\```#__P,`4$L#!!0` M!@`(````(0!#DMI">@(``*`%```8````>&PO=V]R:W-H965T&ULE)1=;YLP%(;O)^T_6+XO!A*2)@JIFD;=*FW2-.WCVC$'L(HQLIVF_?<[ MQ@$E3:=UN2#8?OWX/`($EJ;T]JY;LF8%34H;B/=08LKI3:*.QR: MBMG.`"_Z3:IA:1S/F.*RI8&P-.]AZ+*4`K9:[!6T+D`,--RA?UO+S@XT)=Z# M4]P\[KLKH56'B)ULI'OIH90HL7RH6FWXKL&XGY,I%P.['US@E11&6UVZ"'$L M&+V,><$6#$GK52$Q`I]V8J#,Z6VRW$XH6Z_Z_/R2<+`G[\36^O#)R.*+;`&3 MC=?D+V"G]:.7/A1^"C>SB]WW_05\,Z2`DN\;]UT?/H.L:H>WG6%`/JYE\;(% M*S"AB(G2S).$;M``/HF2OC(P(?RY_S_(PM4YG*NT'A M$^BQVY,)AGY'TYB*4]-O7\/@S8N]MX&Z"1/('LVFKXQ<*B;QN61[*9EGH^3, M[.1_S'IQ3A$^>DNFUR.WS\HF:!9]FM,H>VW^?'FZR.*37W+.PJ;QYPVLZ6Q< M#B&$C@@%H\!4<`=-8XG0>U_M*5H89\=&O$U]JE_-;[!!^W)FXP(V2,L_ M````__\#`%!+`P04``8`"````"$`JXC5SOD.``"520``&````'AL+W=O[F;_^;>=-[.K_6'U]K!ZV;ZM[V9_KO>SG[[^]2]? M?FQWO^V?U^O#E9OA;7\W>SX7S+%]?-SMJ]]OW]_G]]O7=3?%M\[(Y_#E..KMZO;_]Y>EMNUM] M>W&\_S#%ZI[F'G])IG_=W.^V^^WCX=I-=P,+33DO;Y8W;J:O7QXVCH'?]JO= M^O%N]K.YM8V9W7S],F[0?S?K'WOV_ZO]\_;'WW:;AU\W;VNWVRY./@+?MMO? M//27!V]RSC>)MQTC\,_=USO+HNZT5N'/SJVWI_ ML!L_Y>SJ_OO^L'W]'X!&1F&2#"=Q/R&8HZ/[B8[&7!=963?CY4]X%NCI M?G[LDH[52-C]_.`E*_1T/R^ZY`UL]1BY?G58??VRV_ZX;^?>4/E[EU MDU'(@&T(XK$8NN#Y27[VLXQSN?#L7>+]_M44RR\WO[MDN4=,"QAWUB-&(CI" M^,SPT_;:,&B#988;QRC0KY)"8WE0K_,#F)`EDQR;*HXT7$9CC6>C.*LSOAG70$%=,6,"R"VM!K MPZ`-EAG$HEV)X(L^G6X>+,/6%'+#6X!48]2RQ9)E.40-QB.7GCN8IBER.>&@ M'2QWR!:9J8*#(%9_A)@'2V*F5'6@!4PQ,IN[#A8N"\1HF(Y\3P9?/.=%KGG1 M,.$M&49\51Y),B^M5'D_7P>]DZ:GUM,"!NCE2W4$.AJEU?9D\*O-=90'&B6X M)<,(9T58A&R96(;%8;I&IZ%O\Y6L&02"#$2L6!H-4@]_= M>:F#U1D:IPWN@V7TJ`NU"T,8)P\;+*-'4\6J+-GY%GXY.VCXG%TJ?@$#F38O MT]-%X[34WI#%+[7,5/T=PC`YV&#Q#EG=A(8CJ?G.SJAY#7:^(_B[.%4S$^&( M&*28+]2*NS!.*^Z#Q:^8-68\4$R#C!8K\-DB)I!DZ#L^8WCF.($^$,&+6X>9 M2:)BS!J6-.-P9V@X$B/+Z)#%+$-F-$P.-DSA':J8QY*8;_F7$P.!P(F9,F'& M542EFD)G:)36V0?+2*S(E?0PDY4![WAEMZ1/+D%@LMX@U9TIVG%[SB%9RHU)YTB(H"*P\GF4X4PA@09$N M^<+$'893E;A8Z9(MZ^@B"2J%<8;@A++0-:'-`#2M+,(@1:P/%G]*C-'Y%H;) MP:(%-K#A=[N2F3L;EZ=;YM$Z=''/(-T0=(09S,##!A:,=%$V*GV',%_D)ER: M!;O5E^2\(&!GZ;*BD8&,<-=@9TIM>(L@6+59L#L03,]$BPB/+$^T"(['G;'" M0SQKD"R]#O@X2U`/DJ66OQF`@&66Z=!T.![7W`>+S],DDJ188B3)(N&2WZ<$ MB7]FE*1J[)N8J@#"W,L:UE@QC%IB]#@ONN2%47LV("#NB54NRR:Z2**^Z[-` MGJDRH!%D`%65;#,2$GY_Y\DSL2Z,4T3Z8`$/+>*&,$X>-EB\![^$)*>TR85G M<4*C5%JC9`#"D)BR8O4`PYCH%.E35,D3!P3P,,K+5,TR-BU)]5-:)9O0*OKQ M8HN@([459HA+[D_!AS`8(TD3C+&OS3%^2J)<&$K0'")?:U4AV@Q`&,JB+E3= M[1#`.9*6\8M6\PT)W`:+A(L`^ML=?A`]P?-/7D"]17)3*N5,/";4 M2:W522[429XLMD,`YT=Z19X-3#8:C$>)+!(NB2E5=,"$$RB*+#'B9"92T`A$4G6S;Z-K5#!*/2(2`NNP\6'Y,[!LO3"2H#1D)..I1XH``HJYD\NA](WCG=])I],Y1>&Q M*%11'A(/BQ;<1E,=^\"A^)3L&;UT?54T6@0AS48_^^YPG-,$+71L8X;$P\IK M\(V1P?R4[BE`L+@S$95YH[:^15!DT266/K$,B<5RBUR[TC%GRN:$?FEBL<($ M!!#LD@\K/18LO8JV7DA\/%C!O)!1&89#S*R MU*JC*[2E3RQ#8K'<(M9>?DJ;C%[J[.@6U")H6F&&P1">8)$%;=R'(0P2W*(% MHIEE!2N9DN"G=$DYH4N66I<@")8P\0`,Q^.QZH-EDB-<,\+M$;CDYQL]2[[3 M1ZL$62!J^U(_/D%07$B76/K$,B06RRURS;Y%7[YF:.CBH"0?G)8`XFO6EC[! M#(G%1!PEF2"R66^3:E0(X!G]-RUM21W?KS+7XJT+PW3:^V"9I$6S$=P>@0M:U:=DPN@E M98+^X]L6,?@$@W\F.4:U"^.TWCY8INB%08+;8)%P24^)A--1JZ;$@5*3+8(@ M&]W'U?I/XCH$L'0,%KE2*!]A,!(CO2#ADIA+K8\7]M:TSH0-1P`^T"$_DA1CV`K]4*;#.7@VK.(1U-JBJ[2E3RQ#8K'<(M9>?TJ&C%[JBW9: M';8(BGO?)98^L0R)Q7*+7/N'-$8]I3'T/0J")NMS%P8I.WJT0/H94RZ59AD2 M%QLL)Q*J]DW]X@X\HJ6V2&Y1$'.$%VF(R(LL?I'IL_,P&SG88#G%ZD.ZHDYU M12KD$72$5J(J!'S.OR(!QS^,1UXTQRE>OFVS:%UV_&MH]KP!)TH>,4?H:;70 M"[C)E1H9PG!D1U.<8N=[-&-W6C;5T-$Y*Z,/18N@([1($]`J>X3#(2L+O4M# MF(X\;+"[0`ORK3'U8.B8<-EE/\ M?&-F_,[$#=HXY^6^#:SD1#W=ZY$7#49>9/&KG.?Z\X0A3$<>-EA.\?(-^7)> MT+XE+_UTM@80?#E>::@.!V,7ZP5\KK\K.B0.5CC$^64O4QKB3+A`!+BO4-+> MM75BZE)3GYJ&U&2%22RSF9`+_D/%#[X08YQ&MBS#OK`&V@=!_DN6\9,V?3JZ MB**MZ%/3D)JL,$F22E?XTN"?>7R4Y(3@T-]L;-T+9_R#`452?3;<150D&1S) M-*0H_SX;G-ZA@"2\GP;>TY:BZW/_12GILPY%Z*\[YZ M6O]CM7O:O.VO7M:/;N&+:U_U=_!:'?CEL'T?WU?R;7MPK\,9__OL7G^T=J_M M6%P[\.-V>Z!?_/:$%RI]_3\```#__P,`4$L#!!0`!@`(````(0`SQ2%\S@P` M`$A(```8````>&PO=V]R:W-H965T&ULK)Q;;^.Z%87?"_0_ M&'Z?.))\2Y#D8&)RV@.<`D71R[/'41)C8CNP/;=_WT6)%+FX=S*6VY MI#>7*"U1IGSSVX_-R^!;O3^L=]O;87%Q.1S4V]7N8;U]NAW^ZY^?/LR'@\-Q MN7U8ONRV]>WP9WT8_G;WYS_=?-_MOQR>Z_HX0`_;P^WP^7A\O1Z-#JOG>K,\ M7.Q>ZRTBC[O]9GG$G_NGT>%U7R\?FD:;EU%Y>3D=;9;K[;#MX7I_2A^[Q\?U MJC:[U==-O3VVG>SKE^41]1^>UZ^'T-MF=4IWF^7^R]?7#ZO=YA5=?%Z_K(\_ MFTZ'@\WJ^O>G[6Z__/R"UU_/R3_/S@\[[[_9;]^^&.] MK:$VCI,[`I]WNR\N]?<'A]!X)%I_:H[`W_>#A_IQ^?7E^(_=][_6ZZ?G(P[W M!"-R`[M^^&GJPPJ*HIN+4`#^.]BLW=2`(LL?S;_?UP_'Y]MA-;V8 MS"ZK`NF#S_7A^&GMNAP.5E\/Q]WF/VU2,Z*ND])W@G]])V7LXYUVE6^'?WV[ MXJ1V8]\.%?8N>M0*T.AIEL?EWO%C2)\_GT`R;"RDD-&:&)R8!-`)>/HYR67DXLWYW!0VC7#L4*O M[TCMDZKF2'S(9?;1<3=.T^6GG4ZZH5+=F(5IW?H9%ZIUR4VU09][3ZZZ#U\( M8@2Q*:%JH-?IU;ADKJ8E):X_B9K3;N#-+%QT26$01A";$BIPVJ=`E\P%>I+( M)8@1Q*:$JIEQ->YLG^'"%RYS)Y_OKA\NM"4E3M!$R5FF9)?4*2F(30G5[KP[ MN5*]/_%<,A?H2:*D($80FQ*JYHJK<4J>PA,(D4@Y9RE- MFU1VIY%56UUUK:CX`A/^="V;;"XZH$1-B8Q$EA#7Y*[M)Q_?HG4"7`?#5+H/ M*%$RH/>E]%FQ*ZNV*R[?$--=X4\OO/4#*MRC5$R!C+ODNZD3LRPA%M-=T9.: MW/2LYNY>Z(U;I'#!+KP51#'N`TIU]5F_T+7-BEW9T!6U*Z(_\1C<13\9P_LG M?.$M(G[:?4!1L85$1B)+B&MRU_G3:VI=@8ZU1ZF8'I$HE_GY[NYN\_IY&*&H?:]_W1= M99>H%K$C%54GCQ]#EQ6N(\8)ZI1N;_;=%=D2XC$X@SA=5V\GJ:ZIP_B:!#*% M0)80U^2L(*G)Z3JMSI+5FTI:KS<>,OHBN]=?X"J5:6@DLH1H".Z.+!W"^^=^ MD\U'/Z#DW)?(2&0)<4V]#,K-NVQ&>N0^(1I[$6^SVZ,?L[H9*9$EQ&4ZGTB. M_B^D\ZZ2'.%2&,U"(B.1)<0UO6U'/4_T4OJ31TZ11-;\)CYF15F]/R4G.F7Q M$'JY42G=**!T1OJLB(S,LH2X)N<)R:%N+J"S^1GW\^[&()^MWG!8UOR.WC>$ M^%'6KF%`EK)X"+U\J92^%%#4<"&1D<@2XIJ<`22R_N(,:NTB-?G2.PB?Z)FC M+V)6T,E(9`EQFZ=)[RLY5 MTC,]KG'\!;3+BKH*9&-?R*(Q5+V\I\EF[PDHF9(2&8DL(:ZIE_=4TGL\8N\I MXXJFE2YF==))9`EQF;V\IY+>$U`JG;`C([,L(:Y)\9YVI=YS0E;2>CQBZRGC M>L:K*GS&Q(9!:$N(1]#+>BII/0&EJDKKD5F6$->46<_[U\A*VHM'V82,JQ2YMN`!IG8,$J79G&9O>REDO824"J=SXK(R"Q+B&O*[,6Y]OSJG$MD):W' MHVQ&YJN>F!4T-!)90CR$7M932>L)*&JXD,A(9`EQ3>X:G]CA_R!KZQ:IHU>= M@23.4^:KGI@59>T:!F0IBX8P[N4\338[3T")K!(9B2PAKBESGO,7DV/I2AYE MLS5?$<6LH*&1R!+B(?1RI;%TI8!26:4KR2Q+B&M27.F\-?I8VI)'F:SYBBAF M15F%4UG*XB'TLJ6QM*6`4EFE+6ON11-B7S)5',BKJV?:%A0):R M>`R]?&DL?2F@5%>?%9&16980UZ3XTKFZ2F,:=_Z2&E.^)(I9040CD25$8YCT M,J8FFXTIH"CB0B(CD27$-2G&=-9WF1/I2Q[Q;*WRU5+,ZE25R!+B$?3RI8GT MI8!25:4OR2Q+B&M2?.G,!?Q$&I-'F:[Y>BEF15VE,5$6CZ&7,4VD,7F$YYFA M@(5$1B)+B&OJ94P3:4P>L3%5^7HI9H7*C426$)?9RY@FTI@"2J>D-":990EQ M38HQN9.JY_)](DW)HVPZYHNEF!4UE:9$65Q_+U.:2%,**-54FI+,LH2X)L64 MSM%4&M)$,Z0J7RG%K*AIUS`@2UE4_[27(379;$@!)9I*9"2RA+@FQ9#.T'0J M[G@WE6;D4:9J MODJ*65%5:4:4Q2/H9493:48!I:KZK(B,S+*$N*9>9C259N119D;Y*BEF1>G: MOM`P($M97&8O,YI*,PHHZK20R$AD"7%-BAGYC34]_6@J_?C25?A10*JOT(YEE"7%-BA^=*:NTI&GG+,D:J\_I9])Y_&(3_1QOA"*64$G(Y$EQ&7V M0I M$V7Q&'KYTDSZDD?I^E(B(Y$EQ#4IOG3&S>=,FI)'F:;Y(BEF14W;OM`P($M9 M7'\O4YI)4PHHG:O2E&26)<0U*:9TCJ;2D6:=L22.-,X723$K"&@DLH2H_GDO M1VJRV9$"2C25R$AD"7%-O1QI+AW)H\R1\K50S.JDD\@2XC)[.=)<.E)`J732 MD626)<0U*8YTWE=&<^E('F5G>;X8BEE15NE(E,5#Z.5(<^E(`:6R2D>26980 MUY0YTOOW2'-I.AYE,S)?#,6L*)TWG60Q1%E<9B_3F4O3"2B5SF=%9&26)<0U M*:9SUNI\+FW'HVQ"YFNAF!55E;9#63R"7K8SE[834)1P(9&1R!+BFA3;.?,1 M_%Q:CT>9KOEB*&9%73O/"LA2%HWAJI?U--EL/0$ENDID)+*$N*;,>L[?(((W MF_,[3X]8UDF^4(I904,CD7MQVG6/OI#5#J%]$;I]<7=3[Y_J1?WRS25, M1+J7P//('&UPCZ#5AC:P92U2(M)\(R-ZJQ"IU#9C1)KW7$6;"2+-2SAY9(8V M6+\H%=S6@1:X[&7$IF@#;Y@TB)H@Z]NM`BTQAT"+0&M_A:A%HC6]&M0BTQO>36@1:XRM!)3)&&VRV MT2)H@_TM6@1:8Y>)%H'6V+NA1:`U=E!H$6B-?0E*I$(;[`;4(FB#379*9`RM ML=5-BT!K["#3(M`:^[BT"+3&]B@E4J$-=B1K$;3!3E\M`JVQWU:+0&OL>M4B MT!H;3;4(M,;^3252H@W>?=`B:(/7#;0(M,:F?RT"K;&57HE4T!H;VK4(M,8> M*%'^QQHC==JM`BTQMLJ2J3`Y[1; M0O//*=`;7AG5VD!KO/^H1:`UWBK4(M`:[_9I$6C=OOZ;58!?6_FHSC:(INN, M02J?\+&Z_HB;#^6CW75`X^[*H7&,6QTV1JT.&F/6AXP)@5?&4=&H&S-^Q^5U M^53_;;E_6F\/@Y?Z$;=`E\WKC?OVEV#:/XZ[5]Q3XM=<=D?\@DOSO\_XQ9X: M+W1>NL>XC[O=,?SA/J#[#:"[_P(``/__`P!02P,$%``&``@````A`(0U2)EN M`@``H04``!D```!X;"]W;W)K&ULE%1=3]LP%'V? MM/]@^9TX3FE+JZ:(#K$A;=(T[>/9=6X2BSB.;)?"O]^U#:'0"=A+$B?GGGO. M_N!;`$V3H74E;[X1.0^\3B85.>-3O6C6X1S8MWT.GA;W9#2?2Z`$IMJI3 M_CZ24J+E\KKIC17;#GW?\5,A'[GCX8A>*VF-,[7/D(XEH<>>%VS!D&F]JA0Z M"&4G%NJ27O#E9DK9>A7K\UO!WAT\$]>:_6>KJJ^J!RPVMBDT8&O,38!>5^$5 M!K.CZ*O8@.^65%"+7>=_F/T74$WKL=M3-!1\+:O[2W`2"XHT61%E2-.A`+P2 MK<)D8$'$7;SO5>7;DDYFV72>3SC"R1:"B_6*VOV!(<&<[I!A!'D2V0.SF98GW\[0S4AYB($ MQ5!$.^S&[9KG1;YBMUA#^0#:)!!NP`B:3T<(P_2C!LS[4L/D30TAZ+F&8C'2 M1YF;!#F+K3W,-WF>[W6O`5Q2I'JRL2A>)$J8TZ-$I_^3*(!Q,`X2\9P_52Q9 M2J#C3#A&AR5\W5(`/[>$[>,O/"70/'9WOG@J;>I<6I4T21IL`Y^@ZQR19A?6 M@&/4^#9MZ`8WM(@%&C_@A@RB@6_"-JIWI(,:0_-LCIEMVK%T\&:(C=X:C[L1 M'UO\%0).8IXAN#;&/Q["%H\_U_5?````__\#`%!+`P04``8`"````"$`=>AQ MA=82``#^9P``&0```'AL+W=O7E*O/JA;QI_^\_?3X\E?F]?=P_;Y\VGK[.+T9/-\M[U_>/[Q^715 M3/ZX.CW9[6^?[V\?M\^;SZ?_;':G__GRO__SZ??V]<_=S\UF?T(.S[O/IS_W M^Y?!^?GN[N?FZ79WMGW9/-,GW[>O3[=[^N?KC_/=R^OF]OYPT-/C>?OBHG_^ M=/OP?%HZ#%Z/\=A^__YPMQEM[WX];9[WIX8NZ?; MUS]_O?QQMWUZ(8MO#X\/^W\.IJ#\,?S]O7VVR.=]]^M[NT=>Q_^`?9/ M#W>OV]WV^_Z,[,[+0/&O3\R^? M#A=H_;#YO:N\/]G]W/Z>OC[_@\W#CY][JNX>G9$ZL<']/Z/-[HZN*-F'E1JT!6Y_?OP^OOA?O^3WO7/NNW>Y56+]"??-KO]Y$%YGI[<_=KMMT__ MIU7:JW1I:Y<.A5]^WNF?]2XO.N\QZ6H3>F63B[-6]Z+_CD`HY,/IT*OVZ)U= MMBZN.Y?'GTQ?>]"K]FB=7?5ZW?[5.TPNM0F]&I/W7A!JHX>3H5?C\>Y`KK4) MO7[XBK0H+&)OW7I46)YMZ8US>?5U:E*OE.=FD?7^N MM#AIU9M_$0SGK6JZQN;=5X8SM_6O4K?%N:O>Z&`^<&4X>UO_*GU;G+_JS8>O M3)L36+TQ+N_.F38GL'KSX2O3Y@16;]X=S'G9@1_&@]'M_O;+I]?M[Q,:9"FD MW/;7EW[KXM/Y7S0& MW6G-#6I:KF+("C7@*-N1!&,))A),)0@D""6821!)$$N02#"7()4@DV`AP5*" M7()"@I4$ZPHXIRHV]4Q5^]^H9V6CZIEKZ(:!K?BVJ%16\"$C"<823"282A!( M$$HPDR"2()8@D6`N02I!)L%"@J4$N02%!"L)UA7@5"J-04ZEUD_?N(TJ-35S M,O,T4BWJ'-KP'[(-#_7'79,`(W-`U=4V;"=>&NW>$:]2'^+ES+G1Y#`Q/G00 M0R`C(&,@$R!3(`&0$,@,2`0D!I(`F0-)@61`%D"60'(@!9`5D'65.!5(\XQW M5*!2NQ58$IL]0PE&$HPEF$@PE2"0()1@)D$D02Q!(L%<@E2"3(*%!$L)<@D* M"582K"O`J2N:S3EU58[L9^IN9/_SX>[/FVUY@U;3::C67X[KRL2M0DW*NT(U M2`\-L3U`K^L.`J-2TW$G"&*D&!L1-_@)D"F0`$@(9`8D`A(#28#,@:1`,B`+ M($L@.9`"R`K(NB0T_:6-:GTM(9X:KG4]&BV M7!EA.FXJC(W(U+(F+3.H3`VQ1C*E`N-C-?U6SRTL-"(N;&:LF42&6"-96&Q\ MK*;?ZKN%)4;$UG-CS20UQ!K)PC+C8S7]UJ5;V,*(V'IIK)GDAE@C65AA?*R& MEE_C%$AFCO)8+XR(K9=@E`,I MX*@5D'7U*"='Z*;J&E&`19:IQ:E_:NY?#)&C,JNO#35&KV[X263/1 MBDYUY).%3=G&%U'`(F]$(:LXHHX<'F;'1!2QC2^BF$7>B!)6Z8AZ[9ZX1O-C M(DK9QA=1QB)O1`M6<437;3$361X34]%#W+1CLK%(EIJY@$(NCP.Z$-W3J@UI6XF5BRP!=0 MSF7Y`BI8Y`UHQ>65`;4Z%]L:(C(;41JP;/:B-2LIG.E]LD;ML_Y+EOM M'8J)K$;.3*;?%ALG0U;YAJ`1BVQG/M:HTSK,6SKR?G7"G_MG+674;5_A@77B MKB+4J$?30]LP^^+*S^R!%96XKXJTR!M"S")[_@FC1:S(2&?)RO_8^TJ&,7E,<:]6D^TIQV$WM@1272;GI, M"(%UX@P*CPIA9@]L#B$Z)H38.G$(R5$AS.V!S2&DQX20L:AOI@H+-C>];EZ11K"5@S!=>JH815>MR]:G7%"M)<*[P1I6SCBRACD3>B!:O*B%K]=EO< M%2R/B2AG&U]$!8N\$:U854;4:_5ZXAJMWXC(;5T4D;=U%=L7:C9OSLB5C6A> M&E7[:8.:^XN1>NJ-K+IV$VN,:*)19<5E:E&S>X!6(:*9M>*^+K*HV3U&JP31 MW%JQ>VI1LWN&5@M$2VO%[KE%S>X%6JT0K:T5]-.4MMY,.FJ;7(WA,I%*Y,QR M^VV1]$,^D$9Y.UT5'>R(1=2M&5%-/ZT+5-NZ?WVA![>OKIW_1`\PT:XT>;:N MN'*B3\P77W!4?"&79^(34_X9"WP!15R6+Z"81=X+EG!Y94#ML];51?4_\73" MG.6^\%(NV1=>QB)O>`LNKPRO==86:;%D@2^@G,OR!52PR!O0BLLK`^J7&T;R664ZMWED3VXWGVJKE%J5.W!#6I.]9%Z5%CVX(`F6D77@ONI MJ47-[@&ZAXAFUHK=(XN:W6.T2A#-K16[IQ8UNV=HM4"TM%;LGEO4[%Z@U0K1 MVEJ1NY-)ZN%L;R8=U8,?7-RI@$;.3)MF4NX2TI!5-/Z;SEEVHR,640,Q(NS! MM4JOU[W=@[/>NW['1?OB"UCDC2_D\LKU1(I/]N`L\`44<5F^@&(6>0-*N+PR MH#=[<);[PDNY9%]X&8N\X2VXO#*\FAZV_/Y]#]XN=PYI"9Z[C1M&MH\=6F0;$+:RTJHZ!]?'5=#$6G&!4XN: MW0.T"A'-K!6[1Q8UN\=HE2":6RMV3RUJ=L_0:H%H::W8/;>HV;U`JQ6BM;4B M=S>3U"9?-9/\JVOJ:RIBLLW(WGT-$8T0C1%-$$T1!8A"1#-$$:(848)HCBA% ME"%:(%HBRA$5B%:(U@YRZ[5NJXR^FGG$7ED;]\H85?M!^H*F'([U@555O_+D MAQL@S53?DWA*+N8(&E6>2VP#&B$:(YH@FB(*$(6(9H@B1#&B!-$<48HH0[1` MM$24(RH0K1"M'>36*]WMO*=>E5S4:XGLQM)030/5[8$9ID9`QD`F0*9``B`A MD!F0"$@,)`$R!Y("R8`L@"R!Y$`*("L@ZRIQJY#N19TJ_-#Z>5NYB)K5J/+P M**NHALWL'"<7Y7'NT\7RGGRLK4C%0^@$T111@"A$-$,4(8H1)8CFB%)$&:(% MHB6B'%&!:(5HK1%MK<`\@3IU)R?>F"XUHA6(`BYG13= M;CD)^;%.2KF(/-6HFJ>`1FKCC@YTNR3YK82Q5?$9330JS^BPSSY%%-@#[57% M+SU8%=O/T"M"%-L#/?:)5;']'+U21)D]T&._L"JV7Z)7CJC``U>(ULZ!;NJH MI<5WW//H%^!]$V*KXP$T131`&B$-$,480H1I0@ MFB-*$66(%HB6B')$!:(5HK5&-0.9V@=V*O]#_<;!Q>TW-%*S*C.VP#:5'ET:PQHHFUXKYU:E'MZ1W&Z`"M0D0S:\7ND47-[C%: M)8CFUHK=4XN:W3.T6B!:6BMVSRUJ=B_0:H5H;:W(W@$(NKPRH?2V?C9JQP!=0Q&7YKE#,(F]`"9>GKU#G0CR7.F>!+Z"4R_(% ME+'(&]""R^,JNQ9/:BQ9X`LHY[)\`14L\@:TXO+*@%KTQ0'Y'#DK&B)RVU;M M*G#E.?+C=OH[N"+,J-I+:Y6_ERY%E4VAL;:JH`FZ3RUJ;CL!6H6(9M:*>[K( MHF;W&*T21'-KQ>ZI1N4)B*6K.`E]`*9?E"RACD3>@ M!9=G`A)5MF2!+Z"YB$0JD9IZ MF.X7'\?B`RE5C$I.;TN(J*]N+&O*9?D""ECD#2B$@*"3 M/B*@B,OR!12SR!M0`@%!)WU$0"F7Y0LH8Y$WH`4$!)WT$0'E7)8OH()%WH!6 M;D!UG;0_(+>3IE'#V[2.[*25C6A;&E4[:8.:DWND%I')RNFD`4VTRNFDCW`/ MT#U$-$/WR*+FV&.T2A#-K15WHZE%S>X96BT0+:T5N^<6-;L7:+5"M+96T$G3 MU,+)I#=6R)1<9(Q&=A=NJ/:AE,JB$:(QH@FB*:(`48AHABA"%"-*$,T1I8@R M1`M$2T0YH@+1"M':06X/H79MJKM*AW6LHYZXHI\;@#K6B-JJ&=_PB2L^L*JB M/[YOGLLJ`RQ_BJ#\T]-/F]F,=;@\C<0;CI7]",( MAQY)?$);N0.UVT99+3ZAO=J!VG3#3T;M:SKFL)\JCJ'?6OAZV%83_(9^@^&0 MRI*WJ8B:$KYV!E_+WVR0!W0']!=5,:2;MG*JL[IITR'T>!,>0]OM`[4!BI_0 MKOM`[8/B)[35/EC076O=)U?T2=TQM,L^4#NA>`QMM@_4ABA^0@\M#,+:5QBH_6)TH\<6!FK;&#^A9Q4&ZDF$ND^NZ).Z8V[HF)O:3X;TR;#V MDQ%],JXMAW;>Z9.ZQ]CHN8^!VF7'3Y9TJ>MX3A>ZCA>4_75\3;E? MQT>4^76)/VKWJ4D4JK6\8P2M?_'U MVW9//[M"HS']27_ZG9T-_:'>BS.:T'[?;O?\#TK%<_/+/5_^7P````#__P,` M4$L#!!0`!@`(````(0`$VQ8DA`P``!5"```9````>&PO=V]R:W-H965TT%6J`H^O'L=93$ MV-@*;&>S^^][*)$B9X9K6T9?KF_.'-(S1V,>ZFOO?_^Q?1M]K_>'3;-[&" MZ_HXP@R[P\/X]7A\OYM,#NO7>KLZW#3O]0Z1YV:_71WQY_YEC[?KNCY==LU]]?4/=/Y+9:NWF;O\0 MTV\WZWUS:)Z/-YANTB4J:[Z=W$XPT^/]TP85&-E'^_KY8;Q,[G1Q.YX\WK<" M_6=3?QZ"_Q\=7IO/O^PW3W_;[&JHC>-DCL#7IOEFJ'\\&0B#)V+TE_8(_&,_ M>JJ?5Q]OQW\VGW^M-R^O1QSN'!69PNZ>?JKZL(:BF.8FS"_H^W& MM`846?UH/S\W3\?7AW$VO\F+:9:`/OI:'XY?-F;*\6C]<3@VV_]VI,1.U4V2 MVDGP:2=)YC>+/)_-%P5F.3$RLR/Q:4>F-T4ROO3QG0VYS=M]46J1=4]H#7`E$"42'",D&[1IF8UJW MP`K@?K47-Z^9AR;:(2FZ+5"RH')7/YGS[ZADP3M$B@I$"4 M0'2(D&P*FHU1,LV-DJ?S,L-H7A;IEFOS$ZXL@H]`R@654G6DM/_AZ>BHVWX4 M2=[L!X(5['3*ADQ3MD@@I4"40'2(D&QNAV1CR#0;BP0"6N2T@!TI$#`V*O$K M,DDYP8IQN8(MFR;MH$!#"2D):0+1G,Q*'QQ5TY+9PFP$SO1DTED$EDKWLRP= M%(CJH-.J6I:?2D?')=[':`UFZ0]J.-V99G%GS>"@4%?+\I"2+$T@FI-9VR_/ MJ7,"3.?%M%`HIH7.B-FQ_%0ZB8U+O,/2Q(T-7)ZX-0W_;642^DCG/A)2$M($ MHCF9Y3W(J=T\%8LK+,CL>_G![R!J0DG6KX&VA)[ECI"RALG,164,6+<'X0U#"&5FMFY#M79+3G,JD8]']'6=5GN4S[P<"RZ6I)*0)1#+/F.>=-HR637W-04$_ M2$A)2!.(YL1,K#6,*7X]`]LAD_9F(;H\I'RWZUF]J!+2!*(%&&NY^$>6&383 MU4*AJ`)2;J!G:0+1G)B#72UJ[VU.FS+K("8JW^MZEANH)*0)1`L89&29-#(' M>;DJ"2D):0+1G")&=M6UP4PZF868JFRW7GF65U4Z&6'1"@8Y6=8[F?NVTD&A MJI;E(259FD`T)^91IE6O.S'+I']9B,G*]^&>Y0I5$M($HB4P2SNSK/:^Y0VA M6#"3*C-K4F2_F/*=KF?YS/N!#M*$13,?9&59;V5NZM)!_NA7$E(2T@0B.M6%I9GT,`LQ6?E.W+.\K-U<&.@@35BT!&9K9V25YC6S4"BK@)1D M:0+1G)A3&5FO9:34$E($XA6P'SMC*K2O&86"E45D)(L M32":$W,JH^HU)XTSZ6$68J*R];?R+"]J-Q=IU1"B!3!;.R-J;UW>$]*,;?_+ M6<>B)PF<57F6S[P?Z"!-6#3S06XVZ]W,35TZ*&P'R_*0DBQ-()H3\RG3#M=M M$F;2PRS$&H*?)GB6*U1)2!.(E)`S6SO=$"V;.I>#O(:5A)2$-(%H3LRFC*PY ML(&G7F8(.Z>Q$-.4GR5X5J^IA#2!:/[,TLYH*FTKMU"HJ8"49&D"T9R81UVK MJ32OO(.8IOP:5=Q!3E9\B>):34$E($XA6P/SLC*J]:X5VP#;_96[-AYPB9(Q5>9;/ MO!_H($U8-/-!1I;W1N:F+AT4]H-E>4A)EB80S8E9E.D'>R-_:$-(^\H[B#4$ M/T/P+%>HDI`F$"V!.=J9AI"NE5O(:UA)2$E($XCD-&<6=;VL[4S4OBS$9.5G M")[5RRHA32!:`G.TT[+.>^,*?F3=]<+E6$Q;-?)"7 MS:67.2AH"`DI"6D"T9PB7I:DQ17/(LREG5F(-L2,[\,]R\LJ[8RP:`F#[&PN M[0= MUK1EM[X5&@+;8I>6Q0R!L2K/^RRL(Y$=N(S MQJH\RV?>#W20)BR:^2`K*Z25.2AL"&EEDJ4)1'.*6-E5=_/-@WCL&H*%6#_P MC;AG.0F5A#2!:`6#C*R01N:@4%7+\I"2+$T@FE/$R*ZY^EE()[,0$Y5OPSW+ MB]K-A8$.TH1%"QCD9(5T,@=Y!2L)*0EI`M&<(DZVN+WFP32\P"9ZM?>D8)W( MV9E$90<&&BH)F??CS/0=JRNA>]^M>\=J6^]?ZJI^>SN,ULV'>9=M4>#MJ![N M7K0KBP7>M&M?.Q*16_<.'HLLB^G=$BLG#C"+P/(PIGWL1$3,&WUM4XA(BDAL MMF61X7O:0RO&9!B313.8(3*+1G)$VD?'Q6QS1.;1,04B122RG"=W2VPG(AH@ M8L[?8A%4BK.H6`3UX.0D%D$].$6(15`/-MZQ".K!]C<603W86,8BZ`-L[V(1 M]$&TTF4^AP;1HXV(N584F2U'!KAB$XL@`UP(B460`2Y'1")S]%LT@^6LN%OB M.EMD#"+FMD8L@@QP*&X%QB+HMVBER_3V;HE',B)C$#'/P$4B&2K% MDVBQ""K%(UZQ""K%@U:Q""K%$TRQ""K%O!D:BR" M>O!\:"R"[HW/EJ#2[L%45BE>P4$DFG6"K/&22N1[$N2&5T5B$>2&ES)D9)G@ M-Q?5&N]08$Q4@P2=B#<0Y&QEBD[LK@OR>E)T8F?]+()7YY?1/L2`:.>:YHA\ M]Q*M$2VQ-/T<&5":WVT,A[Y1>:%N5%SH%)<)8N"M/<@TZ6O&2_GOJY?Z[ZO] MRV9W&+W5S]CH3-N'@/;=:_W='\?F'>?K>#6_.>)U_/9_7_'/+]1X371JKE,^ M-\W1_6&^H/\''1[_!P``__\#`%!+`P04``8`"````"$`;?CF+@83``!->``` M&0```'AL+W=O7%[N5^__7QY=NGRW_]4WW87%X MOMX][5]VGR[_VATN__'Y/__CXZ_]Z^^'[[O=VT6H\'+X=/G][>W'[?7UX?[[ M[OGN<+7_L7L)1Q[VK\]W;^''UV_7AQ^ON[NOQT;/3]>SFYO5]?/=X\MEJG#[ M>DZ-_WE*1U]W3W5LX_\/WQQ^'MMKS_3GEGN]>?__YX\/] M_OE'*/'E\>GQ[:]CTK4.XZG2A>-T]?+K\K;KU]>;R^O/'HT'_][C[ M=2B^OSA\W__2KX]?_^OQ91?<#L]3?`:^[/>_1ZG]&E%H?`VMU?$9^)_7BZ^[ MA[N?3V__N_]E=H_?OK^%IWL9KBA>V.W7O\3NGRUEXX,>O;]\_7HPE+R_N?Q[>]L__ MGT15+I6*S'.115>DFEW--LMJN9I0)3S>\516?97EU6*V7&^FG,LZ5PG_YPMZ MS[F$X7$\E_!_7V6J+74N$OYOBZRF7U`5^L3Q7.(W;9W9.^JT3W45OFGK5%>; MY7*QVJQ'G^SKU'&._5#H=OAQ%Z>*ZC:6;GM@ZB]=G_R[ M+AGZ8JSR6RSSZ3+X'7K;(8RC/SYO5NN/UW^$OG^?-5O45%31M(K8T6-9P8%, M('PM'F=#JZ@A34TUNBUW9V('":W8)KM6TC7P!KH/GG?%AR!+C MAX=\ZV]41W_;LML$0O'.B!D]_:9MTBOF[`H%2M9+6D6BA#V.&E7HI"C/=;-F M5.5N!(FZ@FN1#5Q)8'"%:X0'$@.%`K*@KERAL;R MPHX#WU;AKH3,,,&5J`Y!IYCZ-NL5/=]MTBRZ^;+A0'`@.5`<:`X,!Y8#QX$O M`.D8(?!,L""JCZFOF_TW,S:C;I-F<5R,5VR9:MJ#[7HB.)`MB&LY;ZY.'=3M MP;:VX<"V8*BV:P^VS7T!B&5Q$P31Y2;TL=-+:6S&O%OSJ)(T81#W_J[YS-UJ MVO,4'$@.%`>:`\.!YR9AQ!ZVIW8BKO#5M!MTJR//:M:SV_B M/SK^FE+"CHD3QV0ZUH];Q8'FP'!@.7`<^`(0RV)&)YZ=]NHH9V9MV-5NLZBZ MF2>_F%'Y<'_%`H@\74*=/JRAG@%B3Y=PIP_[LA[U,RPJQ,^XNQCO@W$?PCOA MALU@VRQJ?5U?';MA_Z62']C2WDQO(EB3L`&LR;\U/(ID3A,ELNECBS4,E\58-$ M4$E5H41F26^?`J*!&"`6B`/B2T(=C'%Z@H,I?9<.SE;@8!+U%]94G`@@$H@" MHH$8(!:(`^)+0NV(H7F"'2ECAZOK.Q3DP"J)2CLX$:"10!00#<0`L4`<$%\2 M:D=,RZ4=9TZ>*627O60S9W%^&^\QAAFVG3QOKN8P5R9%;YS(;7HB1ZNH486& MJ@:(':WBH(TO";4U)O#2UI%I*P5V:B>/BU61ZH\WKAH@`H@$HH!H(`:(!>*` M^))0.V*ZGF!'"N,C@ZY([-D.3D3%B02B@&@@!H@%XH#XDE`[8IJ>8$<*WZ1W M;-A0VE9M0H_;'79/J^D.=ML((+(C`P74J8.Z.]A6-T!L1P:JN^Y@6\"7A%H7 M4W5IW9GS50KCQ$*,2>R&JNB1A4Z*_I9T`"QHU4$VL&W%*>G[UG:2IR> MK[*HM",UZXD`C02B@&@@!H@%XH#XDE`[PK@A@V[$CBCGO8//5[,DRG>.V'ZU M.]A."`*([,CQ_@XMH$X=U-W!MKH!8CLR4-UU!]L"OB34NIB+R_EJQ+HHY]:Q M66@[2Z(0,?M,NF'W)IM.U)ZC`"*!*"`:B`%B@3@@OB34H1B52X?BC+X(P7#$ MJ92PR8R^X9%IUL;P^"Q6S,>F.]I;U.I;(D&C@&@@!H@%XH#XDE"+8DQ^AT4I M75.+V`W&;7SQ/?2X<.%%9V+WXII.U/HB@$@@"H@&8H!8(`Z(+PEUBN?N,SO3 M0/ZN^3VV69N_"Z=J=L.HZ42]4VVSEDC0*"`:B`%B@3@@OB34J1B-W]&G4J(F M?:KFMP=F;>P^Z50K:GT17;.62"`*B`9B@%@@#H@O"76*I_7S(N=L(+77L`HF M41LYEU<;7 M=5#$EX0^=S&,\UX^?F]XEC(\[>60;WGT;W*SWFS$TB_J+;X`((!*(`J*!&"`6B`/B2T+MF!;WYRFWT][!PL4V MB\BZ6O.0UHG:&4\`D4`4$`W$`+%`'!!?$NI0N%C28Q&8NS-0]I651V MG-2L)P(T$H@"HH$8(!:(`^)+0FV9EN[G*;B'KWW6@IO)6=1??`-$`)%`%!`- MQ`"Q0!P07Q)J1XS/Y6P[,JVDM#TRCI*(CB,68IMY*^K'$2<2-`J(!F*`6"`. MB"\)=8@G^1&'!A+\G%W\=MXF^/;B&R`"B`2B@&@@!H@%XH#XDE`[>%P?L2-% MZ9'QP_-V,^=$`)%`%!`-Q`"Q0!P07Q)J!\_D(W8,9'%X@\Z\C=EQ"\RZ3M,= M;+N.`"([,E!`G3JHNX-M=0/$=F2@NB,'V=KINX.A.G61Y_41%X=R.ML`;^=) M5$[*G`C02"`*B`9B@%@@#H@O";6#1^`1.U*J'1EC$'WGG`@@$H@"HH$8(!:( M`^)+0NQ83(N^1SE-,.&%?GJW<9M%Z0T%575\>PB5-.,2,2Z16=)W0P5$`S%` M+!`'Q)>$.C@M+2\P+=EY87`VEYS6>B+.J[0`-$`)&9Y!XZ^&XZ=89&0V4#Q`)Q0'Q)J'4Q(I\? M(1=1SH^`))E%Z14[-L::[F`_-_/4+3M- MS'JL@#IU4'<'V^H&B.W(0'77'6P+^))0ZZ:%\`6&\/J&WRK,HK(GM;&\/2$! M&@E$`=%`#!`+Q`'Q):%V3$O3BQ2+1P86S\Y-;M8;)(!((`J(!F*`6"`.B"\) MM6-:FEZD6$P&%KQY.XO:._HW5_"^DZPH[>%Y6XY64:,*#8]C@-C1*@[:^)(0 M.Y<\C9^WFAV;\66?KV99E-_FNQI*Y5E2^`I$CI=1XQ(-=0T0.U[&02-?$FHM MC^EG6CL4U]G>>[M,HF3M8M#9I"B=Y42.5E&C"IT5_>,8(':TBH,VOB34UAC2 MR_QU>CN]C'+>4_D=\"S*`741WTG.]YA-UO07*H#(,^JH,S0:*AL@]HPZ#EKY MDE!;>>X_L[=B_M\L^99IF42]=0T0`40"44`T$`/$`G%`?$FH+3SMC_2VE/)/ MK[[+)"KMX$2`1@)10#00`\0"<4!\2:@=TU+^,L5ULOI"K,VBTHXVY<OC\X4,U^S`/R]9#7#@_\#_7TG3B[G8,$`E$`=%` M#!`+Q`'Q):&.Q2Q;=J#S5J95BL!E$JHKOC)E43O6PU\#8R]B94'?TP00.59$ MC0DTU#1`[%@1!TU\2:BETS+V*H7ETLH-_(IQ%N5[#_$7C&%#1R5#FVA!)4.O M*\HLZ9\2!40#,4`L$`?$EX0Z."V6KS"6UQ6+E-LL2@[.5\.OVE#1?'/TF75K M046S=".(B606E3ZVNX!V2M"@,4`L$`?$EX3ZR)/[F=,A)OBZ8F-WNTJB_@(; M(`*(!**`:"`&B`7B@/B24%MX&C^=PE(`%$`E%`-!`#Q`)Q M0'Q)J!T\A9_92U(:+^>MNF*OPFQ72=0O`?!+,UE1VI3:]$2.5E&C"@V/8X#8 MT2H.VOB24%MYFC]S9<547U?\]9\5S_`-$`%$`E%`-!`#Q`)Q0'Q)B"UK'N1/ M#[ZC?.R%U2SJ>TP#1`"10!00#<0`L4`<$%\2:L>T`+].2;P<=!OXU>TL*NV` M``\:"40!T1V)J9?=Q#>G#MKN8+OZ.2"^)-2D<+TDI([TF2BGF[[-AK^:LTZB MTB1.!&@D$`5$=Z1X5S;_=4ISCLAVHMXT?HZ^U%#3>+(?,6THT8-I252:QHE8 M5VP<;+.H-"DUZXD` MC02B@.A,\NLZ\Y`\Z8;*C`DLU'1`?$FH6=-B>?S[OFP8UA5_J2J+>FL:(`*( M!**`Z([TP[#F?\C4G".RG:CO83S+^U)#37M?!E\/97!^2R*+2O-X*A>@D4`4 M$`W$9)+[WBQMC6CWL]#*`?$EH49-2^7K%+C#?-C][DM=_$7$V+'A:?N\O=VQ&4U0-;S0F47%X`(B@$@@"H@&8C+I]Y'\S=P6VC@@OB34 M)I["HTWC@VF#:;R>\2UP%I4V01H'C02B@&@@!H@%XH#XDE!;8MHL;PZ?'DR; M%$Y/#Z8L*NW@F5:`1@)10#00`\0"<4!\2:@=,5>6=IPYF%(.6?MFQE*^[8YW>0>(+PDUB2?J,X?20++F)[;=\!S=`!%` M)!`%1`,Q0"P0!\27A-HR+3MO4L`,7>#$NI1%99_AN52`1@)10#00`\0"<4!\ M2:@=[TO%FX%4/(.AQ#-PDYOU1@D@$H@"HH&8CJ2AM&#G8KOC_5#B9^=+#36) M)^(SA])0,N:;U`W/P0T0`40"44`T$`/$`G%`?$FH+3SYCJQ**^:JE$+MR*H$R7?#B0`B@2@@&HCI2!Y*L"KQ M1W9=BW9P^9(0D^JA'#P>\([->`[FMS"RJ)]=&B`"B`2B@&@@!H@%XH#XDE!; M>.X]/93J%%Q/#Z4L*NV`O`L:"40!T4`,$`O$`?$EH7;$)#H]X-4IP)X>2EE4 MVI*:]42`1@)10#00TY$TE)9\5>J.MP/'`?$EH2;%7/H.DV(S/I3X.['J).HM M:8`((!*(`J*!&"`6B`/B2T)MX;EW9"BE*#LRE"#OUIP((!*(`J*!&"`6B`/B M2T+MX'GWO%6I3@&6#B5^VS.+^IL!^6YD>K=&^,JVX`TT8`(Q)I!9T'=,!40# M,4!L)OVISUDP<]#&EX1Z/!2BQ]]57`^$:/XA:]LLZB^X`2*`2"`*B`9B@%@@ M#H@O";6%Q^:1D9B2\,A(A+A<O7[;-;NGI\/%_?YG_,33.KP[M*/ITUCM[-8>/P65<3>[ M#9\U%E9@QL.GM_XVQ+?5K3A^AAK3Z^K6#/%F=ML,U1&S6S'$Y>Q6#G$UNU5' M?MT]PB7?G,57P-[31\'FWYXV_\X?E;GE_U; M^!C7X[??P\?V[L(GX]U&PO=V]R:W-H965T8-.V_ MWQD;B&UH$UZ:X!Z/C\_,'.-LOKV5A?5*:YZS*K+)S+4M6J4LRZM#9/_[S]/7 ME6WQ)JFRI&`5C>QWRNUOVS^^;"ZL?N%'2AL+(E0\LH]-VC+"N[XG!]OL\I8\L/9>T:F20 MFA9)`_SY,3_Q+EJ9WA.N3.J7\^EKRLH3A'C.B[QY%T%MJTS7/PX5JY/G`O;] M1N9)VL46#X/P99[6C+-],X-PCB0ZW'/HA`Y$VFZR'':`LELUW4?V`UG'GF\[ MVXT0Z+^<7KCRW>)'=OFSSK.?>45!;<@39N"9L1>$_LAP""8[@]E/(@-_U59& M]\FY:/YFE^\T/QP;2/<"=H0;6V?OCY2GH"B$F7D+C)2R`@C`7ZO,L31`D>1- M?%[RK#E&MK^<+0+7)P"WGBEOGG(,:5OIF3>L_%^"2!M*!O':(/`Y$N23B7X[ M$3[;B61T)4>R%B(\)DVRW=3L8D%E`9J?$JQ3LH8@N'L?-)1+]GI\)`?H@$$> M,$ID0TO`=`XY?-V&/MDXKZ![VF)V0XR!B#L$I@OH]1Q!%9,C9F@B1XR"'#&% M2'K7#5Q)>SKEN$.8A$`HE=!XJ73:(#BR(52OC;<,]85V$C/ON<7*@";%?,K* M"(9T*BN'OK'%G<0H*RL#VLH@^/U[1K"^Y]#WC3U+#"QWU258Z)BXPY@)6$XA M@V"3S%Q?:"321]OKY M6=6"U";[R)7))%L6:#-1YGG5@M1$C3391\Y,#&N^D8PQ0QXTF03)0\M;SE2W2DR3J062Z>XOD7TO&,&./'QGU;D:_HV9G(-+3.4Z-';B&BQV<#'$#>E<5^:]XHKJ MNS7&=W`]%5DUQSVXMJ(VQOB# MA_?9\1DX96P.;+.[`SM].+B#GI(#_974A[SB5D'W0-R=!:!T+6^Q\J%A)Q`( M;J*L@=NG^'J$7QLHW(#<&8#WC#7=`\K3_WZQ_0T``/__`P!02P,$%``&``@` M```A`'3QM9N=`P``1PT``!D```!X;"]W;W)K&UL MG%?;CILP$'VOU']`O&^(@5R(0E:[76V[4BM552_/#CB)M8"1[6QV_[YC&PBW M)"0O28`S?^>)M8;X8*R++31:&Q;)(M83+-M:/_Y_7PWMRTA<1;C MA&4DM#^(L.]7GS\M#XR_BATATH(,F0CMG93YPG%$M",I%B.6DPR>;!A/L81+ MOG5$S@F.=5":..YX/'523#/;9%CP(3G89D,C\L2B?4HR:9)PDF`)]8L=S469 M+8V&I$LQ?]WG=Q%+T'M'ATD>VLEEJ@OY0<1.VW)7;L M\)73^#O-"*@-ZZ168,W8JX*^Q.H6!#N=Z&>]`C^Y%9,-WB?R%SM\(W2[D[#< M$^A(-;:(/YZ(B$!12#-R)RI3Q!(H`#ZME*K1`$7PN_X^T%CN0MN;CB:SL8<` M;JV)D,]4I;2M:"\D2_\9D.ZH2N(62>"[2(*F(]^=S.8#LCBF(MW@$Y9XM>3L M8,'4`*?(L9I!M(#,JC,/]#%U5+V>:A5Z5$D>5);0AG&'<`'K\[8*O/G2>0-- MHP+S:##P66%0A7"@FJHD**->4K_();,"*V8ENBKET=RHT[C]--XU-`K'"*3"L=8TH\(Y*&2*# MZ1)-FT3ET)Q?*174["SPVIT9C*\GZ(2:LUNX55"+VQ^W5#48T+92?CZ?5IC& MA"I?[]DTY_M70>T:CCO`"&XPIG\7[*&?/KB%7@6UZ=OK;3#=]4;@"/6&SS>J MT9=&JP#U<"F?N%I4]HBUKN,VRV=52+OC-@!6C0A*&6.PTL MP[A2W3T"_]BHF3&=.K3+(7./SQLSCI3+7+\.QIN:%1QWKW> M0&\K_,G[3)*LU,GC[J-HY;%7>`ROG7> MR'5*M>8=KINL#/5YV=$K"YF;9N8>S:;9;8^;#5"XS\YF;85/^9E[E9]I]"4_ M*T!=A=V;_$Q'M0VEK7`!*G=RYW5ASK/FN)<2OB5?2)((*V)[=59%\):M[E;G MZ`=/STCU`(ZQ.=Z2'YAO:2:LA&P@=#R:P1[@YB!L+B3+]6%RS20<8/7/'?QA M(7`D&X\`O&%,EA=J"*N_0*O_````__\#`%!+`P04``8`"````"$`DE"+-04R M```;5@$`&0```'AL+W=OTVUVVD\R<_;P0`/+#<[-)RC79 M:#N7/D"4>`L`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`I^!,OYN^ MO.GK?IK@\,U:WLF]\#RMF39:3>!N)!EYTYII(W^"PT;7\WM[/:V8-ME,<-CD M1FY;P"4/=_/=;JP[?:CS06Y+=,&:^-@:^>3)],D/GTL^T^[LBI0K MEG>RE^S8FIOY-R(?UKA?]_+N=KZFX!K]?I9L M*2]84^DGKR_8J-&-V@LVZDZOF45KET6S:(\_RINN/_K5LS85GA56"IZ"K[!6 MV"@$"EN%<("3=VQT;(T<^N(+UB3ZR7<*J4*FD`]P.,$7"J5"I?NH=46C*UI= MT3DPR\(N45^11;]ZEH7"L\)*P5/P%=8*&X5`8:L0#G#X-D<3.`=&/0#$%ZQ) M]#/M%%*%3"$?X'#C"H52H=)]U+JBT16MKN@'$OEQA/PQKGCE=8*7@* M_@`/+X]^;2ASU?]O?O&WUFTV[C:W]P]WV"1P5]CM7BZP9*M[#14BA5@A4=@I MI`J90JY0*)0*E4*MT"BT"IT#LUIL&C&KY?3AH5^ME2^S@J=AC5.*PDK!4_`'&$IY M>+E7Y8Y?ZR8;A4!AJQ`J1`JQ0C+`B1NV.[LBU9UF"KE"H5`J5`JU0J/0*G0. MS%KI?V.`6,Y?=;QL-J]EL911Q].XR,D%LH)X$'^4X9ZY?;B]Q9%@C8TV>^FG MME)8<.J#V_T'IP?F(22"Q)`$LH.DD`R20PI(":D@-:2!M)#.E7DY]F!O5L[I MPTO_^R4<7U#,L,@M1F4U[NBPQH/XHPS%7-^\'&7DF@4;;2`!9`L)(1$DAB2C MG+B!N_-+4NPW@^20`E)"*D@-:2`MI'-E7D\_Z'-_0W.FGF$NZ%[M+N]E=O#4 M__K1$CN4\0Q903R(/\K=R\7,K3T?XC"`?/GMS1J;;"`!9`L)(1$DAB20'22% M9)`<4D!*2`6I(0VDA72NS,OHIVFO*&,8OKEE/%[CN#(L!K7C.?Z.WL6#ZY?G\^B_?BS_5S?W5XML:?U17O:C*MN7[J6&Q.<^N!V_\'ID!-"(D@, M22`[2`K)(#FD@)20"E)#&D@+L6<8OG3T8 MSD#RY<+FN7\ZU.P\X@.:2`E)`*4D,:2`OI7)F'U,\3OR.D80PY#TF>1/#4/Q5NELTS9`7Q M(/XHP]UT_S(3E&/*&AMM(`%D"PDA$22&)*.#Y)`"4D(J2`UI M("VD43]S_(Z*AE'EO")YFLE3_Z1(J4AEA34>Q!]EN).NEX]'#T>ZYPWV M$T"VD!`206)(,LJI6[B[8$V*/6>0'%)`2D@%J2$-I(5TKLQ#Z@>2WQ'2,,=T M0WI\D(?G3_U39"4DE176>!!_E.%N6CP<'R/IGC?[_1P=/$[+CWQPN]_R<$DT M+9\DPIH8DD!VD!2207)(`2DA%:2&-)`6TKDR2Z=_0O-WI/.RV7QDO;R7*^RG M<='A\=TS9`7Q(/Y>CMS/Z_T'IWMULY#Z MYMC3:];8:@,)(%M("(D@,209Y=0MW%VP)L6>,T@.*2`EI(+4D`;20CI7Y@$= M&TJ?'_[U+WB3(PQ^5SJN<0\PS@AR>)$:UG@0?Y3Q?+(;W4:>*VCWF?("N)!?,@:LH$$D"TDA$20&))`=I`4DD%R2`$I M(16DAC20%M*Y,D_B^P;$U\/LURYJ]DGP">CC(O=HHR/C%=9X$!^RAFP@`60+ M"2$1)(8DD!TDA620'%)`2D@%J2$-I(5TKLR3Z*>D[E'BS`7,,%2='1WP5(QK MG;P^0U80#^+OI1^9R#.!UOL/3I..#22`;"$A)(+$D&0O1V[:[M0'T_T'I]N= M07)(`2DA%:2&-)`6TKDR;Z4?5;ZBE6&R.6M%GU#S=*WCSV?("N)!?,@:LH$$ MD"TDA$20&))`=I`4DD%R2`$I(16DAC20%M*Y,DNAOT*=I7#94W)>-COW4J9Q MD7,F@:P@'L2'K"$;2`#90D)(!(DA"60'22$9)(<4D!)206I(`VDAG2OS)'3* M>F$21Z:M#W*P?[K1V>HS9`7Q(/Y>#E(2N(!_$A:\@&$D"VD!`206)(`ME!4D@&R2$%I(14D!K20%I( MY\H\"1VG7G@..396U:?"W6"L"EE!/(@_RO2$U"M[YRL9AF&;#22`;"$A)(+$ MD&24/[Y]N[,K4NPU@^20`E)"*D@-:2`MI'-EGI`.5$\_H+WA(/6&EQ\Z-WT> M-SL<7U80#^*/,MTU#V]??F][^,^#]RGLEK_Q? M8YL-)(!L(2$D@L20!+*#I)`,DD,*2`FI(#6D@;20SI5Y&CHJ/9/&,.MT9QW+ M!WWVXXT.1)\A*X@'\46/;]_N[(H4>\T@ M.:2`E)`*4D,:2`OI7)FG\[J1ZLV1D>J-/FEM7'0XWSQ#5A`/XD/6D`TD@&PA M(22"Q)`$LH.DD`R20PI(":D@-:2!M)#.E7D*.C&]\'IV&(J>>8B#R>F-R@KB M07S(&K*!!)`M)(1$D!B20':0%))!RO>-5&^/C53UX?"XR&U&AZPKK/$@ M_BB'D_T2X>A^-]A+`-E"0D@$B2')*']\^W9G5Z38:P;)(06DA%20&M)`6DCG MRCRAU\U;;SEOYG/UVZ?[OE@^'L9,-)(!L(2$D M@L20!+*#I)`,DD,*2`FI(#6D@;20SI5Y*SJ0/7-J&@:Q\\<\\L/_=#LLZ:58Q-:?7Q\BPDM9`7Q(/XH4RM7;WE*TL^TP5X"R!82 M0B)(#$E&^>/;MSN[(L5>,T@.*2`EI(+4D`;20CI7YNF\;D+;OT.#_`IP^:"/ MC\=%[F%&9[8KK/$@/F0-V4`"R!820B)(#$D@.T@*R2`YI("4D`I20QI("^E< MF:>@`]C+'A_?#C-6.[Z?>$+BN,A-0D>S*ZSQ(#YD#=E``L@6$D(B2`Q)(#M( M"LD@.:2`E)`*4D,:2`OI7)DG\;K!Z^VQP:M,RI_&16X*.HI=88T'\2%KR`82 M0+:0<"_]PUOY'5"T_^#T"#:&))`=)(5DD!Q20$I(!:DA#:2%=*[,JWC=3/66 M,]4E7D,^+G*K[R`IK/(@/64,VD`"RA82CC*]BX'L!1><6Q-AG`ME!4D@& MR2$%I(14D!K20%I(Y\H\%)VXGKDN'4:FL\-5G%+&16X* MPV8'66&-!_$A:\@&$D"VD'"4\=KC^MA;+$47K(FQYP2R@Z20#))#"D@)J2`U MI(&TD,Z5>2[]V/$5N0Q3RMD5R$*GJ'?#HD,=W<].[(W'2A<]-QD=L-YJ98XT%\R!JR@020+22$1'MQ MIG_Z+R_&ERQ*]HL.!QK]ZE.LR2`YI("4D`I20QI("^ECT]4S#VN&\:A[ M)N)33>YTAOH,64$\B`]90S:0`+*%A'OISSMRG(Q.?3`^]<%D_\%#*_JM2+$F M@^20`E)"*D@-:2`MI'-EWLKKQJYW'+L^ZNL@GL9%[L$%8U>L\2`^9`W90`+( M%A)"HKT<#BZ/CU)1?,FB9+_H$(Q^]2G69)`<4D!*2`6I(0VDA72NS(-YW43V M[LA$]EHN`9[&16XPF,ABC0?Q(6O(!A)`MI`0$HTR7-?T;[*N%S;QV14)]KJ# MI)`,DD,*2`FI(#6D@;20SI5Y*J^;R=YQ)OMXH[_2&1>YJ>B4=H4U'L2'K"$; M2`#90D)(!(DA"60'22$9)(<4D!)206I(`VDAG2NS%.Z/35S[EY2?OC1YV>S< M^P:,BYPD("N(!_$A:\@&$D"VD!`206)(`ME!4D@&R2$%I(14D!K20%I(Y\H\ M"9VXGDEA&)G.KE+Q#C3W.E=]AJP@'L3?2W\M*8>@]?Z#TPE^`PD@6T@(B2`Q M)-G+D9NV._7!=/_!Z79GD!Q20$I(!:DAS5Z.7)ZW^P].-ZUS99Y-/R^]?,QV MWR^?_\[F<:GO*CXNL%R;!62O_[8%[G:P^0U80 M#^)#UI`-)(!L(2$D@L209)1Q0GOTWT+87;`FQ9XS2`XI("6D@M20!M)".E?F MV;QNQ'I_9,2J#_^>QD7N$42'C"NL\2#^*./=<^PY'FMLM#F_47!^R1;[#2$1 M)(8DD!TDA620'%)`2D@%J2$-I(5TKLSK>=V\]9[SUN65OK1O7.36HV/'%=9X M$'^4Z=1RO&[#><\"ZO-*WD!\7N7'HB'&%-1[$WXMS)70EST)=[Q=-U^8;2`#90D)( M!(DA"60'22$9)(<4D!)206I(`VDAG2OS.EXW3;T_,DU]1!TZ.WT>-SOTLH)X M$'^44]<%:VRU@020+22$1)`8DHQRZA;N+EB38L\9)(<4D!)206I(`VDAG2OS M@%XW8[WGC'7Y*#_Q3^.B0R[/D!7$@_B0-60#"2!;2`B)(#$D@>P@*22#Y)`" M4D(J2`UI("VDY*>C4=84U'L2'K"$; M2`#90D)(!(DA"60'24?YXU=P9M@FAQ20$E)!:D@#:2&=*_,T=(YZV:3D@?/4 M)=Z79%SD)H)Y*M9X$!^RAFP@`60+"2$1)(8DD!TDA620'%)`2D@%J2$-I(5T MKLR3^+YYZL,E\]1QD9O$L-E!5ECC07S(&K*!!)`M)(1$D!B20':0%))!B%QXNA@GGZ=_:/N@8]!FR@G@0'[*&;"`! M9`L)(1$DAB20'22%9)`<4D!*2`6I(0VDA72NS)-XW13TX<@4%&^Z.RYRCPXZ M%UUAC0?Q(6O(!A)`MI`0$D%B2`+905)(-HKSP'7^.Z`Q(>L(1M(`-E"0D@$ MB2$)9`=)(1DDAQ20$E)!:D@#:2&=*_,D=,S9'R7./TI]/#+NQ*/4<9&;!,:= M6.-!?,@:LH$$D"TDA$20&))`=I`4DHTR_L;M^OK(ZQYR;%5`2D@%J2$-I(5T MKLPC^;Z!Y^.Q@:>^G')!`?LH9L(`%D"PDA$22&))`=)(5DHXS# MC6-/..PR&U#984U'L2'K"$;2`#90D)(!(DA"60'22$9)(<4 MD!)206I(`VDAG2OS%+YOXODX##-/CS#&16X2.@-=88T'\2%KR`820+:0$!)! M8D@"V4%22`;)(06DA%20&M)`6DCGRCR)UPTX'X\,./'F'N,B-P4,.+'&@_B0 M-60#"2!;2`B)(#$D@>P@*22#Y)`"4D*J488SXM+>WV@^":FQ10-I(9TK\S"^ M;]SY.$PR9Y<62[FI3^,B-Q`=@*ZPQH/XD#5D`PD@6T@(B2`Q)('L("DD@^20 M`E)"*D@-:2`MI'-EGH2..R\;:CT.\\LSIP\=9SY`5 MQ(/XD#5D`PD@6T@(B2`Q)('L("DD@^20`E)"*D@-:2#M*./#L/L;/>MT[B:S M,I8Z[CQ=QLOR^>M=[1PW/\4]C8L.AX1GR`KB07S(&K*!!)`M)(1$D!B20':0 M%))!GX?QNDGF\M@D\[#K]S]\ M^>G-T[C(#0.33*SQ(#YD#=E``L@6$D(B2`Q)(#M("LD@.:2`E)`*4D,:2`OI M1AG"N+^^<]^L;)Z&3C;/'#.&T:0[I7C`E&*I\\MGR`KB07S(&K*!!)`M)(1$ MD!B20':0%))!:%UY1#"/*,U<4.L=\7JJL(![$ MAZPA&T@`V4)"2`2)(0ED!TDA&22'%)`24D%J2`-I(9TK\R1TEGGFZ'!DALG' MHCJQ?%ZJK"`>Q(>L(9M1QO/CPY$G+P38:`L)(1$DAB20'22%9)`<4D!*2`6I M(0VDA72NS-OXOJ'F0Y8.^&<:XR+VXT#'G"FL\B+\7Y_?U2WGU\WJ_ M:/]^!WMQ-Y/;&.P739MM(2$D@L20!+*#I)`,DD,*2`FI(#6D@;20SI5Y.#KZ MO.S)6\LC(]![##,P`ATW.Z2T@G@0'[*&;$89#R[WC[.+K)>+Y``;;2$A)(+$ MD`2R@Z20#))#"D@)J2`UI(&TD,Z562/VO)57/98=ULN#V7OY27^:5AUB>":M M2![))ZU)FXF&2!;V?^5Q5#"M.-RF+2DD1:28E)!VI)24D7)202I)%:DF-:26 MU,U(FM'IZ&47L(NK(V/2>_V76:95A_O)VM'1J;6C9.TH63M*UHZ2M3/0^"#. MOO`C\>A6%H^2Q:-D\2A9/$H6CY+%HV3Q*%D\2A:/DL6C9/$H63Q*%H^2Q:-D M\2A9/`Y)//V$\_+AV>)JF(C.KF.6^HK7:=4LFF'#`UDT2A:-DD6C9-$H631* M=H11LDB4+!(EBT3)(E&R2)0L$B6+1,DB4;)(E"P2)8M$R2)1LDB4+!(EBT3) M(G%((M$)ZZ5'F&&*>OHQRC#CC!*%HN2Q:)DL2A9+$H6BY+%HF2Q M*%DL2A:+DL6B9+$H62Q*%HN2Q:)DL2A9+$H6BY+%HF2Q*%DL2A:+DL7BD,3R MNJGKXNK(V!6OZHLEIU6S9C"SY2IK1E=9,TK6C)(UHV3-*%DS M2M:,DC6C9,TH63-*UHR2-:-DS2A9,TH6B9)%HF21*%DD2A:)DD6B9)$X))'H M*/?22Y=A.&MGN7TLRWMY$&L'&!WA/I/L`*.K+!8EBT7)8E&R6)0L%B6+17/++H+-=B4;)8E"P6)8M%R6)1LEB4+):!AD/\];%?#5@]NIG5HV3U M*%D]2E:/DM6C9/4H63U*5H^2U:-D]2A9/4I6CY+5HV3U*%D]#DD]QP:\Y__M MG\75D0GO4E]Y.:V:G9=TZFOU*%D]2E:/DM6C9/4H63T#C?7<]"^+W3_UXF7T M:_'H5A:/DL6C9/$H63Q*%H^2Q:-D\2A9/$H6CY+%HV3Q*%D\2A:/DL6C9/$X M-(]G\R2>M21M2,-$XSWOYA[8U&MRH<-KJ M<-,C4DQ*2#M22LI(.:D@E:2*5),:4DOJ9B31]&.]5PSO%L,8T+T"7N(?"5J, MJP[?^6>21>.,%%]^]"T:)8M&R:)1LFB4+!JE+3"*^#%,`X\\+OKA3,S?#G/6#M*UHZ2M:-D[2A9.TK6CI*UHV3M*%D[2M:.DK6C9.TH M63M*UHZ2M:-D[2A9.TK6CI*UHV2Q*%DL2A:+DL7BD,32C_.^)Y9A#&@1'@XT MG,C2:YQA M6NBFU#^A:7Y5]K18.$/%J24E:TG)6E*REI2L)25K2SD)0L)"4+2=?KMY'=0>$W3XGI8-0M* MR8)2LJ"4+*B)#B?YQT?Y1;LU-JV:SO'6F)(U-M%A7W;!(/,GJVQ:-NW,*E.R MRI2L,B6K3,DJ4[+*E*PR):M,R2I3LJ:4K"DE:TK)FE*RII2L*8>DJ7YD@I61-*5E32A:0D@6D9`$--/Q0 M+^X?E[RRMWQT.\M'R?)1LGR4+!\ERT?)\E&R?)0L'R7+9Z!37X\%I=M94$H6 ME)(%I61!*5E0#DE0_4C1#>K,]?/U,(*DSRAVF)R!IE3 M3$H6DY+%I&0Q*5E,2A:3DL4TT/#MO[]Z>>=ZU*2;64U*5I.2U:1D-2E934I6 MDY+5I&0U*5E-`YWX!AN__]M+MK"E*R MGI2L)R7K2E*RG@4Y]/1:4;F=!*5E02A:4D@6E9$$Y)$'U`T@WJ',G MN6%@Z8;T<(UG@5T[8\TI)"4+2&[B+_.L&=W(FE&R9I2L&25KQJ%Y,_USUF?-7'B` M>=EN/@^RA\7SBX6GQ;C*?>P.6G&51_)):]*&%)"VI)`4D6)20MJ14E)&RDD% MJ9QH:.?QV/,)JFG-X3M?DQI22^IF)/7T<\97''%NAKFD>\2Q08J\[9!EXXPO MQT,.R++159:-DF6C9-DH639*EHV29:-DV2A9-DJ6C9)EHV39*%DV2I:-DF6C M9-DH6383.=<$"_F1M7#^E[.[W6WB"`,H?"NH%U"RMB.4%8V4[Q#(%Q`"/]-@ M`BH0E`25WGW/>#+Q['E'LLF_T.*'%"2U.:*F2M*3!X6.T MY($CS_N@I?%EX7$UEBQ8G,#B!!8GL#B!Q0DL3F!Q`HL36)S`X@06)[`X@<4) M+$Y@<0*+$UBP.('%"2Q.8*F2L*2QX&.PY''B8&MI7"570\>"Q0DL M3F!Q`HL36)S`X@06)[`X@<4)+$Y@<0*+$UBP.('%"2Q.8,DI7SC/ M/D'I=U_0XX>AQPD]3NBIDO2D&6"M9\&_R\=Y9CA4$[XD?+]J<)%3#1MGD%#C MA!HGU#BAQ@DU.>7#UZ5[06JBA"(_"D5.*')"D1.*G%#DA"(G%#FAR`E%3BAR M0I$3BIQ`XP0:)]`X@:9*0I-F@C6:9:]F\BRQQM.Z0JXFCF7+<0*/$WBX@!4658N`@'E!"`G`#D!R`E`3@!R`I`3@)P`Y`0@)P`Y`<@)0$X` M*FEPP/07'%1E63E@H'("E1.HJB14:798HUJT$^598XV)'ZW^S;C9C:N19-'D MA"8G-#FAR0DY3LAQ0HX3P.('%"2Q.8'$"BQ-8G,#B!!8GL%1IB&7RR`'R['$+ M)SGWJ^J+G)"VNY!V8MJ=I\&VJ_]]]=Y\6=EV]V-Z$=-!3"]C>A7384Q',1W' M=!+3:4RO8WH3T]MYJH].IPN\L_FRQ70>T_N8/@R24*7!8;T#+3A/3?*@ M<7B>ZL)'">^7#315(\K[2^:P"DU>A28GY#@AQPDY3LAQ0HX34.*'$"255DA)^W@,E2YZG)NEQ"[]!<;]J@"4_ M<)[8>IS`X@06)[`X@<4)+$Y@<0*+$UBP.('%"2Q.8'$"BQ-8G,#B M!!8GL#B!Q0DL51*6-`FLMY1EL>0)(L\[G_?%#[Y/\JJYC*TN)+!X%5B M*()OOO/$VV"D[UGHCNHA@<6KP.($%B>P.('%"2Q.8'$"BQ-8G,#B!!8GL#B! MQ0DL3F!Q`HL36)S`X@06)[`X@<4)+%42EC00K+'\6K"CY`%BO:,TON@WJ<:, M94=Q`HD32)Q`X@02)Y`X@<0))$X@<0*)$TB<0.($$B>0.('$"21.('$"B1-( MG$"2T[/9O=G'*_D;CL,/2L'&CX.-$VRJ)#9IY/<[;/*(<,`FWO9B4@T2"QLG MV#C!Q@DV3K!Q@HT3;)Q@XP0;)]@XP<8)-DZP<8*-$VR<8.,$&R?8.,'&"38Y MY3=;UM;">RV8\8,PXX29*LE,&@#69I8]+^7!86V'H;`F!9O=I)HO%CQ.X'$" MCQ-XG,#C!!XG\#B!QPD\3N!Q`H\3>)S`XP0>)_`X@<<)/$[@<0*/$WA*JBX= M_%$O`)55Y8(80$X`JI(`I:%@#>C7@G-5'B)R^\KR@B@);:O1A`2;@5W^O+V[_K8__7*5=A]&/0L,S9YH.#;F)N_#T^DF[TTC MDZ<;[%&=/M*U52TK(+<;;:?1=AMMK]'V&^U%HQTTVLM&>]5HAXUVU&C'C7;2 M:*>-]KK1WC3:VT8[:[1WC7;>:.\;[<.P"5J:%M9[4F*5+K=_&UH>.PX$K>C- M`J#E58*F60W0'I95T$(#6FA`"PUHH0$M-*"%!K30@!8:T$(#6FA`"PUHH0$M M-*"%!K30@!8:T$(#6FA`"PUHH0$M-*#53="0$:`]:D=+3Z0=+;YUL9I7"9H^ MA@RTAV45M-"`%AK00@-::$`+#6BA`2TTH(4&M-"`%AK00@-::$`+#6BA`2TT MH(4&M-"`%AK00@-::$`+#6AUR]">WGZ>3N^V+^XNUI]_F]Y<3;>F7[_>/KF\ M_IGFBMP\H5Z#4WU\+EY_);W^2OOWNO1[LVL__1EV5_N]UFOMC_K]5G\QZ@]:_6C4 M'[7Z\:@_;O6347_2ZAM=O]'JFUV_T_SS=_U!J[_J^L-6/^[Z=ZV^.>JW6J^[ M/>IW6GUWU.^-&L=Z=]SOC5M]TN_-)LA/'WX`M^O/?UQ<30\O;JZ^?+]]\G7Z M"5LK?S[CA'F3+\GR+^ZN?\RNSOZ^ON-R;?:?GZ<7'Z&PO=V]R:W-H965TY(.])JM8=KFI`$=0@1T-,S;[]5+@-ENP_D9J93_EWY['+^`M]_^E&= MO>]%TY;U9>N+6>A[Q26O]^7EN/7_^?O+W5U=(\5B>R^ZG2NI[5;[Y>KS43?9XAG7_$/,L[W.K#T[ZJLR;NJT/ MW0S2!03JKGD=K`/(]'"_+V$%N.U>4QRV_F>QD7'D!P_W:H/^+8N7EOWMM:?Z MY;>FW/]17@K8;:@35N"QKI]0^G6/(9@<.+._J`K\V7C[XI`]G[N_ZI??B_)X MZJ#<"U@1+FRS_RF+-H<=A32S:(&9\OH,`/"O5Y5X-&!'LA_J_Y=RWYVV?IS, M%LLP%B#W'HNV^U)B2M_+G]NNKOXCD="I*$FDD\R!7H]'LVBU$(ODXRP!$:D% MRJS+'NZ;^L6#4P/?V5XS/(-B`YEQ9?,W5P9+PCF?<9*:"NH6RO']081B?A]\ MASW,M6A'(O@)#*+(5*2N(@Y-B70ER\4@"6`-PT)@>^R%Q%#HUTO4+P0GF0N) MUD-ZM=8=25:J%+CXU`Y(%C"(8I/H?1(4P[%@NP5;.BZ56$@T'UGL@&0!@P5* MRW?G?184;WU8UE`YL;912+-4Q4\6H56WE(9'4LD"!ABE@*#;!XGELU8LT MB0*[BV*'C,89&0L89(E)AK^,CP\43K((%RN+D#0]X7KE()*`(;*`@;@T$=^O M*HHMM#"QT$A#:,O0`:-A!L8"!A@V/N8J[X.AV`1;KI86&&G&;T[M@&0!`V5] M"PJ*/_P5DHBQV`')`@:+`$.:OB]*;6Y,;/\,M88J%H?"_AWJ\1%6\H@)AUX[ MN6B"G)F;1&SY^TYK"$Z$26*UB%0+.!VE51&3#EUV.AUY,J=S+4R0B/"B<&G] M&%(]SNEHQBMTZ+O3Z.37'&^YMC9GIU+"D\S8 M*9V(Y!%SN]!NIV\7F3-48^R6;N<6S,)5M5(G(GG$!$*;G0Y$ILPWR+4-9MP: MIX_@<8N%=1JEZ(>=LX6^.YV-7-I@7<>D23@LTP-PZ->#H< MV3:'>\4TF+=KNCZ".Y?8#BQ%/VSO7'13,U!JJQG,[:W3(G;LAPC"1<+LJG(8 M==ANZ@71*[W`>2[3(L[6>STYG`/7#SMP4*'I58U0;6V<8V=:Q.%H&IVY>;*R M&J_D,XPS%Z$O3SYS2FW2+==.66VK3_6TD5?RB,ESD_E'9-(?N)E6C5^?.A') M(R;037:/K[9V^:Q:[+2&X]"L,2*U1C>L->M7)MQ-WA^1JW/'+ M74-CSJ[I[(B,^@C:R'(]-@<3#FUX.AR9M@EGOVE&S-DUG!V1@X8\;CX^`1MT M^&(YG4ZI3=-PGQ^UB)T[)R*'B*);Q&_16=U@VJMP_$I7<-Z%M8A3,MM7NRJU MAHX?O-)'\S<.(%P!WK*+J+9VT6D,*J7Q(.E$\.81$]%=B$A6Z[&349'I7I&N MW:JB.19I<3ZW7EX_XYUA#%<50Y3N,W=BLU/7F58\%9OTM;B$^T\5#X8)V[/N)./_@T/NV M"1($2<=X=I0`@KC?[V\:63-6C&TY),UE__U>S:KLE5W9:`%SSHM%)U=E5M7* M7J@J%,`__?>_?_OUNW]^^/SEXZ???WK3^O[FS7>/O__MIS?;3?^_ M'M]\]^7KN]]_?O?KI]\__/3F?SY\>?/??_Z__^=/__KT^>]??OGPX>MWQO#[ MEY_>_/+UZQ\__O##E_>_?/CMW9?O/_WQX7?[S5\_??[MW5?[W\]_^^'+'Y\_ MO/OYM=%OO_YP>W/3^>&W=Q]_?Q,9?OQ\"<>GO_[UX_L/O4_O__';A]^_1I+/ M'WY]]]7Z_^67CW]\`=MO[R^A^^W=Y[__XX__>O_IMS^,XB\??_WX]7]>2=]\ M]]O['X=_^_W3YW=_^=7&_>]6^]U[<+_^C]#_]O']YT]?/OWUZ_=&]T/LJ([Y MZ8>G'XSISW_Z^:.-H)CV[SY_^.M/;T+KQW!HW7?>_/#G/[U.T>[CAW]]H9^_ M^_++IW^]?/[X\^3C[Q]LOBU310[^\NG3WXO0X<\%9(U_D-;]UQPL/G_W\X>_ MOOO'KU]7G_XU^/#Q;[]\M83?VYB*H?WX\__T/GQY;W-J--_?WA=,[S_]:AVP M_W[WV\?"'#8G[_[]TYL[$_[X\]=?[*?.]_WC_[JZPPRU26?Q0LESMJEL\C<4/B>;^^ZL[`V?'77D=-;SNGUV9OJ MTX7%\0[>*'[XC\=TAZ06/Y0L5X_I#H][\4.BN?YQOX,WBA_*SER;ICLDN_@A ML5SFL#L\[<4/J>73)4_['9Q1_/`?=[R-Q[3X(;&TOV_?WC\\7O6JB92V.:77 MSF(;3UOQP_]#9Y",MB>CY:7W0J^W\<@4/Z3.=*Y_=;W'(U/\<&V:?H@KG-<% M4^_=UW=__M/G3__ZSM:AEJPO?[PK5K6M'PMB+)7B.J-('>ZS+9]LJZ/^/9[N@*9YMI/HM`'_8 M;[,'&1%HTLN!YQSHY\!+#@QR8)@#HQP8Y\`D!Z8Y,,N!>0XLV.;#+@7T.''+@F`.G'`A!D#*92%7H2HQD+TCZ@N0O2`*#9#!("H/D,$@2 M@V0Q2!J#Y#%((H-D,D@J@^0R2#*#9#-(.H/D,TA"`V>T\B#;LK3R(->?8^"U MN(BVEW-+8\.+<0JZL=I!40_9<^Q1L$=/H6>%^@J]*#10:*C02*&Q0A.%I@K- M%)HKM%!HJ=!*H;5"&X6V"NT4VBMT4.BHT$FA$&JPMS58MP:KR7BH27FHR7FH M27JHR7JH27NHR7NH27RHR7RH27VHR7VH27ZHR7ZH27^HR7^H,4"H<4"HL4"H M\4"H,4&HNJ!2)VSC>46=**)?ZP2>[;<)R8K"8U84/`H->PH]*]17Z$6A@4)# MA48*C16:*#15:*;07*&%0DN%5@JM%=HHM%5HI]!>H8-"1X5."H50@Y$%D-S0 MK8FKR7BH27FHR7FH27JHR7JH27NHR7NH27RHR7RH27VHR7VH27ZHR7ZH27^H MR7^H,4"H<4"HL4"H\4"H,4&HNJ!2%.P$Y(JB4$17BT)"LJ+PE!4%CX)O>@H] M*]17Z$6A@4)#A48*C16:*#15:*;07*&%0DN%5@JM%=HHM%5HI]!>H8-"1X5. M"H50@[VMP;HU6$W&0TW*0TW.0TW20TW60TW:0TW>0TWB0TWF0TWJ0TWN0TWR M0TWV0TWZ0TW^0XT!0HT#0HT%0HT'0HT)0M4%E:)@YYE7%(4BNEH4$E(I"O>= MNZPH>%19%!1Z5JBOT(M"`X6&"HT4&BLT46BJT$RAN4(+A98*K11:*[11:*O0 M3J&]0@>%C@J=%`JA!GM;@W5KL%X-5I/R4)/S4)/T4)/U4)/V4)/W4)/X4)/Y M4)/Z4)/[4)/\4)/]4)/^4)/_4&.`4..`4&.!4..!4&."4'5!I2C8^T97%(4B MNEH4$O)4GA1V!>D)\BQ(7Y`700:"#`49"3(69"+(5)"9('-!%H(L!5D)LA9D M(\A6D)T@>T$.@AP%.0D2@D)O%=*T!LUKT,0&S6S0U`;-;=#D!LUNT/0&S6_0 M!`?-<-`4!\UQT"0'S7+0-`?-<]!$!\UTT%2'2JXK#[2]'W?%`UU$5Q_HB+3] M>T\GS:?8`KGL\BNOI\1N3!*K2? MX=_=9(OPU,Q?E7L1N:LVR]Z+?RZ#L'3O"_(BR$"0H2`C0<:"3`29"C(39"[( M0I"E(*N(M'R"UH)LRE8\T]F[GMLR"%.V$V0OR$&0HR`G04)0Z*U"784\^^AE MT%P'37;0;(>4;IJZD/+-D"><)^^^:M.@)@C)!QB#VB8DWT2N2E4I M;LY>459>PZMU)4%66#":+J+\*>DEB,;\K%!?H1>%!@H-%1HI-%9HHM!4H9E" MX+@:$]@M'VU;8P.[Z:-Q,`)-I=WVB7&,D15X,K,K9W8)2"7@#Z:# M01@CA[!$=O!M]X-4`K9A.OB&,1C'9I0DVNVL-,),//%P$]/!.XR1>5@BK[XU MAK)[13SOU1)37#GB:X/--Q):\8:274F`I]\FJ%)B4A27F`C1P)]30X+Z"KTH M-%!HJ-!(H;%"$X6F"LT4FBNT4&BIT"I!E-JU0AMO2,F^R_RT]2BD8Z?07J&# M0D>%3@I9B9%$6HE1K%N#]6JP&A?854+EJ_&!72>,<3255F(4(ROP9&979*S$ MJ"S\P1(P"&/D$))HYXN+&M?8)43M,7S#$C`./2]V%5&[#.MP6QB%,7(*=SDO MO#7NL7K"7:[6D^+.V17U)%Y1J]23"%7J28KB>A(AFHSGXIY4]<6OK]"+0@.% MA@J-%!HK-%%HJM!,H;E""X66"JT21*E=*[31AEN%=@KM%3HH=%3HI)`5#TF1 M%0_%NC58KP:K2;D5#^6K2;H5CQA'\V;%0S'*>W$9_O:FE15AJQNJ"!\P.XS` M&#F!'\)\UU#C#JL;VEGX@R5@$'I4K&YHEV$1;@N/,%9C$KO*K'RP26Q;+1+% MY30N$O&S"M\_V%O17W_Y^/[O;S_9,8C5F)K%R)U])B%]4B%=<>.U2(0JM2-% M<>V(D'U(!J^:S\7G!(O:X5!?H1>%!@H-%1HI-%9HHM!4H9E"#5:33=*L=,8[F MS6J'8F7>:3]6)IXP9)[YD'K&RMQ7=QG9Z95M9-(P2`*&8#HX@C%8HEHME`^F MX+9P!6.E+:@OI2\(@S%BVVJU*&ZM<;6HJ0KV6=7A0:`&+ZNVSW-O0@L(\`.?M8 MH0D@9N^TL[.SJ4>!?@;(Z><*+0!5Z.^SEZFE1X%^E2"RQ%JAC3?TJ<_G9NM! M8-\!\L[O%3H`JG8^.ZXY>A3H3X"$/J M:CL[?9MZ%!Z.F7+-%5IX0Z*_SUX3EQX%^I5RK17::,.M0CMMN%?(OBH%Z>"N M9ON)HT>AJR?ELD(DB;3U4"F`IE9U%.O5M(57R`6V'M*V<`L_#[`+MX5?&(-A MN"T$#,I`M2+0O<`+SP0K<%EY@#&;@ MMD@]8\@]MT7R&4/VN2W2SQCRSVUA`,;@`&X+"S`&#W!;F(`QN""VK58+6PY4 MJL6_:[\GJ]PJ%>'9&\81ZMAYCF^"[K-#X6[Q?43%)BA^Y5;\@H<(/7CQ>$Y1 MCW:04W+==[(7_GZ*>K!+31Z5O2:^J.``[+8W+=O=/F1;DB&BBOUA<7IWG]6( MT27R8Y6?@+A1?HJH*-^Z>;C).CAS?=2HN:HMP-.HMD144FO?/V6)6[F:3]I] M-MEKU=^`N5%_BZASD[V[1'ZO\@<0-\H?$97D[V^?LLW[Z1)]JY7B;JN5$7ND M(PL\!8SU$/?ZG7CQG!+/`3TM5BL37^.([(WU%):&]'"7GT=8-8TAC<^/;?AB M%/Y.ET8Z^ M+QDS'@?6PP/`>O#[8]1K/3UF3XU]O\K`_Z\'QK`>#FYX_A)W[[*S&WF1K M%JT6_N)**"\3OU'XXPU2.[7'K+\MOB#.2GJ'S="YSV:^FZ)HB+T$6>[!]9R@ M1S^%Z&O4BW(-T-#[-03D=Y='RC56K@D:.M<4D'/-E&NN7`LT=*XE(.=:*==: MN39HZ%Q;0,ZU4ZZ]V<%+6EX]ZR"18P<9/5*^X>\,Q\2_TA\R#SS(?7^9#\1W>S51OM M']+/?,@_\\$`S`<':#!Y@/)F`^N"#R5O`8\`_K&>C`J6D.OCOD2Y44%!V#WS@\!%>\9_O// M[8?\LN<(`4U:8]6:H)UK30%%K;M6NYT=0H6(IG&L56R#=BZV!13%.K>/V8)UAX`FK;UJ'=#.M8Z`4GYN;'E=*+U)@K#B4Q2\;=\]ZE+L$D&XE05+?Y(@#/K4?GV"6D]/V5[! MBN,E>K`PZY6F)3UXM-2K68I=H@<7LUYI7-*#3TW/BTVGD[G0EF+-HI6:6WQ' M[A4U]S6\N@=/T`-[IG.?/?-=-'3/]!+$-1>0V[L/R.O0BW(-$.6S-03D:_41 M(.<:*]<$41<,T#.-5>N!:*<:PG(N5:`G&NM7!M$.=<6D'/M`#G77KD. MB'*N(R#G.@%R+OLFM\(PY@!/9'@+S--FW^:6X@A#QBO5"W'$5^;<>V??ZA;Y MK)B41:?,.O4/:>?^E7DG/B2>^8K/4!\,`'SE2YXY:N6A>+*Y.5+L=LB/"L+$:H]_1HSAM25";XHH(#L/ML#0&E%Y+64U9C1Y=HC55K M`F+7F@)*6NU._F[@S,5@K;E2+\#CU$M`B?KA+E^QK)SZ_)RM56P#9A?;`DIB MG?Q;.7:7:.U5ZP!BUSH"BEIWK?O\#=K3)6)6S*))R7Y6S"+&^T78E#'XE#$8 ME?GZX//N6S%+&JG_=[>M;/EMWUD90^PQ.)\9^QY+'0"\R1LQ6-$VGL7>HF5? MQ)\?X,":S8)P*X\0_F1!&-1V?O$D^R8_I8)?F_5@8=:#:5D/'DUZ=:=B%TTH M7,QZ,"[KP:>FY^FI68I]0[1:1<.^7:*]+W#,?DL^G3L@^ M\R']S(?\,Q\,P'QP`//!`LP'#S`?3,!\<$'DJY8%.^.NE(77.Q5/W]MEE^9C M\]NB8;8HBU#'-HCENY"=3O;:TT5#>K\T00^^FG\&9,DKN6H695'1&E*4+,I2 M3UUP`'9?[@\!Q7=V[F]D37:!U#B1V%4AK*4FX'6I*:#X`DHOQ/8G<:IG2"L$-$W86K4V:.=:6T!G)FR'WS=)[57J@'8N=004 MA_5H9V/589T0T*1E%4V,8!4M8E1L8%"">AH%@U*J[=O"DT>\ZU;.$I;Z?I_W MW8I;BFCL//S)>B.T)#U8\"'JW=_DY]/V/>.7Z,&DK%?ZDO1@3/NXRNO:[^DI MNW=IWT=^B1ZLRWJE6TD/YBSU\O-?^][R2_1@7]8K+4MZ<.CKQW'*OP*2[S[L M2\Z;1:LUM[CE>\52+-U/]A?)M[<1JFQ_.YVL\'53%+UB]!)$+RS/"?K6]C:IR"2&H"7I>:`HH/0Z=]DTW1S+50 ML.?*O`"-,R\!1>;6XUVVXUDY\_E1K%5K`V+7V@(Z,V&[2Z3V*G4`KTL=`:5J M=9N_<7.Z1,LJK1C!*FW$>$T(AS(&BS(&CU*VK=@F/N^]%=N$I>ZW\U=Q*[8Q MHM''MK:,4:P'6_):"RY,&]]'F2XKMI?HP:>L!VNR'KQI:[NSQ?82/;B7]6!8 MUH,_2SU]"^*B\<'!K`?7LAY,:GK^T'0Z^>8>QCV7Q&JQ+:YM7U%LXRWORKXW M0MF^-UNS=>U35\5ZF(;82U"EV,:HRKXW0A3UHER#!-%L#0'YV_,C51PKUP0- M_@FJO#,9N9XJ6X!\ MY=[WAEX=Y3:("@[0SCL_!!1?*'.2$7Y=>4LD6SN-56F"=JXT!13?IF_=YW]` M;X8`?]MIKLP+1#GS$E`<0SM_.WZ%WS<-8JU2&[1SJ2V@^NG:X==-2GM5.J"= M*QT!I5L--_DUG1,"FK2LB"6_TON>,"R_/UK:TT\:`OS)<<\U?*4=O?=6Q)*1 MT?W\+3DK:2FBL?_P)STV]C>T4DO2@P?M?<=B0?1TDYUWV/KK$CF8E.5*7Y(< MC)GD[`I(=OIMF]U+]&!=UBOM2GIPI^MEJP[;[%ZB!_^R7FE:TH-'3<\K3">O M0[;9;1:M%MKBYNX5A39>]*VLO]+=7W9,IY/MM[JWJ:$[OI>@2J&-459HL=_K M:]2+<@T0Y;,U!.0OV"-`7LO&RC5!E'--`?G)PPR0<\V5:X$HYUH"\GZM`#G7 M6KDVB'*N+2#GV@%RKKUR'1#E7$=`/L83(.>RTB6)M/57PCQM=@5$,62\6KJ4 MK\RY]\Y*5XSC*QMEUJE_2#L_2V7>B0^)MV<)5K-JE#2(#ZEGOC+WQ(?D,U^9 M?>)#^IFOS#_QP0#,5SJ`^&`!YBL]0'PP`?.5+GCEJY8%V^)=4Q:*\.S=A@A5 MS\#R*PC=VQAE$X\L]!+4\<0\`[)E;].[#4F1JV.^='I1P0'8??&71:6>6<(<#G8Z[,"T0Y\Q)0',1C/OC!ATFO=R)*H]&2C'FQ*#ZIM0U-/20_6[)1'8/F2J'1JHQ[,RWJE84D/_CRO M5]JU40\.9KW2M:0'DYJ>9Z=N"=:EIH#2 M9O?Q+GOX9@CP%]BY,B\0YRY M1JR/EB3V`BR-K9V_/6>%^`+C62'6P8W0DO3@4%M_%5OA1WE?M/1KX_!@85[N ME:XE.=@VR=E66.OP)<.#L5FO-#/IP;OG]4HK-XX/[F:]TM&D!P.;GA>@NCK< M/,A*';ZSGEU1AU_#JVO>!%4_#?&0/31=-*0ZG""NPX!\3]4'Y-7I1;D&B/+9 M&@+R)>0(D'.-E6N"*.>:`O)MX@R0<\V5:X$HYUH"\GZM`#G76KDVB'*N+2#G MV@%RKKUR'1#E7$=`/L83(.>ROV]=&,8XHCON8:O MS#GQ(>F5K7`-']+._2OS3GQ(//>OS#SU#ZEGOC+WQ(?D,U^9?>)#^IFOS#_Q MP0#,5SJ`^&`!YBL]0'PP`?.5+GCEJY8%6PE=4Q:*\*PL1"C;"F>O;]V[&$5O MI/021.^W/"?H&]=!O*%7QWRY\:*"`[#[;`T!Q07]77X_:G2)U%BE)N!UJ2F@ M*/64?R/(S*7P',V5>*%12Q!77GKR<].5-SP_:6L5W(#=1[(%=&;2=I=([57J M`%Z7.@(Z,VFG2Z2LE(GYK)1%C-\MA4D9@TL9@TW)S*$//N]\@`?QT82[_&L! M`RQIS\#YK`2XE/7@3'X7$D:T=R&+55B[E3V$`;9LEH-360[N9#G8,\G9*BR_ M*T%N;1@>#,QZL"OKP9WG]6#6YO'!OZP'S[(>+&IZWON:5=@W/%@MM\5]\,MW MPW?Q^CCOAA-4O1"2O]/535$TQ%Z"*N4VW4[WEYF^1KTHUR!!-%M#0'Y98J1< M8^6:H*$_.%-`SC53KKER+31J"2X?XTJCULJU04/OUQ:0]VNG7'OE.J"A``[?Q9&`**IP>W\M5P^'UEA9,=&H]3$*V/)VCG4E-`4>HA_\-0 M,_S>R\5I0YHYU)' M0&D$UDI9PF+O]9LS M2DI89NT%Z"*M4V1O&M$(UZ4:X!HGRVAH#\57L$R`O:6+DF MB'*N*2#GF@%RKKER+31J"<@?\Q4@YUHKUP91WJ\M(._7#I!S[97K@"CG.@)R MKA,@Y[+*)8FTRI4P'Y)5+L60\6KE4KX^=+UW5KEBG'F_7#256:?^(>W\+)5Y M)SXDGOG*S!,?4L]\9>Z)#\EGOIKLVR),QUOFG_A@`.8K'4#]@P6X?Z4'B`\F M8+[2!:]\U;)0W#N^8A$6KRE7%F$1^M916(RB)63O+D*TTGQ.T+>.PLJ&7AUU M$2:"`[#[;`T!Q<.#UF/^&53OXWFI<0JBL4W`ZU)30%'JL945SIE+P?=S)5YH MU!+$E9<>/0J[8-+6*K@!NX]D"^C,I.W2[RVQYR=MKU('\+K4$="923M=(F6E M3+Q@I2QBO$_LUF!P*EV$Y1^0LT58)&J6@U%Y=#`G[_;@SB1GB[#L7;%`9CUO!"N4.KQ5S?!@ M3M?31=@EXX-]>7RP+(\/#C4][WW=(JQ9M%IMBVN\5U3;>.NW4FTCE)V$93/1 MO8M1-,1>@BK5-D;Q1Z,TZD6Y!@FBV1H"\J..D7*-E6N"AF[D*2#GFBG77+D6 M&K4$E[^2KC1JK5P;-/1^;0%YOW;*M5>N`QHZUQ&0+&T:J/]0_J9#_EG/AB`^>``[A\LP'SP`//!!,P'%T2^:EDH+BE?41;2 M_6I/V%O[>R[%=NU;)V&I(>_-(E39FR6H\5"GGQ2MH5='782)X`#MO/-#0/'P MH)7?:QGA]TU2XQ1$R^,)VKG4%!`.=;)SBAE^[^5BKL0+C5H":IRT%:*:1K)6 MP0W:^4BV@,Y,V@Z_;Y+:J]0![5SJ".C,I)WP^R8I*V7B!2ME":OL)Q7KU<0] M`W,SVR(LMJV>A"4L]OXI/_RTNI8"&KL/DY*_["1,Y>!#VWZ]+L):^>>52E:TU,3X,XD5[L(NV1X\"_KE6XE/9C3];*E1RB]VC@^V)?U2LN2'AQJ M>EYFZA9AS8.L5EM;T%U3;8OP["0L0ME)6';SM&M_->>UH1NTEZ!*M8U1E9.P M!'D1>E&N`;A\MH:`_.AD!,BYQLHU091S30$YUPR0<\V5:Z%12T#^F*\`.==: MN3:(\GYM`7F_=H"<:Z]AZ[VP1%N/,^^4BI\PZ]0]IYV>IS#OQ(?',5V:>^)!ZYBMS3WQ(/O/59-\V M>#K>,O_$!P,P7^D`ZA\LP/TK/4!\,`'SE2YXY:N6A>)>Z16+L'1)V`7?WD4H M.PG+/LS235'TL80>&GJBGP'9YO+\.VM]1'%UU$58[!8)#M#.MQ!#0.E#2ZT[ M.0I+HVO2&B<6TIJ`V+6F@*+6_4U^`SLW;#@$LEN=HKUH'M'.M(Z#T2:/'VVQQ<4)`DY;5 M,S&$U;.$N9K5,\5@U`B,;^PZID,EN* MJ1[,B`]FR1\.L0.QU*I1#W9EO=*A-#Y8U#^XE+U;;UO42_1@8M8K+4MZ,*CK MZ5KL$CU8F/5*UY(>3/JM#TI]8Y"5HMNV5>(51?*U&*#&35P?44T+W!<5''@[O)P/`34*CA#5)#A6P8FW@^`44*/@#%'^HCM7 M^@6B_!5P"2A^`N?^)G^38X6`IJ&L56N#=JZU!10W6H_Y%U+O\/LFJ;U*'=#. MI8Z`XK#:M_GUAA,"FK1"4+'P%ABO(VNP7@WV#,Q-'4IS>N\#O&@?+BBVI)J5 M0-;TE\W\-2K`K;SN*KU)>K!BTFL]R5]=)V.[O9'O MH"NMVI@?N)?U2L.2'OR9]&S/G2WQ0FG71CTXF/5*UY(>3&IZ/EN=Q_S=EM*X M9T2K==<*P#5UMPC/ZFZ$JGO@_,\U==NIH5NTEZ!*W8U1O`?6J!?E&FC4$)`_ M4"-`7L[&RC71J"D@YYH![P`Y MUUZY#HARKB,@[]<)D'-9[9)$6NU*F$]/*!-.&#)>V0.CK1O#:E>R@??.:E?" MO'M6K1)&_4/:^5DJ\TY\2#Q_T*HF\P&I9[XR]\2'Y/,>L\P^]0_I9[XR_\0' M`S!?Z0#B@P68K_0`\<$$S%>ZX)6O6A:*R\F7[X';\2XSOS^9H.H>^#&_DINB MZ&V47H+HW9;G!'WC-H@W].J8OW:]J.``[#Y;0T#Q#?3[AZS;HTNDQBHU`:]+ M30&E8^+'_&M?9ZZ%Q=M@<>8EH#0(^=RZ$Y^?K[5*;<#K4EM`9^9K=XG4 M7J4.X'6I(Z`X7_;G#;/3UM,E6E;&].;^6U"[FI6Q&&?OW[TNF3(C!'+K^4D, M,##9W(I<8B8UN#-]9.K^YC[7@UGMZ6C0@W]9#Y[E=R=AT:1W>R<+&#BV60\F M9CWXEO5@W#2;MF#*DA?@XV8]6)OU5C7S"?>>UX.9F_7@;]:#IWE\L+#I>7;J M%F@Q]>=$JY6XN-I[126.-X$KE3A"U9LBC]F11+<=HVB(O019-U%YGA/$-T4T MZD6Y!FCH;A\"179M6H6XRCC5KN4KU_# MAZ1;+2GYD'7F0]K):`%YY_XA\:#!Y@/)F`^N"#R5+9OBU!V7I9=1NVV4T-?GO<2 M5-FWQ:AO?&;*&WIUU`6:"`Z\'9PU!&0;@/)X7_Y&S0A19S;"[[_[_-.;<0JB M!?0$[?SAFP**1R>M^_RMA!D"?&T^5^8%HIQY"2@N:/(OUUSAUTUC6*O2QMMA MTK:`&B=MAZ@FP;T*'M#.AW8$E":MT\Y>[D\(:-*RBB:6L(J6,-I>EEXE#&:M M;CF5KX^>>.]MRQGC<'PEW;<-:(IH[#_,2@ZSBI=:DAZ<:%NT8JWY=)>]J1-* M7S;*P:HL5[J3Y&#/)&>+L>S=,5N,73(\&)CU2M>2'DQZ7H\\2T]UME`)L#'K ME:8E/7C4])RMYB\:?&.0U:I;7/&]8C$6;P17%F/IDC"GL)/_;8=N.S7DJANA M2M5-D/N]GQI2U(MR#31J",BY1H"\HHV5:X(HG_DI(#^JF0%RKKER+1#E7$M` MOJI8`7*NM7)M-&H+R,>X`^1<>^4Z(,K[=03D8SP!Y;P:F+52/F0>N8K M. MKR@+\7YRI2Q$*#LMRUXNN^T814O)7H)HQ?F MD$[^57XKI_>AW,F-$57<@-X5MX#BV=+#7?:N_:Y.*T_17J4.X'6I(Z`X;7?M M_*^HG2[1LG(F?K!R%C'>R\"HMI6K/)%ID:OV[N:J@?G\N!@U'1HUKIKY^_ZP;?->K`R&3[`O:P'^V(RZ]9I MEXP/!F<]V)GUUIC/E#S5@Y>;QP=[LQXLS7IPL(W/W5"W3FL>9+4@%[>`KRC( M\=)PI2!'*#LTRS+=;<8#R9@/K@@ M\E7+@I68:\I"$9X=FD6H>FCVE+W@=-NIH:_2>PFB#Z0\`TJ7B1[R-^CZ"."] M8OXR^:):`[3SQV`(*)W$M/(;ER,$-&F-56N"=JXU!12U[FT]6/V3P3,$^$)_ MKLP+1#GS$E!\I;_//\&SPN^;!K%6J0W:N=06T+D)VR&@26NO6@>TN]MKQGCTC%9YS'_G!ATKM]E'.KTI2->O`IZY76)#UXT_:"9V^573(^N)?U2L>2 M'@QZ7J_T:^/X8&'6*UU+>C"IZ='Z*[^)'TKCGA&M%MKBNO$5ZZ]X.[FR_HI0 M]599_@3D;)XBF?H(H MYYH":*]<"4\\E7*PKW5CBO*PFMX=?V5H.HY6?YW[[LIBE:/O031XO$94*KK\A<, M^RG`%I)>&&7]I5H#$/M$#0%%K58K_VOHHTNTQJHU`;%K30&E5=+]3;9KG;D6 MMJAS95YHU!+,E9<`^8(A;WA^VM8JN`&[#V4+Z-RT[2[1VJO6`<2N=01T;MI. MEVB%H&+A+:CI,S3P*'\I1VE2BH-+RR M'LS)>O"B[;Q>C_AN\MU+@#6;]>!6UH-!60\.37IVR)>Y.I!AS_LNP,.LM\+< MN1L"#'I>#WYM'A\LS'IP+8\/)C4][WW-U;'4U7.BU7);7(^^?!5V'V]3\RHL M0=53L/RO_793%`VQER`:X3,@7Z'T$V2#02%Z4:X!&GIVAH"<:Z1<8^6:H*%S M30$YUTRYYLJUT*@EN/RE=*51:^7:H*'W:PO(^[53KKUR'=#0N8Z`G.ND7%:[ MH@,HD5:[(L9U"@EGK,QXI78I'W).SK#:E32\>P%9)V]8;5(^Y)WYD'A[EN`K MJT:Q+?,A]3Q>Y)[YD'SFJ\F^U1;M'_+/?#``\\$!W#]8@/L'#S`?3,!\<$'D MJY:%XO;I%64A7E:ME(4(9:=@^=6Q^]30U^"]!-&VZQF03=WYFUQ]1%56'MG- MD!<5'*"=/PM#0/&%\K:='=Z-\/LFJ;%*3=#.I::`XL'.W7U^4#A#@->+N3(O M$.7,2T#IU3[__/<*OV\:Q%JE-FCG4EM`9^9KA]\W2>U5ZH!V+G4$%.>K?9M_ M9\X)`4U:5L;$>%;&(L:;ORZP.#)YEQ*_;A2#?WFG5+K5AV8U+G4@C:U]K^NS M%-&H!_NR7FE9TH-#;6=6K,_:^7U%*XB7R,'"+%>ZEN1@VR1GR[/LX;3EV25Z M,#;KE68F/7CWO%YIY<;IA+M9KW0TZ<'`IN=EJJ.'9-\89+4.%Q>KKZC#\1YV MI0ZGZ]H\Q$[^=VBZ]ZDAU^$(5>IP@ORTI9\:4M2+<@T0Y;,U!.2OYR-`7NG& MRC5!E'--`?D)S0R0<\V5:X$HYUH"\GZM`#G76KDVB'*N+2#GV@%RKKUR'1#E M7$=`/L83(.>RNB:)M+J6TN9L`0DWKY;+GQ[BB.^YAJ_,.?$AZ7RH56:=^)!V M?I;*O!,?$L_]*S-/?$@]\Y6Y)SXDG_G*[!,?TL]\9?Z)#P9@OM(!Q`<+,%_I M`>*#"9BO=,$K7[4L%)=NKR@+17AV2!:A[)`LOTQV'Z-H<=E+$*TMGP'%EY&' M5OX)SGX*L'6F%T8])!.M@;>#28?0XG*FE_J]X7G!<0JBP4W`[IF9`DH+@!NY M.C1S,?1RKM0+\#CU$E`Z'LG?`UTY\?E1K%5JX^W0H2VD&J=MYPW/"^Y5\`!V M']L1$*;M+A_=Z1(QJV?B"JMG$>.M9;<&*ZU:V6XJ'^Q)EK:E6-(XVW_;?<:0 M1E?;?E0%1R#W^0IP(VZ,W=SEBR.8LUD/?B57!SB4!PB+VGXPO6,I-_LO&A], MS'HP+NO!I^?UR+;GW1?@9-:#;UD/-C4]9^O(V\"P[KE)K5;=XF+P%54WW2/V M++^U7A>%.#LKRTXINRF*AMA+$(WP&9"_@O<39(/!@_^2(/L'T$"CA@FBVVBI49KQ0OY4/. MR1E6O!*?=\^J5<2X?T@[]P]Y9SXDOG)CK(8/J6<^Y)[YD'P^BT+VN7](/_,A M_\P'`S!?C0,"+,!\\`#SP03,!Q?$_E7+0G'I](JR$.^H5O9H$:JZ[,"T0Y\Q)0',1M-A,K_+II#&M5VJ"= M*VT!G9FN'7[?)+57J0/:N=01$*8K?S_FA(`F+2M@8CDK8.(YVTTF+(VL>I#&QZOC![N,E/5DM3GQ&M5N#B5O(5%3A>8JY4X`A5KY(]9,>OW?O4D"MP MA"H5.$%^4M-/#2NG9,(U0)3/UA"0OY*/`'FA&R>(IGZ"*.>:`O)^S0`YUURY M%HARKB4@[]<*D'.ME6N#*.?:`G*N'2#GVBO7`5'.=03D8SP!@,:*R>G5Q[3C-2+J%)\E@9M6/ MD>VM_?Y7O,XB`DO,K(Q^3&9B%]F.+KBDV*QZ]K>PKK+ALN!U!,GH;LB>J;DE M%*,[.O3WF+7CLL"_=^H'\B3U(Z%Z4G'8OS5ZBG]?G;9GEWK)=IRV5TJM3MM; M-ER>MG<7_"![CNV34)VVG:U]7ZBU:5L60T$S5Z"@54P\B((66!PY;G=?NT!U MVT2.7A9/X,*9RYT3X_`.;3$CYET9'_VL@G2OCH]FC5.TG>W^\<$KS4T&2#NK MWAT'D^F;Z&#L%.,4K9]0&GK5G;@54GNE>O2UCH\V7M835Z_,)XVN>K2UZM'% MT$NV@_X)G.CLI4'.JW*YZOR+Q5J]&3U;K%5H=HIVL-7]#-[QGQHE0SP)2$9X M2B@_0<\"DD)U[EP7'G5)KOQDN_*H:^>Z8<-TUBVA[->=<]T[UP,;)M`).J57#G&-X]Z=ZX/-LQ^?1+*,7XY%VJ;)1*UK6*22=2VP'*8 M*&#D?DZZG7H.LXX2_ME4^YEW[Q\0K'S,O,SPQ]0[,Y.":W?.&/4;+G0'2"=N^`%V^6S<$FH'FILVUO&*P:L M:5V[U@W;I=8MH3A`^=/_%L<=`_(AOW?F!T8E\R.A^GF_U_^6^Q/_?6T0SR[U MPG8I]4IH:<+>&+"F]>Y:'VR76I^$0@N_&=]]V'PQ8DULFEQM^LN6*3<=$XO% M=/\=UNF$`:MR-+'NJL[84N3HT#@RWL:O573W`*;FV%5!FE@%FV]%D#:EX(Y] M#Z&Y=E6/1E:]YEW1HWFQ;2RKM,%O\#73O7#:.2ZY90S7&Z'D>G>N#T8EUR>AY/HBE%RH;>&`3"1J6Z0MV5#; M`LMAHIP%)GRG`[XSQ@D?DSZ[>,8XX6/:]5EJ>1<^)E[Y6N:%CZE7OI9[X6/R M]&C"92ON>";;UX6R@7=7Y2%>I]W M5A8JU!VI==OFX_+/.(N3->M)0++$/"54Z_K^?O\6X2P"L-S,PM@?"9R[U@6) MX5T%V*\>CJWJD?R)/4CX1( MO=>]=WE*YN49>W:M%Q*GUBNAA1E[VT3JW:4^R)M2GX1B6#M[_;B^-A%#$3/; MH8A53'R'(A98'*/]Z389J&@U8-5X$_TK+I]H696C0^-4:WOGJ+^_C07:)H(T ML0K2N"I(GU+0WNQ/M.WZ`.EDU:-W58_FQ58QCM&Z]?5$+Z_KT=ZJ1T>K'@V\ MK$<_K^O1XJI'6ZL>70R]?*H.MOI5-IV])#JOQ.52]R\J<=P+SX?F;SD_ZR^C M#19H-4J&>!(-982GA/)3_2P@#(8UZCP@X;I@P^S7):%L>.5G.O9N5[8,+E>">48WYSKW;D^V#"Y/@EEO[Z<"[7- M$HG:5C'))&I;8-DUE+.*22Y1O)R/.5<^)EV/O9AUY6/:Q1P3\ZY\3+SR,?/* MQ]0K'W.O?$R^'E,Q^\K']"L?\Z]\-(#RT0'*1PLH'SV@?#2!\M$%E6]>%LIU MXU^4A7H[>;9`JU!WC-;=L3G>CX:YW#\)2*]"$*H')WM'_:]6G3%@84OZ_>O[ MYZYUD>U87"X)82^Q_"71*T:M"5Z[X`W;Y7-W2XC':+Y*JW,D6]1[9WX@33(_ M$JK+F=W=;O*?^.]K@WAVJ9=LQUE[);0Z:V^,6A-\=\$/MLNQ?1**63OL!_?% M@#4M5#/S'ZI9S'>JH9H%%E/9[3-0V5J.Q#7=$2YJG:LUZXH:G1H'6T>'!SV3 M&'=%CU[6S5MSKNC1J#Q(V]KI+_$WWZ[.)JVL>G><&=&C?;%9C'5:/[[FYE4] M&ESUFJE%CQY>UA-+K\PG7:YZS=.B1PM#+]D&/[#!J5D8Y+P@EWO7ORC(]9KV MK"#'S6U5&ZS3HJ$6Y`K-"G)`>9ASMA]0'AZ%1EX3R4.Z*4')=.]<- MHW+F;PEEO^X()=>]">5ZZ(E0O9N8=#WX&F1]8MK%'%BG M>?^8>.5KF9?Q,O7*UW(O_6/R]:"J95_XF'[E:_D7/AI`^08.F&@!Y6L>$#Z: M0/F:"[[[-R\+Y0[O+\I"O?([*PL5*AO_MMXYZ/_8]/%^C9)5YDE`LA@]#>B' M/P>0#5/13]-,\"+;<=EQN9'@539<%KR.(!GA#=DS/;>$ZB?7T:$OUFJ_95;N MG?F!-,G\2*B>7=A2K=$N#^'9A5X"DNZ\4D@_!^RKKV_9<%GPW04_R)XC^R34 MYJP;W-J=RYT-Y,Z)U=%M;_E% M>S'N\ERB(+H@G:OCHU%YJ+;E?[LIF)#T%3U:60P_W7$PF;V)]FWSV?_1>QRJ M;3*A-+CJ/0WTZ.)E/3'UROCH<]6CJW4^:6+H)=N!73"DL9G5[5I4K5`Y'I"IWQYG'^S5*AG@2D#SPIP')-Q;//.KR96K@3>/>G>N#S;,?GT2 MRC%^.1=JFR42M:UBZE4F'%[E1R#*68V3C*-X.1]SKGQ,NAZ"#;*.VN1\S+OR M,?'*Q\QK_YAZ,2YJCX^7R=?Q,OO*Q_0K'_.O_:,!E&_@`"S6?+ST@/+1!,I' M%]3^SR*_[XF=>U2-VR74K>$XJ85?K[?7GW:A-P[]0-Y MDOJ14!W%G_[.T1/_?6T4SR[UPG8I]4IH8<+>^.]K4N\N]<%V*?5)B!-VU/]F MV!MS:^KPZ.%=1/7;"N"="D%#_N_[847GYL,D#Y6O3NV%#U:%YO&N)G6'^`U M)Z^.C^96O69HT:-_E_6:G5?UZ'#5:ZX6/9H8>FF'T4!T5HH\RK]$G0Z851RW1+*PZ8[0LEU[UP/C$JN1T+9KR="R?7L7"^,2JY70LGU1BBYWIWK M@U')]4DHQ_A%*+E0VBR1*&V1HV1#:0LLNX9R9KE$\7*^EG/A8]+U`*QE7?K' MM(LY<*#F_6/BE:]E7OB8>N5KN9?^,?EZ8-6R+WQ,O_*U_`L?#:!\S0'"1PLH M7_.`\-$$RM=<\,TW*POE:?Y%6?@.GZ_1`IH?J/7+A..(DA7K24"RP#PE%'5] M^Z!_,W,6$5AM9F7L/RC/7>R"S#E3EX3JPE'HEM#!A;YM(O;O4 M!WE3ZI-03-C!_F%WX^YK$[%I:1UN-5_?76B7]<%:6$5I&U5D"X-P9VM?GLPT;3K>O2QZM&YJD?K MQG3B6SG==F2BD]?U:&[5HZ%5C_Y=UJ.=U_7H<-6CJU6/)H9>/E2#]=D/'IT7 MXG*9>_/UV4&]^ZWKLX!^.$.+*!GB24`RPE-"^:%^%A!FD!7JW+DNV#`?KDM" MV?#*N:Z=ZX8-D^N64/;KSKGNG>N!#9/KD5#VZ\FYGIWKA0V3ZY50#D?>3'K MRL>T:_^8=^5CXI6/F5<^IE[YF'OE8_+Q;-*GJ#8^7J9?^9A_Y:,!E(\.T/[1 M`LI'#R@?3:!\=$'EFY>%>E84*E:5Q'JUO=R<0QP?14+9M`>D] M"$)Q;+*]M=-=X3YCQ-H^^-S%+K(=LW9)"+EK';<7=U>,6A.\=L$;MLL'[Y90 MC&[OJ/_8NF-$KLOOG?J!44G]2(C4?[H#BR<&K`WCV;5>LAWG[970ZKR],6I- M\-T%/]@N!_=)*`:WO]N/[HL1:V*H:.9!5+2*B0E1T0*KB\-=>^')?U]5.QVH M-??FX+!8"[4VNOY/)6*Q%B&K@O2S;N":>T609N5AVI]^Z8O%VB9ZM+/J-0.+ M'AV,#6/<3NN\B?*YB1X]KGK-UJ)'%R_KB:GER>\.X2?Z7/6:JT6/)H9>L@U^ MTO:'0O"HRX)Y<'<%:'DNG:N&T;ES-\2RH.F.T+)=>]<#XQ*KD="R?5$*+F>G>O% MHUX)Y1C?""77NW-],"K[]4DH^_5%*+E0VBR1*&V6292VP'+MA\5:8,+'E*OW M6\ZS=RA>T3:[AVKE?$R[\K6\"Q\3+U9#-7(^IE[Y6NZ%C\G7PZJ6?1DOTZ]\ M+?_"1P,HW\`!J!VUS\K7/"!\-('R-1=\]V]>%LI]YU^4A1+>':95J#M,ZTK? M\4&-DJ7F24"R(CT-Z(?;:=DP"Y$?J)G@!=ESMBX)U4.4@\/N@_EJ$ZGK")*Q MW9`WI6X)Q1+`7G#=I1;71??._.!1CV36PFRKSJ=LN#QKSR[X0O8!Y6O=FA=CEY5.=I3 MY>C/D,,OV'9'GEB';:)'!ZL>_:IZM.>R'MVZ/CX:6/5H6M6C1Z&7R1E\2^"' M0ZTU1_#RHT/S3;[C)]'%$RQ).`9@6W6BXLZY[IWKP:,>R94?SD\>]>Q<+VR8_7HEE&-\ MD3?YD`!.N98H95^QTP'=&ONP=2E=H M9/>P#JN8.`BER?O'O(L[)B8>SQ(_WE"-G(^IU_$R]\K'Y"O?(/L3TZ]\S+_R MT0#*1P?H>&D!Y:,'E(\F4#ZZH/+-RT*YH/N+LE#O\\ZV9Q7J#LVZK\$='T3# M_$,5)P'AP)&).26$373;ZMF*XHQ1LU.;;N%W[H(7;)/^EMN=XS(";EWZ@=&)?4CH3J*_M;W$_]Y;1#/ MKO3"=JGT2FAAOM[X[VM2[R[UP78I]4FHS5=_F/3%B#4QU#%S'NI8Q:3$T*`" MT:`"T:#;:6.LORH9]DGT,8I88-'YG:/^AV-0TR)DM?J7O.EZ-&8**3U)&RP`MM$C]95O>97T:,]E_6:6U?GDP96 MO69:T:-'RP=%JT2C%=CZ(.>EMMP<_D6IK1>-9Z6V0MV6MUO:'Q_8#>63@.3S MY#2@G[:\E0L-^S<&5]G)9:WK"))/P1L2I]8MH:J% MEQ/=2_6[U.(S>^_,#Z1)YD="L='I]AU/R;L\AF=7>B%M*KT26IJOMTVTWEWK M@\2I]4F(\]5_A'QMHH52:T9`J:V8+@7I4,5H4<7H44DVJFWP9>]1;0.+J=K: M[ON/:EM#5HV,-66-4D':4M=8="%OI6P==,\@JNTF>O2IZM&:JD=O8DVW6&TW MT:-[58^653TZ=%F/AEV?3WI8]6A;U:-+H9>/S:C:K@]R7FW!]9MJ6\*[`\8* M=?O=[AN*QV4&T%"&>!(0_L/B40)UP4;IMTO">6ZY"H@_(>* MUP$)UPT;)M2Z"PC_(==]0,+UP(;)]4@H&SX%A/^0ZSD@X7IAP^1Z)93] M>@L(_R'7>T#"]<&&R?5)*+F^`L)_R(7B98E$\:J8%B4F7#%F7#&F7#J'XA5\ MV3L4K\"R>ZA6%<-_6O^8=N5CWO598N+GET2^9A\W4\R^]H_IE_Y MF'_EHP&4CPY0/EI`^>@!Y:,)E(\NJ'SSLE"N/?]B$18WL3-A?P\JU.UWNQ?! MQQ$E;TU.`IJ]CJQ<\?[ZS^%^]Q[@C&UF1^RVU8U.YJO/"[;+?E\2BI?S^#KR M_(^H73%@3>LZ@F1<-VR76K>$0FOG3W_YY8X1>3AV[]0/C$KJ1T+UL[[_VX-/ M_.>U03R[T@O;I=(KH:4)>V/`FM:[:WVP76I]$FH3=M1]SGPQ8DT,1GJE[SINC1G'B[N;@"VT2/]E6]YEG1HT67]9IC5^>3 M)E:]YEO1HTVAM[X"6Q_DK-26K>4O2NUW^'P%%M#\YD?_"V_';)@>/0E(+'I* M*#?Y9X2R!IT[UP6CY<'XQ*KD]"R?5%*+FFR5K'A`^FD#YF@N^^>9E`0=TORD+);PK"Q6: M'X/U!Y['AS5*UH\G`O=NX2S%N,NZ=^L&C'DD]^^3I__3?4S9X[EE=#2O+UMHO7N6A\D3JU/0HOS]K6)&(J9V0_%K&*Z3:1-%6L^E=>L M-*K8&<4L^++[*&:!1?_Q;;!NG3_1F:N.GFA6%:0_Y0&::,1-=K'KTK.K1HLMZ=.SZ^&ABU:-O58\V MA5[V?G`6%GE>$IV7W'(I>?--+[IC);="\[.PG6[FCZ.A#/$D(!GA*:%U<-VR87+>$DNO.N>Z=Z\&C'LF5'Z=/'O7L M7"]LF/UZ)93]>G.N=^?Z8,/D^B247%_.A>)5TRV3C^)5,2U43+AB+>.SXN5\ MS#EHF7,4K]#([J%:54R\@=KD?,R[\C'QL[.P`1]3K^-E[I6/R=>SID'V45N\ M?\R_\M$`RD<'Z'AI`>T?/:!\-('RT065;UX6RLW>7Y2%N`B<"?M[6*'96=BN M_5'SB))UY$E`\@L6IX3P^=7>N/K=#T;-UA[]@9@+7F0[NNV2T*K@%:/6!*]= M\(;MZCS$7$:O_I6=5K#LW9PJ(LV.HJ<.^PNZ6)-=DFGJQ$0;JUXSK>C1H]!+MOW^TO[4?+N0 MPWGQ+1>4?U%\ZWUFO0V"3[6R3.M.Q_IOJT:4#/$DH%GQK5SXQ3<^XF<>=>Y< M%QYU22BYK@AE8;MVKAM&Y]4@H^_5$*+F>G>O%HUX) M)=<;H>1Z=ZX/1N48/PGE&+\()1=*5SA`3K/^$LMN3,<#C!G7$G?*..%K.<_> MH72%-;)[*%:!2?^8=C':U/(N?$R\GA:US`L?4Z]\+??"Q^0KWR#[6)/Y_+7\ M"Q\-H'P#!Z!V.%_S@/#1!,K77/`]WGE9*#>3?U$6ZD7F65FH4'&U-%HJ8D(SJ!,]=\(+LN$/7VNT<=%>J+AD5^_W^ M^/^*_[ZF?NWJ-VR7^Y1;0@??'V.[.[W6'0-RBNZ=^<&C'@FM3N03H]:&\NR" M+VR70WDEM#!K;_SW-:EWE_I@NY3Z)+0T:U\,6--"?3-'8L\96*JAOCE&Z^Y( M'+TK#L?2K+;%;TO3XJAO@47W[?=`4>TB8K7_]*GJ-6^*'JV(WVHL:Z7M?5^: M;2)'KZIC1 MH^6G+UL1&2W-U@D!W+\]9N4(.#/:[]=U_NN"+)FOAU!,G- MZQNVRZ7%+:&J]*?_4;L[_GNN>.Z=^,&C'@FM3N,3H]9&\NR"+VR7(WDE-)ZS M-_[SFM*[*WVP72I]$EJ8LR_^^YH4ZJ^9`_6W8OEQA_)K$$TK4:<#LK/`9M^3 M(%:[OM\_(JB]X;S5OE\.Y)HIK#KG@3-7I4G#PU7XH:C9G? M6?#2NXD>K:MZS:BB1U\NZS6;KLXFG:MZS:ZB1W?^]!V)'R9U7GK+#=]?E-YZ M(7A6>BO4+7^[BG5\6*/D0/4D(#E//254CS5V#_>[M>E9!.!L-:MG__[KW+4N M2*S%:%!U:R>QT?@^5=GISPNO-I&_=OF;E.IQ3;WSOS@ M48]DGAV*^-OB.M;5F7QVP1>RYX[KE=#2M+U%P*K6NVM]D#BU/@DM3=O7)EJH MO69'U-[(?JJA^`86J_K.U1,]O#JRB;86\V-E[&HT;OAO_ZC_)594Y]IJ7>\R MHE2/UI6G#=5Y-CK[RX:T[;H:G:QJ-*^JT;UX5_*]#O>_>"UF7GZZ<:Y0>ZUZ M3QR)Y([F7=:CE]?'1WNK'AVMXZ.!H9>]'_SP9G1U271>G<'UF^IN /K MEE!RW3G7O7,]>-0CN?)@[,FCGIWKA0VS7Z^$LE]OSO7N7!]LF%R?A)+KR[E0 MURR1J&L5DTRBK@66>4,MJYCD$I7+^9ASY6/24;GH`]0JYV/:]5EBWI6/B0=% MXV/FM7],O?(Q]\K'Y"O?(/NH+3Y>YE_Y:`#EHP.T?[2`]H\>4#Z:0/GH@LHW M+POE4O`O%FWU#O%LT5:A;K_<+<^/#Z-AGEB?!#1[E5&C?OCC-=DPJZ.OW$SP M@NU^6+E%'W@=WKYK09K9HJA;P[EE=#2M+TQ8&W:WEWK@^U2ZY/0TK1],6!- M"Q7.+((*%UB>4:#".4;SSM_*.-\9>Y*]QZEEC8MO#AW\Z;..>A<1J_V_9+_R MF<);FV@I>O0BWF*4U5)_Q0,[YTW4Z%5Q-';.KD9_AAH.+;M'`X>6F^C1P:KW MQ)8R.MIS6:^Y=74V:6#5:YX5/5H4>OG,C`XMUP$DNN.4'+=.]>#1ST2RC$^$4JN9^=Z853VZY50]NN-4'*].]<'HY+KDU!R M?1%*KFERLNDOL1S2U!(N&#,^JUQLF\:86LZS=Q.3KM^.:%F7_C'M8HZIY5WX MF'@\2W3?U#(O?$R]\K7<"Q^3KWR#[$],O_*U_`L?#:!\S0'2/UI`^9H'A(\F M4+[F@F^^>5G`A_$'V];49H^J^WPXUKC91OW;U&_)FKFX)U0]-;+Z[8GJ76O3N MO3,_>-0CF5-I%Z=ZD/\J;4)Z&E6?O:1`OU MK5I9'(GZ5C&<2'.^4=\RZ,CPZ6/7H M5]6C/9?UZ-;U\='`JD?3JAX]"KWL_>#8++*S)#JOP2A(OZG!);Q;FE7HAV,S MW#CMC\T"0C=I^-.`4(,)G7G4N7-=L&&:_9)0TE\YU[5SW;!AZ M=ZX'CWHD5X[QR:.>G>N%#;-?KX1RC&_.]>Y<'VR87)^$,>`G*-[9W[PJ$=" MJS/YQ*BUH3R[X`O;Y5!>"2U-VQL#UK3>7>N#[5+KD]#2M'TQ8$T+%R7G/KZFS2 MP*K7/"MZM"CTLHH,CLU^&.2\"(/K-T6XA'=KLPK-C\WZO[1T7/I<&F9-/`EH M5H1K%!:7K,MG'G7N7!>,RMFZ))3'0%>$LJ1=.]<-HY+KEE!RW1%*KGOG>O"H M1T(YQB="R?7L7"^,RGZ]$LI^O1%*KG?G^F!4$ M;:5CS/B\%? MK,WJ[6)]I7D4%XYUQ7.PV]T`/(XH65F>!"0+T-.`?CHVJXIHF-717FFZX`79 MM:>#M5EEQ]JV?)+M]]O^J^SVLOJUJ]^D.GUX2ZA^:&[_Z3^D[U*+;>Z=^<&C M'LD\^SBR-YK9<'DHSR[X0O:TW2NAA5E[VT3JW:4^R)M2GX269NUK$RW4MYIG M<23J6^1^=FSF&*VK>U1Z5_G.R)>]1WT+OMK]'?MR-*I=C5CU-_:F-4KUZ$W= MJ]&*]'-_E8Z^7%>C556-[E0UVC/4ABNS349'`ZO>$V=.9I/N7-:C6=?'1_^J M'CVKXZ-%H9>/S&AEMC[(>0DN=Z-_48+K5>I9":[0_-1LM]NM'A_5*!GB24"8 M&]:7TX!FIV:UH42=.]<%&V9V+@DE_55`PG7M7#=LF%RWA/)C_,ZY[IWKP:,> MR94?KT\>]>Q<+VR8_7HEE&-\&* M,>.*,>5B#+S0#+[L'2I78-D]U*J*23Y1F2JF?,R[/DM,/)XEN@_[1.=CZI6/ MN5<^)E_Y!MG'RLS[Q_PK'PV@?'2`CI<6T/[1`\I'$R@?75#YYF6A7+?]15FH MMW-G9:%"W:E9]S6\XZ-HJ!NV"N%TD8DYC2BLRLNJZ'#OH'O#=\:`V8JC*T'G MKG7!=C\LRJ)']4.S>Q-S18XU[6O7OF&['.S97^C1^R:RYI^2X7"67NE>D_LJ>C1 MGLMZS:VKTTD#JUZSK>C1I=#+WH\69>N3.J^^6.#]IOJ6\.ZXK$+SX[(^T\=' MT3`=$ MDNO>N1X\ZI%0/NA/A)+KV;E>&)7]>B648WPCE%SOSO7!J.3Z))1C_"*47*A= MEDC4KL!R2#@N?8.M:O&B350K`*3_C'M^BRUO`L?$X]GB9_] MJ$;.Q]0K7\N]\#'YRC?(/FJ+C[?E7_AH`.5K#I#QT@+:O^8!X:,)E*^YX)MO M7A;*155=E/TKWO)M'_T#V[W_N[WW7__YG__;_SOYE__SSW_YGX"W_K%3OG[[ MS__PO__+?YR.Z@W7V?*L0MU]LVY_?AP-Y>;KPE1"W[<>$[1J2% M[YWZP:,>"2&;;;!V:^^)46MC>7;!%[;+PZ570AQ+/V]O#%C3>G>M#[9+K4]" MU+)Y^V+$FA@*74VE&!*%+K"40Z%SC,Z=_7P)X_('>K#[#+L('\VY'_W?/NHG M"W4OFJT.X'(@>,66(D@[\O=+_G0;`93%3>3H5YVOYE"1HT7;[XEL=94`]\TV MT:.)5:]95O3HT&6]9MC5Z:2'5:_95O3HTI]^O^2'0Y-=.5XO0C7^/DR MC5BW2^Y6Y,<,D\^3$V*Z4FM8W4OL;VUUK\+/6L3:VO><4:)W0:S<^FGUR5]@ MM+#AON^J_?.:_C6C1/^&F(SWMF%UO"C]?[H#AKL6DA_/]\2$_H&8O"=^;-CZ MIKF%K8WIF5$B^D),QO3:L.$$OK5_7A-[9Y2(?1`3L<^&+4[@5PM9$YPFAHGB M])>@2$[-S%CTE/UG_Y<`IG3VJN(IR54Q_2VKK&;G.#_:WMK?ZMX03FGO5='+ MD6B:6D2;AV.8]GN]4SIZ5;*97,>9MA;)YNN0Q%:[>_PGM7D^Q?U2;&K.5\TG MCEVSV6R]K)DN7QUG,[YJIMUEG,W=\1,LN[O_Z)[ZJ9E]Z9>:NDJ.!WRVL/ZI MDI?XOI)7;+[CWNT2`/-'4]ER$Y-YA;EKG.RLX.W`LI3!VL8'*T=>,GX8"7C@W>,#X4RL!PO*J/QE3IHA*4.&F.I@P%F%TOM<\YF!GTRT@TY MZJG906Q32IMS-D,H9SI".)LE\(1S&U1JEW,V4RAGND(XFRV4<^2+4HFJD'*F M,X2S64,YTQOYS$S-',J9[A#.9H_9CR\=[':O'TJYJ;W#L%B%9.W2'!8Q7ZX^\(P-%W^](`)310>#`'\9W7U&&%U M;;"]==2-"!:M$:M=@&=KE(P;E@WN3#`<.]<[VN_T8-^F1_?#O<8.\UH'0`X)Y@YL:0KA]!JQJ@?KFQYL;GJHC',]FT+4R0WT M2N4TP5(Y3;%4S@#CRUA;_?.H'D^[V3*GV5YL,J&PNF3S=/Q*T^ZV?]^,[5:G M=4+A]6$V5^L;VV9BO++]?E'3_2Q:*<*5:EVQF5Q'V7RMBLW8H;A]9'_O47V^ M,K/-^JJ)LNTSVWR]K-ELOC[.YGS5;&;7<39O0S,'L7_4G[$TOR\)=ZO(ND8>+`ZB;+$C!MO`YMX^ M1Z5.(:_NPN\Q6:NVCN@S32;L54S M;2R:S;7+FFGBU:EMOE;-=+-H-O/.]O3#Q=_Z!',?G8@<,#J[[=\UN3C,!'T+)KX7_3@]^;7K8<5>L(JSL8 MK];UGU?U\2B8/LS?]%EVX?3`ZGB/=@XZ_\+V38^MX'IC1[&V.'@ZV'_:R[>F M.3%](8#M310^#X'9^C.PX?S!WAN(P>\FAF)M8BC6@2W-'VKU!GJE5IM@J=6F M6(IU@+&1[S-65K*;2#:ORS-1UK8NV=P<&_FC/7NSWLR]:LM2S"N]:J*8NV9S M,-9_WQOY_IM6I9AO,LQF<95LKI9G?VJV#LGQJZ!--)OQ51/%W(?97+VLV4R^ M/K4HYI5>-9O;=9S-W-#,YVU8S-<'VQ7S#[P/*N M`VQ?,#BSOP\#2Q@='&Q\\;'PP; /_C5^&!7XT,5CK8Y M#I@QL'Q]!B\:'ZQH?/!>M,WY@]$"R_'"9\8'FQD?:JCQH88&EN-%U32^4B.- ML-1(8RPU,L#L8BF+SMG,(*8I1=`YFQWP711:I*QAG;,90CF;(\2)4[,$KF0W MSN8)\>+43*&UA;N,,PF,/:PAN&P1K6 M%LXP#,:PMO"%8;"%M479,`QEP]J6LN%@]=V-T]V.]N MZ,"E&_0!MK4^P+6;]`$^GO5A;VO[L'_-!ENW3O"##ZXV29AZ$TG8?"YY=-#_ MLBQ,WQ33`(.-J_4!#\$F?O#[I\__9D6'I(-^H"GQOJ`AV:3/J#.SOJP MMW=TV/^A1M3=#3I1*K'UHBS@-NE&*H3 M64XV9]W8.]S_<]B_2L\G:[4C[4Q:;/4O.%-F_&4'#DC++8=,[F M#6W>S*'@R!UEL>FU9.?MBC?L=WJTIB60Z.MQT[&6"G`^QL M@)T/L(L!=CG`K@;8]0"[&6"W`^QN@-T/L(3(&[@!/8@ M_:ILE/B^;`16OF$GN]'N?1[\,X[+K\]U72O7#_L%TB[*XD^5K5Y;G"V(\#_? MW>ZZV.TFT<5Q7"ZSNRYBI6Q=W#DJ7^;^L9>E:3^1@8S2=;*=W,20]:1^;LC`.FE_9L9QB\],.8W2+O[TK,3IU2S%%=M) M#(XS#)7?,!1^PU#W#4/9-PQ5WS`4?<-0\PU#R3<,%=\P%'S#4.\-0[DW#-7> M,!1[PU#K#7L>8*CT%H=";QCJO&$H\X:ARAN&58!A6`485E8!#F(5X.#("F45 MX)$C,Y15@$>.[%!6`1XY,D19!7CDR!(XE!A$CDPQC5Q15@$N-/)%605XY,@9 M917@D2-OE%6`1X[<458!'MGYHZMLY2CD-V6C'IW,*UI@Y;M5;16P[04MPWA6 M"OLX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX"/LX M"/LX"/LX"/LX"/LX"/LX"/LXB/KB(`J,@Z7"#%"4F`&*&C-`AR[!D>HH=N@3 M'%*,8H=.P7VA4>S0*V7',>COT"UESS&('?JEU)M![-`QI>(,8H>>*35G$#MT M3:DZ@]BA;TK=&<3VSNDJ3SGF^$WEB6.17)S`0X'E+1,XR##XQS"XQS!XQS`X MQS#XQC"XQC!XQC`XQC#XQ3"XQ3!XQ3`XQ3#XQ#"XQ#!XQ#`XQ##XPS"XPS!X MPS`XPS#XPC`4%,-03PPKY<3!D1-PVCF(''FAE!+G'+FA%!*/'/FAE!&/'#FB M%!&/''FBE!"/'+FB%!"/'/EB&AEC&CFC%`_G''FCE`Z/'+FC%`Z/[/PQ+QL[ MOSSM_([O=MO$9@N6@S]V)B!QN6(9@*?;`_!L!)Z/P(L1>#D"KT;@]0B\&8&W M(_!N!-Z/P(<1^#@"GT;@\PA\&8&O(_!M!+Z/P(\1^#D"OT8@2LP@G3@:':'' M0_1DB`YM@HW1B'=H%&R-1K%#JV!S-(H=F@7;HU'LT"[8((UBAX;!S]B,8H>6 M0RG]_ M$P*NXEN0?!$,4SD(3SD(2SD(1SD(0SD(/SD(.SD(-SD(,SD(+SD(*SD()SD( M(SD('SD(&SD(%SD($SD(#SD("SD(!SD(`SF(TN,@2H^#I?0,4)2>`3HT"0Z" M1[%#FY32,^`=&J64GD'LT"JE]`QBAV8II6<0.[1+*3V#V*%A2ND9Q`XM4TK/ M('9HFE)Z!K%#VY32,X@=&J>4GEEL5WKZMYP_E9[!J\V=P/2,QC'XQ^+@'L/@ M'S\^?GW[[=W!A=>!:Y9H@TZVMT\'\K-?7=_Z M^P8_E;3!+8-RR:/+PM5 M_T.6L$\+D],?PV`>P^`=PV`=P^`Z)G=N,&?T?`%B&&PBF%PBF$P MBF'PB6&PB6%PB6$PB6'PB&&PB&%PB&$PB&'PAV&PAV%PAV$PAV'PAF&PAF%P MAF$PAF'PA6&PA6$H&X:A;!A6RH:#*!L.HFPX./)"68!XY,@-90'BD2,_E`6( M1XX<\?\Y.[,=1Y8T/;[*0"_0)RNS*JL.6@-PWW"]/;Z MC%N2X19YJOHF$G#S8#C=[?N3C`B2O``I>YH3O``I>YH5O``I>YH7O``I>YH9 MO``I>YH;O``I>YH=O``I>];\J)4-;K#YE;)QO2'GXW)19+FT?7Q,,:K4FR)* MO2F:U)LB2;TIBM2;(DB]*7K4FR)'O2EJU)LB1KTI6M2;(L5#4VT&N=/@<0;K M'[O\N2\+^G*]8>%I8J]M'Y^VS\S>VSY>[=4_IYW)OO1ZO7SCU)??7FI7`S/W M]QZWEX.9_/MCW]HR^T5;IO^^+Q<;\^BU$_Y9C7N/VR-E.8I'RGH4;5F0^[[7 M1Z]]%B#K<^]Q>_0LT.,C/:_0ZR_>VW'N7[NWX]K&Z_N'%]G%28-;MZ3PWJU< MG5NO.'7O]>6]]F"]EUNW'Y>O#?OQ]5O]N^/[MSYTO3]4_8"#6Z\4A]N$#>]M MGPYB=.]V&42^K>#MO>;2^-;GTT%,;KT>!C&]MWTZB-F]VW4FOKWFD_M____N7OUV_;FM_Z-`VBI@07T1Y#^R?ONUZO%]T>TWEM>\V)[OO4OW^KR=IY MN>WZ:$Y]A;JW7J\?133K?SGHM\]+V^OC<-_K5_2RY-=NCP=]K7]?2-:\.&K6_+[K3<8L\*7M\Z>:-;[O MJD^UML9<@?B5-;Y>L7A:XTM;+?:U`&2-K]W^)/;77A\?HL\:7]LN9G]_RU\M64UBWY9S4O;UQ3'#S?J522K>=_UH5MM(%G,XJ!9 MS/N>MX%D,7_FH%G,^ZYZT-IBF[Y:3$O;1SW/AGOWSX^G'4]\?MZ MW?4Q`?4\);#77A_9R6)>#W`YI?SZI5ZDLI;7'H^QJ3]V5O<^@MND9G6+XV5U MGX_W]E)[+EG8GSA>%K8X7A:V.%X6]OEX/^H_])HU_?QXM37E#/NOK"G]Z_^7 M+VVU@!8?$DE=/9\C^Y.`7GL]!?3:=@GHR^NW^K^_+.JE2]-_GK-66=3[$!X6 MM3A@%O7I@"D(Y:+^Q/&RJ,7QLJC%\;*H3\=[??WQH_9")*OZ^0%KJYKL@2X&NOIP!?#_"X9_$545GP:[=, MR_T`Q3^_K/CU"$__U/_^7>=_T8W,-DUM:>\U._DNC+^:RGDU"OU[:/$.;_Z[U-!W%>]ZSH MI=?#5\FE)!=M6;[[H]UF(VM5M*7D%OMFK8JV%-EBWZQ"T995*/;-*A1MB=OC MOK4)YNW]XP3_D^'B8>J5]-+V7$GK7U69L6+SP=1,R53_ZDI/_EM4#F%4*IR;7N*Z+WM4R\NO1Z^@"<2%&U9]/NC M/42T:$M$BWVSGD5;UJ_8-ZM5M&6UBGVS-$5;EN)QW]K$N+B MZ97JM>WQ3@"^%X#,?K2EXA5MF3D`^' M2&-J<#%=N7XGC29#KM])3],AU^^DIPF1ZW?2TY3(]3OI:5+D^IWT-"UR_4YZ MFABY?B<]38U)D>NWTE/TR/7[YYZ/I>-O&IY+AO\9_^IFYO.>];^F=_: MKCE/OA'M7Y_.`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`V2A[FA&4C;*G.4'9*'N:%92-LJ=Y0=DH>YH9E(VRI[E! MV2A[FAV4C;)GS8]:V>"ZQ:^4CVC^OR4:7>%%'J3=&DWA1)ZDU1 MI-X40>I-T:/>%#GJ35&CWA0QZDW1HMX4*1Z::C/(V?_'&?SGSC>_72XB/$_L MM>WC.D5F]M[V\;:T/+E\[95S<-<;A&I7JC/WE\=)C]O+P4S^_;%O;9G]HBW3 M?]^WZ>:FCQZW1\IR%(^4]2C:LB#U1Z^]E,WZW'O<'CT+]/A(M17B8L'C"OW? ME[>__?WW__+_NG_\X^]__,^<1/B-;X^]_RC=V_7BPM._QDO;\ZG_;[7+@%F= M:[>?WRI'2\K=CG>GYSYOSW0XYG_6]NG M8TBLKD_H>O/%^V_?:W<595U_8@Q9Z?O,W-8L*WUM^W0,6>ZG,;SS(QS/-X!D M]3\?0\T'+A+\B@^7BPK/T;Q>:,@KZ?L2RIU-;]==(^>]FZ3U^F`?%33YO+1] M?NTQ`MQW;3Y`0GP?QFWR$^)KV^-EUMNC/0[W_;UVZV)67`Y:7-S-DA='S9+? M=[V-).M[:?O\J6:-[[OJ4ZVM,5 M'_4V:WQIXY:M^Y[OY/K-8&GNGYI>[Y?XKU6 M7U+7K[L^!J,^&7F)<^WU$:FL\?4`E]/,>1U1OQ,X&;YVR4N,NP;U!\_RWH?P ML+S%`;.\SP?\\E:_72[Y_8D#9FF+`V9IBP-F:6L'_/*E5C"RK)\?\'E9O]II M_I=?_FG9\\/4$GUM>TYT_2>5.R^W;I\G^M;K,='7MB2:5T8UC?JW!WZZ3_'V M,(__G&]M'P\]NN_[7"QJU6A\[_9IL9CQF-WZ?5XLYK=N3:]# M:@O\B]=*OLJUDEO;QPQEV:[]4D,:<]2]]M*6M;H_VJW?0-J&M[:' MQ\M:7?9]:,O"%(^752C:IK>VAWVS"L7C96Y.OE-.'3 MZYYK6ZU>UGZ)+$MQW?7S>GGKE1=O]P63U\&W8UY+J/ST65;K$.5];L.]=-!9$FO![@,0EZ,9X5_8@Q9\^OQ/L:0-?^9,42#IS%\+U^, MQXK/QU#SA),%GWGRDS?`?+V>='C\QWIK>PKHM=^?!/32*U=-;L%+0(NV+/G] MT6[]$M"B+0M<[)O5+-JR?,6^6:RB+8M5[)N5*=JR%(_[UB:>LPF/$_\G[TB_ M7LX^/"?QVO8Q38E=T99Z5[1E.HNV3&?1ENDLVC*=15NFLVC+=!9MF)D6N%DM/TR)7BZ6GB9&K MQ=+3U,C58NEI#_^O>?^NFC_$)[\?[VUO;X M,O>U?.]CW=[?/TX#U<;(F9C'TG9^[?'E_2>^@NCKY23.4?__V//_ZC^[?_^-N__O5__/'O_^V/SA__]F__^)>__Z__S4G` M+[]]YX>7[^!?_OV/__J?_Q,?]/Z=[Q4XOSXOX.L/8&Y:RO^@`KZ]`"__R$KX MY0S/_S-+^'J&K_JP7]^`\<2.^>4W8+YB5^%Y0+E30.%Y0/E2.H7G`>7KJ!1^ M/1_S_(JF>"I?OIWA^3UQ#;8R'#\7(\A1_.T_<;_:8?$#Y]_-GD,L]^7CQ[^=/$)>,#P?_ M?O[\;\ERAN)K'C.GRDN6`[/Y7;=&DP99G*RM;'9D.S59I?G0W-5FE^?C8T6Z7Y'=K0;(WFMWB__IZ-L;Q&8L]L ME;;/-%NE^97>[)NMTOQ<;VBV2O.[O:'9&CT+V>#C6<<&&\\R-KAX5K'!Q'-E MR<;&DE\W_OI[-L;.$C8X>%:PP<"S@`W^G?5KL.\<\H:,GR/>D/"S>`W>G;5K ML.XL78-S9^4:C#L'NR'7YU@WI3IKGG]9V=I_(&I0:+9*L^ZAV2K-RH=FJS1K M'YJMT;/F#99WL2,;LZ,'R\98'Y:-L0$L&V-4O(PT6QLI%2\T6Z4Q+C1;I7$N M-%NEL2XT6Z7Q+C1;I3$O-%NE<2\T6Z6Q+S1;I?$O-%NE,3`T6Z5Q,#1;I>TS MS59I;,B^V2J-#Z'9*HT1H=DJC1.AV2J-%:'9&JV`V1C;P[(Q=I:_P?TC^V5C M^YU@V1CC/TI&FJW1LX@-'IXU;+#P+&&#@V<%&PS<,IAL;"P[6#;&SO(UN'=6 MK\&\LW@-WIVU:[#N'.Z&;)^CW93L/+>\<,[6W@50,4.S51IC0K,U>A:]P?,N M,Y>-S5P/EHVQ/BP;8V?!&_P^EY&&*G(N(DTU)#.:9YBM/4.J96BV2F-I:+9* MXVEHMDIC:FBV2N-J:+9*\SQ#LU6:9QJ:K=(8&YJMTC@;FJW26!N:K=)X&YJM MTO:99JLT%F7?;)7&H]!LE<:DT&R5QJ70;)7&IM!LC5;`;(SM8=D8.\"R,7:$ M96/L!,O&&-4R(\W6Z%G$!@_/&C98>):PP<&S@@T&;AE,-C:6'2P;8V?Y&MP[ MJ]=@WEF\!N_.VC58=PYW0[;/T6Y*=O4C;\2K'_96N[6'[9T=8`=E9\4;##\+ MWN#W6>\&N\]R-[A]5KO![',!::@?Y_+15#V6/+^E/K_6"K9RMH:MG6U@&V=; MV-;9#K9S-H:-G4U@$V=3V-39##9S-H?-G2U@"V==6-=9#]9SUH?UG0U@`V=# MV-#9"#92AM9N]3'DJ/N<0DY*6BV.U'+6AK6==6`=90CF?J&7VX5<[A9JN5D4 M!J\+E`6O"DCE3J&4&X50[A,ZN4V$T[-)-!N2>?B14RV''_9^DNGVV49;MQ9I MW5F4=6,1UGU%5[<56=U5HN_))_@-N5\S"VN=A92FL(VS+6SK;`?;.:M@E;,] M;.]L"ILZF\%FSN:PN;,%;.%L"5LZ6\%6SOJPOK,!;.!L"!LZ&\%&SL:PL;,) M;*+L%'12DO*4O5K.VK"VLPZLXZP+ZSKKP7K*D,P=0S$W#,'<+_1RNR@%7@F. M(4<=&V*Y5VCE5B&5.X52;A0!]7P23T\G,KE+J.0F(9)[A$9N$:'T3!+)AD1N M?^1BVO:'731+T0C;.:M@E;,];._L`#LH0UDW%F'=5W1U6XF^)Y_@-^1^SNCF M.KJ4IK"%LR5LZ6P%6SE;P];.-K"-LR%LZ&P$&SD;P\;.)K")LRELZFP&FSEK MP]K..K".LRZLZZP'ZSGKP_K.!K"!,F1VEU'9349D]_@8+6=M6-M9!]9QUH5UG?5@/65(YHZAF!N& M8.X7>KE=E`*O!,>0HXX-L=PKM'*KD,J=0BDWBH!Z/HFGIQ.9W"54(4'HFB61#(K??<^YW^UVOR.Q@.V<5K'*VA^V='6`'92CKQB*L^XJN;BO1 M]^03_(;K.>L#^L[&\`&RI#9749E-QF1W>-CR%&/ M!Q#*?4(GMPF9W"5426#:DLOJ>0H^YS"CDI27G* MD5K.VK"VLPZLHPS!W"_T+4N"5@$+@=0"IW"F4) M<'HVB69#,@_?U@.V<5K'*VA^V=36%39S/8S-D<-G>V@"V<+6%+ M9RO8RED?UGLE?+61O6=M:!=9QU M85UG/5A/&9*Y8RCFAB&8^X5>;A>EP"O!,>2H8T,L]PJMW"JDL[ZL+ZS`6R@ M#)G=951VDQ'9/3Z&'/4XIY"3DE8K*'7>?(+?D/LESVBISZBU@JV6L#6L[Z\`ZRA#,_4(OMPNYW"W4!Y#* MG4(I-PJAW"=T3:#8D\_#.=VF\V]=*,-T^VVCKUB*M.XNR;BS"NJ_H MZK8BJ[M*]#WY!+\A]VMF8:VSD-(4MG&VA6V=[6`[9Q6LE$)G<)E=PD1'*/T,@M(I2>22+9D,CM>SZ2OGVWSQVG M:(3MG%6PRMD>MG=V@!V4H:P;B[#N*[JZK43?DT_P&W(_9W1S'5U*4]C"V1*V M=+:"K9RM86MG&]C&V1`V=#:"C9R-86-G$]C$V10V=3:#S9RU86UG'5C'61?6 M==:#]9SU87UG`]A`&3*[RZCL)B.R>WP,.>IQ3B$G)2GQ&5U+&7*Y6ZCE9B&6 M>X56;A6EP"L!A<#K`$*Y3^CD-B&3NX1*;A+!]%P2RX945N_YZ'CU;I_(3GD* MVSL[P`[*D-:=15DW%F'=5W1U6Y'5727ZGGR"WY#[)<]HJ<\HI2ELY6P-6SO; MP#;.MK"MLQULYVP,&SN;P";.IK"ILQELYFP.FSM;P!;.NK"NLQZLYZP/ZSL; MP`;.AK"ALQ%LI`R1W>-CR%'W.86KE=R.5N MH9:;12GP2D`A\#J`5.X42KE1".4^H9/;1#@]FT2S(9F';WPKXK2 M2#8D0K;.SO`#LJ0UIU%63<68=U7='5;D=5=)?J>?(+?D/LE MSVBISRBE*6SE;`U;.]O`-LZVL*VS'6SG;`P;.YO`)LZFL*FS&6SF;`Z;.UO` M%LZZL*ZS'JSGK`_K.QO`!LZ&L*&S$6RD#)'=XV/(4??(+?D/LUL[#6 M64AI"MLXV\*VSG:PG;,*5CG;P_;.IK"ILQELYFP.FSM;P!;.EK"ELQ5LY:P/ MZSL;P`;.AK"ALQ%LY&P,&SN;P";*3D$G)2E/V:OEK`UK.^O`.LZZL*ZS'JRG M#,G<,11SPQ#,_4(OMXM2X)7@&'+4L2&6>X56;A52N5,HY4814,\G\?1T(I.[ MA$IN$B*Y1VCD%A%*SR21;$CD]EO._6[SN\SR&;\=;.>L@E7.]K"]LP/LH`QE MW5B$=5_1U6TE^IY\@M^0^SFCF^OH4IK"%LZ6L*6S%6SE;`U;.]O`-LZ&L*&S M$6SD;`P;.YO`)LZFL*FS&6SFK`UK.^O`.LZZL*ZS'JSGK`_K.QO`!LJ0V5U& M93<9D=WC8\A1CW,*.2E)B<_H6LJ0R]U"+3<+L=PKM'*K*`5>"2@$7@<0RGU" M)[<)F=PE5'*3"*;GDE@VI++ZFG._57[76&K;'K9W=H`=E"&M.XNR;BS"NJ_H MZK8BJ[M*]#WY!+\A]TN>T5*?46L%6SE;P];.-K"-LRULZVP'VSD;P\;.)K") MLRELZFP&FSF;P^;.%K"%LRZLZZP'ZSGKP_K.!K"!LR%LZ&P$&RE#9/?X&'+4 M?4XA)R6M%D=J.6O#VLXZL(XR!'._T,OM0BYW"[7<+$J!5P(*@=+6=M M6-M9!]9QUH5UG?5@/65(YHZAF!N&8.X7>KE=E`*O!,>0HXX-L=PKM'*KD,J= M0BDWBH!Z/HFGIQ.9W"54(4'HFB61#(K?\,N\VOY5Z'OR"7Y#[N>,;JZC2VD*6SA;PI;.5K"5 MLS5L[6P#VS@;PH;.1K"1LS%L[&P"FSB;PJ;.9K"9LS:L[:P#ZSCKPKK.>K"> MLSZL[VP`&RA#9G<9E=UD1':/CR%'/!U`*/<)G=PF9'*74,E-(IB>2V+9D,KJ:\[]5E_M&DS*4]C>V0%V M4(:T[BS*NK$(Z[ZBJ]N*K.XJT??D$_R&W"]Y1DM]1BE-82MG:]C:V0:V<;:% M;9WM8#MG8]C8V00V<3:%39W-8#-G<]C'T..NL\IY*0DY2E':CEKP]K..K".,@1SO]#+[4(N=PNUW"Q* M@5<""H'7`:1RIU#*C4(H]PF=W";"Z=DDF@W)/'S-^=7#5[O.P73[;*.M6XNT M[BS*NK$(Z[ZBJ]N*K.XJT??D$_R&W*^9A;7.0DI3V,;9%K9UMH/MG%6PRMD> MMGCZ)IZ<3F=PE5'*3$,D]0B.WB%!Z)HED0R*W M;SGWNWW[H>^783MG%:QRMH?MG1U@!V4HZ\8BK/N*KFXKT??D$_R&W,\9W5Q' MUUK`%LZ6L*6S%6SE;`U;.]O`-LZ&L*&S$6SD;`P;.YO`)LZFL*FS&6SFK`UK M.^O`.LZZL*ZS'JSGK`_K.QO`!LJ0V5U&93<9D=WC8\A1CW,*.2EIM8*RL1PB ME[N%6FX68KE7:.5640J\$NQ"O`X@E/N$3FX3,KE+J.0F$4S/);%L2&7UEG._ MU9M=@TEY"ML[.\`.RI#6G459-Q9AW5=T=5N1U5TE^IY\@M^0^R7/:*G/**4I M;.5L#5L[V\`VSK:PK;,=;.=L#!L[F\`FSJ:PJ;,9;.9L#IL[6\`6SKJPKK,> MK.>L#^L[&\`&SH:PH;,1;*0,D=WC8\A1]SF%G)2D/.5(+6=M6-M9!]91AF#N M%WJY7<7SV\ MV74.IMMG&VW=6J1U9U'6C458]Q5=W59D=5>)OB>?X#?D?LTLK'464IK"-LZV ML*VS'6SGK()5SO:PO;,I;.IL!ILYF\/FSA:PA;,E;.EL!5LYZ\/ZS@:P@;,A M;.AL!!LY&\/&SB:PB;)3T$E)RE/V:CEKP]K..K".LRZLZZP'ZRE#,G<,Q=PP M!'._T,OMHA1X)3B&''5LB.5>H95;A53N%$JY4034\TD\/9W(Y"ZADIN$2.X1 M&KE%A-(S220;$KE]R[G?[9M>@]G!=LXJ6.5L#]L[.\`.RE#6C458]Q5=W5:B M[\DG^`VYGS.ZN8XNI2ELX6P)6SI;P5;.UK"ULPULXVP(&SH;P4;.QK"QLPEL MXFP*FSJ;P6;.VK"VLPZLXZP+ZSKKP7K.^K"^LP%LH`R9W654=I,1V3T^AASU M.*>0DY*4^(RNI0RYW"W4*4N"5@$+@=0"AW"=T) M8'HNB65#*JNWG/NMWNP:3,I3V-[9`790AK3N+,JZL0CKOJ*KVXJL[BK1]^03 M_(;<+WE&2WU&*4UA*V=KV-K9!K9QMH5MG>U@.V=CV-C9!#9Q-H5-G3^+I MZ40F=PF5W"1$O#^LX&L($R9':7 M4=E-1F3W^!ARU..<0DY*4N(SNI8RY'*W4,O-0BSW"JW<*DJ!5X)=B-_()?D/NESRCI3ZCE*:PE;,U;.UL`]LXV\*VSG:PG;,Q;.QL`ILX MF\*FSF:PF;,Y;.YL`5LXZ\*ZSGJPGK,^K.]L`!LX&\*&SD:PD3)$=H^/(4?= MYQ1R4I+RE".UG+5A;6<=6$<9@KE?Z.5V(9>[A5IN%J7`*\$^Q.L`4KE3*.5& M(93[A$YN$^'T;!+-AF0>7O.[KX=7_?WE[.6SC;9N+=*ZLRCKQB*L^XJN;BNR MNJM$WY-/\!MROV86UCH+*4UA&V=;V-;9#K9S5L$J9WO8WMD4-G4V@\VGDYD^^;E_M=U];.]C. M606KG.UA>V<'V$$9RKJQ".N^HJO;2O0]^02_(?=S1C?7T;46L(6S)6SI;`5; M.5O#ULXVL(VS(6SH;`0;.1O#QLXFL(FS*6SJ;`:;.6O#VLXZL(ZS+JSKK`?K M.>O#^LX&L($R9':74=E-1F3W^!ARU..<0DY*6JV@U'G+(7*Y6ZCE9B&6>X56 M;A6EP"L!A<#K`$*Y3^CD-B&3NX1*;A+!]%P2RX945E]R'VCUQ>_'ANV='6`' M94CKSJ*L&XNP[BNZNJW(ZJX2?4\^P6_(_9)GM-1GU%K!5L[6L+6S#6SC;`O; M.MO!=L[&L+&S"6SB;`J;.IO!9L[FL+FS!6SAK`OK.NO!>L[ZL+ZS`6S@;`@; M.AO!1LH0V3T^AAQUGU/(24EJ5([4GDYD0< M1/7%SD&T]K"]LP/LH`QIW5F4=6,1UGU%5[<56=U5HN_))_@-N5_RC);ZC%HK MV,K9&K9VMH%MG&UA6V<[V,[9 V-H%-G$UA4V M]'[L[.6SC;9N+=*ZLRCKQB*L^XJN;BNRNJM$WY-/\!MROV86UCH+K0ULXVP+ MVSK;P7;.*ECE;`_;.YO"ILYFL)FS.6SN;`%;.%O"ELY6L)6S/JSO;``;.!O" MALY&L)&S,6SL;`*;*#L%G92D1F6OEK,VK.VL`^LXZ\*ZSGJPGC(D<\=0S`U# M,/<+O=PN2H%7@F/(4<>&6.X56KE52.5.H90;14`]G\33TXE,[A(JN4F(Y!ZA MD5M$*#V31+(AD<.7G!\9ONC]V"/8R-D,-G.V@JV<[6`[92CKQB*L^XJN;BO1 M]^03?,_]*8,[Z=@2P8R[Y:P-ZSCKPKK.>K">LSYLH&P3M%&R#?&YK4(JW6+_^Z M/@=U_)(,3% MSRNC3$7TES&$92HV.HJP3(5'IK7-5&QU(*U=T.Y%O]JA"MK_L'%4+_FPYOY% MWZ17+SDILG_1#U17+_D`^_Y%3UQ6+[FA=>\C(5=YV:1S,F=.%CXGR2+,UJ:U MS+-+CNSIK8)6/I)UT$;G9,V<;'Q.ULS)QN=DS9QL?$[6S,G&1T)J\U)+YV3, MG$Q\3I)TF#[Q:9Y=4FIS,@N:^4CF00N=DSESLO`YF3,G"Y^3.7.R\#F9,R<+ M'\DP(QDZ&@6-'(V#)C_L28\9_\3'/V;\$Q__F/%/?/QCQC_1D;1__-[6V>_D MS:'NT?V1_P,6WG@:>>0Y;?(.70$U8F"SL&42_K_7Y1 M=G%&:FJ)'0```/__`P!02P,$%``&``@````A`,:\Q![-#```X$D``!D```!X M;"]W;W)K&ULG)Q;;^NX%87?"_0_&'X?.Y(EVPF2 M#$:\M`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` MQFG=.A&S;A=BLWXO+=Q%\W+S^4%.A[;%.F<;HP)-T:VQXD!S8#BP"!#3;M-C MTY?->O'3U/5?MX?7.=L'%6B*]BJP9)6H>#"VF.;`<&`1(,97U/BXU?:#>`&+ MKO7:CJA``P5DO%WBP:X`#@P'%@%2@+_-89?>X7;Q@W@!!2L`-/=P!F;\%,#1 M%1RE(S4>N9JQV@T<36UH$2"5W=]2F1_$*V-7QPHT<&K*&;M&JWBT.S<<&`XL M`J2"S.W;ZT]..XK7P%Q6001%%#-6HNH.=U4(8@2QF-!"?$)>W649Y"K=Z.S* M7P41%+*8L912W>%4",R:&L@(C<6$%N)3[_I"("MI(:ROJPQ$4$@NST@\G`KA MQ'131(W%A!;BX^_Z0B`T:2%LR:L,1%!()L](/!Q-ZFY`)$80BPDMQ.<@*N1R M=&20FJ0`?H-4!5$HH)BQ*YNBQ\6ITOPXRR;3'8_U6DQH=3XP477C\L4_WO"K MV()=@:L@RNX6[468'5;A<-HF6A!S>0J+!]"J?)JRJI:#]R@99#`]=VQMJR"* M5=W-[L390U$>;O`Y,6&65+S%A-;B@Y754KCU'^A#B&-:"[\%R&)F^T>9O)1] M&(_'/M+=B$B,(!836HD/4E3)0`40N[B"?"G.!LIFN-'-.-&"&$$L)M2SCT[D M>>3^@,!U%R)T!\DV0)6A5`[>.=%"8P2QF!#O^4WIWHYBZ;Y@/5X%4=H%"]9; M*BA2AVM!C"`6$UK+30&?]P3\@MV*5$&4G"I!M"`FD+0"=VQ>B\?06EQ/\YX: MOCKE?A0_+_RN*XB2*Y:=*@A2L5H0(XC%A);BLQ9MC\M;VK^2$B7P^ZT@2@Z5 M(%H0(XC%A'IF@3YN2^<0[)>W=!!A[S`L$2TT1A"+"?5^4US[EWABW<66!A%J M'=;0*DR#:X$QB1BAL9C06GI">OC),.\+:>:T"J+D2PFB!3&!I!7@+_F9Q/'(?0+X.[`,>PBKG1`MB!+&84.\L ME@?6&W(5WTK(%SIY#-_VO2Y]8Z"Z@_&^1PMB.N(G8!=FVQUT$Y!*?,?C*^BX ML]".XF'`KO55$*%=((@6Q`AB,:'>;PKE!83RY0X*(NP=AB6BA<8(8C&AWGM" MV!=ZN9,6?2',KSY!E)PJ0;0@)I!T]1$W%'@,K<7G*DKAD3WD1[$>*M(+=GA+ MN``1KH43+31&$(L)]7Y3&B_&I'$08>\BC87&"&(QH=YO2N-%7QJ+'N+)JL*P M5(T6Q`22>D@D&!Y#:V%I/+`/>E*XX`\X"Q`EQTH0+8@1Q&)"/;/4'=GW$*RN MC2\\G"U$^@JB!3&"6$RH=Y:^`^L-\7DYP18Q8WL"2'4'NP03Q`AB,:'VKPK@ M14\`%_Q9/HAPN\1(3IXY,6*4Q81X+FZ*VG;4T(^N@@AY%T0+8@2QF%#O+&HO MMTL!67FY78(HO-AF-SS=P6[I!3&"6$RH?9:V`_9[4K9@+QBJ`D1XR3G10F,$ ML9A0SS[HKD[5`N+Q\M4EB+!W&):(%AHCB,6$>F>I.K#>$(MN^=`5D6_/(F:G MO[JP2[WJ#J9VB?)(C-!83*A]%JP#]GL"M>"/M_Z5J;O;20NL!-&"&$$L)M0S M"]!Q851`1@ZTBPC2,"Q5HP4Q@EA,J'<6I`/K#=DXT"XQ0'V[L%Y213P8FT,+ M8@2QF%#[+$M'+GU/IA;\/JR(F1J=*D&T($80BPGUSH)TI'?(P8&VX6&I"DZT M($80BPGQ7K)`O=PVK9H];XA?JPBB_E#J#L:3H04Q@EA,J/VK,K7LR=2"/>97 M093VI1)$"V($L9A0SS[CK@ZE$I+Q!=O'J MP78!$;1+P5ZAJ3(>3?W"B1$:BPGUST)UW%8M>\*UX"^]@RBMM!)$"V($L9A0 M[RQ11WJ'T'2+AFX,6/97I4A60;0@1A"+"?7.DG6@;R`L+Z=3&1/5IQ.[YJON M8&J;*(_$"(W%A-IGX3IRZ7M"EC=X5?(<58)H08P@%A/J_:9D+2$T!]I&)&L8 MEC:!%L0(8C&AWEFR#K0-1.-`V\3\[&V;>#`VB2XY,8)83(A]_Q/!\5?+5LVN ME@5_(1Q$:8&5(%H0(XC%A'IFB3JNU9>0K)?;)8BP=QB6B!8:(XC%A'KW83.=%AHJ0Q@EA,J/>;`G4)64G:IN2!&D3.;TK=DC]" M=:+4/CR'C=!83&@Y5V7LLB=C2_Z")HC2\BI!M"!&$(L)]7Q3L"XA,P?:1P1K M&):JT8(802PFU/M-P;J$S!QHGQBLN'W8ZQ`59L+EQ&&QH8S06$QH.3[IQE]] M(!=I&>PNK%KR\%2":$&,(!83XGG%`G9<6+6CAEX'!U%:726(%L0(8C&AWF\* MVA4D)EUW?O4)(GKU8<^YJA/%9M&"&$$L)K0<9VE\^ZR\FH<7?Z(*(GP*8%@B M6FB,(!83ZMFG(VKYD>T#F7KYZK,"47*J!-&"&$$L)M2[S\+KO4."#K0/B&C[ M\`?S512E]N'$"(W%A)9S4Q;[/R<4;<1OF8,(GPH>LUIHC"`6$^J=!>_(-H(` M'F@C$&'OG.@5)T80BPGUS@+X\A/6"C*5M(]X_Q=$V'.,XIX7R5K(C2"V(W0" M6LE-<;SJB6/QZZ5!A"OB2:N%Q@AB`TD_VT>_'T)K85D\LJ-Z,EG\2O\*1-$# MBPX5#J=2M2!&$(L)*63=$]#^QR^7VZP=Q=)AR1]M@B@Y58)H08P@%A/J_::` M7D-`7][6082]P[!$M-`802PFU+L/RJO380WQ2K:WV`Q!E)PJ0;0@1A`;2&Q$ M]U<8Z?:1UN*C]/I:((!I+:S;JS6(<"V<:*$Q@43G;%*+!]!"?$"B0@8V`<0I M*8#_E6JUYIFK!-&"&$$L)M3S3;F\AH!U:YD>?\7?"@<17GR1RT)C!+&84.\^ M&,>O-\0H76_VR%ZM8]:BPI;LJ5EUHN[62!`CB,6$EG%51*][(GK)'AVK(,)+ M'R,Z>>;$B%$6$^KYIC!>0ZH.M`V/7A6&I6JT($80BPGUWA.^(S*K)WR7Z8H& MOXJY!E%XF[AD=ZJJ.YQ.0AP0B1$:BPDIY)Z%[^7K3:OFH&JL@2DNM!-&" M&$$L)M3S3:%[/R9T@PA[%Z$K-$80BPGU[JX=^'KC[]J&&\=]KHUXAA&-$T3P MM_"+C)T6%0ZGTK0@1A#_B3K^.[>CH!#X@!SXV)5]?7RK5?WQ<9ILFV_^PV]\ MVW84/IBGRAYT^S$F7O__:+9`-&-0U%4[KZ,,X>GT2`:0`-- M2GK_'_]X^G[UY\/+Z^/SCP_7R;O)]=7#C_OGSX\_OGZX_N^_%W];75^]OMW] M^'SW_?G'PX?K?SZ\7O_'QW__M_=_/;_\_OKMX>'MBB3\>/UP_>WM[>?FYN;U M_MO#T]WKN^>?#S_HRI?GEZ>[-_K?EZ\WKS]?'NX^MX.>OM],)Y/%S=/=XX]K M+V'S,D;&\Y'[W=OI/_KM\>?KR+MZ7Z,N*>[E]__ M^/FW^^>GGR3BM\?OCV__;(5>7SW=;^JO/YY?[G[[3O?]CV1^=R^RV_\!\4^/ M]R_/K\]?WMZ1N!NO*-[S^F9]0Y(^OO_\2'?@S'[U\O#EP_6G9'-,)NOKFX_O M6PO]S^/#7Z_!OZ]>OSW_5;X\?MX__G@@<]-"N27X[?GY=T>M/SN(!M_`Z*)= M@O]\N?K\\.7NC^]O__7\5_7P^/7;&ZUW2K?D[FSS^9_9P^L]F93$O)NF3M+] M\W=2@/Y[]?3H?(-,/#]D[3 MA!RAG=/]0R8=9=-$5M3]0V9-1UDUFJJ'XUTDHT3)J'@%Z@+CE.Q04'AI'QR8CY< MTUJ3V[]21/_Y<359OK_YDX+PGCFWR$EBQE88+N*PL<+'`,@!LR;6=?S. MANGT`.@!Q#)#(A;:$7F-"Q8Q-Z9-[% M]]8"F05R"Q06*"U06:"V0&.!G07V`1!9@*J*"RS@V+$%/#(G"W=.-)N8:-WR ML"%/RSQG1N5*(,A$=-Z1Q!V+3K0@)2!5-RH0G1A/K[MA2K+1T/0*2N.0V74D MT6C?B28D,C[=[`7&=^S8^!XAX\M46^:T1;C?BST2V36=+6*=\XXD@@H05`)2 MP:@:.`UP=H#LPU&1?5SG%E8YPQN'8\?V\4AH'^8$]O%(9)]98BJ](G7U`4`E( M!:-JX#3`V0&R#T=%]G$-160@7R:_Y2'92 M8L.U@C]LSG@HJT2HPH$ULAID[1#:1P-C&[H2 M>7P0ND[,&LM#KE\-S&!2T)8'3BD9="R;@#,A:46=,S1+VO9E;;)Q(9=I#57L MS/0XI/+.SU<(:TKH1DFJ]8XBT5K5FB=GN]L**E->-*UXG5WU? ML$Z^6*?)8CZ)PW?/C%FD MN-HC7B-7RU^P1K[TIQETC;@;".]C-C7I>)LP:\@K,R&I5^8,22R96RWDQ'W4!EV>AO6$7Z(])W#`W%49_B:H\XCLA%+EDC1S=Q MY*$XCF8F*6T39M&?@35BDGIDSN-D/X(X\B-B=\0XZB87*U:B3U3;S4S35PMK M2.M&2*KUCJ&A..I3_-0:N>[O@CAR=+-&'HKB*+5US#;A@<-QQ"3UR)S'R7X$ M:\23GXFC;G)=HVXJ]9G9#&J&;J"R,(XZ42)]QUH/Q9$?-*ZNUK8[PYFT M(9`>:&P1RA#*$2H0*A&J$*H1:A#:(;1'Z(#0,8)B^[E._,O`P4V%2?$Q MV<143+FR)'8+E2Y0B5#%T#3<@6;!\7]L+]>%A/;J.1FD8D>.!IU0&S8>BBJB M=&XZTBT/'#[M$I+6%CE#7!'9[;"0R\.=A<@-3KL$HDVO6\YTKKMM;"37!EQ@ M)$(B-)#MBZH"*W256I M3*#P_IFE05`(2^.M%$AE50R9&]2V-+Y!5T5><(..;D+%0R943';<.FW.APJ3 M0BNP]!-=,(N-BV#T@FYR68-*]"%GT%!)M2^,C719^3S%\IDA%Z#!=%#^<45- M*Z\LDQTR$:5.D#-TJ@V5RV>2;C>Y&HDA,I_J$QQ>1D9R7>X%GM328T\2R+_/ MZ`[/MPAE".4(%0B5"%4(U0@U".T0VB-T0.@80;'];$'L*J'9RKTIVO?XCV#9 MY&G=;5`*%'H2O0`:;TW;/E::GMA478!'Z^OT6]*[EV?5P]*SE46+'ZNG.=AO MKWVL-&B>8_/U%I(3FGNX0IIAZ2A0J-T\,`MKQP-#5IJJB6/M7-$5IEEGO-5Z MS.+ZX0."!T9 MH@:15(UM[TJK?]WVOD"+L@!#VA!L9QTT9'M/6D1%XL*D[9Q%$4MMWTD7J!PS M8:6B`JT6IB2NE272&Y4NT$ZA0);QKKV*"D@+<_!Q4)9(/ZIT@J)5G%]6\[;T M..D(%"R70H&>YF8R)KG8UGA::.G6[I^YLN1F"H1*A"J$:H0:A'8([1$Z('1D MJ"=4YK8P'MX96[HQLB^0H^YK:>LE'N>Z9[4HF)TEA1W1=&F<-A=1Z_;H(EE. MU\;+"F:X;N#D9*6(&=*H$M*@1K6PO$;39#(Q.C=C--J)F"&-]D(:U.@@+-%H M/C?%W_&,1G$@VN;DC(]@2T)/VMPV%A]C+,SZ;YDU?.(GI.`80Z3[5X`6RX79 MU`HAQ&=I<;]6BN"A3;02DLY>BW`_^VHYT2ZES1.-$(9FWXG@H=GW0M+9#R*< M9U_;\\ZC$$[,'B^T;?/.+#1V=_38VRUTE`Q6L,Y,&G+T3"0%)S$"L5>O%\:I M"R:<"?P1LU"^1GGT_L6X;-F-EW(F7HWO="TMD/`O'L]%G.V'V/9V:/ MU]GUN/]R?43O/]O:E"$3YR8@MC)PR-/UI]FC M]3\3YXYN-GV&U$.W\PXZO>MF3*)Z1&JF'*%"10FK5.BT]`I%U0@U*DJD[Q0Z M+7V/H@X('54428^M;@\A?JDCG./9!$-1TDT7QD&VPAK*/)F0!LN+7%@^&='[ M;2;#%TPXDXC]G0S6A)5,-:A0+2RO4+*>&(6:,0KM1,J0A?9"&E3H("ROT'2Z M-%O5\8Q"L>.00E&X6L?Y^_-/"L]SA[%S)\:$,4-A&'?0Z5#(6!05D1)".4*% M3*C22X5.2Z]05(U0HZ)$AYU"IZ7O4=0!H:.*@C"FE8?5F"[:T^;Q'RN:.REF M,3QD-D\]4_:GMC*0LNW)YB83$D581^KII'A"OZ=,YU/CI`6+B1\`FM`J9:XA MA2HA#2I4RWRLT,1^GJ<1PHE-KK703N8:4F@OI$&%#C(?*S1;F%+F*(03"L5A M[,YRAJJND6',1T+!NP)SAC30M@JI!P1/=UI+94R*PMB+"J!"14F@E0J=EEZA M]!JA1D6)])U"IZ7O4=0!H:.*LF&$CA$4V\^=>=BM9S%K M/PH]W/NE_K0D?`@B4)BZ\/6'/E82?#=$K!_MGZ!?LER=?__!O1]GEYJA6#]; M1\G`D$7?!M:=JL3ZN=[6VF\^68_0SXTT"8"A<&9\`X)>8&L'AJPT.`R/]7.M ME-6/SHA&O`*1NJ%&08:BJ>V!PU8&AJSDU)NU*;$B!<]XG:.W2FE26=GO9;AM MA=)A(R74;EM(E^9IP%99DK,RA'*$"H1*A"J$:H0:A'8([1$Z('2,H-@-7$$? MNL$9*_OZ/XIMAH+7'%*`,H1RA`J$2H0JA&J$&H1V".T1.B!TC*#8?J[XO M`@7/7!4*XM2TD1F3W$/]+ICG$Q/,N;(DF`N$2H0JA&J$&H9ZGI,NSM6#X^S% MM5_@,:U@,F%H+V;1#M"9`LI!'N;8M1,"/J M9NUDI8@9TJ@24I@K0*-:6'PHG*S3N2D"FS,JQ<[:6Z.F%WZ=T`+K58:B<[\9 M?&9(!@Z[-4O7!T>Y2/='6,O9PMB@$`(-U41B@K\<,WLE))V]%N%^]O5\:1[- M-T(X,7N\`JXD'K\]+QS=;$X,!;VWL$)?LEZ9,2E\;(50H:(D790*G39NA:)J MA!H5!6FTM_J_V#.Q$5AXR"01^V!)6$,AFPDI-#.$;"XL3B+K50+>ZE4ZDT18 M[R&-*IEK4*-:6)Q$INN)_9Z0ABFG5(I=F%2*7-B67>..E19.C'%MAD+7[J#3 MSI>QJ/!8":%")E3II4*GI5]_;(0P M*@?;%LDY\)2^=?OFCO+&T[=IP'+3T.`X8,G%@ MMN.M#!R,`Q&E76[.D"OU=9'@&80.#%BVU!BC0B6DH-00X=[-I].U/2]JA#'& MSY>N2PIK#9NH1_5[K12S#K[]BIU^I>>.K==M>>#@NQ&9D-3K_K#U<8GLHD*JX5>BT#V9,"NL] MA`H5)4FG5.BT]`I%U0@U*LINBDO;'?Z:;V+3V`JVK^FNS,O,6V8-OZ8KI,&M M*9<)?NH]89R(69^C9;*AK%4):5"C6N;S&B5]]9Y03J@4NS"1!M/(N'IO MZ<28/,)0Z-H==-KY,A85UGL(%3*A2B\5.BV]0E$U0HV*`M>F)1RTU[BTZZ08 M MIBA9C'B^OL2V2*!80=NQ]K'2X*,6D8*KR]J'EMYZGYIH9?N76V;%CU_MUYUN ME24!ER&4(U0@5")4(50CU""T0VB/T`&A8P3%5K8]P[!OKGPG$/JF0,'C5X0R MA'*$"H1*A"J$:H0:A'8([1$Z('2,H-A^E]7[*ZSW&=+&=`M(!D@.2!$BL8JV M]#ZSQ%ACKSQ$A8C[OFK:A,TKI5LAA.$/FYV0!K?\7%C_]E5%R.X8,*XY71ESP7W MR552\.AZY2%=3GMTQX0SR\F"P^5DP=Z`\[D)D4(F'K6;V$SL%RQVWFGWU47+I,Z`5EDL,Q>>&*PA<'DB. MW1=@;9N>B?1PI?TX^E*@-B/0I[F-#Q4R_ZBUMG78F=#%VFO%D*[25J&A6_/C MP@,C'A=`A8JR?>_:%FB_=*332HF=EZ&H[Z4?/.U><_3'C<(:]&`AT9)U:XQ] MK[`X1_4_$3`IZRARA0D7! M2E]6Y*RQR!$H*!(1RA#*$2H0*A&J$*H1:A#:(;1'Z(#0,8*B[7E]6076TLW* M^PHL*!*9I$@&2`Y(`4@)2`5(#4@3(O&MNG)I_-:U=G1SJQYRGPWN0C9=F:IA M*P,IARG+/);)F!2_,;4RV3I7EG1[A4H7J%3H](25B@I(:W,872M+I#^#JG5`5BE*J/@* M!]8(-='`V#JN*@NM,UQ$K'T1%SF)AZ(]-[7?4K/E@<-GS4)2*^0"25,WM?%< M,./4!NN?F8B8H2V_$I).7XMPVCZ[9#&WOV_4""MZ.U532FQP5P->8'!'-VG. M0W&-NM;#.BYR>.!@C;IF4E"C,L0U*GU'IDEZA1"B+*LWR_8>,7N%L],@T-1R:PA#\O63%(/RP7R#I[,5W8E"V:< M_^PAK4@'[4TEF*;E$UH%^U])C[=L\NXZ1K$X3T M2Y=,.Z%&%`+)Q/85PTG>\ZWIL8/H>!3LJJM)!9FP@M8P[\'(LC`#_1)HAYV> M@>S8L63W)#L"1D8+,6,BVZC\HM-B`Y.X+PZF5::/"(IV6\&&M\..%=H7>]". M=KH)% MYQ8B*&:2"6/AU#-X0[B7M@AV0Z,A20,-1UK1#;569"S4$3\SG$QZ:(O@/0^C MHRM)K17//U.G3W'W*,A8J&`*GQGNAH:T1?`I/Z.@*^&L@J,^MIY,?/47YT'& MXLEMF]`-C6FZB7L=;UZ_/3R\97=O=Q_?/SV\?'W8/GS__GIU__S'#XH7>A$V M@*]>'KY\N/Z4+C>?Z+$]);IN@+]"GV3>N(_U]EU9T94V<=LQ2QI#[TO@F$^K MR>:3NPN\1,_L-^X!=M^5A*ZTJ..$_#*IV3SJ6^66S)`KZ5)K3[^I]GF$WU:`">X MG=$=]N&T++W\9$TS]SD&??QVXSX0BW-DBV23DSOC%?I$*(WINY(MIG2E[U9N MR5BWO<:B4\C-MO<*'3UNW,$B:D`';72E;_&S]8*N]"T*G4=NBMXKY72Q<3_Y MTS//;+5QWT#>=V6]<=_;C5?H*[@W[@NV\0I]5S9)Z[M"7SR]<5_?C&.RZ6SC M?@0-K]`/16UN>[7>TA7W1\$I.5_+>*_2;4!OW&TDXIJ`+29_2 M)=FS]T*UV%#ITR.J7FRH_NFYT"PV5/#T7-@O-E3U]%RX);/T7MB257HO9'3K M?1Z3+3=YWWUGJTW>ZQ/D$KVKFTPV5"TZ76^Z7/7Z\?W/NZ\/A[N7KX\_7J^^ M/WRAW6/2OCCV\OC5E5[^?][X*_Y^>WY[>WZBZN#ZZMO#W><'^AV?B?OPS9?G MYS?Y'S?!7\\OO[<[U,?_$P```/__`P!02P,$%``&``@````A`'4(F701!P`` M"!X``!D```!X;"]W;W)K&ULK)G;DJ)($(;O-V+? M@?!^5*`%)5HGV@.*Y]C8PS6-J$2K&$!WS[S]9%%4064RCD[L3:M?__R5E95U M`)Z_?CN?M(\P2:/XTF_HS79#"R]!O(LNAW[CG[_=+]V&EF;^9>>?XDO8;WP/ MT\;7P9]_/'_&R5MZ#,-,`X=+VF\CO\HO.IY;1;ENMLQ]=&MS!2>[QB/?[*`C'Y]AJFF1LQRX86O*=9?/Z/B_3"BIL\%2;P69CH9M/H M=O2.]8`+M)>'`I_"Y>%(K,(#/J5'M]-YLKKV_=VQ"Q/X+$SLYL,F,,'RWL#G M[T?2*TS@4YH\.CBZ&&+V1;@8CW=(-XI@V!?A\QLV4&EY8O2RY/2'QYF5.'8 ML9B2?`+)2?JS.0J3D[F\,)M^`\H'IE\*"\O'P.X:SZT/6`R"0C.D&EU5C(2" MS7QF.\9@@H&+P12#&08>!G,,%A@L,5AAL,9@@\&V`EJ0?#D"4*#_QP@P&S8" M(G=#`FJHI$4R6P3,B'$)61*R(P0CY`Y M(0M"EH2L"%D3LB%D6R5*ZF''?2#U3)VG7B1L6)">K/$1(6-")H2XA$P)F1'B M$3(G9$'(DI`5(6M"-H1LJT1)*FPI#R25J=6D2FM!5I*41KBQM?0I-89EJ2G:2)&PWDIK(,K80ZX?&'NF5L>>$QA[T=2H MT)0+U;C0V%(S(1I7:JK]0GOV5(I$8S-BY!$REU=5K3MJRA92)*R7Q&A%R%I> M5;6V5>N-%`GK;=5(&0UVKT\/I$UV4,Z.4?`VC&%BP%9;LV^;J6,2$WFX<99I)ZIU=1SPNZM*TL:7AL+$92%%.&)/RXT M$*C4 >&^\P7J^53 M(+-Z!C=LM+F,Q(75*L-C,18BV`KD@!DVZMY$J&Y9N4*D6N$:*E0F6YD^!F;; MA!K"120T<,*30>'(/='LW'HK4E>%%5^N\?&X76@C'Y1#.PR MM&452&FVBQ;^$;QIH<%URZG.@^,O4_@SVW.8',)1>#JE6A"_LQ7`C50-MQTXTM?PK@,'2\JWE@/' M2\KA?=-+73Q#]AZJ1C^$#M3I7TSGA;^W0AT;F@X\CJ(-SRP'CN24>Y8#!W/* MYY8#MZ\UW';@MJF&=QTXO%.^M!PXPE,^M)QA'1]9SJB.CRUG7,&PO=V]R:W-H965T[U\?"T?_WV^?+__I7]X^;RXGAZ>'UZ>#Z\[CY?_K4[7O[S[G__Y]/O MP]L?Q^^[W>F"-+P>/U]^/YU^1-?7Q\?ONY>'X]7AQ^Z52KX>WEX>3O3/MV_7 MQQ]ONX>GJM++\_6@UPNO7Q[VKY=:0_1VCH[#UZ_[QUUR>/SYLGL]:25ON^>' M$_7_^'W_X\C:7A[/4??R\/;'SQ__>#R\_"`57_;/^]-?E=++BY?'*/_V>GA[ M^/),X_ZS/WQX9-W5/T#]R_[Q[7`\?#U=D;IKW5$<\^WU[35INOOTM*<1J&F_ M>-M]_7QYWX^VX?CR^NY3-4'_WN]^'YW?+X[?#[^G;_NG8O^ZH]DF.RD+?#D< M_E"B^9-"5/D::F>5!=9O%T^[KP\_GT_;P^_9;O_M^XG,/:(1J8%%3W\EN^,C MS2BIN1J,E*;'PS-U@/Y_\;)72X-FY.'/SY,KV2N7EQ>//X^GP\A\MU#>JM)*A44(_C9*AU=%2CUJH&J>?IMZ@?U;%T%2D MGZ;B^&HX&(UOJEZWM#@V%>FGJ1AHJ_>2N#L[JZJVI M2#^Y16>"6UKLTUJHFE2_F*KG36N?C:I^X4;/&V9_P(W2+]T&VJWP^\+0#E)9[ MI>;S)=6G77XD__7K;GPS_'3]BWS.HY&9H$S?EXA90CD8I3:1()4@DV`JP4R" M7(*Y!`L)"@E*"982K"182["18.N`:S)/;2/:1'^'C90:92.>W0D#:[2!,`A+ M<)5$@E2"3(*I!#,)<@GF$BPD*"0H)5A*L))@+<%&@JT#/(.0:P*##$97M>\_ M>]LH1;3SJ!UGWXQ\(TRTT(!61RT4],:^4%P+U:8"D@+)@$R!S(#D0.9`%D`* M("60)9`5D#60#9"M2SS+T)5]+^Q&LRK)U7+$$B02I! M)L%4@ID$N01S"182%!*4$BP=X,T111`=YDA)^W.DR9!LX#B*&^$H3#4*)&NA MD3BI$RT34%A2RP2]6U]16@OQYLAJU4RF0&9U+4=U7[2?UT*L:`Z*%C6QBN0X MBEJ/E0GZPKV6M1`WMJQ5$_$,1!/2P4!*VC>0)F0@;BHV,K6-X8_2XD]NI?CSI3N[!O6=Z34H(!M;']L/Q#ZW4O4$ MHZXIHAE6S!'-L>("48$52T1+KZ(_TRJO<7/,AAFE:Z)Z2G4:1$$QCWFB;B!H MEM5=DC-9H3]9,4N1ZZFEY)&0L)!-@U*#@GZ5M]Z*\R'C8K)TK3;HB_A[RGJK M2[IJ;K%*D]1>!G):$A<)Z]:0&!6J)_;I#^YK& MO;`)[5LWSJMRADWEMBG'O@-Q\LQ9RL8!"];5-K:"A>S82H.&@VILPWXX%+.V MM(W9+CFSYEM2Y4T=+*G3+&J!YV2BKN]@IP[$L1&S5-O:35C(KMW4(-ZI8J@9 M%[N+MF&GFBZZ.]4@VU3.NKQM,A#^>P>J\O7CW>I$;(K.37U>)>" M;4WC],/QG."%Z\9Y1S;EC92%]LJ<;%O M-?+W;2"<9ZP>,*DM23]JY^GTR3QK,4+NOM6(SUNPK2EVEW&#;8U>][R%IG+3 M16K*=C$((')J:%$.9''.:`L6LJ,M#6K;M^W-^[95V7N'?6N2?7??:N2?MX&( M`6+UT.[C?6N$[$I.3;UW]ZUIW-U%#;:M&[?[%IK*;5.N;2&6:F@1;5LW:%5) MH8*GQ(ZV-*AMW[8W[]M6W2ITL*VYA'`=\/A&'*X3NAVH-JFW`T*Q`V(KQ3.> M($H198BFB&:(Q0;DHSI8K!+W/2TC>X<3 M(TH0I8@R1%-$,T0YHCFB!:("48EHB6B%:(UH@VCK(=\6M,*[V$*)"UMH9//G M6#T=)2%+$B`ID`S(%,@,2`YD#F0!I`!2`ED"60%9`]D`V;K$GWIUBW&^XQJ8 M2P_G4#(HH"BG#B6"4!Y*7)%<6BTEW73"JNA0K86"4!P+J95BAY=9[8RF%EE= MLL&9566%@E!$-;F58NUSJYW1PB*K2S986%56*`B%XR^M%&M?6NV,5A997;+! MM55EA8)09#\;*\7:MU8[(7_)J+L1=\G\5_?D`WW#XEX5&40KB7L1LY3UL0E+ MT>GL+!)QZ9!:*=:5H:XIHAE6S!'-L>("48$52T1+K+A"M,:*&T1;KZ)O-8K; M/*NUW[D/E+CPL1KYF44HLT93L3VS8"'7AH.QB&Q2EKJMKKN"WK"G_O/O^#,C M]%[F7&4R4];D.A:Y568L9!.`G)736>*L-9E?LI2;]4CM"];>UH6"A6P72E;N M=6$L9F')4FU=6+'VMBZL6.0\97PCULN=QMW,P-_':J;#M=[?+`. M]<6(YR;,!8OC)8P0_:C-)`V0J'7K!00ID`S(U!!U@_.NZAE4RX',@2S.45VP MD/6)I4&4I]DN!7+S+%G*3=?DG*Q8NZM*"JU9R'9AP\KU`Y0;7!%ZKKVKRO=7 MA+H?Z;`BS$6-&X)HI'I5&RD80PABI-J6?S(P0A]X)B.E/=-MV.B8M,P'CNF, M/LULG_@LRPWR+T="<$QG=&'!VMNFI6`AZQ7*QBZ,1;"V9"G7-\@5MF+M;5U8 MLY#MPH:5:\=T;*+ MCDGK/=,QJ0N@#HY)B8L589#SZ5!Z"E))690@2A%EB*:(9HAR1'-$"T0%HA+1 M$M$*T1K1!M'60W[8("_85-*A/V']00!17[6Q\YP,#**UX!P7(JJ)FZ6LB_&Z MI[R\MU14]\*@^NQ0>_^JFOZJ8>3W3^1L<;.4#0=R`>;'"\[`H/LS4:,*$&4(LH031'-$.6(YH@6 MB`I$):(EHA6B-:(-HJV'?%NH>XD.ODU?8[@9I0H':$/9""P&D@!)@60N\;NH M\J$.7=3ID]=%C?P41QY9*O)2;ML]."#<9"&*0VJ_@'.)O,K&A=;UB]T%^A MU-1S4&95T4'O]9RD_@8;5EK\=6R0MXZ#GEAN,4O12JUG&<;(0F2W6@B=%DOI MI=T?T;V,,*F1.&MM#V7,+-?VOPX_:,"-[P/0F/G3ZY4:,3$ZO*:/('#0%;.4 M.T":NHY*+.JP-+=XDSZ;$3E89PY']^*&9T8(3<+0)0@2A%EB*:( M9HAR1'-$"T0%HA+1$M$*T1K1!M'60_X^[!93TJ>2C-.T6P*S`"/E9P&WXDE+ M;*5X826(4D09HBFB&:(ZIU^[SZ<7 M@.0QQ\C)`A`EB%)$&:(IHAFB'-$62,G"QA*D@!)@60N\;O8+0P>8AALD'^BVH"D.OQC%FH_4+5R=>'6=J!J M*;JY4)%QT!=G=V::.N\X5:%H!P/IR-5-`H8:^3&A?,ICA-J3`!9R0D)6KI.` M8#P4-R49"[C1H'-"^Y96\66'L2IQL1@U\BR-.<#02+6;V@C9:",U]8Q=0TCN MN/RW)>L4Z\Z]C8=;N&M9HUX\$Y*M7F:GA M!?F.6L^LH[\E4JZT^#-@D&?M8"BS'99JM38+.=8V2-T_UC,7#&6VPU*NS8.A M=2[^3*A(]/P%/C(!KWTT-F%D^QE;9/OIF$);V`A1(,^A2HHHLZID##R2,;", MZL]ZR[?2(FRHHV5_%4.VPQ5;5S$+D?>M#8;9CI$RUQ;T56/65M5492QPCL<: MR>!33LMYR4ZE1LR+B5-=0]?(C@\-K86&2$J/.U$!XE1HA^U$(-YZF1,K>'MW!Y:-HZ*]L9=8N* M*W%Q;C9%Q>)`BKF>.T`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`G]R75B'WA&,U&MB6$(O`4;J M;3$LH7E$,2^@-/^I;4PG];8'[)@M,J,M-/9XH10TMW)/! M]#-N&#R-O:'",HS4M\9A7R?4UTEC7V,J46\)8AUZFS12[XHVE014TE2'7B2- MU'N"6(?>)XW4ZX)80B^11GEC";TE&JDW!;$.O2P:J1<&L20+HZQQ"J9AI+[6 M#VO,PDA]DQ\6S,-(?9\?%BS"2'VK'Q848:2^R`\+)F$T:2R(PRAN+$C"*&WR M%LDX2IL\3W(3T?=O8LO);90V[;FDWXM2W?)UO;KH#U#\>/BV*Q_>ONU?CQ?/ MNZ_D&WO5A[#?])^PT/\XF0]N?#FNZS]>&ULK)U=<]K*TH7O3]7Y#R[?']L" M@VTJR:F8+X$$$I+@O79LDE#;-BE#DKW__=N#IF/ILAC]Y_KT9+>_>WZX M>]P^KS^>_K/>G?[WT[__]>'W]N6OW??U>G]"#L^[CZ??]_L?O?/SW?WW]=/= M[FS[8_U,GWS=OCS=[>F?+]_.=S]>UG'L];%Q?=\Z>[S?-IZ=![.<9C M^_7KYGX]V-[_?%H_[TN3E_7CW9[BWWW?_-BQV]/],79/=R]__?SQG_OMTP^R M^+)YW.S_.9B>GCS=]R;?GK:;__#B[O[MG[\`^P?]K4U'F_I)]<"7[?8O)9T\*$0;G\/6HT,/I"\G#^NO=S\?]]GV M=[C>?/N^I^[NT!ZI'>L]_#-8[^[IB)+-6:NCG.ZWCQ0`_?_D::-2@X[(W=\? M3]O4\.9A_YW>=<\Z5Q?M@.0G7]:[_6BC+$]/[G_N]MNG_RM%@;8J32ZU";UJ MD^#LNM.Y[%Y?'6]"RD,D]*I-.F=7P<5-^PT>7>U!K^\/Y$J;T*LQ>>L1H=/K ML#/T:CS>?$1NM`F]OON(!)11ATC4F_>'$G">J#?&YJU')6AQ,/3&N+SYN`24 MK.4^V:Q]>ZX$G+7JS1\$PWFKSCIC\^8CPYD;_%'J!IR[ZHT.YAU'AK,W^*/T M#3A_U9MW'YD6)[!Z8US>G#,M3F#UYMU'IL4)K-Z\.9CSLO8>2OG@;G_WZI:H6P'$@PE&$DPEB"48"+!5()(@EB"F01S"1() M4@D6$F02Y!(4$BPE6%7`.76QZ6?JVO]%/RL;U<_<0[<,;,>W1*>R@C<92#"4 M8"3!6()0@HD$4PDB"6()9A+,)4@D2"582)!)D$M02+"48%4!3J?2-"^!`,)AA*,)!A+$$HPD6`J021!+,%,@KD$ MB02I!`L),@ER"0H)EA*L*L#I/KKX.]U7UMXS->C_-=W:IAI; M5EYEUJ">\&XEP>&A$W-@(R!A("F0"9 M`HF`Q$!F0.9`$B`ID`60#$@.I`"R!+(J"0W0Z(@YG4^=['1^32?3;1#WLE*[ MO:S)C3U3#?'T#*;6QA M1&R=&6LFN2'62#96&!^KH3MDM[&E$;'UJB0T`";B9!X-\YW,>U?9429N0FI2 M24@@@Y*((B,JT="(>%=&8#0&$IJM[%'J!L)Z8D1L/06C"$ALMO)8SXR(K>=@ ME`!)S58>ZX41L74&1CF0`K9:`EE5MW)RA.[AG!SQ5R>E=I-!D\HUR!"[IS+3 M!Z6&YJRLIAMYK#85F-)`.6D,O1M.Z$O>, M0RVZ.=QT!I>M:Y$OHU+0KE[R9$MC;>*+)M0:>FF.9J)%'$U;7A2FI<`;3:1- M?-'$6D,OS=',M$A'TVEUQ+&9EP)O-(DV\463:@V]-$>ST"*.YJ8E)@BR4N"- M)M:^WY`;![F;'!JUJ_?MW>#& MO2KV><-JT86,81%=]IO/C"$WJ.XQ?WUJ7\JJ,6(!W=L8&]G6F-OR!12RR!O0 MA-OC@"Y$&9NRP!=0Q&WY`HI9Y`UHQNWI@"XN14!S%O@"2K@M7T`IB[P!+;@] M'5!P+6X/,A;X`LJY+5]`!8N\`2VYO3*@H'UQ(Q)VQ8J&B-R32,UJREGJ]K5: M5FQ8;>3[9K5F)(JM1L[PI-NZD.=3N6'+=Z$9L)4MW$.-VD%Y\L@[T!%_[AV. ML*^O\=`Z<36;:-2A:F1/S*XX\E.[844E[I2B8T*(663W?\:HO*ZV.K2(ZA[9 MN6V>XTYX(]_^IKC=0B/__F9VP^;]S8\)H6"1W=\E(][?RPMQN%>O-.\FNIKI ME8D>T#*:.B6/GA)44[PRZ4OD7$1NQ(BGS]OYSO^!%K7M%/%0HRZ=,LUI-[(; M5E0B[<;'A!!:)\Z@R5$A3.V&S2%$QX006R<.8794"'.[87,(R3$AI"SJFAG` M!9N;JGLI3KZ,%0U5]S",S-G9EP<%BVSS2S9O;'[%BH;FW7-!39M7SP7_J%JM MS,NDU\B>KGU65>\-Y-!EH$75D36BD;7B%!A;U-RY(5I-$$VM%;M'%C6[QV@U M0S2W5NR>6-3LGJ+5`E%FK=@]MZC9O4"K):*5M2)W-V,HK9R,>==\AGHF0R92 MB9PA0W`!0P:M\EW%!MJ]54U`G-1@57E5:5]=B3HYTH*FN]/#>3QF%U]`(8N\ M`4U8I0.ZQ"%XN?/>@")V\044L\@;T(Q5^KI['5R*B:&Y5G@C2MC&%U'*(F]$ M"U:5$07=5DO<%63'1)2SC2^B@D7>B):L*B/J!)V..$:K5R)RSRZZ''C/KF+[ M@^Y<7QV1*QMQAZM1M4X;U%PO!NJQ)[*ZM,M20T0CC>B!(JY&8XN:W4.TFB": M6BMVCRQJ=H_1:H9H;JW8/;&HV3U%JP6BS%JQ>VY1LWN!5DM$*VM%[FXFT;VC M-Y..6OA6CZO)1"J1,\KMMD32]WE#RAX[7!4%=L`B[VWN4*O::J'VUR=ZSO7Z MQOE/5(`1ZZE8-C8]YJ9]\84L\L8WX?9,?&+(/V6!+Z"(V_(%%+/(&]",VRL# M:IT%UQ?5_\3S!G.6^\)+N&5?>"F+O.$MN+TRO."L)=(B8X$OH)S;\@54L,@; MT)+;*P-JG^$T"FU/9P'=CM5FE'O>T37%>]X=6<&5C:C@&MD:VU>/@2I5]1*% M(^U2Y%1P0"-KQ75J;%'M;A_&/Z$65=PGB*;6BMTCBYK=8[2:(9I;*W9/+&IV M3]%J@2BS5NR>6]3L7J#5$M'*6I&[FTG4J]Y,.JZ"*Q>12"5R1MHTDG*GD/HJ MJ6C#5R;GM(A>3*VM&6F7*CU?=T0%UWK__)UNFE+9-"US/^2=\,8WT2H;'U3P M(P**N"U?0#&+O`'-W(!>K^!'A)=PR[[P4A9YPUNXX=55\","RKDM7T`%B[P! M+=V`ZBJX/R#WO%/K3-4Y$7F'>V0%U\M5+3,DOE4/RI?EFBM)WZ+F+!YH4:7& M#A&-K!6[CRUJ=@_1:H)H:JW8/;*HV3U&JQFBN;5B]\2B9O<4K1:(,FO%[KE% MS>X%6BT1K:P5N3N9I+[2X&22?W;M('=+-2-[]]5'-$`T1#1"-$84(IH@FB** M$,6(9HCFB!)$*:(%H@Q1CJA`M$2T$K>*^LE;7*)2^:H^54 MO&54K8/TI3AQ.:Y3=2M/=[@!RB6.5Q(/US+4UU14J:H\:8AH@&B(:(1HC"A$ M-$$T110ABA'-$,T1)8A21`M$&:(<48%HB6CE(+=?WS9=W\+I>HWLPE(?R`#( M$,@(R!A("&0"9`HD`A(#F0&9`TF`I$`60#(@.9`"R!+(JDK<+J2;2*P=;UU] M;"D7<:G0J/(X**M\]\@#+7*?%Y;WY$.KXKHU0C1&%"*:()HBBA#%B&:(YH@2 M1"FB!:(,48ZH0+1$M-*(INQ@G$`=Y.3$*^5:R47G:U0MUP8UCW`&ZAZ0K%[Y MKH)5V<[7&]J!R9A5S@JUF-L)652]MPYA%;H/B!F]F M5=S@G)%M,+&HN<&416Z#\GL+5L4-9HQL@[E%S0T6+*HVB-]=L"IN<*51>8UW MBY2:\((!SIN+5#EMYHQU-*KF*:!!JT1N29+?,QA:%>_12*/*J&6,*+0;VJ.* M7V.P*K:?HE>$*+8;>NQG5L7V<_1*$*5V0X_]PJK8/D.O'%&!&RX1K9P-W=2A M8:R3.J_4,B47M4RCZH7,(+O/4($H1+1!EB')$!:(EHI5&=1U MWD\)H,(S(LP2+:(7(\(92[;2Z\SM:_FPYT@KO"O?8[;Q112RR!O1A%4<4>=" M3-A.CXDH8AM?1#&+O!'-6,417<(3NL=$E+"-+Z*41=Z(%JRR$8F[Z.R8B'*V M\454L,@;T9)5940=^N:,>*!E]4I$;FV5,Y.OU%:<@6SA#*1%]H3`LZ;4$^N+@7:8VL%JV(;=81(,^3T7F M!O73]YL:!AD;9\6HO;\@44LL@;T(3;*P-JW0.:<7OZ"+4OQ'.IZR&_&D1L8"7T`YM^4+J&"1 M-Z`EMU<&%+0#^=C^BA4-$;GG5NTL<.4FZ;AU(EIUE"-@1I65?HOL28)G4FE5 M72?2VU70R%IQ+1I;U.P>HM4$T=1:L7MD4;-[C%8S1'-KQ>Z)1H-42TQU,.':D/?,&C`(N\P:*A5]H%:<<:/6$!- MFHBP2!\14'A40!-NSSQ!"T5:'R)?0!&WY3M",8N\1V@&`4&1/B*@A-OR!92R MR!O0`@(279:QP'>$Z113_#-D;247&:.1787K ML\JB`:(AHA&B,:(0T031%%&$*$8T0S1'E"!*$2T098AR1`6B):*5@]Q^I7&E MTZ^'8=Q13URI]2#9QQI5!ZOXQ!5O6%5U*[\)5P98_G)[^7._3^N7;^O^^O%Q M=W*__:E^E;VC!K$&ES\93PNV/;6F1KDK/J$5V9Y:6L-/:'&+MCG\SKS8AGZ` M_O/A83+!;^F'Z0\)*WF+FJAIX7.[]YGV&)N^;5W0%H5A_(2>2>BI)P[J/NG2)W7; MW-(VM[6?].F3?NTG]'1';UC;#JVPTR=U[8QH&[6,CK'1\QT]M9J.GV1TJ.MX M3@>ZCA>4_W5\1=E?QP>4^W6928\NT4EQ>)1-9&9$A[[.*:8#7WO>4 MK'4\H52MXRDE:IU_2FE:IQ_0#M3%?TN=7:?O4U?7\0%U=%V[`^KF.OV(.KF. MCZF+ZWA()T:=?TBG19U^2B?%@9^;CJ$_2O'C[MMZ=O?R;?.\.WE''X MT8V7\L]:E/_8ZR^X?MGNZ<]1T+69?BZ=_OS(FGX/]>*,AF!?M]L]_X-2\=S\ M09-/_R\`````__\#`%!+`P04``8`"````"$`S?>F99T/```I30``&0```'AL M+W=O"]\%4<3%4M#UA MZGZ-C8W9W6<:8YMH8QQ`=\_\_:9*RI*4655`[\[#X#XZ.BFE4JD+17WY_<_] M^^#']GC:'3X>ALYH/!QL/S:'Y]W'Z\/P7W]$ORV&@]-Y_?&\?C]\;!^&?VU/ MP]\?__ZW+S\/QV^GM^WV/`"%C]/#\.U\_O3N[DZ;M^U^?1H=/K=IMM<-A\WV\_SE+D MN'U?GZ']I[?=YPG5]IMKY/;KX[?OG[]M#OM/D/BZ>]^=_ZI%AX/]QDM?/P[' M]==WZ/>?SG2]0>WZ'TQ^O]L<#Z?#RWD$RH;S/R[OE'2@]?GG>00^$VP?' M[/?XI7;0OW?;GR?C[\'I[?`S/NZ>B]W'%KP-XR1&X.OA\$U0 MTV4[5CNJ1^`?Q\'S]F7]_?W\S\//9+M[?3O#<,^@1Z)CWO-?P?:T`8^" MS,BMF[$YO$,#X/^#_4Z$!GAD_>?#T`7#N^?SV\-P,A_-[L<3!^B#K]O3.=H) MR>%@\_UT/NS_(TF.:%0C,E$B\*E$IB-W,7-F&S,=GTMZ>I]ZH>?-[61YAI=5/ALS%XE7.6JB)\ M8A_[N^9`]-2FQ!^WV7(P#L0?M_7/@="15G4,73F*#@:.^$-9=9>CJ3N[7]3Q MUS,>#L:.^..JSM[)T*]G4K`^KQ^_'`\_!Y">H,NGS[5(=HXGU'`.2>O-K.J: M5#`1A,J3D'D8PC##?#E!)OCQN!@[7^Y^P.S=*,Z*Z#$F!1O"&L2,H"1>6DF2 M"\-GD";$E0VI\25#0H9$#(D9DC`D94C&D)PA!4-*AE0F8KD5IOT-;A7LVJWH MC)5"EDUT^@P)&!(R)&)(S)"$(2E#,H;D#"D84C*D,A'+8;`4W>`PP;8=)I&I M]A<%`@J$%(@H$%,@H4!*@8P".04*"I04J`S`\A'L,6[PD6#;/I+(!#Z:B3E= MS,C$5-5@E]"09E.;$R@AV+LTG.EB;I/"AH1!'372B,0-HH6HL:31T9SI8F$; M2QL22F>--")Y@V@A:JQH=#1GNB1K:MF04+IJI`&QA@Q<=,.0";8]9!*!(4-3 MON+HS!`H#GP8HW%O.RAL2"@4,:&8(4E3RY1>VM)I0T+IC`GE#"F:6H;TDBPE M94-"Z`(F8`Z`X MQ@`HCMY*A`R)6*V8(4E3RW3)F'B[(:%+,B:4,Z1@M4J&5&8MR[60"RS7MK@0 M#F;H0\&V?2@1<7;3`;JD&P)%@O%M2'1V!HIC.%HARWI_/'/&8^*N2!(F<(+I ME(VO,)TTIK6.>T\20ZJ,.75K)I/1@DR5[(K6Y%>TIKBF-673&MWDZ9*D\JJ_ M1588B&.@%0?R8'/C%*M5[/A0T!3:T@S2=$D7)JQHAA&+$"3IA!DJ:&+6FR[) M:A4A"S8H31LF4]*&&.5-+=J&!$FZ#2FJBUGRX]&=C^Z)_0P9IGVJG*-RG_D" M2;`F-3UAH5JB/5-JNB2K1H6LCE;9X2'.:V8&[D\3XF:`Y`F$]/SV-:0[0]T2 M*-*TOMJJ$WG(H4A+8>:,-=2MGG"IE$.9ED+U7$/=Z@67*CE4:2E0M[TN#G8W M>%V>`^$$A\URI+P]T2V75DR.A;-'(TUM>B`DF]+2K1GGEBGB[)VE$AJZ-5=E2( M@ZD9%;^6JN7Q%@SK8)'0I52M*IK)A<]:1=)I,A3W=A"*5JJ>L24=6692:DG5 M5[0A45*.;D.*ZBI5P_4A63(S9)CV:>]R5.YS08&D"ZFZU2MD[U%=:)4='M!T M*SPNI&I!)TNV@O1,]\55IV"9L4[=$BB2E:IE/0.*M!0&7JPA/;>I>L+54PYE M6@K5:^^31)+(1T,"9$,3@Z#OJIX(8,K*3VN(=:3&7PR;\G@LM*%#*Z4(4J: M6*?AD:`MX#8D-B%2Q9HT&9Q>0&3(Z,B5*H-?T:+BJA:5:,_.X"1Q5,CJ:)4] M1<4=2E\&_^/P"5.R]>H1`@'OS1QY%6/MMA6DA]A'ENEV.C:!(DWE8Q7B:]^0 M0Y&6PLD5:T@/*E5/N%3*H4Q+H7JNH6[U@DN5'*JT%)VZ+@R9-1K]";.FUPE3 MMVDQ)NO82K'(=YHDK_N:A5T..!1R*.)0S*&$0RF',@[E'"HX5'*HLB`KYH4G M;O&RH-O+4JT`D+Y']SD4<"CD4,2AF$,)AU(.91S*.51PJ.1094&V_VZ[MG'Y MM8V"C&\\&1(P)&1(9")V$\6QTTQK%R:2.F\;.U!70>80-Y">;C3!!*K>Q%I_ M''(8"34+9UMD&;0[(PZ9-W1&T$F\*LCL#(,"5T)6TZ<.22>A9NFFFUIVT\5Y MRFSZ+]WEB!T'[9&"S!XQ*%`5)]:"XY#;AU"S=(],+;M'8K]O]NA"9*GC@1E9 M$A)6F\T'^P;:=Q7+BB,R%@&2]!H;(M2]C5*,KFV4W5NQV;ZAMX).0D]"$T@" M36]G#CWVB]VBJ&CZA$\M10+/-%)LUQ8J*3C$'MG%F+1MI5ABT=7C[]!-FF9AI@HX%'(HXE#, MH81#*8"C$T:0P*&A`R)&!(S)&%(RI",(3E# M"H:4#*E,Q';9;9O&"=\T(F2&W#6;1E7/VGG-')(C0LW"V1]Q*.90PJ&40QF' M<@X5'"HY5"E('I!L)XN]HKF@_M*.<*)VG,:V"B'3]XJEH4"QR(Z0W*"$FJ4] M+;6@(D(Q9R4<2CF4<2CG4,&ADD.5@MH\+?:PIJJ66@QXUHYAPI=L4>^U"R4KRPM.R.)8\4- M7E:G$#/U2,CRLF*9J4="EI<9%(DU0,XF;'K,H41!XJ.9<_S!8LU"K8QKY1PJ M=$4M/W/)G"XU"^4K2\OVLCB5W.!E>8BQ8EE"EI<5R_2RA*`AV*A0)'MPJ0%% M"C(F0JM0L;'UE:=F>ONT4"%\:U2T/"&H*HF#;I.IJ7*,RGWF$R1I\RF*JV\HIR.RH#:Z;?R5?6L/35;2&)5A)ZT;24@)DK3Y%,VKNT[XM3I)FQDR M^LSGJ-QGOD"2-E^BN#3OCN!]!^9_9*&LD-[1%CL>;CN+3_E9'"$=L+Z&NMT< M*!+D),Q/(80I,#M+6UUX+4N3_6&BUH!J3:E ME>O!+_JYA:>)]R2/"E1H`FUJJ;":0HM:\"<7.@Y;,FX"GH4!VVV=6+G06OCV MA=>!"R%/;(!Y"=P+>6(?S$O@,L@35SUM)7,HJ==0TDLX=$-)?6QE)0LHJ6.! ME2RAI*VGL!GWQ%:;MP!NQCQQ[]56,H>2MK;!?0.4M+4-SLA0TM8V.-=!25O; MX-#AB5,&;\%J,O%6<*/)2WPH\5M+`B@15]"\#ESV0DF;&MQ/0TBUE:S`.ZO6 MMOE0XK>6P.6F)TY@O`5P>^F)@Q@O@4M,3YS'>$D!`=(V!@6$1]L(%!`<;?ZO MYA[\*I;KKUSP,2S$O,2'$K^U!)YJ\<0S*[P./#0")6V>A(_.@:\+MFPL.+JC[7K]MR?7S=?9P& M[]L72/MPYH*5XBA?=27_<5;/:WX]G.$55;`+@W?XP"O)MO`&PO=V]R:W-H965TGJNOT*?HRZ\_O16Z\ MD8IEM-R8SLPV#5*F])R5UXWY[6O\:64:K$[*D*Y+JY?7^*:7% M'5*;` M"BS(M%V?,U"`TVY4Y+(Q=TX8.[YI;==\@KYGY,&4_QOL1A^_5-GYMZPD,-O@ M$SIPHO0%J5_."$&P-8B.N0-_5,:97)+7O/Z3/GXEV?56@]US4(3"PO/'@;`4 M9A32S-PY9DII#@7`OT:186O`C"3O_/G(SO5M8WJ+V7QI>P[0C1-A=9QA2M-( M7UE-B[\$R9&I1!)7)H'GDR0C@9X,A*<,7,Q6\[F_6"UA])%`7P;"4P9"0X_P M(1N7"4_)=U>SI6,'WC\,M)"!\!P;R!+3RETZ)'6R75?T84#KP\2Q>X(?DA-" MCL8>46IKV(_\`J,PR0ZS;$R0"%8P:+*W[3+PU]8;-$8J.?LAQ^DSHH:!78!I M#SIPU(%8`2Q0U,H"I_\'69@%934%[1N@T^EJ&AI&$W+0@:,.Q`K0TP!-IVOP M5OB5R$::[`XF`G]A',6>>;_PO2"Y,*$MR5NM^J2H);7R!LAQ@,0JTE,(7X>J M\/F:T/08DKF*9NR]1(+6GVB`'`;(<8#$*M*K#Z9Z>GU([MY2^Z:/ MDA3P@?S`M9?]EHH%P8.-I>T[9:2>9JAFNF8D]S4+Q',;S8M^)9&,@!E_5HE8 MD21GT;;<46;UA,"%/==F()8$:+)G:7L"\="C+,;CWP.2^P(%TIFJ374D?X>" MGE4B!$I.M^8=)2(<]&S/L_OS%@O")`>#?R,0R7V!`ND;B%G]R5*J#-1*R9J"*,N-B3%Q@82/KJ.XVKM$4O& M)",=W'B55A7GAAD>5NI;EK[L*;08<)ZT,,XS[[4=3Z+)%QNZ#ZM"VZ/>:C`' M@H7GR):E+!JBDYOLBM,2\H35X+2CK0%QPYCD-6[I8,#>,N/@AJP4_M_,$[LZC-+ID1N] M:HL7:,M%Q$??F.YX`\M4L+:T#@\WER:5[&G/]@>+DZ1,:VH\"(S,RU=Z_U%3 MJT9C%JVK):0:W4*=P&$+"Y(O;C-X)#["70VS*Q!>W[HV$D:+ZY@XZ!>DNI*( MY#DS4OJ*5ZT%?($MVEX#=]Q)#=_C]1`=UG$WA'/K$-]YX4Y<)_4`+X1SX#!@ M[X=P_@+<:@/@^G=/KN3WI+IF)3-R)UG#QX\[<$!VC\=;/\&``#__P,`4$L#!!0`!@`(````(0"J].0$R0\` M`*%,```9````>&PO=V]R:W-H965T1B2SU]7 M==>EN\JQ^?+[7V^O-W]N]H?M[OWK;3`8W=YLWM>[Q^W[\]?;?_]1_#:]O3D< M5^^/J]?=^^;K[:_-X?;WN[__[UB^; MM]5AL/O8O,.5I]W^;76$7_?/P\/'?K-Z;`>]O0[#T2@9OJVV[[=:PGQ_B8S= MT]-VOC%K+?O*Z.,/_#R_;C0-+>UI>(>UOMO__X^&V]>_L`$=^V MK]OCKU;H[EX_O^_VJV^OL.Z_@GBU)MGM+T+\VW:]WQUV3\-G]+/?; MQ^7V?0/6!C\I#WS;[;XK:OVH(!@\%*.+U@/_W-\\;IY6/UZ/_]K]K#;;YYM"@VPR.JOK[<1*-X^'E_@ MIV0PGHRB`.@WWS:'8[%5(F]OUC\.Q]W;?S4I0%%:2(Q"X).$#()XE"@1/(,!\(G#IQ=8ID`XJ!5J'ZX;HD!>53]0(L$YU]BGB`DM?`#C8U[ M5SK4\=2&9[8ZKNZ^['<_;R#G0?OA8Z5VD&"NY%)@:F.94#T5J1"B2LJ]$O/U M%NP.07B`]/KS;C)+O@S_A)18(^=!<@*?D1)#Q;\2FW$@YT#!@9(#%0=J#C0< M6'!@Z0!#,)RQ'ACL_V$])499C];]0(`U9\A,10P:DG$@YT#!@9(#%0=J#C0< M6'!@Z0">J6#G\DS5O?-1/"DVA"0(NMK-^+9`.A7;L5*D+]T1)PX,(C-G''L)TZF.1&[6".TG;C@2I/CB_;]?>''2P!MHF./2>"PTH? M84J(;S=$'+L))--(9/?N7""%&%4*I#*CU-D9C@+FC=I<-]9P97C64#V#>Z1W MK!HJ/EJV8OO+UH@J"AW'1WYTI$B"21B2B"#DP(?AA!,>04B:M44#U&DCOH,7 MFA%!B67$<%4E2IF8K:Y"!#[,**&\1A(JGP;Q>.JOL]&,4\H]NT/Q>(7=%=NW MNT8B]\R+1RP.4ASF.H<;(T-.8HR1HVAW5#P:^TLMD`0[L+%8%+`SMS3Z*0XK MH:TVVE0L1^Q`;LZH\4RJZNHK;-K2?:,BQ**9E:8IL7K#F4A.KB,4^24(LUE! MK-X()NE."!-D%=8DRE?(@Y98)Q3Z)@91UYA8T9F)-<0"=^9'5ZKZ'#70C4$1 MN41R0A>AR!T7!RRH"F*YP=7O9":LKF4!B_(ULP,)RB542*B44"6A6D*-A!82 M6GJ0;S]5(5]A/UU0@SQ:X$.`D'.42RB34"ZA0D*EA"H)U1)J)+20T-*#?,NH M6(:L34AP8@D%-ULBM`D7! MAR&)9B4G4;I;B6=.H+3)4"#A5+/2DDJ2TC>ABDANY:GG"*6NJNK!9'Y]UW0I M%^W#@@3;3%P2Y"X^#NW=`-^!JGOXE`-UV^$Y$#L1K^$*Q5Z/`R%$C&^D`Y%D MR\A<'0YP1D3J!@-T0=.$149!!/>HX8)+)*F]]Z3VBDA6>TW"59\/V@X2ZS>$KGI55F9Q2'MDWUW!7R_DWM69?D6SO0/YH18OG&PC`E5E]X9T2R MX9T3I),K&8W8)E\@H3^Y2$J?]HI(5GM-PG5R18/$'JMMUC9$<#LZZ2Z2[&07 M07YVV6W;=Q?O!2]VE^P*56.BXM_/+M8:I\CJC>^,2#:^E%)*N^)N$GTXL(KO8.?YF>V*2756;3*YRXVGO\))1;[UDE%DOQ:%-6C^K>/MZ<5;)1E:5BB*K^"VV%%EGL@JE MV[#.2;K.JDDP98=A000WK&52H6`WICBIHBE:[34)UTD5#JPYT5NX=E=YA[>, M=NLML])+O`7BO9RZV%MJ(,LN#?E'5L2.XA3J5#7P3'8AR89W3N.P'IQ,Q1:H MQWCAS1U1DI3^Y!+::QR']:`]4-!7':H[?(5BW?/*:')\%9W:_R#$/N16Q!$B5*]5`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`P:(KC:.]PE;VM893;(XMCFKI]E'+"DQI2DS&FC&-6.:0TL"_T M,R+9T,\1@H_VSQO31&R3J-X-?9X?)0GNTUX1R6JO2;OISVQFZ%.-"*[V#M^A MU>P#+DNKS+':^$1)$H%XSW?]]Q-;.CO+E`2`;)2FQ')W:FZX#$EQ^Q9-N^1< M0H451;%96LBNCTNO+(G&U1)J)+20T-*#_,@'KWO64^UM<.UCJ.I!)[Z':'$^Z94D3(W M'7"$D#\_46-UL.*QW5>\ M^<%!(.>71.W#+OWS:T?Z,4:0.[]XS$JUM)MUHJ.`%/7G=V92IH^P'ISR!]T? M6J'PAP`@&S_'8U8*I)9%:9Q)*)=0(:%20I6$:@DU$EI(:.E!OG]5E>G&WQG[ MZ:+4W79CA.QC1:F$,@GE$BHD5$JHDE`MH49""PDM/C^@UXX4>D.8Z!#[,NN7@D MV4(ICU$P/AD1P:,L_D%1$`/1D*_EY%D MBZP\1DB[=#R*^,/O!3(N\RBHOV:ABLY.&0U9C]K;]&V`I3&.Z?E1#UJ.\!X^1`//NFDYKC8Q(KD=QG/9H M%"?LB"YPS&4.[:IPW(+_HI<"8UGM(.3?A^`N26E@O[-1NNML#4';KM(EB*<) MVQ@*TG^)L\>\C.H_9ENZ']4$63>E%NIQ+Y*@J*(J)9=0844!R]MXQKS`^E0S MW4IA"]*EF'?TR&8:!_8WTT2"L#5Q+H\>8NFHAH>@$N=Q!GWT(.6BN![SRHD; MYK)&MA7#+(,5E>MJ`]D5BD,(14&Q9UVMQSE000I;Z;ZKKZMXQK+B(GON=%?)/*VV3]OTLWKZ^%FO?NAOL,&SJ&[+P;67[`#[ZO-U2M> M$"+B2@17HJXKT62N6FPYYCX.YO@7=GYNJM!'D%OF3HOE,_3+ESQC#A+OY]-+_7=T>X M*6$=7="WA`1;WT+FX%*ZDG5?@3:BY>L])&B0+ M$KC2GGY,/[QN`E>Z9@"O1\W5.R52&KPE-5>OEL@K\&H4N+%K!O"&#USIFL%# M,G_HDI4F\[0+SV`I77B1S.$+`.2`+HCY6 MSYM_K/;/V_?#S>OF"9)OU-XCV>NOF-*_'/'6YK?=$;X:"C9]^)H?^"JP#;P` M.U*OOCSM=D?Z!28T-%\N=O<_````__\#`%!+`P04``8`"````"$`XJ5#J9T` M``"]````$````'AL+V-A;&-#:&%I;BYX;6P\CE$*PC`01/\%[Q#VWZ8M4HHT M+53P!'J`D*Y-(-F4;!"]O4'1SYD';V:8GL&+!R9VD10T50T"R<3%T:K@=KT< M>A"<-2W:1T(%+V28QOUN,-J;L]6.1#$0*[`Y;R[7J?^ZP413V&`AOMK MGAKP.N<%;PS3H1^. MANS>G_J/@Q$+QJ-1&'Q4GBWX^RI!B)YFH\'!5)C"EC]%_5\.N405K8T\B`DEY'@ M*=81]D')$6^HB*V(D34JYR,$XXK/F`+U@9$`)KB#1;H%MDBYI,U6P<-^C5D= MRZ&F2;,!)([*V!)RA60H$U+JKP);#'2Z1SE3I)>-?0K$$O#H(R1;"V4\,&E% M5F!R$,\0R>8DZ&BCJI7F=--5U9QO6J)%Q!'/Q/R-'ZC%QH9 M9M+-)&2V+9S'DO17JK"!(-T<*M:/XY+92AXZSC-)%WF`=YVX2,&=/A-29$7& MUH4M-#`<]Z27LNK?\/%^ER\!R4XC(0Q4AC<:QW>DEQHQS`M;7N!N\[/K+\)'0YGDUG>X!4PC, MC_\NC"VIVBHV;U2I!ZR\W.Q`1W3)_`*1;!P_^WB%Y@D@OV<.=M)-LPH=9H2,4]54U;42$C\"-XW*L"G2 M3;/*_W9SSW$H(V4$&[J&$.P7."KXC2D:^/Z2!>3R01+Y<6X_X0*?8PE1`J#A/3@>L!Q4]U7WRT4OV'`D(WP*'/?/"]X8WSHZ=48&&RX3B(\R MKS?<\^QG]0;M7W^_ZG[KXLNKMN9USJ_-_G\```#__P,`4$L#!!0`!@`(```` M(0">DS,1,@$``$`"```1``@!9&]C4')O<',O8V]R92YX;6P@H@0!**```0`` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````"&>PML M;EE(RQ(U.[G$Q!D7;PC?-F*A!-!N_U[6=75&3Q[)^_+P?!_E?&_J[!-\T(VM M$"T(RL#*1FF[K=#S:I'/4!:BL$K4C84*'2"@.;^^*J5CLO'PZ!L'/FH(62+9 MP*2KT"Y&QS`.<@=&A"(U;`HWC3ZY*)I=#RX-%.O>\E6\A0.[7W0 M0[%MVZ(==QK)G^+U\N&I&S77]K@K"8@?]U.+$)=IE1L-ZO;`]V^^SD+8E?AW M5BK9V3'I041067J/G>S.R&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`+RC+&_.!0``Z!<``!D`````````````````RQD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%**/KOV`P``C0\` M`!D`````````````````D"<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$%0`;IH!0``!14``!D````````````` M````ACP``'AL+W=O&PO=V]R:W-H965T M<`,``#@*```9```` M`````````````,9$``!X;"]W;W)K&UL4$L!`BT` M%``&``@````A`/!/;$Y3!```(@\``!@`````````````````;4@``'AL+W=O M&UL M4$L!`BT`%``&``@````A`&'LD71$#@``D%,``!D`````````````````&5`` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`&^!4:5$`P``'0P``!D`````````````````JVL``'AL+W=O&PO M&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`&@!UKF(!0``LQ0``!D`````````````````C#@!`'AL+W=O&PO=V]R:W-H965TZ6&UL4$L!`BT`%``&``@````A`(J\M(5E`@``E@4``!D````` M````````````GZ,!`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`*IYA]+.`@``1P@``!D`````````````````?[,! M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`#4EC\F#!0``0!8``!D`````````````````5\\!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,C,Q-/2#0``JT\``!D````````` M````````#S4"`'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`%.B^+ON"0``Z2\``!@` M````````````````@(``*`%```8`````````````````)=1`@!X;"]W M;W)K&PO=V]R:W-H965T&UL M4$L!`BT`%``&``@````A`#/%(7S.#```2$@``!@`````````````````=F," M`'AL+W=O&UL4$L!`BT`%``&``@````A`'7H<876$@``_F<``!D````````````` M````'W,"`'AL+W=O&PO=V]R:W-H965T M2`@!X;"]W;W)K&UL4$L!`BT` M%``&``@````A`#Z`[N.$!```!!$``!D`````````````````)*8"`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$6W M"SF:!0``_Q8``!D`````````````````[^`"`'AL+W=O&PO=V]R:W-H965TS0P``.!)```9`````````````````'Q_`P!X;"]W;W)K&UL4$L!`BT`%``&``@````A`!*<6!UI&P``(Y,``!D` M````````````````@(P#`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"7\4:,Z$@``%64``!D````````````````` M_\(#`'AL+W=OF99T/```I30``&0````````````````!PU0,`>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`*KTY`3)#P``H4P``!D`````````````````.>H#`'AL+W=O&UL4$L!`BT`%``&``@````A`)Z3,Q$R`0``0`(``!$````````````` M````E0`$`&1O8U!R;W!S+V-O&UL4$L%!@````!'`$<`6A,``/X"!``` !```` ` end XML 20 R55.htm IDEA: XBRL DOCUMENT v2.4.1.9
Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]  
2015 $ 107,646us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths [1]
2016 13,600us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2017 50,399us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2018 22,658us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2019 3,463us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2020 and After 14,866us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Mortgage Loan Balance 212,632us-gaap_LongTermDebt
Equity Method Investments  
Schedule of Equity Method Investments [Line Items]  
2015 23,832us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
2016 530us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
2017 5,727us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
2018 445us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
2019 466us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
2020 and After 21,728us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
Mortgage Loan Balance 52,728us-gaap_LongTermDebt
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
[2]
Equity Method Investments | Arlington Medical Properties  
Schedule of Equity Method Investments [Line Items]  
Mortgage Loan Balance 23,287us-gaap_LongTermDebt
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_ArlingtonMedicalPropertiesMember
[2],[3]
Maturity Date 2015-10 [3]
Equity Method Investments | FTX MOB Phase II  
Schedule of Equity Method Investments [Line Items]  
Mortgage Loan Balance 5,548us-gaap_LongTermDebt
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FtxMobPhaseTwoMember
[2],[4]
Maturity Date 2017-08 [4]
Equity Method Investments | Grayson Properties  
Schedule of Equity Method Investments [Line Items]  
Mortgage Loan Balance 14,893us-gaap_LongTermDebt
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_GraysonPropertiesMember
[2],[5]
Maturity Date 2021-09 [5]
Equity Method Investments | Brunswick Associates  
Schedule of Equity Method Investments [Line Items]  
Mortgage Loan Balance $ 9,000us-gaap_LongTermDebt
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_BrunswickAssociatesMember
[2],[6]
Maturity Date 2024-12 [6]
[1] Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
[2] All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.
[3] We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.
[4] This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.
[5] This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.
[6] This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July 1, 2015 through December 31, 2024.
XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalence (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares outstanding options, beginning balance 40,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 43,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 51,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Number of shares outstanding options, exercised (4,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised (3,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised (8,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Number of shares outstanding options, ending balance 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 40,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber 43,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Exercise weighted average price, outstanding option beginning balance $ 35.65us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 35.22us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 33.89us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Exercise weighted average price, outstanding option Exercised $ 33.07us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice $ 29.44us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice $ 26.76us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
Exercise weighted average price, outstanding option Ending balance $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 35.65us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice $ 35.22us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant price, Beginning balance $ 36.53uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
$ 36.53uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
$ 36.53uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Grant price, Exercised $ 30.06uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
$ 29.44uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
$ 27.65uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Grant price, ending Balance   $ 36.53uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
$ 36.53uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Grant price, vested and exercisable $ 34.90us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
   
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant price, Beginning balance $ 30.06uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
$ 29.44uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
$ 26.09uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
Grant price, Exercised $ 34.07uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
$ 29.44uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
$ 26.09uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
Grant price, ending Balance   $ 30.06uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
$ 29.44uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
Grant price, vested and exercisable $ 36.53us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
   
XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Business Acquisition [Line Items]      
Intangible assets $ 6,500us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles    
Liabilities (real property and operating) (2,300)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities    
Debt (including fair value adjustment of $799) (29,800)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt    
Net cash paid 7,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet    
2014 Acquisitions      
Business Acquisition [Line Items]      
Land 3,010us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= uht_TwentyFourteenAcquisitionMember
   
Buildings and improvements 10,664us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
/ us-gaap_BusinessAcquisitionAxis
= uht_TwentyFourteenAcquisitionMember
   
Intangible assets 2,076us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwentyFourteenAcquisitionMember
   
Deposit paid in 2011 (150)uht_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDepositLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwentyFourteenAcquisitionMember
   
Net cash paid 15,600us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwentyFourteenAcquisitionMember
   
2013 Acquisitions      
Business Acquisition [Line Items]      
Land   316us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
Buildings and improvements   3,749us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
Intangible assets   610us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
Other assets   21us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
Liabilities (real property and operating)   (11)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
Net cash paid   4,685us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
 
2012 Acquisitions      
Business Acquisition [Line Items]      
Land     1,900us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Buildings and improvements     32,090us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Intangible assets     6,020us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Other assets     799us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Liabilities (real property and operating)     (144)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Deposit paid in 2011     (534)uht_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDepositLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Debt (including fair value adjustment of $799)     (23,240)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
Net cash paid     $ 16,891us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 24 R57.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting - Additional Information (Detail)
12 Months Ended
Dec. 31, 2014
Segment
Segment Reporting Information [Line Items]  
Number of reportable segments 1us-gaap_NumberOfReportableSegments
XML 25 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2014
Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights

Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     (8,000      26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     (3,000      29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2014

     40,000       $ 35.65       $ 36.53/$30.06   

Exercised

     (4,000      33.07       $ 30.06/$34.07   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2014

     36,000       $ 35.94       $ 34.90/$36.53   
  

 

 

    

 

 

    

 

 

 
Information about Options Outstanding and Exercisable Options

The following table provides information about options outstanding and exercisable options at December 31, 2014:

 

     Options
Outstanding
and Exercisable
 

Number

     36,000   

Weighted average exercise price

   $ 35.94   

Aggregate intrinsic value

   $ 438,430   

Weighted average remaining contractual life

     1.6   
Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and to Options Exercisable

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2014 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$34.90 -$34.90

     13,000         34.90         0.7   

$36.53 -$36.53

     23,000         36.53         2.2   
  

 

 

    

 

 

    

 

 

 

Total

     36,000       $ 35.94         1.6   
  

 

 

    

 

 

    

 

 

 
ZIP 26 0001193125-15-079092-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-15-079092-xbrl.zip M4$L#!!0````(`%`L``00E#@``!#D!``#L75ESV\AV?D]5_@.CAU12 ME99Z7U1CWVILHSS(LG2#R?D%)^TXK23=9/T]L-)OT#MHI,D)ZVB M;*?==B]+XP\GSW%Q\I>/__HOO_P;0JVKJU:0I6GDU;HKRX?SL[,?/WZD\6DGNS]K(33ZCM\'KW?>:LE32D_YU*6KK)]VSUO3'_EYW"YA>*L++W+> MHI@(A!G"XAOFYX2=$_._TZ.SA^<\N;TK6__1^4\8C`6".UCKZO3J=`K9O[>^ M9FD!H^\?VNESR_9ZK2MW5]&ZBHLX?XR[I\.'/GW/>RT@-2T^G$SA M9C!B_.PB6?9D&$K._OCM\]?.77S?1O,(0%1NV^V'\9TW[>)[==_P`MQ/.,($ M,3*ZI1M/OJAZHR+NG-YFCV=P8/=&W3+V1<:XA9G@XLS0Y.E0^5@:#(:6I0/^7*0[HI[#3+[&AT0Z#)_ M7G[/\**[C?#8>-[^K?+[^C6^9G3E+. M8$2<)YWQ#6`1UM^3I6CNOGZ9O_!JK55F/WGE1Z=A5?-.J5/GAN85+J6ZNS`:JA#3BW M8)HO;J[B=B\$ZU'&EWGV$.?E@J]VXD]RW>R"KG[Y$ M)ZT$9"/I7@NM-)7J6GG"1(PH9"/N(VY5B&P02*0C&D;6E]H+Y;6S>=?XY*,Q M&.-?SM;!F`7K]0OP944!/N-[DE8NZ2KN9+=I\H^X^ZD+/C&Y2=K?>[$MBK@L M;.?O_22/NS;M?H:/DUY2)G$!UT"0NH,A>Z9I:/>O__8UF&8+B1W((B88 MS_"U?R8:$2L^RQ>!_QG%-Y0K'5EE&9.(:Z/A#VN1L3I`81"$.&(>%]I>DZ%< M$:8VEZLFT8H-T1*/2*N41A[6!'%*&?(8"5$017[(B)38^&.T1M<'"R'`>0AR M43Z#T-QGZ=BMGI#4'XR^??XO(NZWZJ MG*,+GR]^I!`$WR4/EW'>@7^W;^.-K0&EQLTWH9)BF&^.F=937#ST\WCM?(,E M\(A1R'@V1)R("(&$6Q1Z$;-AY#,:>6.KB4^-F,QW;5R'H0.L%,/3XB\E$+,A M':%1/L6^AWSB@;(;81"P$R%AC,Z;C2PQO!Y\[8PD*M+$"4*HKT%1K M]60PU\)LJ/*284]YF"++E$`\M!ZR$E0^BCP9>0'V?3GQ!43..(*YMS\R?[F. MG?K^LCY'].0CO,F;=)=+Z8)_<:;4P)U(O:%L64N#((+``K,0@WG1$AD:6"1T MR+D760QJ-I$M)M]@4+8A:_5EKCYW`KBC^E!"=U>>?^G??X]S-SEI_*/=NWAP M3V^8N&_)_7K'7I\S=O)1`EDKP32D80S+_6H8T9@3HCCR1`@QJA(:HAAB(&`# M+B*LP&[A:[65ANUOHC="76NBZ\/>;*)_2](L!S_^"0!"4+?,?WO/EQ#OI>7& MX;G&L[%JG8!$$^-YH;9(0X`*."T(=,`@4@NQ-EQCZW.860>2G$Y/[08XEMO3 MRAX4B:-H]9"0'NZ*ECJ[$=%R`#!#,*$J&X4(TP,Q1\?$K$HFG<#..Q M\`0!/S8>TA!28-\\5<<_D0 MZFW+R`H*1K'$7FC@0T634RO/%Z`<*/\"6D.F\R]$,K6I?X8LK/)M=*`Q!A]M_F6.#B.E(F9#-I@GO(A1CD+A>R`,GH]` M%A3R+$3N/HLP-\%T^F5W-G9+OT!<.YMS8A1SN6$$CWG$(N$+A`$AXIY'D?:) M0$`?%E:%4A,V#F0X?SOIE[7LK%@+XQTH?((3WV,OV3NV>V>O7>U`1O3908J1]Q:&T(ZRF0=MN0"6]0SOA(B M$,AHSR"&/>8I!:MN3TTR=Q@/Z5H#9U:ZID8-O;FK,LJK\J+BKW%OTX!V'?K) M]ZU3J/KHW:;?1$K6(EI%@-QL9*>$TH`8=KY*!*4$5G]#B48!WZ_2L!=4I`CT@) MEE)P`"6@.RG!9&_YLO^]EW2B7M;>7/2KD&N;&*O6GCB]=K$5-BZX6UA63QFE1!0QDWGN>#+EL/[N/[(]VWATFH*<*!_XG M=B6H$"`\QCDL5<(G6+4D!:QLD\ZF.D!<.=@J2;B&A?+U8JD$72#-""J$'U%8 MCQH)DJ\C9!D/D-4\HC3"7F#P.+!D[%2;"6D'XJ6QR1@8KYUIKU>1$@CL>8'0 M2$HK$%<*PPK'^,@+X4]I)2RIHS'1@LQ(Y]XQSU'J:ESNLEX75M*#5?:GM-/K MN^&765Y]55GFR?=^I1_?LB]9ZCC+LUYO*F6W3_&=\=IL,="/7-((1%5C'"(> M^2'RN'4U3":P%@R;#:L<-T3[E<]V`:S6AL\N&_<#>Y;*2;+*=CK]^W[/E:X& M,;B$3C(H<3\<2X9[4<1"@P(_P(C[3"!/.DW'V`H_Q#HR9FP/%==REIZU4&:1 M^^WB#M9"[G^.S,=VSP4#MO3;>?X,?/W>[O7W:N+6H(?G2@N@D&2!J^KCH&\N MP6`4T.%9S(FB@[0CIR`>1/+9BM%:>%9-_J]Y5KPB=NQL-PT4DK[T$<=<(^W6 MQ<3SP\`'RRZ9/YYY)AEW=7Y+IWX9D,GF<7,.X%=X1!G`"T3M)-^!OI4;D-OX M2I^%1-@0PQ<&''%+`P0Z9I'R/**Q)YCQ_8FOE*>"#;:E#TG3VYR3%>&\'=LAU57KO7!"54BV&?:O+CH]$?F;)V;_\D,&*U,5P5#4O/$=!*A6X M3CYK>U+U-2%#5C7_24CE5-%&2577@S3Y8+FA)?E)B!6$U2FZWI[8X4$-EX(E M3$CY<_!JC&Z85W&MA[PBKBAE^#"^^>A2:?1PJ;313@H3IY2^9109YOJH$HJ[0*^54!Q- M/(>O57RKA*)-TWZ[9[N/\&KYMCL.QMEWUV\RJ74JOEX==?L^R)% M367?V2C[3@;9=VT6ETA'EGU?1\[^Y6>0?2?O.?N^0&JSV7\(H$9 MI\W[YGT><9GZ9&NF1Z?&!.CK5E2'V!H>8(*`;HMX"`&H)L(@PC@)(NE+3PTK MF#$4-2,VT?)\%OK";6.=(9^2:%^O`1XKZ@#@P%)F( MADBH"(>>'X;4V,D1IMDCG6^DN^@ZFNJ[[_IDD26[KDU[[X5VVI]@[,8=S=B6 MM5*1]CTEP@"YC#EP$W)DK.5(^-)8&ACM6^^:7C-6-5H56G(V5;FQ_-77X-M^ M"Z1ID+P6R)4['PLC;;^\RW(G)T<&U%47B/DP]877?PNUJHN<-5:K.MY,%Z=2 M-%([6+]6]3*/;V((3[L-:]A3D9RG2>_#29GWXVT%CYJ%WU&9DKK+=GZ1?W4N MJ5NYX\LXK_`<0!!V4:9!/1-9JDBK(!VNWGB1C?W5&[-1O?%,"Y2MZXV7B?*Q MFE`*D>2"!7T9P$M@WZ;H4SDO^O50K9_V/<=`^S%>>L%XO7:%_+9"7JM"?N3E MYK8DWF.%_(MZLX]=33&ND*@=W_12EPF?VV^H M`60NX=+I@+V>64>GW2K_NGW&[A#8JT9%8O8T9BTL+SG&;2I:UX#=CUL4"VYQ M>4?BK_W[^W85"45)VDY!UGN?TILLOZ]D_G5FU$324UKZB/B@SJ#6'M+6=>/6 MO@YHR`1UOYKB]A<$8[,3NB/(O3(&HC1XPO%1IUQ.Q6"Z5_+&>%>N)1O0EGV8 M!H9'/UBT=+FXI!Q[RD54UL(%77E\!W$7K*0@1LCNX\]947R)RXN;;^VG(X2L M71V7FC>&FX":CP3*=I+&W;"=IVYK:,:)WB2=Y`C=(8.5DCOVQN>/?ZV#LBXX M/D*HIF:`.PMM5KO?`E#N>H0I1N;.NJX#,@L;#%U2QI]![*?J548["6-AL/=N M#?"/9N/<)1LG-4-Y-OSYUQD>-DM:B9><+0?]_KKG+H$O+S(J8UL]Y#H6(,@5]N)Y[M8;0]PWG*F M\<6-#^N$8_1\!`)`LV`H@(S.'"\\#6P-C=RVSWQFZMZ7VTCJ5@"Y( M'I-NG':/T$`SMRW'!%&S'"QY]SIB<(1S#(MI9N"K:DSQ@B\:)!-=._^KN!.# M/7.E\4>IV,3]$`$6;,X/K0*PWHP=H:A6Y_V5XJM:`:V/\9'JL>M2 M(S4U8H4LK`'48&.K7<#7;6Q5;7$R(Z0T*^S8"XVMY@R[G[G?MQWNBAVME8.@ M4RHROT1:B6!2/[]](#:*7B][[6J_U#WIP=U\6.==,T1Q6QS$"*[&9?;-(-^- MV5?<1J[)8Y56-(3L1..*'>:JPU#M![$'$3G6Q9X[JL"5V5TXYLW4 M85L-KB]/W;[5(!VU&E1XGZT&X4&S2Y!MCDD>PE-5/TQ&)LJRY*TGD+[%(!]P MN8AS0!\6G3S[40R/@SF7=IG'#^VD6GP=H5>FM&HM/[&5F\#9S4K\EN7E+4C- MEPS"^V%IT_&9"XA:-":$[F0OED%]$YW]V&NU733.:YE_MEW<:'(.U7:Q:C56 MY9H8>`GYVHT71S\9NW`R<^OH%"B53*@GX%/.MFX;Q=7K"L65]%BDI$$L]#QP MM21"GF="!!.B"16!%F(2FDV=`GD)R_'4>T]ZA6&B=*/5W]*9@JKX>[X6ZMTT M"EL@M=D>GF+4P].1NJ2VZAA[>"Y2U%0/3S'JX4G%X%#K\??P7$?._N5GT,.3 M\L6:S/>KE,WV\!3C'IZ.U9^"T&;[=XIQ_\Y#'APZ"F*;[=\I1OT[':]+RO?> M+:\-]^\4H_Z=@UAG<2_^_?;OG#`][&B#)=';A9662"J]T&VZ<%C+$\Z1I5Z( M-&.>]J.(A&2J?V=S;=T.TKYS^Z*IPU+M%HI$-L?UD3:'?!6N77-(@AOC^DA[ M0[X*U>Z(M]2B,:Z/KS7DUC0O'I%@U!?8!!(Q2B3B`;=`<^0CI2TEPA-*^'S2 M&G*^#/JGZ@SY*L+M"K:;1<_4H@N[Y*' M*9M*7)/_)]6*6 M99@Q(]P#7E&@5(!X*"G(5!`@1;4.J(>%[ZEQ^`74B$6!V@QD8TGWM7343;K7 MIX1LF71_1?$8:Q&A5)(-A46(T!/$2F1\M\7)=8B,#;#;^5><2>S6I^X7)*HS M:?L7EOVT:N1-=J8B@U:-C&%"\?^S=VZ];1S)`OXO>1^C[Y?S$&"N@8"UL\@: M9[%/AF+3QP(^JO37`V*,: M8PLI.@F),*HQMJ!3'-5XS"S:J$:]GOK+Y1LK#NH?V*,:WS[,W6<$^:Z5EME: M])TB*GXZEV5R8DBDCE?E]!,&)F[?ZMTUM1%3JN\(<(6 MNRR1.BZV75/F:$B3N^/=L=.KW_&.7$[[D[X/]?%N_N\O#Q^_U"ZT>?KYNQ,: M?K$W2/^]SQU8(RIPC51&+"SEKIR75`CIG":MW"\07A/+/WALU!R[D*_\^#'' MS[;?SBN,JJ*GQL_ZG_C/\X?DSY9#\FZQ;A;=DO,_,))6HE+0LBIH9DJOP:5Q M'W)%,](8SFRI%RN]U[K.\U\PE'HG9-('34_01J+"'I@RBSBY$O=V*SBV-;OO1F%X?>Y$ZS MB[=AWW4]\11G%[]Z;Z[1T:&WLXNYGV/D(FV$5IG@V<5]>'2\37YV,>."'&RF MQ9I=W$?$KK.+?5V8$N7G$X0/+][?+_KV_NEYZ:LX?\R^K2[7X^^?71`U__CP M[?YK_MD=A/_,[I>-:$>P!#GJ4X?/A^X9#G-'JWNM,Z-2:Q4F4NG$72A75.M7#N5M7H MC.F:,2GSNJK9MJN%\9C[9=O:M6),TL8X8"X",Y(=["\;8I+V&6&OXZ0=3])> M)5V_UK[)X_5\^R]$WYV#]H%\3.LG<&@>64S M7EFRZ@8H(#=7L(8+SD1A2_-AM:U0VX.^N8OE"K8J=W-0N.^_+&=IVA0&`2<_ M6%X:)M]X%JSWT;:JJFEI2@ZNO\X$=RK7JKS*JDH0351#J@:"6U"UUD34M1>N M4X>)EX^;D9?;%X#5P^/'KXO'Y^M&RV<(=DP"N8MKC@B>$^-`Z-F3N[O;/[\7 M/N5_+9XCNC3!0CN#HPXM]#DIAEQ^T"L4Z/)TW+?0<7XPIFP*RP\0T&EWFJRA M_>?^1M]]@.#,^=T'G+3$B[=/=! M1Y?Q;MXLGGV0C:E*._K"T(TL#S?57RY8NS,<.H.ACV6MM>%<531K:DV=965E M9DE>9%516IESD>M&KZH-E!UUP)_\X7LZ^\GFCX2SI$+Q?J[^<>ZH][(,#"5@ M.Z:.@RY]>C==^4R/.'BLVU&<4,7G3D:BB@_>V%+*=*#BVP@6",9'QXF2@?&A MA(>=DWW)^NI,9UN2U)E@,IF2IJ?2=.)%W3>$H$)AWY!@YJC^D-:^H7Z)]&[E M-^APMVGN&\(PI3`85!###^9LI[%O"`/`F<)DX,*A=ZMDX//R<89<=JX,8TQ3 MDS46VOB4<=J0YG66B[+@>25$4ZB-!^T4P,MRR,&/W<,.O'/2OO\^^_K?V5LG M^A=,8]G='@`$HI4(+L(>RSG0WBF$_)/RB]E$EVT1E^^=VNL$F']JN6&K!.GO MG^NY^^T_EWX:YJ34J\;Y_=F40?(=+4M;A@= M3QJ*05K&W^*&T57@8PKG2@^SQ:VSA(%;W*C?XB;9X?:<2[:X=;S:)7IG4D=] MY;?/,Q*4;RA/=2E=7I'_ODC2?P*]Y;MB^_4;?%^T\TE2;DC(409%X#;!SUNG M/V9_W3]`L0+//@47LJ&O1'0Q3^U"Q5_LB*#L8?BV42\=EX#%CJ]E%_92"O4/ MZ"J?1<^HG:C"6!<3T\JY+4+`4["*9KE5[F(():6L9-%H"_,.N=\K(B](GK2+ M=[S#:?ZT6/[<>I"MM[$OG#6FG-8+5-,X340=O*3NMM'XE:L$]XGE1$4$8S:@"085EF2U$ MG>65B\8T+6K*R^T46+;:R=8M^GIENW5'!8XE`75.VS^E<=Q9V7-.SMX(*?/AU3#0XL2\;$%H%^!\BB5!KT-!WA16 M>)U-K!P^-<:.S;M^:/)D^]RI2/MRU1&SVM-',4(0V#_7>U3MV?OP[^9@@S[] MU_<]O%_DGS\[GQOFQ.4(CQ&"#X,^X7)>*%2?(X/6:=7G[$`%Z;!0V$_,HY$7 MAZYN_6,]-^:WQ>+3]X>O"79?4C_#@1Y4U[O(TG:%-AD6=^0V_SI0N)W7UR`_LFE31MIO&4(*>='0AAMM,KDC6Y8Y8'I@TRL>D@ MBR;X#NS+CJ?2J1]8"?]^_1&Y/_IO]_%\002E\E(K]]],YI!B=A6[S;9:(LMT>G'L^CSGE>$"V;C%+K0FE!5698 MF6?64F[J2EG&\NV[)?J&V=VG=_##]E,`PQB,CC>=_O*KYDKWNNC']L1]HP'O M;O3*.;L9*T%G-87(HNT8 MOP_"1H$&>4;O]S$_\U'OGV"OO/V:/LZ63OG[\N%Q\?ZQFWQ:/#]Z9 M^N=R]NW^P6>2$O0'&41`9.,/7BC.L0+WK]1PAV!WOLO^3/-]&WSB)^ZGR3>F M[=WB:?:X'IJ8GDH7T%"NF>FETT^)>GI_V]W\XQ)ZM+>5S3OG0$.KW>^??>_F M?^\?OL)7-XME]?"XFBU[C:>*YQV`JK959;G*M(0HL>(R,R6C&:>VT;+0C:CI MWKHR*X\7N04*]_+F_,O=M0?W1>`)@AY-SP$"+2'?B+V[<_)G[CHO?S6*NZ^> M<#^:NQA^&QDCEM(/[G]6P[9QYOZ(^W],,;+Z365?`7/*TQ6*Y9(W)A.@BY,96IC1%83Z[1U8ZQC1TAFM*)6UCDK9`&'S9<` M_MY'U(%[R'JB[I^"2&,]4=^_]'^]LPXIEQ_?9A_=O[Y?P"^A?&26:"%UST^L MY#65>4W<7UB)3#BW-K.BR#-=%-200G);EA^H\,X?W!SQQE[QYO3#UZ6]Z\0B MMBM3[Z+9=4YMG3M?LI&-BR1,);-<\-H%%F5A%>7.DE1['K;=V]/96:RS[9'_ M>II]V]OVN=E,L#(4=_-UIV#O_3N]0'7JC63KV?,O05U#XN-\H0O29M_OOZ[/ MZY6)K+[KV?6WI-)-S4A6&NE<3"V=BTEKEC%*B=66:1>C;MT"^3)G^/+'/Y<+ MOEH.L?,9.+'AKDM2F*^]1OY&OIH/;L\S)J'`^L*UE$@4_2^]:@*;K=Y(?N/Z M_X#ZU?0_VT;)G$]"_P>`ZJ3_^7IV)'ECHNG_=GURQ4Q#9U2!:E*LC0)_\WK9 M[%PRXB!A\_Y^^7^SI_US>'/^V[\W9_K;4"! M$P39AND?5ANEV$74-*\;3G+J#A7C4-JV62XISQJ:J]*%\5048B][3T]DJWH( MGW3@;87EED:+N_T&^H,FH;_C[A/88X;=[,/U3?@@8?>US[[E0O)H9W]5_/[[ M[)_%'O/LKY_&7S5]@7OV7^X6[KLQ%CX$PR#QQX7#=_'AEV5I.5$N#+5$9J(L M29;S,L^J0E0-LZ(NK(24!O.O&.5U#G\;@CB$]PI/O[FO#>PAPP,-6D93+:\/ M^I#$0>3UU[>OBY^SV=J%//V7;E=D^^__^'[Q!"_6=K\/C9/O%D__F3WMGK/N MOM/JBWS;P/LO]_/>Z9C3'\@%;XB(X37QP9R`J7@Z5UD.[F11EJRJ;$EJ66X] M27XPY7TP8,E:8?@\K(;#>_']('F90UD^*[6H,@'N?%Z0"@KX3+FHD6BZ]NG9 MWY6?+MA#K'#W#X&G4?C9##J#ELU^;2:.H^!:GZCY=F^YIJR1##:2V]HZ'4\U MRPI=BLQ]QX89X7Z*DFR[*.S1%+,3LL3>PKZ3VBE1V*8=:2D[6>VM%B9D+WMT ML3]82JR`ZK\TA,6"X.^-6>7V$V9`&5,T@$%!&],4%<^:"EJ(BJIRND,X!:*+ M0D-.ANG=X0]B$..R*TE9B]8\<]D-K?*R\2VDE#G_0;#,LKS).(/N0B?9GMY8M@G]M#G22VNP#",4^QU^;\BSD[FT4I+]@G\O3,L?619E:Q!)Z4TI2*0K] M`?H,A&^[M(:H6`SD.HM(4V9@F77Q7"P$:A/")8U`$,-L+`1ZW7W$$D,@C-4D MEM`&A+8N#@L1^NW#?+'5:PW&0-ET4M=4T:1;9.S,N6LPL$B^W&'8E^0?*A,P!(,(O#!]\#>7$H M`H.'KA)PXKH*>[PAH[NL\&)OZ&#$&O>?EI;F<[XJ$R5U4F5<-4Y0*XK,2%'# MYH.FR:UR_]C%(NF<8@R!DSG%'84]/L7=9;W\%._L5S/[-%O""SW8.?[^_D=Q M__C00V0C^`^HRSF'+&CQDE245DR7F>-F,\&5S(JP1V#5C.;!ULYEK-CCBYGVLW4R$8V#IU0IAI>TWVNG&N&T9N&RY9ZO:?*VK[M)`G/"."]&I0W\ZQSSN M'9>8#"-V?O9[C*F;N&@,C,B#QNK0&9Q#F%*'I8O''\R%"6]*&6U;8QUH2N.N M]L,%!)O^Q,M]"F&+_I+R+Q#`@7_AL-W(=BY`=#$G5^+D':6TTT/) M'EA\=QFE5'=?7#XZ0XI!4<&;`F9OSI)BL(6DM[NWEQ<4QF)*,2#Z8>ER,K84 M`YD,1#:T,<5@XXPITT%1Z4!E=O00T\/J=T+;8(,V825H> M-92DOD^(TPFW"6$P=/I+BY34%TZ\A$"6AY$=3;2$@!!J>+9G[C:A8`F!F`PC M-KP1C8_&&5%[T.F1N@U50G>9J!0>05K_JI5..09`8.ALJ+7]/=>QV5`$LCR, M[&AL*`)"GPZY/"&>J@U%(";#B`UN0Q'0&#_)NO5@9/8=)AE,.B^@R2R+7V MRB84Z]4_!B#ME/C++/;X'_UC<(-N1UA(*BH M+Y](D:IG@4!,AA$;W+5`0..;;N6H:IV"$QEWTI)_J,A;.\PF$)UC,(1:IY#] MV_1&9D8QT/)`M&,QHQ@,G1EU7S(5,XI!3(81&]J,8J`Q\$"*CRK'+30U)"H6 MXEN&I!F@CK9Z+A-XF,P&!B8-O3X3RVQ@ M_E'TD8!P1:YO63F*9QL%1$'79`?<*1 MMTYVG$"G"P9#/UZNS;Y.5\36T-`"+FUZRHQLLI06C4]SEDG5IKK65.P(AB0(2M%L+<7!8)`RU$"HI>CG8L9A2#H3.C M@O=\$9N.&<4@)L.(#6U&,=#`1@O;^L(L23MJM55Q)P;Y,:UZ(FE*#%P4'M.I MRYLZTND5Q:`$93TUL:H>!C=H&5+LYK(:&&AY(-JQ^&,8#/VH0C.9O`8&,AF( M;&B/#(,-C-BP?%2E8\`2]7FP\-4!W=9)-8&\!@9"!<-;;M..QD;+`]&.R8[& M9LC\L/-)V='8R&0@LA3L:&PVSHYJV7HED[6C41,^8K/X>MJ&-#9#,*3V]L8] M8J#E@6C'9$AC,X1YCZT!Q"CM:&QB,HQ8"F8T-AHPHZ;UG7:R9E1'Q>)WH>H) MSTS&0`AE=J-O;@,-!EH>B'9,5C0V0^8'H$S*C,9&)@.1I6!'8[.!'32V]4HF M:T>CCJL2'.RH:NN$GX@=C8U0^14@-VE'8Z/E@6C'9$=C,W1V5+6^A!RE&8U- M3(812\&*QD8#[6JTM7"L6')BV&EX'3$IF)>OX>I>ATZ MZG@K(51W12?IA'B$3;L?O=41GRT/9CLCK MB`X1B@=D.F_=,9#)0&0)>"#1V<#(&&I;X23K@7188M^#BU_.SH?H"H_E@<3F M!1X("9B/F-0[O>B4]"^_BI>,)O%.+SHW[Y7)V]NSA<&6A[(=DU<6&^*4I\BHUE0"%Q:5BQ\\--:)WAAX]":HGII/$1L<^!16W62B)S9: M'HAV3!Y%;(9LFRR;C%\1&YD,1):"=Q&;#32)TM$]MM`\*A;C"TUF@'%,F(8T M-D,PI%3RFYMJB,&6A[(=DRF-#7%2P7EL6.,,SF-3,:_?PV3M9]210L*NRB1M M'M<(RR2Q>5'8VQ:E/10SIQ&;$N0T]`3G&48'!UO*V.UMHL%`RP/1CLD1B\UP M4HY8;%CC=,1B4X'E#*-:?&H9M33J$V#NNU7:VS]'G\9`0:C\/KP;*P>@D.6! M9!-;X8;"RKS**DGUQJ6)FKSF?+5[1@_P"A%+OR$PA-"@?37V9/4;`EF(#,AD MN]I1$$YJ(@X*L7$.Q$%!XQNI:*NJ2]*(2AYW3!"U*R,Z1)!P_5PM"B\*^XL" MGDB/Z4T="DCG>4@9\#1@Y)X'`ED>2'8LG@<"PI7GT7.\?CJ>!P(Q&4AL:,\# M`0TL6%%T5,E))4S4R4K$#[1E@D\Y/8D`$3:5$7)KL_A0T')HC11BJL-P4!C" MYEC_7'8:9A2!&(SB8Z9_/@[;C"*@,;`ZD,LQ!?!)[E8UI:QU*^B44 M"A[MU/BD6H90J,&4/<)N;,@>"EEHW3:\K6@U>J\"`^&4]M&C`!OE.GH4,C!I M3Z@1[6RS0F@:=?X@]2X%,_;*/L5`-0$,7M"^K2<^9P\%)-0$0N+%<;L=&&2A M)G#8/#\AMP,#H:\)M(:?8_,[,(C)0&(#.QX8:*`F8/28-ED3BH'0F5`YE:(Z!B\9Q&M@\XD!!N)V]]>- MR7P:Q:)NH&>^(9[1U@,SKK@=@Q?UL_4"2KRIO+M&H03/KNFTGEVCF++] M]??(7#$$M'Z2G.D[!BV!QV,8L+RM-*W[_5(TEHHH'A>+;WQGOE]Q`L82@Q<8 M2ZK9>(>4H%""4>X3ZS?`P*;\:)O_,M_W:-\O7T;R]2A2VT1M1T?]%%%P&I\AD)=+VGE__5G+-@$,)L9@Q]`9 M::8-!+R>M?>Z7_BA>5:7%KCH`C#5#+!WCEQT@0RV(5I:Z17TTAICC+=;W)FM M]K.\TA.__-!_%QCJ@QA>K0[M`%F!BQ1/;0?KL0KM`$+,GJL3>Q+[HT([`$PU M`^R]56@'R%AU5\UV@$TN/M#\(OJ2S=< MM&M=L#R)SO4[%+]WI$:[P!!3GY;_;M'<+I#%.F[JKE:)=@%AID1/C8?W1HEV M@9AJB-@[*]$NH$$EZBZJ)]T8I5IMJV/9H MH7,NSV#+7YA5T0&R.*O6Z*LM;>\"0KY:3G,=5D4'B(%58<3I2VFZ-BHZ0`8G MW?"+"G!C+6:KF]`9RY:*5:Y:NWR_O`L(,4/,CN]3OVP%V@6PHAFP%Z(_NT"0 M9W4Q5Z(^NP!,-0/LG=5G%\C@,BA7=1G[J#T=U:)54'A68,5D90SGLLK=N\"+ MX=!>>GP(NS?5[EV`A'$,I:XKDM$%;ECNSJ7\W1(D74`K7F/5UVF+=8$ASZ9* M7XDMU@5@JAE@[VR+=8$,EKMSYZK"//VTQAQK=7X!SR;LL4N=VML%/E?81M<% M;&A7*->@QN[2[8KVHTC@W:% MENJBHCQ*NG:["W6^S:^R1__"HCP=X(63>UV#:7G]B?)T`!*N4+BR^3]=P(:K ME6UEPO)J;;$.D,5R%=5UB*<-1=D!5I@,L1@>(J8:(O;>/ MW@$TZ*/C3R_*]H!_6[7(>+ZP[QW6WK9B>K0/5U:(88ZO^N^/B]X!2"9/0%Z3 MA]X!:E@.ZWZ[`;U=((OUL.[4B7E]-L7:AY`7*=`KL<3:!TPU`^S=#;'VD<$8 MD.0798+?F\EPO,3K>3>=9?IEL9BEWY>+P?=Q\G7Z:3I!5&;3\1C><@/XS$"1 M-T<*A,DO;%HRS4:)R%@$5-F8@-Z,B(R#B/C2BT@8N]#SA`B]2-V;;/DA0"1` M-0"F6V"=!X`^@LJH,ZV"*O$_&:A*8&%D^[@^#N"'M\L%'.X)?M+)$+FM$NUY M]OEG0H?=H_$KL(E'B-+:S1U">GE^7,/Z]?H(J>+\($*_QZ7DBC:;/%@75'N? M)4P0U=\"4,E-LX$1=0$U]YEZ%=G",:E*6U2N%UC%1+/(25U@Q;U>X2JI%1VH MCS[@ZIQM&5>P"E>VCM+&EB+P;0#K+^?I))G/@^G3]W22V=Y?%LFS-X3/GZ?X MU]4WY;]],\E>FB7)73(;@NLW^-'0=2( MP-=&A<3S94"D#CSBO4@.B-$2R#RW^4D"FX<;PE$_4X@?DZ&TQ^3]+_)Z&8$OY(^I"ABO?D\ M6]PWAI)`>#&1W%'B M10$GU!<>I7$-L*PE#,WO M8?4ZQ:UI"T/[FV"HI32T)0Q%%RYLF'R'=V$M*2;%5[_W>;!(OF!*;W0Z4HP: M3C%D8@551T(5:!O16$MBI"^(]+4"E1)R8@0NRWE<*>M3(N.]V"Z%/CI25I=P5;!=SWAN^9P&UOBNRSX#A#W MCN]ENL_/]RRBS7`06Q_Y;B780BWQG?>8[V6ZS\_W+`@OK&9]97M+1AUU*S%O M;2_9WJI1!]2C=I>VM[==MV34K6Z[W`QB](CMS3IMZU//<".VH2[?MKW@ODWU^IMO<N=UPODWU^KF=U/X;9'H;GG!&\K:O.].M5U[UC>HGL\RMUO7>Z M6D^8[J1K*43#:'\MN3+9YV5\2MTFY"N[YQO4SV^>5[ MEG4#([:'87@L^S^ZLKKN:5]%X:7J6_9EA^SS7W6Y=Y?80:9_6CY]3V:W#^L^ MV6((Q0G%6HPZ[/EEG.O-0[Z:;O$6J^,X$-07AAAC?"(]%Q&?Q3ZQ(F*Q42P2 MBF*[3.:B;@1?#Y&RKF];OVN2_!R,;Y^Q+N%44L$?-YMYM:_ITW;OY#XZE0I8 MZ,*0Q%IS(D/X.JMB3?P@"CSMQS&P%?LFLSB$SHO1]C_]FKKU2;Y]N/TY26;S MQ_3Y]<`G65OXW>`5)3'I2>(\$)+).AIX@*/$<]CGJ!1++F+\KX;++PUY7UCQ]"XC3'UV3VA#+AXV"QG&7UB)^3Y\&_V02*VX>[63H9IL^#L?<`8']+!K,X?6F. M%',FZ_J$'S62@M2R6"DO)DH$ADCF8N))&\#YT8Y'OO"57\0K%::@36D,45-Z M&Z-V,\&/^/HX2RX!,Y`QRG#3%+(-8D\$[$+.F,2%*?HTN,YPO&+0ZQ>`EL!@ MLCH1+2#U!+0^`4)??R;CE^0CP/787/]UAQKH02ZLX,UQ*Q-]JC#[.;T`V##( M41K/UX32:JPN``,<1,(/J[6VSN#Z;9`.?^,ZKSYM MT*@<*0]T.W5$17%`9&0!`V M&]`8>3(TYY:GU=37%Z\N5#%Z7"1P$7CD*F+$MR$CU-?9G#$=2?_U]N13V/HL M79OTC=>](WOZQB_KCFC%^*$B@N9W1%T\-!;.3BO0%$U#YG1HVA,?9>K/+SXR MRX0+;JN][1Z<@T:=H'7%QYY.T$NZ(XTZ/.MBLZ?#\Z*P:=*Y61>;/9V;EX6- MHJ8=RZQP=X2X4&2:]*K6/35[>E5[IG:"\0 M\,^Q(0'?<=P^X`/W-2-2,$,\X311G(5P*(SG0B^_(R+/+%%QANSP^]R3M_!I M+D'DV61K>[>D1/SY;TDF*IBT3KQU34J9R6`P?_1>!ND81X'<3*)?N//H]N'K M8/8C683I/)\CF$XG=X-T%$]G-Q/\U?0EV7RM>5":6VY^.6.U/N3Q[1X.(Z(X M.QQ^R`61<>A`>C)!8N;I`#C`I"_OQ6M2EM/=G.QY*#\D?(J([;\A7,?Z".&8 M`J;@`-%L)`*'HX,S4JUR\#?MLGDR67W[#BB".::=)TFLG`%Y8BQQ`D"Q7LA] M:[6*5YEJ-.3A2PCEA%56D6X^_DZ&>I@DHWD\FSY]P-D)@.8L&:5'W)HCJ&R0 MG:Z/!,4>D=WD]'[R6F(V>"PTGW]QD+U1$%"N%"?"`\JDC3WBQ<8G3$E/"QZZ M@`>;[)6$&D(K2P?;9V\570T86I]V8*@KKYNLR=#-MWT9C!/,KE24*1R+Q/GJ M+B)M6$0M\6.CB)16$(>"S^=*<^5S26GTFAG?6W=1E\1M;()I)OYF^2"I=/[/ M6I2R(\``&DH37Y1B&/P$,U+5+M+9U0>UBJ]6"?!"']2@K%,,%)8]MHT!?]6) M0A^%P485U]UR-GP.V$/SPAY+@WR!V]<%O6=`:"#8^:#%/X&V(/+"E M-8M('(-]Y(YZ2W:]%VJ:B6!F&*1F0*`C/!W3?YO*!D_BE9Y'9$_GIR MQ(1/[A`'#CBX`@>-WJ2E(`5>8WJ2"ENG]')73##C*Q],4>)\+R*2J1ATG^>1 MR(^%!UZGX/':%+"'Y&5=TM?'Y#,>'!PL-TL&*%^2IW1^3-V>R&Q$0:7(;8-B MAI[6`,OFIH?_/"PV4=BC,)T).`U\$C#?$NG`@_`Q]ZR<\R7E3KI@#<(J\UY) MP/;IB%-XCN0#$+\Q93,?I?1K`J]G2FMDB_6]VJ>!"I=/1$6(B1P&GJF]- M$K0@-7;9K<.(!38`2QCN/M@[/OA*V@M)&*(.UC$-XZ*\&CS)._E-?&0V7/.[ M(3$]040ZK-B<'4XR3")3Q2>:`G=6"(\#W?40=&@Q_E@R!`,MRY;ZX% M1.Z**HVOTV)@6`-Y>9CH!I)!,X^#O:1(I"./2#_2Q#&0FTPK\)P"XTD_6DN& M\L#4:I+6]_]#`E(U^O6P%V@(]>YY^]_&ZOHF% M><^V6>3R%%23F[B*!,--M!\9[^5-/$AT$U->V$!'(9@L5(!/$T@%VEH$!*." MGN&@JH*U\6+XL3?Q70^#,V#*R&9Z*HOI@9E^I[[IC^<^"*T:=<7=AP/!UD8= MJETN]3ICH.NU1N^):H!-%\-GD4B!42.E'X"X`!_?]SS*`A%3Z<*U[\=W3LR) M5EU1='C[\&$Z.&)];6]`07WV6ORR2]%9Q7]IHBEG#@?8E1TV--)M&!##`U!> MH>/$@>0GRL0T\H,HXLY;BW_UC7W483T-T$HD0YP[E%&GA60E_\X8RLADQLW3 M\R"=X8O!(T9\CU$$&O,.C.5`-"*=AE1&BE,"DA\.K04YZ(7")R!$.3=2RC@" M'P[ISM8O;Y*]_^E+*9[!#`_''$1@MJ8N3,?+XP193J(X1.(]8'V_NVYO-RX1 M4A4;$3EB0JZ)C!VP..8.Q']H="A]%^!,@WN.&8P_Z6:)WGXR]BP4]-&/#Z9/ MS\EDGF]4GLU`0^0[:?U_U^\IM*;WX7N\ MEV0V^)&L7K^;I<,C(KMGA1"C02J(.>%@!8,-A1EC(4/B61ES'E,_=$5OH<2A MM7_*#12[!6B;.:5WYJ&7@HT["Q2]T?\M\TS=&5"NM0>R[LG$T?K;W0P-"2LU ML28+U+4@ME[243+R__U[CK;-+9P*X!'\WG"1OF05_P'@D4Z6\+/BQ:-R;G6. MXEOK;*G0GK2::(&RVDI*K`K`8#5A$/H>EP/^4F^GJ.C35N%>W#U4'L&_W"5M"N2GU>Q])TV&-![(L'?9Q9]OD5564"L>P._)$/P[T?'E3-U)Q<$J@$I2VJ@@H`J,1A, MYXO-V1E?IN,SZ_^W>AO1`N>A(3K0`7BQTA+K"4L8./!A`/:Y%L%]5L0(7V.K M9.`^,K9)7F\?&4Z?DMO%8W)$`_71=.[)*+I8B@B\]2CB'L:J%;&A4H1'6FBJ MG>0B*N@LU]/L>?0R;=NR'VQ#?-.K@1@,GM/%8'S4IKD.C5[LJ1>L1')=BDJQ MB5=7`0.[HU&V?F8P1@OP9E+\TGZ'[G."56E#-)50:OP-Y,X_)_D*F^1+,GL! MYRP7'\4:,/RE7DM$#1K3;%^8CN%Y(XFP+BWMIS-FLEV>XG#:8(.(_>2B"5XX M)7VD$I=D"V84VTOFQL-O4Y==1SP@L^01SDCZDN32Z<-TGD?!OPY^[5VF?0>G MZRP1BB-V`!H+5F48$T7]$$PIY1.?29^`>C$RQ$H&BTA(W!:^W9MU(I7GV@SV M.7D"(0BJ''GR/X.T6[E3TR;%V,59MH+M4%LR50=C+$!K\I`N\.[T66_RW-34KIPM*9Z]U/,`Y*ZHC0=# M7._Y;^%_;48PGZ;+5H7>KKV)9;TTLB&QUF*3E!\3%S$XK1%(.\]XEO+H/JMG MLKJ<&CJ&J&TX\+HB2+>3/2FE)CFS[L27WCK2]0BI[T2W%6.IP&&W5J9FF`4G MP>NMT=A'4U4R%%8F^UIS]I+]F*.P2FZ/]MKS\&]Y7MYP.%MF)1;%H,)ADKZ@ M4=!7[PL(Y_P-Y^L0476ZXU#IX=[D]:T*T_GS=#X8]_(LF"U1<"Q).PF7LO6X MLAS[:`2K3/F5LG4':-CO\\33V5:U3+[_&C!:6S\;AF`O_2*^N0_\-/(J,?)& M+X/)$-P%[^$!E&S7MFQ=">%`)RA;"<4N%?5VQ.^/Z0)H9O>JI=),@3HYC9&\\LGKN.`OFR?'H:S!"R&)S) MR3#%@7T/T]E3$9QZ22;+;B^/46E0XBE#RDMA8/7!5J*R@?/(#`_J]U`L"3K13%<&R[<=_ M(_RYCK^N8R!?EM_GZ2B%8]`Q4^MJQ6TOZ6B:*GR#K`QSGDO';/I"UF";3M*G MY5/VVGO<\+K6(F;A3&GA]=&4[50V]=Q=LK/B?#\6`^ M3Q_28=Z+\EK5@P:-=QO<;,63^APU$UON9`M$5_?U;2:M/TT7R1RL8=2]?3QO M`E4FVPE'UZ"FJNX3SN;R:9DMT=K4O.]8".JD'\>H@(!R2B2N"/,UMFQ1ZJD@ MHC9VA7!FRMI25.DHLJHQ6]DK-XY*UGDE=J@L_F=1J0[R7!@U>&JY* M)LWF4U?3\Y[^1$V;U*(_852U/W'0C:CHKGL-Y5Y>%Z%P?_Q%F)&.E:-S)Q#: M18-\=]$PNQW&;MP*O^458)\%KEW$LJALZM7RF,$'W9GW<#JD$`?<3H(N\,S^Z,$*4X_FF$[JP5WA/26;D+>2$!O&$^':>C[F7ML7$-AW&`;:R. MI:]:I&"Y&=84W,[RZYB')?MX;H3%!9JEQ/_;I+PE33-/Z+)$JGE#I!XFJ1PW MGB_062ZLK7[F%CC8WLH(60KX_C][U];<-JZD?\'Y#RQ/,I6I,A7>+\G.`TE1 MB7=]23F:,V?V)45)L,T=BM225&R?7[_=`&^ZT=2-DKQ^22R)!-"-[D8WT/AZ M=N3[2H5I.YY?=S> M8R177;R%N'SP2RUEDI:VM-@T/4:5%@5V&=M<9O.64E'BI96@)9X_ZD?N>!)$ MSX38)"1W?IKTX^D^CSX7KPHHCJ/IEBKQ8M?6868-A[?MKL"[CB&YLJTJKFYD M.W&"5L#!-:&BBA'7?D*/:8F*:>D.;TEFEU<<":'N9).WQ)YH*:JK"([Z@Y8H MJR2NE6,M!]\G$#)#[_YX,(T3!@*5;^UG]V7:/KAH**:@C4J%LF:$E(0OGG'D M+20DAL7:389Q])CD"='0%(2/$Y"'VZ.]Y(M(&J40;T=@':-NZ9V!_-[$4;(" M85*5.E[,TE!2NTG6R"'/NALFR,@(*9)O*^Z&S.UX=BS[L@WY!ZJE"+*Y%?]> MWL:%AAGB:J6J$%ZSOKEXS]M#R2?48'Q`N/])09;Z)FK-L!A8O^1GF0 M?XO`0;O@03/(IX8.!J8A"`O^Q?RH2[J:H%M\\T!^O.`[2=.`,/#:/;)C?]MO M](*Y6#!GQZ17:IVM?BDY*,.:1EOZ+*/6H:?JK1[\VEK#`V%,\Q4TM>*[UMQ( M0ZTB@]1*DNF8C&["RB,'`UAH>HBA%[:Q"0E5@O4@1`PE3(^@9]Y4-XXS;@%70M*QC&XNUS7C?\G'6GUS]TO< M=JIVPQDWB@G?B*0:3ZDLW,AV8T_/2<(;=G(E;-F.Q&6[,AF*.!4*K.D3=*=2U0\M&0\AD1.OIJ+*: M*\CB^)>[.DNSH?8-G;AQJI>292TO.CZKZ6BVIW<22R0"H!KY]9-U"2KYYC+TP\>NATM&>&(BU*6\KW_)CK]AZ7 M)^]WIZ0?(5HCLND>D;M6K(DWT$.>M@$^=OQ'.*Q\1C3AH_0,%!%3>A2Q9D-S M_XPII^7%.A(OE)&H(&_-`3U_@292+$.\DU(;/TP(EV7IR11T15U1=;TQEKLC MNZ)JN0)TV55XQ9*Z/%ASB]=M6S0$6Y5-QP'1QLH;>EEYXP#<.N5Y,D5A106A M'<\3K3)G',,\U9XD-^@]QY[,BWDG=%GL/WAA-B[:^ZJ*+<70>IX?4R"T;2;1 MD*0GF$G%,)1M9U$7+-'&XL4FK">*:'9YV^B*O*(KB@H+B2P85E'+2Y$[ZCIE M;MIBY6%F>/<3V&PKO/F4"1C5R"^F4>R>-4M`#ND#R_``L;_!KM)2&BE'?2I# M<_9B-I\!%K6J$NN3.I<>'@31T,NKKRQ,U99'GSM@CV#(+KB?,J\H$GA2NJ6! M[]DU>=MQI&X7/$]7=8HJOPM@XHVHV\'"^J*\_I,E8Z,9N0)>HDOW%_$V#E(7 M&+NQ4"&VHB"JO*!MN5INRH)Z=%;:R`X@/'Y@`7I%1H89YBI?9!=./15%3:A% M:ITGZD`H3"WS1-PE+A.]0)J=**Q3R?:`#%#-&0;,4%":(+RB@"%?<6MC-J-E MJZVMENF5BB.!)D35L.`JBM-[\,3`8B#7MKP%W3(7U-5<6$Y7#2/F0&Y/A`/: M:@[,$51#^O)]D!/A@+":`\OIJF'$KN!)6F:!N)H%*Z!*ECW:)7_+"W5^,IMK[0XP@UIF MEO[BVEU#8]M>K:&8VC[/:V@8`_X<+PEZ<61SI+YM*[P`Z=`D45W-B[4]W$*Y M^@]^3(]^GV>+,.U`<5IAC8E7=%8SYF4Z#^`+M\(86A)4K.',N@YQ>SYA*_S1 M$*2S1J5VX!CNS\=IA4,4:4PU:TWPT;LZ;7!*%]`(53*.]N?PE`D'._=S6I$I M""QDS6C`J!4^SNRN9@5F'_2R*$^%-\6WRMX!IJB:9@!3)$51)?RH2^*3J4KR M9J5OO]GA%=`W>5@V3MQS;-GJB`-PSV#D!FFUM:07.EX@]"(=, MD!M!:(E!-.D`K[N8VO8,JBT:OW6A\Y4<:7HMJ@$[Y.PL6%05791?+-,V1UGK MXM*"@,C929L\C\*SB8`L17%%'*QD^\N[V_.C9SN6:TDFK_9D!2\!6;QMR1KO MJ+(JVX;NV(+*8LL"P_@%@-HYTAI`,MV!M1YC,5=@9%N<6`)]V%PT)&#%?#'6 M%RF;.[9.F&9E22LT$VG;C-@F/&B<^=.<&YCY(W9TL7(@74/<4<+Y`^=T6(*> M3(17-_9ZW5+[86;8_O/%O?:*['\4.%'ML[E5T*CMJQ&7#!(%MC&(KHHI9HL*=LJ:A,PC>69G+<$[QT/,2<6N_T#2(;@BB$2D.\D M_LE<:^@?KQ?=A_YN)+`U!FM+LH#;9=;^?+BVF'CB3EQK;#I`/;5M"XH=0"/7 M*2]V@+6Q-3[,I_]NM2X>6?C=FLJU$W\?#U+7`>2T%=RN=MT[593-O?).QG]R M[T[^?^?=M<7?HW'NCM%`M#4);=J'W?D[IFGLF3WJ#V-==Z?GPW#():Q'H_DD M^%LRAF4+3P0K>*),'+>Y[V0HFOD$8]-$PUB$,)$<53"[&B]+HL8K7<7B+:GG M\+IA2:)JJ[KJ*,7E[&_F7^:5:'1+(C>D9OGMMUX45T_`\D3NFTJAO%T`'98L M,0U1D#>#1Y$-1W.[-F\)>.3I*"IOVK+#FY(H6+IDBZ:C%4>>"Q42-Z-W/@0+ ML0@\J^ESZR=_EU7AMQ(6514QUT2#/WZ`%IF*@&>!JE[=(Y],8U)_\M?K.;)@ MRSJOZW@CU3)!@<2>S1NR*_9`4UQ9%9`_,B:9"!U)J@93JPEKDP4P:8:P;Q9( MR`*\*M21A;58@%8X#*=@8*>@40R9-V%]XFU)U235Q@TPETTYYHD41]\K"-E_*14@63(D'4@V-*V)F[U( MLBZ[/5FP1-[N2C(6.C1Y"TGNB9;FF#KT:RO,"B!2I#)WVM^@M@HRAYU_LV0] M,JJ8ABVO@JU)O;8%]9@&(QM"=+<1TI(+*Z?C"%E]8F7=D`]&M1 MKQLA8XD4)EONF&8YWRO(6!-9)'D!NB;'I5D%;;(=RL]N6(C65'40*T\Q@87H M:%FRTN4M`^&$>X+=-=$0@].!WK_<$?0U\$5VRB`V.2/B?^I&0XIQT'^>;,&V M.4:@IG0=5^5MAP(<`3=LRW5YM0?*8W=MQW+`\:(&$UK]CX_S`RF'YX:IGS[? MDGO$&/7"]-K;8#%8-4Q8R$Q;%S3>Z%H]K-+8Y0T-\WA$2>A:74?4P%E@)[4" MB/T?UQ?_=&^_6Y?<5]>Z['_E;O&_O[B+:^?FRN7ZMW]\[S-:EHUZGJ8_21#\ M5Q@]AM]A=8C`9-+P>?VK0[L@#IR5ZZ@Z]!6#*VGHQQ[N_GY_'@^BX"!C!N'Y MXVO&[YG1S!J>.2VXGHX'),Y,%#M3KX!BE0'@#BQ(HWR!IE87EIK9O<(-Z5KP M-$$^ARFX*3>#P+^G-J?G)T,O0#R3*R^=QB`->?GF/MW=!Z[8P2;IB*MFW9!< MIPO1)R_VW"ZO&.!,6JIC@!55I9XI&Y9CR,Q:_!JDGT?^SU_OT\]`!WZ:<$GZ M')#?SZZLVR\7U[Q]T^_?7'WBA,G39R[[KG_S+?NB[_ZKSU]<=]WK_B=.>7]6 M:>@.B,G;ZMU<]_F>=75Q^=09ZJ,(?!-$@AEAF#)DHF'">!"H2_GV%(0N(S;A#%P$U\JMIO7/TPRM\WS/<%31_3T>PS/[.&!U&: M1N.B3W7U*[OY_N/L8&-N<`^,B8"D7QS'=7N]L^7C3*/)6OYB9V77U"_*;Z>7^)N4T$JT;$UFI]7>K>K=U?+I(Q&OMM>2N?&[*T_A#` M#8B]R>]G[/\M!['!+,Q+\1'*K/9Z97:+CG=^R?*Y+ M2[A\:M)\A+)KO,GNGF5749;X9ZPT42O&F*#=^>5*-MM MHGM9O[#3/QPL1S?IE@G'NC*_UPZ7/'[BBV4_2KW@]5J:P^X:J=*;@3D&`R.# MOH\BS"5IR\)LWN-Z)N8CW).CR^B<)RKY/$@[8=3.'M\;L MK)#U7*H6%M3/W)\7W?[73YRB3])MC@C%@C,#_(.F+M#3PLM+AU(V*"@^EH6K M(8O.%O@.>@+*$=*LF%GAW]3RSW$OA]^D7\3P$"S)1D?_`Z MO]7Q>P;KV/:LA2"DAHLFG+0V3@]!]>*\6)=&H7<%1GY0R^`(52*IG\8 M9/)]+%;D50;:\KEDG."N_=MD;S",FV$:#4A,,WA>P7[WL=FS7O]?W-6-S7U[ M\!+"75S`"#X,WVS8WL5:/5>5$PSEW^9Z$Y]A>C]-4FK!3G#5.CT?[4OL/2?@ MH95^&5JUT9M5V[NDB\JY8]!^[DV;' MTS!Y](=_*Y>5 M)QFN$Y<^Q-'T_H$;9X>Z-,_7ITBPA/.X@1<$411"&POOO1&[[2#U!%Z53TE*%O/Q(NSH7DI&^<#61B,GT,PQ[AOT>$N\"([ MBO\710WA MSW^P"_Z3#&.)FZ9^X/\;W[B;(L`@R'(JX]%BR)77L%Y+WZ%%`K)\PVV0$_=[%T1@,+@)#I/%T2)%/Z8,@ MN1Z52_81E+1R#J2<I-5E;+RM(=\Z.0E>K>8RDJZ8N"(G94X3T^G:U$B);J M@[>7^$_,?T10&?`-9]^2.YKR'B9S#,8%9Q!>_L]I4$D-9)`Y:N%GKD+5D90M MQ>UC!B(T`TVY.1+20E'+:`Q//'V#L&CXO'N\)%FQ9%>79+XKJ`ZO"&J7MRW- MY=V>X]BJK/<$6=H%7M*V^SA!E@/:(Z"&(!V,,6A=O">2T'D8%-.W\CAIU8AY M;2_7`0X,*'4=H5OWTT?;"@T]@-(.",'0"4(L5,^[C)D^PT5-O2=,21X--9J$H[&R'`'M8=(6BF$&Z(K3MY+1!^GB&T/40`C6+:@'0[LZL!"^2>;IF0Z M^!\0$^8[>L5,D2>$E:22",R<4`A3<`S`/44L]!&L(W0Q&4!,`X%8GTI4Y1V" M@I'`.',GE&&/(?090SDSU&(^84&']2M^9E$4SMPDF":21+4@BT$7WCI'E1KA*HIR?!W1O8Y,76D_%<(* MW855-V`1)X53(WEL2/.XJ7"R[15X/HSHJ[A6CZ;D309+&KJN3G+'(?^7=W&+*C_0GIY@&5FYA, MHCA'UJO.&?L!!:0PO2-F\+!WUAJX."29L=A54TT%F(E7!":+Z@85809^S"PJ M0_%+4G],D?^F";F;!ER`^PCX8<04,=,Y8,$D)IBF@:*(#>#;B/2'.G./C<]( M*HY@//'\F-K#((*.WVS>C.-,2N1&:.D^9G7/BME"%J.P#*+H;_3>IR0W8)/R M:D9E_DN;-;-F4^S%";SR1*.;>*9K)C4$N\XE\)XL:;LRRK\YA4A/[X:??*%&5WT@U!=25-= MO:>)ANH>DX^+2-^W-SE%RR8<1NQR!`=N[(@Q#E3HFD\I-<#)A30 M&VUCN>&)ZA>`O%&[R,PN6Q/HSQD/$$/G,P2_H$+GW&#J!Z-\_4!O-:OID5O< M`:)JTU,*:(CNNV9V-]\;\T&1P5HR3:<;RO--Y`G$`O[&)3+AB.Y_&&\DTH$PKEDVZ MT9WWZ%5*MM`7PX3V^D[M:&47N:&%5]\I'77Q![#(G=)$OY,ZZJR]%BN_LJ46 MMS7HN#66D4__->C3**:S-AT"I"7CQ!D-JQ/*))'-'3<>LZQAP+$ M!^CW93#'A?RM\)N*F';6(.1A`[A$X"0Q?YS&*I5VHMB_]S$*9@VB7.=-HJJ5 M#5+(_H2YDY+**VHNT9E35I7-N4;+)I>-:*9EF9?5;$)AJ#=A=AY0`$53+^5\ MUBW,19X*"'@'2NE6+)FD>@D1*V*/1Q)KO)Z)"+0@;2BBT@:.S0J79:Y.1;;! M=W.WO"`#K:^655RP4%\AR-@3++K6M2S%UC7>T1R'5\#CX0VQ*_)R5U4,R;($ MRW:.%!8=%8>AB;,%@&WOT_@#CQ+\$&9[G$4J@VB:YJ<(H$@%9GT6Z!%6MH(V MD#]5Z_*^9I3RK<%%#&U]VG[79&X7AMSC3LUM?L[:]9-A M$"73>`_;++9ER):H.+RL:`ZO6(K-V[8L8+E?17!,MRM;VJIMEMKP/O^C&J$O M!/;S@7\UT*\Q,]EC\ONS]1('\6_^SAO[P?.G9@=;'\RUL!/S\<\-;"=1>Y6X MFM8WI?2[^^4*C##T=^M^N[GM7UQ_:4QYTZM58R^^]T,>!OT)-YRRCTSO/^%1 MWPY/]FK[HMM=J#^\'XY`U3ZMWO9KS,F;:8SQP)@EZ`QPK_[_V/O7YK:-I'T< M?N\J?0=4_O93=A7($#S3V4T515&Q]K8M_2PEN?=^XP+)H8@$!+@X2-9^^J>[ M9W`B08J2*!&$>K>22!0QF)D^3D_WU<+W,7XO,Z\PJ&KN_POA+_.S?_%M0@)GSL@S+0;/=6P-N$AS%2 M:;53"06.&VAS(8*H/,1VG>L*)?RGLMM07"W M0#1)^PYVPE(MJY%"#M!W(F`+W(6\=Z`[K-2=8YQWU%5&>154#[J19 MR`S&*'M#I63@.Z\%L!1=G4A:S3#@+&2S>G7)*+^BE>&*<'S?U=\?"3R\Q5P(8:0;\?H,IZ,!+$Q<9'![%;#Q@<>"W&9+W M&@98R`S`B"*^S#&\%NXU^$@SY&.5F"-O7.,$&[PME[D"*#.@%V`83,V"8>>@ MA62BGQ(W3(U'%2`9Q8*5JO?)ZX@D"0PS%TR9\&>"&,2)"70#3%Q"66=A-*E? M<.6>@`=D!9Q,(=2PJ"Q^@5)!F`88L5H\2*(!,/,@YV-M!NZ^3#>,M9U*)*"R MC1Q=E\IY4`D.O@5T-KU(QH(9[<.UZ='E.C#/C`CH8#*\%"$!7I@[M\9Q!5$B MI#K6$9B@/60<.:&00&9#P)M0[9E^2I=%1Y=TTEV:1/<<6U;]T_O]R>7V MW*>6+;P![.*UZ]WMI<%UYZ=?^V/P#Y52H@FE>W1G9K@\_3]<.W0"L,3T+7\O M"V@O=Q5?FE36Y_\J@H'ISR[D)>'D^.YWX,XSYSR2#W5N`,X:R`QS^.P\T09/ M[]=M^6ZS;G2^_WYYIV3P&K2-7J?3 MKW0&[7JE.3PYJ1RW>H-*[;C3[W2.FYV3?O-1YZ47+_-J[+3,*SDQU1^%-I^> MF?%N-R>F9RHJBY?Z;?BY?W5V_O7RT]F%]N?9U2?M]T^7\/K^UQ.-_C8\T2[Z MWZ[^K5U]ZW^][`_HRSL_5;V*E$E\TL(?/E.2ETQSL-9&>')^^E-$Q7<.1;$PO-0_;=Y-D'*KY3-8'OXU<)_3E:,D1VA-)%AYM*+Q" MNN#_"<'\"`_>(_WOE%MI2I+`4_(414<]_`"&\V/(!C5`?#9#PM*#'C*(*[.! MHB^IL@A:,%)B#:M(YW7=%H9PZG.B)RA@3_RO@ ML)NAC8LGUG#)>2?@AJ<43621G+):Q*BGL)W6@^04(-,+"#K"@JCD>.WG':85 M:>1I@S8YIEIR:J`XPQ@+P)2L9FLC&NVX%BS`KF\QST3IAU.I3*04WY?%J+W/ MCE[OOLOD,<)`]PY!C)*=HRR-EA(7YYMN-:-&E!%<_R#Y&MQ0CV16%J0=O5$O M]2,IHI,9/JEC5`6KD&0$#L[KD9:E)^)T>@7G0K@FWJ2R0-=1FUN.2X`^25@M MRD#W*9L:;T*P;1']1AH!-0.^#([);NC#VV;"GL#IW:$K)O#D4&CGYE]KQ\4R M4*1VE+0M=PKSQ%..+!V6X6$-73W\2FI3X:LX(V5Z1G!.=2+>(2B4F`3YJ;&: MF$ZE\9'`+JEZA/1NT>>;]@93\[&TG'^!N@( MFXN[6DEO:XP)$Y$(\X)IS908W'AW1)5AO=8[?7O)R\H=[FI6-I)U1?*>W50D M0G9=J7!;6CRW%$YX>ED\ZRN"=?]8LU*5?_QZY),UX MZ5=G&#"Y-+G&4@J\ET@ID*F,TT?*(^76KW>X=*EP3%]%U*4CZ$H/.CVZU(U' MV7(A\%#'GC6*&)A.*.2YHHR!`X;W+3!8Z*?K_S&`;-[Y:`I1R!.@(\N)H_DK MP&'X=]3EJ/EB*8^F3JD`M"(I:YZ8AC[Z\>Y'[;WU(=GRV'+(I20GG,BU3RE< M561.@668I]&MR6F;V#D[9R^4\?"QCR#EW>G1'QS2Q7+2OBJ%)[%.3+R+1[:":(^.!.]34K2-D>G`O%=5,KR)WZ(B4D6,Z? M6@&,06NH2O\VI+'L03U)W?H M5L1EB>F-2IORF(4H_D:W@&D('G<42*P5\',%72>KLP/(-L:_LJ`(="I-T#IP MQU=5Z!$V<4W?329/IP>F%TM76=["HIG0H^I0RG*(B\DJ=,N)QC0+SV`T4K6Q5ESW321R59(!GFAE96@2AHP.',&ML&]$ MA10TWFI:[N3^HMAF55-J('WZL='?D?BH=!#2XPG(DZ=..0Z$;Y-$#>_2E]KQ M99,TX@0?BH<.M+;)U.DT&J]S>3]2A<8P"8?.@DZ(@3496@;;XDAX*1D\6Z]3 M)%>R[E^C^W//>23#D:Z"(UH4DM=S]19:$#BK@E<#HA[CAZKCNR>PW,PF!D$R MXO$PK8#^%+YMCEVE[KY8OD\^SI7X8?I5;8B,"8]$$`/^JNP8#;U=0_?&[2-O-,8X5:%^W_JAYX;V M4WD58"?&810!5MY7'(Z`=U&OU!/.P7FLV M/\3G[/H[)4O*UGHRB4T&!>GHGH'<`O,[#VV"&E:>]7SAAF1R53EXI.REYKAU M<8C-TTR%66!NZ8FV8***<+BE*3#F%96>FKZZ+4ECZZ2()1%VX@!?.N<+P>R6 M-$^]VCU*`>-$BTOR_=1U2QR)4_I)!E?B`V=T:R23YU+V,&M^L.+O)L/+_+>X5#\ZOL_?U"5_'()24XY^;*HW%>N'C?O:-46P3/5IW^* M)/VK.=]89+['*J5'5_<_RXY=W2U$,GMWFOQ\JDZ0C\E%*MC./3LN0I^,./V: M@!]\L1QK'LZ7/OT&+W[F+64RK2'3,`U'`;R>I4SZ,@/^?@5>!A-J/X3Z)OVZ M)0)%%$E]])X.%H_*EWS%>")?QGW;QCM<,<&Z!YC`@,A7*#NYTVK>/IZ\D[!D\&U3*%^96998VN\6]0GO=:HL35^-?J8K?%KIO[^ MK?'H\=:X^$?E2S<,9K>(I/\I1I>`65S>^8&8Z]J90^CZ?YAPGKX#0S9?A#Z; MZP-;UG[-=5UO-[MLKE^-PF9S_9JI?\#F>NOZ^3IF2:RY5:A56XL@NA!>R2OY M?/9U6/DT//OM$UCO+GZB[HR-%)S=^B268L%#[+@+L+F_)L!)G0!FBLITKZ,W M*]DW9K"I1IN#1FYTPSJM*^_U"N(-SF4P_-AV$_5MX&%<,L/Z'BC0S M68J8PYI7>Q>5%%,:Z[8"[WJK]#UZD_Z*'A5(18U9:491A[,H:9+>EU0]"P)# MC-NI)TLDW2)J<&XXNSS\$@"L1%/5-9A;&!&RH^^I9*G4:9Y\!$F5&/9 M!LU=9AZ[7I2G[V:S3T$F?L;D1$=B4`2NFNL1=>62&8T+%_$,91DZL-A(.I+J&L7 MICV?($W4-89V89O_-2/`3RM3$!!]%[/(!]C>V_4<"[ZK2#NF>(KLW9A.Y-5! M'6$!XEP61D9)^9B&;05Q$?1]%6UR0L3`-/\$S\&D=_XKM.\22BB`#4P^AS5\ M.3^.\0GQNY&:C/+N\W6I8DA;1`43JDYBD8+`]F"05!=K*M*+T"S2 M;Z;J"UE#*O$IM24(!UG5E(*^3'6LCOR&?X5.*CNC45-@)E$_^J,WLG9,5G(1 M0##,W1%3:TP$C8:A!>-[J]HP(B8\FTM(76X*[M.M;)R-\)'"B[8GV9BC-\M; M$[6.S"+-;%HHJ4=0WDO`'1)(9%GE*'@.U9%055/E+B)>^7I$&%98J1[@::8P M'1"QE2UM9LNAUB+=H+7+Q[I!SY<`6=ZO:L*DI%D".U_"H'_[.7__$,.YX'00 MMY0`LA`CY^C-"I[+!I@<1,G)8.3(`K^'`-30CCCNK8:]92.`FB-97K%N#V)T M'>V]JNR]E9`A'Q*PG:,WRW`[\-A\'=P.\W$Z:4#ZX]-0E7V^K5?;24FI$VD0 M:*H^N#@PJJL4KMO;IBQ9TFG\'ZKVGQ"V$"@HARN74(8D=#LI MW/=7X@>L*I7HD.9\J<4C0&Y=2U49ZM*<)7#`!.R.T\^.*'V.M*=Q(AS+CXL- M8_CQM$4^>I-ODW/+)FN)(Y#V:6(DJ&77Q:2K$\(FCSW*V".2'DIJ53@7!22' MM<>T-KQL&E>S^#]JU5'90Q:)A4#P-OM`J450?$1F/B@ MF=&1Y"O8KDG5]-@FMG>4*K*+5XW\`LXZ*"1?'7#T;/].5:BYJ::Y[R=FW)+H M]E0].A%>XN(S2C23@@LPG12F MNX0I6,7"VFCB6;7EH)3V)S<@L-0)HA\5VW[<%JF45F5%82W2@;9Y:R)XNA0B MJ332HJ3>MRQ"]PB03OT%T)[CT5.-H4[KJ)PQR!%]?)QKP/=ZIDP+>1/6^-U0JK"P" M0>((#+;-7`4B"B-;MF7&J*`XP`IGG&6`,:)1,KQ!=>Q)QP\B3+Q(R88IJF=X M+,L/V&@D#&!._Q5I0`[^.N0:V+`3;P'^"7IU$&R M'M\+4-7W'2D6T*_8>8;0NV*4%VEI1W=$G7QIT*7+DB)?%A8DU?N!_!7$8T`^ MAJ']*4@SK(L:O("F4`IS*F27^UJU`^>=218Z)0*$I)L)#"4@E]>J[=:[!)#+ MJ.M1<#OJ1A&WR"%0#4'A`=0OOB\"VUR;!YN9Q211PDED,EEQPBAW8[>1"7^_KJQP*-?V.98I/8[31$6WJSP M*@XDD8M93S&>`O!.<08P(:GT!]GYLF?(B@Y"'"(@$?T"G^<:TT:5`-AM%X<<$;UP% M_U&EP+@3,16$)@:'5>]:013)5\NEX\4);4]Z]1B0,^](*\7(Y%G--/DK5)X' M`?JAZG0,;H5WH2^02Z2 MTE4(2C\>BP4%TI,@T@*4P=A:V.I*$TZ3Q/+HU^%:<671Y=$4=D8>PZD;$M!O MR<=(5H>1<-H!_Z&[B4N/$+1P9Q&_4`I,@HU%-WV3:(XDCDI0LF*"ZIEHZV?@ MT_`&AMA;.JYB)`&1P*TX>,0!(!Q5%7T^0^I1,3/(E]\*:D]NJHO.N;,6V M'+5,N?95[:N;94O59H'@_5/*6<6KI=JOH^VEV#ZR4Y:KU=H4MI)0-[G`CM@D M;E)-^R'T-GA:0@;&307>PTN4!'_`-5#X9:Z.X_#[VWJU%84CDDL..4GX6S,. MI"5_D:C/\$-AK=^"WTVD:]G?/: MYA+BNWZ4AHM]&J!0V6Q@'%4XAQ/7F`23.'DX7]CNG7A4-Q1T%]UX..QG9J,+ M):(A9>SOGCM(=<>30DYV\UT:*1K\<7?Z$H='PQ<>S"=*1[FSC[Z772\8_0 M?*,5NHZHT"UI>ETXC?3*UJXKRM10*IM\"[[VSQ4FZM4,0YU'ET"/D*+^/5<4 MBGWD,8N">21)K6KO'?VA737>Z1F]%Q^[4K%DM# MX8!,BNIYF+7,4G\]@N!(0SK\ISQJF9FS[CWXUTL!5C[=$G<8W4"1QJ#05/9J M!&:?C9^J._NT[S2UZ'9?J40Y`]D)4#:\SW'A+8<""8$RSO!TTKXH9X#0V3A$ M5;M$[T>Y[MDV&WDI5W%[I[5@NZET+U1_'N$2KW:I42*2WVW#?U!O"]D:HU&+ M!J6[Q)2#GQGT$:TW4AX._20=1S/'F*JVP,I#U+4[-T3J4M,OO&8"9RR-.$S9 M).'(ML9XFDA\>@MO+Z,VL+\[H%0\A.J7]5_`B5$8DVX2XNY$&7[#F-.M@/FA MIX?GA]O;VZHOQM5K]X9.&7[R'E,EML".R_V3]NM M8;M2,^"QYN#XN'+<:!Q73EN#T^YQPSCN&J?KFD8^07L_OK&AW)DCQ/N*-X=V M?Q03Y<$&H)Q]"=&/CG2$TAUPHDZUH2(G3?;"BW([E=C)ZVH]TT4FT7KPW%Q" ML,G8T/MT6[T/>BILI-KLD094]P_2^J1?$RE%BT[$%0\;.)-305%N%24E54S! M+DJH0",!IS[P40FZGL(8"%#KZYG#8&#^B`T;7;]0HV;V23(Q3$5+>6T0R*AE MNIE,RDQB$V_K![+`C;KZ2G=LE-WHTVC%2<.M;-ZS7R6X/AEYPS;OF*[@3:); MO6QP)'T9MA+E6FUN1=E0\LQN2RSU."=<9=A@7`A-JJ/L,'QJ"^K/7EKXVO9-EJRLWATD1%/0'5BP4G`\L?R)M/7KN4)%3>>6M@H M=8(R'%@+%9#VY'6#0LQ66YFM>LAV(9?'YC1^N'1;J)\`]H9+PFET:4697/&` MEE.AR-S1FTQMAKP/R>6+3(9?W+T@PP;IW92=D]+TP`/T#;I1*M-4MA3`^V_Y M4Q4.X7%#3Z)QBE>(!2)4[#CV14'":,MPUNCV12TILFX2AD>CF:37EZ6"BGRF MIT)*&QDNCA@G(4!\7^*:9Z_$UO<3S:J`HS=K9KS4=G3]2^'-E:L[!$_IXKXV\I4:;,NBFHL]P MD%9GT;3FMZVI2MU73\3?CXJ$4!%0\Q,TM%&I4"8]+VK[O,TYX`_+6NZ>;?Z%./YCL[O( MKQ%_^(X/$PU/=GC;P$91.'8%MOIE&5:Z.GOEP5>[]W\J;V5)-_2E[Y*O,98_ MECP?;\:%1.A,?8$(S/0M/'V_1;[QTN>#Q%->^LMG\)N3;7IO.4M__W?YX.B5 MTXP0(Q^-:JV&*'OIHTM%?OA8^BD(MD:SVJLE:ZRH#PIL3IZTWF=%H]IZ%D9C M.]RYY69`S[03155N):#T&FEB0I>-T+5JY^#(_#2,]A>R3^UJJY&Q3_0!VZ?G M9.8ZVZ=70NDUTL2$+ANAZ]7ZP9%YY425?B>.C:?9-:>JI2EO1>%U,]SBV36A M0;P`67/B7H^FNN_WY7R==X]WKQ"[=Y!!EBLWD`$M=EF?T9%AE_6Y*?T<_1JV M)W"KVFLR?OWTOIW#[ M=P\V_FIVY_.G:V;30X<$%?&%\M7/$GP!F5*ZL\S.8:=A'/>:W4JM>7I2:78' M_4JOWQE4NHU^VZB=U`;MTVZ1RHA2.X%IO9^MN26S.S\K>(<[*I\V'+ZN0KD-+/I.N3EE"ZUU>71;5Z@8^#SW5/D$]*7.) M88^62F&L)38'WCUZD\`?3]P(V!,W-E7LD@7*QBV+9QCAH&>PFRF_.`50G'ZO M+,,@2)T;5]8AHP])$\%]DY4O5#]A^3[6L\:H1J,PH`G:4CSA*Q_AJ?=6JM$2 MJ!)XDT5M$)(:D+M?X%OIKZE*Y%$XN0:6D!B"IDW0+\Z$OIS^MN)42NV.D._] MJ+PTM;:DBXK>"VYL+`9T4"5']DZJGPL+90'&]+Y%DL"P7 MME%V59"%)PKO2]8&8X%$C`PLBW9$H.JK%.`3348AZN"&ZXHITT@[LC9/5\5= M*3R:-`BF0JK"[8NP?'`I-J'URH3VJ2K,B1I(R!H2SYU:BJMMUZ>B;"I(P1HP M52M&B+,I_E$HA&IPPB_TD#C1RBI!$&];:,!&"*K06-,IKNXV'R-";*$GX'Q7#5%:4.D MPU`>JG'<:`21-[74-J.Q<%7Q6P1:O[0IM+F5R*0LX:X>O5%0TK*ZB3!BH^*Z M.?5!(D&F%Z_BW!^]T9:AZ^,E5K4A%JXI<.D$>LP7]K3B@V8S%5`9%3*:4GL1 MR!>0)2XEQ9?+9P.R&L@#%NK@Y.O4@H?<`%0[2:E7\HT,*`;I68E#D&X:HLP< M88"]MZ9H/\![5CA8!.F=![J-('C]"(*(NGC@]Q+@(`?4E'/MDM5/>#$DS-T8 M32/:@]!7O.4GN[C,5KBH"BTJV0M==OD`):JKHFMJ<^+2?_4(RI=PZ2/W(X(A MC!$*T1ZC5.1:9!UF<>V`1AV;M/.R9I@JX2:6^,ROZ4""-Z;X0%BMCK7#^>L@!1)PX8)*<7A^P"D/%'UZI>DK6-36NR MG7HL<@U2_7+(F;P?F3_J2U353A46BRKE)$?DLDTLG4SE71_J)RIZ4F_IJ-[NKE0MY'ET\ORT$?I)A3< MA.1AS73ZX358P_S=?VPO'1W<7.RK/J2:7&WD_Z,W6]`@]RCR'C8]0FTZHIYB'^Z12EK&VJY&Z&K\N=3. MZ"'-C-!!4WZOU";*1U1];.Y7/O=Q7$ZCHPUMCL@6Q'YJML_1$BK#.BVDT!HB M;D83`PR*AAV;Z:U30QG5MT;V5'7W8Y3?1AJNF]-1NH'>>G8T4W9#6@WE9,N= M1EY5L9&LV"B\U&5H6ZH+CZ,2<9]/;-B`QPKLY0EL[`NA?77AS-R(T.;NC_BI M(U;BD4UB-"R0O'.%S$O8S#'6!0I'&L`Z`NZ:8Q#@O_(C!;ZPC((2MR&5_4>] M!%7A*`%N4)-_*$_X?G6"L@C/JS!%#O M"D\[NT>$:`WZ]=[I::WT!K5:,1$A)&"" M/&6KUMGA'(&U_DL'L^1(%#KN",^4$?!YO+O`2[CM$2_[\+PJN`Y]%=E#)D2` M/HEZXU'0*M87&`V[EI=$4F=^QM9>((J*>U-

=&!))?4'=OVFTN5W\NHB&](GSR*S&>.=9_0D8.V`LI?D\Y M0'0I@%X/DV(?I*!$H;UN_4'F]U\(` MLX;WFQ5>TU5_Y/MG4;")ZH03_)Y'Z_]S/&,>:+\ M/+&.![Z9@6#ZEY_^G6IKS[K_W:.]F\V^3''88U_?XU6]*E'&OB>4KLRZ^W40 MO'O`NOL@3J9?72^8W6)2SY7X8?J97`R8D.S*J%VYMQ)*D\^GN^;PGM[FX^EK M46=\/&6>V'P\A3>R;_,Z"-^MM@_6M^%S*:^*17GE7,K!Q==&^=[!'E!7H";B M@R=VIJO,"*[_8S=)WLO/Y:O#)]F[YUJUM0AR\Y*,6I(ZN1Y!0R5#WI>@ETKF M6T[Z6TX*3"6U0=%W5'3`B=XH<4S=.YQS+7AI)ND@ZJ2:$1VTL>=2I M%:8N,_4G2;$8E<1+-HMF`!KD;Z'^$F7*NUYP;5Z+)_+4:CK[XW/4L[GNO_OB M?#I46^?O+'^]T>W5>\?=0>5XT*E5FOU.O=(]-?J5P_ M4W$#3"#>"MKV44RMM0'"UP5?2&-JX`EN]%13Z(_Q-O MV(.+9K+:06J.B;`^GKCC$%=U05,9.I,37/VNE(?1;P].!L,6*(^3)BB/7KMR MW!\.*ZU3HWE\?'(\Z`\,4![UGW[%02I&O=(P_O'SVGEE%=XQHOD(WQ^X\Q&0 M"=FFG[1./I]^AK]=S4P'K"V,@MF(7UTG52YXI@S`96).I`K>V?)/3P>-VG&C M4^ET.L>X_&'EV#@]KG0;0^.TTS*&C5;M>_U[^Z=?41JUB5"U8(I99"V>GX%] MD:78V-I1/,?$3@L+%W M.8CQ2**<$&B"HLJ#E?U6_+\D,NXS9MWH?/_]\N0[6+_OU-K9_PE5'Z@RV__G3XU5#[33'TCGL]7O59JG M76RG?7)-WDF_,U#R5:^VZK74-FRQIJV@)'>O,YH]8]@^[C8JX$.# MSFC7FI5^WSBN&,>GO/;`$TM@8?L3D\\2BL]6H-M#"5@\81M+GRQ&C#86"VZ5&>1Q"'N#RTTV@\O M!FWNKRSR$:_>VRIVWJ-9L4O$S"IBJ<45-+]H?YZ=7'WZJ+5ZJDWS(^5[J93F MJSE71VD0Y)\_7VSK'+QPR'[+75J):6\H67JLH[7<73SRA>F3I*1R@1HT66+@ M+OT]\M&7/HXGVX_C5[KX:_/L>J/G\"[`NKSQ[)P,@'%R\D'A$RV;QU:1@;.0=1*?L;S MVI[Y^Q&4>EK;W^?7V%D(--;7K*\/3%__8?F!&2,!7"%RY5C(G!C\)\;X.S]F MC?UL&EM3\;3#U\_%][%/_O@R8"W]@EIZBZ1$UM+W,2T!&.?#%[->WCW3RON. M\JCEHBGA"'`;WGPYACWSZ%5\0:L>-;$K(D/WT&^&'SB>,8^6+W+ M\8RGTS+NUK%-KPY6V*RP#\YUEMUE6$/OPX%F#;T#!_J>]DBLE%DIE\.+OG1# M;`'DL))F)7U@2EKUITOA0^5YT\F?L6-=\IN,4Z?!I;PTU!2'K5G-'Z3OC;T7 MD\5@!\9-:4ZL\EGE'Y#*)_S-Y2M&]LA956^AJM#UHJYDH\&GGZ??2BC6O;=N*?[U M[.R!\ELT:3WV0L>_M<9_:WW?=[$=O4!(JGQH2);9G6C2&``[?`OWGF'<(8)]*+ M]G=<4+$MD_WE&X,=T/)*_(`/GUCI?WCV^/3J?]'/T"X(>_/L#&5VPC++,GL( M,GOJ>DXZ-6/'I]RM+X*P68.V)DR7:MN0SKL/)I>/;;)Q!G;`H1!9IW MT-/AL10[R#EU_-+!_CFQJH1 MHO3.YU802*1LB77INR^JEATI(ZXR&BJ_HXETK MW)-=09G7:B>=TV&]5AET6T:EV6FU*UUC6*_4#:/6Z_3JG4X+&P0U?OKUHO7O M9(&/F')VS?\O!/H*S[X[C7JTI!LE[1RQO7WAZ>V-!T[W_]70^Z5W-&7I?:IY:UT+U!>W%[I M_VH)<@EG'F?"%"D.1:[PY,H$*0Y!3MW0"V9,D>)0Y,H-9/X/^PLO[Q[NAH3O MHX:Y%D:PW=`WG0E=DH@?V$T8^^)JU!DPZJQ;+/_PJ;DHZ@2/\8F/1K56PVP4 MC%%5+&<"V_RQ(C]\6KCBFVI#O+JV8N>?;+W`MP]G['NS3K9^N='4Z]WN_3-8 M2C39Z08\`PF8P"D"-XP.$[B\!&[I]19+<*D)W*MO40/'!#Y0`K=Z>J?;/C@" MKWB3Z7?BV'AR6N-1+DUY*]JNF^$6SRX[KNJ`AS=1:TYWZQ,L]_V^G*_S[O'N M\>[Q[KWJW7M:,=R+A#*^"DI:=.="&XFIZV%:X;5I.1S;>!:_JJ$W^6!4;OK6 MF+YEIF^MR?0M,WV-;7K",'T/E+X&"'"O=W`$/LA;LM_`C<0ZFJEI>3BC$'U+ M+`6X=J@`!W[V0QNST;6IY\ZIWF81>F.J\7:GVMQR7`\K'")\3KS3A"'FYE_T M><4EB#=$^2RML_J4J^8=:D7C\$*!ST[F%UKO4^>Q0S;X_\60,*1\ MJJ#>`@-:G)L?U@&L`U@'O+P.:-8.WXDNL,L\L;`JU0I"CSQA3U#;P0CROE#> M+JO`PNY9850@\TAA]XQYA'GD8'BD?*X4QB.;Q3E.,:69TIQ15X#WY7R==X]W MCW>/=^]5[]Y!7H0F.7:KQK8D]Y1[3MKH;-/%=-W>_IR4EV9Z5OOZD;3 M8`*7EL!&6Z_768++2^"6H;=:AR?!Y0AN-,#IGK@APDR^C)?_]!<6ZI#$^[?O MY?#^\?[Q_FTP3/FSW6M0@Z#"M)'I6V--F)YC.=<^@DO!9`A>:M7T7O(UJ&2H'.<11#!>?]X_W MC_>/]^^U[M]!9G+(H,?$LD-LT<=ACY=RO3CL47;RIR[/;SL8GWC_>/]X_W[ZG[MVUC:MMR1&4FT'Q_[":=J?,;5=?ADVR#N%JU MM0BRI3B_4(??CT:JJ_GZ9>V[JWKSV;JJQQUQ-[HSZ=>MA)X>_>X_$63[VG2T MP-7,\1C;KVE3%V-'%Z8]GYBPY5_$Q!J;MG8AL5XL&,QT)MKEPO3^]O/^ZCJ: M"0.,78>H;6)@"K-R?$U,IV(<6#="^Y?IA*9WE]#;T#6$':AJ?2`88C&:MGVG M:[>(T)@W0UC%#P):U-Z?"!_>K/T!3XB[>$(#:F&G:Y>F$^!T3@7.<2I\GP;7 M+FSSOZ8.>^(+9R2\:VTPL^R))QPU)YA-[Y?4^NCK,,ZE)3S/Q&&UOA.XCN4N M?4>[F+G"@=GE#S@T_0"&4;,=8-L[.57:U4;7,+1A53L&7HW'/0YA(`2ES+SH M`XR"6YVWT::/(#W]\#KT@]4]?I"GRIWJN5,]O[H8KW[%K4B77".E99ZQ4WV# M.]6_&+GWW?69.]47BR#J+QI%N%/]'MW#W9"0.]5SI_K# MOAHU&GJ7VP65F\"M6IT)7&8"-[FA6]D)S"JZO`1N-?5ZMW9P!"Y'@E+I\"5Y M]WCW>/=X]U[;[AT`X`RCZ#YSGK?>K'<.SH]B^F[[\KK>8Y#5$M.WH3=JA]=? MA.G[`/W>EK-'2CS956^W'H2UAIP/O'^\?[Q_OW6O?O(/,U&%5W3_@C M'/DH-7GY8%QJ\C)Z4*G)R\JYO.0%K^GPT(,XZ%%0IY_WC_>/]X_W[[7NWP'D M<3"&+OO1[$=SD(/)RT$.)B\KY]=`7@YRL)//AR3>/]X_WC_>OZ?N'V/H,H:N MHWEB:B.^K7.M!3,$KD5(7)-^]X0?VH%/R+6KR+H(YTI8KHX6.FDX5QA#`KHN M0L\/39ABX%[_%=HK@+J-JG;A603H"T_F?D.G`:>6 M8SIC"V83315&#&8(VNL$^*I;X>&2/#%&[IBL@YZM:E"5=&+Y#Q@&6H+831SY-X('>NK['`B:!`U*@RQ?AOI_9[0;F$P MQ]7F,#,/5V7-@6MI^]S0TQR!&+RR=@M?:ZI5RT4+;2*2E5FP4K47\,Q"XAS? M/1%$]^>)=8.__N/GT*]O\+SV MC^B9R_%,3$);G$]/Q"@X<_S`"^=`+S_^/E((XZ7?Q/2?/PG7_GXQ[-8:C0K\ MSV@:M^T M-^BY5NNW=:Z3>Z1J=MM.JU9O,[/O@K+D^M;EG]?>E_^^WL M:^7X_.KJ_,M'#56>ICZ[.K]0'UP-__>JGG^]JISV MOYQ]_O=';7-X%_G/M6WW%B01!4%JP7`.ZA:^YA-'N&'@!\"?**QSUPNNS6L$ MN@ZT$S$6\Y'P$KEI&`@)A7NEY0)&??BXRAN+1V['5N?7C6_;J/,14LLV%[Y8 MU>P;49:5ZHQPUA*#<;\-:#(JC+X(;`AC88'1CMJZFJ:T?QFHMR#[/E)JU$338@ M%N;Y(8_8O_-$F=%G"4+DL6F#<1%+G[ZWG&3AB1Y+/GMO[A?I[A73\@P'$ROX MQ-_`L3E`DCP?(9YE\[^80>B!(EK:_).';/ZNL_Z5A_!Y>`K^D8$7XAF/J6*L MN0[?WF&Z7'BH.6*J_4&]*I+?E<.=?'`^G5J@5.+?HX85R2=3ZX>8)+_"J0C= M^,C12OY@NV9*%;T?Y9WJBGWUOOTV/T?\?_NW-_5>?0N0JBV\AL?/X4!O>!ZU MP'W2NE5M[9O4[_9M6'9*UU,Q\K!_$450[L/R>UH&U/.K^]S^23`-U99H"CI9 MQK!`:<X2B+KZGGA\#QP`Y^MNLL?>;3G:)]=?6%AOD#C:,GR2M/D\.SO;Y'6S^GYFD38,O5;?`J&=]7<) MB,T>]X[I&EV89Q7X?:4"!^A["Q.4]B=AVL$LY6^GPMJLK5]"@.N&7M^F80IK MZQ(0NU5M;U&VP-IZZ]7T%YYE4W3DOFJ?HKO8_7`4>DX<"4GYT#`7]J)?7%0[ MNM'=HOZ3U7():%VO]OB"L1AJN?B.&M+9IH+U3Y9M^QN\;TX6V:/W M7=/;S3IK[%=!;$X6V76TQ'3B.IK[;.'A>=^7"]/[.ZVX(XW]\Q^6'YCQ7>65 M\#Q,)LG7X_`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`^R)U?8;%24W2T1XI>82]1@B"_ MI3Z?"].::!9BODQ#VT9"1BFDB;P9-8G;KFMA8-G6?RGL%#H3'W?4`W MQ)`)L<.I)VY<^P:_-/;$Q`JTJ>HCQSRQGB?&>^2)/X4F?BP$]F6="5^&#WUL MKGD[L\8S;6;>"!1OU81+PS:SV&DS@^FO8T_7$3:'E2ULL74L-G?%-J[PCZ.- M0\\#I0'#>'^+`)Z7_=0HL%>J!:U ME^'H+]C;*_?.ZW4:^UZO7XRJ+=J_7L[Q6YLC$V6&^=:L8`P3O!Q?9=8_'FK)L[8)%;* M^4C8[BT,-1$!;)HOVRW_P*1!H+J->P;O]N8^IIL`/SCB%E,,%]BF5_8[%B;P MKCM5//C[ITMM%F4B*FZQA+]MC]C[-N)QQXA5'^:1NFN=5DR:B2MMD>K+MT;7 MJ3>TZB_2'W:'0_&K[__\2:UIU_-0+":2(R.YB"..T2G@%UKGQU9M$6S3*7(+ MK;'4*#+.-2YPO]HUP::HB?-V.[FC_;JZ6Z2Z/KK3Y.>H]^^F3=SOOJUO^?JR M>]AWG%#&3U.M2;]8CC4/YTN??H/Y/?.&,I%RB31T)AD^S]*%7+#D[U?@5S"9 M]D&F;]*/6R)/1(]TJ^P[87K^?KMA[_JF1SF5>*#[:%1K-;SK2;O7%?GA8[=: M51N-^[8MG)7^DD4VD4]:<'\FT;Z-)E M7W*7>W!`MUM/7=\>B?VXAC),^A*0_MZ^;\],Y??FAT=;Y0+:X#^%;5O.=>`Z M<"*XIHS.5V:/-3;#.Q3/AEYKU-@,OPY=S&;XU9)^[V9X]'@S?!"'XTLW#&:W M>"LI^PF.,<'A\LX/Q!RO0\\<&R^;_HAPFN>+T&<[?5"KVJN=KNOM9I?M].M0 MUFRG7RWI#]=.KT_UA`.KJ,P$;L[';I(!D9\0@8F@V0N#5/KGTF7P#C(\DRR' M5$;$$)H MK0K>J42I-/#N*)G&#)83;V3.UGMXS@VO9UJ]UC`^/&=RWV$3>+1W`KO.6O)N M0]VZ\8&RK();5PUS]&8EYUS^ MW5(V7P`?S5P;>,X?_B>T@KNO;B!.+']LNW[H/4/:7G]X?-H>G)Y6&O"-2G-8 M'U2.&\U.97C:.:D-NXWAL'>R+FVO6`FRC9TFR.*3=-'[OOVH6]_TS(QW6_DP M#QO[&99Z_]KX.A=O'M_+=O_2]; M;\/U$#;U>KEJM? M8R[9K>(-*5`#]EER9[CV7)OST]MZM577P*_0_!E&#MVIK*"`J;XUJLU.-_4W MK+X!YK`SJZ3S-BHMVKR29CKVVJCUDK>G.>;;0M2 MN6_;PL+,PIP2YL;CA+G9:ZV5YEY[&V&NMAJMI>^9='8"B229BZ1W`B-5[8>FYQ5#JT@YF, MLFAGOA]B%2E,Z<)SKSUSS@>U[0YJ<#RC(U;H!3/M/Z'I81]AX$\T@SH>Q^K)6/P2__J2_+KR2\?-"&)8RGB:`M)&EU;A!Y^ M%&`1,%7\8F4FQAB5\.)[Y^:=YH.>U[6IY\ZU`-92"=P*_E>G2;F.%!T?'Y.E MY"/AB*DUQN:;<<%PN,"WX-ROKSUQC<7(OFG#4PL/46Q1%$$LYY9M@[#B>=7% MZN(HFOE%>![\2?M\YXQGNG9A"6\,[S\5C@/[A,KCPL78Y61Y M8S*#9+9(AQ.NFHYYC>7.,.+/+BXE!E"X1S$45]:?@6,"$01 M1%/-7,`[?EAS^,6^T][66]5VQ#4RT.&(``R#/\.YC(68J"KUL;!N4#_[VGO\ M!KPK,Q+:GF@<3!H9NXZOPNOH[[GSA7!\,Y!OT=ZVVQW,"$`N76)-$T,I\"N% M3-XV>@9]#T4#),P#N^Y9;NAK4R%D#326\#N^\(D'.N" M9KVM&]U.H@M@MLO:0.J"3K5EI-W!3:J`',U>M952!ENK`IQ`5JUT:B2W^GUZ MH%5K*SUP]&:])L"9M3;K`7@\K0F$\9)M(71:NH=H[&% MMC"JG0=IBW9B\1^B+,"HM\CX;^$F&&UC*S?!Z+6W=1->QP'U&9S6,P>IYMZ`4T M`YH`#E[5$+E'`<-1A-.F-K!PU816E8@:K@1O(QW7J9!$6H&8^R0S"Q@$"ZTF"'F&1]9! MFE27`?Q'8MR141_@PZ?H3F^F2+(?]PC7:M[*MIDF,D%E(JR/?9C@!"=Y:IO7 M.TM`,?KMP=UDTNF?^*.">LK^LU<\JF+?U)>9IBTI>V[6N(W'H^/;'L$#Z])%$\#P,_`'8E$+7' M+BAT+/F4%.^?\-X?])CM__.G2F-EO2>UUFFG,>Q5.B?U=J5YVC,J_=-Z#^AV MTFF?-(][@UH;UEMO_O2K4>\UD&J)@#QP3=D-&9J>`Q_Z%\*C;QZ;OC7>P;(M MWVW6C<[WWR]/OH/#\'UU&^J/WH7:3[\VJKU>L@.YBUA:)VF.+R*8N9,SYT;X M`2FQYTQ8J]5.:Z?]T]/*2?T8F7AP4NDUC[N5]K#?JK>;G6:_UGC="6O=5Y.P M=OG[%W"_SOYO>**=GGWM?QV<]3]CPMK7T_-O7_I79^=?M?-3E8IU.]^R&GE.$/.-A2NA-C);[B0.C'$UR M2!VY>['VD+F_,]<7F4^#&;A"7`[ M0X_L5A!X,!R,R$&3(\`1;(X.8!SU]\"]`V\;)^I-R'=6OK;03N.E]N4R9..Z M2U3_I@=>X+$+_TEB\[U?_&P,_[1_>9R]W?#C9W'!UZ$U43=0Y,S2W8H;;1KA MD\+LE[?)$S`C0;NOW<"GH')]C&&C.RN?I,=PLT,G0XWT2.`2?_X\\).[DXD+ M/FP@R8T4`K]9W?5$=S)STOFT]_$,I6\,)Q-O4EF87H"'U3EYKO0*Z9BGWTN! M=A@0UG#CTAJI&L:7VXZ7+1XALL(^T*G`U_P0)FC"$D=A@%/4;&MN2 M2M6A@.:']UBX(]*G7JC\[%_@>^DOFH2G!@-.KH&WZ&P$>DN&LO`BQLI\6[$\ M.3%S>#4MA!:>79L>WR)[0OG^6J/Q#I?2:[V3)P3%_70&OX73OC^S%C'_XK'! MD]R`W$@4LP)@0#B?@"!(\?'IP@=V9>3#-L([\(^3OT*?I-.-$)+QN!+=I%A@R:C$D+P[EI7L;UTHHA/-VDZ#9!::E6[2%W'C6&/30)X-J\] M(=1FP+3=L2D'`9Z)+M#4"8J2-CUW:BFN!M_!%^HHY.,E.]W2"&32#/_@%=]( M1(/#DF&V2&8$$7<=>;RE.`7&-R@]%"_G5K=:,Z=X:XFG/&MJ$?JXF`H/'Y"I M,T@&%#%,0?7QU*1X=R2$HV'8Q,?'^*8M50"V MD0P\Z@$WJI=)_=W##?9$Q!6D^H1W8\EM3EL>.!&-`M#==%EJ6V/<\@]R-V@1 M_L`W(9@+[!W0)!@G<:AH%U>Y`9=5H64E>Z&KQ(54S@(-13D+:)@L<*P0IUQ-!.5"ZEODQ87K M;S:1.LSBV@$5-S8I:A:E(5&,=F(I[X&*J(A-K#F^4R3N!NUJ;`*K,$2\:Z(W#UHW`@:_$26\.35B!ABB3MY8)E M_X>$)N;D1@&_(T65[,&.2)=#HLI'EIF$:`[[)/=*N0+`ZG!()4=/IF[,1/0W M9'Q6Y[$Z'TZG4I"1Y.$UR'PJ+2VE1X$+QS-@GPGMY28UHY--=:[)LT5F;Y%S M9+3>Z=I,V,0E:8%..9*^]4,2E-R,V&D%HWV#=P_`&C0`R'C:L"2:-9H,/)SV MMGQD7AEY#K*P\&1&3(P#AW80:V;T;E<7&.T`N>%8=DW&"$,%^*`J:TFI=J7' M1N#L.BF'/[)#<]GK),?XB/M)`IZ99^$X[GJBI8P,'HV2@T/D0:(!?(CY(ZY^H8`FM$I584.@L]$!1R0J*]&4>("KYJWBH MJ)"@I.1#:NRU$I+B_O5;'DER+`"/9O_$!BGVA]='NZQK%Z8]G\"I)P+>TRYB M.W.TE.T7?34;+<";+!5:H7W'`V!>_`6]Y34:(\I)Q&:H*3]8=MMIH`),$PX+ M!^:FCPJBOZ2WR@&X"2P''1/XWGD*M"491\/'?/UTF+5W`P2#W"&;V MK]!>H<-]UU)4J\A'+]D*201OM%6F,\]/,R=.5X4G^*/`9=TXTNQB^/ M&\VU>HO@*69E"<@<^T_(@RXHLI\_7VP*<>\1,&S+75J!I]D`&/_8JX2E#3R/ M[!)]D@"_+]"$)$L,W*6_1X9MZ>/(7"Z/IBS>8RYH]HSV_WRT?19Z1F@>=M+(0AI3Q73$_;*JH?7W'K9SSMZD_+T"J6+=]KT^EF!T+:?1F\+ M)+1G;7S]KH#Z_+$LG$Q`\7+RP85M_M?([-/?/W(RCU-(#\ MY]?8EPO3^]MG?)XY%A+<$O_1(@8_/V:-_6P:6U,1 MQQRF&B2['L&<^'1E9%;,J+KPJCE@7?8BI\'V9:L0Q#=;$)7&0 M+P:?.)ZQ#U;O5,BOE,GK1U*%34`$@*VE6TH>DI"]F MKG"L'\G[<[WIY,]#,UT?(N/4J8>Q,6OR&X>M6RFE;3 MG%CEL\H_()7_U440]J4K1O;(655OH:H?AK%)$[L\^[_A1TQ6SQ9A&755A84# M92=3H(I,!%N0D.6RECZN"9?E7S%JBT\5C@0WL5Q(2>6*6":W5#X90SM@O6). M36'H3(275S&+)7CN=`-6Q2/!U5]'G5S[$75RK?W5R3WXU5RLQC4Z.<5J7$=6 MW#JRPPMZ78:CT!N9'/!Z45>RT>#3S]-O)13KWENW%/]Z=O9`^2V:M!Y[H>/? M6N._M;[ONV-+@6N]-ZL?6&:?668[^S[RE4%FOU@3;>!B=^]/KB_!R.ZO4SD\ MJ]KW\&`8N!MU4V)NX\_>CPHJR-%6OJP4IW&D=R+"#P@ZTKM9?E=2:2UX[$M2 MLJIRM-*9M>1+)Q@8YPAV*+3CT+(Q!'#@%O@WS[SS76<)SFE<4+$MD_WE&X,= MT/)*_(`/GUCI?WCV^/3J?]'/T"X0C$<[.T.9G;#,LLP>@LR>NIZ33LW8\2EW MZXN@.MXJK`G3U:JM11!%D51VU.K;\ M'%AM[$L7-TF"4>Z[X> M>A+[]#[Z2@Q73R@\?P42+M'^CV2#S`3]&UL3)D.HUR&D]SHV)2:%86(VK3>J MC941-C,L/)YB66;8)S!L[C%H3PQ;3]JM/XAA]7R.Q6%7^;4I6V,J%AVI(RXR MFNKZ.(;Q0U^V+/K]T^41]F-0<2]\#3)T(!PS[G<4-5.*L74MZHN"SR9R@*/D M2D(B!\"GO7OT]=&;'(U][_8P]Z_E_MP#Q0MS?[Z6#1?X*XA$TG0\)1`K?1ZH MDZOD&=#(34Q744\AVU$/'"5E]RK+C.Y&^=G`LZUD>NLU-J[F@2S[1(W]JG#K MCQ'37?;=D$W7W/F(FKWXZ8ZUJI54U+-`@;7GYSP=+<&DW]=R6$*3RS:W==DC M9V(&F'45O>U.F)XFB/\V^!U1_V.5SJ6`TX_>*,1S/QX.NTN8(_=&5'!YP'Q1 M:Z%TYE<&IO\HMQ%$IJ&.S!544XG>M!">13W4CN*F`"F,=IM@U.F!]Y/00\Z6 MKZ<>,JMI92@)2XEE:HL_)-N6LVE'&YHCU;/;MO!ENK`!M^D%T?=",BVT1+DE[!U%RWQZ$TRN_<#T[D#)?-)F'8P&R,3)E%6 MG=JHK>XVNF_QF+#QIV+DQ;V&>U\ M'+BP3W*P^SJ:O^YLO$ZC[*CU!_/J!R4./G^\JP")>4;MF=+%3I5ZQ4;9VG"3 M>J65[2MUCSGBI5(UT7['@9M]D?MU[W\CCD/P_N]C_^NT_TE.RV3/U"B;\GMY M*_=>^?^R`1\V@/3!L?:+1=;BWT)_$S?""_6'3V'? MA7E,X^W?7C?T6LU@&I>:.T;-X-I_5*TKK7:AT?KE=-5^J4Q?-Z:(]82_;:B\[HI;O'L MLFE4E\F4H;9ZDYS#&P\U9<_ZPIRO\_[Q_A5F_PXO[O)5!%&>]TA,74]HUZ;E M8&7+T9M,KF]YG=S]7H,U]'KO`".,3.('9"SHO1J3N-0DKNOUS@&&3\OFR3;` ML$_<<&2+EW(E'O_&8OIBO(.\@^OU0]&\U_,05-8,:\C<*49BE2L+$UER9C.N M;,F1-/=M"9OU`[2$3.*'D+BV=\@G)O$SD[C1/D`2LS];7%^"=Y!W<-\[>'CQ MV8R'>X"AV=V:A$<8Q:7W[])(JFW!8N`B;E9A'2/F">:),CG+7;U5+T&.'3O+ MQ7%4>`=Y!_>]@PP@72#8R7T"2*^/LBL$NQQ,/SW!F(L;IZH\$V%ZJNE>B&"1 MK@/S]BPW]#5S][3::",BJ(W!E M[R@!KL27PT,Z5M,$.H^T#O&9"2,1EV[E7GPA?>,%R8^P!8:+HVJ7I$)[DJ>R!':*`DF_#7U2E7 M88RK;>$^8Z6R%NY3SI.89`GGDW@'H5FT.7#IS(]A,A&3<_55K"R*"0#^,&5Q MN3"]OU/"'`.-KDH0#I&2(8723:/XGB6PZ?ICX'1CU2ZF4VFT<]04C"/1<\TT M)\#3:,,D1WR@.>4R1(1CC)IKO0(E(%O\^#%;*_5DO)8G["?PNFG[;A[#R]4= MO5E>WX5ISRC-MBP_`U(%KJX1*KU2P3D(X(KL3SX1D)_-;.,BE8;M=Y4 MP4B;]N'67(:Q7J\,4DC(2-(*V8X(XEF:JW^%CDB1L9:04>H!9X/HIN&ILV-+ M^.B\=<=S6L]#Q+:>S(!9QZI+N@C]$7C"AGV7XH2SDE:,F.[HS::Y;I[I1GYG M0UO,7@-YAC:#YCVU/#C3_0=4!CJQ$M1<0G'37]W0`PY9^K,>@X4?O!7/S+[(AZ`3G6)&-Z.)9G'`8(48*_Z"CTEK8 M@C#+TZEB,/&Y4B&N;'$9]?_PE8A[PB:!]N"5B*5.C>6K6N;0O,FI/DI!FV>\ MZ_2FK.HK5/ZY*F6-#\[]$7;0'V%DVAB@`,(*D6HNL(1^G^/2*9E9ZI&P35=[>W79@'"?CH+W2<^?-H`).Z MWFP=8.H/T_@!U=M&3V\U.X='Y,(7[V%`&0[!/ARERZN@GF)[=\C%';W1/D`> M9EH_8AH]O=DY0'S/LN6CE@?6B/?OM94=7;G4O+SDMGG/AX>>WC78)I>:QD:] MI]?JC'&Y=V-2IL1\WL%=&^2BF=_/ECFR;$H%8.O[/)JYH3<.L?L8DWC[M[?T M1J,,IK?PIX4OKA==304]88GU6D.A/ MJZYW&('KE1"[6],-XP";X1;=`>M'E8A*E\FBJ6)KK\(@13"^!NN]9]9[];K> M,PZP)=#A^79#2EDNLMXK!4,;#;W3/$"&9F(_1GO5]/8AWL:7+2AWJ]=H!A$C;6Q34UO(.[-=:,%)N6]/5N M2@F18A'),2KG77C"QT)A](#2L(T9#)7XVXB4(LSQ+$'+N4G`)H_>2'05K46F)4R[6%TD4'6X MK[DB?O1&P00^6/GX&$TOA@^*>G(N-M1(7* M^IU9"VO44Y[H>B.Z9XRN_KWJ7=?,ZVL/Y#!`*#6@HK7`FB9%\TDHD'ASE;IX M]":;O$CPY%FJHN3J"K)NU1)M@/D"&<'OK^9"ZG(<9$#;=F^1VU)H&"DLC#(# M@/6>BO_5>SC^5^NE0;B*'[X"B?@V9R+F[+P;$&2 M55J-`P2X.4C]FW/3S+R\XXJ@3OT`[_,/0`_G%)PP[^Z4=YO-`[S;.D@]G(.= MP[R\6UYNER#AIGB<6Z]1L*$_A4,T\_!S'^J,PZRS+-M5='F3D(MO+"DMN;R: M9L_P!0=:R%TV!<.9&H=QD?#D3B*=#;TYUMTD-/?72>397_T@:/L\M;.&U]?V M$8C3>)J=1?"4*\(EB/FOYES(V\+/GP>TLE&\XJ(8KBVW:`^M%B)T%_K`TWY6 M\_[LFL[21\?R=CU9-G?(V"/9S"#$3FG):D[,0.R5&H?GX/8];#L7N$Y^_E!^ MFE19W-^B'+0;>KU[@%%[)O9CJFC&@3O"#+C\?(2BT[SH,<+3J__5OIP?:Q?8 MEUD[.X,9Y+?S9AVVXXO'%J--OA):RP16TF`':+4.ST?[S3/O?/#0$K\,M5IN M[V36:KNMG6_JW5[C\'BD(NFKUYN$1O6P7;>6YR=_] M_CW_]Y[J^!^Z4N++_D,R/"\L"P>N6'U3)NK2UW*\XT*VTTL:[== MUX$Q5I[5P@66.:OG&/*BF)`7?R)BA&V)&PE3$`AOKNK;@YGE$Z=0K?BM!;\[ MVCCT/*3MW/3^%H&L/;\%^B+#=!$LA?BS$.,#J4T`;1&R;`(S`"7KU133MPG:!2]4`@;]T)TU-3,P,YSYE8F8R%20S"#S0/ MXQ95[0P+V9&]0T>^74PT6*<32$P7F!0N+'14FXW\+T7?4UG`0MZ-8" MB8)QP5$5FDL=Q>7CN!#3AB\Z)@)Y^(@'(04&_J(C#`!\03Z`6WKM$U`$O@.? M=$,OJN*W''@Z(%&RG"-9X+^0H>8[+0PLV_HO/C$%(OC(RYY["RLDDM`PGKAQ M[1M)&3&Q$`["O(9]Q1%9'->+8^ZUY`N)XU7,>;>FCV`E-T!M0C*:>NY(!:>X"N<]G7EG/*[D1\T+P2CKVF+!*<"^C&-56[1U^6UDBRP&K M#]X>0DN1_XB@,N`;9I]J5-O-=T#,.2@7I"`\_*_07D&U:L5^YCI4G?I30=-> M-L-\SQA%%TKG*XT/8Z';8)*;!D3Z&6B^,+W`$9X_LQ:)^B>K,'?!ATJCX1%R M&#&/Q"`"[P?,$`P6DM\T<^T)80SAAQ[(+;YE;O[ETGG!O55O(3=(>FC`*M*) ML[Q)!2>"D$5(=>(@_-.51Q8,^="Y4U[DS+P1BODH\(7OGIM_"\3!/I] M@ATV^.4^M#PC$^*"Z)T@1[ATYCM#.)YZH<;Z$MO36RW#D3REFT[!EW":_+ MSI:D&LYI8X)^F@B4=0O1XT9W>2_%F[_TV%<>G!IQ^`L<(C.TKKG>+[#:]'+! M[QA3LE>R9-SOO$4_>&T7:NR5]44@6*!:T6]&=QD.O0AB%R!3I1<@;5[^>V%L MK5W#7>_5M(EY1PC:DKP?<5ON6>>&549O.GH3O4O-.CNYO`TE_K%`1C=MIF*4 MY06M;`V=V#=L#FW-V';EH43./8B^,@?AQ->/X006G0RSVZ6>,,=C<$WH3*5X M++W;\1YLUJ4_3ZP;_/4?/X=^Y=HT%Q]E:[`OA')V%I^2_!/+QQF'GK@"9^78 M=L=__PIC:/^(GCN;+TS+P^^>>_#EA>N;]OGT,QS(/H.>F_1]7P3^6716.W-@ MYM<6F!'YAPO7ML9W\M_Q"T@3PB_?Q/2?/PG7_GXQ[-8:C0K\SV@:M:+>^H\DUZ@WC._@MUN2?/UF3[ZUNIUMO=[Z?=`8GPU:G43DY'AJ5 M9L<85'J-VFEE6*N=UFH=^%O_Y#L^^"ONB=J2I]NV!T?J;97E3WL"[T_VE&@U MBDGX8-M8:9?1%'\3X"0!AX*,D06,N95LG2=L@OBS8EX#U8S,1K$).,%;XE;B M_.'#\5:#U1$.>/>>#&B`O'D:*"'G6A!^W]CRQN'<#R3XO^5@`4$@;:=2!&/3 M\^[(&R#4OTA>X_#"G`RLXP;:"*AS.:X*;()+S)E#,@,%"-F$68GQ&T4YW1#$$];F!.4!N*N9%HHSY?AR(?) MH5I)Z9!$LM:MR/0L7UIQBDVEGH6E67@70!(EIRD%$=G?(0&#_?"CB'!6(G&) MME0<8ZFL5O88M)_TM)V43L3-_&'Y2K%&7TD+@!P8%^7!R175D7P'!DL=,F92 MLD!H%6PNACR"K;9"*@:I8ITM%(.N@F^@3"B2#)LS%R;Z+M2X14GNCS%J&_7H M?3H;=;0\M,&.P"#Y"HDE.+D3`TOK^V1/XX-7;.NPW=T=@?$2`<:P>2:P-LB1 M+V*S/7:1W]`=!@*2:9L(LLUX1L;SJKH[D.P?7;/0.0PX"P_H&4.+%E:&:8%6 M8//G*IJ_&K2E62".,YR$03"0F2,5$@6"Z1 MX]5SZ'Z0O9[(HZ(2:6;[A.V=^/I)>C%B#N=`T[M+.YAH8)R4N_JSZB4EU3N& MA#2ZX$,Z@SW[KYA(OE^O^=+76;[BDI2CF&:8D>F3QPC>+8P0JWTC^U'1@0H.,N3#7-N/1X MWFJW8U5\/&;6[5AU]33\#*?:[+'YBX`9>GY_#/K$EZYAWYG(5\E?DY.WO_N3 M<:-SVFQUVJU*QV@=5YJ]D]/*<:=Q7&EU6J>-X]-AJ][OKSL9%^N2H;'32X;X M*/Z^\2BL@_3,C'>/4VLO=*611!T&_^_WL\NSJ[/SKY=:_^L)7FB<75ZH4/M"@[)@J*R]N<3Z:9M(8YGT[Q!N+"]/[6\9(:5*PM*M(=IIC& MK:L^A.FXX)6,5#\7'SUJ>8.5B@VAH[(`T_Z#[*M]!R,8;:RET3`W2*K__X3H MF$[A7"QC'3+BIIT'03B_-77MS,5_RR!;9C#M;;-J@(]NV\`#3_$A#[_M"5!: MM212KE=$=Z3`*MUUZ?7__NE25X<,S`R,CZI3)#,,XHA;^ZX2)[6H"!SX@D`[ MV'[X.MY/33TA*AC.)#].S-$?<<9W%'[!ZT,93\U<%IT.3_SL[5"*\'\*WS;' M+KWKBT5-CI#SP'4QX;PSQ(8\\+ST3GT9.K$7B\ENE1%Z@I;A!EJL&['$&A$AHEF*E^0&9*!^EX:)3) M&.H`F-S;TB-X%]^B+Y!G#IL+FRX/CG08'0GPT,4/,0YQ:O0(O#_I0@2+IHL? M%(-8P%(SH!-ATJMH"OZ2:@J/F0;+8OC6J%>[D?#H\=5N,C()J(U1;N&$,`C, M6]U&AGX2UU+)`R(ZEL3GWR1RLB2SO5H-%0"NP@&.AOT"I?&NTJNU(TF7O.0H]R6@DM9BB-%0X=%MC7ZG*+^?'9>XN M]8"CXBJLXN[.8&KL^FY/GI%AK=>?>-[F3^9#L5T MAI$/$C=.--']K6]P/#-.#/P:@NWRA7>#SG#:I:$"B[EY31*C!D_Y+E\$7K2` M&-W`#(6N_='7EW-^H\R6C&N=.%^6#&4M+!APD4T42Z+,N!RCEG8VR%WX-.AK MG\"5@Q\OY=SIVW]8'LS70E?:&5=UN8I[Y*W(!W+6!:P+I"[H5.N)"YO$DDVT M>>1EXA$$PZ#R[@%E%"&U0?E??`7F"F)5XB76#U]1&.?E*XQ<0D)[>I3-<9$1= M%\Q;UJ3-54C)E2&E*%"4,I>8WA"_0=?ZWM\H;C)5G>T3"]=A"]=7UPMFMYBB MEFWC38(57H/K-@"G\^]ER0+[U%D5K7EH!]:#).M88$]OY8=&HG7?]277;&P@ M:!P;@Y%BYT%F[,NR6`R[I8[1!*E*L3<[HDR<3Q6E9,"W;$LF=U!G>GF:F431 MS2B_.\JQB(\)\I1N33#;?&KEY:CJR44]O-+RHIPNK!E)KKGQDALS7E)A1%E] M8%JV/-+0P4->_`NZAL>,M`"3R"BQ!?ZU/AO$SW197THXJ"QLLIVB+.M3,Q:N,9HYMR$<5%(Z+Q$)9DYMQ.] M:I=*K?Q-[WV?1$EO!:8(861*;U9,K#!)I"^P3G@FA M]JJ=>^=X].:>66K=]"@;Y@@C1;.,M$@JMERHV.V.#6_WJ2W(4W9XV^X=W()\ M1?5^!@EXB-EB?*GMW][0:\8!XAH6'JHSOA17=GH.^OM&7@:6EY4+@M]HU/1V MNPRXC877S$FV8NS1,G<_=]L3O=;A+KD[9^43%2=>F)8Z/^-YG+GYF;GYO=': MM_MQ'Q1(V4`?RP.G>W@&\RM6<&)!`ZJ9\BJ7_9YIC!:F_QV^B3QT15,F=-FG MA,(//[NX/Y$UYQCPQ6,H7BL9AZX#ME#NA%0S5&U2RH,IRCXIH#Q"58#-T-*; M(FU3V%]T>+47]4V!*M\D>VW?R!3>FA[\21>X#FDI-SL/#(V)D M8BYZM_5.EH3V6N]V'E1^84CC)\2,&VUN-EV05^^OSW6K]WQ]KG_^?$&+&\6+ M+HH+NN4N[:%G\GFDO.B3I+'U`M0>8IXM?1SIY*6/(\6W/$B$EK:!*CL@Q%[& M+"Y)+Z*+]/-;6=5R=&\7^((2H13D&!((C$40DMR/_.&(HJ8]IRR]O';DA5+R M90QB]O;=D?K=OO5\&:D:R50R'25[4[^^#+@P]P+&KM]WQRSL7N6 MGMX^R(_VAVG;XB[E4JPLH>LW%02")T,@'')\-3Q0-GM5_,/6Q>`37Z'M@]6['&(L M(56_N;YP1L*[S@>:.7H3(V.P67L]7%$VLU8T(W9I8>2>[=A>#F-LQTI(5251 M<";3^@BJ9+EIZ6+3]6H8H6RFZS!.9)=NB&4U#ILR-F5LRIXH3S-7.-:/9#:Y M)[/DST/3#Y+?Y/U9ZF'32R6(\&7:*V*DLIG"HAF^1M<)T2#JV89PRH3E'.,] MC$S?BH%[153VJ$TDK'0*A"$%P6".W!M1U2Y2[6"HV3&";L0OA:>I?XWI37!B M>2^@Q=\*3T3=QPF0&GL[>Q.:[]&;&&$ZC-XHPR5KD M>Q2BM:F]K;>JS1C=@X`C$`;DVK0ZG[M*XA7O@UL/%_(T0.6]R(5'I^ M(P+23K6LGEG",X'1"1Y<"P,@TW^CIC0<]E*BAI#Y7)N\(.XB#CMC MVG>X+)(#T_810QM9YHWU+;N[*6VQF,,;JCT6$4'-^7:"82[MR30#0$ MV@]\XF6(G=IK@B2G#4DU4R2V$A[LE204,KP?L4R&A!XU@I0=URV?]('\#`%6 MJ$$GS*CSKM*M=EKO:-SNNTH/?]&EF"I8^`/NQ+A/Q/\OY\?^*LP_BD8*'34& M[G__MMM,<)$^Z!LQ_.';[6KKZ$WJZZ2"761.1+"?B%$`7ZKWDEZ>'YX;H3]: M\K;`_$NP_$=QX]"1Y:0@Z;="Z-/)Q%H/;1RPU)(J,[.J=DYP5,',="(;X`E2.Q.T=&-+F0!2'8I*\B,% M:Z5L>`S21$HX_3W)*D=OGNN>FYZI(M0$7>D@^D(;T]8&#$ MSH;O1-A9*%;2E*&OE/+^U#P27RN9GO+H#E:Y/?608:L>JB<6>AY6$,*F<0_5 M-8C6L=1%(J5+&PT287DQ5Z%Q./:LR;6X-9>UDO`M77,HWR1E9ZN4/W+&[Q?">]`A\!0);GADW35.`68Z% MF/C9`TNZ?Z4R`;13=":)7.A[]HI<-CB(R]-%W/3^!NT2V\#,ZD"7AE[<#%M'/42^M$^^YXTU MD:VQ96=QZD&(+I4Z)<'JIJ$S4;ZA^HXT'=3Y.S[B++7*-I+V]E'[[:AGMCP3 MK.I52S%@5>O#\PWP-*YI:U;.4?#T`T]2F7/4T2:8PHTGJ?0Y"IWFE:V/F&'D MNG^G/1)80^SW/T&);(3C[.X*(2\X]PO/L6ZI'.)NW=>9-^;'2 MN#5(^T:F1HK=GZ8W@4,UMC\]E_&N/T`%H7^::2]W:J+ZO`Y`]7R"OX-*_`(^ MOW5M.FB-0%8S'>O@P!`%U,"_2YVF)J1DEO1>,]%[>M0)S<_KUF6T]<::ELX' MZ^T]#]G_%3I"C[O?KA"]5:LUM0O7)8-O3B2]4B[!B7`L'ZEQ)7Y@@TXWPH@= MPPZ$1!OX"[QYJ=6B683:Q"PSRMEUO8;??#O3X\8+-R5\FXMN1;P%F?VEI=%V$,V0>VSI2)>Z M)CZL9R+R9U[7Q#C>0FRPH6NB9/"U?1.7NB;J.6T3:0KW-$Z\/R@#H]P3EMF@ MLF4L`B>R-DJ#8C`2Y+*NMD^$?YPH/D%.]S8QFJ2'XKWQCFZUN56\HU"25K0V M@[V'0T9O0)G>S>>'EVG*;0:?[]*]87#+*FXR6*8TDH;>:?8.GZ>+KY:YQ^#+ M,W>;>\+NGI'E71QS\(MP<-TX?`8NOF[^G#J%O\_<4*E+\?@Z)*?)(G/\CCMI M[IOE/SR>T]/O.L!.=^5MJ5DTC<,--%]`E33U]M[Q>'9A/P]E"01 M>QAJ.6:?#M&;OHS^/S2=>V-N>68HC!S)=(]'9(:O3N"!F>%';W)RPQ^<&8[N MYG)N>.E3P7?'Y(>9[@%_/Y))3($7CCGK8Z/"<<0M796/H^T"ACMU/2>I@U37 MVF=GZ7M_^15U[:_N98$U%[:@>W)YQ'/D=_L+S[)ECD%>"L@\+K=<*J/2LQ>W M6J.&=_FY5_6HBG``U;-/,S4;=`-.!5O;)AUFDU:U,]>&>6)3V:/5[K2K36FK M6M^7J6:?/P]0[SEN(*1HH]5;WG4`9K:LM2';D;KYF71AFF@MVHD#4NE4$QQYZQJ7"Z#PU5?S*3\6:O>>I=WY0Y)54EV['[2(=2=<#$5% M8]>3/!I;3)\:!8G/#_7Z(^=CO,M;UL8GEZL M,29K]GKD?$4^E^N"SR4S,]7A!6:TIAP^[3-FI)>?@OLCID-84L/R%-GE'QE+22\B8S"S/I:K`NF8-& MQ97W"-#NPAJ;ZA#:6Y4AL#"_>F&F4JU;/'W($UJZ6T045[IRP6G4DG!(XQ>0 M\TX=Y1QFE)'TO`/;!C&'Q_MS.`?9MAMGAB"]:OOH3;Z$;Y9O M56"KY#N*_:0B9JVJ(27Z'E^88Y2/S^9^VZPE9>SW5L.K&-U#$KCST[EO/87$5_;W[VO>9P.3^[`X1;SL]& MFYQ3*-^*O[HN/_OH#6=HWV=JOBN7?&\U]HPX_/E&[ M:(Q](A:N;P64#2SCD?5:7AX\\_!N>;C5.%P>+KZZ/B%03QE#).C%.'")ZGKR M5RCA@RD*"Q:4=?:S\WN]H=>;^W:VN;Z&ZVNXOJ8,L=:VWNWMNUJ/"VRXP*;$ ME]>89I#-#/`3^-A-)36KO0ZB.AB\(K[%AERF3]]'L%N?LN%-#\'QDB_B;3B^ M(JFPL?&4K:YZUR=@;2C:(>3=+>:;JMJAB^-,V0X,L::EPT/*=H[>I&M?+$3# M?7CA3G)[_M3"':20[;O;%>XLHP%;9#+@$W(>&O6'YSPT MGCOG@5_]PJ_>[KRSQL%=8K\-3E8D6BOGMU^T/\].KCY]U.K&(L@;\#%ZRXB? M'.$/_>2N:!3O0E&.35ONTT\KM`"-`6K"02W]/-MVBAKU#XGX'M"GGO:SFGQN MIEGR"VKQ3?N]@RU^CC%+03:D6.097XGQS+'^$PHFQGZ(\7O*'3IZHWP@)L9^ MB/$-NZWM=?,/[ZIC_5D8YO+>K'YX/ZJ6^'YCSZB\-<3$QSJ0AT]CW['(PZ)S M0>ZQ9%N?9#*#3`PH^;RO8DC,%J^"+=:QP3[RJ5R;-)U$7:-;@KX;FW4/6X,4_J"X5VL,$UI;:\W'U>3B\I[?YM/J* M-!J?5IDM[CVMPBO9R7DUM.]6V_O6_GQ,/+X"HG?.]SS MZM;9U77,]%MS4UVKMA9!E*2TDF7Y^>SKL/)I>/;;)SB^=O$3E<=DU)*4R_79 MX_M#!DR;M11,X`XA[_!6>'O&R07B>_S+KW+;`-@RZQ11SY+DZ:6."6NSQ7-R M@1_">Z4F=>[E_PN1FJHP+5_SQ!AW@]+WK8``\$,/P>E3M$ZQ1(KLZ<1EF9I# M.3I16:<+'P3`.1)3T73@46"DL=`I7UR'&2N8184O[R'>H>2T:`9ST_M;J+\H M7D2,N&OS6CR1K5Y5"OII!KWP*-5,),%5E]#."3/$CUI.>]D<2 M60$+*E2AQ@H.W]MZ@U`XM??B1\04@6']*0. MMI#@J4Z,O=HX@!'+UR&6GXJ11_#*1V\4*P],YPXTE,R\&F-)RT6ZG"=NJQ'! M=-Y)R^4@8,C[I$!G\,OGSX/DUY-?/F2:;\@^'=1]`WMOI%IO'+W):;ZAIUJ+ M$,!K0MM(NZEY7RY0`E!2,\U+J'L'=@*QX).H:X&=1/P) MY]33)*E3"F:6-ZG@@'>Q7@5YMQ-44VI'$A4NR?*M]*Q'=TDSD6OAX&3P%5DM MT*T:1S$.KBS-P@)6XGFPH@HG3 M?KJ(2O-GII?N640#JQXMJ>G",$"&T%88WJ9V;5I.CMKJ),#HS\>!BXC*L4RW.BWM MD^E-[K0S!VGJ$J*Y;&23)Y2U[5KB;);*(UD,.$!(7@(&R^V`SQ`IT4);"Q*2(`U+_B:'*1+@!TL< M\%(])7#H4#U(Y")A0[E[O+BEA0V]A77B9E2-:++ZJKPI:3MZP_+VC/+6CPI< M)<8FL9QR*/UE__&!Y--N MW=">:#/S!O&CA;/,5JU6HL:5L_K6,*KMA-<0I+W:JVM@W&!M=DA\A;RMIV"U M;6Q^9P4S.,W`*-?6#>Z2F$[AKU'=+_*ULE6)]57B%#O4TJE5V\*LEV8]J:+6 M4KHIF4ARRC(2>>`&H(SAI)%Q,MXKU?;6Z"4G%FQ9%LY56;/"&B?GZ8,Z=?K+ M$.AQ"?>J@`'X_DC^":F__Q)N/;WBV&W MUFA4X']&TZA5_J<&5/M^>77RO=%N?4<2&O6&\;WVDQ8ZEGS*\MUFW>A\__WR MY"=M(L8@MK;_SY\JC9\T:P)_GGQO=3O=>KOS'49N]YO==J7=..E6FMUFK=)M M#5J57N=D<'+_^G72KW;;L,1,MF-^U:27??E>"8FH2W.IZ
>Q?-/[`'X:(+,K'M`,!`Z11@BI\Q2I/>5 M7T+(8SBA\0P+F_RH*P*.`R!]4'U MHYC#B=*1RY4`%91*)1\NF60,9:'](T(`FD MK@O11C]LJ';>85>!UJ%U%5!4Q'CN1Z-:JV%N7UHB*_+#W'#2UC()2B:GWWFQ ML_:V7MQS).UM_?)F3Z_7.O?/8+GR?Y<;L`.DJV+R;+NT//NL=]3;,V];K[6V MP&DK./,>B@K.41/,SCMDYT9-;S2VR+DH.#L7DWF[S+S/RKSUEKY5LX"",^^A MZ.* MB6-_+"R,L8PG48PKACJ*4DKS&..I(,:[?%_.UP_?5E[1_?7>?Z2GAS3$1^IBNT7JO=:C6[_M1N6XUCRI#.NM6K\U[`U. MC-Z]5VC%OA9/$G6S^3%JRR?:!+:7=+;*1_+3K7>BK#__@[JMRKNK.GKSB-NJ M5PD*W:L5$!3Z\,`H\+[JOJ,,78(+R+P'=V=U<,Q;K^OM5LXV'QKS'H0N M/K@[JX-CYX;>;#<.GYN+QKN?S0.\JCHXYC6:>K==@D-=YJ4'V'6SO,U\BV\E MZ;:JO)IFOV&CN@'>7J/.&F;?&H;[^C+RU/,@3^T/C4@6SU-Q5E0WC_6;W5ZU M>Y0!CTBC"L&^>=16U=="!W90(F`(;^[+;WK:6Z-52SWOB1O7I@K>L2EKI][K]2OW$:!F#AF&<'+?779L^J(9LF?UW7T36+N*-'+_Z M];SZP2FE]SF?3W,Y=^W0)FT'C>[*U7DVWT55JJ[)LUNR'%OD*BVU)T1]IL7@ MB:-X`;O>JX?YFJ4E]TJ7R9>E]JGE^W#W<#0ES,544\HM8!`3N)0'KU!>+Y1\> M1!'(-X78MKJV8D?6MU[@7DL^C*9>[VZ11%&PB@\F\`,(W,C+I&,"EX7`+;V^ M31H4$_AP"=RK;Y$9Q`0^4`*W>GJGRY7>+WBQ7>9*;]X]WCW>/=Z]U[9[!P!E M]C7!FQ^)J4L(Q83?OFII.;:Q`TP^OH>U;HC6?8(,.=)BWN MHLYD"GMG;OY%GU=D9[//GP?E=5:?Q0S90L\+$ MTF+O66%XI'RJH-X"`UJ\O`YHU@[?B2ZPR[S4"=L3IGV4])TN ME+?+*K"P>U88%<@\4M@]8QYA'CD8'BF?*X7QR&9QCE-,::8T9]05X'TY7^?= MX]WCW>/=>]6[=Y`7H4F.W:JQ+G+275EIF^]JQO- MP^N[S@3>^NS;UNMUEN#R$KAEZ*W6X4EP.8(;)6S2R/O'^\?[Q_OW6O?O`%)5 M9"/LD>E;8TV8GD.HTPOAP60(7FK5]'*HX^F.5JU:/[S$*R;O`\C+F?;E)6^] MFM>#C\E;$O(:U3J'H]8<]F#R)2/=^CE?Q"'7X_[J"M>])] M.M6I>KFC]7+'ZW2'ZXQISM(KU<@]'?&YM[/ZULY$W!%WHSN3?MU*Z.G1[_X3 M0;:O34<+7,TZ=HL(C7DSA%7\(*!%[?V)\.'-VA_PA+B+)S2@%G:Z=FDZ`4[G5.`< MI\+W:7#MPC;_:^JP)[YP1L*[U@8SRYYXPE%S@MGT?DFMC[X.XUQ:PO-,'%;K M.X'K6.[2=[2+F2L>7E:FLRCQW MJM_\.;_ZM;SZ%;Y4_V+DWG?79^Y47RR"<*?ZHE&$.]47 MC"#/=X]U[;;MW`(`SC*+[S'G>>K/> M.3@_BNF[[H]!5DM,WX;>J!U>?Q&F[P/T6EK]'0C3976NW'H2]A MI0'O'^\?[Q_OWVO=OX/,UV!4W3WACW#DH]3DY8-QJ/]X_WK_7NG\'D,?!&+KL1[,?S4$.)B\'.9B\K)Q?`WDY MR,%./A^2>/]X_WC_>/^>NG^,H`GFA]NI>US0T]S!&+PRMHM M?*VI5BT7+;2)2%9FP4K57L`S"XES?/=$$-V?)]8-_OJ/GT._G)_J>9SK78@YT/+Y+OG)AWN%'_5O3FYPO\(O^\(?PQI:/;_B3=)28]&^` M@Z_%-S$W+8R*#F#!'FQD:-I7PIL;R`$8C_TFIO_\2;CV]XMAM]9H5.!_1M.H M5?ZG5C.:WR^O3KXWVJWOB#YLU!O&=]`-D_YIK=D[_FY\;_STZX7Q[\Z7]DEJYUY^V4O[ M#GK$F@(/PK@2H1H>N0#N&5O"CVFULZT:'K=..^W3>F5@P./P:*-R;-2[E=YQ MP^AU!IW^L#/XC@_^BIRF&&T;"X``6[:Y\,6JGM\2_?_G2__9O M[?Q4NSS[[>O9Z=F@__4*WM\?#,Y__WIU]O4W[>+\\]G@;'BY]9YLZ\W`FW\[ M^UHY/K^Z.O_R4:NTP6'1U(=7YQW^MSUZ6[^:00A&Q)W"',ZE M$0=%L6D#MYEQ`3;H%^UJ^+]7E;.O)\.O5Q^U9L9K>]RF_>Y8H"U]TX91/@G3 M#F;:-_S/G78F[>N5%TK;K_GAR+.)&6^HOIW=DXF@=OT80?@(DG8WX#/Z-NUP(6^A7,&GE^ ML+_2<`K84WP(/27TH"R?O%]W^K%0$K,_*Y@JC(.+Z-(@9BQ-+$V'+$VAIRT\ MX8]GKFN32[1R4LD)F.Z^?H<]G8:8CR"G,\X.._&<0D0LM`&Q21` M+4W-&]>#[;I3$>](84T$!L)=^00>V,"@P_-P@`9%YLZM,9[79.<]7[N=6>.9 M&E4%QBU'!LSA;.@+!9`O-">%AW)C_#>3%T+`>. MNV)2A0$N9S1F,#,#S1W#"1MT+"A@\RYY#<;>Z243^@8H4?`[/#Q3:B8&[9'5 MUFEL#!#<8N<\%=*?A.-HN:G[`SR<8I(O;0W]06ZE*^\B\`5Y)P.Y*;>X`#(` MRSM-#TI"@?IR0KS,<#`(H+UWY?NE;Y43+[F4<0BP.&?.N)KW]@_RH`\;M7`# MO)'!]HAT;D?[H3GBVJ2^BM%4Y`O5;&S<3IR-N(5!@0_F,FX@`S"A,\'+!K1R MH#="$=V!Q+-8Q*T=E[LSR@$B3DK%8V"FWM\B@`GZP);"6<>8:H05YHR9DE0) M$)*XA(9<85/8%-R#"6ZJ2*B!2\A;FE15R8JN:`8!A2\PU!\Q2^:M\7[!7V&! MRL;#-\Q+"+/]Y-[B8[3UJ%M-!\7><8'C0OLNY28TUZ-79^NQ<`B>^ZME#(IV10U2LU4D0`'B.>,(T3;%;AJ8T1: M5*YA5!`!D`TWO)ZIU\A8')#O/K/QJBS!%],QY8V61G>1H4/4A7U=(($5T\LF MJZ!8IT`H$E)3_@&T">FXB>6/0]^G/:9;5LD&1$ZE.%8OKI7DV`(>%!0(E%^U M/!HEIO!$]/"_!#G(M/]PH83@7+H^&M.PT# MI@+M#]VQ),Y%8/X0T0S`M$H/Z6!EZ!EX!%-P%"V)2(YLF6VBEL^+>0.QK!_( M`IJ$$*E]1H^RAM/<8Z42P#0O5SUNJQRJ(+[)'E%D3)PO1$23K>:6C*]+/ M2,53T(E:"K%\.3^F5EQT5T?Q>3=2RN@P_@#W65HI1Y!+A9_:PKD.9CHNT)-Z MY;]D]4)?Y6C!UGHFNGX5S,R+TJFDL8H.07'F!VVDK^0F&4]#842YBS8O4>SP MK6O3F]AJ:K*%]9%HI($[[F+;G[[>`$MFJF,E[G*5T5 MF[:@34N9M5S$!F6%K=7+Z@*]$HWRLZPF39(+V;L-@E M>N`A[,;T[H@<\.P"CRZ32N!6Y$]5[3C6E-)A2/$*L4!T^"0W)5RX*T=K80+G M*0&]RWI!C@CBF:37EZ6":D^7G@HI;60X/&N!:F)48K? M?!&JNRXB`$4V/2)'6@4DE^=+,U;WZ-'HZY+"1K:'5F^.Q%\I,@M0NDB8P06%)"JIIJ*R`[`!`)US/Y&#- MS>Y<-I")891]<98D";#;ENNV22Z;R`-,5N/)#-Q%Z(UGR-S@CXW)2S+C;%-4 MZF"]5;I%+"C1G[,RACHHYN`A)S"=:PM/)":A@Z?IW)U*+M' M'9E@3G(ODNVJ:I?A""\G510,W1K:4ES%ZD(C#UDY+>NF*:.+)^`Q8T@SX:J& M3)-NZC1E.BF/R%J#3?IOVF?RHF31R!8I*_3>O+Y&/P`(?ZO22S53YI?B-)K5 MI@H!W3,!&0+$A.P?"WER)=L4A4TC\M&I/GZCFJ=4WTJ1X5O?MJKMY!5S6!7R M(3SZMEEMK?Y!>]NH]C3UF_:V7FW%O^"DWAJIOTK]*W.+X-]M^G>'_MVE;R.; MZBG+8=^!3T&0C<>'IVO+3 MJ61L)\]&9)(8Q->0RPX/@'0Y#FEHYH,H[K6=>6`U^2`R)?1T.BJ"4#4J:U M.O[56Y5F*^)H%31-\^;2H,F0>3/*C-RH-%J*H##5\_SZ`QV=WV0K(Y8G!C%` MUF"`]43:S"%&BNV/WCSH<<4B,$+]D2Q:?_4.QP"#?;B-^`/,8P@&`30"NQP; MZI+(]N$)#&PDC#4#[0$&T[9@ZR;IC%F\IO!"*7)T@(JE=(Y'1!DF(!LK[[#F M,*$918'I;`N&:*2BL2*ARJOGV#XZ(.@I%C^@`OE(/X\HPN M`$W/HZO#)#!";GKDDL\I>0@O`T;RB(\^'D;,R$K:):Z'5;?BR9 M^!O-F4KJ\/H2I6R^Q1T(3B9Q]%9N1'1R0WT_9<\C"TM&<6+A`V`OY03E)6[F M5C9:@HY1',NGPB85-4`=X89!XK7#SGK7Y.O3?;-/P1J'MC.UDYG[Y;B2#KP. M*[6TP/R;*!*X47A[HA(=XBA6%#../6&U^N30+P.0N`>!!VN5G`1O))]S)0"E M[LS(#9F`&P_G)Q4:%X$ZH>'9R\ZY0<5Q7;R,C29WL%KO>>+0T>W^'*Q)5$J9 M8:?4'9Z'Q@,C2WY24'?T)G4P!=9,)$-?"F;&S``C>[XZ-,H4[4`QXLBTZ4[! MG^$M)9W%2=PIJ0//$G2F(NY*ID5Y*W#@A,FA6DGID)3'O69%IF?Y\D1('FSJ M63R]CJV%C-;):4I!1/9WI!%61Z35\[ZZT$QE.JSL,6@_XDK32>E$W$R,G$JV MC;Z2%@`Y<.J:-)7;DBZ:!:%5A<@_,!UEJZT0T>THJH8M%(,,B]BN[\?'[CD< M]S"7",^X2G+C`.\V.CL^+&%D(QVSR"@DEN!8@M&%\7VRI\K]2]DZ>>D/0AG* M`YRZ,8_2C:39IOL[;8XE8"-!IFTB9!@\*CS"N'?$_K8%UEH*I:EN&+*&%BWL M$16S`ZVP*GI-:H&:!5;&*U<6F#E2$2C29'1BC1.2$SL'V4NI&]./RNV7E@RO M0"5!-L+'<_/9%%<3A]83)R+?:8&UJ"LDY3-(];!JPY=8?$5>%$66WR+YW`K2 MQC^)Y9'[0?8:U5TBTLSV"=L[RJA'7HR8+UP/+WU2#B;=E*7D$]"+_/G MB1A3_`AF22]/VU%0@7])(ZJ^YVQ63EB`N'*3];:$L&),JEPYF`0*-+ M)J^%;L"O)"T0G[\BD!:)?2+(RDB?!M.",/MB!`<\<*DM^`WO4%!S]0"?/M[C85P>/&]%]"0] MAGNTE/-A+;$Y\"Z,H!*Q09.YY!6HC4UE=631<>@@$,TP3OB=6=ZD@M5L^#T, MN49)[4N4D/D&_\'\CQM7ID2B/Q*G+,H4#_(4+-_'^PEU.L4K..FV1-5!@?L1 MGGIO?4B$8(+1[\!2:`.Q"_H+?"O]-=-Q<`*C<'(-+&$N,$)NVE'M$'XY_6W% MJ3#55+$V+3R[-I4)1B8*JS=0BS<:[W`IO=8[F+I3B9B6LG1N'=BEF;6(V4Z> M]X]2J$`J<0AOY8(D?3BJ_9='*/PC95C(J(W*VL1,`$6W.",S:J^N2P-$D[%& M*ILZ/-'"]_%65?$NY=\C)HZ/CQVL MZ7P.+^^^&]_HA+(L"3&?QF2FBZT,-@(P,14-_N5:R/(563R(*DPI,/A@(W*# M%%=Z0"6>H*6A?&5*G\\S1S((BA?B,I/%UY1<*\"N97RQ?'0Q#!-D-"@HUC'9 MD[LX`7J-";)$-(E82R^9HK0ATF$H#]4X;K2+$5(MM3;Z@3;&)M(TR38,7,3<0H`%,Q1?MA`]L!]3[(W:##!NZ4"IT! M&X04]^K;&.>]GJER$_A><+=`CH7%.J"FG&M75L?&O!@N4+-%TXKW((R.TGZR MB\MLA8NJT**2O4`9I*#!G:ZRBS$?!(>RT"R@'83#$96*1.Y'%(8`IEZXOK+' M%##*L\AZ.MBX)D*>R5-)WT[C?M.NQA:WFFR98GU\G:J$B,[;P/"^*PLTR)++ MH'OH1S83Q%-0E08H=@H^FW'5%6W2T9MHP5(*$IJH$RCEMRD1=CWEW^!]@&LZ M'*!.68`(0Q`&B5$$DWS36]/7EOS1M:I77HT2X?\5.B)E36I1!D"@="*QL$6N M@8\F74:JR)DT27&"^HOL18R81$&GWS]=(FNB8%6U4Y5_H'(6R1')!7B,)[8^ M/2'MC,=W::L`B\G6)$&WC*6@Y-IT?=%(@#SKRQ"+E`D>I;LIORGCD"MMC%9U MQ1-"*FR8FJYBV3(E]5^FD\4]2MMVB=JY='I9'AHW(EGW.M1+EJE8IH:I[>^' MUPFBU]+N1PPP>1CYL18$@YU1/GR+SBM&ZQW&L1#$2GH'[T_`U'CHX/T!FA$L M3,0I`RI'U[5+T/>F=BJ0NE.9XAYAB.JP+'":0%+0!QE@);LGG.S!.`,Z"J-9 MX(J;.*C6=P+7L=RE;R`;S5SAP/SR!QQB3:B:ZP"UNIPHV9A&US"T854[%I3& M$8U\K)S%[*L^@'<2D6`C_^.%TKTTR#V*O(=-1UE1>>.PX1_ND4I:QB4,_;>? M\U=T-?X4..0/I:P+)4?K--"*N$OXF8T,<"@$2SN.C6447UK9$]>_3U* M^6VDX;HYX6%B"W8T4W9#6@WE9,?YB_G)SM&MBI.`KY#I%EZJ_,B,2E+3UW[` MQKX0VE<7SLR-Z*+G_HB?.F(E'AE.VW;Q6A(D[SR^-9!W`ZJ0FF`-4FF)\G22 MFYR[5.X375:J>+B7E$<>)14*:O+KN'HM3T_<(UES+B_&%-<&H%]]>2=-7OMR MG7>FNIM\40I?Y4)3/,4PDLFY//N_X4?-6#9=1C?5Z&,]X/D^8O.G8D)U_1+] M$F\:L5R1,[_R-NVK*X]POL+-C.`BZ)(8%=)4;:8J*`S,'ZES'1T?@8TQ.&M- M[TC1DU0DI:++J*#*<;T4BKV[K3:R>+==2Q3-&C-VI.&'!#A8]'4#TZ$8H?8KX(U)7OROJ4GB7S M+!/5Z5 M`_NG)!,G#K->)Z@KJXB$JW4\GF@@IW7%BRL3"B)A#-U)' M;S)"KLL\JHD%_I@G]4]RQX)W0.".J#N9-,WD'R@](%*]D[A<4XTF*(TVK;'3 MJIH86/E7F`=$OBJR<.*\11'6_"*64$832-^2S*VX4W&:CB\'J;=I:B%6XS,,G+=OW/3YJPL_1.=E;'95(.+0<\?1&8X MZ[UMMGO98K*&T3Z*JW2RA6(ZVKWU-S8'2]%=^9Z7@3O^NW)L2G%)M\-@_W.- MJ8_.7=+W(XR#"F4&ITY=!,J`!I/,FH^;K)FW=.T?9Y32/3Y=6D4P`'^F*O_I M*VL'ES'4RDC1;9RBFXQ@I-(DZB2\4RZ+BDQ!1OD MHAV)$)S(8$I2+!$B:2A#(!NFC%#)^QB9HD:)-4CI03J,<)GX/$!K*F,[E=F= MJ73*$)GEYK"1<+%7"2U_-49T-7]E@E(2_89)E&*.-IB)(0'5I4)JF7X"^K,*OT M7:3_%R72RECR\OB9.6#N1KP#=`,?KP5CRDG,-'/[CB?OD6UAE6KV\9D%0NB- M9W=R<1.)71/"-U,Y"YNG=/0FR?A5WYP@HI8[DKD&"AL(3HVJG"U!`(K"&HD; MKY(%W[LC3!90D0'PJM7FTUV\#2^7>4:H%2FF_5F`"Z89LH8_1@F-UO8AY85G M7Y0)V,H(>V:WS1&6DMU#DO>ADTR7G$N:\,H\U2P;J_,CY4SPG7A6H8M6V'9+ M9C\(S%3&6U90KPD=EX*O]X19HH/,2LXB!GZ0:]-+4`N($V6R]_@QK2D,D-VO M@U7?SV3*,Z*V2J)LPB/:6->);/%F2E)F!VV\C&6``ODK=&2MEKRM3S!)E(I+ MG3&5O;V3)9&I+'Y9YA6Q:9R][\LLP#@;)@'T2\,QQ5$>%?F);@_H3&6.9U2L MEDIH46*"U93R2L"="%N>IRF@&`<2,FR^-HBJL"/6;>)21ER4'+U"J M=;I4H^`"N`+TYC/2=`F=9<:W:1.TO!MJ0&G%@?XTR`U*8Y6OT=#DH1,J+X MH?@G[QXTN71-,1IPJY`5$*D[>'!/A;_U]2X;UX2U+M7M.`S2J/27`1I/+'_A MJ@]TXJB$)DL7TS#`VWJKVHS#?'ALI2N+^(9>W4!0@H(TM8Y(6=HDMK%Z#YXI M)UO)!$A5MQVMIL/J>=?MZ6OT^_."H[245(+WP3+1K@[8O_O*BQA&M;1\S%ZG MO!<>]M2*.D[*KX4\VN6E[<1( M#9.4H<_=D.QA,S,E\EY5_W'\6HS?F;KF3-UIJ6AM/\+XI2P6BA=@M"%]62;+ M].(->_5BCG]/&E[CR2.J%F1QS[W4_8%R*B^^@W1Z=*#*-JE<@,"5,W+L.O#S M6#%^VE*B?!Z]B1NJZ!@"DZY3@A"ILK7"PV779Z#$F:/2(V7V(8R%I:^R@'.B M]2]_!\>GFFJ6"U^J()YENI+Z(E'1/R3!YJ__$:U,@-$U/8<[?UE M.`I<.,/!%%J59NV#CBY5HBUAF-\=5URH6MN':O1@O"(ST9*8/B*#AI1,*ZM^QFHEEJPRH^.?0F6)XZ[* MO"D,G#Q%'CH$%R41WP/+3@JM5@*'$K=.SF\D,`P"AG&.!U(GJ&I+]%A3I!$5 M+L237J0@-^>$P!7756+>CUQ/9L'R'*\R&%*%Q6?3"%;'20+B2]"\R0I(^K-K MT/-WR)]%[4OD9HI)4GZQO"NK\R(TBJ5:[PSK-6IZPUC?T[- MX%CE_,)CB6E(7&4&_DMWBF11=\ M?@(6K$W<$&-Z)$EK^"S=S&:\)$H9-E"7?>@2P#%(!?$VDE!>0L3I@KD$79*M MB*`9UT[6L4[<2#2N)>PSN>-1"P/A3&)_-3T7,DJIW/0H1TW5M:L2)B&C0[+0>37+(P$4 MIAY;,@\[/4`,=0V_S>//B%UH3,PHQ_("5?^8\-<"-R1`8""\M*QOG^0"98,1O9K)&%0X@=VUB"F(C%(U$/B=^H';OP'RU6>8614NI$2GXNA1&:Y4"W(`0=`5"*B1N>>"5U!]C(I+ M8[6&1-E0I=XX`T2*#L0U:'A_9DT#377.(!V9-/LR9?#B**K04"7B>4HQU6PR MV^!.G9=0<%`<)^Y"$@[F'&UEO'^@%.(*%"(M?CN.X,B69O0,;,!$]<+;4'JP M)IIW]&;[>-[/$^L&?_W'SZ%?N3;-Q<=40#QAT`MXRQA\L"OQ(SBVW?'?O\+S MVC\FPOHHG3&LU8*S^!EH\1__(^Y(S<-WOXGI/W\2KOW]8MBM-1H5^)_1-&J5 M_ZG!-GR_O#KYWFBWON.>&/6&\;WVDV9-_OF3-?G>ZG:Z]7;G^Z!1ZQUW:NU* M]Z1_6FDV&B>5;KO;J_2->NVD?S(PVJW6=^-[LP;_J__T*_ZGTX-G&__X>>WD MY-RC]7XF`/7SZ6=J[)9XH/%2=[:6^DGWN-5IURLGIR?@\`X[#5C5:;,"C]7Z MS5ZK6VO7O^.#OR)E%&&.MN@Q'/V0[AJ\TEUXN?MPNMMP^D7Y+88;[W[:W%1W M64OBSY6I.;?LNX_;':;?-S]L.C4OM_A-^@%G)O8HF[$\=GIQ&T9_[$H_#_N7 MP\NM%[MM+^"YZ5U;3@7F^1'MF?IUY`:!._^(`84=&M2-[R)KBB)3L2@%X^-Z M8[KUYO5E:6.JP:&_G*=AI@$BTLV0TLV\Z(HYOCG,%-(V9!VM@NZ7[1@7LFDG M*N'XBE6GD]R-J%"=0]07S%7)"7!H70_'**O.L/T1C?&#[@N=8*8NN:.628BT MDT4D2:]'N?14%2]AR;$NGD;&,P&.KGP_,'^C5"NFI-S/^"`1($7F[_$%0/[P M<9I&IG/*(UHUR;6J>&6$H!37DL1-F:BH1#4_DAMD^6M;,QTIX.JX.=-2UZ6E M)DOY+9:.WB37A5&3I1T)Q"'+WA?5%3%NPIWB55E$07F@X.'89*84KZ9E?F%BN%,QS=>H9SXW?)O&V]UC(.GGD/107GJ`EFYQVRWBGDP+@X\TX<^Z.1*M;82+RMB+QNAEL\NRP_,IY$,2Z8HT8!/>W_J]'_ M\ACCH>S^G._+^?KAV\HK%Q&3YBJHB['F/0[E!=W*K,D>6/,1]D)0M8IK;K5GKB\!^*+K;7E7C:DT41EC&K]Q M8=Y)D.*DD0-U1UQ%TDH7K<7=*V$70H\RJ9;:*DG,)[*QZ"3!!,#8V2GF9^AEBTI@+=(ZX2(>+=+A(AXMT'G7XRQX=O\'! M>4AO[SL3&">T^0]P:WUB>G/BZ`&ITG+\[WX%3S;P#TI!IWJT9\U!;S8?GH-N/'<..K^:7\VO?K%7[W%) M!=J%U_#J!Z5_:9Y["S;*B:SM@VPEXJ>J:^#DDVSZR2^TZH\-8Q$\P1,PLI[` MB?#'GK5X2(^3761RK+S@/HJ/75ONK=%<-MI+M^CKMN^Q&1!+&W8FRX&/L#_, M9H=W#]M4[JW_35Y8RXYO)NW]R--^5K.7%<8(YFN)R=+?S``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`>/6`Z5MOZHTN1ZU+2U^CUVLR=ZS;I6CF#U0213_REL MVW*N`]>),ZFC4#;,YYY,:N$'VH5IS[5C88YGNG8*J[4FG$W]B'EP6)M5Y],- MHV[T^(1=7O(V]7:+P]I%6,LNJ=K1&QP7*S%]]7:[P>0M*WD;AMYJ\JW4YC$Y MK%T,7FWH=:,X#D0Q>?6`Z6NT]7JKR_0M*WWKM1H'/DM+70YKEYFZI0EKYV_8 M7H/8LBO1I1L&,^U$F&/7$3ZVV_HF9K+=H>SF\RGJ.8TOHOCT\,9T_!O+MH6N MG3D3RW0X>/V(>7#PFA7DDRG?JG$0K+3$;>N]9G'R;9BH.XILUMH<32@M>5DA MEYBX79T+NSEJ?2"LVF)6+2]Y6^!%\/U9:6(2AZDQ_WIFCM-VO%*2MDHNXHB-UML,R6E[RLD,M+W*Y>+Q#,4S')RT'L M@K!JDZ_3RDQ>UD0E)B\'LM3^HYVXHX#UTNB MGKU?,/LZ0L0^GTZML=#6M?JV53#[K7AR'AXFZF[MZ1CPL+W%9&Y>7MG6]QKTH.(A](*S:84U4 M6O+V:AS"+BUQC5Z/`>W+3-WBE--3YQZ[H37;L2/TR& M"GG$/#B$S1J38R9,W,VH$L4YB#)1=T/4+CNPI24NJ^,2$Q=SK#FWL;3DY=K\ MTI*VKC?;G')>6O)V&3ZXO,3EB"]3EZE[F-0M33S_(%+.!S/A!\(;>:[[M]8? MFQ,QO\/!\N+W_7`2CEQ'URZ$X_AW]HWI6(R3\HAY33CY[3&)RQ'N0C!JCQM5E)>XC1KG6N`PA7G+JXGSX-C)*PG=X#QP#&2TA*W:Q2G8FTO)"W*VEB3 ML["S)F?BED*3%Y.X'.TN!*-RD7R)B=MH<%^$TA+7Z/48,JS,U.5H=VFI6YIH M=_Z&'4QL&X8(W%N.;3]Y'AP18:VX`YO'9Y'2$K?3+$[FS5Y(6I2UL29G86=- MSL0MA28O)G$YMET(1NUQR4%YB=LP.->WM,3EV';)JW2#8.9\!QMX`E_#$-K`_B7\&!"9]K[4?7#ZL(YCLW1#]:`SV7?=*/!N7VE M)6]+KQ7(.V6B[H2H[^MZO;/G$^4')BNK8B;O0Q!C]&Z=PT";Q^1@="%8M:'W M6LRJI24ON`]MOA8K+7D-1@4J-W4Y(%U:ZI8F()V_884./R?QY[STZV_6C?`F MIBUT[3?APG0Y]_H1\^"8]8LK2>8,Y@SFC`/C#':G=G7]P>`&Y25OM\9'H=(2 MMZG7&0"7X^6'P*IL9DI-7D/O-;G59&G)6Z_5^-J]M-0U>CT&%BHM=1MEB9T_F[[VA[@V?1U&O3$GG/;^B'EPZ/[% M-2-S!G/&:[&9AM[J%"=5DHFZ$Z*V^8!:,+YE55XTSBB?U!MZN\FGV\UCE@CY0>2\7\[$=&H)>Z)] M$1-K;-IQQ!RF\WZ\'C"F']BF$Y@,%\-':M:7^SVG=-IC@:4E+4(ML8=<6O(: M>J/)R03E)2]'>YFZ3-V#I&YI8OGY&[;7R'T4KY>P-)H[U?X4/OSDP&P&KN.( M<6"-PP#'SXO?GYC.*/3N].7O%B:&7SYI:.H=!CLH+WD-W>"V4N4E;TLW.L4) M[S%1=T/4)O>2*BUQ62&7FKPMO5/GL-[F,3F7O!"LVM:[^^YH77A6/6#RUO4N M1[%*3%Y&4&?J,G4/DKJ-6DDBT`>13?Z'-?),[9/K+ZS`M#$F/7"]1>AC2'KF M67Y@X=!YX6CYO>A;1811+Y]LU/5>K3AXRJSZ=A_^J'%TJ[3D;>FM6G'27O9" MU**LC#F87@E7;>MO@8T-IR6O4.$FIO-2MU]C,,'69 MNH=(7<8.?[[(=7]ACF="^U?HC`/+=2(T%)C+A6W^U]3>3S9`H62?U;7^_]&J MBQ*YYC`)ATE>BXZL-_DRM[3$;>BM7G'(RT3=33BASIEQI24NJ^,2$[>IUPV6 MW=*2ETE;6M(V]6:+0_CE)6^!VN4P<7' M\K7SZ=0:BZ.D)ZAV=K8YKD_/Z]J??=J"HH3SRR<6'=WH,K3FRZ[RJ?/@VQJV MASO(-2H4-"=3=3=4+1!.#BMS5N:%Y(P2BGU-;[#D/60Z:O7&AQ' M*RUYX=#`-QQ,7:;N`5*WT2Y)##Q_P_8:\3[^=KP4[LZT\]P0Z_X?^,JMZTX8 M>>5%2@ M4W=.Q[%,6_MDV;:?`I99"M!O#,]_-GWM#W%M^KKV]0_:#`[./V-N2+O)U9$O MN\JGSH,S&-DT[J`9N=YE@)E"K&67)U&NJ"P:X[(R+QIGE$_LZ^#&\=5`>>EK M&)R_75KB@O!V.0A58OKJ1HMUO<"+C$Y.WU MN#Z'J5DCEYBX1EUO MLO"6F+XM!O4H+W'K>J_'B9WEI:_.2'@E)F^=+\J9NDS=@Z0NZ.5X'N6(V^?O MW%ZC]#+K7OO#M&UQIWUR_845F#:&X[6S@TV^+Y\L-/5>G=V4EUWE4^?!M15L M!'>1?%^@V"`3=3>>38.S3`K&N*S+B\89Y1/[GMYEP2\O>1L<)BXM;4%T.UR4 M45KR&GJMSMTU2TO>>HW1+IFZ3-U#I&ZCQ4G[1;@.@.F[7!!07O+V>DQ=IBY3]P"IRRC^10CG'VX\OWP2 M81AZA\L7RTO?1H>C0*4E+IPDNP5"(&6J[B8MO\4Y8*4E+NOC$A/7Z.CM+@MO M:>G+4?GRTM;HZK4>8T&4EKYUO5:@!!8F[^ZSKYFZ3%VF[@%2MS11^?P-*V8, MGH/PQ1$``S$$.2/D95?YU'EPT02;OJ=+?E/O%6/;&<:QPT[S8@^JJN_=:GA1?E M,H"C"QQ=>"UJLM/EXV=IB=LH5%'X7HA:E+6Q+F=Q9UW.Q"V)+B\F>??U/6;5 M;$F#7F]TF%7+2MY&C_50:8D+;B-?:#!UF;H'2-W2M*;-W["]!KA/7<\1=]H7 M,;'&IJU=V.9_S70P6_Y=UZ[^EQ;$H>P'S8/#'ZS^GMZ%CMM8E9>XAJ'W"@0^ MS53=CF#2,+^;/XMM`O7<@(1!ZK[7N!OD8O]S;VU11!P_/IQ\^#X-2O+ M'?BQ1H%@.YB\NXZ'Z44"G&.B<@";:JW#"?.E)2_'.)FZ3-W#I&YI(MCY&[;7>/55Z(]-1[OPW*GP?.!N<:6E+2ODQB\&K;;W+ MO%IB^NJM5I/)6UKRU@S./F/J,G4/D+JE"6+G;]A>0]9?72^8W0H_T*[$#]-? M3I\^GTZML="NW%OAX3OR`MA]F*AEVV[ADJ@Y4L*1$N8,YHS7;3T[NM$MSKF5 MQ9W%O4#BSIS!G,&&@,F[[^\QJS*KOA[R-KO%*25DXG(LEJG+U&7J7I)_FMY$&YK7MHCB[']8MFU>BW1T_=3TYI9S';B.]@G^ZNO:ES-:,4?9'S0/ M/D(?M'Y\NU>C5^?#2'EMGEXD\NZ%J$59&ZMP%G?6Y4STU@MUK,TG+:M%:]>*`+^Z%I$59&^MO%G96 MY$S;,BCR8A*78]>%8-1V@5J!%)-1#YBX=8;'+"]M.;3)U&7J'B1U2Q.X/HC< M[!/A"R_0_C!M6]Q%6-[:`,87'DSH_;3Z`?>;;:W7N?BSO$+;U-OUX@`M[H6H15D;!ZQ9W%F;,WE+H\V9 MO+N67KYN*BUMVWJOP9JYM.3ML%HN+6V-'NSD#%['#(O6/]%C&>F8XW]&\NVA:[]4:P.G!PIXDC1 M\RO&O8;[#;W!/=[*:^[:>KU``:*]$+4H:V,ESN+.VIS)6QIM7DSR854M,7H8A+BUMT6]DZC)UF;J'1UU.4W_)@#>U[US.4K^PS?^:!YJDSK$2 MCI4\OZK<+Q8+9]V4U_RU]5Z!JOCW0M2BK(U5.(L[ZW(F;DET>3')R\'N0K!J M1^^VF%5+2U[#X#+GTA(7W$9V(IBZ3-T#I"XG\>R%J4=;&2IS%G;4YD[H>)G4YL?LE@]]7,Z$-9I8]\823'+I[O_C:P+8<:PR3,@/MJM`Y]"]$+4H:V,5SN+.NIR)6Q)= M7DSR\K89^K>TM.4`*5.7J7N8U"U-^#M_P_8:[/[F^L(9 M">\Z/^0-<\I`FQPDL$GY)**K-SM<<_@,Y-UKR)J/%J45V'I#;]2*`YNX%ZH6 M96TI>X#4 M+4W(^B`RME7@>6T(>VCZ0834/3`]$:&98#";P]QB\&KAMYC751B M^K;XCJ*TQ*W7:IQ7S]1EZAX@=4L3QL[?L/T&K4U[CN`@#^L=J1[2M4&?ULE! MZN<+4M=JC(?V#.3E'.NR4;08`FO4]%:K.-=*>Z%J4=;&`6J6=U;E3-IRJ'*F M[X[IVV3'NK2T!=EMUQI,W[+2M]'A8'UIB5OGF`=3EZG[).JFX[:%('NC46TM M3:S`4?W\[2MU_OJEZ02F=BJT"\^="M^W7&?+^X#+,5#"5QCCQ4I;YU`4AZ*> M7_7N.^.]QU&HTKI+AMYK%X>\>R%J4=;&2IS%G;4YD[CR67J MJ%J4M;$&9WEG5U_6'Y@IN+:5QCS'HNEY>,_VN7"]/[VM2_GQYL3WNEKNO;U#]J4H@3! MRR*X[CLA:A%61L'LEG<69,S:4NAR9F\NXX-,G'+ M2]R>WF0P\_*2M]%ANUM:XC(\"E.7J7N8U"U/7#_]3AS[H['XL2:V_YA)@Y'H3X54"=X$STWS7MB;:_U>C_^6]XJ&Q^.=\W^-V@/>,]XSWC/>, M]XSWC/>,]XSW[-#W;&_?XYD^X7N[J^IM/%?"$SXXPA^NSJ_ZGR]IUJ-X-9E3 MX$'G*.T7=K%>U[M=CK*7C:Z-AMYI>LM'5T(T>.\!EHVJSVP8M7!Q/B>FZ(VFMM?5F MEYVFS6/NZWN\EGVNY9#S'QJ+']K$#4>V>*$`^]-?^+@]X%WC7>-=XUWC7>-= MXUWC7>-=*]NN[>U[/-.='9Y^#DS@M#R6M"U'5&8"(QD?NXL?OZA<"&316O*K M?-7'.GRB>%A]4JNV%D$VL^>76VL2S#X:M7>Q#*QG:II7-)?C\V\GPV^5P?GG MS_V+R^''Z(>?-/G2?_Y4^TD;"]M>F).)Y5S'O_L+PU'EI>1H;X0\"3W8 M#`WKDW3-U-XVJVT-GK*!6O#JA>?>6-@16)NZGF;ZO@@T:[XP+6^.U+TU? MEW8<6C92BKED#:TFQ>"26Z$M0F\\,WVR'4!D^,?R)I6%Z05WP#V.ZUGP@X52 M+]#J`&O`MWR!_+007F`)^NQV9HUG,!PQFKBQW-"W[[09\H3C.L!,@><")\*+ MY^9?/[S0"G`FO05U]E>@+>!4/=5>AY9K`U9!9[]$X< MW_*E9@`+`LK"P=V"UXY,VP02`Q7ICR=B+.8CL"8-X$3$,=)<)\-^$S$*B!\T MRX?'@9$JJ*)"#W@"?)O09^JOH<&T`.JER>IED=F^Z$HK?08SZBN'L%KJTFO] MP6HYN3W_0(=C180>D^N69LL'$K@><\8(?_C]Z]D?PV^7_<\PVJ=A__/5)^T; M_N??VMG7P?F7H7;U[??+*YKX*-Z]S%8^?#V5MMJ<9/I;WG@6:^^^GE\-+[6K M/+[YR'XU&>[W:SG7,#)<##\#*K[MM$-9_!1"U3P]BX\<]MMI9F\VTX./\Z./M\UK\Z._^J MG9^24H/7#R^O^E=#[>+;^<7PV]79<&.%SZ.,1)$T7[9`JOGNR<)W!;9_"H;5 MO96^H&1L=.>+R\2JSSUW+GV+],)3>\N66FD>.KH"T:^ M9/+GR*G\6#!97I;'97E-RV=:KN_5`6N5Y1K1[C3>;1V#CIZIKW]D5Y^_QE=O M5][X8@F6NTX=U,8NLKR#NF")39=NSI2XK:DF?NR9)%;N][DI>T]MW1&X4H'V MN\'[_:+[7=_K?A]8JPKIFAS+L)1&@8$<-V.S5=^O:GW2PO>4&2]?WNBU]'9[ M;Q4/]>>BP5XK'@I`5ZSY;7;V5D_(='TN>6TW]&9O;S7ZCZ;K[J!#GLT`GI.84*FHWW^/'AORM9(A;%$+T3GI\YCAR*@9E6XEAME MUGE/<SW9,WNEZN-AM[F:Y;RTA=/ MVH>GM9B\VQHEL$H]X^#H>P#GHQ/+7[B^:;,!>NX[D9IN&'MK:%R0.Y%2TG5O M>)4%(2H'\DH7R,NMQ%MSA'H:1,PN88NXC1/O&>_9(_;L(*,GF43DW(JFTKJT M^TU9W2_X>ID/VYQBSG3E%/-2^:0,IOAB?:R?`"OB+_NO6T&5WB>DMTB?YX',Y#VPS$!$Y7"_BK)?.( M&5^B*/@2&Q[9U>>O\=6,+\'X$CLL1/N]-:^31JG MW+'`O\J*)/@.>,`SH*#T/.PV=N=,#TX M#B97H#`;\6,A'%^P&7S>JMVFWE1W%H?$VWR6VY:^=;U9((`LIN_NZ5NO'Y[\ M'N31[!R[S[(]>E9^+D[(G174;L[9S3UK)SYD\U&*"R5*653)A:B\9_LHWBV@ M;\JENGLZ?]7:>K.[9WR2B7R/TM8/,DEI[QK12O4M2U'5&;4 MAN1C-ZGLRR_TJ\,GV5J-6K6U"++^]"]4%_;12%71KE]6>:MX\Y-2E]DF_;K= MU>QB0>G<]`/A:;8P?0&K#6::":^]G;FV?5=Q;QTQT?QPY%L3R_3N,,'V]T^7 MFB=D@6G@:A>F/9^80)PO8F*-31L>3C4U%S\6E@=?%-.I&`?6#9PE?!SD7Z&= MJ0[!(M.&9CH377X!1@EF9J!-X#6Z=BNTD;@V'ADF M/0D]I#?&_70BV947^G@@783>>`9<.Z%/YY;C>DA*Y%G/GUD+S<+B,>$'OC83 M-I#^#KYH>9/*PI2-)>9TGO7A>ZG^2MI[5;R$W*CUPVMXF:R!_H!?O)U9XQDP M)+[?$S>6&_KVG1S?<9'5`@\D!R<\-_]:.Z&JUO=)SN"WT*:\=5B#G[N*:)E^ M:O4T-S?T8(18.)'IP;/$)S5D&!Q4F##9>'!:'CZ)XTPM!\[V%@FLG`7\S1,P MQ[$=3F!38;'P!BTC/>F'_``^F@L'5O,TL?EY8MW@K__X.?0KUZ:Y^/A-F/:0 MQN\[DU1!>[J>_<3RQ[;KAYZX$C^"8]L=__TK#*C]8R*LCR:+>^ M(]6->L/X#J)H3?[YDS7YWNIVNO5VY[O1;P].!L-6Y7APTJPT^[UVY;@_'%9: MIT;S^/CD>-`?&-^-[\V??CW]]S]^WC@G.>UH[0-WCBDJM$98_7"^L-T[(8Z% M(Z96<&&;CA\O>&>KZ9_"`6;0.:FTCGOU2G-8;U9Z]>/32K?3'+;:Q[W>2;/Y M'1_\%0FFZ+6-UL.B3MM<^&)5MVU9LK]EC"Q597ZOVCL]_WI5.>U_.?O\[X_: MEA`;G0=!;.3-S'BW-)DG'INWTO"/6.K9U\'PZ]79'T.TY)_[7R^W7OBVON27 M_K??SKY6CL^OKLZ_?-00EN,737UX=7[Q4=L)4,2ZU]5RWO:+=C7\WZO*V=<3 M6/I';3U6Q_;[&9NM6@XBCX]6/7]";X+%D"(:1*]V>@O,%IFZ!!,Q<+S[U1AO%W!T;U M?-+9GT"Q@H>'^A5L#+S3G4<6!2<*?_`#SQJCJK\,4,'@9+3W,$SBGH,:&?Q" MW\8_)A^>_/(!S!JXA`$X8C"]3DL'+U].S`>+";;%#,'+\F"3)C`<.G"6[X<4 M88X<,O#-%OA*7)*9C-7JZ-UZ2XVE:XX(I(\XQH=!P5`K#EV;F3?H*0J'!H9% M@.W$%P3HJ.)>@/F=^](@JC?AKC9Z>KW9PH^E=:=A;F`K8`3IKJX'1H$EKPV. MTQ?PO;AT^,?HZ$8G6@48W;EI.TV\UM.[K1IZ-C%#RVV'W92V%-T8$`'ID:WG*<5)BH$R,N=.8124-T6AE&.: MX;J8);AFFF& M6\=NZ&K%#(=^DCP2XY]36^J3BQ39;7#8$G(0%7`41U0"(*'F+P3M^#AUO-/, M6W#E?&UN3@1N%GIWXH<8A^0'1MN+KH%#*&_7CA7YC3`3R\.HFNL%DAH4>K!& M(=$-GX`/'(RY42",`GLWIH?Q"LU,]2_3P&:G0A`=ZXC\AO!)8@":! M>\J2GTC^GR(J9=&D"4&.8PJ^*XV,6D.(YGHD16,,2O`J$: MG!ZD"TI1F`F)$M)I06&+2%1HM"J,<99F-\EL,N1$T_(I@HL<[*$4941`K4(* M')U;?EAS>*5]AVJ@AT<('7Y2APGDD+>->B_^99+U_Z(HLE2)N/R%##O;=Z0H M4DZW>C%RJ.]B3$E,:.)2C\93!_%>F5;7B-]_:]DVG#B2Q>'&R2%2[UI1>4O; MB4=H/,V31*3/\]+FI`_0=.A?.4!K>&ZWD(^0)5*2C9(#08SQ6HYP&7,G[]"M/AM_\[-M@Q4+%%[-67%=A8/G:V`Z1 M@E8N`!Q\I2ZA^>6,5HFE/;R^>:BU'[B\I+"DH:/J\L>5CU`C?3Y<]WH2. MQ)%&D2=BJ2SPUY30@$_@"16/UOH@E=F](J\HFJJ2^CPCHTOK]3.,8EM3>M:H MMJ/-10JCFQP9WECG6[G6#Z-"2(Z)A5=#@8PJF1JJ:0]5N*4@B[:^9HF,7>I2 M1TY-`QH1VN_:+5\VC:S\5PY1DF)3H`60+_$]4?UWI?I?#;RF568<=$7%`O2: M2)HI*4FS=5HQI;26/`9$6A0%RNS"O,,O M$3A6GK6`6:@#TQB]%Z%N2LDG6ZA#`C%U-%!@)2="$O\@I?M(K",9Q,UP/:6M M\""ET;T./CP7($K1R0'.&\ZUD+ME_M!L\Y9\()BD)Q>HJV-?M&`*D-,VBXD> MK3Y:O#:6%>!X%KUG[>H\*<4HOMY-%)_IR:U4ZH^.1R8(M.N!B9IJ>"L)/]W. MA*-7)%>H@]2R8PQDB9Z.#LGZLBLM)XZ[@Z=)?'\4($==.AY[81PL)_V4O"'. MX8!G:._(VL3!`WQ^C4#-HUP/V*.WO:8Z"V!R-/RDW)&WAM&6?\BLB?5;K-\N MTWZ05"O1"3_B)]CV47*VB,[VJ>N4R*$AT@D;]`_:8\LA00$/PL\XC*&7)6_L M,I)?#$(Z-Q-+F9(#>>Z*=/SQ.6(]9*R\/#I-?*9S#&*%=.J MN"N_&(-:E#@Q!^<.+Z.0;R6NOK\MSOV+,,Z.;]9[M7W5[?Z]^]E4_".I^)>\\RP-Y[*V8+6)OE;&IQ351OVA_GIU07`+\U=-^ M5K-VI\GB9'!IZPR/XJ#+EX(\0^4F+Q'H3W4GTV3M%VC_F'C[(=YO MZ!,MTR+^]1L>:);H]_X3T+7RV;U]5"Y98=L+*+_G\_`4/%8#"U$S/FS%6%.& MNKT+J^I0]0WMBPIE$+8H['I`8MYS(FYL/XT677H\?`I+SL?.]J(P&FJGQ'Z. M.L;MW]YH5+=I$,PD/F`2MZNMQL]OZ^UJ[0`I_33,A(RA:CR'H8HN4T!B75:1^>DCHL6N_7'-4[U7:K-.8H\]++L_\;?M0*"Z&@ M3M04K5X]3N=H@:>6M>_TA3E?Y_WC_2O,_I4QQI(#N%C$ MWO,!O%6MYT0KF<0E(K&*L?2JS2U`\HM&:8ZQ[)U]"V*.WA?!''&,Y7D/X(>I MI`Z+UGN.L2")2V...,92E#,N[Q_O'\=8=AMCR5'0[-3N-L92*X!3RQ[/<\=8 MVEOT?&(2'S")98RE4:O6#O"*F&,L>V??@IBC]\T"F"..L3QW6F6M.=Y!W<)U^V+JO22G1I-8W7&A*A+(,ZF:,`Z=P&E5'#VP<.!.5N>L([,-U M(\$UI]K;9E,WVK6JEL;5S\!%KK[CZ,TV;TF_HZW7>YEW+(.G=W>P$J/9U7N- M&@.19;H-1COL((Y8Z"@(N1C/]MY>*PC!*9&Z"!8.!?'H303_AP!^";B8.7+# M(!YZ`ZSHT9MD`IM@],H,#2:;;BF]^QALL.X&M*T5?Z^0*%F/(LG+'AB*BX63 MPN=*X=VD0C%+?X$/DX4/$UFD98_B#=CU7C_P&%#X6%<"[\5!*@Y2/5+_[8]] M_UQNBQ`Y6633(VBS4G(V1^1V$:CJ MS09KZ^?7UG'_A*,WLON4.0ZPFP2V3B@O=Q?$)S&J!Y_V^+H#:1C*B/J.X(EH M6:A61$KVF[K/99*]I-9$/8+4.]>.X*<:I4RI>4-R7[Y5H.1(-0AX':CJ3PZ= M=!H/#YVT]H=M7N97<\!H.6!DU)XW8I2.$:FXD)V)%!4U./1@0[OF"NM^B/UF M=Q$\Q=RLP1R'T>Z%#V=,_9P-9,C\?>Y^=`I94A,1-'ZN\EC^>`FJ_6*E0P*1 MF"E\`!3^%KG+2Y\/$N=YZ2^?\70:;]1[RUGZ^[^Q%1@#]#\PY$,)8,D"*^J# M(EF44D8!BH#04_KXU(,:U+2.M:M01E9,6S4I2?G+92^0G+;*5V"T#% M5NKU$/M`:P"8UH\1[.H!(MF6K=JC/,6FO'^\?_OW,J?)]8-_OJ/GT._KBTKM2#?T*-PO*BBI?24="'/UQ M%$=7NF5:BF%>C2W/\!0Q1"D`KP M-ZBC2.L&V][+PTOQ^NSG(AB8/K.(%Y'`L.S!N?$^.& M710W:#N-(\+.Q]\?OS$'&'ZRX@`2OZ:%OA>",,Q*H!;&RDN",D?6!*,`KG6;:Z,@J*0,BNBX!Q M=))G,X%F91ZR(^,1`3<8(>^S";(([L_)/,O9K+FHA'?9-27Y+=LY'*?SLJB8 MCWNDPP0>#G*L6@/$*6XR(;+.9Q&"3)8BUK?%Z+7T/WA>9Y@X:IW1=172#OP0G,P.DPX<"ENR49 M0<#EC"+^,$*R?QKPS`W-Q\6P.L^$^#RZ\!>U_S^VI68@VO.HO<"GU&0H,MN M$IGC(YAD8LI<,/N&@J^/(B8%9CO%!IU(F&\*_B85*Y;BX.,B/4'.3U`$"4$7 M#X1&7TO6R(-'#Q`S_+H,;A.0;I;3JG='PT-L8UR\]N%,E+0FI:]E=,.OF@7` MK^L%_)L&-U6`Y:J%42='1B6@4G=U9\%C`&IJS)T;#P;@#?.(^=-E$Q=.+2," MF$H+F']W7:D'\`V.<6DG,W#]-S!UNI1^5(6?^K&=Z^4K0W"\]P)C%IH8?`1^ MK>42E5KE87M*TP,/&`9YOJC.&LS0 M+F@5@[G?0F95'!<`D!G:"3I`\JW2 MGTJ;&QJ''B#)$)35%`VTE=RQ?CP,K_`A`9["-95*H]WC(@O3MPEXF11-@2L@ MG]407%>J=4&(\"5CH5$5G76LXT'`B^D\J[YXSS1J+1-0JX2Q>*43/ROZL2;, MXB1!%Y2"#MZ@SP+UPT-EX-'7';BJ4)N26J3E@]3DCS>"YV)75/Z`)0%\;LLT M($:MYNK!S8/Y1)'Y1!;>T0!HF3"PNE*S.8#H*3AJ'!B\789I-H(PDM-I/&=Q MC3LJ!O!FP5=VA8A71`SO/:!$]ZL6G5/V9J;/.Z6<3LZ9L:,17Y`JCGQW:E\" M4]E=U5!'P*<0S#ZA?QR=?!G?R_U5?^RX(T\3#=M21,W457%D*&-1]\>2JNBF M:SH6S_WE-;W;)]XD\"*1"L.KB@)W=S&-I:9TUBQ%^ MUHY-S'\KNT7+1!`W3TK*QE@]#`S\6*U?Q_QU!B$`L0$,@6X8P,B"H:S*&\]S M\;3H#L_;ED`+3V"#F$6TZDUC[&2NSK,N#'F3!'P&CWGK MG-/]'>),7F)X^(:E09;ZX2T9-L>KNXKU/=[OR]S+K0>,ZDUGP@4+H@$"DNT' MAG]%*E>NA`&6W;YD2I((H5\-MU7,8'Z&'2#AZ>0[8`KR,UK%.=XU#O(*0->_ MXM45]]8\!IS('G`+.05\9!))178<.P.AL9K(U];T:I/+@_1FY20M_1<."&W] MEZX!\R%#>*ARS`E\U/'E]7GE;0>CEW]L.O2S6I-JELBK)ZC?T1I.V]\AX[?\ MZ&<_Q,KU9JF;JXTYR^6.WQEA'W1[OGG)MH.K;AT.^Q+,JJP;S/NW3V==:]+[ M737?<6BN(R>?B7VG2W_%OED?>IN#I\O!4;6^7KKAUM=+7]<>I/+@NV32TX.3 M!RO0LSR;$PQ_IPQ27R^X91R@"-Z`,/S)!#.Q6TS`<+%QKU)X[LV,%0Q)R*3X M(!]+$FYGK`-RD7_YO:SDD/PL2&91`.CE,XFP9/<3'M9F&AY71^Y[ZN&?1/6+ M;HOJ/`N[PQM36Y#@6;GP2\]\_!L0Z=*W7"5G48*3+REL'Y\0&HW[\(G5Y4]+BS82M M'@:IBR`M`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`?A[45X_\Z#M&C+8O7Q M/$COO2K\W7]`KN*G[&YXN??C8.-HV8)TPQ%BF`U@Y0UO`>QWP>?@7EFCR\,K MJ%Y>V'M^!95Z;-F#B-^TB/'EN+_]K!C'T@%*^AG?[ZV^1*!:`KIH"$Q*.WO4A'`TUEI=-P`_321V6K/=<8T$1OYEP--18^I+C#OP;^#?46)ZW MQK+!00^@]GEK+%(/0.V`>%ZZQF)T.*$VB/B`1A".AAK+2V^KE,S#L]AR.,0Q".M(.4]%!CZ6N.._!OX-]08WF, M^ZL?&ZV.D@NWA!8D@KD$>!Z<8UMVMCJ@0C81/!(2=DYRQ0AU:QN$`?X^4ITZ0[7:2F%+CE%`2>1FLSE)*6N7Q,=PTN@DQ38&\2TY M2X*4G@'H#Q?/UEK*571I-%9-$3[IHF:YNFCI%OSEVV/-5/31"&Y[AM923_7Q M2=6#@;%79,R"6=3YQ01SO?+*6S'\MEF+QHNT=-IS_ZW_)9#^((\(]LB"H6ZP MB848!041)D&R`/46TJ5;DK/^6IA308X%8\Q) M'F?1L0"#YR3,;E)X(+MDZ^#8DJM8B->5W,*:W%B*%H1A5@)]DRROFH(5,!0- M0I[.8;^VFXH`'%CD`[/AA!DIIC";YQ/#P0O](T*,14"P&FI&`9TBB*#NV[(L7"2,DF[(!8L/[!A+PKXA]\& MLG;A!F&,O=7>UY_5%OM2+?%!::OG&VI5&L:0KZ>D$.(4;L2N;S@$#C[/,VSU M%@G7"P'[OP:HEP(JRVV,O6`?T(4-[OOQ'KCEPM%B3B@M2>25.@Z!:X\FC2>(LB4C\P0=N%0NWS'/@VSF99SE*"-6D MI,\7NE3)'IF2(5J>,Q8U5?5$R[!LT9$5R7,\5S9T'0A#JB3]Z./_$?JOWQZ: M7%.JR[9,51LFWEL+0CQC0:WL!)H3AR\B4%&]1[8GZ6-3]6W1]!1#U,:V+#IC MQ08&>*;A:2/;E0P@6U&./LJ*K9@-H3Z*HDXJ_A=Z8O!#[)>`]P0ANKKJ1;8]&2)!\X@9JM.;[HC6W/<4`?'%^_LB7)O@*-D"3%!([8 MEM9)S9MD-3D!.A,LF+L#SI&PS.%6N6`7^JOJ.* MOJ\XHN:8`$P]71<5WU`-R;`U1?6YV[+4ID0W3+Q-69@3X?^>I.RBTV4D M<8-Y7`3)%])+D9$T6L^6V0G`4QQ+SJILVQ\7R% M%ID!_0GDTG/"&^B2"Y+?QB'AEG3.$2*+^7WV#O;11]6V&VQ]9?8T97-6F2@\ M&1L3YR!41.`<9O51+]&]JFK3T^PB8C.YIQ.OZN/;2RI5`]1$,65K(YFUR3>I M8^:("I*3*>@(0$GNG3YEE()5GDXN@V]G"$0`;Q:@.=R-A(]US(U3P-+L9`3Z(94N<&&)U+99-FR23>,=QVG MS*HN"C*O=>GV65*Y=O>5BI%SR$4""E$-9?+O('Y=O],1G\D`215=DYH>YQF) M;J&W(`&`-SDG0>)33-=>E2>2-E84Q3-%PS5<49,T2[0].)R[@F;B7L5M5,,CHTE8TUJ"@Y2#S;!(7:$I] M#J.J>O11EW6]Z1C6I22T9<6:L-O1R5.OWJ'8,59%\ M"S)*RP*%]4=CT?9ET%H?G)]C.I:D^%?*E8H*JQE24Z"/H:K)#[1;Y-)IBEI_ M.JE>;[/`ND.!EC^?O78TZ.K.#(S^DJ8V.-&-GNYYYDM54KIG)=V**?+11TT# M/]8MS=Q13&E$UK4+Q-M8<*@AU-?U=X:E.ZKB@GUXH!6:;8H.\$54#=NRM-'8 MT$8./$.7$";`KZIT'RCL)J=%_S*360.*7EH!.@1;TIH@>,/D'TI(G3#,0566 M81Z2!!+?(E;J:U(*A!O*`SGI+J*:#.$@YS,K[*\S!E08?'O'VJMX,9UG-$AZ MJ0N0#]78\5B2F@S9`*J7@+J/N8'.0(#2-/H=-#R(_$=!?@,L.BOS<`JZA.PZ M7ZX\1?O`![ZLF[*KB(;B*Z+FF:[H**8MZKIICB77'ONVS:M3B/&EAS!^!_(V M9\OC+(>8&A(2T7&>S3P"NA,#D$S7SK7^DJ,^N@Z%@2AI8S[]2/+N>=7*VX[8 M>X60JZ?Y!C@2$PB[11YD.>"R(%^<%&1&G31RRUF9!+CNX[,7#0$P=_@Z)9;4 MIKA6]KH<=3R(JXKK@--!CD+V+3JR;8BJ9&FN"QR6E=$5/(5!L58MZU6XL55) MG>@6ST%?9LYD`GCXM?//KE',;KCLG?/O5M_Y,\WO>WA`?K>,D=3)8US9KB/" M/KMU4"Q1EO5.-9_OIWSS,@0677L*?C0(=W"]M7$5HIIW%WQSL7H_V1@L+PWC M(*F]/NV&;(&P`&".YGH0[0 MMF9(K56ZQJP?L.I1&2=8O^RG^6I<33>G$_=IV)8Q8+:Q.8#U4T^!;`C%;032 M@9JGXY+]&7%'=*+ABJVM/1F<[##[':4-^)24J&L;%SZ_9"ER+,^2A-4'>3#I M]0+/8VL[W\.`)GJ)L#3"5P: MI#N4VYIS\0RB@6AIG6IG3Z#\WIZ15?&\OLWD2U80"JB8M43HH=;A+I+F]I$'R6C7 MC#:M#UQ.\ZR\F8XSB,!)AINE7M?F.FZ#4AE@M5HUI8X$M393^.[R:.+)R4E] MD)"7\W'G=P.0K/[>1W"VM=%XC,$9M$$2-5?5Q9$Q5D1`&([N^I(U9LMJN&*D M:7)SK\G32=V..GL9O67&A5;\KL]Z.SW[!,\=`9B%X-FRMH/GG9@9W"$&\+/J MH-AH\2?%C0>K\J6S.BOF9KB`5<)W5:3JZ3*I:D/\`*_06GYY&J';H\6&_5K` M\/UL0>M:^[%P&4)MUWZZ$[4+S^/Y&"^F;+WS+">SN)SUD0=\4[:R`])O(*23 MZ?`JR4&:#A[M@&BK6ETLIR.=VRT'-_GA6O%ISM6-EYKZR!<5#<963&VKP6RF MY2&OP6#M8;D.[$+2=NRY$7JPP3Q`*N'KFTQ'A*4MCZWP81V]VWF?[Z*]Q=:[E$1+ M@_L\2LK:%B-S';F?`I2V\N23[K__$E>2OM&VGHTN:HCW3J]X\" M;Y[\QE!`BW6P6%4_^^BS9-RW95B6LLFI;Z2BHG=:K%=V<'_;9>;/YDFV(&1$ M4C*)"WJ9ER^YC'G_8([FNH;IZ(HH>R,3)&NYXF@$",=W+<57_Y^]:^UMVUC: MWPOD/RR"!G``TN55$EL@@*Z-B\0V8O<4[Z=B):TLMA2I0TIQ='[].S.[O-F2 M+#N2=0F_]"*3R]VY[^[,,RW7Z=8;,HLEO0G>1G+-AQJ]92D/+YYI/ M?L7U?W[C_2!WIW#O788NVQI\2Z/1]'KU&N@BR*KNU*RV[C5!7-M&O>[V:F:S MU:IO`WEL!_A*+1%$]PP,@H*D&E`F/P%G%8&0%&Z1PK1BGSZUDQ3H"I[%G^?A M4()KP2`2(DNA63$^6P-23/^T"3@+_L,Z9PCX-.0SCO!8ZFL+P6,&L@U?6CT0 M3C&8#V&E^,HH37J`86*1S`-81CI?AU07,`7A2(C$,DA&Y3.+W.=F6$`W>6TDVJTRV M:1S%!(/%J5`CT;+I2BH0'!I,&O[/C]G0I_.%&9[5:_+#]Y$DY6P,7*>*^QCSWW1)J8Z^Q;$P@?$_T8R2L6@X* MDEMWV4<>#Q=,FH:;2KP2P".LG!WA\4$!MEF3S`D&Q???K4 MO+[I_@IZ&P1\FHBW;"""()ER/#$E[X+_/^7#8?K_]_YP-H:/&\:[#$874^9$ M_);UHQ@$#!\K8D[SNI7MO7[C_CIS3HR/0,(>L_@TF4A M3]7J<;^`1P0'+0#1#U&Z'\KV2T$[S3)H9T^9U_]#`]9=9U[7@7AN@9S/0X6N M),+:D4"@_S[KG[_?*[M_;/K;9X.*_GNDOT7TSU9S-MPS-T[-^+V^ESM3\3^$ MQ!2P1_,$`NODL-AZ^.U\TNJY]8%]U;GCI5\WZYKE6<^?PKY[=E0\WOSKEJD9 MAEGQ^,1Y[#B-X^/Q%CLA[Z:=7'K9@6>RZLK_='W1@72%JVGUFG=\LESQ^@73 M:&AUPZUX_8/PVJL?82?`X]LUE:H58-L),^"%O-_*@>TZ&M.\VA$&8Q6O7S`- M1S/L*ECY47AM.D?8K?C0-UD762)!*&:5<]JY$%NUZC3HQ^!U3;./L2-SQ>L7 M\=IP:\?'ZU/KOIW?)"^1C5TT/G[Q!Y<\7M&OHM_!T._XSETN\_ZT?<+59@CD MGK`(*U0XN5?/,Q8K*)@1<'5]N'0HM>K.9@LK&S&^K0P"V5A(@^"V5(H MR\ZX2E:NXMD=>$+'.D)/6+'X.2PVO"H!YL19;->.D,55/'NXL41%P8J"^Z;@ M\9W/EB+<(SR:W:Y+>(%3?/#];3I)118L!CY$8AUL8%3)1"43IQ0L-S37.H$< MNRI8/IQ`I:)@1<%]4[!L'WXA**HU07"*3V$A$-8*S`KCW)W.9.K%$IR[3Q>7 M7?UC]^+WCQ`[-_"7ORXZMQ_!#!DYZ-WJ]>T$*VLC<*SB-J&`_Y3ZF$",OM?% M+#^Q7B5"-(_M?7SU*;M"L%N"Z:?E&',IZ%J:9R)XC.A[_06;)S!&%,*\8S^: M)XQ+T-F$3?A0L)F"E8./\NDTCK[Y$SX3P8+]W+`=#<1)8S^;Y]X;Q.D+`E4W MA#^YZ0\:P@!.$=+V*[RW!-CM.?)^TN+5WZ-X-8'?&28C831J[%[>X=SQ$,5` M(2(2VB`".9)8G'5$(N(9^P\/`K%@G\70'_"`M0D316,W/"0\R1[A"XY$DE"_ M8W8=\/]Q#>:1B+`OXCO6'OO!,!9A'KE[OR79$.<1QEF!!_H`#91T$_[Z>,KG,,;MIG"?F5%9"?@S!G0Z&,-PB$*.J206]H*L\R")E@F\7!T*6GE]USR8##F8GDU$7JX92;&9R(^! M5;-(P\>Y6C(%9Q"N)/O/CS<2`?D-P97X,3R1\U_-K&2B%:%6NRH8:1T=[OE#&.O5QJ"`A(PL MU&CEZT[F]-J&2*QC64&S"I1 M?6"+,!Z!-[#_@U0GG)7T8B1T;WY:-]?U,UTK[Y6C7>UHAP?F:$MHWB,_ACW= M?\%D8!`K09"VZ>!DG'$;(D,+?:VBTL)DY8I874\5@XA-E0J+1R!^`Y551 M>:)4/!;42(IARR#$4J=N.>>LM&E>%U2_*4";EZ+K(E$>VRLT_DM-RHH8_#OU M[!?5P$"V9]A:-X:\P<.M`/+,O@A_TI_'B6Q"D/9@[H'>[J'%](9M2-RW'^J& ME;6NV&PA^<(?-Z-.1X#M+9"VFPSBZ#[IB&F4^#34=2RFW!]^H3X-!]A^!MN0 MZ;9A9R3YOB6N(Q4^\`5\B__U4%M!8Y,:UW77T**\AJ=:GN0ZUDL-2D&[4ER" M?30_KKMNO68Z;;W9L)JZ8[B>WFA8CFXU&Z;CM2W;JF1E!MK#,[Z/9 MH306WI!^H%R65VM\%_V>[D,,`V-WT8Z?S&*_/Z%\, M/_F\C^9M@2VF>/C:YGK37IDF$-!"^BD";F&=C_M*(5<@,D/5QAOF;5""HHFD M2(2+R]Y+&TF!5;+S=DNK9IVO*VU-?C7*Y*D-,2%:\61'#9;L1K?>]+HX]2;H M0[/>!??;=/1VK^MY1L=S>[W>@398NJ4(.`BB>Q4ODW?*;D0X[(%1/1=I;!AC MJ(8[7XI"?;P$8=2H-]'8'?!&@GG2KAAW_/C*(*4^T9O[8;YM4PWXFG>QH/"# MG0UQ'X0;]/P@HP#P_>OCT+#J>),.T#"JCC?/+PG:&O[[SO.0#K?)0FI?:=K] M;`';IM5>QCQBT]LJ5X\MCON7AG8^6/11X#7H/`>=XO2.H M\A%?C#=@N9@>\?PY[#LC<1\&[,A8VS`UQSW"^LI#KR3NB+X,K:,9)10,^-2' M_SI=$_4]*>G;SI>'MYF[[W+#=R=EI@Z$O;9QOF\_M#E?CR^J(JN%9^AX,84G M`C&_PPLE.CNH;-=KV*[2=.QSP_AV?,ZY,FB;%\:[Y\X1+ M[5]MT7VNY;7U7L_`?!+7T!NFV]3-IF?#6U:GU^ENXVKK>WD4J$-121B9E)@1 M1^(.K#@"W>0"2:_MY`9ISW=_?X8^Q.$)G2+(-#3V!?^U8#(IBMW&\V1&N6A9 M)BQ>E9_)7+"\:J3]&SV9_]#Y[3WS$Q;%=SS$FWV9B/N9QXL`1Z,$-)%@SA5E MUZ6I`&R&PYRSOX3Z$6__QGF"'+X[GL,ZLIV$2FG#G,]"YM4\CF&T8*'N,;$P MA0_F,]AXX"CC**$3DP2+KL;R@IS$!$8I_`V6K,NW\J'QU_A.Q`LFC_+AAU$L MA`Y+"8?J[G,BX(EPL&!#,>6Q3#?3V`!+;>CSZDU:3#EA#W-YTY0]RJF.1JPG M^G$YU]EJ4#JJ2\G58_Z5TEQG"ST*!1$6YT"D+1`665%(=DX8V`BNTF<%FFDA M@*;X$J8[8JJ>GV!C1IC!"Z]<=Z0Q^TNB?7QKN15G7E96;R8EVUL7UBND:EK4^ES79V/0R8+&:PQT@_)?B]HN$X#OHUS1GY"] MK=0<5WI1Z<5N]$)*?^@%9S!"(NS9*5& M'RLI'E0B!#)1$OZM,B4IL4VFA)X5(UPL!2D%N%C?!VI6:5.E3<>L3?,8JW>2 MP3B*`@J)'NU4EM3C;%W"=Y.AN>?]-196C>9X'O&F5/<2H&3S``N`P2R- M^-APTT&+)HX@]POR9KF1-5IB9' M576O?DA[;%G#D:29M^$<4\=P-E,130.<@)A,@VB!F_5P^`M5>/LA;'?%$)$/ M;L8T)M4;1P/888.-!0/,%_EG,-V;/C*D)\"(0MP1XYZ2<#=+DRZ_BK".>T.[@`<@`/*4TO2D:! M^0KG"2G%5DO.2V[D.01XG(MP<+[LZ[+$&PDUC698-<<#^##N MV]%_L%#<<:H?3J>LJ>K=\?.:&B"5I,)Y#,PT_E?,8(()B*4(5PEF6@_X4#@SH213(M.[ MU9"/Q!2(@C08(E%%S@U#`O?<3'_9DLLV!X7TV#3'DR(W`.))LLE`=*P2!AA#0; M4HDYD@1'R#@ZA]E^C.[Q-4T6I\.^-$2U#R.0>%`RS*/'Q:!ZY107:RCH@[+@ M1]//!8N"FA.M!E%"5>_@D6-*[T]2S:93H\),%0MP@&S..$)*KEFD"".*JG(' MH\[&69&W_(P\BP/V/>4V?BA/\)F'_$Y6.!",P3PD[@)=I\A@)?2R;`(,ZP@8 M14K*Y1_`FI"-&_K)8)XD1&,J=)9B0.Q4AD/Y%A#GHL,!I@4"7A1T$"@?]:G* M(N?P1(B9_)U%?0@PE(?*BW2E^9$VQH^E;<+%$'("BGB^RC*@$-8HHZSANTIV MLMO3!':LT01G^$:!,@P+2I[[QUS,&2W46ZYK[D_O`C;,N'O&O;S0)`;,9L%1/2KT0Y+NC8O;G-Z=MMP&SV]81A= MW>FUNWK+:7;U3L_K-)NVW6EVW;\]P_#^-K$4V6J\_>`Y67W7EE>>DW3-2\E> MZ;5A,:!=+]'I.LLUG)YE69VZ7FO7VKIC.`V] MT;0;NMEJ=SOMAM.KV6U8KO/V@VG7ZOF"ET^]4,XH^K,FN%*(,*_"PB-8(IF^ M>8A\=8"O:6WC!DMXJH"X@&S0CB9]++9K\0!=]\T8#/Q*>(/M71AWS%ZG:W9T MK]EIZ8Y5K^M>%]2_:7CUEN6Z;:OK'&@M9$N`0R)'(8/;@2(@1(A$098@"9,2 M/)-TTJOPL=[\M`1B3B(%K<:.2W&5[*K:<+^KFDNTSQG"\;[8_6/3WT;Z9S#`E?EW-I9AE4&Z%:T^82/OB^HG#B2-.2=]O;6O-TAQWW]5BKY9X_F/R MV#0]S77JQ\?D0R^@(7A!O/6`K?3I&J@#J9^H:W;M"&6XXO4+IN%I3MT[/EZ? M6G.O?'NT1#9VT5?IQ1]<\GA%ORW2[_AV$[>(*7+ROGG/FP=/:YB53SYI'IN6 MIQE6[?B8?&K.^)2Z'%84W+9#/C3WF\(U^X?=*?V8+;.MV@]^M_`YBF=W_([R*N&I*5]@C@C61851J,=B$&%;$-C]J$'8,VTK;.R9;(#[6%;KYTQ]7LGLG7L+RHH<`Z< M:I7=VR6FH:5YIGE\S#Z^V$YFEQ^RW3L)@39MK>XQI_: MH?#IW#!6]#OM`V%Y'QODQ\*JDZ\X<>]OE.N;F@K9WQB]XL5!;?MD`]_ MHXP@3]3O%HMZ5:&O=-(\/4R<150J7+GK'1V&:S5CWRV9*F^]VUM[3[.,(SPF MJ9SUX;J:BH+;==8;8SU:B$^QHK;8.'>G,[G77X+X\>GBLJM_[%[\_A%\=P-_ M^>NB<_L1E,C(X3]6KV]_>*?%,*4`?KI%(,^L*'TC^[@47O3E'\LBM%Y$2<3#CC<*$(\_`E!-U?CJRS!['J.6)^T%/7W*$7-A"&"D1\AY`[!VV&+"_AL7]P!MR&* M5D)`(G#-@\F0`R<^*TC1ZQPU#@%T;J8\_C=)_PJC%/Z.XL.6R(X$X$,1_(.' MY:X;J>S`0#!/'B31LLDNGRIV+""LH+,.Z$:,6*C_X4$@%MGN`_X]K0#)0+)!H*NY&D-Y8A/F].`+M9:20+]SX(HXY#LJ: MX2P*_>C!$TB5<21"F-_R`;L(=ZGFVD8UE!,E`ML-TV3=<]8"N8:!TI%;"M*U M_*GW*VF>ZFMS?I>WD"D0G!6-2RQ&@<3^0[HN5?$WU/3W"Q)61--;2-`YA5=6R%Q6T&6Q M&%X7<1P/#GC-N)B=#BR?B"V$%7T;A%]F+B)#Y7GG)'VNI]<[ M5DUW>IZI-WL6]NOJU&L=I^6UC1HN^>T'V[0;M0Q4;\W\GP*:0T@Z%*#?N1]^ MBA(@5,=/IE'"@]]C^-]#Y'@C8_B+EI13I,V3,?QI%OM]"1!\$7:_#7XUD MYZQ>'$T^RLUTVGJS835UQW`]O=&P'-UJ-JC9GVTY*!%`@%J]E@O$5A::TZTG MAHBA#3+E)^*6?_NR'7A.<+YBO2#`:S6S[CAZK][MZ$Z]U=4]![2BU:HUO*[; M[;AU3^)3&N>&(]>^;+)%:T"HM&@U7E?*'_/6KC?;K7;=T!VW"=:_U[#TEMUI MZ1XLKF>#I-?;CO0#)BS.2E7]\?R70\8.YI,Y^8B.@&T>,)N83'@>KRG!GM/J M]=#;@0F#I;9M5V_5>I8.BMMTVUVCT?,\"2&KNTOQ8U>O(U_W+37@_"+\21^K M&"AL:H9#>NHHG#TLO^Z@_BH"/&M!.1VN8HCF82LDK?Y^S/F+!=U$07?J#4F! M)Y92X'W,PX13!XIVE+PR'O2&[#5A;8Y5S]G[8,[Y:BY44X".:L^!.-K)&%B/ M_\JQHI/.7-Q&7\0@0C+=78U6>OV3X^L]6Q.SVS9NENS7/!_9L=O>E"--#Q MC%K-:;7JW;:["I_YL(Z^[.UV>`I28$+W11B$RWH]/7&7MZ^#MFRIG6[KEC4O M.ZQW<=F\;%\T/\&W+RYO;K_\^;E[>7NS,1T.JZ_9/OI.XW_X1%-0:PG<[6>3 M6T'"'[?S]$7(_IAC'R(P5'1D=T]G;R*FKAYX?,I^-EV#3?P@P,9"L?@:!5_Q M5%$UQ.%WL:`0!MXMM>EKR[\WT[_G?\.>U++O$+BG1/5<'^(9G?@V]3%_`X%( M<5HY$2U']EJFEM08[:B6(],XPKTP'N1A$Y&[:.;+IBNRC\G#2>!YJ<:P811U MRKF7[7]@$(Q`2CV`\&_8TP4&&48LB>A0&>8GL$5,1+T)`S$3U"-K&O"!'%X1 M136=6LB^89]Y/!@_.EYTY8'JHQFJTU+LOO5S3G@\!YWW99-$.O>$CU/S:EAX MRHD0FQ[];.7,*KV!(V#OH<`/Q2_).(IG.C9.84$$X6]UDHG7. M6EGG)!AAPH%7Z>%N>K3[:.[4D*>/'6E\DN=DIF$/&2D7"P(]6O[(R_SR53-EO@PXD?XH&3;(?&[QZU$9K&8%*HH=QO[*Q? M'H"-Y!9=MIZ"X?*KG#A;OH$KTJAI)SL;%`;`UNF/"&_"XILPTDA0:I=Q;AM$ M%QHEY3,;P,[A#ML)_3][5]KCMK%LOP?P?R`"!_`%1(5+-Y>+>R]`:DGF/=MC MC"<)_&G`D5HS1#2D+BG-\G[]J^KFIGT710T3)+8VDG6J^G155W57D/0MF_`. M1F#G:*\BL?#AIT+O=8&H0#YI+,9OVB@H*VU9EO\J>0ZDH'O>(VDR2GIT\4Y" M>*,^3#S<+/F8Z(F@'D08KTR&\GYD"VPBZW@F$$$0D:9!F5I3013'C_/?S27` M+ZKBBWF_NEP<+@Q^!U"EO]2=P@I)T'7J@OD`^\Q]M.RFE5$N[_$U3ML^8\IT MJN>;]-%HZL4OS]/X],^]!UP,$HT1E\^]?%;D#T-)4RE<'Z_P[/E#;E#SI-R0 M`C9.,_Z%&\\\]8>?5C_GVD8J?*CQYINB^1>?/AE$R7RJ3G."$>/Y'1YX)=E& M;._WD&4=D;@+=Q4-T58C(U*&'U6%-`WD[`09&"M"B1^MHD+$V[K0E$F;9.83 M[4/29`TB4)A11F'2W#NCN'2J$=TVB]V/9QD$/@3(M";Y)7\8K:G],O4,A8\U M@4C/BZ*WQ#0X**)9HN='&*.(]HP%Y17AFIDQ%WE'2`33]@S3UXKD[J(*CG=+ M&-'J;&'8C;:8**IN,?9XN0\V" M-\J;>8S.'CZ3((^/VUZ`N;%A$DDV5Z$70:Q14PSYZ< M>H^M`;%+K?#?ER-1&TW1:&8"G6QHK;07NZEF0W2!M>`4OXV]S%H+,N4R>YD\ M/;$(@@CI][2Y;5I?,F,RN(*QI=DLPZ*VF-QB6N#D8?X`9\,(4P4X?),@*&?R M9"Y-G$.`$U/?+Y)(8PUQ_XK-B&E[NW M,&N)@%*$486FI3#389_:W$;1"TZ_S3W;!WBX!^Y4BXF+>R>9:40PR_C/Z*<( M1RF[STT7`6P(F=!'P:ZFN>>#`7._D$-OP*#!-J.%Y\5( MJIAEYYY*@F(_B_C?Q/0_XZG'K#?._"W\[`K=``3A1K3+EEIAGV.OVI;!Q8M$ MD@?^?,`$&+_C`[KO@1@YQ4;0?I;DE<;1)$;G*%\$X8_EBQ4+?#3@\6*PD]C* MTGD\<<_P>ACKW[.A#X^<]M++6G6#5X:-7*?OYR>5HA/L%I[J-&EXG,47+[PI M<\IC]4">KM4=A,,A=]7X6$1;*BS_Q#RE_Y;ZYYDQ%E20#LH'/Z%]X8JF?)#K M'Y,6'F^AF"R#M[;@C>**RWH MCZZ>".J-G+L?NT`;,(RV?X:R=W*606`54ZVE-@BMX`FTYWX(4+N8V,'P2J1V M+I>BSN2X-OX8\&N)EGVZP"\715-GHEY=:98]#VVNU^IY59RU8A8]X^(LK@A@ M2@W7='#MH.:N4W#7U./H345YK=[D7!/:YL>+TB:IH(:KXG[QQ?W!,'RI2>S$ M#EB1Q&A-8A>M<[6IV174\(X%\#Q/,7T8U'3>0M4*QT,M/]FFY)P2+P-[9EC` M.F8L*"18XT::&A1U`*(0:[8Y4'98`\_&BR3OS,D*4^WJ/F;(#WGJKI-LB MGIXUT'6)E^S0+V*.QOMPUTQVI9OL(H"K??6>&)=M21*E1#_O?+-3USF9\??R MG%1RMLS,NY_\(!<\Y['\/=PDL$()I7M8%ZS+JZ2@>$9E?&]']51R/$4=JD9:OZLO)FZ=8& ML9UARPG@W.A>G(0YOP$D.6!R`)S,2\SY[LWI2OY/O4LFZ#,9O7K#,BIXX'JM MZUUTW2R]!>%E,?5U;QS>XWF^.Q#U^7OJ\RI=2;C)>N8=?,??32 M$-.JES_>AZZ-9NE'0%P6<__/!(\3OP!_>LLEZYJN2URN-K6RE?)7D MZV*!R.7YVBM[2L/C+.LJ79-Y6?Y8@]2^]SO1-6U:9>_MT?#N,5WG==+%*B]ZTT#*+5C/TNE%T7BQQZM<0+LGTTZ^;"ZGG?WT=> M]'>1N%/&_O5//QY[6:[RED41%I,LYG'X7I5TO*&L963=GO1M>D6?K"V&51]A?O4OWN/_W[ MR,O3EN%`:H71:(+$W7J,P/7V:\HN:QAK#5NIETO>AZZ-.EFYZ)I+"#$][&KN MY-'Y.RZB?+EV MXYKGRTMD&DK9(7;-\Z=RS6F]*^<8183:.D^I>KZY>^.NZ!==TW5Y=&W6NW7> MAZY)4UM7'%'3]=Y;WK?F[G-CZMM)W/,"Z5L4#E@,^L5\P2/WOFF3>2;9GQ[["RE!RCSE>1 MYL]07Z"(;:GZJ#=<\/4CXU?:]P[PI-4+!6_#B^Z=6W9[;ZUA6;6?<-[C_DAS MXV7/8#I,*/UPK MKQWY]\[5;[_#E&;A.TE'*U7)F_$MU_91FJMMU$VM.'L7&H:E,\B0#?:=0#YY MBTZ*7J96_AR'N[F#2PKPNB]A+YJ>/^)K#R/O[8EANSW/OJQ.(+\Q8NEB(T\OR_Y>.;+8()M*0,I M+2'-QYNJB'/;&])D[`_]_^/+3I.@'R.B4?@"Y@&O\`P9WJ=@I%*Z(_P52;Q)%0!IPF>AO-H;?BWYJ M?.4REL(HM<49$X-+S!O9T4SLM#U!2^Y1BPU9LQZK<"5D\YB!GK"][!O77,2\ M(5!_.&(1*#X<\#?ODZ7G&-O.OL#@@C]Q5DB_-F1>#'?U@KZ$&H]%Z]>\FVMB M3UDCVH'G1VC:$]QB`_?P1G"I5Q_LC<%L\E'52-/,^M&NZW3;_(#%A5Z`-P(; M3:PM,3+>2;>X8H[M;"7_"<@"9C.4#9\%KL"?!F^$7VB`Q/"M,3QX#&%9\GV\ M6F;$,#>B>??1CK$K.M+I,'Q98(WE=:`MV=H<5!Q<85638M2.]_`0L0=4SE2_ MX[CWR/J3(?PM:4&,=)&X(9]$K^2IGL'_X.8,"A,MA^-BCV!.2W67X%4S7G(! M6]F^2[!^[%:]U5MAPPDR[=U:K[$=8>^WV3!(V0F:'=1P[JGGQ0?&7XK1GDEN M4=4;1NF'_QW`>"M!PPL*;FIS/FRJ7&GH=@4W`U:`BQ?L$*N-]["[HK2&0(4&,2I837SN5/S9@T"Z-MYC^\6D81D7$-15/@5+LRZ-82ZID*@NG3FCI/JB)?<3Y=2O>$J*Q7F>"M.) M'RV[:<&]TVPFO!5.QO'8"WCV2F2Z>6I5Y+IY]IQ%3['X9B1]5*E2^/U<'MQ[ MB!C#NUUL(GQ?NH5?WJ=_\?$O75ZOX//*IJL@'D<3GE44>4$_>][L1]N+(1NE MHW:$A&Y[PH]W`!/E^50_ZDO_G7A1TDL*XGN](;TPB6<=&=88C4/)"Z8+/Z2> M-^+%8W@)]'5@;AWS+6Z22-?R0:,JF<&_/,*/[]_PPKQ:Q)-&$7OR)T\BN?Q1 MU8T&<&93RI].&O@1W&[ZVRRDU$F#XJ-?88*:O?9X%8,T"`4-I'*F6>\&?[>'=V31"&3SL>8" M'["/I3CP-;C*1%0U]/W!`.X<])ATS\8OC`62VJ3*+[Q&(PR8S$OW8"J!"4#R M!_E;<`GQ9N3SDH[[\)DE/^WG`"-#I<4A`%-3ZD;A$]9$L!$BP\TC"B7@CR@"3W;Q]^6B3T:!+%$P]L!958)$Q1S01/%">53.QU MY$>\RB20DB-O"U5NNCBO?$W1QJ]]_QE?_NO7R>/XGVUV/W:"?L8A!0)I^W%O M&,:3B-VRU[$[#'M__P>N(?UK$LL/GC?ZY_='#ZS!BUF_%3Z-6!![B)831:AW MO(3[EG_EFX#&>?&B_C6'->Z\LJCGQ\C6:1]\!NV)/G!Z">%D@1 M>;WQQ!O>`BHJUE2,X6ENV.#?/[-P>/>M8RFZ+L,_*E$5^7\54,7=]]OVG6[0 M.]2+JNGJG7)G*ZJB:Z^J8BB6I?TL^?U__^SW[ZAE6IIAWA&K;74LB\@=Q>[* MI&O9LMU6%-DR#=6F'4=SJ7NGW]&?__--_6%^,=J`7GDH3*NAZ_G1GUCO34`AX'QAKC MN[#!B(BFO/OQF+E:'!&<=>3CKN$=*YSIWV&='Z+\/Y@A@DOL6\1GJUR:$#] M."2::M[]\;U]!P9P%^/3QJLA;ND=E3H=!6[9)C)QM+9L$]>13==5+<6ENMUJ MW:D&QQA`UF&X&0+E4\.5*^KK!-V%Z\%MY.&O09=^V#_2Z-14S7%)B\JTJP`7 MZ5U-MHR6*YNJWC95U6F1EIV/3EMI"W`6/N(,"?D!@T')0[1N4JG\1S!!/#V, MJ<=O@.N3/T;B#"*\,V[%<;&$;55@S+JZ_=.53:;M0[.,1>_SKXTXM\ MG/R1^O?V;Q;A=6>KND+Q,XL8]!CH:8B>S<%3B^!M*O4Y8F4K1#\&5CIB97*L MM#VP@G$[,W'>L("]>,.$L9PQ.A=?>/4X=S'XE_`*X'!"$,$)\`?SHH.A:!*B MH']M4ML`&!4;7MI4H^8\48%3;5JF;LI&V]1ETM%L<".H)G=<57'XS#3(!1> MJ9:NST'2`<0,M6W)+4+0CVRKLF.#-Z'#D*6T3=VNR;E;A_\!>>M%UVH#&4H7 MFFH*W4UH#86V0&:RF\Q@.%I8`K[B^>^[Q[RJLCA7_&DE8AVL% M>V`%XQ9BO0<_N`[<),ZK,!ZJ\*.2.'=6L))$IH:N'85LS'2%-EML6RGTN:QS M)%`=>IU#2W)A>-)OQ=?0,>2W9]SM\USEF!9Y]U4.@B*;(+)VIJL< M0M#]5SDR_TO5SV*5(Y%K_U6.A3'BND6.Q8XY?S=V)N/',,+#J_[`6KKOX[#W MMR`!-(=XRN&^04?^CQ$8"__;9Q]">MRA,(-,A>C(U@G53Z$# MOJRI$[%T5=/1YJK9#6RD(ZLFH[,<".IQ!\(.9+3YHB5?FHRO#N`!6QI6CNH$ M\"K`/@_SHHB8MEJVKH`_K$%X()-62Y$=O>7(;9>TNYI-.JY-LPP9A=_0=5CO MBL`TNIVGT3!\8^P[BYY!'8MO]34,GEF,HP>O&O/=?,7/6V$\_AJ.?S!`I!<^ M!*AZ<;-N&"5OX??V8I@I]&>S-Y;>46@7@FNB63(Q'4-VNFT;0HZ6UF[;+:5# MDTH"C9?NYMB>5OX#63;&?^.W0HWV]?B11;>/7K!0X\O6ZK,DW>$'Q2Y<9)EN MIV50559:+0+AE45EU]!5V2*=MFEW(-1TE&R($+VIJ0<8(H>&LAP-E\5JFZL, M(F+;HFLGD,-#,Z,0G(OX%UA?;*T1W^*Z6^QN''5P%`%6]H`7:(UH%.;L`L#; MBSJ-E3,#9G?;`^W;85I6!_FTEW@%1SFE<4OM&? M?!XY?R\$0Q];(W3/Q/$BX0^`Z5H.P#N!Q2,U?\$-8$[0WW?U?Y7_L?E`U7&% M7S7DO4O2=X7@0%$F_U]RBQN<$^/#9+L19=LT57.[:A3%:3DZU5RY99*V3*BJ MRXZKM&6UU=&,CJ8IIDH*U2ASWO6A(3AL++^\[F)9'*L=2@<[XTR.L$=N!QP. M5RN4YR3VS3@T&_$G&R7]56RR?HJ^#ZYC_V^[T6XI[<:V&`\ MA?GL(C);RSH-%83#+';B&.:F_CYA_PEAH#::B$:5*1RF!"D4M(4!'I#O],;^ MLX_;MV\`+`CUF?^,RXWS5`,* MBA9@FW0%&HOE6P&(T^M%$]9/!TU%D#``"14W42[#84:L%0"T\%70QS_0:7T& MHJW,M$%QVE"II2X'8K%X*_``R&!:]L%J@%9899"`2<(@MK(^>EWAG7ZH&5!2"3LTR M5DU;VXF]?EI/U@GC="BGUZ@.9B:2ET96#,/UHI[:+[:(#0'=T8#A-7P&;H,X M:Y?X)"B8RU'8VA7.QM4M'K/VS8O&;^DRIO`B#S!F3@**O1R4]3*6X"J?!!2R M`I1M?>33.8@G@<98#LT!7,/C^3<`B)3V8!O]G5HLN\PP+??;!@QJ&!7AHA%`-7YJ: MBKLH]-WRW[K25EVGVY)-P^W(A+H&X.)8J3?<'*/M\NN9"I+^_LA?^T5[X+$1DL^S_1G#H29*4:(9J MF3/E)&LE.[FYG,!`]"1O;RKJ_@9R%?0BW.'49N+/JP"B*][0-8\G3H6'/)]_ M[+HMI^-HMDR[.I&)0AS9=71#;E&=ZJYEMER%9GET-5OSVD*X_V?O6GO;-K;M M7R'Y#1H`#Y[#,1QD+@'M_=+P$B4S5M9$D0YC_/K[QZ2LF1+MFF. M*'%8%45KO4BN-7OV[-?LV=B<-TC38:XZ[2Y94TTR;FZFDX+*`W)17SC(4GO< M$X_GH#U(3>?EY*H2VD5Q-$RQXJ,V2:A=GEF?CB*=^(KCM=ST$^`.WV*AY:8* M;L&)4S556*L\::6I0ICF@WE6I/4O1NM;YHN]]+MBJ3D/H#?^`.6P4*FPZ
96.AJE@^*'19-S:S:^S=6!$^C'4]4<''XV^$6U`[?6.X077\(_OGIL MG^;35#XOMZNJBE"S4<-NN$=%[1FWD6,3]K08/GCTIP1N&==0Q%P6+JHZX:ON\O,4_I[.K3S[MCG\R<1*9K-Q-B@6WINB^X"ERF944WAKI!K` MXU<._U$U92=%PWBX4K(H1%!5TUA%_X7G+U5<"22RNE31>_XQN=M@]/$U4XU= MOAR\G:O`Q]9*H3$XA2N"GE@K[T':>TN4O3:,D85&+#O%X74^.MLQ9J\]491Y M"?R4'=.)!C]@A3QH*["CHN"J"0@B[I8^S)$Z&Y2ZK@UF,[)9(*GM1P&UA6I$ M%>)08AQ_6E4$XZKMQQ-/NH)S^7T&.GNIK0^,`.P];W`+:C``^?U?E7[NO[G/8:I*D%K1M%^L:-:J^=BD4C0`]RL=R3\3S!+?$ MR9VF+LY%>DY5UZ=,[;+92EA]Q/<7M%7X'Q2@-QCYGI\$%9I"62PEB@):$]+`$F@)6#U,4I-Z(H%5C%EZ1JK)G3QHR;X.ZPF MP$W>3#'4Y`-5:H*9K"9*`MI3$ZA0$Q@)8I2>T)6+0D^XTE@]H8N_U!.T+WH" MXZW[RVOR@2L]0J)(N*#&9?")$6A+1BEHA"F*@IM_(7?L3P)04M1 MM!U.AG?$INU4*YI)NA%.UD)P^'"RUN/7#B=W8[WAPFGLSF-F?I"K(J"]]0:S M,N>)N5'+C:Y<&.Z_:N,OEQO4&[N42]K83L=5,)SM6$\<:&9H,E'.#',-,5W\ MI<=&>C,S!'-D8\-4]FEFZ#)A^LS0Q8^:X._PS)#P9N-4D=..;7F8F:'+1)DT M?&&4JT,S0Q<_:H+_(,X[D7S+D1RU?$?:#>=="\'AG7>MQS?+>:>P;#1W4D2I M8(G!SGM%0(O.NU`B(5R37'=MJ2C-,&-32MKX41/\W37#@`^V6;%?=_%U>V2& M:3-AN!FFC7]W9E@W9@:3S9//F)L?_*X(:'']Y$7PVS4J]JTM%N4"^L)48X?4 MA"Y^U`1_=]4$HX@W+WG%/5I`M9DPO/A9&W_/BI^9@]TMQ];4Y`-5,T.8NX!6 M!+2X10(MJY5,6D&UY:+0$\A8%U0;/VJ"O[MZ@A/X7N-J<&3^)HF*@!8W211Z M0A"C]E)IBT6I)IBI:D(;/VJ"O\-J@E'6.$U$E@E#9K":*`EH44TX2DT8%<[6 M%HI221A;5:"-'S7!WV$EX>KP@;GR?SO=%$YE0/:>0.F$#2D>* MY@7YLIV$S$','FTF#/>.M/'W;-.2XJ-Q\1-#/2KVT6:B+/8Q-CNGC1\UP=_M MF='806*X9VN&%A/ES'AAKAF-"V89[=G,T&*B!S-#"W\/9T;CK!1KJ?'6P6:&%A-EYM[8307:^%$3 M_)V>&4[CJDC6TJZ\0\T,/28,+WW3QM^STC?%QV9KB[I\5/T>*/U+G/=C;FAQ M4VXT/G"`.?V*3NDQ87C_#VW\/>O_H?AH7,K$W)[-#"TF M>F!/:>'OH3W5./?)>I8%UV.B!]:4%OY>65.28(D;A[&IZ(T+KD]$&;5]8;/C MKLP+??BH"?SN3@O*FQ]J1EO*9NROE+O&WJ"3<0DF8U(Q57RB,WI6J#W]W MFU*[H"(8;F:,BM(4"-SFJKS,J0AM^KTXJ ME)PST;AF"`GCK8@*?XM61'$D"I,FJ0AMH3#;BM"&WZL..)*[@C3>V$>HZ6TF ME_A;;"!'RRZ31JD(7:$PNC9$'WZO2D.D0*+Y(;>DIW/FA3X19J^=VO#+:=&7;3L2"=J8 M#L*-#^97^%L,YI>1.O4TYBR=VE)11O-?&*KJC([0AH^:P.^PCI`:1W&:7UE8 MX6]11Y25A9@8I2(TA<)LZUH;?K^L:\F9;)[_;&E3_#Y51(F_11515!92H_)] MVD)A]!'6^O![=8*UE`Z2C1NCTY::NNY3193X6VP0P)2*<*A)&D)7)LQN$*`- MOU\-`E2CH<:[-C893&_2=^GB8G29?(-7X]MA M-KEZ/YT7BG6QF&>?;Q?)YW%Z.7TWG2@VYM/Q&+YR!KS,TWRAPY#$P!!\[C0K M'&$Q#1!W8QM,L=_IS,81BS_Z;#/Y)L\G::YQ>3,)UG7V#XOJ2Y-\]RN&9X.UG0W@< M[D#-Y+X^7%]??$7GXDS*9 MB7/RAK'[[G4]=+48*4[$;8^0W8L4_L0K5G@=3N[CZ_A\)!PUJ\VN2YY*@%03 M\L`S<==RQXC3K!BM+G6J-*D2/"S=!^TX&@C?FJ-[.?6&PTS1FXS?)]GP;!(D MLVR1C(L)[2?@!*@A@O$IC,(/P/$\&X"I6-SV3\";INV9K/;LDGV1:+AALC>:2LN$H/U9)F'V)1NF MDZ%)P@1^*R4.OI\%O`/2:4]I;QSMQU6Z7M32A>\3D$Y0B>EB,4[55R]&R^&* M0/=]2<;PWH?LZEHO?KSGA<$]>;/L<;-['@YBM7!,FX7>ZU)'/XF5T4+E/\YH MV1?!G;%9NJ@@]C4(>]0/NUO%I9J7K;+#/[DO7<0_#J[3X>TXO1A5$@:+U1E\ M;Y&-LG3HY7FZR)=A>6\R?)LEG[,Q$`RK%VB-FQ16+&40`2_^&"18@R27"?D- MU+_`6QKSLH#B('"Y+21A-L.AM'WD<_@+.QR`\Y!YG^`Z)V]^&B]>#[,O/UTM M7@-0]6IFY8OOX_3WDW/OPQ]G[VS_XO+RXOPW"\V^O;:J]RXOWE=O7$;__6>S'D[4+C0#;\EKQQ;M+._;.S][^]9MUF=W`&@&:U/HPO4DF)U8. M-/Y^0HH?7UZG5G)U-4^ODD4*5YK=S@?7H`BL&<6&!?P[?,+/[>^)CE<(1D#U2J!8"VFZE,K*8;)2B9# M:[P:("M9RP;E6;X`Q0^W@PLLDLE5!L,&CS"=I?/%]^*G637L:D"M;'+WI?+J MI]9GI;VLZ41=X#K-YA:8O+-TH$P9:Y3`ZR]J/8';+LH[Y\4\/(7?@W0ODFP, MO\XFZK?%(ZA+?T['TZ^O%+>_*G(57<6+6H1RJ8A1P^69R,WO]PSGEB#=#S.9\D`./W]!)6O M9\EPN'S]-1LNKG\_<=&/)S!>V=7D]Y-!JMR$$^OS=#Y,Y^I;Z_>=K[\8WOU> M_GB'Z=?%\/YWOE07_CQ=+*8W=_<4C_]D-^__>O]AY];G*R!F"I!^"((HBN.3 M[<^YF,Y.GAC8MU$,4PZG-P\FH0UO/1C8E\[!MR#?3X_[<^36$:PG1.Q%5W\I MNG^]^'Y+D9RK!4_S[A2+E]]_,OTZ3V:_GY3_UWR"!D/P4(2[)K#^;396NJ10 MZG#[#'S+Z9?"<,G[*\@:-]ZI1)\Z3)HOT]U7RV=W1H:R:@HSXRC<+0NWP,A\ MT>Z:(!""39?@+NOF]<\?>MG%<:^U M\NDX&VX3B)?*>:LWW/)UHQ;1=^G"&B3YM35+LJ.WWI(J8:?"Y3U8/PW7*A0F M^7!Z"Y[/OM1*\SN^3*_\6D10U]^HHO%KZI/`IY,K[T;5=/RW2,&5Z36=K2-/)BXH"3B2H;`IP<)F(?-LC\2![;@> MP=SG#@_4/CMUHN#)F_?N7^R\V1`4HK.!0S_)L#<>Q@J-F!8=SK.`X5G!T.B:$3R4Z)@6/ M-1Q]2IE09=B1QQJ[8QW'/TKD M?\:,'5CFFQ=R=$VPPW0VS;-%42U@96I7BFI5>93AMF684W-EN/OJ.DP_+ZR? MLV7S@;6PG%+7=QL=BQ@CK*!'G=VZO!-Z2MBAC>UC_=VQ_NY8?]>'6*LX=>6A MJWF/!7C'`KS^%>!M3S/CV'6IB)!-,'9MQCUA>\@+[2#D3""/>I$O5P5XZZV; M=U)[U[ED/,<.WE*F&`72\PFV,?)\FWDDL'V72YL3*3`F0KC"T/X*J]S[8`Q# M-B@3[.<7OGEI^&,6OGD6WGUY%IX?L_#'+/P^=YVCX];<8Q:^5\$3C$Z%.'2X M\!^1YCEFX?04.-_M)[-"C-+>>G.2'-C^V9#-Z'83J;VR[^POF,=J] M#_N/GXH^E!:;KFB.T>[>1;M=>&/S]&<11CAP`VHSQW%L1GUI2^&%=A@RY"`1 MHS"F9;2;GKQYS_YRSS'9]7;SPU'"I,";6_(\)R:^2^Q('=W'N$>!DL"QJ>_Y M$DE/4#]2E%`5W7XO_Q+G?>%#NAAMV:9:AP^B^"@[$K0A(OO=H"I!]O'F*:>U M]FIR,_>GZD$F)V\^3/-T\CF=7UG!=38>SM/)3PFX9:]S,QL42.90=XMNJ,.' M8ZH(Z$!6+2FNI^DD^[8A`%&2+ZS_).-Q^MT*DGEJ!45"QAA1X,1U&O+B&BH* M6I!!%-Z!/K]>CKF9"D`PYFP>Z5N+`FKHJ&M!AE$/TQR>\N&PZ\[V`YE#TA&N M.G.QB<%,E,',BO(0>H[=75M#P72B2*Y2+=B<8[`"B8`_ M/DDP!]7)UIQP9_TDV-GM/%T_?62SI440$3`^8%%WRS;,KS M0\20*@@2D51GG1-;^BRRO3``K8+]"--`C7K9O(JUTK?L\8O\F:>CV_';;)2V M!#\"81$X=&U`"R,>A]CVI``GB0G.>-K2:7P!_-63KY8#=4S<()DM M0`Z'']/B\/?+K^GX2QIGH\5W=73$]P%-QDE1SV.`2"@J30+#'#B/Z!"K] MT^;YQIN>)'6\P`\+EJ-,"[ M(DMMD#B;Y(OYK4KAGR=P%5AISH&.:V\R_"M-YCK<.`2I9FXN/.L&W$"X$8H% MLQWFPWKA"VY[44ALA\),0;YT@5)UN:6Y(&WDE("??^;]XF/PP6:SNKKX*I>8 M$!N3;N+C8,(TQH>6+K]C(]9-?((@MKE*U<6W[+C5XWX0DDFR_NR%DM#J*;\/BVP&]=>.Y*MW12=TJ'4+09TZ@+3W1\:9<. M)H`VRW]CNN.'KMS M&YH(YX=TDGY-QA>SPEM,YS?Y>?(MN[F]63OOMX@AZ*!<#P\]0,DY#@,:1S;Q M'6$SE\:V*V)?Q0?B0"#F$M=;Q4.PB\(28^WG7D%]=WOS.9U?C-ZF:I=0%6+- M=`XA?R3PM8S>KGOY9^_B9N$OJ@QO?O(&5S;;8RB>&M*]C66`0QF&=BP$L5D( M5W1Y+&P_B`)/^'$,(JOP%*9,N26PUN.NH!6@JQ^\FR[N3O$^N'`6)0Y+V7SL M*=<2%<7KR^G[:D_=A[N-:N6PQLE@62HS6J3SXLV"FH,#Q?=F86,<]P.2*C3U M=IKG%Y,PRXLB91C]BU$9U]2&[#BN/1]\TW@-(^'@"+FV#]/19L"++3FF MMD^X(-PGH(>CNZH?3,L2K56T\DE8#X0Z^C;+RF#VKI:6=>R-<>$J0;?TB)]X MUA4@;S*Y3<8?59$:?/ML,IC>:`56]S:*,(LQ7@[B(T`.DVS%6#I``B+P%KPB MHHRG;CT<(^(>!KM"VCR*`YM%;FQ[8-_;'A=(4)>*P'7,.Q"D!08,/AYD.QO; M#\ZHQ89QAX6TP(#I1X<\0LG60S5J46+<02(M,+"'8T7N^VO*/MHU`P!3;(8_ MF"`>I[%K,TJES1`XEQ(62SMVG"#R1,1E3-:L/K36PV/SD0\]R-LA!C^5A M&V"&X&)Q:4MPNFVP=BF/O1@,7%X.\GDVM(*I*L'[]S2?90L8Z6:#VG;,X`7H M9"8;+H`M=1`49\=3^>3A[68UMF9411LW9Y0BP):VD#99&&= M)_/OR\KD>\;0Q>C_R;NVY<21;/LK$_.N"N4]\V4B=)WCB.YVA>V>B7YR4%BV MB<'@(\#E^ON3.R6!)"21@!#RG'[HJC(&M%9F[EONRS/T_RGZ/WP5"=G,BI6$ M1)F$/"6`/`()V5*R8"4>OER51O\$_#?5;#2STUC.8,7.EZO@Z)^`_\9ZCD:6 MFDL=K%CZQ\YE&@$'E'<81B%>K6%I\+2M;T8<>2H!:"52#.ADX?D<_DVZ4.B5ZDI+OJC MSW6R`-\KNR$_YSZT`_[V7BW[ED.I"_;K3_4&;]K:;?#:Z/B^7$-KB7UWLPZ*OB_T]745C'!,7`<'4)H9^U1O9"$=SB(> M"2X\#7N;U:*_"CLD3PL\\+PE8!])JB'?+#Z2E19Y=\ED'JW6^E?.3NDX;EGW MD^7MEU5;9X3OFDX6V^;]VO_-]\@M^YOV_F^;JUZ$0DL-8H#<(IEJO4096.Z&AXTD: M8QR[?JC<1UJ(//Y-\%(SJ$$)JBY.[3B*M*SA_).IBL7K4N@M)/;8;^N8+BV=MB.J$'?J5) MT0LT';/%1O\L?_%(8_/P3CQ`E/YD[E')'4Y"Z5!)74>R@#E*A$'H>R[5/J4F M"FG[BKA"D@I9Y^$\&%+0GQLOT[?)N(0>\R,W]B/FA-S3JCQ`6J]%7#HN%4P3 M&4I?\"SPXGY3N#/$<`!@O:W`V]MR<;]>3O^S5U)L5@%:S`Y!R8G%TZ:\''_3 M:J_<4>`P)@NY<_O<=D+')F^T9P832-1AF=..J=LBT+)^-AVY/>`>L@<,B"K. MG>67J:J;Q32%#-$PR?XV/?\'8G3^2G^:584T*&I/`!4-6KWJD MF8!M0;W("6.M"3Q"0B]B8-*J1X3!`Z)@6C";'5(%5901)XJPYU!/ M,$>&C#DXXH2[7%%,HD?3;1/5PS,-CU['5I6#VI"$7]I:D\'$I`B:9M?C6U2D M%Q6WSP^3S.[3V6BZ\M=XY/S:F1_?#\KO>7;V$,^R9B(34)E88.\SU0VU7,-_Q M$?6=,)""AM3%2@(3T+FN%!0_#V"SCZX_[\=L80[4_3IY+U^:Z[^M?^U$?;Z[ MDKOD3CU&L$5TAI M??::U$B7S[,U;+(QZQ8$CJBBVE>I"(WMLU3Q1I.QGM/`=_^SSFO;&D[(/9>UZ6<\A8>]C.!+/UR,-*I5,32[[)P MS+=V[4['C'+]H7(<_)7J]?'^PQ_R3[SI--V8MIA&`6B3,9E]@/HK%\ABE48D!#?@KDD]5+\R7R4FT&;QY+AZEXX%MA>I+YN M;A6FUA@-1F:4H*@JP0X,S?Y!O$RUX)PFR=,J3I=O^>`[S5'IRGYG.8W2AX#; M0`?5%.2)^`Y>;JV*RQ]-ZR#BLJ%"R^XF"_0$JBT\=D,=6>AO?\ MK,V.(W-O!A.9*HM>M^V)?11V#B;T#=Z3)EK9?DP@Y7CEI9K4Q4M9"8]9A&`K MG_-TS,U!4(CWC%334BU4A5*T,0*:/[>-+KW?O+U-4J`LUB[H8CJ;S&\6SW#( MLFC61[+8#'MN!&."(QHXGH0(L,N4=CLP=;`GD38U,<$4YW>]B%)IH5:M,-8] M://#45J7VKE@Q,2A*FYS]L!ML;4<^>+EZ!3,P>(`D`%2N[)H>_X#`=-=Q'87 M.KG?_%C-GF9Z'PR\JK:V0=5G/!I3BZ-D>CNM,O%X#S:$R=^=+:"K7M[2;/@C M;FLYPR4/);+9B[)%MI(;8T M3H`;+,ZW33J.?9=_='F9?K*OI\TVMA5SY<]>2+$H+>/M<'^TTZ.FT&M%D(C%"UJM&.E'4`I.3%=2#P1\@[CXF?DD)QE.1N59F[UXJN;LE%X;(T<(VL>*^C$X#Z=]SL1=,IU/ M5JO9\VR:%:-L,W7`XO!N@YM*R&?,,2UBG4=Q(NB]&_-M<+E\R?[';EU=M:FB.EY!2,>RA,8M+/>%*ZV*PES?`[E;*[KL2!R9:Q41A#21%:3T,Z' MVFYVCE)](\-"[:B4G[H=SS6M9TL+3!ZRGCN-YI9:LFU@\>O5S!$%U1^N1*H> M*SH#:+O2:$A>T81?)Q''-C8CJT%5>S1=ECQDS8>SU112EKZGR=MLUMFFVW+`8T1EZ( M/BF$M=M8S4@."0MCU'XMB2%`A2+!6IFP059/UUFMP?W);8IQAG.Q7G_!5'4' MU)_\,DU>AL*HX,JXIBPM>KHT[(%@.9]GLYAOG[](FHF$+#2&6K=U-Z1V*GY; M+EZ@\='X\\Q10TN4@TAL.H:,$2W;+VIJ?OC&T,MJO3OTVWC-&(^T2;"GK":N MNU"4.G)M&P),9D\/R^CM?;[\E21^LDB>9^O50[I977`C[V=5TR#@PF/80:$O M],K*P/%][?-&@<01\1F-A,QOQ0L?R!+%#O-#HIT`_5RSMQ^;=)7U<"D"<[NY M7F-<:;VA:=$=Q!K(#OA^A++XA%62:BLO6DW3Y<]5D76I/TH;Q.^:TKO1EMV9 M'FUBR\AY"+N8NC.IR462]BBY@!8`''=P4<6P0WO*K>PU+ZLL+Z#)W__!7;:3 M$CW`/(^SL82:+/G#)F7%/8N_PY$I_<'@=FH7/"N,!&?R]EDC*D(U%?.DL=/H M2"^)H"-;3ET/"/=U]NX>[@X:6_3!@5U+$DLE#>WWR)Z.KC]UN6GDX8+S[Y,4 MNHS>)^OUW"B\7='Q!>BX7%X`E(.X.]'4,_12X^'V-ZVN2IBMPR*J1!V#ISPX M^.K5,99W7-"FA:@BCZ[UT:LM=;W5:O.6/-TN2K\"`J9XYQ@7ED+#!$SI#JD- MDO+&_I4M?_Z6TD7Z;5$B?N(H[,'T`Y0O(%3:VT=!VG'A9U.9H<<)I/*;.SUS M4,;IQ8#-+C#:J8:.YS]D<+57"_XS'3HOTG+99;D4\E1@'<;3S2+ZG";Z'<]9 M\L37LYM<2)HKVO>=#;$IV)%WP+M2![]CC069M72LQSIR$.?Y)-N8T%4"\Y:> MB#:DI1+T+$]D#VCY"!D#"X[:L%OCY":?T-_N&^*\.!_[SV\7[OH2^D+;1)R7 M5O\H0#L>;M,GO2W27YG(N(XL.'G!37-OK&C&P`$HI;5/)XO5Q-QHC/9&"A)V M3$9QL;RU9^Z*RC5GI8:;Y&$)K<6`IA=HH=.B&F[U-RQ6R_GL"7;,;?JGYG/W M;^@#.4H%27>!A6M04KTMB2>SU+0NN5F\;_07Y:D4=V?X'8]:]3,J/I4KD%3Z M7Y)R]:DP4J@\T.5]DR9E0NG^X2(NXL*-'<)CWZ&8<<>C`M)1/1]QR;&O/)A% M8(:YN-]MA8T7Z%,C(.DX1E(2%2$/0N2NF?R>R_9+SJ\: M`"O*1Q/^U/;AWQZ2STGSO-^'Y<]S9E<.)_^4(LCM7P20?.X%B(#QRK]+@D<& MO.@`/R;YES-QXK%`7UO^G0O^*\F_<['J;?T]F4R3_TDF\_7K;@3E?+:834\; MY'=P&,Z!63BE;H>U;NS_U!^QAEE;OHDO$%9:LH:^L^86F#JSP?3_Z2F^U.AW=*9'V_$+"CLL0+IG/E].)\6$I+VE.C/]JP=Z7$DBE\7$H11+API/F_DP_-(/`AR&*G`C%@`] M)A]E;\:!%;H>%.O!_?JOK,@&Y,BI\W`[B3UY4VUGN?,SU>6I%.S8APN./+K_ ML`QGIBYIK=V2LRO<-5M8=J4&Z$Y0DHX MROKN<\YH'U[N1FZW80[,IS1*5E,"Q MDZK-HNWC$L`(-.YVMEBO@[I2P\"!.4%]MA`TG13R=!ST-0A@JD)`!<%.E/ZQ M7$SAHFA;TUG-#3]KYM7`>/'V,LP&5`<%OR_3]8LVZ+7>`=;.;`#L#-4`=T)MO3[\(`VX[`\VX.HCHJU/7P!2@=@I:NG8U_6J8 M/"=IJBW<;#K\/Y?+IY^S^;Q(,LG>?T93[(%)(>VDV"+M(&N(&K*!"9/MA)U6 M3]:@F8J4YI*!]F5V%%5=.K<969?0+9)/=N^X6?2>LCKP'J(=PO@HO(<5=9'1 M6)S:'IKG#4R6.*B[.S`.;=5*JO@%\[NP<6,Z[+EQ6+6#L-"Q+XZV:K<'ZN%U MEIKTT%_5T8(]')9!2.D0OHS+DMGE'_=NP`RRC3H\AE9H?0]SU9"%0NXG)%6HEJ27 MGLJ8*>2[%)-=A=UDUY:QE^:R2!^KG^:E/L`K@CHOL<_`C1[-/809;5#M*V0% M[G(KCIEK<7MZ!G+Y:&ZI8,FSZ7TG+[BY>NYQO2D6^*+0Q6-V/P>UV2ZS6?8J MQ-J%ND6I?_,=ZUT")9!3N*V&K_U3(]8Z*JN33NZ3]&,V3;+OAT*/E\7LS,2% MH?GE#??SPY)UN?,Y%(G'B>2S9VA<89=83=083S>1*S`T2&^1864\0\0F#^-T M[N`R_?^OB!^*WM%(^#'*AZ$684CQT)^"44I>F![V*(^=V%3,[-+;\L=L879E M,;*KU'D@FJ0+&'IWFYKLG.<\$R6YGRVFY:X^H6GRL]ZW&UZ<#I M:&LU@3/]S,EOLP^3;5+)-[A+WB8SV/CE)HB9@CHGM:R@C`G!]W,L8RD)CUP' M(R2AQ01W/-<+G2!DE+L>\2)?[8K%Q%^ETK_3@-2;OB]@P&DV(N!NMOK/;N+I M69`90QHRYOHOCUH[**H5!,.:@8X"T?U:DS@.B.L3X0BHGZ.>BJ"(SGQY_0LR5GMKQ`(T$$XT#9RVF0K]MF4Q=]>F>0*6J*@A/1IO MR21=++0(OM_HDV9:>9@BW3/8,)M""*EL[N_W55,8<8$B5SJ^W@H.I9(X2ANI MCH\9Q\S'VF:*LO/AUG+8FX!_U\V:&)':II8XLY"D!.5C:6W9@D3Z4&CVFFCO+9ZVCC:,73AR(U`F@`JZE8^,";'=BK,*2%A#:" M!B+(])J!F0S-8\*/(ZCOVZ1]?AH9L2N)M**#Y$8]DZXZ^RKI\MOEF`W2(%GM M*:D41)UUAII&-SUK5^EMN3#O_1)T@*)A72-;&J'52A97V7[*A;0I0S_>W#J> M!.NR;WLZ8(`-^Z9$J1BQ`UPIXV#S]B-)R[V$=YUT"Q_/G@JF@`GF8BSSTC@) M[3NH9-"^@Q(A\L2#LA=;6`8'I8>'PS`.N>,2[;E1)+FC<.@Y3$:4^K'G(G]7 M4(WSK`,+>*5&H:NU_GZCIDUDP'2':W"!+TR(O7JQ9H3__1^J9)78`MU1\QM8 MK-Y+FAC3[=C*^F-H.!FCE@C?D?M7AK#I>SKP7ZC)4VJ5-F=#&U!]VORJ[C[U5E M6Y'`QJ6R3R+$6F7;,P+]?\_3V0TO;C^D%,6_)D%-_0_L&8+X&I9NYW5%.^*^ MC)MC^#@9ZY6,FT&PG6KH\D3@>%B%#@TP-'PA M2L..D4=91-V`/>9]IK$H]3%I!M&-%-IP3T>-DQS":2#L#5K/K@J.2[FT0'<@ M0\02$TR'IK@:W*T\;M\UR5WPAM)7IB^V$`_VI MPG&1@T@I@[/Y:;-C!"/E^GN]_M"=+P/;0\:YD'IX[F=)-B*I6\U MCS*SA1-W&,L2YQ8T&5C-#X^3',+9HP5]&%T?QJ?9IEA1=!GI.!0(8T$S%U_: M@D:9+.ECRUG)?9Q;T/P:1VM0G/P0SH:C-3:[[S!K?=@".+/[W"]K]PU%$VN@ MJ5_)]G_L76MSXCC6_BM;\WVF?;],]6X5D-"=&7*IP/94[9>WA*V`WAB)E6W` M\^M7LKF8A!AW@HF,-#530QQ#L)Y'1^=^SO`0N=YGZF[3DLTH)+5_KL/47"L- MYY9LYW].\QV2[;U;Z_C3G>*\S3-M35,SF]E:YWJ(7&FPK,9-JO+SG,BDTC_7 MI*IZHN9,*KTPJ79EDN$Z/ MK\TI3OS\O#!L_F>D])V>:Y7Y":99K=6AS[5,/"G*TYMR#YSK*?A);QOVD9/^ M5$KT.V:0OU.YM#XI=GW^YSQG[/KXTYU"_[0*,]YOR#X]UT.LE>C&8]=&JC=_,E6`]P3RV;.87[_LWK;YX"][G_QUOLOV-$(>EVXQ?39U_=%BZZ>N7TH=__;)>D'>MCBGBZICU5L=L?'4V M-H)0JV/]JKFUN*-Q7U:3W#GHB6MZK?ARP$E^,GY=C6D4HM_A:AZA`"6WD)=1 M_"-$[+!?^1=; M__77>!?#:V%HG@M#L1@NPNKL!=J$6AVVL:UZ^]]I=G5,$5?'K+2@9EF1=7:/89'Y$'M/W>P!G;[Y_H4,A$$,#/D)]R?RF@Q*:PX)3ZGWMN$0$C" MU9&9HR4YF?2[<(HUDZ4U)9[2"E=:@=I'90DRV/6KN#&CZ#P$KM(+6# MU!FD=I#:02?HI2CD)E&<>C>GC%\-KQ%.5;;G%9)%NZ'!^T*VD]P"^@R33C)C M])I0,#M&F8^%93\]+>,GFK,+"B3/-!IR><#?.2!!7C6POQGS\\8@-!""C%(;R&E*(H&&0ZF/(V/W"6W"59$.C&1*H>*",6<$"*FK$^8(I)_ MFQUF_\9H`6D,HN],2TFFZU&0\?W3%8S`$E`^D*9!$(UZJH!Q3A#+HX"$`G&G M4$:\=RD?-%D>LA9WL_)O=AAW*0HG<`DRV8`L3;@2$LCM>*L=5NLAHCQ36RZT MJJ:T"0G>JYENW:S+;+?IC)V!.SS7B=FG\T_\W-9_0[Q+)]2KQB"VF%U%U3$, M%;T^FU[EP:)"$NI`%_0=CJ,E&4U)&@,<%A,82WV>]$=@LGQ.<'$J*H.8+:K[61/`1)H#;KYO.%I+!:'F6NZCN'\:H!E*8#A`8(RB->@`(R@IJJ;' M5-?6H=I3F!["U/`<)G`=3]-='N9S#(TA;#&,!741#-E?#%/>X:40P+-``X*;N;.@Q.%,])#**X M6_9"OOQNPSDMSHS_G#K.RC!1SRD$J2 M\9??`0VSXDY"!>`E7R0,([#FY,;]QJ5F!%>2L5/W#*-PI(J:1]-9,O[LY[#< MY&$71BW>8VRTY$3[#Z0DYYQL^.VJI<2$[]TE21>*%*\I:`]2M1+W+PTIS;9X M[KJK>_XFU.3[OJD+:OY51IH>(`A@H2"NS[M>Q+;?L=!O[3_>!XC^`%$*N]GV MY7?V0(`&TVS`!'*TSZCM33=XGB9Q?H>I^.4;NJ\+*A(^#AN<*FE]T MB1P<31%-LFLTF2;7$8]6=&$4;6*CBI<[7EJNZ2E>GHV7#\%T2%+>SD")QST: M:L*&Z2^4ADH8OF*AKCF>KIF*AN>B88?RO/.$8$7&0V2T=4.Y;3[);3,08F#% M9U/0-%Q?L'C$)5-PR-:$`B4,#S#1T'Q'*8AG8V*7ICA>HN"Y$\3A'-#G6,G#0TQT?5O0:HN+9"+`">C#84"2)`Y!=*R%D10J(^%%`2EPV[%6-``3$EG7*#H.B:JC#`B>))#.KN#X M1=O>O+;I>XI#"L/A%(1D.0`8=G#XC40A+[$\V%+JEM!D`B9P0$"3A5'B8NWY MEJAQQ+>Q?GFB\J+9/EK!D,^LE1Y2U[=\04L5WX:4%YU"C!&3P2B*XH.;E<]@ MD1Y!F\FK#M<-Z&=U/7RH]8>O_T%_=14-PC M&$-F%P5IHH3P!E]FU)JMPW=`9N`'8FNY!EI6N]5P-5%=2Q6R-^__\P-$$+_:)UN';I6*G)!^'4/+-]OHD?:$S!1@C?/_4( MG:=Q;TJ9.8O45E73_UJ%EN9YEK/R7=NQ!;57^^P(3.``+6!X@Q.`\V2K3AS# M).YFM^#_">U%("YA>8.9O1K``02Q;`E+:I:CRK5IGEUJEJ.B5R/TRKMFNHXG MZJRCRJZ9?P"<`IJ5)CKV24H3V&C[:G%A%+@34R6,,K)VRC9/T.,&%FQ_4,T@FSB3*I,607!'5#5V+822=IG!3#&O>DCLP>CHHLXLKJW:)W%)">:EN$*:F_41/,!4'913O`,6]28?TWP[@CFBT!)Q/M, MWW!?:NX?EQ%,W3<%]8C7!)-=GQ$\3$CP+"F"FB^HR5$3P4>8`)[3=0TH9OM1 M4@6'F?Z"FAQU%9P@*)15&-[S)`!^'X53_FD+/O23S&1S"KB6I0D]N3S/R%X; M^]F+S.QW#BZ_4`Q=7]11<548OE7,]"?[;TE(F,\,EQ10S1%4%:-'IZI67 M[H8N>#GI2DXH;4O4MAQ54)8;"DG- M$=6RK$22YR+_!U+"_]LU>MUV>94>5X^;*NW#M3?-VY*-*2'/G0"$<);]>QE, M(X`?(,9Q%BT`1D!*1%W7M@7UQE;NU"ED2BV,PK4ZM%%N.TG$@]'?(*$361$U M3$-09T*E=CN%FP*"'H4Q+P>4,M.U`-'Q75U0/WL5B'_!:#V]\1%.\GC77N(Y M[P[)LPVZ$`33?D0H"N76;G^ZX0P@2$[/ M@L/TWC::HPXZHHU8K=5UXO-F][,C:EM-"/T,?S%"479$@(?0@ MK,,I90;LG-!D0'C>%\!RGJZ6)6P%9A6^1UMI;W'F;HJ\?^`5P..49J5[I`3< M='2OA49L>69%@7HGX=&9'B7LJHK4K'S#L43-Q:W2VS4&^!\O':J$@C\A23C\B3P_TW18Z$LLC1T:\SC.`ZU)!,BY>R&F[%H`* M6NE9Z6+*JW6'`'=P0C`B>P,K"&\7"GI26JL%HBT\/M=5GV5IFZ.Y*P/M_"TO MH"V,DA^:?+JY)O/>;*&K\,4(F4,39-:W2+Q'G1;Z"%]-?MK;K`K2%CJ+1E.X M`7/=MRTITD.YW-V]ZLAKP+31;72X\QZ#-IT`VJ,0/G,@ M/I!BV,%AGD;*C]ZB@#%@)L\PBQ,X.X*ZFAMQ+AY:FM["8_]/&,4P8_^.211N M5/5RO%Y.-&U?MUIH21^H";F#RRY%O!^![&4A#%7/M%IX]'?2<4KQP>RXXE=_ MR8JGU4H\WRB4E3TYF>%I6&VLE>W,`?L^?Z0X*'IG[ZSG_=_(JJ);KNZU$-;# M!032;U++U$1MZ%N%YO6,T*R37*689Y]FF_]_D_3H-"V_C3TF>%PAFU,8QQR] MU[G&Q=$J;=8B;WRO62TT0_MH`3<]"O@\B@="(OA(0'AX=+FLT&HM%+S;_A/W MN"B&'A%,YF"Z/4?A`LA9,:MKAF_[+4RJ>=,9>8,C@,--5L9LGDHJA75?:V6E M.Z#A-9A$L!"W/U`4@0E4(GB'JV.UL6O>`;=@)PW3,5$^04VW_396MQ_V]"9D MJ2!ED#JB=IY]5[.8&_3(8VT\84KB'D`ZO^*T,*?\2'!74BQUSVNAAE16<`]W M`V+J$9D!V@,1>B)46AFL^5H;_4N%01-S,7P%`5L%&,>/<`K&*$()X$[\C3/X MFAVP12+5#0YE[4K!1]3 M2E$4#3(<3#LX[)&[Y#;!BDA-$\GR+),1R;-\4;L;;TDS#"!F^API>QG9@\Q;/:3;8AJ7FW"LUQ;2SHXY#)C MSC^CFY7TNDTLI%[-0?,TEH(TNF<*>K2]BS0WLSDEB]R4/W:Z*`)]D$"J(]=) M.W*IT[8=O#^4]V`[IB%="%L@:A_(K.!IHC"$%$3]%(?Q]=,3'R^WD#'-XCA_ M54:8M@+Q7;E?Q MJ*W MGTTOBYFZC%7B)A]TTQCQ3LN=X+\IBM%^YY7>%$4A96]93R?&X1VAA0O]7&T< M!495Z:@TV6V M[5"*+!W>XX1@'ALM[=-TEC(YS(3N%5KPOQK*B:)FZVU%<=->(PSS70BB!X#" M&]P#Q?A3*=&T#%?0Q MUWMD!%/W34$[I=0$DUV?$3Q,2/`L*8*:+ZA)6Q/!1Y@`;M->`XJ+R2$RPJCI MHHY7JZO@!$&AK,(P;PO+[Z-PRC]M`8M6H)(AVX(&K2)T2!42.M6L63'HXPQ2 MS9H5D3Y*)-6L^8)15.WY?BI0O!V(:5R1\5&2JR,1'&61Q=Q>?1Z MRZ,WN3SZ7N*Q2O5[#XYY1NTG)][F.!K[:16^H?NZH.*Z,JMBFQDS@BL0,ROT MB=V91W+OGYY0`$=DV6BBC%$/4.,,@&IK0`W/R>?5FH;E;#JQ^([CZJ+&Z#_< M)J7/-.1<)TXR_O([TZ.SXDYRLO')0S3![%$#7E%?2MOI,#Q1/"+S!L,< MW$;%:RT,C28QU(J-Z>UO3.Z/%C1SI!+$[P"3!:37,T@G$`?9.;:A]ZMFU-B& MWKDA9`JZH(95)82==)(R;3SW59[G M=6>JW67R',93_MV&IR4-B.EMR:EY_+4;,\6 MU8A/QS'\;\KYMMC/$SA\0X/PV?7@RV\SO$;@TSW#V6_3H.II+Z7@4?O\W@EO MTDL5U"I^G8)?*M)SFDB/*0",FJL5,B)O`*:SI6?K+R:.'^@`MJO@ZQ)*R9+= M.2*/<`ZR^S1A$."\+S*AR01,8!=$@,F?9LU2MYY[K[BM*?29!JEK+S5(Q86? MYD)K]6!=JZ4'Z\W8UMK^0:):/!V'$&'.T&3O;-A<:PX9W7?SZE%V:1LR]M@_ M@JJ/UQ&:H'$$;Q(XNZ??*$GG?4+[`-$?($KA_?QU@<5AY\CI/!P?]L)\HR"+ M"6YJQ(=`O+*8E:)X=;;DB&1U2\8/4Q##T9)<*JD\U;P$Q#(\5]#X_"42*^^WE5VCR32YCKC+N@NCJ.&1:N*0 MS7)-3Y'M;&1["*;YQ!M()1!DEB9L6O&%.28!` M!"*6 MYFJB=ANY1&(]@&A6\.FR)9?DC&H%7"H[57QT!,Y$%S4G_#/AT@U#U/+AGX)K M,\C\8`O$R]A>KE&,T1%5K1X0/$D@G5W!\8OFL7G#EN\I#BD,AU,0DN4`8-C! MX3<2A;S<;ZU<%'U\-DU3-FF[`P).7%;\F0!ZOB5JB/9M`%\J@;PJLX]6,,Q' MK5\D3JYO^8+VK7D;I[R)`L:('5DHBN*#V^H>7RIBIB%J@/IMQ$;I_]B[VN;$ M<67]5V[M_E0$&8OI5.K"]N_9[.E(MQW>SU[,'&,[F+^.V58+KHLO?^G\ M4Y[VLS25*M8?+>:6^T"U6#:U\\_KH'W,IM'G6#V@)_1L60\7B'#?,36Y5.'Z MBIXIGZ,D67?S>0=+J;+WF:%]EUX'ZRJ;R51]ZG[=FO#]K*I*R%HWOBXGF4SC M[VO`SJ+9O!QM_2B7Y>SU'H!KW7IX(&TDBR:*\=H,6`>=\!09EKM M('Z22UMA'MW93-5Z_9)/^%A\`;62CS>S4[0)YP, MWOM9WNJWF/*OGB,K:93"T*CL M>G7>=TGDUPS6+%5_SC9H7HOI(HGT8=&#^$'?=6P1-"HT:RLTJ].]UTUI+Z-X M?)[VHZ=4MC40`?<-#=#VA.@RRB5V1]Z?B@AW33UE<4]$/F6I?@1YENC>).>Z M2%>Z9,SSJ(\+4]. ML@8;M:HQ=$VS;R0P&I6AFAQ?Z`RGOBZ7$RWM0?<3SZ96K'=\`,?HXT3_B/X_ MRY_6,N+0+&#TWM;5L%S&MUZG^J?X]9-K[1Q\#;A)(3&DIFK$*I MW,#R(E5PGNM3.VZ0CSS_J?BX8"HSN`J?36[PFE25W7V,9I_E?33[]&`10D[8 MQ@GH)>?-5G@\4U=`E?!H[L#_R3S3_YYW+Z^W+ML)5J"C[_:!U9\46XCN\BS[ MVAU%8SE=_ODXFB11>BG3=+9,'J(T1CY0]F?"Y/NN:V@FKG),3:0*Z60R?HH; M5J%==Y[H>M!O,LOOK8*)"V[H2K8RMIO(%36GG\N9/L:SI,_;@XP7^LS0Q&D5 M,G_)Y*F%\Y6\+TH-6]L;]$9*7<7KJ;7M9)AD>3RV:#1YC+5Q-*EUJVZ`LHKR M^A.%UWVF`*9V1J^,].3;K4ZL MA,L%KX6+W&$TC9/E(!O-LWPG5M>37"VTOF7Y_&.F*2E1:M&,!6`L";@*M#?; M,ZS!TVOD8E?>($KO%OERXQI[4!0>"UJXV-KL+51"V9W_LSA2.5.O6IM/YQX$ M+8P2_QCI5&VZ-?2>7K,-(%=XAI;>JP"JVIJW]8=M<`FWC=[O8_157F:Q^N9/ M0ZJ;SV=7V6,BYW.;RE.DZ2KOI/$OC;*NQ MD'HB:DW5MV=55<+4PBGI:<_+IK,K('K>!-/]EV4HM;"4N*OG\>HUZT91"S-* M/S3EVM63Z^D2VT:3J2?"5:'UHNO=UK"R%*<6IA]N)G*%4$F#[\^_ M=2V+R=N8B%@OG;9R10JOQ7V4]W,IO_:DC@,?XL1"P%I(E2T`VVI&:+7W:V%1 M\?-8\D#A[70 MV_U3)C.Y5/_?980+5<_?[-I.A(0MG'K MI\[E+;_E&\8-<[3+4[3TOLRR15UDTWMVK MW2J\G!;ZO?6VT(NTW"1UDZ79MVBRGIOD0V31IAOF\%"M%34Z0A4XKM[5%^?@LND]DZ>T^QTD2W4O;/2#S MH(W]679DC[J+\>(NLS5UQ-RPC5O9=F?YYMFCO3AYIO8-.VJW]7E\I8+#7-?= M;=L9S_0K7@LY?&]LP+8)(!8$+0PE-L.[W7OD51R13:.\'R7QERRWRP4ZH;'' MV%;6WXL8?::]X$!&ZAG(V>Q*3J*[.(GGD<[*KA*!9VK2*NOQY^G8JLVB^L2R ML(T[;*$^""OD/N.W(>.^`]_5#^X;FJ55P??&EU,%B`Q$G`SG60.2\Z-A@ MI8F\-Z-H!S["]34GQ#/N'(HX?9`SO1[4/_1GSF>SA!*1LG93..PX9LVQD*TG&66G9U;8N('(3=T&WXU)C?R>S:U\R30$AD(C-TS M7(W,I:ZL3+(L49-[L=%QM-XM;`\Z(F`^/#>?PO+R]>(N&BWF^X !VK M[+)%(W7;%E28T<8N0=W"$/8=J2=CV,L8-*4K<`S-L53V$MBJ")U,HKY)F&D# M[PT+Y@1@;-.(:C"&N93Z&6EFWGKW]$!^B_(BY6(31E[`G%8N2KKY$V/%WG6) M0L=EIG8S?V,$S;__D=U=3J*9O'G,/GZS"!,!`0]N0^:$.@1EG'N&\LBK$=I) M0WYK[!QP[^*8T$OE,993.HF(7XJRWW'SGQSK@-%;O?(S+<*@XAC1*E]:: MCN,&CJ'EG[:93A%?J\=W\9C*L5IJS^)Q'.7+/_4AW+,LB[Y\]A`*4S>G[GKV:H5GS[/7IRZ[FK<7 M\*)FZYFVGV]Z_-%WJQX_#Q0O=XV'VCEZ]*^2F:2LM7WL]VK$R5V6'';\>Y)SNVS(X;-TVC MOK.:^E_N?S"YU/43=D-85@)SF/J?VJ3>O1$9C)A8K0.>1KW+7=_49=@A(^SU M!,G;:9'CX1)-^^PU7$X`7J@WWWC,U"U0O<4LUCTPNJ._]9GH&R&.WF3PF-U, MLL4L2L.SZ(\;93'18^-PTQMNKEO)#`:E:&:'%_H M+ISZNEQ.M+0'70G.ILU52PCA.J45VH;8J;ANPN,_%==_PN,WJ9K0^'?FVYFI MD+/0U,W:E8FI]<'$Q=$RF^?.E"SVF^RQP6X+G!@FY1YAGLG$!]E\B!) MTH>$^)S2AX9#3Y4?Y()-M,UE?=)Y^6\QGQ17"5J-YS\FBDP4=9$$F)54;_\[LE`TZ MTAP9-32G;)#Y$)VR0:8AO(YPF MO[-8[>#D0:!C:N'I7=S"<8O)R`%#^[H-U`-X*-(!Y^K1Y`O]\:MX]G7;0:Y" MZJM('Z+Q5F?IO6_^.L+48S@1,7R!8*.\MV8A!"=P-IL%&=@B MK&7MN(*&VW$%IPYO[ZW#&Y5);?=/-]:B:I<^3O91VSXLLX@V/7Y=#&OK\-RK M-'8:GK7MPS*+,/_Q&U:?:O8[NXYPO,+D>!!HYC<$;G@Z-7C_M>CB;B;_7NA5 MITX);!Q.M?N"QD:'J\L@CM>DI7`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`H_WPNZMT/>J>+Q'""%0N,)TCQ!RM,)N M`'WA=%7`,@S4';INV`D=GW<&?2'<87?8!W"5[55H>ZB$AE5UG,JQ=H20QA46 M&`H+0H4!0V$@5-C%4-BE4EC4'FZ":KA!;56!2E6WMJHNAJK]8?>L%_H=$?K* MMS/!.[U>GW5N>-ZH[K`35L!*UAY5`&%:!%[A=P?M*_,#K`*C0L^NY*O[TPB"` MWM"#7E<%G*S2!HX00J!PA24<(81`81=#89=0X8IO-(X0TKG"(H7!(IS!W M$":.32$$"M>?.#:%$"A",$/)PQ^.(9;XX1NC6,$/YPP^.$8?I@3 M^F&.X8(81`802W1ECVXAA5)$Y815+W0O`2@M!+8)2].&'9BV.4 MO3AAV8M7`F/T$MX&%["(_02�P3D@#XQBL*D[(JN(8K"I.R*KB&*RJ32$$"B,, M.D)6%0\P5AP!X8HCP/`2`:&7"#!6'`'ABB/`<&L!H5L+,-Q:0.C6`@RW%A"Z MM0##K06$;@V#>\DIN9%ACQ ML"",AP5&/"P(XV&!$0\+PGA88,3#@C`>%ACQL"",AP5&/"P(XV&H[)MWA!`" MA>N[-2#&0<<%0CJNNA>"6_,(W1H&?Q@(^<.`P1\&0OXP8/"'@9`_ M#!C\82#D#P-&WTL@['L)&(1G("0\`T;?2R#L>PD8#&T@9&@#!D,;"!G:ZEX( M;LTG=&L8#&T@9&@#!D,;"!G:@,'0!D*&-F`PM(&0H0T8#&T@9&@#!N$9"`G/ M@$%X!D+",V`0/("0X`$8!`\@)'@`!L$#"`D>@$'P`$*"!V`0/("0X`$8!`\@ M)'@`!L$#"`D>@$'P`$*"AXM!>';)",]<'\19<8K3$4(:5[CR-+YD]X,4"I7K+CM^D$*@EM2"%2N;\F;0AI7F*%8,J.T9(9BR8S2 MDAF*)3-*2\;(;7+"W*8^\`C!DCFE)7,42^:4ELQ1+)E36C)&TIL3)KTY2CJ+ M4Z:S.$HZBU.FLSA*.HM3IK,X1CJ+$Z:S.$HZBU.FLSA*.HM3IK,X2CJ+4Z:S M.$8ZBQ.FL_1)%@B6[%):LHMBR2ZE);LHENQ26C)&GI,3YCGU60`(ENQ16K*' M8LD>I25[*);L45HR1@*<$R;`.4H"G%,FP#E*`IQ3)L`Y2@*<4R;`.48"G!,F MP'F`8LD!I24'*)8<4%IR@&+)`:4E8U1&.&5E)$2QY)#2DD,42PXI+3E$L>20 MTI)##$L.Z2Q9H-3X!&6-3Z#4^`1EC4^@U/@$98U/8-3X!&&-3V`DP`5A`EQ@ MY#D%89Y38*2S!&$Z2Z!,TX)RFA8HT[2@G*8%RC0M**=I0.$#`"4?`%#X`$#) M!P`4/@!0\@$`I90#E*4<0"GE`&4I!U!*.4!9R@&4R@A05D8`I3("E)410*F, M`&5E!%`*#4!9:`"40@-0%AH`I=``E(4&0,G;`V7>'E#R]D"9MP>4O#U0YNT! M)0T.E&EP0$F#`V4:'%#2X$"9!@>4Y2I0+EKVF40=OU^ MI\O#@;J1>D#=@0@[739D77#/P.FK.+%2U0,E-*UJA=4>*J%I52OZ(!TJH6E5 M*T;6H1*:5;5Z6!THH6E5Z]HJI[)57MM6.96M5A8X#I70K*JBMJT**EL5M6U5 M4-FJJ&VK@LI6*VM;ATIH5M7*HY0.E="TJG5M%>,$I3UO5-=6,*E4V<+B0QA6N#EP/%]*XPM71R^%"&E>X>@H[7$BS"E=' M7`=*:%;5Z@GW0`G'JSKT>G[@]3NL?Q9VH#?L=8+N8-B!H!\,^)EP>2]0WK(B M=WBHA*95K3+7`R4TK6J5`1PHH6E5JR*N`R4TK6I5Q'6@A*95K>@X_>_VKK:W M<20Y_Q5B,9OL`**'_<*WY"X`24G8/6QPB\Q=]N.`EFF;B2SZ2,H>[Z]/=9-Z MLZVF9)&*JG"?=D.,*RH_&1> MY>?B57.B=>0(0XMZ*J_VDG(?]J!3>;67#N%A#SJ55WOI$![V(,.G!XX=86A1 M3PT!_%PA@)\<`OBY0@`_.03P'D)`-(9,G2>1+:?CP):".7;$0L\63B"31`:2 M\=B.,+2H!K(Z=H2A1360U;$C#"VJ@:R.'6%8 M48V9U;$C#"WJJ0S01V9UX(-.=:L^BH#R',Q@#R9`>2Y&$">S`#R7`Q@W-)P M[`A#BWHJ`[@],$`\E=Q)QHD=<#Z&IT6)'?I^;,=LRH)`A!,6J4-QS?L$/C#( M&00VY"T?&.0,`AMH]@.##"NPWO5A,.`/#/)A@1,OF#A33]J^C(4M8\^UH\F8 MV[YPI./$8>#);AO^P"!G$-@PPQ\89'"!C9V-#PQR!H%[F.$^6AR'/LM8Y'Y@ MD#,(W,,,]U'M'OHL8Q'Q@4$&%]B8\WQ@D,$%]OH0V#NCP'X?`OMG%#CH0^#@ MC`*'?0@@0@^9'4UY:$LQ]KVQC,-$Y5C?F*$K/<3@PAH:P$G"AN<2EALVV1X]Q.#"&D+$T4,,*RP_G0WXV=B`GVZS_&PVRT^W67XV MF^6GVRP_F\V*TVU6G,UFX4F&I;:CA_BXL`'GW&>!#<^(;>D%W(Y9-+$CF<0B M&DLYC3WS.V+'CO!A42?<8:$(`COP$W4$4"CL>)((V_.9&(_9.&1L:GY%Z-@1 MAA75N.O^V!&&%=5X+,.Q(QA%O2V*>E'4V>[35K]^DT(*$0;!NDE<%G,8[+ZN M'__MRY?GY^67#)C?4,LY`!Q@>`=F-=`\H;:_E8+/0553H'O+/BX3$M\PI^3!\?RR*= MW?<".AQ6Q]%#4=;Y'X#GL>@Z4K9>[2\6\*#V`BWM6KE.X80:3<)]E]?I:A3\# MJEI-T6W^M*6^^A[8/7VCPOVJ:NWHC8+ZF<++88O?TOG##=#^QKW*XA%80TV: M\LFO$`K^MWKOK_L<,+N]S6:UFOV_I(ME6KYLO!`$2^=5\4\N.XG+MCT$LK\Y MS'9KSJ^M58R.=YQMTJMR=3G\^/(>_QF&AU6)?+F;+NYC)ET!88Q4/SSWS1JG-%]Z]G2EVZ MIGE]2WH'.:ORF'[F9UCJ^7WER*UA*F-72!1KI/I?JTCV/ODH?SC5L'3(6]G4 M)O)O_VR,^XK#E`>T1E]FLZ)4H72/ES8.6:K0N\P:7,W@)3BMHH(*!H#__`.X M$+2K']+(D&[[;\N$V_[:CFF8*OULD%$9XP)X%:0J%9X<,OB9GB10E+4`;X=Q MBX=,/3)MT:Z,[";;8%)FNYJ#QX;J7WHQ.SZL6R9%!=J;I8]YG:U6EY78"598S/I#`RFRA70?G`-7\@]0)0!EFPJTN>\O@<-/M\7\_F+73PO M6H3Y3:XB+>A.E;IE-M?V"8!-\3W[_IB7<-DF8K]U(&7!H_9WG40IR]\*V&U( M4)[=E4X8W'I/*MV+BL2PIC=>E@K\IIKX6ZFB-1#5[%Y7U^JWAWQ1E`J7TEA9 MW>>/X)"@U4R9[7TVAWEX45Y7WMB0;VG\*C16*EYD^=U]W69!JXQ*T1NLJ&!J?O>9V255K6RX,72W="GJ`/![B0-,1VAD.AN%6 M[SVN4`[L=]DU1+5J$YX!:*Z"P+(L%=EOFEQ;G;"M?E>5WRWR6^"HA0J.C\NZ M:NU,37,,0E!>]YSFNL,:'Z2Y]RG$R]NE;K)\MX$Z7ZB$147(].9&)RC@Q)_8%5L-K'(]L'?@2\T;Z4Z\V%08 M2D]<7(G5;:,V+N2*B!>V397L#=]B/Z"L= MWS=J<\_7/:--_;;[EV-*N%[ZMM6FZV+NT9KAK^I#%:RK/6W@C95>6;]L"$'/ M]A&)9;[8--`V.?YN.\GZ*=W6*MSRT_75YT:[36[QKGK5LYO,;;\JU^7"\=/7 MI(9KX8^=LZ/[C%UER_'VJLKRNAB]+KC3W7*NB0`ZOAY6V35Q:8G`0,8UE`U#I+K'LVK#Y,U*:)U>P_QHJ^E#IE[(_?R+!FWTW+2SVAY6 MV\+BF[H-1H5Y>?7GD:Y+M`?O*4\;,U_%U]TZ=60L5*V?DG3Q`I;TZ=7M>:94W;2(\GI99MHH'EIO*&ZA+`"B M:)OUS6"KEDJ9J67E56O,VLD[C$MVZX;4[I+BUF0;Y=E']G]7[E6)!@+;5!*(VLHDBJBK-Y`?/UYLZFTEO=U<_\G*%_ M/L^SI^SU:L!JW4'9FHH5X%&OBDUM%L^`M*FJ6=,< M!MK3YIIMC;_)F-V6^=26&=5N!^;6'89&J+1N)%2$_DJ0G;*XTBF,NA2"@7ZR M\H$GW8]5"0((I"`M%YIQ]PBE"\:T*MJ+E``:RC.DT@K/7+%]H8+NR@%5.3.' M"Q>IBH_5:%/HFI\?;F:R+OFS^H)3?%?KARK*7ZUK+.Y_D? MNN\)$U^U]:_J+FCO5(,,7.,.O&=J=ZEKK14=(K]FC[4.<:M<7%E*VNX_6!O) M2!E)"AKYKHBS;86X5XZ0/[;%;+LFUM9A*EI`^&GZ6-EW,+A*-QJ:3E8_>_%%GEUGC M"UMYBKLO3^']5/H#;_/Z_2(V,JQ;-/.7?^Y>.&;W0B\6-JP3;U9TV#L5]\XJ MS:KZWJFYF^+U<6-@'UV;V328(8A^;?=BJ+BK(_F;Q^C,8*M\/'VNI>,,O-MK M/==.`#QF?9)7WKIA!M">85+O@2]S9=*O^:*7*1MX7T\"])57=?5F5:-9]]F['=#2.Z;!E9E5E'J!+[_Y4#5SF\[@IC[J:ICH@7=IO$[,-6B8R]LE)#C@ MP]/LNFQ2/&W>5;24GGZN[H_>5= M-=;KQ5U`HM8)VUIXU6]4D]N^CS.#;&39K##J[O]]4>D=;OH1^GVF#'R^;K>W MKQIB.YMOFG6#(]:.045A?^KN1=N#<[#6]GNK\0S^614KEXZ5+N==]X8=.24(+\&UM;S2NTM;R MSS^PJU?OIL+E^UY+/!74]BE%[X#:Y`^7`BI@4]>-IK8K$M^6+)S:D0P2.V%> MR">QB-VX/7K2,^'R+TU90CC,\YVI+;QI;$ON>H#+']M21#'S`H_'8?1-[)X! M^A;7UHN9I'!M;<9#A\M$&ICU923#B].7&\A$.!&SQ30`-)$;VJ'CXOJ,OI,ZU>]+K>[A0VJ$P M,R%.(Y1F)L1I@6X'J(LSOV0:3>+0MT7H0RQF@MMQG##;95(&X9BY8SEMDG-IRCH^@36/\COR#;RXS'R(%Y>9#_'B\HGB,O,\7EQFGL>* M*S!OE6%8XU=($Q=WS#W#BUM:/1R7L<.&&-?^N(P;EW'?.V)<^^,R;ES[XS)N M7/OC,F9<'>\ID,2%.2Z;]W%AUA=-GF=$^9`1Y<..C6HD<6'FPXX]>(CU19/G M.=$ZA1.-7YQHG<*)QF5.-"YW[#8DB0MS7.[8R8987S1Y7A#E>=-^&]RX:/*\ MZ45=W+AH\J%I?Q1N7#1Y7A+E>=.^+]RX:/*\Z>@,JK@PY_.FLR9PZXMF7':) MQF67:%QVB<9EEVA<=HG&98]H7#;APAR7/:+QRR/*\QY1GO>(\KQ'E.=-[Z?@ MQD63-TSO<>#&19,W3.]Q8,85$.T#!$3Y,"#:!PB(\GQ`E.<#HCP?$.5YTWMM M5'%A[@.$1.-R2#0NAT3CI7L:-RWCN'&)<)'D>6DZWP8W+I)\ M*$WGVV#&1;2N[,2%5U\TXY?I?5C&\6-BV;\,KTWBAL7S?AE>K\2,RZB[R%VXL*K+YKQR_3>*&Y<-..7 MZ7U8W+A(KA-)T_NPN''1C,L=WZ%#C(LFSW=\APXQ+IH\W_$=.L2X:/)\QW?H MT.(RO;^,&Q=-GC>]OXP;%TV>-[WGBQL733XDNF^Y$Q=>?=&,7T3W+4NB^Y8E MT7W+DNB^94ETW[(DNF_9)?D^+(C#OLF]N$08D2AV2*G5(JM1!-/LU MXL*L+Z)9/2.:U3._B^I1MJ4:8&:J1PS,3/5X@5%U,3/58]47T<*9.R9*1'M2 M6P.,X)&<#3""9TIK8%1=S(@+K;X85>I@5*F#4:4.HLN77;C0ZHM3I0Y.E3HX M5>H@ND.@"Q=:?1E7^I`#HTD=QI4^W,!H4D<'+K3Z,J[T(0=&DSJ,*WVX@=&D MC@Y<:/7E4J4.ERIUN%2I@^BBIH+J;5%#=32J([B;MPH567T3WX0BBFP0$T15,8/9>`XS@X7MR2IBE*XP9[Y,!HFF+7(0F8@=$TQ:Y#$M`",V[%00Z, MIBD:M^)@!F;N0%V:LL*(R3#R$SOBX1A`@=JBL0CMB$U9)-V)=!(H5LR@+LX"#P1E7.;# M"FK_UTD0@S(2!4Y0'42!%11!G^(4?:IC<1DG*$'1IP1%GQ(4?:IC8P-.4)*B M3TF*/B4I^E3'IAJF\BXJY[R M48+J2F@OKD=Q$"CU=3.C!?I4<>$T0O75-C-C8-57!RZT=MA1B5#%%6#%U9'E MHM57!ZX`)1]V5,0XC;"C)+D\34V]V`^\Q&;))+1E/(WM(!I/;1DDP9A/A,OC M`')"X\M/%_>9FP-!&7T**RBC^6$%9:R(L8(R5L180>W_2CMB4/L_T8X8U/[O MLZ,%Q2G&J2Y0*#.*CH(1JZ;,H)!JBF!&T04*J:8(IDE=H)!JBF#NUP4*J:9< MBIHR@T*J*8*E1Q\$*BB!1=+Q9@!440?83%-E/4&2_CEUD M6$$19+^NKPTB!460_21%]I,4V:_C;1VLH'"Q7SR5W$G&B1UP/@9D46*'OA_; M,9NR(!#AA$7J.^@=+X`$%[>-MA]J;XZ<5V>OA(OF#A33]J^C(4M8\^UH\F8V[YPI./$8>#)0^+7Q<7E M/G#!A0(O+N/A;&AQF5=&\-JA"1=<>''GLQV.RVB':'&9&^]X[="$"[>^:-JA MN06*UP[-S0V\N#RBN'RBN`*BN$*:N)A#%!?1^HL1S><9T?R0$*W#U2ABQ45KMT:AZ+"M5WC4%0A153<>/`%6E2XMJ$%(@CLP$_4 M]^5"8<>31-B>S\1XS,8A8]..TQ^#BSO[]B!0'2<`B4LSOX-`=7P-YBR@_O1E M%].OP$`%``<`'5H M="TR,#$T,3(S,5]C86PN>&UL550)``-6B?E45HGY5'5X"P`!!"4.```$.0$` M`.U=6W/C-I9^GZKY#UI/U=9NU?K6[LQ,NM(S)=\ZJK);CB0GV7U)T20D84*! M6H"TK?SZ.0!)@9()7D&#L/LE:8L$<+Y#X.#<C@G__X\Y]^^(_#P\%D,K@,"$&^CS:#7UWD(^J$ M:#!SG@,2K#:#"\=W(]\)H;?!#2:_/S@,_<^`_]<;P$^_GD]N!A^.3@>#91BN M/QT?/ST]'2%OX=##@/B8H",W6!T/#@_3\7Z.*?LT^.O1AP]''S-/)D%$O$^# M[$\7%,4C>T#3I\&'D]/O#D_.#D^^FYU\_'1Z]NG#R?]EWP[6&XH7RW#P7^Y_ MP\LGWQU"B[/!Y&ARE`'YGX-I0!B\O5H[9#,8^OY@PENQP00Q1!^1=Y1TZB=X M!\!2PCX?9"`^/U#_**"+8QCF[#A]\>#/?QK$+W]Z9GBGP=-9^OKI\:^W-U-W MB5;.(28L=(B[TY!WEM?T]/OOOS\63^.W&?[$1"\W@2NX5('`@?(-_M=A^MHA M_^GP],/AV>G1,_,._L$'_($&/IJ@^4#0\"G^+Z#F-XCI%W.$&. M?\7XV^,U7S/PG-4#TVXH\VCO'(IJ?K_VXX5+%&+7\;7C'X&07"$Y[H@\(A;R M9S,:L;#YMRWM6#>2,?"($5]=F6 M_DO,7#]@$473:+5RZ`:XB1<$1)3KD'#HNJ"RA*!8W04^=C%B0\\3HLSQF^]P M6H;4!WR"8N6/+?'Z%QPN[W^@N'N-`;<;51_\='#O%I,`J-Z,GPCL MJR"A1B1$%!2[IA`K]-R7KZAE$>LD01]C?HH<;E<"75PCVBZ@X4,0A9E]^)X$ M#]Q7X#SX\-HZ"MF,_[,I+UJ.J@^^D*AZ9551EQKU,W>)O,A'XSDL'[R*5M=1 M"#^?P]BP,83LF@:KKP%QN;/%YTR+R6JLFS4<3A_@2_00:OU.Z@X[T*(G*%[; MW`+Q,>?2A(\%.OP%]],)C8ZK?&)S!QT?7L7A<$&14/I;:]0MA^^`(6-8S-RK M!5K-;4##A;-`[.K9]2/^RU<4\J]S1]$*1ZO6Z.N,I7'+60#_%J"Z`XL9&"_< MI>NEZ\CC8T[0VMFT^;YUAC`"3,_&V70\C<('/V(/$8\KG[%+803;,E]'=S18 M4&>E5S(U&TT?W!$,1?C>?.<[FC7Y*EWK`Y(81^<(.D=#[U]1XH<,X@>)^O4% MR+F:ST$,SH)+[$>P;4S(R,-^?QZ1M3%C&_9R?.6<$N[ MUP?H%\3#6*`P/R(*,GV"5@XH)V0!CT#=.S3^`WG;@$5F;8[GB4=U/@?[!`1Q%R[`MH-K-`_P"L-72W@)H]DKN:%9W0TF]6:9E1W1/6(1//'9_K>],E0B$89*:F6DLR.K`Y8$>$ M;6'M^,,5'YA=1FA,4JON:Q!R7_>&;XGGFWOXR-)@N+FYD-1JXUCG=-G#0KVV MWJL0J5%K0@LN6<`0!1*Y>J95*ZK4N5:?,`T1]3<3Q"*_;B9(03_ZW9^CT4B& MOT$GAB\?K2(1,+U$:XI`@VS%^9K#&`.H9?&U&E-G!![6LRLT?*'T2UKN:+!& M5.P[VC]URU&U9(X(N38+MK;/5F-AA2D1,_0J)(_Y+S5_O'K#-D?]"(PJ&T2U!^X8T[<(KI`E!7D04C2],N#AJ/WDB=Z M)THK&CKF3QR"!:L-,890AQ*C?"#32/5^]*K#=8Q:!+!)UE/*0AK%C[K[V#5' M[14/]$Z#1F-WK3.%,-1.[C-_M\/I4'W`CI%SAS&"C5KD$1'O"GH,-@B=(X+F M.!311NW@:XW9(_QZUT&#D3OF1=;C(T^?="D5:XS8&^QZ9T'M<;N6A'M.LRYE M8(6A.D:[=;7EQ4VU`ZXX6B\PZYWEM<;LW#HN]]%UZB=H-GS"%5>>L[X!'NQP M!]Y%Q./9\_&OG)+VQV7C<8_W!NZ0FG;G705A0!HP;8<T-VYDU`CCCC/ M'?8@SCE'['#A..MC/JF.D1^R]!^<,0Y M(!4BQ=M&*!.)1N8*O_V?$CI""[6ELC MJ(+5*B#"="L$L/^:$5KC50>+;)L6JR(WYTT3%%^B.:(BV9Z%6R%8.,&+6IA$ M,!%:K8NP.('#95L)@)P&)N@?<0U@@8&$F(E`QS;?_TL0>$_85PG%2DT-81*' MXI*TAXN(\N@K3!9^[";^0PVIM*491*F5>!YA/TEJ3?\Y@MTU>(PU326NJNW- MHF,C[A89>H\\E0ITZ4SZ:GCM8%HD@NOV8@+I#6C;"O+%(R,TE>JKIK72747Y MI1NUG.S\9F:P$)2>&E/2G7G%!(UW--FC2M6>O#=-4)Q702?)1=DHDU]R$37I MJ6^(U,4%AUTVF]S>1.SQDB#I]ZH@8ANV(N M#9X8R"#N(>.;&\CAM8.%3?%BZ=1MOB4WX^@;TEW*'>JFP\`_7WCY=LL')F\< M,WYBB?=VB$.T2MO/:;!ZX;](!PO*EOX@H,!I4W@+K(B2"A_MUJJ*I- M5N+[WFI\M?PI6]"G)V\!=*$;3V(]M0=KCE&S,` M*SD))?"/;P9XQX>-$K]%2D%E^'&D M1F*T2"94$X&Y3GZY`5AD;%;#^S*10X*UR/*L!E:9W20W.8L,SVJ8JSC%)7R+ M-K2*\SLO^4?BM6F/JCC'Z^8J2F8TV;"LR8;=K35@DO;2VTW:!T;2JKJ.#V9[ MYBAR3C)#R=LFHDKG$0.)Q5A<0TA\B&F(UIDCLDE-R\17,2))X6M>'P\Y/%F< M<_,+R#U%.$KG"&;2+V./XM4S/S>ES%!Y\9J95$!I'O#0S8H?"%'L%ZI\P0K M-C:33)?N?+S0N.*HF3*%KDI;DRF=R0(O2=],WS)!*>@;DHT*.G??,4%EHBZ0 M12FM>6\:I3@N*1!3LU4VDE+[XMD$/2*B3%FKWX\1M+%&RT*YJ6T)5P$K:F($ MPQ-88ZEDO'6(LQ`L%GNU"D-1$R.ID(CR(MRB(K%R-]A[R4Q&F)BKZKRYY+'& M7"2\>H@HBUW%:00I>Z/5"^V[8L..2:QB)]1KKX-@63@I=WGDO6)BFNW5WOX: MK1X0%:78D2?N$MRIN[VMXZZ8E4U[ZPWR\5Q%;1W$!;WT".D+XL"8QFX]G(H^ MC#J;5!;F;GY+@65G92Y:%=3%^[>5>6F58!>J7E:FJQ7"SMU^K$Q0RS6]=CYM MGM5C9?96*=2*;@`K,[M*P6OUJUJ9`U;*HJKN+RO3P$K1UW=T6ID05D%*[+G5 M%!E@/0\8%GBS=B/$J9%LY:F)BBA?;O:*#.R>?]1]ET;N1E[=&6AI+EL.#\K" MGHK$-`N1*IQPEF:>Y7_*FKXJ*S/2FF#/NA*M/.37T&.4G?@U73%69N]UQ:8J M7LEV&8"&LFI4R4XFJN#ED%%2&ZZHQ;=P;4DXL##![8X[)6'AAB'%#U'(#S7- M@C@9K#ABV+C7OG%B@M+4.#>68=NESGT@P_'%""PZ1/&C2),LJV+8Q4A]XM@] MH2_M74GSD&+&"_1&E%_J`K\'7D.&M1C(L->T5+AE=Z$]26*EO5$3$@B]V:]7701J/8O:N_QH9N2O>YH\$:%OFZ\;2;^[H$_ MR0LK:W*\`H\TKRI%=/4M[1+].6W$:T9=^\$3&Q$/4^2&\N"1D0L",DE"XSFO MH\)O>."79-Y1M,+12B&1RMM].ZG4RY-*N97+8F$`2X7R8-0EBO^OTDOJ=*$A MZY0/!),K%I7\Z."(7#V[\`W2HWM<"=Z[R'[#98!#\O-F6W;8!21^._$\/D,) MHID&+D(>:XVK0:^F3Z3!OWW4[&B:LJF&#U8W$^,+S5'F&O?3AX-G8F.+ M_CI5&(8N6(UBHE^`68I)!+]E;C-3!B';=-HC/L2;EF8^5.VT1WS8"@:=?*C: MZ5N,M><*).[\X7;5EAW)5I2F1U:XMJ]A+QT2KW)P5VG2!5GYEFL5ZA0M.R$R MM<6DUCPB=6]6^PZ1S=LU5<70/8+E%V[8;0*A?:5&K6!7DMC8)V_1G1??CET+!ZHA7R3E6ZS\X[&M@NLL8= M?XK"T$^B)-OB@'*WG?"H5!Z7:S770NXF'B7A069#&J?>_O1`;.9K\02E6L5G)+:3,S6.0RJ2(SU.^;IK[\"E75VR8H%RF&_!"[Q]UYB+"B M5!3%RV9S41MD>^T=%FH5$K+R'H>.F%8YGKAEVD>+CI%WQ+3*P>@MT[ZSZ(B6 MG@C\7O9\F98IIY=%167T32:WD2VY95,ZAV_F4?ROIQ^_? M]VQ2NO>D[#[YQJ%]EZUDCDU5L30RIW:`2'+,IMNDNA7?*@^:Y)5%-:KT).SE MK;Q\A[#B.C8[)U0;+M5P.2NN='MW+"N.HBKN>GL_,TO#\2XK+T3NF(5-CI-) M/EKD=M"_8LO]QI)1]AO0>D1;O=0*R;\W8%[K5#HR473)H[^_3QXUR;.23'L# MEK;.B56>C"*=%&_`9M*DXE:+`4O.O6\+JDY`6?+,?I6MYO&H2J7X['>DMN!* MM6H`5EYPHY]9%^A>MO`%%H06_M%8::EF`RWZF M-J^PHKCVZ%VQKKS&@N)ZI/?#I:3']H5$;+U@J=/I5N^8G.+RIG?#PK*YJ"C> MH[@VX]L:+BB`H[@YHZ\\TU<.(%VK-4X&VU4)_A58I:H685?%\E>94SF'N%N6 M'G^#;*I>F\&N^P9>@76JH@N*&[?>\20K*+2BN$WR&[,*2[TH[DWO*]?:GD=N MHSB%Z&'_"X[Y2S MCV[&\RE>$'&G'PE!BO"D#7$UE(]=+EXV$V_X_BN)))L*#ACB:#[NYY09^J*V".:I57<1=9?` M_#N*Q1D>87>D2<@`)!M`CB6WB=N\4+D5.TS>&=VQ`V94/92?? M%:E"-L4$N^3X*]C#EN5GV3G-*ZB>+3.^S/@J4_^D=XN)H&_\1!#EOOIMQ-9: M3VIOG-<_10[,M1#Z?T09'_7P(8C"3##GG@0//,;)I^2(K*.0S40J@4'*1>"@ M?Q[VJ;M$7L1#>S!M\2I:74=A%!_3%5%@7DU`A)&)BWS.PQB'"=>Z/`XF2(@) M3:A.@YV7D:JL?-76)BS[BK0EBED[@&DG/<;):RX^HO]%#E4YP!ITU&^\043U MX-UVU&N\,QA5SP?.]-1OQ$^!'KQI/SU&.P.3$3GS4!EYJ]^/406[YL:359SK M2G8K_7?=\R>[?JSTN;T*BS)"U4H_V6LP*;/36NG3>A4>2>U+X89Z[SS*[G`* MIU&O?17$SXH&Y&+@)"XYC7/?Q1I>.FE(<,% M2#]1(:D/$,91R$*'\#!1>JJ!73V[?L1_^8I"_@'2^F`FO4(+X-K""1$PE@4^ M]G@F:>H2$+=G;"_5,&'Q5PA(Y\>+#=%XZX"X2`Z4R;M([B@F+EX[_I`+#"Y8 MN8"M@*=6=SW'/B)?8;[.GI#_B&X#$BY5EE"[/GO/!7V?/].7':A!\]*&FO=E M!6JAE.N"'7=F!^ZG0!MJZ,JH/IFW#665QI9BT$J;7RM/MA/&2MM>/RMBF6&E M#:^=&?&V8:6MKI\70G&PTB;7R(L]-=I&^[N&W=6;T/OVOK>DDGRX2:\TNZ/! M@CJKWCD41D`;X9D"O(1R_T+OR;'!^=G! M1-Q[24+JN&'D^#=XSBM.[+V9P(AS9*X#6H;5O->)IV(E=Q7N3/'TJL'MI6?] M6PG*VBC)H6P`%M![&(1F:U3;1W%O9#E,?X\7R_#BA#[8>WA9L?BNG^3*MX#N M8:SV.5J==\RO0%X\O;.75;RXHV+7`.U@!`V'/)N0E&84)C5/-`'=[]6$HZ$) MW7NWN.1Z'=KW:^A3;R-2:7T;31_[9;^V?.X)>D1$F>?7ID>C%I*VF9\UJUKQ MUTK'E%XVZENT"M=6S\\6](*;A5N\956N^\37%UJ$PLO6[W,77>BR_574SQV? MNURF2\0/Y\T[U='-;?%I>5IM.WS2H2$=+AY=>1UC3MF"[@:R1M"4505L"B/HQ.. M:MT5K4P)Z1-;B^XGLBBSI&]K/^W-ZKP4F6RSXMX$?N9EG+L.SS?WQ,TDL=S< M7$@71*]"MEUCZXW/:(H6\<7-:^XG)8O>A?M_BAP:(NIO)HA%8#3VH?[%:#22 M]VMQ)[/K1JM(5%;/NI]-.-"XX"'0]T82R-/&0AJYL1<7%&(7*2.?E9N;\`=4 MX?F%0^F&SV.Q7,?S;?T]:#):K6GPB)*["'+Q:QW"%AX5U-MMW)U9[.*V^6&8 M4O:SXRM#P"6-C&HKU0!E=9#FG]]*4_AU&*26(5;:O_695GU3:6>^6K&K]T9U MXT7UB"O2-+F!-I?$)TZOV&`I5$Y>DW*A+<^"K1FT#;VRPIMU9C#@.>P:O]M' M"#_L5B3Q-_M^=, MYR[?5,EW5/=]@5:GNG\R]IS5 M6Y]K7LC"8HK[-S&J&)RU)LL/QYRT!U`SNQ:X?J M-5V^JE*M2MUS>U\F4"0D<9LB-2!959I?;X`/@9(`$"!!`6#1X;OK*>&1F020 M[\R__=^7=?CF":(DB*._O_WX_H>W;V#DQ7X0+?_^]NO#N\G#^?7UV__[?_[K M?_G;?WOW[LUL]N8BCB(8AG#[YC\\&$($4OAF#E[B*%YOWUS`11`%*5[LS4T0 M?7\$"?S?;\C_]M_@/_W'V>SFS:?W']^\6:7IYI?/KA MXT_O?OC\[H>?YC_\^,O'S[]\^N$_ZZ/CS18%RU7ZYG]Z_PL/_N&G=WC&YS>S M][/W-1S_QYN'.$KPZ/4&1-LWDS!\,R.SDC\;3-$H^?O; M&HHOCRA\'Z/E![S-YP_5P+?_];^\*0;_\I($>Q.>/U?#/W[XC]N;!V\%U^!= M$"4IB+R]B60QUM2/?_WK7S_DO]9'8SC\=#>\#M9/'XH?B]%)\$N2[WD3>SE- M)=!YPQU!_NM=->P=^=.[CY_>??[X_B7QW_X?LN'?4!S"&5R\R2'^)=UNX-_? M)L%Z$\*WY=]6""[^_C9;I>0S_?CQ4S']OU_$7K:&$::+?QFE0;J]CA8Q6N=` MOWU#EOTZN]Z#/ENA(,T/6EJ>V@]DV`?A2A\Z@CG#$W]_2/'!)%M,%U=!A+]D M`,+[.,FOR]?("T&2!(L`^N]F$(27"1D]W9`+AG]/U)#IMI5Y;.\!@HK?K_M^ MZ0JF@0="[?A?XQ=U#>F^U]$33%+RVQQE2=K^VS8NK!N3*:81(H\A@BL8)<$3 M+$!HC0%W02V0>\&[VEX/*_R55W'H8ZYR^4>&K_@D\K5CI+:+:32[733UK7J[ M8^<@65V%\7-R'?D!@EY*;T5K]$1K=H7_(DB\,$XR!!^R]1J@+:9FL(SP$^6! M*)UX'A9P4BR%W<=AX`4PF?A^_I2!L#V'T[*E/L1G,"Q>WU6P^2U(5U^_/.#C MD_\5^OBTI-LY`E$"O'R05@+HV%H?(2Y?@H00_@9B`6D.T3K)@8G@,PBGFQR$ MJQA=`F\U76!(O\3))DA!>`6\(,2`044&HG-CBXBP_[Z8HHC>5XX"-O'P^UI( M,P0D_,,FKOY3Y\U0WD:K^(6ZCE*(L%D6)E6WY MBEHNL4X0]!'F'QD@>B6&BTA$NPLT>8RSM,:'OT;Q([$L@,<0#]MD:3(G_VQ+ MBXZ[ZD,_?U'UOE6B)37*9]X*^ED(IPM\?8)UMK[*4OSG,[PW9@QI<0T$Q*B%6"UELU:;JY"B9["XVT0#"0-"I1G9"\OPY\2J METMT1.3+F3N6\?'0()TL$R#(%%]F8M7"4LUMC-(E6,+D\L4+ M,_*7.YB2KW./X#K(UIVQ5]E+(\M98OHML>B.29Q@Y848@/WJ'OEDSQG<@&V7 M[ZNRA1'$]##.MOMI?'R"I\"'D4^$S\*D<(W9,KE']RA>(K#6^S*UVTT?NM=X MJXCPYOL0:);D99;6ATBI')U!O#B<^/_*2CMD7/Q0BE^_8G`N%PO\#,[CBR#, M"'B$[D\@A,2ST1)5/9MK)T;M-23GZP4B+T@(RRY_[XANX_+Z$/H-$J<7%IB? M(,)O^@RN`19.HB5^)U($O#0#X4VP@!B,@Y$E5(7XC37G)M#;DN1T`.KFT,&? MT-\Y+&IW<[HH+:J+!=9/\$/"O4JECV\+C2K2RPBZ)X8S1 MU\B'J(#L%J:KN+72WW(WT^AJ8?(ZMM9'"'Q!,0-.5A"F6"$S==0Z@M&#SH$Y(F8+&Q!.UF3C MY"*#TZC2ZN[BE-BZMX0EGFV_XH],%8:;FW,*K3:*]0Z7.R34J^N=!$B-4A-< MDI<%*Z(81"*>:96*I!;7:A-&*43A=@:3+%2-!!&LH]_\>7U]3=W?6";&7SY; M9[G#]`)N$,029"?**VYC#$$MEZ_3GCH]\/@^>[F$GPO]%)9[%&\@ROF.]D_= M<5L4)BG*BI_Z^]B*NUI%`[W' MH-7>?M-BY9UK4+3XT^Z3/5U%A1VMPUWL*E/?M^R4\,)KU^09*;-4S MMCM3&\MOJAUAR=VLP%GO*5?:LW?MN-E&UZN=H-WV)54`\F0)P\GAK;*#2?+N M3SG!0!B^?5,N7$=P-RN(T@]^L/Y0COE`)O0(#]Z*Y)K%T3L?+D`6IFK0'4\_ M#:PQ"5-I#6HQNT](\QW>K>'Z$2)%,/>F]@CC"B^!O.P1OMM11@U2U@(EO/ZN MG,$-AFP/9GS)8.23M)/BKV2I[GGF^;9X8WQ]]W;+\QEBQ"11CE@"O??+^.F# M#X,/Y&4C_\B?N'<_?"Q3[?\[_M/O$[RU3[:_"L&R6BX$CS#\^]OCWS_T#L]Y MAHAKXPJ_7B#\)P3H,O(O\IS-(]"X0_N'LOIFQ=[W$`6Q?X7_EC#`Y(\]-9R$ M1G)0TI&G@[%V[/'E@M>8UXD`90XW`FV9CB,#:3V'YA10%J>-?X78XTX'WQPO M*P`K_[E_:(IG]QR2R%`L5/KPY=_AE@$6>]S)X(O7ZSC*C3YYFGT]))4/K&C2 MR2`O'NJ=DD8$6>8C)!Q^*F@O2AF,`]U%7P\"["F.0_X#_'YZ8JU^_$%L#]/_^-D49I'^,HQ3K19=A;K;`>EUA MK7O[9H/%#9)W_O>WG]Z^R1*,4KPIPNKZ(LF!YJJ#.(7P4A'D_0\?"3F-8Y$3%'\/!@4CY0]BN2/`T-R3_.F:/[D/)H';(2B]K/SJ+%E-(KA M7P:"X9$^25'\-^=1Y)OI*)9_=1[+!H%XA^K''P:"*D]3IYBZ+^1PM#"*HOO" M#M-T0!%T7]21L8A1?-V7>ACV%HJ>(6F'Z6>30'+/7%XA>*3*4S9BZFT] MXL8Q/^Q_L\J:J(K/WS[L^QK[\S]V*PW=VJ"R`,EC3O@L>;<$8%-856"8)M5? M#LTKY9]_GW@>RO938U.:V-Q-UPJH*X^`5S+V)D^0.XN\T!R]\ M_)16,8+I+H?R'@3^=70.\I*9/(PXHXU`GA<+Y`%:_&@.KLECDIP_!R&/E4A--8137G6WK*M0:N'XZ)*ZGL5_ M\%%JG&D&HRH,_2P+PK)J5O7/:RR3Q$]%*"L7+]GY9K%+KDG>Q<1_(K5:DGE< MJX^57H$`B1B"ZBHF,+W!VC0'_/RG83EY.]"I4?,PK5_451ZQH,@::1KBR#_. M=I,`GSG-#"X1K(K[&,,D/"%)"2?)<`D1*RR=[U6@0>]TF7F&@"GP>(58.B?#<'\/H((Q!6-NDC MC\@AH,<#C<++R@7@##(#IZ0098G8=`Q&P\LEF*#AV9K#")`G*6_TFEPF'HJ? M$\QAB;>$")M8RMB`(+?;'!U8U>FG=TJ*K;'.`E2)B>S*7S>%4BGA)F:YM MCJU2Q%;'M"^P7,)X5\=+T@._P_B3O?Q>$F.1 M]Y6B:5^LLBR:/&O*#K?/]O).R4\HY_*E"-O+5!7/+#/F@>)I+S.5,CJRE:U& M?S&]M/:R5F7\6_D%*"7LY;=:*7'P:-O+C96Q+OSL%#5[#2=:/NC>-39D+3E* MDFXV/N\I=``&\P7S5/W0-U+CPI/B0HACJ%@N-"2\L#4R1!4E.-H^7)"-JF&0+ M'D)V))A@"_S-3*EIUAC+W',LE'TFJG; MR#;#\;0TR_##<;O(2E##<<$TR5;&'3"]8EI)7RYD1[3'DEV"S^*,"#E4IHA,1YXO$IPP)5V#-W'"+<:JO(P)7"D8#R"$TT45 M/7X?@B@E&&S6_()ZDI/-5)VK@DBNL&C$:?K.04MNKLG:A^4SSX5_?]3HABOH M<@=3^FDYM-L?8Z2R6!$W$RT;866--`KQ#1;RL%Z80[,3W6^Q5K#.UOEO,_@$ M(V[=,?5UC%5^(_(6%;=V@/,0$TTQ@L-S1,S$Q6M]"R*PS$F<2Y$\'$13C#@] ML2Y,U*]EKH7Q?)S[@\P4Q,K/*K_X6?FS2=@:2YP=#!M=PS:4N1*670K6CQE* MBCS0*BOV"GBY`1THYQ*\[<]U)W=*(XB_G"*6H4;E5': MHUS7]8R72AD#7_4&JAP?C.&$M5)[V7#"5_D2TG`"5IE^B^%$J4HZ%(<3L*HU MGF@XP:VR#O/AQ+>JAT,,)^CUR.$^G`V^X\>A6?>>5';SE0EWM=@CNXKQ< M**0MAZ*BE=N%8MH=$)=QX;A0=[O3M^?[2M5[504K(=%?5 ML+IME)G!JJB:5[BT=ZR>F!\FT_-KK'!!%#SEQ0*3AE>NCYULHMC7"!VKHQ3F M"0H2+"E<9`C_;RPU!['?DF`=-AICYEPMI_):O,*:7VI&"(?6B^N";=D`23MQ M#Q?,UX9H*B6U&;=SCY[6TUA)G7>S:KM%0_+2"JP'QAVUK]K(E%O]]FMK1]S2 MX28L3Q(5S6_W#NB!4"L_WX1;@7"!]@FH;E M4:H*Z].6CC-B;V8E=>C>PA5C00^_T&$>[%,XR-7-ZZUV&0"E&BNY]+.;A@>7T9R$?="%8XU4I*'-5)A$ MI[\/Q>?3M?H).89QA-]K)J#BL4Y"W:D\_\`\;,R7Y`)ZB&1[$`L2_G<<)7$8 M^**J3NKKV(.MD(,+I[CM%SF%2\24-Z2P7`B_[-X0,Z7\XT60"ES;M0%F*D;L MMV434I,S6(,H4D8!+#`V&3>"4WR8C32S([W8[\\YU1YH"+)@R&)C=G M=(S:4$Q$%YR'7>TT*I.:%C=&EZ)@>XN)"6I#\!Y7W0KJ0*R2-][YF[T(VD#1J8O.4"UD_S:B* M?0O&TWM>4RBHDFWEJ)^YA(9C=4$KW=@?ZD'F:UUI1;Z/(`RK:TBU/A\GC\(P M7ZE*W(Y4R9QX7(W@B)N8?U2%3$(ONF,STP%&&NLRG0XG1%G8)-%>K:4!.4D> M8CS>6%^?6AI\XT+*CF1>@'J,A`NY-9T#Y;L9*(VGS]@29&\C8I(R3(GJI^'D M$Q36I15,`P]#W3UX8?<@TFZX^PXRYIBA1"8.*U;N5042C&:U42$ZC83,>"*- MZS6VR`9&&.8Y2%978?R<7&--#$$OI9V8C:3;U>UIQ/`5>4$(]Y)UYS&!^1[% MY"3Y9]NO^-9<1[LJM1,OQ6>,U,=N2,CH92LCF6"UEBC3Q05\3"^"Q(NS*+U' M9P$9K>5HFWCIW,)*WA,\DEFK)_Z%F]F22G@.$MOA8YLX)#NYR M<^W!JK"`XQN9J]^5&JZ$'&<)'7E3>"-\90I%&!\;_(9>OGCX9%5=[8FYX"98 M!RGT;P+P2.KVYVH5B-@-T#HNV`=*T\6,,""`'T>L^Z/8@]!/.N/58E539Y(P M1V+>P/\LBB23AS_RKRKH*1,@KR>6X?#ST)0*V'59'1^Z;L.:+KATYR<"JBV@ M`63"H29)DJVA/XUJKS4Y3#N9A:%QRTS3`I[7E:;*2QC)N:PU9,/_#F$NAQ]V M9F,>?*FI+MM#F`=#M<[ZKXB1)=1Z'1-'Y+"6?FZ`:^[/WCC-!EQX?0&D,.), M-H'7H4!$I%P/943!*<1>K!)!+$,]YCH1!S_%1:S"LWI4B?I6VHAI:S3ZFRKF MLLMJ>%B.86!+P!<9+#1<1!PX`JXRC2A7Q]P2?8V\VG^3FNRL=\D(&'8?Q(')SHN^Z-&WU,9@P!3EMV1 MH1OB=Q+?JXP\I\4=P^\DA]@=%W6/#@UOL:;%+:(+M2-H/!^RB[I'AW;G0W5Q MB^C"\%MT/Q^RB[I'AW;G0W7Q(7;:8(I%I;&SYC,K]*5=Z\Q261*H7BU7Z1%X M7F$#F2E]@,56O&2@X\SL!M(Q9W0=<5>D6ISB/F3>P5UO@I0WCA[ MN^_P5(.9OTH?P%_`!40(^N<@#*M[/TD2F"8,E:/36GT@@LD$ MHF6`E#RM#_`ZFB:ZK6>F*F"*67'A#OS(DWWVQF@@NR!1,I$H5ZTT M70NXVV*7D@8UAC2M8F'\TI7!YG"J*YBI&IC#F%S%:.(_8:4?SN/)8H'!9/B1 MI>88QJ(>1U%=N6E$7[N:[YM;A+#E:B8QKUV&!JSJ(\U"O+,RG<<,<:MIN$G8 M\7DOKB]-=J9Q<@_98Q+X`4!\OYGZ.E9@>Y8%(?%:2:-%)U@!?[/S73C%4,74 MW0-T'H(@EJ4E[$# MU^YHVH4A%<64@J0;IYG!A5X3F3>#/]XT]`_0RS`D).A4`O;Z:"-9@Q[6U_$I M^!HE&^@%BP##(NJPP!_O-/2=>D1T+!!^5!B(!SQ[\)@;JP!O=0!D2IKOC74N MH_>4<&:;36&6`F&5V7`=+6*T+EK4BMVHLK/-);7VF9*X5TY%*J[>A?*>IZ*8 M1.*C"R5#3T4N'KMQH=;HJ6@D&^UOOG:I/333FK'K0I7\W@G;/FG(A3+XISJ7 M*N'Z+I2WUY6-NJO%(95/N:/,3Q:6MNV),@KA!I0\]E9E[)T\O+`S2AQ[A=7> MB7,H(KQ0B,H92Q5Q3MG3+R(6Z47/9*H?T_/HKAI)1H]DJ8O1.- M%^1'B6.O_-@[<8Z"NRE57H]TJ!+AO*//SQ;V?CCQJ1'F,U!"O6)A6B;^G!+J M%8O5:L&YE&2O1-AF1_12,KP2X9ICN3RNN4(I8Z]PK5YBH;H]S=4`K.Y0U`U_ M[FS56B=6-S+JX8RT?&)M[&'4[PGB5`4RWX[H]!3A%T6AU##%>P96>EOBZ^HM M$G'0O+DIH)5^<'M9:G\$$D3M4<+8:YDZS/1X>8(4;K8:X0Z!5U8;:<^ORK^I)Q12NEDKU1_FM>8EVA#*62O9-\?A;H6 M'*/4LU<+T%LLBO4TL9/M*&WLM4?U2!N%)#Y**>>$:8VGB)..3HGCG$#=A3@: MNBQ0RCDG9NNF7)MF#I1\SHGC&FYE5TNM_,2.;#\Z)[KW(3+4 MZ@M0RC@GK'=\KY3KSE!2.2>U]W&(FDMR4(*]2D%=.?^=TNNU"^^-.?245*]1 M>N]:DIE2SSGQOF4YW0/JU0O24F(X)[%K($8_Z3&4ILZ)\7H.6*>*V)1Z]@KY MC=40=FJA8ILRXPUZ=2*OWJ6-HF](9AK[3VOJ/ZWYF:$'PU[AL!-%E.4B2A%[ M9/7:!7[P5X1KKE;O9D&:Y1V]HIJ7<[,4:=JBK#% MTI4TU\LE_XVZQ[)06IN1+&C4)%R`+TP9ZL,I([9T"OC!J/J)2 M&"&J#]7?/UF`[`K/1%[V"-_MT&[`=Z_65A44>Q0S.P3$&CYUB>(GFT-_%2N/ M[4=U'S0HI"F>_'Z0PI>XBA>;S_DA*!/YD.V7@.TG2X>@F6$[YI'C+!>7O"*^'.Q&.$1FT_- M"["CQ=ON70$F7I9"S+GA.23$XS8Q9X\S49ENOSY84\,5N4DF\*B<@]?K#=9' M\@//Z2'?/,$D_%(P&X6S*&15\U1C_<8C[\L23A??8G+-=DFJE4.2BT^KQ4SB M72O@=0;0$C^_]QGR5ECQ(L5%#C9[0_KO M3[N??K,'T='/)BC&KDHV?8X@2E;!AAYP#CGEYVMH8W,%,4O'@MN+%R1P#EYF MC%8!O&$FB'M%1`=X$SSEV79[;*?.E,H"`W=8H)@_P_`)WL91NN*QLXZ+VD^' M?T*`KO!8+?CO%G,$[SCCL=.6B[F!]QQOK^^#%ZLY@OESK`]OO)9E6)]M;\&_ M8G0>`BPX\8MTJZQ@&884NCNPAL)R]:JKV(7IUP0NLO`F6*A?U-I4'6(`OMT) M7I\H%Y=KB)8P\K98K@,H%6A2\A,U@)@7;^7"4?]5PV9?XB3/6.=O>#A"PZ;7 MT7T(/'A#O"C\C5FCN@O=02YHDC/]N?PW@>]S[307?_V]5D`N23*(&"^0:*1! M2)GOB'AL_\H,I]1`39\Y'&'B!6/[ZK9"6X5XC@DL% M.*FL8`S#*OZT24#@#+8#;B'3YPXW`_M+L,[6#>>F/D8#J[B%?N"!<+I8!![- MB^#R#.%P(T3#A&L?A+"\ M[I1"%NV2*P>QZ?P5VV)O2O8E1:)LN? MP6R!] MR,RT"B,"E5`JD9DY.(P,=07D0M9H49&9::0_)HB6HOM"?S<&G5!:JX\PV^GU M\.DN(T;94#?,,MRSEC)=P<'@#;<%=N$3(YB@@='.X*JP/N1F_08.*QALAI0A ML2;DI;\;2'@TT#2\@W-<=D$S1Y!'C8H?L:8PXP&2K?P9=;#4)4=A<8CCR7"91;7Z;FKPQU0GF!+N[T!Y!%D61`N%"#699/-FRA?FRG'))9PI6R(/2/%+'O)#??.*4[1ONQ$N9+T\L=N@:#+*<6ZI$!U(DCV6C`K42& MHQ!)%UJ'R:,G&Q'K0L<)>:S%<44N%!^7QU7""^]"07&^G^!((Y6-?72AA9L< MV@V!J^8[6D@R(%77RCY+.J:4"ZQ(NES=7F:`"PVCI#&KQ?,9;Q]R7&%/V0^U MLS9(N(:&6(&O'<&D(BBMKC^I!6]AU*7Q^I.]H2^7/&9UF<5.^#?5)[&ZG&)/ M7UXNU=WJLHHGI,PN)=CJ>HNG)DB1'6YU&<43DZ0H%&!UG<534R0O&4%+#UJH M*W2BB%04L=55*#NAOU_:QWR%R;[P5"C(0XDP-#FR;=TN2I&A299*V7V4#(,1 M,[7E65':#$;0Y%;&HK@.389L3*"@J`]-5FQ;VX]2Q)"LV%SB5BD0V^5:OLJ( M-L1V&Z_MVR/*2@'9)2$^#XD0PE#D$N$?AX2P4IA828"?AD@`?BQ'B?7/0\2: M%[E*LXC0MZ?!O@Z0##9DKT?RKY;&L)GI(F"A5GY]#,GQ1\SY)1+WB0GHPS$AK``0! MP]^\/82Y:;@.TJE_[_Z_YQD*_"5\!IPZ>(P1.C8]MN-AO((U>3/.XX0T!J>_ ML$!2FF])I?T:2-/%#?YMO@+1QQ]^*"\P::L41RE^7L.:$;/&+J^C3<9M9M'? M?AH^=P$4KRSA\0`3'^P``LR#Y?@8C;[4&Z+LP0;YQVH!P,50FYQBL M[0XP00I[XS0K<*'<^Z,L'O4I8Z,*IQI5[)C4##[!*(-Y.TD&,V,\D=)3=8!9 MJ@5Y9OXM2#.B=1!?.@LN[MC74='[*B/8TY.#6=DZ*#9AP248;>+V$)<`Z3,_ MC;!&MXDK:4'8-TL\1TL)<;PD"/,31;6RH@$M@Z;"X5K`D?NVNK_J6-6\WZKF M)X1667)B'L3\A._L%=S[P!QFI.!Z#@A"Q'97)?8*!#;N<%M@%PK/@@F.PZ_Q M\-+G.8_OG40^1ZH0C=8%S`Q&\!F$=W$:>%!\FUA#Q[8*4MEI[,-F75N%FSA: MSB%:W\0@2N[!EE7:331TB$7[QRKY-E?)+S.*\O?)Y]>A%PU]?37TA:1DNM4Y MO5]EIVD%+V="T]SG)_K.!P,U@%`L-8TXU9,9([1M.G^.&S:E(TRR]?/)@D).`7+6&ZB_(EBC\( M2*CO=6XU#9Y@_3?6K>EA$\VH[SA)Q5IJWG7VBZ\R6WNGBT-:W69)>@8)+:$/ M_;-MVX_3965]2!:.[4);RB-H\8Z(_!OX4/6!A;60>5T&^,TC"2`@%"G9_ M!3PB8I,;N\#?/_\CD5XYU&ZYEJ'V">3#)U+P&@+Y&6)9'"0B_8&$A73U` M]!1XI!Z1QX6I<4I_8$T7%_@./P,$6P#(FFRN6)IL1!XMV;[WG+M0PE$5Q<.@ MT!V./]I=IUTV'+&>X]%,&^/)J7)9+7T@;WMM=EX49'6055XO>LC-5RAG'?*A MM+?IO8>/[8?VY%U\?C3_J46O=E,LTEZ]74'LC/EO+O5.ZT'7]D,N'^Q4G?0C M1R:5K"RLE-82O9K+E%Y/4Q5_7F63K;'#A\E^2[UU^/C1\@+K8X@4+4.%ZH[[!2BZ M"_8S$8JWL?M#P@_.P\ MJ_L:M,2V0P"OU4T-M`D!W(@KJYL:M$2?75[-ZK8&76XY+R'8ZA8&'3B!4LRZ MU5T+.A"AH>B(U5T*.JMQHA1#JWL0=/C@_!J,5GFT[`O>KLW0IX$(;TUEWBC" M`Q'4^%7/**H#$:C[=3JSN48J=$&8[XUD=Y!4JG MP;(`4A MC5]1Z_-G5[,:1VJ:2[3+T-$G8[C5S'E-9O?)*!YL!]S"LC?L]J:^AHR@5'C]=E%SYJ`WJ\0`-6_X&\S#F M-(YF<)F+,7*/@]R\,7-=H]@NYG_B=NSVH-HLM#?QR\KF+6)F+B1GR.(I>45= MR-"01;G%"VX\VX*;CRHGN+"S444\=L#)IPHD8[!-%Q(PU3!L)V2ZD)"I1@>Y MQ`2+,S$[H7N<:F4HT*N%D;5966AR2CGEH)1#MTFR4W5'.FEZ+$)35S`E(HW+ M=LC1\C9:WJR#7;E#J!O]#P=GW72C%:,;-EAV899)NL>J9B!E]N=JO];I$+D" M`;H%Z#M,L2:<01WX\)?4CU8S+:G,RW'8=5VQ?Z2X!.V*F^S"?:-(9+UV=TIR MG=,@T.$NJ2TW=BESL4N9NYVR%.$U)"C:VP_KU;A++>T\T^#V(/7O>5Z"MEY+ MB35'CZ8J/J+2_\-P:9[(>^M*R7^]_EM[ M-S878&W7Z\:1FJJ=.X,8JR0LI[P.L#Z!F<(,5BBVO0?Y'.>)#AA971%-[F'> M(EO:J7(+W0/YI*LJF`AGJY6,)(%LM2K(M8XGU]$B1NM<'E0+6&,:NMEUQ8]L MU\QA)EP:_)+!3#<&=[@&'\$D6V9).G^&4;J]BC.40F)/Y!C_!8,U@'+4(.MH M_\,1)KX=HS)J6>,:"OV%S?-LP8;O*>2-UO'QCY>NU=]%T"^>P1H_P!HE?F^9 M408=%K/D(^`K?D4>R$N`(LPI2#G'AQ5`\"((LQ0>9;ZW7ZB?3W?X\!^9$\0? MBS_]-.`R?]@6K`[TIE`_O!PYMN&75FXN@5>U4R3&-7Z)E5@ MU:2CZMY.4=Y4HGK!X$,0>751BU2WG7@IEF\:R*!].WMI5W[=WHFFLH\EU)I! M+UY&P9_0O_9)-==%0-ZM0A6IF"1^V:J.K*2269)DZTI;D2=7UXU#!IR!:?3?7*5?[RPDH5]_-=OS:;7G3LH$$!/0?1-HYHH!JM%LLU?#5.T0;6PP81^;^,K\.WYD_0 M`!5_A@Z@R&6/8`C*Y<^R(/3Q=OA3;D+XP@=-:IX.`%=X8?QX)^=X9.#A%^8N M1D4HHEP6I>("^D&6ALH25%&[F'5BZUHZ,*\\8()_6>DGR8_OCTU MCSMT0W@'UF+S=<,D._#@=AJ71(DWWQ[LB!.(2$&'74:Y%@SE930\,/(=Y8[> M'.FI)CX)"6[+P]J*_N3G8#/C/T&K_4*6X7NVS2-#FFJ(J*Q@&884ND:NI+K*J\'4 M4"ZJ`$J^4:IADF5X8)40TQ>K$O5'HJ@K]E$=0>%J&ECQ%=[T@;#2=$O^^04@ M?UN(`3%?)9&8I`FT_X0H)O]#@DGNXSB$LQCXI=HS72P"#U:*FQ!8Y65T@!^C M"&ZE]&3N4!U@((B_"X@(A+/T4!HLD$9?SB/+P)R&P)2/9*\4:1SX@N#QLUS-`#V!43Q$T2[;]A@;Q`. MUP#.=81/N%=D?O!/'VN4ALW_'X@R@+;SYWB^BK,$G^[&F+;&*;JZ5^Q:THJ; M5QP.&SMYC)T\CI_(FV"-18J=OV-+[)H@XD1.2LUY/37N6'(!_Z42#A_KW`F@ MS$/3*Y\*PZQVMBT*E_)QD%[!!(:8A\\(&$261Q!PL#@$`*SH8^G8G[-:? MPQ=`(NL6,$GR(/_BSLSC9QGH)&;K`+;,:;[/D+[&\V"C3_8R(';Y6,? M]YGDG3[1%(WD9+:^+-WR`L(*IVD%KYZE+`1H;Z")KUR5H;_*L[](W_7D"L5K MK)D1I0;K-[5VW+6(5LX!:+N:2>M!@,_``@_J%77\<*;+DO M4?,$#5?E'F)UK`@PJ/A$*/0.-TPP0M+Z":?:]G11.9!*Q?L<)*OB=VXF1:NE M3./\`$AZH6JTE8KC_J6H57N^JE,AGSSD.T:P_"8,:,05JVKDG#16.2G23%M=M)3-(#VDZG M)@P+K@-V*BAGH!80-H5$-EWYNE+,6Y!J;PW6ZUU"O$V5#,!=%DX1\9N7C$92^4 MT]AC+8!ZCO<373O.:$L@%Q\E[GBGH5<^[4PF6G.[SE=![G:MWS>N]4%NGF8` MGV'X!)7!X\W24>`=(/\2+`DK)K;R;T$8`J*'J<3/J*]AKC:>=.V5JE0>)]5A M5SWL)WLK&RKCVN(P4#K86R-Y1E?.V4`O86G^[TI''E,8JY MJ>+2/6`NCO.D*`^(E:LFUU(BF*I[W`,11!4:=PC_94"";',0+T5[0,):DP>> M(FU*2I,J;=U04;)>Z%>"1,;K/!^W[6E9\;#ZS/+E!X?8P*U;WZNF" M-R_>U.J>/!H0[J-LG=5->S1=#G$PIM4M>C2<&GYM;:N;\73\]NP,(_--=DYQ MVO=C>ZWN>]@19YF`#/.]7_K#7[ZPB-6]BS2\4)`,3*'LX0WO5G"GA M!B:7EH03U2NDN`],/N4?FA8E;BF5!B;%2N5R[K#_-$SI52DYG!)C8.)LYPO# MJ'],B35,09A7@I'B/5`Y5U3"D2(_RK(=:M%3,@Y3PM5)QKVV)I1PHQRLH>,$ M)>52]TD&)A@RB=%18E*U,"ZR<,*(*RNA=D^A_AQF,)K4U<3 MBO\P)=$VW9Y-&V)^U^-X2Z1Q2S7*WB7K]_8V9Q6'+)0DVR%LTR' M/8JU*1,:3=V&"Y"%*1OS%FU')1\Z=J=+XY*R7$K[:5^IL(DL(A6A2RU]1A2K'_?WO"`\?L@)0./7)V%>Q#\@B0U5K;I[E!?HE<@1>FN@+P3+F\TL5WG0 M'Z)YGHDN%US?O#0.IKJ+,&"Y.8S-:`:?3C&)@XY\N::NJ/WLY3K5SHL4PV+D M-%UQ&P+UO*F&'BW5(MDG2_\;NGZT]C)_>S]3]=UTY]UD=H[Q<@NSE.J.16_?SHVPM">R@GTWB_C)ZS^!`6!\3\. MZ7KLLMQ#^>CG_J'A^%=K`!V.,-M6E14;=+:M_==>9!"WE:KD,EHZVM4[2=1V M$'2S$\\8^P!JZ0-H?XN*QJ-C=0U^'2V'9+JHV5B.7P?NS>V6C!75'SN3B/$\ M,B&QLSED>=D0.Y.T))Y^!='J!@T64(G9\L7"Q#L+2,6NTF9C,P@+B,6RF5K= M3,("FK&K.MO8>4*56">P/%O=H\*"PZ52*M'&5A0F0D!V+0JK8N>[VGY5(>\QS&,,\ZC!T=)^L>F;.9PT8' ME5X'%?,#W8-P[8,05D'.S=^J:88.H+R5`CS\P7I`>8@SHK1'UEL%P17\$3C,Y@&,K#IS3=*FN`V`/'9LV#=+1R M'Z5!NE9%W-.\1[6/SRM^`AWU>S5^9+Y6G(J6?>@\0T99*.AK=8&X)IWM=PNB#1 M2A/_7UE1.XJ5==PXQ7W'UJOW`8PY1.H9)>;%75&AHH%9"TYO(K&B<-%H)#%M M"FAFF.9=0*,"W)\6.'`RB.P`5BO`_\@`@1@0LU2MZ>SD,<[26MW"KU'\F$#T M1/"^CC996K;#,"`>%GHYLZ4X4P[DC[=$LQJ8QGY*#=>\=JB'CKO3>;;=_?-+ M`!%^PU;;&_@$0P%9)2<;Q:MX,\[!9@92WD7E#+8`;O)FQ%F4R@._-\,"#/)C M\)FM@4K,,(K!+03DN<[%Q.,#+GPUU=9X%5@:LH4R821_R,6-.?164?!'QJT% M)CW=?2,:T[!T%Z-T]0R3=`Y?`.E"GV:(AD^V^S.+YJM3WP_*$"ID:2]K]Z\EY5I@BMPK>$N ML(/RQ_8`",]JR1[GOL="CX?H!M\YF!_@(%I.$"(=T7-!;XJ?`7R"HV5!OQF, MX#,(28E(CK.HS4HV8TP`G"[.L;Z(@,?K6=)R,1-X'W2S9Z*S/\8(E/B9;H1R M;XP./U]&5IHNRJ,YS3D*ZT'C##1!J!DY:H+X%/J[,>B$'[$^XI3VJT;^5:EX M'/XR4&N3'%DZ/J'F+;0ZB"!X,*QVS_7UE?=$`^/N.2G]12@[.JZ[-N+&X"#& MM#)$;[$K6JE\"$I8)F6Y2? MXRI+\9_/\),QRYVQ&'_2'P!$'@S)PU&\)@.U8A3(EY2X!]N MV,PAF#):/(I;>R"],"EVD?$BSF5G6XQ9V9"G&X+5(A;C>1U=!4_PGQ`@GH[< M8B&[\8TSI`??W4)6XSO'N^KYP+65[,;X.=:#;[6.Q=C.5Q!!L$BY)B3U=4YO M:)(3,?9M3B*^/VCSDP*Q6K(\-RQ0O=&A_H"X8:OJDQ0U[F'<;&6:GP6K- M_"2TH&*C[9%_/=.BSH)M#_+KF106!/@IF'^;30?V6KD-VX)-F.6*LCQ:PX_D.EU' M"=:%R+N'CVJ0/&PP(_.GT3>`\B:OY.SR^O])3S>/VP5,/!3D#]AT403>V`%1;PRXLB2M=[N,=SS*/"=>!TC#:/.2W`$M-Y/'B M5YP13#`/OZ@P*VND>8B_1F`=HY2TX+Y'L(\DL#]N?PW@?AS#>+BKS40[N)"%YNL20+7`<1-H\W2N@I.I(<@^0)#OY'J MO'DN%PIDEY&'/D0@O,HB/]D)@WR-5V*&B0]>%_W.P4:HK;/'CA$A5:!KFI*# M7VBP0D(RAYJ#.:D@F69IDH+()Y&ZK!=+>IH17+`*4$'$@[L^Q#2,.TO2$WX4 MEE":]BI+V(+CYPV4#4?CW3V(LYU/%`4_`F ME+RR9<,;IQG!)8[\.,IEJ$<0?9]B`1##1V2IF^NSZ4S\.:3F&L)J24R&Q+*R MHS0?"\98#:+X+4#+()I&E3N)(7L?#1F39^U*GH7/,_@4AT^$0>P+-TL$\\@S MZMK3T#(&I5+5Y]/E*;-'*ZEU'(E"Q!KB8=(R,5%\!3X,/*3Z^CR MQ8,)X6(@64V>0)`GTES%"+.Q%`6/65H+W-BKQ]Q]52U%FW.#>G(/`I\LO[,/ ML2@M&&SB@-ZCV(/0S].8]D0)SE'ECQ]3^C6E])\0PH<5ON25F$(,^`):LL=: M`;704\$;[2SDAMPK#]EC`O_(\'M[^<1ER,*Q%D#==,8YHRV!7'Q:N.--0%_W MRPH(?C3,-*Q"$C,&.@9O_>TP4N^<'X)8CS!F!]%9'F?;'457JI*+8AQW!5_Z M57)W9/K\<>AD.D;94/H1MSMM0S1;_=@SPZ^&F**G3AHI9Y+5Z7AZ<.:[FZQ. MP%-'7J![6YU=U_76,P)WKZG2YKH@WQ=I;G2"G@#S3+6,\^:W_ MEUK2F6QU9?MNE+"@1KUFY!JCI"C"]DK>'<^U*!B$HC]8`8P?I461'X0`II@U M1;$?A%!VTQAP0A$>H%2VG[I$475;#M/E:Z7T<%LTX_GA*7Z#D,Z:<\0HPFX+ M88VQ#3M$/PU#(&,'G5$L!R&%2>3B4(R=%KP:\Z8HGF[+6`V!,13-00A34HFM M%.>!R%.<9$6*IR%AJKGNC\@=03&UL]R/+NQ$#DOC]>UU(\D-!%%MEV8]IN(\ MZ!+='P>#+B>&K<3SI\'@>1Q14Z+X\V!0/.ZO\1>;PR!DRB;4T>/D'U._OODN M[*+0'9GZ"NQWB$4>XUQ4+IA')])VA/>,?6.8S\XKZ!OSR5Y35\N^,9]-Z5%R M+Z8PO%XHPSAVO;HB:L?+V'Q,&^+WCQVIAPG(]"[::U9709*18TTOIRG#CMR1 M%2<&-*B.]MQ/B>_9E$@@P/7XHYI_AT0O+B_M@*=(V?,=I0YM._1<>5WY>0T' M#A&9V@+TI;77WR6'\&%U:7H7[755-V`F4U*,HBG'*HTT!\S6:X"VI*WM'UF` MC^%YO-Z$`4E4F)&H[>0ZPFI@1)"+H]^"=)6'NU8<GX--D(*07Y1&>7[O M`">KJS!^5J?OX=S>`)UC+2O`M_(.IK]A&6\E#>711/-U<(\\4\[43.ZWYC#W M.*B\`[W>>/F[W>,MEKNOW6ZF784]AUN-FOPPH-T]TD>UUB2E\TH8K:Z\!3`'' MILOI>/H=3RTQGFTWAE)VBV`R%T$Y1GJP/\^0(CTX<1$6%P=I&;LB6?'#J!.` M4;4HN7SQPHS\!0L?Y`VI\K&ZJZ:3[#%#T2WT`P^$\^>XVO(F!A&W6J[$)`U: M\QEZ++>8+A:8:9]E05BGBA!$ANQJ0\I_E]^AWZ11PN8Q^\T[@()7TR5*G,;1^EJ$OFD;7JC'X8YR3Q1C7@R M$HC2;R`,X;:\8/FU0UAFSGN2YRYDF=O:=J71!Z#7!\#\S#<8NV\!YJ;EE[F. M/.Z'Y(\UU20BE:NHS!QJ`\S"HJ*_83X(T2[TP\O2 MJ^"EB%&2>IHZ+?>JVAS<@W#M@Q"6%+L/P9]`C=:J*VAIA@`\^`6",%U57QI/ M"3Q%P%NLH@/X50RCX.5\A>59A/7Q2Y"43/0<(%AR4#5$.JZH`:E9G,`(K[7< M`='^0+5?2P,B#_`)1E^R"._K/ZR`'S_?@`ABB?'7&,-"M*C6>IFVI76@N2$; M[LEN;3!JL8H.X+/U&B(\ZDNNVWND0DC11=%E-A\<_2SP0 M;>]1O(!)DMN6JCW5WH&6"VE`X5OPB$!%O>GB/$:;+#E?(2PC!VHXM%UI#(&P MQMXZ%LEJ8[`:4KDL&?N3\:)9HYM1Q@3:& M/!?"2>70EXE`<"&,5`[;;C9^%R).M=[^IN-@KUHE>?>[VL%=B%R5(T6'&!KC MX:W:B"#P6+O0,D(.R0Y^$A=:1\@1H;5YU87^$9(\0)N;R846$W(T40EZ=*'; MA!S6;=TEJOTE3`3V3I9+!)>D6&<<)7$8^,1(_."MH)^%T"=TR9N5JE?P&(/" M5&#J%A]4%3(31`7MAIB&L;3-!S#9':QDNKC'#ZH7;$`X6>#[2.SU5\$3+^RR M]7*6XWX=W>$;/7^&X1/,71>BH+KV:UI/!7V?O[:6&UC'V9&+NM-:3F"=6]%T MH5TLY@;>STX#P_U[!E%BA1Y.DE2;)6L<$GH);'V(:QJHK8%EIY"Q&*'X.HN4YV.!?TJT$ M#HU+6*F\CLKYJ)R/ROF@E?.]I_@5Z-I*S[IQ'7N4!8]EP8O@*?#Q(LDD\@MD MKY,D(^TF[E&\1&`]\?V@@/(Z6L1H38H(1CJ*36'-"7V'Z21=ESLE_!I3W+$Z MZC45A2Y_Q5>%7X?I:(S>C9-[B!Y66-86[TV'F1``SN/U.HX>TMC[OCLU%4"D MQB3IRBJF[!;ERMGL03JW9HK` MQP.&4O"I_3FYCC!3*I)D\TQ3LA/A\OQ;*)IA$0;",P@LE.^R-CP0!"3+ MO/B_U]'$\^(,BVHSZ,'@2:":2DTU@U,E;S94_6(,-`_O.3X>2RSO_ID?#F&' M#8F)`\.GTRVQQ7S)J5N&4!"&-]O(([4`SN.[]#85U243#-<`SA3Y0030MGBS MCF1/!D1-,TR%\Z#Z>(*DS+R@FB)OVTN_5?* MY7F2`)F1YZ$^*G@;W M*,"://^T-T[1`A8,%S.X#)(4Y6_@3G3X!L*,#95XAA'S=W4`H7^1D8043*(@ M]@L"WL'G_">N:5]NL@9B?XT0],`FS4@>3=$EM(@`N@H6Z988$60>P3:KF*V8 MP53D]TKU'&JFQJWXD,XHLNW75L<+2N'5BH5:'0THA7:CF&9U7)_T M`R0KQUD=J2?Y09O4`>/1>5J^J(1.9G61$'E$9=5JJPN!2*,K9],U7N^C.:J` MZR%RN;RD$"F.\F*\G*0FM%B6^1*WS^[C)O#,E4C^:(/.++(&2+@7)7!VS%*@ M$VE7K`A2_DM:;TWDFW"AEHX\N@+/@?D".;*7F.?_Y+_%;"^=^9,L>8'U(.S. MY95UL.[J0_*#!LU7`S,;9&XB>!0_1_CC!4_P/@11HB%25(^K9A+FB\-"J3_# MJ@-^Z]?D#R\ M%0W5&6)'#,3S^'*]">,MA&8H2XZRGV2GF?B6%21E$WKV8;N+\Q<2 M^OE73>9Q"L+Z[T3=OXO3?\*4=-E81L&?>??3'#PN!YTRGX0R7:'.@X[L2;6G0#B\'W#N\/HIA,7_ MW>8E+KF14$K3^P&7%[W,':H!C/U5G_&_M_\)42RFE<0D]\/K-(6MD&?A\?"! MF2`$HF6N0YYMZ9#2P)P_(/G_^H9?(=)[(6?CC>V[^]G+&-6.GN5C3,X.,:FN M2M5OY^@9_A4OD2;74<$A180\Q?9#INUOD)RDG>LK__$""_97($#,P#/KX-,5 M$M@+,N5UO!J>.]5U&&-9T4;AK)UFZ(D80J/UMX.[C,K6>0!`2 M402K&OD%ZIEH1]N9O*+[L'W+%0:=UX^YOE.'I7PF+E^P-!$DY,,5..D^)=Q] M'*?6`8LJ?RFB2/JGH7!WDQ=O!^HF*"*E2+TKG3>/O8&+AZE?<=PCMG8%*8K=B_,O)<'PWQ4AU0@BQ'J M6!'UPDP1DW%451$N?+?,0-/&I(G3GYW-]FRSDY&(H[39GJJFWVE[;J'J M&9*-GK4]R5`5;X.1@L9S&%TA)2>XU7AED#XXI/Z@+?,I$A8\]!SGG=797P9T M0(;/W'S>F+4D$CO*K>[-?LKGJ8O+3K6]N[5$%.;44"S=E\7E4G8HQL,0G]MX M@'8T^#0,4;J%5XB28!@B<&\!(910AF1=J3H33=DECE<^D4&/XPPS7@-E:,VP M9+H<]1B]47$[F40F>G_XJ1O5PLH(=_N`C"C""_DP&QIN!PAN9P,^C*AF;"NNO[8XQ`B0]W M(Y1[8TQ`.2./B*!Z`?W=&'1""M9'F.W!V?Z9EFO3V75]*X,T>2`?2?*Z`M1O M6B:8VQ&\7[/3])HW<[R/X]0RD#3-\4'B'%3(#@!MFXJ8$\6NBN%PB+0N]/FVHP MFJ:Z1\L?*45UZ^&>3F(>H6;[$4.)JN-SH$U;'7HMB=&^YFT\6+I%EW--RJ3+ M1OT^:<*XZ,:]`,>)*MJ5Z#UWF#ZZ#C$/IE_:ZS<#6)WVT"\QN[CW;4Q]<.7H M2898V1C(;Y;$FM4MJ[,%^J'TR8TW5H?6NTQC;F"FA4%'5C_,78UEJJ'H!GWZ MM6.5X[O#L$K?&+WV%GKM1T_IZ"D]71&JVJMP':58+4@"+^?EO,K[/6[HU'D: M*S2.%1KMO,>2F2DGN.#2D(Q>&0>,P78:R$=S\*CZ:<@,M=B+9STQ94<#VC8M#Y$V[;/<<.FNP$V&C4++S0M;?D5OX6HYI3.V[2> M;?=>J@*M#I;.CILZ;H`9S56CN6HT5W4S5QD_RU)/V/$#ULX9TGDS]^D6/T-4 M(K4.U'IV:=K2>1I^W6Q.3]UH1'\R%;KT%.YJL@`I$7@/`Z M6L1HG1-HNBBJ\4T6BR`,0(H_B^\'!="U8>V]E>T-)F=9@C]XDDP\#&&2PT3+ MV4\7WV)2YOX:2R_X+*7%*,2MI7,0;>/H"P1ANO+P`;Q',690:0`3 MKJ^I<4K_[MK3.(_;'X[BU-Y"_(3XUT6M7-C86[5ADAUXD(=I^AQ!E*R"3;U_ M@R1*O/D:CO)5\`3SVISD'U_PV[DMMHP1_RPWS^E^F(-\14+TS^6_">R?:^0N M_OH[I5">PXL8GG[12(.0,L^U>.P8TU%'PL2RJ`,I<;*S$#\;K?;:]QW)` MQ'/TJ*Q@`L.JBOT,BS2728K%3"K2<%`23M%PM*OUYPCXNSH.C#/-'JA[ME,/%I;*N!"^[-EF5WC35,ECMT M#7K.WAD4Z!5.',E&O:AZ/,4V.1>;EUB_].0L>^FG)04^EF60B:B?MG:,_G(GA=G MF,?[5S'*XZ[KN*J%^3+#&B8(CUBF<20?O=`X14.TQ1G*HN0Y\+Y/DB3V\D!G M+CS\L2:\7PR1M6@B'CQ!4M1^NJC]PBOPH+B(!H)?/*T]B6_/'&8D$#<,E@$I M$H&(DM`X#66GS\&;X_!V_T&;_>)'>4ASA+5Q#)'![1:!W`%&MNR4OJGVTYGB067'(3=;0# M!_AAOX(/7IRF27%,.+3BC;0Q$FN,MANC[92B[3I;V4-LFZ1 MDA=3C5OEM<=W\@^J<9>+=EP%=B@7XLS4D&VV!;H0KJ2&,U>#,A^PI#TNFZ.O MFH_1U8TIVY@YO$A[KE9B/F)4-ZHBW=E\-H'V#RN6EBG"]H:W*']>OCV"HFMO M^(H:NFI"-L5_*&)5HWF.HCP4X4HZ4<9>R4K5-M\9)S1&?8]1 MWU:$LXY1WQ5GE/2%O,K8;V$@C?&8[S'>5W_DGX*1=LCQP%H#(:4#A]T)A"P2 M'58P)<+U&!795U2D^8`V6P-QKC)R[NE%Q,<6G^/\,K/@$(QV,"J("80L+710 MP<:P)$W%,.-H28I7W\0@2N[!5N#+9PZUI6;86._,.?A__V1G/,N1TC#&ZYRJ M.M9P;61P`;(PW4=H>'5-3EC&!;\>%B"LLY"+2G2$O7XJ>7PE(B/L=4?)H]D8 M%6%Q>(\\EE)Q3(8\3Z--WDX#+%OW&+;Y7:C'#]CFSE?8AVQ6E\ZN'Z2-7>14 MD+:BF[`1G\=X@:AH'?:(C[/_0#Y=[C!<7$=X)KR*T8$A66\JO5U&T3[S1\G5 M(,W(?L5@W<1),HWP=]C$"0@/<&B]C`9;(WM/<2>U"[A!D$A"Y*)&_F0=XVO_ M9]$][=A*J7L'0TA7U:(N7TC+O2,K@Z95[3F]8KCO8%H\%^1$*AUGE74-?>HI MYAN`E$_HX+2+[CG'/D.T1U4,Q?G8(GQVB);1B)04YIR0KE:M('X\91 M;1[5YE%M'M5F]D-J7!T>I0H)J>(,A%AW@`\K"--DNAB]J5H<%&I>)G=<*Y,D M@8K(22UHR'=6[%ZEXM[CFY!.(I^LM"&3L0ZMR9DFL9$K1Z"8H_$(E`NZ@G_M M:=1(A/JJ#E*B/,Q:SP5S>4,/Q6V,TB58PKLXA;ST+)U+FXHE()(;^XW7L*)) MI`2W5M>RHSU@M`>,]H#1'O":[0$]RN'&S0G646V/6P_8KZY!7QVP&UV7*C-@ M-[I6H7_`GG1M`O9K=;++64Z,N]NMI`[;FN!"=?8^:%6_1*;*M8_^DV/_R62Y M1!ANDD`8X!.\`>%D3=PCR44&ITR.<;;]&F'9/XG#P"<-C6]NSJE/9>STVFM- M,W8'5/B87D<)5L[(V;P%:49.V2U6SU;XX?DG!"R()"89,=N.W5$-FLB'U!UU M[!]ZHOZADD4+Q]ZA]EFVJT(9A!EPSM7>$-,PEFP*?\@9W(!M?F6G"RJY+%*( M".NZ"IZ:B@TJ+V##@\JI/.-_RXJ+8V@.''1+6T"0TX$JJ;B7#`H4^=K>?##WG:]WX,.(A) M,D;`>&B2[?$Y+B'Y".0!*!XH5HZCY$3M(-[CJX.9"`B)[+#; M#A,EB/U&,(63S9\6`I74J<@'C@&";.S&`$';`P0[XV&HQ^08ZMA?J*-3N"F? MOS&2LM?/?@M>@G6V%E[$_3%&H,1Z1R.4>V,T'+)"N&&QY/T?M6W%OF"'/Y]V M.SWWM5AQ&D'N/3T0DL[;(\! M@V/`H!T!@Z*NW*\F8M">^$E7>GKW%D%IL0]/>V2AO>$B/406VAL#5&R`G M[!VII7O=N^LZE_FS)B6OR2)D_?7AZ[UUC`XL9BX$C#5AM&^IM"E*7W217EU8 MNXW1_E9W[+P0D$DP?"#^%6B;08B=;>J5@83HL0_,H!2 MB,+M#"89?@W;2PWM7]BS+,$D3I*B56I.\X<4;B8>%N&2'/-"F*/=;_.?$(0S M?+8`08-0_%=^^++.'8S$UP,4X4.98$'U8040/`-)X'%P98^U`>J+(,Q2>)2, MU#!ZS'8K.WA@-`>([UL;N@L(1W>4G]@TB4WF2FZ0!M!E\@E'&VK_Z M951<6HKNRF>SLE/)')=$.5HFU9'[6M%>*>H&H_H;K9Z*DF13K>$JTR6U]?7 M,XC!3T@@"V9@F%L5+`SZ%W"#(,E)4/9_L6L`;0#>\_]ED4<6K-)90O`GV/]E M\B>_)I#J$AI$]TGVF*%JK^EB$7CP+`M"GW@*\Y]^`WQXI>=J*6;TR-SIW_'_ M/,>Q/X2'ZV!F#/,7N#481OUY<@#!/FUC<@^8:O5G+WQ(6ZU3(ZP%^1 M*`;TB.+X^\0#/EQO)YF?/9*PGRA*MN$3P$#QP5:9W@^X=_#Y#+\1F`6TA5BX M0F]`I_%S%X@YT_L!]^NSM\("75MP^=.UE+M*L,#Y@'D39M7UEU3BULG/U0;H M-ZSXPVVY5W[KT?TJAE'P(F`7TE,U@'FYCM%VDEYD$7DMM]7__97_Q9MFN&RJ M9W<4!.L@Q.MY>#CSI7[`DY]RU]]-3-1%$/&IUV$Q':A@!?\_(8K)_Y#RR_BO\]GG)$V;Q\!O_2"A-UP$NEIO351)GZ>H"`B\F=H\97!4-P7.I^4N< M;/`_PTO\>!?[7T>^\%AW7U,#8M<19CM^\6[.X#)75?;>S]_P@<3/`CH'88!U M(Q%?:[^6&2?:$P8*O\M4)SJ/\T#O7*^X)CGI'N1Z7:2G:_A(_P[#!&[Q_W^, M0_\[["WWT9DP^/=O]U'>)5XH"O MFK181`/H-^`[O(\#?$3+XSI!:3*+GT.8IH)W4FK:Z,FLTA3_%:/*]GD>@B01 M5/'A#+8#;F&]/^YP#&E?7@.P=%CA7>RI'+BPU*RN2$W6!^(SI MM$>Z2?J0+3$;QO3Y?D:X6)0+%Q,DAEAY'9T(Y`<57ZP%YJFY9%$(S//X&4J` M+3';Q.,R35<040&"I!3E@M_$_U=6YEUPWAF9F3IJ!8)P[8,0[AW3\F_G?$E0 M:IJ64H;`@X4<71W,7,815#843M`!4G&)L:P28DDFN@1):94X!PC*6C-:+*(# M]-K]J"YX75:4LRZW6<5(@40)5TC1:6&ZN(SPSX\(1!XW+J[UIT/!;':]F*]4VP@%\3Z%_%J/[GCQV0YRYI+PW$V7QJ M:V@)P6W>D+1(*^/16%U>E)J8`6(7).D`EQBCB]IM&\(%X>^9Q%&_`:N=!AT_`Y^O22M-U@DO^ MYV$%_/@9(K[;` M?Z4T70>X`40(X,,X(::S(-[WN.(=(R"PL:C,U@%L'@)26"$J]PS^C->!S&F0 MGML?H.W![`7(;+V&I-SW'CFD:"DYLS<@6\-X*A!;`M@'>/,5K/AAY7PM#AGA M,?1?`L.[Z@J:@-YBX2))B)GNV)Q7["HV`JJOH0?PG$$2GQ#>FI3I*W:[#F;! M$T2$4$T\0'V-/@%7!U,C4%GB@>-6!-?HB7PYOE=<;IX&`+\%CPA4%YBH,FB3 M)>E[$H=Y5:4&V(+O%,2E%TNSNH6>J;KH)545U>IV>:<\.>R*?%8WV3-)'IF[9:^^VYED M\ET/C+?P.^T)8IG;D]93I4XZ.$L5>G/@EA:'5% M2I)7+@'SJX52$LD)P@[T$;T'"#\D*Y@2BXQ:4U$]-1DG20)3S.-!@,B3=KX" M:,FMW\T9[')GMN$VDQGKEY^P#N]8M<8&6Z:=EMS1@.F,?,+CAJKF21.2QPSB MC^4%88'F=$&)04,0=34T'WGXR3E:R_K8?5;#;MHDMU$>0B@_T4J"YZ!=8!$_ MUV0EI`BY9:S$E0YXB$.)5A52JV@^>'^0ZD3,3\$?:)K8%)3Y"L79^[+6_WWYLL&:+A>][@N/MH?1]C#:'H9C>Y!WL[X*!Q%; MX'AEL5`,+O\JHIL4M*5AQS@)M-U7$;W$$!=?10B2A.'OE87=2-JHAAURT]I* M.>R`&XW:VK##]]'5Y>-KB[);\()^ M'BN77$=>F)%K^$&%#GWL9(1B$7X)X1R\2*+-&VX&]EU:DR3P MO/'N:S3,J*,[D.(K.EU,,2\O MQDR\Q!.,LCPT=EF(.'+(-<\SHIJM`()G``OWY_&:V*L*>TTNXY%,W8AT_,$/ MYGT((C$K;;/2J#SWK#R?$,ZO"7Z5+I,T6&-0>#0]�J^:.2?THE7XKE&E?M MM1DS)%B5"\$/Q7$/2*0UP@\.*.)^:'+P&/Q@=?"#R@?D6:SD5Q@M.6,8Q&@A<=]"TN;Q M,&XP&?EV*[Z=$Z%#.,3(O7OD%670\711I;L]9(__@EXZCZ=H\@2"D'R\JQB5 M=LQH>8.UID:6WGG9D<^/?'[D\X/A\]V?F9'Y6\3\;TD[.934D_HFD5_8S8,# M,6!,7K!;`FCY+=G@ON`H<1XJ@XQSFYQM:_\E;V=26,HLSF64W)_0O_9)G,4BJ,*+ MJH8:^)F]",DR=;0ESJ%L,X66$N=31=B-COASCWVYH,XA68%2V5R6;2<36+IOGC::G5VA<&`7545`]G30B\7@9%SU'_YX"/Q[# M=BWF8SO5YRHC=09N\<%99^L9_K`@O`?;_`L?A=,EBDZ$+FN/W'WD[B-W'PQW MU_3@C!*`11+`!7Q,)Y&_^^4Z2O`Y+G[JJIXSO6^*&QX[XA07&$KXR\!DEY%+ MCUQZY-*Z"XZI/JXC*W:6%8^:N<7<;23#$P^?DV"RTGA ME+T6/!1DYX]BV2B6F6#;\@?1?[G>A/$6PC,883#2O,:T M!I;=H66>"GSLMU-IB=$I-8HEHSUE9-ROAG&K/;`C[W:4=X].*8NYV\[DQ>[] MD?\UF63I"I_)/Z'_%9\CE`O<15>0_$N?;2]?\,T($GB/`@_.0+14\*7TMK&5 M]*08)!,O#9[PQU?T/;5>V#`]:@#.XC"\BM$S0*K52^16&>7$44X[X(!]>NT9N@*MV,Q>88%1?1J%OE'H M&X6^TS>6'=UZP^'9YDI"G^,+@X"79B"KS"$(/PG!*@,_]I6\J:4 MD:+;FBX[_YCQY)QC\)"MUR`7SK'@_H@?`/\,8*G<@P\K"%/IFLOZ-S@%RD4/ MZ=U5T8JM]-H6R:8M)=)1#AWET%$.'>50DW*H3=*GE@0'C!0EDD4%G4YLB?7JOWESV=?'[JSA\OY_.QO?_WSGW[ZCVX7W-^#*\>VD66A M-_"K@2Q$H(?`(WQU;&?]!F[@$[)<<(/MWY^@BSJ`_6T"QP:_?KR_`?JY!L#* M\S8?+BY>7E[.D;F$I.O8%K;1N>&L+T"W&U3UBU#J`QB=Z_KY(/;-O;.US0\@ M_M$E0="C3P.3JO,!Z#UMV.WUN[WA8V_P0>M_T*;_BC_M;-X(7JX\\,YX3Q_N M#;NT1!_KV!]AN861:X9Z5<<(]<1)Z1>>X+M7Q[`?6F M[?Y\%C/Q]8E8YPY97M!J^A?!@V=__A,0#W]X=7&BP$L_>%R[^/7SS8.Q0FO8 MQ;;K0=M(%&3"THIJT^GT@G\KGG;Q!Y=+N7$,[B4)!4'F$^RW;O!8EWW4U?1N M7SM_=[1`G`=/GAO&_3SF8O7&PN=^9^M"%JD:V$1"[]ET[^VLD"P3"P+=`W/_])/2HUC2/\A*ZJ=\^_3#[9B09?Y`8@9[T MQP(#_2D?7*A!CUD2SD!PR=L88^I9)NWW@J1 MV$?9KUBB;+.8*E9(,ORT_G`X#N'%Q(*8$`!M$W#)\4^5(:UBJ_6XU>AU@VS7 M-]GA)EOY)C<(/OG8W<&AI,<407*[WEJLJ>8ZLC60Z[+(;6 M5@TVY((MT:3E>*-%.,E/-7/+J,=,N5QJJ/6GJ$L;9S&M8JT:#2E:]0T M^=FOP7B?(+U]@HQRQ@[@>G;%$I^XIAT0Z0JXLH!I"QRR_\7L!1*3%?`-`;XE M0)@"8K:HRDW;^\)XMAMSJ MXF,2^MBF/L;"Q_1S]IO!'+R).=@)W0I#33ZTADPK1G@F8U;YZBH9M7C&KD/> M9DN">#I]_;K!A-/U%>TSI?:6\DLT/JJ0JXY$"3JNM12`(RZR,5^ M4I(M65PX3>U24[]KD3IGM6URA9O,:*0TDFT_1^-^,'`6R,WL]H'K[%Y&`UE& M]7:+R824?I3:%2>EXC71FLN[Z'`@NL@X7SK/%R;"`H/TAUWHT8^^SR@%F(P& M/EEPN?-.][]O`$![E4HOU^]I0Q\C07'`RC>+@^/4U^74KSO&,P.#A7&ZA4J: MC+5#//P'1\WMX@H]>5?8Y3L<[@A:X^TZBZ,*RS794!0I(\N5DTDOF&".B60I M"A,*`JG@G2_WO:(&HE)[]7U[:6K&[-T(:4J;"-GX3+0.4OY1#[OS?R1UYXA2#LN;,J*1I!5"E#JE\M".H% MK&(@:JX3NYD#-`VZ26N_F_*'>1KTE1[S%0Q\M4",\L`FX2KZ!_K>PH&W"/,6 M$MY2R)'5\5`X@E3!*ZB,71^VE+9I%UJ,A&<&S,YC2G@PJ8/L@*36U_5Q@MT" M.?Z4E`*J.L82K6%+)-CD&'."'&DK5EQ!89BP"D%B(U,MZM/QD81RBOU5X',# MC17ZGZUM,%1\1B8VH'5GP3]@\IO9']G[G\J*:!K7)?63#:VA/M""N20N"`22 M@%\)X+6`G6\[8/8O1=NJ:O6$UD)/Y/-*K>[0#W*',AXZD`="CCK$ETK&1VC& M=[N(TIT[PA8L>&]9'?6LQYL<$\G007;0NC\8!/NDJ236`,;["($T10,A5=BF MQVV#QK^WF+"U*%MLL;/9E`YZ%$1;8K@CSQ55-/6$/K'T(G0*^1BYV4U[49&F MF_("?609>C31>GW1=`=>!K*66ZD66*FN>);$;-LE/]QDTYNJ08F% M$<%D-Y,#(D'`EZ2HT3W>*MWGSF?,#AX%"X>(X3.`0[%*V]W<,$NTNMF^4(:/ M7#PT'__2D3'M]_18O-<4W8X'K<+H+J?SB.G\R`3G#)DW&KO9L:HZ-HLV.20? M:CQ6RYX?.M3&XWC,JM\!<+@9>F2&VA7WJ8&R'\GJSS7E:GRBW/\+.^V`K>&P M''=+,E>P9C[?>)RG*"&];$`?C>(AWP%,&.#20"1.9?@?:QU'0LPJ-E':$F+/ MB;9]A&3YH8KA`.\S)+\C;^:M:1ZW)'"=,PZ0^6S3`P!9BDA&QU#O3P:BX_^P M0A8;"5MB1D*U[9G-[*)78HE`L0<>5P@(>>#=[/'S>Q#(5-DUK\1"T:9Y76IA M-V'AM1A?F;ONEAWV'UBLK(=>!*>P:Y[KEBJ`O7W:DJ#C?[M88`-]](="Q5?_ MA-E`ER[;-/!E%9.>I)GT!SX3"`'A:(^0#@+Q0'S=`?^<*9JUJ\=TK46FY_-( M/?;K$O;/YS$7*&.6LG@.F::4XZIFGL<7Y[-#O"5D:B1[ M]H_>[_DK!/CJ_KE-4PU>-=!ZO?\"],6[CH79)L74!2C-4,KQ%J91"94*`K&` MR6T+@QQO;AIS4*986([8]\ZO>5H'MM-/4S/+QJDC%Y"IG)'MJDK(8KEUO<<7 MBH:W3_1]>PCED43FPXV30Y8FLLW/A+IA&&0>3!@0TD`@3E6:48UAFBK#"BB@ M&NOTF'5:AUV>-@`S0QQN0P-&W01A(9HBA.=ZH@IDE]\QT;(=$54L3]=Z(VVJ M!PL$V[:9H4H+-946YJ.^2C/UN)EMW$!0,51'5 M[`")>PJNW+/4=QYJ,*Z3-4N?AC`8^?D>*P^8`,6'HQ]AAYZP0V5(I\=*/*93 MS*P@;^-265ID?6&G./*K=O@YO/L+M`J>;CA?RU%%MHG7>_VA?WXXFTOABTP` M#'<,B:U"!#TC>XMTL9_T/:?K7SR:(F-.(*5_2K6B+(/+43;4@1>H`N< M)POSXZG!UC;9[8A4(C\DCQ"J&!)G[1&TI&1E^:?PLR6GXAHG5B_]VF$7.MGB M*$[W'#RNL!OHB%X-:VM2U=@25"J7'R(MU.57,KK!)B[_PV9/,J_L!<7(AHL# M5![P!0)?8O-I9F7F11Q$N+@NE=W_ MI?^_.([YB%YA]GQVF=)-,O'6EMFQNAQ02#@+_,H&T%HS6U8>RT7$4]_LV4>"S25Z@6\YY))\ MHG$&250O.\$ZGDS]N;&O_W@(4]^5XXI[AA;0X%OR&F:(PTWQ6<`7H!3EAQNA M!]WB4(@ZB*:&?83#?2,K`=O6=E^P\?O,=1T#TY#,ZUID/=LX`#,4D>^23D?3 M'WB3;$4.\A'NRP*1,*5@K\0T/L*@&OL25ZG&92F=1R@,N<2<0KXG5&)& M"B?JL%'RZEV]-]S!0SL@<(`9>MR,5L1Z<7PKCVD7V\AU8XO&9N+$&G3EK"'. MNN:QN%RCD5^@C&P4]?3@ONU`9'PU70<$4L$W(5<91*JT5S_2WN8P)1FJ29C) MN*HMR,M>8I3UM&*4E5BP,QF,J2C\.%-3WX<;"FLCWDWFBD^R.5J4'( MJF-WH`<5`E$CB%49W`'5[-+?IER3S3S*79,_=M*0?\2@JJ3)C0RN'$T5X>C+ M<2YL27)PO5@@=B$G8C?N^;J+;S3Y9BU/B-I4(DJF[(^E#@YZ0VA= M8APB*J(V@PCUD.^WC[6\$0DF$'")[1F7.,S(G,&)`B,5I@=[H5B0#"1=TQ(\ MQ>\X^L5A6R'F_N("-^A]R+]\&6%J,2BAH6S@CB:C7EXVG[QW3%0&PMK"WGQK MD%NU:\21QPDGK+'-%[8`Y\6F&J[P!FRH:2M^W3?#&_!6F)A=UK:^@36?>5(\ M378,8`KX0-;A;6$*XGQRR!I>0V*SZ4NJ/K_K^PI;6Z\42Q0(4LP0^=J5F.\= MY;(#<0"O!P05,<(`O*H.\"MK#S=4Z)1D6Q]/NC?$67"7H,`E&^H25[C$S':) M2C:0`T41$TBXMYZA`G=FFU?8W3C^KYGI==GBZ@<*,G63O^-"#RXL2\.PRS>* MQFNH/R,O,5!0D?F9%*;"_+(#!17Y(+-W@E4:<+EDYY-X"-CLGJ?,RZ`5]E[R0[F@TY+C ML+8A]5X/^+YA?HIVM08#'H^X*6-%]B` M-J63S3;S5K?ZZE,`\LJ-*#%$/]FAAI@NG<0)&^+;]-D51NRTRBNGC?5$F+\",D2 M8OO.G_3Z._WY/CP;;\:/II,/9!EA:BE-0D/9AGTPV4ME$GSE5P6"NCJ`U0:B MZBBE\0I;PT-5.X>3#.M?<3^P2V;9?6[/_#XW_P!&SCW4OJW%)Z/]&5<43L(F MYFAQ.%5-Q05'$G0=?J+!SW(OIB6<$J0!\YM/GG&EW+Y\TBW MA'7)PG7DZ('V0E&,5=FJU)GA;6&)L*VF.K6\5(D-TD,#XW%NIA5UPF+J=*)I M88<`IE*X')QM=W295HDG%LC:F66LHKGD_BTPK9>1%D!T,.H6([ZAH&855 MBN0"DJONU;27!OV><>W\5Z:>UA%?">7E!V'VYFUD&,_7Y`D"?&4Z:N[\:8=;Q=9> M?H5`V!/=$&RT8J2^>D06,%@5GC]U"@O/2&H@8*.Z3I3(0@-D5Y?T^L/=\P:J MY;+<(ZY.B\X.LAMK&@CD ME$I/E._V+2F1;?1K)3Y?-;]`!W#M3I\$C_0X9T->3.65CXT"N2XBS'@3%2[" MKD++*\27;\:^R%DS6U.%BA9\UV.-]$T2X]%TL+-./*:1-,'-T@D.^)K%OU.R MPKP-7LYL1]KOY:GPLLV'$,VB1>VM4G.TEI@\W,6H0K^U$\^B8";+IW'@\R2&^"A+H3]C&'NK>X&H<$X&?;0_GA%Y!`.?5G&CCP'27GI<>C^IM%9@RI]\"E'8IY[DL MVT^1LN*XJXNK0B^?/$EECY[47-NI4E;9SN54ZP][-3-7S0,ES1+8@0X6^1I\ MX[?7+AP2/_2'W7''+G_;P#>F1>/C'"URDQCCB(?1.X+8FHC@-D$69>Q'R%;O MI^ZQ89P*=G82%SH\(*]5?9VI/VMD36UJ&P=6EO=.0KV>!G07?%A\!^E%8A1 M65WL'SC[Y%F?OADQ#1S[[L:QEX^(K*_04R-M0J$.I]IB%!DFG=)-)[G;OHYO M3T)-X]_3+@=5MDL9<@V8NC]`DU/I&RD:.[:H8,"]9U;N/37=D8HCVI^(??+` M.VP;UI9?C!#;:@S-W[8NOQF!-=__.9Y.?YB>BC3QUM:"2;W*4V_?[OS^[AT- M1X\^<4V?W;"`:@`LV76?:'N6:9!TWJE/UXG-%-'] M.00[!'C._KE-X3!JRYCB8)`5,,IA;C\MYKE':P3=+>';"-G!5)5'Y7X-)\%# M>VJ7&-38O:?G&#I*Z,&/H#LU6CK.DYR=_J[N`#I%:V";B=+0N>[)>?>HH<]F MO#M(>/='.!+QV$:EF@8W_;54L&/Q$MIOCOT/!"UO94""_`X[[<%_YC<'IFQI M*BS2\*[!(GVD-TGU^I.)V/M<5K,N$@FB(2";T*L M@NM?JK54+[)4U98W6<`%F]:DW%(9$3S0KI"]I*)-;$#KSH)_P`(>R"ZAA`8R MU9%LQT:3GC9.D(`K)(*U$`DV3*8*$JC&M#@%^!*!+Q)PF:Z1G@_D8 M([1FC2B`ZS&6Z'%+EAF=_&8`F1'Z$033[*P6=.%UM?E^CAY3![U0!^F,;#3L MC_?A%[NL614`#S1E#X1UFR(+PP/MV8-B=&=T"T"Y!XT47"8-5S$>?0G=UVP3%D*87DMV&.M0`R[HJO3.$_ MQ"1W`/1`(!QPZ;7@B(8U=LQK.W?PK'KC!PGC^;)S%#<>L3U)"R"TJ]'P!P\2 MKUG3AP6F/Z$EMMF)^34[H'"POWK3]5S350YSEN*J^`"FO)/:0\%W/*CFMD$0 M=-$5$O^6BH(,$!?44M.ELT4;AVIS!-\5%%EW M@0.+V?ZJTP%Q?K078SG'DRV"M&-AX^T1O7H?:=V_EPN5G;+J09Q42/I.1/JG M&+U<-OCF_\LJ`;P61:O[JO>`GNN!%N(S/70E@)GBI$J&(-S5%78]@I^V?$GA M_/_;>]?EQG$L7?15$!,SNZLBE-TB=>_YY70ZJ[S'F?:V7=5[IGZA_U5^34G;MW MX_SD]^DZV!\C"=SBTZ`)!M?7/\-)@=\-@7UJI<5 MU#F?,U5)(VY=J4[<_[\MW#*6Z,V..YQ`IEG'%(NZ2.6,MCF/%,PB5;R/3=NF M"6GTD4_H]`[S$)1XOWV$6]=W_#4:XCR$P1K"3=2;%SM(U4V.XB9SKPBL[#&# M(".3&'+@"+!8$B&^H!>DBB^!*0>.6#U;XH"%A8`=R@$SB3"[DPN3-3N&7-?X M[JL7O.-#N>BOMP3UR&K4__V:>G"UCMTW;GV`KP-KN7$5F^QBD>%?6SE M'2Y9R^6B0#!8):U_@/^5:27#J$POR!6#7+/V0V)*0T88YNEX.'AD\Z7C8:9) M!!)F]@/_$PDBDNU'#JG#$_U=]]!3!JK.1Z6]8RZC=X:^`?1]U_%^=CTOW1%S MO]VZ:YC><'3G1+_"5R?Z_L;>R])%C.K^5P<;>1O/Y=R>)4ORF19`U&2[I*BB M[!XR@%0!H@O1QJ^:]LX,'1'+U(@T=[J&#HO=/2S:.EH]>"+K676-JR*>N_?A MMR",7YU7>!7,YL5JFE[M0ZKOW/JH<2(6`6L\_@]<2"\* M/'>#S]<81VS]'1=C-Z0/I`H!UF@XP_6/CQC-;;V`%)$%(:[*N$\CA7ZJ;RMC M7](083YVO"71G^M#STE4ITKQD-6#'XU4U_Z>!EIK-8IWEG@\L:?SO.M&Y&:' M$U[2Y%Q3T8JGR^3[:97]3+&8@3`1K9F:)#MM\SFMDV6XL5ED%+XPR6"/'1J< MPO`E#(+?K];.!NY/5\?-\27P'Q"K12?OS4'#92KT#0"',Q]RR3WFQEGL!C88C'01D`=X)WQD&CPAJ&C[_#] M<^C&CMN9D1HEZ">E)O-XDW*VLJ9-O(1T@$2)H=PD+PIL>M(4!5&*DA<*-DLQ M0V$04_$@OX&L6L,X&%_%P7L?LF*\;@13U=O&W7;.5I-9,TUA!>92E`SW&_E) MM?L=N$E&#!J)J1H#LTBI&=[-C-00O&'HZ)?W]0Y]D:YTQ'Y=/QTQ;>.3^U/5_.$BS^XA?WTM##F<4?/,(WZ`]4Y8.)S!Y.44@F`G1"L8S))$/,'A=@Q&)'(!,\RNMEC>BA[0?&-:P#HFDHQVVZO7#M M.>F57?B.6;#)G==;7:M#[I8.`O#&2S,@ZUM6YG-ZH"8TL3.V5A.KBBM=K9$4 M;^R"-Q&680@D:IJ=1G\U)_N#$]Z'3S%NN$D-)E8U28$W]0""90YO+9^QM9S6 M-3U(+@A0DT,DTPISVFHV#N1U"4KX;=S2.,GU%H;`JBU/&4!KC(]FZ!%#HJMC MO`M"?$-B^]>NO*$':N=F"/"V70'=7"B?P*GT44-L&+E(`-. MM7$Q`D:W473DAU#RM$[X4!-X$VL\R2KPUT!G!*@T0W#3P;4ZS+A,G[0!I9QE MC2`I!,$(@-P?XRA&8TK7?^7]CL57=$*E8(=`4BV;\%(0:0AHNCI9AYR@V3MM M\*G)P48,G<=$,Y`:*W&?/Z8',$+%AJ?3R;@.)$2(,6V*N$MUD/CWOXZM?%#S MGV`U&XW'8_R_:M_L/Y.FATS!%;#T=X!S!'P"UF0T&5LC>SS%/YF`3Y8]6LZ6 MH_ET8@C>V(68ZP*K"5<'Z$=D'0G?[[X_>,$)PL_0AULWQM>^1ZUU6D5$J,4C MMUV\B6TM5OG,>":=9&@J'R0*`-$`?M-?M'6H.!"`W_KX)F'W#5)_-0-/.)?/ M0"D6*%V`#>$.V8EB3JLJ?H?Q_?;9^6CX_JPW%,.1809WLX+8/4=?)BRM._K# M71!%/XX`$HOK.B'!(W`5T[IJSHL'\0WA#ZB1\6--M<\E18"4.G_&VL@Q\3P. MM*JH;@BV9.HM^#@O; M`9FN1XE068Q'!J$A&;D]NM'O:,BVWNV=\/5]3RD'-MO`O?>8S M[@6)`(L$F4SP&Y6JC00D.FOWKC*@3:FJ_JP5I^>S5BK"9(16'N`(?Z!\PHMW@]> M?$4GQ@IV\";=S%Y,6?@BN]`3@89`JZN'!%;YR_3^"W)^(P*OT((==P75BU1^B5G M+XL*)@U\?A[EK?*;(NL,Y/F0F'2E,33\;/ M1\>[?_'<5V+N5S=:.]Y_0R?\YL3'$)G[M-[!S1$-P\E8O'51OH],M9V$[H;R M#Q3GJPSDJ3J0ZQL!JA%@E2#5"5*EX#>BUH#[5Y4%BS#!U>MK"%]Q=?2'T/77 M[@%%Z&H?',FE;D?42_'S`O/I">$X/)(;=,#W($8\^>"<2.A>3N#L2#%BE;]$ MX&J]QO+0OW_Q-S`$R?5QWV"\J[])7F$GIS\HSWI!/;^='FZ*X@AOAOC`6R.J M-R.R'E/*(&7=O.M>JTE^U`A)H)MX$AFZ%@![>#*O]V0$R$X!O5"JSZ$R.FI< M-R'A6Y>_&(]K!(#XHLA\S@*"`0M&$IPCK5DJ0?,J3W-Z-6%"_SI+"#=N_-59 MD^YSTTQO]4&5>*AH%TB6M)](9(!4B-X)W'[^V&+^*$,",YE*&*CW77_V-Z\L MUCVJ#0%"BVK6V+9L!@;T+AKV]:D>!R:L#38D%AL+NM<`C_NCY^"-WUD5$=:' MJWE2)1:JZGG3!OV9[O;/A.1%<.3"8$4]\],(A+X.3<\\VC1YI`P$['PJ M88#AO(PEA*IH]FH!\UG5"P,L0SA38K5:3M(K.FIR7--4OQ2GF,#5.7DOQ3/; M*`#S0">;D6_TOWL[%L'U7U^#M[]MH$N;,/27\Y8+_0CI#_'YCWS:[<;??$&$ M>_:I&A]5T'8UZ>?>KC'.:A502:4Y;B0,8&EJ(2#-+[N+7T,C@2?!,!!:HR"A M,?E-NX6YWYB*2N`#%S9Z8=0*EK1>3PO7">"(L4U&X;#@"N9+A M#WBR6LDA8V`9%H/&1G7(0-CM@=#5Z':#>-H2=PB:+%J*(J1G<^]?K?]U=".7 M+LX_0L>[B>)J6\S]F@X*:K&)^_HA:SY>%(F'RL4+K$XNF>X*0\D'B7"U=P/+ M=S?GF$0NN/=!03*XWP(L&U#AFGA%JLNVV!?6RBR<*"WQ"4^P=$Q68>-R5FM9 MTF,\K'#*JMX"_LG.21%!+]L<;]4S6`U)UEQ$JLA#KK0D3?_GYW( MC9X.B(80D']U0A=O1'E$Z&5M-^=^73&">&SB'71.9BN[@*E<]`@0X8!*QW2> MR@>/ZANM(;TGR/OFA*^N#PZ!BT<`SF:#FK`X`/$.HG9K"]&0=HW^IJOIZIC/ MY]#D#IVD#G&N[SIX@Z@_'N.?/L'PS5W#"/\L=%ZQ6C=@]%)$)&CH)@N8Q]N? M&J_&*ZO08\Y5@%0'(+](M8!4#2!ZE/>=!XM!'2MIC$%KCWJP0"2;UZG,$?4\ MHF+!.G4\9#FNJE_=`>S%+K9H]`:EJ.?@VCFXL>/E!WJ$/GK=^\;04XUQG.WE M=#5)KU%JQN5S`!(=0Y]D$V>FONYST)(Z]SN24M\8U#$2[BW1TEU4M'E[HD#>G$35F!4EZB/WQRD MH\CO'HS3U7D&VZRQMUOLK:%]'P9Z^;CF/%B#\FV9/5>-)"+ZEH4K&*"#>`67KYVTPKBOSMP"B]G#ZCD\Q+'WGY MSO)2'Y.P\-E,([41TC\'^P5&Z]`]T/63XKP3F9#BFO5K$:%M+K;9+NZB&9-) M_\D`;E:C$JL8@4R)]BH_PP6"GDO, M''73")BU@L*9UVST\H3,+/C2NPI[8+)#;7)!I[F0[16" MY,:+@L>#N/<&PY=`BX,6\?`1;LFV0%*'S`L MK_-??Q1WF%./5'Z"3[E^SJ2]S9D#Z\3RJW'6CE M-C,ZN-V_'W4PK5*'.[-@G[I[@*&KM\I<.[C8U%")B?2UKU3#M\"/=U?^!I]3 M;%U\J'U)ZYI7G46\6\OF$]2ZU"YXY2R`_H8EDQ-B6+;&Y:[^KC83GA)7!5:Z M^OM;)D!=1X?%L%>_IL6,A71>^'[$1_;OMS_,_Z)6?F!9 MQ=G0S);S"6.['Y6,#[)ELD$B7"-)2/&W=B2AVE\!II#B=&EV#-^KE1ZP/5?/)VV8K>>4QJA)YY4'U/'T8]?Q\,Q`IO*!]-):/W#CRUKYI% MFM>T(:-J"_=MX]9LP@\<19$._04+$TRXXGW?U/(5PC M9R)R@?,Q&H$-CM!AP$@(S\/W_>XD&'B??-$U@U:TV=!D,PLC)I)&QR)E`(PY M\-_K-/=\98_GA:&N*2?X)3AE:7&J=<0JP;-\]=V\(_?D*/Q MG4]`DY+[X^*T>&S$8??>#ED:'&H%<&^O[*)7QIQ/YSR)/O"9<[[3Y0:<(^]V M>'BZLE:+QQ%+M2-FL]]0.D'(-(.W[L!XFF]`H\)` M?B,ED0>H0%W3@G(\M$L>KG=.^(KO:7T-@LV[ZWF%.4*'"!_AF@MZY\A:<[(\ M/=8<)YVP>D3M[B-<0_<-3[M&WR&["C3S!0V@JEK!.^^Z7*YF9YC"PD!!V@A7 M+M$+J9[^Y240,'9>`O\8`7(U3)C)!#BEP2\_/YD`)'86UN&($1P],#J@D+JU M/=>Z1Y1")=?+G3Q3*QLQYF_K@D)'^^US^P&D%P;KS?1JHI1S^\Q;W=F,VJDK MNHS#F]SG;VC*]3,S!%)G64U]7#[GX$&219A*BY)1,Q'XAS#8'-=FH*2/YU70 M8'>=@CA3T,-(3!:8ZH*B&UM93HF#C/FJ)K2Q[.%>!E_.)V*PTX\S*3Y?#N#: MLI6%O,8PZ8%@B+J,N-8.\QX#YM=O?U,I`%O-X=_NN9BF^$N%&GJ'AUR?[;+/ MP,VWM([`W>WG^T<#2KMPYVL9@WR1T@O!Z\`GM_P\(Y7E*]Z9'[[F%2V@J]HA MD'FS<[2!5!SXC0K3MF=X#CZGAH)'?TSQ>) MVIY6`)(6$WA[,*O9PJZ"))4%J#"U,)'I&3UOD'KC,+T9&A&.^WN8C M+0I0.!7Y,_0J)_2YW]/2I#",X2;AR=BJP4U6!:)X8A3+U=W2R'"7@BESL=+4 M`.!T^)OFN(.?RK%R!@ M^Z]XIC0]J'H7.'X+#XE+TL)*PF:*[*&=ECCJC:@"^R1+UT09WK%/M-%V!1YBZK*4$N5@50;+6F=G8S&"K6SV,#!L?L$1R_#=>:-,M]U"_"0 M[/>P"Z#O?ES](4YWYZ^:PF]G=O'FZ&IQ3FBU.3H"B?P1N/H?G7TNV9ZW4I=" MS[MQ52_W6\FIY+YQ;,3`<2O]U,5,R_R*&ZV](#J&\'Z+#Z-`/R+`?X0>OIF$ M;*9_VCDA?'$BN'EP3F1H>O42D54ZU@1`/Z$J9V9Z6LSTX;F,HD:0 MJ*1G3T:`:/U$U()4+_@MU:QKW4U=N.S!PZ5L9D@*Q$K31OT_@XR^C?OF;J"_ MN?G7T45C$++8^+JK'AAK>E1UWX5A!WV2R'#(TN!0 MQ4262,0'.,H=OP-&@1HZU:T0"CK1C0%1$^W@1K$7,?/?J^T M,4^4\F\1SC:*I:_*3?85-=J'KYB7FUO63K9/2\:#'_[=_NO,_EN$N?]'7(X7 M?[X1^?%T-2O_?$*V0I-?S956[XBE'2FOA-N\!*S^@`@-`^J$EV M-B#+(ZU[NSH[8?,ZH3R7F3NV*KYJS>GF'<)G3^G(:Z%]LC@ISNE=]^[?'HZ< M9[<)VWSK$ZT1WK!L4ZQ_2--[(+>`MV;!8K*SR2",:_L;$ME%& M1S?.(3BT&UQCBXZ^G*.PQ1>5@X@J%LZ'#V<^R\3A@^-NGH.;_<$+3A!^AC[< MNG'T'!ZCRB0A[VNZL-I@$V>J3,;3Q?(`Y`*ABDD@$1K0?0LGRU]/O* MAWI9#K?,+H`#CD`<@&"[==?(,C+8(FJ@QG)6`FBM<$=;Y*2R"0S)_&7CETR? MT<83B0&\ZUT3:[JG.,=.4&DZ$1V)T=*."Y\#?T0 M/8-`%8]%?V6"K_9JH>H#NF`G<,\.^LC3B7V.N4$O#6K%6P?SS_O/6NX\ZNG# M>;]9XW5&S%RO0*SKY47U^$H2_,K?W/BQ&Y]N_6T0[FGY%,9Z.N]KJK'(81-O M;\K",W<4H(E4\`ED?\6])JH"%'0,O0[.!+%LOZV2WU=:G&V&O&R/[?X>*R$( M`;!FM,$;J_XG"S?0I=.[Z"_GL[KH1YDI7]UH30K4N\'F*_K9^2Q9\[,*9G@; M#>"^-.0Y9G=Q;&B,<"49!D9['%2C`5]0SH>%_$DM M2,C4\^Z;6HZS0L9GZ8)%F8&";D[58J#9*?4(J"16??Z7(Z`N^PNM$6O1I/5Q MQ3BHLX$W;R;C;,]EFC>E+H:V10BI#MJ='52)CZ;4.P<),R1:D%(W%]+XJ#Z$ M"-T_/)U/ITWHT#'%(,VO!E#HFW;@2;`&+,BX1UD4![2G=N-OOE1K-K*?4XR` MDG+>-)E/5N>-0]*C1H(TU.B1XY`MZI#*G*]-IO.$K_JN+MMQQ;F&ST)^K3BW ML4[>#+`FB_-!,'Y=7QX+&V]S&:\R9XLI<9ZJF7LRIH;?]NN',#C`,&Z\0:SN M,=53OS4V<'YEU#2GIR<2"2=P_^[##7@Y,2]_.N$]R>\[=[T#[Q#LG#<('+!W M_AG@8EWT_NHU+AD9>!X^OXP7XN-35B1&[>QPW]!0]"(I(!>C\[QG7W\HH'_] M=EWP1]N$;@/$L@E.*&/:W2DR[RXRO#Z_"LU/JMP@VZM`=PS/`L[ M*3R3BLGW$]`BV6L]NW7[>Y7>$.2N`4Q]:]QBT-NI-QB^!$.[91&_GLF%O2\" MWJG:E]R(G>+N9'8H3(#\%]<[HC:1\S.F3VN$?6(";RZ-I^DE877`3X29`?TN MGB5;'LB+!L._TTA,$H8GM_L@_!T%7\Y^N]!L#FE?_[D,$?J M;6\H'K2WF,.[DV\Z&<^28PU$(G!BD,K*_C("/UWI*<\DU4M+MY>-0W.IKMKU MKGX^NAZNC5#R6=?PG1."Z4B>)SY:FO;D],03#-_<-4S''+AD2U[%Y7M`:G'# MS=6[$VXBTLLJ_AZ7=_D>Q/\-\?6LP:OO_@$WZ:::,/D1?LYB-4-JC5#9R5#J M&?="_6*>]E32XU")@:6J144;R*67U$I`S1R5JQ]A(W&]?'""Y%+EQ,Y1NNJ# M&_Z"K9KZ.^9^#L)YI8@FM]=&P$^B&A:B>J!1#;;I3W7?'*B'2$J],/4?]T_% MV+DD^A*YKOYYY_BT_\H[#?!_Y3'*Q_)RB,[O-ZB.R/U?226APT6,)_ MMB!;>4YRB`@%1&K2^J(6M[E.I!*,R'+6[NFL0OQPI.<9F-J"I`Q9QS#$)3KA M`5_'[K\^Q4Y<>]RH\7&U:*JU@;>K92_M<1E'5!S(Y`$J4!M^^KMG=W1/(6(: MT^X,*^R`J$));;'!RJ^5HD#L&N[I?+HL9;V>VH*]S+7Q=52@K4.JLK2 MKZX'PVLGAJ]!R!X1E)]2FK,EU?QGQ\X(FT@!J1A="=S=%UO(%W797)L^Y:2N M.JTJMQ^.+YZ[)A5U0S%T2VY[,2EE-9=#;K73E=%<_;`$_U.5S M3X[>J'/\U\(Y^[(2TR6`/*,^?4YKE9\KY6_%)N4>2R:'M MN;:A8Q]_;$%_U&4Z(Y7*J5[GNJI<_P?TO/_R@W?_"3I1X,/-;10=*WOMVI]7 MFOL,(P3(L=Q_P?(^_8X%@E0BH")UH4&&AW9G#]7AHR7]RCAI"HJ6/0OD$&3+ M'7UG#ZEUWX?5PP^9V0]EJ--Y;4/ZL\T\\,$-BGMB@E?"9'\R4F_;VRA;U2BP-&>E7A4!<$&0<.B/!; M'U_E[K[!!Q32NX9[3AH?5WW4H,$6WL/CD]DT*0F;Y$@F#F!Y^NY!D>:2.1U_8S`M(TS MQ18+:S%K8HA4`?W+"1`5FDXE#>5^`X=H<%^45>3$@+",M5HMB-\&D4DK>!O( MI3DTPY`-Z\X'YJ/Z242D+N!J/IU-&[L4&JZ$D.)34T]"UST14AQKZD#HO3RB M#3X-T)91Q;'OV/D;C'?!YI;NU89X$8-C$,U\2?EHFF4)[P!T8&L9AYN"ILYE/P('0^?-/L) MM19W013=^U_<"%&!(Y8?#6*T$S3;-MX=9]/LFF8V3Z=:`%8#?L"*?@2!#U)= MAG&VI*`DU'U,2IKA$@"O2&*$/=^X6)F+3XKJ.H0[I.O$<_*QR[[B&!S2`KY! M6L`7C(3_G="-<$<'IQ9Y=I,8@1]$E)#T M!/>T.7$SZ]5>=JP@@HV-YUG;B96!^[SE!$2?W(BL:$1\^(K)IGFF;MC`3%E$ M:3I/]N69\CQ@ER";TXMFEJ-A/*V]3RQ2)F325.B!*1:#-GV.4PT;,G1T(S>-@APH+HQK`:A';7=:]0C1B8^PX_X,S+@ M=['\J1.@'^,U5O%?%#%==(!WKA'\AG4"HM0LK/>-"H'YTW&_1Z,G/"CXZOJH M(79)[:+\KD+46">1N]IN7<]%G6$3F^B&S.?`-RN4!D&[?M,=USOZ`2RTIVIL M6].6D:RV^ZBDN]G3=^6DY(5R# M37='>1<"!?$%US+]['AX2/^T@[!R>3"S8RI?@1$3Y%VMYYW>M)"!5FE/:4UK M6>CEI4:`Q`I`S"AV^4R8%%<3M98^AE#4DNV@&IE3LO MOG/<8/;]D5P/@,D67*W7>%D'TAL#?D$R0E#Z+F;-O/>EO.8I^5Z?2P7-W_KK M8`]QK3Y8=SU\+X;GEFT:N?,:SMEWF4S'9T<%F@F*J@>9?H,)?9!(\5-Y4Z0N M@\0'"2"+OC,U9$-)$KP*B3?TIR^7VT5YCIO6A3Z@08/FCI/*)DTE"T^5+JQ9 MZP2R=M88PF="")<';,$,YAA$FPK'G$^RF?L"DUQ%$13<+\$E4#N$>:SDWITP M'<_:-ARWK9",`-4Y#.3Q[27BD)<>HWE^T;+#]%8OMD7@T(YZ[@@.-N#BL>`A MV?^,#W7&5_X&2SK@E[_#R@Z/X109,13KZP4G'&Q[.5DVC\M:&2,A#)":0XX3 MQP`9!#*+P/>!=JR+#=N41K5Y\ZK14>TPH%,:6GHL#,;9B8D1]Z]0E8LG*P2]]NE1UP;R4;E2ZAN5"F!9("HHOIV_5-5K)NFFCQR;WLFI@TK>K=1[*"V2,9.Y/ MZC"L5OSE<$AFLP`\5E+)A$Q^##EF&V+UM7<$"VNQWEDLX$6.ZYI@)I%ZRM'6 M-.;[%H3QJ_,*OPS?N.`5,#`+$`)"88 M/Q+L'[>>XT&%<9,^*NP?/-+/RT+@DQ`0F3:[A7<"2L=R72<^6+=/S/'V_[^3,%=V" M3BI_7DZWKWO4YNG>#9=Z_@*14,A?_]/DKE\MH/KV^:JAUM39NS_`$/W%?TVF MR_AK/XK*O8!N7L5HWN9V:JVL<7,?CX<[,OWI]/4PW@]0]:;;A6%3'KG MKF?<:+FZS'?8X+NI/3@F\_3IOM6'51>WQCL8UA]RD"#Q$O@T-Y=W3@Z,!X^1?,;L&"A*E<1=C>="Y%%(+WH\BZ%.8FQ8ZY0E M]E(H4GP=SY[;RY:S][P<,/3*IW2R[!HM*8RI;YU81\@(=UZEU8^3J-'?%7J4>S&-3Z)AD\,)F8*;$=MV9+&,T9-E%[.OI(N42)4D;QX M<7-\9WCH.[M7C)^,+E84NWM\PT,B]\L1/@>?CY'KPRBZ6B,#\=5/]5T2WE=5 M=Y4X[>*]"'(7RVS/"YN=LRA.-VV?$0 M)YN'_M!(0!V@FO5`1$(D@U(^8NAOX.8..A'\YL3'$)'*U,Q>I,$=YOO\"7^&KS MSV-2)JCF,[6^HACC;?;P+I/,%_8\*8*!10(J$Q"AX'X+L%A0D*L4]'*=M/0Z MV<@"J:>%?+"F<(^"SB+3F':[47P$:DC4`F#_R&A6DJJS>`IW87 M3U4-\L42M3B>%XB45@3>^H=C'-&UFO]S=/S8Q6WF&^0N9=Q?H`ZD"EO)?='" M;#P_1R^@VM+R>"-0U&A6T5VU<2+8_\4/7B(8OA'/SR*#E9/C',B"X_Y`8G3$ M17GC@,XUA.CO#_F5I==H;/L:T%E2?+D%QAEX1L"IG155SB*=P5;++-V^C0%L M<^T<'M&'XLN]]&%]+)%8P'UQX'*\8C(`D@6P,"-@W<4Q6AS;.:!<\Y(*,DR' M-.'K++T:L%,,@`&XP'>OX3K"_.`HO:$/(44S^._\6LR8,$D%FH.5SB[2P63J M3V@65.HRK@$OE2`8`!K2QD\:[P1L>D,?:(IF\)P[L M\:0ZG"L(-^^ZP&%"<`9&([#'F[BU2.2*CBFXC*I32%^"O>-65C8ZR=",3Z9A MW-TL.ZUW6,!H81:12C,(CG(\MCMYK!.EK6G1 M66:+^W7=&*VQB7_:8&(W-:&H1Y=)![EX@^#:UWF"U!H?C<-G0^*V0I,5)*VH MO"=3QC>>^^J^>/`VAOO[\*/=;[?N M&GX^NAZ^<^-IAS=3'H(PO@OP]D/'=^HG<_H)4[Z_J*NEO(<.9]/Y.-UXA'4! MJNPO$4CT`:H0I!I!KG($,J7#3A:Q=R8I"8]E>'A:]C0IB9'=.T;ZMD/UI99\ MHU2O4,N@2;A!`QKOYF/M1O#9^:A;`F(]IIK::FS@KBIA+R96PEI4#*!R`!(T MW&(/DX9ZNV*I=J69,GK[8Q?]@=2?&/F#UZW`^P[Z^(85O)`5;,%R]A_XCR!$ M"''"4UJ4Z>`=(["BOW/\$UC3Q6)2I2E]!DF&&I'BI]WFIV;`MP'N#/N-,=$RU>'Z;@SOD#&;6P1.GXSF MZ)ZPJS5"[-'#Q[V:;L7K+DCE](>P==RGBFTKW6Y-='PB2D"N)=NU65"D\]XU M-1%)[_M(@^`D07`*0=!^V5IO#)1F1KH%U#30%^Q+BI-]AQ_Q\SOTWN"WP(]W MS+6(?D(-(8-V2WEAL%HM5IS$4%":U@?$%5H_8D`5`ZK9/**0'"T6:<#L_+3S M^AK"5]R]*9)'5E@0;(,0H*2?F4HG_.CBI1;.3V`^S>`3IE_1LU+2,!-F+*VD M%O("9#E-:T-UHQ.L#V"%E\`BG8(CC3U6E\,>YZ#ISAJED%\(6Z`TE9=N6)C9 M;('T,] MX!ZN3Y?S_G3Q'EP,60B&1AI5S"^,*G*\]"2*)."&T<3GTS?GGT%X[:$/VE1C M1D""&91P;A;O!N7EK*><")!)J'%!%';7SNQW/>MV&8JZ0B)P0 M2T-B&*(>(<:ZZ[\6N_(/,'2#C27^W1NEF8'!)A/Y.XP33G!FVLI#::K/.-A* MBTW]"+H\6#X0N<")P08/I/&&X>8"\@;`G@W_K.ZHW^+<9Q'O2Q)I/%NG11;P+G`@E M6UL`$0LRN9JV^$K*8+6;G'FK;YL\+O6RC/U<\9))"?*JH M:F<%]DNZ:(%I$6=C,Y\OTCMY\_QQ$TE_U<,`WXSP$R*''P-G4GD)N9`5A,1IX0M1&WJ9G8H^G MP%ZFI4Q1ED%40^O"4*'KPG#\<^I/G#S8QM;VBFH1: M[.%-N+&]7*77/A$!&>"(4$!_.`+/_U?3$$:JGY9V/YN91:JS-H>SVAB$$X$9 M6_!$9A!F$&`$4YA`+%GF<\LVILLAQ1\^)6,VQ"B08WC MX[["S1Z&K]!?G[[`@Q/2"^+8*.9[436FN:SBS9WE=)5=[8@$?THE`YB*!IM< MMN()B@$\M:J>9J)!0;9..AC`;4(.W]PHP@N2^*JI?\#(<]9H2%505A\);?0A M!-N,3/B#)X-:XH]OPN7L7;QB_\1UOG7$;_K^@@AZ#NJI1L)T:'T$G\`)`D04?C\`+@[Z.03 M"7[1S@4:`.&9!NK7[2WPDH^.T>4C$W;N01M;-"(Q8P=V**2S`2<7F,`$0M/? MR^E\^?\=&N@0&@8'F$(`'3RJ1;\92.?!N624'_&U\W2E!$,,)3C*>>:5\`U/ MJ\8\VQ3N*>CI9)*L7E)I(!<'"O+4`E:67Y8>OYJQ*\LY>J4E>3LF]\9F_B%F M3O@6#PPV^)K[K>L[_AHQ\0ALB0&#./X&PY=`@>L6A^]-CBIAM796R@2+/SE1_CS^P;.+ M6[)AYU];MU[*"Y>=A0O%9N/BA';C8TCV2!\:?%2UZY(KJXO;+=M#HQ><3XX' M[[?W\0Z&.7^TXY/QFA:(UMO"7?5S/IO7HA2+Q6E'!!=:?TWE#*7ZF\$LPIX> MD+&X8QQA=_>N3X9@V5`KPDUB.C#[%)!QW=W=M=;C2;SY6X_$A@":`,:4RTES MD+4&G&G!>%DC,.LMXFX5)ND<6K=&U`RP2HA!4\L8XI78IN:QN\\H MGK)H-8@SP:;SY2JYD87D5R(3/`>@*!4?,0;W6WRWB=(9#+EN6KK=;)S0D.MK MSI-AXFL<%*E#UW">&WWIH)XO+#)X(71.4>`GY.-"]O8'UI.J.:#>#-X);/1_ MBS_Q:H6,Z%#"H()`+DGCBH4,K^QZK[0Q0C/N,AYH\%P*^E$'I`'Q^6^5HSQ3 MS?F55PM[F>Q<(B_KV8/5XP[$=MX5UU6B]4\V2&0B"_L+*,* M1J"L8@1^O=(#X.$"8)D5@$8F&"X*MF@4=%%*%Y"GG",4XU$H>!)"'N82,IF$8`(H"7"G#H>/$.?<-X]P4ZR'@8 M18]P1X>J!%H_!Q&Y=?;FS?$IR=SZF\:[Y?O+5$T5?0WF/A>W&J_23@O1^81U M@DPI*&L%J5J0ZQV!1+.FGHS:4%D7$*IF.E,;+UM*O+21HRPRRAA42O1ET&RB MACTM[D.ZZH_K/=P%_BNI8D>W4MWZR5:Y\V*3#X'GKD_TO\_P M(_Z,+/V=L80]A":%.R\&,)^[8.+*2MK_W`@0A"`U`R_88T.2\I%IC=C,F+H" MLM04\%OR)[8)$*,T56?7'5Y"&D08R$W1N?%A0&`6=TD,%7<)/06D%9F%K,`[ M-I[?<>4L7*&&%-%B=AXX7E+X]U9;Z=X):E:Z7?6%F`;H1L80X!\6=YCG%H[(F8Z2G8`8JJG' M8UQP"[=ED``GD7W%6]FU=H548KK4.5+VB?12Y5<4[ANRJ^H;C'?!IOVP"M^[ M6JBJP2#NNZ!GXVD=U>"T!%0VH,+U'UV1[SBA@9MTDUU*!HA*C^AO?H0Z^QNR M]9-U3J6WSTT'58?[W,3M^V,(HIU#-\'[]51XMEW>$&KDP'`]M;4%4!\U/>'J M=]B0JY<(D>N:=4R'];1R^JF8P'V)W"HM9)$03B8)_);*TC4Q(\$SNX-G:A'$ M3+4J9NI#80!*[K`F-_`;KJ!M>D,?6HIF\.;5;)Y6EZOD52I.ZW6RLERLAPZ' MBYKP4Y>$#1BJQ,4@'#5>_-K\CGXLB5UB:D\FDU8T:;V]59Z;;8@RX%)6KH3D M0)7F"U>I5<_.!^<"(>MQY6BJVB"08?,2D)`H`Q?;9'A)JY3!#0P=#^3>FC`> M8J=<%32,*&C"2PB="'Z!],];/YDLBA[A&KIOSHO'NB61ZU6U.&JUAWMX/I[9 M&::(-/!#*O='/$.1B@:Y;&VXDNMU-B-["(,UA)L(A(TN*H09=Z:>08XO0,;` M+SR2JQS)2=/<1O9]X8)"=$.2:1E_82EKU@9.K`2D6@H@'>".L%:^MJ=V*W.9P&87A],RY"_&Z#"E/=']`71>\$%/XG6BR\(HU`>>< MMO*F^F*UG'`AOR";K,#2FE^9ZN+O#6JVAXJ87>0&^'&`?I3$)2!Q\9JCH9TQ M!('$Q2$B<9:SL>S,CFLGVN'E6O0'7@IY_^ZL#!V'_Y26BC[[$35"5E=9JC?_*;<1^X#L\NQ/9Q60++J.\">:]``DKKIT&(2A;#HCIJK?N&?YMFEJ7/\>W M:=MX:/@'LHL?Z&\_;(H?:(V_RX9^B[#T+>ZN2=`=4-3^M[/=!2^LF"O:$JFM MA2ALLM3S]]7)QI,V$$P M1!!HE7FZAPX[[I`3":1)*/2A_VY6)[HMJYN[RXUQ,P2VIWOJDR^G$/AO,I2+!+:[-ZL=#KP_Q#[1ZN&CI<9&# M)J1[.J47(2.O-*]Z"2"-W7NOB<0@#/`,?0=KBF#X!J.;"+GW'GV!I)X[GEY[ M".'!<3>/=;O[^PO4SAXBUO*FXVR57L'':+VI4I!J'8%$[PBDFDE+GN@F2-4] MUS-8G)IZ.<;$27#>9;!@D4%,$I4PBPI,H[(I1N601"5D144/#W;A&S9+"D=: M"H>BSK7CW6$+;CX.;DC8Y@&&;K"I38^&QY7S']L6[J(IDW'&;D0:(.)`+@]0 M@8H92Y)GEB[/6CA&DGMVT3V/N(<4UQ]J54,0[6#*X=\2!"G@1D'<_.IX'CP] MPEZ7_+*I2B MP+H`5092;2!1EY;13!6.0*Y25\4*);&Q3(Y-"S4I"9#=+T#Z^*TGG^3DUR?, M4ICQP7/6D+`ONQI?W5/*V:QB`F<3N2`7\B4T!8@4V@705)NOKR>6K2E=;VNWA3"ND M<)HMCU9JWN&-]#_DU_ZFLG_4M2PJV6W[S.UD0?0'7,8@V`)GO:;52.`&./L@ MC-T_G/2"QW^W5G]=@#W2B'^`6^1_MR;%G\1XIIED/)A8(X"3DCQV_M/)"$]C M'.`:USSQ3K6A5;>8PP^1\C(.YX?1A'NRW?J&[AQEYU;I*;5H+JKF/NZ"FH0, MN/2@0")!WW)G#T>F)4^2;;X&+&_6)L]9\E>\UIGG])`>64=M^4[%)S7D>T$] M__*WM3K+>2IE1+<#:&N7>CEDEQQ*ZN=`)\27`**FY,T)W>`8`6?SYJ"$C<#> MV9`]@KJOO6[(N#J`G(=')T@>''?3M,>F_)0&<"2JN:O1S5;3,V!@"0/L?A$% M11='RH#`JQ-%9O>E]PDOFU\<0+WU=^9OOR$WZC];/Q7Y3"PR8 MYO!3K#VI0..D\\BS7-=*QZ/,.#K)G83U&&J.BTY MZ9,HT`6N`=RGYPUN'_0B3"Q5RZ`3"(HN'-+"HY^/KH=GVU!SF?[U=G\(@S?8 M7).8]WW%2.0RBG^J=V'E4*2B02J0S,EF_RB*UP=$^=X3)*92Z-XXM\55E0`5 MRN%SA/)'2\H*<*KP.MCOW?J*W\SGE*\"UQC!N^5@NEI,D[/>A;?QM)-+Q*J] MNU:"*^<,4!"D8QVXMS]V^=/D7X9U#U-OCYJJC$OZ1@6G8C*96LSC\'5]NMZ[DHTM%5_-5QPU\=[\C>=B0F10O(N$SCG1E4H_+R^IQK;-Z7#_\&]X*\F\_ M&K!=JA,HZI'.'V>]^']&JAIOD*D\J`7%J7;NRU06=G7:%`O1?$M,+W_..Y`M M_JC'S7DRU4.CY+O^[+]&H'P-PF1[=,OJ>.N+VM!19XU`5ZLR]Q!IOP%&JG>5 M5LJ,BU]X$Y&-)&9D)"P8_&_'/SKAZ?D]>-X%QPBUZE_1AXYAPX7LK:\H7D9H MLX?W`--\.4X.P"82`1()4ID@%:KGG)E4)RW-3C8N/4CUU"YZFAYSN5K_Z^A& M+DXG;8?3>'&7SM)S144"'_P7]")X0O__$GB;:_2TN[Z*_PN7.@N#*$)_,FF! M]TW%[,!I%N\ZT'PZMI+SIU3RIR"B(I?\E`JD"/80QB-^6.7XWN>NG=<`'Y(/LW_=>DA*X++/ ML7<0HII[A"WD;-SFEF4O$Q:B.D"J!"1R0:(F_?<(I)HT\=&PL;!,C$4S1PT; M$+M;0+3Q5F=&R"BL6SPEL-F=\SM\"/#1AJ3:QU481X_!NP?C^/F#R5]'?V36;+I'XKE@JHV*P0#!8,$LDC\/Q_];"2='\M,_QM9![I3MN-3F>[ M5PO>ZZ(9$:BFQ,(=+AT3G7=H),B87B._4CA9B?4)[+]?I5CQ51?KZVJOW62O MJ@G%X@E>&=W\TY9$]62=*5FJRD>IB"F=CE,X,V8YF4RL8@]=1@GL$ZC?X M'N9M4B;^&89['4?/I'VP`GOAFO`@6N_@YNCABZ?QJ3,GUG:=#@=-E'K(#=&0 M3UK-0UC=5S[TN#+`&L_LJ;6JYRAMH]A^OM2RDMYQ;#^'SD!K``%U^BS)00T? MOCL>85+PPPE!-M)3$K8-Y`RRD7L5!1&>A.1[$+MKV,PT=8_J()L:.[B383Q. MS]W3E$YDC0"5IHUT>OMD:?&IG7QZ.T:`>W\@-$JN[D;RZ,4R(^!3!^FT&CB@ M_X;X&B+&ZV](#J&\,[UX6T, M]W5U9-C/ZFC6Z@SAWN,W6\ZFA78M`KDP\!L6!X@\Q?L3Y+AE:7*KO7'K[YO= MS3=EK543DDK-%3,4`V#ZF7&7=/USFK'\+'#1\'QIC5=,&!-)>A$L[@P+O`,Z M(X1;<8]8D&5[I`.MSW6W0+.=EX;2K\<8"?[F^N[^N']P3N0P6WLCW/*:%@PW MV\1=>VMLK28E3%.Y(!$,4LFZVVF9[EHFN,O!`S)]MB7XK(XI^'!:)@Z.:`W+ M(\T-?\,KYO"'2'LSL1;3!1]U:.L;2'*2BS#T]ADD>M[K=W,(H@+/1[6NIPM;^G?':KP1C>;<#C^719`AI96<9"R_U8W96YY#I< MP)O^^3".5*Q.D;5%HG^EQPUT*:C07\ZQA'Z$['AUO!L_=N-3S?[+NB<4X*-& M+6]BV$L[:W)><>TV(D'+ULJ^7M@"7@R=ZPVI@K.:Y:J>E@$C"N,+ES7/=Z!% M]P>(UUK]5XJ]9!4&+Q@SV4ID%4FT%+*EKI7'_BE?;I.ZA:>YY]0-`%^C4AU(/^&&4% M,B2$&S=N+)Q7^ZA2Y%;UK$C21G:9N4BP`O01@&[^2FJJ._073A9:RQ-@1?[:E:Q5I+N+3@+BDF[4+F MB=7"$RK1E*OE+B$PMM.-./G+P\`CB!VO$1X=K9]CZY^Q=-#B@[)LKR9(*;'/ M'-6U)/3XCLHYXM*;NO?#=K3(?O,H;\;DNF-6T(9/NO.?'_S%`?K MWW>!AQK,Z(;^K6VDAPL!__40. MBF,YS1-`*C#1T9<$`M0#.L0N#,*5GZ?M_6G:9Q1"^!9X;_A7B;M9!2R]<*_B MI(SNLXCH!O-79TUHY@I]3N<5ZJW\ MN=N&R[JPF0+';\X'WL+\.>W67#L'])N&&1\!$9H!RK)+H`[A=/]K,Q^>F-=76L3FIJPW$;1S6&SA2R>H2X7"*RK@]= M-0C13%ALR[@3>#IKHZQ,B=&D)2D4R3#!<3U\-"K+ MX#T"N4J`=()G'8+5)[(3_BYP M--W*?%E:@"A/>NC'&D[+GB&N-FHP"&\'>^=5% M44IN!+OUU^QK_IC/JBZIP3*$,Y=F]FPRH[4TOL"7&-SZ41P2C<`:C_\#]77\ M*/#<#6N.=1AVD.98LF"^=P"1E=UAAZ3IO*M/BF^T*3TXX>]1YE=Z+=_?RNZB M!C9TUA!\]0)Z!NL1EW_]AMK>5[PJAIM>;44UVE"75=-H#)J6]C?P-X%_ZZ-O M_>+XO]]OMQ!Q%`[MW>WG^\?F7BG7NRI;8AZ#>`=3:#@UR3:K(+$@DPL2P30# M?R"R?]3=I97N.FV;\<?-T M8B^G]?#+M>'URE0?GOS(-`('JR37G@&L5#].!PL1@;(]ML?DA`Z1HVW3A9*4 M2&[O9OBI@ZBZ()[%9<)Q,YSN;OWO\"-^?H?>&R07Q#$/@/>2:2;Q50WE/HDW MRVYDZT8K(4)K=B&TP$9&1VY@Q,]X@I#7&2K( M,I401-L\U%WO1P27TP?J&)P4]ZN+P;VDOL!9O"X#YRC#I&4*EF4TSI%Z_J/W MU;.>'7".-%X*SD6#D^)\>5DX+R1\/YRG\;H(G#\C[=(:="K,9*03"[F'L8OY MLC_4B%*P+RX*[*6L[X7V/&*7`??W0%JN(%%&0_T]X%];FDPD`/T] MN!28"X8F!?G\LD">YWH_B"?1T@7P.#'V&2FKNUP,0 M2])RR84TM^P.;JG$%"N]SC%3&P03,/$EP$>E.#]?\K!&7%`+>+@^E1S5T[(KZ!18: ML\D8]#9(7A^![^C;'L.0<0Q,79>LLU,$%\\[-]Q\.CAA?"+E-,@&$-UX8*55 M71^KXKX.+'QS_AF@3M[I_MV'FZ?C2^1N7"<\_>(7]\\W;@@6D:`0.0)F<==X M68X30*7"/Q'I(!>/SZ,6%6C>(#Q4$&RA(.@$98?\+F)5-(#:(/P0!@>(J/#: M%@U,"L6<-_&-9V."Q@$J2!`)&D=#$EPS.[@F%(D,=.L`IKZ0)B! MC\9!$?-QK1@1&CW@TX'3)I1H'1A)<:X!*08,C=I2KADMG8='M:=#OSGAJ^O? M^Y^=".*3,.=?I>X1Q6=!S_7SWK\]GL^7]`@HE0#N?8!ED#-:2@]]]O+`4NE! MX_G.7F[8!3<.@8N7`IS-!O4,XP#$.PA>L%\APR\5)S992$@/:M9ZKZ?%(H7* M6H9=Q6>4MDT%Q?R]FW0#6%I.4/?`J*L3=L$)O4U,38Z4VY5S%V4T)FO'\Z"? MG&2^AOBD9?*S9_CA1,RZ`YPOJFYXN*SBS`][/EVFS='Z"LO(CK%3R2#Y,;Y! M%0D?%@+,EDJ^RY8A+CH/2%\\FF![DN-7$"3I)0(YW M#X!OB%+Q+[(OC MOQS#4^$9-@=(E*Z:-.29SME23:<+:Y5T2LHH#+8@T0\*PK-"/("80#=H@L2( M4>E)/=T731&T+BZ"S42H*8PV?QCK(J:-7.436L;&DK^$"OK^ZG[0JCII\06\ ME-V=KYO$F4;0#;9R`F$^7HV-+%RGS'`<]D^G27I8[D51> MUM?1-9DES3E+GW,\;"/!PQ*=!-3#EU2@9J)H!-89$;!#H66I!H:OZ/M=K?]U M=",78Q!?S_S%C0Y!\L^\WF_T##_BS\B8WUFK$MV$J5S\Z60A?PG*13;2(GI& MH*B)U`8JZBK4Q488Q>H`T:=K46GXX-#+7IIBHG5-JA<82HM7W4,II;D/0]?S M[D[^>H?47@??XV]QTP"GX7'ES3W;%M[VPIY.9S9M[LGE&5%$,NW!<54/2&3Y MDG(*%@>(/(`$HBXT^!X#)%-K`R_+23OY8`?H1_1FS3@`):?UM?+M>,I;^99X M:&GE7;]]0T;I&95MQCMW$-^-=+GTX.#3P>Q/Q6W!+4PX#6+^VHM:Y;T1_&1J<"/ MD1$>GME/=8Q`IJ5PT1AX.0&J2!N6!HF$G43B4S$4;J($'(:]:(VCN?X1_2P//Z,-Z2E487^GGZ6\AVV6\[3X"-('L$*0 M:L3-W`]8*6KY?@297I`K)FOWB>J6S.^/Z+9[-13&:Y[&:XWC=:0A`MLL0DZF M2F<'00Y^BGT&"2&^/"*Y>HGB$'W10=(N$WXQQ)):S-O#'B_G4]D$`WY+K=`T MFZ$AA'3V#X=OZP7O$D73KS(@*OQAB M$6V)$6"6L@G&U,[,D"&L[(7JYQQ.2_F7 M)E83+J[)]%Y89V:(>)4[,X="O((L2D9W:`0QQ$$J(F&^/#+IUJ$1%7XQY-)A M:F$FFV1,[=`,&<+:#DT=Y9C8H>D(-7G<8T*'YM9?!WMX%T0-_9/",VH9(5?, M?1G1:CG/@4W?!S]@"3^"JS@.W9=CC`O3XCV$.O>R='?.3IUSR?O:NC8=S9^W MFZ^0%JK9?X;N,R]E[`:![!(`^>]4[^^`0J>><;T(>Y44^<`?4\LIJ8Y&6TJ, M;MZ)TKL1]9TA:D?#L,/A4U`7=J<-0(5A_5D^/O5>AT<<3?R%74X M??37-22W%]&=2RV["KN*48H1,=L$DB^;4GH'N0I0UC'*MNDE?VH_>3=H0.R: M@#S%CK]QPHWF*:)NF5Y&;8?(2>G=O3_"M\![0VJO0[AQXZ])N;.KUQ`2`ZXV M&W+4S_$^!V$8O*,GGP-R%=G],8[P!T`_2<_\?W;0EUS#AA[CD/J4]T('=(:W MJ[58CX MDL5]O(/AG>N\8#O0$W5?NH,4U00C;B)O0SQ=3,=)W=)$2V%A$21Z`$P4D2HH M`58%O%R76E8:.A:6>;%H9JJA`Y+4PNGJO1+.ZLX$&7MU#..`/)8>"1;XZ-DK MAC!4:@_O!3>S65JSLP&!Z0%P(WBGDX=M'#.HAYW8I).;)>9H\DDG1YRCK(T0 M2I$8`OUX`P>NR(/^N/G7T7US/#Q+R/.M&&_JYH)ZLS@S:6G/9FQ*(%M]<%-$ M_E*0KI<;)'C,H@CBZ)4JC\6X0H+;^08N_%6)\[#91RW2$HIV-U(6B+S%)B@@A*"+KTX%X#:G7QDTQ M\<._G;.:8S<$>7V!6QB&<'.]<\)7&/T4!)MWU_/2F?"K*()Q]!URS4]SR])- M9+R&\K:IUG1ILP>+J3:PINI&X#516%A@<8C.$?#K=]JK8[9A8L,B."-B(S8! M-DR`;+H3I'\TM'"@*(LPF5`HN$/P(6)<]+5Z.+)B,H[NOGMW"#>V=GY M)+UT/85J?IAVA%O>1&J2@XJ+YDKUDD5(N5!`I1K`.+TF[T$,'YP3/H[#\[T8;^IFA7JS.)/)GDVF8V87)]N,BYLI M+!PDTO4RA`2/63R1>7REPF,QOI#@-KT(I/A5:>?#1_(B<*`241\D\#^%<(W\ MBXQ7Q7-]&P#.._8W$^9^]7 MQ-(!%5]86(H`XXRR.K:1XS:+<%2[+48YT%>V"#3X:C_Z22P2?:V&D> MWO1UETTD/C[4GWE+)!M!(?W\)>3Q6/\I#2(.)AP;.*,^,$/0Q3/T':PM@B&B MIYL(>?D>?8'DIE"\/?HAA`?'W3SR[E84DJ>;8$2,Y9[=6RYF['$3U0A2E2.0 M*!V!5"WI>R>*"70U+WP-%R,67QD3(S$Z&RY0A.B2J(195&`:E4TQ*HKI1O`K"A7Z>^!'@>=N:OFJLQR5I51$ MC>.OG6^-6^Z.3+70:I!G>I0OD*L)R)2N&94DX'O1=.TI[)OKI5HJG4)G#K0; MKS=N?$4[8,7N#4:=[VDC-C5?ABS-Q]H;6QOWX.@%'/ORY-:0:(+18S*3C`LB ML+]FZ2FU8"FJYBY`.IOD^/B42@!8A#9`=/:#8"`M;X-:&B0+9"ZE4^?#]+XY M[BSN]86(:\4",SKKRC1CX@S+%9^E3`R$\>Y7Q_/@Z1O_":SB'8:M%JMYMG,>"094,DA$`R)[!!+I(W#U/YI*;@W@ MM66,URW#+"FI)N#$@.@"1-D(%-2A1'W4 MR$S#1L4R-RKMS#5L:.P^H='*;%U9HT1TG8([&.\)TIM)+":6>\OI:C%M(2N# MR*B+<\V<8QJG=/&PD3K,H@81!A@(Z,_PPXD>PF`+HXB4Y+S?;MTU?`[>>7#/ M\;8N&F@WC7?IWEI9E1X,D0Z*X@&5#X@"S2PAV7?+(-_Y2$1R`&RA`&CG&'Y, M5RB',W!Z9E]C&%U%$8+_QF).KQ6?43KS6E#,.ZLWGV;7!Y,]R\G[NN9;+R/`PR6MLC]OM^>X<7 M!C<(7@<8LLI[L!Y5W8XR[.#,C/EJ/ILDC2:1A*?B/2(+7\.:"%/;.LKPR-+A M47.;)\,MN^Q60%NSEZ/KX76&:`2"=Y]>`7IW=TW.V8'WG;O>(71#L"9'PT]@ M%WB;B#P91COWH/\8?`OJLL:O*8(2T?\]\-.#*-DZ5,,'K7U<$PO4V<+;@YK/ MLXW-68*5#N7L4XF*=S/+\JW("?=DP3%4L][(Q0N]W;-Y/IUNC#=AZQSGS(A( MQ/H#^I8[3">?4PYM^$0U#VO">=42SE29C:?3V3G*,VD@$Z<%X3V]LO1XQ87N MGJZ=83L3`@ZI7-W`9@/I'-:,4&@9JB8FY4>IV'U^GE=4#F0;[.`=%=K3<:6G M7#P;^*"KNRS;QS/XF'0D4"`32\/?MM!(;"/K=%RM_W5T0[AIH+S&US2UFTTV M\1(R^J]5:D'O6:@!J6@MK:DT7RW]OG*UL=(_^@%'9U+$^>U`;.12MX)V7F:Q6DRH=$$D@$:4)_IV]J0!^>&\X`=[9 MI3-((W5[?)"-^!6P_5*+YCJT5/%;B8'>GO,!#5M?T%+K_G< M"H'^Y+3:9TZE@52<[@YS+_D>M. M:,D(WMMB5ZNY?=X)300!*DE+'[2[+Y9R7[AZH-T=.L/YQCE%8!N$>!7JT_UV MBP3BB\C)O@L`75(@#^_.2(::`#T90<\#N!@#2B(T6JM9P,5OH`?)L?4SF;H[ MM[40/._;5J.KHWFF+$1.LZZ#/;P+(E9S7/>DPN:W1CUO-V\ZGR15$#(A@$H! M/V`Y/RJ^/4F21\FE2,2/%XC@!?-2_^C_R<\1^(Y^?MP?;H"77"+E99=(K;.[ M$G[X-[R1XM]^'.4@2ZZT)3517AU7T\"Q/5F+C2XKL%KQ1?=QT-*[=ZX/;V.X M;X5:_4LZ4%=K"?\XRYJ?`Y`*3&I%@]^P3$"$:BIW(-%3NX^GRK'4F)BUL&)' M2$(WMJPENO+]H^-]/<;'$'YS?7=_W#\X)S(TR$N[U?1A.HE1W`GN8B/OJ9.9 M/5XF"S=GF1B-`-4$J"J0Z`*ILD*-0Z7]Z.'#44=!VL/1V!4?/B;T&FH:@=1U M7/)+5Q^Z#_[3+G;GJ.GO(42U9GXY5CA.\&UM?0:F2=Q51L:+2N\]12X+LDB\ MYCZ]1-])/_\9:P;[Q-$7/$K65YJP6^:R^Q+-<3(8E-?'$'^%?LF0"C$/HHEE M`N=N9AV0.@+?X4<,GM^A]X8W)_OQ3M-T]X!A(^M_==_@?T,GY!N)*;,1C1)*#J(S048B.K5.8,IXVAG12-EE(+I35%)$+R\#T><) MW@W1I4@9C>AGI%5.(UV09"*F<_,$&J1)5U`3;1>!ZHYQ26&]N`A85[.\$Z[/ M8F4VL-\#.;!.Y1@)ZL0X[M1=+9:=(?T>7`:@N\0DA?/\,N!\EMO=P%R,D\%0 M?M[!$#K;F%FW7UR.>5#.C>--V\EBVJW+G:LR&L@=(T*OX6ETT3`X5_.[`YS/ MHF4`G.GV&+(U%1N9F$Q^]PC?H,^[Z,0A1Q^?G\#66>/-98S#U)K@S9_O#?#FC)[\G3#U9Z*N MXIL/-\J>>JP[3]%+EMX],?R&WAI;]G0U[T226#.@J@'1;3I;R@E5 M%\Y4'RH9Y"DG7NT4NL71V=/HO)'H7`Z7MC*0(*4VQUP^L[93^LW'P0T)2>$) MJO9L$I:HEU=%S>7,_-$X-3C8J3"*,.&BQ" MJ(]\/5%\J"N-S(D1&0ULVI5U&&3:*=S#(&S_A&A"W/LP[1/!8!-S8C[T0)A;D+$Y"%OD*0_/R,PSWW:92 M.>68Q+HL(WGS?68M%[PDBW69.'DZ0$0XZ5-Y1+HSI92PU!)CG`3!X(E2,8+@ MXKS&>*JAN!Z3HV+BS".\GC-7UG@VL9;^Q][>6"I M]*"%%7JX08#^U0TC!&M\EL:08KR,[,\!6G59&N:>WX,6S.5/:,%6"H]X,!<1S<(YNX<7"@0.6$4XBJY7T98/BT<\+:\DDM;ZA&9+,YO(FQ&$]6JP2AB<1DY^8(9$)' MN.XF('+58E:FCY9>'YM1+=-1N^1H4O40=2Q!Q')."JDYDF5>[ZKZGGK4H]7:2UN(B0KTY?*T56.L*=']KE'?]>Z M$9N=2*6MU@RGM>7^=;`_A'`'_\POM\^.Q\/08@;K*LX#MV7(ZFW M_QP\.$TE@7I*58VI[J;R'PF:S(KX*VDLE^G%A8)BO%T,:48M&-4-BLIQ36BJ M7E/Y+X4Q*Y0%"TCDUJ7(>4BE?LSW!U"%'WJ&]P*YA*?ME2#]_P)#]PW]]@UF[G9(R:Z:#"&FCN;SHFN)^NW<)'5N"\B-H3=B8',` M^GG!H"*UR>6K%0VL#U_Q%0-=&4M)?*>DW#&^(=[]@T8.!22[[0"OK8&U6U/I_#)([[Q<=72[E_P,U/CNMCSTIV7X5NY/JO7X[X_I@'<\_C^6Q:I@J4 MOOA:M43@"&0BM?9:^CM9F"(*LDV@R45R)G0X&C.P!G?LB&B#46)-_0XJ]H.J M(5/2SCW-N!R7Q@F)$%W[D.3X8U?\T0Z$VARJI'_596U)_X@:NQMR0S3>#7PV M*<&L(LOQIFI8-)O#7[M\O"KB!$L%5.P(9((+,X.ZRL)*=IG>6):_C!=D/CN1 MJ[]IX4O0"L0X8J,%<^\^W#R$N`F/3]\]P>\@$6],K*E'68`?_`&2> MGNG#TD`J#N3R2!].%ZIDN9C`Z<-AB^!(H^LBDN$(W[Y^4DK M0W#`J40-;>&0L#'XP?'V&\=#K?O&73O>@^?\X7QU/^`&'[+Y%H3Q*])Z%S@^ M,]V+J:II>K?H$O,;CUHS@D=@!K//X/4+QP6^D>XB'=)528 M*@")!D!4`**#G-<#J1:`U6@\.S!D*.R&4&Q)*,BTU#X-A8?4Z-J*W!'BZ=;D M+F$=W`,F6O3:(6%DB;^*0V3`.0".U+N3"Z\C=/!R?\/:K\AIM9^&5I MIAMN0[E/M,YGXRGEH,*,0S8\TDHU`SG+X)],)IG&I_KJ?FL.*0T4'P93<<;' M%/H2I@<6IXE%>4BB$ZH>->:;>H;JXEDK#QG(-%W\;.,3 MXQA#D!F-:X>E1Q1.W!;U\IYWG-H+.X4&/9:A=:&PLPMTV][/S_1< M]B[P-DC57\#-OXYN?;=*U?6+&WXB'009>+Q5MA-J@#`3`,(B8J_ M*FX/!W+>*CJ?BP?WV[SL`<@U`*I"^9:Z04,P[90`^EI3<8CG3:M@#*50THEJ MNHHB!/#-G>N\))>K@1O['02->"@J[\^8`RLLQ@D.L!=.0:IFL'&++P\-60HIE+S00U?=<)_ M3EGBX=0S.DCL_.KZCK]V_5<\C1$'Z]]OD>'H)[!I!PCOVTK'%%PF<1=?L"V[ M@N1,-)WJPL)!*EWG+I$A?+?/?(^(MV[J[1H)U#M:$;\X`QCOJ85AO"/?YMNFJW(Q&8!N$(!&(=_ED(G6=EI'H MYS39QX2%1&#O;(B'=W?76K6@\;'IGK$\!/@`%X`T!`ZI?&8`;PV7'M-N_FN@MBZE`W\CI[1%&5S?`='+=VVZEJ%-6D4AU"SMW6 MF_U9UY]CE%M]7`L.RC9P$_)J8E7!D`]D!QBU=H%$'^>FM.Q^ZA$>F5)TX)8G MVYV+1^RT@J(?X#O9#LX)%^\R`T'UZ5@/HYI0Z<02ZN336:VKS88T;HYWFQS; MO_6?CB^1NW&=L&:FO+,<#>CC-DX@<^TS6.)1+54"T\#Q,/ MTFV^=J(=12\>5QR0"SM\'PXBK;WK!Z$;G[*R$!$.RM[Y)_GIIX".WW8JW7MM'%0!92/9E.-E!*O<^F^PN6Q$XRLZF:5@!_\DP?)\ M9K;`+06!QD"LLY,$9(6W<8MN7!->DWV-`#J/AHR]3.N=P&$!]L.J=R@Q+>%, MD^EX824W0&7U'&AYAY<3N'/W;ES8CG,BY?P<'_<0P?O.7>_`.P0[YPT")^LG MCH`?^)]0&L3(`X]4NB(;=K->I=KM2W("1,D"^6O6&0,YSM']"]<_FW2PH!6. MV2ZBYAC(H8:GX(CGPWP^;F`^K9X<6*;PYL=BDM9U^+.R@Y0(9?202C.&'Z2X MEQ%$C7L:&:(-E06*:`R##(Z`SAK^#!TO3MGH&KWBK@5KQW20HII3Q$WDOP)\ M:BV,+"(SM,^4/K`60-5D+3%59&0YF:E>"8EPEF>Z@SZBI8Q0'I"QA=C*+ MB(2:M]5J8HV3_@T;?D:030>_6FG%//;HX&65)]J_GDYV$","V9A''Q%AZA7> M;_$2T-6;XWIX;?_6O_E8PRC"USF$KS#^XD;TUBX$O@?'W7P-PEL?O^J^P>+O M:@]UR5>BG%MD>\"9T8LQ^K^4CU(;\"PX6:_+S,`#+&H(O=4%FP**^L!#.IN> MF5/ZO>(C9'K#:5UH.%L(5&M,:4%1WS\BFG6SF&PA/7%`"XT")\(7CQ?"3A9Z MG"SL.*";@@GZF'HH5LS9?9"O);E%0)I"Z$3Y?>NY=26CD5%%6UJRLZM4C9S? MT63>\K8G5/Z_1:D>@O% M#6XS6K^O4#Y27Z)PO0RN)&AVM1WLF64F$'9/TJICZ#Y?0S(EX\GV,-JYAW1; MTB/T\/P7*?=07U)!X&V-%-MB&F]FV\O9>%;78<[DY]M"$PT@4:&-(:6Z7M.Y MU>0Z-]E)];]":IGS*!+!,8YBQ\=[;4"$:TCI6ZT0QW0=,_&$3C(#5?NEWXY1 M_!EB1H0;N/E\ZCHWT$>R1N;J839W>SV?S2=UK%8W-L7:P0L$J7Z\-&OBR%]9 MW&HHT=2X<7.FLN#5=!*3!7HT*$'1@FFT<*CRD;]IO4()K%7'OWT_@W1N_J"3 M"/CNR^?@K<961 M[\F5VF1HE-QL^QR`SP7B0#C!`\U$>_:0\P$R`S3RL8*(U0S4S8R8`!,K"%L- M"Q?K`KC9_E<0)]%T::#BG1.CKFYP]#:8K3>%L"+^#N'>(>-[;!,I/P&V2:#3 M]YT/,SK)?:FMGKU[?#HMV_0SXQ_1'^>)6?^0RJWX)G M6Z)1"O@`()'^`;]XS"WL;6?^.GN*P'SY\`_1@"7!7:\3[_\_`2V MSCHI=J=U*WYMAI4VWU<=E]>+H2M(Y.M?[8.C'Z=3;VP29K^BI_?!M(%'N68!D78W(!%1H-KVMH[L@QT5+JXL\[;LV8PDU]KP0[5S?LI)ZO9V"JC MAPK0@9\NIENJ3.?`4!?[;4[[U>&HG-ME)!4\E(:E>Q\V[(0N/Z$%49EZ;GZT M)I,RJ"Q-]V'VL=]29S\'MCHZ8=,Z7-EQ!CJ9[M)K*MP/L`_\>*=S'J8.`&7, ME3V7!KOGX"&IU?,(HP-#<^V$)X81,X>@D.(*[;08-$A;\P*ECI:ZT$P90+L&GMY5/D>M/10 M\B?TT%JJGGM+SWAEE7LHMLX>2D?[+77V\U!$-R?.>RCK8(\^.*D:^K^/W@E8 M(X#2<@;B71@<7W?@"UP3+6!"?F-/-:/\'!MGV"T%108B=P'TW8_KG>MM0NC? M.%'\J^-Y\'3MA/`:XMU:R2-7?[!!*RY$-:Z%+12YX3T]^40E@%3+7R*`%0&J M"6!5@.H:@>39$;CZ'TU,,7!$+&,CTLP]`X?%[A$6;XUSNXUT:75.X8:K2$]W+PV6J>E@8NR0.I0/!;*E+7E>?R_+2[^ZEL$Q%74I8V M%;7'1PNZD"P8AI!>>R1N"`8O*&=6E%IE!"EQ#*'S_]2"6V1%?'>!>$[A]PPY43E9>T(?/<$MZL M'"]G$P8BJ4B0RS0!A;W\%$-?\FNGT7\]*&0E*QM]M7$S!77X(F`AQ"4O:$8; MM4*`_U?-2*/RS$%9!__$$.8R'=8)JW(VMD&J$"13X'2?'UD7^-K%MS0#JV`* M[SAG,;=8/O[+/^:LKB&1,S*HP1)W3`Q!__[7L94/Q_X3S$;C\1C_K]I+_$]/^RBI2O<%ANZ;@_>\U.Z_8S^L>MV&:0EGQLWF MTYF=7H%`9=%RD*2"6"Y.[5*+'*\L/5XUKXK(<R\%P MM-X%@7?E;\C2QSI;[&"OT[:^HQ[1S0;Q7FVQS'>1%^1<]>!Y^$=L(%_O[W: MO#DH!L_!U7;K>JX3LWO7W`*4=KIYK>),2A2^Y30%()5-2V_DTG'7-9%/ZB>G M&G3US@>)`('E(SRD-R[B>K=48@3VSH9XKOUF0N&<+O>^A0*G&[1?<-N:03P M1;=IY?E4G7Y\#Q*8PN7TI>ALH$CO>K?TT0"M<;P)O9ROEK4 M(3X52K!-Q-)Y-OW0[N_NV?7DJ=]!"$*XAFAP^N+!)`P1%F[$FA!GTK)@R8Z: M,1@,GQP/V7=#RG**)$+Y1=TH+%DCT+[,FV$8`BP7PY%*-@B(W3TF2"Q232"^42``O01@&[^0'SL%9X\ZHLT&_0*,Y!#.'5+XR!5^U MZ[CV.>G)-_>D!?D9O*5SM;@&CUGL[`X3(=$*[DYB5R"DS%J1"F"$Q81<(?=#%+HSP>&4D'OG%\N['$3"UP&_N6$013Z MY$J)%/^#A.(-AB^!GF!8)!I88L1>AN**@CZ.ZTEO,IF-L9\LV,(H(M,B=$_* M5?Q?:"QW'0817M7#?W\/@LTS_'"BAAUFXE*4[SD3-I&W9OS<6F;;2W,EZ9XL M)P98]E\BD*H"J:X1(-IT[4X;-B"6J0%IV<^08>P6+WU`;=\KT$=RL>I#$)(];%ZHOP[V!\>O+#_SOZB^!>>P MBO>(P6P\G66--AT^WZ?#YT0TR&2#1+CJ!EJVOY8)_K:UO[*=)@QP%44P'N8L M3-,(::#/:#.^X]VUQAZ"`-<4.@6\L='4#Z@??7T^/2/==7<<";RIMN?09@[_ M^>=S'DGF9!D%7$PI]=>=";QI`DQSO# MVQC6WHXF0:CBV;O^%G/??C.=6RLZM5=4"@I:`5$+"GI!43&@FL%O6#<@RM6N MS:D.EG4)P6J<-U0=,5M!Q%3,V\ECIW1.3]*7T,F\SW5[J?L+O!3&?>;?B&R- M%]9X:6=OJ(AA8_/MQ:,SV>F6JX^$96B<`0J:!KOP&QE%]B"*@"9AA(64%()(-B'`3!Q/=/#\#XR.,CE[]AE`CQ@>5;.4>%I3#HP.&C^AK-&V.S'^O M$$R94MZLL<9I@T5>U;J5L9OQ-H_QJK*]DA3%A"[[IRUGZ\\WUCRA.F^%#II9 MXY5EE3)7Z_ZAK@[8?`XHS=^:HVT,+R4,EHC(>Y^1E=4'%`^"RMHY/^UJ,IU- MZ'B'?EHD0,_QUQ[F6PK-;QRP]/`AV87GKB&@GEBZ1B#U:9Z.-FI9J7 MP55R4380O@K]:(U@P#%\7#A[@%=>XJ=,%;GW`P[]QF^NK[?XI^RT20O"$MC3*Z@R&BNVQ21JGMU M+,[WHNKFG48=]^(KU,3L10_A- MF)'IDI)NA1`X7-SH$D>-I7>KKFNQ"K7]=K(Q$=O[`4^"Q[B84E6(2KLNF M\9=T7\[[P;KX%-9L+*S[!(B@^G9_<-;D]L$-S$M=)_>P.KZV2DC]("`$]YH8 M2N[Z_^OH1FYMX\M^4&/7/K>"=R5D;MN3NIY\+DE;M[VC,S6]](&=:9[5Z^\1 MK=[6XH7J7G@5&76][C./=;?%N3G/NS`XONZ^!HA,Z`D"GNYU\_N:VM]&HP0: ME@5'RSLJH0DD"D%1HZ8M%H,$Y*QH4G)[FC']:*YT9K6H[5'2C%9_PVCVK\C5 M=??;&Q_]^B4DEZ^WIX68.#U8%K*1-Y-GJS'76!D7-&%WK*D%Y$;2@@W:P3Y< MQ&A9F/QM0T#?"14,#A`/GJF4\/F4LG3M$9H>D@PC@C/S!+83VOTYX.64W42C MZ8B*HDC9BB)E$G\P("1*'75A-Y4UKITP/+G^:TIWV3T4Z)7;_2$,WB"Y9J]' M%G*K,(QG>.WFA=5BOICT)Z#4JD)OI'!W"'JU:)JYU#1(<`EGB47#)/H1Q:(H M+PG%_%((ZPY]98EY2,093D381H$Q_'(0TL%&7`Z]"(>,4`G+1Y-)HXB'O@21 M1)J!^@1+E$2ETB'4S25B&@ MJS1CN43T)#V>'YA*)1/ME094!,P^7Y1M"L_E\$1CB8(^<365*6Y]-W8=[SJ( MAIDNX9-O&)MP&2TPEI_U'[,D)@%LTZ7.DL@/*V&A8FA&66#`_W+VA_^\J!D3 M(2R*$A-_\"^"JGI.E%1EF4Q!@N-]"0M#YW1C]OQ(OV#5D,@E3)4PX="+&8R? M),'7F/P2P;+=GTW%_:L!6X#N#-F`;A,.?&Y5" M$%(B1W=MOL'0>869W[@\.^OF))/8H@TVHJ31&%%SN8-1YKF3#./80:@6,+ZY MSNX_\:&Q./+@L1&:X]!?+[D/$,3A+[F*,H_2_X9.2+:YAK#2]^\B0M^Y#B[[ M.'-UOER.ES4G/IIR%:L!J1Y=YT'D!Z%Z4D1O$'C/D7`!J.%J_0*DQLFDY^]20B M2H$U`=<[$J-32H)'XVM?TC+6JK-$H$83SQ:543;#:MXY]_[N7]:Q]J9LK1\? M,2.D%W9?X0:&N'[^.MC#9^?CLQ.QZ]:WO*4%>+6F""P,\AU\3;0`J@8@/8`H MTCV-T=][TGK^%`91!-:87EZP!#)[X4/TKR#X';PYWA$6+D%W843F<[=)4%P: ME!@%Y7`,#T%4?S10/4H;D[L>INR`ZL4I^4)7<;I/]5?\25JSH_8E+2BMLX0S M3>UQ5MBA!:1$B0D%*7M[:VPURMZ>\9>B[$^C0>QXBMR:8[>>L4(SF*^)+NJ) MCQD"O;QWZ[_!*,;CLO1D8=>JO?R2M#`DMWG5T=`8/Z$HTYR@O!-%2FP*U]CJ/XK&9H"=1]M>9- M@(H,`Y*88P0^R'[`<,XTN+1,-9R'P1AH<)\HK7M'-U3$3SRNQNV0,>C89U]? M*SN5"@+_;AR$^`YCLF*B%U*D('53&5F.-[3`J6(&-TTO)CR[AM,"[!J+LTKV MV2ZO7E76KJ#[NHO-6;YB9F8]O.ICHQ=<#V3J\M9?A]")X!=(_VS]S(S7M,"L MWA8!,NLAV!`JS3C,U@2;;CQG/:X'=R4;>--M.DG7BHN=IZS0W_V[CQ)_YQ[T M7I0NP\E*#U'(20UXJDU!!HZJ83$%/_22;X$/F[R@&4/4"MX$6\R7-3,4N33= ME[7+<9"%H#8'=6*GG'YMZ"D$1;G8O"`)6FZ4)=27Y9FOQJV9(LQSF[ZIR^K<-M\,FW!SOECRWFC[J&C95,Y0:M MUG?=V?\<.G[DK/E.'[>\I@D9=;;PGZ.=U>*D(-.((\02O:U!D8BW.E#5E*0L MC#'C9!#BVE>]6E[3CSCA]:#%PEJT("XR8.5+HK/-@&MS5C/>6A;#.,)D$MX^ MGXJ_:9P\Y!9@``:K5O'WJZ;CVGZBUOG$0;RLZST:,*$HFJ@\^&-$RB0DBE0` MYI=@`!:[%ZX=3Z?C]J;1L$J^PP0AQRJ6AN?^W]UX!W[Y^8F<$F.'QT0LS9.ISH3(8!(`5B, MX@G.?EY82KUHF<[LYPJ!]S_(_A2$8B)UXKS[81`%M<"FC1KZNF277-K#C;M&A!!LMQCB+\G5$AJ1W8"7`HQ949"$V4>X MANX;UD%VVC.^Q/E3&M!Z9@)G)JR6XYE-H?J\@R`YBXW;@(V[W4+4S\2Y`.-W M"'V`Y.*>9XR;#>=$MFZC?]-ZG?AF;2=I$IS7$))Z?606JO!64HTH"`'\.$`? M?2KTFW7PZKM_(`FH!78`7A'!`]Y/'EY?)16/1OB%@)Q*B4Y1C`:4L;LFHD,G M::!I9:1]$&)5!Q1B&JPW4AH)&Q"[N/%R8H0I'YD!WG?N>@>.$3'F!34&6S<& M2,1KZ/AXL(U^ND'\_X9;09231$;2*AZRT\#8B35^.@Z0C*(KKE_U%01H`$^- M0>U-:EA%*(HC_7D48;=#\C<(1X7VV3O]%3P=D?UA]LVQ[>@K'-?)E_"\X!U7 M;\$M=QRZ+T<*\C@8D?)0KA_%^-E4'+"//?;N\"I MY\+R$\JIN*2>MV.^F"QG:8\I$8`9PD,B5*.ON_U6V7[4/\(B=("NNP]VY1N@ MYN3-#8Z1=\(L_>9N$#WNR;Y,\GGTX;`6"3D&JS'0L["9=A60(:A)1W]E[IHB7#"-Z5]*DU7IW!(2+W;V%AI/HQ$:>OHI$4_Z9IT8>PX*0/2,\- MG[1E^JANJ;$E^Z3*?BI24`6>L[CHP<[L8-` MO+EQ0I_(XE0E2H>"'7Y&(M[.S^'O*BXKD%<6.M MH8UMF4D0M]@N6*QQ8;24J/FL0.Z//#@T'`M3^U&!MO>4]L5:C.'? M$;^8E)._(',$J%3P6_*G`6<"9/IM,_S6VVGC3,]R_XTG+!K1QCX*E_Q:/7:X M#WC-EDN[!)&!-JZTUQON8/>\:+<15;C+^5"3Q3K/DU$#6D].GSVF(7E%#PO; MB]59$AMP#KJ'*_I[.RTY4Y?8/8XNUX\D@@CZJ"_U>KUSO4T(_6]T.]J#Y_SA M/.P"Z+L?5W^P!QHBKZL>APC8QMM/7BU6\W0@GXH'J?R_1"!1`8@.U/>A6D;@ MZG\T#6<&BX%E7`R:1T6#!<+N$`AM8ZL.:,^&7J(1'(*=HJ+2K^X'W#PZ,?R6 MK.7A#1?\5,4M2S=O\1K*F[?+Z6H^/R>Q=9ZWZ8[D`]8'ME@AWO$)LS53'=NC MU`2%D]4`40BP1I"J)'NN3&*X82+$27?,"!E#?:)4PN1!H3CK&),\.1[>5).7 M+&7TIJO/*1R55)1S+S>/T\M*B(BSN\!U;5OIZ0[9L/+%C0Y!Y'A:!R?,Y"F. M3NJ]E=`!>')0._D5U]C=PBBBQ\,PS)[601Q'&Z2V87`B\++B)I[?,H&^Z"(Y M3T*$@Z^DP'(F/NV$YAKT#4J&\MXRROO&QGJH$-B"(=#5&HOC.FU^!2,GCX-R M!6V$4WE2#[NY<6C/Y!*Z#_<'Q3_GA MKG<(=LX;!`[8._\,0A[.=5 M=L%91O"OB-K)2G`J:@0*PC17]Y;CGMW-/67=];;$*W7;&R.B!S?TRJ[[[>=C MA,^"1,4KUCZ?"O]ZQIOTF9]:4(Q2E(G9QE_+-UUCSNX]0T/A5$?I7D%RV+GP M`_`;T:0-EP,&Q)8>$'5([@:%,L`[A-9TW+=LLNHDRE#\"VY)LNRY->['`?KW M9PT>'T()#\CN':D`\ M*5M40D1V\['VCN2'^$PTB0BI2'344YY5.)7KT=H8-KW8O"&S-]]@O,/7KZ;7 MR59_"N%W9P\;KC'H)5(+GL7MY&^;[*3MSN6.`):B];8#9:[;@JZKQW'WM*]' M>,>`FHC]Z*[E*-Y6ML3VOMM=4.J#B04&^`9=W#12#RL"[>PQ, M07HUR45P?19'(U',-Z?6^+))Z!6:+K(7\YJQ)QI^^KZCK]V'>\Z>(/HKXDBYL!6[&752\S72,5[1]T@ M`C^Y;WAH?[/=PG6,*[Y^A^^%(+E^4M,-7*75;[6M50MC/5N^%HNRWK[#UV-\ M#.$WU\=EVTDA:.\A*4'U-0CO#Q!7!T[NG6GA.*FRM?0\>AC,VSJO)HM9#6$0 MQ2#1#*AJD.HFQ88S[?0R)@,(15OX*IV;-&Y)&#_C\MF/-'*X[/3WP/]TC5G( M(Q&C^LWH[TB`7WUWJ.^WT,M*WQQD/;DS`Q=>]5_QW1)X"E60@#C%:.$:/MOX M<;%:5FDEUU&SSF`>?PP0$GKETROJ3.!-_JBGX4>!YVY(B;Y4,2V)"?+:BV90 M@Q@&ZEE`(*)Z`5\FI,U5%$'>"8R&5[4`FVT/]QK9TJH95)QU`#:`2C9EZD*2 MVY6VO8/;ZK':GK[U^&P)FEY,IOO%GXXO_T2CM>?@/KQZ]PC/'=SC\'T<'%PZROV05M9I!)/]S5$TV/KZ&7A/[/T0E1UGFG M;"[EUD=?SL+OV&:V)$1)8FNN(V4`!!JSI2HI=R$'F@J(HXC%6B]'/,'7/;D;\A"$N'M:Z+)]/B6_Y&,(?DE:^('; M/%X`S*VZ76&)))#I*0Z%"`;2)PRAAF'B4B$&*7%1SPK"\*CG!+$@:V:$G1-" MO.J]P3MN(.(O;.95B*CLE6RB04R6/Y.L`U^].^&&DR=ZRM?#'OV,YM]NN:R9 MQ"6"/[V0!8NB>E#43R!4>#"Q`1`CC"$;A6&L4M"@8=3`37*`RF`L"5_*1!XC M/XVNCO$N"/$([Q=_`\.G&`W8Z-3^`\HLY-K-!PS7;@3)&/D1^]R'W'HJ-8CQ M^GDB@-^:HS(L_([H;R*0FP6.V"Y`#$O6;``QC?0T4NN2&1!BG]D,J3#LW+0Y M>-A-850YE"%"LQ(^]Y^+>[GGVP=3_*?@8/$IY%7-K+P*0C!IUMZ(KT!H^1_0 M?=WA^;.K-QCBLMF/$-?DPJ/I:UQ"T5G'1\<#=^X6DDG\RO-G$:<+DW1'0[&" M`GXW#K)?)6_IOOI:';VHX6J#5@H8KN5>1,FJ]4EP_;.S8)/XMM5:@0Z6&)\6 M>!-19JK\5^#,)M)$.`:+BEZB(7'-/Z:*--)#8L4N0)@)2#18B)=2(\'K0*5>/\9(HZ` MX&KSSR,]N9WW9O)=#S_AN]3SLZ-?7.](KE?'9[_?'(\L5N#NDRFD(8(1!D-P M1UT+'=QWM[F%T9LDC1Z M6\N+FZ6=G0RYN7-P8MDI#X%R"-D=D5;[&($?7#^M MZNC#&"'O)08'6M41=X3^?69/1N/QF,C\]^5D2O^!RS^N2>E_,+%&`&<)>>+\ MIY,10'$Z0-Q7AM[I1ZT@KN9L"8UGH=<#J_+.AI;;C9F/*P5T&$4-PZS.5X4R.&:LSAGMI9 M6A8+3KE8-(C5/GR5[',]S$S"5D-Z-L&,%1@3$%>8/KQK*TS*\ZI&S-79P[VF M-+.6+-"5SN[=:2]"*MMK1NLFXK4N/#8E;Q,@F3&34<80OD'_YZ._03W1IYVS M"=[O'!]>^9N?`F\3(N7)';CWVZV[AI^/KH=[[ESWQ\^!<=X]QSX MP<'9W3G1K_#5B;[#-V?C-',J[^LZ>)/3-MZ[*R=(?4*.E!2P?(`4`*(!)"I0 MED>`*!D!JD;3!UG<\GU@5IB+_*;;$_\O9'_ZSU!:74O97 MS;PU3%3.RVN5<,1E>.AG=2$2:)";6+AU#+W5+LCBS7/4?^P MROFE6@LXD]$>V_-T39*QGU'3_%%_KPC$'B$:5;MK-(;^6X3WT20.KHL'"4U8 M]V_,N=(D$3LPVL#RTG#@,#EO^')^WI#\YU=(ZO;1#5L/$"41:L%?F3N"!M&E M&JJR'>"?1;57S4@OGJAM/%`[2L[5)A8E&^Y&(#=*(VEHC6]I/^,KTHN(9P3> MDC@=,J'XKW0'4A0[=":;E*D/4"^`_)C\"\_]X;T11)!V>AH*Y15V&^0+FM.3 MJ'I3.8Q-+S(J7!9ZCS?9/.\UDP.:Y)??D$-]U?'#7]UO&-C M;]8(^_Z$]-WJ-'^O;M(R/AZ>WT?5$\'D$8`]`M@E0'SZ<[<#`F-1U-"E\FR%@;&Y/IU2PT2-`S":[.+#A M:I>&S/XLUI_\LS2O39G];>K;UCR([%&KDK4L7:2>+85I^7H7-02K;).5U>>\ MT[(#O+>UO%U;"WT(2:,5$_:0JXV;K29NQ@\5*N"3TL>_Z[I,;?3_B_0A) MJ99"S2C9:_S:W^5+:1`LU)JO25*QM=V%4)B6LA-GRF"1S'4Y> M[P]7E,-3'WA>_"(YJPVB4BBL\5M<,J,5;@$DDRD#)W%%W07RV[D/_%6/ED/2 M7.F"T)]8VP8NA^]ZA;F>]L*L^.:?C?58,!Z"_&H_C,XIU[)]>"1<[:!)EW\I M4Z5UQG-":3J=SR8"LZ"?&Z;;4L*ZSPB+FG(9$YN]@\@_9VE,$(>9ANP=R7IF M?V/&P>AYQ2;FZCUGR`SU16T63N8W"Z5A;_TX=/W(79,%/TOVAM!VA9>P;;C5 M"^[J>8N%K'G%4;ZH4K!K!#++M.]ET!]I>OWKZVL(7_$.#S<+S1LK-,9O!.9& ML)3=P'R?XZ*&[%67*+7+'H`Q]5S"()UE//_6H.ED8)ZC!@U";X<@8E"^> M2G^(3@F7_9%7N%&_:>8;A7,%/(;@67LOVAUGI.("ZLQ60J:_]# M?C5O:LEPC8[T_0_]HRAI`X3**`ZS`:)_*(LM\@A7,$LC<;C,PU6-#-9[%P0[ MWI:#'`;$MF5/5,PF5. MJ,B(\MDFU6,B$01)]W5S)%6>XQW4V6E3@V.9`_2F;W.)W;G[?#YMT"U=53T7 MU*FK&,]_$F@EKX!71G@%U>_.(D<9`-4^F_7QR/ M=>1*4L"><%%=)U[ME]F( MR-CM8"\G\BJJUS,VU*KHH%]$5K%+([_(H"NL@WX6,L%'@Y4T@JFLBUU_[TD:[.Q/="*=Q=++FC; M1`?W!!;[AUYA_-,?8!GZ\]#MLH6N`;D,.%]FRT]45.8W+_U810^*D;EKH^L7 MOL2%.UIF[TS-?/4X&MK#/YM$]M3\[54>M! M')`?&U`.8?!=Q0H_777V[BV/_9^DR(P<(I*YEB7A`QO9(D0LO\E_GI%]R.<' ME);?G3W\$N`6KRN$NJ@RB;T[V,]_!_!X3CDYN=>+S@W]1J68>HW-T`&QA0)B M#+?U@)008W4-_V7Q4/ET,V1=IBFE)RK7B(O@KBZ>\7=7+($S&Y%@B0S8?-/P M1?0J]7T6N_.>,ZU+Q5KI1`X[=_ZTYO`V=0&U+K?H2_FXSAQN9J*'P'/7)R$L M-$O2SJ"-Y@ELG9\WTV!*;F0(EZD"1!>@RL!OR9_/\",&G]$G_]VH;J&\2-%3 MMGB:\U-U7=4\TN'"0CMSM,?/'/B3GQ;N$?O%W\"0?#'J!;&\Q%^/F!7O.EV. MVEN9=A+IZP'_IN?IHHUGJ"V%:P7!$5L#B#DI"QF<]*$",,O9V5:5!;KQQ M54&0]3*>+/BWDZ*4CWKYO!F\PS!Q;.^*77(H2>7%C!_K/H^L M4QK1+2D9EDSO$9T/R";\*]:NX:97=)R&:+"'+Y.M\6*Y6JT*1Q@B0&5F\_:4 M`AXP4^#?JS]K(,U)2Z^3[>?3I'E*[_U+?(L\$HOGJ)R%Y"YC=K?$D+*319Q)M'D\EL995H`35Q+YE8?)4D MD?M7#7P@S[\B(]QO02X6I'+!;ZEDU;-K`[AKES]GC;M_UTL,/``L4T-K<+2- MIHH;E9MZLJ7G5(];BLIY%X6L\:JXBZ!\Q$!S(9G._I##:LG!M-&0%2=%ZK=T M]F;&Z8W2,4@=("H#AXK+4AIWN-VZT-M\@QMW[7B?CZZ'Y5_%*$"Q\Q-$+KG. M-UA7,E'T=>4-/K]MO&7A%[-95KLCD0X2\2"5#Q(%(Y"H`+]1)<.TDNS^P$#N M6T:YW]))&"@&MF`,]'4=Q.&==R($@R>'CKSM(WQU<2^%S(T@>),M2NRJ#LUO MJ">=)G,XDVRZ'-LYSWA;4)0(,I%:*AS(\\_2Z%\;;4ASDC(%7!]#-W9QA]!Y M?0WA*ZZ.@"0440QO@XXQ?X$I/-Y!\N>^=.W;-* M!Q).83RN,]P()&`(M"0W(D3-MFE[Z.V5T<4]=1;TBR= M%0>4^CO7A!(CSAPU)EPC4CJ?_*GO3;HP M#)VD^_H0!@<8XC:8/9IM?%YU3[+)&.ZY37NQ2CJ2B8@3N'_WX0:?7R'+ANBO M=Z[SXGKXX!I>E73\$SZK\KYSUSOP#L'.>8/``7OGGP'JPIQ&P`_\3^1*S,#S M\%@'TD-OZ:RWVNZHO"!1RB#RLO%<+E'G(%:>CW:CC]HZH3PPS;J@K=&01AQ/ MCG_EQX'O!JDZS_G#^8I2W_&=ZX9),8&WM9`*EVF\F;5:K!:39*Q*,PN)!XG\ M/,NPAA%(=(S`]96F6;&A`F`9%@`.2AD@"K9P%/22CA#$RQ3$'STIA/3JNUND MQ8^OUNO@Z,>HY27G;1#WW;'.JO"_J)R&>*SB[!3/QLMYNAR?RP6Y8)!*'OY` M")MVI#ML&>%P"\U(]]J6X;4:?A%!;$XMW!$;FE6><9T8T8]*7S*)38A%G"DV MGXVG*TXF(7(-(A%Q/_D(9$`_NW.'N+-\O,%V5CMEE.#(11=YD+1,.S::!C]B MT[!>-SOG?!$+K%M#H+6R4RA-"[- M;?+'33L^_W5T(Y=4^KCR-U_W/OI\FU\=SX.G:V=_.#8LE0K+4#TI(&H@[T2W MO4RE(=(%<"J)81H'H` M502H)IT+',/&P^X4#VWS"EWQGDTS=(JF#*8Z..'OD<`&CL;G53-0DS&\^6:M M%I-T=97(XURW'XYIY'EE-7JEDSWD^6@+?SDEC,"#JPS]K=&0@O30]5\ID_R< M-*7?@I=;]\Z)?H6O3O3]K0'UO.\J9P!.PWAS:C:=3*7XZV,8SKA]/*^E6V,)IN.5*.":)(.U?UVZZYA>K;R M6Q#&KPZN?>?X7*3#*T4C`7&:R'L=[&* MN\&3,MJH9PB7:V@H'5!0/?GIXU03P*H,X:,A0E+#3:R0;-T/N`$A/G:Y3Z/C M(:TF\)4@$]1QETATM:PKI>=$Z0U)^)Q)X..+)YJ6E1O?4;E2U&0(]]+'*KU? M)KDD*A>C=Q%8FG.VJ'/*UFQXDJ^T.-,:$ZT8NFN[FZ#ZH`ZTW`EN\+4L:[Q, MFKFL`H`!)?S[^6.+^:,<$Y5DJ@7"G?XJ]:DI]]MK)]I]]8+WB%5_D.<5'8BH ML8/_X*\].<=&L`58'B`"]17CD^VEW=U+Y>AI2,9:'+%BHQE17UW?\7&9P(>` M;D3@1Q;[53T(8]K#OW-M8=<@+9,+4L$F(4Z.UU7D"7NM`8&MRWPG*NY\AG`'_VL:Q*!E0T2:!5GH(:EI. M\1!H0+!(LC/`S!U+S;@F9?UW@;=!>4)'E_QH;GA7#X;9!@ET^*8UR"T*_@M( MYA0,0JXDQZMX[>"X!KRV)S$#I2UQTXK-IS7TG=`->&8D2\_JP%[1`.Y[69;3 MM)5,WC9CXK&S+S:G+\H14I=*M8BHN*X5`;4GONL?TI'S(H=^QW-[6AG%Z3G+ MW-^-\RE$C:>4&U.F-L4UGT+&#/'I(1^[;5JWR&=1`C"+73CXU#7!G!@ M;]C@T,O.(.K)N&M\%B1JNA5F!'P:EC6^@<#SB+IH!%QRD<\(O+%J'JL#=V?, ME!F@6]"UT42I7]J42>4'58.\I)T[35?3<0'#YR.,JQBE[LLQQEP-X@`\H*_C M#W2%81`[7BM8NSLYQTX^8R6)<]JA5)M7%:14/38#"*W3$V;,2?02*._N:86/`9,*Y2;?^VCMN2.6/D*PQ%!+I.?B.8I)7 MTDWOZ.+^V)V$:X5E%XMYZ7]B9:7Q:R",CV0FND&BO(+JLO[LXC>-]W:I#V#Q MLB^MEWRI=WW6XKH^&NS#(LV4V3FH9M#K]R"&7]QH[041&EZVEA7C?E\K23*, M$FC2)PU=&2P=Y.)-J#`V2`1(I^:+^^9NH+^A=462".`K3'NG3^B<1)/K.X%HXO4/KI_,F_TXB']O,'P)E'MHY=<*)Q-\VLF& M&XT5IN$+C7$T0WYY?R#3K#.@/S[$9^PPA/[ M$6'S@$H$,!4)-I38XQT$AX36`^30]BTNR+)+?8IP& M:91'R5A^;*01;JYD1]4@WB1+-!U[9V?OZF?'LD$"$P)6>]\L60$UM&O6P_-" MS\Q`0-;G)P<&:R)B&NPD]%8:Y!@"QUYMRW1FC;FA21])5&4=$K.Z(9)"0C!+ M9`EU0DS%=]_VMB6J,JIY'%^<]3&&UQ!/C+++==0]IKH>1XT-O-=8CY=V>BE* M(@50,9I*_/1UQ5+N2G.1C+[^)+V&%%/>:$&/"O1-MB=>"&LDW2!Q?CN&+X_.4 M9&<]JGX$5&L'[^VC,[S1GXR"$@DG]WC?N>L=>(=@Y[Q!X("]\\\@)!O2_,#_5-QO!NGV!'?(;6<-HZK^X4DI M@D@RI)2[#+]LAE\:QUJ-\"N,M]C.2Z&!_1Z&Z*FL=&I=&<)G)`'R%3;M)4\Y MH?0PEK?B]]P>3VTCJYVJ\]Y*;XLD^@K5AQFE/HE23Q?6;T'ZDN`\DZOJG#>'C1KQRV8>=L`&8YG.)&,FQW2\ MW&4^GD]F+0QC+L'T-W.+R=32C5E4$DM'6C&15+K>%S7&MT`T M48JA?-++WR8V,9E*>CG=1"3&LD@7#I'`(+(6G@\'CQR^<;RTA/RMOPW"O<-3 MKYWS;:6+TEPF\>]Z6*7%'PJ"\YL#0$&V_K(M`_AN5WS?9.>`(UIN#(5BBT/A MYJKTEGL1R^GR"C=_!"4T^,\H_NZ+![_#^!]!&.]J.+;RB.*&_%P_;\?06EC) MC<*I!%*VC\A0VC+W+WU M@;->!^&&U+)X=^,=/=41!F]N1$Y](-9'/W%#X$$G@L!Y#2%5/T(_=R,`*86" M$!Z0X_@7P/$0DY)Z2.N=$[ZBIF-SQ+M6D%$;#^D".#V`BYZ,B5M_10TK>C]V M7`\?.<%M#:ZT$=`9=:(7:4/$#."'LT>1"\5`P+VS@FL@S<8(N%P'X'H MN-X!U)6,G0\LX1@G<1H1^>M@OT<-N1-"!PG&AY1A]%>U="7_JU(2H]$I"R8^ M$]$@EZV!W.3[;!=\#JL^!UCTIU]^?@+;1K^5T*$0+64DR1^S@:GS>^`_0@\O MA#XX80<&K;YO$)%6C..==9]9L_1X4W="_?_Y=%`^[?EQN7@5Z0")$I!H,8M@ M>P:!BVB1CD]A$H0#.PBZV9;)9#RD6Q]'B=P;P?`-1C<129,]#M!?'0_`"-];`/!V65J7'?WX#?J(LC'ETJW/7=/Y`\#"E$J/`$<%SP-G!G\T:\0II0@Q(CP_+&94/KHSCX7YLC^@W2A4.- M*!_Q<\K/<&SV>%\*>AIO)3\D57B2J"3-P@_X)0A_+![\ M1ART3]JRO`W[*WC"BJA,VGZXI#@D,G)WBLA&F40A\B&QG6R$QZT?W)*:]NF/ M[LXZ/Z/T7%.3U3E?3(C][RRT+E3\"B8812'60:"1:`%&CKVF1'X1R MRY(&`:9!V!2#<$B"$+*"H+)I$2'J\Y:%.XQ2&I:/8.\DN[0XCMPT/Z^\Z6@P MAG.HN%CB@IX3>LL&+NQ/63H]B*.83&3YDY`'%I?M1#3BS(P\%^U&%_7AGP-/ M.>#;@J%C.3"K[-JR\%=]3N$27T4Y_X',R3*#1U*;6/NB73]O;"%O5*W`,=.H MN-96[[B,=FT'KW>NMT&=@6OTK+N^BI\.N).Z<3R8_^V*75I'5(+JMD_,/-YN MUVJQFB^3-3O4#4]5_"4"5`L>2.721Z6_7SWJV7!*CC'VS17Q$1.!ZM;T0U(_9T&KKJPC(T4)B0 M@;R9.IFN5K,"B>5*0%%+6I^+ZAD11?H8;,!(6.9%HI7`!@R'W24<.OFK$Q,4 M&4P\F'(X["DXXGDZ_QJI7R-M5..M^^B^P1#SYD\0Q<-UFCA,4(9Z#A,SD#=5 MK=E\4>B(I4I`JB7-T=M;D"D:@425-A8;,A:6B;%HX[$A`V)W"XA&)NO&!P4F MZQ#.(9E,G+<,8RFQ>3=[8G-1DF'TT\%)#JXQD5,I!(L81AB`]R"8#-XQ/ M-^[K+K[Q\'+M9^AY`@LH(J\KIPE^VWB+7-G+A?4GKFTV6,@2!L+2`1$/J'R` M%1BVIC-4#`@W39:6Q7):'S.)?,Q,")7.^AC-8U=/S((3NKKH.H?C/;^2.J6\DS_;R#ML74'J?=YUP$6&,9 MBC[ M%\OUGFI@\AC%>Q9],5[-$[`2L75=+BIY!)[_KUKX2O?3XO539R]3NM=VP>O2 M]']>K*WQ`RLA!A&`9FS!'2II%'(J!C"-WU=XA M$D$J$A1DZB08F7X2*L&?JNBBP#HZ0[G3*%!-# MF$(`DSE?\$9%,FN\0^\-"G,&ZRV-C,$PB7NWW6RQF-?Q!9&K$#P\9"'%UQJJ M4.TK-U%(<3BE"=LXFF@!81U)-$5$!D6@Y^^W25V64]W7*3^@&O@E[=RMA36Q M4XPC`?B<=BI"+91[6&\IL[X9G#U9SBJ%6:P3GG)!MV8NDM$5)S-!G&%G`Z^^+I=R71ACV=\@6=4@%*!L! MDF*3[;L4B.)-NI'C_0P=+]X])45(;OTULW_<^HIRX#;;P[V["76>TCDU4B3F M$ZX7A*>]77_M'AP/T%H0BI$LT;D$U(E$0$6"IZSP#)*JL1\LU56[W55]H.># M7(Y_CK@,1P7WVR\(#N]."#N00MW+9M!#C67;,`-Y^Z=Q:C--! M0RX"$!F*^:"/!Y9"#UI@W<<-N^*&BV5HFS=CYGX.QSIWI:`NA&OG$!]#N'FB M!17I--Q7=QN??G)<_XN+:QCZF^@!AD\[A/S:KR$N13ERA4WD3JG%RDJQG2L! MB19@V;,QP`I&(%,Q`@_X>#O6HAC]PT;!,BH*+0PR;"CLYE#@*I]@DVH`!Q2( MB!4(-134F0ARDNH641TUUGZ)X/WV)HK=/1K]5PXYU#^DL+I:63/OZ97Y)-U* M@]['?=!,`D):X+GK$_@M^3.O5J:IXEH/#^TZ#W566JM/IF*9M1IO=63]KT[H MXBX$WKEW]>&R\K[RF,+,/]?-F1G69#Q+1J6I!+I/]3Z\[V+\$>M3\Y0D58T#6=_"G+N\;_-&1 M^>5D8N5^P7<)`[5?W9?022^OO-]>!^'A&%WO0ADZR1&\5"MBXV\ M7?/99)XL_!`M^>VFJ"]!98-$^-D_1T!C>;K!(V*9&I'&(=S@8;&[AT77.*X/ M3Z0#N,W`8VU*HE-#;Y_. M0F/:R;:>],##<`K.MOV*]*37#CS#,'36\.G@A+]'WX(7^I?S>\Q+J<']LG(J MX[5,H.3U8IKVUY#P['!\(A[\+V=_^$]`A>,;ZD?)W_']]+KZ:L,$P3(Q""T< M-DPD[&Z1T$=9HF#/64HH@!*(Z1].N+EQ7CUX3^ZD_-7U/$2`B0GT9^D18"8_ MB];F$\[@9YH,:BQ MEQ((KB:^#'!F'#3#NSGG.<#=$$X9LQ:0U*&/`_\1OI(Z9Q>@M4_6L1E^#>8>R\\4LK.[LRH]&_C-TUKNO7A"Z&_8ED]UEF<4O;$,Y!P[SU2);0&H')%8'L#Y`%(Y`HE+3 M4I*2V/"2E9[8]&$Q20'B[6BQ`F0HX[7S"2<+MH29$DH2A#LD%_T;_0O]Y<6) M(/K'_PM02P,$%`````@`5S!F1K2QWVV/;@``H!`)`!0`'`!U:'0M,C`Q-#$R M,S%?<')E+GAM;%54"0`#5HGY5%:)^51U>`L``00E#@``!#D!``#MO6F3XSB: M)OA]S.8_^.:8K+ASC>^_WK_WU;AQP!N*T'I[\1##!$8I2/%P%W=!]/T9)/`/%^3_]2_PG_[K&G M]Q<7JS3=_.7=N]?7UY^@OP3QCR@*@PC^Y*'UNXL??RPG_%:0]I>+/_[TX<-/ MGRJ_S%$6^7^YJ/[I*H;%S#XFZB\7'WY^_\N//W_\\>=?GG[^])?W'__RX>?_ MKK9&FVT<+%?IQ?_V_C_<^.=??L0]/E[,?YK_5%GE_WOQB*($MUYO0+2]F(3A MQ9ST2B[F>*WQ"_1_V@T:[M9[@3&-DK_]4%GBVW,<_H3BY3L\S<=W9<,?_N?_ MN"@:_^4M"6H=7C^6S=^_^Z_[NT=O!=?@QR!*4A!YM8YD,%;7]W_^\Y_?Y;\6 MK9/@+TD^RAWRA/"'W=]6,5S\[8=LE1+@/[W_4'3_7]?(R]9D%T7^ M390&Z78:+5"\SHG^X8(,^W4^K5&?K>(@S;=.NMN)[TBS=\*1WG4D+WZSY?NH)IX(%0^_JG^)9<0SKO-'J!24I^>XJS)&W_;1L'UKV2 M&<8H)M=;#%@7<`;50[@4_5N9Z7.&OO$*AC]^)FW]E^(A/(E_[ MBM1F,;W,;@=-?:K>SM@52%:W(7I-II$?Q-!+Z:EHO3S1F%WIOPX2+T1)%L/' M;+T&\1:C&2PC?$5Y($HGGH=9EA1S5@\H#+P`)A/?SZ\R$+9_X;1,J6_A5_ZCP9RO-H7&(8[L2-V>(AB[T5_@0/<>#! M)S1)$I@F.6TQ]#%==P%XWB&.?\.,N]]ZP=UFU;?\XWPNXIO MJ&F40BPLIVV7*#'R4+ZBED.LDP1]P/QG!HADB'-'^`$V>4996WN&O$7HF MN@+P'.)FFRQ-GL@_VV+1<59]R\]O5+UWE6A(C?R9MX)^%L+9`A^?8)VM;[,4 M__D2SXT?AC2YC='Z"XH\HFP)"6@%6:UYLY;3Z5OP-7Q.M7XG_H`]<-%S6)QM M(H&$`4%I3N;"//P5T=/E'!UA^?+''?/XN&F03I8QS)G^SAQUQ^E[`&2&#S/1 M:F&NYA[%Z1(L87+SYH49^92Z-3\X2X[?$K#N&.,'" M"U'I^N4Y\LF<<[@!VR[?5V4*(PO3\W"VG4_CY1.\!#Z,?,)\%BJ%*7Z6R3EZ MB-$R!FN]-U.[V?0M=XJGBLC;_!`"S9R\S-#Z%K(3CBXA'AQ._']F.STD*G[8 ML5^_8G)N%@M\#3ZAZR#,"'D$]Q<00F*K:+E4/9-K!Z-R&Y+]]09C+TC(D[W[ MO>-R&X?7MZ#?(#%C88;Y!<;X3I_#-<#,2;3$]T0:`R_-0'@7+"`FXZ#ECJJ" M_<:2E$\=?(AW%!V3U,5ZBUT-]R-M/+U?+(ZYA:'Q#X@.(' M.,D9YN<@PNS&H7D+4W-`8C1!L;YNZ/]4W><58OG2'ZO/:&][+/G6!*A2\03?$LO0^1]5UM[ MY]D&L>;R#Z==^W[6GC'@.7_0?:O]XZM,.9S5YX9!;9M`?>*>D;B'\1+&B<`/ M@I*F_SYH.?L@,=&[43K1T#,^A0D62VTP22#L\<9HGLCT2O5^=-GI>EYU;L". MJIK2)(VSXJ?^/K;BK(/"0.\V:#5WWSQ3BJ>J^3Z3MCUN!_D)>UXY41A#_%#G M?D21?X-'1%L(+V$$%T&:6QNU+UYIS@&M7^\Y:#%SSUA4-3XT^J3/6U%AQL&L M7>\N4)ZW[YOP0&G6YQTH,57/J]VKVEAV4^T+EIQM$&O6N\N5YNQ=.F[6T?6J M)V@W_0Z53270^@Z#4(,'-X:13]SGB[\24KK'R^83XZDQ&;79_QFZR M/&@X@=Y/2_3RSH?!._*%R#_R3_7CS^]W(JRPF*MI;_!5`^'<(XALLF^:Q9T>D<9NJ47FTA_$?_E%^E`GC MHTR>D]P5YH`DZ6[]@UB244#S`.,`^;?X;PD#17[;4]-)/J$A#ZS6*O[QB15U.AGEQ3NRYX4)O\"\ MA(3-3T7M-2(>F5SJ=C^?BIK;((3Q%3Z52Q3S]V2]U:EH>\B>P\"[#1$X?*K9 M;4Y%UQPN`\(*1.D7L&;=+\QFIZ+N&PHSS(S&Q4?C'X/#=J>B[S<8AO\1H=?H M$8($1=`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`E54L2EMR"(10^"ZB@F5GH'(I]#?OZ370XX'7!JE#Q, MRQ=5D4?,*+):FJ8X\H\#/B7(9W8SLY8(EOFMN717FIB@L<(G->P05DL3%#^4 MVIY&YIO5T@3%K.IDNSP_6VYB(>:*VHPTM!7S6>"F7D-9">^V9[<=#-4-YUO< M1T-D5EVRR:^30U(XK=.FN(G-RDW@Q>DTPUT"V(&&@,>>T`4&NBSHZA*K=C80B"'7D MQ*@H^5+:ZMHI#Y"RVL-6?T]YR)@RE:U^GO*PE/K[;OZ<*`7A,)$8L!N#F2TA MT#Y5]T5=36*K&ZLB*#5VW5:G545,I"PFMGJP*F(EZ2]CJTNK+%K*O+"M?JW* M=S9S$[5Q:!WN@RZA(Z]B(NGHLD?K@YV,H"1:(@<)"I%=$3^R$/&4I7M:D**KP M4W\N4(SRZDW^B'`\>![MY+>4$2L:R-9 M^ED[GT(Y5)CBGZVI8]2@$9GP;,T=TW[SL'WWNB60.:.K1\(EH+ZWZF9WVRT# M;#>#T04'-\,A.H#V!@3+>TU4,6(ZAE+=I)U,H1I$QU%K%!\[K?5J^'"C5"E, M=BIMU6"2\8VDB-FIPU4\>*P03"J(J5S?YZ3[4#Q]JM'P%$`[5;QJ\`D9[@]M MI%H5AON,,F74:TF;#1['M,SB?#5^_B(_P#C/IL1Q"Y7I:3@Y!F>X38*;DM#0,Y;R`+O8&,V?H*(S#+K_DISA*:JZ3,@?\) ML\S"'/C%@'^H);JG@U[L1NV><.42))"$=('P"XKF,!>Q,?O!2AW9T-J$1N@R M2_!&2Q)\G3_CBXQ\WL<4;B;>O[*@N,X*>W,9H#V-\I]BB%>QAB#)XASP7X]- M)'W,8,8&5T17W;QM8)1P\X$>-1L"K0UZ2FYS,W9"&CQ$DM$TFZU$/4RLH/29 M*H4-?-8#CT,[N^T0J+X.PBSEFD=XK9TUMKC%[B&6HWSZSI#7ATA5Y/HB'DZS MZ#I(-BCAUL=0'L;$6BD9CR"$LT49P_80@B@E*]@0HCDKE.QL)A%XZ8EVB_DV M]J?@ISB7Z6MN57OFJ.%1X+4VF4A_]T!Q*:ZW[>ALC::H+ MY[UHV4@KJZ51BN\P>PJ3@P-S'T3!.EOGO\WA"XRX2:S5QS&61IQPBI11W!/. M6YBHBY$UO$;$E%>\,_<@`LL?X46]D)KMR MOE?YF;1W/YNDK3%?]D$SYR\SA/S"PGRWP?HYBY,B@T>9"^46>)PB'O(=>R91 M1F>DUE\'P3&($KSOL2#-O")934QLN=]@L%P1CY87_+@LX9=L_0SCG41Z9)28 M^/_,"BZ`<^$^RO'%ECUKMZ^Z9JE;&/"9P]9D?K<_D6/SGCK4&[5+RV@))NK2>+>, MC';#5=6OV)ZB4A*9(#5=;[QX7:M/,+ZQ1_8]$^._+^:1=YZ6P#J#)6-^[%16S&CZ1";]; MON,SNN9=K*`8#M$^&T6L("^%[!ZD,D;PWSZ)8P1K8^PB!@UE#3U<"TV%RW1I M$?6P)1;'>>,;\_869F=^((Y&^!Y,TSAXSE)R/3VA(O.NV"&\]:AGB$2#B[&N MT8>&S!R6&9J]XK'<\WU$6SF974UGT36,@Y<\8WK2<,OU,=.0$/L:Q<=Z($KS M)`X2S/I=9S'^?['H%B"_)6`=)G*^[TJY(@N\2;'@XZ\@GS92:I2S\_)W[D>& M:\KJ>\X8/J-:;S?;4^,9^!R=GN=VYL1S4KT;^B)23'6W_'YGI/II9?88M6>- MMFWK$MPV:F*Z^>:"EN\S97Z,@Q2)0X?L' M'V'\$GBPD#RQ8(2642#(-G=J*@S7&Q,>C.-VAJCE\6KXO\*,F,V9K.\7A!M' M*;ZAP]S%N'`S4[>TM9K%`J0:TTKV,YN&"Y=1K)6]T85MC:3'I,5EF:#3WVTQ M_W9-Q4BV(8KP?*%Z+)::SA M2=]Y2BXN8907J`=A$YLBU\F(=54R<=,P4C.UIO8?'\S:K@_>_(3Q`,OU<;X1 M2KX1S47O^1X1@KYGYP=Q4CH/8=,H&FL:W.'"'-S8+8F)+VI=53FUXA+_`E_S MG_AWCE3G`:TK+P_7+P/0F$&CA.&<%2?K2]OJ(T-@TF2]MK+$KCQ%-$V![Z+;^1Y"W[ MML>#2V-6UQ#:'O$M#8M816Y[9'=8N#_%9R)NM=^;)'==LSW&6<9%W>I M&G?Y87QP2(I.^Q!,AY"+3!5%IA9VD15,`P]3WMU]=\_KEJF)&=ZZQVULB7&Q M*UK$N::>O6NJ,QH-X(GBJE`8E^5HLN`XCMAQQ([?T\'O78%D=1NBUV2*9>L8 M>GDQFIN$--CCM,N@_2>"@C"#-A[K(A_L#Q=DF(MBG#]<[)4@%_.;Z5-B)*%) MU?Q&[&21%X2PED7L"9$%/,2(W*O^Y?9K`OUIM*\^-O%2?..2`H<-W$`O4QG) MM5&I(C];7,/G]#I(/)1%Z4,,UT&VY@'0V,_$:BYUEO]BKEOG#$8R0^`]2;)\ MX?^A-OUDDEZ!.-[B;9E[47#6+M?7RE49BLUATU8X`N";)K>%E#81I>5QAM"1 M<0-/A*^"0@..CP-^=&[>/'QBRAQSQ'9S%ZP#8FT)P#,I*)MKIT`4',?C=!^P MCR7-%G.XP*2=)DJVA/XLJKQ#93(=, M7E7#)M--"WE>5TR5AS"2K0=B+MX+<@KQOT.82SZ17V63.!M?JNLYZS^9&T.U M2N:O,2,O1NMQ3&R1PRJJN<*]5L*7N3T:NPUA+;R*L%(KXG0VL:Y#AHAP[UZ< M$<&M8.>QJ`SPV,G\(` M`UE?;?ON:%2Y#K@#]++]Y_E[6-XX4EOUH$LO9#U!S-3C61(8X[?L)O%B])I@ M_@=A1I1<$@\QW(#`G[.>QNX#FME)Q?5/P@%$VZ7>RMF:=PZA,&7I4QFR(;XG M\;G*R'5:G#%\3W+`[CCH^>'0'0;G^H#CX@7!CV MF.[[0W;0\\.AW?Y0'=S&:-1`9284D@>K4ELW MY*K1S!^E#^*O=SXK5RL0+V'R*T+^:Q"&Y;F?)`E,$X;(T6FL/A:"80+1,L!" M9S&/#,%'??H@[![%Z1(L28&L+RB%#V#+$:9E>_9!)#7=5/3#DI^=V[_)S&Y!;%$_\%"_WP"4T6"TPFPXXLU+ M*_S:!SQ%6G,_TZN98YZUO(ISWI`C$ZET-;VFBH=-S2EE4B1`$SFU*`\SC+5V M7^:P5DA9,24GZ<9N9M9"CXG,G<%O;YKZ1^AEF!+B="I!>[6UD7A:#\OK>!=\ MC9(-]()%@&D1513DMS=6I.DHOR"/='9C%TNN%$N^CZ^3#R$_[F)T#>46EBF, M56M[=O'NIZ0SVVP*U10(R^\]C18H7A=QL0V;1;*WR9C;/@,N:_GQI+SK;4]E M?RJT)4)";4^/?RJH>8^U[7GU3X6O;)Q"NSS]YY0Z\E2(:XW`;E=MS'V6RF=I M'VIE?T&Q4YT)E1");H7"AG_SZXH>WF=(DHI_W:/ZBV6U('I"5<&UA$)K9SZJ MWJ'EN2=28.T49WH']MB9C$)JI]AR@FN`X;A%4;536.D=57GW30JU7?7$3G?9 M*KI94\#;I+P??MW6W@'G. MDRQ\JOTJC&RB,#LQK=L6%D2Q4)"M*]QW*IC5`@0HX$Z0:X2;'9%`(72"FRR$ MS?FF**I.<)-%M87+-X6YC=`V?!E"/0-0>;$V)ZMI5_WXG!ZKENAQ>ZLF\K*V M3'(/N[/ENZ]4(=EZ9)MV+B?57KM2QV.^"?AYRBB6*NS4.6#I:LP<;"J]Z:)J MG%!S:`O=9W8RF/V!*_#]IZ#:ZJMTFCW+#V"B"-M9Y_8TV[86]$$AM=69J,=- MRXV0IJBJJ/P=JG546=77/]HJ;O8`J'(N#XJRBL@YE<"F_KA!M8P>OCDZWVRM.(+'(YN2C:=CJ(G1)K M*9B=?*A%LR1=GH8B;Z<3F=ZR)`?(5PM[4"!')1%J`+*?<'GZ/48E)NK9V)TJ M&E'DVPB1P[]2&O/X[=4=BB6JJ<^0G?85:>#4JWM3Z.R,A>!G,=1W8-F!FKWDUQMY,' M[;)7)_@ZB.,M1OD;"+/:)FW!-F[RG8_IB=/10/:/#]6T7BW`-16B]+4BCC_-C MMEZ#>#M;/`;+"%^T'C&T>7F*=>)?A:43C^C(*S;F/9(_&"ADP"!-7+M`T$%# M)[GE:#F5QW)7G\ M)8B7F`5]R&)O!1)(DMH0M0^^-G^'I/Y'QBU5UG(P$^NNUC?AK*;6I#V-"?1^ M6J*7=YBM+C*/V[%0?I5TJOR^8(7IZA>$+ MO$=1NN(]9QT''3X.?X<@OL5MM:Q_/]B9K!MEO.>TY6#GL>XG/+V^#UZ,=B8K M?T7ZUHW'&MBJ+[?WX)\HO@H!9ISX1?%41AC8"BEU7\`:"@M`B M"^^"A?I!K735P0;@TYW@\8EP<;.&\1)&WA;S=2!.!9*4?$<-).:E?[AT5'_5 M,-EGE.0IJ?@3'K;0,.DT>@B!!^^(<9D_,:M5=Z8[R!E-LJ<_[OY-Z/M8V0J*5!2IGWB+AM_\(,)R%819XY;&'B!F.[,&R%N@IQ'Q.K MR!\$3`D1I?Q]1,RV[G8A7)/*",966,9(-#$(G,;#H%OXZ'.;FZ']+5AGZX9] M4VVCX:FXAW[@@7"V6`0>C5CDOAG"YD9`PWQ-(VBU-H:HS(][J8%DZ&`NMP^Y M`8J_!ND1-&R++S#E[@'ZFPDHOV1DZFKENVK\)Q,[81>3:\C-J,DT^FT5>*OB M92Z\3!N7(NJIX?,_@'#M@Q#NCCN%:Q+YCY@E_YX<_<+=+NW'TK&0BA'@";P1 M>W81R/.$+N$^^P/T;U&\TTSN?@9O-V]PO6$IJW4-JV-Y^"KP5@B1,EI7Q'#M M-5L,F_N8.!+<>,S+[1.>6\!]R/0,WMG,[95#?T,KN2R@,EV!B\YD.A77C!"#IH>)3F M<%5(ZKD*O.$U$C0V`V5().^\J%0#A$<-3=/[%(,H`7GBN^1R6_U%N)&E!S"Q MOL8HS8/E\-MKV-A"1[:[0P?WRB:7[-@WB35W3EGRBDY&OKW(I_OPNS/;Z@`T M>P:YBYWX&F,V,^FKVNS.6$:CR6P9VUWC6QA)J]Z]RA;($>,I,LG2`$F&_:I= M;9SA8R9A#B.X--BB;-U14B8XFBZNM=JJ7<&1X>/G:@4=7$UBRU;U5N?;DL:' M$?N\<8(4;*^V)PN/2!!N5RO&/HS8_'6[5/CG@XZ"MOL@C6&S2MGVRTE!KU[% M[C`LQO:R;1UA8D4_M2MI:TS0J/!4L))\G]DF;#^##5:94H>Z,A'N%U!#K(&+W?;2Q>J&Z7K/,,QQ+;S M"M+)B&NQ2[:7<)9&I>*MW*TXY8`Q4?8_J.6[%3I-6YOJ6PMF0B=M:U-]=X). M+D[5VL3>G;!K2J-D;0+OGG:<7#8/:Q-YGQ#5?<:$;AF^'9@'B3>L3=Q]8CB+ M_"V=,GL[-`^R`'5*^6TMFE*!,M:F_NX$73U+G+5IO3MAI)`7C@+HY).JD;M= MZDF*II-8VH6F5R!L(;Z\P/@960:BMB!EBJP38?[&SS59P]ZTE``BUU`RG\)$A1O M)\L8YM_LYFT3%`6LK]FE.9IZZ*AJ%449",N);B%^^9.J]FOR`F/\CX('A3YE M%=A%I#2,J&U1CQF^.O)BSD1OPJ7TH)F10ETQ!`Q7L.TAS4W-=4"G_KW[_YZ7 M<>`OX2O@9*5FM-`QZ;%)`J\K6),[XPHE*=[)]!<624K]!U+WJD+2;'&'?WM: M@0B_G[L#3,H!HRC%UVM8L<=4GN-IM,FXI>7ZFT_#YRZ(XB4)/VY@XH-=83@P M*L4+,`^2[Y1*G>Y!FA%.%%K7<3,882ETO`+2@,/ MBO:H,K4G6'HN43C-=W"$3)`]BRDO^*FMI8`DD3E:[F4"\U MAW8!E_G]Y/.K^HB:CJ\BD1!*IJU][\[,A57832MY^2,TR^TVHN]\T%`#"<50 MLXA37X/10MND3Z^H85+:PL1^SA-]E%K^>Q"!@GDB6F3>?A9V/(@%XL43B)YKK\((76/V-=6IZF$3STO0.!$0!(KG_A9XA,4F)W:!OW_^1\*]W,5H_XBMJMN`Z&7(N8I417,&M8<'BM M!T*YN)P?M[V&0_D$W_!8\HH#<7L-!'V-L%P2)R#\C!F?=/4(XY?`(ZGG/"Y- MC5WZ(VNVN,9G^!7$L`6!K,XF/=ME?=UH:9?:A6Y[IF!5>`[=&_?X?+(L<8:B M>V$U1J(94UNSWO)<`LO=HW+AT)UE5Q8E5Q5P4%4!/]F%GZPW4"VIN<#[QM9] M)N]Y5&ZV([LB90TLR_31$IJ*]9.>+KM2V;J:FZZPEM["6I:606Q96.N392D5S=`F0.(*+/G)VZ7W:HL5SJ;6VMD]+G&2LV=86]6F#F530 MN;6E?#H@)EMSRWXN01:Q-GGM;:O7T_'Z/XZ=L;883X>-UF,J&FN+];3+0Q>5R_0&NK\+2$CIW,SMHZ/%UN-5[H?Z>:.\,N<=+A MS56*;>E4:,=:"!L2[70JK6/A(94+@K:V;$Z'C<;/$&IM\9PN#\%1^A]K:^6T M1$F0"\[:0CCMI8"&F-P]8A\.]-PA!&NZ0'5Y`H5[GY+`6-C=1JP8"`_27G%UKT(V7R M`9@-G;04NJG.D!16T]LLQ;?R+L7-`]CF_@MSZ,'@A95,N.TP0TKI?8[IR2D_ MR]PG@?4FXV?S M51]#1\IAW'ZVV'$86P95!PTT3/D;S$,64Q3-X3)GR^0N.KE^+KW:`,0!,0]0 MSZC%>W7'AQ$[+8N(&;`]Z%P6(\DKQ?;(1R[&M^Z1D!Z^F[3EM MU-!IQVO;GN-.Y>%Y+D]MT@NHXF\/(O-`EG8]$LI3MO)>*1-GDF3`"J[`< M2$W,_XA\B-0`:[KN3FED.UO32!'2MH(I8?O/V4[B+`/.,J"3]EK&<@[!U38C MMU\<)+QG`U9KXZPL/"L+.P7L)*U=]G/,P[(*9;;/L5=L3:^D@Q\C..#$[,9B;LD/P:1TS;([>Y!L/>)%MF M2?KTBG?$]A9E<0J)^8%CL1,TUD#*457ZH_D/6YCX=HSR)+N"7E#HKM#<;RBK MX9OW>:UU?/SCH2L%=/`%63P_E=?[YFT#HX3I--1AL(%\!'S$;\D%>0/B"#\G M),__XPH_6]=!F*7T>F[^/DT#]?/I#B_^(Q6@^&/QNY^&7*8CB$K7@>RBI/SZ M7V!:/'>DA*/\YN'T']KJ=M6C6JRK[&ER195"X"59%>ZH/+>S.*^^6=Y@\#&( MO"JK14JF3+P4\S<-,&B?;KC8[;YN[Z"IS#,0M.;00\LH^!WZ4Q]S<\$B(/=6 M(:^4CR2^V>[PG\O"WTF2K4N11AZNKA.=.UY3+&E%RP`W/@5HU=G.';G*7TZ` M7'6VMS$1(;9N07CD_\[:*"*WT,'4>3" MBF`(=L-?9D'HX^GPI]R$\(U/FE0_'0020PA^@)(KW#+P\"WY!<6%![5<8+?B M`/I)EJ7,H-Z8O.33"-_;&3F'92'ZHM(I\\0+.O2?9N(T22_:HUE<=O1 M%>`'*(5WP4M535-*,%ZVSG)/E,D:OYS![X"UM]H/-+#U7FYS#Z:FQ$`J(PQL MA92ZQE=)=92!K92O;&KH-+!U8#$)HXO9Z^K!*3),OE=?H'`T#<_3+9[TD3PO MZ9;\\S.(_6WQ-"(^FR[121-I_PUC1/Z/.(D\(!3".0+^3A28+1:!!TMA1DBL M\C`ZR$=Q!+=2LB.WJ0XRL.2>X#U%%G>SAO$21M[V&FY`G#,_?#%;LJ.)TW?( MJ>5H'Q M_ALVR.#"YAK(F49XAWM%%!9_][%::9C\WT&4@7C[](J>5BA+\.YN]%5K[**K MC-1DB4\<.5KB*E*'S5Q)K6H[ESBSN.[N@C5F*?9VC"W1]8&(XQ$IU6<\J2A9 M?`'_IA(V=^DH!53F;N>EG8&A:KK<%AEZ^6N0'L'$"O$;/B=D$%X^AH"SBL-6 M&C:PHM*];Q7[?OPG^`:(Q]P")DGNO%^(!;'"J-[^4Z(+:8-'8Q`6MWA5-J>+4JCRD[P MO@+)JOB=&R'1:BC3:WX$)!)1U8M*901#*V13LS?'\1@S&FF9NL(-%Q5X M]IP45V\GT4D/:7N9FCQ8,3Q? M)\'^[S2D$0R"910L,(N*'W]61"8(\=FMG&31VML,-=`U5\@4WMNMAC*R9BS3 MP7]E9`L2X[608V&W'0#53W@^T0;DM!X(Y>*-Q&VOX3JN&/">5D%NP*ON5JX< M*]=/,X&O,'R!RN3Q>NG(VP]B_P8LR:5.M*[?@C`$A*-7\<10'\-DZA[I_!QE M5D".*_D^]]@O=J8X4L:IQ5:B&-J9LEX9PW:^47L8_VAGYDYE&"7?!(J;G=GI MU;-0F5G#GIEJ,3>!!0N.W/,*\,EMEU3N.Q,(=\>+AG;.D7/SJ3QG:Y_ M+L=-4;,S*;PR:F)_4@J78]7:Q+16`+0S=;@R@*+,DGNP_N2$*SEOY0ID3@B0 M<52H`#8>[I^3?EX"6VM3K;=,4+GGU`2.A=96/^N"&<^+UMHJ9QK`ZB-!G[5E MT#0=:+%KJ[5%SS3L5G[VA.-X66M+4VO<9LHA-!14)WL<@MHZ)0H% MU0D8?0IT>8(="K:31QI?G^;X,@JG$U3ZW+NU'.X4="?O'((NR@Y*<7-RC\1F M;9&,FB+LI*,C1:XP.GV/W`8EB*6H.1FJ`;-Z0#W+.D12H7`+A;&%Y&3OEA1D^Z"(.9&ICM=QSAB*E9-M M))CLKF6B*=S.@^C=Y.O-*&A?,-\'HX))U M9B612"B?<9(BZF0=.7Y)5`INC^8G)_[4F8"#_&04*.=A5P5*HK(+A:2PR%[%N.5]+ M6,<:XLV%525Q=`GB!P?BP=[D93LM$?OH$#M`K%7VXA+.3P[.@U-,2RV4&/WB M,))F7XY+2`"<%'<@VJ*H2*'EX;'I03U.X&R9>J\5 M7B1[\R/1?*9;\L_/(/:W12]TG`;P%\ML0&U8""4.A':N?@';3ZPR(/4MR:S* M3O>@7=I/01GODC\K?AG+YCDJ+WP.`C%J];6I@?$,HNI)!KU M\NP4#,4`PQTP,BDN)GGT_Z&N(I3CG*'8G>TNN!G/9X=2B85YW1E"RYQ?+ M?(9T@DCB:"-\7^X`+/,2DBH_&"AGRG(T8E:6"(N/)-_/1'%6KMN4]!I,E95E MT')WZ&S73#[M8G(-.M(V5)+D"A>O=ZYS1^VJR'11M)RE*VXEZ)XGU5"<5R>% MNR2XM82+=5CZG_#ZHZV[DC=P.7!Z> MT#MB9):S1ZHY(U3_.#;2,!"4C_R*FD&A7=JO(8'>3TOT\LZ'04$^_L6_:MYX!U]>>1@-3&&]8&9EAKH] MM\+5-?700I14P74&:3+]-!/(+0DL)(_7:PA.D-(U,1LWC[4E"W74DA;L;&NK M%YZF!K=M-0A="58]:!WI_WHK1)$+J-96=1P`PLRZN'8ZE)F$F9UBV;8*D@,` MFJ5GMK8"Y0#P9I<*4BI7^><"Z`@+H.FN[?E#?0([0;O2EE:B;3@[NU*-3/*)BRKB^MJJ*4^;8N3MRYFB`;`19T/J%[W* M\W+*:'E3;GFE*YY?5IW;IZ(O:Z(YUSOG>E>AY6:Q@%X:O$"29WN7,+KXY;W\ M@D2##&2=1VSF&;H8&K)0:UU#B[*LLFM5'UJ#Q?'Z9>T=)\PX,C$RFSFG`;U. M`\P/]`#"M0]"6,;.-'^KIAXZB/)6"O3P&^LAY1%E1+$9R='";:V#F%UA(L*U M^)=;3L@LBRZYCAI(?`3X[KB%CQY*TZ38)ARL>"V=)XP:X`'FT8'\<1&WUT$0 M%F:^)PH$"=OK\'HA'@O;FV"Y2F]"DICH$H:A/'U*W8>@W)+V3F`_SL[YY0`F M[I7FW%T.D!*]VV/T?$1NA,T>!YIO3HC=!%HF&S-8E% M(W1R:+C.Q&Q?.U^%\\;+.3GV:.ANH2EKY\%A(:H*JH1V3A=G49:WXUZ4M1)T M\ZDXGUWG?"J<3X7SJ3@?P)Q/A?.I,)_JZ"'_2BN8$K'!.5\XYPOGE&!'V#S3 M%',+@O@>Q-]A^@V$&;YXB6?WQ/]G5N0G967C:>QR_H;YT=LP75QZFVAAN\5) MITC3K?)IOGS'8M!TJ@JGJABF[%B7O!UX3L_C-!7:-!7_F0&R9P#1U$^C!8K7 MQ3=\1EE:R:/^-4+/"8Q?")#3:).EN[J(!GCZ0H%"'N[\R:9+X3#O_/8#$>F= M:L6I)0;CF-\>T?T)N]SN__DY@#&^T5?;._@"0\'6D.QL=%W%O7<%-G.0\BX; M3N,!T$WN/91%J3SQM1X#6$&^#3ZR51\2/8RNX!X"\N3D,N7Q!A?>_&IC#&:5 MY`_Y'?D$O544_"OC)BV6[G[^6DVFIN\+BM/5*TS2)_@&DH<8+?`CD_.&L\4B MMQF]PIBK\5/IK2/DH#IG1)CS&NP]DC.FO8-=RFMF.I M)F16-Z(B*SX:(%4D$R:>+.',5H.L,_F4VT@K4]O:`=^V.$#]J#8KS:T-$^P- M3'E]A[4QA+T(*1>+SU6HP$^N^!V_!.EL+W4#J M;8Q0&43-5-;:Z'`DR,A(L\5N:\[RUX]UH7$:F@!J3K::P#&,_FZ,.N%'K+8P MJ<]G/Z,EI\9Y9&S63C<^\%5IH.UE:JN=0QY`P;5CK0]!7[NKQIQ8ZT/0Q/.. M+Z!%!A'&>VFUQJ<9$/$I/*5>P=F@C;(^1RSDT7DY=DNP&(DZNUK%XD`HL=:* M+HE&79`\G1GI_PK'H^<&6D8:_X M%>E9;SG.@%?[M((Q!(N4JQ]6'V?H6F31BV^M@*7(CE7E#-47SWZ= M^[7/?<)8>;3L5T3W"&2%V[%6W7(2'"F7;'.\0L\X5KD5FT,3>H:Q:U@"2D%X MEN`IV>G&Q@0*+%1-.]$9JPP8JTRIX8L,LUI]@3ND02/*?Y"*?9P.&ID0QZ_P M%@C26^#E@:`"?S%&0_/T"O,[,9N:H)ELS&F$1?^,W$_XHP?)(SX,P)]%WT`< MD.N-[(+WG'5(=S>_MFN8>'&07P>S196XG&JI]34,87Z-9=DW0M.^%E>U\IO$ M(IO&&-8JB=^4W,<[[F5^)5R37D-K\Y3?`\S=D*N+GUE0T,$\_:+*#ZR6YBG^ M&H$UBM/@=^@_Q'`=9+Q@AL9N9M82!R]YT!CWD>`NI[FGV165KL%/>$KAJR_L M8G8-=,/,@^2[@-<2=C&[ANH5TTQ^O75W)X0@>L&O"Z'[X^[?A.*/%8J+OU9( M^((*>6"R)C'F!Q0WM3:+=>G_33=!\AE209"+.J^?D=7LQ3/BWK_>P"C)9;(Y M#/&>\*]0DB:/*RSF/F-9R"]%^`:7H(Z#GG-*:7:E*XAE>Q#>9I&?[-E)OO0I MT->J_."+X4EE,9>98BAK/'F;1/$^6MQ+="YR/0< MRHIV_M:7*([1*P8CG(80U5H*S5?GM M70X:33EH3DCAXPH?\I)-(68,`9;LMH.@6FBOX;4V0GGVG,!_9?C.NGGA/FK" MM@.@NFF?<%H/A'+Q7N&V-T%]U3HJ`/RHF6E:A1`S&IJ,F^*[IU7=B]E.8=:Z MRPI774&G?UEF#_'']P[B9NF(PF59Z-3>!"UTO*JE[I)1S5L;L:<'+[[BW]H8 M/77@!!*4M0%XZB@U.G]:&V37%2N1.[>U$75=06OR$[ M1$GSJ;4E>[JAV+'XS@N,GY%-T#1Z)%&X[!1_.IY&D=,&A6!2XT;/V MBG%9%+G1L_MWC9P+%9O2&QKV*]&CS'GH0E,I]&C@RC*MLO(X>$RPW9 MF^SR^++EIP.J0L7)*$'=\&P54YLS#K'?,!:LMKO1ZLE0PS^AEE=P&'`B6EJ#LM*:J`,1( M-D)/F)U:YH:PP`8MSVA.65,(H@"GXYUD)T:\0$>>"F,L>X@G=`4V00I"?DX\Y?Z]$YRL M;D/TJH[O8=_>"'W"`FJ`[Z(O,/T-<]8K:2J/.II/Y'_D),`X:L,L^M!OT03N M=E"Y!WH]\?)GN\=3+'=>NYW,ZN8QGU>\#37GD0S;93IT";U8+31<%1(O)O]M M-&1AYG.CHS5A*;JNRG)/+KU$"S;<)9IH)V^Y7!.J=2=PH?,TO29+?T+ M>\^):=Q.RDC6%&_H+Y?'*IEKD2NFO!)MES%D?WT`\\$#Z]HG+*.P0B M;ET0B4X:%'27\?-NBMEB@?G4RPQOI@HJ0A(5.FL@]0KO#!A%`0@_!V&8,&>> M15"*\O9CF;)_G=9&WH?=KAIK\IB2R('&@FT*`YA?WY&0TXM%5<)<709VWZ,H M74TB_^\0L,Z`1"?SH!HQ]B8P3K^!,(3;W<607Q+W_!K`N.];YR7I;?!6^%Z*G7`.PTWJG)N#R!<^R"$.\0>0O`[4,-:=00M M1=^`!S]#$*:K\DOC+H&G2'B+4700OT(P"MZNB'2(Y<3D!B2[I^@*RXV[=TAM M(1U'U+"H.<+R(1YKN2>B_89J/Y:&A3S"%QA]SB(\K_^X`CYZO0,1Q'S7KPC3 M0F2HUE*9MJ%U+'-#)JQQ0&U6U&(4'<1GZS6,<:O/*,E-7,RYG_`(:#F0AB5\"YYC4*)'8NOC399< MK6+,:09J:V@[DFG[AO.U&EXJ7&NRN[;00G5*BVO)II+4)XTK-:ZSTBN8I-D* M"F>P=P9[9[!O5N&)3M)8\6%'_K:2+FVW^&ZVT[<$/O"=2V[&.P\UOUZE%.PRU`FUEQR.+/%S;\RXCX#TQ7RIWGY MVYS2(_>;@Y4J###(]8EBMR0[FW;GD/-/E$7"5JN]<^\XK)F@?/1YE=9;L$6V M.SB<$-S]2V2[U\.I,2VX&MN=(DZ,:L$AV^XD<6I0)DX%ZH,/HY&QQ M%H$*^I#MZE:!4A">.59*7OCCY2[Y5<85-N,IO='/P#+QD'^6%4R)3,M\(*0W!Y%,KU+%,?H-8B65V"#?TFW$FMH'&*0"BVG ML',*.RLX":>PT\NEUR[P3OJW,<@T2D]))\V;'6@ZJ<=)/3JEGNO@)?#Q(,DD M\@M$IDF2D6*A#S%:QF`]\?'1S"F=1@L4KW-*=.3!3>]!_!VFDW2]FRGAI[_E MMM612K8H6?$K?MOX*6*/VNB=.'F`\>,*;WOQW+29"9;Q"JW7*'I,D?=]OVM* M@DC5A@<0^!R&4:JKD02C^^W/SYM8;V.42F&FQ,-6.M*?ED-RI1UV(YU3,P61 MXP:VJ#/:[Y)IA"_Z(H]-GDR"S$2>9/[.%O48T`J$NU['$O,?_V>;PUAS4N)CN>O MJN2DPXWC(`SOMI%'$CM=H2_I?2I*=RMHKH&<6>P'$8BWQ?D^XAH8%#7U,+$/ M9^D*QC=O&Q@EXEJKC(8FZ'TH#!RSQ2V&,O*P](V_;V$4+ M63!DQVVGA8`8>F"39B1LDF1V0%'A3'@;+-(MD3]E;N$V MHQ@U%+`DP%J*MD/ARW;E&D?:W.4B'*?=>?"_CX8,7^!""*-'@RZO')#L)\\%AH7.[Q'(N?C#7Y#'(2=J]"QR3 MK&1G$Z;FR2N(_08/J7H;,^ZDY?;(-55[Y.8P)+#FNI@"[4YYDS1%F78; M5*/'*'%C?P$A'GX>+%?'SBJBICH=5XG-[PG=K#4O-KYZR>Y.GDA^@>KOY/-_0>G?84J*4RXC%ND7W]N3.<\YHO8`@)*P(%C7R`]0S:$?3F3RB==J^Y0*#SN/' M'/^L-LONFKAYP]Q$D)`/5ZQ)]R[ASG/F:!T\4;M?"G>U_C$4SF[RX.U)W02% M,RC)'ZGSY+$G.,?-U"^[.S"FMHWHLUO"7N-3OW1U"UH-LYTC>4&U#R2#/=,([;]3($OFY@@JLH3"-0"]3 M&8MVS.^9NG=[+JBQ-PX/DA8C#2Z^,_^Q_F+S!1;U@0:TWN*S=%^N8!R3+B%, MTVHMJJ.7R\):GPFMMN#2P8*OJK<61TGSCM).55?`V!Q9>C)X.9*`S6&ITMCJ M5__8'-EJZD8X5C+:'`Q[,I25;64VQ]@.%74)*UJG@%[;/DL;.='F>-^3/(7M MC94V1Q&K[EU9]V&;PXE5,3/H7FASM/)@/@/'F];FU$RM.!']'F:VQA>=[%'D M6"FMC9DTH--@.!9TBK8)`,*QS/!ZAQ< M4K@TGEQ[$RVYG!R'E?IZ=.$K-YM,9":]P2U3TIP09[6X88IXW^H;4\E5=ES# M)5R@&$[\?V:[E$6H^"$7^)_0KQBJF\4">OB'ZR#,"'1[FS^/04ICG'P.-3))?AX'0 M5=G9';(]S:Z\:WL)"^83NW>>%&)F@H3S@(V;N>74TSNX5*8_T\>DB*B81#YQ M?/3P/Y\0^9/9]`@=B1KD=^"R_0=F.9Y/NA;<]1(QH`#6TP;LGG>LI7Z1V%9# MA+/('.S"(S54=4/5M$"C0()13H"M^[0VQ%82C;J.U=J@V+Z4C>-SH^@32<9E M9J_?Q2F`U*$^MM>M0[^27:?O.4/YVBFX?E-PT2F(TU%^CBY.K$IA]G\N\([P MDY#NVHX-ZQ[L`=VB[XO-?Q.YS]&G\KU3)/[8[Z<3JZFL#?JWX2C5[[L6$2CC MO.].;M?HE(I@K!>>$1NGM=D*SOD;54UTW7(:C/.^&X91[X2I$@S[A%>V=([6 M'I\R*8KS^G9>WX/U^G:>ML[3]G1Y\2NWXS1*XR!*`B]_ZWG%0'N<\*SVDRL: MXXK&#/,<2V9C.<$!EZ;$.08YQZ!Q.P:=W.7!(>DL]>/2GXC2\%GJ5C;X#R%K M_&JAL=J@)"#A_J/]0CU)A=:6CCB7+R+/WW>J/Z&89=24SE<"C;M@0?*KB.Z: M6Q0W*8^=UMAIC8>K-1YO?@MFW&0^W"SBS'G<0->43[A!PZ35)MJF?44-D^X; M#-&D47AWTI)J7_&;$%>;+SQPV]PGBWJ'7`8Z][G?+L,?RZV9P:P\,IQV5LZLI; MV6HNX?7Q?*? M`MV^Q+>QNA+H$GS[^T:'HJ*UI>#/^SL=B:/6%H\?R'?2Y*[3)G#]C/U!!OY] M>@QA'W:M4S,?S9P;2=]%%DTYD3QFZS7(/])M$('("T`XC18H7NA_6,%^N*O_Z`XY0G'8H;[E*BE04J9)UCP<0*RP+/<\R\W228JZ\P;YPE";MHV-KE^$\Q\/=))QE[ MFMU.`P$/(%S[((2[0T-7AU_P1RR!?D^.?N$>O/9C.<_E\ZO,QSH2(CAYS8=" MNU`Z$70P0W_NMH/O4HX<*&AHFEY\A44)%@6(6NAR6_U%N'ND!S#K:,Z6AWC" MK6#%G88<(@;)D8)1<<65`0:Y/KF@`&%GD\ID.:U-Z7K2K#FS/:6B&EX22HO3 MYVTZGX#-KJ*2BA0")P-6AO1H8.^T!V$'PZI?4=,'[.-=FY)FNN M$]7"7\("-#@UQ-ID+CX'-!H4`;5#(Q"\K3]#C4J'\FT2*[QM+\W`5VY4=U*# M/>5TOB/F09+3J-2/X3'$MA\_'3J:*H9-\M_8\3S6]XC1X_I6V![KU`U(L5'+ M]N"H;MBU]6(;3Y15&U25#,FG3!5V5F#RC!V9R8H MV%3`#EOK1(ZHYZ$,,[S^+8KS@*LJ7FH1.DP_O4F,6RQ3%,F[XS5VT>`^>!EG M4?(:>-\G28*\/$:)2P^_K0EW#H;L=[-80(^$:I+B@[-%Y1=>&CC%030`?OVR M]B2^/;.9D2B3,%@&))TWOB-F\:\QRC;XA.PK.Q;A@0(W*/G^+N[*Q5VYN"L] M<5>]KE3HU2SN8V(5!W<-XT(2GB_I[CHBX]*W>_3\L`()29!UM^&'P[$;:B#A MUQAL$Q1)/%&\EN3J'O:SUX*P5Z^(WUD/*(LG0%8YG-(VJM@YAB MS"UY,_S++G8OP81[2W-1:E'4IL[;B+1*R]>#S!T?8X!3681*J1\45J M"C>46)"B8-GI+*F\K?AJ+@J5GJ%@C85C M=Y'Y+:%4M18VQ\0P!"*[7@<7=NXBU888@7'B2+4SJ1/0.II%UJ;:*63-YHB@ MEHZ+HP]64PH7@O%W*A1/U'*(PWC?:A2CT&J)0Q..N8$HD8!>OT%>\ M@KVNYL-S8AZJB^QM1DXX72\^H/C$YBMGT2%H?8;^NDPB9+'0@<(0'8;UG,D[ M%"U)Y:P[!*+D`6P%7G;,ID-)Q.V2B)^&?N>':EO"9J>U=ZIGE\O1%$[=_0'M MLNNH8R7A"VBG<5\>HD8_0$N=<.41DO)4MM..W\VPP)8?7/9%GD%+*,>[Q(L\ MV!H!$MR@^ M,+#H3?XT'F,!N=9(Y?M?,5EW*$EF$?X.&Y3@3:!B+1`,,YRUGH%AA#WE8[9> M@YC@>QM$(,+L=#B-%BA>YT?P&N(#25AL_Z?#.V][AD,+;I, M:WSSMB%7A::%'HXZG+TKIOL+3(N+D9P]I=VL,JZA3SW#W!8@.L6I5JB/I#O;K;.GOX4/1,9NMEV4@M!F@"5% ME$[FWQ$$3:FK(#O9BBV)Y5,RKXR73W7F%8/FE0Z!*^.QM0S+_J!+>5=P:L7& MF9&4.EQ5W7%+IYASBCFGF'.*.:>8TR^Q,.[ET2O<'"OM6.E>6>E+$(+(@X\K M"--DMG!.2GH89S4&>4B46\CRM]$V3I($*GY&J0$-N:04LY>YE![PF4_Q)R(C M;4CG+_#H^_8WT;EL@:*/QBVP&_!40EXV`)U#FW+1(_(%^X[7,*+)10E.K:YAG1+,*<&<$LPIP9P2S+3; MB0Q;/WH=FE;$:XR#1SC&P;[S3;O7LZ2W/..TWGG<"6F6Q//F+@WN7L M83M3EYS^BB@5&R[?28^7;T6!U*U4X3@?N>K!M[1VH3,*.Z/P28W"D^4RQKN' M)(H)\,VU`>%D36R^R74&9TSNYG+[-?)0E*`P\`&Q%]]=44-Q1RNQRPO>@I!K M^)Q.HR2-,[*![T&:D9UVCZ)TA1^-R9N!<.U)]3*Q"M=[=P8*DNVM/_2^9^%_?S7[J3/OVFNO* M1)7DV>/LJUH3TS3N'F3\(>=P`[;YD9TM*(^VP,PE>:1O@Y>FA/W*PPU\[=/H M"^9[GUYA^`)S?H7'"W0;<_`HZ/O\E;'.8]4HX[UV[<8ZBU4_X=FU?>QBL/-8 M]RO2MFH\U!"=*7A,M4#0Z33D$#%P#C,#=YA1E_M]&A1@TFF)L1[.],G.=](;5"JZKHDC*#'N]`N MZ)Q;J:*Q4T9Z$.^K^CTX=CSE2MZTU%0YCUQMX.Z5`\X55R^FA:+))8G4BFJA MM'3.MWI!S?7?SMM6$Z@'9B7G92N+J_.;Y7M\R[@G=?.&M0`]5Y6LFUNG@G9Z M[]7I4%35VH@ES1+8\0J.SNMX(%[''3*\.A?D4UA+ZTQ!F?]OCJG*\_OZ#S#V MR`9<\BRF"@-H=['^DA'<\%DF!R$A`6KYJ6+EW)#LJ)W$!WQT,.,`0L*A[J?# MH`3(;R13V-G\;B%42>V*O*'S8F>OSGFQ.R]VY\4^"B]VYT:NZZ/?@[=@G:V% M6[7>Q@B50=1,9:V-ADU6L`>L1ZW^H[:IV,?K\&=MT\TBR#TVARVT32H*.CEL M86*GS4&T%'FITM^-42<\!=460W0:=8[!SC'8.0:/PBNE-\=@2XUWVIU>[?3' MZ<'IU4XG&^?T>E9.KY:9V9W3:[F'F*)D>3_5)3_[,6#?TD<"J;7N$U)`,"-] M[(R&.I*WJU=G3=RU]FSP9?LJ%@#\Z7*MZ%^>%W[S]#I0V.X1^<0@IJXCOQN4(_@B79-ESN$%Q&D3+B>\'!6&5 M#/JV5!JVRQ>JY*>+;T%A M$_N2@3DTJ^5 MWMW7W>7`*MG9Q+JF$;Z9("'N$N*[&A)29S&#V``F-V_X-<37,3Z]\3:_RR>1 M?Y6MLQ"?YA=XLUA`CZ24V85FXXUTM2+:;QYO?IJYGV-A2@'G2>FU-B:H MW+^%K&J*E1P"8NE5=10-,3O"*;E2JGS'ODEDZCCD.FD@;0Y?8)2QYB]_<3+Z M`/C[EJ>S-!/(;$!K(52^(TK4]F?#6L>9=M"@=YU*IP"E\P9LY/8897A4=N`H M?$%VYI3I=#J'>-,DQ-D9,V>8$RO8,^A?0TP$B4M5]@IAI_7;`#SGOV>11P8L M0ZE#\#NH_S+YG9_F3W4(#9+R)'O.XG*NV6(1>/`RPQN2F*ORGWX#?'JE^VK) M3_C,G.D_\/^](N0_P3<@RE@HWUL#L5=X;\,HPD?PG/%SC-#WB0=\N-Y.,C][)@[:491LPQ>`B>*3K=*]'W*_P-=+ M?$=@7KB,Z1:]=*.9T[X?"@L-;2P3+!0LTC?I\P8U6] M225.G7Q?;81^`V$(M[NY\E,?/ZP0C((WP7,AW54#F3=K%&\GZ746D=MR6_[O MK_POWM3CG&V`[/KN8!V$>#P/-V?>U(^X\TOND7"'B#H#1'ST.@RF8RG!"_QO M&"/R?Z36R`/"W-4<`9])"G\1;8;103Z*H_V1R$]N\9>G-SZI35TTD/491`A+ M93=K&"]AY&V+PWH/O16^^[SD!3_Q\!M_2RAUUT$NYIO358*R='4-@8>(7FX. M5^`Y"(."A?X=:!-TD)MWX5HR01W3JR/740&40^%IO+/7NUPM]]B),E7" M/U%O0I`D@ER+G,;#H%N8?IC;7,,VO??(U1K5KM3=W\0"OV1''216IY@M M?LL%G0A?C!'$UZ*7I7N6C1A>\X)XUR!ZSN)MI0U_'1I'U[#8+YCA7-5$CIQ9 M:A96)#OJ(O$5XU2#;I(^9DO\#&-\OE^25RS*F8M)+*98>1R="\@W*CY8"_RF MYIQ%P3`_H5.;,D@7/L@ MA+5MNOO;%9\3E.JF)9DS\&#!1Y<;,^=Q!+F=A1UTD%01Q'6Y; M#S?4M5]N2S9&%*+99J2AKA@?KGA+[#6[SU1R$\21:;K>Q.@%BJYDK5.<"T9W M6.+7B$<^W%#7+NTBW7*PH:Y[&@4D.=$52OHY%'+CGP4Z'8_#\5A#7?5=L(!? M$^C?HKCZY_<=%L\=XH1DSQ95#6L' MX@\&,KN_?B5\\20M7\(\*5?CAF)V,KL.FFNGY/9X_D5-BY,?2BA-$R)?"XA5Z*R#5**$(^;.600?B97K M"45H`U9[SP'X`GR^#D&INTYRR?\]KH"/7O$+#']%^+,20PEZEG"7:#&(#M)7 M<+$(8%C:DO>.9RGQ8P>_0GRT!78[I>XZR`U@'`.\&2=$91B@NJ49SQ@!@6Y) MI;<.8G/7ET+[4IJE\&>/%9C%K.*E9_J M8^@A/'\@B2T,3TU26!>S38-Y\`)C`E33&Z`^1I^$JY.ID:@L\(@28/:?XBW:JMAM)"/F?P=3$_D*??P M>0;Q]P3?1<4_!!>80F<-I/X&8O\&+$ED(+$6?@O"$"RAFM^?^A@Z"(?$1X:4 ML6/[86'QBICC+B'P5K*>'6XR2F$EL5C*T*HP7>;0FEGS5=9*-OX^%+L M[*HLJ8I=EY`8BJ%E=0A5]Y^L(_P>L`_CYEA:N711\.PL]B@+GEKD+T7-L@Q2 MW5$3!R!3X"S+_M0=.$%4,45MW`*%6N@X16W<8D6CYI4"-6[AH85NG4(W;F&A MA3V%0C=N64'-=8*B-F[I0,T-8H_:QW&+"%I#]BBHXQ8=VMGH*'KC%B'4TX=1 MY,8M0RAD,*.0C5N`4,JE1D$;M_S0+J<;16_<0H5"0BX*V;B%B3;>N12[D4L3 MLIZA%+"1"Q+R/K][R#Z-6XJ0:5T6!2T<;/S M+=SX]]#],FZVOEWR8XK>N-E\^7SF%+%Q,_IJ::$I:N/F]F4345*\QLWTM\R* M2>$;MR2@'-U+@1NW4*"6:X2B-G+9H$5&38K=N.4%N?RM%*UQ"PHJR77VF/UQ MW!*"4C(7"MJX!0.5&'B*F9VB08=TO?BSX=_K8$.WU(8^;04QQ'LV0I/^I.'UN]2 M\(8BM-X6I%$URJ.W@GX6PNET*@/50_[%5C`ERN5E7-EPTY4'NF$3YA+)NQL=:8Q<[8F M9VL:*KQ"MIW'YIW.DF2*(9]##T5>$!8@S1842AH(Q`>U/4ON6-N3,#PMJ]KI MJ6$W\-7\XX/F@I#L:7)#U2&-\AT'"7E.VC66Y',UFP33+#?,(-=*&SPB^@"I M+O5@%,T;[U\D!S?S4_`;F@:;DO*TBE&V7-TBC%;Q*LGL*''_H0J:3J7@5`J= M5`I&5EEXJRC>A,Q.KG[QH-:AS`/I7DG.`H@>,(D>)E;P"$*85'HP<\I2IRP]+W@E?1R:W,-: M*$WQEPB0_YB".!T-C&SNNIVW_9\+&"-\&:>[MF.`D,%&.@]Z>5^E)F6,\Z.7 M\)*ALC[ M;B1:X(BML9%WEZ6JR6C,:&J57Y$5QT,CD M>]!\,]08E8/5V:J2=F:X@VW"/X:U[2%Y"=F>!X=]"8PV>(,/AVA[G=*>>%X< M9/F'\7*2[>F_`LD*2S[D?V[^E04O("2XYZ1MF]@DN;ZV\,?M,2;@I-M[F*Z0 M3_-,[(#B8"ON8V(5MR"(<\WU/03$VI3GRLC)D=LM\OU-K([&%,WBZR#9H(34 MH;A#T?(N>(%^'G>43",OS$C:GRE)0;L,\.U=_*""0Q\S&4$LPC!!C)-,%Q,?^@M\K3RX,68Z MLLB#E:M4[OLK#V/&5_<%1ED>*+B,`HF/)MW/B.)@A?GH2Y!`_PJMB4Z_T$OG M?"I)NH;QQU_C!3Z$(!(_I6U&\=$HGAI,>(T/I^T9E>6`$K#-MCMQR@$DJ4VQW4M335@.L$,9S?9T MP'*HJ&NO;/=Z=)9D9TEN94F>P]PQ\P&0^-$8/UB@\,>F\:D:'!*'9;`-T6G!3WRWY>[%L:H,E?5@BI<2J-1 M'#L^T_&9/?&9.98=G!8=M^FX32G>9A=*.5N4"70>L^=_0B]]0K-X\@*"D&S$ M6Q3O[(31\@Z"I)$%[3RLXTL=7VHMS^7X4FUFB,[7EV-6';/JF%4&LWH/XR6F MNYH-:1+YA2T^.&!;S09L7V8)_E1)\SEYA*+-KWD7E_`[]J4_\C1=!&1JPNSI]_%3< M!>`Y"(.\!F:29&OH2VU.W;,XV7$(4:/,@/:G5SS:]A9E<0IA5-GG]W#]S"S[ MV-1#"U'H:86R!$3^TRHXG"<1D";33S.!KS!\@F4F[V8VS5QWJ/1>DK" MJB+$N;0#7942H\E+P%4R[PJ<%\I+T1@NVU M.`5$#;KV@T;FZ!1]2A'IHGY..SU"_:.!:YM]TIQ`YP0Z2>Y9X@HG:5)-/9 M1W'"@Q=.?0!;O&TMXT;'Q'>=D,[]OF\0DH[;.9YH2.\6FR=J<7TZQL$E-,/]%3?K#T,DQS/8X,SL&ZN`!E#LP8^2UU5A,M>?'<9F.RW1<9D=`7)Q$N#%[R)%5UL6@]L&(\*@7,4AK4Z)#_* M@%8J[W"B,(!3I3C!Z11O0LO3.T8!PLF:K1A9E5MS-$*48T@=0]H/0VJNS.<5 MBO(W(@/A[#D,ECDXMYA"$/X=@G@7PK,M!5LIW6ZW,6WQ4K*;.6?&57.F?,S6 M:Y#K.XKZ/="_!"$^+/!Q!6$J76U3_P2G6/(TPE<&W%\*6E@J.`V'P+M"H'I$CV=G&B/G.B$GL.7 MK>'8CU$R5G0?D[E\1B,3.G[1\8LJ_.)_9B#&A(?;2@)A*KHZEG'(+*/PV]%K ML(&35!UE<"MMXC$E.SLVT[&9UK)2+:\*QWTV<9^R-Y-C0!T#ZAC0U@RHRP'@ MV%#S;"B-5!/O6K58;I6Q')/JF%1K.2['I/8>8:MT;SF>U?&LCF=E\*QSB'=& M0OYS$OD3S\O668C_P[^&F!+`L``00E#@``!#D!``#L7>MSV[BU_]Z9_@^X_G!G.[.RK#C9-IG- M=F1;3M3:EE=6DFV_="`2DG!#`2H`VM;^]?<`?(@22(B4Y(3:X4RWD8GSQ/D1 MCX,'?_[[\SQ`CT1(RMG[D\[IV0DBS.,^9=/W)Y\>6MV'RW[_Y.^__/E//_]/ MJX6&0W3%&2-!0);H-X\$1&!%T`@_<\;G2_3@S<@<_XC&6!(?<89^NQC>H%>G M'81F2BW>M=M/3T^GQ)]BT>(LH(R<>GS>1JU6HN%S9,L[]-/IJU>GKS,E0QXR M_QW*/KH4!"N@1CY8\0Z].NN\:9V=M\[>C,Y>O^N6FB^6@DYG"OW@ M_06(S]ZT@.,<#4^'IQFW_A<]<":!>K[`;(FZ08"&FDNB(9%$/!+_-!8JC;<( MJI#)]R<9!Y_.3[F8MD%%I_W;[4U4*R=__A.*:-\]CT5`USCTDX3GO$V95)AY M),,"=?75P:&+=:5GE5@LL5F=MV_?MDUIACJ4K2G&BY1^@N784,<%H*;SNG76 M:9UWUKG4";J37+PIF@RD!!DW=>K1$S"$TXSW?>5Z*M];2!J`54 M1%`OR[J=S^+1-/[*O&P]OVE'A1EJ#U"IQ'*=7!+O=,H?VW&A=NK MM2+6N#2__GQ"\]F@()^#/'NS?!9=DL]#V2.1*I\K*LOWC&'JR7PV4Z2Y.A:7 MI%X^#Q04<*B%*&"!DDT>A<64J#L\)W*!/5(&?]"^S0E3UUS,K\@$AP%4QG]# M'-`))?X)PDH).@X562,(V8KD%RWE9\P85Z:A,G_K)XL%91,>_PD/]-OX3O"` MC`"42/_X-.P7F*CBUK:MR=I7W`NUD9CY/::H6O9!L)@;=2>(^N]/G!2I"8D1 M/IE01HVQG;,.:J&$/?L31*%(%LH(^[F]*6%3>`C=PH#]8GY[./#"P##>P-\Q M9VH%S95DQ7_PTB<4A0O0`MAH@#2;7E$'#3G%PSZ4QY!/S`BRE M@4MK2'#0DYIZL-`]*Y3+*(9#D/.?_>2X(WT.X4WEP^_+P=W#X*9_U1WUKM!% M]Z9[=]E##Q][O=%#$^87"/,]AN9>S8BB4&&'BKD1NB7PK\L''OVP9N5?&B!L M!4(?!M-SLHI-WW2;NFPD0JD*WNZM7.Z0OG&%]&$$_]SV[B"<@VO4O[L#.[)O M*T2V^_`17=\,OC3CZX(0WG%%Y(BGP^"T8N4#G3(8!7N8J:YGDBZ43>]Y0#T* M'.19703<^YH)[MZBG&'OG.FY,I5>P&4HB,9`.)]CL41\@C(*T$H#2E0TP:\: M_"&!"B`^-(-J.1*82>R9R<\J`-404$6>&P:=31@8T5K6C"[0$U4S].GC@TFF MQ$J1T8JR:AM`5`7$+1%3Z)J['O3-T4190@<-@5C$\^9,*"NV#CN*=L/DU29, MLN(-.K(*&CQ4Q<,-P9+(P>2&2$G(KLW"=BGN*)]O1CD2V(2S:CBOR%C!2Y>6 M])E4(HR*=HQM19'N0+_>#+26;E[C5#[**&@`4'FTIR`(:_,O3;MK[,M+"3P6>-]&O>]QX8)MG$%WMG>?!'P)2$7 MA(&EZCZ`D5,U`%02Z,;`3YL8Z$.H87S_"/'6C.?KHWJJ5_8E<[PC/`Y*0J.Z5#+OE>]$.DJT')-TK\5@#,7@KGB!A7?)'-8`1,[B'4C8EL6L8'`-T@G5@!`9:'N M\!\FM=B`Y(6S4!4`4DF@&QQ6UM'*2#6!WW9@*JV^>/(^F#AS!%W?-T:N12T^ M67404>Z(6SG("BD'F$6D&M=:C!^NB,*TV2VZ'2/9*?P7F,'#!!XZ^:+,02FL M'$*D$S/G.1G+'1(1#7KV1D_OF4K]2IH9W8B(N3219N0)!X.%J>9K+GK8FPTF M$)&/7"ZHPL$U]J`;5VF*\Y`"WDK*SH82&U?ORA@5AIB#FRF*6ZLS?4L:!>#EX M8D3H`66?P0242+6)B!(<[JA;J=%4(DI$HE0F2H0V,?U&+8!SB'%(T6Z46.G2 M@[4-S=!B1US]&F)].0Q6YAALVC=WQSQ4F9S%)\;'^D8MG:_JLT6HI$E=;4)I M3VEN]%C9UOVT-2`I#9)HE;/44--%Z@ZOE2^-UU:;X>/^V5-O1OPP((,)=,9T M'LZO0P6/+Z!^ASKK?2WX_(XS3Q]W"/2[$56]E3G=48P[[G;6-%:CNX1YI`A- MC"9S62$29G%U`LJ0ODINI0X%\6I\`XR2P#"+Y&5>ZV)"9W!?6^E-LV3>O-*' M6Q`9DFALI->V`ZK?A:'V1_;9I;XGTR2(=>K:Y&X&DTL@I:H[%<0L>!4NCNPI MUHT*U][,1#%::4:1:D096BF/I0&L#02%\]2-GTE@LU MQ5,B>\]>$.HG=T3I=_=>D#D-YX6XJ2+##1(K&9D!248+2M7\B%)%"#1%34VL MJX%#^9GF%-ZA*58$WC7)`ZHO[/63/MG7E3HD"[S,:SVJL+J#;Z<8$]$H*SL= M*_A1M%/Q3;Q?(M[N-,*N^X,BW>%H-CB60D`9%G>XM^ZS;`*[=V#CI=P+`I5'NO[_ MA?$UICPJB#/"'Z#.>Y,)C,%'_(H&H8Z!?ML><4#T-?@;H3^,4#ZU7\FPJ-2IVCB\@*8;&5S M`\'*("9`R$X73/>PDIS2-#$N&^,O1']C@_C=1R)@WC4D?F$]$]I2)M3ZVFQ0W2*Q\:JPE72M? MHE0/2A699L:H2@`3*6LP\<*8<*91#B'2C18KL;HG6IK\RH[H@;&!3Y@TBRQC MRHAO?5<"0KV!AZKMS8OH<./+RMVF-J#$B,Q-V]!=1788@&U"T89@V#18-8.< MLSE[>85N,%KIXY<'8],>'@J<%SC0Z=N'&2%*W]UPX*9P3_%NX%D9ZAS@Q0:@ MR`*-OJ;]^T:+73#1AJG3`@?=N:Y<>162`4N6DLWYX'N\U)/LB^4G:!%6"TTW M-Y_`)D8A8Q6*S4+C)5HW#&G+?LR@ MLYE*U!F9Y=9NOXER-V:M=/XWQVS3@>^:9=NXJK5<%JT4DQLSVV]X;3)@^XKD[:-NO;&UB4WF+=[_?+W.U:M'6[K+LSLC^9">MDRW=(+_T MG:Q-]%\J^LZQP%ZRW+BP]_WNAHNF@][YBA08#7EF4(KP*PT-FU*+$W_W]BMN)V$2`Q?T\%H'A?W5V=AXA<*/^8JL2 M"3-!)N]/PIEJO3KKO.Z\.N_\!QA.G^=!0J&HTDHN5V*0E@-#>1P$)^WZ.KX> MQ>U^`WV.WU>IE"-Q.\!C$I3S&$AS/+[1`H[$VM\\[IL_1C$ZM8L*KH:A8D?%4MF&`Y-J)"V=)(D6T=C=99!P04 MVF#T9SFG&"\,8YO`]"25U5K)JEX=OA)M+:6M#S.R<$X$]V MR4B)I99Z7L:\ID?NVEGYH+:BL#(L,6_]X+#@Q3SS26G2I&K+BBGZV5@.HF2.I5-B#A MT3_V4ZX6HKKVA,G\*M!/@FC161OP_J3KA8I MHK)QM)`+!61,U8%J\Y%*+I;IB>;>\X)&6J_TU^PSM;.%,.OM])8S-;O"N[I[ M",<`JSA(K+XF^B:A>R+T>1X\)8-)O"G$7$ M5JE2HK'P@8)M7'D(Q^8&BV@+RJ:CFZ4O!V+/G*4_C&/0L,[(/T)FSNS?@ER8 MV=\'^'>\7M+]W6KP*G/6JBV$8C95*\/3*:;EYU;*6OFE;K'X2E17S>,SE;9# MQ22U\B0WJ2M/742 M'44'>"'&N0W&/^&_)PZ6D&=L-:&5F.H$X2+#74U.%9YZ^4K]*7G"2]NAC8)Z M61TR^42]K]!6<,\<#K/M+R2IE2>AI(S(["?^+KF$>5]R6VA/7PZ9_4`#3(ST M!MQL^[*'C*-H9&W_H*>@<]V.9AR-2IS5XF([CH;8]FGS+O0;(-!VNP'BX,I6 M!#@-C5B=WHY-PS,WN)9T->;XQF[ZZMULJ6?HX=A4M-OA:'.]T:!W#$R9/BK; M]_5M(1.JM96XT_B*&)O5^F-"_QQV M.V6=NI3(VH>%AK3,IASRW7(0ULLKDR']`#;8?EA%-;5<9_8>9H"@7.,SI6M) M/?/L^Z4Z+[&<0?L)3>38L,D^C!\\:#S2LV^"SPL/_&8]W4_.,0Q5+!_U?K)) M=,,!FT*[X1'BRUTK;!=A1U%K>C6(,8J#CR!,YDZD;K#\3*98WCU:K_].W+5J M(4IX,&#$-?_<0T3=:@(&)@&.'4A,-]?HDN<\KTN0U\K#F4YWB;'@_&O7PSZ9 M+[NA'XXYNX?XR67P""^NW557XJJYOW?DZ4)`IT>KNNQFK+_7BC_MX'(15\W] M_?3DS:"GJ.BO@ZM>_D)#(PB3EP%EU(-YT1VTK+,G\"=NBO(W0%3EJ['/6URK MI0?QD77+](WG];(Y.?A)]>F$PI&>[5,UOEKY')UZH(^K:W($ MR]ZL!NK#HL^UK]RKRK?FLTJ>?[\YH[$_2@\-6"87ESU>L^'M5NJC2-!J5U;! MNN2/!")HOA?P0,0C#,:E?F8N?M2VK-=!)<;Z[/LI-GW$DXUMZ8ZF,A[GLNWG M[\'176RYG%T'_*ET>"V6N@=VA-F4@N`[HK[HP[*+5:A M_OJCV7<([?*_"!9%;N?39EV>ZD>FN"X0O@MUUSF8])X5#.!TRYN]X=CVL9@^ MZR>%D>R4B+HX><^53A?@0']N)[7\WB@OENBDSF*[F1KQ_$" M7<1+^%#8%]2ZU?=VG'-4YZS76%T2H7*6PXI3SQ58ZN?I9QP$9+F6=@`\8GW/ M#F6W>6/NTSXKWY(N!+0BX((Q.JY$B$R=?,UYQQ4A_'=#AUQ5KXSBFJTZIW M:M[&!J/-Y[7<1G3%/3-\U1^$,'O_UCXL'1F5<:D4=9U>I\>Y5[Q;)[^T3BUR M;ZY/NJFKD.E]T,ODWP_6`LE6PEIY%7T6+?N9K)R6VDU5(Y#E&'H'ANIS%^;? MY0-YM(]I5..J>?@VFKYBBEHV@MFK.Z-3)M$-C3C0FQSUAJL;+N6`17M#<0`* MI`74RNQ'T2WG^R977V7)NUPZTRN8L.KG7J%/QR[>'WK0=Y;T!^TJS`^YAX<.HRTHW@]D[."0SUC M"\E52$8\YWA9IFY* MGW$0DL'$[#=:7<>T\F<[Y1&\\-=X3H/E%?<4%[GG`!YF`@"JKPV[X1J3F%F) MIWUDU"FI<4U\Z.&"WK/^+NT(/P_7]IWEE]9HHU%LX'7(?!E]W9L^$K.VMAFO M;82U"@K89M)@^L='+/QEU)-P8>5R2Y#6TC.UM`PN=,U!6S??_DT$U__I"VCN M.0_(D&,__]Z+'&^K<]?*?RY8NNQK%OFC)R/K5-)VRGK[M=V?6OHA"$F^,=Z; M$S'5][9>D0464=]M>562OE8^JN=;/KZ?P6AK],1O%I9/!>7U]<'M02WMU]\N MS,Q]+OE\3JV!I(OH",:0>GDCOJEJQ*^H=@,$""+OB!I,8*BTJMD5P1[7B8XAF469'J/F(Y=FFV[O$;,H,GWH<7-FG`<0 M5:N:B8VUWD6KH$Y6KZ_MF[LF]8`]=Z=#&=J:^29TFNJ*1/_J2[>E/J"A_UGM M?)0F:ZDAGIW,0R?>M(3_$G&UVKIV\ON!4Q+J#]<'V/N*^J=\_,`O!*IA]CV8\E("T MHBNIMU/6*6#_)%"E2_C?F`=^?/V&TG<17^K944[*LC1#K;RDS(>N*AEE7LZ@ M59ARW2R(]*]^`,YP:KUSN_#6R?<;_)7<G=]&#YU_G-I)9"TK?^=SU%M&)DL8/.KW/%$:=<3<)TTZK*RTFJ5/_>8O% ME+(!,]_C6-L(8I?4:!/(K:=G>FS]?KCH6>YW-\K2URHT7M>VV?*KF*96OF0- M'$R^F#L.=;:.Z6TY7JC2/50Z53J:P8CM"K-Q*)89&LOY0PH]JMJZIL_$WW8A MP7Y2:E@?Z_MA['?<254O?X0`*3=+YIET-[]3MRHG?BZJ.OES]__575F3VC@0 M_D5;^P?V!9ACIRH)V4"29V$+[%JP*,GFV%^_:LFW9%LV,+3>9JQNH:]UM_H` M*U>ZW.:F\_),S_9Q<+5X=@U3-G`A<-CZ1HUUI_8)52_0\P]Z8ON34L>`:OZ- M!.J!I+P!5RE6YXQS=I:4\+)R)-=EEA:&/\5JD/LCFN@?^C.>272"=%`B94D` M;V]@(ZOSF`2!K"LL?&#D^M/M_S")V8MGJ2YDA6_:L`PJ2C\!VU]D>W!W,?CP MLF:"*5Z6JZ>+C\0A2\7-%?DMK1%+10^/IQ.F`+2.8JY26EZ+&!%Z)7"21@^S MGV)YH5MYG*7A(B)\1\4[8^%9_DRQ-6C?P88G^PU5>#E[9!?G06';'ID.I'X. MBN((J$+^I]3P?79F\!-^%^"Y,*%"FX7\48/625%?A)X> M#+UHIEQ8.0U8QD6I"[>`L5/="NB>8:J+EG[/>`#N8F&I!C?1V&A0=DYUYJG& M49%\UX353XT4H#(B,?(+=)5C''%K3F`,M8UD.HIQ6DTY2?Z\>P9ZXBG M%3+E!LGTU.2#@(8[NK(#;!H\WEQ173Q/CK4S@*6SCR?*QKD^7T0$>69&K3.N M[*BW(1N(\0O+R%JP202((45SZ^9D%&"Z'>G&6>(X&`6H6@W.E7`(4:%U>W(4 M#!(VS`2?G+'@.]D?0K*GC<`S+L93HQDQ]:6M\<6WA>$ZYT:-&5]UT4O"U5&N M;,(H&0(]H@HO).&,%R%Y7;]VVA&/\011,,#O8<&U1@/HA4$]J"\)[Q.+Q$J-)0$5(E>@.#$5.2276V73=2*QJO,C>;T$5`B(8\5W-'V)P2UGH^J&Y%QO MC)=A4.IE]=7I`74W3IU/S1591U?&HR@VH@IA`[@$5L=C%]7DRG#*9GE.*!=1 M?"R,F_*(:6H?IQW#99`))U9S.'_-1#JGT'\TI.'\.G+:W%0A5AE=]!H`]\HU MFU>MIC#Q\W"^>3&YO%[HX=@]6:;7=IMT'K$(ZS<%[0XD+ MEJQX=HF;@[O\5C^,?H[/9Q@?=!KK;I]/W<`7M2NWFUU\1;:!RXHMRC.C`%^K MUZQXG?Y!Q5%'[M:F!+DW!5S4MW(#4!]!JVF,I$E5X%)_YD!,1:)1@*H'M>75 M(HKW(:?)*Q%Y=N`%X70@F?`47L38A0V`VY7HUHI028730YP=1'Z"?Y&_:?C$".8Z)-"&IYCEF6KN)=$F_C M0%+\3-@&+(WUN?J868.5W*.N3S[_/40TK4`GM];S^4=BAS`H$A27,WI_M66X MLH\-)WI<_=_=9+./!VE1]N,/DL@KLWE3:'_'M"ZKMJF8'M96-TKPM=L\T[>_ MHVIS:5,["X+LD"F-6SW#:[^UE!UK&4V>J$'6N]W#-L2=C156`7 M9EI;C^?$=-YQ;?UR"_'$Y<\$33WC5'XM@TS\`7^(4L.P>KHXZBD%['>6/AI< M2Q7\?&'^!FJ=.@:S#)?&IV&MIW1252B5MFF]"RUV=%_)!0SDQX#L9$&'-84J M9IR2Y59I-QJ9B;O**RT]D27/;7^G9^YC''$?[]&@0A!INQC0E=4!M0J\4#GE M*77K,/(//C7?W&D:GU%M+DS01+9J5^AEG3R4QW&AQBM&V]'>4`4F2:SDPD3> M:%V;J0"L`I:F`@PKS7X?PX,0:]7,#F`F`2H4043#3.Y.VU(;LV`G%2]!Z]0L MT0G'\#2P(HA3J&*<_IVI;`6KB(3L_(4D<#]Y9W+>J` M"I)R+1.J;"O7+&%'$GTAXA?=$?&-GDAHV,B/XT*)5R4B*[NQ[$.V*3&<.E&/ MX$6%'9Q/('YU",\NQ=5I'"1'N]4![("_IW+G>Z M^\EU_"]7ZH'G^]9]`GKP5%4^JI\J\]JOWBCO>YK*ZF7K0XBL;+$:%*:'YC`E MNF$DEMLY3:@\2*I74VW:/F,AS'A>N\1?=;R+X(OZI?-N1T`@)C$@\0>J!,7,54+CJ#_F@#9*BZ3S55 MWNYG$#TN9@U-#8.8H\3T'A[%A`MM:74S"P*PE8<`19".0':/Q7C%E1[3^M/7 MY);QB@LM2N,5=1V'*'K:L0YL*5=7>;8_U%/"+LCAF)ES__1N"EPX#@"6QJP?_3M.:X, M^%&.!>D?QG$(<>-;YVD?OM'T-P2/KK"8)1Y:5*,9E0_CDY`==T^&NP.H%<.%'%D(,,WLE>]V`-,J?[_?`"-8H+%5Y. M$D&4N\:"-7*UF26/VUKO>,+*1$`20_0?'/*3KB]&Q[F1H^HQU>1K?:4LKIY. M!JI3^5')X"S_OKZQC*>4)C4_-`/L$"$N5&P=L4R0)%0+2K/%YJ+C1HX5X9GN M3]057R/Q?S0T[0\ZBA$]^?U, MX*PDR%X_::WDW2@.Y`J>&,$HARDQ#::.UBZW+_+">P8#%F>$5AY<6%M!(.J0 MC")JMWB;7M^E4'L"RT]BQF3)]"O><%+H$L'WEQ\S ML8@X))YH_&.]^4WCQC1N^Q`XG<4F5X!+"B(ME#-KL(T):/X"SS;Z#U,3/88' M$];?8+!.=N`Q`V\^OZ#&';4_UK8@3V!%A5S>:&734M"X[M2MH9F,,PD[C4L, M2=Q>E4>2&8G>0X2_94=!NH4Y)4'TMI>'1=.?Z(8JGBB)O_X4040/1/[Y/U!+ M`0(>`Q0````(`%&UL550%``-6B?E4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`5S!F1O[:64V8&0``FWL!`!0`&````````0```*2!6/X!`'5H="TR M,#$T,3(S,5]C86PN>&UL550%``-6B?E4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`5S!F1BHL*:[*:```K\T'`!0`&````````0```*2!/A@"`'5H="TR M,#$T,3(S,5]D968N>&UL550%``-6B?E4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`5S!F1F@_H8K5R@``EN@*`!0`&````````0```*2!5H$"`'5H="TR M,#$T,3(S,5]L86(N>&UL550%``-6B?E4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`5S!F1K2QWVV/;@``H!`)`!0`&````````0```*2!>4P#`'5H="TR M,#$T,3(S,5]P&UL550%``-6B?E4=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`5S!F1CH\[2I>(@``M8P!`!``&````````0```*2!5KL#`'5H="TR M,#$T,3(S,2YX`L``00E#@``!#D!``!02P4&``````8` ,!@`4`@``_MT#```` ` end XML 27 R50.htm IDEA: XBRL DOCUMENT v2.4.1.9
Limited Liability Companies Accounted for Under Equity Method (Detail) (Equity Method Investments)
12 Months Ended
Dec. 31, 2014
Suburban Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_SuburbanPropertiesMember
Property Owned by LLC Suburban Medical Plaza II
Brunswick Associates
 
Schedule of Equity Method Investments [Line Items]  
Ownership 74.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_BrunswickAssociatesMember
[1]
Property Owned by LLC Mid Coast Hospital MOB [1]
Arlington Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 75.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_ArlingtonMedicalPropertiesMember
[2]
Property Owned by LLC Saint Mary's Professional Office Building [2]
Grayson Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_GraysonPropertiesMember
[3]
Property Owned by LLC Texoma Medical Plaza [3]
FTX MOB Phase II limited partnership
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FtxMobPhaseTwoLpMember
[4]
Property Owned by LLC Forney Medical Plaza II [4]
DVMC Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 90.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_DvmcPropertiesMember
Property Owned by LLC Desert Valley Medical Center
Effective Date Aug. 01, 2014
Santa Fe Scottsdale
 
Schedule of Equity Method Investments [Line Items]  
Ownership 90.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_SantaFeScottsdaleMember
Property Owned by LLC Santa Fe Professional Plaza
Effective Date Aug. 01, 2014
PCH Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 85.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_PchMedicalPropertiesMember
Property Owned by LLC Rosenberg Children's Medical Plaza
Effective Date Aug. 01, 2014
Sierra Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_SierraMedicalPropertiesMember
Property Owned by LLC Sierra San Antonio Medical Plaza
Effective Date Aug. 01, 2014
PCH Southern Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_PchSouthernPropertiesMember
Property Owned by LLC Phoenix Children's East Valley Care Center
Effective Date Aug. 01, 2014
3811 Bell Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_ThirtyEightElevenBellMedicalPropertiesMember
Property Owned by LLC North Valley Medical Plaza
Effective Date Aug. 01, 2014
Palmdale Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_PalmdaleMedicalPropertiesMember
Property Owned by LLC Palmdale Medical Plaza
Effective Date Jan. 01, 2014
Sparks Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_SparksMedicalPropertiesMember
Property Owned by LLC Vista Medical Terrace & Sparks MOB
Effective Date Jan. 01, 2014
[1] This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December 31, 2014.
[2] We have funded $5.2 million in equity as of December 31, 2014 and are committed to invest an additional $1.1 million. This LLC has a third-party term loan of $23.3 million, which is non-recourse to us, outstanding as of December 31, 2014.
[3] We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014
[4] We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December 31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December 31, 2014.
XML 28 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
Aggregate Consolidated Scheduled Debt Repayment (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Schedule of Equity Method Investments [Line Items]  
2015 $ 107,646us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths [1]
2016 13,600us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
2017 50,399us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2018 22,658us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2019 3,463us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
Later 14,866us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Total $ 212,632us-gaap_LongTermDebt
[1] Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
XML 29 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
Leases - Additional Information (Detail)
12 Months Ended
Dec. 31, 2014
Leases Disclosure [Line Items]  
Renewal option term 5 years
Minimum  
Leases Disclosure [Line Items]  
Operating Lease Terms 3 years
Maximum  
Leases Disclosure [Line Items]  
Operating Lease Terms 15 years
Number of term renewal options 5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
XML 30 R52.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Schedule of Equity Method Investments [Line Items]      
Revenues $ 17,292us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue [1] $ 21,001us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue [2] $ 21,448us-gaap_EquityMethodInvestmentSummarizedFinancialInformationRevenue [2],[3]
Operating expenses 6,769uht_EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses [1] 8,705uht_EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses [2] 8,974uht_EquityMethodInvestmentSummarizedFinancialInformationOperatingExpenses [2],[3]
Depreciation and amortization 2,968uht_EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization [1] 4,039uht_EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization [2] 4,140uht_EquityMethodInvestmentSummarizedFinancialInformationDepreciationAndAmortization [2],[3]
Interest, net 4,261uht_EquityMethodInvestmentSummarizedFinancialInformationInterestExpense [1] 6,353uht_EquityMethodInvestmentSummarizedFinancialInformationInterestExpense [2] 6,056uht_EquityMethodInvestmentSummarizedFinancialInformationInterestExpense [2],[3]
Net income before gains on divestitures 3,294us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss [1] 1,904us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss [2] 2,278us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss [2],[3]
Our share of net income before gains on divestitures 2,428us-gaap_IncomeLossFromEquityMethodInvestments [1],[4] 2,095us-gaap_IncomeLossFromEquityMethodInvestments [2],[4] 2,365us-gaap_IncomeLossFromEquityMethodInvestments [2],[3],[4]
Our share of gains on divestitures $ 0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal $ 0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal $ 8,520us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal [2],[3]
[1] As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014.
[2] As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
[3] As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
[4] Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.
XML 31 R61.htm IDEA: XBRL DOCUMENT v2.4.1.9
Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Real Estate and Accumulated Depreciation [Line Items]      
Beginning balance $ 395,669us-gaap_RealEstateGrossAtCarryingValue $ 401,474us-gaap_RealEstateGrossAtCarryingValue $ 363,498us-gaap_RealEstateGrossAtCarryingValue
Impact of deconsolidation of an LLC   (13,185)us-gaap_RealEstateCostOfRealEstateSold [1]  
Impact of consolidation of eight LLC 84,064us-gaap_RealEstateOtherAcquisitions [2]    
Property additions 3,298us-gaap_RealEstateAcquisitionsThroughForeclosures 3,415us-gaap_RealEstateAcquisitionsThroughForeclosures 3,985us-gaap_RealEstateAcquisitionsThroughForeclosures
Acquisitions 13,674uht_RealEstateAcquisitions 4,065uht_RealEstateAcquisitions 33,991uht_RealEstateAcquisitions
Disposals (10,116)us-gaap_SalesOfRealEstate (100)us-gaap_SalesOfRealEstate  
Ending balance 486,589us-gaap_RealEstateGrossAtCarryingValue 395,669us-gaap_RealEstateGrossAtCarryingValue 401,474us-gaap_RealEstateGrossAtCarryingValue
Beginning balance 97,921us-gaap_RealEstateAccumulatedDepreciation 87,088us-gaap_RealEstateAccumulatedDepreciation 74,865us-gaap_RealEstateAccumulatedDepreciation
Impact of deconsolidation of an LLC   (1,588)us-gaap_RealEstateAccumulatedDepreciationRealEstateSold [1]  
Disposals (5,859)us-gaap_RealEstateAccumulatedDepreciationOtherDeductions    
Current year depreciation expense 14,413us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense 12,464us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense 12,223us-gaap_SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
Other 5uht_RealEstateAccumulatedDepreciationOther (43)uht_RealEstateAccumulatedDepreciationOther  
Ending balance $ 106,480us-gaap_RealEstateAccumulatedDepreciation $ 97,921us-gaap_RealEstateAccumulatedDepreciation $ 87,088us-gaap_RealEstateAccumulatedDepreciation
[1] The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
[2] During 2014, the Trust purchased the minority ownership interests held by third-party members in eight LLCs (January and August, 2014) in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.
XML 32 R47.htm IDEA: XBRL DOCUMENT v2.4.1.9
Options Outstanding and Exercisable Options (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Weighted average exercise price $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
Aggregate intrinsic value $ 438,430us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
Weighted average remaining contractual life 1 year 7 months 6 days
XML 33 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2014
Summary of Significant Accounting Policies
(1)   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings. As of February 28, 2015, we have sixty-one real estate investments or commitments located in eighteen states consisting of:

 

   

six hospital facilities including three acute care, one rehabilitation and two sub-acute;

 

   

three free-standing emergency departments;

 

   

forty-eight medical office buildings, including five owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the three Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

 

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2014, and will be amortized over the remaining lease terms (aggregate weighted average of 4.4 years at December 31, 2014) and is expected to result in estimated aggregate amortization expense of $5.6 million, $4.5 million, $3.9 million $2.5 million and $1.9 million for 2015, 2016, 2017, 2018 and 2019, respectively. Amortization expense on intangible values of in place leases was $6.1 million for the year ended December 31, 2014, $6.0 million for the year ended December 31, 2013 and $7.8 million for the year ended December 31, 2012. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $14.4 million for the year ended December 31, 2014, $12.5 million for the year ended December 31, 2013 and $12.2 million for the year ended December 31, 2012.

 

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

 

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July 1, 2013 through December 31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January 1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.

 

Effective August 1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January 1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August 1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014, as discussed below. Each of the property’s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.

 

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $469 million and $316 million, respectively, at December 31, 2014.

 

Stock-Based Compensation

 

We expense the grant-date fair value of restricted stock awards over the vesting period. We recognize the grant-date fair value of equity-based compensation and account for these transactions using the fair-value based method.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

 

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $25.4 million net gain recorded during 2014 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2014 that impacted, or are expected to impact us.

 

In August 2014, FASB issued ASU No. 2014-15, “Preparation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, “Presentation of Financial Statements—Liquidation Basis of Accounting”. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.

 

In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. We adopted this updated guidance in 2014 and the adoption of this update did not have a material impact on our consolidated financial statements.

EXCEL 34 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U M86$V8S4T,C$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E M;&%T:6]N#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D%C<75I#I%>&-E;%=O M#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E86Q?17-T871E7V%N9%]!8V-U;75L871E9%]$93PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D1E8G1?86YD7T9I;F%N8VEA M;%]);G-T#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E%U87)T97)L>5]297-U;'1S7U1A8FQE#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C<75I#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M5]O9E]297%U:7)E9%]#;VUP;&EA;F-E/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]O9E]/=71S=&%N9&EN M9U]-;W)T9V%G/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I=FED96YD#I7;W)K#I7;W)K#I7;W)K#I7;W)KF5D7T9I;F%N8VEA;%]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I.86UE/D-O;F1E;G-E9%]#;VUB:6YE9%]3=&%T M96UE;G1?;SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;F1E;G-E9%]#;VUB:6YE9%]3=&%T96UE;G1?;S$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E8V]N8VEL:6%T:6]N7V]F7U)E86Q?17-T871E7SPO>#I. M86UE/@T*("`@(#QX.E=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP M/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V4S.3DU8F0T7S$V8F%?-&$R95]A-V,U7V5D,35A M839C-30R,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E,SDY-6)D M-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L'0^1&5C(#,Q+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q-#QS M<&%N/CPO'0^1ED\2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!6;VQU;G1A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q M-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A-F,U M-#(Q+U=O'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2D\+W1D/@T*("`@("`@("`\=&0@8VQA3H\+W-TF5D.R!N;VYE(&ES&-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4L M(&YO;BUR96-O=7)S92!T;R!U'0^)FYB'0^)FYB M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F965S('1O(%5(4SPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'!E;G-E2!C;VUP86YI97,@*"),3$-S(BDL(&EN=&5R97-T(&5X<&5N2!I;B!I;F-O;64@;V8@=6YC;VYS;VQI M9&%T960@3$Q#3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!-961I8V%L($-E;G1E"!#:&EL9')E M;B=S($5A2!M M971H;V0@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S:7,N(%1H92!Y96%R(&5N M9&5D($1E8V5M8F5R(#,Q+"`R,#$T+"!I;F-L=61E('1H92!F:6YA;F-I86P@ M2`S,2P@,C`Q-"X\+W1D/@T*("`@("`@/"]T2`Q+"`R,#$T+B!0 M2!W97)E(&%C8V]U;G1E9"!F;W(@=6YD97(@=&AE M(&5Q=6ET>2!M971H;V0@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S:7,N(%1H M97-E(&%M;W5N=',@:6YC;'5D92!T:&4@9FEN86YC:6%L(')E2!O=VYE9"!V87)I;W5S(&YO;F-O;G1R M;VQL:6YG+"!M86IO2!O=VYE2X@3W5R('-H87)E M(&]F('1H92!F:6YA;F-I86P@2!M971H;V0N/"]T M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA2P@ M=V4@8F5G86X@=&\@86-C;W5N="!F;W(@F$L(%!H;V5N:7@@0VAI;&1R96XG M2!#87)E($-E;G1E2!M971H;V0@87,@;V8@2G5L>2`Q+"`R,#$S+B!02!W97)E(')E8V]R9&5D(&]N(&$@8V]N'1087)T7V4S.3DU8F0T7S$V8F%?-&$R95]A-V,U M7V5D,35A839C-30R,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E M,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D(&QO2P@=V4@8F5G86X@=&\@86-C;W5N="!F;W(@F$L(%!H;V5N:7@@ M0VAI;&1R96XG2!#87)E($-E;G1EF$@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S:7,@<'5R2!M971H;V0@87,@;V8@2G5L>2`Q+"`R,#$S+B!02!W97)E(')E8V]R9&5D(&]N(&$@8V]N'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA3QB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,CD\ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PY-S4\ M2!I;G1E M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6UE;G1S(&]N(&QI M;F4@;V8@8W)E9&ET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S M+#DU,"D\6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I;G1E6%B;&4L(&YO;BUR96-O=7)S92!T;R!U6%B;&4@=&\@<')E=FEO=7,@=&AI2UO=VYE9"!,3$-S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M/B@R-2PT,#DI/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2UO=VYE9"!,3$-S/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XT+#6%B;&4L(&YO;BUR96-O=7)S92!T;R!U2`Q+"`R,#$T+B!! M9&1I=&EO;F%L;'DL('=E(&)E9V%N('1O(&%C8V]U;G0@9F]R('-I>"!,3$-S M("A$97-EF$L(%)OF$L(%-I97)R82!386X@06YT;VYI;R!-961I8V%L(%!L87IA+"!0:&]E M;FEX($-H:6QDF$I(&]N M(&$@8V]N2`Q+"`R,#$S+"!T:&4@9FEN86YC:6%L(')EF$N(%1H M97)E('=A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q M-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A-F,U M-#(Q+U=O'0O:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV M/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E M)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CQB/B@Q*3PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV M<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U14 M3TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY5;FEV97)S86P-"B!(96%L=&@@4F5A;'1Y($EN8V]M92!4F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1T;W`@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1'1O M<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!A M;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/G1H#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/F9O2!C;VUP86YI97,@*"8C>#(P,4,[3$Q##(P,40[*2P-"B!A M;F0[/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0.B`P M<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE M('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R M)2!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@65D(&%N9"]O2!R97-U;'0@:6X@9&5C M2!R871E2!P;W1E;G1I86QL>2!H879E#0H@82!N96=A=&EV92!I M;7!A8W0@;VX@=&AE(&9U='5R92!L96%S92!R96YE=V%L('1E0T*(&EN8W)E M87-E(&]UF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@2P@=&AA="!T:&4@9F%C=&]R2!T;R!M965T('1H96ER(&]B;&EG871I M;VYS('5N9&5R('1H92!T97)M2!A9F9E8W1E9"!I;B!T:&4@;F5A6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CY2979E M;G5E#0H@4F5C;V=N:71I;VX\+V(^/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS M1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0.B`P<'@G/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@&5S(&%N9`T*('5T:6QI=&EE6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H92!M:6YI;75M#0H@0T*(&]UF5D(&5V96YL>2!O=F5R('1H M92!L96%S92!T97)M(')E9V%R9&QE&-E2!V87)Y(&9R;VT- M"B!P97)I;V0M=&\M<&5R:6]D+B!";VYUF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/E)E86P@17-T871E#0H@26YV97-T;65N M=',\+V(^/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]- M.B`M-G!X.R!-05)'24XM5$]0.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$T+"!A;F0@ M=VEL;"!B92!A;6]R=&EZ960@;W9E'!E8W1E M9"!T;R!R97-U;'0@:6X@97-T:6UA=&5D#0H@86=G'!E;G-E(&]F("0U+C8F(WA!,#MM:6QL:6]N+`T*("0T+C4F(WA! M,#MM:6QL:6]N+"`D,RXY(&UI;&QI;VX@)#(N-2!M:6QL:6]N(&%N9"`D,2XY M(&UI;&QI;VX@9F]R#0H@,C`Q-2P@,C`Q-BP@,C`Q-RP@,C`Q."!A;F0@,C`Q M.2P@$$P.S,Q+"`R,#$S(&%N9"`D-RXX(&UI;&QI;VX@9F]R('1H92!Y M96%R(&5N9&5D#0H@1&5C96UB97(F(WA!,#LS,2P@,C`Q,BX@1&5P'!E;G-E('=A65A M$$P.S,Q+"`R,#$R+CPO9F]N=#X\+W`^#0H@ M/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D-A6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!C;VYS M:61E6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T M>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\8CY!F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M2!M:6=H="!N;W0@8F4@ M2!T;R!B92!H96QD(&%N9"!U2!I9@T*(&UA;F%G96UE;G0F M(W@R,#$Y.W,@97-T:6UA=&4@;V8@=&AE(&%G9W)E9V%T92!F=71U6EN9R!V86QU92!O9B!T:&4@<')O<&5R='DN(%1H M:7,@97-T:6UA=&4@=&%K97,@:6YT;PT*(&-O;G-I9&5R871I;VX@9F%C=&]R M"<^/&9O M;G0@#L@5$585"U)3D1% M3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4-"B!D971E2!C;W5L9"!I;7!A8W0@=&AE(&1E=&5R;6EN871I;VX@;V8@=VAE=&AE M'1E;G0@97-T:6UA=&5D('5N9&ES8V]U;G1E9"!C87-H(&9L M;W=S(&%R92!L97-S#0H@=&AA;B!T:&4@8V%R2!O=F5R('1H92!F86ER#0H@=F%L=64@;V8@=&AE('!R;W!EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'`@2!E>'!E8W1E9"X-"B!4:&ES(')E<75I2!O M9B!S=6-H#0H@8V]S=',N($EF('=E(&1E=&5R;6EN92!T:&%T('1H92!I;G1A M;F=I8FQE(&%S6EN9R!V86QU92!O M9@T*('1H92!I;G1A;F=I8FQE(&%S"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!;B!O=&AE2!A;F0-"B!D=7)A=&EO;B!O9B!T:&4@9&5C;&EN92!I;B!V86QU92P@:6YC M;'5D:6YG('!R;VIE8W1E9"!D96-L:6YEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@#(P,3D[2!M971H M;V0@;V8@86-C;W5N=&EN9RX@5&AE#0H@=&AI2!A="!O=7(@8V]S="!A;F0@2!A6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D%T#0H@1&5C96UB97(F(WA!,#LS,2P@,C`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`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY%9F9E8W1I=F4-"B!! M=6=U2!- M961I8V%L($-E;G1E#(P,3D[F$I M+B!%9F9E8W1I=F4@2F%N=6%R>28C>$$P.S$L(#(P,30L('=E#0H@<'5R8VAA M2!M:6YO2!O=VYE"!,3$-S(&UE;G1I;VYE9"!A8F]V92!O;B!A(&-O;G-O;&ED871E M9"!B87-I6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB M/D9E9&5R86P@26YC;VUE#0H@5&%X97,\+V(^/"]F;VYT/CPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0.B`P<'@G M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`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`^#0H@/'`@2`D-#8Y(&UI;&QI;VX@86YD("0S,38-"B!M:6QL:6]N+"!R97-P96-T:79E M;'DL(&%T($1E8V5M8F5R)B-X03`[,S$L(#(P,30N/"]F;VYT/CPO<#X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P M>"<^/&9O;G0@"<^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'`@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@ M97AP96YS90T*(&%S'!E;G-E(&ES(&%N(&%D:G5S M=&UE;G0@=&\@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CQB/D9A:7(-"B!686QU93PO8CX\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O M;G0@#L@5$585"U)3D1% M3E0Z(#0E)SX-"B`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`[/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H92!C87)R>6EN9PT*(&%M;W5N M=',@2P@ M=&AEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@2!O=VYE M6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CX\8CY5F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@"<^/&9O;G0@"<^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M$$P.S(P,30M,34L("8C>#(P,4,[ M4')E<&%R871I;VX@;V8@1FEN86YC:6%L#0H@4W1A=&5M96YT#(P,30[ M1V]I;F<@0V]N8V5R;B`H4W5B=&]P:6,@,C`U+30P*2P@1&ES8VQO#(P,30[3&EQ=6ED871I;VX@0F%S M:7,-"B!O9B!!8V-O=6YT:6YG)B-X,C`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`@("`\=&%B;&4@8VQA'0^/&1I=CX-"B`\=&%B M;&4@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/E)%3$%424].4TA)4"!7251((%5(4PT*($%.1"!2 M14Q!5$5$(%!!4E19(%1204Y304-424].4SPO8CX\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#PO=&%B;&4^#0H@/'`@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/CQI/DQE87-E2!L96%S:6YG('1H92!P"!A9&1I=&EO M;F%L(#4M>65A2!G=6%R86YT965D(&)Y(%5(4R!A;F0@ M87)E#0H@8W)O&EM871E;'D@,S8E(&]F(&]U&EM871E;'D@,C@E(&9O65A<@T*(&5N9&5D($1E8V5M8F5R)B-X M03`[,S$L(#(P,30@86YD(&%P<')O>&EM871E;'D@,S`E(&9O2!O=VYE2`R,"4@;V8@=&AE(&-O M;6)I;F5D(&-O;G-O;&ED871E9"!A;F0@=6YC;VYS;VQI9&%T960-"B!R979E M;G5E(&9O$$P.S,Q M+"`R,#$T#0H@*&%P<')O>&EM871E;'D@,C(E(&9O$$P.S,Q+`T*(#(P,30@86YD(#(P,3,@ M86YD(#(Q)2!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(F(WA!,#LS,2P@ M,C`Q,BDN#0H@26X@861D:71I;VXL(&EN8VQU9&EN9R!T:&4@='=O(&9R964M M#(P,4,[1D5$ M#(P,40[*2!A8W%U:7)E9"!B>2!U2!O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E!U$$P.S(T+"`Q.3@V("AT:&4@)B-X,C`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`@;6EL;&EO;B!I M65A M2!O<&5R M871I;F<@86-T:79I=&EE28C>#(P,3D[6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1U&EM871E;'D@,3,L-C`P M#0H@65A M65A2`D M,3(N.`T*(&UI;&QI;VXL(&%N9"!T:&4@86=G6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS M1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL"!S;VQI9#L@5TE$5$@Z(#4P<'0G(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/DAO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@$$P M.V]F)B-X03`[1F%C:6QI='D\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.U1EF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/E)E;F5W86P\8G(@+SX-"B!4 M97)M/&)R("\^#0H@*'EE87)S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/DUC06QL96X@365D:6-A;`T*($-E M;G1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`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`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E M;&QI;F=T;VX@4F5G:6]N86P@365D:6-A;`T*($-E;G1EF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#,P+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3;W5T M:'=E2!#86UP M=7,\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D%C=71E($-AF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D1E8V5M8F5R+"8C>$$P.S(P,38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$U/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/4#H@,'!X M.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA!,#L\+W`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAB*3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E5(4R!H87,@;VYE(#4M>65AF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!L97-S(&9A=F]R86)L92!T;R!U&5R8VES92!T:&5I'!I"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY!28C>$$P.S$L(#(P,3,N(%1H:7,@34]"+"!T96YA;G1S(&]F('=H M:6-H#0H@:6YC;'5D92!S=6)S:61I87)I97,@;V8@54A3+"!W87,@8V]M<&QE M=&5D(&%N9"!O<&5N960@9'5R:6YG('1H90T*('1H:7)D('%U87)T97(@;V8@ M,C`P."!A="!W:&EC:"!T:6UE('1H92!M87-T97(@;&5A2!A;F0@:7,@86-C M;W5N=&5D(&9O28C>$$P.S$L(#(P,3,@=&AR;W5G:"!$96-E M;6)E$$P.S,Q+"`R,#$S+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@28C>$$P.S$L(#(P M,30L('=E('!U2!O=VYE2!O=VYE"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY792!H879E(&9U;F1E9`T*("0R+C8@;6EL;&EO;B!I;B!E<75I='D@87,@ M;V8@1&5C96UB97(F(WA!,#LS,2P@,C`Q-"P@86YD(&%R90T*(&-O;6UI='1E M9"!T;R!F=6YD(&%N(&%D9&ET:6]N86P@)#0P,"PP,#`L(&EN(&5X8VAA;F=E M(&9O&]M82P@26YC+B`H)B-X,C`Q0SM497AO;6$@2&]S<&ET86PF(W@R,#%$.RDL M(&$-"B!W:&]L;'DM;W=N960@2!O9B!52%,N(%1H:7,@34]" M(&AA$$P.S,Q+"`R,#$T+B!! M6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQI/D%D=FES;W)Y#0H@06=R965M96YT.B8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.SPO:3Y52%,@;V8@1&5L87=A#(P,4,[061V:7-O#(P,40[*2P@82!W:&]L;'DM;W=N960@ M2!O9B!52%,L('-E0T*($%G#(P,40[*2!D871E9"!$96-E;6)E$$P M.S(T+"`Q.3@V+B!0=7)S=6%N="!T;R!T:&4-"B!!9'9I2!!9W)E96UE M;G0L('1H92!!9'9I0T*('1H92!4#(P,4,[26YD97!E;F1E;G0-"B!4#(P,40[*2X@26X@<&5R9F]R;6EN9R!I=',@2!R96%S;VX@=7!O;B!S:7AT>2!D87ES M('=R:71T96X-"B!N;W1I8V4@8GD@=7,@;W(@=&AE($%D=FES;W(N/"]F;VYT M/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@061V:7-O M$$P.S,Q(&]F M(&5A8V@@>65A2!P965R(&=R;W5P+`T* M('1H92!!9'9I2!!9W)E96UE;G0@=V%S(')E;F5W960@9F]R(#(P,34@ M<'5R"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@879E M2!F964@:7,@<&%Y86)L92!Q=6%R=&5R M;'DL('-U8FIE8W0@=&\@861J=7-T;65N="!A=`T*('EE87(M96YD(&)A2!!9W)E96UE;G0L(&5X8V5E9',@,34E(&]F#0H@;W5R(&5Q M=6ET>2!A2!!9W)E96UE;G0-"B!D969I;F5S(&-AF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@65E2UO M=VYE9"!S=6)S:61I87)Y(&]F(%5(4R!A;F0@86QT:&]U9V@@87,@;V8-"B!$ M96-E;6)E$$P.S,Q+"`R,#$T('=E(&AA9"!N;R!S86QA2!R96-E:79E(&%N M;G5A;"!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@87=A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`Q1#LI(&%N9"!I2`R."4@;V8@;W5R(&-O;G-O;&ED M871E9`T*(')E=F5N=65S(&9O65A$$P.S,Q+"`R,#$T(&%N9"`S,"4@;V8@;W5R#0H@8V]N$$P.S,Q+`T*(#(P,3,@86YD(#(P,3(L(&%N9"!S:6YC92!A('-U8G-I9&EA M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CQB/B@S*3PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^/&9O;G0@#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CX\8CX\:3XR,#$U.CPO:3X\+V(^/"]F;VYT/CPO<#X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0.B`P M<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQI/D%C<75IF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@&EM871E;'D-"B`Q-BPP,#`@ M2`D-"XQ(&UI;&QI;VXN/"]F;VYT/CPO M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($9/3E0M4TE: M13H@,7!X.R!-05)'24XM5$]0.B`Q,G!X)SX-"B`F(WA!,#L\+W`^#0H@/'`@ M2!A;F0- M"B!&96)R=6%R>2!O9B`R,#$U+"!W92!P=7)C:&%S960L(&9R;VT@54A3+"!T M:&4@2!O9B!T=V\-"B!N97=L>2UC;VYS=')U8W1E9"!A M;F0@&EM871E;'D@,3,L-C`P('-Q=6%R92!F965T(&%N9`T* M('=I;&P@8F4@;W!E"`U+7EE M87(-"B!R96YE=V%L('1E&5C=71E9"!W:71H(%5( M4R!F;W(@96%C:"!&140N(%1H90T*(&%G9W)E9V%T92!A8W%U:7-I=&EO;B!C M;W-T(&]F('1H97-E(&9A8VEL:71I97,@=V%S(&%P<')O>&EM871E;'D-"B`D M,3(N."!M:6QL:6]N+"!A;F0@=&AE(&%G9W)E9V%T92!R96YT86P@2`D.3`P+#`P,`T*(&%N;G5A M;&QY+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CQB/CQI/C(P,30Z/"]I/CPO8CX\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[ M($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$=7)I;F<@ M,C`Q-"P@=V4-"B!S<&5N="`D,34N-B!M:6QL:6]N('1O(&%C<75I6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S M='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/G-P96YT("0X+C8@;6EL;&EO;B!T;R!A8W%U:7)E('1H92!( M86YO=F5R($5M97)G96YC>2!#96YT97(L(&$-"B`R,BPP,#`@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O M;G0@6QE/3-$ M)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@ M#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O M;&QA<'-E)R!C96QL6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P M,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^ M#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E1H92!.;W)T:'=E"<^/&9O M;G0@#L@5$585"U)3D1% M3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@86=G2!A;F0-"B!I9&5N=&EF:65D M(&EN=&%N9VEB;&4@87-S971S+"!B87-E9"!O;B!T:&5IF5D M(&]V97(@=&AE(&%V97)A9V4@0T*(#DN."!Y96%R65A M0T*($-E;G1E2`Y+C<@>65A MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D)U:6QD:6YG6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXQ,"PV-C0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);G1A;F=I8FQE#0H@87-S971S M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY$97!O6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BD\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY.970@8V%S:"!P86ED/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C$U+#8P,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@1D].5"U325I%.B`Q<'@[($U!4D=)3BU43U`Z M(#$R<'@G/@T*("8C>$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY!9&1I=&EO;F%L;'DL#0H@9'5R:6YG(#(P,30L('=E('-P M96YT(&%N(&%G9W)E9V%T92!O9B`D-RXP(&UI;&QI;VXL(&EN8VQU9&EN9R`D M-"XW#0H@;6EL;&EO;B!I;B!C87-H('!L=7,@86X@861D:71I;VYA;"`D,BXS M(&UI;&QI;VX@:6X@=&AE(&9O2P@,C`Q-2!A;F0@:7,@#(P,4,[06-C'!E;G-E#(P,40[(&]N(&]U2!O=VYE"<^)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,O M3%`\+V(^/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]L3QBF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/E!R;W!E6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!A;&UD86QE)B-X03`[365D:6-A;"8C>$$P.U!L87IA/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY*86YU87)Y)B-X03`[,2PF(WA!,#LR,#$T/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E9I$$P.U1E$$P.U-P87)K$$P.TU/0CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2`Q+"`R,#$T/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$97-EF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D%U9W5S="`Q+"`R,#$T/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY386YT82!&92!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY00T@@365D:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX-3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E)O#(P,3D[F$\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U9W5S="`Q+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E!#2"!3;W5T:&5R;@T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F M(WA!,#L\+V9O;G0^/"]T9#X-"B`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C,X,3$@0F5L;"!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!O=VYE$$P.S,Q+"`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`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`T*(#(P,30L('5P;VX@97AP M:7)A=&EO;B!O9B!4:&4@0G)I9&=E=V%Y)B-X,C`Q.3MS(&QE87-E('1E2!O9B!52%,@97AE2!O M9B!T:&4@9F%C:6QI='DN(%1H92!S86QE(&]F(%1H92!"2!O9B!52%,@=V5R92!B;W1H#0H@$$P.S,Q+"`R,#$T+"!R97!R97-E M;G1I;F<@=&AE(&1I9F9E6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M1D].5"U325I%.B`Q<'@[($U!4D=)3BU43U`Z(#$X<'@G/@T*("8C>$$P.SPO M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU4 M3U`Z(#!P>"<^/&9O;G0@#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CX\:3Y!8W%U:7-I=&EO;CH\+VD^/"]F;VYT/CPO<#X- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0 M.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN($IU;F4L M(#(P,3,L#0H@=V4@<'5R8VAA&%S+"!O;@T*('1H92!C86UP=7,@ M;V8@5&5X;VUA($UE9&EC86P@0V5N=&5R+"!A('=H;VQL>2UO=VYE9"!S=6)S M:61I87)Y(&]F#0H@54A3+B!4:&ES('-I;F=L92UT96YA;G0@34]"+"!W:&EC M:"!W87,@<'5R8VAA&EM871E;'D@-"PT,#`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@&EM871E;'D@)#0N-R!M:6QL:6]N(&9O65A"<^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY,86YD/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,Q-CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)U:6QD:6YG6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=&%N9VEB;&4-"B!A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV,3`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=&AE6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXR,3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DQI86)I;&ET:65S("AR96%L('!R;W!E M6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXH,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXI)B-X03`[/"]F M;VYT/CPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`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`^#0H@/'`@#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H92!N97=L>0T* M(&-O;G-T2!-961I8V%L(%!L87IA($E)(&QO8V%T960@ M:6X@1F]R;F5Y+"!497AA2!M971H M;V0N/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P M<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[ M($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&5R M92!W97)E(&YO#0H@9&EV97-T:71UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/CQI/C(P,3(Z/"]I/CPO8CX\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z M(#!P>"<^/&9O;G0@"<^ M/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DEN($IA;G5AF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1T;W`@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M&EM871E;'D@=&5N('EE M87)S+"!A;F0[/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#PO='(^#0H@/"]T86)L M93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($9/3E0M4TE: M13H@,7!X.R!-05)'24XM5$]0.B`V<'@G/@T*("8C>$$P.SPO<#X-"B`\=&%B M;&4@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@F5D(&]V97(@=&AE('1H96X-"B!A=F5R86=E(')E;6%I M;FEN9R!L96%S92!T97)M(&]F(&%P<')O>&EM871E;'D@-RXP('EE87)S("AA M9V=R96=A=&4-"B!W96EG:'1E9"!A=F5R86=E(&]F(#4N,"!Y96%R$$P.S,Q+`T*(#(P,30I+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)U:6QD:6YG6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS,BPP.3`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY);G1A;F=I8FQE#0H@87-S971S/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW.3D\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY,:6%B:6QI=&EE0T* M(&%N9"!O<&5R871I;F6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY$97!O6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY$96)T("AI;F-L=61I;F<@9F%I6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXH,C,L,C0P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DYE="!C87-H('!A M:60\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ MFEN9R!T:&4@:6YC;VUE(&-A M<&ET86QI>F%T:6]N(&%P<')O86-H+"!A'!E8W1A;F-Y(&]F#0H@=&AE('!R;W!E2!C87-H(&9L;W=S(&9R;VT@=&AE('9A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E. M1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E1H92!F;VQL;W=I;F<-"B!T86)L92!S M=6UM87)I>F5S('-I9VYI9FEC86YT('5N;V)S97)V86)L92!Q=6%N=&ET871I M=F4@:6YP=71S(&%N9`T*(&%S3H\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S M='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D%SF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/CQB/E5N;V)S97)V86)L M90T*(&EN<'5TF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY096%C94AE86QT M:"!-961I8V%L($-L:6YI8PT*("AA+BDH8BXI/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,P+#0P,"PP,#`\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DEN8V]M928C>$$P.T-A<&ET86QI>F%T:6]N)B-X03`[07!PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-A<&ET86QI>F%T:6]N)B-X03`[4F%T93PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QTF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY. M;W)T:'=E6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/CDL-C`P+#`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`],T1N;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T M;W`^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY$:7-C;W5N="8C>$$P.U)A=&4\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDN M-3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/ M4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA! M,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E1H92!F86ER('9A;'5E(&]F('1H92!L86YD#0H@=V%S(&5S=&EM871E9"!B M87-E9"!U<&]N('1H92!S86QE6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D9O&EM871E;'D@)#(S,BPP,#`@*&5X M8VQU9&EN9R!T6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF M(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\:3Y$:79EF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@6]N($AE86QT:&-A2!C;VUP86YY#0H@*"8C>#(P M,4,[3$Q#)B-X,C`Q1#LI(&EN('=H:6-H('=E(&]W;F5D(&$@.34E(&YO;F-O M;G1R;VQL:6YG#0H@;W=N97)S:&EP(&EN=&5R97-T+"!C;VUP;&5T960@=&AE M(&1I=F5S=&ET=7)E(&]F('1H92!#86YY;VX@4W!R:6YGF$N($%S('!A&EM M871E;'D@)#@N,0T*(&UI;&QI;VX@;V8@8V%S:"!P2`D M-RXT(&UI;&QI;VX@=VAI8V@@:7,@:6YC;'5D960-"B!I;B!O=7(@8V]N6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E. M1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DEN($]C=&]B97(L#0H@,C`Q,BP@-3&EM871E;'D@)#$R+C(@;6EL;&EO;B!O9@T*(&-A M0T*(&UE;6)E2`D,2XQ(&UI;&QI;VXL('=H:6-H(&ES(&EN8VQU9&5D M(&EN(&]U<@T*(&-O;G-O;&ED871E9"!S=&%T96UE;G0@;V8@:6YC;VUE(&9O M65A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!65A&EM871E;'D@)#4U+C0@;6EL;&EO;@T*(&%N9"`D,3$N-B!M:6QL M:6]N+"!O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D%S(&]F#0H@1&5C M96UB97(F(WA!,#LS,2P@,C`Q-"P@;W5R(&YE="!I;G1A;F=I8FQE(&%SF%T:6]N('!E7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/&1I M=CX-"B`\=&%B;&4@3I4 M:6UEF4],T0R/CQB/B@T*3PO8CX\+V9O;G0^/"]T M9#X-"B`\=&0@=VED=&@],T0Q)2!V86QI9VX],T1T;W`^/&9O;G0@6QE/3-$;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/D%L;"!O9B!O M=7(-"B!L96%S97,@87)E(&-L87-S:69I960@87,@;W!E7!I8V%L;'D@65A2!E87)N('!EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@'0M M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE MF4],T0R/DUI;FEM=6T@9G5T=7)E#0H@8F%S92!R M96YT6QE/3-$;6%R9VEN M+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@6QE/3-$0D]2 M1$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&%L:6=N/3-$8V5N=&5R/@T*(#QT6QE/3-$)VUA3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/C(P,38\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUA3I4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C,P+#,S,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4] M,T0R/C(P,3D\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUAF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C4W+#DQ-CPO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4Z,7!X/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@3I4 M:6UEF4],T0R/E1O=&%L(&UI;FEM=6T@8F%S90T* M(')E;G1S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)V)O6QE/3-$ M)V)O#MM87)G:6XM8F]T=&]M.C!P>#X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)VUA'!E;G-E'1U2!C86QC=6QA=&5D(&]P97)A=&EN9R!E M>'!E;G-E#0H@2!I;G-U&5S+B!496YA;G1S(&]F('1H92!M961I8V%L#0H@;V9F:6-E(&)U M:6QD:6YG2!T:&5I28C>#(P,3D['1087)T7V4S.3DU8F0T7S$V8F%?-&$R M95]A-V,U7V5D,35A839C-30R,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO M+R]#.B]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$O5V]R M:W-H965T'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%P#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CX\:3Y$96)T.CPO:3X\+V(^ M/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X M.R!-05)'24XM5$]0.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@2P@,C`Q,2P-"B!W92!E;G1E'!I M'!E8W0@=&\@8V]M<&QE=&4@82!R97!L86-E M;65N="!C$$P.S,Q+"`R,#$U M+B!4:&4@0W)E9&ET($%G2!B>2!A;@T*(&%D9&ET:6]N86P@)#4P(&UI;&QI;VXL M('-U8FIE8W0@=&\@;&5N9&5R(&%G$$P.W1H90T*(&%D;6EN:7-T$$P.W1H92!F961E$$P.S,Q+"`R,#$T+"!T:&4@87!P;&EC86)L92!M87)G:6X@ M;W9E$$P.S,Q+"`R,#$T+"!W M92!H860@)#@Y+C@@;6EL;&EO;B!O9B!O=71S=&%N9&EN9PT*(&)O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]N#0H@ M1F5B0T*('1H M92!O=71S=&%N9&EN9R!M;W)T9V%G92!B86QA;F-E(&]N('1H92!3<')I;F<@ M5F%L;&5Y($UE9&EC86P-"B!/9F9I8V4@0G5I;&1I;F"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY/;B!*=6QY)B-X03`[,2P-"B`R,#$T+"!W92!B;W)R;W=E M9"!A;B!A9&1I=&EO;F%L("0Y+C$@;6EL;&EO;B!U;F1EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`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`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D1E8V5M8F5R)B-X03`[,S$L/&)R("\^#0H@,C`Q-#PO8CX\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E1A;F=I8FQE(&YE=`T*('=O6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R-2PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF;'0[(#4U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$96)T('-E MF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9G=#LF(WA!,#LS+C`P>#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY$96)T('1O(&-A$$P.S,N-3!X/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXQ+C(Y>#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)' M24XM0D]45$]-.B`P<'@[($9/3E0M4TE:13H@,7!X.R!-05)'24XM5$]0.B`Q M,G!X)SX-"B`F(WA!,#L\+W`^#0H@/'`@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL M93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL"!S;VQI9#L@5TE$5$@Z(#0W<'0G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D9A8VEL:71Y#0H@3F%M93PO8CX\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB M/DUA='5R:71Y/&)R("\^#0H@1&%T93PO8CX\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY3<')I;F$$P M.W)A=&4-"B!M;W)T9V%G928C>$$P.VQO86XF(WA!,#LH8BXI/"]F;VYT/CPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C0L.3(P/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXU+C4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2P@,C`Q-3PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L M.#8Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXS+C0Q/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@&5D M(')A=&4@;6]R=&=A9V4@;&]A;B`H8RXI/"]F;VYT/CPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,N M-CD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D]C=&]B97(L)B-X M03`[,C`Q-3PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E-U;6UE6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXQ,2PP,C4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C,N-#$\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1E8V5M8F5R+"8C>$$P.S(P,38\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY096%C92!(96%L=&@@ M9FEX960@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,2PR-#@\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C4N-C0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`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`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY-961I8V%L($-E M;G1EF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C8N,#`\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DIU;F4L(#(P,3<\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY3=6UM97)L:6X@2&]S<&ET86P@365D:6-A;`T*($]F9FEC92!"=6EL9&EN M9R!)22!F:7AE9"!R871E(&UO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,2PW,CD\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C4N-3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]C=&]B M97(L(#(P,3<\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY0 M:&]E;FEX($-H:6QDF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C4N.#@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E8V5M M8F5R+"`R,#$W/"]F;VYT/CPO=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C$P+#8T,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@2P@,C`Q.#PO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E-P87)KF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C,N-#$\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D9E8G)U87)Y+"`R,#$X/"]F;VYT/CPO=&0^ M#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX+#0W.3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/DIU;'DL(#(P,3D\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C0N-30\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DIU;F4L M(#(P,C(\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`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`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`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@ M$$P.SPO<#X-"B`\=&%B;&4@ MF5D('!R:6YC M:7!A;`T*('!A>6UE;G1S(&%R92!M861E(&]N(&$@;6]N=&AL>2!B87-I6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H:7,@;&]A;B!W87,@28C>$$P.S$P+"`R,#$U+"!U=&EL:7II M;F<@9G5N9',@8F]R6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E(&5X<&5C M="!T:&5S92!L;V%N"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@;6]R=&=A9V5S M#0H@87)E('-E8W5R960@8GD@=&AE(')E86P@<')O<&5R='D@;V8@=&AE(&)U M:6QD:6YG&EM871E;'D@)#$R-"XW(&UI;&QI;VX@87,@;V8@1&5C96UB M97(F(WA!,#LS,2P@,C`Q-"X-"B!#:&%N9V5S(&EN(&UA6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%S(&]F#0H@1&5C96UB97(F(WA!,#LS,2P@ M,C`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(P,3<\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXU,"PS.3D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXR,#$X/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,L-#8S/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ-"PX M-C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT"<^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY4;W1A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P M.SPO<#X-"B`\=&%B;&4@6UE;G0@;V8@)#@Y+C@-"B!M:6QL:6]N(&]F(&]U='-T M86YD:6YG(&)OF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/CQB/CQI/D9I;F%N M8VEA;`T*($ENF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!W92!P86ED(&$@<')E;6EU;2!O9@T*("0Q,S8L,#`P M+B!$=7)I;F<@=&AE(&9I$$P.VUI;&QI;VX@=VAE2!W92!P86ED('!R96UI=6US(&]F("0Q,S0L M-3`P+B!);@T*(&5X8VAA;F=E(&9O$$P.S,Q+"`R,#$T+"!N;R!P87EM96YT0T*('1H92!C;W5N=&5R<&%R=&EE'!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX-"B`\=&%B M;&4@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D1)5DE$14Y$4R!!3D0@15%52519#0H@25-354%. M0T4@4%)/1U)!33PO8CX\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^ M#0H@/'`@#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CX\8CX\:3Y$:79I9&5N9',Z/"]I/CPO8CX\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU4 M3U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$=7)I;F<@96%C:"!O M9@T*('1H92!L87-T('1H2!UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A M8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@=VED=&@] M,T0S)2!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0S)2!A;&EG;CTS1&QE9G0^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1T;W`@=VED=&@],T0S)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CX\:3Y% M<75I='D@27-S=6%N8V4-"B!0F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M#(P,4,[051-)B-X,C`Q1#LI(&5Q=6ET>2!I#(P,4,[365R6YC:"8C>#(P,40[*2P@ M87,@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M20Q+C$@;6EL;&EO;BP-"B!C;VYS:7-T:6YG(&]F M(&-O;7!E;G-A=&EO;B!O9B`D-C8W+#`P,"!T;R!-97)R:6QL($QY;F-H+"!A M'!E;G-E6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^ M/&9O;G0@&EM M871E;'D-"B`D,3DN-2!M:6QL:6]N(&]F(&YE="!C87-H('!R;V-E961S(&]R M(')E8V5I=F%B;&5S("AN970@;V8-"B!A<'!R;WAI;6%T96QY("0W,#$L,#`P M+"!C;VYS:7-T:6YG(&]F(&-O;7!E;G-A=&EO;B!O9B`D-3`V+#`P,"!T;PT* M($UE#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O M<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQU M/C(P,3,Z/"]U/B8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.U=E(&ES0T*("0V M+C$@;6EL;&EO;B!O9B!N970@8V%S:"!P6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/DEN(&-O;FYE8W1I;VX-"B!W:71H M('1H:7,@051-('!R;V=R86TL(&]U2P@,C`Q-"P@$$P.S,Q+"`R,#$T(&%N9"`R,#$S+CPO9F]N=#X\+W`^#0H@/"]D:78^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D M-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A M-F,U-#(Q+U=O'0O:'1M;#L@8VAA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CQB/B@W*3PO8CX\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)TU!4D=) M3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY$=7)I;F<@,C`P-RP-"B!U<&]N('1H92!E>'!I#(P,40[*2X@02!T;W1A;"!O9B`W-2PP,#`@$$P.S,Q+"`R,#$T+B!!=`T*($1E M8V5M8F5R)B-X03`[,S$L(#(P,30@=&AEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!O M9B!T:&4@9&%T92!O9B!G"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY$=7)I;F<@,C`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`[,S$L(#(P,30N/"]F M;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY02!);F-O;64@5')U$$P.W!E$$P.S,Q+"`R,#$T+"!T:&5R92!W M97)E(#,V+#`P,"!O<'1I;VYS#0H@;W5T65AF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!T:&4-"B!O<'1I;VYS+"!W:71H('!A>6UE M;G0@=&EE9"!T;R!T:&4@9&%T92!T:&4@;W!T:6]N65A2X\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-T;V-K M(&]P=&EO;G,-"B!T;R!P=7)C:&%S92!S:&%R97,@;V8@8F5N969I8VEA;"!I M;G1EF5D(&%S(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^ M/&9O;G0@"!S;VQI9#L@5TE$5$@Z(#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D]U='-T86YD:6YG($]P=&EO;G,\+V(^ M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQB/D5X97)C:7-E/&)R("\^#0H@5V5I9VAT960M/&)R("\^#0H@079E$$P.U!R:6-E/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@28C>$$P.S$L#0H@,C`Q,CPO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4Q+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,S+C@Y/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C M0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)A M;&%N8V4L($IA;G5A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT,RPP,#`\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V+C4S+R0R.2XT-#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D5X97)C:7-E9#PO9F]N=#X\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B@S+#`P,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Y+C0T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY"86QA;F-E+"!*86YU87)Y)B-X03`[,2P-"B`R,#$T/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU, M1494.B`S96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY%>&5R8VES M960\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXH M-"PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXI)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXS,RXP-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,P+C`V+R0S-"XP M-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V M+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U+CDT/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@&5R8VES960@=VET:"!A('1O M=&%L(&EN+71H92UM;VYE>0T*('9A;'5E(&]F("0Q-#@L.3,P+CPO9F]N=#X\ M+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P&5R8VES86)L93PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/DYU;6)EF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C,V+#`P,#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D(&%V M97)A9V4@97AEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D%G9W)E9V%T M92!I;G1R:6YS:6,-"B!V86QU93PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@ M-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!W96EG:'1E9`T*(&%V97)A9V4@&5R8VES86)L92!O<'1I;VYS(&%T($1E8V5M8F5R)B-X03`[,S$L M(#(P,30-"B!W97)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0Q,"!A;&EG;CTS1&-E;G1E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/CQB/D5X97)C:7-E#0H@ M4')I8V4\+V(^/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L&5R8VES93QBF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E=E:6=H=&5D M/&)R("\^#0H@079E$$P.RAI;CQBF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G M8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0S-"XY,"8C>$$P.RTD,S0N.3`\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,RPP,#`\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C,T+CDP/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXP+C<\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXD,S8N-3,F(WA!,#LM)#,V+C4S M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXS-BXU,SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U+CDT/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXQ+C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!!9F9I;&EA=&5S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/@T*(#QT86)L92!S='EL93TS M1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/B@X*3PO8CX\+V9O;G0^/"]T9#X-"B`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`Q M-"P@=V4@:&%V92!N;VXM8V]N=')O;&QI;F<@97%U:71Y(&EN=F5S=&UE;G1S M#0H@;W(@8V]M;6ET;65N=',@:6X@9FEV92!J;VEN=&QY+6]W;F5D($Q,0W,@ M=VAI8V@@;W=N($U/0G,N($%S(&]F#0H@1&5C96UB97(F(WA!,#LS,2P@,C`Q M-"P@=V4@86-C;W5N=&5D(&9O2!M971H;V0@ M2!A2!O9B!T:&5S92!,3$-S(&%R90T*(&IO:6YT+79E M;G1U2!O=VYE2P@9G)O;2!T:6UE('1O M('1I;64L('!R;W9I9&4@9G5N9&EN9PT*(&9O7!I8V%L;'D@861V86YC960@87,-"B!E<75I='D@;W(@;65M8F5R(&QO86YS M+B!4:&5S92!,3$-S(&UA:6YT86EN('!R;W!EF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!O=VYE2!O=VYE2!O=VYE28C>$$P M.S$L(#(P,30L('=E('!U2!O=VYE2!M971H;V0N(%!R979I;W5S;'DL(%!A;&UD86QE($UE9&EC M86P@4')O<&5R=&EE6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L M92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,O3%`\+V(^/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]LF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E!A;&UD86QE M($UE9&EC86P-"B!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E!A;&UD86QE)B-X03`[365D:6-A;"8C>$$P.U!L87IA/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY*86YU87)Y)B-X03`[,2PF(WA!,#LR M,#$T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E9I6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY*86YU87)Y M(#$L(#(P,30\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$5DU#(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@2!-961I8V%L($-E M;G1E6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY386YT82!&90T*(%-C;W1T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!=6=U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!#2"!-961I8V%L#0H@4')O<&5R=&EEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C@U/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY3:65R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D%U9W5S="`Q+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.T-E;G1E6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS.#$Q)B-X03`[0F5L;"8C>$$P M.TUE9&EC86PF(WA!,#M06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DYO2!-961I8V%L(%!L87IA/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY!=6=U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L M93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($9/3E0M4TE: M13H@,7!X.R!-05)'24XM5$]0.B`Q,G!X)SX-"B`F(WA!,#L\+W`^#0H@/'`@ MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!724142#H@-3EP="<^#0H@/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E!R;W!E6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3=6)U6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXS,SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B4\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$F(WA!,#M)23PO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D)R=6YS=VEC:R!!F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C$$P.U!R;W!E6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-A M:6YT($UA7-O;B!0F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY&5%@@34]"(%!H87-E($E)#0H@*&0N*3PO9F]N=#X\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F$F(WA! M,#M)23PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,"XU<'0@#L@3$E.12U(14E'2%0Z M(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL M93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&ES($Q,0R!H87,@82!T:&ER M9"UP87)T>0T*('1E$$P.S,Q+"`R,#$T+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T M86)L93X-"B`\=&%B;&4@6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E=E(&AA=F4@9G5N9&5D("0R+C8@;6EL M;&EO;@T*(&EN(&5Q=6ET>2!A$$P.S,Q+"`R,#$T M+"!A;F0@87)E(&-O;6UI='1E9"!T;R!F=6YD#0H@86X@861D:71I;VYA;"`D M-#`P+#`P,"X@5&AI2!A;F0@9&5B="!F:6YA;F-I;F$$P.S,Q M+"`R,#$T+B!4:&ES($Q,0R!H87,-"B!A('1H:7)D+7!A$$P.S,Q+"`R,#$T M+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS M1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY"96QO=R!A$$P.S,Q M+"`R,#$T+"`R,#$S(&%N9"`R,#$R+B!4:&4@9&%T80T*(&9O65A M$$P.S,Q+"`R,#$T(&EN8VQU9&5S('1H92!F M:6YA;F-I86P-"B!R97-U;'1S(&9O2!O M=VYE65A6]N($AE86QT:&-A2P@ M,C`Q,B!A;F0@-36QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C M96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/D9OF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P,30H8BXI/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/BAA;6]U;G1S(&EN#0H@=&AO M=7-A;F1S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E)E=F5N=65S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$W+#(Y,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C(Q+#`P,3PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C(Q+#0T.#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]P97)A=&EN9PT*(&5X<&5NF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C@L-S`U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX+#DW-#PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D1E<')E8VEA=&EO;B!A;F0-"B!A;6]R=&EZ871I;VX\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR+#DV.#PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C0L,30P/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C0L,C8Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+#,U,SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DYE="!I;F-O;64@8F5F;W)E(&=A:6YS M(&]N#0H@9&EV97-T:71U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,CDT/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C(L,S8U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@ M34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E M)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]U6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAB M+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY!"!#:&EL9')E;B8C M>#(P,3D[$$P.S$L(#(P,30N M(%!R:6]R('1O#0H@075G=7-T)B-X03`[,2P@,C`Q-"P@=&AE(&9I;F%N8VEA M;"!R97-U;'1S(&]F('1H97-E(&5N=&ET:65S('=E"!M96YT:6]N960@3$Q#28C>$$P.S,Q+"`R,#$T+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T M86)L93X-"B`\=&%B;&4@28C>$$P.S$L(#(P,30L#0H@=&AE(&9I;F%N8VEA;"!R97-U;'1S M(&]F('1H:7,@96YT:71Y('=E"!,3$-S(&9O M65A$$P.S,Q+"`R,#$S(&%N M9"`R,#$R+B!!2!O9B!52%,@=VAI8V@-"B!E>'!I"UM;VYT M:"!P97)I;V0@;V8-"B!*=6QY)B-X03`[,2P@,C`Q,R!T:')O=6=H($1E8V5M M8F5R)B-X03`[,S$L(#(P,3,N(%1H97)E9F]R92!T:&4-"B!F:6YA;F-I86P@ M2!A6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D%S(&UE;G1I;VYE9"!A8F]V M92P@9'5R:6YG#0H@=&AE(&9I2!O=VYE9"!V87)I;W5S(&YO;F-O;G1R;VQL:6YG+"!M M86IO0T*(&]W;F5R0T*($EN=F5S=&]R2X@3W5R('-H87)E(&]F M('1H92!F:6YA;F-I86P@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY"96QO=R!A2!M971H;V0@87,@;V8@1&5C96UB97(F(WA! M,#LS,2P@,C`Q-"!A;F0@,C`Q,SH\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P,3,H82XI*&(N*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/BAA;6]U;G1S(&EN#0H@=&AO=7-A;F1S*3PO M8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DYE="!P2P@:6YC;'5D:6YG#0H@0TE0/"]F;VYT/CPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C8R+#0U,#PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q M.2PU-#<\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY/=&AE6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXW+#,V-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8Y+#@Q-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C$R.2PP,C8\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/DQI86)I;&ET:65S/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,L,S0X/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`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`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C8Y+#@Q-SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R.2PP,C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D]UF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,Y+#(P,3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]21$52 M+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/4#H@,'!X M.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA!,#L\+W`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!A M;6]U;G1S('!R97-E;G1E9`T*(&EN8VQU9&4@=&AE(&)A;&%N8V4@$$P.S,Q+"`R,#$T+CPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/"]T86)L93X-"B`\=&%B;&4@2!-961I8V%L($-E;G1E#(P,3D[F$I(&]N(&$@8V]N2!M971H;V0@87,@;V8@1&5C96UB97(F(WA!,#LS,2P@,C`Q,RX\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@#L@34%21TE.+51/ M4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%S(&]F#0H@1&5C96UB97(F(WA!,#LS,2P@,C`Q-"P@ M86=G6%B;&4@8GD@=6YC;VYS;VQI9&%T960@3$Q#F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXR,#$V/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C4L-S(W/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ MF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C0T-3PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3D\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXT-C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXR,#(P(&%N9"!!9G1EF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(Q+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C4R+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL M93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL"!S;VQI9#L@5TE$5$@Z(#0W<'0G/@T*(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,\+V(^/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.RAA+BD\+V(^/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQB/DUA='5R:71Y)B-X03`[1&%T93PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D%R;&EN9W1O;B!-961I8V%L M#0H@4')O<&5R=&EE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/8W1O8F5R M+"`R,#$U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY"6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY+#`P,#PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C4R+#6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/"]T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P M="!S;VQI9#L@34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!7 M24142#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/ M4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%L;"!M;W)T9V%G92!L;V%N2!P2!A;F0@:6YC;'5D92!A(&)A;&QO;VX-"B!P'!E8W0@=&\@65A'!E8W1E9"!E=F5N="!T:&%T('=E(&%R92!U;F%B;&4@=&\@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAC+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&ES(&QO86X@=V%S(&-O M;G9E6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E1H:7,@;&]A;B!W87,@65A&5D(')A=&4@ M;V8@-2XP,S0E+@T*(%1H:7,@;&]A;B!I;F-L=61E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BAE+BD\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4 M:&ES(&QO86X@=V%S(')E9FEN86YC960@:6X-"B!$96-E;6)E"!M;VYT:',L(&%N9"!F:7AE9"!R871E M(&]F(#,N-C0E(&-O;6UE;F-I;F<-"B!*=6QY)B-X03`[,2P@,C`Q-2!T:')O M=6=H($1E8V5M8F5R)B-X03`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`\=&%B M;&4@3I4:6UEF4],T0R/CQB/B@Y*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@ M=VED=&@],T0Q)2!V86QI9VX],T1T;W`^/&9O;G0@#X\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)VUA2!F6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O M;3HP<'@^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!297-U;'1S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/@T*(#QT86)L M92!S='EL93TS1$)/4D1%4BU#3TQ,05!313I#3TQ,05!312!B;W)D97(],T0P M(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG/3-$ M,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O3I4:6UEF4],T0Q/CQB/C(P,30@*&$N*3PO8CX\+V9O;G0^/"]T9#X-"B`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/C$T+#(X.#PO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$T M+#,Q-SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$U+#(U.#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/C$U+#DR,SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C4Y M+#6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@ M/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/C,L,#0X/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/D=A:6X@;VX@9F%I2!I;G1E M2UO=VYE9"!,3$-S/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0R/C,Q-CPO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`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`T,SPO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE M/3-$)V)O$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$)VUA3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#`X/"]F M;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O M6QE/3-$)V)O$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,CD\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0R/C$N,C0\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V)O M6QE/3-$)V)O$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C8\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,N.3D\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P M>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O6QE/3-$)V)O M$$P.SPO<#X-"B`\=&%B;&4@3I4:6UEF4] M,T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`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`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)VUA3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0R/C(L.30Q/"]F;VYT/CPO=&0^#0H@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UE MF4],T0R/C$S+#$V.3PO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4Z,7!X/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O M6QE/3-$)V)O$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/E1O=&%L(&)A3I4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C8\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/E1O=&%L(&1I;'5T960@96%R;FEN9W,@<&5R#0H@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)V)O6QE/3-$ M)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)VQI;F4M M:&5I9VAT.CAP>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C)P>#MB M;W)D97(M8F]T=&]M.C`N-7!T('-O;&ED(",P,#`P,#`[=VED=&@Z,3`E)SX- M"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$0D]21$52+4-/3$Q!4%-% M.D-/3$Q!4%-%(&)O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX- M"B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@2!);F-O;64@5')U6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@#(P,30[ M($1E8V5M8F5R)B-X03`[,S$L#0H@,C`Q-#PO8CX\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@@86QI M9VX],T1C96YT97(^#0H@/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@=VED=&@],T0Q,#`E(&)O6QE/3-$)VUA3I4:6UE MF4],T0Q/CQB/DEN:71I86P-"B!#;W-T/"]B/CPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB M/D=R;W-S(&%M;W5N="!A=#QB6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/CQB/F%S(&]F($1E8RX-"B`S M,2P\8G(@+SX-"B`R,#$T/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$ M)V)O6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/CQB/D%C<75IF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@"!S;VQI9"`C,#`P,#`P M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/D1A=&4\8G(@+SX-"B!!8W%U:7)E9#PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(')O=W-P86X],T0R/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@"!S;VQI9"`C M,#`P,#`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`[/&)R("\^#0H@ M26UP6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0Q/DEN;&%N M9"!686QL97D@4F5G:6]N86P-"B!-961I8V%L($-E;G1EF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/C(U+#(Y-SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C0P+#`W,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(T+#,X M-3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`^#0H@ M/'`@3I4:6UEF4],T0Q/E=E;&QI;F=T;VX@4F5G:6]N86P@365D:6-A;`T* M($-E;G1E3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$T+#8U,CPO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C,S+#(Q,CPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C4L,#8Y/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C8L-#`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`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0Q/C$Y.#8\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/DME M;'-E>2U397EB;VQD($-L:6YI8R!A=`T*($MI;F3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q M/C(L-#@X/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`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`^#0H@/'`@3I4:6UEF4],T0Q/E!R;V9E&%S/"]I/CPO9F]N=#X\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`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`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C,\+V9O;G0^ M/"]T9#X-"B`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`\ M=&0@;F]W3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.34\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/C0U(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)VUA3QB6QV86YI83PO:3X\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$L,S`S/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.38\ M+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.38\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`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`],T1N;W=R87`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`^#0H@/'`@F4],T0Q M/D-H97-T97)BF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C@Q-3PO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`\=&0@;F]W3I4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.38\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0Q/C0U(%EE87)S/"]F;VYT M/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)VUA3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y M-3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0Q/CDT-#PO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`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`],T1N;W=R87`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`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.38\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0Q/C0U(%EE87)S/"]F;VYT/CPO=&0^ M#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)VUA3I4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C@P-CPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C4W,SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C4X-3PO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/C

3I4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[ M)B-X03`[)B-X03`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`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`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.3D\+V9O;G0^/"]T9#X-"B`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$L,3`T/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C4L-3`X/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`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`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UEF4],T0Q/B8C M>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C$W-CPO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C$P+#,W-CPO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,#D\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C(P,#D\+V9O;G0^/"]T9#X- M"B`\=&0@;F]W3I4:6UEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,V(%EE M87)S/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$ M)VUA&%S/"]I/CPO9F]N=#X\+W`^#0H@/"]T9#X- M"B`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`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C0\+V9O;G0^/"]T M9#X-"B`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`\+V9O;G0^/"]T9#X-"B`\=&0@ M;F]W3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C(P,3`\+V9O;G0^ M/"]T9#X-"B`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`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`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`],T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`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`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$P+#`P M,SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`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`],T1N;W=R87`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`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[ M)B-X03`[)B-X03`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`^#0H@/'`@3I4:6UEF4],T0Q/E-P6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0Q/CDL.#`P/"]F;VYT/CPO=&0^#0H@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X M03`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`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/C4Q,CPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,W,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`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`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4] M,T0Q/E-U;6UE3I4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Q+#`R-3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/D5M M;W)Y(&%T($1U;G=O;V1Y#0H@0G5I;&1I;F<\8G(@+SX-"B`\:3Y$=6YW;V]D M>2P@1T$\+VD^/"]F;VYT/CPO<#X-"B`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`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/D9O M2!-961I8V%L(%!L87IA#0H@/&D^1F]R;F5Y+"!46#PO:3X\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`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`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/CDL,#`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C$P+#$S,3PO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,U M(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)VUAF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C$R+#4R-3PO9F]N M=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$L,3`P/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0Q/E!E86-E($AE86QT:"!-961I M8V%L#0H@0VQI;FEC/&)R("\^#0H@/&D^0F5L;&EN9VAA;2P@5T$\+VD^/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0Q/C(Q+#(T.#PO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(T+#DQ,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/C(T+#DQ,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@&%S(%!R;V9E3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`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`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`\=&0@;F]W3I4:6UEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,3(\ M+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,L,C(P/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0Q/B8C>#(P,30[)B-X03`[)B-X03`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`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`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,3,\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0Q/C8R-3PO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,3,\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE MF4],T0Q/C(P,3,\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4 M:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`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`P/"]F;VYT/CPO=&0^ M#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C(P,30\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/C(P,30\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,U(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)VUA3I4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/CDS,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`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`],T1N;W=R87`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`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/DYO MF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C(L.#

F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[ M)B-X03`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`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/C8Q,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`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`],T1N;W=R87`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`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@"P@05H\+VD^/"]F;VYT/CPO<#X-"B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X M03`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`\=&0@;F]W M3I4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0Q/C(P,#$\+V9O;G0^/"]T M9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0Q/C$Q+#DU,#PO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q M/C8L,#`X/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`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`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`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`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Y.3D\+V9O;G0^/"]T9#X-"B`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`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0Q/C`\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/C$Q+#4S.#PO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0Q/C$X-#PO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`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`^#0H@/'`@3I4:6UEF4],T0Q/E9I M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/C,W,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)V)O$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O M$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O M$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/"]T'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0Q/C,S+#6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/C0P,2PX.3D\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4 M:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B0\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4Z,7!X M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO M=&%B;&4^#0H@/'`@$$P.SPO<#X-"B`\=&%B M;&4@3I4:6UEF4],T0Q/F$N+CPO9F]N=#X\+W1D/@T*(#QT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q M/F(N/"]F;VYT/CPO=&0^#0H@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1T M;W`^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0Q/D1U6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@2!M:6YO2!I;G1E2!O=VYE9"!I;G1E6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4:6UE MF4],T0Q/D-O;G-I3I4:6UEF4] M,T0Q/F8N/"]F;VYT/CPO=&0^#0H@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX] M,T1T;W`^/&9O;G0@2!H96QD(&YO;F-O;G1R M;VQL:6YG(&UA:F]R:71Y(&]W;F5D(&EN=&5R97-T2UO=VYE9"X\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@F4Z,7!X.VUA#MM87)G:6XM8F]T=&]M.C!P>#X- M"B`F(WA!,#L\+W`^#0H@/'`@#MM87)G M:6XM8F]T=&]M.C!P>"!A;&EG;CTS1&-E;G1E3I4:6UEF4],T0R/CQB/E5. M259%4E-!3`T*($A%04Q42"!214%,5%D@24Y#3TU%(%1255-4/"]B/CPO9F]N M=#X\+W`^#0H@/'`@#MM87)G:6XM8F]T M=&]M.BTV<'@^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@@86QI M9VX],T1C96YT97(^#0H@/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/ M3$Q!4%-%(&)O6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@'0M:6YD96YT M.C0E)SX-"B`\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/E1H92!F;VQL;W=I;F<-"B!T86)L92!R96-O;F-I M;&5S('1H92!296%L($5S=&%T92!028C M>$$P.S$L#0H@,C`Q,B!T;R!$96-E;6)E$$P.S,Q+"`R,#$T.CPO9F]N M=#X\+W`^#0H@/'`@#MM87)G:6XM8F]T M=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT M86)L92!C96QL6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q! M4%-%(&%L:6=N/3-$8V5N=&5R/@T*(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0Q/CQB/C(P,30\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4] M,T0R/D)A;&%N8V4@870-"B!*86YU87)Y)B-X03`[,2P\+V9O;G0^/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UE MF4],T0R/C,Y-2PV-CD\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4] M,T0R/DEM<&%C="!O9B!C;VYS;VQI9&%T:6]N(&]F#0H@96EG:'0@3$Q#6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`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`\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/BDF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/D)A;&%N8V4@870-"B!$96-E M;6)E$$P.S,Q+#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,Y-2PV-CD\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)V)O6QE/3-$)V)O$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1&UAF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$0D]21$52+4-/3$Q! M4%-%.D-/3$Q!4%-%(&)O#MM87)G:6XM8F]T=&]M M.BTV<'@^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB M/C(P,3(\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)VUA28C>$$P.S$L/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/DEM<&%C="!O9B!D96-O;G-O;&ED871I;VX@;V8-"B!A M;B!,3$,H82XI/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/B@Q+#4X.#PO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G M8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/D1IF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/BDF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)VUA MF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R M/C$R+#0V-#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)VUAF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)V)O$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/D)A;&%N8V4@ M870-"B!$96-E;6)E$$P.S,Q+#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UE MF4],T0R/CDW+#DR,3PO9F]N=#X\+W1D/@T*(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/C@W+#`X.#PO9F]N=#X\ M+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4Z,7!X/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO<#X-"B`\=&%B;&4@3I4:6UEF4],T0R/BAA M+BD\+V9O;G0^/"]T9#X-"B`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`R,#$U+"!W92!H879E('-I>'1Y+6]N92!R96%L#0H@ M97-T871E(&EN=F5S=&UE;G1S(&]R(&-O;6UI=&UE;G1S(&QO8V%T960@:6X@ M96EG:'1E96X@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z M(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T M;W`@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1T;W`@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O;G0@0T*('5N8V]N6QE/3-$)TU!4D=) M3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY/=7(@9G5T=7)E#0H@2!T:&4@;W!E2P@=&AE#0H@9V5N97)A;"!R96%L(&5S=&%T92!M87)K970@:&%S(&)E96X@ M=6YF879O"<^/&9O;G0@#L@5$58 M5"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY-86YA9V5M96YT(&ES#0H@=6YA M8FQE('1O('!R961I8W0@=&AE(&5F9F5C="P@:68@86YY+"!T:&%T('1H92!F M86-T;W)S(&1I6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CX\8CY2979E;G5E#0H@4F5C;V=N:71I;VX\+V(^/"]F;VYT/CPO<#X- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM5$]0 M.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M&5S(&%N9`T*('5T:6QI=&EE6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!M:6YI M;75M#0H@0T*(&]U&-E2!V87)Y(&9R;VT-"B!P97)I;V0M=&\M<&5R:6]D+B!";VYU'0^/&1I M=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU4 M3U`Z(#!P>"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ M("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY/;B!T:&4@9&%T92!O9@T*(&%C<75I2!IF%T M:6]N(&5X<&5N$$P.VUI;&QI;VXL#0H@)#0N-28C>$$P M.VUI;&QI;VXL("0S+CD@;6EL;&EO;B`D,BXU(&UI;&QI;VX@86YD("0Q+CD@ M;6EL;&EO;B!F;W(-"B`R,#$U+"`R,#$V+"`R,#$W+"`R,#$X(&%N9"`R,#$Y M+"!R97-P96-T:79E;'DN($%M;W)T:7IA=&EO;B!E>'!E;G-E#0H@;VX@:6YT M86YG:6)L92!V86QU97,@;V8@:6X@<&QA8V4@;&5A65A$$P.S,Q+"`R,#$R+B!$97!R96-I871I M;VX@:7,@8V]M<'5T960@=7-I;F<@=&AE#0H@65A65A$$P.S,Q+"`R,#$S(&%N9"`D,3(N,B!M:6QL:6]N(&9O6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D-A M6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P M>"<^/&9O;G0@#L@5$58 M5"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!C;VYS:61E'0^ M/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E)E M86P@97-T871E#0H@:6YV97-T;65N=',@86YD(')E;&%T960@:6YT86YG:6)L M92!A'!E;F1I='5R97,L('1O(&)E(&=E;F5R871E9"!B>2!T:&4-"B!P2P@=6YD:7-C;W5N=&5D(&%N9"!W:71H;W5T(&EN=&5R97-T(&-H87)G M97,L(&%R92!L97-S('1H86X-"B!T:&4@8V%R'!E8W1E9"!F=71UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@2!M86YA9V5M96YT+"!I;F-L=61I M;F<@=&AE(&5X<&5C=&5D(&-O=7)S92!O9B!A8W1I;VX@870-"B!T:&4@8F%L M86YC92!S:&5E="!D871E('1H870@=V]U;&0@;&5A9"!T;R!S=6-H(&-A2P@=&AE(&QO&-E2X\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D%S&-EF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@2!I;7!A:7)M96YT(&]F(&%N(&EN=F5S M=&UE;G0O861V86YC92!I;B!A;B!,3$,@:7,-"B!R96-O9VYI>F5D('=H96X@ M=&AE(&-A'1E;G0@:6UP86ER;65N="!H87,@;V-C=7)R M960L('1H92!E>&-E6EN9R!V86QU92!O9B!T:&4@87-S970@ M;W9E6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\ M8CY);G9E#(P,40[*3PO9F]N=#X\+W`^#0H@/'`@ M#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D]U<@T*(&-O;G-O;&ED871E9"!F M:6YA;F-I86P@0T*(&)E;F5F:6-I87)Y+B!);B!A8V-O2!A9&IU2!I;B!T:&4@;F5T(&EN8V]M92P@8V%S:"!C;VYT"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!=`T*($1E8V5M8F5R M)B-X03`[,S$L(#(P,30L('=E(&AA=F4@;F]N+6-O;G1R;VQL:6YG(&5Q=6ET M>2!I;G9E2UO=VYE9"!,3$-S('=H:6-H(&]W;B!M961I8V%L(&]F9FEC90T*(&)U:6QD M:6YG2!O=VYE2!D96)T("AI9B!A<'!L:6-A8FQE*2!T:&%T(&ES(&YO M;BUR96-O=7)S92!T;R!U7!I8V%L M;'D@;F\@;VYG;VEN9R!F:6YA;F-I86P@2!A2!A9'9A;F-E9"!A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY086QM9&%L90T* M($UE9&EC86P@4')O<&5R=&EE$$P.S,P+"`R M,#$S(&%T('=H:6-H('1I;64@:71S(&UA2!O9B!52%,@97AP:7)E9"X@1F]R('1H M92!P97)I;V0@;V8-"B!*=6QY)B-X03`[,2P@,C`Q,R!T:')O=6=H($1E8V5M M8F5R)B-X03`[,S$L(#(P,3,L('=E(&%C8V]U;G1E9"!F;W(-"B!086QM9&%L M92!-961I8V%L(%!R;W!E2!M971H;V0N M($%S(&1I28C>$$P.S$L(#(P,30L('=E(&)E9V%N(&%C8V]U M;G1I;F<@9F]R(%!A;&UD86QE($UE9&EC86P-"B!0F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!M:6YO0T*(&]W M;F5R"!,3$-S("A$97-EF$L#0H@4&AO96YI>"!#:&EL9')E;B8C>#(P,3D[2!#87)E($-E;G1E2!H96QD(&YO M;BUC;VYT2!O=VYE28C>$$P.S$L(#(P,30L(&%S(&1I28C>#(P,3D['!E;G-E(')E'0^/&1I=CX-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P M>"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.;R!P2!A&5S M(&%N9"!W90T*(&%R92!R97%U:7)E9"!T;R!D:7-T&%B;&4@ M:6YC;VUE('1O(&]U"<^ M/&9O;G0@#L@5$585"U) M3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!A&-I65A M"!E<75A;',@-"4@;V8@=&AE(&%M M;W5N="!B>2!W:&EC:"`X-24@;V8@;W5R(&]R9&EN87)Y#0H@:6YC;VUE('!L M=7,@.34E(&]F(&%N>2!C87!I=&%L(&=A:6X@:6YC;VUE(&9O65A<@T*(&5X8V5E9',@8V%S:"!D:7-T65A"!W87,@9'5E+CPO9F]N M=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'`@"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@86=G2P@870@1&5C96UB97(F(WA!,#LS,2P@,C`Q-"X\ M+V9O;G0^/"]P/@T*(#PO9&EV/CQS<&%N/CPO6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\8CY3=&]C:RU"87-E9`T*($-O;7!E;G-A=&EO;CPO8CX\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!E>'!E M;G-E('1H90T*(&=R86YT+61A=&4@9F%IF4@=&AE(&=R86YT+61A=&4@9F%I6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H M92!E>'!E;G-E#0H@87-S;V-I871E9"!W:71H('-H87)E+6)A6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CQB/D9A:7(-"B!686QU93PO8CX\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[ M($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E1H92!C87)R>6EN9PT*(&%M;W5N=',@2P@=&AEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!O=VYE'0^/&1I M=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU4 M3U`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`R,#$T+`T*($9!4T(@:7-S M=65D($%352!.;RXF(WA!,#LR,#$T+3$U+"`F(W@R,#%#.U!R97!A28C>#(P,3D[2!R969E M28C>#(P,3D[2!T;R!C M;VYT:6YU92!A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY);B!!<')I;"`R,#$T+`T*('1H92!&:6YA;F-I86P@ M06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A28C>#(P,3D[3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY M-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q M-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA2!4'0M:6YD96YT.C0E)SX-"B`\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R M/E1H92!T86)L92!B96QO=PT*(&1E=&%I;',@=&AE(&5X:7-T:6YG(&QE87-E M('1EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O6QE/3-$)V)OF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1C96YT97(@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@8V]LF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/CQB/D5N9"8C>$$P.V]F/&)R("\^#0H@3&5A6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@65A'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UEF4],T0R/D%C=71E)B-X03`[0V%R93PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3I4:6UEF4],T0R/D1E8V5M8F5R+"8C>$$P M.S(P,38\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C$U/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)VUA6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0R/D1E8V5M8F5R+"8C>$$P.S(P,38\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/C$U/"]F;VYT M/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)VUA6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/D1E8V5M8F5R+"8C>$$P.S(P,38\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C$U M/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@$$P.SPO<#X-"B`\ M=&%B;&4@3I4:6UEF4],T0R/BAA*3PO9F]N=#X\+W1D/@T*(#QT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@&ES=&EN9R!L96%S M92!R871E65A<@T*(')E;F5W M86P@;W!T:6]N7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/&1I=CX-"B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P M>#MM87)G:6XM8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/@T*(#QF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6%B;&4@=&\@=&AE('!R979I M;W5S('1H:7)D+7!A$$P.S,Q+"`R,#$T*2!T;R!P=7)C:&%S92!T:&4@;6EN M;W)I='D@;W=N97)S:&EP#0H@:6YT97)E2!H96QD('9A#MM87)G:6XM8F]T=&]M.C!P>#XF M(WA!,#L\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@=VED=&@],T0Q,#`E(&)O6QE/3-$)V)O MF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UE MF4],T0Q/CQB/E!R;W!E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E!A;&UD M86QE($UE9&EC86P-"B!0F4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@F$\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4 M:6UEF4],T0R/DIA;G5A$$P M.S(P,30\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E-P87)K#(P,C8[/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/CDU/"]F;VYT M/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@$$P.R9A;7`[)B-X03`[ M4W!AF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`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`^#0H@/'`@3I4:6UEF4],T0R/E-A M;G1A($9E#0H@4V-O='1S9&%L93PO9F]N=#X\+W`^#0H@/"]T9#X-"B`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`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`^#0H@/'`@ M3I4:6UEF4],T0R/E-I97)R82!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/E-I97)R M82!386X@06YT;VYI;R!-961I8V%L#0H@4&QA>F$\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/D%U M9W5S="`Q+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)VUA3I4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@"8C>$$P.T-H:6QD3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/D%U9W5S="`Q+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)VUA6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F5D(&EN M($QE=F5L(%1H6QE/3-$)VUAF5D M(&EN#0H@3&5V96P@,R!O9B!T:&4@9F%IF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@] M,T0Q,#`E(&)O6QE/3-$)V)O3I4:6UE MF4],T0Q/CQB/D9A:7(@5F%L=64@870\8G(@+SX- M"B!$96-E;6)E$$P.S,Q+"8C>$$P.S(P,3(\+V(^/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E!E86-E2&5A;'1H($UE M9&EC86P@0VQI;FEC#0H@*&$N*2AB+BD\+V9O;G0^/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,P+#0P,"PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/DEN8V]M928C M>$$P.T-A<&ET86QI>F%T:6]N)B-X03`[07!PF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R M/D-A<&ET86QI>F%T:6]N)B-X03`[4F%T93PO9F]N=#X\+W1D/@T*(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M/@T*(#QT9"!V86QI9VX],T1T;W`^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@3I4 M:6UEF4],T0R/DYO6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/CDL-C`P+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R M87`],T1N;W=R87`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`\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4 M:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@$$P M.SPO<#X-"B`\=&%B;&4@3I4:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X- M"B`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/E1H92!F M86ER('9A;'5E(&]F('1H92!L86YD#0H@=V%S(&5S=&EM871E9"!B87-E9"!U M<&]N('1H92!S86QE3I4:6UEF4],T0R/BAB M+BD\+V9O;G0^/"]T9#X-"B`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O M<#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/D1E8G0@:7,@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H92!A9V=R96=A M=&4-"B!P=7)C:&%S92!P"<^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY,86YD/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#$P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+#8V-#PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=&%N9VEB;&4-"B!A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR+#`W-CPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E<&]S:70@ M<&%I9"!I;@T*(#(P,3,\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXH,34P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G M8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!C87-H('!A:60\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U! M4D=)3BU43U`Z(#!P>#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4 M:&4@86=G2`D-"XW(&UI;&QI;VX@9F]R('1H97-E($U/0G,@=V%S#0H@86QL;V-A=&5D M('1O('1H92!A2!A;F0@:61E;G1I9FEA8FQE M(&EN=&%N9VEB;&4@87-S971S+"!B87-E9"!O;@T*('1H96ER(')EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/ M4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY" M=6EL9&EN9W,@86YD#0H@:6UP6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY);G1A;F=I8FQE#0H@87-S971S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY,:6%B:6QI=&EE0T*(&%N9"!O<&5R871I M;F$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/DYE="!C87-H('!A:60\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I M=CX\6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!A9V=R96=A=&4-"B!P=7)C:&%S92!P MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D)U:6QD:6YG6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS,BPP.3`\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY);G1A;F=I8FQE#0H@87-S971S/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW.3D\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY,:6%B:6QI=&EE0T*(&%N M9"!O<&5R871I;F6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY$97!O6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$ M96)T("AI;F-L=61I;F<@9F%I6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXH M,C,L,C0P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/DYE="!C87-H('!A:60\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W M8S5?960Q-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA'0^/&1I=CX-"B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM M8F]T=&]M.C!P>#L@=&5X="UI;F1E;G0Z-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@&-L=61I;F<@:6YC3I4:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/C0Y+#(P-SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/C(P,3<\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUA3I4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C(U+#6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@3I4:6UEF4],T0R/E1H97)E869T97(\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O M$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C(S,"PT,S`\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE M.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F;VQL;W=I;F<-"B!T86)L92!I;F-L M=61E6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/CQB/D1E8V5M8F5R)B-X03`[ M,S$L/&)R("\^#0H@,C`Q-#PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E1A;F=I8FQE(&YE=`T*('=O6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C$R-2PP,#`\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;'0[(#4U/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY$96)T('-EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9G=#LF M(WA!,#LS+C`P>#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$96)T('1O(&-A$$P.S,N-3!X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+C(Y>#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L M93X-"B`\+V1I=CX\$$P.S,Q+`T*(#(P,30@*&%M M;W5N=',@:6X@=&AO=7-A;F1S*3H\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL"!S;VQI9#L@5TE$5$@Z(#0W<'0G/@T*(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D9A8VEL:71Y#0H@3F%M93PO8CX\+V9O;G0^/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DUA='5R M:71Y/&)R("\^#0H@1&%T93PO8CX\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY3<')I;F$$P.W)A=&4- M"B!M;W)T9V%G928C>$$P.VQO86XF(WA!,#LH8BXI/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C0L.3(P/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU M+C4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@2P@ M,C`Q-3PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L.#8Q/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXS+C0Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@&5D(')A=&4@ M;6]R=&=A9V4@;&]A;B`H8RXI/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,N-CD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D]C=&]B97(L)B-X03`[,C`Q M-3PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-U;6UE6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXQ,2PP,C4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C,N-#$\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E8V5M8F5R+"8C>$$P.S(P,38\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY096%C92!(96%L=&@@9FEX960@ M6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXR,2PR-#@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N-C0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X- M"B`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`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY-961I8V%L($-E;G1EF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C8N,#`\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DIU;F4L(#(P,3<\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3=6UM M97)L:6X@2&]S<&ET86P@365D:6-A;`T*($]F9FEC92!"=6EL9&EN9R!)22!F M:7AE9"!R871E(&UO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,2PW,CD\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N M-3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D]C=&]B97(L(#(P M,3<\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY0:&]E;FEX M($-H:6QDF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N M.#@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D1E8V5M8F5R+"`R M,#$W/"]F;VYT/CPO=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P M+#8T,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@2P@,C`Q.#PO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-P87)KF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,N-#$\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D9E8G)U87)Y+"`R,#$X/"]F;VYT/CPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXX+#0W.3PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DIU;'DL(#(P,3D\+V9O;G0^/"]P/@T*(#PO M=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0N M-30\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DIU;F4L(#(P,C(\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`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`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`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@$$P.SPO<#X-"B`\=&%B;&4@F5D('!R:6YC:7!A;`T* M('!A>6UE;G1S(&%R92!M861E(&]N(&$@;6]N=&AL>2!B87-I6QE/3-$)T)/ M4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H:7,@;&]A;B!W87,@28C>$$P.S$P+"`R,#$U+"!U=&EL:7II;F<@9G5N M9',@8F]R2X\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'1A8FQE M('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E=E(&5X<&5C="!T:&5S M92!L;V%N'0^/&1I M=CX-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU4 M3U`Z(#!P>#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(P,34H82D\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,38\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,RPV M,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$W/"]F;VYT/CPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C(R+#8U.#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G M8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3D\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXS+#0V,SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA=&5R/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P M="!S;VQI9#L@34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!7 M24142#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/ M4D1%4BU#3TQ,05!313H@8V]L;&%P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/DEN9F]R;6%T:6]N#0H@ M=VET:"!R97-P96-T('1O('1H97-E(&]P=&EO;G,L(&)E9F]R92!A9&IUF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%PF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYU;6)E&5R8VES93QB MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.U)A;F=E/&)R("\^ M#0H@*$AI9V@M3&]W*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)A;&%N8V4L($IA;G5A6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXU,2PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V+C4S+R0R M-BXP.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D5X97)C:7-E9#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@X+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C(V+C6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"86QA;F-E+"!*86YU87)Y M)B-X03`[,2P-"B`R,#$S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`S96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY%>&5R8VES960\+V9O;G0^/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXH,RPP,#`\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXI)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T28C>$$P.S$L#0H@,C`Q-#PO9F]N=#X\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C0P+#`P,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U+C8U M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D]U='-T86YD:6YG(&]P=&EO;G,@=F5S=&5D#0H@86YD(&5X97)C:7-A M8FQE(&%S(&]F($1E8V5M8F5R)B-X03`[,S$L(#(P,30\+V9O;G0^/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS-BPP,#`\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,T+CDP+R0S-BXU,SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0^/&1I=CX-"B`\<"!S='EL93TS1"=-05)'24XM M0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY4:&4@9F]L;&]W:6YG#0H@=&%B;&4@<')O=FED97,@ M:6YF;W)M871I;VX@86)O=70@;W!T:6]N&5R8VES86)L92!O<'1I;VYS(&%T($1E8V5M8F5R)B-X03`[,S$L(#(P,30Z M/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[ M($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D]P=&EO;G,\8G(@+SX-"B!/=71S=&%N9&EN9SQB M$$P.T5X97)C:7-A8FQE/"]B/CPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@&5R8VES90T*('!R:6-E/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,U+CDT/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0S."PT,S`\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY796EG:'1E9"!A=F5R86=E(')E M;6%I;FEN9PT*(&-O;G1R86-T=6%L(&QI9F4\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+C8\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`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`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`^#0H@/'`@3I4:6UEF4],T0R/B0S-BXU,R8C>$$P.RTD,S8N-3,\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E1O=&%L/"]F;VYT/CPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3I4:6UEF4],T0R/C,V+#`P,#PO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,U M+CDT/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE M.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAAF5D($9I;F%N8VEA;"!);F9O'0^/&1I=CX-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY0"<^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED.R!724142#H@-3EP="<^#0H@/&9O;G0@$$P.W1O M/&)R("\^#0H@;6EN;W)I='D\8G(@+SX-"B!I;G1E2!/=VYE9"!B>2!,3$,\+V(^/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F$\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DIA;G5A$$P.S(P,30\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY3<&%R:W,@365D:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DIA;G5A6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D1634,@4')O M<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CDP/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY!=6=U6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-A;G1A($9E#0H@4V-O='1S9&%L93PO9F]N M=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U9W5S="`Q M+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E)O#(P,3D[6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY!=6=U6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E-I97)R82!-961I8V%L#0H@ M4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY0 M0T@@4V]U=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E!H;V5N:7@F(WA!,#M#:&EL9')E;B8C>#(P,3D[$$P.T5A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!=6=U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,X,3$F(WA! M,#M"96QL)B-X03`[365D:6-A;"8C>$$P.U!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F$\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D%U9W5S="`Q+"`R,#$T M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@1D].5"U325I%.B`Q<'@[($U!4D=)3BU43U`Z(#$R<'@G/@T*("8C>$$P M.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=) M3BU43U`Z(#!P>#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@ M9F]L;&]W:6YG#0H@<')O<&5R='D@=&%B;&4@"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/D]W;F5RF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E-U8G5R8F%N#0H@4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DUI9"!#;V%S="!(;W-P:71A;"!-3T(\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!$$P.RAB+BD\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M=&]P/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1T;W`@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW-3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1T;W`@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@28C>#(P,3D[6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY'6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1E M>&]M828C>$$P.TUE9&EC86PF(WA!,#M0;&%Z83PO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D946"!-3T(@4&AA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D9O28C>$$P.TUE9&EC86PF(WA! M,#M0;&%Z828C>$$P.TE)/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]21$52+4)/ M5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/4#H@,'!X.R!, M24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@ M/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H:7,@3$Q# M(&AA6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAB M+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY792!H879E(&9U;F1E9"`D-2XR(&UI;&QI;VX-"B!I;B!E M<75I='D@87,@;V8@1&5C96UB97(F(WA!,#LS,2P@,C`Q-"!A;F0@87)E(&-O M;6UI='1E9"!T;R!I;G9E2!T97)M#0H@;&]A M;B!O9B`D,C,N,R8C>$$P.VUI;&QI;VXL('=H:6-H(&ES(&YO;BUR96-O=7)S M92!T;R!U$$P.S,Q M+"`R,#$T+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\=&%B M;&4@$$P.S,Q+"`R,#$T/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAD+BD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY792!H879E(&-O;6UI='1E9"!T;R!I;G9E6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)E;&]W(&%R92!T:&4-"B!C;VUB:6YE9"!S M=&%T96UE;G1S(&]F(&EN8V]M92!F;W(@=&AE($Q,0W,@86-C;W5N=&5D(&9O M2!M971H;V0I+B!4:&4@9&%T82!F;W(@=&AE('EE87(@96YD960- M"B!$96-E;6)E$$P.S,Q+"`R,#$R(&EN8VQU9&5S('1H92!PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P,3,H8RXI M/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M$$P.RAD+BD\+V(^/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`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`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXT+#`S.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);G1EF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C8L,S4S/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXV+#`U-CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(L,C$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY/=7(@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(L,#DU/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D]UF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L M-3(P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\=&%B;&4@2!U&EM871E;'D@)#@S-"PP,#`L("0Q+CD-"B!M:6QL:6]N M(&%N9"`D,2XU(&UI;&QI;VXL(')E2X\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%S(&UE;G1I;VYE9"!A8F]V92P@=V4-"B!B96=A;B!T M;R!A8V-O=6YT(&9O2!-961I8V%L M($-E;G1EF$L(%)O#(P,3D[F$I#0H@;VX@ M82!C;VYS;VQI9&%T960@8F%S:7,@87,@;V8@075G=7-T)B-X03`[,2P@,C`Q M-"X@4')I;W(@=&\-"B!!=6=U6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/BAC+BD\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY!2!M971H;V0@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S:7,N M(%1H97-E(&%M;W5N=',@:6YC;'5D92!T:&4-"B!F:6YA;F-I86P@2!O=VYE"!,3$-S(&5F9F5C=&EV92!!=6=U2UO=VYE9"!S=6)S M:61I87)Y(&]F(%5(4R!W:&EC:`T*(&5X<&ER960@969F96-T:79E(&%S(&]F M($IU;'DF(WA!,#LQ+"`R,#$S+"!T:&4@9FEN86YC:6%L(')E$$P.S,Q+"`R M,#$S+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\=&%B;&4@ M6]N($AE86QT M:&-A2!A8V-O=6YT960@9F]R(&]N(&%N#0H@ M=6YC;VYS;VQI9&%T960@8F%S:7,@=6YD97(@=&AE(&5Q=6ET>2!M971H;V0N M/"]F;VYT/CPO=&0^#0H@/"]T'0^/&1I=CX-"B`\<"!S='EL93TS M1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@5$585"U) M3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"96QO=R!A2!M971H;V0@87,@;V8@1&5C M96UB97(F(WA!,#LS,2P@,C`Q-"!A;F0@,C`Q,SH\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S M='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P,3,H82XI*&(N*3PO8CX\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/BAA;6]U;G1S(&EN#0H@=&AO M=7-A;F1S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!P2P@:6YC;'5D:6YG#0H@0TE0/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C8R+#0U,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q.2PU-#<\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY/=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW+#,V-SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8Y+#@Q-SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R.2PP,C8\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT"<^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQI86)I M;&ET:65S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L M,S0X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`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`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8Y M+#@Q-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R.2PP,C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D]UF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,Y M+#(P,3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P M>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE. M+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F M(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E1H92!A;6]U;G1S('!R97-E;G1E9`T*(&EN8VQU9&4@=&AE(&)A;&%N M8V4@$$P.S,Q+"`R,#$T+CPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\=&%B;&4@#(P,3D[F$I(&]N(&$@8V]N M2!M971H;V0@87,@;V8@1&5C96UB97(F(WA!,#LS M,2P@,C`Q,RX\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!5;F-O;G-O M;&ED871E9"!,3$,G'0^/&1I=CX-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@5$58 M5"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!2!M971H;V0@86YD(&%R92!N;VXM6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT M86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4S,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-% M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(P,3@\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXT-#4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$Y/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,2PW,C@\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT"<^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY4;W1A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T M86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB M/DUO28C>$$P.T1A=&4\+V(^/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D946"!-3T(@4&AAF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U9W5S="P@,C`Q-SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D=R87ES;VX@4')O<&5R=&EE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ-"PX.3,\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E-E<'1E;6)EF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1E8V5M8F5R+"`R,#(T/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,"XU<'0@#L@3$E.12U( M14E'2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L M92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!;&P@;6]R=&=A9V4@ M;&]A;G,@6UE;G1S('1H M6UE;G0@=7!O;B!M871U2X\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#PO=&%B;&4^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E(&)E;&EE=F4@=&AE('1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/BAD+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY4:&ES(&QO86X@=V%S(')E9FEN86YC960@:6X- M"B!397!T96UB97(L(#(P,30L(&9O28C>$$P M.S$L(#(P,34@=&AR;W5G:"!$96-E;6)E$$P.S,Q+"`R,#(T+CPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!297-U;'1S(&9O'0^/&1I=CX-"B`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`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)VUA3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#`X M/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$S+#`Y.3PO M9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C(U+#0P.3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/DYE="!I;F-O;64\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/C,L-SF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VUAF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/C`N,C8\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,N M.3D\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)VUA3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C(N,3@\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4Z,7!X/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X- M"B`\<"!S='EL93TS1"=L:6YE+6AE:6=H=#HX<'@[;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HR<'@[8F]R9&5R+6)O='1O;3HP+C5P="!S;VQI9"`C M,#`P,#`P.W=I9'1H.C$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL M93TS1$)/4D1%4BU#3TQ,05!313I#3TQ,05!312!B;W)D97(],T0P(&-E;&QP M861D:6YG/3-$,"!C96QL6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@28C>$$P.S$L(#(P,30N($%D9&ET:6]N86QL>2P@=V4- M"B!B96=A;B!T;R!A8V-O=6YT(&9O2!-961I8V%L($-E;G1EF$L(%)O#(P,3D[F$I#0H@;VX@82!C;VYS;VQI9&%T960@8F%S:7,@87,@;V8@075G=7-T)B-X M03`[,2P@,C`Q-"X\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@ M/'`@#MM87)G:6XM8F]T=&]M.C!P>#X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!C96QL M6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&%L:6=N M/3-$8V5N=&5R/@T*(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UE MF4],T0Q/CQB/D9IF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/E-E8V]N9#QBF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E)E=F5N M=65S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@3I4:6UEF4],T0R/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#(W/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#DX/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\ M+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\+V9O;G0^ M/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V)O6QE M/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C,\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/C$N,#0\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO<#X-"B`\=&%B;&4@3I4:6UEF4],T0R/BAA+BD\ M+V9O;G0^/"]T9#X-"B`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/E=E(&)E9V%N(')E9FQE8W1I;F<@=&AE#0H@;W!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3QB'!E;G-E+"!I;G1A;F=I8FQE(&%S'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&-I&-E961S(&-A2UO=VYE M9"!,3$-S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2XT/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!I;G1E2!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#;VUP M86YI97,@?"!-87AI;75M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\2!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!$97!A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^,C4@>65A&EM=6T\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S4@>65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!#;VUP86YI97,\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!M96UB97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!O=VYE'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!43QB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^5&AE("!D96-R96%S92!D M=7)I;F<@,C`Q-"!A3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F964@87,@<&5R8V5N=&%G92!O9B!O M9B!A=F5R86=E(&EN=F5S=&5D(')E86P@97-T871E(&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!F964\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!4'0^,3,@>65A&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!4'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&]M82!-961I8V%L(%!R;W!E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!T97)M(&QO M86X\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!#;VUP86YI97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!A9W)E96UE;G0@97AP:7)A=&EO M;B!D871E(&]F(&5A8V@@>65A'0^+2TQ,BTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,3`@>65A2!$97!A2!4'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^,C`U-#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E M7V$W8S5?960Q-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^,C`Q-BTQ,CQS<&%N M/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^06-U=&4@0V%R M93QS<&%N/CPO'0^,C`Q-BTQ M,CQS<&%N/CPO2!#86UP=7,\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^06-U=&4@0V%R93QS<&%N/CPO'0^,34@>65A&ES=&EN9R!L M96%S92!R871E'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA&ES=&EN9R!,96%S92!497)M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&ES=&EN M9R!L96%S92!R871E'0^ M-2!Y96%R65A'0^,C`S,3QS<&%N/CPO'0^-2!Y96%R'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA3QB'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O=VYE'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!D871E M+"!N;W1E2!P87)E;G0\+W1D/@T*("`@("`@("`\=&0@8VQA M2UO=VYE9"!,3$-S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PP.3,L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!$97!A'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-"!Y96%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I;G1E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F%T:6]N(%)A M=&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3`@>65A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`Q-"TQ,CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6]N M($AE86QT:&-AF$\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$6UE;G0@;V8@<')E=FEO=7-L>2!P'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7,\ M7,\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y M96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#96YT97(\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$65A7,\ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7,\7,\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$65A65A2`Q+"`R,#$T($%C<75I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$65A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&0@8V]L2!-961I8V%L($-E;G1E"!#:&EL9')E;B=S M($5A2`Q+"`R,#$T+"!T:&4@9FEN86YC:6%L(')E M65A2UO=VYE M9"!S=6)S:61I87)Y(&]F(%5(4R!W:&EC:"!E>'!I2!A M"UM M;VYT:"!P97)I;V0@;V8@2G5L>2`Q+"`R,#$S('1H2!);G9E M7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E M,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5? M960Q-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA2!I;G1E2!/=VYE9"!B>2!,3$,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F$\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^075G(#$L#0H) M"3(P,30\'0^4VEEF$\'0^4&AO96YI>"!#:&EL M9')E;B=S($5A'0^075G(#$L#0H)"3(P M,30\'0^3F]R=&@@5F%L;&5Y($UE9&EC86P@4&QA>F$\ M2!I;G1E2!/=VYE9"!B>2!,3$,\ M+W1D/@T*("`@("`@("`\=&0@8VQAF$\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^2F%N(#$L#0H)"3(P,30\ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N(%)A=&4\F%T:6]N(%)A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA&%S(%!R M;V9EF%T:6]N(%)A M=&4\F%T M:6]N(%)A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A65A'0^,34@>65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V M8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1? M,39B85\T83)E7V$W8S5?960Q-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^2F%N(#4L#0H)"3(P,34\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2F%N(#$S M+`T*"0DR,#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^2F%N(#$S+`T*"0DR,#$W/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!P97)I;V0\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^2G5L(#(T+`T*"0DR M,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!A9&1I=&EO;F%L(&%M M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S"!M;VYT:"!,24)/ M4B!P;'5S(&%N(&%P<&QI8V%B;&4@;6%R9VEN(')A;F=I;F<@(&9R;VT@,2XW M-24@=&\@,BXU,"4@;W(@870@=&AE($)A'0^1W)E871E6%B;&4@;VX@=6YU M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE M;G1S(&%R92!M861E(&]N(&$@;6]N=&AL>2!B87-I7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-L=61I;F<@3F5T($1E8G0@ M4')E;6EU;2`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H;W5S86YD&5D(')A=&4@;6]R=&=A9V4@;&]A;CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2!-961I8V%L($-E;G1E2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#$U+3$P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF$@9FEX960@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,C`Q-2TQ,#QS<&%N/CPO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XR,#$V+3$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`Q-RTP-CQS M<&%N/CPO&5D(')A=&4@;6]R M=&=A9V4@;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XR,#$W+3$P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`Q-RTQ,CQS<&%N/CPO'0^,C`Q."TP,3QS M<&%N/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF$@1FEX960@ M4F%T92!-;W)T9V%G92!,;V%N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,C`Q."TP-3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^,C`Q.2TP-SQS<&%N/CPO&5D(')A=&4@;6]R=&=A9V4@;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!$871E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XR,#(R+3$R/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S&5D M(')A=&4@;6]R=&=A9V4@;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`R-2TP-CQS<&%N/CPOFEN9R!F M=6YD2X\+W1D/@T*("`@("`@/"]T'!E8W0@=&AE2!D871E M(&EN($]C=&]B97(L(#(P,34L('1O(&)E(')E9FEN86YC960@870@=&AE('1H M96X@8W5RFEN9R!F=6YD7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6YC:#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA2!);F-E;G1I M=F4@4&QA;B!;3&EN92!)=&5M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5R8VES960@9'5R:6YG('1H92!P97)I M;V0L('-H87)E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,C`Q-2TP-CQS<&%N/CPO'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!);F-E M;G1I=F4@4&QA;B!;3&EN92!)=&5M65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A7,\'10 M87)T7V4S.3DU8F0T7S$V8F%?-&$R95]A-V,U7V5D,35A839C-30R,0T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E,SDY-6)D-%\Q-F)A7S1A,F5? M83=C-5]E9#$U86$V8S4T,C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5R8VES92!W96EG:'1E9"!A=F5R86=E M('!R:6-E+"!O=71S=&%N9&EN9R!O<'1I;VX@17AE6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5R8VES960\+W1D/@T*("`@("`@("`\=&0@ M8VQA'1087)T M7V4S.3DU8F0T7S$V8F%?-&$R95]A-V,U7V5D,35A839C-30R,0T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C M-5]E9#$U86$V8S4T,C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA65A7,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5R8VES86)L92`H1&5T86EL*2`H55-$("0I/&)R/CPO&5R8VES92!0F5D M('5N9&5R(%-T;V-K($]P=&EO;B!0;&%N'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!P&5R8VES92!P'0^,B!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,2!Y96%R(#<@;6]N M=&AS(#8@9&%Y7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!!9F9I;&EA=&5S M("T@061D:71I;VYA;"!);F9O2!O=VYE'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!M96UB97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\2!O=VYE2!O=VYE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!M96UB97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\7,@9F]R($YO;BU/9F9E7,\2!#;VUP86YI97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!M96UB97)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!-971H;V0@26YV97-T;65N M=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\7,@9F]R($YO;BU/9F9E7,\&EM=6T@?"!,:6UI=&5D($QI86)I;&ET>2!# M;VUP86YI97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!M96UB97)S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!#;VUP86YI97,@06-C;W5N=&5D(&9O M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S2!-971H M;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQAF$@24D\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!-971H;V0@26YV97-T;65N=',@6TQI M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\'0^5&5X;VUA($UE9&EC86P@4&QA>F$\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^075G(#$L#0H)"3(P,30\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF$\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!- M971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA MF$\ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!/=VYE9"!B>2!,3$,\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^ M075G(#$L#0H)"3(P,30\'0^4&AO96YI>"!# M:&EL9')E;B=S($5A'0^075G(#$L#0H)"3(P,30\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2F%N(#$L#0H) M"3(P,30\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^2F%N(#$L#0H)"3(P,30\2!T97)M(&QO86X@;V8@)#DN,"!M:6QL:6]N+"!W:&EC:"!I2!T97)M(&QO86X@;V8@)#(S+C,@;6EL;&EO;BP@=VAI8V@@:7,@;F]N M+7)E8V]U3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q-F)A7S1A,F5?83=C M-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A-F,U-#(Q+U=O'0O:'1M;#L@8VAA M2!A;F0@9&5B="!F:6YA;F-I;F7-O;B!0'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!T97)M(&QO86X\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!-971H;V0@26YV97-T;65N=',@6TQI;F4@ M271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!-971H;V0@*$1E=&%I;"D@*%531"`D*3QB2!-971H M;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR+#DV M.#QS<&%N/CPO2!-961I8V%L($-E;G1E"!# M:&EL9')E;B=S($5A2!M971H;V0@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S:7,N(%1H92!Y M96%R(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$T+"!I;F-L=61E('1H92!F:6YA M;F-I86P@2`S,2P@,C`Q-"X\+W1D/@T*("`@("`@ M/"]T2`Q+"`R M,#$T+B!02!W97)E(&%C8V]U;G1E9"!F;W(@=6YD M97(@=&AE(&5Q=6ET>2!M971H;V0@;VX@86X@=6YC;VYS;VQI9&%T960@8F%S M:7,N(%1H97-E(&%M;W5N=',@:6YC;'5D92!T:&4@9FEN86YC:6%L(')E2!O=VYE9"!V87)I;W5S(&YO M;F-O;G1R;VQL:6YG+"!M86IO2!O=VYE2X@3W5R M('-H87)E(&]F('1H92!F:6YA;F-I86P@2!M971H M;V0N/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA2X\+W1D/@T*("`@("`@/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-961I8V%L($-E M;G1E"!#:&EL9')E;B=S($5A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D M-%\Q-F)A7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A M-F,U-#(Q+U=O'0O:'1M;#L@8VAA2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,C`Q M-2TQ,#QS<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!$ M871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#(Q+3`Y/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-971H;V0@26YV97-T;65N=',@?"!"'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^,C`R-"TQ,CQS M<&%N/CPO'!E8W0@=&\@FEN9R!F=6YD65A"!M;VYT:',L(&%N9"!F:7AE9"!R871E(&]F(#,N-C0E(&-O;6UE;F-I M;F<@2G5L>2`Q+"`R,#$U('1H'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6%B;&4@8GD@56YC;VYS;VQI9&%T960@3$Q# M2!-971H;V0@*%!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!-971H;V0@26YV M97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'1E;G-I;VX@;W!T:6]N2!-971H;V0@26YV97-T;65N=',@?"!"'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!-971H;V0@26YV97-T M;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\2`Q M+"`R,#$U('1H'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A&EM=6T@?"!!3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q-F)A M7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A-F,U-#(Q M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!297-U M;'1S("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!E>&-E<'0@ M4&5R(%-H87)E(&1A=&$L('5N;&5S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!I;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2P@=V4@8F5G86X@=&\@86-C;W5N="!F;W(@F$L(%!H;V5N:7@@ M0VAI;&1R96XG2!#87)E($-E;G1E2`Q+"`R,#$S+"!T:&4@9FEN86YC:6%L(')EF$N(%1H97)E M('=A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,SDY-6)D-%\Q-F)A M7S1A,F5?83=C-5]E9#$U86$V8S4T,C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO93,Y.35B9#1?,39B85\T83)E7V$W8S5?960Q-6%A-F,U-#(Q M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&%S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^,3DY-#QS<&%N/CPO'0^,3DX-CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-#`@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3DY,SQS<&%N/CPO'0^ M,3DX-CQS<&%N/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-#4@>65A2U397EB;VQD M($-L:6YI8R!A="!+:6YG)W,@0W)O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,3DY-3QS<&%N/CPO'0^,3DY-3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^-#4@>65A6QV86YI83PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,3DY-CQS<&%N/CPO'0^,3DY-CQS<&%N/CPO6QV86YI83PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^-#4@>65A6QV86YI83PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^-#4@>65A6QV86YI83PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^-#4@>65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,3DY-CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^,C`P,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M,S4@>65A&%S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,S4@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C4@>65A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,3DY M.3QS<&%N/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2P@0V]N;F5C=&EC=70\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,C`P.#QS<&%N/CPO'0^,C`P.#QS<&%N/CPOF$@07!A8VAE($IU;F-T M:6]N+"!!6CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^,C`P.3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,3DY.#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`P-#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^,3DY.3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S`@>65A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^,C`P,#QS M<&%N/CPO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`P.3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S4@ M>65A2!- M961I8V%L(%!L87IA($9O2P@5%@\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S4@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,3QS<&%N/CPO'0^,C`Q,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S4@>65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,S4@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3DY-CQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^,C`Q-#QS<&%N/CPO'0^,C`Q-#QS<&%N/CPOF$L(%!H;V5N M:7@L($%:/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S`@ M>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,S4@>65AF$L(%!H;V5N:7@L($%: M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`P,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#87)E($-E M;G1E"P@05H\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F$L(%-C;W1T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3DY M.3QS<&%N/CPO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^,S`@>65AF$L($9O;G1A;F$L($-!/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^,C`P.#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!D96)T('1H870@:7,@;F]N+7)E M8V]UF5D+V1I=F5S=&5D('-U8G-E<75E;G0@=&\@ M86-Q=6ES:71I;VXN/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`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`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A M9&1I=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2UO=VYE9"!S=6)S M:61I87)Y(&]F(%5(4R!R96QA=&5D('1O(%!A;&UD86QE($UE9&EC86P@4')O M<&5R=&EE'!I2!A;F0@075G=7-T+"`R,#$T*2!I;B!W:&EC:"!W92!P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC XML 35 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]    
Outstanding borrowings under revolving credit agreement $ 89,750,000us-gaap_LineOfCredit $ 93,700,000us-gaap_LineOfCredit
Revolving credit agreement value $ 150,000,000us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity  

XML 36 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Relationship with UHS and Related Party Transactions - Additional Information (Detail) (USD $)
12 Months Ended 0 Months Ended 1 Months Ended 2 Months Ended 60 Months Ended
Dec. 31, 2014
Property
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2014
Dec. 31, 2014
Feb. 28, 2015
Property
Times
sqft
Mar. 06, 2015
Property
Times
sqft
Dec. 31, 2014
Aug. 01, 2014
Jan. 01, 2014
Property
Related Party Transaction [Line Items]                    
Number of real estate investments 61us-gaap_NumberOfRealEstateProperties     61us-gaap_NumberOfRealEstateProperties 61us-gaap_NumberOfRealEstateProperties     61us-gaap_NumberOfRealEstateProperties    
Acquisition of Third-party minority ownership interest The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests.                  
Sales proceeds from divestiture of real property $ 17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment $ 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment $ 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment              
Non-controlling interest percentage 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent     100.00%us-gaap_MinorityInterestOwnershipPercentageByParent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent     100.00%us-gaap_MinorityInterestOwnershipPercentageByParent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent  
Annual advisory fee as percentage of of average invested real estate assets 0.70%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets 0.70%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets 0.65%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets 0.70%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets 0.70%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets     0.70%uht_AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets    
Advisory fee 2,545,000us-gaap_OwnedPropertyManagementCosts 2,369,000us-gaap_OwnedPropertyManagementCosts 2,119,000us-gaap_OwnedPropertyManagementCosts              
Minimum                    
Related Party Transaction [Line Items]                    
Non-controlling equity interest, ownership percentage 33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
    33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
    33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
   
Maximum                    
Related Party Transaction [Line Items]                    
Number of term renewal options 5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
    5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
    5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
   
Non-controlling equity interest, ownership percentage 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
    95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
    95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
   
Universal Health Services, Inc                    
Related Party Transaction [Line Items]                    
Number of term renewal options 6uht_NumberOfRenewalOptions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
    6uht_NumberOfRenewalOptions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
6uht_NumberOfRenewalOptions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
    6uht_NumberOfRenewalOptions
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
   
Additional renewal terms 5 years                  
Number of office buildings, owned by LLCs, in which the company holds ownership interest 15uht_NumberOfLeasedProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
                 
Option to renew lease, notice period prior to termination date of current term 90 days                  
Period to purchase respective leased facilities at same price after lease terms 180 days                  
Renewal period of respective leased facilities at same price after lease terms 180 days                  
Percentage ownership of outstanding shares 5.90%uht_PercentageOfOwnershipInterestRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
6.10%uht_PercentageOfOwnershipInterestRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
  5.90%uht_PercentageOfOwnershipInterestRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
5.90%uht_PercentageOfOwnershipInterestRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
    5.90%uht_PercentageOfOwnershipInterestRelatedParties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
   
Universal Health Services, Inc | Minimum                    
Related Party Transaction [Line Items]                    
Initial lease terms 13 years                  
Universal Health Services, Inc | Maximum                    
Related Party Transaction [Line Items]                    
Initial lease terms 15 years                  
Limited Liability Companies                    
Related Party Transaction [Line Items]                    
Number of real estate investments 8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
    8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
    8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
6us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
The Bridgeway                    
Related Party Transaction [Line Items]                    
Amount of annual lease earned 1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
             
Lease term scheduled end date 2014-12                  
Sales proceeds from divestiture of real property       17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
         
Gain on divestiture of property 13,000,000us-gaap_GainLossOnDispositionOfAssets
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
                 
Mission and Weslaco Freestanding Emergency Departments                    
Related Party Transaction [Line Items]                    
Number of real estate investments 3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
    3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
    3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
   
Texoma Medical Properties                    
Related Party Transaction [Line Items]                    
Non-controlling interest percentage 95.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    95.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
95.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    95.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
   
Committed investment in equity, funded 2,600,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    2,600,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
2,600,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    2,600,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
   
Committed investment in equity and debt financing 400,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    400,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
400,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    400,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
   
Third-party term loan 14,900,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    14,900,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
14,900,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
    14,900,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_TexomaMedicalPropertiesMember
   
Palmdale Medical Properties and Sparks Medical Properties                    
Related Party Transaction [Line Items]                    
Number of real estate investments   2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
              2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
Non-controlling interest percentage 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
    100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
    100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
   
Palmdale Medical Properties and Sparks Medical Properties | Limited Liability Companies                    
Related Party Transaction [Line Items]                    
Non-controlling interest percentage                 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
Universal Health Services of Delaware Inc                    
Related Party Transaction [Line Items]                    
Advisory agreement expiration date of each year --12-31                  
Annual incentive fee to Advisor as percentage of cash available for distribution 20.00%uht_PercentageOfCashAvailableInExcessOfTargetDistributionPaidForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
    20.00%uht_PercentageOfCashAvailableInExcessOfTargetDistributionPaidForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
20.00%uht_PercentageOfCashAvailableInExcessOfTargetDistributionPaidForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
    20.00%uht_PercentageOfCashAvailableInExcessOfTargetDistributionPaidForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
   
Advisory fee 2,500,000us-gaap_OwnedPropertyManagementCosts
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
2,400,000us-gaap_OwnedPropertyManagementCosts
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
2,100,000us-gaap_OwnedPropertyManagementCosts
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
             
Average invested real estate assets 363,000,000uht_AverageInvestedRealEstateAssets
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
338,000,000uht_AverageInvestedRealEstateAssets
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
326,000,000uht_AverageInvestedRealEstateAssets
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
             
Universal Health Services of Delaware Inc | Minimum                    
Related Party Transaction [Line Items]                    
Percentage of equity to be exceeded for incentive distribution 15.00%uht_PercentageOfTargetDistributionMustBeExceededByForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
    15.00%uht_PercentageOfTargetDistributionMustBeExceededByForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
15.00%uht_PercentageOfTargetDistributionMustBeExceededByForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
    15.00%uht_PercentageOfTargetDistributionMustBeExceededByForIncentiveDistributions
/ dei_LegalEntityAxis
= uht_UniversalHealthServicesOfDelawareIncMember
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
   
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments                    
Related Party Transaction [Line Items]                    
Number of term renewal options           6uht_NumberOfRenewalOptions
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
6uht_NumberOfRenewalOptions
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Additional renewal terms           5 years 5 years      
Number of real properties purchased           2uht_NumberOfRealEstatePropertiesAcquired
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
2uht_NumberOfRealEstatePropertiesAcquired
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Area of acquired building           13,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
13,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Lease agreement period           10 years 10 years      
Estimated acquisition cost of free-standing emergency departments             12,800,000uht_BusinessAcquisitionEstimatedCostOfAcquisition
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Estimated rental revenues           $ 900,000uht_EstimatedRevenueDueToBusinessAcquisition
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
$ 900,000uht_EstimatedRevenueDueToBusinessAcquisition
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments | First four renewal options                    
Related Party Transaction [Line Items]                    
Percentage increase in annual lease rate             2.00%uht_PercentAnnualLeaseAmountIncrease
/ us-gaap_LeaseArrangementTypeAxis
= uht_OptionOneMember
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments | First four renewal options | Minimum                    
Related Party Transaction [Line Items]                    
Additional renewal terms, covering year             2025      
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments | First four renewal options | Maximum                    
Related Party Transaction [Line Items]                    
Additional renewal terms, covering year             2044      
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments | Last two renewal options | Minimum                    
Related Party Transaction [Line Items]                    
Additional renewal terms, covering year             2045      
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments | Last two renewal options | Maximum                    
Related Party Transaction [Line Items]                    
Additional renewal terms, covering year             2054      
Revenues | Universal Health Services, Inc                    
Related Party Transaction [Line Items]                    
Percentage of revenues generated from leases 28.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_RevenueMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
30.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_RevenueMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
30.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_RevenueMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
        36.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_RevenueMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
   
Combined consolidated and unconsolidated revenue | Universal Health Services, Inc                    
Related Party Transaction [Line Items]                    
Percentage of revenues generated from leases 22.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_CombinedMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
22.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_CombinedMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
21.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_CombinedMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
        20.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= uht_CombinedMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
   
XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
State
Property
Dec. 31, 2013
Dec. 31, 2012
Aug. 01, 2014
Jan. 01, 2014
Property
Significant Accounting Policies [Line Items]          
Number of real estate investments 61us-gaap_NumberOfRealEstateProperties        
Number of states that real estate investments are located 18us-gaap_NumberOfStatesInWhichEntityOperates        
Amortization expense, intangible assets $ 6.1us-gaap_AmortizationOfIntangibleAssets $ 6.0us-gaap_AmortizationOfIntangibleAssets $ 7.8us-gaap_AmortizationOfIntangibleAssets    
Intangible assets, estimated aggregate amortization expenses for 2015 5.6us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths        
Intangible assets, estimated aggregate amortization expenses for 2016 4.5us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo        
Intangible assets, estimated aggregate amortization expenses for 2017 3.9us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree        
Intangible assets, estimated aggregate amortization expenses for 2018 2.5us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour        
Intangible assets, estimated aggregate amortization expenses for 2019 1.9us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive        
Depreciation expense 14.4us-gaap_Depreciation 12.5us-gaap_Depreciation 12.2us-gaap_Depreciation    
Percentage of minority ownership interests by parent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent     100.00%us-gaap_MinorityInterestOwnershipPercentageByParent  
Federal excise tax rate when amount of 85% of ordinary income plus 95% of any capital gain income exceeds cash distributions 4.00%uht_FederalExciseTaxRate        
Net gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs 25.4us-gaap_BusinessCombinationBargainPurchaseGainRecognizedAmount        
Minimum          
Significant Accounting Policies [Line Items]          
Non-controlling equity interest, ownership percentage 33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
       
Percentage of minority ownership purchased from third-party members       5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
 
Percentage of real estate investment taxable income that should be distributed to remain exempt from federal income taxes 90.00%uht_PercentageOfTaxableIncomeToBeDistributedForFederalIncomeTaxExemption
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
       
Maximum          
Significant Accounting Policies [Line Items]          
Non-controlling equity interest, ownership percentage 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
       
Percentage of minority ownership purchased from third-party members       15.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
 
Limited Liability Companies          
Significant Accounting Policies [Line Items]          
Number of real estate investments 8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
    6us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
Limited Liability Companies | Minimum          
Significant Accounting Policies [Line Items]          
Percentage of minority ownership purchased from third-party members       5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
Limited Liability Companies | Maximum          
Significant Accounting Policies [Line Items]          
Percentage of minority ownership purchased from third-party members       15.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
Hospitals          
Significant Accounting Policies [Line Items]          
Number of real estate investments 6us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_HospitalsMember
       
Hospitals | Acute Care          
Significant Accounting Policies [Line Items]          
Number of real estate investments 3us-gaap_NumberOfRealEstateProperties
/ us-gaap_MajorPropertyClassAxis
= uht_AcuteCareCenterMember
/ us-gaap_RealEstatePropertiesAxis
= uht_HospitalsMember
       
Hospitals | Rehabilitation          
Significant Accounting Policies [Line Items]          
Number of real estate investments 1us-gaap_NumberOfRealEstateProperties
/ us-gaap_MajorPropertyClassAxis
= uht_RehabilitationCenterMember
/ us-gaap_RealEstatePropertiesAxis
= uht_HospitalsMember
       
Hospitals | Sub-acute          
Significant Accounting Policies [Line Items]          
Number of real estate investments 2us-gaap_NumberOfRealEstateProperties
/ us-gaap_MajorPropertyClassAxis
= uht_SubacuteCenterMember
/ us-gaap_RealEstatePropertiesAxis
= uht_HospitalsMember
       
Mission and Weslaco Freestanding Emergency Departments          
Significant Accounting Policies [Line Items]          
Number of real estate investments 3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
       
Medical office buildings          
Significant Accounting Policies [Line Items]          
Number of real estate investments 48us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_MedicalOfficeBuildingsMember
       
Medical office buildings | Majority-Owned Subsidiary, Unconsolidated          
Significant Accounting Policies [Line Items]          
Number of real estate investments 5us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_MedicalOfficeBuildingsMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_MajorityOwnedSubsidiaryUnconsolidatedMember
       
Medical office buildings | Limited Liability Companies          
Significant Accounting Policies [Line Items]          
Number of real estate investments 5us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_MedicalOfficeBuildingsMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
       
Preschool and childcare Centers          
Significant Accounting Policies [Line Items]          
Number of real estate investments 4us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_PreschoolAndChildcareCenterMember
       
Buildings | Minimum          
Significant Accounting Policies [Line Items]          
Estimated original useful lives of property plant and equipment 25 years        
Buildings | Maximum          
Significant Accounting Policies [Line Items]          
Estimated original useful lives of property plant and equipment 45 years        
Capital Improvements | Minimum          
Significant Accounting Policies [Line Items]          
Estimated original useful lives of property plant and equipment 3 years        
Capital Improvements | Maximum          
Significant Accounting Policies [Line Items]          
Estimated original useful lives of property plant and equipment 35 years        
Palmdale Medical Properties and Sparks Medical Properties          
Significant Accounting Policies [Line Items]          
Number of real estate investments   2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
    2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
Percentage of minority ownership purchased from third-party members         5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
Percentage of minority ownership interests by parent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
       
Palmdale Medical Properties and Sparks Medical Properties | Limited Liability Companies          
Significant Accounting Policies [Line Items]          
Percentage of minority ownership purchased from third-party members         5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
Percentage of minority ownership interests by parent       100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
In Place Leases          
Significant Accounting Policies [Line Items]          
Intangible asset, useful life 4 years 4 months 24 days        
Gross          
Significant Accounting Policies [Line Items]          
Gross cost basis and net book value of properties for federal income tax purposes 469us-gaap_RealEstateFederalIncomeTaxBasis
/ us-gaap_StatementScenarioAxis
= uht_GrossMember
       
Net          
Significant Accounting Policies [Line Items]          
Gross cost basis and net book value of properties for federal income tax purposes $ 316us-gaap_RealEstateFederalIncomeTaxBasis
/ us-gaap_StatementScenarioAxis
= uht_NetMember
       
XML 38 R56.htm IDEA: XBRL DOCUMENT v2.4.1.9
Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail)
12 Months Ended
Dec. 31, 2014
Option
Equity Method Investments | Grayson Properties  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, term 7 years
Refinance of loan, interest rate 5.034%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_GraysonPropertiesMember
Refinancing of loan, number of extension options 2uht_DebtInstrumentNumberOfExtensionOptions
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_GraysonPropertiesMember
Refinancing of loan, extension option term in years 1 year
Equity Method Investments | Brunswick Associates  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, term 10 years
Equity Method Investments | Brunswick Associates | Fixed rate for initial six months  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, interest rate 1.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ uht_PeriodAxis
= uht_PeriodOneMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_BrunswickAssociatesMember
Equity Method Investments | Brunswick Associates | Fixed rate commencing July 1, 2015 through December 31, 2024  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, interest rate 3.64%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_EligibleItemOrGroupForFairValueOptionAxis
= us-gaap_EquityMethodInvestmentsMember
/ uht_PeriodAxis
= uht_PeriodTwoMember
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_BrunswickAssociatesMember
Minimum | Arlington Medical Properties  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, term 3 years
Maximum | Arlington Medical Properties  
Schedule of Equity Method Investments [Line Items]  
Refinance of loan, term 10 years
XML 39 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Dividends and Equity Issuance Program - Additional Information (Detail) (USD $)
12 Months Ended 15 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2014
Dividends [Line Items]        
Declared and paid dividends, per share $ 2.520us-gaap_CommonStockDividendsPerShareCashPaid $ 2.495us-gaap_CommonStockDividendsPerShareCashPaid $ 2.460us-gaap_CommonStockDividendsPerShareCashPaid  
Ordinary income per share $ 1.478uht_OrdinaryIncomeDividendsPerShare $ 1.960uht_OrdinaryIncomeDividendsPerShare $ 1.294uht_OrdinaryIncomeDividendsPerShare  
Capital gain per share $ 1.042uht_CapitalGainsPerShare $ 0.535uht_CapitalGainsPerShare $ 1.166uht_CapitalGainsPerShare  
Securities, aggregate sales price   $ 50,000,000uht_ShelfRegistrationStatementValue    
At-The-Market (ATM) Equity Issuance Program        
Dividends [Line Items]        
Share issued 426,187us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
154,713us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  580,900us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
Average sale price per share $ 47.51uht_SharesIssuedAveragePricePerShare
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
$ 41.71uht_SharesIssuedAveragePricePerShare
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  $ 45.97uht_SharesIssuedAveragePricePerShare
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
Net cash proceeds or receivables from stock issued 19,500,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
6,100,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  25,600,000us-gaap_ProceedsFromIssuanceOfCommonStock
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
Payment of stock issuance cost 701,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
357,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  1,100,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
Net proceeds receivable 1,100,000us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
600,000us-gaap_IncreaseDecreaseInAccountsReceivable
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
   
At-The-Market (ATM) Equity Issuance Program | Compensation to Merrill Lynch        
Dividends [Line Items]        
Payment of stock issuance cost 506,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= uht_MerrillLynchAndCoNtMtnMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
161,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= uht_MerrillLynchAndCoNtMtnMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  667,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= uht_MerrillLynchAndCoNtMtnMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
At-The-Market (ATM) Equity Issuance Program | Other Expense        
Dividends [Line Items]        
Payment of stock issuance cost $ 195,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_OtherExpenseMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
$ 196,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_OtherExpenseMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
  $ 391,000us-gaap_PaymentOfFinancingAndStockIssuanceCosts
/ us-gaap_IncomeStatementLocationAxis
= us-gaap_OtherExpenseMember
/ us-gaap_InvestmentTypeAxis
= uht_AtMarketAtmProgramsMember
Capital gain        
Dividends [Line Items]        
Unrecaptured Section 1250 gain dividends per share $ 0.305uht_UnrecapturedSectionTwelveFiftyGainDividendsPerShare
/ us-gaap_DividendsAxis
= uht_CapitalGainMember
  $ 0.281uht_UnrecapturedSectionTwelveFiftyGainDividendsPerShare
/ us-gaap_DividendsAxis
= uht_CapitalGainMember
 
XML 40 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
McAllen Medical Center  
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent $ 5,485,000uht_OperatingLeasesAnnualFutureMinimumPaymentsReceivable
/ us-gaap_MajorPropertyClassAxis
= uht_McAllenMedicalCenterMember
End of Lease Term 2016-12
Renewal Term (years) 15 years [1]
Wellington Regional Medical Center  
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent 3,030,000uht_OperatingLeasesAnnualFutureMinimumPaymentsReceivable
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterMember
End of Lease Term 2016-12
Renewal Term (years) 15 years [2]
Southwest Healthcare System, Inland Valley Campus  
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent $ 2,648,000uht_OperatingLeasesAnnualFutureMinimumPaymentsReceivable
/ us-gaap_MajorPropertyClassAxis
= uht_SouthwestHealthcareSystemInlandValleyCampusMember
End of Lease Term 2016-12
Renewal Term (years) 15 years [2]
[1] UHS has three 5-year renewal options at existing lease rates (through 2031).
[2] UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
XML 41 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) (Universal Health Services, Inc)
12 Months Ended
Dec. 31, 2014
Times
McAllen Medical Center  
Operating Leased Assets [Line Items]  
Number of renewal options at existing lease rates 3uht_OperatingLeasesNumberOfRenewalOptionsAtExistingLeaseRates
/ us-gaap_MajorPropertyClassAxis
= uht_McAllenMedicalCenterMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
Renewal options term at existing lease rates 5 years
Renewal options at existing lease rates expiration year 2031
Wellington Regional Medical Center And Southwest Healthcare System  
Operating Leased Assets [Line Items]  
Number of renewal options at existing lease rates 1uht_OperatingLeasesNumberOfRenewalOptionsAtExistingLeaseRates
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
Renewal options term at existing lease rates 5 years
Renewal options at existing lease rates expiration year 2021
Number of renewal options at fair market value lease rates 2uht_OperatingLeasesNumberOfRenewalOptionsAtFairMarketValueLeaseRates
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_UniversalHealthServicesIncMember
Renewal options term at fair market value lease rates 5 years
Minimum | Wellington Regional Medical Center And Southwest Healthcare System  
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2022
Maximum | Wellington Regional Medical Center And Southwest Healthcare System  
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2031
XML 42 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cash flows from operating activities:      
Net income $ 51,551us-gaap_NetIncomeLoss [1] $ 13,169us-gaap_NetIncomeLoss [2] $ 19,477us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 20,975us-gaap_DepreciationDepletionAndAmortization 18,843us-gaap_DepreciationDepletionAndAmortization 20,216us-gaap_DepreciationDepletionAndAmortization
Amortization on debt premium (312)us-gaap_AmortizationOfDebtDiscountPremium (433)us-gaap_AmortizationOfDebtDiscountPremium (657)us-gaap_AmortizationOfDebtDiscountPremium
Restricted/stock-based compensation expense 399us-gaap_ShareBasedCompensation 375us-gaap_ShareBasedCompensation 329us-gaap_ShareBasedCompensation
Gain on divestiture of real property (13,043)us-gaap_GainLossOnSaleOfPropertyPlantEquipment [1] 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Gains on purchase of minority interests in majority-owned LLCs (25,409)us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1] 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Gains on divestiture of properties owned by unconsolidated LLCs 0uht_EquityMethodInvestmentRealizedGainLossOnDisposalGross 0uht_EquityMethodInvestmentRealizedGainLossOnDisposalGross (8,520)uht_EquityMethodInvestmentRealizedGainLossOnDisposalGross
Changes in assets and liabilities:      
Rent receivable (555)uht_IncreaseDecreaseInRentReceivable (746)uht_IncreaseDecreaseInRentReceivable (862)uht_IncreaseDecreaseInRentReceivable
Accrued expenses and other liabilities (509)us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities 523us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities 278us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
Tenant reserves, escrows, deposits and prepaid rents (303)uht_IncreaseDecreaseInTenantReservesEscrowsDepositsAndPrepaidRents 16uht_IncreaseDecreaseInTenantReservesEscrowsDepositsAndPrepaidRents 207uht_IncreaseDecreaseInTenantReservesEscrowsDepositsAndPrepaidRents
Accrued interest (62)us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet (22)us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet 66us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet
Other, net 64us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet (431)us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet 249us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet
Net cash provided by operating activities 32,796us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 31,294us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 30,783us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:      
Investments in LLCs (1,337)us-gaap_PaymentsToAcquireInvestments (3,013)us-gaap_PaymentsToAcquireInvestments (2,973)us-gaap_PaymentsToAcquireInvestments
Repayments of advances made to LLCs 0us-gaap_ProceedsFromCollectionOfAdvanceToAffiliate 114us-gaap_ProceedsFromCollectionOfAdvanceToAffiliate 8,551us-gaap_ProceedsFromCollectionOfAdvanceToAffiliate
Advances made to LLCs 0us-gaap_PaymentsForAdvanceToAffiliate (4,580)us-gaap_PaymentsForAdvanceToAffiliate (8,000)us-gaap_PaymentsForAdvanceToAffiliate
Cash distributions in excess of income from LLCs 1,029uht_CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies 2,346uht_CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies 3,169uht_CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
Cash distribution of refinancing proceeds from LLCs 2,280uht_CashDistributionsOfRefinancingProceedsFromLimitedLiabilityCompanies 0uht_CashDistributionsOfRefinancingProceedsFromLimitedLiabilityCompanies 0uht_CashDistributionsOfRefinancingProceedsFromLimitedLiabilityCompanies
Additions to real estate investments, net (2,866)us-gaap_RealEstatePeriodIncreaseDecrease (3,415)us-gaap_RealEstatePeriodIncreaseDecrease (3,985)us-gaap_RealEstatePeriodIncreaseDecrease
Deposits on real estate assets (100)us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions (150)us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions 100us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
Net cash paid for acquisition of medical office buildings (15,600)us-gaap_PaymentsToAcquireBuildings (4,675)us-gaap_PaymentsToAcquireBuildings (16,891)us-gaap_PaymentsToAcquireBuildings
Payment of assumed liabilities on acquired properties 0uht_PaymentOfAssumedLiabilitiesOnAcquiredProperties 0uht_PaymentOfAssumedLiabilitiesOnAcquiredProperties (711)uht_PaymentOfAssumedLiabilitiesOnAcquiredProperties
Cash paid to acquire minority interests in majority-owned LLCs (4,744)us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Cash proceeds received from divestiture of property owned by unconsolidated LLCs, net 0us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment 12,175us-gaap_ProceedsFromSaleOfOtherPropertyPlantAndEquipment
Cash proceeds received from divestiture of real property 17,300us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
Net cash used in investing activities (4,038)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (13,373)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (8,565)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:      
Net borrowings on line of credit 0us-gaap_ProceedsFromLongTermLinesOfCredit 11,950us-gaap_ProceedsFromLongTermLinesOfCredit 4,600us-gaap_ProceedsFromLongTermLinesOfCredit
Net repayments on line of credit (3,950)us-gaap_RepaymentsOfLinesOfCredit 0us-gaap_RepaymentsOfLinesOfCredit 0us-gaap_RepaymentsOfLinesOfCredit
Proceeds from mortgages and other notes payable 0us-gaap_ProceedsFromRepaymentsOfNotesPayable 11,150us-gaap_ProceedsFromRepaymentsOfNotesPayable 14,000us-gaap_ProceedsFromRepaymentsOfNotesPayable
Repayments of mortgages and other notes payable (12,327)us-gaap_RepaymentsOfSecuredDebt (14,401)us-gaap_RepaymentsOfSecuredDebt (18,084)us-gaap_RepaymentsOfSecuredDebt
Financing costs paid on mortgage and other notes payable 0us-gaap_PaymentsOfFinancingCosts (95)us-gaap_PaymentsOfFinancingCosts (384)us-gaap_PaymentsOfFinancingCosts
Dividends paid (32,718)us-gaap_PaymentsOfDividends (31,751)us-gaap_PaymentsOfDividends (31,195)us-gaap_PaymentsOfDividends
Partial settlement of dividends equivalent rights (94)uht_PartialSettlementOfDividendsEquivalentRights (101)uht_PartialSettlementOfDividendsEquivalentRights (106)uht_PartialSettlementOfDividendsEquivalentRights
Issuance of shares of beneficial interest, net 19,274us-gaap_ProceedsFromIssuanceOrSaleOfEquity 5,757us-gaap_ProceedsFromIssuanceOrSaleOfEquity 350us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Net cash used in financing activities (29,815)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (17,491)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (30,819)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
(Decrease)/increase in cash and cash equivalents (1,057)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 430us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (8,601)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Increase/(decrease) in cash due to recording of LLCs on a consolidated/unconsolidated basis 1,581uht_IncreaseDecreaseInCashAndCashEquivalentsDueToRecordingOfLimitedLiabilityCompaniesOnConsolidatedOrUnconsolidatedBasis (141)uht_IncreaseDecreaseInCashAndCashEquivalentsDueToRecordingOfLimitedLiabilityCompaniesOnConsolidatedOrUnconsolidatedBasis 0uht_IncreaseDecreaseInCashAndCashEquivalentsDueToRecordingOfLimitedLiabilityCompaniesOnConsolidatedOrUnconsolidatedBasis
Cash and cash equivalents, beginning of period 3,337us-gaap_CashAndCashEquivalentsAtCarryingValue 3,048us-gaap_CashAndCashEquivalentsAtCarryingValue 11,649us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of period 3,861us-gaap_CashAndCashEquivalentsAtCarryingValue 3,337us-gaap_CashAndCashEquivalentsAtCarryingValue 3,048us-gaap_CashAndCashEquivalentsAtCarryingValue
Supplemental disclosures of cash flow information:      
Interest paid 8,268us-gaap_InterestPaidNet 7,517us-gaap_InterestPaidNet 7,994us-gaap_InterestPaidNet
Supplemental disclosures of non-cash transactions:      
Debt assumed on acquisition of real estate 0uht_DebtAssumedOnAcquisitionOfRealEstate 0uht_DebtAssumedOnAcquisitionOfRealEstate 22,441uht_DebtAssumedOnAcquisitionOfRealEstate
Cash paid for purchase of minority interests in majority-owned LLCs 4,744us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
Consolidation of LLC      
Cash flows from investing activities:      
Cash paid to acquire minority interests in majority-owned LLCs (4,744)us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Supplemental disclosures of non-cash transactions:      
Net real estate investments (84,064)uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Cash and cash equivalents (1,581)uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Intangible assets 6,490uht_NoncashActivitiesIntangibleAssets
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesIntangibleAssets
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesIntangibleAssets
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Rent receivable - other 388uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Deferred charges, goodwill and other assets, net (100)uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Investment in LLC 28,616uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Mortgage and other notes payable, non-recourse to us (29,758)uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Accrued interest (116)uht_NoncashActivitiesAccruedInterest
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesAccruedInterest
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesAccruedInterest
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Accrued expenses and other liabilities (1,245)uht_NoncashActivitiesAccruedExpensesAndOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesAccruedExpensesAndOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesAccruedExpensesAndOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Tenant reserves, escrows, deposits and prepaid rents (485)uht_NoncashActivitiesTenantReservesEscrowsDepositsAndPrepaidRents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesTenantReservesEscrowsDepositsAndPrepaidRents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesTenantReservesEscrowsDepositsAndPrepaidRents
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Note payable to previous third party member (2,250)us-gaap_NotesAssumed1
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_NotesAssumed1
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_NotesAssumed1
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Gains on purchases of minority interests in majority-owned LLCs (25,409)us-gaap_GainLossOnSaleOfOtherInvestments
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_GainLossOnSaleOfOtherInvestments
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_GainLossOnSaleOfOtherInvestments
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Cash paid for purchase of minority interests in majority-owned LLCs 4,744us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries
/ us-gaap_StatementScenarioAxis
= uht_ConsolidationOfLimitedLiabilityCompaniesMember
Deconsolidation of Limited Liability Companies      
Supplemental disclosures of non-cash transactions:      
Net real estate investments 0uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
11,597uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRealEstateInvestmentsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Cash and cash equivalents 0uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
141uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCashAndCashEquivalents
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Rent receivable - other 0uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
(207)uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesRentReceivableOther
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Deferred charges, goodwill and other assets, net 0uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
135uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesDeferredChargesGoodwillAndOtherAssetsNet
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Investment in LLC 0uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
5,443uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCompaniesInvestmentInLimitedLiabilityCompanies
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Mortgage and other notes payable, non-recourse to us 0uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
6,215uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesMortgageAndNotePayable
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Other liabilities 0uht_NoncashActivitiesCompaniesOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
(368)uht_NoncashActivitiesCompaniesOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
0uht_NoncashActivitiesCompaniesOtherLiabilities
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
Third-party equity interest $ 0uht_NoncashActivitiesCompaniesThirdPartyEquityInterests
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
$ (54)uht_NoncashActivitiesCompaniesThirdPartyEquityInterests
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
$ 0uht_NoncashActivitiesCompaniesThirdPartyEquityInterests
/ us-gaap_StatementScenarioAxis
= uht_DeconsolidationOfLimitedLiabilityCompaniesMember
[1] We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.
[2] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 43 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and Dispositions - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 1 Months Ended 2 Months Ended 0 Months Ended 1 Months Ended
Sep. 30, 2014
Mar. 31, 2014
Dec. 31, 2014
Property
Dec. 31, 2013
Dec. 31, 2012
Feb. 28, 2015
Building
sqft
Feb. 28, 2015
Property
Times
sqft
Mar. 06, 2015
Property
Times
sqft
Dec. 31, 2014
Dec. 31, 2014
Feb. 29, 2012
Oct. 31, 2012
Apr. 30, 2013
sqft
Dec. 31, 2012
sqft
Aug. 31, 2014
sqft
Jan. 31, 2014
Jan. 31, 2012
sqft
Aug. 01, 2014
Aug. 31, 2013
sqft
Jun. 30, 2013
sqft
Business Acquisitions and Dispositions [Line Items]                                        
Net cash paid for acquisition of medical office buildings     $ 15,600,000us-gaap_PaymentsToAcquireBuildings $ 4,675,000us-gaap_PaymentsToAcquireBuildings $ 16,891,000us-gaap_PaymentsToAcquireBuildings                              
Deposits on real estate assets     100,000us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions 150,000us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions (100,000)us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions                              
Aggregate purchase price in connection with the purchase of minority ownership interests     7,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet           7,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet 7,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet                    
Cash paid for purchase of minority interests in majority-owned LLCs     4,744,000us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries 0us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries                              
Payment for acquisition, notes payable     2,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities           2,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities 2,300,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities                    
Maturity date, notes payable     Jan. 05, 2015                                  
Number of real estate investments     61us-gaap_NumberOfRealEstateProperties           61us-gaap_NumberOfRealEstateProperties 61us-gaap_NumberOfRealEstateProperties                    
Percentage of minority ownership interests by parent     100.00%us-gaap_MinorityInterestOwnershipPercentageByParent           100.00%us-gaap_MinorityInterestOwnershipPercentageByParent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent               100.00%us-gaap_MinorityInterestOwnershipPercentageByParent    
Gains on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs 25,093,000us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1] 316,000us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1] 25,409,000us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1] 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain                              
Purchase price allocation, tangible property     84,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment           84,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment 84,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment                    
Purchase price allocation, identifiable intangible assets     6,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles           6,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles 6,500,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles                    
Purchase price allocation, long term debt     29,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt           29,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt 29,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt                    
Sales proceeds from divestiture of real property     17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment 0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment                              
Gain on divestiture of property owned by an unconsolidated LLC, net     0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal 0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal 8,520,000us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal [2],[3]                              
Acquired aggregate revenue         55,400,000us-gaap_BusinessAcquisitionsProFormaRevenue                              
Acquired aggregate net income         11,600,000us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss                              
Business acquisition proforma earnings per share, diluted         $ 0.92us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted                              
Net intangible assets     23,100,000us-gaap_FiniteLivedIntangibleAssetsNet           23,100,000us-gaap_FiniteLivedIntangibleAssetsNet 23,100,000us-gaap_FiniteLivedIntangibleAssetsNet                    
Intangible assets, accumulated amortization     19,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization 13,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization         19,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization 19,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization                    
Mission and Weslaco Freestanding Emergency Departments                                        
Business Acquisitions and Dispositions [Line Items]                                        
Number of real estate investments     3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
          3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
3us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
                   
In Place Leases                                        
Business Acquisitions and Dispositions [Line Items]                                        
Intangible assets amortization period at date of acquisition     4 years 4 months 24 days                                  
Minimum                                        
Business Acquisitions and Dispositions [Line Items]                                        
Ownership prior to minority interest purchase     85.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
          85.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
85.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
                   
Capitalization Rate     7.00%us-gaap_FairValueInputsCapRate
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
                                 
Discount rate     8.00%us-gaap_FairValueInputsDiscountRate
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
                                 
Non-controlling ownership interest     33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
          33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
                   
Maximum                                        
Business Acquisitions and Dispositions [Line Items]                                        
Number of term renewal options     5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
          5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
5uht_NumberOfRenewalOptions
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
                   
Ownership prior to minority interest purchase     95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
          95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
                   
Capitalization Rate     8.75%us-gaap_FairValueInputsCapRate
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
                                 
Discount rate     9.75%us-gaap_FairValueInputsDiscountRate
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
                                 
Non-controlling ownership interest     95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
          95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
                   
Subsequent Event                                        
Business Acquisitions and Dispositions [Line Items]                                        
Number of Buildings purchased           2uht_NumberOfPurchasedBuildings
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                           
Net rentable area           16,000us-gaap_NetRentableArea
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
16,000us-gaap_NetRentableArea
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                         
Total purchase price           4,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
4,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                         
Subsequent Event | Mission and Weslaco Freestanding Emergency Departments                                        
Business Acquisitions and Dispositions [Line Items]                                        
Total purchase price           12,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
12,800,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                         
Number of real properties purchased             2uht_NumberOfRealEstatePropertiesAcquired
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
2uht_NumberOfRealEstatePropertiesAcquired
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                       
Area of acquired building           13,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
13,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
13,600us-gaap_AreaOfRealEstateProperty
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                       
Lease agreement period             10 years 10 years                        
Number of term renewal options           6uht_NumberOfRenewalOptions
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
6uht_NumberOfRenewalOptions
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
6uht_NumberOfRenewalOptions
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                       
Additional renewal terms             5 years 5 years                        
Estimated rental revenues             900,000uht_EstimatedRevenueDueToBusinessAcquisition
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
900,000uht_EstimatedRevenueDueToBusinessAcquisition
/ us-gaap_RealEstatePropertiesAxis
= uht_FreestandingEmergencyDepartmentsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
                       
Limited Liability Companies                                        
Business Acquisitions and Dispositions [Line Items]                                        
Number of real estate investments     8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
          8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
              6us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
   
The Bridgeway                                        
Business Acquisitions and Dispositions [Line Items]                                        
Sales proceeds from divestiture of real property                 17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
17,300,000us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
                   
Amount of annual lease earned     1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
1,100,000uht_AnnualSubleaseIncome
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
                             
Gain on divestiture of property     13,000,000us-gaap_GainLossOnDispositionOfAssets
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
                                 
Lease term scheduled end date     2014-12                                  
Property at fair value     17,300,000us-gaap_PropertyPlantAndEquipmentFairValueDisclosure
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
          17,300,000us-gaap_PropertyPlantAndEquipmentFairValueDisclosure
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
17,300,000us-gaap_PropertyPlantAndEquipmentFairValueDisclosure
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= uht_BridgewayMember
                   
Canyon Healthcare Properties                                        
Business Acquisitions and Dispositions [Line Items]                                        
Non-controlling ownership interest                     95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_CanyonHealthcarePropertiesMember
                 
Canyon Healthcare Properties | Canyon Springs Medical Plaza                                        
Business Acquisitions and Dispositions [Line Items]                                        
Cash proceeds from divestiture, net of closing costs and minority members' share                     8,100,000us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_CanyonHealthcarePropertiesMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= uht_CanyonSpringsMedicalPlazaMember
                 
Gain on divestiture of property owned by an unconsolidated LLC, net         7,400,000us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_CanyonHealthcarePropertiesMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= uht_CanyonSpringsMedicalPlazaMember
                             
575 Hardy Investor                                        
Business Acquisitions and Dispositions [Line Items]                                        
Non-controlling ownership interest                       90.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FiveSeventyFiveHardyInvestorMember
               
575 Hardy Investor | Centinela Medical Building Complex                                        
Business Acquisitions and Dispositions [Line Items]                                        
Cash proceeds from divestiture, net of closing costs and minority members' share                       12,200,000us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FiveSeventyFiveHardyInvestorMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= uht_CentinelaMedicalBuildingComplexMember
               
Repayment of previously provided member loan                       8,000,000uht_RepaymentOfLoan
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FiveSeventyFiveHardyInvestorMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= uht_CentinelaMedicalBuildingComplexMember
               
Gain related to divestiture         1,100,000uht_GainRelatedToDivestituresNetOfTax
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FiveSeventyFiveHardyInvestorMember
/ us-gaap_SignificantAcquisitionsAndDisposalsByTransactionAxis
= uht_CentinelaMedicalBuildingComplexMember
                             
Children's Clinic                                        
Business Acquisitions and Dispositions [Line Items]                                        
Area of acquired building                               9,800us-gaap_AreaOfRealEstateProperty
/ us-gaap_BusinessAcquisitionAxis
= uht_ChildrensClinicMember
       
Ward Eagle Office Village Medical Office Building                                        
Business Acquisitions and Dispositions [Line Items]                                        
Net rentable area                                     16,300us-gaap_NetRentableArea
/ us-gaap_BusinessAcquisitionAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
 
Total purchase price                                     4,100,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
 
5004 Poole Road MOB Office building                                        
Business Acquisitions and Dispositions [Line Items]                                        
Net rentable area                                       4,400us-gaap_NetRentableArea
/ us-gaap_BusinessAcquisitionAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
Total purchase price                                       625,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
2013 Acquisitions                                        
Business Acquisitions and Dispositions [Line Items]                                        
Total purchase price       4,700,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
                               
Intangible assets amortization period at date of acquisition     8 years 4 months 24 days 9 years 9 months 18 days                                
Aggregate purchase price in connection with the purchase of minority ownership interests       4,685,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
                               
Payment for acquisition, notes payable       11,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
                               
Purchase price allocation, identifiable intangible assets       610,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandThirteenAcquisitionsMember
                               
Forney Medical Plaza                                        
Business Acquisitions and Dispositions [Line Items]                                        
Non-controlling ownership interest                         95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_ForneyMedicalPlazaMember
             
Rentable medical office building                         30,000uht_RentableAreaOfPremises
/ us-gaap_BusinessAcquisitionAxis
= uht_ForneyMedicalPlazaMember
             
Medical office buildings                                        
Business Acquisitions and Dispositions [Line Items]                                        
Aggregate revenue from acquired entity         2,700,000us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual
/ us-gaap_BusinessAcquisitionAxis
= uht_MedicalOfficeBuildingsMember
                             
Aggregate net income from acquired entity         232,000us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual
/ us-gaap_BusinessAcquisitionAxis
= uht_MedicalOfficeBuildingsMember
                             
Transaction Expenses         680,000uht_BusinessAcquisitionCostOfAcquiredEntityTransactionExpenses
/ us-gaap_BusinessAcquisitionAxis
= uht_MedicalOfficeBuildingsMember
                             
Northwest Medical Center                                        
Business Acquisitions and Dispositions [Line Items]                                        
Area of acquired building                               13,700us-gaap_AreaOfRealEstateProperty
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestMedicalCenterMember
       
Northwest Texas Professional Office Tower                                        
Business Acquisitions and Dispositions [Line Items]                                        
Total purchase price         9,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
                9,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
           
Area of acquired building         72,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
                72,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
           
Weighted average remaining lease term                           5 years 1 month 6 days            
2012 Acquisitions                                        
Business Acquisitions and Dispositions [Line Items]                                        
Total purchase price         40,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
                40,000,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
           
Intangible assets amortization period at date of acquisition     5 years   7 years                              
Aggregate purchase price in connection with the purchase of minority ownership interests         16,891,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
                16,891,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
           
Payment for acquisition, notes payable         144,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
                144,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
           
Purchase price allocation, identifiable intangible assets         6,020,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
                6,020,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
           
Purchase price allocation, long term debt         23,240,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
                23,240,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
           
Hanover Emergency Center                                        
Business Acquisitions and Dispositions [Line Items]                                        
Net rentable area                             22,000us-gaap_NetRentableArea
/ us-gaap_BusinessAcquisitionAxis
= uht_HanoverEmergencyCenterMember
         
Net cash paid for acquisition of medical office buildings                             8,600,000us-gaap_PaymentsToAcquireBuildings
/ us-gaap_BusinessAcquisitionAxis
= uht_HanoverEmergencyCenterMember
         
Lease term                             10 years          
Intangible assets amortization period at date of acquisition     9 years 6 months                       9 years 9 months 18 days          
Children's Clinic and Northwest Medical Center                                        
Business Acquisitions and Dispositions [Line Items]                                        
Net cash paid for acquisition of medical office buildings                               7,200,000us-gaap_PaymentsToAcquireBuildings
/ us-gaap_BusinessAcquisitionAxis
= uht_ChildrensClinicAndNorthwestMedicalCenterMember
       
Deposits on real estate assets       150,000us-gaap_PaymentsForProceedsFromDepositsOnRealEstateAcquisitions
/ us-gaap_BusinessAcquisitionAxis
= uht_ChildrensClinicAndNorthwestMedicalCenterMember
                               
Intangible assets amortization period at date of acquisition     8 years 8 months 12 days                         9 years 8 months 12 days        
August 1, 2014 Acquisitions                                        
Business Acquisitions and Dispositions [Line Items]                                        
Intangible assets amortization period at date of acquisition     4 years 8 months 12 days                       4 years 3 months 18 days          
January 1, 2014 Acquisitions                                        
Business Acquisitions and Dispositions [Line Items]                                        
Intangible assets amortization period at date of acquisition     5 years 3 months 18 days                         5 years 6 months        
Peace Health Medical Clinic                                        
Business Acquisitions and Dispositions [Line Items]                                        
Total purchase price                                 $ 30,400,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
/ us-gaap_BusinessAcquisitionAxis
= uht_PeaceHealthMedicalClinicMember
     
Area of acquired building                                 99,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_BusinessAcquisitionAxis
= uht_PeaceHealthMedicalClinicMember
     
Weighted average remaining lease term                                 10 years      
[1] We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.
[2] As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
[3] As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
XML 44 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Debt Instrument [Line Items]  
Covenant, Tangible net worth 125,000uht_DebtInstrumentCovenantTangibleNetWorth
Tangible net worth 181,458uht_TangibleNetWorth
Debt to total capital 30.00%uht_DebtToCapitalPercentage
Debt service coverage ratio 2540.00%uht_DebtServicesCoverageRatio
Debt to cash flow ratio 129.00%uht_DebtToCashFlowRatio
Maximum  
Debt Instrument [Line Items]  
Covenant, Debt to total capital 55.00%uht_DebtInstrumentCovenantDebtToCapitalPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Covenant, Debt to cash flow ratio 350.00%uht_DebtInstrumentCovenantDebtToCashFlowRatio
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
Minimum  
Debt Instrument [Line Items]  
Covenant, Debt service coverage ratio 300.00%uht_DebtInstrumentCovenantDebtServicesCoverageRatio
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
XML 45 R53.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Schedule of Equity Method Investments [Line Items]      
Interest income earned on various advances made to LLCs $ 834,000us-gaap_InterestIncomeOther $ 1,900,000us-gaap_InterestIncomeOther $ 1,500,000us-gaap_InterestIncomeOther
XML 46 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Real Estate Investments:    
Buildings and improvements $ 451,005us-gaap_InvestmentBuildingAndBuildingImprovements $ 368,295us-gaap_InvestmentBuildingAndBuildingImprovements
Accumulated depreciation (106,480)us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation (97,921)us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
Real Estate Investment Property, Net, Total 344,525us-gaap_RealEstateInvestmentPropertyNet 270,374us-gaap_RealEstateInvestmentPropertyNet
Land 35,584us-gaap_Land 27,374us-gaap_Land
Net Real Estate Investments 380,109us-gaap_RealEstateInvestments 297,748us-gaap_RealEstateInvestments
Investments in and advances to limited liability companies ("LLCs"), net 8,605us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValue 39,201us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValue
Other Assets:    
Cash and cash equivalents 3,861us-gaap_CashAndCashEquivalentsAtCarryingValue 3,337us-gaap_CashAndCashEquivalentsAtCarryingValue
Base and bonus rent receivable from UHS 2,086us-gaap_DeferredRentReceivablesNet 2,053us-gaap_DeferredRentReceivablesNet
Rent receivable-other 4,219uht_RentReceivableOther 3,310uht_RentReceivableOther
Intangible assets (net of accumulated amortization of $19.7 million and $13.7 million at December 31, 2014 and December 31, 2013, respectively) 23,123us-gaap_IntangibleAssetsNetExcludingGoodwill 20,782us-gaap_IntangibleAssetsNetExcludingGoodwill
Deferred charges, goodwill and other assets, net 6,863us-gaap_DeferredCostsAndOtherAssets 6,714us-gaap_DeferredCostsAndOtherAssets
Total Assets 428,866us-gaap_Assets 373,145us-gaap_Assets
Liabilities:    
Line of credit borrowings 89,750us-gaap_LineOfCredit 93,700us-gaap_LineOfCredit
Mortgage and other notes payable, non-recourse to us (including net debt premium of $523,000 and $834,000 at December 31, 2014 and December 31, 2013, respectively) 123,405us-gaap_SecuredDebt 106,287us-gaap_SecuredDebt
Accrued interest 545us-gaap_InterestPayableCurrentAndNoncurrent 491us-gaap_InterestPayableCurrentAndNoncurrent
Accrued expenses and other liabilities 8,522us-gaap_AccruedLiabilitiesAndOtherLiabilities 5,156us-gaap_AccruedLiabilitiesAndOtherLiabilities
Tenant reserves, escrows, deposits and prepaid rents 2,063uht_TenantReservesEscrowsDepositsAndPrepaidRents 1,881uht_TenantReservesEscrowsDepositsAndPrepaidRents
Total Liabilities 224,285us-gaap_Liabilities 207,515us-gaap_Liabilities
Equity:    
Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding      
Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2014 - 13,301,204 2013 -12,858,643 133us-gaap_CommonStockValue 128us-gaap_CommonStockValue
Capital in excess of par value 240,835us-gaap_AdditionalPaidInCapital 220,691us-gaap_AdditionalPaidInCapital
Cumulative net income 531,595us-gaap_RetainedEarningsAccumulatedDeficit 480,044us-gaap_RetainedEarningsAccumulatedDeficit
Cumulative dividends (567,894)us-gaap_CumulativeDividends (535,176)us-gaap_CumulativeDividends
Accumulated other comprehensive loss (88)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax (57)us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Total Equity 204,581us-gaap_StockholdersEquity 165,630us-gaap_StockholdersEquity
Total Liabilities and Equity $ 428,866us-gaap_LiabilitiesAndStockholdersEquity $ 373,145us-gaap_LiabilitiesAndStockholdersEquity
XML 47 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Incentive Plans - Additional Information (Detail) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Equity Incentive Plan [Line Items]      
Options outstanding and exercisable 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber    
Options outstanding and exercisable, average price per share $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice    
Dividend equivalent rights, outstanding 36,000uht_DividendEquivalentRights 40,000uht_DividendEquivalentRights 43,000uht_DividendEquivalentRights
Dividend equivalent rights paid to officers and Trustees $ 94,000uht_DividendsPaidToEmployeeBenefitsTrust $ 106,000uht_DividendsPaidToEmployeeBenefitsTrust $ 116,000uht_DividendsPaidToEmployeeBenefitsTrust
Number of stock options exercised during the period, shares 4,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised 3,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised 8,000us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Value of stock options exercised during the period 44,160us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised 46,290us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised 148,930us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Number of unvested options during the period 0us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares    
Incentive Plan 2007      
Equity Incentive Plan [Line Items]      
Number of shares authorized for issuance 75,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
   
Shares issued, net of cancellation 57,825us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
   
Number of shares vested 39,245uht_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesVested
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
   
Number of shares remaining for issuance 17,175us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
   
Restricted shares issued, net of cancellation 9,850us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
8,730us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
10,375us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
Restricted shares issued, weighted average grant price $ 43.21us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
$ 43.54us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
$ 39.05us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
Restricted shares of beneficial interest, net of cancellations, issued, value 425,619us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
380,104us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
405,144us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
Restricted shares, Vesting Period 2016-06 2015-06 2014-06
Compensation expenses 399,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
375,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
329,000us-gaap_AllocatedShareBasedCompensationExpense
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
Compensation expenses remained to be recognized in future $ 381,000us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
/ us-gaap_AwardTypeAxis
= uht_IncentivePlanTwentyZeroSevenMember
   
Compensation expenses not yet recognized, period of recognition 1 year    
1997 Plan      
Equity Incentive Plan [Line Items]      
Options granted, vesting percentage per year starting from one year from date of grant 25.00%us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
/ us-gaap_AwardTypeAxis
= uht_EquityIncentivePlanNineteenNinetySevenMember
   
Options, expiration period 10 years    
Options outstanding and exercisable 36,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
/ us-gaap_AwardTypeAxis
= uht_EquityIncentivePlanNineteenNinetySevenMember
   
Options outstanding and exercisable, average price per share $ 35.94us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
/ us-gaap_AwardTypeAxis
= uht_EquityIncentivePlanNineteenNinetySevenMember
   
Outstanding stock options, remaining weighted average life 1 year 7 months 6 days    
XML 48 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common stock
Capital in excess of par value
Cumulative net income
Accumulated other comprehensive loss
UHT Shareholders' Equity
Non-controlling Interests
Cumulative dividends
Balance at Dec. 31, 2011 $ 188,945us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $ 127us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
$ 213,566us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
$ 447,398us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
  $ 188,861us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
$ 84us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
$ (472,230)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Balance, Shares at Dec. 31, 2011   12,667,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Shares of Beneficial Interest:                
Issued (in shares)   22,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Issued 305us-gaap_StockIssuedDuringPeriodValueNewIssues   305us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    305us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Partial settlement of dividend equivalent rights (106)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights   (106)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    (106)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Restricted stock-based compensation expense 329us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition   329us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    329us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Dividends ($2.52/share) in 2014, ($2.495/share) in 2013 and ($2.46/share) in 2012 (31,195)us-gaap_Dividends         (31,195)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
  (31,195)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Comprehensive income:                
Net income 19,467us-gaap_ProfitLoss     19,477us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
  19,477us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
(10)us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
 
Balance at Dec. 31, 2012 177,745us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 127us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
214,094us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
466,875us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
  177,671us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
74us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
(503,425)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Balance, Shares at Dec. 31, 2012   12,689,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Shares of Beneficial Interest:                
Issued (in shares)   170,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Issued 6,324us-gaap_StockIssuedDuringPeriodValueNewIssues 1us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
6,323us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    6,324us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Partial settlement of dividend equivalent rights (101)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights   (101)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    (101)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Restricted stock-based compensation expense 375us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition   375us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    375us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Dividends ($2.52/share) in 2014, ($2.495/share) in 2013 and ($2.46/share) in 2012 (31,751)us-gaap_Dividends         (31,751)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
  (31,751)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Deconsolidation of LLC (74)us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation         0us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
(74)us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
 
Comprehensive income:                
Net income 13,169us-gaap_ProfitLoss     13,169us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
  13,169us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Unrealized loss on interest rate cap (57)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax       (57)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
(57)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Subtotal - comprehensive income 13,112us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest     13,169us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
(57)us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
13,112us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
0us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
 
Balance at Dec. 31, 2013 165,630us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 128us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
220,691us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
480,044us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
(57)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
165,630us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
0us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
(535,176)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Balance, Shares at Dec. 31, 2013   12,859,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Shares of Beneficial Interest:                
Issued (in shares)   443,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
Issued 19,844us-gaap_StockIssuedDuringPeriodValueNewIssues 5us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
19,839us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    19,844us-gaap_StockIssuedDuringPeriodValueNewIssues
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Partial settlement of dividend equivalent rights (94)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights   (94)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    (94)uht_AdjustmentsToAdditionalPaidInCapitalPartialSettlementOfDividendEquivalentRights
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Restricted stock-based compensation expense 399us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition   399us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
    399us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Dividends ($2.52/share) in 2014, ($2.495/share) in 2013 and ($2.46/share) in 2012 (32,718)us-gaap_Dividends         (32,718)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
  (32,718)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Comprehensive income:                
Net income 51,551us-gaap_ProfitLoss     51,551us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
  51,551us-gaap_ProfitLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Unrealized loss on interest rate cap (31)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax       (31)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
(31)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
   
Subtotal - comprehensive income 51,520us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest     51,551us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
(31)us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
51,520us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
0us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
 
Balance at Dec. 31, 2014 $ 204,581us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $ 133us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
$ 240,835us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember
$ 531,595us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember
$ (88)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember
$ 204,581us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_ParentMember
$ 0us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_NoncontrollingInterestMember
$ (567,894)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= uht_CumulativeDividendsMember
Balance, Shares at Dec. 31, 2014   13,302,000us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember
           
XML 49 R59.htm IDEA: XBRL DOCUMENT v2.4.1.9
Schedule III Real Estate and Accumulated Depreciation (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance $ 122,882us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances [1]      
Initial Cost, Land 33,768us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand      
Initial Cost, Building & Improvements 401,899us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements      
Adjustments to Basis 49,730us-gaap_OtherRealEstateValuationAdjustments [2]      
Land 35,584us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand      
Buildings and Improvements 449,813us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements      
CIP 1,192us-gaap_InventoryRealEstateConstructionInProcess      
Total 486,589us-gaap_RealEstateGrossAtCarryingValue 395,669us-gaap_RealEstateGrossAtCarryingValue 401,474us-gaap_RealEstateGrossAtCarryingValue 363,498us-gaap_RealEstateGrossAtCarryingValue
Accumulated Depreciation 106,480us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation 97,921us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation    
Inland Valley Regional Medical Center Wildomar, California        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 2,050us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Initial Cost, Building & Improvements 10,701us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Adjustments to Basis 14,596us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
[2]      
Land 2,050us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Buildings and Improvements 25,297us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Total 27,347us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Accumulated Depreciation 11,175us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_InlandValleyRegionalMedicalCenterWildomarCaliforniaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2007      
Date Acquired 1986      
Average Depreciable Life 43 years      
McAllen Medical Center McAllen, Texas        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 4,720us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Initial Cost, Building & Improvements 31,442us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Adjustments to Basis 10,189us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
[2]      
Land 6,281us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Buildings and Improvements 40,070us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Total 46,351us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Accumulated Depreciation 24,385us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_McallenMedicalCenterMcallenTexasMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1994      
Date Acquired 1986      
Average Depreciable Life 42 years      
Wellington Regional Medical Center West Palm Beach, Florida        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,190us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Initial Cost, Building & Improvements 14,652us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Adjustments to Basis 17,370us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
[2]      
Land 1,663us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Buildings and Improvements 31,549us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Total 33,212us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Accumulated Depreciation 16,258us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2006      
Date Acquired 1986      
Average Depreciable Life 42 years      
HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 500us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Initial Cost, Building & Improvements 6,945us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Adjustments to Basis 1,062us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
[2]      
Land 500us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Buildings and Improvements 8,007us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Total 8,507us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Accumulated Depreciation 5,069us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1993      
Date Acquired 1989      
Average Depreciable Life 40 years      
Kindred Hospital Chicago Central Chicago, Illinois        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 158us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Initial Cost, Building & Improvements 6,404us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Adjustments to Basis 1,838us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
[2]      
Land 158us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Buildings and Improvements 8,242us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Total 8,400us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Accumulated Depreciation 8,242us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_KindredHospitalChicagoCentralChicagoIllinoisMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1993      
Date Acquired 1986      
Average Depreciable Life 25 years      
Family Doctor's Medical Office Building Shreveport, Louisiana        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 54us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Initial Cost, Building & Improvements 1,526us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Adjustments to Basis 494us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
[2]      
Land 54us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Buildings and Improvements 2,020us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Total 2,074us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Accumulated Depreciation 902us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1991      
Date Acquired 1995      
Average Depreciable Life 45 years      
Kelsey-Seybold Clinic at King's Crossing        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 439us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Initial Cost, Building & Improvements 1,618us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Adjustments to Basis 870us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
[2]      
Land 439us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Buildings and Improvements 2,488us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Total 2,927us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Accumulated Depreciation 1,091us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_KelseyseyboldClinicAtKingCrossingMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1995      
Date Acquired 1995      
Average Depreciable Life 45 years      
Professional Buildings at King's Crossing Kingwood, Texas        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 439us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Initial Cost, Building & Improvements 1,837us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Adjustments to Basis 185us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
[2]      
Land 439us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Buildings and Improvements 2,022us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
CIP 3us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Total 2,464us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Accumulated Depreciation 889us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ProfessionalCenterAtKingCrossingKingwoodTexasMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1995      
Date Acquired 1995      
Average Depreciable Life 45 years      
Chesterbrook Academy Audubon, Pennsylvania        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 307us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Initial Cost, Building & Improvements 996us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Land 307us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Buildings and Improvements 996us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Total 1,303us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Accumulated Depreciation 413us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyAudubonPennsylvaniaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1996      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy New Britain, Pennsylvania        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 250us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Initial Cost, Building & Improvements 744us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Land 250us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Buildings and Improvements 744us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Total 994us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Accumulated Depreciation 309us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewBritainPennsylvaniaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1991      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy Uwchlan, Pennsylvania        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 180us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Initial Cost, Building & Improvements 815us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Land 180us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Buildings and Improvements 815us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Total 995us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Accumulated Depreciation 338us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyUwchlanPennsylvaniaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1992      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy Newtown, Pennsylvania        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 195us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Initial Cost, Building & Improvements 749us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Land 195us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Buildings and Improvements 749us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Total 944us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Accumulated Depreciation 311us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ChesterbrookAcademyNewtownPennsylvaniaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1992      
Date Acquired 1996      
Average Depreciable Life 45 years      
The Southern Crescent Center I        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,130us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Initial Cost, Building & Improvements 5,092us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Adjustments to Basis (2,271)us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[2],[3]      
Land 1,130us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Buildings and Improvements 2,821us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Total 3,951us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Accumulated Depreciation 2,269us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterMember
[3]      
Date of Completion of Construction, Acquisition or Significant Improvement 1994 [3]      
Date Acquired 1996 [3]      
Average Depreciable Life 45 years [3]      
The Southern Crescent Center II Riverdale, Georgia        
Real Estate and Accumulated Depreciation [Line Items]        
Adjustments to Basis 5,015us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterIiRiverdaleGeorgiaMember
[2],[3]      
Land 806us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterIiRiverdaleGeorgiaMember
[3]      
Buildings and Improvements 4,209us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterIiRiverdaleGeorgiaMember
[3]      
Total 5,015us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterIiRiverdaleGeorgiaMember
[3]      
Accumulated Depreciation 1,943us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_TheSouthernCrescentCenterIiRiverdaleGeorgiaMember
[3]      
Date of Completion of Construction, Acquisition or Significant Improvement 2000 [3]      
Date Acquired 1998 [3]      
Average Depreciable Life 35 years [3]      
The Cypresswood Professional Center Spring,Texas        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 573us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Initial Cost, Building & Improvements 3,842us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Adjustments to Basis 585us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
[2]      
Land 573us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Buildings and Improvements 4,427us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
CIP 53us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Total 5,053us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Accumulated Depreciation 2,398us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_TheCypresswoodProfessionalCenterSpringTexasMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1997      
Date Acquired 1997      
Average Depreciable Life 35 years      
701 South Tonopah Building Las Vegas, Nevada        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 1,579us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroOneSouthTonopahLasVegasNevadaMember
     
Adjustments to Basis 68us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroOneSouthTonopahLasVegasNevadaMember
[2]      
Buildings and Improvements 1,647us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroOneSouthTonopahLasVegasNevadaMember
     
Total 1,647us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroOneSouthTonopahLasVegasNevadaMember
     
Accumulated Depreciation 931us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroOneSouthTonopahLasVegasNevadaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 1999      
Date Acquired 1999      
Average Depreciable Life 25 years      
Sheffield Medical Building Atlanta, Georgia        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,760us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Initial Cost, Building & Improvements 9,766us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Adjustments to Basis (7,327)us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[2],[4]      
Land 736us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Buildings and Improvements 3,463us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
CIP 1us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Total 4,200us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Accumulated Depreciation 1,348us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SheffieldMedicalBuildingAtlantaGeorgiaMember
[4]      
Date of Completion of Construction, Acquisition or Significant Improvement 1999 [4]      
Date Acquired 1999 [4]      
Average Depreciable Life 25 years [4]      
Medical Center of Western Connecticut Danbury, Connecticut        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 4,785us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
[1]      
Initial Cost, Land 1,151us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Initial Cost, Building & Improvements 5,176us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Adjustments to Basis 544us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
[2]      
Land 1,151us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Buildings and Improvements 5,720us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Total 6,871us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Accumulated Depreciation 2,899us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2000      
Date Acquired 2000      
Average Depreciable Life 30 years      
Vibra Hospital of Corpus Christi Corpus Christi, Texas        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 2,902us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
[1]      
Initial Cost, Land 1,104us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Initial Cost, Building & Improvements 5,508us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Land 1,104us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Buildings and Improvements 5,508us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Total 6,612us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Accumulated Depreciation 1,085us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_VibraHospitalOfCorpusChristiCorpusChristiTexasMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2008      
Date Acquired 2008      
Average Depreciable Life 35 years      
Apache Junction Medical Plaza Apache Junction, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 240us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Initial Cost, Building & Improvements 3,590us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Adjustments to Basis 621us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[2],[5]      
Land 240us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Buildings and Improvements 4,211us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
CIP 1us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Total 4,452us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Accumulated Depreciation 479us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ApacheJunctionMedicalPlazaApacheJunctionAzMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2004 [5]      
Date Acquired 2004 [5]      
Average Depreciable Life 30 years [5]      
Auburn Medical Office Building II Auburn, WA        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 7,183us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[1],[5]      
Initial Cost, Building & Improvements 10,200us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[5]      
Adjustments to Basis 176us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[2],[5]      
Buildings and Improvements 10,376us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[5]      
Total 10,376us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[5]      
Accumulated Depreciation 1,034us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_AuburnMedicalOfficeBuildingAuburnWaMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2009 [5]      
Date Acquired 2009 [5]      
Average Depreciable Life 36 years [5]      
BRB Medical Office Building Kingwood, Texas        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,673us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[1],[5]      
Initial Cost, Land 430us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Initial Cost, Building & Improvements 8,970us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Adjustments to Basis 24us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[2],[5]      
Land 430us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Buildings and Improvements 8,994us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
CIP 4us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Total 9,428us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Accumulated Depreciation 885us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_BrbMedicalOfficeBuildingKingwoodTexasMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2010 [5]      
Date Acquired 2010 [5]      
Average Depreciable Life 37 years [5]      
Centennial Hills Medical Office Building Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 10,642us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[1],[5]      
Initial Cost, Building & Improvements 19,890us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[5]      
Adjustments to Basis 804us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[2],[5]      
Buildings and Improvements 20,694us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[5]      
CIP 116us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[5]      
Total 20,810us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[5]      
Accumulated Depreciation 2,154us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_CentennialHillsMedicalOfficeBuildingLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [5]      
Date Acquired 2006 [5]      
Average Depreciable Life 34 years [5]      
Desert Springs Medical Plaza Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,200us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Initial Cost, Building & Improvements 9,560us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Adjustments to Basis 443us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[2],[5]      
Land 1,200us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Buildings and Improvements 10,003us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
CIP 144us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Total 11,347us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Accumulated Depreciation 1,212us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_DesertSpringsMedicalPlazaLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 1998 [5]      
Date Acquired 1998 [5]      
Average Depreciable Life 30 years [5]      
700 Shadow Lane & Goldring MOBs Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,601us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[1],[5]      
Initial Cost, Land 400us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Initial Cost, Building & Improvements 11,300us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Adjustments to Basis 1,141us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[2],[5]      
Land 400us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Buildings and Improvements 12,441us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
CIP 155us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Total 12,996us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Accumulated Depreciation 1,430us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2003 [5]      
Date Acquired 2003 [5]      
Average Depreciable Life 30 years [5]      
Spring Valley Hospital MOB I Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 4,920us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[1],[5]      
Initial Cost, Building & Improvements 9,500us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[5]      
Adjustments to Basis 338us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[2],[5]      
Buildings and Improvements 9,838us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[5]      
CIP 36us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[5]      
Total 9,874us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[5]      
Accumulated Depreciation 1,029us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2004 [5]      
Date Acquired 2004 [5]      
Average Depreciable Life 35 years [5]      
Spring Valley Hospital MOB II Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 9,800us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[5]      
Adjustments to Basis 8us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[2],[5]      
Buildings and Improvements 9,808us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[5]      
CIP 202us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[5]      
Total 10,010us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[5]      
Accumulated Depreciation 1,031us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SpringValleyHospitalMobIiLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [5]      
Date Acquired 2006 [5]      
Average Depreciable Life 34 years [5]      
Summerlin Hospital MOB Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 460us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Initial Cost, Building & Improvements 15,440us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Adjustments to Basis 512us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[2],[5]      
Land 460us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Buildings and Improvements 15,952us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
CIP 43us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Total 16,455us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Accumulated Depreciation 1,889us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 1999 [5]      
Date Acquired 1999 [5]      
Average Depreciable Life 30 years [5]      
Summerlin Hospital MOB II Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 11,729us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[1],[5]      
Initial Cost, Land 370us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Initial Cost, Building & Improvements 16,830us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Adjustments to Basis 851us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[2],[5]      
Land 370us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Buildings and Improvements 17,681us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
CIP 43us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Total 18,094us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Accumulated Depreciation 2,040us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2000 [5]      
Date Acquired 2000 [5]      
Average Depreciable Life 30 years [5]      
Summerlin Hospital MOB III Las Vegas, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 11,025us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[1],[5]      
Initial Cost, Building & Improvements 14,900us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[5]      
Adjustments to Basis 1,459us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[2],[5]      
Buildings and Improvements 16,359us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[5]      
CIP 32us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[5]      
Total 16,391us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[5]      
Accumulated Depreciation 1,581us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SummerlinHospitalMobIiiLasVegasNvMember
[5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2009 [5]      
Date Acquired 2009 [5]      
Average Depreciable Life 36 years [5]      
Emory at Dunwoody Building Dunwoody, GA        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 782us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Initial Cost, Building & Improvements 3,455us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Land 782us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Buildings and Improvements 3,455us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Total 4,237us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Accumulated Depreciation 395us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_EmoryAtDunwoodyDunwoodyGaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Forney Medical Plaza Forney, TX        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 910us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Initial Cost, Building & Improvements 11,960us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Adjustments to Basis 31us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
[2]      
Land 910us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Buildings and Improvements 11,991us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Total 12,901us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Accumulated Depreciation 1,621us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_ForneyMedicalPlazaForneyTxMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Lake Pointe Medical Arts Building Rowlett, TX        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Initial Cost, Building & Improvements 9,000us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Adjustments to Basis 31us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
[2]      
Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Buildings and Improvements 9,031us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Total 10,131us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Accumulated Depreciation 1,077us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_LakePointeMedicalArtsRowlettTxMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Tuscan Professional Building Irving, TX        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 5,862us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
[1]      
Initial Cost, Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Initial Cost, Building & Improvements 12,525us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Adjustments to Basis 73us-gaap_OtherRealEstateValuationAdjustments
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
[2]      
Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Buildings and Improvements 12,598us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Total 13,698us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Accumulated Depreciation 1,299us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_TuscanMedicalPropertiesIrvingTxMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Peace Health Medical Clinic        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 21,248us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
[1]      
Initial Cost, Land 1,900us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Initial Cost, Building & Improvements 24,910us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Land 1,900us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Buildings and Improvements 24,910us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Total 26,810us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Accumulated Depreciation 2,554us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_PeaceHealthMedicalClinicMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2012      
Date Acquired 2012      
Average Depreciable Life 35 years      
Northwest Texas Professional Office Tower        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 7,180us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
     
Buildings and Improvements 7,180us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
     
Total 7,180us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
     
Accumulated Depreciation 485us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2012      
Date Acquired 2012      
Average Depreciable Life 35 years      
Ward Eagle Office Village Medical Office Building        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 220us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Initial Cost, Building & Improvements 3,220us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Land 220us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Buildings and Improvements 3,220us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Total 3,440us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Accumulated Depreciation 165us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_WardEagleOfficeVillageMedicalOfficeBuildingMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2013      
Date Acquired 2013      
Average Depreciable Life 35 years      
5004 Poole Road MOB Office building        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 96us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Initial Cost, Building & Improvements 529us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Land 96us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Buildings and Improvements 529us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Total 625us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Accumulated Depreciation 28us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2013      
Date Acquired 2013      
Average Depreciable Life 35 years      
Desert Valley Medical Center, Phoenix, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 3,861us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[1],[6]      
Initial Cost, Land 2,280us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Initial Cost, Building & Improvements 4,624us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Land 2,280us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Buildings and Improvements 4,624us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
CIP 26us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Total 6,930us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Accumulated Depreciation 74us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_DesertValleyMedicalCenterPhoenixAzMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 1996 [6]      
Date Acquired 1996 [6]      
Average Depreciable Life 30 years [6]      
Hanover Emergency Center, Mechanicsville, VA        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,300us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Initial Cost, Building & Improvements 6,224us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Land 1,300us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Buildings and Improvements 6,224us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Total 7,524us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Accumulated Depreciation 72us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_HanoverEmergencyCenterMechanicsvilleVaMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2014      
Date Acquired 2014      
Average Depreciable Life 35 years      
North Valley Medical Plaza, Phoenix, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 930us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Initial Cost, Building & Improvements 6,929us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Land 930us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Buildings and Improvements 6,929us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Total 7,859us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Accumulated Depreciation 111us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_NorthValleyMedicalPlazaPhoenixAzMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2010 [6]      
Date Acquired 2010 [6]      
Average Depreciable Life 30 years [6]      
Northwest Medical Center at Sugar Creek, Bentonville, AR        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Initial Cost, Building & Improvements 2,870us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Land 1,100us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Buildings and Improvements 2,870us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Total 3,970us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Accumulated Depreciation 78us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_NorthwestMedicalCenterAtSugarCreekBentonvilleArMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2014      
Date Acquired 2014      
Average Depreciable Life 35 years      
The Children's Clinic at Springdale, Springdale, AR        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 610us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Initial Cost, Building & Improvements 1,570us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Land 610us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Buildings and Improvements 1,570us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Total 2,180us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Accumulated Depreciation 66us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_TheChildrenClinicAtSpringdaleSpringdaleArMember
     
Date of Completion of Construction, Acquisition or Significant Improvement 2014      
Date Acquired 2014      
Average Depreciable Life 35 years      
Rosenberg Children's Medical Plaza, Phoenix, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 8,479us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[1],[6]      
Initial Cost, Land 0us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Initial Cost, Building & Improvements 23,302us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Land 0us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Buildings and Improvements 23,302us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Total 23,302us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Accumulated Depreciation 327us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_RosenbergChildrenMedicalPlazaPhoenixAzMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2001 [6]      
Date Acquired 2001 [6]      
Average Depreciable Life 35 years [6]      
Phoenix Children's East Valley Care Center, Phoenix, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,485us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[1],[6]      
Initial Cost, Land 1,050us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Initial Cost, Building & Improvements 10,900us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Land 1,050us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Buildings and Improvements 10,900us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Total 11,950us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Accumulated Depreciation 152us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_PhoenixChildrenEastValleyCareCenterPhoenixAzMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [6]      
Date Acquired 2006 [6]      
Average Depreciable Life 35 years [6]      
Palmdale Medical Plaza, Palmdale, CA        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,008us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[1],[6]      
Initial Cost, Land 0us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Initial Cost, Building & Improvements 10,555us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Land 0us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Buildings and Improvements 10,555us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
CIP 48us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Total 10,603us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Accumulated Depreciation 372us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_PalmdaleMedicalPlazaPalmdaleCaMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2008 [6]      
Date Acquired 2008 [6]      
Average Depreciable Life 33 years 6 months [6]      
Santa Fe Professional Plaza, Scottsdale, AZ        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,090us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Initial Cost, Building & Improvements 1,960us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Land 1,090us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Buildings and Improvements 1,960us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
CIP 109us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Total 3,159us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Accumulated Depreciation 31us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SantaFeProfessionalPlazaScottsdaleAzMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 1999 [6]      
Date Acquired 1999 [6]      
Average Depreciable Life 30 years [6]      
Sierra San Antonio Medical Plaza, Fontana, CA        
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 0us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Initial Cost, Building & Improvements 11,538us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Land 0us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Buildings and Improvements 11,538us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Total 11,538us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Accumulated Depreciation 184us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_SierraSanAntonioMedicalPlazaFontanaCaMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [6]      
Date Acquired 2006 [6]      
Average Depreciable Life 30 years [6]      
Vista Medical Terrace & Sparks MOB, Sparks, NV        
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 4,479us-gaap_RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[1],[6]      
Initial Cost, Land 0us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Initial Cost, Building & Improvements 9,276us-gaap_RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Land 0us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfLand
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Buildings and Improvements 9,276us-gaap_RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
CIP 176us-gaap_InventoryRealEstateConstructionInProcess
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Total 9,452us-gaap_RealEstateGrossAtCarryingValue
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Accumulated Depreciation $ 370us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation
/ us-gaap_MajorPropertyClassAxis
= uht_VistaMedicalTerraceSparksMobSparksNvMember
[6]      
Date of Completion of Construction, Acquisition or Significant Improvement 2008 [6]      
Date Acquired 2008 [6]      
Average Depreciable Life 30 years [6]      
[1] Consists of outstanding balances as of December 31, 2014 on third-party debt that is non-recourse to us.
[2] Costs capitalized/divested subsequent to acquisition.
[3] During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
[4] During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
[5] During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
[6] During 2014, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
XML 50 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) (2012 Acquisitions, USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
2012 Acquisitions
 
Business Acquisition [Line Items]  
Debt, fair value adjustment $ 799uht_FairMarketValueOfDebtAdjustments
/ us-gaap_BusinessAcquisitionAxis
= uht_TwoThousandTwelveAcquisitionsMember
XML 51 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and Dispositions (Tables)
12 Months Ended
Dec. 31, 2014
Purchased Minority Ownership Interests

Additionally, during 2014, we spent an aggregate of $7.0 million, including $4.7 million in cash plus an additional $2.3 million in the form of a note payable to the previous third-party member (which was fully repaid in January, 2015 and is reflected in “Accrued expenses and other liabilities” on our Consolidated Balance Sheet at December 31, 2014) to purchase the minority ownership interests held by third party members in eight LLCs (as noted in the table below) in which we previously held various non-controlling majority ownership interests ranging from 85% to 95%.

 

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC      Effective Date  

Palmdale Medical Properties

     95     Palmdale Medical Plaza         January 1, 2014   

Sparks Medical Properties…

     95     Vista Medical Terrace & Sparks MOB        January 1, 2014   

DVMC Properties

     90     Desert Valley Medical Center         August 1, 2014   

Santa Fe Scottsdale

     90     Santa Fe Professional Plaza         August 1, 2014   

PCH Medical Properties

     85     Rosenberg Children’s Medical Plaza         August 1, 2014   

Sierra Medical Properties

     95     Sierra San Antonio Medical Plaza         August 1, 2014   

PCH Southern Properties

     95     Phoenix Children’s East Valley Care Center         August 1, 2014   

3811 Bell Medical Properties

     95     North Valley Medical Plaza         August 1, 2014   
Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets

   Fair Value at
December 31, 2012
     Valuation Technique      Unobservable inputs      Range  

PeaceHealth Medical Clinic (a.)(b.)

   $ 30,400,000         Income Capitalization Approach         Capitalization Rate         7.50
           Discount Rate         8.50

Northwest Texas Professional Office Tower

   $ 9,600,000         Income Capitalization Approach         Capitalization Rate         8.60
           Discount Rate         9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.
2014 Acquisitions  
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

The aggregate purchase price for these clinics and MOB was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition as detailed in the table below.

 

Land

   $ 3,010   

Buildings and improvements

     10,664   

Intangible assets

     2,076   

Deposit paid in 2013

     (150 )
  

 

 

 

Net cash paid

   $ 15,600   
  

 

 

 
2013 Acquisitions  
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below.

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 
2012 Acquisitions  
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below.

 

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 
XML 52 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
QuantitativeInformationAboutSignificantUnobservableInputsTable (Detail) (Fair Value, Inputs, Level 3, USD $)
12 Months Ended
Dec. 31, 2012
Peace Health Medical Clinic
 
Quantitative Information About Significant Unobservable Inputs [Line Items]  
Assets PeaceHealth Medical Clinic [1],[2]
Fair Value of Assets $ 30,400,000us-gaap_AssetsFairValueDisclosure
/ us-gaap_BusinessAcquisitionAxis
= uht_PeaceHealthMedicalClinicMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
[1],[2]
Valuation Technique Income Capitalization Approach [1],[2]
Unobservable inputs Capitalization Rate [1],[2]
Capitalization Rate 7.50%us-gaap_FairValueInputsCapRate
/ us-gaap_BusinessAcquisitionAxis
= uht_PeaceHealthMedicalClinicMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
[1],[2]
Discount rate 8.50%us-gaap_FairValueInputsDiscountRate
/ us-gaap_BusinessAcquisitionAxis
= uht_PeaceHealthMedicalClinicMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
[1],[2]
Northwest Texas Professional Office Tower
 
Quantitative Information About Significant Unobservable Inputs [Line Items]  
Assets Northwest Texas Professional Office Tower
Fair Value of Assets $ 9,600,000us-gaap_AssetsFairValueDisclosure
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
Valuation Technique Income Capitalization Approach
Unobservable inputs Capitalization Rate
Capitalization Rate 8.60%us-gaap_FairValueInputsCapRate
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
Discount rate 9.50%us-gaap_FairValueInputsDiscountRate
/ us-gaap_BusinessAcquisitionAxis
= uht_NorthwestTexasProfessionalOfficeTowerMember
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
[1] The fair value of the land was estimated based upon the sales comparison approach.
[2] Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.
XML 53 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt and Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2014
Summary of Required Compliance Ratios Giving Effect to New Covenants in Credit Agreement

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2014
 

Tangible net worth

   $ 125,000      $ 181,458   

Debt to total capital

     < 55     30.0

Debt service coverage ratio

     > 3.00x        25.4x   

Debt to cash flow ratio

     < 3.50x        1.29x   
Outstanding Mortgages, Excluding Net Debt Premium

The following table summarizes our outstanding mortgages at December 31, 2014 (amounts in thousands):

 

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date

Spring Valley Medical Office Building fixed rate mortgage loan (b.)

   $ 4,920         5.50   February, 2015

Desert Valley Medical Center floating rate mortgage loan (c.)

     3,861         3.41   October, 2015

Palmdale Medical Plaza fixed rate mortgage loan (c.)

     6,008         3.69   October, 2015

Summerlin Hospital Medical Office Building III floating rate mortgage loan

     11,025         3.41   December, 2016

Peace Health fixed rate mortgage loan

     21,248         5.64   April, 2017

Auburn Medical II floating rate mortgage loan

     7,183         2.90   April, 2017

Medical Center of Western Connecticut fixed rate mortgage loan

     4,785         6.00   June, 2017

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

     11,729         5.50   October, 2017

Phoenix Children’s East Valley Care Center fixed rate mortgage loan

     6,485         5.88   December, 2017

Centennial Hills Medical Office Building floating rate mortgage loan

     10,642         3.41   January, 2018

Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan

     4,479         3.41   February, 2018

Rosenberg Children’s Medical Plaza fixed rate mortgage loan

     8,479         4.85   May, 2018

Vibra Hospital of Corpus Christi fixed rate mortgage loan

     2,902         6.50  

July, 2019

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

     6,601         4.54   June, 2022

BRB Medical Office Building fixed rate mortgage loan

     6,673         4.27   December, 2022

Tuscan Professional Building fixed rate mortgage loan

     5,862         5.56   June, 2025
  

 

 

      

Total

   $ 122,882        
  

 

 

      

 

(a.) Amortized principal payments are made on a monthly basis.
(b.) This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility.
(c.) We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.
Aggregate Consolidated Scheduled Debt Repayments

As of December 31, 2014, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2015(a)

   $ 107,646   

2016

     13,600   

2017

     50,399   

2018

     22,658   

2019

     3,463   

Later

     14,866   
  

 

 

 

Total

   $ 212,632   
  

 

 

 

 

(a) Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
XML 54 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) (USD $)
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dividend, per share $ 2.52uht_DividendsPerShare $ 2.495uht_DividendsPerShare $ 2.46uht_DividendsPerShare
XML 56 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Intangible assets, accumulated amortization $ 19,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization $ 13,700,000us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
Mortgage and other notes payable, non-recourse to us, debt premium $ 523,000us-gaap_DebtInstrumentUnamortizedPremium $ 834,000us-gaap_DebtInstrumentUnamortizedPremium
Preferred shares of beneficial interest, par value $ 0.01us-gaap_PreferredStockParOrStatedValuePerShare $ 0.01us-gaap_PreferredStockParOrStatedValuePerShare
Preferred shares of beneficial interest, shares authorized 5,000,000us-gaap_PreferredStockSharesAuthorized 5,000,000us-gaap_PreferredStockSharesAuthorized
Preferred shares of beneficial interest, issued      
Preferred shares of beneficial interest, outstanding      
Common shares, par value $ 0.01us-gaap_CommonStockParOrStatedValuePerShare $ 0.01us-gaap_CommonStockParOrStatedValuePerShare
Common shares, shares authorized 95,000,000us-gaap_CommonStockSharesAuthorized 95,000,000us-gaap_CommonStockSharesAuthorized
Common shares, issued 13,301,204us-gaap_CommonStockSharesIssued 12,858,643us-gaap_CommonStockSharesIssued
Common shares, outstanding 13,301,204us-gaap_CommonStockSharesOutstanding 12,858,643us-gaap_CommonStockSharesOutstanding
XML 57 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting
12 Months Ended
Dec. 31, 2014
Segment Reporting
(9)   SEGMENT REPORTING

 

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

 

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

XML 58 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2014
Jan. 31, 2015
Jun. 30, 2014
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
Trading Symbol UHT    
Entity Registrant Name UNIVERSAL HEALTH REALTY INCOME TRUST    
Entity Central Index Key 0000798783    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   13,301,298dei_EntityCommonStockSharesOutstanding  
Entity Public Float     $ 555,012,765dei_EntityPublicFloat
XML 59 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quarterly Results
12 Months Ended
Dec. 31, 2014
Quarterly Results
(10)   QUARTERLY RESULTS (unaudited)

 

     2014 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 14,288       $ 14,317       $ 15,258       $ 15,923       $ 59,786   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 3,458       $ 3,408       $ 3,048       $ 3,185       $ 13,099   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     316         —           25,093        —           25,409   

Gain on divestiture of real property

     —           —           —           13,043         13,043   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,774       $ 3,408       $ 28,141       $ 16,228       $ 51,551   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.

 

     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 60 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF INCOME (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Revenues      
Base rental-UHS facilities $ 15,601us-gaap_OperatingLeasesIncomeStatementMinimumLeaseRevenue $ 14,773us-gaap_OperatingLeasesIncomeStatementMinimumLeaseRevenue $ 15,438us-gaap_OperatingLeasesIncomeStatementMinimumLeaseRevenue
Base rental-Non-related parties 31,386uht_BaseRentalNonRelatedParties 27,955uht_BaseRentalNonRelatedParties 27,213uht_BaseRentalNonRelatedParties
Bonus rental-UHS facilities 4,607us-gaap_PercentageRent 4,260us-gaap_PercentageRent 4,142us-gaap_PercentageRent
Tenant reimbursements and other-Non-related parties 7,490uht_TenantReimbursementsAndOtherNonRelatedParties 6,812uht_TenantReimbursementsAndOtherNonRelatedParties 6,674uht_TenantReimbursementsAndOtherNonRelatedParties
Tenant reimbursements and other-UHS facilities 702uht_TenantReimbursementsAndOtherFacilities 480uht_TenantReimbursementsAndOtherFacilities 483uht_TenantReimbursementsAndOtherFacilities
Revenues, Total 59,786us-gaap_Revenues 54,280us-gaap_Revenues 53,950us-gaap_Revenues
Expenses:      
Depreciation and amortization 20,885us-gaap_DepreciationAndAmortization 18,753us-gaap_DepreciationAndAmortization 20,216us-gaap_DepreciationAndAmortization
Advisory fees to UHS 2,545us-gaap_OwnedPropertyManagementCosts 2,369us-gaap_OwnedPropertyManagementCosts 2,119us-gaap_OwnedPropertyManagementCosts
Other operating expenses 16,882us-gaap_OtherCostAndExpenseOperating 14,409us-gaap_OtherCostAndExpenseOperating 14,575us-gaap_OtherCostAndExpenseOperating
Transaction costs 427uht_TransactionCosts 203uht_TransactionCosts 680uht_TransactionCosts
Costs and Expenses, Total 40,739us-gaap_CostsAndExpenses 35,734us-gaap_CostsAndExpenses 37,590us-gaap_CostsAndExpenses
Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gains 19,047us-gaap_OperatingIncomeLoss 18,546us-gaap_OperatingIncomeLoss 16,360us-gaap_OperatingIncomeLoss
Equity in income of unconsolidated LLCs 2,428us-gaap_IncomeLossFromEquityMethodInvestments [1],[2] 2,095us-gaap_IncomeLossFromEquityMethodInvestments [1],[3] 2,365us-gaap_IncomeLossFromEquityMethodInvestments [1],[3],[4]
Gains on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs 25,409us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [5] 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Gain on divestiture of real property 13,043us-gaap_GainLossOnSaleOfPropertyPlantEquipment [5] 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Gains on divestitures of properties owned by unconsolidated LLCs 0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal 0us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal 8,520us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal [3],[4]
Interest expense, net (8,376)us-gaap_InterestExpense (7,472)us-gaap_InterestExpense (7,768)us-gaap_InterestExpense
Net income $ 51,551us-gaap_NetIncomeLoss [5] $ 13,169us-gaap_NetIncomeLoss [6] $ 19,477us-gaap_NetIncomeLoss
Basic earnings per share $ 3.99us-gaap_EarningsPerShareBasic [5] $ 1.04us-gaap_EarningsPerShareBasic [6] $ 1.54us-gaap_EarningsPerShareBasic
Diluted earnings per share $ 3.99us-gaap_EarningsPerShareDiluted [5] $ 1.04us-gaap_EarningsPerShareDiluted [6] $ 1.54us-gaap_EarningsPerShareDiluted
Weighted average number of shares outstanding-Basic 12,927us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 12,689us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 12,661us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Weighted average number of share equivalents 7us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment 12us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment 8us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment
Weighted average number of shares and equivalents outstanding-Diluted 12,934us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 12,701us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 12,669us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
[1] Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.
[2] As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014.
[3] As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
[4] As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
[5] We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.
[6] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 61 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Leases
12 Months Ended
Dec. 31, 2014
Leases
(4)   LEASES

 

All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility’s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.

 

Minimum future base rents from non-cancelable leases related to properties included in our financial statements on a consolidated basis, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2015

   $ 49,207   

2016

     46,051   

2017

     30,330   

2018

     25,799   

2019

     21,127   

Thereafter

     57,916   
  

 

 

 

Total minimum base rents

   $ 230,430   
  

 

 

 

 

Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property’s operating costs.

XML 62 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions and Dispositions
12 Months Ended
Dec. 31, 2014
Acquisitions and Dispositions
(3)   ACQUISITIONS AND DISPOSITIONS

 

2015:

 

Acquisitions:

 

In February, 2015, we purchased the Haas Medical Office Park, a single-tenant, two single story buildings having an aggregate of approximately 16,000 rentable square feet, located in Ottumwa, Iowa, for approximately $4.1 million.

 

In January and February of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened free-standing emergency departments (“FEDs”) located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six 5-year renewal terms have been executed with UHS for each FED. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.

 

2014:

 

Acquisitions:

 

During 2014, we spent $15.6 million to acquire the following clinics and MOB:

 

   

spent $8.6 million to acquire the Hanover Emergency Center, a 22,000 rentable square feet, free-standing, full service emergency and imaging center, located in Mechanicsville, VA, in August, 2014. The single-tenant property is occupied pursuant to the terms of a 10-year lease with HCA Health Services of Virginia, Inc., and;

 

   

spent $7.2 million, including a $150,000 deposit made in 2013, to purchase the following in a single transaction in January, 2014:

 

   

The Children’s Clinic at Springdale – a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;

 

   

The Northwest Medical Center at Sugar Creek – a 13,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.

 

The aggregate purchase price for these clinics and MOB was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the clinics and MOB at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years at the time of acquisition (aggregate weighted average of 9.5 years at December 31, 2014) for the Hanover Emergency Center and approximately 9.7 years at the time of acquisition (aggregate weighted average of 8.7 years at December 31, 2014) for the Arkansas facilities.

 

Land

   $ 3,010   

Buildings and improvements

     10,664   

Intangible assets

     2,076   

Deposit paid in 2013

     (150 )
  

 

 

 

Net cash paid

   $ 15,600   
  

 

 

 

 

Additionally, during 2014, we spent an aggregate of $7.0 million, including $4.7 million in cash plus an additional $2.3 million in the form of a note payable to the previous third-party member (which was fully repaid in January, 2015 and is reflected in “Accrued expenses and other liabilities” on our Consolidated Balance Sheet at December 31, 2014) to purchase the minority ownership interests held by third party members in eight LLCs (as noted in the table below) in which we previously held various non-controlling majority ownership interests ranging from 85% to 95%.

 

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC      Effective Date  

Palmdale Medical Properties

     95     Palmdale Medical Plaza         January 1, 2014   

Sparks Medical Properties…

     95     Vista Medical Terrace & Sparks MOB        January 1, 2014   

DVMC Properties

     90     Desert Valley Medical Center         August 1, 2014   

Santa Fe Scottsdale

     90     Santa Fe Professional Plaza         August 1, 2014   

PCH Medical Properties

     85     Rosenberg Children’s Medical Plaza         August 1, 2014   

Sierra Medical Properties

     95     Sierra San Antonio Medical Plaza         August 1, 2014   

PCH Southern Properties

     95     Phoenix Children’s East Valley Care Center         August 1, 2014   

3811 Bell Medical Properties

     95     North Valley Medical Plaza         August 1, 2014   

 

As a result of these minority ownership purchases, we now own 100% of each of these LLCs, which own medical office buildings, and began accounting for each on a consolidated basis at the effective date as noted in the table above. Pursuant to current accounting standards, at the effective date, we were required to record each property’s assets and liabilities at their fair values which resulted in the recording of a $25.4 million non-cash gain, which is included in our Consolidated Statement of Income for the twelve months ended December 31, 2014, representing the difference between the fair values and the equity method carrying value of each investment. The calculated fair value, categorized in level 3 of the fair value hierarchy and utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property. Each property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates. The capitalization rate and discount rate ranged from 7%-8.75% and 8%-9.75%, respectively.

 

The aggregate purchase price for these MOBs was allocated to net tangible property ($84.0 million), identified intangible assets ($6.5 million), and long term debt ($29.8 million). Substantially all of the intangible assets include the value of the in-place leases at these MOBs at the time of acquisition which will be amortized over the combined average remaining lease term of approximately 4.7 years at the time of acquisition (aggregate weighted average of 4.3 years at December 31, 2014) for the August, 2014 transactions and 5.3 years at the time of acquisition (aggregate weighted average of 5.5 years at December 31, 2014) for the January, 2014 transactions. Other than the increased depreciation and amortization expense resulting from the amortization of the intangible assets recorded in connection with these transactions, there was no material impact on our net income as a result of the consolidation of these LLCs.

 

Divestitures:

 

In December, 2014, upon expiration of The Bridgeway’s lease term, a wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility. The sale of The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, generated $17.3 million of sale proceeds. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value of $17.3 million. Our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with this lease. A $13.0 gain is included in our Consolidated Statement of Income for the twelve months ended December 31, 2014, representing the difference between the fair market value and the book value of this property.

 

2013:

 

Acquisition:

 

In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.

 

In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.

 

The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which are being amortized over the then average remaining lease term of approximately 9.8 years (aggregate weighted average of 8.4 years at December 31, 2014).

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 

 

The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

New Construction:

 

The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

 

Divestitures:

 

There were no divestitures during 2013.

 

2012:

 

Acquisitions and New Construction:

 

In January and December, 2012, we purchased the:

 

   

PeaceHealth Medical Clinic, a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;

 

   

Northwest Texas Professional Office Tower – a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.

 

The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 5.0 years at December 31, 2014).

 

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 

 

The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets

   Fair Value at
December 31, 2012
     Valuation Technique      Unobservable inputs      Range  

PeaceHealth Medical Clinic (a.)(b.)

   $ 30,400,000         Income Capitalization Approach         Capitalization Rate         7.50
           Discount Rate         8.50

Northwest Texas Professional Office Tower

   $ 9,600,000         Income Capitalization Approach         Capitalization Rate         8.60
           Discount Rate         9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.

 

For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.

 

Divestiture:

 

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December 31, 2012.

 

In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December 31, 2012.

 

Assuming the 2012 acquisitions and divestitures occurred on January 1, 2012, our pro forma net revenues and net income for the year ended December 31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

 

As of December 31, 2014, our net intangible assets total $23.1 million (net of $19.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 4.4 years.

XML 63 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Leases (Tables)
12 Months Ended
Dec. 31, 2014
Schedule of Minimum Future Base Rents from Non-Cancelable Leases

Minimum future base rents from non-cancelable leases related to properties included in our financial statements on a consolidated basis, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2015

   $ 49,207   

2016

     46,051   

2017

     30,330   

2018

     25,799   

2019

     21,127   

Thereafter

     57,916   
  

 

 

 

Total minimum base rents

   $ 230,430   
  

 

 

 
XML 64 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Real Estate and Accumulated Depreciation
12 Months Ended
Dec. 31, 2014
Real Estate and Accumulated Depreciation

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2014

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2014
    Date of
Completion of

Construction,
Acquisition
or Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments
to Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Inland Valley Regional Medical Center
Wildomar, California

    —        $ 2,050      $ 10,701     $ 14,596      $ 2,050      $ 25,297        $ 27,347      $ 11,175        2007        1986        43 Years   

McAllen Medical Center
McAllen, Texas

    —          4,720        31,442       10,189        6,281        40,070          46,351        24,385        1994        1986        42 Years   

Wellington Regional Medical Center
West Palm Beach, Florida

    —          1,190        14,652       17,370        1,663        31,549          33,212        16,258        2006        1986        42 Years   

HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana

    —          500        6,945       1,062        500        8,007          8,507        5,069        1993        1989        40 Years   

Kindred Hospital Chicago
Central Chicago, Illinois

    —          158        6,404       1,838        158        8,242          8,400        8,242        1993        1986        25 Years   

Family Doctor’s Medical Office Building
Shreveport, Louisiana

    —          54        1,526       494        54        2,020          2,074        902        1991        1995        45 Years   

Kelsey-Seybold Clinic at King’s Crossing

    —          439        1,618       870        439        2,488          2,927        1,091        1995        1995        45 Years   

Professional Buildings at King’s Crossing
Kingwood, Texas

    —          439        1,837       185        439        2,022        3        2,464        889        1995        1995        45 Years   

Chesterbrook Academy
Audubon, Pennsylvania

    —          307        996       —          307        996          1,303        413        1996        1996        45 Years   

Chesterbrook Academy
New Britain, Pennsylvania

    —          250        744       —          250        744          994        309        1991        1996        45 Years   

Chesterbrook Academy
Uwchlan, Pennsylvania

    —          180        815       —          180        815          995        338        1992        1996        45 Years   

Chesterbrook Academy
Newtown, Pennsylvania

    —          195        749       —          195        749          944        311        1992        1996        45 Years   

The Southern Crescent Center I (b.)

    —          1,130        5,092       (2,271     1,130        2,821          3,951        2,269        1994        1996        45 Years   

The Southern Crescent Center II (b.)
Riverdale, Georgia

    —          —          —         5,015        806        4,209          5,015        1,943        2000        1998        35 Years   

The Cypresswood Professional Center
Spring, Texas

    —          573        3,842       585        573        4,427        53        5,053        2,398        1997        1997        35 Years   

701 South Tonopah Building
Las Vegas, Nevada

    —          —          1,579       68        —          1,647          1,647        931        1999        1999        25 Years   

Sheffield Medical Building (c.)
Atlanta, Georgia

    —          1,760        9,766       (7,327     736        3,463        1        4,200        1,348        1999        1999        25 Years   

Medical Center of Western Connecticut
Danbury, Connecticut

    4,785        1,151        5,176       544        1,151        5,720          6,871        2,899        2000        2000        30 Years   

Vibra Hospital of Corpus Christi
Corpus Christi, Texas

    2,902        1,104        5,508       —          1,104        5,508          6,612        1085        2008        2008        35 Years   

Apache Junction Medical Plaza (d.)
Apache Junction, AZ

    —          240        3,590       621        240        4,211        1        4,452        479        2004        2004        30 Years   

Auburn Medical Office Building II (d.)
Auburn, WA

    7,183        —          10,200       176        —          10,376          10,376        1,034        2009        2009        36 Years   

BRB Medical Office Building (d.)
Kingwood, Texas

    6,673        430        8,970       24        430        8,994        4        9,428        885        2010        2010        37 Years   

Centennial Hills Medical Office Building (d.)
Las Vegas, NV

    10,642        —          19,890       804        —          20,694        116        20,810        2,154        2006        2006        34 Years   

Desert Springs Medical Plaza (d.)
Las Vegas, NV

    —          1,200        9,560       443        1,200        10,003        144        11,347        1,212        1998        1998        30 Years   

700 Shadow Lane & Goldring MOBs (d.)
Las Vegas, NV

    6,601        400        11,300       1,141        400        12,441        155        12,996        1,430        2003        2003        30 Years   

Spring Valley Hospital MOB I (d.)
Las Vegas, NV

    4,920        —          9,500       338        —          9,838        36        9,874        1,029        2004        2004        35 Years   

Spring Valley Hospital MOB II (d.)
Las Vegas, NV

    —          —          9,800       8        —          9,808        202        10,010        1,031        2006        2006        34 Years   

Summerlin Hospital MOB I (d.)
Las Vegas, NV

    —          460        15,440       512        460        15,952        43        16,455        1,889        1999        1999        30 Years   

Summerlin Hospital MOB II (d.)
Las Vegas, NV

    11,729        370        16,830       851        370        17,681        43        18,094        2,040        2000        2000        30 Years   

Summerlin Hospital MOB III (d.)
Las Vegas, NV

    11,025        —          14,900       1,459        —          16,359        32        16,391        1,581        2009        2009        36 Years   

Emory at Dunwoody Building
Dunwoody, GA

    —          782        3,455       —          782        3,455          4,237        395        2011        2011        35 Years   

Forney Medical Plaza Forney, TX

    —          910        11,960       31        910        11,991          12,901        1,621        2011        2011        35 Years   

Lake Pointe Medical Arts Building
Rowlett, TX

    —          1,100        9,000       31        1,100        9,031          10,131        1,077        2011        2011        35 Years   

Tuscan Professional Building
Irving, TX

    5,862        1,100        12,525       73        1,100        12,598          13,698        1,299        2011        2011        35 Years   

Peace Health Medical Clinic
Bellingham, WA

    21,248        1,900        24,910       —          1,900        24,910          26,810        2,554        2012        2012        35 Years   

Northwest Texas Professional Office Tower
Amarillo, TX

    —          —          7,180       —          —          7,180          7,180        485        2012        2012        35 Years   

Ward Eagle Office Village Farmington Hills, MI

    —        $ 220        3,220       —          220        3,220          3,440        165        2013        2013        35 Years   

5004 Poole Road MOB Denison, TX

    —        $ 96        529       —          96        529          625        28        2013        2013        35 Years   

Desert Valley Medical Center (f.)
Phoenix, AZ

    3,861      $ 2,280        4,624       —          2,280        4,624        26        6,930        74        1996        1996        30 Years   

Hanover Emergency Center
Mechanicsville, VA

    —        $ 1,300        6,224       —          1,300        6,224          7,524        72        2014        2014        35 Years   

North Valley Medical Plaza (f.)
Phoenix, AZ

    —        $ 930        6,929       —          930        6,929          7,859        111        2010        2010        30 Years   

Northwest Medical Center at Sugar Creek
Bentonville, AR

    —        $ 1,100        2,870       —          1,100        2,870          3,970        78        2014        2014        35 Years   

The Children’s Clinic at Springdale
Springdale, AR

    —        $ 610        1,570       —          610        1,570          2,180        66        2014        2014        35 Years   

Rosenberg Children’s Medical Plaza (f.)
Phoenix, AZ

    8,479      $ 0        23,302       —          0        23,302          23,302        327        2001        2001        35 Years   

Phoenix Children’s East Valley Care Center (f.) Phoenix, AZ

    6,485      $ 1,050        10,900       —          1,050        10,900          11,950        152        2006        2006        35 Years   

Palmdale Medical Plaza (f.)
Palmdale, CA

    6,008      $ 0        10,555       —          0        10,555        48        10,603        372        2008        2008       
 
33.5
Years
  
  

Santa Fe Professional Plaza (f.)
Scottsdale, AZ

    —        $ 1,090        1,960       —          1,090        1,960        109        3,159        31        1999        1999        30 Years   

Sierra San Antonio Medical Plaza (f.) Fontana, CA

    —        $ 0        11,538       —          0        11,538          11,538        184        2006        2006        30 Years   

Vista Medical Terrace & Sparks MOB (f.)
Sparks, NV

    4,479      $ 0        9,276       —          0        9,276        176        9,452        370        2008        2008        30 Years   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

TOTALS

  $ 122,882      $ 33,768      $ 401,899     $ 49,730      $ 35,584      $ 449,813      $ 1,192      $ 486,589      $ 106,480         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

a.. Costs capitalized/divested subsequent to acquisition.
b. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
c. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
d. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
e. Consists of outstanding balances as of December 31, 2014 on third-party debt that is non-recourse to us.
f. During 2014, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO SCHEDULE III

DECEMBER 31, 2014

(amounts in thousands)

 

(1) RECONCILIATION OF REAL ESTATE PROPERTIES

 

The following table reconciles the Real Estate Properties from January 1, 2012 to December 31, 2014:

 

     2014     2013     2012  

Balance at January 1,

   $ 395,669      $ 401,474      $ 363,498   

Impact of deconsolidation of an LLC(a.)

     —          (13,185     —     

Impact of consolidation of eight LLCs(b.)

     84,064       —          —     

Property additions

     3,298        3,415        3,985   

Acquisitions

     13,674        4,065        33,991   

Disposals

     (10,116     (100     —     
  

 

 

   

 

 

   

 

 

 

Balance at December 31,

   $ 486,589      $ 395,669      $ 401,474   
  

 

 

   

 

 

   

 

 

 

 

(2) RECONCILIATION OF ACCUMULATED DEPRECIATION

 

The following table reconciles the Accumulated Depreciation from January 1, 2012 to December 31, 2014:

 

     2014     2013     2012  

Balance at January 1,

   $ 97,921      $ 87,088      $ 74,865   

Impact of deconsolidation of an LLC(a.)

     —          (1,588     —     

Disposals

     (5,859     —          —     

Current year depreciation expense

     14,413        12,464        12,223   

Other

     5       (43     —     
  

 

 

   

 

 

   

 

 

 

Balance at December 31,

   $ 106,480      $ 97,921      $ 87,088   
  

 

 

   

 

 

   

 

 

 

 

(a.) The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
(b.) During 2014, the Trust purchased the minority ownership interests held by third-party members in eight LLCs (January and August, 2014) in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.
XML 65 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Incentive Plans
12 Months Ended
Dec. 31, 2014
Incentive Plans
(7)   INCENTIVE PLANS

 

During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the “2007 Plan”). A total of 75,000 shares were authorized for issuance under this plan and a total of 57,825 shares, net of cancellations, have been issued pursuant to the terms of this plan, 39,245 of which have vested as of December 31, 2014. At December 31, 2014 there are 17,175 shares remaining for issuance under the terms of the 2007 Plan.

 

During 2014, there were 9,850 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.21 per share ($425,619 in the aggregate). These restricted shares are scheduled to vest in June of 2016 (the second anniversary of the date of grant).

 

During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).

 

During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares vested in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.

 

We expense the grant-date fair value restricted stock awards under the straight-line method over the stated vesting period of the award. In connection with these grants, we recorded compensation expense of approximately $399,000, $375,000 and $329,000 and during 2014, 2013 and 2012, respectively. The remaining expenses associated with these grants is approximately $381,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December 31, 2014.

 

Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the “1997 Plan”) provided for the granting of stock options and dividend equivalents rights (“DERs”) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25% per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. As of December 31, 2014, there were 36,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.94 per share and a remaining weighted average life of 1.6 years. The net expense recorded in connection with the DERs did not have a material impact on our consolidated financial statements during each of the years ended December 31, 2014, 2013 and 2012.

 

During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. DERs with respect to 36,000 shares, 40,000 shares and 43,000 shares were outstanding at December 31, 2014, 2013 and 2012, respectively. In December of 2014, 2013 and 2012, DERs which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $94,000, $106,000 and $116,000, respectively.

 

Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     (8,000      26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     (3,000      29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2014

     40,000       $ 35.65       $ 36.53/$30.06   

Exercised

     (4,000      33.07       $ 30.06/$34.07   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2014

     36,000       $ 35.94       $ 34.90/$36.53   
  

 

 

    

 

 

    

 

 

 

 

During 2014, there were 4,000 stock options exercised with a total in-the-money value of $44,160. During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930.

 

There were no unvested options as of December 31, 2014. The following table provides information about options outstanding and exercisable options at December 31, 2014:

 

     Options
Outstanding
and Exercisable
 

Number

     36,000   

Weighted average exercise price

   $ 35.94   

Aggregate intrinsic value

   $ 438,430   

Weighted average remaining contractual life

     1.6   

 

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2014 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$34.90 -$34.90

     13,000         34.90         0.7   

$36.53 -$36.53

     23,000         36.53         2.2   
  

 

 

    

 

 

    

 

 

 

Total

     36,000       $ 35.94         1.6   
  

 

 

    

 

 

    

 

 

 
XML 66 R60.htm IDEA: XBRL DOCUMENT v2.4.1.9
Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2008
Real Estate and Accumulated Depreciation [Line Items]    
Provision for asset impairment $ 5.4us-gaap_AssetImpairmentCharges $ 4.6us-gaap_AssetImpairmentCharges
XML 67 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt and Financial Instruments
12 Months Ended
Dec. 31, 2014
Debt and Financial Instruments
(5)   DEBT AND FINANCIAL INSTRUMENTS

 

Debt:

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. We are in the process of renegotiating our Credit Agreement and, although we can provide no assurance we will do so, we expect to complete a replacement credit facility by March 31, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2014, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2014, we had $89.8 million of outstanding borrowings and $6.3 million of letters of credit outstanding against our revolving credit agreement. We had $54.0 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2014. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $104.6 million in 2014, $86.3 million in 2013 and $75.4 million in 2012 with corresponding effective interest rates, including commitment fees, of 2.4% in 2014, 2.2% in 2013 and 2.4% in 2012. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $89.8 million at December 31, 2014.

 

On February 10, 2015, we borrowed an additional $4.9 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Spring Valley Medical Office Building. The mortgage loan on this property matured on February 10, 2015.

 

On July 1, 2014, we borrowed an additional $9.1 million under our revolving credit agreement, which was utilized to repay the outstanding mortgage balance on the Summerlin Hospital Medical Office Building I. The mortgage loan on this property matured on July 1, 2014.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2014. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2014
 

Tangible net worth

   $ 125,000      $ 181,458   

Debt to total capital

     < 55     30.0

Debt service coverage ratio

     > 3.00x        25.4x   

Debt to cash flow ratio

     < 3.50x        1.29x   

 

We have sixteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2014, with a combined outstanding balance of $122.9 million (excluding net debt premium of $523,000 at December 31, 2014). The following table summarizes our outstanding mortgages at December 31, 2014 (amounts in thousands):

 

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date

Spring Valley Medical Office Building fixed rate mortgage loan (b.)

   $ 4,920         5.50   February, 2015

Desert Valley Medical Center floating rate mortgage loan (c.)

     3,861         3.41   October, 2015

Palmdale Medical Plaza fixed rate mortgage loan (c.)

     6,008         3.69   October, 2015

Summerlin Hospital Medical Office Building III floating rate mortgage loan

     11,025         3.41   December, 2016

Peace Health fixed rate mortgage loan

     21,248         5.64   April, 2017

Auburn Medical II floating rate mortgage loan

     7,183         2.90   April, 2017

Medical Center of Western Connecticut fixed rate mortgage loan

     4,785         6.00   June, 2017

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

     11,729         5.50   October, 2017

Phoenix Children’s East Valley Care Center fixed rate mortgage loan

     6,485         5.88   December, 2017

Centennial Hills Medical Office Building floating rate mortgage loan

     10,642         3.41   January, 2018

Sparks Medical Building/Vista Medical Terrace floating rate mortgage loan

     4,479         3.41   February, 2018

Rosenberg Children’s Medical Plaza fixed rate mortgage loan

     8,479         4.85   May, 2018

Vibra Hospital of Corpus Christi fixed rate mortgage loan

     2,902         6.50  

July, 2019

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

     6,601         4.54   June, 2022

BRB Medical Office Building fixed rate mortgage loan

     6,673         4.27   December, 2022

Tuscan Professional Building fixed rate mortgage loan

     5,862         5.56   June, 2025
  

 

 

      

Total

   $ 122,882        
  

 

 

      

 

(a.) Amortized principal payments are made on a monthly basis.
(b.) This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility.
(c.) We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.

 

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $124.7 million as of December 31, 2014. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

 

As of December 31, 2014, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2015(a)

   $ 107,646   

2016

     13,600   

2017

     50,399   

2018

     22,658   

2019

     3,463   

Later

     14,866   
  

 

 

 

Total

   $ 212,632   
  

 

 

 

 

(a) Includes repayment of $89.8 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.

 

Financial Instruments:

 

During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. During the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20 million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. From inception through December 31, 2014, no payments have been made to us by the counterparties pursuant to the terms of these caps which expire on January 13, 2017.

XML 68 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Dividends and Equity Issuance Program
12 Months Ended
Dec. 31, 2014
Dividends and Equity Issuance Program
(6)   DIVIDENDS AND EQUITY ISSUANCE PROGRAM

 

Dividends:

 

During each of the last three years, dividends were declared and paid by us as follows:

 

   

2014:    $2.52 per share of which $1.478 per share was ordinary income and $1.042 per share was total capital gain (total capital gain amount includes Unrecaptured Section 1250 gain of $.305 per share).

 

   

2013:    $2.495 per share of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution.

 

   

2012:    $2.46 per share of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain includes Unrecaptured Section 1250 gain of $.281 per share).

 

Equity Issuance Program:

 

During the fourth quarter of 2013, we commenced an at-the-market (“ATM”) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $50 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (“Merrill Lynch”), as sales agent and/or principal.

 

Since inception of this program, we have issued 580,900 shares at an average price of $45.97 per share, which generated approximately $25.6 million of net cash proceeds or receivables (net of approximately$1.1 million, consisting of compensation of $667,000 to Merrill Lynch, as well as $391,000 of other various fees and expenses), as follows:

 

   

2014:    We issued 426,187 shares at an average price of $47.51 per share which generated approximately $19.5 million of net cash proceeds or receivables (net of approximately $701,000, consisting of compensation of $506,000 to Merrill Lynch, as well as $195,000 of other various fees and expenses), and;

 

   

2013:    We issued 154,713 shares at an average price of $41.71 per share which generated approximately $6.1 million of net cash proceeds or receivables (net of $357,000, consisting of compensation of $161,000 to Merrill Lynch, as well as $196,000 of other various fees and expenses).

 

In connection with this ATM program, our consolidated balance sheet includes approximately $1.1 million at December 31, 2014, and $600,000 at December 31, 2013, of net proceeds due to us in connection with shares issued in late December 2014 and 2013. The payment related to these shares was received by us in early January 2015, and early January, 2014, respectively. The net proceeds receivable were non-cash items, as presented on the Consolidated Statements of Cash Flows at December 31, 2014 and 2013.

XML 69 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summarized Financial Information of Equity Affiliates
12 Months Ended
Dec. 31, 2014
Summarized Financial Information of Equity Affiliates
(8)   SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are or were the primary beneficiary. In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own MOBs. As of December 31, 2014, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. The majority of these LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans. These LLCs maintain property insurance on the properties.

 

Effective August 1, 2014, we purchased the minority ownership interests, ranging from 5% to 15%, held by third-party members in six LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and began to account for them on a consolidated basis effective August 1, 2014. Prior to August 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method.

 

Effective January 1, 2014, we purchased the 5% minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests, as noted in the table below. As a result of these minority ownership purchases, we now own 100% of each of these LLCs and account for them on a consolidated basis. Prior to January 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method. Previously, Palmdale Medical Properties (“Palmdale”) was included in our financial statements on a consolidated basis through June 30, 2013 as a result of a master lease arrangement with a wholly-owned subsidiary of UHS, which expired on July 1, 2013.

 

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC    Effective Date  

Palmdale Medical Properties

     95 %   Palmdale Medical Plaza      January 1, 2014   

Sparks Medical Properties

     95 %   Vista Medical Terrace & Sparks MOB      January 1, 2014   

DVMC Properties

     90 %   Desert Valley Medical Center      August 1, 2014   

Santa Fe Scottsdale

     90 %   Santa Fe Professional Plaza      August 1, 2014   

PCH Medical Properties

     85 %   Rosenberg Children’s Medical Plaza      August 1, 2014   

Sierra Medical Properties

     95 %   Sierra San Antonio Medical Plaza      August 1, 2014   

PCH Southern Properties

     95 %   Phoenix Children’s East Valley Care Center      August 1, 2014   

3811 Bell Medical Properties

     95 %   North Valley Medical Plaza      August 1, 2014   

 

The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of December 31, 2014:

 

Name of LLC/LP

   Ownership     Property Owned by LLC

Suburban Properties

     33 %   Suburban Medical Plaza II

Brunswick Associates (a.)

     74 %   Mid Coast Hospital MOB

Arlington Medical Properties (b.)

     75 %   Saint Mary’s Professional
Office Building

Grayson Properties (c.)

     95 %   Texoma Medical Plaza

FTX MOB Phase II (d.)

     95 %   Forney Medical Plaza II

 

(a.) This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December 31, 2014.
(b.) We have funded $5.2 million in equity as of December 31, 2014 and are committed to invest an additional $1.1 million. This LLC has a third-party term loan of $23.3 million, which is non-recourse to us, outstanding as of December 31, 2014.
(c.) We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014
(d.) We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December 31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December 31, 2014.

 

Below are the combined statements of income for the LLCs accounted for under the equity method at December 31, 2014, 2013 and 2012. The data for the year ended December 31, 2014 includes the financial results for the six above-mentioned LLCs in which we purchased the minority ownership interests in August, 2014 for the period of January through July of 2014 (during which they were accounted for under the equity method). The data for the year ended December 31, 2012 includes the prorated amounts, through the date of their divestitures, for two LLCs that were divested during the year (Canyon Healthcare Properties, 95% ownership interest, divested in February, 2012 and 575 Hardy Investors, 90% ownership interest, divested in October, 2012).

 

     For the Year Ended December 31,  
     2014(b.)      2013(c.)      2012(c.) (d.)  
     (amounts in thousands)  

Revenues

   $ 17,292       $ 21,001       $ 21,448   

Operating expenses

     6,769         8,705         8,974   

Depreciation and amortization

     2,968         4,039         4,140   

Interest, net

     4,261         6,353         6,056   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 3,294       $ 1,904       $ 2,278   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures (a.)

   $ 2,428       $ 2,095       $ 2,365   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ —        $ 8,520   
  

 

 

    

 

 

    

 

 

 

 

(a.) Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.
(b.) As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014.
(c.) As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
(d.) As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.

 

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2014 and 2013:

 

     December 31,  
     2014(a.)      2013(a.)(b.)  
     (amounts in thousands)  

Net property, including CIP

   $ 62,450       $ 119,547   

Other assets

     7,367         9,479   
  

 

 

    

 

 

 

Total assets

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Liabilities

   $ 3,348       $ 5,336   

Mortgage notes payable, non-recourse to us

     52,728         80,112   

Advances payable to us

     —           22,911   

Equity

     13,741         20,667   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 8,605       $ 39,201   
  

 

 

    

 

 

 

 

(a.) The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December 31, 2014.
(b.) As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. The amounts reflected for December 31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December 31, 2013.

 

As of December 31, 2014, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2015

   $ 23,832   

2016

     530   

2017

     5,727   

2018

     445   

2019

     466   

2020 and After

     21,728   
  

 

 

 

Total

   $ 52,728   
  

 

 

 

 

Name of LLC

   Mortgage
Loan
Balance (a.)
     Maturity Date  

Arlington Medical Properties (b.)

     23,287         October, 2015   

FTX MOB Phase II (c.)

     5,548         August, 2017   

Grayson Properties (d.)

     14,893         September, 2021   

Brunswick Associates (e.)

     9,000         December, 2024   
  

 

 

    
   $ 52,728      
  

 

 

    

 

(a.) All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(b.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.
(c.) This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.
(d.) This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.
(e.) This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July 1, 2015 through December 31, 2024.

 

Pursuant to the operating and/or partnership agreements of most of the five LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 to 90 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 to 90 days of the acceptance by the Non-Offering Member

XML 70 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Purchased Minority Ownership Interest (Detail)
12 Months Ended
Dec. 31, 2014
DVMC Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 90.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_DvmcPropertiesMember
Property Owned by LLC Desert Valley Medical Center
Effective Date Aug. 01, 2014
Santa Fe Scottsdale  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 90.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_SantaFeScottsdaleMember
Property Owned by LLC Santa Fe Professional Plaza
Effective Date Aug. 01, 2014
PCH Medical Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 85.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_PchMedicalPropertiesMember
Property Owned by LLC Rosenberg Children's Medical Plaza
Effective Date Aug. 01, 2014
Sierra Medical Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_SierraMedicalPropertiesMember
Property Owned by LLC Sierra San Antonio Medical Plaza
Effective Date Aug. 01, 2014
PCH Southern Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_PchSouthernPropertiesMember
Property Owned by LLC Phoenix Children's East Valley Care Center
Effective Date Aug. 01, 2014
3811 Bell Medical Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_ThirtyEightElevenBellMedicalPropertiesMember
Property Owned by LLC North Valley Medical Plaza
Effective Date Aug. 01, 2014
Palmdale Medical Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_PalmdaleMedicalPropertiesMember
Property Owned by LLC Palmdale Medical Plaza
Effective Date Jan. 01, 2014
Sparks Medical Properties  
Business Acquisition [Line Items]  
Ownership prior to minority interest purchase 95.00%us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
/ us-gaap_BusinessAcquisitionAxis
= uht_SparksMedicalPropertiesMember
Property Owned by LLC Vista Medical Terrace & Sparks MOB
Effective Date Jan. 01, 2014
XML 71 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9
Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) (USD $)
Dec. 31, 2014
Arlington Medical Properties  
Schedule of Equity Method Investments [Line Items]  
Third-party term loan $ 23,300,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_ArlingtonMedicalPropertiesMember
Committed investment in equity and debt financing, funded 5,200,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_ArlingtonMedicalPropertiesMember
Commitment to investment 1,100,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_ArlingtonMedicalPropertiesMember
Grayson Properties  
Schedule of Equity Method Investments [Line Items]  
Third-party term loan 14,900,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_GraysonPropertiesMember
Committed investment in equity and debt financing, funded 2,600,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_GraysonPropertiesMember
Commitment to investment 400,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_GraysonPropertiesMember
FTX MOB Phase II limited partnership  
Schedule of Equity Method Investments [Line Items]  
Third-party term loan 5,500,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_FtxMobPhaseTwoLpMember
Committed investment in equity and debt financing, funded 1,400,000uht_FundedInvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_FtxMobPhaseTwoLpMember
Commitment to investment 2,500,000uht_InvestmentCommitments
/ us-gaap_RealEstatePropertiesAxis
= uht_FtxMobPhaseTwoLpMember
Brunswick Associates  
Schedule of Equity Method Investments [Line Items]  
Third-party term loan $ 9,000,000us-gaap_LongTermLoansPayable
/ us-gaap_RealEstatePropertiesAxis
= uht_BrunswickAssociatesMember
XML 72 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Relationship with UHS and Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2014
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
XML 73 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summarized Financial Information of Equity Affiliates (Tables)
12 Months Ended
Dec. 31, 2014
Limited Liability Companies Accounted for Under Equity Method

Prior to August 1, 2014, these LLCs were accounted for on an unconsolidated basis pursuant to the equity method.

  

Name of LLC/LP

   Ownership
prior to
minority
interest
purchase
    Property Owned by LLC    Effective Date  

Palmdale Medical Properties

     95 %   Palmdale Medical Plaza      January 1, 2014   

Sparks Medical Properties

     95 %   Vista Medical Terrace & Sparks MOB      January 1, 2014   

DVMC Properties

     90 %   Desert Valley Medical Center      August 1, 2014   

Santa Fe Scottsdale

     90 %   Santa Fe Professional Plaza      August 1, 2014   

PCH Medical Properties

     85 %   Rosenberg Children’s Medical Plaza      August 1, 2014   

Sierra Medical Properties

     95 %   Sierra San Antonio Medical Plaza      August 1, 2014   

PCH Southern Properties

     95 %   Phoenix Children’s East Valley Care Center      August 1, 2014   

3811 Bell Medical Properties

     95 %   North Valley Medical Plaza      August 1, 2014   

 

The following property table represents the five LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of December 31, 2014:

 

Name of LLC/LP

   Ownership     Property Owned by LLC

Suburban Properties

     33 %   Suburban Medical Plaza II

Brunswick Associates (a.)

     74 %   Mid Coast Hospital MOB

Arlington Medical Properties (b.)

     75 %   Saint Mary’s Professional
Office Building

Grayson Properties (c.)

     95 %   Texoma Medical Plaza

FTX MOB Phase II (d.)

     95 %   Forney Medical Plaza II

 

(a.) This LLC has a third-party term loan of $9.0 million, which is non-recourse to us, outstanding as of December 31, 2014.
(b.) We have funded $5.2 million in equity as of December 31, 2014 and are committed to invest an additional $1.1 million. This LLC has a third-party term loan of $23.3 million, which is non-recourse to us, outstanding as of December 31, 2014.
(c.) We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000. This building is on the campus of a UHS hospital and has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014
(d.) We have committed to invest up to $2.5 million in equity and debt financing, of which $1.4 million has been funded as of December 31, 2014. This LLC has a third-party term loan of $5.5 million, which is non-recourse to us, outstanding as of December 31, 2014.
Condensed Combined Statements of Income (Unaudited) for Limited Liability Companies Accounted for Under Equity Method

Below are the combined statements of income for the LLCs accounted for under the equity method at December 31, 2014, 2013 and 2012. The data for the year ended December 31, 2014 includes the financial results for the six above-mentioned LLCs in which we purchased the minority ownership interests in August, 2014 for the period of January through July of 2014 (during which they were accounted for under the equity method). The data for the year ended December 31, 2012 includes the prorated amounts, through the date of their divestitures, for two LLCs that were divested during the year (Canyon Healthcare Properties, 95% ownership interest, divested in February, 2012 and 575 Hardy Investors, 90% ownership interest, divested in October, 2012).

 

     For the Year Ended December 31,  
     2014(b.)      2013(c.)      2012(c.) (d.)  
     (amounts in thousands)  

Revenues

   $ 17,292       $ 21,001       $ 21,448   

Operating expenses

     6,769         8,705         8,974   

Depreciation and amortization

     2,968         4,039         4,140   

Interest, net

     4,261         6,353         6,056   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 3,294       $ 1,904       $ 2,278   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures (a.)

   $ 2,428       $ 2,095       $ 2,365   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ —        $ 8,520   
  

 

 

    

 

 

    

 

 

 

 

(a.) Our share of net income during 2014, 2013 and 2012, includes interest income earned by us on various advances made to LLCs of approximately $834,000, $1.9 million and $1.5 million, respectively.
(b.) As mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. Prior to August 1, 2014, the financial results of these entities were accounted for under the equity method on an unconsolidated basis. The year ended December 31, 2014, include the financial results of the six mentioned LLCs for seven months ended July 31, 2014.
(c.) As mentioned above, we began to account for Sparks Medical Properties on a consolidated basis as of January 1, 2014. Prior to January 1, 2014, the financial results of this entity were accounted for under the equity method on an unconsolidated basis. These amounts include the financial results for Sparks Medical Properties for the years ended December 31, 2013 and 2012. In addition, we purchased the minority ownership interests in six LLCs effective August 1, 2014 (as mentioned in (b.) above) and began to account for the LLCs a consolidated basis as of that date. These amounts include the financial results for these six LLCs for the years ended December 31, 2013 and 2012. As also mentioned above, we began to account for Palmdale Medical Properties on a consolidated basis as of January 1, 2014. Prior thereto, as a result of a master lease commitment with a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013, the financial results of Palmdale Medical Properties was accounted for on a consolidated basis through the six-month period ended June 30, 2013 and then on an unconsolidated basis for the six-month period of July 1, 2013 through December 31, 2013. Therefore the financial results of this entity are reflected in the table above for the six-month period of July 1, 2013 through December 31, 2013.
(d.) As mentioned above, during the first quarter of 2012 and the fourth quarter of 2012, two LLCs in which we previously owned various noncontrolling, majority ownership interests (Canyon Healthcare Properties and 575 Hardy Investors), completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
Condensed Combined Balance Sheets (Unaudited) for LLCs Accounted for Under Equity Method

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2014 and 2013:

 

     December 31,  
     2014(a.)      2013(a.)(b.)  
     (amounts in thousands)  

Net property, including CIP

   $ 62,450       $ 119,547   

Other assets

     7,367         9,479   
  

 

 

    

 

 

 

Total assets

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Liabilities

   $ 3,348       $ 5,336   

Mortgage notes payable, non-recourse to us

     52,728         80,112   

Advances payable to us

     —           22,911   

Equity

     13,741         20,667   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 69,817       $ 129,026   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 8,605       $ 39,201   
  

 

 

    

 

 

 

 

(a.) The amounts presented include the balance sheet amounts for each of the five entities that are accounted for on an unconsolidated basis as of December 31, 2014.
(b.) As mentioned above, we began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. As also mentioned above, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014. The amounts reflected for December 31, 2013, include the balance sheet amounts for each of these entities since they were accounted for on an unconsolidated basis pursuant to the equity method as of December 31, 2013.
Aggregate Principal Amounts due on Mortgage and Construction Notes Payable by Unconsolidated LLC's Accounted Under Equity Method

As of December 31, 2014, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2015

   $ 23,832   

2016

     530   

2017

     5,727   

2018

     445   

2019

     466   

2020 and After

     21,728   
  

 

 

 

Total

   $ 52,728   
  

 

 

 

 

Name of LLC

   Mortgage
Loan
Balance (a.)
     Maturity Date  

Arlington Medical Properties (b.)

     23,287         October, 2015   

FTX MOB Phase II (c.)

     5,548         August, 2017   

Grayson Properties (d.)

     14,893         September, 2021   

Brunswick Associates (e.)

     9,000         December, 2024   
  

 

 

    
   $ 52,728      
  

 

 

    

 

(a.) All mortgage loans require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(b.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2015 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, increasing our equity investment in the property utilizing funds borrowed under our revolving credit agreement.
(c.) This loan was converted from a construction loan to a term loan in August, 2014, pursuant to the terms of the loan agreement.
(d.) This loan was refinanced in September, 2014, for a seven year term, at a fixed rate of 5.034%. This loan includes two one-year extension options.
(e.) This loan was refinanced in December, 2014, for a ten year term, at a fixed rate of 1.50% for the initial six months, and fixed rate of 3.64% commencing July 1, 2015 through December 31, 2024.
XML 74 R49.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summarized Financial Information of Equity Affiliates - Additional Information (Detail)
12 Months Ended
Dec. 31, 2014
Aug. 01, 2014
Feb. 29, 2012
Oct. 31, 2012
Jan. 01, 2014
Property
Dec. 31, 2013
Property
Schedule of Equity Method Investments [Line Items]            
Number of real estate investments 61us-gaap_NumberOfRealEstateProperties          
Percentage of minority ownership interests by parent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent        
Canyon Healthcare Properties            
Schedule of Equity Method Investments [Line Items]            
Non-controlling equity interest, ownership percentage     95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_CanyonHealthcarePropertiesMember
     
575 Hardy Investors            
Schedule of Equity Method Investments [Line Items]            
Non-controlling equity interest, ownership percentage       90.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= uht_FiveSevenFiveHardyInvestorsMember
   
Medical office buildings            
Schedule of Equity Method Investments [Line Items]            
Number of real estate investments 48us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_MedicalOfficeBuildingsMember
         
Limited Liability Companies            
Schedule of Equity Method Investments [Line Items]            
Number of real estate investments 8us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
6us-gaap_NumberOfRealEstateProperties
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
       
Limited Liability Companies | Medical office buildings            
Schedule of Equity Method Investments [Line Items]            
Number of real estate investments 5us-gaap_NumberOfRealEstateProperties
/ us-gaap_RealEstatePropertiesAxis
= uht_MedicalOfficeBuildingsMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
         
Palmdale Medical Properties and Sparks Medical Properties            
Schedule of Equity Method Investments [Line Items]            
Number of real estate investments         2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
2us-gaap_NumberOfRealEstateProperties
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
Percentage of minority ownership purchased from third-party members         5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
 
Percentage of minority ownership interests by parent 100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
         
Palmdale Medical Properties and Sparks Medical Properties | Limited Liability Companies            
Schedule of Equity Method Investments [Line Items]            
Percentage of minority ownership purchased from third-party members         5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
 
Percentage of minority ownership interests by parent   100.00%us-gaap_MinorityInterestOwnershipPercentageByParent
/ invest_InvestmentIssuerAxis
= uht_PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
       
Minimum            
Schedule of Equity Method Investments [Line Items]            
Non-controlling equity interest, ownership percentage 33.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
         
Percentage of minority ownership purchased from third-party members   5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
       
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member 60 days          
Minimum | Limited Liability Companies            
Schedule of Equity Method Investments [Line Items]            
Percentage of minority ownership purchased from third-party members   5.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
       
Maximum            
Schedule of Equity Method Investments [Line Items]            
Non-controlling equity interest, ownership percentage 95.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
         
Percentage of minority ownership purchased from third-party members   15.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
       
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member 90 days          
Maximum | Limited Liability Companies            
Schedule of Equity Method Investments [Line Items]            
Percentage of minority ownership purchased from third-party members   15.00%us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_LimitedLiabilityCompanyMember
       
XML 75 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Outstanding Mortgages, Excluding Net Debt Premium (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Debt Instrument [Line Items]  
Outstanding Balance $ 122,882us-gaap_NonRecourseDebt [1]
Spring Valley Medical Office Building fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 4,920us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_SpringValleyMedicalOfficeBuildingMortgageLoanMember
[1],[2]
Interest Rate 5.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_SpringValleyMedicalOfficeBuildingMortgageLoanMember
[2]
Maturity Date 2015-02 [2]
Desert Valley Medical Center Floating Rate Mortgage Loan  
Debt Instrument [Line Items]  
Outstanding Balance 3,861us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_DesertValleyMedicalCenterFloatingRateMortgageLoanMember
[1],[3]
Interest Rate 3.41%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_DesertValleyMedicalCenterFloatingRateMortgageLoanMember
[3]
Maturity Date 2015-10 [3]
Palmdale Medical Plaza fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 6,008us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_PalmdaleMedicalPlazaFixedRateMortgageLoanMember
[1],[3]
Interest Rate 3.69%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_PalmdaleMedicalPlazaFixedRateMortgageLoanMember
[3]
Maturity Date 2015-10 [3]
Summerlin Hospital Medical Office Building III floating rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 11,025us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_SummerlinHospitalMedicalOfficeBuildingThreeMortgageLoanMember
[1]
Interest Rate 3.41%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_SummerlinHospitalMedicalOfficeBuildingThreeMortgageLoanMember
Maturity Date 2016-12
Peace Health fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 21,248us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_PeaceHealthMedicalClinicFixedRateMortgageLoanMember
[1]
Interest Rate 5.64%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_PeaceHealthMedicalClinicFixedRateMortgageLoanMember
Maturity Date 2017-04
Auburn Medical II floating rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 7,183us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_AuburnMedicalTwoMortgageLoanMember
[1]
Interest Rate 2.90%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_AuburnMedicalTwoMortgageLoanMember
Maturity Date 2017-04
Medical Center of Western Connecticut fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 4,785us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember
[1]
Interest Rate 6.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember
Maturity Date 2017-06
Summerlin Hospital Medical Office Building II fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 11,729us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember
[1]
Interest Rate 5.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember
Maturity Date 2017-10
Phoenix Children's East Valley Care Center Fixed Rate Mortgage Loan  
Debt Instrument [Line Items]  
Outstanding Balance 6,485us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_PhoenixChildrensEastValleyCareCenterFixedRateMortgageLoanMember
[1]
Interest Rate 5.88%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_PhoenixChildrensEastValleyCareCenterFixedRateMortgageLoanMember
Maturity Date 2017-12
Centennial Hills Medical Office Building floating rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 10,642us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember
[1]
Interest Rate 3.41%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember
Maturity Date 2018-01
Sparks Medical Building/Vista Medical Terrace Floating Rate Mortgage Loan  
Debt Instrument [Line Items]  
Outstanding Balance 4,479us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_LomaVistaMedicalIncMember
[1]
Interest Rate 3.41%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_LomaVistaMedicalIncMember
Maturity Date 2018-02
Rosenberg Children's Medical Plaza Fixed Rate Mortgage Loan  
Debt Instrument [Line Items]  
Outstanding Balance 8,479us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_RosenbergChildrensMedicalPlazaFixedRateMortgageLoanMember
[1]
Interest Rate 4.85%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_RosenbergChildrensMedicalPlazaFixedRateMortgageLoanMember
Maturity Date 2018-05
Vibra Hospital-Corpus Christi fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 2,902us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_VibraHospitalOfCorpusChristiFixedRateMortgageLoanMember
[1]
Interest Rate 6.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_VibraHospitalOfCorpusChristiFixedRateMortgageLoanMember
Maturity Date 2019-07
700 Shadow Lane and Goldring MOBs fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 6,601us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember
[1]
Interest Rate 4.54%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember
Maturity Date 2022-06
BRB Medical Office Building fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance 6,673us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_BrbMedicalOfficeBuildingMortgageLoanMember
[1]
Interest Rate 4.27%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_BrbMedicalOfficeBuildingMortgageLoanMember
Maturity Date 2022-12
Tuscan Professional Building fixed rate mortgage loan  
Debt Instrument [Line Items]  
Outstanding Balance $ 5,862us-gaap_NonRecourseDebt
/ us-gaap_LongtermDebtTypeAxis
= uht_TuscanyProfessionalBuildingFixedRateMortgageLoanMember
[1]
Interest Rate 5.56%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_LongtermDebtTypeAxis
= uht_TuscanyProfessionalBuildingFixedRateMortgageLoanMember
Maturity Date 2025-06
[1] Amortized principal payments are made on a monthly basis.
[2] This loan was repaid in full on February 10, 2015, utilizing funds borrowed under our revolving credit facility.
[3] We expect these loans, which have a maturity date in October, 2015, to be refinanced at the then current market interest rates or repaid utilizing funds borrowed under our revolving credit facility.
XML 76 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Net income $ 51,551us-gaap_NetIncomeLoss [1] $ 13,169us-gaap_NetIncomeLoss [2] $ 19,477us-gaap_NetIncomeLoss
Other comprehensive loss:      
Unrealized losses on interest rate caps (115)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax (57)us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax 0us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
Amortization of interest rate cap fees 84us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax 0us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax 0us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
Total other comprehensive loss: (31)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent (57)us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent 0us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
Total comprehensive income $ 51,520us-gaap_ComprehensiveIncomeNetOfTax $ 13,112us-gaap_ComprehensiveIncomeNetOfTax $ 19,477us-gaap_ComprehensiveIncomeNetOfTax
[1] We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.
[2] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 77 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Relationship with UHS and Related Party Transactions
12 Months Ended
Dec. 31, 2014
Relationship with UHS and Related Party Transactions
(2)   RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. The hospital leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each hospital leased to subsidiaries of UHS are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The hospital leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 36% of our total revenue for the five years ended December 31, 2014 (approximately 28% for the year ended December 31, 2014 and approximately 30% for each of the years ended December 31, 2013 and 2012). The decrease during 2014 as compared to 2013, is due primarily to the 2014 purchase of the third-party minority ownership interests in eight LLCs in which we previously held noncontrolling majority ownership interests. As a result of these transactions, we own 100% of each of these LLCs and began accounting for each on a consolidated basis effective on the date of purchase of the minority ownership interests. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2014 (approximately 22% for each of the years ended December 31, 2014 and 2013 and 21% for the year ended December 31, 2012). In addition, including the two free-standing emergency departments (“FEDs”) acquired by us from subsidiaries of UHS during the first quarter of 2015 (as discussed below), fifteen MOBs/FEDs, that are either wholly or jointly-owned, include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the three leased hospital properties listed below at their appraised fair market value.

 

During the third quarter of 2014, a wholly-owned subsidiary of UHS provided notification to us that, upon expiration of The Bridgeway’s lease term which occurred in December, 2014, it intended to exercise its option to purchase the real property of the facility. Upon expiration of the lease, the wholly-owned subsidiary of UHS exercised its option to purchase the real property of the facility and on December 31, 2014, The Bridgeway, a 103-bed behavioral health facility located in North Little Rock, Arkansas, was sold to UHS. Pursuant to the terms of the lease, we and the wholly-owned subsidiary of UHS were both required to obtain independent appraisals of the property to determine its fair market value. Based upon the property appraisals obtained by each party, the sales price of The Bridgeway was $17.3 million. A gain on divestiture of approximately $13.0 million is included in our results of operations for the twelve-month period ended December 31, 2014. During each of the last three years, our revenues, net cash provided by operating activities and funds from operations have included approximately $1.1 million earned annually in connection with The Bridgeway’s lease.

 

During the first quarter of 2015, we purchased, from UHS, the real property of two newly-constructed and recently opened FEDs located in Weslaco and Mission, Texas. Each FED consists of approximately 13,600 square feet and will be operated by wholly-owned subsidiaries of UHS. In connection with these acquisitions, ten-year lease agreements with six, 5-year renewal terms have been executed with UHS for each FED. The first four, 5-year renewal terms (covering years 2025 through 2044) include 2% annual lease rate increases, computed on accumulative and compounded basis, and the last two, 5-year renewal terms (covering the years 2045 through 2054) will be at the then fair market value lease rates. The aggregate acquisition cost of these facilities was approximately $12.8 million, and the aggregate rental revenues earned by us at the commencement of the leases will be approximately $900,000 annually.

 

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).

 

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. In addition, if subsidiaries of UHS exercise their options to purchase the respective leased hospital facilities upon expiration of the lease terms, our future revenues could decrease if we were unable to earn a favorable rate of return on the sale proceeds received, as compared to the rental revenue currently earned pursuant to the hospital leases.

 

As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired effective as of July 1, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC was no longer deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method from July 1, 2013 through December 31, 2013.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and began accounting for them on a consolidated basis.

 

We have funded $2.6 million in equity as of December 31, 2014, and are committed to fund an additional $400,000, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by UHS of Texoma, Inc. (“Texoma Hospital”), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $14.9 million, which is non-recourse to us, outstanding as of December 31, 2014. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor.

 

The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. Our advisory fee was 0.70% during each of 2014 and 2013, and 0.65% during 2012, of our average invested real estate assets, as derived from our consolidated balance sheet. In December of 2014, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2015 pursuant to the same terms as the Advisory Agreement in place during 2014 and 2013.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2014, 2013 or 2012 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.5 million during 2014, $2.4 million during 2013 and $2.1 million during 2012 and were based upon average invested real estate assets of $363 million, $338 million and $326 million during 2014, 2013 and 2012, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2014 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2014 and 2013, UHS owned 5.9% and 6.1%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the Securities and Exchange Commission (“SEC”) and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 28% of our consolidated revenues for the year ended December 31, 2014 and 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

XML 78 R58.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quarterly Results (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Quarterly Financial Information [Line Items]                      
Revenues $ 15,923uht_Revenue [1] $ 15,258uht_Revenue [1] $ 14,317uht_Revenue [1] $ 14,288uht_Revenue [1] $ 13,445uht_Revenue [2] $ 13,448uht_Revenue [2] $ 13,502uht_Revenue [2] $ 13,885uht_Revenue [2] $ 59,786uht_Revenue [1] $ 54,280uht_Revenue [2]  
Net income before gains 3,185us-gaap_IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges [1] 3,048us-gaap_IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges [1] 3,408us-gaap_IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges [1] 3,458us-gaap_IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges [1]         13,099us-gaap_IncomeLossBeforeGainOrLossOnSaleOfPropertiesExtraordinaryItemsAndCumulativeEffectsOfAccountingChanges [1]    
Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs   25,093us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1]   316us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1]         25,409us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain [1] 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain 0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Gain on divestiture of real property 13,043us-gaap_GainLossOnSaleOfPropertyPlantEquipment [1]               13,043us-gaap_GainLossOnSaleOfPropertyPlantEquipment [1] 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment 0us-gaap_GainLossOnSaleOfPropertyPlantEquipment
Net income $ 16,228us-gaap_NetIncomeLoss [1] $ 28,141us-gaap_NetIncomeLoss [1] $ 3,408us-gaap_NetIncomeLoss [1] $ 3,774us-gaap_NetIncomeLoss [1] $ 3,498us-gaap_NetIncomeLoss [2] $ 3,303us-gaap_NetIncomeLoss [2] $ 2,941us-gaap_NetIncomeLoss [2] $ 3,427us-gaap_NetIncomeLoss [2] $ 51,551us-gaap_NetIncomeLoss [1] $ 13,169us-gaap_NetIncomeLoss [2] $ 19,477us-gaap_NetIncomeLoss
Total basic earnings per share $ 1.24us-gaap_EarningsPerShareBasic [1] $ 2.18us-gaap_EarningsPerShareBasic [1] $ 0.26us-gaap_EarningsPerShareBasic [1] $ 0.29us-gaap_EarningsPerShareBasic [1] $ 0.27us-gaap_EarningsPerShareBasic [2] $ 0.26us-gaap_EarningsPerShareBasic [2] $ 0.23us-gaap_EarningsPerShareBasic [2] $ 0.27us-gaap_EarningsPerShareBasic [2] $ 3.99us-gaap_EarningsPerShareBasic [1] $ 1.04us-gaap_EarningsPerShareBasic [2] $ 1.54us-gaap_EarningsPerShareBasic
Total diluted earnings per share $ 1.24us-gaap_EarningsPerShareDiluted [1] $ 2.18us-gaap_EarningsPerShareDiluted [1] $ 0.26us-gaap_EarningsPerShareDiluted [1] $ 0.29us-gaap_EarningsPerShareDiluted [1] $ 0.27us-gaap_EarningsPerShareDiluted [2] $ 0.26us-gaap_EarningsPerShareDiluted [2] $ 0.23us-gaap_EarningsPerShareDiluted [2] $ 0.27us-gaap_EarningsPerShareDiluted [2] $ 3.99us-gaap_EarningsPerShareDiluted [1] $ 1.04us-gaap_EarningsPerShareDiluted [2] $ 1.54us-gaap_EarningsPerShareDiluted
[1] We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children's Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children's East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.
[2] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 79 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quarterly Results (Tables)
12 Months Ended
Dec. 31, 2014
Quarterly Results for Operating Activities
     2014 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 14,288       $ 14,317       $ 15,258       $ 15,923       $ 59,786   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 3,458       $ 3,408       $ 3,048       $ 3,185       $ 13,099   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     316         —           25,093        —           25,409   

Gain on divestiture of real property

     —           —           —           13,043         13,043   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,774       $ 3,408       $ 28,141       $ 16,228       $ 51,551   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.29       $ 0.26       $ 2.18       $ 1.24       $ 3.99   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began to account for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014. Additionally, we began to account for six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza) on a consolidated basis as of August 1, 2014.

 

     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 80 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 426 401 1 true 171 0 false 14 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.uhrit.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.uhrit.com/taxonomy/role/StatementOfFinancialPositionUnclassified-RealEstateOperations CONSOLIDATED BALANCE SHEETS false false R3.htm 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.uhrit.com/taxonomy/role/StatementOfFinancialPositionUnclassified-RealEstateOperationsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - CONSOLIDATED STATEMENTS OF INCOME Sheet http://www.uhrit.com/taxonomy/role/StatementOfIncomeRealEstateInvestmentTrusts CONSOLIDATED STATEMENTS OF INCOME false false R5.htm 106 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.uhrit.com/taxonomy/role/StatementOfOtherComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME false false R6.htm 107 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://www.uhrit.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY false false R7.htm 108 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) Sheet http://www.uhrit.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) false false R8.htm 109 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.uhrit.com/taxonomy/role/StatementOfCashFlowsIndirectRealEstate CONSOLIDATED STATEMENTS OF CASH FLOWS false false R9.htm 110 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies false false R10.htm 111 - Disclosure - Relationship with UHS and Related Party Transactions Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Relationship with UHS and Related Party Transactions false false R11.htm 112 - Disclosure - Acquisitions and Dispositions Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsMergersAcquisitionsAndDispositionsDisclosuresTextBlock Acquisitions and Dispositions false false R12.htm 113 - Disclosure - Leases Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlock Leases false false R13.htm 114 - Disclosure - Debt and Financial Instruments Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsDebtAndFinancialInstrumentsDisclosureTextBlock Debt and Financial Instruments false false R14.htm 115 - Disclosure - Dividends and Equity Issuance Program Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Dividends and Equity Issuance Program false false R15.htm 116 - Disclosure - Incentive Plans Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlock Incentive Plans false false R16.htm 117 - Disclosure - Summarized Financial Information of Equity Affiliates Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlock Summarized Financial Information of Equity Affiliates false false R17.htm 118 - Disclosure - Segment Reporting Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Segment Reporting false false R18.htm 119 - Disclosure - Quarterly Results Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock Quarterly Results false false R19.htm 120 - Disclosure - Real Estate and Accumulated Depreciation Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRealEstateAndAccumulatedDepreciationDisclosureTextBlock Real Estate and Accumulated Depreciation false false R20.htm 121 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R21.htm 122 - Disclosure - Relationship with UHS and Related Party Transactions (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables Relationship with UHS and Related Party Transactions (Tables) false false R22.htm 123 - Disclosure - Acquisitions and Dispositions (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsMergersAcquisitionsAndDispositionsDisclosuresTextBlockTables Acquisitions and Dispositions (Tables) false false R23.htm 124 - Disclosure - Leases (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlockTables Leases (Tables) false false R24.htm 125 - Disclosure - Debt and Financial Instruments (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsDebtAndFinancialInstrumentsDisclosureTextBlockTables Debt and Financial Instruments (Tables) false false R25.htm 126 - Disclosure - Incentive Plans (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlockTables Incentive Plans (Tables) false false R26.htm 127 - Disclosure - Summarized Financial Information of Equity Affiliates (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlockTables Summarized Financial Information of Equity Affiliates (Tables) false false R27.htm 128 - Disclosure - Quarterly Results (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables Quarterly Results (Tables) false false R28.htm 129 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) false false R29.htm 130 - Disclosure - Relationship with UHS and Related Party Transactions - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureRelationshipWithUHSAndRelatedPartyTransactionsAdditionalInformation Relationship with UHS and Related Party Transactions - Additional Information (Detail) false false R30.htm 131 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureExistingLeaseTermsAndRenewalOptionsForEachOfUHSHospitalFacilities Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) false false R31.htm 132 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureExistingLeaseTermsAndRenewalOptionsForEachOfUHSHospitalFacilitiesParenthetical Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) false false R32.htm 133 - Disclosure - Acquisitions and Dispositions - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAcquisitionsAndDispositionsAdditionalInformation Acquisitions and Dispositions - Additional Information (Detail) false false R33.htm 134 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAllocationOfPurchasePriceToAssetsAcquiredAndLiabilitiesAssumed Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) false false R34.htm 135 - Disclosure - Purchased Minority Ownership Interest (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosurePurchasedMinorityOwnershipInterest Purchased Minority Ownership Interest (Detail) false false R35.htm 136 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAllocationOfPurchasePriceToAssetsAcquiredAndLiabilitiesAssumedParenthetical Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) false false R36.htm 137 - Disclosure - QuantitativeInformationAboutSignificantUnobservableInputsTable (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureQuantitativeInformationAboutSignificantUnobservableInputsTable QuantitativeInformationAboutSignificantUnobservableInputsTable (Detail) false false R37.htm 138 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLeasesAdditionalInformation Leases - Additional Information (Detail) false false R38.htm 139 - Disclosure - Schedule of minimum future base rents from non-cancelable leases (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleOfMinimumFutureBaseRentsFromNoncancelableLeases Schedule of minimum future base rents from non-cancelable leases (Detail) false false R39.htm 140 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) false false R40.htm 141 - Disclosure - Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfRequiredComplianceRatiosInConnectionWithTermsOfCreditAgreement Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) false false R41.htm 142 - Disclosure - Summary of Outstanding Mortgages, Excluding Net Debt Premium (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfOutstandingMortgagesExcludingNetDebtPremium Summary of Outstanding Mortgages, Excluding Net Debt Premium (Detail) false false R42.htm 143 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAggregateConsolidatedScheduledDebtRepayment Aggregate Consolidated Scheduled Debt Repayment (Detail) false false R43.htm 144 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAggregateConsolidatedScheduledDebtRepaymentParenthetical Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) false false R44.htm 145 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureDividendsAndEquityIssuanceProgramAdditionalInformation Dividends and Equity Issuance Program - Additional Information (Detail) false false R45.htm 146 - Disclosure - Incentive Plans - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureIncentivePlansAdditionalInformation Incentive Plans - Additional Information (Detail) false false R46.htm 147 - Disclosure - Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalence (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureOptionsBeforeAdjustmentToOptionPriceToGiveEffectToDilutiveEquivalence Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalence (Detail) false false R47.htm 148 - Disclosure - Options Outstanding and Exercisable Options (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureOptionsOutstandingAndExercisableOptions Options Outstanding and Exercisable Options (Detail) false false R48.htm 149 - Disclosure - Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureWeightedAverageRemainingContractualLifeAndWeightedAverageExercisePriceForOptionsOutstandingAndExercisable Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) false false R49.htm 150 - Disclosure - Summarized Financial Information of Equity Affiliates - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummarizedFinancialInformationOfEquityAffiliatesAdditionalInformation Summarized Financial Information of Equity Affiliates - Additional Information (Detail) false false R50.htm 151 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesAccountedForUnderEquityMethod Limited Liability Companies Accounted for Under Equity Method (Detail) false false R51.htm 152 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesAccountedForUnderEquityMethodParenthetical Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) false false R52.htm 153 - Disclosure - Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCondensedCombinedStatementOfIncomeForLimitedLiabilitiesAccountedForUnderEquityMethod Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) false false R53.htm 154 - Disclosure - Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCondensedCombinedStatementOfIncomeForLimitedLiabilitiesAccountedForUnderEquityMethodParenthetical Condensed Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) false false R54.htm 155 - Disclosure - Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCondensedCombinedBalanceSheetsOfLimitedLiabilitiesAccountedForUnderEquityMethod Condensed Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) false false R55.htm 156 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) Notes http://www.uhrit.com/taxonomy/role/DisclosureAggregatePrincipalAmountsDueOnMortgageNotesPayableByUnconsolidatedLLCsAccountedUnderEquityMethod Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) false false R56.htm 157 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) Notes http://www.uhrit.com/taxonomy/role/DisclosureAggregatePrincipalAmountsDueOnMortgageNotesPayableByUnconsolidatedLLCsAccountedUnderEquityMethodParenthetical Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) false false R57.htm 158 - Disclosure - Segment Reporting - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSegmentReportingAdditionalInformation Segment Reporting - Additional Information (Detail) false false R58.htm 159 - Disclosure - Quarterly Results (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureQuarterlyResults Quarterly Results (Detail) false false R59.htm 160 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleIIIRealEstateAndAccumulatedDepreciation Schedule III Real Estate and Accumulated Depreciation (Detail) false false R60.htm 161 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleIIIRealEstateAndAccumulatedDepreciationParenthetical Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) false false R61.htm 162 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureReconciliationOfRealEstatePropertiesAndAccumulatedDepreciation Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) false false All Reports Book All Reports Element uht_DividendsPerShare had a mix of decimals attribute values: 2 3. Element uht_InvestmentCommitments had a mix of decimals attribute values: -5 0. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets had a mix of decimals attribute values: -5 0. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt had a mix of decimals attribute values: -5 -3. Element us-gaap_EquityMethodInvestmentOwnershipPercentage had a mix of decimals attribute values: 0 2. Element us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal had a mix of decimals attribute values: -5 -3. Element us-gaap_InterestIncomeOther had a mix of decimals attribute values: -5 0. Element us-gaap_OwnedPropertyManagementCosts had a mix of decimals attribute values: -5 -3. Element us-gaap_PaymentsToAcquireBuildings had a mix of decimals attribute values: -5 -3. Element us-gaap_ProceedsFromLinesOfCredit had a mix of decimals attribute values: -6 -5. Element us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment had a mix of decimals attribute values: -5 -3. Element us-gaap_StockIssuedDuringPeriodSharesNewIssues had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)' had a mix of different decimal attribute values. 'Shares' elements on report '107 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY' had a mix of different decimal attribute values. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '1/1/2013 - 3/31/2013' is shorter (89 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '4/1/2013 - 6/30/2013' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '7/1/2013 - 9/30/2013' is shorter (91 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '10/1/2013 - 12/31/2013' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '1/1/2014 - 3/31/2014' is shorter (89 days) and has only 3 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '4/1/2014 - 6/30/2014' is shorter (90 days) and has only 1 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '7/1/2014 - 9/30/2014' is shorter (91 days) and has only 2 values, so it is being removed. Columns in Cash Flows statement 'CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)' have maximum duration 365 days and at least 66 values. Shorter duration columns must have at least one fourth (16) as many values. Column '10/1/2014 - 12/31/2014' is shorter (91 days) and has only 3 values, so it is being removed. 'Monetary' elements on report '130 - Disclosure - Relationship with UHS and Related Party Transactions - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '133 - Disclosure - Acquisitions and Dispositions - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '140 - Disclosure - Debt - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '144 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '145 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '152 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 105 - Statement - CONSOLIDATED STATEMENTS OF INCOME Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 106 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2014' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2014' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: 108 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) Process Flow-Through: 109 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS uht-20141231.xml uht-20141231.xsd uht-20141231_cal.xml uht-20141231_def.xml uht-20141231_lab.xml uht-20141231_pre.xml true true XML 81 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
Schedule of minimum future base rents from non-cancelable leases (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Leases Future Minimum Payments [Line Items]  
2015 $ 49,207us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent
2016 46,051us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2017 30,330us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2018 25,799us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears
2019 21,127us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears
Thereafter 57,916us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter
Total minimum base rents $ 230,430us-gaap_OperatingLeasesFutureMinimumPaymentsDue
XML 82 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2014
Nature of Operations

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities currently including acute care hospitals, rehabilitation hospitals, sub-acute facilities, surgery centers, free-standing emergency departments, childcare centers and medical office buildings. As of February 28, 2015, we have sixty-one real estate investments or commitments located in eighteen states consisting of:

 

   

six hospital facilities including three acute care, one rehabilitation and two sub-acute;

 

   

three free-standing emergency departments;

 

   

forty-eight medical office buildings, including five owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the three Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

Revenue Recognition

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our properties, including our consolidated and unconsolidated MOBs, relating to leases in excess of one year in length, is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, stipulated rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

Real Estate Investments

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2014, and will be amortized over the remaining lease terms (aggregate weighted average of 4.4 years at December 31, 2014) and is expected to result in estimated aggregate amortization expense of $5.6 million, $4.5 million, $3.9 million $2.5 million and $1.9 million for 2015, 2016, 2017, 2018 and 2019, respectively. Amortization expense on intangible values of in place leases was $6.1 million for the year ended December 31, 2014, $6.0 million for the year ended December 31, 2013 and $7.8 million for the year ended December 31, 2012. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $14.4 million for the year ended December 31, 2014, $12.5 million for the year ended December 31, 2013 and $12.2 million for the year ended December 31, 2012.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

Asset Impairment

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

Investments in Limited Liability Companies ("LLCs")

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2014, we have non-controlling equity investments or commitments in five jointly-owned LLCs which own medical office buildings. These LLCs are included in our financial statements for all periods presented on an unconsolidated basis pursuant to the equity method since they are not variable interest entities for which we are the primary beneficiary, nor do we hold a controlling voting interest. These LLCs are joint-ventures between us and non-related parties that manage and hold minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013 at which time its master lease with a wholly-owned subsidiary of UHS expired. For the period of July 1, 2013 through December 31, 2013, we accounted for Palmdale Medical Properties under the equity method. As discussed below, as a result of our purchase of the third-party minority ownership interest in Palmdale Medical Properties, effective January 1, 2014, we began accounting for Palmdale Medical Properties on a consolidated basis.

 

Effective August 1, 2014, we purchased the third-party minority ownership interests, ranging from 5% to 15%, in six LLCs (Desert Valley Medical Center, Santa Fe Professional Plaza, Rosenberg Children’s Medical Plaza, Sierra San Antonio Medical Plaza, Phoenix Children’s East Valley Care Center and 3811 E. Bell Medical Building Medical Plaza). Effective January 1, 2014, we purchased the third-party minority ownership interests (5% for each LLC) in Palmdale Medical Properties and Sparks Medical Properties. We formerly held non-controlling majority ownership interests in all of these LLCs, and as a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs. As a result, we began accounting for the six LLCs mentioned above on a consolidated basis effective August 1, 2014 and we began accounting for Palmdale Medical Properties and Sparks Medical Properties on a consolidated basis effective January 1, 2014, as discussed below. Each of the property’s assets and liabilities were recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). Other than an increase in depreciation and amortization expense resulting from the fair value recognition related to the purchase of the minority ownership interests, we do not expect these transactions to have a material impact on our future results of operations.

Federal Income Taxes

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $469 million and $316 million, respectively, at December 31, 2014.

Stock-Based Compensation

Stock-Based Compensation

 

We expense the grant-date fair value of restricted stock awards over the vesting period. We recognize the grant-date fair value of equity-based compensation and account for these transactions using the fair-value based method.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

Fair Value

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $25.4 million net gain recorded during 2014 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

New Accounting Standards

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2014 that impacted, or are expected to impact us.

 

In August 2014, FASB issued ASU No. 2014-15, “Preparation of Financial Statements—Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (ASU 2014-15). Continuation of a reporting entity as a going concern is presumed as the basis for preparing financial statements unless and until the entity’s liquidation becomes imminent. Preparation of financial statements under this presumption is commonly referred to as the going concern basis of accounting. If and when an entity’s liquidation becomes imminent, financial statements should be prepared under the liquidation basis of accounting in accordance with Subtopic 205-30, “Presentation of Financial Statements—Liquidation Basis of Accounting”. Even when an entity’s liquidation is not imminent, there may be conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern. In those situations, financial statements should continue to be prepared under the going concern basis of accounting, but the new criteria in ASU 2014-15 should be followed to determine whether to disclose information about the relevant conditions and events. The amendments in ASU 2014-15 are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. We will evaluate the going concern considerations in this ASU.

 

In April 2014, the Financial Accounting Standards Board updated the accounting guidance related to the definition of a discontinued operation and the related disclosures. The updated accounting guidance defines a discontinued operation as a disposal of a component or a group of components that is to be disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity’s operations and financial results. We adopted this updated guidance in 2014 and the adoption of this update did not have a material impact on our consolidated financial statements.